PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fraga, A; Ribeiro, L; Lobato, M; Santos, V; Silva, JR; Gomes, H; Moraes, JLD; Menezes, JD; de Oliveira, CJL; Campos, E; da Fonseca, RN				Fraga, Amanda; Ribeiro, Lupis; Lobato, Mariana; Santos, Vitoria; Silva, Jose Roberto; Gomes, Helga; da Cunha Moraes, Jorge Luiz; Menezes, Jackson de Souza; Logullo de Oliveira, Carlos Jorge; Campos, Eldo; da Fonseca, Rodrigo Nunes			Glycogen and Glucose Metabolism Are Essential for Early Embryonic Development of the Red Flour Beetle Tribolium castaneum	PLOS ONE			English	Article							INSECT FLIGHT-MUSCLE; DROSOPHILA-MELANOGASTER; WNT PATHWAY; HEXOKINASE; EVOLUTION; EXPRESSION; XENOPUS; IDENTIFICATION; EMBRYOGENESIS; LOCALIZATION	Control of energy metabolism is an essential process for life. In insects, egg formation (oogenesis) and embryogenesis is dependent on stored molecules deposited by the mother or transcribed later by the zygote. In oviparous insects the egg becomes an isolated system after egg laying with all energy conversion taking place during embryogenesis. Previous studies in a few vector species showed a strong correlation of key morphogenetic events and changes in glucose metabolism. Here, we investigate glycogen and glucose metabolism in the red flour beetle Tribolium castaneum, an insect amenable to functional genomic studies. To examine the role of the key enzymes on glycogen and glucose regulation we cloned and analyzed the function of glycogen synthase kinase 3 (GSK-3) and hexokinase (HexA) genes during T. castaneum embryogenesis. Expression analysis via in situ hybridization shows that both genes are expressed only in the embryonic tissue, suggesting that embryonic and extra-embryonic cells display different metabolic activities. dsRNA adult female injection (parental RNAi) of both genes lead a reduction in egg laying and to embryonic lethality. Morphological analysis via DAPI stainings indicates that early development is impaired in Tc-GSK-3 and Tc-HexA1 RNAi embryos. Importantly, glycogen levels are upregulated after Tc-GSK-3 RNAi and glucose levels are upregulated after Tc-HexA1 RNAi, indicating that both genes control metabolism during embryogenesis and oogenesis, respectively. Altogether our results show that T. castaneum embryogenesis depends on the proper control of glucose and glycogen.	[Fraga, Amanda; Ribeiro, Lupis; Lobato, Mariana; Santos, Vitoria; Silva, Jose Roberto; Gomes, Helga; da Cunha Moraes, Jorge Luiz; Menezes, Jackson de Souza; Campos, Eldo; da Fonseca, Rodrigo Nunes] Univ Fed Rio de Janeiro, Nucleo Pesquisas Ecol & Socioambientais Macae NUP, Lab Integrado Bioquim Hatisaburo Masuda, Rio De Janeiro, Brazil; [Fraga, Amanda; Ribeiro, Lupis; Silva, Jose Roberto; da Cunha Moraes, Jorge Luiz; Menezes, Jackson de Souza; Logullo de Oliveira, Carlos Jorge; Campos, Eldo; da Fonseca, Rodrigo Nunes] Univ Fed Rio de Janeiro, Programa Posgrad Prod Bioativos & Biociencias PPG, Rio De Janeiro, Brazil; [Logullo de Oliveira, Carlos Jorge] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil; [Logullo de Oliveira, Carlos Jorge] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Unidade Expt Anim, Rio De Janeiro, Brazil; [Silva, Jose Roberto; da Cunha Moraes, Jorge Luiz; Menezes, Jackson de Souza; Logullo de Oliveira, Carlos Jorge; Campos, Eldo; da Fonseca, Rodrigo Nunes] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	da Fonseca, RN (corresponding author), Univ Fed Rio de Janeiro, Nucleo Pesquisas Ecol & Socioambientais Macae NUP, Lab Integrado Bioquim Hatisaburo Masuda, UFRJCampus Macae, Rio De Janeiro, Brazil.	rnfonseca@macae.ufrj.br	da Fonseca, Rodrigo Nunes/S-3964-2018; Logullo de Oliveira, Carlos Jorge/G-3436-2013; Silva, José Roberto/F-2931-2017; Lobato, Mariana/GPX-7165-2022; Fernandes Gomes, Helga/AFV-5696-2022; Nunes-da-Fonseca, Rodrigo/ABI-1404-2022; Moraes, Jorge Luiz/M-4659-2014; Fonseca, Rodrigo/B-2981-2009	da Fonseca, Rodrigo Nunes/0000-0001-9576-2849; Nunes-da-Fonseca, Rodrigo/0000-0001-9576-2849; Fonseca, Rodrigo/0000-0003-3063-7806; Tobias Santos, Vitoria/0000-0001-5958-9700	FAPERJ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Portuguese: Research Support Foundation of the State of Rio de Janeiro; Brazil); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil); INCT-Entomologia Molecular	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Portuguese: Research Support Foundation of the State of Rio de Janeiro; Brazil); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-Entomologia Molecular	Brazil is funded by FAPERJ, (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Portuguese: Research Support Foundation of the State of Rio de Janeiro; Brazil)) CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)) and INCT-Entomologia Molecular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Baumer D, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-15; BORK P, 1993, PROTEIN SCI, V2, P31; Brown SJ, 2009, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.EM0126; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CAVENER DR, 1980, BIOCHEM GENET, V18, P929, DOI 10.1007/BF00500125; CHILDRES.CC, 1970, J BIOL CHEM, V245, P2927; CHILDRES.CC, 1970, J CELL BIOL, V45, P83, DOI 10.1083/jcb.45.1.83; da Fonseca RN, 2008, DEV CELL, V14, P605, DOI 10.1016/j.devcel.2008.02.011; da Fonseca RN, 2010, DEV BIOL, V345, P80, DOI 10.1016/j.ydbio.2010.05.019; da Fonseca RN, 2009, CURR OPIN GENET DEV, V19, P404, DOI 10.1016/j.gde.2009.04.009; Duvernell DD, 2000, GENETICS, V156, P1191; Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017; EldarFinkelman H, 1996, P NATL ACAD SCI USA, V93, P10228, DOI 10.1073/pnas.93.19.10228; FORD WCL, 1972, BIOCHEM J, V130, P1101, DOI 10.1042/bj1301101; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fritz HL, 1999, HISTOCHEM CELL BIOL, V112, P359, DOI 10.1007/s004180050417; Frommer WB, 2003, SCIENCE, V300, P261, DOI 10.1126/science.1084120; Fu JP, 2012, P NATL ACAD SCI USA, V109, P7782, DOI 10.1073/pnas.1116641109; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Galina A, 2000, PHYTOCHEMISTRY, V53, P29, DOI 10.1016/S0031-9422(99)00456-2; Gonzalez-Alvarez R, 2009, COMP BIOCHEM PHYS B, V152, P189, DOI 10.1016/j.cbpb.2008.11.004; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; HANSFORD RG, 1970, FEBS LETT, V7, P183, DOI 10.1016/0014-5793(70)80152-1; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heming BS., 2003, INSECT DEV EVOLUTION; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jayakumar PC, 2007, INSECT MOL BIOL, V16, P3, DOI 10.1111/j.1365-2583.2006.00664.x; Jayakumar PC, 2001, INSECT BIOCHEM MOLEC, V31, P1165, DOI 10.1016/S0965-1748(01)00062-5; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Lee SY, 2012, CANC RES; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lynch J, 2003, CURR BIOL, V13, pR557, DOI 10.1016/S0960-9822(03)00472-X; Lynch JA, 2010, CURR BIOL, V20, P1042, DOI 10.1016/j.cub.2010.04.023; Moraes J, 2007, COMP BIOCHEM PHYS A, V146, P528, DOI 10.1016/j.cbpa.2006.05.009; MURRAY RF, 1967, SCIENCE, V156, P81, DOI 10.1126/science.156.3771.81; Pace NR, 2001, P NATL ACAD SCI USA, V98, P805, DOI 10.1073/pnas.98.3.805; Philip BN, 2011, METHODS MOL BIOL, V772, P471, DOI 10.1007/978-1-61779-228-1_28; Posnien N, 2009, COLD SPRING HARB PRO, V2009; RADDATZ E, 1986, EXP CELL BIOL, V54, P53; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sonanez-Organis JG, 2011, COMP BIOCHEM PHYS B, V158, P242, DOI 10.1016/j.cbpb.2010.12.006; SURHOLT B, 1981, BIOCHEM J, V198, P621, DOI 10.1042/bj1980621; SURHOLT B, 1983, BIOCHEM J, V210, P49, DOI 10.1042/bj2100049; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25; Wang LJ, 2007, NUCLEIC ACIDS RES, V35, pD476, DOI 10.1093/nar/gkl776; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Worthington C.C., 1988, WORTHINGTON ENZYME M; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002	60	40	41	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65125	10.1371/journal.pone.0065125	http://dx.doi.org/10.1371/journal.pone.0065125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750237	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900039
J	Huang, YQ; Wang, J; Zhang, LD; Zuo, KJ				Huang, Yiqun; Wang, Jin; Zhang, Lida; Zuo, Kaijing			A Cotton Annexin Protein AnxGb6 Regulates Fiber Elongation through Its Interaction with Actin 1	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; BINDING PROTEINS; CELL ELONGATION; F-ACTIN; IDENTIFICATION; GROWTH; COMPONENTS; PURIFICATION; CYTOSKELETON	Annexins are assumed to be involved in regulating cotton fiber elongation, but direct evidence remains to be presented. Here we cloned six Annexin genes (AnxGb) abundantly expressed in fiber from sea-island cotton (G. barbadense). qRT-PCR results indicated that all six G. barbadense annexin genes were expressed in elongating cotton fibers, while only the expression of AnxGb6 was cotton fiber-specific. Yeast two hybridization and BiFC analysis revealed that AnxGb6 homodimer interacted with a cotton fiber specific actin GbAct1. Ectopic-expressed AnxGb6 in Arabidopsis enhanced its root elongation without increasing the root cell number. Ectopic AnxGb6 expression resulted in more F-actin accumulation in the basal part of the root cell elongation zone. Analysis of AnxGb6 expression in three cotton genotypes with different fiber length confirmed that AnxGb6 expression was correlated to cotton fiber length, especially fiber elongation rate. Our results demonstrated that AnxGb6 was important for fiber elongation by potentially providing a domain for F-actin organization.	[Huang, Yiqun; Zhang, Lida; Zuo, Kaijing] Shanghai Jiao Tong Univ, Sch Agr & Biol, SJTU Cornell Inst Sustainable Agr & Biotechnol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Wang, Jin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zuo, KJ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, SJTU Cornell Inst Sustainable Agr & Biotechnol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China.	kjzuo@sjtu.edu.cn			973 project in China [2013CB733903]; NSFC [31071458]; China Transgenic Plant Project [2011AA100605]	973 project in China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); China Transgenic Plant Project	This work was funded by the 973 project in China (2013CB733903), NSFC (31071458) and China Transgenic Plant Project (2011AA100605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlvarezMartinez MT, 1997, BBA-PROTEIN STRUCT M, V1339, P331, DOI 10.1016/S0167-4838(97)00018-6; ANDRAWIS A, 1993, PLANT J, V3, P763, DOI 10.1111/j.1365-313X.1993.00763.x; Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Bassani M, 2004, PLANT MOL BIOL, V56, P367, DOI 10.1007/s11103-004-3474-y; BLACKBOURN HD, 1992, PLANT PHYSIOL, V99, P864, DOI 10.1104/pp.99.3.864; BOUSTEAD CM, 1989, FEBS LETT, V244, P456, DOI 10.1016/0014-5793(89)80582-4; Calvert CM, 1996, PLANT CELL, V8, P333, DOI 10.1105/tpc.8.2.333; Carroll AD, 1998, PLANT CELL, V10, P1267, DOI 10.1105/tpc.10.8.1267; Clark GB, 2001, PLANT PHYSIOL, V126, P1072, DOI 10.1104/pp.126.3.1072; Clark GB, 2012, NEW PHYTOL, V196, P695, DOI 10.1111/j.1469-8137.2012.04308.x; CREUTZ CE, 1978, J BIOL CHEM, V253, P2858; Dai S, 2006, PROTEOMICS, V6, P2504, DOI 10.1002/pmic.200401351; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; DIAZMUNOZ M, 1990, J BIOL CHEM, V265, P15894; Divya K, 2010, PLANT MOL BIOL, V73, P293, DOI 10.1007/s11103-010-9615-6; Dixon DC, 2000, INT J PLANT SCI, V161, P63, DOI 10.1086/314224; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gao P, 2007, PLANT SCI, V173, P61, DOI 10.1016/j.plantsci.2007.04.008; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; HASENFRATZ MP, 1995, PLANT PHYSIOL, V108, P1395, DOI 10.1104/pp.108.4.1395; Hofmann A, 2003, EUR J BIOCHEM, V270, P2557, DOI 10.1046/j.1432-1033.2003.03612.x; Hoshino D, 2004, PLANTA, V219, P867, DOI 10.1007/s00425-004-1285-7; Hu SQ, 2000, PLANT J, V24, P127, DOI 10.1046/j.1365-313x.2000.00852.x; Huang QS, 2008, PLANT CELL REP, V27, P1869, DOI 10.1007/s00299-008-0603-0; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Konopka-Postupolska D, 2007, PROTOPLASMA, V230, P203, DOI 10.1007/s00709-006-0234-7; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwon HK, 2005, PLANT CELL PHYSIOL, V46, P843, DOI 10.1093/pcp/pci089; Lafont F, 1998, J CELL BIOL, V142, P1413, DOI 10.1083/jcb.142.6.1413; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Laohavisit A, 2009, PLANT CELL, V21, P479, DOI 10.1105/tpc.108.059550; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Lim EK, 1998, J BIOL CHEM, V273, P34920, DOI 10.1074/jbc.273.52.34920; Liu K, 2012, GENOMICS, V100, P42, DOI 10.1016/j.ygeno.2012.04.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McArthur S, 2009, FASEB J, V23, P4000, DOI 10.1096/fj.09-131391; Mei WQ, 2009, J GENET GENOMICS, V36, P141, DOI 10.1016/S1673-8527(08)60101-0; Miwa N, 2008, FEBS J, V275, P4945, DOI 10.1111/j.1742-4658.2008.06653.x; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Mortimer JC, 2008, J EXP BOT, V59, P533, DOI 10.1093/jxb/erm344; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pei WK, 2012, PLANT SCI, V187, P10, DOI 10.1016/j.plantsci.2012.01.008; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; QUADER H, 1987, PROTOPLASMA, V137, P56, DOI 10.1007/BF01281176; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rohila JS, 2006, PLANT J, V46, P1, DOI 10.1111/j.1365-313X.2006.02671.x; SEAGULL RW, 1990, PROTOPLASMA, V159, P44, DOI 10.1007/BF01326634; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Waller F, 2002, PROTOPLASMA, V219, P72, DOI 10.1007/s007090200007; Wang HY, 2009, PLANT BIOTECHNOL J, V7, P13, DOI 10.1111/j.1467-7652.2008.00367.x; Wang JA, 2010, PLANT CELL PHYSIOL, V51, P1276, DOI 10.1093/pcp/pcq086; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang LK, 2010, MOL BIOL REP, V37, P3327, DOI 10.1007/s11033-009-9919-2; Wang YC, 2009, BIOSCIENCE REP, V29, P111, DOI 10.1042/BSR20070052; Wang YS, 2008, NEW PHYTOL, V177, P525, DOI 10.1111/j.1469-8137.2007.02261.x; Whittaker DJ, 1999, PLANT PHYSIOL, V121, P181, DOI 10.1104/pp.121.1.181; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t; Zhou L, 2011, J INTEGR PLANT BIOL, V53, P347, DOI 10.1111/j.1744-7909.2011.01034.x; Zobiack N, 2002, J CELL SCI, V115, P91	72	95	98	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66160	10.1371/journal.pone.0066160	http://dx.doi.org/10.1371/journal.pone.0066160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750279	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900081
J	Jutfelt, F; de Souza, KB; Vuylsteke, A; Sturve, J				Jutfelt, Fredrik; de Souza, Karine Bresolin; Vuylsteke, Amandine; Sturve, Joachim			Behavioural Disturbances in a Temperate Fish Exposed to Sustained High-CO2 Levels	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CARBON-DIOXIDE; HIGH CO2; SEAWATER; ACCLIMATION; TOLERANCE	As atmospheric CO2 levels rise, the CO2 concentration in ocean surface waters increases through a process commonly referred to as ocean acidification. Recently, surprising behavioural modifications has been detected in the early life stages of tropical coral reef fish exposed to ocean acidification-relevant CO2 concentrations, but it has been unclear if this effect could occur in temperate waters. Here we show several severe behavioural disturbances, including effects on boldness, exploratory behaviour, lateralisation, and learning in a temperate fish, the three-spined stickleback (Gasterosteus aculeatus). The behavioural effects were consistent throughout the exposure period and increased in effect size with exposure time. We observed the effects on adult sticklebacks, a species known to be tolerant to other environmental stressors. Our findings suggest that behavioural abnormalities that stem from CO2 exposure are not restricted to sensitive tropical species or early life stages and may therefore affect fish on a global scale. The severity of disturbances and the possibility of a serious behavioural problem for fish across the globe is cause for concern.	[Jutfelt, Fredrik; de Souza, Karine Bresolin; Vuylsteke, Amandine; Sturve, Joachim] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Jutfelt, F (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	fredrik.jutfelt@bioenv.gu.se	Vuylsteke, Alain/AAF-2108-2020; Jutfelt, Fredrik/B-6988-2014	Jutfelt, Fredrik/0000-0001-9838-3991; Sturve, Joachim/0000-0001-9370-993X	Swedish Research Council Formas through the grant Jutfelt [2009-596]	Swedish Research Council Formas through the grant Jutfelt	This work was funded by the Swedish Research Council Formas through the grant Jutfelt 2009-596. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2011, P ROY SOC B-BIOL SCI, V278, P233, DOI 10.1098/rspb.2010.0923; Brauner CJ, 2009, PATTERNS ACID BASE R, DOI [10.1007/978-3-540-93985-6, DOI 10.1007/978-3-540-93985-6]; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; Dadda M, 2006, BEHAV ECOL, V17, P358, DOI 10.1093/beheco/arj040; Dahlbom SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023565; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Ferrari MCO, 2012, FUNCT ECOL, V26, P553, DOI 10.1111/j.1365-2435.2011.01951.x; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; Fivelstad S, 1998, AQUACULTURE, V160, P305, DOI 10.1016/S0044-8486(97)00166-X; Foss A, 2003, AQUACULTURE, V220, P607, DOI 10.1016/S0044-8486(02)00613-0; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; Lutterschmidt W, 2011, MEASURES THERMAL TOL, DOI [10.1016/B978-0-1237-4553-8.00200-8, DOI 10.1016/B978-0-1237-4553-8.00200-8]; Maneja RH, 2013, MAR BIOL, V160, P1963, DOI 10.1007/s00227-012-2054-y; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2009, AQUAT TOXICOL, V92, P30, DOI 10.1016/j.aquatox.2008.12.011; Munday PL, 2013, MAR BIOL, V160, P2137, DOI 10.1007/s00227-012-2111-6; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nepomnyashchikh V.A., 2006, J ICHTHYOL, V46, pS235, DOI [10.1134/S0032945206110142, DOI 10.1134/S0032945206110142]; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Ostlund-Nilsson S, 2006, BIOL 3 SPINED STICKL; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pottinger TG, 2002, J FISH BIOL, V61, P207, DOI 10.1006/jfbi.2002.2034; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Sangiao-Alvarellos S, 2005, J EXP BIOL, V208, P4291, DOI 10.1242/jeb.01900; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Sloman K., 2005, FISH PHYSL BEHAV PHY, V24; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17	33	114	116	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65825	10.1371/journal.pone.0065825	http://dx.doi.org/10.1371/journal.pone.0065825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750274	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900076
J	Karthikeyan, RS; Priya, JL; Leal, SM; Toska, J; Rietsch, A; Prajna, V; Pearlman, E; Lalitha, P				Karthikeyan, Rajapandian SivaGanesa; Priya, Jeganathan Lakshmi; Leal, Sixto M., Jr.; Toska, Jonida; Rietsch, Arne; Prajna, Venkatesh; Pearlman, Eric; Lalitha, Prajna			Host Response and Bacterial Virulence Factor Expression in Pseudomonas aeruginosa and Streptococcus pneumoniae Corneal Ulcers	PLOS ONE			English	Article							III SECRETION SYSTEM; OCULAR INFECTIONS; SOUTH-INDIA; CASPASE-1 ACTIVATION; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; RISK-FACTORS; PNEUMOLYSIN; KERATITIS; INFLAMMASOMES	P. aeruginosa and S. pneumoniae are major bacterial causes of corneal ulcers in industrialized and in developing countries. The current study examined host innate immune responses at the site of infection, and also expression of bacterial virulence factors in clinical isolates from patients in south India. Corneal ulcer material was obtained from 49 patients with confirmed P. aeruginosa and 27 patients with S. pneumoniae, and gene expression of Toll Like Receptors (TLR), cytokines and inflammasome proteins was measured by quantitative PCR. Expression of P. aeruginosa type III secretion exotoxins and S. pneumoniae pneumolysin was detected by western blot analysis. We found that neutrophils comprised >90% cells in corneal ulcers, and that there was elevated expression of TLR2, TLR4, TLR5 and TLR9, the NLRP3 and NLRC4 inflammasomes and the ASC adaptor molecule. IL-1 alpha IL-1b beta and IFN-gamma expression was also elevated; however, there was no significant difference in expression of any of these genes between corneal ulcers from P. aeruginosa and S. pneumoniae infected patients. We also show that 41/49 (84%) of P. aeruginosa clinical isolates expressed ExoS and ExoT, whereas 5/49 (10%) of isolates expressed ExoS, ExoT and ExoU with only 2/49 isolates expressing ExoT and ExoU. In contrast, all 27 S. pneumoniae clinical isolates produced pneumolysin. Taken together, these findings demonstrate that ExoS/T expressing P. aeruginosa and pneumolysin expressing S. pneumoniae predominate in bacterial keratitis. While P. aeruginosa strains expressing both ExoU and ExoS are usually rare, these strains actually outnumbered strains expressing only ExoU in the current study. Further, as neutrophils are the predominant cell type in these corneal ulcers, they are the likely source of cytokines and of the increased TLR and inflammasome expression.	[Karthikeyan, Rajapandian SivaGanesa; Priya, Jeganathan Lakshmi; Prajna, Venkatesh; Lalitha, Prajna] Aravind Eye Hosp, Dr G Venkatasamy Eye Res Inst, Madurai, Tamil Nadu, India; [Leal, Sixto M., Jr.; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Toska, Jonida; Rietsch, Arne] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Lalitha, P (corresponding author), Aravind Eye Hosp, Dr G Venkatasamy Eye Res Inst, Madurai, Tamil Nadu, India.	lalitha@aravind.org		Namperumalsamy, Venkatesh Prajna/0000-0003-2019-4044; Leal, Sixto/0000-0001-6939-9572; Rietsch, Arne/0000-0002-1556-7064; Siva Ganesa Karthikeyan, Rajapandian/0000-0002-7449-2402	Indian Council for Medical Research; NIH [RO1 EY14362, EY22052]; Alcon Research Institute award; NATIONAL EYE INSTITUTE [R01EY022052, R01EY014362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Indian Council for Medical Research(Indian Council of Medical Research (ICMR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alcon Research Institute award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Indian Council for Medical Research (LP), NIH grants RO1 EY14362 (EP), EY22052 (AR). EP is a recipient of an Alcon Research Institute award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; Angus AA, 2010, INFECT IMMUN, V78, P4500, DOI 10.1128/IAI.00417-10; Bharathi MJ, 2007, OPHTHAL EPIDEMIOL, V14, P61, DOI 10.1080/09286580601001347; Bharathi MJ, 2010, INDIAN J OPHTHALMOL, V58, P497, DOI 10.4103/0301-4738.71678; Bharathi MJ, 2009, INDIAN J MED RES, V130, P749; Borkar DS, 2013, JAMA OPHTHALMOL, V131, P147, DOI 10.1001/jamaophthalmol.2013.778; Cockeran R, 2009, EUR RESPIR J, V34, P1167, DOI 10.1183/09031936.00007109; Cockeran R, 2001, J INFECT DIS, V183, P604, DOI 10.1086/318536; Cole N, 1998, CURR EYE RES, V17, P730, DOI 10.1080/02713689808951250; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Fleiszig SMJ, 1996, INFECT IMMUN, V64, P2288, DOI 10.1128/IAI.64.6.2288-2294.1996; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; JOHNSON MK, 1992, CURR EYE RES, V11, P1221, DOI 10.3109/02713689208999547; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Karthikeyan RS, 2011, J INFECT DIS, V204, P942, DOI 10.1093/infdis/jir426; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Norcross Erin W, 2011, J Bacteriol Parasitol, V2, P108; Parmar P, 2003, CLIN EXP OPHTHALMOL, V31, P44, DOI 10.1046/j.1442-9071.2003.00598.x; Pearlman E, 2013, INT REV IMMUNOL, V32, P4, DOI 10.3109/08830185.2012.749400; Ramesh S, 2010, INDIAN J PATHOL MICR, V53, P281, DOI 10.4103/0377-4929.64336; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Szczotka-Flynn LB, 2010, EYE CONTACT LENS, V36, P116, DOI 10.1097/ICL.0b013e3181d20cae; Tam C, 2007, EXP EYE RES, V85, P799, DOI 10.1016/j.exer.2007.08.015; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; UPADHYAY MP, 1991, AM J OPHTHALMOL, V111, P92, DOI 10.1016/S0002-9394(14)76903-X; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143	39	46	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64867	10.1371/journal.pone.0064867	http://dx.doi.org/10.1371/journal.pone.0064867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750216	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900018
J	Yan, GR; Zhou, HH; Wang, Y; Zhong, Y; Tan, ZL; Wang, YQ; He, QY				Yan, Guang-Rong; Zhou, Hui-Hua; Wang, Yang; Zhong, Yin; Tan, Zi-Lu; Wang, Yuqiang; He, Qing-Yu			Protective Effects of Andrographolide Analogue AL-1 on ROS-Induced RIN-m beta Cell Death by Inducing ROS Generation	PLOS ONE			English	Article							OXYGEN SPECIES ROS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; CARDIOVASCULAR-DISEASE; SUPEROXIDE-DISMUTASE; CANCER CELLS; CYTOTOXICITY; PHOSPHORYLATION; HOMEOSTASIS	Oxidative stress is considered to be a major factor contributing to pathogenesis and progression of many diseases. A novel andrographolide-lipoic acid conjugate (AL-1) could protect pancreatic beta-cells from reactive oxygen species (ROS)-induced oxidative injury. However, its protective mechanism is still unclear. In this work, we used proteomics to identify AL-1-regulated proteins in beta-cells and found that 13 of the 71 proteins regulated by AL-1 were closely associated with antioxidation. These differential proteins were mainly involved in the ERK1/2 and AKT1 signaling pathways. Functional investigation demonstrated that AL-1 exerted its protective effects on H2O2-induced cell death of beta-cells by generating NADPH oxidase-dependent ROS to activate ERK1/2 and AKT1 signaling pathways. As a consequence, the expressions of antioxidant proteins including Trx1, Prx1 and Prx5, and anti-apoptotic proteins including PDCD6IP, prohibitin, galectin-1 and HSP were upregulated. AL-1 probably worked as a "vaccinum" to activate the cellular antioxidant system by inducing the generation of low concentration ROS which then reciprocally protected beta-cells from oxidative damage caused by high-level ROS from H2O2. To the best of our knowledge, this is the first comprehensive proteomic analysis illustrating a novel molecular mechanism for the protective effects of antioxidants on beta-cells from H2O2-induced cell death.	[Yan, Guang-Rong; Zhou, Hui-Hua; Wang, Yang; Zhong, Yin; Tan, Zi-Lu; He, Qing-Yu] Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Guangdong Higher Educ Inst,Key Lab Funct Prot Res, Guangzhou, Guangdong, Peoples R China; [Wang, Yuqiang] Jinan Univ, Coll Pharm, Inst New Drug Res, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Yan, GR (corresponding author), Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Guangdong Higher Educ Inst,Key Lab Funct Prot Res, Guangzhou, Guangdong, Peoples R China.	tgryan@jnu.edu.cn; tqyhe@jnu.edu.cn	He, Qing-Yu/H-7078-2014; Wang, Yang/GQH-2363-2022	He, Qing-Yu/0000-0003-0503-9492; Wang, Yang/0000-0001-6440-0204	National "973'' Projects of China [2011CB910700]; National Natural Science Foundation of China [81071618, 81272285]; Fundamental Research Funds for the Central Universities [21600201, 21610101]; China New Drug Development Project [2009ZX09102-010]	National "973'' Projects of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China New Drug Development Project	This work was partially supported by National "973'' Projects of China (2011CB910700), National Natural Science Foundation of China (81071618, 81272285), the Fundamental Research Funds for the Central Universities (21600201, 21610101), the China New Drug Development Project (2009ZX09102-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birringer M, 2010, FREE RADICAL BIO MED, V49, P1315, DOI 10.1016/j.freeradbiomed.2010.07.024; Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006; Chen Y, 2010, PEDIATR PULM, V45, P1192, DOI 10.1002/ppul.21307; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Elbling L, 2010, FREE RADICAL BIO MED, V49, P1444, DOI 10.1016/j.freeradbiomed.2010.08.008; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; FIGTREE GA, 2012, FREE RADIC BIOL MED; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Gao YA, 2010, BRAIN RES, V1358, P239, DOI 10.1016/j.brainres.2010.08.043; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; Gil-Izquierdo A, 2012, CURR PHARM BIOTECHNO, V13, P624, DOI 10.2174/138920112799857585; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SB, 2009, MOL CELLS, V28, P583, DOI 10.1007/s10059-009-0152-6; Lee WC, 2005, NEUROCHEM RES, V30, P263, DOI 10.1007/s11064-005-2449-y; Lee YM, 2009, NUTR RES PRACT, V3, P156, DOI 10.4162/nrp.2009.3.2.156; Lei YL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005397; Lonn ME, 2012, FREE RADICAL BIO MED, V53, P863, DOI 10.1016/j.freeradbiomed.2012.05.027; Lu YH, 2010, NEUROSCI LETT, V484, P6, DOI 10.1016/j.neulet.2010.07.078; Murakami T, 2005, J BIOL CHEM, V280, P31841, DOI 10.1074/jbc.M503108200; Mustafi SB, 2009, CELL STRESS CHAPERON, V14, P579, DOI 10.1007/s12192-009-0109-x; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Schreibelt G, 2008, FREE RADICAL BIO MED, V45, P256, DOI 10.1016/j.freeradbiomed.2008.03.024; Selvaraju V, 2012, TOXICOL MECH METHOD, V22, P330, DOI 10.3109/15376516.2012.666648; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tian YY, 2006, LIFE SCI, V80, P193, DOI 10.1016/j.lfs.2006.09.010; Wang Y, 2006, PROTEOMICS, V6, P2422, DOI 10.1002/pmic.200500595; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Yan GG, 2006, PROTEOMICS, V6, P1810, DOI 10.1002/pmic.200500156; Yan GR, 2012, PROTEOMICS, V12, P2391, DOI 10.1002/pmic.201100652; Yan GR, 2010, PROTEOMICS, V10, P976, DOI 10.1002/pmic.200900662; Yang HL, 2009, MOL CELL PROTEOMICS, V8, P571, DOI 10.1074/mcp.M800297-MCP200; Yi XW, 2006, DIABETES, V55, P2238, DOI 10.2337/db06-0251; Yu BC, 2003, PLANTA MED, V69, P1075, DOI 10.1055/s-2003-45185; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang ZJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-62; Zhou F, 2009, BRAIN RES, V1272, P62, DOI 10.1016/j.brainres.2009.03.023; Zhu YY, 2013, PROTEOMICS, V13, P169, DOI 10.1002/pmic.201200273	46	22	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e63656	10.1371/journal.pone.0063656	http://dx.doi.org/10.1371/journal.pone.0063656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750203	gold, Green Published			2022-12-27	WOS:000319961900005
J	Zhu, SH; Fang, Z; Hu, SY; Wang, Z; Rao, HY				Zhu, Senhua; Fang, Zhuo; Hu, Siyuan; Wang, Ze; Rao, Hengyi			Resting State Brain Function Analysis Using Concurrent BOLD in ASL Perfusion fMRI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; DEFAULT-MODE; CINGULATE CORTEX; MRI; CONNECTIVITY; FLUCTUATIONS; NETWORK; SIGNAL; ASSOCIATION	The past decade has seen astounding discoveries about resting-state brain activity patterns in normal brain as well as their alterations in brain diseases. While the vast majority of resting-state studies are based on the blood-oxygen-level-dependent (BOLD) functional MRI (fMRI), arterial spin labeling (ASL) perfusion fMRI can simultaneously capture BOLD and cerebral blood flow (CBF) signals, providing a unique opportunity for assessing resting brain functions with concurrent BOLD (ccBOLD) and CBF signals. Before taking that benefit, it is necessary to validate the utility of ccBOLD signal for resting-state analysis using conventional BOLD (cvBOLD) signal acquired without ASL modulations. To address this technical issue, resting cvBOLD and ASL perfusion MRI were acquired from a large cohort (n = 89) of healthy subjects. Four widely used resting-state brain function analyses were conducted and compared between the two types of BOLD signal, including the posterior cingulate cortex (PCC) seed-based functional connectivity (FC) analysis, independent component analysis (ICA), analysis of amplitude of low frequency fluctuation (ALFF), and analysis of regional homogeneity (ReHo). Consistent default mode network (DMN) as well as other resting-state networks (RSNs) were observed from cvBOLD and ccBOLD using PCC-FC analysis and ICA. ALFF from both modalities were the same for most of brain regions but were different in peripheral regions suffering from the susceptibility gradients induced signal drop. ReHo showed difference in many brain regions, likely reflecting the SNR and resolution differences between the two BOLD modalities. The DMN and auditory networks showed highest CBF values among all RSNs. These results demonstrated the feasibility of ASL perfusion MRI for assessing resting brain functions using its concurrent BOLD in addition to CBF signal, which provides a potentially useful way to maximize the utility of ASL perfusion MRI.	[Zhu, Senhua; Fang, Zhuo; Rao, Hengyi] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Senhua; Fang, Zhuo; Hu, Siyuan; Wang, Ze; Rao, Hengyi] Univ Penn, Dept Neurol, Perelman Sch Med, Ctr Funct Neuroimaging, Philadelphia, PA 19104 USA; [Wang, Ze; Rao, Hengyi] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hu, Siyuan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Sun Yat Sen University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Beijing Normal University	Wang, Z (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Ctr Funct Neuroimaging, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu; hengyi@mail.med.upenn.edu	Rao, Hengyi/AAQ-4919-2020; Rao, Hengyi/A-7064-2009; Rao, Hengyi/K-5152-2019	Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; 	National Institutes of Health (NIH) [R01 HL102119, R21 DA032022, R03 DA027098]; National Nature Science Foundation of China [31070984, 31000507, 91124004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027098, R21DA032022] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported in part by National Institutes of Health (NIH) Grants R01 HL102119, R21 DA032022, and R03 DA027098, and the National Nature Science Foundation of China Grants 31070984, 31000507, and 91124004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Detre JA, 2007, 15 ISMRM BERL GERM; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Floyd TF, 2001, 9 ISMRM GLASG SCOTL; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Liu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048181; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Marchetti I, 2012, NEUROPSYCHOL REV, V22, P229, DOI 10.1007/s11065-012-9199-9; Nandy R, 2007, NEUROIMAGE, V34, P1562, DOI 10.1016/j.neuroimage.2006.10.025; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rao HY, 2007, HUM BRAIN MAPP, V28, P593, DOI 10.1002/hbm.20288; Sanz-Arigita EJ, 2012, HUMAN BRAIN IN PRESS; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tomasi D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010815; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Wang Z, 2008, NEUROIMAGE, V39, P973, DOI 10.1016/j.neuroimage.2007.09.045; Wang Z, 2012, MAGN RESON IMAGING, V30, P1409, DOI 10.1016/j.mri.2012.05.004; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042730; Wong EC, 2000, MAGNET RESON MED, V44, P511, DOI 10.1002/1522-2594(200010)44:4<511::AID-MRM2>3.0.CO;2-6; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	45	33	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65884	10.1371/journal.pone.0065884	http://dx.doi.org/10.1371/journal.pone.0065884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750275	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900077
J	Boyer, TC; Hanson, T; Singer, RS				Boyer, Tim C.; Hanson, Tim; Singer, Randall S.			Estimation of Low Quantity Genes: A Hierarchical Model for Analyzing Censored Quantitative Real-Time PCR Data	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE GENES; CONFERRING RESISTANCE; STREPTOGRAMIN-B; QUANTIFICATION; LAGOONS; SIMULATION; MICROBIOTA; DIVERSITY; WINBUGS; CATTLE	Analysis of gene quantities measured by quantitative real-time PCR (qPCR) can be complicated by observations that are below the limit of quantification (LOQ) of the assay. A hierarchical model estimated using MCMC methods was developed to analyze qPCR data of genes with observations that fall below the LOQ (censored observations). Simulated datasets with moderate to very high levels of censoring were used to assess the performance of the model; model results were compared to approaches that replace censored observations with a value on the log scale approximating zero or with values ranging from one to the LOQ of ten gene copies. The model was also compared to a Tobit regression model. Finally, all approaches for handling censored observations were evaluated with DNA extracted from samples that were spiked with known quantities of the antibiotic resistance gene tetL. For the simulated datasets, the model outperformed substitution of all values from 1-10 under all censoring scenarios in terms of bias, mean square error, and coverage of 95% confidence intervals for regression parameters. The model performed as well or better than substitution of a value approximating zero under two censoring scenarios (approximately 57% and 79% censored values). The model also performed as well or better than Tobit regression in two of three censoring scenarios (approximately 79% and 93% censored values). Under the levels of censoring present in the three scenarios of this study, substitution of any values greater than 0 produced the least accurate results. When applied to data produced from spiked samples, the model produced the lowest mean square error of the three approaches. This model provides a good alternative for analyzing large amounts of left-censored qPCR data when the goal is estimation of population parameters. The flexibility of this approach can accommodate complex study designs such as longitudinal studies.	[Boyer, Tim C.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; [Hanson, Tim] Univ S Carolina, Dept Stat, Columbia, SC 29208 USA; [Singer, Randall S.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Minnesota System; University of Minnesota Twin Cities	Singer, RS (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	rsinger@umn.edu	Hanson, Timothy/A-9127-2016		National Research Initiative from the USDA National Institute of Food and Agriculture, Epidemiological Approaches for Food Safety [2003-35212-13853, 2004-35212-14885]	National Research Initiative from the USDA National Institute of Food and Agriculture, Epidemiological Approaches for Food Safety	This project was supported by National Research Initiative Grant numbers 2003-35212-13853 and 2004-35212-14885 from the USDA National Institute of Food and Agriculture, Epidemiological Approaches for Food Safety -32.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alali WQ, 2009, FOODBORNE PATHOG DIS, V6, P917, DOI 10.1089/fpd.2009.0271; BENTORCHA F, 1991, ANTIMICROB AGENTS CH, V35, P808, DOI 10.1128/AAC.35.5.808; Berdal KG, 2001, EUR FOOD RES TECHNOL, V213, P432, DOI 10.1007/s002170100403; Berdal KG, 2008, EUR FOOD RES TECHNOL, V227, P1149, DOI 10.1007/s00217-008-0830-1; Bibbal D, 2007, APPL ENVIRON MICROB, V73, P4785, DOI 10.1128/AEM.00252-07; Burns M, 2008, EUR FOOD RES TECHNOL, V227, P1721, DOI 10.1007/s00217-008-0899-6; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Burns MJ, 2010, EUR FOOD RES TECHNOL, V231, P353, DOI 10.1007/s00217-010-1277-8; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Burns MJ, 2004, ANAL BIOANAL CHEM, V378, P1616, DOI 10.1007/s00216-003-2441-9; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Bustin SA., 2004, A Z QUANTITATIVE PCR, P447; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001; Chen J, 2008, J ANIM SCI, V86, P2385, DOI 10.2527/jas.2007-0705; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Ellison SLR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-33; Gelman A., 2007, DATA ANAL USING REGR; Helsel D. R., 2005, NONDETECTS DATA ANAL; Huggett J, 2006, REAL TIME PCR, P83; Jacqmin-Gadda H, 2000, Biostatistics, V1, P355, DOI 10.1093/biostatistics/1.4.355; Kubista M., 2007, GIT LAB J, V9, P33; Larsen R., 2006, MARX INTRO; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Peak N, 2007, ENVIRON MICROBIOL, V9, P143, DOI 10.1111/j.1462-2920.2006.01123.x; Peccoud J, 1996, BIOPHYS J, V71, P101, DOI 10.1016/S0006-3495(96)79205-6; R Core Team, 2016, R FDN STAT COMP; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smith MS, 2004, APPL ENVIRON MICROB, V70, P7372, DOI 10.1128/AEM.70.12.7372-7377.2004; Storteboom HN, 2007, J ENVIRON QUAL, V36, P1695, DOI 10.2134/jeq2007.0006; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; U.S. Environmental Protection Agency Office of Pesticide Programs, 2000, ASS VAL NOND NONQ PE; Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Yu ZT, 2005, APPL ENVIRON MICROB, V71, P6926, DOI 10.1128/AEM.71.11.6926-6933.2005	38	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64900	10.1371/journal.pone.0064900	http://dx.doi.org/10.1371/journal.pone.0064900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741414	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900127
J	Branco, P; Santos, JM; Katopodis, C; Pinheiro, A; Ferreira, MT				Branco, Paulo; Santos, Jose M.; Katopodis, Christos; Pinheiro, Antonio; Ferreira, Maria T.			Pool-Type Fishways: Two Different Morpho-Ecological Cyprinid Species Facing Plunging and Streaming Flows	PLOS ONE			English	Article							BARBEL BARBUS-BOCAGEI; SWIMMING BEHAVIOR; CHINOOK SALMON; PASSAGE; RIVER; MANAGEMENT; ENTRANCE; CHANNEL; SPEED; DAM	Fish are particularly sensitive to connectivity loss as their ability to reach spawning grounds is seriously affected. The most common way to circumvent a barrier to longitudinal connectivity, and to mitigate its impacts, is to implement a fish passage device. However, these structures are often non-effective for species with different morphological and ecological characteristics so there is a need to determine optimum dimensioning values and hydraulic parameters. The aim of this work is to study the behaviour and performance of two species with different ecological characteristics (Iberian barbel Luciobarbus bocagei-bottom oriented, and Iberian chub Squalius pyrenaicus-water column) in a full-scale experimental pool-type fishway that offers two different flow regimes-plunging and streaming. Results showed that both species passed through the surface notch more readily during streaming flow than during plunging flow. The surface oriented species used the surface notch more readily in streaming flow, and both species were more successful in moving upstream in streaming flow than in plunging flow. Streaming flow enhances upstream movement of both species, and seems the most suitable for fishways in river systems where a wide range of fish morpho-ecological traits are found.	[Branco, Paulo; Santos, Jose M.; Ferreira, Maria T.] Univ Tecn Lisboa, CEF, Inst Super Agron, P-1100 Lisbon, Portugal; [Katopodis, Christos] Katopodis Ecohydraul Ltd, Winnipeg, MB, Canada; [Pinheiro, Antonio] Univ Tecn Lisboa, Inst Super Tecn, CEHIDRO Ctr Estudos Hidrossistemas, P-1096 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Branco, P (corresponding author), Univ Tecn Lisboa, CEF, Inst Super Agron, P-1100 Lisbon, Portugal.	pjbranco@isa.utl.pt	Branco, Paulo/B-6854-2012; Ferreira, Teresa/C-9785-2012; Santos, José Maria/F-9022-2010; Pinheiro, António N./E-2520-2012	Branco, Paulo/0000-0002-2502-5533; Ferreira, Teresa/0000-0002-3900-1460; Santos, José Maria/0000-0003-1232-2560; Pinheiro, António N./0000-0002-1423-5391	Foundation for Science and Technology (FCT) through the project FISHMOVE [PTDC/AGR-CFL/117761/2010]; Foundation for Science and Technology (FCT) [SFRH/BD/44938/2008]	Foundation for Science and Technology (FCT) through the project FISHMOVE; Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support for the study came from the Foundation for Science and Technology (FCT) through the project FISHMOVE (PTDC/AGR-CFL/117761/2010). Paulo Branco was supported by a PhD grant from the Foundation for Science and Technology (FCT) (SFRH/BD/44938/2008). The funding agency (FCT) played no part in the designing and conducting of the work nor in the writing and publishing process of the manuscript.	Agostinho AA, 2007, AQUAT ECOSYST HEALTH, V10, P174, DOI 10.1080/14634980701341719; Agostinho AA, 2002, RIVER RES APPL, V18, P299, DOI 10.1002/rra.674; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Branco P, 2012, ECOL ENG, V48, P70, DOI 10.1016/j.ecoleng.2011.05.008; Bunt Christopher M., 1999, North American Journal of Fisheries Management, V19, P793, DOI 10.1577/1548-8675(1999)019<0793:AAPEOW>2.0.CO;2; Bunt CM, 2001, FISHERIES MANAG ECOL, V8, P95, DOI 10.1046/j.1365-2400.2001.00238.x; Cada GF, 2001, FISHERIES, V26, P14, DOI 10.1577/1548-8446(2001)026<0014:TDOAHT>2.0.CO;2; Castro-Santos T, 2005, J EXP BIOL, V208, P421, DOI 10.1242/jeb.01380; CEN (Comite Europeen de Normalisation), 2003, 140112003E CEN EN; Chan MD, 2001, THESIS VIRGINIA TECH; Clay C.H., 1995, DESIGN FISHWAYS OTHE, V2nd, DOI 10.1201/9781315141046; Coutant C. C., 1998, ORNLTM13608; Ead SA, 2004, J ENVIRON ENG SCI, V3, P379, DOI 10.1139/S03-073; ERMAN NA, 1986, FRESHWATER BIOL, V16, P455, DOI 10.1111/j.1365-2427.1986.tb00988.x; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; Ferreira MT, 2007, ECOL FRESHW FISH, V16, P504, DOI 10.1111/j.1600-0633.2007.00241.x; Ficke AD, 2011, T AM FISH SOC, V140, P1521, DOI 10.1080/00028487.2011.638579; Francis F, 1870, REPORTS SALMON LADDE; GOEDMAKERS A, 1981, BIJDR DIERKD, V51, P145; Goring DG, 2002, J HYDRAUL ENG-ASCE, V128, P117, DOI 10.1061/(ASCE)0733-9429(2002)128:1(117); Gorley C.K., 2006, GETTING STARTED PRIM; Green TM, 2011, RIVER RES APPL, V27, P1290, DOI 10.1002/rra.1426; Guiny E, 2003, ECOL FRESHW FISH, V12, P190, DOI 10.1034/j.1600-0633.2003.00025.x; Haro Alex, 1999, North American Journal of Fisheries Management, V19, P51, DOI 10.1577/1548-8675(1999)019<0051:EOSAHO>2.0.CO;2; Hasler Caleb T., 2011, Endangered Species Research, V14, P79, DOI 10.3354/esr00343; Hinch SG, 2000, T AM FISH SOC, V129, P598, DOI 10.1577/1548-8659(2000)129<0598:EOSSAA>2.0.CO;2; INAG, 2008, MAN AV BIOL QUAL AG; Johnson EL, 2012, T AM FISH SOC, V141, P571, DOI 10.1080/00028487.2012.683468; Katopodis C, 2005, J HYDRAUL RES, V43, P451, DOI 10.1080/00221680509500144; Katopodis C, 2012, RIVER RES APPL, V28, P444, DOI 10.1002/rra.1566; Katopodis C, 2012, ECOL ENG, V48, P8, DOI 10.1016/j.ecoleng.2011.07.004; Kondratieff MC, 2005, T AM FISH SOC, V134, P503, DOI 10.1577/T03-174.1; Larinier M., 2004, P 2 INT S MAN LARG R; Larinier M, 2008, HYDROBIOLOGIA, V609, P97, DOI 10.1007/s10750-008-9398-9; Leonard P.M., 1988, North American Journal of Fisheries Management, V8, P399, DOI 10.1577/1548-8675(1988)008<0399:UOHGOF>2.3.CO;2; Lucas M.C., 2000, P87, DOI 10.1002/9780470696026.ch7; Mallen-Cooper M, 2007, FISHERIES MANAG ECOL, V14, P319, DOI 10.1111/j.1365-2400.2007.00557.x; Mateus CS, 2008, J FISH BIOL, V73, P1783, DOI 10.1111/j.1095-8649.2008.02023.x; Naughton GP, 2007, RIVER RES APPL, V23, P99, DOI 10.1002/rra.957; Neitzel DA, 2004, T AM FISH SOC, V133, P447, DOI 10.1577/02-021; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Noonan MJ, 2012, FISH FISH, V13, P450, DOI 10.1111/j.1467-2979.2011.00445.x; Northcote TG, 1998, FISH MIGRATION AND FISH BYPASSES, P3; Odeh M., 2002, EVALUATION EFFECTS T, P46; Pon LB, 2009, J FISH BIOL, V74, P1323, DOI 10.1111/j.1095-8649.2009.02213.x; RAJARATNAM N, 1988, J HYDRAUL ENG-ASCE, V114, P939, DOI 10.1061/(ASCE)0733-9429(1988)114:8(939); Romao F, 2012, J APPL ICHTHYOL, V28, P26, DOI 10.1111/j.1439-0426.2011.01882.x; Roscoe DW, 2010, FISH FISH, V11, P12, DOI 10.1111/j.1467-2979.2009.00333.x; Santos JM, 2005, J APPL ICHTHYOL, V21, P381, DOI 10.1111/j.1439-0426.2005.00616.x; Santos JM, 2002, J APPL ICHTHYOL, V18, P118, DOI 10.1046/j.1439-0426.2002.00309.x; Santos JM, 2012, ECOL ENG, V48, P38, DOI 10.1016/j.ecoleng.2011.03.006; Silva AT, 2009, J APPL ICHTHYOL, V25, P173, DOI 10.1111/j.1439-0426.2009.01237.x; Silva AT, 2012, ECOL ENG, V44, P314, DOI 10.1016/j.ecoleng.2012.04.015; StatSoft, 2000, STAT WIND COMP PROGR; Stuart T.A., 1962, FRESHWATER SALMON FI, V28, P1; Videler J.J., 1991, Reviews in Fish Biology and Fisheries, V1, P23, DOI 10.1007/BF00042660; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Wahl TL, 2003, J HYDRAUL ENG-ASCE, V129, P484, DOI 10.1061/(ASCE)0733-9429(2003)129:6(484); Wahl TL, 2001, WINADV FREE WARE SOF; Walters K, 2006, J EXP MAR BIOL ECOL, V330, P81, DOI 10.1016/j.jembe.2005.12.018; Wang RW, 2010, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2010002; Williams JG, 2012, RIVER RES APPL, V28, P407, DOI 10.1002/rra.1551	63	45	45	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65089	10.1371/journal.pone.0065089	http://dx.doi.org/10.1371/journal.pone.0065089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741465	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900178
J	Kumar, A; Purohit, R				Kumar, Ambuj; Purohit, Rituraj			Cancer Associated E17K Mutation Causes Rapid Conformational Drift in AKT1 Pleckstrin Homology (PH) Domain	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; TRANSFORMING MUTATION; ONCOGENIC MUTATION; PROTEINS; PATHWAY; KINASE; NSSNPS	Background: AKT1 (v-akt murine thymoma viral oncogene homologue 1) kinase is one of the most frequently activated proliferated and survival pathway of cancer. Recently it has been shown that E17K mutation in the Pleckstrin Homology (PH) domain of AKT1 protein leads to cancer by amplifying the phosphorylation and membrane localization of protein. The mutant has shown resistance to AKT1/2 inhibitor VIII drug molecule. In this study we have demonstrated the detailed structural and molecular consequences associated with the activity regulation of mutant protein. Methods: The docking score exhibited significant loss in the interaction affinity to AKT1/2 inhibitor VIII drug molecule. Furthermore, the molecular dynamics simulation studies presented an evidence of rapid conformational drift observed in mutant structure. Results: There was no stability loss in mutant as compared to native structure and the major cation-p interactions were also shown to be retained. Moreover, the active residues involved in membrane localization of protein exhibited significant rise in NHbonds formation in mutant. The rise in NHbond formation in active residues accounts for the 4-fold increase in the membrane localization potential of protein. Conclusion: The overall result suggested that, although the mutation did not induce any stability loss in structure, the associated pathological consequences might have occurred due to the rapid conformational drifts observed in the mutant AKT1 PH domain. General Significance: The methodology implemented and the results obtained in this work will facilitate in determining the core molecular mechanisms of cancer-associated mutations and in designing their potential drug inhibitors.	[Kumar, Ambuj; Purohit, Rituraj] Vellore Inst Technol Univ, Sch Bio Sci & Technol, Bioinformat Div, Vellore, Tamil Nadu, India; [Purohit, Rituraj] Human Genet Fdn, Turin, Italy	Vellore Institute of Technology	Purohit, R (corresponding author), Vellore Inst Technol Univ, Sch Bio Sci & Technol, Bioinformat Div, Vellore, Tamil Nadu, India.	riturajpurohit@gmail.com	Kumar, Ambuj/U-5268-2019; Purohit, Rituraj/I-8856-2012; Purohit, Rituraj/AAF-6257-2021; Kumar, Ambuj/E-4649-2012	Purohit, Rituraj/0000-0002-2101-9398; Purohit, Rituraj/0000-0002-2101-9398; Kumar, Ambuj/0000-0003-3692-3694				AHMED NN, 1993, ONCOGENE, V8, P1957; Balu K, 2013, CELL BIOCHEM BIOPHYS, V67, P623, DOI 10.1007/s12013-013-9551-6; Balu K, 2013, GENE, V513, P184, DOI 10.1016/j.gene.2012.09.128; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Cohen Y, 2010, GYNECOL ONCOL, V116, P88, DOI 10.1016/j.ygyno.2009.09.038; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Guo G, 2010, ONCOGENE, V29, P3845, DOI 10.1038/onc.2010.149; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jo H, 2011, P NATL ACAD SCI USA, V108, P6486, DOI 10.1073/pnas.1019062108; Khan S, 2004, INT J CANCER, V112, P407, DOI 10.1002/ijc.20447; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Kumar A, 2013, CELL BIOCHEM BIOPHYS, V66, P787, DOI 10.1007/s12013-013-9524-9; Kumar A, 2014, J BIOMOL STRUCT DYN, V32, P394, DOI 10.1080/07391102.2013.770373; Kumar A, 2012, FEBS OPEN BIO, V2, P285, DOI 10.1016/j.fob.2012.09.003; Kumar A, 2012, MUTAT RES-FUND MOL M, V738, P28, DOI 10.1016/j.mrfmmm.2012.08.005; Kumar A, 2012, GENE, V503, P75, DOI 10.1016/j.gene.2012.04.032; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Mahmoud IS, 2008, BRIT J CANCER, V99, P488, DOI 10.1038/sj.bjc.6604512; Mashiach E, 2010, PROTEINS, V78, P3197, DOI 10.1002/prot.22790; Mohamedali A, 2008, TECHNOL CANCER RES T, V7, P407, DOI 10.1177/153303460800700509; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pilling C, 2011, BIOCHEMISTRY-US, V50, P9845, DOI 10.1021/bi2011306; Psachoulia E, 2008, BIOCHEMISTRY-US, V47, P4211, DOI 10.1021/bi702319k; Purohit R, 2011, J BIOMOL STRUCT DYN, V29, P137, DOI 10.1080/07391102.2011.10507379; Purohit R, 2011, J MOL MODEL, V17, P869, DOI 10.1007/s00894-010-0785-6; Rajendran V, 2014, J BIOMOL STRUCT DYN, V32, P209, DOI 10.1080/07391102.2012.759885; Rajendran V, 2012, AMINO ACIDS, V43, P603, DOI 10.1007/s00726-011-1108-7; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogiatzi P, 2007, CANCER BIOL THER, V6, P1521, DOI 10.4161/cbt.6.10.4834; Zenz T, 2008, BRIT J HAEMATOL, V141, P742, DOI 10.1111/j.1365-2141.2008.07113.x; Zilberman DE, 2009, CANCER GENET CYTOGEN, V191, P34, DOI 10.1016/j.cancergencyto.2009.01.009	41	53	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64364	10.1371/journal.pone.0064364	http://dx.doi.org/10.1371/journal.pone.0064364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741320	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900032
J	Tada, H; Omori, Y; Hirokawa, K; Ohira, H; Tomonaga, M				Tada, Hideoki; Omori, Yasuko; Hirokawa, Kumi; Ohira, Hideki; Tomonaga, Masaki			Eye-Blink Behaviors in 71 Species of Primates	PLOS ONE			English	Article							VIGILANCE BEHAVIOR; COGNITIVE LOAD; RATES; FREQUENCY; EYEBLINK; MONKEYS; INFANTS; PARKINSONISM; MOVEMENTS; REFLEX	The present study was performed to investigate the associations between eye-blink behaviors and various other factors in primates. We video-recorded 141 individuals across 71 primate species and analyzed the blink rate, blink duration, and "isolated'' blink ratio (i.e., blinks without eye or head movement) in relation to activity rhythms, habitat types, group size, and body size factors. The results showed close relationships between three types of eye-blink measures and body size factors. All of these measures increased as a function of body weight. In addition, diurnal primates showed more blinks than nocturnal species even after controlling for body size factors. The most important findings were the relationships between eye-blink behaviors and social factors, e.g., group size. Among diurnal primates, only the blink rate was significantly correlated even after controlling for body size factors. The blink rate increased as the group size increased. Enlargement of the neocortex is strongly correlated with group size in primate species and considered strong evidence for the social brain hypothesis. Our results suggest that spontaneous eye-blinks have acquired a role in social communication, similar to grooming, to adapt to complex social living during primate evolution.	[Tada, Hideoki] Tohoku Gakuin Univ, Dept Psychol, Sendai, Miyagi 980, Japan; [Omori, Yasuko] Jinai Univ, Echizen, Japan; [Hirokawa, Kumi] Okayama Univ, Okayama, Japan; [Ohira, Hideki] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan	Tohoku Gakuin University; Okayama University; Nagoya University; Kyoto University	Tomonaga, M (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	tomonaga@pri.kyoto-u.ac.jp		Hirokawa, Kumi/0000-0002-5603-3739	Japan Society for the Promotion of Science [16530474, 23220006]; Cooperative Research Program of Primate Research Institute, Kyoto University [B-26(2003), B-26(2004), B-18(2005), B-9(2006)]; Grants-in-Aid for Scientific Research [25284003, 23220006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cooperative Research Program of Primate Research Institute, Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in Aid for Scientific Research from the Japan Society for the Promotion of Science (Research project numbers: 16530474 and 23220006) and by the Cooperative Research Program of Primate Research Institute, Kyoto University (Nos. B-26(2003), B-26(2004), B-18(2005), and B-9(2006)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankel-Simons F., 2007, PRIMATE ANATOMY, V3rd ed; APPEL VH, 1968, J COUNS PSYCHOL, V15, P153, DOI 10.1037/h0025545; Bacher LF, 2010, OPTOMETRY VISION SCI, V87, P337, DOI 10.1097/OPX.0b013e3181d951b2; Bacher LF, 2004, DEV PSYCHOBIOL, V44, P140, DOI 10.1002/dev.10159; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; Blount W., 1927, Q J EXP PHYSL, V18, P16, DOI [DOI 10.1113/EXPPHYSIOL.1927.SP000426, 10.1113/expphysiol.1927.sp000426]; BRANDT K, 1969, PERCEPT MOTOR SKILL, V29, P663, DOI 10.2466/pms.1969.29.2.663; Byrne R., 1988, MACHIAVELLIAN INTELL; Campbell CJ, 2007, PRIMATES PERSPECTIVE; CARRINGTON SD, 1987, J SMALL ANIM PRACT, V28, P605, DOI 10.1111/j.1748-5827.1987.tb01276.x; DEIKER T, 1976, AM J MENT DEF, V80, P665; DOANE MG, 1980, AM J OPHTHALMOL, V89, P507, DOI 10.1016/0002-9394(80)90058-6; Drew GC, 1951, Q J EXP PSYCHOL, V3, P73, DOI 10.1080/17470215108416776; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; ELSWORTH JD, 1991, J PHARMACOL EXP THER, V259, P595; EVINGER C, 1984, J NEUROPHYSIOL, V52, P323, DOI 10.1152/jn.1984.52.2.323; Fischer M.H, 1956, Z VERGL PHYSIOL, V39, P209; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; FREED WJ, 1981, BIOL PSYCHIAT, V16, P789; Groves C.P., 2001, PRIMATE TAXONOMY; Hall RJ, 1972, 1872 US ARM AB RES D; Hart WM, 1992, ADLERS PHYSL EYE, P1; HEGLUND NC, 1988, J EXP BIOL, V138, P301; Hirsch BT, 2002, BEHAV ECOL SOCIOBIOL, V52, P458, DOI 10.1007/s00265-002-0536-5; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; ISON JR, 1971, J COMP PHYSIOL PSYCH, V75, P157, DOI 10.1037/h0030671; Karson C N, 1988, Adv Neurol, V49, P25; KARSON CN, 1990, SCHIZOPHRENIA BULL, V16, P344, DOI 10.1093/schbul/16.2.345; KARSON CN, 1981, NEUROPHARMACOLOGY, V20, P91, DOI 10.1016/0028-3908(81)90049-6; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; KARSON CN, 1983, PSYCHOPHARMACOL BULL, V19, P620; KARSON CN, 1979, AM J PSYCHIAT, V136, P1057; KARSON CN, 1981, BIOL PSYCHIAT, V16, P249; KARSON CN, 1982, ANN NEUROL, V12, P580, DOI 10.1002/ana.410120614; Kingdon J, 2007, FOLIA PRIMATOL, V78, P389, DOI 10.1159/000105151; KIRSTEN SJ, 1983, CONDOR, V85, P92, DOI 10.2307/1367896; Knorr A, 1929, WURZUBURGER ABHANDLU, V25, P197; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Kobayashi H, 2011, EVOL HUM BEHAV, V32, P157, DOI 10.1016/j.evolhumbehav.2010.08.003; Kutsukake N, 2007, INT J PRIMATOL, V28, P907, DOI 10.1007/s10764-007-9156-2; LANCMAN ME, 1993, EPILEPSIA, V34, P1085, DOI 10.1111/j.1528-1157.1993.tb02137.x; LAWRENCE MS, 1991, LIFE SCI, V49, pPL229, DOI 10.1016/0024-3205(91)90299-Q; Macdonald DW, 1984, ENCY ANIMALS; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; MENZEL CR, 1980, ANIM BEHAV, V28, P151, DOI 10.1016/S0003-3472(80)80020-0; Mowrer OH, 1933, J COMP PSYCHOL, V15, P75, DOI 10.1037/h0071100; Nakano T, 2009, P ROY SOC B-BIOL SCI, V276, P3635, DOI 10.1098/rspb.2009.0828; Napier J. R., 1985, NATURAL HIST PRIMATE; NORN MS, 1969, ACTA OPHTHALMOL, V47, P865; O'Regan JK, 2000, VIS COGN, V7, P191, DOI 10.1080/135062800394766; Ohira H, 1996, PERCEPT MOTOR SKILL, V82, P835, DOI 10.2466/pms.1996.82.3.835; Omori Y, 2001, SOC BEHAV PERSONAL, V29, P159, DOI 10.2224/sbp.2001.29.2.159; OSTOW M, 1945, J NERV MENT DIS, V102, P294, DOI 10.1097/00005053-194509000-00012; Paas F, 2003, EDUC PSYCHOL-US, V38, P63, DOI 10.1207/S15326985EP3801_8; Ponder E, 1927, Q J EXP PHYSL, V18, P99; Rowe N, 2011, ALL WORLDS PRIMATES; Rowe N, 1996, PICTORIAL GUIDE LIVI; Sato Yoshiaki, 2010, Japanese Journal of Animal Psychology, V60, P139, DOI 10.2502/janip.60.2.4; Segraves T, 1996, AM J PSYCHIAT, V153, P844; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Smuts B. B., 1987, PRIMATE SOC; Stern JA, 2005, PSYCHOLOGIA, V48, P133, DOI 10.2117/psysoc.2005.133; STERN JA, 1984, PSYCHOPHYSIOLOGY, V21, P22, DOI 10.1111/j.1469-8986.1984.tb02312.x; STEVENS JR, 1978, EXP NEUROL, V60, P541, DOI 10.1016/0014-4886(78)90009-2; Sugiyama T, 2008, INT J PSYCHOPHYSIOL, V69, P232, DOI 10.1016/j.ijpsycho.2008.05.094; Taylor JR, 1999, EXP NEUROL, V158, P214, DOI 10.1006/exnr.1999.7093; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; Whiten A., 1997, MACHIAVELLIAN INTELL, DOI [10.1017/CBO9780511525636, DOI 10.1017/CBO9780511525636]; Zaman ML, 1997, OPHTHAL PHYSL OPT, V17, P421, DOI 10.1111/j.1475-1313.1997.tb00075.x; ZAMETKIN AJ, 1979, ANN NEUROL, V5, P453, DOI 10.1002/ana.410050509	71	25	25	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e66018	10.1371/journal.pone.0066018	http://dx.doi.org/10.1371/journal.pone.0066018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741522	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900235
J	Wang, WB; Yang, L; Hu, L; Li, F; Ren, L; Yu, HJ; Liu, Y; Xia, L; Lei, H; Liao, ZK; Zhou, FX; Xie, CH; Zhou, YF				Wang, Wenbo; Yang, Lei; Hu, Liu; Li, Fen; Ren, Li; Yu, Haijun; Liu, Yu; Xia, Ling; Lei, Han; Liao, Zhengkai; Zhou, Fuxiang; Xie, Conghua; Zhou, Yunfeng			Inhibition of UBE2D3 Expression Attenuates Radiosensitivity of MCF-7 Human Breast Cancer Cells by Increasing hTERT Expression and Activity	PLOS ONE			English	Article							HUMAN TELOMERASE ACTIVITY; THERAPY; CYCLIN; RNA; ACTIVATION; P53	The known functions of telomerase in tumor cells include replenishing telomeric DNA and maintaining cell immortality. We have previously shown the existence of a negative correlation between human telomerase reverse transcriptase (hTERT) and radiosensitivity in tumor cells. Here we set out to elucidate the molecular mechanisms underlying regulation by telomerase of radiosensitivity in MCF-7 cells. Toward this aim, yeast two-hybrid (Y2H) screening of a human laryngeal squamous cell carcinoma radioresistant (Hep2R) cDNA library was first performed to search for potential hTERT interacting proteins. We identified ubiquitin-conjugating enzyme E2D3 (UBE2D3) as a principle hTERT-interacting protein and validated this association biochemically. ShRNA-mediated inhibition of UBE2D3 expression attenuated MCF-7 radiosensitivity, and induced the accumulation of hTERT and cyclin D1 in these cells. Moreover, down-regulation of UBE2D3 increased hTERT activity and cell proliferation, accelerating G1 to S phase transition in MCF-7 cells. Collectively these findings suggest that UBE2D3 participates in the process of hTERT-mediated radiosensitivity in human breast cancer MCF-7 cells by regulating hTERT and cyclin D1.	[Wang, Wenbo; Yang, Lei; Hu, Liu; Li, Fen; Ren, Li; Yu, Haijun; Liu, Yu; Xia, Ling; Lei, Han; Liao, Zhengkai; Zhou, Fuxiang; Xie, Conghua; Zhou, Yunfeng] Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Tumor Biol Behav, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China; [Yu, Haijun; Liu, Yu; Xia, Ling; Lei, Han; Liao, Zhengkai; Zhou, Fuxiang; Xie, Conghua; Zhou, Yunfeng] Wuhan Univ, Zhongnan Hosp, Dept Radiat Oncol & Med Oncol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zhou, YF (corresponding author), Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Tumor Biol Behav, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China.	yfzhouwhu@163.com			National Basic Research Program of China [2009CB526410]; National Natural Science Foundation of China [81071825]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (No.2009CB526410) and National Natural Science Foundation of China (No.81071825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Bouffler SD, 1998, MUTAT RES-FUND MOL M, V404, P199, DOI 10.1016/S0027-5107(98)00114-6; Chen M, 2007, CANCER-AM CANCER SOC, V109, P1157, DOI 10.1002/cncr.22493; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Finley D., 2004, CELL, V116, pS32; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Hattori H, 2007, BLOOD, V110, P640, DOI 10.1182/blood-2006-11-059048; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Inderberg-Suso EM, 2012, ONCOIMMUNOLOGY, V1, P670, DOI 10.4161/onci.20426; Ji XM, 2006, ACTA PHARMACOL SIN, V27, P1185, DOI 10.1111/j.1745-7254.2006.00417.x; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kirkpatrick KL, 2003, EUR J SURG ONCOL, V29, P321, DOI 10.1053/ejso.2002.1374; Kurvinen K, 2006, INT J RADIAT BIOL, V82, P859, DOI 10.1080/09553000600969812; Leteurtre F, 1997, LEUKEMIA, V11, P1681, DOI 10.1038/sj.leu.2400784; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; Mansfield L, 2007, ANTICANCER RES, V27, P2265; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Moll UM, 2003, MOL CANCER RES, V1, P1001; Oh ST, 2001, J VIROL, V75, P5559, DOI 10.1128/JVI.75.12.5559-5566.2001; Okamoto Y, 2003, CANCER RES, V63, P4167; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Sawant SG, 1999, FASEB J, V13, P1047, DOI 10.1096/fasebj.13.9.1047; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shimura T, 2010, ONCOGENE, V29, P4826, DOI 10.1038/onc.2010.238; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Wang XW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2533; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Xiong J, 2012, CANCER-AM CANCER SOC, V118, P536, DOI 10.1002/cncr.26289; Zhang XD, 2005, NAT CELL BIOL, V7, P12, DOI 10.1038/ncb0105-12; Zhong YH, 2008, BIOCHEM BIOPH RES CO, V367, P84, DOI 10.1016/j.bbrc.2007.12.078; Zhou FX, 2007, BIOCHEM BIOPH RES CO, V354, P351, DOI 10.1016/j.bbrc.2006.12.180	37	39	39	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64660	10.1371/journal.pone.0064660	http://dx.doi.org/10.1371/journal.pone.0064660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741361	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900074
J	Xu, WH; Li, ZC; Yu, B; He, XY; Shi, JS; Zhou, R; Liu, DW; Wu, ZF				Xu, Weihua; Li, Zicong; Yu, Bo; He, Xiaoyan; Shi, Junsong; Zhou, Rong; Liu, Dewu; Wu, Zhenfang			Effects of DNMT1 and HDAC Inhibitors on Gene-Specific Methylation Reprogramming during Porcine Somatic Cell Nuclear Transfer	PLOS ONE			English	Article							XIST EXPRESSION; MECHANISMS; PIG; DISRUPTION; EFFICIENCY; REGIONS; CLONING; LOCUS; IGF2	Somatic cell nuclear transfer (SCNT) in mammalian cloning currently remains inefficient. Incomplete or erroneous epigenetic reprogramming of specialized donor somatic nuclear and resulting aberrant gene expression during development of cloned embryos is commonly believed as the main reason that causes the low efficiency of SCNT. Use of small molecular reprogramming modifiers to assist the somatic nucleus to mimic naturally occurring DNA methylation and chromatin remodeling in nucleus of fertilization-derived zygotes, has been widely attempted to improve cloning efficiency. However, impacts of these small modifiers on gene-specific methylation dynamics and their potential effects on methylation of imprinted gene have rarely been traced. Here, we attempted two relatively novel DNMT1 inhibitor (DNMTi) and histone deacetylase inhibitor (HDACi), scriptaid and RG108, and demonstrated their effects on dynamics of gene-specific DNA methylation and transcription of porcine SCNT embryos. We found that scriptaid and RG108 had synergetic effects on rescuing the disrupted methylation imprint of H19 during SCNT at least partially by repression over-expressed MBD3 in eight-cell cloned embryos. Furthermore, we firstly identified a differential methylation regions (DMRs) at 59 flanking regions of XIST gene and found that scriptaid alone and its combination with RG108 modify the dynamics of both transcription and DNA methylation levels in cloned embryos, by different manners. Additionally, we found that scriptaid alone and its combination with RG108 can significantly promote the transcription of NANOG in cloned embryos and enhance their preimplantation developmental capacity. Our results would contribute to uncovering the epigenetic reprogramming mechanisms underlying the effects of assisted small molecules on improvement of mammalian cloning efficiency.	[Xu, Weihua; Li, Zicong; Yu, Bo; Liu, Dewu; Wu, Zhenfang] South China Agr Univ, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Xu, Weihua] Longyan Univ, Coll Life Sci, Longyan, Fujian, Peoples R China; [He, Xiaoyan; Shi, Junsong; Zhou, Rong; Wu, Zhenfang] Wens Res Inst, Yunfu, Guangdong, Peoples R China	South China Agricultural University; Longyan University	Wu, ZF (corresponding author), South China Agr Univ, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China.	wzfemail@163.com		Wu, Zhenfang/0000-0002-5586-6771	National High Technology Research and Development Program of China ("863" Program) [2011AA100304]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2011ZX08006004]; Department of Science and Technology of Guangdong [2011A020901001]; Guangdong Science and Technology Project [2011A020102003]	National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China); National Science and Technology Major Project of the Ministry of Science and Technology of China; Department of Science and Technology of Guangdong; Guangdong Science and Technology Project	This study was supported by a grant from the National High Technology Research and Development Program of China ("863" Program, grant number: 2011AA100304), and a grant from the National Science and Technology Major Project of the Ministry of Science and Technology of China (grant number: 2011ZX08006004), and a grant from Department of Science and Technology of Guangdong (grant number: 2011A020901001), and a grant from Guangdong Science and Technology Project (grant number: 2011A020102003), and a grant from Department of Science and Technology of Guangdong (2008A024200012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SE, 2008, GENE, V420, P99, DOI 10.1016/j.gene.2008.05.009; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Cervera RP, 2009, THERIOGENOLOGY, V72, P1097, DOI 10.1016/j.theriogenology.2009.06.030; Chen HL, 2006, EMBO J, V25, P5329, DOI 10.1038/sj.emboj.7601399; Deng W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019986; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Li C, 2011, REPROD FERT DEVELOP, V23, P138, DOI 10.1071/RDv23n1Ab64; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Li ZC, 2013, CELL REPROGRAM, V15, P35, DOI 10.1089/cell.2012.0042; Lucifero D, 2004, HUM REPROD UPDATE, V10, P3, DOI 10.1093/humupd/dmh002; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Miyamoto K, 2009, BIOL REPROD, V80, P935, DOI 10.1095/biolreprod.108.073676; MONK M, 1995, DEV GENET, V17, P188, DOI 10.1002/dvg.1020170303; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; Ogawa H, 2003, REPRODUCTION, V126, P549, DOI 10.1530/rep.0.1260549; Park CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051398; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; Peat JR, 2012, NAT GENET, V44, P965, DOI 10.1038/ng.2393; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Reese KJ, 2007, PLOS GENET, V3, P1407, DOI 10.1371/journal.pgen.0030137; Shemer R, 1996, P NATL ACAD SCI USA, V93, P6371, DOI 10.1073/pnas.93.13.6371; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Su GH, 2000, CANCER RES, V60, P3137; Sumer H, 2010, THERIOGENOLOGY, V74, P525, DOI 10.1016/j.theriogenology.2010.05.030; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Weaver JR, 2009, MAMM GENOME, V20, P532, DOI 10.1007/s00335-009-9225-2; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020154; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yoshioka K, 2003, BIOL REPROD, V69, P2092, DOI 10.1095/biolreprod.103.020081; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Yuan X, 2011, PROG DRUG RES, V67, P253, DOI 10.1007/978-3-7643-8989-5_13; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	46	48	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64705	10.1371/journal.pone.0064705	http://dx.doi.org/10.1371/journal.pone.0064705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741375	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900088
J	Yang, DR; Xue, BB; Wang, XH; Yu, XY; Liu, NL; Gao, YM; Liu, C; Zhu, HZ				Yang, Darong; Xue, Binbin; Wang, Xiaohong; Yu, Xiaoyan; Liu, Nianli; Gao, Yimin; Liu, Chen; Zhu, Haizhen			2-Octynoic Acid Inhibits Hepatitis C Virus Infection through Activation of AMP-Activated Protein Kinase	PLOS ONE			English	Article							REPLICATION; RESISTANCE; IDENTIFICATION	Many chronic hepatitis C virus (HCV)-infected patients with current therapy do not clear the virus. It is necessary to find novel treatments. The effect of 2-octynoic acid (2-OA) on HCV infection in human hepatocytes was examined. The mechanism of 2-OA antiviral activity was explored. Our data showed that 2-OA abrogated lipid accumulation in HCV replicon cells and virus-infected hepatocytes. It suppressed HCV RNA replication and infectious virus production with no cytotoxicity to the host cells. 2-OA did not affect hepatitis B virus replication in HepG2.2.15 cells derived from HepG2 cells transfected with full genome of HBV. Further study demonstrated that 2-OA activated AMP-activated protein kinase (AMPK) and inhibited acetyl-CoA carboxylase in viral-infected cells. Compound C, a specific inhibitor of AMPK, inhibited AMPK activity and reversed the reduction of intracellular lipid accumulation and the antiviral effect of 2-OA. Knockdown of AMPK expression by RNA interference abolished the activation of AMPK by 2-OA and blocked 2-OA antiviral activity. Interestingly, 2-OA induced interferon-stimulated genes (ISGs) and inhibited microRNA-122 (miR-122) expression in virus-infected hepatocytes. MiR-122 overexpression reversed the antiviral effect of 2-OA. Furthermore, knockdown of AMPK expression reversed both the induction of ISGs and suppression of miR-122 by 2-OA, implying that activated AMPK induces the intracellular innate response through the induction of ISGs and inhibiting miR-122 expression. 2-OA inhibits HCV infection through regulation of innate immune response by activated AMPK. These findings reveal a novel mechanism by which active AMPK inhibits HCV infection. 2-OA and its derivatives hold promise for novel drug development for chronic hepatitis C.	[Yang, Darong; Xue, Binbin; Wang, Xiaohong; Yu, Xiaoyan; Liu, Nianli; Gao, Yimin; Zhu, Haizhen] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Coll Biol, Dept Mol Med, Changsha, Hunan, Peoples R China; [Yang, Darong; Liu, Nianli; Zhu, Haizhen] Hunan Univ, Res Ctr Canc Prevent & Treatment, Changsha, Hunan, Peoples R China; [Yang, Darong; Liu, Nianli; Zhu, Haizhen] Cent South Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Hunan Prov Tumor Hosp,Translat Med Res Ctr Liver, Changsha, Hunan, Peoples R China; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Hunan University; Hunan University; Central South University; State University System of Florida; University of Florida	Zhu, HZ (corresponding author), Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Coll Biol, Dept Mol Med, Changsha, Hunan, Peoples R China.	zhuhaizhen69@yahoo.com	Yang, Darong/HHZ-5465-2022; Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022; Gao, Yu/HGE-1937-2022	Yang, Darong/0000-0002-5343-9047	National Science and Technology Major Project of the Ministry of Science and Technology of China [2009ZX10004-312]; National Natural Science Foundation of China [81271885]; Program for New Century Excellent Talents in University [NCET-09-0339]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Science and Technology Major Project of the Ministry of Science and Technology of China (2009ZX10004-312), National Natural Science Foundation of China (81271885), and Program for New Century Excellent Talents in University (NCET-09-0339) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2005, J IMMUNOL, V174, P5874, DOI 10.4049/jimmunol.174.9.5874; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chin G, 2010, SCIENCE, V330, P297; De Francesco R, 2005, NATURE, V436, P953, DOI 10.1038/nature04080; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Guo JT, 2003, J VIROL, V75, P8516; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Kim J, 2005, J CHEM ECOL, V31, P1381, DOI 10.1007/s10886-005-5292-3; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; Rice Charles M, 2011, Top Antivir Med, V19, P117; Shindo H, 2012, HEPATOL INT, V6, P482, DOI 10.1007/s12072-011-9306-7; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Yang DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027552; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017; Zhu HZ, 2003, J VIROL, V77, P5493, DOI 10.1128/JVI.77.9.5493-5498.2003; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184	29	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64932	10.1371/journal.pone.0064932	http://dx.doi.org/10.1371/journal.pone.0064932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741428	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900141
J	Zhang, TJ; Guo, XG; Chen, YL				Zhang, Tiejun; Guo, Xiaogang; Chen, Yonglong			Retinoic Acid-Activated Ndrg1a Represses Wnt/beta-catenin Signaling to Allow Xenopus Pancreas, Oesophagus, Stomach, and Duodenum Specification	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-3; LIVER DYSFUNCTION; GENE-EXPRESSION; BETA-CATENIN; ENDODERM; ATF3; ENDOCRINE; FATE; DOWNSTREAM; PROTEIN	How cells integrate multiple patterning signals to achieve early endoderm regionalization remains largely unknown. Between gastrulation and neurulation, retinoic acid (RA) signaling is required, while Wnt/beta-catenin signaling has to be repressed for the specification of the pancreas, oesophagus, stomach, and duodenum primordia in Xenopus embryos. In attempt to screen for RA regulated genes in Xenopus endoderm, we identified a direct RA target gene, N-myc downstream regulated gene 1a (ndrg1a) that showed expression early in the archenteron roof endoderm and late in the developing pancreas, oesophagus, stomach, and duodenum. Both antisense morpholino oligonucleotide mediated knockdown of ndrg1a in Xenopus laevis and the transcription activator-like effector nucleases (TALEN) mediated disruption of ndrg1 in Xenopus tropicalis demonstrate that like RA signaling, Ndrg1a is specifically required for the specification of Xenopus pancreas, oesophagus, stomach, and duodenum primordia. Immunofluorescence data suggest that RA-activated Ndrg1a suppresses Wnt/beta-catenin signaling in Xenopus archenteron roof endoderm cells. Blocking Wnt/beta-catenin signaling rescued Ndrg1a knockdown phenotype. Furthermore, overexpression of the putative Wnt/beta-catenin target gene Atf3 phenocopied knockdown of Ndrg1a or inhibition of RA signaling, while Atf3 knockdown can rescue Ndrg1a knockdown phenotype. Lastly, the pancreas/stomach/duodenum transcription factor Pdx1 was able to rescue Atf3 overexpression or Ndrg1a knockdown phenotype. Together, we conclude that RA activated Ndrg1a represses Wnt/beta-catenin signaling to allow the specification of pancreas, oesophagus, stomach, and duodenum progenitor cells in Xenopus embryos.	[Zhang, Tiejun; Guo, Xiaogang; Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Peoples R China; [Zhang, Tiejun; Guo, Xiaogang; Chen, Yonglong] Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China; [Zhang, Tiejun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, YL (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Peoples R China.	chen_yonglong@gibh.ac.cn	Zhang, Tiejun/HDM-7091-2022		National Basic Research Program of China [2009CB941200]; National Natural Science Foundation of China [31271554]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the National Basic Research Program of China (2009CB941200) and the National Natural Science Foundation of China (31271554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afelik S, 2004, GENE EXPR PATTERNS, V4, P71, DOI 10.1016/S1567-133X(03)00150-9; Afelik S, 2006, GENE DEV, V20, P1441, DOI 10.1101/gad.378706; Allen-Jennings AE, 2002, J BIOL CHEM, V277, P20020, DOI 10.1074/jbc.M200727200; Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Arima K, 2005, DEV DYNAM, V232, P414, DOI 10.1002/dvdy.20231; Bayha E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005845; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chalmers AD, 2000, DEVELOPMENT, V127, P381; Chalmers AD, 2000, MECH DEVELOP, V96, P125, DOI 10.1016/S0925-4773(00)00379-8; Chen F, 2010, J CLIN INVEST, V120, P2040, DOI 10.1172/JCI40253; Chen S, 2009, LEUKEMIA RES, V33, P1108, DOI 10.1016/j.leukres.2008.10.016; Chen Y, 2003, MECH DEVELOP, V120, P277, DOI 10.1016/S0925-4773(02)00460-4; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Costa RMB, 2003, GENE EXPR PATTERNS, V3, P509, DOI 10.1016/S1567-133X(03)00086-3; Dalgin G, 2011, DEVELOPMENT, V138, P4597, DOI 10.1242/dev.067736; Damianitsch K, 2009, DEV BIOL, V329, P327, DOI 10.1016/j.ydbio.2009.03.004; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Franklin V, 2008, MECH DEVELOP, V125, P587, DOI 10.1016/j.mod.2008.04.001; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hausen P., 1991, EARLY DEV XENOPUS LA; Horb ME, 2002, MECH DEVELOP, V113, P153, DOI 10.1016/S0925-4773(02)00019-9; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Jang MK, 2011, BIOCHEM BIOPH RES CO, V412, P385, DOI 10.1016/j.bbrc.2011.07.108; Jarikji ZH, 2007, DEV BIOL, V304, P786, DOI 10.1016/j.ydbio.2007.01.027; Jiang Z, 2008, PLOS BIOL, V6, P2450, DOI 10.1371/journal.pbio.0060293; Jung EU, 2010, CANCER LETT, V298, P9, DOI 10.1016/j.canlet.2010.05.020; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; Kelly OG, 2000, DEV DYNAM, V218, P615, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1027>3.0.CO;2-8; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kim WH, 2011, BIOCHEM BIOPH RES CO, V414, P681, DOI 10.1016/j.bbrc.2011.09.132; Kimura W, 2006, DEV BIOL, V289, P283, DOI 10.1016/j.ydbio.2005.09.009; King RHM, 2011, NEUROBIOL DIS, V42, P368, DOI 10.1016/j.nbd.2011.01.030; Kinkel MD, 2008, DEVELOPMENT, V135, P919, DOI 10.1242/dev.010660; Kinkel MD, 2009, P NATL ACAD SCI USA, V106, P7864, DOI 10.1073/pnas.0813108106; Kyuno J, 2003, BIOCHEM BIOPH RES CO, V309, P52, DOI 10.1016/S0006-291X(03)01522-5; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Lewis SL, 2006, DEV DYNAM, V235, P2315, DOI 10.1002/dvdy.20846; Li SW, 2008, DIFFERENTIATION, V76, P897, DOI 10.1111/j.1432-0436.2008.00269.x; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Neto A, 2012, DEVELOPMENT, V139, P301, DOI 10.1242/dev.074856; Newman CS, 1997, MECH DEVELOP, V66, P83, DOI 10.1016/S0925-4773(97)00092-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Pan FC, 2007, MECH DEVELOP, V124, P518, DOI 10.1016/j.mod.2007.06.003; Piquemal D, 1999, BBA-MOL CELL RES, V1450, P364, DOI 10.1016/S0167-4889(99)00056-7; Rankin SA, 2012, DEVELOPMENT, V139, P3010, DOI 10.1242/dev.078220; Rankin SA, 2011, DEV BIOL, V351, P297, DOI 10.1016/j.ydbio.2010.11.037; Schohl A, 2002, DEVELOPMENT, V129, P37; Seo YW, 2002, J BIOL CHEM, V277, P17836, DOI 10.1074/jbc.M111795200; Small EM, 2000, MECH DEVELOP, V96, P259, DOI 10.1016/S0925-4773(00)00400-7; Spagnoli FM, 2006, DEV BIOL, V292, P442, DOI 10.1016/j.ydbio.2006.01.022; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003; Tschan MP, 2010, LEUKEMIA RES, V34, P393, DOI 10.1016/j.leukres.2009.08.037; Warga RM, 1999, DEVELOPMENT, V126, P827; WRIGHT CVE, 1989, DEVELOPMENT, V105, P787; Zhao H, 2012, P NATL ACAD SCI USA, V109, P8594, DOI 10.1073/pnas.1206547109; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	71	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65058	10.1371/journal.pone.0065058	http://dx.doi.org/10.1371/journal.pone.0065058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741453	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900166
J	Wang, JX; Zhang, PP; Shen, QQ; Wang, Q; Liu, DM; Li, J; Wang, L				Wang, Jinxiang; Zhang, Pingping; Shen, Qingqing; Wang, Qian; Liu, Dongmei; Li, Jing; Wang, Lan			The Effects of Cadmium Exposure on the Oxidative State and Cell Death in the Gill of Freshwater Crab Sinopotamon henanense	PLOS ONE			English	Article							HUMAN PROMONOCYTIC CELLS; METALLOTHIONEIN ISOFORMS; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; GENE-EXPRESSION; APOPTOSIS; STRESS; NECROSIS; INDUCTION; RESPONSES	We studied here the short-term toxicity effects of Cd on the oxidative state and cell death in the gill of freshwater crab Sinopotamon henanense. Crabs were exposed to Cd that resulted in Cd accumulation and a significant increase in the metallothionein (MT) level in the gill, but MT level increased disproportionally compared to the Cd accumulation with an extension of exposure time. Significant changes in the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were observed. An increase in the levels of reactive oxygen species (ROS) and lipid peroxidation (LPO) was detected that will cause oxidative stress. Histological abnormalities of the gills were discovered, including the expansion of gill cavity, a decrease in the numbers of connection of the upper and the lower of the gill lamellae and epithelial cells, and an increase in the number of hemocytes. The results of a TUNEL test and transmission electron microscope (TEM) showed that more gill cells had apoptotic characteristics after 48 h of Cd treatment compared to the control, but epithelial cell necrosis and inflammatory response appeared only after 72 h. It was concluded that (1) Cd induced the ROS production and accumulation through inhibiting antioxidant enzyme activities and exceeding the saturation values of MT binging; (2) Cd led to lipid peroxidation and histopathological alternations; and (3) Cd induced apoptotic response at short time exposure, followed by necrotic features and inflammatory reaction after longer time exposure.	[Wang, Jinxiang; Zhang, Pingping; Shen, Qingqing; Wang, Qian; Liu, Dongmei; Li, Jing; Wang, Lan] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China; [Wang, Jinxiang] Shanxi Datong Univ, Sch Life Sci, Datong, Peoples R China	Shanxi University; Shanxi Datong University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China.	lanwang.sxu@qq.com			National Natural Science Foundation of China [30870267, 30970361]; China Postdoctoral Science Foundation [2012M511081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (No. 30870267; 30970361) and a China Postdoctoral Science Foundation Funded Project (No. 2012M511081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Akashi K, 2004, BIOCHEM BIOPH RES CO, V323, P72, DOI 10.1016/j.bbrc.2004.08.056; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buico A, 2008, J INORG BIOCHEM, V102, P921, DOI 10.1016/j.jinorgbio.2007.12.012; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Galan A, 2001, EUR J CELL BIOL, V80, P312, DOI 10.1078/0171-9335-00159; Gao AB, 2012, EXP TOXICOL PATHOL, V64, P253, DOI 10.1016/j.etp.2010.08.017; Ghoshal K, 2000, BIOCHEM PHARMACOL, V59, P95; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hollis L, 1999, AQUAT TOXICOL, V46, P101, DOI 10.1016/S0166-445X(98)00118-0; Ishido M, 2002, ENVIRON HEALTH PERSP, V110, P37, DOI 10.1289/ehp.0211037; Kaoud HA, 2011, LIFE SCI J, V8, P185; Kefaloyianni E, 2005, J EXP BIOL, V208, P4427, DOI 10.1242/jeb.01924; Kim SC, 2003, TOXICOL LETT, V144, P325, DOI 10.1016/S0378-4274(03)00233-9; Lei WW, 2011, CHEMOSPHERE, V84, P689, DOI 10.1016/j.chemosphere.2011.03.023; Li N, 2007, ARCH ENVIRON CON TOX, V52, P73, DOI 10.1007/s00244-005-0214-5; Li Y, 2012, AQUAT TOXICOL, V120, P90, DOI 10.1016/j.aquatox.2012.04.016; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Lopez E, 2006, FREE RADICAL BIO MED, V40, P940, DOI 10.1016/j.freeradbiomed.2005.10.062; Ma WL, 2008, ENVIRON TOXICOL, V23, P393, DOI 10.1002/tox.20339; Matz CJ, 2007, ENVIRON SCI TECHNOL, V41, P5143, DOI 10.1021/es070452c; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nzengue Y, 2008, FREE RADICAL RES, V42, P142, DOI 10.1080/10715760701837100; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Palomba L, 1999, BIOCHEM PHARMACOL, V58, P1743, DOI 10.1016/S0006-2952(99)00271-3; PEDERSEN KL, 1994, BIOCHEM J, V297, P609, DOI 10.1042/bj2970609; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Qin Q, 2012, AQUAT TOXICOL, V106, P140, DOI 10.1016/j.aquatox.2011.08.013; Risso-de Faverney C, 2004, AQUAT TOXICOL, V69, P247, DOI 10.1016/j.aquatox.2004.05.011; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Samali A, 1999, BIOCHEM BIOPH RES CO, V255, P6, DOI 10.1006/bbrc.1998.0139; SCHLENK D, 1993, MAR ENVIRON RES, V35, P7, DOI 10.1016/0141-1136(93)90005-K; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Somji S, 2004, TOXICOL SCI, V80, P358, DOI 10.1093/toxsci/kfh158; STEGEMAN JJ, 1992, SETAC SP P, P235; Troyano A, 2001, J BIOL CHEM, V276, P47107, DOI 10.1074/jbc.M104516200; Tully DB, 2000, TOXICOL APPL PHARM, V168, P79, DOI 10.1006/taap.2000.9014; VERBOST PM, 1989, J EXP BIOL, V145, P185; Wang JX, 2012, COMP BIOCHEM PHYS C, V156, P195, DOI 10.1016/j.cbpc.2012.05.006; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024405; Yang PM, 2007, CHEM RES TOXICOL, V20, P406, DOI 10.1021/tx060144c	44	45	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64020	10.1371/journal.pone.0064020	http://dx.doi.org/10.1371/journal.pone.0064020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737962	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700026
J	Xu, HB; Nobile, CJ; Dongari-Bagtzoglou, A				Xu, Hongbin; Nobile, Clarissa J.; Dongari-Bagtzoglou, Anna			Glucanase Induces Filamentation of the Fungal Pathogen Candida albicans	PLOS ONE			English	Article							GERM-TUBE FORMATION; MOLECULAR-CLONING; O-MANNOSYLATION; GENE; MORPHOGENESIS; INDUCTION; PATHWAY; GROWTH	Candida albicans is the most common human fungal pathogen. Many organisms, including C. albicans, secrete glucanases under different environmental conditions. Here, we report a novel role for beta-1, 3-glucanase in inducing Candida albicans to form filaments at 22 degrees C and enhancing filamentation at 37 degrees C in nutrient-rich medium. Quorum sensing, the efg1-signaling and cek1 MAP kinase pathways are involved in this process. Our data suggest that the natural antifungal agent beta-glucanase may support morphologic transformation of Candida albicans at a wide range of ambient temperatures.	[Xu, Hongbin; Dongari-Bagtzoglou, Anna] Univ Connecticut, Ctr Hlth, Dept Oral Hlth & Diagnost Sci, Farmington, CT 06030 USA; [Nobile, Clarissa J.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Connecticut; University of California System; University of California San Francisco	Xu, HB (corresponding author), Univ Connecticut, Ctr Hlth, Dept Oral Hlth & Diagnost Sci, Farmington, CT 06030 USA.	hxu@uchc.edu	Nobile, Clarissa/C-2407-2015; Xu, Hongbin/B-3965-2016	Nobile, Clarissa/0000-0003-0799-6499; Xu, Hongbin/0000-0003-1246-3849	National Institutes for Health [R01 DE13986]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013986] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by National Institutes for Health R01 DE13986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Ait-Lahsen H, 2001, APPL ENVIRON MICROB, V67, P5833, DOI 10.1128/AEM.67.12.5833-5839.2001; Argimon S, 2007, EUKARYOT CELL, V6, P682, DOI 10.1128/EC.00340-06; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Balasubramanian V, 2012, BIOTECHNOL LETT, V34, P1983, DOI 10.1007/s10529-012-1012-6; Bassilana M, 2006, EUKARYOT CELL, V5, P321, DOI 10.1128/EC.5.2.321-329.2006; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Calderone RA., 2002, CANDIDA CANDIDIASIS; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; Cantero PD, 2011, MOL MICROBIOL, V80, P715, DOI 10.1111/j.1365-2958.2011.07604.x; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Desalermos A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002451; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Ferrer P, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-10; Ganguly S, 2011, EUKARYOT CELL, V10, P1448, DOI 10.1128/EC.05196-11; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Huang H, 2008, MICROBIOL RES, V163, P380, DOI 10.1016/j.micres.2008.03.001; KAUFFMANN S, 1987, EMBO J, V6, P3209, DOI 10.1002/j.1460-2075.1987.tb02637.x; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; MCCREATH KJ, 1995, P NATL ACAD SCI USA, V92, P2544, DOI 10.1073/pnas.92.7.2544; MOLINA M, 1987, J GEN MICROBIOL, V133, P609; Nett JE, 2010, INFECT IMMUN, V78, P3650, DOI 10.1128/IAI.00480-10; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; RAM SP, 1984, J GEN MICROBIOL, V130, P1227; SABIE F, 1988, MYCOPATHOLOGIA, V101, P77, DOI 10.1007/BF00452890; Sandini S, 2007, CELL MICROBIOL, V9, P1223, DOI 10.1111/j.1462-5822.2006.00862.x; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; TAKEUCHI Y, 1990, PLANT PHYSIOL, V93, P673, DOI 10.1104/pp.93.2.673; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021394; Vazquez-Garciduenas S, 1998, APPL ENVIRON MICROB, V64, P1442; Xie ZH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-93; Xu WJ, 2012, CURR BIOL, V22, pR225, DOI 10.1016/j.cub.2012.02.037	37	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63736	10.1371/journal.pone.0063736	http://dx.doi.org/10.1371/journal.pone.0063736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737947	gold, Green Published			2022-12-27	WOS:000321394700010
J	Badley, EM; Canizares, M; MacKay, C; Mahomed, NN; Davis, AM				Badley, Elizabeth M.; Canizares, Mayilee; MacKay, Crystal; Mahomed, Nizar N.; Davis, Aileen M.			Surgery or Consultation: A Population-Based Cohort Study of Use of Orthopaedic Surgeon Services	PLOS ONE			English	Article							TOTAL HIP-REPLACEMENT; WAITING-TIMES; JOINT REPLACEMENT; UNITED-STATES; PRIMARY-CARE; HEALTH-CARE; SOCIOECONOMIC-STATUS; KNEE REPLACEMENT; ARTHRITIS; EQUITY	Background: This population-based cohort study has the objective to understand the sociodemographic characteristics and health conditions of patients who do not receive surgery within 18 months following an ambulatory visit to an orthopaedic surgeon. Methods: Administrative healthcare databases in Ontario, Canada were linked to identify all patients making an initial ambulatory visit to orthopaedic surgeons between October 1st, 2004 and September 30th, 2005. Logistic regression was used to examine predictors of not receiving surgery within 18 months. Results: Of the 477,945 patients in the cohort 49% visited orthopaedic surgeons for injury, and 24% for arthritis. Overall, 79.3% did not receive surgery within 18 months of the initial visit, which varied somewhat by diagnosis at first visit (84.5% for injury and 73.0% for arthritis) with highest proportions in the 0-24 and 25-44 age groups. The distribution by income quintile of patients visiting was skewed towards higher incomes. Regression analysis for each diagnostic group showed that younger patients were significantly more likely to be non-surgical than those aged 65+ years (age 0-24: OR 3.45 95% CI 3.33-3.57; age 25-44: OR 1.30 95% CI 1.27-1.33). The odds of not getting surgery were significantly higher for women than men for injury and other conditions; the opposite was true for arthritis and bone conditions. Conclusion: A substantial proportion of referrals were for expert diagnosis or advice on management and treatment. The findings also suggest socioeconomic inequalities in access to orthopaedic care. Further research is needed to investigate whether the high caseload of non-surgical cases affects waiting times to see a surgeon. This paper contributes to the development of evidence-based strategies to streamline access to surgery, and to develop models of care for non-surgical patients to optimize the use of scarce orthopaedic surgeon resources and to enhance the management of musculoskeletal disorders across the care continuum.	[Badley, Elizabeth M.; Canizares, Mayilee; MacKay, Crystal; Mahomed, Nizar N.; Davis, Aileen M.] Toronto Western Res Inst, Arthrit Community Res & Evaluat Unit, Div Hlth Care & Outcomes Res, Toronto, ON, Canada; [Badley, Elizabeth M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Badley, Elizabeth M.; Mahomed, Nizar N.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Mahomed, Nizar N.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Badley, Elizabeth M.; MacKay, Crystal; Davis, Aileen M.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Davis, Aileen M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Badley, EM (corresponding author), Toronto Western Res Inst, Arthrit Community Res & Evaluat Unit, Div Hlth Care & Outcomes Res, Toronto, ON, Canada.	e.badley@utoronto.ca		Badley, Elizabeth/0000-0002-6045-2549; Davis, Aileen/0000-0002-9903-9399	Health System Linked Research Unit Grant from the Ontario Ministry of Health and Long-Term Care [04166]; Canadian Institutes of Health Research Team Grant in Models of Care in Arthritis [ETG 92253]; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC)	Health System Linked Research Unit Grant from the Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research Team Grant in Models of Care in Arthritis(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by a Health System Linked Research Unit Grant from the Ontario Ministry of Health and Long-Term Care (Grant 04166), and by a Canadian Institutes of Health Research Team Grant in Models of Care in Arthritis (ETG 92253). Additional support was given by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Aiken Alice B, 2009, Healthc Q, V12, P80; Aiken Alice B, 2008, Healthc Q, V11, P62; Akesson K, 2003, B WORLD HEALTH ORGAN, V81, P677; American Orthopaedic Association, 2005, J Bone Joint Surg Am, V87, P1389; Badley EM, 2011, J BONE JOINT SURG AM, V93A, P863, DOI 10.2106/JBJS.I.01782; Baker R, 2005, BRIT J GEN PRACT, V55, P912; Barua B, 2011, SSRN J, P1, DOI [10.2139/ssrn.1783079, DOI 10.2139/SSRN.1783079]; Beran Matthew C, 2012, J Bone Joint Surg Am, V94, pe36, DOI 10.2106/JBJS.K.00518; Birrell F, 2009, AGE AGEING, V38, P2, DOI 10.1093/ageing/afn272; Boden SD, 2005, J BONE JOINT SURG AM, V87A, P2812, DOI 10.2106/JBJS.E.00791; Borkhoff CM, 2011, CLIN ORTHOP RELAT R, V469, P1829, DOI 10.1007/s11999-011-1879-x; Borugian MJ, 2005, EPIDEMIOLOGY, V16, P526, DOI 10.1097/01.ede.0000164813.46859.63; Bridgman S, 2005, BRIT J GEN PRACT, V55, P704; Brinker MR, 2002, J BONE JOINT SURG AM, V84A, P1926, DOI 10.2106/00004623-200211000-00003; Buckwalter JA, 2003, J BONE JOINT SURG AM, V85A, P748, DOI 10.2106/00004623-200304000-00024; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; *CAN I HLTH INF, 2003, COP INTR ICD 10 CA C; Canizares M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-56; *CHART SOC PHYS, 2004, MAK PHYS COUNT; Cipriano Lauren E, 2007, Health Care Manag Sci, V10, P195, DOI 10.1007/s10729-007-9013-z; CLEWS G, 2006, HLTH SERV J S3, V116; Cookson Richard, 2007, J Health Serv Res Policy, V12 Suppl 1, pS1; Cooper ZN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3264; DE CC, 2007, J EVAL CLIN PRACT, V13, P192; Department of Health, 2002, DEL NHS PLAN NEXT ST; Dimakou S, 2009, HEALTH CARE MANAG SC, V12, P1, DOI 10.1007/s10729-008-9069-4; Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724; Dykes DC, 2009, CLIN ORTHOP RELAT R, V467, P2598, DOI 10.1007/s11999-009-0993-5; Etzioni DA, 2003, ANN SURG, V238, P170, DOI 10.1097/01.SLA.0000081085.98792.3d; Fitzpatrick R, 2004, J EVAL CLIN PRACT, V10, P3, DOI 10.1111/j.1365-2753.2003.00448.x; Foot C., 2010, QUALITY GP DIAGNOSIS; Gaudet MC, 2007, CAN J SURG, V50, P101; Glazier RH, 1996, CAN MED ASSOC J, V155, P679; Hacker J, 2004, J PUBLIC HEALTH, V26, P56, DOI 10.1093/pubmed/fdh115; Haralson RH, 2009, JAMA-J AM MED ASSOC, V302, P1586, DOI 10.1001/jama.2009.1489; Hattam P, 1999, Clin Perform Qual Health Care, V7, P121, DOI 10.1108/14664109910306749; Holland R, 2003, RHEUMATOLOGY, V42, P503, DOI 10.1093/rheumatology/keg197; Hootman JM, 2002, ARTHRIT RHEUM-ARTHR, V47, P571, DOI 10.1002/art.10791; Iorio R, 2008, J BONE JOINT SURG AM, V90A, P1598, DOI 10.2106/JBJS.H.00067; Judge A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4092; Kreindler SA, 2010, BRIT MED BULL, V95, P7, DOI 10.1093/bmb/ldq014; Mable A., 2012, CANADIAN PRIMARY HEA; MacKay C, 2010, ARTHRIT CARE RES, V62, P161, DOI 10.1002/acr.20064; MacKay C, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-147; MacKay C, 2009, J EVAL CLIN PRACT, V15, P178, DOI 10.1111/j.1365-2753.2008.00979.x; McHugh GA, 2012, J EVAL CLIN PRACT, V18, P534, DOI 10.1111/j.1365-2753.2010.01616.x; McPherson Kathryn, 2006, J Health Serv Res Policy, V11, P240, DOI 10.1258/135581906778476544; Milner PC, 2004, EUR J PUBLIC HEALTH, V14, P58, DOI 10.1093/eurpub/14.1.58; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; Perruccio AV, 2006, J RHEUMATOL, V33, P1856; Robarts Susan, 2008, Healthc Q, V11, P67; Rymaszewski LA, 2005, ANN ROY COLL SURG, V87, P174, DOI 10.1308/1478708051793; Schoch PA, 2012, AUST HEALTH REV, V36, P233, DOI 10.1071/AH11040; Sephton R, 2010, PHYSIOTHERAPY, V96, P296, DOI 10.1016/j.physio.2010.03.003; Shipton D, 2003, J BONE JOINT SURG AM, V85A, P1710, DOI 10.2106/00004623-200309000-00009; Siciliani L, 2005, HEALTH POLICY, V72, P201, DOI 10.1016/j.healthpol.2004.07.003; Snider MG, 2005, CAN J SURG, V48, P355; Speed CA, 2005, RHEUMATOLOGY, V44, P469, DOI 10.1093/rheumatology/keh504; Stanhope J, 2012, J MULTIDISCIP HEALTH, V5, P37, DOI 10.2147/JMDH.S28891; Strope SA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-121; Truscott Jennifer M, 2007, N Z Med J, V120, pU2799; Willcox S, 2007, HEALTH AFFAIR, V26, P1078, DOI 10.1377/hlthaff.26.4.1078; Yong PFK, 2004, ANN RHEUM DIS, V63, P1483, DOI 10.1136/ard.2003.013938	64	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65560	10.1371/journal.pone.0065560	http://dx.doi.org/10.1371/journal.pone.0065560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IE	23750266	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900068
J	Pfirrmann, T; Lokapally, A; Andreasson, C; Ljungdahl, P; Hollemann, T				Pfirrmann, Thorsten; Lokapally, Ashwin; Andreasson, Claes; Ljungdahl, Per; Hollemann, Thomas			SOMA: A Single Oligonucleotide Mutagenesis and Cloning Approach	PLOS ONE			English	Article							SITE; STRATEGY; DESIGN; PRIMER; SENSOR	Modern biology research requires simple techniques for efficient and restriction site-independent modification of genetic material. Classical cloning and mutagenesis strategies are limited by their dependency on restriction sites and the use of complementary primer pairs. Here, we describe the Single Oligonucleotide Mutagenesis and Cloning Approach (SOMA) that is independent of restriction sites and only requires a single mutagenic oligonucleotide to modify a plasmid. We demonstrate the broad application spectrum of SOMA with three examples. First, we present a novel plasmid that in a standardized and rapid fashion can be used as a template for SOMA to generate GFP-reporters. We successfully use such a reporter to assess the in vivo knock-down quality of morpholinos in Xenopus laevis embryos. In a second example, we show how to use a SOMA-based protocol for restriction-site independent cloning to generate chimeric proteins by domain swapping between the two human hRMD5a and hRMD5b isoforms. Last, we show that SOMA simplifies the generation of randomized single-site mutagenized gene libraries. As an example we random-mutagenize a single codon affecting the catalytic activity of the yeast Ssy5 endoprotease and identify a spectrum of tolerated and non-tolerated substitutions. Thus, SOMA represents a highly efficient alternative to classical cloning and mutagenesis strategies.	[Pfirrmann, Thorsten; Lokapally, Ashwin; Hollemann, Thomas] Univ Halle Wittenberg, Inst Physiol Chem, Dept Mol Med, D-06108 Halle, Germany; [Andreasson, Claes; Ljungdahl, Per] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Martin Luther University Halle Wittenberg; Stockholm University	Pfirrmann, T (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, Dept Mol Med, D-06108 Halle, Germany.	thorsten.pfirrmann@medizin.uni-halle.de	Pfirrmann, Thorsten/AAC-5563-2019; Ljungdahl, Per O/M-5258-2013	Ljungdahl, Per O/0000-0002-6625-3540; Andreasson, Claes/0000-0001-8948-0685; Pfirrmann, Thorsten/0000-0002-9474-9535; Lokapally, Ashwin/0000-0002-1192-9849	Swedish Research Council; Fonds der Chemischen Industrie, Frankfurt	Swedish Research Council(Swedish Research CouncilEuropean Commission); Fonds der Chemischen Industrie, Frankfurt(Fonds der Chemischen Industrie)	This research was supported by funding from the Swedish Research Council and the Fonds der Chemischen Industrie, Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Antikainen NM, 2005, BIOORGAN MED CHEM, V13, P2701, DOI 10.1016/j.bmc.2005.01.059; Benders GA, 2010, NUCLEIC ACIDS RES, V38, P2558, DOI 10.1093/nar/gkq119; Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Braman J, 1996, Methods Mol Biol, V57, P31; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Diamond SL, 2007, CURR OPIN CHEM BIOL, V11, P46, DOI 10.1016/j.cbpa.2006.11.021; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Faber J., 1967, NORMAL TABLE XENOPUS; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gurdon J.B., 1977, Methods Cell Biol, V16, P125; Hogrefe HH, 2002, BIOTECHNIQUES, V33, P1158, DOI 10.2144/02335pf01; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Peccoud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043231; PFIRRMANN T, 2012, HDB PROTEOLYTIC ENZY; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; Pleiss J, 2011, CURR OPIN BIOTECH, V22, P611, DOI 10.1016/j.copbio.2011.03.004; Poulsen P, 2006, EUKARYOT CELL, V5, P601, DOI 10.1128/EC.5.3.601-608.2006; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SHULDINER AR, 1991, ANAL BIOCHEM, V194, P9, DOI 10.1016/0003-2697(91)90144-I; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Zawaira A, 2012, MOL BIOTECHNOL, V51, P67, DOI 10.1007/s12033-011-9448-9; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536; Zuo PJ, 2010, CURR ISSUES MOL BIOL, V12, P11	33	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64870	10.1371/journal.pone.0064870	http://dx.doi.org/10.1371/journal.pone.0064870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750217	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900019
J	Varriale, A; Marabotti, A; Mei, G; Staiano, M; D'Auria, S				Varriale, Antonio; Marabotti, Anna; Mei, Giampiero; Staiano, Maria; D'Auria, Sabato			Correlation Spectroscopy and Molecular Dynamics Simulations to Study the Structural Features of Proteins	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ACID-BINDING PROTEIN; ARCHAEON SULFOLOBUS-SOLFATARICUS; BETA-GLYCOSIDASE; CONFORMATIONAL DYNAMICS; DENATURED PROTEINS; ASCORBATE OXIDASE; TRYPTOPHAN; STABILITY; THERMOSTABILITY	In this work, we used a combination of fluorescence correlation spectroscopy (FCS) and molecular dynamics (MD) simulation methodologies to acquire structural information on pH-induced unfolding of the maltotriose-binding protein from Thermus thermophilus (MalE2). FCS has emerged as a powerful technique for characterizing the dynamics of molecules and it is, in fact, used to study molecular diffusion on timescale of microsecond and longer. Our results showed that keeping temperature constant, the protein diffusion coefficient decreased from 84 +/- 4 mu m(2)/s to 44 +/- 3 mu m(2)/s when pH was changed from 7.0 to 4.0. An even more marked decrease of the MalE2 diffusion coefficient (31 +/- 3 mu m(2)/s) was registered when pH was raised from 7.0 to 10.0. According to the size of MalE2 (a monomeric protein with a molecular weight of 43 kDa) as well as of its globular native shape, the values of 44 mu m(2)/s and 31 mu m(2)/s could be ascribed to deformations of the protein structure, which enhances its propensity to form aggregates at extreme pH values. The obtained fluorescence correlation data, corroborated by circular dichroism, fluorescence emission and light-scattering experiments, are discussed together with the MD simulations results.	[Varriale, Antonio; Staiano, Maria; D'Auria, Sabato] IBP CNR, Lab Mol Sensing, Naples, Italy; [Marabotti, Anna] Univ Salerno, Dept Biol & Chem, Fisciano, SA, Italy; [Marabotti, Anna] ISA CNR, Lab Bioinformat, Avellino, Italy; [Mei, Giampiero] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Rome Tor Vergata	Varriale, A (corresponding author), IBP CNR, Lab Mol Sensing, Naples, Italy.	a.varriale@ibp.cnr.it; s.dauria@ibp.cnr.it	d'auria, sabato/C-3565-2015; Varriale, Antonio/AAL-1439-2020; STAIANO, MARIA/B-9584-2015	d'auria, sabato/0000-0001-9320-494X; STAIANO, MARIA/0000-0003-0223-1825; Marabotti, Anna/0000-0002-9510-5205	CNR Commessa "Diagnostica Avanzata ed Alimentazione''; CNR Italian Bioinformatics Network (CNR-National Research Council)	CNR Commessa "Diagnostica Avanzata ed Alimentazione''; CNR Italian Bioinformatics Network (CNR-National Research Council)	This project was realized in the frame of the CNR Commessa "Diagnostica Avanzata ed Alimentazione'' (AV, MS, SD) and in the frame of CNR Italian Bioinformatics Network (AM) (CNR-National Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bakowies D, 2002, J MOL BIOL, V315, P713, DOI 10.1006/jmbi.2001.5202; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; Chattopadhyay K, 2002, P NATL ACAD SCI USA, V99, P14171, DOI 10.1073/pnas.172524899; Cuneo MJ, 2009, J MOL BIOL, V389, P157, DOI 10.1016/j.jmb.2009.04.008; D'Auria S, 1999, BIOPHYS CHEM, V81, P23, DOI 10.1016/S0301-4622(99)00086-1; D'Auria S, 1998, BIOCHIMIE, V80, P949, DOI 10.1016/S0300-9084(00)88892-6; D'Auria S, 2008, J PROTEOME RES, V7, P1151, DOI 10.1021/pr700755z; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; DAuria S, 1997, PROTEINS, V27, P71; Di Venere A, 1998, EUR J BIOCHEM, V257, P337, DOI 10.1046/j.1432-1327.1998.2570337.x; Di Venere A, 2000, J BIOL CHEM, V275, P3915, DOI 10.1074/jbc.275.6.3915; Di Venere A, 2011, FEBS J, V278, P1585, DOI 10.1111/j.1742-4658.2011.08084.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frieden C, 2002, ADV PROTEIN CHEM, V62, P91; FRIEDEN C, 1995, BIOCHEMISTRY-US, V34, P2724, DOI 10.1021/bi00008a040; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hess ST, 2002, BIOPHYS J, V83, P2300, DOI 10.1016/S0006-3495(02)73990-8; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; JIANG N, 1993, BIOCHEMISTRY-US, V32, P11015, DOI 10.1021/bi00092a010; Kutzner C, 2007, J COMPUT CHEM, V28, P2075, DOI 10.1002/jcc.20703; Lakowicz J R, 1999, PRINCIPLES FLUORESCE, P367, DOI 10.1007/978-1-4757-3061-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Marabotti A, 2008, PROTEINS, V72, P769, DOI 10.1002/prot.21966; Mei G, 2008, BIOCHEMISTRY-US, V47, P9234, DOI 10.1021/bi800638v; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Papaleo E, 2009, J MOL GRAPH MODEL, V27, P889, DOI 10.1016/j.jmgm.2009.01.006; Perrin F, 1936, J PHYS-PARIS, V7, P1, DOI 10.1051/jphysrad:01936007010100; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scire A, 2010, MOL BIOSYST, V6, P687, DOI 10.1039/b922092e; Scire A, 2009, J PROTEOME RES, V8, P4005, DOI 10.1021/pr900346z; Sherman E, 2008, BIOPHYS J, V94, P4819, DOI 10.1529/biophysj.107.120220; Silva Z, 2005, J BACTERIOL, V187, P1210, DOI 10.1128/JB.187.4.1210-1218.2005; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Stepanenko OV, 2008, PROTEINS, V71, P35, DOI 10.1002/prot.21658; TEMPLETON EFG, 1985, MOL IMMUNOL, V22, P45, DOI 10.1016/0161-5890(85)90033-1; van Gunsteren WF, 1996, BIOMOLECULAR SIMULAT, V1042; Varriale A, 2007, ANAL CHEM, V79, P4687, DOI 10.1021/ac070475+; Varriale A, 2009, PROTEIN PEPTIDE LETT, V16, P1425, DOI 10.2174/092986609789839359; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yeh SR, 2001, BIOCHEMISTRY-US, V40, P4205, DOI 10.1021/bi0155044	52	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64840	10.1371/journal.pone.0064840	http://dx.doi.org/10.1371/journal.pone.0064840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750215	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900017
J	Vodovnik, M; Duncan, SH; Reid, MD; Cantlay, L; Turner, K; Parkhill, J; Lamed, R; Yeoman, CJ; Miller, MEB; White, BA; Bayer, EA; Marinsek-Logar, R; Flint, HJ				Vodovnik, Masa; Duncan, Sylvia H.; Reid, Martin D.; Cantlay, Louise; Turner, Keith; Parkhill, Julian; Lamed, Raphael; Yeoman, Carl J.; Miller, Margret E. Berg; White, Bryan A.; Bayer, Edward A.; Marinsek-Logar, Romana; Flint, Harry J.			Expression of Cellulosome Components and Type IV Pili within the Extracellular Proteome of Ruminococcus flavefaciens 007	PLOS ONE			English	Article							RUBRERYTHRIN-LIKE PROTEIN; CLOSTRIDIUM-THERMOCELLUM; BACTERIAL ADHESION; BINDING PROTEIN; ALBUS; GENES; ACID; RUMINOCOCCUS-FLAVEFACIENS-17; IDENTIFICATION; REDUCTASE	Background: Ruminococcus flavefaciens is an important fibre-degrading bacterium found in the mammalian gut. Cellulolytic strains from the bovine rumen have been shown to produce complex cellulosome structures that are associated with the cell surface. R. flavefaciens 007 is a highly cellulolytic strain whose ability to degrade dewaxed cotton, but not Avicel cellulose, was lost following initial isolation in the variant 007S. The ability was recovered after serial subculture to give the cotton-degrading strain 007C. This has allowed us to investigate the factors required for degradation of this particularly recalcitrant form of cellulose. Methodology/Principal Findings: The major proteins associated with the bacterial cell surface and with the culture supernatant were analyzed for R. flavefaciens 007S and 007C grown with cellobiose, xylan or Avicel cellulose as energy sources. Identification of the proteins was enabled by a draft genome sequence obtained for 007C. Among supernatant proteins a cellulosomal GH48 hydrolase, a rubrerthyrin-like protein and a protein with type IV pili N-terminal domain were the most strongly up-regulated in 007C cultures grown on Avicel compared with cellobiose. Strain 007S also showed substrate-related changes, but supernatant expression of the Pil protein and rubrerythrin in particular were markedly lower in 007S than in 007C during growth on Avicel. Conclusions/Significance: This study provides new information on the extracellular proteome of R. flavefaciens and its regulation in response to different growth substrates. Furthermore it suggests that the cotton cellulose non-degrading strain (007S) has altered regulation of multiple proteins that may be required for breakdown of cotton cellulose. One of these, the type IV pilus was previously shown to play a role in adhesion to cellulose in R. albus, and a related pilin protein was identified here for the first time as a major extracellular protein in R. flavefaciens.	[Vodovnik, Masa; Marinsek-Logar, Romana] Univ Ljubljana, Biotech Fac, Chair Microbiol & Microbial Biotechnol, Ljubljana, Slovenia; [Vodovnik, Masa; Duncan, Sylvia H.; Reid, Martin D.; Cantlay, Louise; Flint, Harry J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Turner, Keith; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Yeoman, Carl J.; Miller, Margret E. Berg; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Ljubljana; University of Aberdeen; Wellcome Trust Sanger Institute; Weizmann Institute of Science; Tel Aviv University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Flint, HJ (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	h.flint@abdn.ac.uk	Yeoman, Carl/ABA-1906-2021; Parkhill, Julian/G-4703-2011; Vodovnik, Masa/U-4580-2019	Yeoman, Carl/0000-0002-8775-7879; Parkhill, Julian/0000-0002-7069-5958; Duncan, Sylvia/0000-0002-4903-0978; Berg, Margret/0000-0002-0411-1619; Vodovnik, Masa/0000-0002-1189-2417	SG-RESAS (Scottish Government Rural and Environmental Science and Analysis Service); FEMS; Slovene human resources development and scholarship funds; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Israel Science Foundation [966/09, 159/07 291/08]	SG-RESAS (Scottish Government Rural and Environmental Science and Analysis Service); FEMS; Slovene human resources development and scholarship funds; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	The Rowett Institute receives funding from SG-RESAS (Scottish Government Rural and Environmental Science and Analysis Service). Visit of M.V. was supported by research grants from FEMS and Slovene human resources development and scholarship funds. Parts of this work were funded by grants from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel - BSF Energy Research grant to E.A.B. and B.A.W. and Regular BSF Research grants to R.L. and B.A.W. - and by the Israel Science Foundation (grant nos 966/09 and 159/07 291/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; Dror TW, 2003, J BACTERIOL, V185, P3042, DOI 10.1128/JB.185.10.3042-3048.2003; Geissmann TA, 1999, J BACTERIOL, V181, P7136, DOI 10.1128/JB.181.22.7136-7139.1999; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hillmann F, 2006, ARCH MICROBIOL, V185, P270, DOI 10.1007/s00203-006-0091-y; HUNGATE RE, 1982, APPL ENVIRON MICROB, V44, P79, DOI 10.1128/AEM.44.1.79-83.1982; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Jun HS, 2007, J BACTERIOL, V189, P6806, DOI 10.1128/JB.00560-07; Kawasaki S, 2007, FEBS LETT, V581, P2460, DOI 10.1016/j.febslet.2007.04.050; Kurtz DM, 2006, J INORG BIOCHEM, V100, P679, DOI 10.1016/j.jinorgbio.2005.12.017; LEVER M, 1977, ANAL BIOCHEM, V81, P21, DOI 10.1016/0003-2697(77)90594-2; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Morisaka H, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-37; Morrison M, 2000, FEMS MICROBIOL LETT, V185, P109; Mosoni P, 2001, ARCH MICROBIOL, V176, P52, DOI 10.1007/s002030100292; Pegden RS, 1998, J BACTERIOL, V180, P5921, DOI 10.1128/JB.180.22.5921-5927.1998; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Rakotoarivonina H, 2005, MICROBIOL-SGM, V151, P1291, DOI 10.1099/mic.0.27735-0; Rakotoarivonina H, 2009, ARCH MICROBIOL, V191, P379, DOI 10.1007/s00203-009-0463-1; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012476; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; Rincon MT, 2001, APPL ENVIRON MICROB, V67, P4426, DOI 10.1128/AEM.67.10.4426-4431.2001; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; STEWART CS, 1990, J APPL BACTERIOL, V68, P349, DOI 10.1111/j.1365-2672.1990.tb02885.x; STEWART CS, 1990, FEMS MICROBIOL LETT, V72, P47, DOI 10.1016/0378-1097(90)90342-N; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Varga JJ, 2006, MOL MICROBIOL, V62, P680, DOI 10.1111/j.1365-2958.2006.05414.x; Weinberg MV, 2004, J BACTERIOL, V186, P7888, DOI 10.1128/JB.186.23.7888-7895.2004	37	24	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65333	10.1371/journal.pone.0065333	http://dx.doi.org/10.1371/journal.pone.0065333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750253	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900055
J	Wu, T; Fu, F; Zhang, YL; Wang, L				Wu, Te; Fu, Feng; Zhang, Yanling; Wang, Long			The Increased Risk of Joint Venture Promotes Social Cooperation	PLOS ONE			English	Article							EVOLUTION; GOODS; DYNAMICS; DILEMMA; CLIMATE	The joint venture of many members is common both in animal world and human society. In these public enterprizes, highly cooperative groups are more likely to while low cooperative groups are still possible but not probable to succeed. Existent literature mostly focuses on the traditional public goods game, in which cooperators create public wealth unconditionally and benefit all group members unbiasedly. We here institute a model addressing this public goods dilemma with incorporating the public resource foraging failure risk. Risk-averse individuals tend to lead a autarkic life, while risk-preferential ones tend to participate in the risky public goods game. For participants, group's success relies on its cooperativeness, with increasing contribution leading to increasing success likelihood. We introduce a function with one tunable parameter to describe the risk removal pattern and study in detail three representative classes. Analytical results show that the widely replicated population dynamics of cyclical dominance of loner, cooperator and defector disappear, while most of the time loners act as savors while eventually they also disappear. Depending on the way that group's success relies on its cooperativeness, either cooperators pervade the entire population or they coexist with defectors. Even in the later case, cooperators still hold salient superiority in number as some defectors also survive by parasitizing. The harder the joint venture succeeds, the higher level of cooperation once cooperators can win the evolutionary race. Our work may enrich the literature concerning the risky public goods games.	[Wu, Te; Zhang, Yanling; Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Ctr Syst & Control, Beijing 100871, Peoples R China; [Fu, Feng] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Fu, Feng] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Peking University; Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wu, T (corresponding author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Ctr Syst & Control, Beijing 100871, Peoples R China.	wute@pku.edu.cn	Gao, Y./GWZ-3665-2022; Fu, Feng/A-3376-2009; Fu, Feng/R-3686-2017; Wang, Long/A-7798-2010	Fu, Feng/0000-0001-8252-1990; Fu, Feng/0000-0001-8252-1990; Wang, Long/0000-0001-5600-8157	National 973 Program [2012CB821203]; Natural Science Foundation of China (NSFC) [61020106005, 10972002]	National 973 Program(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The authors are supported by National 973 Program (2012CB821203) and Natural Science Foundation of China (NSFC) (61020106005 and 10972002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Binmore K., 1994, PLAYING FAIR GAME TH; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2007, SCIENCE, V316, P1858, DOI 10.1126/science.1144339; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; CHAKRA MA, 2012, PLOS COMPUT BIOL, V0008; Chen XJ, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/68003; Chen XJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036101; Chen XJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066133; Chen XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043724, 10.1371/journal.pone.0036895]; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Gurven M, 2004, BEHAV ECOL SOCIOBIOL, V56, P366, DOI 10.1007/s00265-004-0793-6; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2002, CURR ANTHROPOL, V43, P172, DOI 10.1086/338291; Kagel JH, 1995, HDB EXPT EC; MAY RM, 1981, NATURE, V292, P291, DOI 10.1038/292291a0; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ostrom E, 1999, ANNU REV POLIT SCI, V2, P493, DOI 10.1146/annurev.polisci.2.1.493; Pacheco JM, 2008, P ROYAL SOC B, V276, P315, DOI [10.1098/rspb.2008.1126, DOI 10.1098/RSPB.2008.112618812288]; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/142; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Skyrms B., 2001, PROC ADDRESS AM PHIL, V75, P31, DOI DOI 10.2307/3218711; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; STANDER PE, 1992, BEHAV ECOL SOCIOBIOL, V29, P445; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; TAYLOR M, 1982, POLIT STUD-LONDON, V30, P350, DOI 10.1111/j.1467-9248.1982.tb00545.x; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wakano JY, 2009, P NATL ACAD SCI USA, V106, P7910, DOI 10.1073/pnas.0812644106; Wang J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016101	51	7	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e63801	10.1371/journal.pone.0063801	http://dx.doi.org/10.1371/journal.pone.0063801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750204	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900006
J	Yuan, LX; Zhu, YY; Lin, ZQ; Banuelos, G; Li, W; Yin, XB				Yuan, Linxi; Zhu, Yuanyuan; Lin, Zhi-Qing; Banuelos, Gary; Li, Wei; Yin, Xuebin			A Novel Selenocystine-Accumulating Plant in Selenium-Mine Drainage Area in Enshi, China	PLOS ONE			English	Article							HYPERACCUMULATOR STANLEYA-PINNATA; PRAIRIE DOG HERBIVORY; INDIAN MUSTARD; MOLECULAR-MECHANISMS; ENDEMIC DISEASES; BRASSICA-JUNCEA; PROTECTS PLANTS; HUBEI PROVINCE; ASTRAGALUS; SPECIATION	Plant samples of Cardamine hupingshanesis (Brassicaceae), Ligulariafischeri (Ledeb.) turcz (Steraceae) and their underlying top sediments were collected from selenium (Se) mine drainage areas in Enshi, China. Concentrations of total Se were measured using Hydride Generation-Atomic Fluorescence Spectrometry (HG-AFS) and Se speciation were determined using liquid chromatography/UV irradiation-hydride generation-atomic fluorescence spectrometry (LC-UV-HG-AFS). The results showed that C. hupingshanesis could accumulate Se to 239 +/- 201 mg/kg DW in roots, 316 +/- 184 mg/kg DW in stems, and 380 +/- 323 mg/kg DW in leaves, which identifies it as Se secondary accumulator. Particularly, it could accumulate Se up to 1965 +/- 271 mg/kg DW in leaves, 1787 +/- 167 mg/kg DW in stem and 4414 +/- 3446 mg/kg DW in roots, living near Se mine tailing. Moreover, over 70% of the total Se accumulated in C. hupingshanesis were in the form of selenocystine (SeCys(2)), increasing with increased total Se concentration in plant, in contrast to selenomethionine (SeMet) in non-accumulators (eg. Arabidopsis) and secondary accumulators (eg. Brassica juncea), and selenomethylcysteine (SeMeCys) in hyperaccumulators (eg. Stanleya pinnata). There is no convincing explanation on SeCys(2) accumulation in C. hupingshanesis based on current Se metabolism theory in higher plants, and further study will be needed.	[Yuan, Linxi; Zhu, Yuanyuan; Li, Wei; Yin, Xuebin] Jiangsu Bioengn Res Ctr Selenium, Suzhou, Jiangsu, Peoples R China; [Yuan, Linxi; Yin, Xuebin] Univ Sci & Technol China, Sch Earth & Space Sci, Hefei, Anhui, Peoples R China; [Lin, Zhi-Qing] So Illinois Univ, Environm Sci Program, Edwardsville, IL 62026 USA; [Lin, Zhi-Qing] So Illinois Univ, Dept Biol Sci, Edwardsville, IL 62026 USA; [Banuelos, Gary] USDA ARS, Parlier, CA USA; [Yuan, Linxi; Yin, Xuebin] Univ Sci & Technol China, Suzhou Inst Adv Study, Adv Lab Selenium & Human Hlth, Suzhou, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Southern Illinois University System; Southern Illinois University Edwardsville; Southern Illinois University System; Southern Illinois University Edwardsville; United States Department of Agriculture (USDA); Chinese Academy of Sciences; University of Science & Technology of China, CAS	Yuan, LX (corresponding author), Jiangsu Bioengn Res Ctr Selenium, Suzhou, Jiangsu, Peoples R China.	yuanli@mail.ustc.edu.cn; xbyin@ustc.edu.cn	Yuan, Linxi/Y-9313-2019	Yuan, Linxi/0000-0002-1043-8933	Natural Science Youth Foundation of Jiangsu Province for Youth, China [BK2012202]; Open Fund of State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences [Y052010020]; Open Fund of SOA Key Laboratory for Polar Science, Polar Research Institute of China [KP201106]; National Science Foundation of China [NSFC 40601088]	Natural Science Youth Foundation of Jiangsu Province for Youth, China; Open Fund of State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences(Chinese Academy of Sciences); Open Fund of SOA Key Laboratory for Polar Science, Polar Research Institute of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Youth Foundation of Jiangsu Province for Youth, China (BK2012202) (http://www.jsnsf.gov.cn/Index.aspx), Open Fund of State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences (Y052010020) (http://www.ssa.ac.cn/), Open Fund of SOA Key Laboratory for Polar Science, Polar Research Institute of China (KP201106) (http://www.pric.gov.cn/bmm.asp?bigid = 19), National Science Foundation of China (NSFC 40601088) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford ER, 2010, PLANT SOIL, V337, P33, DOI 10.1007/s11104-010-0482-3; Banuelos G, 2005, ENVIRON SCI TECHNOL, V39, P1771, DOI 10.1021/es049035f; Banuelos G, 2007, ENVIRON SCI TECHNOL, V41, P599, DOI 10.1021/es061152i; Banuelos GS, 1997, J ENVIRON QUAL, V26, P639, DOI 10.2134/jeq1997.00472425002600030008x; Banuelos GS, 2002, INT J PHYTOREMEDIAT, V4, P315, DOI 10.1080/15226510208500090; Beilstein M A, 1991, Biomed Environ Sci, V4, P392; Bierla K, 2008, CURRENT ADVANCES IN SELENIUM RESEARCH AND APPLICATIONS, VOL 1, P107; BROWN TA, 1982, BIOL REV, V57, P59, DOI 10.1111/j.1469-185X.1982.tb00364.x; BROWN TA, 1981, PLANT PHYSIOL, V67, P1051, DOI 10.1104/pp.67.5.1051; DAVIS AM, 1986, AGRON J, V78, P727, DOI 10.2134/agronj1986.00021962007800040033x; DAVIS AM, 1972, AGRON J, V64, P751, DOI 10.2134/agronj1972.00021962006400060013x; de Souza MP, 1998, PLANT PHYSIOL, V117, P1487, DOI 10.1104/pp.117.4.1487; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Environmental Protection Administration (EPA) USA, 1997, 3114 ARS SEL HYDR GE; Feng CX, 2009, ACTA PETROL SIN, V25, P1253; Fordyce FM, 2000, APPL GEOCHEM, V15, P117, DOI 10.1016/S0883-2927(99)00035-9; Freeman JL, 2007, NEW PHYTOL, V175, P490, DOI 10.1111/j.1469-8137.2007.02119.x; Freeman JL, 2006, CURR BIOL, V16, P2181, DOI 10.1016/j.cub.2006.09.015; Freeman JL, 2006, PLANT PHYSIOL, V142, P124, DOI 10.1104/pp.106.081158; Freeman JL, 2011, ENVIRON SCI TECHNOL, V45, P9703, DOI 10.1021/es201600f; Freeman JL, 2010, PLANT PHYSIOL, V153, P1630, DOI [10.1104/pp.110.156570, 10.1186/1472-6785-10-19]; Freeman JL, 2009, AM J BOT, V96, P1075, DOI 10.3732/ajb.0800287; Galeas ML, 2008, NEW PHYTOL, V177, P715, DOI 10.1111/j.1469-8137.2007.02285.x; Galeas ML, 2007, NEW PHYTOL, V173, P517, DOI 10.1111/j.1469-8137.2006.01943.x; Gao J, 2011, FOOD CHEM, V126, P1088, DOI 10.1016/j.foodchem.2010.11.137; Hanson B, 2004, NEW PHYTOL, V162, P655, DOI 10.1111/j.1469-8137.2004.01067.x; Hanson B, 2003, NEW PHYTOL, V159, P461, DOI 10.1046/j.1469-8137.2003.00786.x; Jitaru P, 2010, ACCREDIT QUAL ASSUR, V15, P343, DOI 10.1007/s00769-010-0637-1; Kahakachchi C, 2004, J CHROMATOGR A, V1054, P303, DOI 10.1016/j.chroma.2004.07.083; LeDuc DL, 2004, PLANT PHYSIOL, V135, P377, DOI 10.1104/pp.103.026989; Li HF, 2008, NEW PHYTOL, V178, P92, DOI 10.1111/j.1469-8137.2007.02343.x; Liang L, 2006, J CHROMATOGR A, V1118, P139, DOI 10.1016/j.chroma.2006.03.113; Mazej D, 2006, TALANTA, V68, P558, DOI 10.1016/j.talanta.2005.04.056; Montes-Bayon M, 2002, J ANAL ATOM SPECTROM, V17, P872, DOI 10.1039/b202608m; Neuhierl B, 1999, J BIOL CHEM, V274, P5407, DOI 10.1074/jbc.274.9.5407; Neuhierl B, 1996, EUR J BIOCHEM, V239, P235, DOI 10.1111/j.1432-1033.1996.0235u.x; Persans MW, 2000, BIOTECHNOL GENET ENG, V17, P389, DOI 10.1080/02648725.2000.10647999; Pickering IJ, 2003, J SYNCHROTRON RADIAT, V10, P289, DOI 10.1107/S0909049503003273; Pilon-Smits EAH, 2010, PLANT CELL MONOGR, V17, P225, DOI [10.1007/978-3-642-10613-2_10, 10.1016/j.bbagen.2018.05.006]; Quinn CF, 2011, J EXP BOT, DOI [10.1093/jxb/errr247, DOI 10.1093/JXB/ERRR247]; Quinn CF, 2008, OECOLOGIA, V155, P267, DOI 10.1007/s00442-007-0907-8; Seppanen MM, 2010, PLANT SOIL, V337, P273, DOI 10.1007/s11104-010-0523-y; Stadlober M, 2001, FOOD CHEM, V73, P357, DOI 10.1016/S0308-8146(01)00115-7; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Tan JA, 2002, SCI TOTAL ENVIRON, V284, P227, DOI 10.1016/S0048-9697(01)00889-0; TAN JN, 1991, WATER AIR SOIL POLL, V57-8, P59, DOI 10.1007/BF00282869; Terry N, 2000, ANNU REV PLANT PHYS, V51, P401, DOI 10.1146/annurev.arplant.51.1.401; VIRUPAKSHA TK, 1965, BIOCHIM BIOPHYS ACTA, V107, P69, DOI 10.1016/0304-4165(65)90389-2; Wangeline AL, 2011, AM J BOT, V98, P1139, DOI 10.3732/ajb.1000369; White PJ, 2004, J EXP BOT, V55, P1927, DOI 10.1093/jxb/erh192; YANG GQ, 1983, AM J CLIN NUTR, V37, P872, DOI 10.1093/ajcn/37.5.872; Yin S.A., 1996, ACTA NUTRIMENTA SINI, V18, P367; Yu RY, 1993, HUBEI GEOLOGY, V7, P50; Zayed A, 1998, PLANTA, V206, P284, DOI 10.1007/s004250050402; Zhu JM, 2008, SCI TOTAL ENVIRON, V392, P252, DOI 10.1016/j.scitotenv.2007.12.019; Zhu JM, 2001, APPL GEOCHEM, V16, P1333, DOI 10.1016/S0883-2927(01)00047-6; Zhu YG, 2009, TRENDS PLANT SCI, V14, P436, DOI 10.1016/j.tplants.2009.06.006	57	74	83	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65615	10.1371/journal.pone.0065615	http://dx.doi.org/10.1371/journal.pone.0065615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750270	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900072
J	de Goede, J; Verschuren, WMM; Boer, JMA; Verberne, LDM; Kromhout, D; Geleijnse, JM				de Goede, Janette; Verschuren, W. M. Monique; Boer, Jolanda M. A.; Verberne, Lisa D. M.; Kromhout, Daan; Geleijnse, Johanna M.			N-6 and N-3 Fatty Acid Cholesteryl Esters in Relation to Fatal CHD in a Dutch Adult Population: A Nested Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALPHA-LINOLENIC ACID; CARDIOVASCULAR-DISEASE; ERYTHROCYTE-MEMBRANES; ADIPOSE-TISSUE; RISK; BIOMARKERS; HUMANS; CHAIN; CONVERSION	Background: Dietary polyunsaturated fatty acids (PUFA) are inversely related to coronary heart disease (CHD) in epidemiological studies. We examined the associations of plasma n-6 and n-3 PUFA in cholesteryl esters with fatal CHD in a nested case-control study. Additionally, we performed a dose-response meta-analysis of similar prospective studies on cholesteryl ester PUFA. Methods: We used data from two population-based cohort studies in Dutch adults aged 20-65y. Blood and data collection took place from 1987-1997 and subjects were followed for 8-19y. We identified 279 incident cases of fatal CHD and randomly selected 279 controls, matched on age, gender, and enrollment date. Odds ratios (OR) were calculated per standard deviation (SD) increase of cholesteryl ester PUFA. Results: After adjustment for confounders, the OR (95% CI) for fatal CHD per SD increase in plasma linoleic acid was 0.89 (0.74-1.06). Additional adjustment for plasma total cholesterol and systolic blood pressure attenuated this association (OR:0.95; 95% CI: 0.78-1.15). Arachidonic acid was not associated with fatal CHD (OR per SD:1.11; 95% CI: 0.92-1.35). The ORs (95% CI) for fatal CHD for an SD increase in n-3 PUFA were 0.92 (0.74-1.15) for alpha-linolenic acid and 1.06 (0.88-1.27) for EPA-DHA. In the meta-analysis, a 5% higher linoleic acid level was associated with a 9% lower risk (relative risk: 0.91; 95% CI: 0.84-0.98) of CHD. The other fatty acids were not associated with CHD. Conclusion: In this Dutch population, n-6 and n-3 PUFA in cholesteryl esters were not significantly related to fatal CHD. Our data, together with findings from previous prospective studies, support that linoleic acid in plasma cholesteryl is inversely associated with CHD.	[de Goede, Janette; Verberne, Lisa D. M.; Kromhout, Daan; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Verschuren, W. M. Monique; Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	de Goede, J (corresponding author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.	Janette.deGoede@wur.nl	Kromhout, Daan/A-8566-2014; Geleijnse, Johanna Marianna M/B-5749-2012	Geleijnse, Johanna Marianna M/0000-0001-7638-0589	Alpro Foundation, Belgium; Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health; Environment, Bilthoven, The Netherlands; European Union	Alpro Foundation, Belgium; Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health; Environment, Bilthoven, The Netherlands; European Union(European Commission)	This work was supported by an unrestricted grant from the Alpro Foundation, Belgium, to Wageningen University to cover the costs of fatty acid measurements and data analysis for the present study. The Monitoring Project on Risk Factors for Chronic Diseases (MORGEN Project) and the Monitoring Project on Cardiovascular Disease Risk Factors (MP-CVDRF) were financially supported by the Ministry of Health, Welfare and Sport of the Netherlands, the National Institute for Public Health and the Environment, Bilthoven, The Netherlands, and the Europe Against Cancer Program of the European Union. The funders had no role in study design, data collection and analysis, interpretation, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, NETH J CARDIOL; Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Calder PC, 2004, CLIN SCI, V107, P1, DOI 10.1042/CS20040119; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Erkkila AT, 2003, AM J CLIN NUTR, V78, P65, DOI 10.1093/ajcn/78.1.65; Fekete K, 2009, AM J CLIN NUTR, V89, p2070S, DOI 10.3945/ajcn.2009.27230I; GLATZ JFC, 1989, AM J CLIN NUTR, V49, P269, DOI 10.1093/ajcn/49.2.269; Goyens PL, 2006, AM J CLIN NUTR, V84, P44, DOI 10.1093/ajcn/84.1.44; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GUALLAR E, 1995, J AM COLL CARDIOL, V25, P387, DOI 10.1016/0735-1097(94)00370-6; Harris WS, 2007, ATHEROSCLEROSIS, V193, P1, DOI 10.1016/j.atherosclerosis.2007.03.018; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; Katan MB, 1997, J LIPID RES, V38, P2012; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; MA J, 1995, AM J CLIN NUTR, V62, P572, DOI 10.1093/ajcn/62.3.572; Matthan NR, 2010, J LIPID RES, V51, P2826, DOI 10.1194/jlr.D007534; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; ROTHMAN KJ, 1998, CASE CONTROL STUDIES; SIMON JA, 1995, AM J EPIDEMIOL, V142, P469, DOI 10.1093/oxfordjournals.aje.a117662; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Wang L, 2003, NUTR METAB CARDIOVAS, V13, P256, DOI 10.1016/S0939-4753(03)80029-7; Warensjo E, 2008, AM J CLIN NUTR, V88, P203, DOI 10.1093/ajcn/88.1.203; Willett W., 1998, NUTR EPIDEMIOLOGY, V30, P321, DOI [DOI 10.1093/AJCN/69.5.1020, DOI 10.1093/acprof:oso/9780195122978.003.13]; Zhou L, 2001, J LIPID RES, V42, P1521; Zock PL, 1997, AM J EPIDEMIOL, V145, P1114, DOI 10.1093/oxfordjournals.aje.a009074	34	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e59408	10.1371/journal.pone.0059408	http://dx.doi.org/10.1371/journal.pone.0059408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741290	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900002
J	Der, BS; Kluwe, C; Miklos, AE; Jacak, R; Lyskov, S; Gray, JJ; Georgiou, G; Ellington, AD; Kuhlman, B				Der, Bryan S.; Kluwe, Christien; Miklos, Aleksandr E.; Jacak, Ron; Lyskov, Sergey; Gray, Jeffrey J.; Georgiou, George; Ellington, Andrew D.; Kuhlman, Brian			Alternative Computational Protocols for Supercharging Protein Surfaces for Reversible Unfolding and Retention of Stability	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SALT BRIDGES; CELLULAR UPTAKE; IN-VITRO; AGGREGATION; DESIGN; MECHANISMS; PEPTIDES; ARGININE; INTERMEDIATE	Reengineering protein surfaces to exhibit high net charge, referred to as "supercharging", can improve reversibility of unfolding by preventing aggregation of partially unfolded states. Incorporation of charged side chains should be optimized while considering structural and energetic consequences, as numerous mutations and accumulation of like-charges can also destabilize the native state. A previously demonstrated approach deterministically mutates flexible polar residues (amino acids DERKNQ) with the fewest average neighboring atoms per side chain atom (AvNAPSA). Our approach uses Rosetta-based energy calculations to choose the surface mutations. Both protocols are available for use through the ROSIE web server. The automated Rosetta and AvNAPSA approaches for supercharging choose dissimilar mutations, raising an interesting division in surface charging strategy. Rosetta-supercharged variants of GFP (RscG) ranging from -11 to -61 and +7 to +58 were experimentally tested, and for comparison, we re-tested the previously developed AvNAPSA-supercharged variants of GFP (AscG) with +36 and -30 net charge. Mid-charge variants demonstrated similar to 3-fold improvement in refolding with retention of stability. However, as we pushed to higher net charges, expression and soluble yield decreased, indicating that net charge or mutational load may be limiting factors. Interestingly, the two different approaches resulted in GFP variants with similar refolding properties. Our results show that there are multiple sets of residues that can be mutated to successfully supercharge a protein, and combining alternative supercharge protocols with experimental testing can be an effective approach for charge-based improvement to refolding.	[Der, Bryan S.; Jacak, Ron; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Kluwe, Christien; Miklos, Aleksandr E.; Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Kluwe, Christien; Miklos, Aleksandr E.; Georgiou, George; Ellington, Andrew D.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Miklos, Aleksandr E.; Ellington, Andrew D.] Univ Texas Austin, Appl Res Labs, Austin, TX 78712 USA; [Lyskov, Sergey; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Kuhlman, Brian] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Kuhlman, B (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	bkuhlman@email.unc.edu	Gray, Jeffrey J./B-5682-2008	Gray, Jeffrey J./0000-0001-6380-2324; Miklos, Aleksandr/0000-0001-6375-2304	Defense Advanced Research Projects Agency [HR-0011-10-1-0052]; Welch Foundation [F-1654]; National Institutes of Health [GM073960, R01-GM073151, T32GM008570]; Rosetta Commons; National Science Foundation [2009070950]; UNC Royster Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570, R01GM073151, R01GM073960, R01GM078221] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosetta Commons; National Science Foundation(National Science Foundation (NSF)); UNC Royster Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Defense Advanced Research Projects Agency (HR-0011-10-1-0052 to A. E.) and the Welch Foundation (F-1654 to A. E.), the National Institutes of Health grants GM073960 (B. K.) and R01-GM073151 (J. G. and S. L.), the Rosetta Commons (S. L.), the National Science Foundation graduate research fellowship (2009070950 to B. D.), the UNC Royster Society Pogue fellowship (B. D.), and National Institutes of Health grant T32GM008570 for the UNC Program in Molecular and Cellular Biophysics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORDERS CL, 1994, PROTEIN SCI, V3, P541; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dasnoy S, 2011, PHARM RES-DORDR, V28, P1591, DOI 10.1007/s11095-011-0393-x; DEFELIPPIS MR, 1993, BIOCHEMISTRY-US, V32, P1555, DOI 10.1021/bi00057a021; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407; FIELDS GB, 1992, J PHYS CHEM-US, V96, P3974, DOI 10.1021/j100189a013; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Fowler SB, 2005, P NATL ACAD SCI USA, V102, P10105, DOI 10.1073/pnas.0501215102; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Fuchs SM, 2007, ACS CHEM BIOL, V2, P167, DOI 10.1021/cb600429k; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Glukhov E, 2008, BIOPOLYMERS, V89, P360, DOI 10.1002/bip.20917; GOLDBERG ME, 1991, BIOCHEMISTRY-US, V30, P2790, DOI 10.1021/bi00225a008; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Herberhold H, 2003, J MOL BIOL, V330, P1153, DOI 10.1016/S0022-2836(03)00657-0; Hirst SJ, 2011, J STRUCT BIOL, V173, P506, DOI 10.1016/j.jsb.2010.10.013; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Jacak R, 2012, PROTEINS, V80, P825, DOI 10.1002/prot.23241; Kamerzell TJ, 2011, ADV DRUG DELIVER REV, V63, P1118, DOI 10.1016/j.addr.2011.07.006; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li S, 2013, PROTEINS; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Loladze VV, 2002, PROTEIN SCI, V11, P174, DOI 10.1110/ps.ps.29902; LONDON J, 1974, EUR J BIOCHEM, V47, P409, DOI 10.1111/j.1432-1033.1974.tb03707.x; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; Miklos AE, 2012, CHEM BIOL, V19, P449, DOI 10.1016/j.chembiol.2012.01.018; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; MRABET NT, 1992, BIOCHEMISTRY-US, V31, P2239, DOI 10.1021/bi00123a005; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Ramm K, 1999, J MOL BIOL, V290, P535, DOI 10.1006/jmbi.1999.2854; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rohl C. A., 2004, METHODS ENZYMOLOGY; Scheyhing CH, 2002, BIOPOLYMERS, V65, P244, DOI 10.1002/bip.10237; Simeonov P, 2012, PROTEINS; Simeonov P, 2011, PROTEIN ENG DES SEL, V24, P261, DOI 10.1093/protein/gzq104; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; SOKALINGAM S, 2012, PLOS ONE, V7; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; SPEED MA, 1995, PROTEIN SCI, V4, P900; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Thompson DB, 2012, CHEM BIOL, V19, P831, DOI 10.1016/j.chembiol.2012.06.014; Thompson DB, 2012, METHOD ENZYMOL, V503, P293, DOI 10.1016/B978-0-12-396962-0.00012-4; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Zbilut JP, 2004, PHYSICA A, V343, P348, DOI 10.1016/j.physa.2004.05.081	60	53	52	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64363	10.1371/journal.pone.0064363	http://dx.doi.org/10.1371/journal.pone.0064363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741319	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900031
J	Janicek, R; Hotka, M; Zahradnikova, A; Zahradnikova, A; Zahradnik, I				Janicek, Radoslav; Hotka, Matej; Zahradnikova, Alexandra, Jr.; Zahradnikova, Alexandra; Zahradnik, Ivan			Quantitative Analysis of Calcium Spikes in Noisy Fluorescent Background	PLOS ONE			English	Article							CA2+ SPARKS; RYANODINE RECEPTORS; RELEASE FLUX; RAT; ACTIVATION; AMPLITUDE; IMAGES; WAVES	Intracellular calcium signals are studied by laser-scanning confocal fluorescence microscopy. The required spatio-temporal resolution makes description of calcium signals difficult because of the low signal-to-noise ratio. We designed a new procedure of calcium spike analysis based on their fitting with a model. The accuracy and precision of calcium spike description were tested on synthetic datasets generated either with randomly varied spike parameters and Gaussian noise of constant amplitude, or with constant spike parameters and Gaussian noise of various amplitudes. Statistical analysis was used to evaluate the performance of spike fitting algorithms. The procedure was optimized for reliable estimation of calcium spike parameters and for dismissal of false events. A new algorithm was introduced that corrects the acquisition time of pixels in line-scan images that is in error due to sequential acquisition of individual pixels along the space coordinate. New software was developed in Matlab and provided for general use. It allows interactive dissection of temporal profiles of calcium spikes from x-t images, their fitting with predefined function(s) and acceptance of results on statistical grounds, thus allowing efficient analysis and reliable description of calcium signaling in cardiac myocytes down to the in situ function of ryanodine receptors.	[Janicek, Radoslav; Hotka, Matej; Zahradnikova, Alexandra, Jr.; Zahradnikova, Alexandra; Zahradnik, Ivan] Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia; [Hotka, Matej] Safarik Univ, Fac Nat Sci, Dept Biophys, Kosice, Slovakia	Slovak Academy of Sciences; University of Pavol Jozef Safarik Kosice	Zahradnik, I (corresponding author), Slovak Acad Sci, Inst Mol Physiol & Genet, Vlarska 5, Bratislava 83334, Slovakia.	ivan.zahradnik@savba.sk	Zahradnikova, Alexandra/B-1826-2009; Alexandra, Zahradnikova/C-2918-2009	Zahradnikova, Alexandra/0000-0002-7296-9617; Alexandra, Zahradnikova/0000-0001-5170-118X; Hotka, Matej/0000-0002-0482-9401; Janicek, Radoslav/0000-0002-8924-1024	Slovak Grant Agency VEGA [2/0917/11, 2/0203/11]; Slovak Research and Development Agency [APVV-0721-10]	Slovak Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Slovak Research and Development Agency(Slovak Research and Development Agency)	This work was supported by the Slovak Grant Agency VEGA, projects no. 2/0917/11 and 2/0203/11, and by the Slovak Research and Development Agency under contract no. APVV-0721-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano J, 2007, CIRC RES, V101, P590, DOI 10.1161/CIRCRESAHA.107.152322; Bray MA, 2007, BIOPHYS J, V92, P4433, DOI 10.1529/biophysj.106.089359; CANNELL MB, 1994, BIOPHYS J, V67, P1942, DOI 10.1016/S0006-3495(94)80677-0; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Cheng H, 1996, AM J PHYSIOL-CELL PH, V270, pC148; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Cheng HP, 2002, FRONT BIOSCI, V7, pD1867, DOI 10.2741/cheng; Janicek R, 2012, J PHYSIOL-LONDON, V590, P5091, DOI 10.1113/jphysiol.2012.234823; Kong CHT, 2008, BIOPHYS J, V95, P6016, DOI 10.1529/biophysj.108.135251; Lacampagne A, 1999, J GEN PHYSIOL, V113, P187, DOI 10.1085/jgp.113.2.187; Lukyanenko V, 1999, J PHYSIOL-LONDON, V521, P575, DOI 10.1111/j.1469-7793.1999.00575.x; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Polakova E, 2008, J PHYSIOL-LONDON, V586, P3839, DOI 10.1113/jphysiol.2007.149989; Rios E, 2002, FRONT BIOSCI-LANDMRK, V7, pD1195, DOI 10.2741/rios; Sham JSK, 1998, P NATL ACAD SCI USA, V95, P15096, DOI 10.1073/pnas.95.25.15096; Soeller C, 2007, P NATL ACAD SCI USA, V104, P14958, DOI 10.1073/pnas.0703016104; Song LS, 2001, CIRC RES, V88, P794, DOI 10.1161/hh0801.090461; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; Szabo LZ, 2010, J THEOR BIOL, V264, P1279, DOI 10.1016/j.jtbi.2010.04.005; Wang SQ, 2002, BIOPHYS J, V83, P242, DOI 10.1016/S0006-3495(02)75165-5; Zahradnikova A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00322; Zahradnikova A, 2010, J GEN PHYSIOL, V136, P581, DOI 10.1085/jgp.201010542; Zahradnikova A, 2007, J PHYSIOL-LONDON, V578, P677, DOI 10.1113/jphysiol.2006.117796	24	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64394	10.1371/journal.pone.0064394	http://dx.doi.org/10.1371/journal.pone.0064394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741324	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900036
J	Jansen, T; Gislason, H				Jansen, Teunis; Gislason, Henrik			Population Structure of Atlantic Mackerel (Scomber scombrus)	PLOS ONE			English	Article							NORTH-SEA; FISH; WESTERN; EASTERN	Atlantic mackerel (Scomber scombrus) occurs on both sides of the north Atlantic and has traditionally been grouped into 5 spawning components, some of which were thought to be isolated natal homing stocks. Previous studies have provided no evidence for cross Atlantic migration and no or weak support for isolated spawning components within either side of the North Atlantic. We question the de-facto accepted hypothesis of isolation between spawning components on the basis of spawning and age distribution data. The spawning intensities, proxied by larval abundances, are negatively correlated between the North Sea and Celtic Sea, which indicates that the two spawning components may be connected by straying individuals. This finding is based on unique larvae samples collected before the collapse of North Sea component, thus showing that the exchange is not a recent phenomenon due to the collapse. The analyses of old as well as more recent age distributions show that strong year classes spread into other areas where they spawn as adults ("twinning"). Our findings are in accordance with the lack of solid evidence for stock separation from previous analyses of tagging data, genetics, ectoparasite infections, otolith shapes, and blood phenotypes. Because no method has been able to identify the origin of spawning mackerel unequivocally from any of the traditional spawning components, and in the light of our results, we conclude that straying outweighs spatial segregation. We propose a new model where the population structure of mackerel is described as a dynamic cline, rather than as connected contingents. Temporal changes in hydrography and mackerel behavior may affect the steepness of the cline at various locations. The new interpretation of the population structure of Atlantic mackerel has important implications for research, assessment and management.	[Jansen, Teunis; Gislason, Henrik] Tech Univ Denmark, DTU AQUA Natl Inst Aquat Resources, Charlottenlund, Denmark	Technical University of Denmark	Jansen, T (corresponding author), Tech Univ Denmark, DTU AQUA Natl Inst Aquat Resources, Charlottenlund, Denmark.	Tej@aqua.dtu.dk	Gislason, Henrik/R-9567-2019; Gislason, Henrik/C-1357-2008	Gislason, Henrik/0000-0003-0242-3333; Jansen, Teunis/0000-0001-8722-4493	DEFINEIT under MariFish ERA-NET [ERAC-CT-2006-025989]; European Commission [264933, 266445]; Directorate For Geosciences [1154661] Funding Source: National Science Foundation; Villum Fonden [00007178] Funding Source: researchfish	DEFINEIT under MariFish ERA-NET; European Commission(European CommissionEuropean Commission Joint Research Centre); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Villum Fonden(Villum Fonden)	This study was funded by DEFINEIT under MariFish ERA-NET (ERAC-CT-2006-025989), the European Commission's within the Seventh Framework Programmes EURO BASIN (Grant Agreement #264933) and VECTORS (Grant Agreement #266445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken E, 1986, 1986H65 ICES CM; Bakken E, 1977, CM1977H26 ICES; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Bekkevold D, 2011, MAR ECOL PROG SER, V442, P187, DOI 10.3354/meps09352; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; CASTONGUAY M, 1991, CAN J FISH AQUAT SCI, V48, P296, DOI 10.1139/f91-041; COLEBROOK J M, 1975, Bulletins of Marine Ecology, V8, P123; DAWSON WA, 1991, J CONSEIL, V47, P303; DAWSON WA, 1986, J MAR BIOL ASSOC UK, V66, P367, DOI 10.1017/S0025315400043009; Eltink ATGW, 1982, CM1982H31 ICES; Eltink ATGW, 1986, 1986H49 ICES CM; Godo OR, 2004, ICES J MAR SCI, V61, P1093, DOI 10.1016/j.icesjms.2004.06.009; Gregoire F, 2010, 201011 TRANSB RES AS; Hamre J., 1978, RAPP P V REUN CONS I, V172, P197; Hannesson R., 2012, ICES J MAR SCI; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; Hopkins P, 1986, 1986H7 ICES CM; Hughes K, 2011, 2011SSGESST07 ICES C; ICES, 1977, 1977H2 ICES CM; *ICES, 1981, 1981H7 ICES CM; ICES, 2000, 2000G01 ICES CM; ICES, 2005, 2005ACFM08 ICES CM; ICES, 2008, 2008ACOM13 ICES CM; ICES, 2012, ICES HYDR DAT; ICES, 1979, 1979H5 ICES CM; ICES, 1991, CM199119 ICES; ICES, 2011, 2011SSGESST07 ICES C; ICES, 2019, ICES SCI REPORTS, V1, DOI 10.17895/ices.pub.4982; ICES, 2008, ICES, P10; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Iversen S.A., 2002, ICES J MAR SCI, V215, P382, DOI [10.17895/ices.pub.8877, DOI 10.17895/ICES.PUB.8877]; JAMIESON A, 1987, J CONSEIL, V44, P66; Jansen T., 2012, PLOS ONE, V7; Jansen T, MACKEREL SCOMBER SCO; Jansen T., 2013, PLOS ONE, V8; Jansen T, 2011, CONT SHELF RES, V31, P64, DOI 10.1016/j.csr.2010.11.003; Johnson P. O, 1977, FISH RES TECH REP MA, V77, P1; Lambrey de Souza J., 2006, CAN TECH REP FISH AQ, V2625; Langoy H, 2006, 2006F12 ICES CM; LEVINS RICHARD, 1968; Lewy P, 2009, CAN J FISH AQUAT SCI, V66, P1809, DOI 10.1139/F09-114; LOCKWOOD S J, 1981, Journal of Plankton Research, V3, P217, DOI 10.1093/plankt/3.2.217; Lockwood SJ, 1988, MACKEREL ITS BIOL AS; Lohmann KJ, 2008, P NATL ACAD SCI USA, V105, P19096, DOI 10.1073/pnas.0801859105; MacKay KT, 1973, 70 ICNAF; MacKay KT, 1967, 31 FISH RES BOARD, V31; MACKENZIE K, 1990, J CONSEIL, V46, P155; Maguire J. J., 1987, 8771 CAFSAC; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; Naevdal, 1970, FISK DIR SKR SERV HA, V15, P573; Nesbo CL, 2000, P ROY SOC B-BIOL SCI, V267, P281, DOI 10.1098/rspb.2000.0998; Nolan GD, 2012, ICES COOP RES REP, V314, P1; Olla B., 1975, COMBINED EFFECTS RAD, P299; PEPIN P, 1987, CAN J FISH AQUAT SCI, V44, P2012, DOI 10.1139/f87-247; PEPIN P, 1988, CAN J FISH AQUAT SCI, V45, P879, DOI 10.1139/f88-106; Petitgas P, 2010, ICES J MAR SCI, V67, P1841, DOI 10.1093/icesjms/fsq082; Pitois SG, 2006, ICES J MAR SCI, V63, P785, DOI 10.1016/j.icesjms.2006.03.009; Pitois SG, 2012, MAR ECOL PROG SER, V456, P169, DOI 10.3354/meps09710; POSTUMA KH, 1972, J CONSEIL, V34, P455; Ringuette M, 2002, CAN J FISH AQUAT SCI, V59, P646, DOI 10.1139/F02-039; Robert D, 2008, J PLANKTON RES, V30, P673, DOI 10.1093/plankt/fbn030; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Sette O.E., 1950, FISH B, V51, P249; Smedbol RK, 2002, FISH FISH, V3, P20, DOI 10.1046/j.1467-2979.2002.00062.x; SOMDAL O, 1992, SARSIA, V77, P19, DOI 10.1080/00364827.1992.10413489; Teixeira AS, 1985, 1985H68 ICES CM; Tenningen M, 2011, FISH RES, V107, P68, DOI 10.1016/j.fishres.2010.10.009; Trenkel VM, PROG OCEANOGR; Uriarte A., 2001, 2001O17 ICES CM; Walsh M, 1981, CM1981H54 ICES; Zuur Alain F., 2009, P1; [No title captured]	74	35	35	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64744	10.1371/journal.pone.0064744	http://dx.doi.org/10.1371/journal.pone.0064744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741381	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900094
J	Lipson, DA; Haggerty, JM; Srinivas, A; Raab, TK; Sathe, S; Dinsdale, EA				Lipson, David A.; Haggerty, John Matthew; Srinivas, Archana; Raab, Theodore K.; Sathe, Shashank; Dinsdale, Elizabeth A.			Metagenomic Insights into Anaerobic Metabolism along an Arctic Peat Soil Profile	PLOS ONE			English	Article							EXTRACELLULAR ELECTRON-TRANSFER; OUTER-MEMBRANE CYTOCHROMES; METHANE PRODUCTION; SUPEROXIDE-DISMUTASE; CLIMATE-CHANGE; FE(III) OXIDE; REDUCTION; SHEWANELLA; TRANSPORT; OXIDATION	A metagenomic analysis was performed on a soil profile from a wet tundra site in northern Alaska. The goal was to link existing biogeochemical knowledge of the system with the organisms and genes responsible for the relevant metabolic pathways. We specifically investigated how the importance of iron (Fe) oxides and humic substances (HS) as terminal electron acceptors in this ecosystem is expressed genetically, and how respiratory and fermentative processes varied with soil depth into the active layer and into the upper permafrost. Overall, the metagenomes reflected a microbial community enriched in a diverse range of anaerobic pathways, with a preponderance of known Fe reducing species at all depths in the profile. The abundance of sequences associated with anaerobic metabolic processes generally increased with depth, while aerobic cytochrome c oxidases decreased. Methanogenesis genes and methanogen genomes followed the pattern of CH4 fluxes : they increased steeply with depth into the active layer, but declined somewhat over the transition zone between the lower active layer and the upper permafrost. The latter was relatively enriched in fermentative and anaerobic respiratory pathways. A survey of decaheme cytochromes (MtrA, MtrC and their homologs) revealed that this is a promising approach to identifying potential reducers of Fe(III) or HS, and indicated a possible role for Acidobacteria as Fe reducers in these soils. Methanogens appear to coexist in the same layers, though in lower abundance, with Fe reducing bacteria and other potential competitors, including acetogens. These observations provide a rich set of hypotheses for further targeted study.	[Lipson, David A.; Haggerty, John Matthew; Srinivas, Archana; Sathe, Shashank; Dinsdale, Elizabeth A.] San Diego State Univ, San Diego, CA 92182 USA; [Raab, Theodore K.] Carnegie Inst Sci, Stanford, CA USA	California State University System; San Diego State University; Carnegie Institution for Science	Lipson, DA (corresponding author), San Diego State Univ, San Diego, CA 92182 USA.	dlipson@mail.sdsu.edu	Raab, Ted K./A-7478-2008	Raab, Ted K./0000-0002-3965-8729; dinsdale, elizabeth/0000-0002-2177-203X	National Science Foundation (NSF) OPP grant [0808604]; NSF TUES grant [1044453]	National Science Foundation (NSF) OPP grant(National Science Foundation (NSF)); NSF TUES grant	This work was funded in part by National Science Foundation (NSF) OPP grant #0808604 to Lipson and Raab, and NSF TUES grant #1044453 to Dinsdale (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2010, ENVIRON MICROBIOL, V12, P642, DOI 10.1111/j.1462-2920.2009.02104.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUSEBEL FM, 1994, CURRENT PROTOCOLS MO; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bapteste Eric, 2005, Archaea, V1, P353, DOI 10.1155/2005/859728; Bastviken D, 2009, ENVIRON SCI TECHNOL, V43, P3569, DOI 10.1021/es8035779; Bond DR, 2012, CHEMSUSCHEM, V5, P1099, DOI 10.1002/cssc.201100748; Bond DR, 2002, ENVIRON MICROBIOL, V4, P115, DOI 10.1046/j.1462-2920.2002.00279.x; Brauer S, 2010, INT J SYST IN PRESS, DOI [10.1099/ijs.1090.021782-021780, DOI 10.1099/IJS.1090.021782-021780]; Brioukhanov AL, 2002, MICROBIOLOGY+, V71, P281, DOI 10.1023/A:1015846409735; Brioukhanov AL, 2006, MICROBIOL-SGM, V152, P1671, DOI 10.1099/mic.0.28542-0; Bucking C, 2012, MICROBIOL-SGM, V158, P2144, DOI 10.1099/mic.0.058404-0; Burns JL, 2010, ENVIRON SCI TECHNOL, V44, P68, DOI 10.1021/es9018699; Carlson HK, 2012, P NATL ACAD SCI USA, V109, P1702, DOI 10.1073/pnas.1112905109; Coates JD, 1999, INT J SYST BACTERIOL, V49, P1615, DOI 10.1099/00207713-49-4-1615; Coates JD, 2002, APPL ENVIRON MICROB, V68, P2445, DOI 10.1128/AEM.68.5.2445-2452.2002; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Conrad R, 1999, FEMS MICROBIOL ECOL, V28, P193, DOI 10.1016/S0168-6496(98)00086-5; CONRAD R, 1990, ARCH MICROBIOL, V155, P94, DOI 10.1007/BF00291281; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Friedman ES, 2012, BIOSENS BIOELECTRON, V32, P309, DOI 10.1016/j.bios.2011.12.013; Futagami T, 2008, CHEM REC, V8, P1, DOI 10.1002/tcr.20134; George IF, 2011, APPL ENVIRON MICROB, V77, P8184, DOI 10.1128/AEM.05956-11; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Graham DE, 2012, ISME J, V6, P709, DOI 10.1038/ismej.2011.163; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hines ME, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002903; HOLMER M, 1994, MAR ECOL PROG SER, V107, P177, DOI 10.3354/meps107177; Huang H, 2010, BIOTECHNOL ADV, V28, P651, DOI 10.1016/j.biotechadv.2010.05.015; Jerman V, 2009, BIOGEOSCIENCES, V6, P1127, DOI 10.5194/bg-6-1127-2009; Jiao Y, 2007, J BACTERIOL, V189, P1765, DOI 10.1128/JB.00776-06; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Keppler F, 2000, NATURE, V403, P298, DOI 10.1038/35002055; Kittelmann S, 2008, ENVIRON MICROBIOL, V10, P31, DOI 10.1111/j.1462-2920.2007.01427.x; Kotsyurbenko OR, 2001, FEMS MICROBIOL ECOL, V38, P153, DOI 10.1111/j.1574-6941.2001.tb00893.x; Kusel K, 2008, BIOGEOSCIENCES, V5, P1537; Lipson DA, 2012, BIOGEOSCIENCES, V9, P577, DOI 10.5194/bg-9-577-2012; Lipson DA, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001147; Liu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00037; Lower BH, 2008, ENVIRON SCI TECHNOL, V42, P3821, DOI 10.1021/es702688c; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metje M, 2007, ENVIRON MICROBIOL, V9, P954, DOI 10.1111/j.1462-2920.2006.01217.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MILLER MJ, 1983, J BIOL CHEM, V258, P9159; Oberg G, 2002, APPL MICROBIOL BIOT, V58, P565, DOI 10.1007/s00253-001-0895-2; Olivas PC, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001254; PARKIN TB, 1993, J ENVIRON QUAL, V22, P409, DOI 10.2134/jeq1993.00472425002200030004x; PHELPS TJ, 1984, APPL ENVIRON MICROB, V48, P1088, DOI 10.1128/AEM.48.6.1088-1095.1984; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Richardson DJ, 2012, MOL MICROBIOL, V85, P201, DOI 10.1111/j.1365-2958.2012.08088.x; Risso C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-447; Roden EE, 1996, LIMNOL OCEANOGR, V41, P1733, DOI 10.4319/lo.1996.41.8.1733; ROLFE RD, 1978, APPL ENVIRON MICROB, V36, P306, DOI 10.1128/AEM.36.2.306-313.1978; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Sharma S, 2010, J BIOL INORG CHEM, V15, P559, DOI 10.1007/s00775-010-0623-4; Shi L, 2008, J BACTERIOL, V190, P5512, DOI 10.1128/JB.00514-08; Shi L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00050; Shi LA, 2009, ENV MICROBIOL REP, V1, P220, DOI 10.1111/j.1758-2229.2009.00035.x; Shiklomanov NI, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001248; Stams AJM, 2006, ENVIRON MICROBIOL, V8, P371, DOI 10.1111/j.1462-2920.2006.00989.x; Svensson T, 2007, BIOGEOCHEMISTRY, V82, P181, DOI 10.1007/s10533-006-9062-2; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tveit A, 2013, ISME J, V7, P299, DOI 10.1038/ismej.2012.99; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Zona D, 2011, ECOLOGY, V92, P633, DOI 10.1890/10-0822.1; Zona D, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003487	73	70	71	7	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64659	10.1371/journal.pone.0064659	http://dx.doi.org/10.1371/journal.pone.0064659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741360	gold, Green Published			2022-12-27	WOS:000319799900073
J	Lu, ML; Lin, CH; Chen, YC; Yang, HC; Wu, TH				Lu, Mong-Liang; Lin, Chia-Hui; Chen, Yi-Chuan; Yang, Huai-Chih; Wu, Tzu-Hua			Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; KOREAN SCHIZOPHRENIC-PATIENTS; ELECTROCHEMICAL DETECTION; ATYPICAL ANTIPSYCHOTICS; COULOMETRIC DETECTION; CONSENSUS GUIDELINES; EXTRACTION PROCEDURE; HOMOCYSTEINE LEVELS; SERUM HOMOCYSTEINE; INSULIN-SECRETION	Background: Olanzapine (OLZ) is one of the most prescribed atypical antipsychotic drugs but its use is associated with unfavorable metabolic abnormalities. N- desmethyl- olanzapine (DMO), one of the OLZ metabolites by CYP1A2, has been reported to have a normalizing action on metabolic abnormalities, but this remains unclear. Our aim was to explore the correlation between the concentrations of OLZ or DMO with various metabolic parameters in schizophrenic patients. Methods: The chromatographic analysis was carried out with a solvent delivery system coupled to a Coulochem III coulometric detector to determine OLZ and DMO simultaneously in OLZ- treated patients. The correlation between the concentration of OLZ or DMO and the metabolic parameters was analyzed by the Spearman rank order correlation method (rs). Principal Findings: The established analytical method met proper standards for accuracy and reliability and the lower limitation of quantification for each injection of DMO or OLZ was 0.02 ng. The method was successfully used for the analysis of samples from nonsmoking patients (n = 48) treated with OLZ in the dosage range of 5-20 mg per day. There was no correlation between OLZ concentrations and tested metabolic parameters. DMO concentrations were negatively correlated with glucose (rs = -0.45) and DMO concentrations normalized by doses were also negatively correlated with insulin levels (r(s) = -0.39); however, there was a marginally positive correlation between DMO and homocysteine levels (r(s) = +0.38). Conclusions: The observed negative correlations between levels of DMO and glucose or insulin suggest a metabolic normalization role for DMO regardless of its positive correlation with a known cardiovascular risk factor, homocysteine. Additional studies of the mechanisms underlying DMO's metabolic effects are warranted.	[Lu, Mong-Liang] Taipei Med Univ, Wan Fang Med Ctr, Dept Psychiat, Taipei, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Coll Med, Dept Psychiat, Taipei, Taiwan; [Lin, Chia-Hui; Chen, Yi-Chuan; Yang, Huai-Chih; Wu, Tzu-Hua] Taipei Med Univ, Coll Pharm, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University	Wu, TH (corresponding author), Taipei Med Univ, Coll Pharm, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	thwu@tmu.edu.tw		Lu, Mong-Liang/0000-0003-3184-6554	National Science Council	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 2004, PHARMACOPSYCHIATRY, V37, P243, DOI 10.1055/s-2004-832687; Beasley CM, 1996, NEUROPSYCHOPHARMACOL, V14, P111, DOI 10.1016/0893-133X(95)00069-P; Benjamini Y, 2001, ANN STAT, V29, P1165; Bergemann N, 2004, PHARMACOPSYCHIATRY, V37, P63; Bogusz MJ, 1999, J CHROMATOGR B, V732, P257, DOI 10.1016/S0378-4347(99)00287-X; Bymaster F, 1999, BRIT J PSYCHIAT, V174, P36, DOI 10.1192/S0007125000293653; Callaghan JT, 1999, CLIN PHARMACOKINET, V37, P177, DOI 10.2165/00003088-199937030-00001; CATLOW JT, 1995, J CHROMATOGR B, V668, P85, DOI 10.1016/0378-4347(95)00061-M; Chin C, 2004, J PHARMACEUT BIOMED, V35, P1149, DOI 10.1016/j.jpba.2004.01.005; Chiu CC, 2006, J CLIN PSYCHOPHARM, V26, P504, DOI 10.1097/01.jcp.0000237947.80764.d9; Chiu CC, 2010, PROG NEURO-PSYCHOPH, V34, P866, DOI 10.1016/j.pnpbp.2010.04.003; Chiu JA, 1996, J PHARMACEUT BIOMED, V14, P609, DOI 10.1016/0731-7085(95)01651-1; Citrome L, 2011, CLIN DRUG INVEST, V31, P455, DOI 10.2165/11589060-000000000-00000; D'Arrigo C, 2006, THER DRUG MONIT, V28, P388, DOI 10.1097/01.ftd.0000211800.66569.c9; Dicker-Brown A, 2001, ATHEROSCLEROSIS, V158, P297, DOI 10.1016/S0021-9150(01)00442-7; Elman I, 2006, NEUROPSYCHOPHARMACOL, V31, P2091, DOI [10.1038/sj.npp.1301141, 10.1038/sj.npp.1301051]; Ghotbi R, 2010, EUR J CLIN PHARMACOL, V66, P465, DOI 10.1007/s00228-009-0783-8; Guidance for Industry, GUID IND BIOAN METH; Haddad PM, 2007, CNS DRUGS, V21, P911, DOI 10.2165/00023210-200721110-00004; Haslemo T, 2006, EUR J CLIN PHARMACOL, V62, P1049, DOI 10.1007/s00228-006-0209-9; Henderson DC, 2006, ACTA PSYCHIAT SCAND, V113, P121, DOI 10.1111/j.1600-0447.2005.00621.x; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; Josefsson M, 2010, J PHARMACEUT BIOMED, V53, P576, DOI 10.1016/j.jpba.2010.03.040; Kim TH, 2011, PSYCHIAT INVEST, V8, P134, DOI 10.4306/pi.2011.8.2.134; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006654.pub2; Laika B, 2010, PHARMACOGENOMICS J, V10, P20, DOI 10.1038/tpj.2009.32; Lee YS, 2006, NEUROREPORT, V17, P743, DOI 10.1097/01.wnr.0000215777.99473.52; Levine J, 2005, PROG NEURO-PSYCHOPH, V29, P1181, DOI 10.1016/j.pnpbp.2005.06.029; Levine J, 2002, AM J PSYCHIAT, V159, P1790, DOI 10.1176/appi.ajp.159.10.1790; Melkersson KI, 2000, J CLIN PSYCHIAT, V61, P742, DOI 10.4088/JCP.v61n1006; Melkersson KI, 2003, PSYCHOPHARMACOLOGY, V170, P157, DOI 10.1007/s00213-003-1529-4; Muench J, 2010, AM FAM PHYSICIAN, V81, P617; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; Nozawa M, 2008, THER DRUG MONIT, V30, P35, DOI 10.1097/FTD.0b013e31816336fd; Raggi MA, 2001, CHROMATOGRAPHIA, V54, P203, DOI 10.1007/BF02492246; Raggi MA, 2001, J CHROMATOGR B, V750, P137, DOI 10.1016/S0378-4347(00)00438-2; Refsum H, 2006, J NUTR, V136, p1731S, DOI 10.1093/jn/136.6.1731S; Reif A, 2005, PROG NEURO-PSYCHOPH, V29, P1162, DOI 10.1016/j.pnpbp.2005.06.027; Sabbioni C, 2004, ANAL CHIM ACTA, V516, P111, DOI 10.1016/j.aca.2004.04.031; Saracino MA, 2007, THER DRUG MONIT, V29, P773, DOI 10.1097/FTD.0b013e31815bde43; Saracino MA, 2006, J CHROMATOGR A, V1122, P21, DOI 10.1016/j.chroma.2006.04.011; Schwenger E, 2011, CLIN PHARMACOKINET, V50, P415, DOI 10.2165/11587240-000000000-00000; Simon V, 2009, J CLIN PSYCHIAT, V70, P1041, DOI 10.4088/JCP.08r04392; Skogh E, 2002, THER DRUG MONIT, V24, P518, DOI 10.1097/00007691-200208000-00010; Susser E, 1998, BIOL PSYCHIAT, V44, P141, DOI 10.1016/S0006-3223(97)00427-7; Theisen FM, 2006, THER DRUG MONIT, V28, P750, DOI 10.1097/01.ftd.0000249950.75462.7f; Virgos C, 1999, NEUROREPORT, V10, P2035, DOI 10.1097/00001756-199907130-00008; Vuksan-Cusa B, 2011, PSYCHIAT RES, V189, P21, DOI 10.1016/j.psychres.2010.11.021; Wu TH, 2008, PROG NEURO-PSYCHOPH, V32, P1889, DOI 10.1016/j.pnpbp.2008.08.022	50	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65719	10.1371/journal.pone.0065719	http://dx.doi.org/10.1371/journal.pone.0065719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741510	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900223
J	Muwonge, A; Malama, S; Johansen, TB; Kankya, C; Biffa, D; Ssengooba, W; Godfroid, J; Djonne, B; Skjerve, E				Muwonge, Adrian; Malama, Sydney; Johansen, Tone B.; Kankya, Clovice; Biffa, Demelash; Ssengooba, Willy; Godfroid, Jacques; Djonne, Berit; Skjerve, Eystein			Molecular Epidemiology, Drug Susceptibility and Economic Aspects of Tuberculosis in Mubende District, Uganda	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENETIC DIVERSITY; KAMPALA; SPOLIGOTYPES; SURVEILLANCE; RESISTANCE; AFRICANUM; PATTERN; BURDEN; TB	Background: Tuberculosis (TB) remains a global public health problem whose effects have major impact in developing countries like Uganda. This study aimed at investigating genotypic characteristics and drug resistance profiles of Mycobacterium tuberculosis isolated from suspected TB patients. Furthermore, risk factors and economic burdens that could affect the current control strategies were studied. Methods: TB suspected patients were examined in a cross-sectional study at the Mubende regional referral hospital between February and July 2011. A questionnaire was administered to each patient to obtain information associated with TB prevalence. Isolates of M. tuberculosis recovered during sampling were examined for drug resistance to first line anti-TB drugs using the BACTEC-MGIT960 (TM) system. All isolates were further characterized using deletion analysis, spoligotyping and MIRU-VNTR analysis. Data were analyzed using different software; MIRU-VNTR plus, SITVITWEB, BioNumerics and multivariable regression models. Results: M. tuberculosis was isolated from 74 out of 344 patients, 48 of these were co-infected with HIV. Results from the questionnaire showed that previously treated TB, co-infection with HIV, cigarette smoking, and overcrowding were risk factors associated with TB, while high medical related transport bills were identified as an economic burden. Out of the 67 isolates that gave interpretable results, 23 different spoligopatterns were detected, nine of which were novel patterns. T2 with the sub types Uganda-I and Uganda-II was the most predominant lineage detected. Antibiotic resistance was detected in 19% and multidrug resistance was detected in 3% of the isolates. Conclusion: The study detected M. tuberculosis from 21% of examined TB patients, 62% of whom were also HIV positive. There is a heterogeneous pool of genotypes that circulate in this area, with the T2 lineage being the most predominant. High medical related transport bills and drug resistance could undermine the usefulness of the current TB strategic interventions.	[Muwonge, Adrian; Malama, Sydney; Skjerve, Eystein] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Ctr Epidemiol & Biostat, Oslo, Norway; [Malama, Sydney] Evelyn Hone Coll, Dept Hlth Sci, Lusaka, Zambia; [Johansen, Tone B.; Djonne, Berit] Norwegian Vet Inst, Oslo, Norway; [Kankya, Clovice] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Dept Publ Hlth & Prevent Med, Kampala, Uganda; [Biffa, Demelash] Univ Arizona, Coll Med, Tucson, AZ USA; [Ssengooba, Willy] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Mycobacteriol Lab, Kampala, Uganda; [Godfroid, Jacques] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Sect Arctic Vet Med, Tromso, Norway; [Muwonge, Adrian] Univ Edinburgh, Roslin Inst, Easter Bush Roslin, Midlothian, Scotland	Norwegian University of Life Sciences; Norwegian Veterinary Institute; Makerere University; University of Arizona; Makerere University; Norwegian University of Life Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Muwonge, A (corresponding author), Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Ctr Epidemiol & Biostat, Oslo, Norway.	Adrian.Muwonge@roslin.ed.ac.uk	Ssengooba, Willy/ABE-2168-2020; Ssengooba, Willy/AAG-1202-2020; Skjerve, Eystein/D-7491-2014; Godfroid, Jacques/HCI-7835-2022; godfroid, jacques/U-3524-2017	Ssengooba, Willy/0000-0002-1643-110X; Ssengooba, Willy/0000-0002-1643-110X; Skjerve, Eystein/0000-0001-9652-6952; godfroid, jacques/0000-0002-0782-7858; ADRIAN, MUWONGE/0000-0002-8579-0384	Norwegian Educational Load fund; Centre for Epidemiology and Biostatistics, Norwegian School of Veterinary Science; National Veterinary Institute	Norwegian Educational Load fund; Centre for Epidemiology and Biostatistics, Norwegian School of Veterinary Science; National Veterinary Institute	This work was carried out by the generous financial support obtained from the Norwegian Educational Load fund as quota scholarship to Dr. Adrian Muwonge as well as from core funding source of the Centre for Epidemiology and Biostatistics, Norwegian School of Veterinary Science and the National Veterinary Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHAJOJ S, 2013, INFECT GENETICS EVOL; Asiimwe BB, 2008, INT J TUBERC LUNG D, V12, P386; Asiimwe BB, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-101; Bazira J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-81; Bretzel G, 1999, INT J TUBERC LUNG D, V3, P810; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dickman KR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-349; EKRAKENE T, 2010, INT J BIOMED H SCI, V6, P91; Garcia de Viedma D, 2005, J CLIN MICROBIOL, V43, P5660, DOI 10.1128/JCM.43.11.5660-5664.2005; Gibson A, 2005, APPL ENVIRON MICROB, V71, P8207, DOI 10.1128/AEM.71.12.8207-8213.2005; *GLOB CO UK, 2010, ADV 8000 TB AFF PERS, V2012, P1; GRIMARD F, 2004, IMPACT TUBERCULOSIS; Hirano K, 2004, J CLIN MICROBIOL, V42, P390, DOI 10.1128/JCM.42.1.390-392.2004; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kankya C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-471; Kaufmann SHE, 2005, TRENDS MICROBIOL, V13, P469, DOI 10.1016/j.tim.2005.08.003; Kent PT, 1985, PUBLIC HLTH MYCOBACT, P207; Kisa O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030331; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; MUWONGE A, 2013, INFECT GENET EVOL, V13, P1348; Nabyonga Lydia, 2011, BMC Res Notes, V4, P280, DOI 10.1186/1756-0500-4-280; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Niemann S, 2004, J CLIN MICROBIOL, V42, P3958, DOI 10.1128/JCM.42.9.3958-3962.2004; Niemann S, 2002, J CLIN MICROBIOL, V40, P3398, DOI 10.1128/JCM.40.9.3398-3405.2002; REICHMAN LB, 2012, GLOBAL EPIDEMIC MULT, P43; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; RWABWOGO MO, 2007, UGANDA DISTRICT INFO, P10; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; SIDDIQUI SH, 2007, MYCOBACTERIA GROWTH; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tupasi TE, 2000, INT J TUBERC LUNG D, V4, P4; Van Soolingen Dick, 2003, VVolume 2, P17; Wen CP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-156; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; *WHO, 2010, WHO LAB MAN EX PROC, P15; *WHO, 2011, WHOHTMTB20113, V3, P7; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129; WORLD HEALTH ORG, 2012, WHOHTMTB20126, P9; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	43	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64745	10.1371/journal.pone.0064745	http://dx.doi.org/10.1371/journal.pone.0064745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741382	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900095
J	Stefanon, I; Valero-Munoz, M; Fernandes, AA; Ribeiro, RF; Rodriguez, C; Miana, M; Martinez-Gonzalez, J; Spalenza, JS; Lahera, V; Vassallo, PF; Cachofeiro, V				Stefanon, Ivanita; Valero-Munoz, Maria; Fernandes, Aurelia Araujo; Ribeiro, Rogerio Faustino, Jr.; Rodriguez, Cristina; Miana, Maria; Martinez-Gonzalez, Jose; Spalenza, Jessica S.; Lahera, Vicente; Vassallo, Paula F.; Cachofeiro, Victoria			Left and Right Ventricle Late Remodeling Following Myocardial Infarction in Rats	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; LYSYL OXIDASE; HEART-FAILURE; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; APOPTOSIS; FIBROSIS; PERFORMANCE; MECHANISMS; MOUSE	Background: The mechanisms involved in cardiac remodeling in left (LV) and right ventricles (RV) after myocardial infarction (MI) are still unclear. We assayed factors involved in collagen turnover in both ventricles following MI in rats either presenting signs of heart failure (pulmonary congestion and increased LVEDP) or not (INF-HF or INF, respectively). Methods: MI was induced in male rats by ligation of the left coronary artery. Four weeks after MI gene expression of collagen I, connective tissue growth factor (CTGF), transforming growth factor beta (TGF-beta) and lysyl oxidase (LOX), metalloproteinase-2 (MMP2) and tissue inhibitor metalloproteinase-2 (TIMP2) as well as cardiac hemodynamic in both ventricles were evaluated. Results: Ventricular dilatation, hypertrophy and an increase in interstitial fibrosis and myocyte size were observed in the RV and LV from INF-HF animals, whereas only LV dilatation and fibrosis in RV was present in INF. The LV fibrosis in INF-HF was associated with higher mRNA of collagen I, CTGF, TGF-beta and LOX expressions than in INF and SHAM animals, while MMP2/TIMP2 mRNA ratio did not change. RV fibrosis in INF and INF-HF groups was associated with an increase in LOX mRNA and a reduction in MMP2/TIMP2 ratio. CTGF mRNA was increased only in the INF-HF group. Conclusions: INF and INF-HF animals presented different patterns of remodeling in both ventricles. In the INF-HF group, fibrosis seems to be consequence of collagen production in LV, and by reductions in collagen degradation in RV of both INF and INF-HF animals.	[Stefanon, Ivanita; Fernandes, Aurelia Araujo; Ribeiro, Rogerio Faustino, Jr.; Spalenza, Jessica S.; Vassallo, Paula F.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Espirito Santo, Brazil; [Valero-Munoz, Maria; Miana, Maria; Lahera, Vicente; Cachofeiro, Victoria] Univ Complutense, Dept Physiol, E-28040 Madrid, Spain; [Rodriguez, Cristina; Martinez-Gonzalez, Jose] CSIC ICCC, Inst Invest Biomed Sant Pau, Barcelona, Spain	Universidade Federal do Espirito Santo; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Cachofeiro, V (corresponding author), Univ Complutense, Dept Physiol, E-28040 Madrid, Spain.	vcara@med.ucm.es	Rodriguez, Cristina/D-3099-2011; Ribeiro, Rogerio/F-7116-2012; Stefanon, Ivanita/J-4729-2014	Rodriguez, Cristina/0000-0002-6472-5647; Ribeiro, Rogerio/0000-0002-9725-3869; Martinez-Gonzalez, Jose/0000-0002-3894-7166; Miana, Maria/0000-0002-0801-8024; Lahera, Vicente/0000-0002-9688-4503; Stefanon, Ivanita/0000-0003-2638-5183; Cachofeiro, Victoria/0000-0001-6959-6293	National Council for Scientific and Technological Development (CNPq, Brazil); Espirito Santo Research Foundation (FAPES/FUNCITEC, Brazil); Fondo de Investigaciones Sanitarias [PI12/01729, PI12/01952]; Red de Investigacion Cardiovascular [RD12/0042/0033, RD12/0042/0053]; Red Cardiovascular del FIS [RD12/0042/0033]	National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Espirito Santo Research Foundation (FAPES/FUNCITEC, Brazil); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Red de Investigacion Cardiovascular; Red Cardiovascular del FIS	This work was supported by grants from The National Council for Scientific and Technological Development (CNPq, Brazil), Espirito Santo Research Foundation (FAPES/FUNCITEC, Brazil), Fondo de Investigaciones Sanitarias (PI12/01729, PI12/01952) and Red de Investigacion Cardiovascular (RD12/0042/0033 and RD12/0042/0053). M. Miana was remunerated through a Grant from Red Cardiovascular del FIS (RD12/0042/0033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	Abbate A, 2008, AM J CARDIOL, V102, P658, DOI 10.1016/j.amjcard.2008.05.007; Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; Aoki T, 2009, ARTERIOSCL THROM VAS, V29, P1080, DOI 10.1161/ATVBAHA.108.180760; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Burlew Brad S., 2000, Cardiology Clinics, V18, P435, DOI 10.1016/S0733-8651(05)70154-5; Bussani R, 2003, J CLIN PATHOL, V56, P672, DOI 10.1136/jcp.56.9.672; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Dobaczewski M, 2010, J MOL CELL CARDIOL, V2010; Faria TD, 2011, ARCH MED RES, V42, P274, DOI 10.1016/j.arcmed.2011.06.002; Fraccarollo D, 2005, CARDIOVASC RES, V67, P97, DOI 10.1016/j.cardiores.2005.03.001; Guo J, 2007, INFLAMMATION, V30, P97, DOI 10.1007/s10753-007-9025-3; Hayata N, 2008, BIOCHEM BIOPH RES CO, V370, P274, DOI 10.1016/j.bbrc.2008.03.100; Koshy SKG, 2003, CARDIOVASC RES, V57, P594, DOI 10.1016/S0008-6363(02)00877-5; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes SMCDS, 2004, DEV DYNAM, V231, P542, DOI 10.1002/dvdy.20162; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Miana M, 2011, J PHYSIOL PHARMACOL, V62, P87; MILL JG, 1990, CARDIOVASC RES, V24, P748, DOI 10.1093/cvr/24.9.748; Novaes MAS, 1996, BRAZ J MED BIOL RES, V29, P1683; Ono K, 1998, CIRCULATION, V98, P149, DOI 10.1161/01.CIR.98.2.149; Ocaranza MP, 2010, J HYPERTENS, V28, P1054, DOI 10.1097/HJH.0b013e328335d291; Pereira RB, 2005, J PHARMACOL EXP THER, V312, P1321, DOI 10.1124/jpet.104.077701; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Rodriguez C, 2008, ATHEROSCLEROSIS, V196, P558, DOI 10.1016/j.atherosclerosis.2007.06.002; Rodriguez C, 2008, DRUG NEWS PERSPECT, V21, P218, DOI 10.1358/dnp.2008.21.4.1213351; Sivakumar P, 2008, MOL CELL BIOCHEM, V307, P159, DOI 10.1007/s11010-007-9595-2; STEFANON I, 1990, CARDIOVASC RES, V24, P254, DOI 10.1093/cvr/24.3.254; Stefanon I, 2009, BRAZ J MED BIOL RES, V42, P902, DOI 10.1590/S0100-879X2009005000015; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Toldo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018102; Tsuda T, 2003, CARDIOVASC RES, V59, P926, DOI 10.1016/S0008-6363(03)00519-4; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Van Tassell BW, 2012, INT J CARDIOL, V155, P314, DOI 10.1016/j.ijcard.2011.12.004; Vilahur G, 2011, J MOL CELL CARDIOL, V50, P522, DOI 10.1016/j.yjmcc.2010.12.021; Yuan SM, 2010, INTERACT CARDIOV TH, V11, P455, DOI 10.1510/icvts.2010.234773; Zitta K, 2010, BIOCHEM BIOPH RES CO, V399, P542, DOI 10.1016/j.bbrc.2010.07.106	44	52	52	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64986	10.1371/journal.pone.0064986	http://dx.doi.org/10.1371/journal.pone.0064986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741440	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900153
J	Svercel, M; Filippini, M; Perony, N; Rossetti, V; Bagheri, HC				Svercel, Miroslav; Filippini, Manuela; Perony, Nicolas; Rossetti, Valentina; Bagheri, Homayoun C.			Use of a Four-Tiered Graph to Parse the Factors Leading to Phenotypic Clustering in Bacteria: A Case Study Based on Samples from the Aletsch Glacier	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; CULTURABLE BACTERIA; MICROBIAL COMMUNITY; ICE; DIVERSITY; MICROORGANISMS; CRYOCONITE; INTERFACE; MOUNTAINS; SEQUENCE	An understanding of bacterial diversity and evolution in any environment requires knowledge of phenotypic diversity. In this study, the underlying factors leading to phenotypic clustering were analyzed and interpreted using a novel approach based on a four-tiered graph. Bacterial isolates were organized into equivalence classes based on their phenotypic profile. Likewise, phenotypes were organized in equivalence classes based on the bacteria that manifest them. The linking of these equivalence classes in a four-tiered graph allowed for a quick visual identification of the phenotypic measurements leading to the clustering patterns deduced from principal component analyses. For evaluation of the method, we investigated phenotypic variation in enzyme production and carbon assimilation of members of the genera Pseudomonas and Serratia, isolated from the Aletsch Glacier in Switzerland. The analysis indicates that the genera isolated produce at least six common enzymes and can exploit a wide range of carbon resources, though some specialist species within the pseudomonads were also observed. We further found that pairwise distances between enzyme profiles strongly correlate with distances based on carbon profiles. However, phenotypic distances weakly correlate with phylogenetic distances. The method developed in this study facilitates a more comprehensive understanding of phenotypic clustering than what would be deduced from principal component analysis alone.	[Svercel, Miroslav; Filippini, Manuela; Rossetti, Valentina; Bagheri, Homayoun C.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Perony, Nicolas] Swiss Fed Inst Technol, Chair Syst Design, Zurich, Switzerland	University of Zurich; ETH Zurich	Svercel, M (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	miro.svercel@gmail.com; bagheri@ieu.uzh.ch	Svercel, Miroslav/A-9728-2010	Svercel, Miroslav/0000-0002-7845-290X; Perony, Nicolas/0000-0002-2918-163X; Bagheri, Homayoun/0000-0002-2495-7785	University of Zurich; Kanton Zurich	University of Zurich; Kanton Zurich	This project was funded by the University of Zurich and the Kanton Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfreider A, 1996, APPL ENVIRON MICROB, V62, P2138, DOI 10.1128/AEM.62.6.2138-2144.1996; Bai Y, 2006, RES MICROBIOL, V157, P741, DOI 10.1016/j.resmic.2006.03.006; Battin TJ, 2001, APPL ENVIRON MICROB, V67, P799, DOI 10.1128/AEM.67.2.799-807.2001; Bhatia M, 2006, APPL ENVIRON MICROB, V72, P5838, DOI 10.1128/AEM.00595-06; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Carpenter EJ, 2000, APPL ENVIRON MICROB, V66, P4514, DOI 10.1128/AEM.66.10.4514-4517.2000; Christner BC, 2000, ICARUS, V144, P479, DOI 10.1006/icar.1999.6288; Dancer SJ, 1997, J APPL MICROBIOL, V82, P597, DOI 10.1111/j.1365-2672.1997.tb03590.x; Fenchel T, 2006, PHILOS T R SOC B, V361, P1965, DOI 10.1098/rstb.2006.1924; Foreman CM, 2007, J GEOPHYS RES BIOGEO, V112, P11; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Gause GF, 1935, STRUGGLE EXISTENCE; Grzesiak J, 2009, POL POLAR RES, V30, P37; Hammerli A, 2007, EUR J SOIL SCI, V58, P1437, DOI 10.1111/j.1365-2389.2007.00948.x; Keel C, 1996, APPL ENVIRON MICROB, V62, P552, DOI 10.1128/AEM.62.2.552-563.1996; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lazzaro A, 2009, EUR J SOIL SCI, V60, P860, DOI 10.1111/j.1365-2389.2009.01182.x; Liu YQ, 2009, EXTREMOPHILES, V13, P411, DOI 10.1007/s00792-009-0227-5; Liu YQ, 2009, EXTREMOPHILES, V13, P89, DOI 10.1007/s00792-008-0200-8; Margesin R, 2002, ARCT ANTARCT ALP RES, V34, P88, DOI 10.2307/1552512; Miteva Vanya, 2008, P31, DOI 10.1007/978-3-540-74335-4_3; Miteva VI, 2004, APPL ENVIRON MICROB, V70, P202, DOI 10.1128/AEM.70.1.202-213.2004; Mudryk ZJ, 2004, ESTUAR COAST SHELF S, V59, P59, DOI 10.1016/j.ecss.2003.08.001; Mudryk ZJ, 2004, POL J ENVIRON STUD, V15, P441; Mueller DR, 2004, POLAR BIOL, V27, P66, DOI 10.1007/s00300-003-0580-2; Rothschild LJ, 2006, NATURE, V443, P249, DOI DOI 10.1038/443248A; SCHINNER F, 1992, ARCTIC ALPINE RES, V24, P88, DOI 10.2307/1551325; Segawa T, 2005, APPL ENVIRON MICROB, V71, P123, DOI 10.1128/AEM.71.1.123-130.2005; Sharp M, 1999, GEOLOGY, V27, P107, DOI 10.1130/0091-7613(1999)027<0107:WBPAGB>2.3.CO;2; Sigler WV, 2002, MICROB ECOL, V43, P397, DOI 10.1007/s00248-001-0045-5; Skidmore M, 2005, APPL ENVIRON MICROB, V71, P6986, DOI 10.1128/AEM.71.11.6986-6997.2005; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Xiang SR, 2009, APPL ENVIRON MICROB, V75, P7287, DOI 10.1128/AEM.00915-09; Xiang SR, 2009, FEMS MICROBIOL ECOL, V70, P165, DOI 10.1111/j.1574-6941.2009.00759.x; Xiang SR, 2005, APPL ENVIRON MICROB, V71, P4619, DOI 10.1128/AEM.71.8.4619-4627.2005; Zhang S, 2007, BIOGEOSCIENCES, V4, P1, DOI 10.5194/bg-4-1-2007; Zhang XJ, 2009, FEMS MICROBIOL ECOL, V67, P21, DOI 10.1111/j.1574-6941.2008.00604.x	39	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65059	10.1371/journal.pone.0065059	http://dx.doi.org/10.1371/journal.pone.0065059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741454	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900167
J	Balandraud, N; Picard, C; Reviron, D; Landais, C; Toussirot, E; Lambert, N; Telle, E; Charpin, C; Wendling, D; Pardoux, E; Auger, I; Roudier, J				Balandraud, Nathalie; Picard, Christophe; Reviron, Denis; Landais, Cyril; Toussirot, Eric; Lambert, Nathalie; Telle, Emmanuel; Charpin, Caroline; Wendling, Daniel; Pardoux, Etienne; Auger, Isabelle; Roudier, Jean			HLA-DRB1 Genotypes and the Risk of Developing Anti Citrullinated Protein Antibody (ACPA) Positive Rheumatoid Arthritis	PLOS ONE			English	Article							SHARED EPITOPE HYPOTHESIS; RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; SUSCEPTIBILITY; ALLELES; CLASSIFICATION; POPULATION; GENETICS; CRITERIA; DISEASE	Objective: To provide a table indicating the risk for developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis (RA) according to one's HLA-DRB1 genotype. Methods: We HLA-DRB1 genotyped 857 patients with ACPA positive RA and 2178 controls from South Eastern and Eastern France and calculated Odds Ratios (OR) for developing RA for 106 of 132 possible genotypes accounting for 97% of subjects. Results: HLA-DRB1 genotypic ORs for developing ACPA positive RA range from 28 to 0.19. HLA-DRB1 genotypes with HLA-DRB1*04SE (HLA-DRB1*0404, HLA-DRB1*0405, HLA-DRB1*0408), HLA-DRB1*04:01, HLA-DRB1*01 are usually associated with high risk for developing RA. The second HLA-DRB1 allele in genotype somewhat modulates shared epitope associated risk. We did not identify any absolutely protective allele. Neither the Reviron, nor the du Montcel models accurately explains our data which are compatible with the shared epitope hypothesis and suggest a dosage effect among shared epitope positive HLA-DRB1 alleles, double dose genotypes carrying higher ORs than single dose genotypes. Conclusion: HLA-DRB1 genotypic risk for developing ACPA positive RA is influenced by both HLA-DRB1 alleles in genotype. We provide an HLA-DRB1 genotypic risk table for ACPA positive RA.	[Balandraud, Nathalie; Charpin, Caroline; Roudier, Jean] Hop St Marguerite, Assistance Publ Hop Marseille, Marseille, France; [Balandraud, Nathalie; Lambert, Nathalie; Telle, Emmanuel; Charpin, Caroline; Auger, Isabelle; Roudier, Jean] Aix Marseille Univ, Inst Natl Sci & Rech Med, Unite Mixte Rech Sante 1097, Marseille, France; [Picard, Christophe; Reviron, Denis] Etab Francais Sang Alpes Mediterranee, Lab Immunogenet & Histocompatibilite, Marseille, France; [Toussirot, Eric] Hop St Jacques, Ctr Invest Clin 506, F-25030 Besancon, France; [Toussirot, Eric; Wendling, Daniel] Hop Jean Minjoz, F-25030 Besancon, France; [Landais, Cyril; Pardoux, Etienne] Aix Marseille Univ, CNRS, Unite Mixte Rech 6632, Equipe Evolut Biol & Modelisat, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Roudier, J (corresponding author), Hop St Marguerite, Assistance Publ Hop Marseille, Marseille, France.	jean.roudier@inserm.fr	Lambert, Nathalie C/P-6816-2016; AUGER, ISABELLE/P-6294-2016; roudier, jean/A-8654-2011; Balandraud, Nathalie/ABD-6012-2020	Lambert, Nathalie C/0000-0001-5817-8686; AUGER, ISABELLE/0000-0002-1414-8095; roudier, jean/0000-0001-5435-8567; Balandraud, Nathalie/0000-0002-3839-0185	INSERM (Institut National des Sciences et de la Recherche Medicale); Arthritis Fondation Clarins; Societe Francaise de Rhumatologie	INSERM (Institut National des Sciences et de la Recherche Medicale); Arthritis Fondation Clarins; Societe Francaise de Rhumatologie	This study was funded by INSERM (Institut National des Sciences et de la Recherche Medicale), Arthritis Fondation Clarins and Societe Francaise de Rhumatologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; BENAZET JF, 1995, J RHEUMATOL, V22, P607; de Hair MJH, 2012, ARTHRITIS RHEUM-US, V64, P389, DOI 10.1002/art.33348; de Rooy DPC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3505; du Montcel ST, 2005, ARTHRITIS RHEUM-US, V52, P1063, DOI 10.1002/art.20989; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Mackie SL, 2012, GENES IMMUN, V13, P120, DOI 10.1038/gene.2011.60; Mattey DL, 2001, J RHEUMATOL, V28, P232; OLLIER W, 1992, RHEUM DIS CLIN N AM, V18, P741; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reviron D, 2001, ARTHRITIS RHEUM, V44, P535, DOI 10.1002/1529-0131(200103)44:3<535::AID-ANR101>3.0.CO;2-Z	12	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64108	10.1371/journal.pone.0064108	http://dx.doi.org/10.1371/journal.pone.0064108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737967	Green Published, gold			2022-12-27	WOS:000321394700031
J	Radhakrishna, KV; Hemalatha, R; Geddam, JJB; Kumar, PA; Balakrishna, N; Shatrugna, V				Radhakrishna, K. V.; Hemalatha, R.; Geddam, J. J. Babu; Kumar, P. Ajey; Balakrishna, N.; Shatrugna, Veena			Effectiveness of Zinc Supplementation to Full Term Normal Infants: A Community Based Double Blind, Randomized, Controlled, Clinical Trial	PLOS ONE			English	Article							NUTRITIONAL SUPPLEMENTATION; GROWTH; CHILDREN; DEFICIENCY; MORBIDITY; WEIGHT; STIMULATION; RISK; MO	The study was aimed to test whether zinc supplementation, if initiated early, can prevent stunting and promote optimum body composition in full term infants. For this, full term pregnant women from low income urban community were enrolled and were followed-up for 24 months postpartum. Body mass index (BMI) was calculated from maternal weight and height that were collected one month after delivery. Infants' weight, and length, head, chest and mid upper arm circumferences and skin fold thicknesses at triceps, biceps and subscapular area were collected at baseline (before randomization) and once in three months up till 24 months. Three hundred and twenty four infants were randomized and allocated to zinc (163) or placebo (161) groups respectively. Supplementation of zinc was initiated from 4 months of age and continued till children attained 18 months. The control (placebo) group of children received riboflavin 0.5 mg/day, whereas the intervention (zinc) group received 5 mg zinc plus riboflavin 0.5 mg/day. When infants were 18 months old, dietary intakes (in 78 children) were calculated by 24 hour diet recall method and hemoglobin, zinc, copper and vitamin A were quantified in blood samples collected from 70 children. The results showed prevalence of undernutrition (body mass index <18.5) in 37% of the mothers. Mean+/-SD calorie consumption and zinc intakes from diets in infants were 590+/-282.8 Kcal/day and 0.97+/-0.608 mg/day respectively. Multiple linear regression models demonstrated maternal weight as a strong predictor of infants' weight and length at 18 months of age. As expected, diarrhea duration impacted infants' linear growth and weight gain adversely. Zinc supplementation for a mean period of 190 days, starting from 4 months up to 18 months of age, in full term normal infants, consuming an average energy of 590 Kcal/day, had significant effect on the skin fold thicknesses, but not on their linear growth.	[Radhakrishna, K. V.; Hemalatha, R.; Geddam, J. J. Babu; Kumar, P. Ajey; Balakrishna, N.; Shatrugna, Veena] Natl Inst Nutr ICMR, Hyderabad, Andhra Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Hemalatha, R (corresponding author), Natl Inst Nutr ICMR, Hyderabad, Andhra Pradesh, India.	rhemalathanin@yahoo.com	Nagalla, Balakrishna/GRR-4393-2022	Nagalla, Balakrishna/0000-0002-5613-0942	authors' institute - National Institute of Nutrition, ICMR, Government of India	authors' institute - National Institute of Nutrition, ICMR, Government of India	The study was funded by the authors' institute - National Institute of Nutrition, ICMR, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agte VV, 1998, BIOL TRACE ELEM RES, V65, P109, DOI 10.1007/BF02784263; [Anonymous], NAT FAM HLTH SURV NF, P3; Bhandari N, 2001, J NUTR, V131, P1946, DOI 10.1093/jn/131.7.1946; BHASKARAM P, 1995, INDIAN J MED RES, V102, P210; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; BUTTE NF, 1992, AM J CLIN NUTR, V55, P1109, DOI 10.1093/ajcn/55.6.1109; Castillo-Duran C, 2001, J PEDIATR-US, V138, P229, DOI 10.1067/mpd.2001.110530; CAVAN KR, 1993, AM J CLIN NUTR, V57, P344, DOI 10.1093/ajcn/57.3.344; GOLDEN MHN, 1981, AM J CLIN NUTR, V34, P900, DOI 10.1093/ajcn/34.5.900; Heinig MJ, 2006, AM J CLIN NUTR, V84, P594, DOI 10.1093/ajcn/84.3.594; Hotz C, 2001, NUTR REV, V59, P80; Lira PIC, 1998, AM J CLIN NUTR, V68, p418S, DOI 10.1093/ajcn/68.2.418S; Mamidi RS, 2011, INDIAN PEDIATR, V48, P855, DOI 10.1007/s13312-011-0139-1; MORA JO, 1981, AM J CLIN NUTR, V34, P1885, DOI 10.1093/ajcn/34.9.1885; National Family Health Survey, NAT FAM HLTH SURV IN, P2; National Nutrition Monitoring Bureau (NNMB), 2002, 21 NNMB NAT I NUTR; NEUMANN CG, 1994, EUR J CLIN NUTR, V48, pS90; Osendarp SJM, 2002, AM J CLIN NUTR, V76, P1401, DOI 10.1093/ajcn/76.6.1401; PARK JHY, 1986, J NUTR, V116, P610, DOI 10.1093/jn/116.4.610; Powers HJ, 2003, AM J CLIN NUTR, V77, P1352; Rehman AM, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-44; Rivera JA, 1988, J NUR, V128, P556; Sandstrom B, 2001, BRIT J NUTR, V85, pS181, DOI 10.1079/BJN2000312; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Umeta M, 2003, LANCET, V335, P2021; WALKER SP, 1991, AM J CLIN NUTR, V54, P642, DOI 10.1093/ajcn/54.4.642; WALRAVENS PA, 1992, LANCET, V340, P683, DOI 10.1016/0140-6736(92)92229-9; Waterlow JC, 1988, NESTLE NUTRITION WOR, V14, P1; WHO, 2006, WHO CHILD GROWTH STA; WRIGHT JT, 1995, IN VITRO CELL DEV-AN, V31, P404	32	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e61486	10.1371/journal.pone.0061486	http://dx.doi.org/10.1371/journal.pone.0061486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737940	gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700004
J	Beresford, AE; Eshiamwata, GW; Donald, PF; Balmford, A; Bertzky, B; Brink, AB; Fishpool, LDC; Mayaux, P; Phalan, B; Simonetti, D; Buchanan, GM				Beresford, Alison E.; Eshiamwata, George W.; Donald, Paul F.; Balmford, Andrew; Bertzky, Bastian; Brink, Andreas B.; Fishpool, Lincoln D. C.; Mayaux, Philippe; Phalan, Ben; Simonetti, Dario; Buchanan, Graeme M.			Protection Reduces Loss of Natural Land-Cover at Sites of Conservation Importance across Africa	PLOS ONE			English	Article							MANAGEMENT EFFECTIVENESS; AREAS; DEFORESTATION; TERRESTRIAL	There is an emerging consensus that protected areas are key in reducing adverse land-cover change, but their efficacy remains difficult to quantify. Many previous assessments of protected area effectiveness have compared changes between sets of protected and unprotected sites that differ systematically in other potentially confounding respects (e.g. altitude, accessibility), have considered only forest loss or changes at single sites, or have analysed changes derived from land-cover data of low spatial resolution. We assessed the effectiveness of protection in reducing land-cover change in Important Bird Areas (IBAs) across Africa using a dedicated visual interpretation of higher resolution satellite imagery. We compared rates of change in natural land-cover over a c. 20-year period from around 1990 at a large number of points across 45 protected IBAs to those from 48 unprotected IBAs. A matching algorithm was used to select sample points to control for potentially confounding differences between protected and unprotected IBAs. The rate of loss of natural land-cover at sample points within protected IBAs was just 42% of that at matched points in unprotected IBAs. Conversion was especially marked in forests, but protection reduced rates of forest loss by a similar relative amount. Rates of conversion increased from the centre to the edges of both protected and unprotected IBAs, but rates of loss in 20-km buffer zones surrounding protected IBAs and unprotected IBAs were similar, with no evidence of displacement of conversion from within protected areas to their immediate surrounds (leakage).	[Beresford, Alison E.; Buchanan, Graeme M.] Royal Soc Protect Birds, Edinburgh, Midlothian, Scotland; [Eshiamwata, George W.] BirdLife Int, Africa Partnership Secretariat, Nairobi, Kenya; [Donald, Paul F.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Balmford, Andrew; Phalan, Ben] Univ Cambridge, Dept Zool, Cambridge, England; [Bertzky, Bastian] World Conservat Monitoring Ctr, United Nations Environm Programme, Cambridge, England; [Brink, Andreas B.; Mayaux, Philippe] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy; [Fishpool, Lincoln D. C.] BirdLife Int, Cambridge, England; [Simonetti, Dario] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Reggiani SpA, I-21020 Ispra, Italy	Royal Society for Protection of Birds; BirdLife International; Royal Society for Protection of Birds; University of Cambridge; European Commission Joint Research Centre; EC JRC ISPRA Site; BirdLife International; European Commission Joint Research Centre; EC JRC ISPRA Site	Buchanan, GM (corresponding author), Royal Soc Protect Birds, Edinburgh, Midlothian, Scotland.	graeme.buchanan@rspb.org.uk	Phalan, Ben/A-5783-2009; Bertzky, Bastian/I-6909-2013; Simonetti, Dario/AAD-8087-2022	Phalan, Ben/0000-0001-7876-7226; Bertzky, Bastian/0000-0001-7025-4733; Simonetti, Dario/0000-0003-3835-6013; Balmford, Andrew/0000-0002-0144-3589; Donald, Paul F./0000-0003-0023-6200	Cambridge Conservation Initiative (CCI) Collaborative Fund; RSPB; BirdLife	Cambridge Conservation Initiative (CCI) Collaborative Fund; RSPB; BirdLife	This work was supported by a grant from the Cambridge Conservation Initiative (CCI) Collaborative Fund, thanks to the generosity of Arcadia. The work was also funded by the authors' organisations, RSPB and BirdLife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2006, SAS MIXED MODELS; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Bastin L, ECOLOGICAL IN PRESS; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; Brink AB, 2009, APPL GEOGR, V29, P501, DOI 10.1016/j.apgeog.2008.10.004; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Buchanan GM, 2009, CONSERV BIOL, V23, P499, DOI 10.1111/j.1523-1739.2008.01083.x; Buchanan GM, 2009, BIRD CONSERV INT, V19, P49, DOI 10.1017/S0959270908007697; Chai SL, 2009, BIOL CONSERV, V142, P2484, DOI 10.1016/j.biocon.2009.05.020; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chape S., 2009, BIOSCIENCE, V59, P623; CIESIN, 2004, GLOB RUR URB MAPP PR; Convention on Biological Diversity (CBD), 2010, COP DEC X 2 STRAT PL; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Ervin J, 2003, BIOSCIENCE, V53, P833, DOI 10.1641/0006-3568(2003)053[0833:RAOPAM]2.0.CO;2; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Fishpool L. D., 2001, IMPORTANT BIRD AREAS; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Gregoire J-M, INT J WILDLAND FIRE; Gregorio A.D., 2000, LAND COVER CLASSIFIC; Ho DE., 2011, J STAT SOFTW, V42, P1, DOI DOI 10.18637/JSS.V042.I08; Hockings M, 2003, BIOSCIENCE, V53, P823, DOI 10.1641/0006-3568(2003)053[0823:SFATEO]2.0.CO;2; IUCN UNEP-WCMC, 2010, WORLD DAT PROT AR; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Joseph S, 2009, ENVIRON MONIT ASSESS, V158, P169, DOI 10.1007/s10661-008-0571-4; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Mas JF, 2005, ENVIRON MONIT ASSESS, V105, P69, DOI 10.1007/s10661-005-3156-5; Mayaux P, 2004, J BIOGEOGR, V31, P861, DOI 10.1111/j.1365-2699.2004.01073.x; Mayaux Philippe, 2008, P85, DOI 10.1007/978-1-4020-6358-9_5; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Pavese HB, 2007, NAT CONSERVACAO, V5, P152; Pfeifer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039337; Rayn D, 2011, BIODIVERS CONSERV, V20, P1625, DOI 10.1007/s10531-011-0051-y; Songer M, 2009, BIODIVERS CONSERV, V18, P1001, DOI 10.1007/s10531-008-9490-5; Stoll-Kleemann S, 2010, BASIC APPL ECOL, V11, P377, DOI 10.1016/j.baae.2010.06.004; Thompson M, 2009, ENVIRON MANAGE, V43, P585, DOI 10.1007/s00267-008-9228-x; Tucker CJ, 2004, PHOTOGRAMM ENG REM S, V70, P313, DOI 10.14358/PERS.70.3.313	48	43	43	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65370	10.1371/journal.pone.0065370	http://dx.doi.org/10.1371/journal.pone.0065370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734249	Green Published, Green Submitted, gold			2022-12-27	WOS:000319725500017
J	Patke, S; Srinivasan, S; Maheshwari, R; Srivastava, SK; Aguilera, JJ; Colon, W; Kane, RS				Patke, Sanket; Srinivasan, Saipraveen; Maheshwari, Ronak; Srivastava, Sunit K.; Aguilera, J. Javier; Colon, Wilfredo; Kane, Ravi S.			Characterization of the Oligomerization and Aggregation of Human Serum Amyloid A	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ACUTE-PHASE PROTEIN; AMINO-ACID-SEQUENCE; FIBRIL FORMATION; A-PROTEIN; PHYSIOLOGICAL TEMPERATURE; MARGINAL STABILITY; SOLUBLE OLIGOMERS; SAA; DISEASE	The fibrillation of Serum Amyloid A (SAA) - a major acute phase protein - is believed to play a role in the disease Amyloid A (AA) Amyloidosis. To better understand the amyloid formation pathway of SAA, we characterized the oligomerization, misfolding, and aggregation of a disease-associated isoform of human SAA - human SAA1.1 (hSAA1.1) - using techniques ranging from circular dichroism spectroscopy to atomic force microscopy, fluorescence spectroscopy, immunoblot studies, solubility measurements, and seeding experiments. We found that hSAA1.1 formed alpha helix-rich, marginally stable oligomers in vitro on refolding and cross-beta-rich aggregates following incubation at 37 degrees C. Strikingly, while hSAA1.1 was not highly amyloidogenic in vitro, the addition of a single N-terminal methionine residue significantly enhanced the fibrillation propensity of hSAA1.1 and modulated its fibrillation pathway. A deeper understanding of the oligomerization and fibrillation pathway of hSAA1.1 may help elucidate its pathological role.	[Patke, Sanket; Kane, Ravi S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Patke, Sanket; Srinivasan, Saipraveen; Maheshwari, Ronak; Srivastava, Sunit K.; Aguilera, J. Javier; Colon, Wilfredo; Kane, Ravi S.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12181 USA; [Aguilera, J. Javier; Colon, Wilfredo] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Colon, W (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12181 USA.	colonw@rpi.edu; kaner@rpi.edu	Colon, Wilfredo/A-8343-2012		National Institutes of Health [R01 AG028158]; P.K. Lashmet Chair Fund; NATIONAL INSTITUTE ON AGING [R01AG028158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P.K. Lashmet Chair Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge support from National Institutes of Health grant R01 AG028158 to W.C. and from the P.K. Lashmet Chair Fund to R.S.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; BANKA CL, 1995, J LIPID RES, V36, P1058; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Cai H, 2007, J IMMUNOL, V178, P1852, DOI 10.4049/jimmunol.178.3.1852; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Digambaranath JL, 2010, BIOPOLYMERS, V93, P299, DOI 10.1002/bip.21324; ERIKSEN N, 1980, P NATL ACAD SCI-BIOL, V77, P6860, DOI 10.1073/pnas.77.11.6860; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Hirakura Y, 2002, AMYLOID, V9, P13, DOI 10.3109/13506120209072440; Hosoai H, 1999, J LIPID RES, V40, P648; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kinkley SM, 2006, AMYLOID, V13, P123, DOI 10.1080/13506120600877201; Kisilevsky R, 2002, PEDIATR PATHOL MOL M, V21, P291, DOI 10.1080/02770930290056523; KISILEVSKY R, 1992, LAB INVEST, V66, P778; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Klunk WE, 1999, ANAL BIOCHEM, V266, P66, DOI 10.1006/abio.1998.2933; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LIEPNIEKS JJ, 1995, BBA-MOL BASIS DIS, V1270, P81, DOI 10.1016/0925-4439(94)00076-3; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; Noborn F, 2012, J BIOL CHEM, V287, P25669, DOI 10.1074/jbc.M112.363895; PARMELEE DC, 1982, BIOCHEMISTRY-US, V21, P3298, DOI 10.1021/bi00257a008; Patel H, 1996, BIOCHEM J, V318, P1041, DOI 10.1042/bj3181041; Patke S, 2012, BIOCHEMISTRY-US, V51, P3092, DOI 10.1021/bi201903s; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rocken C, 2002, VIRCHOWS ARCH, V440, P111, DOI 10.1007/s00428-001-0582-9; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; SLETTEN K, 1976, BIOCHEM BIOPH RES CO, V69, P19, DOI 10.1016/S0006-291X(76)80266-5; Srinivasan R, 2003, J MOL BIOL, V333, P1003, DOI 10.1016/j.jmb.2003.09.001; Srinivasan S, 2013, J BIOL CHEM, V288, P2744, DOI 10.1074/jbc.M112.394155; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; TAPE C, 1988, SCAND J IMMUNOL, V28, P317, DOI 10.1111/j.1365-3083.1988.tb01455.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Wang LM, 2007, BIOCHEMISTRY-US, V46, P5562, DOI 10.1021/bi602629y; Wang LM, 2005, AMYLOID, V12, P139, DOI 10.1080/13506120500223084; Wang LM, 2005, PROTEIN SCI, V14, P1811, DOI 10.1110/ps.051387005; Wang LM, 2002, P NATL ACAD SCI USA, V99, P15947, DOI 10.1073/pnas.252508399; Wang Y, 2011, BIOCHEM BIOPH RES CO, V407, P725, DOI 10.1016/j.bbrc.2011.03.090; WESTERMARK GT, 1992, BIOCHEM BIOPH RES CO, V182, P27, DOI 10.1016/S0006-291X(05)80107-X; YAMADA T, 1994, BBA-MOL BASIS DIS, V1226, P323, DOI 10.1016/0925-4439(94)90044-2; Ye ZQ, 2011, BIOCHEMISTRY-US, V50, P9184, DOI 10.1021/bi200856v	48	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64974	10.1371/journal.pone.0064974	http://dx.doi.org/10.1371/journal.pone.0064974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750222	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900024
J	Rovini, A; Gauthier, G; Berges, R; Kruczynski, A; Braguer, D; Honore, S				Rovini, Amandine; Gauthier, Geraldine; Berges, Raphael; Kruczynski, Anna; Braguer, Diane; Honore, Stephane			Anti-Migratory Effect of Vinflunine in Endothelial and Glioblastoma Cells Is Associated with Changes in EB1 C-Terminal Detyrosinated/Tyrosinated Status	PLOS ONE			English	Article							PLUS-END TRACKING; CAP-GLY DOMAIN; ALPHA-TUBULIN; MICROTUBULE DYNAMICS; POSTTRANSLATIONAL NITROTYROSINATION; BINDING-PROTEINS; NITRIC-OXIDE; SUPPRESSION; INHIBITION; ARREST	We previously showed that vinflunine, a microtubule-targeting drug of the Vinca-alkaloid family exerted its anti-angiogenic/anti-migratory activities through an increase in microtubule dynamics and an inhibition of microtubule targeting to adhesion sites. Such effect was associated with a reduction of EB1 comet length at microtubule (+) ends. In this work we first showed that the pro-angiogenic vascular endothelial growth factor VEGF suppressed microtubule dynamics in living Human Umbilical Vein Endothelial Cells (HUVECs), increased EB1 comet length by 40%, and induced EB1 to bind all along the microtubules, without modifying its expression level. Such microtubule (+) end stabilization occurred close to the plasma membrane in the vicinity of focal adhesion as shown by TIRF microscopy experiments. Vinflunine completely abolished the effect of VEGF on EB1 comets. Interestingly, we found a correlation between the reduction of EB1 comet length by vinflunine and the inhibition of cell migration. By using 2D gel electrophoresis we demonstrated for the first time that EB1 underwent several post-translational modifications in endothelial and tumor cells. Particularly, the C-terminal EEY sequence was poorly detectable in control and VEGF-treated HUVECs suggesting the existence of a non-tyrosinated form of EB1. By using specific antibodies that specifically recognized and discriminated the native tyrosinated form of EB1 and a putative C-terminal detyrosinated form, we showed that a detyrosinated form of EB1 exists in HUVECs and tumor cells. Interestingly, vinflunine decreased the level of the detyrosinated form and increased the native tyrosinated form of EB1. Using 3-L-Nitrotyrosine incorporation experiments, we concluded that the EB1 C-terminal modifications result from a detyrosination/retyrosination cycle as described for tubulin. Altogether, our results show that vinflunine inhibits endothelial cell migration through an alteration of EB1 comet length and EB1 detyrosination/retyrosination cycle.	[Rovini, Amandine; Gauthier, Geraldine; Berges, Raphael; Braguer, Diane; Honore, Stephane] Aix Marseille Univ, INSERM, UMR S 911, Marseille, France; [Gauthier, Geraldine; Braguer, Diane; Honore, Stephane] Hop Enfants La Timone, APHM, Marseille, France; [Kruczynski, Anna] Inst Rech Pierre Fabre, Ctr Rech Oncol Expt, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Honore, S (corresponding author), Aix Marseille Univ, INSERM, UMR S 911, Marseille, France.	stephane.honore@univ-amu.fr	rovini, amandine/W-1703-2019	Rovini, Amandine/0000-0003-0483-9092	INCa; Inserm; DGOS (SIRIC label) INCa-DGOS-Inserm [6038]; ARC foundation (Association pour la Recherche contre le Cancer) fellowship	INCa(Institut National du Cancer (INCA) France); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); DGOS (SIRIC label) INCa-DGOS-Inserm; ARC foundation (Association pour la Recherche contre le Cancer) fellowship	The authors acknowledge the financial support of INCa, Inserm and DGOS (SIRIC label) INCa-DGOS-Inserm 6038. AR received an ARC foundation (Association pour la Recherche contre le Cancer) fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Behrens J, 2012, J BIOL CHEM; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bisig CG, 2002, EUR J BIOCHEM, V269, P5037, DOI 10.1046/j.1432-1033.2002.03220.x; Bosson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033490; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Calligaris D, 2012, J PROTEOMICS, V75, P3605, DOI 10.1016/j.jprot.2012.04.006; Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Eiserich JP, 1999, P NATL ACAD SCI USA, V96, P6365, DOI 10.1073/pnas.96.11.6365; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; GOTLIEB AI, 1983, J CELL BIOL, V96, P1266, DOI 10.1083/jcb.96.5.1266; Gouveia SM, 2010, INT REV CEL MOL BIO, V285, P1, DOI 10.1016/S1937-6448(10)85001-4; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honore S, 2004, CANCER RES, V64, P4957, DOI 10.1158/0008-5472.CAN-04-0693; Honore S, 2003, MOL CANCER THER, V2, P1303; Honore S, 2008, MOL CANCER THER, V7, P2080, DOI 10.1158/1535-7163.MCT-08-0156; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kalisz HM, 2000, BBA-PROTEIN STRUCT M, V1481, P131, DOI 10.1016/S0167-4838(00)00110-2; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Mialhe A, 2001, CANCER RES, V61, P5024; Murtagh J, 2006, CANCER RES, V66, P8192, DOI 10.1158/0008-5472.CAN-06-0748; Pagano A, 2012, BIOCHEM PHARMACOL, V84, P432, DOI 10.1016/j.bcp.2012.05.010; Pasquier E, 2005, CANCER RES, V65, P2433, DOI 10.1158/0008-5472.CAN-04-2624; Pasquier E, 2006, DRUG RESIST UPDATE, V9, P74, DOI 10.1016/j.drup.2006.04.003; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Phung AD, 2006, EUR J CELL BIOL, V85, P1241, DOI 10.1016/j.ejcb.2006.05.016; Pourroy B, 2006, CANCER RES, V66, P3256, DOI 10.1158/0008-5472.CAN-05-3885; Pourroy B, 2004, MOL PHARMACOL, V66, P580; Rovini A, 2010, BIOCHEM PHARMACOL, V80, P884, DOI 10.1016/j.bcp.2010.04.018; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; Schober JM, 2009, CANCER LETT, V284, P30, DOI 10.1016/j.canlet.2009.04.007; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Scolz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051259; Skube SB, 2010, CYTOSKELETON, V67, P1, DOI 10.1002/cm.20409; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wasylyk C, 2010, INT J CANCER, V127, P2542, DOI 10.1002/ijc.25261; WEHLAND J, 1984, EMBO J, V3, P1295, DOI 10.1002/j.1460-2075.1984.tb01965.x; Wen YD, 2004, KENYON REV, V26, P1; Whipple RA, 2010, CANCER RES, V70, P8127, DOI 10.1158/0008-5472.CAN-09-4613; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	53	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65694	10.1371/journal.pone.0065694	http://dx.doi.org/10.1371/journal.pone.0065694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750272	Green Published, gold			2022-12-27	WOS:000319961900074
J	Folpp, H; Lowry, M; Gregson, M; Suthers, IM				Folpp, Heath; Lowry, Michael; Gregson, Marcus; Suthers, Iain M.			Fish Assemblages on Estuarine Artificial Reefs: Natural Rocky-Reef Mimics or Discrete Assemblages?	PLOS ONE			English	Article							UNDERWATER VIDEO STATIONS; NEW-SOUTH-WALES; MARINE PARK; CORAL-REEFS; HABITAT; AUSTRALIA; DENSITY; COMMUNITIES; SYSTEM; COLONIZATION	If the primary goal of artificial reef construction is the creation of additional reef habitat that is comparable to adjacent natural rocky-reef, then performance should be evaluated using simultaneous comparisons with adjacent natural habitats. Using baited remote underwater video (BRUV) fish assemblages on purpose-built estuarine artificial reefs and adjacent natural rocky-reef and sand-flat were assessed 18 months post-deployment in three south-east Australian estuaries. Fish abundance, species richness and diversity were found to be greater on the artificial reefs than on either naturally occurring reef or sand-flat in all estuaries. Comparisons within each estuary identified significant differences in the species composition between the artificial and natural rocky-reefs. The artificial reef assemblage was dominated by sparid species including Acanthopagrus australis and Rhabdosargus sarba. The preference for a range of habitats by theses sparid species is evident by their detection on sand-flat, natural rocky reef and artificial reef habitats. The fish assemblage identified on the artificial reefs remained distinct from the adjacent rocky-reef, comprising a range of species drawn from naturally occurring rocky-reef and sand-flat. In addition, some mid-water schooling species including Trachurus novaezelandiae and Pseudocaranx georgianus were only identified on the artificial reef community; presumably as result of the reef's isolated location in open-water. We concluded that estuarine artificial reef assemblages are likely to differ significantly from adjacent rocky-reef, potentially as a result of physical factors such as reef isolation, coupled with species specific behavioural traits such as the ability of some species to traverse large sand flats in order to locate reef structure, and feeding preferences. Artificial reefs should not be viewed as direct surrogates for natural reef. The assemblages are likely to remain distinct from naturally occurring habitat comprised of species that reside on a range of adjacent natural habitats.	[Folpp, Heath; Gregson, Marcus] NSW Dept Primary Ind, Recreat & Indigenous Fishing Div, Coffs Harbour Jetty, NSW, Australia; [Lowry, Michael] Port Stephens Fisheries Inst, NSW Dept Primary Ind, Wild Fisheries Res Div, Nelson Bay, NSW, Australia; [Folpp, Heath; Suthers, Iain M.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	NSW Department of Primary Industries; NSW Department of Primary Industries; University of New South Wales Sydney	Folpp, H (corresponding author), NSW Dept Primary Ind, Recreat & Indigenous Fishing Div, Coffs Harbour Jetty, NSW, Australia.	heath.folpp@dpi.nsw.gov.au	Suthers, Iain M/C-4559-2008	Suthers, Iain M/0000-0002-9340-7461	NSW Recreational Fishing Trust	NSW Recreational Fishing Trust	The authors would like to thank the NSW Recreational Fishing Trust for funding the construction of the artificial reefs and also funding this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANI A, 2008, ENV ASSESSMENT BOT B; AMBROSE RF, 1990, MAR BIOL, V107, P41, DOI 10.1007/BF01313240; Anderson M. J., 2005, PERMANOVA FORTRAN CO, P24; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; ANDERSON TW, 1989, B MAR SCI, V44, P681; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; Bell J. D., 1994, B MAR SCI, V55, P1344; BELL JD, 1986, J EXP MAR BIOL ECOL, V104, P275; Belmaker J, 2005, MAR ECOL PROG SER, V289, P273, DOI 10.3354/meps289273; BOHNSACK JA, 1989, B MAR SCI, V44, P631; BORTONE SA, 1994, B MAR SCI, V55, P319; BURCHMORE JJ, 1985, B MAR SCI, V37, P70; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Caddy J. F., 2007, MARINE HABITAT COVER; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2006, AUSTR SOC FISH BIOL, P101; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Chapman MG, 2006, J EXP MAR BIOL ECOL, V338, P164, DOI 10.1016/j.jembe.2006.06.018; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Charbonnel E, 2002, ICES J MAR SCI, V59, pS208, DOI 10.1006/jmsc.2002.1263; Clark S, 1999, AQUAT CONSERV, P9; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clynick BG, 2008, AUSTRAL ECOL, V33, P140, DOI 10.1111/j.1442-9993.2007.01802.x; Coll J, 1998, HYDROBIOLOGIA, V385, P139, DOI 10.1023/A:1003457810293; Connell SD, 1998, MAR ECOL PROG SER, V169, P251, DOI 10.3354/meps169251; Edwards RA, 2005, MAR FRESHWATER RES, V56, P133, DOI 10.1071/MF04202; Einbinder S, 2006, MAR ENVIRON RES, V61, P110, DOI 10.1016/j.marenvres.2005.07.001; Folpp H, 2011, BRAZ J OCEANOGR, V59, P55, DOI 10.1590/S1679-87592011000500008; Fujita T, 1996, ENVIRON BIOL FISH, V46, P351, DOI 10.1007/BF00005013; Gregg Kurtis L., 1995, North American Journal of Fisheries Management, V15, P316, DOI 10.1577/1548-8675(1995)015<0316:COTMAR>2.3.CO;2; KAILOLA PJ, 1993, AUSTR FISHERIES RESO; Kim CG, 2001, FISHERIES, V26, P15, DOI 10.1577/1548-8446(2001)026<0015:ARIK>2.0.CO;2; Kuiter R. H., 2000, COASTAL FISHES S E A; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; Lowry M, 2012, J EXPT MARINE BIOL E; Lowry M, 2011, BRAZ J OCEANOGR, V59, P119, DOI 10.1590/S1679-87592011000300014; Lowry M, 2011, FISH RES, V110, P10, DOI 10.1016/j.fishres.2011.03.003; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Mckenzie R, 2011, BRAZ J OCEANOGR, V59, P107, DOI 10.1590/S1679-87592011000300013; NLWRA, 2009, NATL LAND WATER RESO; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Perkol-Finkel S, 2004, CORAL REEFS, V23, P195, DOI 10.1007/s00338-004-0384-z; Pickering H, 1997, FISH RES, V31, P39, DOI 10.1016/S0165-7836(97)00019-2; Pizzolon M, 2008, ESTUAR COAST SHELF S, V78, P166, DOI 10.1016/j.ecss.2007.11.014; POLLARD DA, 1985, B MAR SCI, V37, P299; Pondella DJ, 2002, ICES J MAR SCI, V59, pS88, DOI 10.1006/jmsc.2002.1219; Rilov G, 2000, MAR BIOL, V136, P931, DOI 10.1007/s002279900250; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; Rowling K, 2010, STATUS FISHERIES RES, P295; Rowling K, 2010, STATUS FISHERIES RES, P373; Smith L, 1994, B MARINE SCI, P55; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; STEPHENS JS, 1994, B MAR SCI, V55, P1224; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Vega Fernandez T, 2008, AQUAT BIOL, V1, P239, DOI 10.3354/ab00027; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Zalmon IR, 2002, ICES J MAR SCI, V59, pS83, DOI 10.1006/jmsc.2002.1273	59	50	52	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63505	10.1371/journal.pone.0063505	http://dx.doi.org/10.1371/journal.pone.0063505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755106	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300011
J	Areeshi, MY; Mandal, RK; Panda, AK; Bisht, SC; Haque, S				Areeshi, M. Y.; Mandal, Raju K.; Panda, Aditya K.; Bisht, Shekhar C.; Haque, Shafiul			CD14-159 C > T Gene Polymorphism with Increased Risk of Tuberculosis: Evidence from a Meta-Analysis	PLOS ONE			English	Article							SERUM-SOLUBLE CD14; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; PROMOTER POLYMORPHISM; BINDING-PROTEIN; SUSCEPTIBILITY; ASSOCIATION; RECEPTOR; RECOGNITION; ACTIVATION	Cluster of differentiation 14 (CD14) gene is an important component of the human innate immune system and its role in tuberculosis (TB) has been sparsely documented. The enhanced plasma CD14 levels in TB patients as compared to healthy controls are associated with CD14 gene promoter (C-159T) polymorphism. In the past few years, the relationship between CD14 - 159 C>T (rs2569190) polymorphism and risk of TB has been reported in various ethnic populations; however, those studies have yielded contradictory results. In this study systemic assessment was done for the published studies based on the association between CD14 - 159 C>T polymorphism and TB risk retrieved from PubMed (Medline) and EMBASE search. A total number of 1389 TB cases and 1421 controls were included in this study and meta-analysis was performed to elucidate the association between CD14 - 159 C>T polymorphism and its susceptibility towards TB. Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for allele contrast, homozygous comparison, heterozygous comparison, dominant and recessive genetic model. It was found that T allele carrier was significantly associated with increased TB risk (T vs. C: p-value = 0.023; OR = 1.305, 95% CI = 1.038 to 1.640). Similarly, homozygous mutant TT genotype also revealed 1.6 fold increased risk of TB (TT vs. CC; p-value = 0.040; OR = 1.652, 95% CI = 1.023 to 2.667). Additionally, dominant genetic model demonstrated increased risk of developing TB (TT vs. CC+CT: p-value = 0.006; OR = 1.585, 95% CI = 1.142 to 2.201). The study demonstrates that CD14 gene (-159 C>T) polymorphism contributes increased susceptibility for TB. Moreover, this meta-analysis also suggests for future larger studies with stratified case control population and biological characterization for validation studies.	[Areeshi, M. Y.] Jazan Univ, Coll Nursing & Allied Hlth Sci, Dept Med Microbiol, Jazan, Saudi Arabia; [Mandal, Raju K.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Urol, Lucknow, Uttar Pradesh, India; [Panda, Aditya K.] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Odisha, India; [Bisht, Shekhar C.] Hemwati Nanadan Bahuguna Garhwal Univ, Dept Biotechnol, Srinagar, Uttarakhand, India; [Haque, Shafiul] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India	College Nursing & Allied Health Science Saudi Arabia; Jazan University; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Hemwati Nandan Bahuguna Garhwal University; Jamia Millia Islamia	Haque, S (corresponding author), Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India.	shafiul.haque@hotmail.com	HAQUE, SHAFIUL/AAN-2946-2020; BISHT, SHEKHAR CHANDRA/I-5005-2012; Panda, Aditya K/E-1267-2012	HAQUE, SHAFIUL/0000-0002-2989-121X; BISHT, SHEKHAR CHANDRA/0000-0002-7932-765X; Panda, Aditya K/0000-0002-1192-1978; Mandal, Raju/0000-0001-6206-1413	Jazan University, KSA; College of Nursing & Allied Health Sciences	Jazan University, KSA; College of Nursing & Allied Health Sciences	Annual research grant from Jazan University, KSA. Fund allocated from Dean, College of Nursing & Allied Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi-Naini R, 2012, INT J TUBERC LUNG D, V16, P1383, DOI 10.5588/ijtld.11.0827; Ayaslioglu E, 2005, JPN J INFECT DIS, V58, P11; Ayaslioglu E, 2012, J MICROBIOL IMMUNOL; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Chao YC, 2005, WORLD J GASTROENTERO, V11, P6043, DOI 10.3748/wjg.v11.i38.6043; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Druszczynska Magdalena, 2006, Polish Journal of Microbiology, V55, P7; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; HAZIOT A, 1988, J IMMUNOL, V141, P547; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOHEISEL G, 1995, CHEST, V108, P1614, DOI 10.1378/chest.108.6.1614; Juffermans NP, 1998, J INFECT DIS, V178, P1839, DOI 10.1086/314492; Kang HJ, 2006, INT J PEDIATR OTORHI, V70, P2081, DOI 10.1016/j.ijporl.2006.07.024; Kang YA, 2009, FEMS IMMUNOL MED MIC, V57, P229, DOI 10.1111/j.1574-695X.2009.00602.x; King KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016317; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; MANTEL N, 1959, J NATL CANCER I, V22, P719; Pacheco E, 2004, FEMS IMMUNOL MED MIC, V40, P207, DOI 10.1016/S0928-8244(03)00369-9; PETERSON PK, 1995, INFECT IMMUN, V63, P1598, DOI 10.1128/IAI.63.4.1598-1602.1995; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Rosas-Taraco AG, 2007, J INFECT DIS, V196, P1698, DOI 10.1086/522147; Shams H, 2003, FEMS IMMUNOL MED MIC, V36, P63, DOI 10.1016/S0928-8244(03)00039-7; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Vercelli D, 2001, INT ARCH ALLERGY IMM, V124, P20, DOI 10.1159/000053658; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu RL, 1999, BIOMETRICS, V55, P355; Zhao MY, 2012, GENET MOL RES, V11, P3425, DOI 10.4238/2012.September.25.11	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64747	10.1371/journal.pone.0064747	http://dx.doi.org/10.1371/journal.pone.0064747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741383	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900096
J	Chao, LJ; Lu, L; Yang, HW; Zhu, Y; Li, Y; Wang, Q; Yu, XW; Jiang, SB; Chen, YH				Chao, Lijun; Lu, Lu; Yang, Hengwen; Zhu, Yun; Li, Yuan; Wang, Qian; Yu, Xiaowen; Jiang, Shibo; Chen, Ying-Hua			Identification of a Human Protein-Derived HIV-1 Fusion Inhibitor Targeting the gp41 Fusion Core Structure	PLOS ONE			English	Article							VIRUS TYPE-1 ENTRY; CLATHRIN-MEDIATED ENDOCYTOSIS; TRANSMEMBRANE GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODY; ANTI-HIV-1 ACTIVITY; 6-HELIX BUNDLES; SOLUBLE CD4; DOMAIN; BINDING	The HIV-1 envelope glycoprotein (Env) gp41 plays a crucial role in the viral fusion process. The peptides derived from the C-terminal heptad repeat (CHR) of gp41 are potent HIV fusion inhibitors. However, the activity of these anti-HIV-1 peptides in vivo may be attenuated by their induction of anti-gp41 antibodies. Thus, it is essential to identify antiviral peptides or proteins with low, or no, immunogenicity to humans. Here, we found that the C-terminal fragment (aa 462-521) of the human POB1 (the partner of RalBP1), designated C60, is an HIV-1 fusion inhibitor. It bound to N36, the peptide derived from the N-terminal heptad repeat (NHR) of gp41, and to the six-helix bundle (6-HB) formed by N36 and C34, a CHR-peptide, but it did not bind to C34. Unlike the CHR-peptides, C60 did not block gp41 6-HB formation. Rather, results suggest that C60 inhibits HIV-1 fusion by binding to the 6-HB, in particular, the residues in the gp41 NHR domain that are exposed on the surface of 6-HB. Since 6-HB plays a crucial role in the late stage of fusion between the viral envelope and endosomal membrane during the endocytic process of HIV-1, C60 may serve as a host restriction factor to suppress HIV-1 entry into CD4+ T lymphocytes. Taken together, it can be concluded from these results that C60 can be used as a lead for the development of anti-HIV-1 therapeutics or microbicides for the treatment and prevention of HIV-1 infection, as well as a molecular probe to study the fusogenic mechanism of HIV-1.	[Chao, Lijun; Lu, Lu; Yang, Hengwen; Zhu, Yun; Li, Yuan; Yu, Xiaowen; Chen, Ying-Hua] Tsinghua Univ, Sch Life Sci, Immunol Lab,Minst Educ, Beijing Key Lab Prot Therapeut,Prorotein Sci Lab, Beijing 100084, Peoples R China; [Lu, Lu; Li, Yuan; Wang, Qian; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Lab Med Mol Virol, Minist Educ & Hlth, Shanghai 200433, Peoples R China; [Lu, Lu; Li, Yuan; Wang, Qian; Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Viral Immunol, New York, NY 10021 USA	Tsinghua University; Fudan University; Fudan University; New York Blood Center	Jiang, SB (corresponding author), Tsinghua Univ, Sch Life Sci, Immunol Lab,Minst Educ, Beijing Key Lab Prot Therapeut,Prorotein Sci Lab, Beijing 100084, Peoples R China.	sjiang@nybloodcenter.org; chenyh@mail.tsinghua.edu.cn	Yang, Hengwen/G-8091-2012; lu, lu/HII-7530-2022; Jiang, Shibo/L-4500-2014; lu, lu/HGA-0894-2022; chen, ying/HHS-8254-2022; Lu, Lu/K-7070-2014; yang, hengwen/GQH-7922-2022	Jiang, Shibo/0000-0001-8283-7135; Lu, Lu/0000-0002-2255-0391; Zhu, Yun/0000-0001-9382-8592; yang, hengwen/0000-0002-6418-1985	National Natural Science Foundation of China [81171548, 81173098, 81102476]; National Key Basic Research and Development Program of China [973-2012CB519001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (#81171548 to YHC, #81173098 to SJ and #81102476 to LL), National Key Basic Research and Development Program of China (#973-2012CB519001 to SJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammaranond P, 2012, FUND CLIN PHARMACOL, V26, P146, DOI 10.1111/j.1472-8206.2011.01009.x; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Chen X, 2010, J BIOL CHEM, V285, P25506, DOI 10.1074/jbc.M110.101170; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Guo Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-39; Huang JH, 2007, J BIOL CHEM, V282, P6143, DOI 10.1074/jbc.M607701200; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Li L, 2010, ANTIMICROB AGENTS CH, V54, P1700, DOI 10.1128/AAC.01046-09; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Liu SW, 2003, PEPTIDES, V24, P1303, DOI 10.1016/j.peptides.2003.07.013; Liu ZQ, 2004, J IMMUNOL METHODS, V285, P93, DOI 10.1016/j.jim.2003.10.018; Lu L, 2008, J BIOL CHEM, V283, P16723, DOI 10.1074/jbc.M801083200; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-6; Qi Z, 2008, J BIOL CHEM, V283, P30376, DOI 10.1074/jbc.M804672200; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; SATTENTAU QJ, 1993, PHILOS T R SOC B, V342, P59, DOI 10.1098/rstb.1993.0136; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; UNAIDS/WHO, 2009, AIDS EP UPD NOV 2009; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vincent N, 2005, JAIDS-J ACQ IMM DEF, V38, P254; Wang HT, 2009, ANTIMICROB AGENTS CH, V53, P4987, DOI 10.1128/AAC.00670-09; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD C, 1994, P NATL ACAD SCI USA, V91, P12676, DOI 10.1073/pnas.91.26.12676; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Woods M, 2011, KEY IDEAS GEOGR, P1; Zhu Y, 2007, CHEM BIOL DRUG DES, V70, P311, DOI 10.1111/j.1747-0285.2007.00564.x; Zhu Y, 2010, J VIROL, V84, P9359, DOI 10.1128/JVI.00644-10	50	7	7	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e66156	10.1371/journal.pone.0066156	http://dx.doi.org/10.1371/journal.pone.0066156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741527	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900240
J	Ferguson, AM; Harvey, ES; Taylor, MD; Knott, NA				Ferguson, Adrian M.; Harvey, Euan S.; Taylor, Matthew D.; Knott, Nathan A.			A Herbivore Knows Its Patch: Luderick, Girella tricuspidata, Exhibit Strong Site Fidelity on Shallow Subtidal Reefs in a Temperate Marine Park	PLOS ONE			English	Article							SNAPPER PAGRUS-AURATUS; TERM MOVEMENT PATTERNS; NEW-SOUTH-WALES; HOME-RANGE; ROCKY REEFS; PELAGIC MPAS; NEW-ZEALAND; FISH; ECOLOGY; DYNAMICS	Understanding movement patterns, habitat use and behaviour of fish is critical to determining how targeted species may respond to protection provided by "no-take" sanctuary zones within marine parks. We assessed the fine and broad scale movement patterns of an exploited herbivore, luderick (Girella tricuspidata), using acoustic telemetry to evaluate how this species may respond to protection within Jervis Bay (New South Wales, Australia). We surgically implanted fourteen fish with acoustic transmitters and actively and passively tracked individuals to determine fine and broad scale movement patterns respectively. Eight fish were actively tracked for 24 h d(1) for 6 d (May 2011), and then intermittently over the following 30 d. Six fish were passively tracked from December 2011 to March 2012, using a fixed array of receivers deployed across rocky reefs around the perimeter of the bay. Luderick exhibited strong site fidelity on shallow subtidal reefs, tending to remain on or return consistently to the reef where they were caught and released. All eight fish actively tracked used core areas solely on their release reef, with the exception of one fish that used multiple core areas, and four of the six fish passively tracked spent between 75 to 96% of days on release reefs over the entire tracking period. Luderick did move frequently to adjacent reefs, and occasionally to more distant reefs, however consistently returned to their release reef. Luderick also exhibited predictable patterns in movement between spatially distinct daytime and night-time core use areas. Night-time core use areas were generally located in sheltered areas behind the edge of reefs. Overall, our data indicate luderick exhibit strong site fidelity on shallow subtidal reefs in Jervis Bay and suggests that this important herbivore may be likely to show a positive response to protection within the marine park.	[Ferguson, Adrian M.; Harvey, Euan S.] Univ Western Australia, Fac Nat & Agr Sci, UWA Oceans Inst, Crawley, WA, Australia; [Ferguson, Adrian M.; Harvey, Euan S.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Crawley, WA, Australia; [Ferguson, Adrian M.] Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia; [Taylor, Matthew D.] Port Stephens Fisheries Inst, NSW Dept Primary Ind, Taylors Beach, NSW, Australia; [Knott, Nathan A.] Jervis Bay Marine Park, NSW Dept Primary Ind, Huskisson, NSW, Australia	University of Western Australia; University of Western Australia; University of Wollongong; NSW Department of Primary Industries; NSW Department of Primary Industries	Ferguson, AM (corresponding author), Univ Western Australia, Fac Nat & Agr Sci, UWA Oceans Inst, Crawley, WA, Australia.	adrianferguson79@gmail.com	Harvey, Euan/B-2896-2011; Knott, Nathan/AAA-8888-2019; Taylor, Matthew/C-4833-2008	Harvey, Euan/0000-0002-9069-4581; Knott, Nathan/0000-0002-7873-0412; 	University of Western Australia; Jervis Bay Marine Park; NSW Department of Primary Industries; NSW Marine Parks Authority; Booderee National Park	University of Western Australia; Jervis Bay Marine Park; NSW Department of Primary Industries; NSW Marine Parks Authority; Booderee National Park	The sources of funding that have supported this work include: The University of Western Australia, Jervis Bay Marine Park, NSW Department of Primary Industries, NSW Marine Parks Authority, Booderee National Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; ATTWOOD CG, 1994, CAN J FISH AQUAT SCI, V51, P1247, DOI 10.1139/f94-124; BARRETT NS, 1995, MAR FRESHWATER RES, V46, P853, DOI 10.1071/MF9950853; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bryars S, 2012, MAR FRESHWATER RES, V63, P552, DOI 10.1071/MF12016; Ceccarelli DM, 2011, VALUE OCEANIC MARINE; CHOAT JH, 1982, ANNU REV ECOL SYST, V13, P423, DOI 10.1146/annurev.es.13.110182.002231; Clements KD, 1997, MAR BIOL, V127, P579, DOI 10.1007/s002270050048; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Curley BG, 2013, REV FISH BIOL FISHER, V23, P435, DOI 10.1007/s11160-013-9309-7; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Egli DP, 2004, ICES J MAR SCI, V61, P1137, DOI 10.1016/j.icesjms.2004.07.004; Game ET, 2010, TRENDS ECOL EVOL, V25, P63, DOI 10.1016/j.tree.2009.09.002; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gray CA, 2012, AQUAT BIOL, V16, P53, DOI 10.3354/ab00428; Gray CA, 2010, J FISH BIOL, V76, P880, DOI 10.1111/j.1095-8649.2010.02544.x; Green KM, 2011, MAR ECOL PROG SER, V436, P219, DOI 10.3354/meps09263; Griffiths MH, 2002, MAR FRESHWATER RES, V53, P233, DOI 10.1071/MF01148; Halpern BS, 2003, ECOL APPL, V13, pS117; Henry GW, 2003, NATL RECREATIONAL IN; Industry & Investment NSW, 2010, STAT FISH RES NSW 20, P191; JONES GP, 1988, NEW ZEAL J MAR FRESH, V22, P445, DOI 10.1080/00288330.1988.9516315; JONES GP, 1990, AUST J ECOL, V15, P505, DOI 10.1111/j.1442-9993.1990.tb01474.x; Jorgensen SJ, 2006, MAR ECOL PROG SER, V327, P157, DOI 10.3354/meps327157; Kaplan DM, 2010, TRENDS ECOL EVOL, V25, P62, DOI 10.1016/j.tree.2009.09.003; Kerr LA, 2009, FISHERIES, V34, P114, DOI 10.1577/1548-8446-34.3.114; Kingsford M, 2002, FISHERIES SCI, V68, P131, DOI 10.2331/fishsci.68.sup1_131; KINGSFORD MJ, 1991, MAR ECOL PROG SER, V72, P1, DOI 10.3354/meps072001; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Kuiter R. H., 2000, COASTAL FISHES S E A; Lowry MB, 1998, MAR BIOL, V132, P569, DOI 10.1007/s002270050422; Morrison, 1990, THESIS U AUCKLAND AU; Murawski SA, 2000, B MAR SCI, V66, P775; Parsons DM, 2010, BIOL CONSERV, V143, P2039, DOI 10.1016/j.biocon.2010.05.009; Parsons DM, 2003, MAR ECOL PROG SER, V262, P253, DOI 10.3354/meps262253; Raubenheimer D, 2005, ECOLOGY, V86, P2601, DOI 10.1890/04-1472; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; RUSSELL BC, 1977, NEW ZEAL J MAR FRESH, V11, P23, DOI 10.1080/00288330.1977.9515659; Taylor MD, 2006, MAR ECOL PROG SER, V328, P237, DOI 10.3354/meps328237; THOMSON J. M., 1959, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V10, P375; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; West R, 1993, NO RIVERS REPORT A; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Zemke-White WL, 2002, MAR BIOL, V141, P571, DOI 10.1007/s00227-002-0849-y; [No title captured]	49	19	19	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65838	10.1371/journal.pone.0065838	http://dx.doi.org/10.1371/journal.pone.0065838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741515	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900228
J	Jeker, LT; Zhou, XY; Blelloch, R; Bluestone, JA				Jeker, Lukas T.; Zhou, Xuyu; Blelloch, Robert; Bluestone, Jeffrey A.			DGCR8-Mediated Production of Canonical Micrornas Is Critical for Regulatory T Cell Function and Stability	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; INTERFERON-GAMMA; ES CELLS; DGCR8; PLASTICITY; DICER; MICROPROCESSOR; LINEAGE; SELF; DIFFERENTIATION	Regulatory T cells (Treg) are integral for immune homeostasis. Here we demonstrate that canonical microRNAs ( miRNAs) are required for Treg function because mice with DGCR8-deficient Treg cells spontaneously develop a scurfy-like disease. Using genetic lineage marking we show that absence of miRNAs leads to reduced FoxP3 expression in Treg cells in vivo. In vitro culture of purified DGCR8-deficient Treg leads to a loss of FoxP3 expression. We conclude that canonical miRNAs are essential to maintain stable FoxP3 expression and Treg function. Thus, signals interfering with miRNA homeostasis might contribute to autoimmune diseases.	[Jeker, Lukas T.; Zhou, Xuyu; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Jeker, Lukas T.; Zhou, Xuyu; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Jeker, Lukas T.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Blelloch, Robert] Univ Calif San Francisco, Ctr Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	Jeff.bluestone@ucsf.edu	Zhou, Xuyu/L-7422-2019	Zhou, Xuyu/0000-0002-6626-0898; Jeker, Lukas/0000-0002-3359-8796	National Institutes of Health [P01 AI35297, U19 AI056388, P30 DK63720]; Juvenile Diabetes Research Foundation [JDRF 16-2008-643]; Swiss National Science Foundation [PBBSB-118644]; Swiss Foundation for Grants in Biology and Medicine (SFGBM)/SNSF [PASMP3-124274/1]; Roche Research Foundation; Novartis Foundation formerly Ciba-Geigy Jubilee Foundation; ADA Mentor-Based Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056388, P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Grants in Biology and Medicine (SFGBM)/SNSF; Roche Research Foundation; Novartis Foundation formerly Ciba-Geigy Jubilee Foundation(Novartis); ADA Mentor-Based Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (www.nih.gov) Grants P01 AI35297 and U19 AI056388 (JAB), P30 DK63720 (for core support), and a Scholar Award from the Juvenile Diabetes Research Foundation (www.jdrf.org), JDRF 16-2008-643 (JAB). LTJ was supported by the Swiss National Science Foundation (www.snf.ch) (PBBSB-118644), and the Swiss Foundation for Grants in Biology and Medicine (SFGBM)/SNSF (PASMP3-124274/1), the Roche Research Foundation and the Novartis Foundation formerly Ciba-Geigy Jubilee Foundation (http://www.jubilaeumsstiftung.novartis.com). XZ was supported by an ADA Mentor-Based Award (www.diabetes.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Bailey-Bucktrout SL, 2011, TRENDS IMMUNOL, V32, P301, DOI 10.1016/j.it.2011.04.002; Barad O, 2012, NAT STRUCT MOL BIOL, V19, P650, DOI 10.1038/nsmb.2293; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gadina M, 2009, NAT MED, V15, P1365, DOI 10.1038/nm1209-1365; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jeker LT, 2013, IMMUNOL REV, V253, P65, DOI 10.1111/imr.12061; Jeker LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036684; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Ravi A, 2012, CANCER CELL, V21, P848, DOI 10.1016/j.ccr.2012.04.037; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shenoy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006971; Smith KM, 2012, J IMMUNOL, V189, P1567, DOI 10.4049/jimmunol.1103171; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	49	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e66282	10.1371/journal.pone.0066282	http://dx.doi.org/10.1371/journal.pone.0066282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741528	gold, Green Published			2022-12-27	WOS:000319799900241
J	Khandelwal, RA; Olivier, BG; Roling, WFM; Teusink, B; Bruggeman, FJ				Khandelwal, Ruchir A.; Olivier, Brett G.; Roling, Wilfred F. M.; Teusink, Bas; Bruggeman, Frank J.			Community Flux Balance Analysis for Microbial Consortia at Balanced Growth	PLOS ONE			English	Article							ESCHERICHIA-COLI; METABOLIC INTERACTIONS; SYSTEMS; MODELS; DIVERSITY; EVOLUTION; NETWORK	A central focus in studies of microbial communities is the elucidation of the relationships between genotype, phenotype, and dynamic community structure. Here, we present a new computational method called community flux balance analysis (cFBA) to study the metabolic behavior of microbial communities. cFBA integrates the comprehensive metabolic capacities of individual microorganisms in terms of (genome-scale) stoichiometric models of metabolism, and the metabolic interactions between species in the community and abiotic processes. In addition, cFBA considers constraints deriving from reaction stoichiometry, reaction thermodynamics, and the ecosystem. cFBA predicts for communities at balanced growth the maximal community growth rate, the required rates of metabolic reactions within and between microbes and the relative species abundances. In order to predict species abundances and metabolic activities at the optimal community growth rate, a nonlinear optimization problem needs to be solved. We outline the methodology of cFBA and illustrate the approach with two examples of microbial communities. These examples illustrate two useful applications of cFBA. Firstly, cFBA can be used to study how specific biochemical limitations in reaction capacities cause different types of metabolic limitations that microbial consortia can encounter. In silico variations of those maximal capacities allow for a global view of the consortium responses to various metabolic and environmental constraints. Secondly, cFBA is very useful for comparing the performance of different metabolic cross-feeding strategies to either find one that agrees with experimental data or one that is most efficient for the community of microorganisms.	[Khandelwal, Ruchir A.; Olivier, Brett G.; Roling, Wilfred F. M.; Teusink, Bas; Bruggeman, Frank J.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; [Olivier, Brett G.; Roling, Wilfred F. M.; Teusink, Bas; Bruggeman, Frank J.] Netherlands Inst Syst Biol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Bruggeman, FJ (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands.	f.j.bruggeman@vu.nl	Bruggeman, Frank/C-4356-2015; Bruggeman, Frank/AAS-8371-2020; Olivier, Brett G/A-2800-2008	Bruggeman, Frank/0000-0002-0255-4766; Bruggeman, Frank/0000-0002-0255-4766; Olivier, Brett G/0000-0002-5293-5321; Teusink, Bas/0000-0003-3929-0423	NWO Computational Life Science MEMESA Project [635.100.021]; ZonMW Genomics-Zenith Program [93511039]; Netherlands Institute for Systems Biology (NISB)	NWO Computational Life Science MEMESA Project; ZonMW Genomics-Zenith Program; Netherlands Institute for Systems Biology (NISB)	Funded by NWO Computational Life Science MEMESA Project (635.100.021) url: http://www.nwo.nl/en/research-and-results/research-projects/31/2300150131.html, ZonMW Genomics-Zenith Program, project number 93511039, and Netherlands Institute for Systems Biology (NISB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bizukojc M, 2010, BIOPROC BIOSYST ENG, V33, P507, DOI 10.1007/s00449-009-0359-0; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Borenstein E, 2012, BRIEF BIOINFORM, V13, P769, DOI 10.1093/bib/bbs022; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; dos Santos FB, 2013, CURR OPIN BIOTECH, V24, P200, DOI 10.1016/j.copbio.2012.11.003; Edwards JS, 2002, BIOTECHNOL BIOENG, V77, P27, DOI 10.1002/bit.10047; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Gurieff N, 2007, BIORESOURCE TECHNOL, V98, P3393, DOI 10.1016/j.biortech.2006.10.046; HELLING RB, 1987, GENETICS, V116, P349; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kelk SM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00580; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; LaPara TM, 2002, WATER RES, V36, P638, DOI 10.1016/S0043-1354(01)00277-9; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Olivier BG, 2005, BIOINFORMATICS, V21, P560, DOI 10.1093/bioinformatics/bti046; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Roels JA, 2009, BIOTECHNOL BIOENG, V103, P2, DOI 10.1002/bit.22325; Roels JA, 1980, BIOTECHNOL BIOENG, V103, P51; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Salimi F, 2010, BIOTECHNOL J, V5, P726, DOI 10.1002/biot.201000159; Santos F, 2011, METHOD ENZYMOL, V500, P509, DOI 10.1016/B978-0-12-385118-5.00024-4; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Tzamali E, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-167; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Zhuang K, 2011, ISME J, V5, P305, DOI 10.1038/ismej.2010.117; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363	36	119	122	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64567	10.1371/journal.pone.0064567	http://dx.doi.org/10.1371/journal.pone.0064567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741341	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900054
J	Le Bihan, T; Rayner, J; Roy, MM; Spagnolo, L				Le Bihan, Thierry; Rayner, Joe; Roy, Marcia M.; Spagnolo, Laura			Photobacterium profundum under Pressure: A MS-Based Label-Free Quantitative Proteomics Study	PLOS ONE			English	Article							DEEP-SEA BACTERIUM; HYDROSTATIC-PRESSURE; MASS-SPECTROMETRY; ESCHERICHIA-COLI; GENE-EXPRESSION; PROTEIN; IDENTIFICATION; SS9; TRANSLATION; ADAPTATION	Photobacterium profundum SS9 is a Gram-negative bacterium, originally collected from the Sulu Sea. Its genome consists of two chromosomes and a 80 kb plasmid. Although it can grow under a wide range of pressures, P. profundum grows optimally at 28 MPa and 15 degrees C. Its ability to grow at atmospheric pressure allows for both easy genetic manipulation and culture, making it a model organism to study piezophily. Here, we report a shotgun proteomic analysis of P. profundum grown at atmospheric compared to high pressure using label-free quantitation and mass spectrometry analysis. We have identified differentially expressed proteins involved in high pressure adaptation, which have been previously reported using other methods. Proteins involved in key metabolic pathways were also identified as being differentially expressed. Proteins involved in the glycolysis/gluconeogenesis pathway were up-regulated at high pressure. Conversely, several proteins involved in the oxidative phosphorylation pathway were up-regulated at atmospheric pressure. Some of the proteins that were differentially identified are regulated directly in response to the physical impact of pressure. The expression of some proteins involved in nutrient transport or assimilation, are likely to be directly regulated by pressure. In a natural environment, different hydrostatic pressures represent distinct ecosystems with their own particular nutrient limitations and abundances. However, the only variable considered in this study was atmospheric pressure.	[Le Bihan, Thierry; Rayner, Joe] Univ Edinburgh, SynthSys, Edinburgh, Midlothian, Scotland; [Le Bihan, Thierry; Spagnolo, Laura] Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh, Midlothian, Scotland; [Rayner, Joe; Spagnolo, Laura] Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh, Midlothian, Scotland; [Roy, Marcia M.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Le Bihan, T (corresponding author), Univ Edinburgh, SynthSys, Edinburgh, Midlothian, Scotland.	thierry.lebihan@ed.ac.uk; laura.spagnolo@ed.ac.uk	Le Bihan, Thierry/AAN-2534-2020; Spagnolo, Laura/A-4600-2011	Spagnolo, Laura/0000-0002-0794-566X; Roy, Marcia/0000-0002-4088-3958; Le Bihan, Thierry/0000-0003-0498-8063	Leverhulme Trust [F/00158/V]; SynthSys Edinburgh is a Centre for Integrative Systems Biology (CISB); BBSRC; EPSRC [BB/D019621/1]; European Research Council [233457-SCG]; BBSRC [BB/J005673/1, BB/D019621/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1, BB/J005673/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); SynthSys Edinburgh is a Centre for Integrative Systems Biology (CISB); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LS acknowledges funding by a Leverhulme Trust grant awarded to the Centre for Science at Extreme Conditions (reference F/00158/V). TLB is funded by the SynthSys Edinburgh is a Centre for Integrative Systems Biology (CISB) funded by BBSRC and EPSRC, reference BB/D019621/1. MMR was supported by a grant from the European Research Council (233457-SCG) to M. Tyers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. P. profundum SS9 was a kind gift of Dr Rosalind Allen and Dr Gail Ferguson.	Adams MWW, 1999, J APPL MICROBIOL, V85, p108S; Allen EE, 1999, APPL ENVIRON MICROB, V65, P1710; Alpas H, 2003, INT J FOOD MICROBIOL, V87, P229, DOI 10.1016/S0168-1605(03)00066-7; Aono E, 2010, MOL BIOSYST, V6, P1216, DOI 10.1039/c000396d; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; BARTLETT D, 1989, NATURE, V342, P572, DOI 10.1038/342572a0; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; BARTLETT DH, 1995, J BACTERIOL, V177, P1008, DOI 10.1128/jb.177.4.1008-1016.1995; BARTLETT DH, 1995, RES MICROBIOL, V146, P697, DOI 10.1016/0923-2508(96)81066-7; Bartlett DH, 2010, ANN NY ACAD SCI, V1189, P1, DOI 10.1111/j.1749-6632.2009.05412.x; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Campanaro S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-122; CHI E, 1993, J BACTERIOL, V175, P7533, DOI 10.1128/JB.175.23.7533-7540.1993; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; El-Hajj ZW, 2010, ANN NY ACAD SCI, V1189, P143, DOI 10.1111/j.1749-6632.2009.05178.x; El-Hajj ZW, 2009, J BACTERIOL, V191, P6383, DOI 10.1128/JB.00576-09; Eloe EA, 2008, APPL ENVIRON MICROB, V74, P6298, DOI 10.1128/AEM.01316-08; Futcher B, 1999, MOL CELL BIOL, V19, P7357; GROSS M, 1990, FEBS LETT, V267, P239, DOI 10.1016/0014-5793(90)80934-B; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hack Catherine Jane, 2004, Briefings in Functional Genomics & Proteomics, V3, P212, DOI 10.1093/bfgp/3.3.212; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kato Chiaki, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P87; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; LANDAU JV, 1967, BIOCHIM BIOPHYS ACTA, V149, P506, DOI 10.1016/0005-2787(67)90178-5; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Le Bihan T, 2004, J PROTEOME RES, V3, P1138, DOI 10.1021/pr049909x; Le Bihan T, 2011, J PROTEOMICS, V74, P2060, DOI 10.1016/j.jprot.2011.05.028; Le Bihan T, 2010, RAPID COMMUN MASS SP, V24, P1093, DOI 10.1002/rcm.4487; Lin X, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00235; Martin SF, 2011, J PROTEOME RES; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Pavlovic M, 2005, ARCH MICROBIOL, V184, P11, DOI 10.1007/s00203-005-0021-4; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; Simonato F, 2006, J BIOTECHNOL, V126, P11, DOI 10.1016/j.jbiotec.2006.03.038; Stewart II, 2004, RAPID COMMUN MASS SP, V18, P1697, DOI 10.1002/rcm.1538; TAKAHASHI T, 1981, CARBON CYCLE MODELLI; Tamegai H, 2011, BIOSCI BIOTECH BIOCH, V75, P919, DOI 10.1271/bbb.100882; Valerio E, 2010, TOXINS, V2, P2359, DOI 10.3390/toxins2102359; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Waldbauer JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043432; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Welch TJ, 1998, MOL MICROBIOL, V27, P977, DOI 10.1046/j.1365-2958.1998.00742.x; Worden AZ, 2006, TRENDS MICROBIOL, V14, P331, DOI 10.1016/j.tim.2006.06.008; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	48	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e60897	10.1371/journal.pone.0060897	http://dx.doi.org/10.1371/journal.pone.0060897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741291	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900003
J	Sandilands, A; Smith, FJD; Lunny, DP; Campbell, LE; Davidson, KM; MacCallum, SF; Corden, LD; Christie, L; Fleming, S; Lane, EB; McLean, WHI				Sandilands, Aileen; Smith, Frances J. D.; Lunny, Declan P.; Campbell, Linda E.; Davidson, Kirsty M.; MacCallum, Stephanie F.; Corden, Laura D.; Christie, Lesley; Fleming, Stewart; Lane, E. Birgitte; McLean, W. H. Irwin			Generation and Characterisation of Keratin 7 (K7) Knockout Mice	PLOS ONE			English	Article							MOUSE URINARY-BLADDER; LIVER-DISEASE; CELLS; CYTOKERATINS; EXPRESSION; EPITHELIUM; MUTATIONS; LETHALITY; FRAGILITY	Keratin 7 (K7) is a Type II member of the keratin superfamily and despite its widespread expression in different types of simple and transitional epithelia, its functional role in vivo remains elusive, in part due to the lack of any appropriate mouse models or any human diseases that are associated with KRT7 gene mutations. Using conventional gene targeting in mouse embryonic stem cells, we report here the generation and characterisation of the first K7 knockout mouse. Loss of K7 led to increased proliferation of the bladder urothelium although this was not associated with hyperplasia. K18, a presumptive type I assembly partner for K7, showed reduced expression in the bladder whereas K20, a marker of the terminally differentiated superficial urothelial cells was transcriptionally up-regulated. No other epithelia were seen to be adversely affected by the loss of K7 and western blot and immunofluorescence microscopy analysis revealed that the expression of K8, K18, K19 and K20 were not altered in the absence of K7, with the exception of the kidney where there was reduced K18 expression.	[Sandilands, Aileen; Smith, Frances J. D.; Campbell, Linda E.; Davidson, Kirsty M.; MacCallum, Stephanie F.; Corden, Laura D.; McLean, W. H. Irwin] Univ Dundee, Colleges Life Sci & Med Dent & Nursing, Ctr Dermatol & Genet Med, Div Mol Med, Dundee, Scotland; [Lunny, Declan P.; Lane, E. Birgitte] ASTAR Inst Med Biol, Singapore, Singapore; [Christie, Lesley; Fleming, Stewart] Univ Dundee, Sch Med, Med Res Inst, Div Canc Res, Dundee, Scotland	University of Dundee; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Dundee	Sandilands, A (corresponding author), Univ Dundee, Colleges Life Sci & Med Dent & Nursing, Ctr Dermatol & Genet Med, Div Mol Med, Dundee, Scotland.	a.sandilands@dundee.ac.uk		McLean, William Henry Irwin/0000-0001-5539-5757	Wellcome Trust [092530/Z/10/Z]; Medical Research Council [G0801742]; MRC [G0802780, G0801742] Funding Source: UKRI; Medical Research Council [G0802780] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Senior Research Fellowship (to WHIM), Wellcome Trust Programme Grant (092530/Z/10/Z), and a Medical Research Council Programme Grant (G0801742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; FARSUND T, 1975, VIRCHOWS ARCH B, V18, P35; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; Ku NO, 2003, P NATL ACAD SCI USA, V100, P6063, DOI 10.1073/pnas.0936165100; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Ness SL, 1998, J BIOL CHEM, V273, P23904, DOI 10.1074/jbc.273.37.23904; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Pan X, 2012, CURRENT OPINION CELL; Relchelt J, 2002, J CELL SCI, V115, P2639; Sandilands A, 2003, EXP EYE RES, V76, P385, DOI 10.1016/S0014-4835(02)00330-5; Smith FJD, 2002, BIOCHEM BIOPH RES CO, V297, P818, DOI 10.1016/S0006-291X(02)02288-X; Tamai Y, 2000, J CELL BIOL, V151, P563, DOI 10.1083/jcb.151.3.563; Veranic P, 2004, EUR J CELL BIOL, V83, P27, DOI 10.1078/0171-9335-00351; WALKER BE, 1960, J ULTRA MOL STRUCT R, V3, P345, DOI 10.1016/S0022-5320(60)90014-9; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; Zhou Q, 2003, MOL BIOL CELL, V14, P2959, DOI 10.1091/mbc.E03-02-0059	21	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64404	10.1371/journal.pone.0064404	http://dx.doi.org/10.1371/journal.pone.0064404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741325	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900037
J	Simon, R; Wang, JY; Boyd, MA; Tulapurkar, ME; Ramachandran, G; Tennant, SM; Pasetti, M; Galen, JE; Levine, MM				Simon, Raphael; Wang, Jin Y.; Boyd, Mary A.; Tulapurkar, Mohan E.; Ramachandran, Girish; Tennant, Sharon M.; Pasetti, Marcela; Galen, James E.; Levine, Myron M.			Sustained Protection in Mice Immunized with Fractional Doses of Salmonella Enteritidis Core and O Polysaccharide-Flagellin Glycoconjugates	PLOS ONE			English	Article							ENTERICA SEROVAR-TYPHI; VI CONJUGATE VACCINE; NONTYPHOIDAL SALMONELLA; EFFICACY; FEVER; BLOOD; IMMUNOGENICITY; TYPHIMURIUM; PARATYPHI; INFECTION	Non-typhoidal Salmonella (NTS) serovars S. Enteritidis and S. Typhimurium are a major cause of invasive bacterial disease (e. g., bacteremia, meningitis) in infants and young children in sub-Saharan Africa and also occasionally cause invasive disease in highly susceptible hosts (young infants, the elderly, and immunocompromised subjects) in industrialized countries. No licensed vaccines exist against human NTS infections. NTS core and O polysaccharide (COPS) and FliC (Phase 1 flagellin subunits) each constitute protective antigens in murine models. S. Enteritidis COPS conjugated to FliC represents a promising vaccine approach that elicits binding and opsonophagocytic antibodies and protects mice against lethal challenge with virulent S. Enteritidis. We examined the protective efficacy of fractional dosages of S. Enteritidis COPS: FliC conjugate vaccines in mice, and also established that protection can be passively transferred to naive mice by administering sera from mice immunized with conjugate. Mice were immunized with three doses of either 10 mu g, 2.5 mu g (full dose), 0.25 mu g, or 0.025 mu g S. Enteritidis COPS: FliC conjugate at 28 day intervals. Antibody titers to COPS and FliC measured by ELISA fell consonant with progressively smaller vaccine dosage levels; anti-FliC IgG responses remained robust at fractional dosages for which anti-COPS serum IgG titers were decreased. Nevertheless, >90% protection against intraperitoneal challenge was observed in mice immunized with fractional dosages of conjugate that elicited diminished titers to both FliC and COPS. Passive transfer of immune sera from mice immunized with the highest dose of COPS: FliC to naive mice was also protective, demonstrating the role of antibodies in mediating protection. These results provide important insights regarding the potency of Salmonella glycoconjugate vaccines that use flagellin as a carrier protein.	[Simon, Raphael; Wang, Jin Y.; Boyd, Mary A.; Ramachandran, Girish; Tennant, Sharon M.; Pasetti, Marcela; Galen, James E.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Simon, Raphael; Wang, Jin Y.; Tulapurkar, Mohan E.; Ramachandran, Girish; Tennant, Sharon M.; Pasetti, Marcela; Galen, James E.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Boyd, Mary A.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Tulapurkar, Mohan E.] Univ Maryland, Sch Med, Div Pulm & Crit Care, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simon, R (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	rsimon@medicine.umaryland.edu	tulapurkar, mohan/F-1926-2015	tulapurkar, mohan/0000-0002-2476-5417; Pasetti, Marcela/0000-0003-0894-4009	Middle Atlantic RCE Program, National Institute of Allergy and Infectious Diseases/National Institutes of Health [2 U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	Middle Atlantic RCE Program, National Institute of Allergy and Infectious Diseases/National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Middle Atlantic RCE Program, National Institute of Allergy and Infectious Diseases/National Institutes of Health 2 U54 AI057168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CJ, 2005, VACCINE, V23, P5618, DOI 10.1016/j.vaccine.2005.06.035; Arya SC, 1999, VACCINE, V17, P1015; Arya SC, 1997, VACCINE, V15, P244, DOI 10.1016/S0264-410X(96)00168-5; Baker S, 2005, J CLIN MICROBIOL, V43, P4418, DOI 10.1128/JCM.43.9.4418-4425.2005; Canh DG, 2004, INFECT IMMUN, V72, P6586, DOI 10.1128/IAI.72.11.6586-6588.2004; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; KLUGMAN KP, 1987, LANCET, V2, P1165; Konadu EY, 2000, INFECT IMMUN, V68, P1529, DOI 10.1128/IAI.68.3.1529-1534.2000; Lanh MN, 2003, NEW ENGL J MED, V349, P1390, DOI 10.1056/NEJM200310023491423; Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7; Levy H, 2008, J CLIN MICROBIOL, V46, P1861, DOI 10.1128/JCM.00109-08; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; Martin LB, 2012, CURR OPIN INFECT DIS, V25, P489, DOI 10.1097/QCO.0b013e328356ffeb; Mehta G, 2002, J CLIN MICROBIOL, V40, P1127, DOI 10.1128/JCM.40.2.1127-1128.2002; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; ROANTREE RJ, 1960, J CLIN INVEST, V39, P72, DOI 10.1172/JCI104029; ROBBINS JD, 1984, J INFECT DIS, V150, P436, DOI 10.1093/infdis/150.3.436; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Simon R, 2012, HUM VACC IMMUNOTHER, V8, P494, DOI 10.4161/hv.19158; Simon R, 2011, INFECT IMMUN, V79, P4240, DOI 10.1128/IAI.05484-11; Simon R, 2011, VACCINE, V29, P5094, DOI 10.1016/j.vaccine.2011.05.022; SVENSON SB, 1979, INFECT IMMUN, V25, P863, DOI 10.1128/IAI.25.3.863-872.1979; Tennant SM, 2011, INFECT IMMUN, V79, P4175, DOI 10.1128/IAI.05278-11; Thiem VD, 2011, CLIN VACCINE IMMUNOL, V18, P730, DOI 10.1128/CVI.00532-10; WATSON DC, 1992, INFECT IMMUN, V60, P4679, DOI 10.1128/IAI.60.11.4679-4686.1992	30	39	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64680	10.1371/journal.pone.0064680	http://dx.doi.org/10.1371/journal.pone.0064680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741368	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900081
J	Su, J; Jin, LL; Jiang, Q; Sun, W; Zhang, FL; Li, ZY				Su, Jing; Jin, Liling; Jiang, Qun; Sun, Wei; Zhang, Fengli; Li, Zhiyong			Phylogenetically Diverse ureC Genes and Their Expression Suggest the Urea Utilization by Bacterial Symbionts in Marine Sponge Xestospongia testudinaria	PLOS ONE			English	Article							DISSOLVED ORGANIC NITROGEN; 16S RIBOSOMAL-RNA; MICROBIAL COMMUNITY; NATURAL-POPULATIONS; HOST-SPECIFICITY; EXCRETION; PHYTOPLANKTON; PHYSIOLOGY; TRANSPORT; EVOLUTION	Urea is one of the dominant organic nitrogenous compounds in the oligotrophic oceans. Compared to the knowledge of nitrogen transformation of nitrogen fixation, ammonia oxidization, nitrate and nitrite reduction mediated by sponge-associated microbes, our knowledge of urea utilization in sponges and the phylogenetic diversity of sponge-associated microbes with urea utilization potential is very limited. In this study, Marinobacter litoralis isolated from the marine sponge Xestospongia testudinaria and the slurry of X. testudinaria were found to have urease activity. Subsequently, phylogenetically diverse bacterial ureC genes were detected in the total genomic DNA and RNA of sponge X. testudinaria, i.e., 19 operative taxonomic units (OTUs) in genomic DNA library and 8 OTUs in cDNA library at 90% stringency. Particularly, 6 OTUs were common to both the genomic DNA library and the cDNA library, which suggested that some ureC genes were expressed in this sponge. BLAST and phylogenetic analysis showed that most of the ureC sequences were similar with the urease alpha subunit of members from Proteobacteria, which were the predominant component in sponge X. testudinaria, and the remaining ureC sequences were related to those from Magnetococcus, Cyanobacteria, and Actinobacteria. This study is the first assessment of the role of sponge bacterial symbionts in the regenerated utilization of urea by the detection of transcriptional activity of ureC gene, as well as the phylogenetic diversity of ureC gene of sponge bacterial symbionts. The results suggested the urea utilization by bacterial symbionts in marine sponge X. testudinaria, extending our understanding of nitrogen cycling mediated by sponge-associated microbiota.	[Su, Jing; Jin, Liling; Jiang, Qun; Sun, Wei; Zhang, Fengli; Li, Zhiyong] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Marine Biotechnol Lab, Shanghai 200030, Peoples R China; [Su, Jing; Jin, Liling; Jiang, Qun; Sun, Wei; Zhang, Fengli; Li, Zhiyong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, ZY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Marine Biotechnol Lab, Shanghai 200030, Peoples R China.	zyli@sjtu.edu.cn			National Natural Science Foundation of China (NSFC) [41076077, 31000062]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC) (41076077; 31000062) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2012, P NATL ACAD SCI USA, V109, P17989, DOI 10.1073/pnas.1201914109; Andrews R K, 1984, Adv Inorg Biochem, V6, P245; ANNIE F, 2010, ADV BIOSCI BIOTECHNO, V1, P330; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; BEKHEET IA, 1977, BRIT PHYCOL J, V12, P137, DOI 10.1080/00071617700650151; BRONK DA, 1994, SCIENCE, V265, P1843, DOI 10.1126/science.265.5180.1843; CAPONE DG, 1992, MAR ECOL PROG SER, V80, P75, DOI 10.3354/meps080075; Cho BC, 1996, MAR ECOL PROG SER, V142, P19, DOI 10.3354/meps142019; COLLINS CM, 1993, MOL MICROBIOL, V9, P907, DOI 10.1111/j.1365-2958.1993.tb01220.x; Conover RJ, 1999, MAR ECOL PROG SER, V179, P41, DOI 10.3354/meps179041; CORREDOR JE, 1988, LIMNOL OCEANOGR, V33, P114, DOI 10.4319/lo.1988.33.1.0114; Crandall JB, 2012, CORAL REEFS, V31, P207, DOI 10.1007/s00338-011-0836-1; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Gao Z, 2008, APPL ENVIRON MICROB, V74, P6091, DOI 10.1128/AEM.01315-08; Garson MJ, 1998, CELL TISSUE RES, V293, P365, DOI 10.1007/s004410051128; Gresham TLT, 2007, GEOMICROBIOL J, V24, P353, DOI 10.1080/01490450701459283; Grover R, 2006, J EXP MAR BIOL ECOL, V332, P216, DOI 10.1016/j.jembe.2005.11.020; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; HARVEY WA, 1976, PAC SCI, V30, P329; Hausinger RP, 2001, ASM NEWS, V67, P78; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Koper TE, 2004, APPL ENVIRON MICROB, V70, P2342, DOI 10.1128/AEM.70.4.2342-2348.2004; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Li ZY, 2006, LETT APPL MICROBIOL, V43, P410, DOI 10.1111/j.1472-765X.2006.01976.x; MCCARTHY JJ, 1972, LIMNOL OCEANOGR, V17, P738, DOI 10.4319/lo.1972.17.5.0738; MCCARTHY JJ, 1972, FISH BULL NATL OC AT, V70, P395; McDonald MD, 2006, J MEMBRANE BIOL, V212, P93, DOI 10.1007/s00232-006-0869-5; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; OLIVEIRA L, 1986, CAN J FISH AQUAT SCI, V43, P2427, DOI 10.1139/f86-301; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; RACHEL LS, 2011, J EXP MAR BIOL ECOL, V397, P38; SATOH Y, 1980, INT REV GES HYDROBIO, V65, P295, DOI 10.1002/iroh.19800650216; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmitt S, 2012, HYDROBIOLOGIA, V687, P341, DOI 10.1007/s10750-011-0799-9; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Vacelet J., 1982, Proceedings of the International Coral Reef Symposium, P713; Vogel G, 2008, SCIENCE, V320, P1028, DOI 10.1126/science.320.5879.1028; Vonk JA, 2008, LIMNOL OCEANOGR, V53, P542, DOI 10.4319/lo.2008.53.2.0542; WAFAR MVM, 1986, B MAR SCI, V38, P273; Walsh PJ, 2001, MAR BIOL, V139, P839; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983; Wood CM, 1998, J EXP BIOL, V201, P805; Yoon JH, 2003, INT J SYST EVOL MICR, V53, P563, DOI 10.1099/ijs.0.02363-0; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	60	23	23	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64848	10.1371/journal.pone.0064848	http://dx.doi.org/10.1371/journal.pone.0064848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741404	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900117
J	Vleugels, R; Lenaerts, C; Baumann, A; Vanden Broeck, J; Verlinden, H				Vleugels, Rut; Lenaerts, Cynthia; Baumann, Arnd; Vanden Broeck, Jozef; Verlinden, Heleen			Pharmacological Characterization of a 5-HT1-Type Serotonin Receptor in the Red Flour Beetle, Tribolium castaneum	PLOS ONE			English	Article							STOMATOGASTRIC NERVOUS-SYSTEM; PROTEIN-COUPLED RECEPTORS; AFRICAN MIGRATORY LOCUST; FUNCTIONAL EXPRESSION; NEUROHORMONE GPCRS; MOLECULAR-CLONING; SALIVARY-GLANDS; AEDES-AEGYPTI; INSECT; 5-HYDROXYTRYPTAMINE	Serotonin (5-hydroxytryptamine, 5-HT) is known for its key role in modulating diverse physiological processes and behaviors by binding various 5-HT receptors. However, a lack of pharmacological knowledge impedes studies on invertebrate 5-HT receptors. Moreover, pharmacological information is urgently needed in order to establish a reliable classification system for invertebrate 5-HT receptors. In this study we report on the molecular cloning and pharmacological characterization of a 5-HT1 receptor from the red flour beetle, Tribolium castaneum (Trica5-HT1). The Trica5-HT1 receptor encoding cDNA shows considerable sequence similarity with members of the 5-HT1 receptor class. Real time PCR showed high expression in the brain (without optic lobes) and the optic lobes, consistent with the role of 5-HT as neurotransmitter. Activation of Trica5-HT1 in mammalian cells decreased NKH-477-stimulated cyclic AMP levels in a dose-dependent manner, but did not influence intracellular Ca2+ signaling. We studied the pharmacological profile of the 5-HT1 receptor and demonstrated that alpha-methylserotonin, 5-methoxytryptamine and 5-carboxamidotryptamine acted as agonists. Prazosin, methiothepin and methysergide were the most potent antagonists and showed competitive inhibition in presence of 5-HT. This study offers important information on a 5-HT1 receptor from T. castaneum facilitating functional research of 5-HT receptors in insects and other invertebrates. The pharmacological profiles may contribute to establish a reliable classification scheme for invertebrate 5-HT receptors.	[Vleugels, Rut; Lenaerts, Cynthia; Vanden Broeck, Jozef; Verlinden, Heleen] Katholieke Univ Leuven, Inst Zool, Dept Anim Physiol & Neurobiol, Louvain, Belgium; [Baumann, Arnd] Res Ctr Julich, Inst Complex Syst ICS4, Julich, Germany	KU Leuven; Helmholtz Association; Research Center Julich	Vanden Broeck, J (corresponding author), Katholieke Univ Leuven, Inst Zool, Dept Anim Physiol & Neurobiol, Louvain, Belgium.	jozef.vandenbroeck@bio.kuleuven.be	Baumann, Arnd/I-7941-2013; Verlinden, Heleen/D-1033-2011	Baumann, Arnd/0000-0001-9456-7275; Verlinden, Heleen/0000-0001-6721-3973; Lenaerts, Cynthia/0000-0003-4643-7462; Vanden Broeck, Jozef/0000-0001-7653-0516	Interuniversity Attraction Poles program (Belgian Science Policy Grant) [P7/40]; KU Leuven Research Foundation [GOA/11/02]; Agency for Innovation by Science and Technology (IWT); Research Foundation of Flanders(FWO)	Interuniversity Attraction Poles program (Belgian Science Policy Grant); KU Leuven Research Foundation; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation of Flanders(FWO)(FWO)	The authors thank the Interuniversity Attraction Poles program (Belgian Science Policy Grant P7/40) and the KU Leuven Research Foundation (GOA/11/02) for financial support. RV and CL were supported by the Agency for Innovation by Science and Technology (IWT). HV was supported by the Research Foundation of Flanders(FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers A, 1998, J NEUROSCI, V18, P5586; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BANNER SE, 1987, COMP BIOCHEM PHYS C, V88, P131, DOI 10.1016/0742-8413(87)90056-9; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Barbas D, 2002, J NEUROCHEM, V80, P335, DOI 10.1046/j.0022-3042.2001.00703.x; Beeman RW, 2009, BEETLE BEETLE WRANGL; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; BERRIDGE MJ, 1968, SCIENCE, V162, P462, DOI 10.1126/science.162.3852.462; Blanpain C, 1999, BLOOD, V94, P1899; Chen A, 2004, INSECT MOL BIOL, V13, P45, DOI 10.1111/j.1365-2583.2004.00457.x; CHIANG RG, 1992, EXPERIENTIA, V48, P1122, DOI 10.1007/BF01948003; COHEN RW, 1988, J INSECT PHYSIOL, V34, P935, DOI 10.1016/0022-1910(88)90129-1; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Cook BJ, 2013, COMP BIOCH PHYSL C, V61, P291; DAVEY KG, 1962, J EXP BIOL, V39, P319; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; FREEMAN MA, 1966, COMP BIOCHEM PHYSIOL, V17, P755, DOI 10.1016/0010-406X(66)90118-6; George SE, 1997, J BIOMOL SCREEN, V2, P235, DOI 10.1177/108705719700200408; Gerhardt CC, 1997, EUR J PHARMACOL, V334, P1, DOI 10.1016/S0014-2999(97)01115-1; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; HOYER D, 1994, PHARMACOL REV, V46, P157; HUDDART H, 1982, COMP BIOCHEM PHYS C, V73, P303, DOI 10.1016/0306-4492(82)90126-5; Jones BJ, 2002, PHARMACOL BIOCHEM BE, V71, P555, DOI 10.1016/S0091-3057(01)00745-6; KENAKIN TP, 1982, CAN J PHYSIOL PHARM, V60, P249, DOI 10.1139/y82-036; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; KLEMM N, 1986, NEUROSCIENCE, V17, P247, DOI 10.1016/0306-4522(86)90240-X; Kristiansen K, 2000, J PHARMACOL EXP THER, V293, P735; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; LUFFY D, 1991, J INSECT PHYSIOL, V37, P269, DOI 10.1016/0022-1910(91)90061-4; Molaei G, 2003, J INSECT PHYSIOL, V49, P1073, DOI 10.1016/j.jinsphys.2003.08.004; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; NODA K, 1994, J BIOL CHEM, V269, P6743; NOVAK MG, 1995, J EXP BIOL, V198, P167; Olde B, 1997, J MOL NEUROSCI, V8, P53, DOI 10.1007/BF02736863; Ott SR, 2012, P NATL ACAD SCI USA, V109, pE381, DOI 10.1073/pnas.1114990109; PEROUTKA SJ, 1994, NEUROPHARMACOLOGY, V33, P319, DOI 10.1016/0028-3908(94)90060-4; Pietrantonio PV, 2001, INSECT MOL BIOL, V10, P357, DOI 10.1046/j.0962-1075.2001.00274.x; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roser C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049459; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Schlenstedt J, 2006, J NEUROCHEM, V98, P1985, DOI 10.1111/j.1471-4159.2006.04012.x; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; Spitzer N, 2008, J EXP BIOL, V211, P92, DOI 10.1242/jeb.012450; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; SUGAMORI KS, 1993, P NATL ACAD SCI USA, V90, P11, DOI 10.1073/pnas.90.1.11; Thamm M, 2010, CELL MOL LIFE SCI, V67, P2467, DOI 10.1007/s00018-010-0350-6; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; Torfs H, 2002, BIOCHEM PHARMACOL, V63, P1675, DOI 10.1016/S0006-2952(02)00914-0; TRIMMER BA, 1985, J EXP BIOL, V114, P307; Troppmann B, 2010, BRIT J PHARMACOL, V159, P1450, DOI 10.1111/j.1476-5381.2010.00638.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker RJ, 1996, PARASITOLOGY, V113, pS3, DOI 10.1017/S0031182000077878; Walz B, 2006, ARCH INSECT BIOCHEM, V62, P141, DOI 10.1002/arch.20128; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	67	28	32	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65052	10.1371/journal.pone.0065052	http://dx.doi.org/10.1371/journal.pone.0065052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741451	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900164
J	Xie, K; Kuang, H; Tsien, JZ				Xie, Kun; Kuang, Hui; Tsien, Joe Z.			Mild Blast Events Alter Anxiety, Memory, and Neural Activity Patterns in the Anterior Cingulate Cortex	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; BRAIN-INJURY; ENHANCEMENT; SURVIVORS; DEFICITS; COMBAT; TRAUMA; IMPACT; MODEL	There is a general interest in understanding of whether and how exposure to emotionally traumatizing events can alter memory function and anxiety behaviors. Here we have developed a novel laboratory-version of mild blast exposure comprised of high decibel bomb explosion sound coupled with strong air blast to mice. This model allows us to isolate the effects of emotionally fearful components from those of traumatic brain injury or bodily injury typical associated with bomb blasts. We demonstrate that this mild blast exposure is capable of impairing object recognition memory, increasing anxiety in elevated O-maze test, and resulting contextual generalization. Our in vivo neural ensemble recording reveal that such mild blast exposures produced diverse firing changes in the anterior cingulate cortex, a region processing emotional memory and inhibitory control. Moreover, we show that these real-time neural ensemble patterns underwent post-event reverberations, indicating rapid consolidation of those fearful experiences. Identification of blast-induced neural activity changes in the frontal brain may allow us to better understand how mild blast experiences result in abnormal changes in memory functions and excessive fear generalization related to post-traumatic stress disorder.	[Xie, Kun; Kuang, Hui; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA USA; [Xie, Kun; Kuang, Hui; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Tsien, JZ (corresponding author), Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA USA.	jtsien@gru.edu	Xie, Kun/L-9926-2013; Kuang, Hui/I-1006-2013; Kılıç, Cengiz/I-9145-2013	Kuang, Hui/0000-0002-7806-2864; 	US Army Research Office [W911NF-09-1-0112]; Yunnan Province Department of Science and Technology [2012BA009]; National Institutes of Health [NS079774-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079774] Funding Source: NIH RePORTER	US Army Research Office; Yunnan Province Department of Science and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from US Army Research Office (W911NF-09-1-0112), Yunnan Province Department of Science and Technology (Grant # 2012BA009), and National Institutes of Health (NS079774-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Cao XH, 2008, NEURON, V60, P353, DOI 10.1016/j.neuron.2008.08.027; Cesur R, 2013, J HEALTH ECON, V32, P51, DOI 10.1016/j.jhealeco.2012.09.001; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Eren-Kocak E, 2009, ACTA PSYCHIAT SCAND, V119, P35, DOI 10.1111/j.1600-0447.2008.01281.x; Fani N, 2012, BIOL PSYCHOL, V90, P134, DOI 10.1016/j.biopsycho.2012.03.001; Golub Y, 2009, BEHAV BRAIN RES, V205, P544, DOI 10.1016/j.bbr.2009.08.019; Jovanovic N, 2010, CROAT MED J, V51, P131, DOI 10.3325/cmj.2010.51.131; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; Lin LN, 2006, TRENDS NEUROSCI, V29, P48, DOI 10.1016/j.tins.2005.11.004; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; MACGREGOR AJ, 2012, INJURY; Miller MM, 2006, ANN NY ACAD SCI, V1071, P294, DOI 10.1196/annals.1364.023; Mumby DG, 1996, BEHAV NEUROSCI, V110, P266, DOI 10.1037/0735-7044.110.2.266; Osan R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000404; Quinn JJ, 2008, LEARN MEMORY, V15, P368, DOI 10.1101/lm.813608; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Shalev AY, 2000, AM J PSYCHIAT, V157, P255, DOI 10.1176/appi.ajp.157.2.255; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Solomon Z, 2001, J CLIN PSYCHIAT, V62, P11; SQUIRE LR, 1987, MEMORY BRAIN, pR12; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; van Wingen GA, 2012, P NATL ACAD SCI USA, V109, P15508, DOI 10.1073/pnas.1206330109; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017047; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29	29	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64907	10.1371/journal.pone.0064907	http://dx.doi.org/10.1371/journal.pone.0064907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741416	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900129
J	Yang, Y; Li, H; Hou, SC; Hu, B; Liu, J; Wang, J				Yang, Yong; Li, Hui; Hou, Shengcai; Hu, Bin; Liu, Jie; Wang, Jun			The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell	PLOS ONE			English	Article							INDUCED-APOPTOSIS; GENE-EXPRESSION; BETA-CATENIN; STEM-CELLS; MICRORNA; WNT; NETWORK; GROWTH; CARCINOMA; PATHWAY	Background: The efficacy of cisplatin-based chemotherapy in non-small-cell lung cancer is limited by the acquired drug resistance. Identification the RNAs related to the cisplatin resistance may help to improve clinical response rates. Methods: Microarray expression profiling of mRNAs, lncRNA and miRNA was undertaken in A549 cells and cisplatin resistant A549/CDDP cells. Differentially expressed mRNAs, lncRNAs and miRNAs, verified by realtime RT-PCR, were subjected to pathway analysis. Expression of NKD2 and beta-catenin was assessed by realtime RT-PCR and western blot analysis. The effect of lncRNA AK126698 on cisplatin induced apoptosis was investigated by annexin-V/PI flow cytometry. Results: In total, 1471 mRNAs, 1380 lncRNAs and 25 miRNAs differentially expressed in A549/CDDP and A549 cells. Among them, 8 mRNAs, 8 lncRNAs and 5 miRNAs differentially expressed in gene chip analysis were validated. High-enrichment pathway analysis identified that some classical pathways participated in proliferation, differentiation, avoidance of apoptosis, and drug metabolism were differently expressed in these cells lines. Gene co-expression network identified many genes like FN1, CTSB, EGFR, and NKD2; lncRNAs including BX648420, ENST00000366408, and AK126698; and miRNAs such as miR-26a and let-7i potentially played a key role in cisplatin resistance. Among which, the canonical Wnt pathway was investigated because it was demonstrated to be targeted by both lncRNAs and miRNAs including lncRNA AK126698. Knockdown lncRNA AK126698 not only greatly decreased NKD2 which can negatively regulate Wnt/beta-catenin signaling but also increased the accumulation and nuclear translocation of b-catenin, and significantly depressed apoptosis rate induced by cisplatin in A549 cells. Conclusion: Cisplatin resistance in non-small-cell lung cancer cells may relate to the changes in noncoding RNAs. Among these, AK126698 appears to confer cisplatin resistance by targeting the Wnt pathway.	[Yang, Yong; Li, Hui; Hou, Shengcai; Hu, Bin; Liu, Jie; Wang, Jun] Capital Med Univ, Beijing Key Lab Resp & Pulm Circulat, Beijing, Peoples R China; [Yang, Yong; Li, Hui; Hou, Shengcai; Hu, Bin] Capital Med Univ, Beijing Chao Yang Hosp, Dept Thorac Surg, Beijing, Peoples R China; [Liu, Jie; Wang, Jun] Capital Med Univ, Dept Physiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Li, H (corresponding author), Capital Med Univ, Beijing Key Lab Resp & Pulm Circulat, Beijing, Peoples R China.	huilee@vip.sina.com; wang_jun@ccmu.edu.cn	, 大李飞刀/AAM-3057-2020		Natural Science Foundation of China [81071910, 81070042]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the Natural Science Foundation of China (No. 81071910, 81070042). LncRNA microarray experiments were performed by KangChen Bio-tech, Shanghai, China. MiRNA microarray experiments were performed by Genminix Informatics Ltd., Shanghai, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Amundson SA, 2010, CANCER BIOL THER, V10, P1252, DOI 10.4161/cbt.10.12.13731; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bogush T. A., 2003, Antibiotiki i Khimioterapiya, V48, P11; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Cheng WW, 2012, FEBS J, V279, P2047, DOI 10.1111/j.1742-4658.2012.08589.x; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Cui Z, 2012, UROL ONCOL; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gong Ming, 2007, Zhonghua Zhongliu Zazhi, V29, P14; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Hu TH, 2010, J BIOL CHEM, V285, P13561, DOI 10.1074/jbc.M109.075945; Ivanova T, 2012, GUT; Jansen MPHM, 2012, BREAST CANCER RES TR, V133, P937, DOI 10.1007/s10549-011-1877-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Katoh M, 2011, CURR PHARM BIOTECHNO, V12, P160, DOI 10.2174/138920111794295710; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee RX, 2012, ANTICANCER RES, V32, P3103; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li F, 2006, HISTOL HISTOPATHOL, V21, P103, DOI 10.14670/HH-21.103; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu HY, 2010, CANCER BIOL THER, V9, P832, DOI 10.4161/cbt.9.10.11589; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nikiforova Victoria J, 2007, EXS, V97, P245; Noel EE, 2010, AM J PATHOL, V176, P2607, DOI 10.2353/ajpath.2010.090780; Nordentoft I, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-40; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rapicavoli NA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-32; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Scanlon K J, 1989, Cancer Commun, V1, P269; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Seve P, 2010, LUNG CANCER, V67, P136, DOI 10.1016/j.lungcan.2009.09.007; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Smidtas S, 2006, CR BIOL, V329, P945, DOI 10.1016/j.crvi.2006.06.010; Spizzo R, 2012, ONCOGENE; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Suh JH, 2012, BIOCHEM BIOPH RES CO, V423, P404, DOI 10.1016/j.bbrc.2012.05.138; Sun YG, 2012, INT J RADIAT ONCOL, V82, pE563, DOI 10.1016/j.ijrobp.2011.06.1999; Sun ZJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-33; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tavassoli M, 2002, CARCINOGENESIS, V23, P1569, DOI 10.1093/carcin/23.10.1569; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Wang S, 2012, MOL CARCINOG; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Wei W, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-76; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wu ZZ, 2011, BIOCHEM PHARMACOL, V82, P1630, DOI 10.1016/j.bcp.2011.08.018; Xu S, 2011, J VIROL, V85, P276, DOI 10.1128/JVI.01392-10; Yang F, 2011, HEPATOLOGY; Yang HY, 2005, CLIN EXP METASTAS, V22, P593, DOI 10.1007/s10585-005-6244-6; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Yu XF, 2011, WORLD J GASTROENTERO, V17, P4711, DOI 10.3748/wjg.v17.i42.4711; Zeller C, 2012, ONCOGENE; Zhu W, 2011, CANC CHEMOTHER PHARM	73	146	160	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65309	10.1371/journal.pone.0065309	http://dx.doi.org/10.1371/journal.pone.0065309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741487	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900200
J	Buitinga, M; Truckenmuller, R; Engelse, MA; Moroni, L; Ten Hoopen, HWM; van Blitterswijk, CA; de Koning, EJP; van Apeldoorn, AA; Karperien, M				Buitinga, Mijke; Truckenmuller, Roman; Engelse, Marten A.; Moroni, Lorenzo; Ten Hoopen, Hetty W. M.; van Blitterswijk, Clemens A.; de Koning, Eelco J. P.; van Apeldoorn, Aart A.; Karperien, Marcel			Microwell Scaffolds for the Extrahepatic Transplantation of Islets of Langerhans	PLOS ONE			English	Article							MOUSE PANCREATIC-ISLETS; IN-VITRO; CULTURE; SURVIVAL; RELEASE; SYSTEM; SITE	Allogeneic islet transplantation into the liver has the potential to restore normoglycemia in patients with type 1 diabetes. However, the suboptimal microenvironment for islets in the liver is likely to be involved in the progressive islet dysfunction that is often observed post-transplantation. This study validates a novel microwell scaffold platform to be used for the extrahepatic transplantation of islet of Langerhans. Scaffolds were fabricated from either a thin polymer film or an electrospun mesh of poly(ethylene oxide terephthalate)-poly(butylene terephthalate) (PEOT/PBT) block copolymer (composition: 4000PEOT30PBT70) and were imprinted with microwells, similar to 400 mu m in diameter and similar to 350 mu m in depth. The water contact angle and water uptake were 39 +/- 2 degrees and 52.1 +/- 4.0 wt%, respectively. The glucose flux through electrospun scaffolds was three times higher than for thin film scaffolds, indicating enhanced nutrient diffusion. Human islets cultured in microwell scaffolds for seven days showed insulin release and insulin content comparable to those of free-floating control islets. Islet morphology and insulin and glucagon expression were maintained during culture in the microwell scaffolds. Our results indicate that the microwell scaffold platform prevents islet aggregation by confinement of individual islets in separate microwells, preserves the islet's native rounded morphology, and provides a protective environment without impairing islet functionality, making it a promising platform for use in extrahepatic islet transplantation.	[Buitinga, Mijke; van Apeldoorn, Aart A.; Karperien, Marcel] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Dev BioEngn, NL-7500 AE Enschede, Netherlands; [Truckenmuller, Roman; Moroni, Lorenzo] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands; [Engelse, Marten A.; van Blitterswijk, Clemens A.; de Koning, Eelco J. P.] Leiden Univ, Dept Nephrol, Med Ctr, Leiden, Netherlands; [Ten Hoopen, Hetty W. M.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Biomed Chem, NL-7500 AE Enschede, Netherlands; [de Koning, Eelco J. P.] Leiden Univ, Dept Endocrinol, Med Ctr, Leiden, Netherlands; [de Koning, Eelco J. P.] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [de Koning, Eelco J. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands	University of Twente; University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Apeldoorn, AA (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Dev BioEngn, POB 217, NL-7500 AE Enschede, Netherlands.	a.a.vanapeldoorn@utwente.nl	de Koning, Eelco JP/H-6030-2011; Moroni, Lorenzo/D-2826-2014; van Apeldoorn, Aart/AAP-5433-2021; Karperien, Marcel/R-3270-2018	de Koning, Eelco JP/0000-0002-1232-7022; Moroni, Lorenzo/0000-0003-1298-6025; van Apeldoorn, Aart/0000-0002-2940-5699; Karperien, Marcel/0000-0003-0751-0604; van Blitterswijk, Clemens/0000-0003-2371-4615	Dutch Fund for Economic Reinforcement (FES); Diabetes Fund Netherlands as part of the diabetes cell therapy initiative [2008.50.001]	Dutch Fund for Economic Reinforcement (FES); Diabetes Fund Netherlands as part of the diabetes cell therapy initiative	This project was financially supported by the Dutch Fund for Economic Reinforcement (FES) and the Diabetes Fund Netherlands (2008.50.001) as part of the diabetes cell therapy initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON A, 1978, DIABETOLOGIA, V14, P397, DOI 10.1007/BF01228134; Berman DM, 2009, AM J TRANSPLANT, V9, P91, DOI 10.1111/j.1600-6143.2008.02489.x; Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4; Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21; BRUNSTEDT J, 1978, DIABETOLOGIA, V15, P181, DOI 10.1007/BF00421236; Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806; Carlsson PO, 2011, UPSALA J MED SCI, V116, P1, DOI 10.3109/03009734.2010.548609; Daoud JT, 2011, BIOMATERIALS, V32, P1536, DOI 10.1016/j.biomaterials.2010.10.036; de Kort H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d217; Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7; Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323; Giselbrecht S, 2006, BIOMED MICRODEVICES, V8, P191, DOI 10.1007/s10544-006-8174-8; GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211; Gottwald E, 2007, LAB CHIP, V7, P777, DOI 10.1039/b618488j; Hiscox AM, 2008, TISSUE ENG PT A, V14, P433, DOI 10.1089/tea.2007.0099; Juang JH, 1996, TRANSPLANTATION, V61, P1557, DOI 10.1097/00007890-199606150-00001; Kin T, 2008, ARTIF ORGANS, V32, P990, DOI 10.1111/j.1525-1594.2008.00688.x; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; Mahmood TA, 2004, EXP CELL RES, V301, P179, DOI 10.1016/j.yexcr.2004.07.027; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Mensik I., 2002, Cell and Tissue Banking, V3, P245; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023; Perez-Basterrechea M, 2009, TISSUE ENG PT A, V15, P569, DOI 10.1089/ten.tea.2008.0088; Rafael E, 2008, AM J TRANSPLANT, V8, P458, DOI 10.1111/j.1600-6143.2007.02060.x; Riekerink MBO, 2003, J BIOMED MATER RES A, V65A, P417, DOI 10.1002/jbm.a.10520; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Soltesz G, 2003, DIABETOLOGIA, V46, P447, DOI 10.1007/s00125-003-1101-0; Song C, 2009, TRANSPL P, V41, P1789, DOI 10.1016/j.transproceed.2009.01.079; Truckenmuller R, 2008, LAB CHIP, V8, P1570, DOI 10.1039/b803619e; Truckenmuller R, 2004, IEE Proc Nanobiotechnol, V151, P163, DOI 10.1049/ip-nbt:20040823; Truckenmuller R, 2011, ADV MATER, V23, P1311, DOI 10.1002/adma.201003538; van Dijkhuizen-Radersma R, 2002, BIOMATERIALS, V23, P1527, DOI 10.1016/S0142-9612(01)00286-1; van Dijkhuizen-Radersma R, 2002, BIOMATERIALS, V23, P4719, DOI 10.1016/S0142-9612(02)00220-X; Vantyghem MC, 2009, DIABETES CARE, V32, P1473, DOI 10.2337/dc08-1685; Zhao M, 2010, J BIOMED MATER RES A, V94A, P667, DOI 10.1002/jbm.a.32624	42	41	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64772	10.1371/journal.pone.0064772	http://dx.doi.org/10.1371/journal.pone.0064772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737999	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700061
J	Ndour, C; Gbete, SD; Bru, N; Abrahamowicz, M; Fauconnier, A; Traore, M; Diop, A; Fournier, P; Dumont, A				Ndour, Cheikh; Gbete, Simplice Dossou; Bru, Noelle; Abrahamowicz, Michal; Fauconnier, Arnaud; Traore, Mamadou; Diop, Aliou; Fournier, Pierre; Dumont, Alexandre			Predicting In-Hospital Maternal Mortality in Senegal and Mali	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; PREGNANCY OUTCOMES; PERINATAL HEALTH; GLOBAL SURVEY; SURVIVAL; DELIVERY	Objective: We sought to identify predictors of in-hospital maternal mortality among women attending referral hospitals in Mali and Senegal. Methods: We conducted a cross-sectional epidemiological survey using data from a cluster randomized controlled trial (QUARITE trial) in 46 referral hospitals in Mali and Senegal, during the pre-intervention period of the trial (from October 1st 2007 to October 1st 2008). We included 89,518 women who delivered in the 46 hospitals during this period. Data were collected on women's characteristics, obstetric complications, and vital status until the hospital discharge. We developed a tree-like classification rule (classification rule) to identify patient subgroups at high risk of maternal in-hospital mortality. Results: Our analyses confirm that patients with uterine rupture, hemorrhage or prolonged/obstructed labor, and those who have an emergency ante-partum cesarean delivery have an increased risk of in-hospital mortality, especially if they are referred from another health facility. Twenty relevant patterns, based on fourteen predictors variables, are used to predict in-hospital maternal mortality with 81.41% sensitivity (95% CI = [77.12%-87.70%]) and 81.6% specificity (95% CI = [81.16%-82.02%]). Conclusion: The proposed class association rule method will help health care professionals in referral hospitals in Mali and Senegal to identify mothers at high risk of in-hospital death, and can provide scientific evidence on which to base their decisions to manage patients delivering in their health facilities.	[Ndour, Cheikh; Diop, Aliou] Univ Gaston Berger, Lab Etud & Rech Stat & Dev, St Louis, Senegal; [Ndour, Cheikh; Gbete, Simplice Dossou; Bru, Noelle] Univ Pau & Pays Adour, Lab Math & Leurs Applicat Pau, UMR CNRS 5142, Pau, France; [Abrahamowicz, Michal] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Fauconnier, Arnaud] UVSQ, EA Risk & Safety Clin Med Women & Perinatal Hlth, Versailles, France; [Traore, Mamadou] Referral Hlth Ctr Commune V, URFOSAME, Bamako, Mali; [Fournier, Pierre] Univ Montreal, Int Hlth Unit, Ctr Rech, Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Dumont, Alexandre] Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Pau et des Pays de l'Adour; McGill University; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD)	Dumont, A (corresponding author), Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Paris, France.	alexandre.dumont@ird.fr	Dumont, Alexandre/I-9429-2016	Dumont, Alexandre/0000-0003-3826-0193; DIOP, Aliou/0000-0002-0808-5622; Abrahamowicz, Michal/0000-0002-3172-3952	S.C.A.C (Service d'Actions Culturelles) of France Ambassade	S.C.A.C (Service d'Actions Culturelles) of France Ambassade	This work is supported by the S.C.A.C (Service d'Actions Culturelles) of France Ambassade which has funded my stays at the Laboratory of Mathematics of Pau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 1993, RJ9839 IBM ALM RES C; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Dogba M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-13; Dumont A, 2006, B WORLD HEALTH ORGAN, V84, P218, DOI 10.2471/BLT.05.023903; Dumont A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-85; Fauveau V, 2007, INT J GYNECOL OBSTET, V96, P233, DOI 10.1016/j.ijgo.2006.12.004; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Igberase GO, 2007, J OBSTET GYNAECOL, V27, P275, DOI 10.1080/01443610701213687; KAMPIKAHO A, 1990, INT J EPIDEMIOL, V19, P1116, DOI 10.1093/ije/19.4.1116; Li J, 2005, MINING RISK MED DATA; Li JY, 2009, ARTIF INTELL MED, V45, P77, DOI 10.1016/j.artmed.2008.07.008; Li JY, 2002, KNOWL-BASED SYST, V15, P399, DOI 10.1016/S0950-7051(02)00024-2; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Mbola Mbassi S, 2009, Med Trop (Mars), V69, P480; Menardi G, 2014, DATA MIN KNOWL DISC, V28, P92, DOI 10.1007/s10618-012-0295-5; Ndour C, 2012, ARXIV12025514STATML, P14; R Core Team, 2016, R FDN STAT COMP; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Ronsmans C, 2009, BEST PRACT RES CL OB, V23, P305, DOI 10.1016/j.bpobgyn.2009.01.001; Salama P, 2008, LANCET, V371, P1219, DOI 10.1016/S0140-6736(08)60534-6; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Scarpa B, 2005, STUD CLASS DATA ANAL, P39, DOI 10.1007/3-540-27373-5_5; Shah A, 2009, INT J GYNECOL OBSTET, V107, P191, DOI 10.1016/j.ijgo.2009.08.013; Teguete I, 2010, INT J GYNECOL OBSTET, V108, P194, DOI 10.1016/j.ijgo.2009.09.026; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thonneau PF, 2004, EUR J OBSTET GYN R B, V114, P150, DOI 10.1016/j.ejogrb.2003.12.004; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7	27	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64157	10.1371/journal.pone.0064157	http://dx.doi.org/10.1371/journal.pone.0064157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737972	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700036
J	Okada, S; Koretake, K; Miyamoto, Y; Oue, H; Akagawa, Y				Okada, Shinsuke; Koretake, Katsunori; Miyamoto, Yasunari; Oue, Hiroshi; Akagawa, Yasumasa			Increased Crown-To-Implant Ratio May Not Be a Risk Factor for Dental Implant Failure under Appropriate Plaque Control	PLOS ONE			English	Article							PERI-IMPLANTITIS; SUPPORTED RESTORATIONS; STABILITY QUOTIENT; BONE LOSS; OSSEOINTEGRATION; PROSTHESES; SURVIVAL; DISEASES; CONTACT; STRESS	Objective: The aim of this study was to evaluate whether increased crown-to-implant (C/I) ratio influences implant stability or not under proper healthy control of peri-implant mucosa. The hypothesis of this study is that implant stability can be maintained despite High C/I, under appropriate plaque control. Materials and Methods: Five male Beagle-Labrador hybrid dogs (2 years old) were used. Their bilateral mandibular premolar extraction was performed. After allowing 12 weeks for bone healing, 3 types of vertical marginal bone loss were simultaneously prepared randomly. Then, 30 titanium implants were placed in the edentulous areas and defined as High C/I, Mid C/I and Low C/I groups. This time point was designated as the baseline (0 Week). Twelve weeks after implant placement, metal superstructures were cemented to the implants and an occlusal plate was set at the opposite side. At the same time, Calcein green was injected for remodeling evaluation. Implants were loaded by feeding the dogs a hard pellet diet. Tooth brushing was performed 5 days per week during the study to maintain healthy peri-implant mucosa. Twenty-four weeks following implant placement, the interface structure was evaluated clinically, radiologically, and histologically. Result: Implant stability quotient (ISQ) increased with time in all 3 groups, without any significant correlation with the C/I value (p>0.05). Moreover, mean marginal bone loss adjacent around implants in all 3 groups ranged between 0.11 and 0.19 mm, with no significant difference (p>0.05). Many fluorescence-labeled bones are shown in the High C/I group. It is considered that high remodeling activity prevent marginal bone loss in the High C/I group and this may provide favorable implant stability under proper plaque control. Conclusion: These findings suggest that increased C/I may not be a risk factor for implant failure if the peri-implant mucosa is kept healthy, as was the case in this animal model.	[Okada, Shinsuke; Oue, Hiroshi] Hiroshima Univ, Dept Adv Prosthodont, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Koretake, Katsunori; Miyamoto, Yasunari; Akagawa, Yasumasa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Adv Prosthodont, Hiroshima, Japan	Hiroshima University; Hiroshima University	Okada, S (corresponding author), Hiroshima Univ, Dept Adv Prosthodont, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	shinsuke0517@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22791887]; Brain circulation program to develop new leaders for international dental education course through international collaborative dental research	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Brain circulation program to develop new leaders for international dental education course through international collaborative dental research	This study was supported in part by a Grant-in Aid for Scientific Research (22791887) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and the Brain circulation program to develop new leaders for international dental education course through international collaborative dental research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBREKTSSON T, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P365; [Anonymous], 2005, J PROSTHET DENT, V94, P28; Barewal RM, 2003, INT J ORAL MAX IMPL, V18, P641; Becker W, 2005, J PERIODONTOL, V76, P391, DOI 10.1902/jop.2005.76.3.391; Blanes RJ, 2007, CLIN ORAL IMPLAN RES, V18, P707, DOI 10.1111/j.1600-0501.2006.01307.x; BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2; Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x; Degidi M, 2010, INT J ORAL MAX IMPL, V25, P45; Gentile MA, 2005, INT J ORAL MAX IMPL, V20, P930; Gomez-Polo M, 2010, INT J PROSTHODONT, V23, P33; Isidor F, 1996, CLIN ORAL IMPLAN RES, V7, P143, DOI 10.1034/j.1600-0501.1996.070208.x; Lindhe J, 2008, J CLIN PERIODONTOL, V35, P282, DOI 10.1111/j.1600-051X.2008.01283.x; Lindquist LW, 1996, CLIN ORAL IMPLAN RES, V7, P329, DOI 10.1034/j.1600-0501.1996.070405.x; Miller BF., 1992, ENCY DICT MED NURSIN, V7th ed; Misch C E, 1993, J Dent Symp, V1, P50; Mombelli A, 1997, CURR OPIN PERIODONT, V4, P127; Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P520, DOI 10.1111/j.1600-0501.2004.01059.x; Nissan J, 2011, J ORAL MAXIL SURG, V69, P2990, DOI 10.1016/j.joms.2011.06.210; Quirynen M, 2006, CLIN ORAL IMPLAN RES, V17, P25, DOI 10.1111/j.1600-0501.2005.01194.x; Rangert BR, 1997, INT J ORAL MAX IMPL, V12, P360; Renvert S, 2009, J CLIN PERIODONTOL, V36, P9, DOI 10.1111/j.1600-051X.2009.01416.x; Rokni S, 2005, INT J ORAL MAX IMPL, V20, P69; Sahm N, 2011, J CLIN PERIODONTOL, V38, P872, DOI 10.1111/j.1600-051X.2011.01762.x; Scarano A, 2006, CLIN IMPLANT DENT R, V8, P218, DOI 10.1111/j.1708-8208.2006.00022.x; Schulte J, 2007, J PROSTHET DENT, V98, P1, DOI 10.1016/S0022-3913(07)60031-6; Tawil G, 2006, INT J ORAL MAX IMPL, V21, P275; Terai K, 1999, J BONE MINER RES, V14, P839, DOI 10.1359/jbmr.1999.14.6.839; Zarb GA, 1998, J PROSTHET DENT, V80, P639, DOI 10.1016/S0022-3913(98)70047-2; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63992	10.1371/journal.pone.0063992	http://dx.doi.org/10.1371/journal.pone.0063992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737960	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700024
J	Thyrock, A; Ossendorf, E; Stehling, M; Kail, M; Kurtz, T; Pohlentz, G; Waschbusch, D; Eggert, S; Formstecher, E; Muthing, J; Dreisewerd, K; Kins, S; Goud, B; Barnekow, A				Thyrock, Anika; Ossendorf, Edith; Stehling, Martin; Kail, Mark; Kurtz, Tanja; Pohlentz, Gottfried; Waschbuesch, Dieter; Eggert, Simone; Formstecher, Etienne; Muething, Johannes; Dreisewerd, Klaus; Kins, Stefan; Goud, Bruno; Barnekow, Angelika			A New Mint1 Isoform, but Not the Conventional Mint1, Interacts with the Small GTPase Rab6	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; ALPHA-SECRETASE; TRANSPORT; BINDING; GENE; ADAPTER; IDENTIFICATION; PHOSPHORYLATION; PURIFICATION	Small GTPases of the Rab family are important regulators of a large variety of different cellular functions such as membrane organization and vesicle trafficking. They have been shown to play a role in several human diseases. One prominent member, Rab6, is thought to be involved in the development of Alzheimer's Disease, the most prevalent mental disorder worldwide. Previous studies have shown that Rab6 impairs the processing of the amyloid precursor protein (APP), which is cleaved to beta-amyloid in brains of patients suffering from Alzheimer's Disease. Additionally, all three members of the Mint adaptor family are implied to participate in the amyloidogenic pathway. Here, we report the identification of a new Mint1 isoform in a yeast two-hybrid screening, Mint1 826, which lacks an eleven amino acid (aa) sequence in the conserved C-terminal region. Mint1 826, but not the conventional Mint1, interacts with Rab6 via the PTB domain. This interaction is nucleotide-dependent, Rab6-specific and influences the subcellular localization of Mint1 826. We were able to detect and sequence a corresponding proteolytic peptide derived from cellular Mint1 826 by mass spectrometry proving the absence of aa 495-505 and could show that the deletion does not influence the ability of this adaptor protein to interact with APP. Taking into account that APP interacts and co-localizes with Mint1 826 and is transported in Rab6 positive vesicles, our data suggest that Mint1 826 bridges APP to the small GTPase at distinct cellular sorting points, establishing Mint1 826 as an important player in regulation of APP trafficking and processing.	[Thyrock, Anika; Ossendorf, Edith; Kail, Mark; Kurtz, Tanja; Waschbuesch, Dieter; Barnekow, Angelika] Univ Munster, Dept Expt Tumorbiol, D-48149 Munster, Germany; [Stehling, Martin] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Pohlentz, Gottfried; Muething, Johannes; Dreisewerd, Klaus] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Formstecher, Etienne] Hybrigen Serv, Paris, France; [Eggert, Simone; Kins, Stefan] Univ Kaiserslautern, Dept Human Biol & Human Genet, D-67663 Kaiserslautern, Germany; [Goud, Bruno] Inst Curie, Ctr Rech, Paris, France	University of Munster; Max Planck Society; University of Munster; University of Kaiserslautern; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Barnekow, A (corresponding author), Univ Munster, Dept Expt Tumorbiol, D-48149 Munster, Germany.	barneko@uni-muenster.de	Goud, Bruno/GWC-4807-2022; Dreisewerd, Klaus/K-3884-2015	Dreisewerd, Klaus/0000-0002-7619-808X; Waschbusch, Dieter/0000-0002-8953-2585; FORMSTECHER, Etienne/0000-0002-6410-4365	Studienstiftung des Deutschen Volkes; German Science Foundation [DR416/9-1]; French GenHomme Network [02490-6088]; Verband der Chemischen Industrie; Deutsche Forschungsgemeinschaft; University of Muenster	Studienstiftung des Deutschen Volkes; German Science Foundation(German Research Foundation (DFG)); French GenHomme Network; Verband der Chemischen Industrie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	This work is part of the PhD thesis of AT. AT is a grant holder from the Studienstiftung des Deutschen Volkes. This work was supported by grants from the German Science Foundation [grant DR416/9-1 (to KD and JM)], from the French GenHomme Network [grant 02490-6088 (to Hybrigenics and Institute Curie)] and from the Verband der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Anliker B, 2006, NEURODEGENER DIS, V3, P239, DOI 10.1159/000095262; Back S, 2007, J NEUROSCI RES, V85, P2580, DOI 10.1002/jnr.21239; Barnekow A, 2009, INT REV CEL MOL BIO, V274, P235, DOI 10.1016/S1937-6448(08)02005-4; Bartel P. L., 1993, CELLULAR INTERACTION, P153; Blanco G, 1998, MAMM GENOME, V9, P473, DOI 10.1007/s003359900800; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brunholz S, 2012, EXP BRAIN RES, V217, P353, DOI 10.1007/s00221-011-2870-1; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; DUCLOS F, 1993, P NATL ACAD SCI USA, V90, P109, DOI 10.1073/pnas.90.1.109; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; ELAZAR Z, 1994, J BIOL CHEM, V269, P794; Elfrink HL, 2012, J ALZHEIMERS DIS, V28, P917, DOI 10.3233/JAD-2011-110971; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hyvola N, 2006, EMBO J, V25, P3750, DOI 10.1038/sj.emboj.7601274; Kail Mark, 2008, V440, P111, DOI 10.1007/978-1-59745-178-9_9; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Marashi V, 2004, PHYSIOL BEHAV, V82, P765, DOI 10.1016/j.physbeh.2004.05.009; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Matos MF, 2012, P NATL ACAD SCI USA, V109, P3802, DOI 10.1073/pnas.1119075109; McConlogue L, 1996, J BIOL CHEM, V271, P1343, DOI 10.1074/jbc.271.3.1343; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Opdam FJM, 2000, J CELL SCI, V113, P2725; Saito Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022108; Saluja I, 2009, NEUROBIOL DIS, V36, P162, DOI 10.1016/j.nbd.2009.07.006; Scheper W, 2004, MOL BRAIN RES, V122, P17, DOI 10.1016/j.molbrainres.2003.11.013; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Shrivastava-Ranjan P, 2008, MOL BIOL CELL, V19, P51, DOI 10.1091/mbc.E07-05-0465; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Tanahashi H, 1999, NEUROREPORT, V10, P2575, DOI 10.1097/00001756-199908200-00025; Teber I, 2005, BIOL CHEM, V386, P671, DOI 10.1515/BC.2005.078; Thyrock A, 2010, BIOCHEM BIOPH RES CO, V396, P679, DOI 10.1016/j.bbrc.2010.04.161; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wanschers BFJ, 2007, EXP CELL RES, V313, P3408, DOI 10.1016/j.yexcr.2007.05.032; Weide T, 2003, BIOCHEM BIOPH RES CO, V306, P79, DOI 10.1016/S0006-291X(03)00918-5; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	56	9	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64149	10.1371/journal.pone.0064149	http://dx.doi.org/10.1371/journal.pone.0064149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737971	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700035
J	Yuan, QY; Nsoesie, EO; Lv, BF; Peng, G; Chunara, R; Brownstein, JS				Yuan, Qingyu; Nsoesie, Elaine O.; Lv, Benfu; Peng, Geng; Chunara, Rumi; Brownstein, John S.			Monitoring Influenza Epidemics in China with Search Query from Baidu	PLOS ONE			English	Article							MEDIA	Several approaches have been proposed for near real-time detection and prediction of the spread of influenza. These include search query data for influenza related terms, which has been explored as a tool for augmenting traditional surveillance methods. In this paper, we present a method that uses Internet search query data from Baidu to model and monitor influenza activity in China. The objectives of the study are to present a comprehensive technique for: (i) keyword selection, (ii) keyword filtering, (iii) index composition and (iv) modeling and detection of influenza activity in China. Sequential time-series for the selected composite keyword index is significantly correlated with Chinese influenza case data. In addition, one-month ahead prediction of influenza cases for the first eight months of 2012 has a mean absolute percent error less than 11%. To our knowledge, this is the first study on the use of search query data from Baidu in conjunction with this approach for estimation of influenza activity in China.	[Yuan, Qingyu; Lv, Benfu; Peng, Geng] Univ Chinese Acad Sci, Sch Management, Beijing, Peoples R China; [Yuan, Qingyu; Nsoesie, Elaine O.; Chunara, Rumi; Brownstein, John S.] Boston Childrens Hosp, Childrens Hosp, Informat Program, Div Emergency Med, Boston, MA USA; [Nsoesie, Elaine O.; Chunara, Rumi; Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Nsoesie, Elaine O.] Virginia Tech, Network Dynam & Simulat Sci Lab, Virginia Bioinformat Inst, Blacksburg, VA USA; [Brownstein, John S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Virginia Polytechnic Institute & State University; McGill University	Yuan, QY (corresponding author), Univ Chinese Acad Sci, Sch Management, Beijing, Peoples R China.	Qingyu.Yuan@childrens.harvard.edu		Nsoesie, Elaine/0000-0001-9170-8714	National Library of Medicine; National Institutes of Health [5R01LM010812-03, 5G08LM009776-03]; National Natural Science Foundation of China [71202115, 71172199, 7103218]; Foundation of Dean of Graduate University of Chinese Academy of Sciences [Y15101QY00]; Postdoctoral Science Foundation [2011M500422]; NATIONAL LIBRARY OF MEDICINE [R01LM010812, G08LM009776] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Dean of Graduate University of Chinese Academy of Sciences; Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work supported by research grants from the National Library of Medicine, the National Institutes of Health (5R01LM010812-03 and 5G08LM009776-03), the National Natural Science Foundation of China under Grant 71202115, 71172199, 7103218, Foundation of Dean of Graduate University of Chinese Academy of Sciences under Grant Y15101QY00, and Postdoctoral Science Foundation under Grant 2011M500422. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki E., 2011, P C EMPIRICAL METHOD, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199; Askitas N., 2009, APPL EC Q, V55, P107, DOI [10.1016/1047-2797(94)90062-0, DOI 10.1016/1047-2797(94)90062-0, DOI 10.3790/AEQ.55.2.107]; Boehm E.A., 2001, INDIAN ECON REV, V36, P1; Brownstein J, 2011, CNN; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Chen L, 2010, ACM MOBILE CLOUD COM, DOI 10.1145/1810931.1810935; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Choi H, 2009, PREDICITNG INITIAL C; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Christakis N. A., 2010, PLOS ONE, V5; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Chunquan O, 2007, CHINESE J HLTH STAT; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Doornik J.A., 2009, TECHNICAL REPORT, P1; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Francesco D.A., 2009, 18403 MPRA; Francesco DA, 2009, ISER WORKING PAPER S; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Kholodilin KA, 2009, DISCUSSION PAPERS DI; Lampos V, 2010, LECT NOTES ARTIF INT, V6323, P599, DOI 10.1007/978-3-642-15939-8_42; Liu Y, 2012, PREPROCESSING METHOD; Paul M.J., 2011, P 5 INT AAAI C WEBL, P265; Saaty TL, 2003, EUR J OPER RES, V145, P85, DOI 10.1016/S0377-2217(02)00227-8; Schmidt CW, 2012, ENVIRON HEALTH PERSP, V120, pA30, DOI 10.1289/ehp.120-a30; Schmidt T., 2009, RUHR EC PAPERS; Shiskin J., 1967, OCCASIONAL PAPER, V103; Shortridge KF, 1997, CHINESE MED J-PEKING, V110, P637; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Szomszor M., 2011, 2011 IEEE/WIC/ACM International Joint Conferences on Web Intelligence (WI) and Intelligent Agent Technologies, P320, DOI 10.1109/WI-IAT.2011.311; World Health Organization, 2009, J AM MED INFORM ASS; Wu L, 2009, ICIS 2009 P; Xin W, 2011, CHINA TROPICAL MED, DOI CNKI:SUN:RDYX.0.2011-06-005; Zhao Y, 2012, DIS SURVEILLANCE, DOI 10.3784/j.issn.1003-9961.2012.9.007	36	124	137	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64323	10.1371/journal.pone.0064323	http://dx.doi.org/10.1371/journal.pone.0064323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23750192	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700043
J	Lin, CL; Chien, RN; Lin, SM; Ke, PY; Lin, CC; Yeh, CT				Lin, Chih-Lang; Chien, Rong-Nan; Lin, Shi-Ming; Ke, Po-Yuan; Lin, Chen-Chun; Yeh, Chau-Ting			RETRACTED: An Occult Hepatitis B-Derived Hepatoma Cell Line Carrying Persistent Nuclear Viral DNA and Permissive for Exogenous Hepatitis B Virus Infection (Retracted article. See vol. 16, 2021)	PLOS ONE			English	Article; Retracted Publication							HEPATOCELLULAR-CARCINOMA; HUMAN HEPATOCYTES; TREATED PATIENTS; REPLICATION; IDENTIFICATION; LOCALIZATION; CLEARANCE; EMERGENCE; MUTATION	Occult hepatitis B virus (HBV) infection is defined as persistence of HBV DNA in liver tissues, with or without detectability of HBV DNA in the serum, in individuals with negative serum HBV surface antigen (HBsAg). Despite accumulating evidence suggesting its important clinical roles, the molecular and virological basis of occult hepatitis B remains unclear. In an attempt to establish new hepatoma cell lines, we achieved a new cell line derived from a hepatoma patient with chronic hepatitis C virus (HCV) and occult HBV infection. Characterization of this cell line revealed previously unrecognized properties. Two novel human hepatoma cell lines were established. Hep-Y1 was derived from a male hepatoma patient negative for HCV and HBV infection. Hep-Y2 was derived from a female hepatoma patient suffering from chronic HCV and occult HBV infection. Morphological, cytogenetic and functional studies were performed. Permissiveness to HBV infection was assessed. Both cell lines showed typical hepatocyte-like morphology under phase-contrast and electron microscopy and expressed alpha-fetoprotein, albumin, transferrin, and aldolase B. Cytogenetic analysis revealed extensive chromosomal anomalies. An extrachromosomal form of HBV DNA persisted in the nuclear fraction of Hep-Y2 cells, while no HBsAg was detected in the medium. After treated with 2% dimethyl sulfoxide, both cell lines were permissive for exogenous HBV infection with transient elevation of the replication intermediates in the cytosol with detectable viral antigens by immunoflurescence analysis. In conclusions, we established two new hepatoma cell lines including one from occult HBV infection (Hep-Y2). Both cell lines were permissive for HBV infection. Additionally, Hep-Y2 cells carried persistent extrachromosomal HBV DNA in the nuclei. This cell line could serve as a useful tool to establish the molecular and virological basis of occult HBV infection.	[Lin, Chih-Lang; Chien, Rong-Nan] Chang Gung Mem Hosp, Liver Res Unit, Keelung, Taiwan; [Lin, Chih-Lang; Chien, Rong-Nan] Chang Gung Univ, Coll Med, Keelung, Taiwan; [Lin, Chih-Lang] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Lin, Shi-Ming; Lin, Chen-Chun; Yeh, Chau-Ting] Chang Gung Mem Hosp, Liver Res Ctr, Taipei 10591, Taiwan; [Ke, Po-Yuan] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Yeh, CT (corresponding author), Chang Gung Mem Hosp, Liver Res Ctr, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	chautingy@gmail.com		Ke, Po-Yuan/0000-0002-0471-0806	Chang Gung Medical Research Council [CMRPG 371693, CMRPG 3A0522]	Chang Gung Medical Research Council	The study is supported by grants from Chang Gung Medical Research Council (CMRPG 371693; CMRPG 3A0522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; Chemin I, 2005, J CLIN VIROL, V34, pS15, DOI 10.1016/S1386-6532(05)80005-8; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Dandri M, 2006, SEMIN LIVER DIS, V26, P181, DOI 10.1055/s-2006-939760; Donato F, 2006, ONCOGENE, V25, P3756, DOI 10.1038/sj.onc.1209557; Fellig Y, 2004, BIOCHEM BIOPH RES CO, V321, P269, DOI 10.1016/j.bbrc.2004.06.148; GALLE PR, 1994, GASTROENTEROLOGY, V106, P664, DOI 10.1016/0016-5085(94)90700-5; Garcia JRG, 2006, BLOOD, V108, P3952, DOI 10.1182/blood-2006-06-031351; GRIPON P, 1993, VIROLOGY, V192, P534, DOI 10.1006/viro.1993.1069; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hsu CW, 2007, GASTROENTEROLOGY, V132, P543, DOI 10.1053/j.gastro.2006.12.001; KANN M, 1995, J HEPATOL, V22, P9; Liaw YF, 1999, HEPATOLOGY, V30, P567, DOI 10.1002/hep.510300221; Lin CL, 2012, J ANTIMICROB CHEMOTH, V67, P39, DOI 10.1093/jac/dkr416; Narayan R, 2009, J PROTEOME RES, V8, P118, DOI 10.1021/pr800562j; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Sagnelli E, 2001, J MED VIROL, V65, P681, DOI 10.1002/jmv.2090; Sun DX, 2006, J HEPATOL, V45, P636, DOI 10.1016/j.jhep.2006.05.019; Tai DI, 2011, ANTICANCER RES, V31, P129; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Weiss L, 1996, VIROLOGY, V216, P214, DOI 10.1006/viro.1996.0049; Yeh CT, 1998, J MED VIROL, V55, P42, DOI 10.1002/(SICI)1096-9071(199805)55:1<42::AID-JMV8>3.0.CO;2-O; Yeh CT, 2000, HEPATOLOGY, V31, P1318, DOI 10.1053/jhep.2000.7296; YEH CT, 1993, P NATL ACAD SCI USA, V90, P6459, DOI 10.1073/pnas.90.14.6459; Zignego AL, 1997, J MED VIROL, V51, P313, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt;313::AID-JMV9&gt;3.0.CO;2-8	26	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65456	10.1371/journal.pone.0065456	http://dx.doi.org/10.1371/journal.pone.0065456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734258	Green Published, Green Submitted, gold			2022-12-27	WOS:000319725500008
J	Huang, YH; Terabe, M; Pendleton, CD; Khursigara, DS; Bera, TK; Pastan, I; Berzofsky, JA				Huang, Yi-Hsiang; Terabe, Masaki; Pendleton, C. David; Khursigara, Deborah Stewart; Bera, Tapan K.; Pastan, Ira; Berzofsky, Jay A.			Identification and Enhancement of HLA-A2.1-Restricted CTL Epitopes in a New Human Cancer Antigen-POTE	PLOS ONE			English	Article							CLASS-I MOLECULES; PROSTATE-CANCER; T-LYMPHOCYTES; INDEPENDENT BINDING; PEPTIDE MOTIFS; SIPULEUCEL-T; IMMUNOTHERAPY; HLA-A2.1; VACCINES; MICE	Identification of CD8(+) T cell epitopes that can induce T cells to kill tumor cells is a fundamental step for development of a peptide cancer vaccine. POTE protein is a newly identified cancer antigen that was found to be expressed in a wide variety of human cancers, including prostate, colon, lung, breast, ovary and pancreas. Here, we determined HLA-A2.1-restricted cytotoxic T lymphocyte (CTL) epitopes in the POTE protein, and also designed enhanced epitopes by amino acid (AA) substitutions. Five 9-mer peptides were first selected and their binding affinity to HLA-A2 molecules was measured by the T2 binding assay. POTE 272-280 and POTE 323-331 showed the strongest HLA-A2 binding affinity. AA substituted peptides POTE 252-9V (with valine at position 9), POTE 553-1Y (with tyrosine at position 1) and POTE 323-3F (with phenylalanine at position 3) conferred higher affinity for HLA-A2, and induced CTL responses cross-reactive with wild type antigens. While POTE 252-9V was the strongest in this respect, POTE 323-3F had the greatest increase in immunogenicity compared to wild type. Importantly, two modified epitopes (POTE-553-1Y and POTE-323-3F) induced CTLs that killed NCI-H522, a POTE-expressing HLA-A2(+) human non-small cell lung cancer cell line, indicating natural endogenous processing of these epitopes. In conclusion, the immunogenicity of POTE epitopes can be enhanced by peptide modification to induce T cells that kill human cancer cells. A combination of POTE 553-1Y and POTE 323-3F epitopes might be an attractive vaccine strategy for HLA-A2 cancer patients to overcome tolerance induced by tumors and prevent escape.	[Huang, Yi-Hsiang] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Gastroenterol, Infect & Immun Res Ctr,Inst Clin Med, Taipei 112, Taiwan; [Huang, Yi-Hsiang; Terabe, Masaki; Pendleton, C. David; Khursigara, Deborah Stewart; Berzofsky, Jay A.] NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Bera, Tapan K.; Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Terabe, M (corresponding author), NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	terabe@mail.nih.gov; berzofsk@helix.nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Huang, Yi-Hsiang/0000-0001-5241-5425	Taiwan Merit Scholarship [TMS-094-2-B-015]; NCI intramural funding from the NCI Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA; Taipei Veterans General Hospital [V97S5-002, V100C-104, V101C-147]; NATIONAL CANCER INSTITUTE [ZIABC008753, ZIASC004020] Funding Source: NIH RePORTER	Taiwan Merit Scholarship; NCI intramural funding from the NCI Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA; Taipei Veterans General Hospital(Taipei Veterans General Hospital); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Yi-Hsiang Huang was supported by Taiwan Merit Scholarship (TMS-094-2-B-015) and NCI intramural funding from the NCI Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA; and by funding from Taipei Veterans General Hospital (V97S5-002, V100C-104 and V101C-147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Andersen MLM, 2003, SCAND J IMMUNOL, V57, P21, DOI 10.1046/j.1365-3083.2003.01182.x; Bera TK, 2006, CANCER RES, V66, P52, DOI 10.1158/0008-5472.CAN-05-3014; Bera TK, 2004, GENE, V337, P45, DOI 10.1016/j.gene.2004.05.009; Bera TK, 2002, P NATL ACAD SCI USA, V99, P16975, DOI 10.1073/pnas.262655399; Berzofsky JA, 2005, CANC TREAT, V123, P115; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Berzofsky JA, 2004, J CLIN INVEST, V113, P1515, DOI 10.1172/JCI200421926; Berzofsky JA, 2011, VACCINE; Berzofsky JA, 2012, SEMIN ONCOL, V39, P348, DOI 10.1053/j.seminoncol.2012.02.002; Cheever MA, 2011, CLIN CANCER RES, V17, P3520, DOI 10.1158/1078-0432.CCR-10-3126; Cole DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1665; Denkberg G, 2002, P NATL ACAD SCI USA, V99, P9421, DOI 10.1073/pnas.132285699; Fauquembergue E, 2010, J IMMUNOTHER, V33, P402, DOI 10.1097/CJI.0b013e3181d366da; Firat H, 2001, EUR J IMMUNOL, V31, P3064, DOI 10.1002/1521-4141(2001010)31:10<3064::AID-IMMU3064>3.0.CO;2-L; Firat H, 2002, INT IMMUNOL, V14, P925, DOI 10.1093/intimm/dxf056; Godel P, 2012, J VIROL, V86, P12422, DOI 10.1128/JVI.01607-12; Gross DA, 2004, J CLIN INVEST, V113, P425, DOI 10.1172/JCI200419418; HOGAN KT, 1988, J IMMUNOL, V141, P2519; Huang YH, 2009, J HEPATOL, V50, P779, DOI 10.1016/j.jhep.2008.11.028; Hutchinson Lisa, 2012, Nat Rev Clin Oncol, V9, P487, DOI 10.1038/nrclinonc.2012.143; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kudrin A, 2012, HUM VACC IMMUNOTHER, V8, P1135, DOI 10.4161/hv.20474; Moingeon P, 2001, VACCINE, V19, P1305, DOI 10.1016/S0264-410X(00)00372-8; Newberg MH, 1996, J IMMUNOL, V156, P2473; NEWBERG MH, 1992, J IMMUNOL, V149, P136; NIJMAN HW, 1993, EUR J IMMUNOL, V23, P1215, DOI 10.1002/eji.1830230603; Oh S, 2004, CANCER RES, V64, P2610, DOI 10.1158/0008-5472.CAN-03-2183; Okazaki T, 2003, J IMMUNOL, V171, P2548, DOI 10.4049/jimmunol.171.5.2548; Ono T, 2001, P NATL ACAD SCI USA, V98, P3282, DOI 10.1073/pnas.041625098; PARKER KC, 1994, J IMMUNOL, V152, P163; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Peters B, 2003, BIOINFORMATICS, V19, P1765, DOI 10.1093/bioinformatics/btg247; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Schwaab T, 2011, EXPERT REV VACCINES, V10, P1113, DOI [10.1586/erv.11.85, 10.1586/ERV.11.85]; SHIRAI M, 1995, J IMMUNOL, V154, P2733; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Tourdot S, 2000, EUR J IMMUNOL, V30, P3411, DOI 10.1002/1521-4141(2000012)30:12<3411::AID-IMMU3411>3.0.CO;2-R; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883	42	8	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64365	10.1371/journal.pone.0064365	http://dx.doi.org/10.1371/journal.pone.0064365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750208	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900010
J	Karim, AM; Admassu, K; Schellenberg, J; Alemu, H; Getachew, N; Ameha, A; Tadesse, L; Betemariam, W				Karim, Ali Mehryar; Admassu, Kesetebirhane; Schellenberg, Joanna; Alemu, Hibret; Getachew, Nebiyu; Ameha, Agazi; Tadesse, Luche; Betemariam, Wuleta			Effect of Ethiopia's Health Extension Program on Maternal and Newborn Health Care Practices in 101 Rural Districts: A Dose-Response Study	PLOS ONE			English	Article							NEONATAL-MORTALITY; IMPACT; INTERVENTIONS; SERVICES; OUTCOMES; WORKERS	Background: Improving newborn survival is essential if Ethiopia is to achieve Millennium Development Goal 4. The national Health Extension Program (HEP) includes community-based newborn survival interventions. We report the effect of these interventions on changes in maternal and newborn health care practices between 2008 and 2010 in 101 districts, comprising 11.6 million people, or 16% of Ethiopia's population. Methods and Findings: Using data from cross-sectional surveys in December 2008 and December 2010 from a representative sample of 117 communities (kebeles), we estimated the prevalence of maternal and newborn care practices, and a program intensity score in each community. Women with children aged 0 to 11 months reported care practices for their most recent pregnancy and childbirth. The program intensity score ranged between zero and ten and was derived from four outreach activities of the HEP front-line health workers. Dose-response relationships between changes in program intensity and the changes in maternal and newborn health were investigated using regression methods, controlling for secular trend, respondents' background characteristics, and community-level factors. Between 2008 and 2010, median program intensity score increased 2.4-fold. For every unit increase in the score, the odds of receiving antenatal care increased by 1.13 times (95% CI 1.03-1.23); the odds of birth preparedness increased by 1.31 times (1.19-1.44); the odds of receiving postnatal care increased by 1.60 times (1.34-1.91); and the odds of initiating breastfeeding immediately after birth increased by 1.10 times (1.02-1.20). Program intensity score was not associated with skilled deliveries, nor with some of the other newborn health care indicators. Conclusions: The results of our analysis suggest that Ethiopia's HEP platform has improved maternal and newborn health care practices at scale. However, implementation research will be required to address the maternal and newborn care practices that were not influenced by the HEP outreach activities.	[Karim, Ali Mehryar; Alemu, Hibret; Getachew, Nebiyu; Ameha, Agazi; Tadesse, Luche; Betemariam, Wuleta] JSI Res & Training Inst Inc, Last Kilometers Project 10, Addis Ababa, Ethiopia; [Admassu, Kesetebirhane] Minist Hlth, Fed Democrat Republ Ethiopia, Addis Ababa, Ethiopia; [Schellenberg, Joanna] London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Karim, AM (corresponding author), JSI Res & Training Inst Inc, Last Kilometers Project 10, Addis Ababa, Ethiopia.	akarim@jsi.com	Karim, Ali/AAX-4495-2021; Ejeta, Luche Tadesse/J-8021-2019	Ejeta, Luche Tadesse/0000-0003-3529-8516; Schellenberg, Joanna/0000-0002-0708-3676	Bill & Melinda Gates Foundation; Regional Health Bureaus of Amhara; Oromia; Tigray; Southern Nations and Nationalities People's Regions	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Regional Health Bureaus of Amhara; Oromia; Tigray; Southern Nations and Nationalities People's Regions	Work was funded by the Bill & Melinda Gates Foundation. However, the views expressed in this study do not necessarily reflect the views of the foundation. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the health extension workers, community health promoters, and the women in the L10K areas for making this research possible. The supports from the Regional Health Bureaus of Amhara, Oromia, Tigray, and Southern Nations and Nationalities People's Regions, and the L10K implementing partners, i.e., Amhara Development Association, Bench Maji Development Association, Ethiopian Kale Hiwot Church, Fayyaa Integrated Development Organization, Illu Women and Children Integrated Development Association, Oromia Development Association, Relief Society of Tigray, Sheka Peoples' Development Association, Siltie Development Association, Southern Region's Women's Association, and Women's Association of Tigray were critical for the data collection. Logistics, supervision, and management supports throughout the study period by the L10K central and regional team members were fundamental for conducting the study. We are thankful to Mary Taylor for her support. The review of the paper by W Brown, S Hodgins and E Allen were very useful for finalizing the manuscript. Comments from S Cousens on an early analysis of the L10K baseline and follow-up survey data were very helpful. A Becker helped us with the illustrations.	Admassie A, 2009, J DEV EFFECT, V1, P430, DOI 10.1080/19439340903375724; Angeles G, 2005, SOCIOL METHOD RES, V34, P76, DOI 10.1177/0049124104273069; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Birhanu Z, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-74; Central Statistical Agency of Ethiopia, 2011, ETH DEM HLTH SURV 20; Croft T, 1991, DEMOGRAPHIC HLTH SUR, VII, P1337; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, HLTH EXT PROGR IMPL; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR, p[26, 58]; Federal Democratic Republic of Ethiopia Ministry of Health, 2008, HLTH SECT DEV PROGR; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, ANN PERF REP 2009 20; Federal Democratic Republic of Ethiopia Ministry of Health, 2011, HLTH HLTH REL IND 20; Feysia B, 2012, HLTH WORKFORCE ETHIO, DOI [10.1596/978-0-8213-8984-3, DOI 10.1596/978-0-8213-8984-3.ACCESSED]; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Friberg IK, 2010, INT J EPIDEMIOL, V39, P11, DOI 10.1093/ije/dyq017; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Karim AM, 2010, ETHIOP J HEALTH DEV, V24, P92; Koblinsky M, 2010, ETHIOP J HEALTH DEV, V24, P105; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Lemeshow S, 1985, World Health Stat Q, V38, P65; Marsh David R, 2002, J Perinatol, V22, P572, DOI 10.1038/sj.jp.7210793; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Morgenstern H, 1999, MODERN EPIDEMIOLOGY, P459; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Seward N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001180; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Soofi S, 2012, LANCET, V379, P1029, DOI 10.1016/S0140-6736(11)61877-1; StataCorp, 2011, STATA STAT SOFTWARE; StataCorp, 2011, LONG DAT PAN DAT REF, P11; The Partnership for Maternal Newborn & Child Health, 2011, ESS INT COMM GUID RE, P17; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Wakabi W, 2008, LANCET, V372, P880, DOI 10.1016/S0140-6736(08)61381-1; Wooldridge JM, 2003, INTRO ECONOMETRICS M, P461	36	76	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65160	10.1371/journal.pone.0065160	http://dx.doi.org/10.1371/journal.pone.0065160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750240	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900042
J	Smart, CE; Morrison, BJ; Saunus, JM; Vargas, AC; Keith, P; Reid, L; Wockner, L; Amiri, MA; Sarkar, D; Simpson, PT; Clarke, C; Schmidt, CW; Reynolds, BA; Lakhani, SR; Lopez, JA				Smart, Chanel E.; Morrison, Brian J.; Saunus, Jodi M.; Vargas, Ana Cristina; Keith, Patricia; Reid, Lynne; Wockner, Leesa; Amiri, Marjan Askarian; Sarkar, Debina; Simpson, Peter T.; Clarke, Catherine; Schmidt, Chris W.; Reynolds, Brent A.; Lakhani, Sunil R.; Lopez, J. Alejandro			In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; STEM-CELLS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR HETEROGENEITY; CARCINOMA; POPULATION; TUMORIGENICITY; PROPAGATION; PHENOTYPE; CULTURE	Mammosphere and breast tumoursphere culture have gained popularity as in vitro assays for propagating and analysing normal and cancer stem cells. Whether the spheres derived from different sources or parent cultures themselves are indeed single entities enriched in stem/progenitor cells compared to other culture formats has not been fully determined. We surveyed sphere-forming capacity across 26 breast cell lines, immunophenotyped spheres from six luminal- and basal-like lines by immunohistochemistry and flow cytometry and compared clonogenicity between sphere, adherent and matrigel culture formats using in vitro functional assays. Analyses revealed morphological and molecular intra- and inter-sphere heterogeneity, consistent with adherent parental cell line phenotypes. Flow cytometry showed sphere culture does not universally enrich for markers previously associated with stem cell phenotypes, although we found some cell-line specific changes between sphere and adherent formats. Sphere-forming efficiency was significantly lower than adherent or matrigel clonogenicity and constant over serial passage. Surprisingly, self-renewal capacity of sphere-derived cells was similar/lower than other culture formats. We observed significant correlation between long-term-proliferating-cell symmetric division rates in sphere and adherent cultures, suggesting functional overlap between the compartments sustaining them. Experiments with normal primary human mammary epithelia, including sorted luminal (MUC1(+)) and basal/myoepithelial (CD10(+)) cells revealed distinct luminal-like, basal-like and mesenchymal entities amongst primary mammospheres. Morphological and colony-forming-cell assay data suggested mammosphere culture may enrich for a luminal progenitor phenotype, or induce reversion/relaxation of the basal/mesenchymal in vitro selection occurring with adherent culture. Overall, cell line tumourspheres and primary mammospheres are not homogenous entities enriched for stem cells, suggesting a more cautious approach to interpreting data from these assays and careful consideration of its limitations. Sphere culture may represent an alternative 3-dimensional culture system which rather than universally 'enriching' for stem cells, has utility as one of a suite of functional assays that provide a read-out of progenitor activity.	[Smart, Chanel E.; Saunus, Jodi M.; Vargas, Ana Cristina; Keith, Patricia; Reid, Lynne; Amiri, Marjan Askarian; Sarkar, Debina; Simpson, Peter T.; Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Smart, Chanel E.; Morrison, Brian J.; Keith, Patricia; Reid, Lynne; Wockner, Leesa; Simpson, Peter T.; Schmidt, Chris W.; Lopez, J. Alejandro] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Morrison, Brian J.; Lopez, J. Alejandro] Griffith Univ, Sch Biomol & Phys Sci, Brisbane, Qld 4111, Australia; [Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL USA; [Lakhani, Sunil R.] Pathol Queensland Royal Brisbane & Womens Hosp, Dept Anat Pathol, Brisbane, Qld, Australia; [Clarke, Catherine; Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; Griffith University; State University System of Florida; University of Florida; Royal Brisbane & Women's Hospital; University of Queensland	Smart, CE (corresponding author), Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia.	c.smart@uq.edu.au	Vargas, Ana/GSE-1963-2022; Sarkar, Debina/AAA-8212-2020; Saunus, Jodi/AAE-5291-2020; Simpson, Peter/F-1225-2010; Lakhani, Sunil R/I-1970-2018; Smart, Chanel E/C-9583-2011; Lopez, J. Alejandro/B-9290-2008; Askarian-Amiri, Marjan E./F-7910-2010; Lopez, J. Alejandro/P-4129-2019; Saunus, Jodi M/C-6657-2011; Schmidt, Christopher/A-4353-2009	Sarkar, Debina/0000-0002-6734-8875; Saunus, Jodi/0000-0002-4604-4709; Simpson, Peter/0000-0002-4816-8289; Lakhani, Sunil R/0000-0003-4067-2760; Lopez, J. Alejandro/0000-0001-9370-1516; Askarian-Amiri, Marjan E./0000-0003-3524-9626; Lopez, J. Alejandro/0000-0001-9370-1516; Saunus, Jodi M/0000-0002-4604-4709; Schmidt, Christopher/0000-0002-3955-5076; Wockner, Leesa/0000-0002-8921-9265	Australian National Health and Medical Research Council the Queensland Cancer Council; National Breast Cancer Foundation; Griffith University	Australian National Health and Medical Research Council the Queensland Cancer Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Griffith University(Griffith University)	The authors wish to acknowledge the Australian National Health and Medical Research Council the Queensland Cancer Council, the National Breast Cancer Foundation and Griffith University for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bachelard-Cascales E, 2010, STEM CELLS, V28, P1081, DOI 10.1002/stem.435; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chu JS, 1999, CANCER LETT, V142, P121, DOI 10.1016/S0304-3835(99)00161-5; Clarke CL, 2006, BRIT J CANCER, V95, P515, DOI 10.1038/sj.bjc.6603298; CROKER AK, 2008, J CELL MOL MED; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Heppner Gloria H., 1999, Breast J, V5, P122, DOI 10.1046/j.1524-4741.1999.00136.x; HIRSCHHAEUSER F, 2010, J BIOTECHNOL; HOLLESTELLE A, 2009, BREAST CANC RES TREA; INCH WR, 1970, GROWTH, V34, P271; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Kok M, 2009, J PATHOL, V218, P316, DOI 10.1002/path.2544; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; KUREBAYASHI J, 1995, BRIT J CANCER, V71, P845, DOI 10.1038/bjc.1995.163; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Maguer-Satta V, 2011, P NATL ACAD SCI USA, V108, pE1264, DOI 10.1073/pnas.1116567108; MATILAINEN H, 2012, CANC LETT; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; PENG T, 2011, PLOS ONE, V0006; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl John, 2005, Methods Mol Biol, V290, P249; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; WHITEHEAD RH, 1983, J NATL CANCER I, V71, P1193; Wicha MS, 2007, STEM CELL REV, V3, P110, DOI 10.1007/s12015-007-0016-4; Xie GZ, 2012, CANCER LETT, V316, P53, DOI 10.1016/j.canlet.2011.10.018; Yoshino Kaori, 2006, Hum Cell, V19, P43, DOI 10.1111/j.1749-0774.2005.00007.x	55	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64388	10.1371/journal.pone.0064388	http://dx.doi.org/10.1371/journal.pone.0064388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750209	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900011
J	Ariza, A; Moroz, OV; Blagova, EV; Turkenburg, JP; Waterman, J; Roberts, SM; Vind, J; Sjoholm, C; Lassen, SF; De Maria, L; Glitsoe, V; Skov, LK; Wilson, KS				Ariza, Antonio; Moroz, Olga V.; Blagova, Elena V.; Turkenburg, Johan P.; Waterman, Jitka; Roberts, Shirley M.; Vind, Jesper; Sjoholm, Carsten; Lassen, Soren F.; De Maria, Leonardo; Glitsoe, Vibe; Skov, Lars K.; Wilson, Keith S.			Degradation of Phytate by the 6-Phytase from Hafnia alvei: A Combined Structural and Solution Study	PLOS ONE			English	Article							MYOINOSITOL HEXAKISPHOSPHATE DEPHOSPHORYLATION; MULTIPLE SEQUENCE ALIGNMENTS; CRYSTAL-STRUCTURES; ACID-PHOSPHATASE; DEGRADING ENZYME; IN-VITRO; STRUCTURE VALIDATION; PENIOPHORA-LYCII; SUBSTRATE; COMPLEX	Phytases hydrolyse phytate (myo-inositol hexakisphosphate), the principal form of phosphate stored in plant seeds to produce phosphate and lower phosphorylated myo-inositols. They are used extensively in the feed industry, and have been characterised biochemically and structurally with a number of structures in the PDB. They are divided into four distinct families: histidine acid phosphatases (HAP), beta-propeller phytases, cysteine phosphatases and purple acid phosphatases and also split into three enzyme classes, the 3-, 5- and 6-phytases, depending on the position of the first phosphate in the inositol ring to be removed. We report identification, cloning, purification and 3D structures of 6-phytases from two bacteria, Hafnia alvei and Yersinia kristensenii, together with their pH optima, thermal stability, and degradation profiles for phytate. An important result is the structure of the H. alvei enzyme in complex with the substrate analogue myo-inositol hexakissulphate. In contrast to the only previous structure of a ligand-bound 6-phytase, where the 3-phosphate was unexpectedly in the catalytic site, in the H. alvei complex the expected scissile 6-phosphate (sulphate in the inhibitor) is placed in the catalytic site.	[Ariza, Antonio; Moroz, Olga V.; Blagova, Elena V.; Turkenburg, Johan P.; Waterman, Jitka; Roberts, Shirley M.; Wilson, Keith S.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Vind, Jesper; Sjoholm, Carsten; Lassen, Soren F.; De Maria, Leonardo; Glitsoe, Vibe; Skov, Lars K.] Novozymes AS, Bagsvaerd, Denmark	University of York - UK; Novozymes	Wilson, KS (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	keith.wilson@york.ac.uk	De Maria, Leonardo/AAH-1026-2021; Ariza, Antonio/H-7830-2019	De Maria, Leonardo/0000-0002-8061-4242; Ariza, Antonio/0000-0003-4364-823X; Moroz, Olga/0000-0002-0354-6119; Turkenburg, Johan/0000-0001-6992-6838; Wilson, Keith/0000-0002-3581-2194	Novozymes A/S	Novozymes A/S	This work is a collaboration between the University of York and Novozymes A/S. The study was funded by Novozymes A/S, the employer of Jesper Vind, Carsten Sjoholm, Soren F. Lassen, Leonardo De Maria, Vibe Glitsoe, and Lars K. Skov. The Novozymes employees have financial interests, including stock options with the company. Novozymes is the producer of phytases for the animal feed market. Diamond Light Source Ltd provided data collection facilities for this study. Novozymes has patent applications on the Hafnia alvei phytase and variants thereof. While these have not been granted, they are with "grant of patent intended." There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agranoff BW, 2009, J BIOL CHEM, V284, P21121, DOI 10.1074/jbc.X109.004747; AGRANOFF BW, 1978, TRENDS BIOCHEM SCI, V3, pN283; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLANK GE, 1971, BIOCHEM BIOPH RES CO, V44, P319, DOI 10.1016/0006-291X(71)90602-4; Bohm K, 2010, FEBS J, V277, P1284, DOI 10.1111/j.1742-4658.2010.07559.x; Brask-Pedersen DN, 2011, J DAIRY SCI, V94, P951, DOI 10.3168/jds.2010-3504; Carlsson NG, 2001, J AGR FOOD CHEM, V49, P1695, DOI 10.1021/jf000861r; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chu HM, 2004, STRUCTURE, V12, P2015, DOI 10.1016/j.str.2004.08.010; COSGROVE DJ, 1966, REV PURE APPL CHEM, V16, P209; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CREA FDS, 2008, COORDINATION CHEM RE, P252; Elser J, 2011, NATURE, V478, P29, DOI 10.1038/478029a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELEN AJ, 1994, J AOAC INT, V77, P760; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; EVANS WJ, 1982, J AM OIL CHEM SOC, V59, P189, DOI 10.1007/BF02680274; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREINER R, 1993, ARCH BIOCHEM BIOPHYS, V303, P107, DOI 10.1006/abbi.1993.1261; Greiner R, 2001, J AGR FOOD CHEM, V49, P2228, DOI 10.1021/jf0100090; Greiner R, 2001, J AGR FOOD CHEM, V49, P2234, DOI 10.1021/jf0100806; Greiner R, 2000, J BIOTECHNOL, V84, P53, DOI 10.1016/S0168-1656(00)00331-X; Haefner S, 2005, APPL MICROBIOL BIOT, V68, P588, DOI 10.1007/s00253-005-0005-y; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kostrewa D, 1997, NAT STRUCT BIOL, V4, P185, DOI 10.1038/nsb0397-185; LaCount MW, 1998, J BIOL CHEM, V273, P30406, DOI 10.1074/jbc.273.46.30406; LASKOWSKI RA, 1993, J APP CRYST, V26; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lassen SF, 2001, APPL ENVIRON MICROB, V67, P4701, DOI 10.1128/AEM.67.10.4701-4707.2001; Lee DC, 2003, J BIOL CHEM, V278, P31412, DOI 10.1074/jbc.M213154200; Lei XG, 2003, BIOTECHNOL LETT, V25, P1787, DOI 10.1023/A:1026224101580; LEI XG, 2007, PHYTASE SOURCE STRUC, P5005; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Lichtenberg J, 2011, REGUL TOXICOL PHARM, V60, P401, DOI 10.1016/j.yrtph.2011.05.010; Lim D, 2000, NAT STRUCT BIOL, V7, P108; LINDQVIST Y, 1994, EUR J BIOCHEM, V221, P139, DOI 10.1111/j.1432-1033.1994.tb18722.x; Liu BL, 1998, ENZYME MICROB TECH, V22, P415, DOI 10.1016/S0141-0229(97)00210-X; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mitchell DB, 1997, MICROBIOL-SGM, V143, P245, DOI 10.1099/00221287-143-1-245; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2000, BIOSCI BIOTECH BIOCH, V64, P841, DOI 10.1271/bbb.64.841; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oakley AJ, 2010, BIOCHEM BIOPH RES CO, V397, P745, DOI 10.1016/j.bbrc.2010.06.024; Oh BC, 2004, APPL MICROBIOL BIOT, V63, P362, DOI 10.1007/s00253-003-1345-0; OSTANIN K, 1993, J BIOL CHEM, V268, P20778; Pandey A, 2001, BIORESOURCE TECHNOL, V77, P203, DOI 10.1016/S0960-8524(00)00139-5; Pontoppidan K, 2007, J SCI FOOD AGR, V87, P2700, DOI 10.1002/jsfa.3033; Pontoppidan K, 2012, ARCH ANIM NUTR, V66, P431, DOI 10.1080/1745039X.2012.735082; PORVARI KS, 1994, J BIOL CHEM, V269, P22642; Ragon M, 2009, ACTA CRYSTALLOGR F, V65, P321, DOI 10.1107/S1744309109008653; REDDY NR, 1982, ADV FOOD RES, V28, P1; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; ROY AV, 1971, CLIN CHEM, V17, P1093; Sajidan A, 2004, APPL MICROBIOL BIOT, V65, P110, DOI 10.1007/s00253-003-1530-1; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Skoglund E, 1997, J AGR FOOD CHEM, V45, P431, DOI 10.1021/jf9603238; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Ullah AHJ, 1998, BIOCHEM BIOPH RES CO, V251, P260, DOI 10.1006/bbrc.1998.9456; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vats P, 2006, ENZYME MICROB TECH, V39, P596, DOI 10.1016/j.enzmictec.2005.11.009; WANG HL, 1980, J FOOD SCI, V45, P1262, DOI 10.1111/j.1365-2621.1980.tb06534.x; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wodzinski RJ, 1996, ADV APPL MICROBIOL, V42, P263, DOI 10.1016/S0065-2164(08)70375-7; Wyss M, 1999, APPL ENVIRON MICROB, V65, P367; Xiang T, 2004, J MOL BIOL, V339, P437, DOI 10.1016/j.jmb.2004.03.057; Zeng YF, 2011, J MOL BIOL, V409, P214, DOI 10.1016/j.jmb.2011.03.063; 1989, BIOCH J, V258, P1	71	28	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65062	10.1371/journal.pone.0065062	http://dx.doi.org/10.1371/journal.pone.0065062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741456	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900169
J	Barnett, LAK; Winton, MV; Ainsley, SM; Cailliet, GM; Ebert, DA				Barnett, Lewis A. K.; Winton, Megan V.; Ainsley, Shaara M.; Cailliet, Gregor M.; Ebert, David A.			Comparative Demography of Skates: Life-History Correlates of Productivity and Implications for Management	PLOS ONE			English	Article							EASTERN BERING-SEA; RAY RAJA-CLAVATA; POPULATION-DYNAMICS; FALKLAND ISLANDS; EXTINCTION RISK; THORNBACK RAY; WESTERN GULF; NORTH-SEA; REPRODUCTIVE PARAMETERS; LEUCORAJA-ERINACEA	Age-structured demographic models were constructed based on empirical estimates of longevity and maturity for five deepwater Bering Sea skates to investigate how observed differences in life history parameters affect population growth rates. Monte Carlo simulations were used to incorporate parameter uncertainty. Estimated population growth rates ranged from 1.045 to 1.129 yr(-1) and were lower than those reported for other Alaskan skates and most chondrichthyans. Population growth rates of these and other high-latitude skates increased with relative reproductive lifespan, but displayed no significant relationship with body size or depth distribution, suggesting that assemblage shifts may be difficult to predict for data-poor taxa. Elasticity analyses indicated that juvenile and adult survival had greater per-unit effects on population growth rates than did egg-case survival or fecundity. Population growth rate was affected more by uncertainty in age at maturity than maximum age. The results of this study indicate that if skates are deemed to be a management concern, gear modifications or depth-specific effort controls may be effective.	[Barnett, Lewis A. K.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Barnett, Lewis A. K.; Winton, Megan V.; Ainsley, Shaara M.; Cailliet, Gregor M.; Ebert, David A.] Moss Landing Marine Labs, Pacific Shark Res Ctr, Moss Landing, CA 95039 USA	University of California System; University of California Davis; Moss Landing Marine Laboratories	Barnett, LAK (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.	labarnett@ucdavis.edu		Ainsley, Shaara/0000-0002-0080-7336; Barnett, Lewis/0000-0002-9381-8375	North Pacific Research Board [715]; David and Lucile Packard Foundation	North Pacific Research Board; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	Funding for this project was provided by the North Pacific Research Board (www.nprb.org/) under project 715 and a Graduate Student Research Award, and the David and Lucile Packard Foundation (http://www.packard.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2000, CAN J FISH AQUAT SCI, V57, P429, DOI 10.1139/cjfas-57-2-429; Ainsley SM, 2011, ICES J MAR SCI, V68, P1426, DOI 10.1093/icesjms/fsr072; Ainsley SM, 2011, MAR FRESHWATER RES, V62, P557, DOI 10.1071/MF10140; Aires-da-Silva AM, 2007, MAR FRESHWATER RES, V58, P570, DOI 10.1071/MF06156; AU DW, 2008, SHARKS OPEN OCEAN BI, P298, DOI DOI 10.1002/9781444302516.CH26; BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Beerkircher L, 2003, FISH B-NOAA, V101, P168; Brewer D, 1998, FISH RES, V36, P195, DOI 10.1016/S0165-7836(98)00096-4; Brickle P, 2003, J MAR BIOL ASSOC UK, V83, P1119, DOI 10.1017/S0025315403008373h; Carlson JD, 2003, FISH B-NOAA, V101, P281; Caswell, 2000, MATRIX POPULATION MO; CASWELL H, 1984, AQUACULTURE, V43, P123, DOI 10.1016/0044-8486(84)90016-4; Charnov EL, 2002, EVOL ECOL RES, V4, P749; CHARNOV EL, 1990, EVOL ECOL, V4, P273, DOI 10.1007/BF02214335; CHARNOV EL, 1991, EVOL ECOL, V5, P63, DOI 10.1007/BF02285246; Charnov EL, 2012, FISH FISH; CHEN S, 1989, NIPPON SUISAN GAKK, V55, P205; Chevolot M, 2006, J SEA RES, V56, P305, DOI 10.1016/j.seares.2006.05.005; Cortes E, 1998, FISH RES, V39, P199, DOI 10.1016/S0165-7836(98)00183-0; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Cortes E, 2007, MAR FRESHWATER RES, V58, P4, DOI 10.1071/MF06191; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; DEKROON H, 1986, ECOLOGY, V67, P1427, DOI 10.2307/1938700; DUBUIT MH, 1976, J FISH BIOL, V8, P199; Dulvy NK, 2010, CRC MAR BIOL SER, P639; Dulvy NK, 2002, CONSERV BIOL, V16, P440, DOI 10.1046/j.1523-1739.2002.00416.x; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Ebert D. A., 2003, SHARKS RAYS CHIMAERA; Ebert DA, 2005, J FISH BIOL, V66, P618, DOI 10.1111/j.0022-1112.2005.00628.x; EBERT DA, 2007, 510 N PAC RES BOARD; EBERT DA, 2009, 715 N PAC RES BOARD; Ebert DA, 2008, FISH RES, V94, P48, DOI 10.1016/j.fishres.2008.06.016; Enever R, 2009, FISH RES, V97, P72, DOI 10.1016/j.fishres.2009.01.001; Eschmeyer WN, 1983, FIELD GUIDE PACIFIC; Forrest RE, 2009, CAN J FISH AQUAT SCI, V66, P2062, DOI 10.1139/F09-137; FOWLER CW, 1988, EVOL ECOL, V2, P197, DOI 10.1007/BF02214283; Frisk MG, 2002, ICES J MAR SCI, V59, P576, DOI 10.1006/jmsc.2002.1177; Frisk Michael G., 2005, Journal of Northwest Atlantic Fishery Science, V35, P27; Frisk MG, 2006, CAN J FISH AQUAT SCI, V63, P1078, DOI 10.1139/F06-005; Frisk MG, 2010, CRC MAR BIOL SER, P283; Gallagher M. J., 2005, Journal of Northwest Atlantic Fishery Science, V35, P47; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; Gburski CM, 2007, ENVIRON BIOL FISH, V80, P337, DOI 10.1007/s10641-007-9231-8; Gedamke T, 2007, N AM J FISH MANAGE, V27, P605, DOI 10.1577/M05-157.1; Gedamke Todd, 2005, Journal of Northwest Atlantic Fishery Science, V35, P67; Gemmill AW, 1999, J EVOLUTION BIOL, V12, P1148, DOI 10.1046/j.1420-9101.1999.00117.x; Goldman K.J, 2002, THESIS VIRGINIA I MA; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Heppell SS, 1999, AM FISH S S, V23, P137; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; HOENIG JM, 1983, FISH B US, V82, P898, DOI DOI 10.1890/04-0594; HOENIG JM, 1990, 90 NOAA NMFS, P1; Hoff GR, 2009, J FISH BIOL, V74, P250, DOI 10.1111/j.1095-8649.2008.02137.x; Hoff GR, 2010, MAR ECOL PROG SER, V403, P243, DOI 10.3354/meps08424; HOFF GR, 2007, THESIS U WASHINGTON; HOLDEN M J, 1973, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V164, P360; Holden M.J., 1974, P117; HOLDEN MJ, 1975, J CONSEIL, V36, P110; HOLDEN MJ, 1971, J CONSEIL, V33, P335; HOLDEN MJ, 1972, J CONSEIL, V34, P161; Hunter E, 2005, J MAR BIOL ASSOC UK, V85, P1095, DOI 10.1017/S0025315405012142; Hutchings JA, 2012, ECOL APPL, V22, P1061, DOI 10.1890/11-1313.1; ISHIHARA H, 1985, JPN J ICHTHYOL, V32, P143, DOI 10.1007/BF02938446; Ishihara H, 1997, REPROD STRATEGY JAPA, P236; Jensen AL, 1996, CAN J FISH AQUAT SCI, V53, P820, DOI 10.1139/cjfas-53-4-820; Juan-Jorda MJ, 2012, REV FISH BIOL FISHER, P1; Kinney MJ, 2009, CONSERV LETT, V2, P53, DOI 10.1111/j.1755-263X.2008.00046.x; Kotwicki Stan, 2005, Alaska Fishery Research Bulletin, V11, P135; Kulka D. W., 2002, 2002073 DEP FISH OC; Kulka DW, 2003, 0357N4875 NAFO SCR; Laptikhovsky VV, 2004, FISH B-NOAA, V102, P757; LUER CA, 1985, ENVIRON BIOL FISH, V13, P161, DOI 10.1007/BF00000926; Matta ME, 2007, ENVIRON BIOL FISH, V80, P309, DOI 10.1007/s10641-007-9223-8; Maurer J.R.F, 2009, THESIS; McAuley RB, 2007, ICES J MAR SCI, V64, P1710, DOI 10.1093/icesjms/fsm146; MCEACHRAN JD, 1975, FISH B-NOAA, V73, P110; McFarlane GA, 2006, FISH RES, V78, P169, DOI 10.1016/j.fishres.2006.01.009; McPhie RP, 2009, J FISH BIOL, V75, P223, DOI 10.1111/j.1095-8649.2009.02282.x; Miller D. J., 1972, CALIF DEP FISH GAME, V157; Mollet HF, 2002, MAR FRESHWATER RES, V53, P503, DOI 10.1071/MF01083; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Musick JA, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:CTDERI>2.0.CO;2; Mytilineou C, 2005, BELG J ZOOL, V135, P229; Ormseth O., 2010, STOCK ASSESSMENT FIS, P1365; Ormseth O, 2007, STOCK ASSESSMENT FIS, P909; Parent S, 2008, ZOO BIOL, V27, P145, DOI 10.1002/zoo.20170; Price B, 2011, NMFSSEFSC615 NOAA; Romine JG, 2009, ENVIRON BIOL FISH, V84, P277, DOI 10.1007/s10641-008-9435-6; RYLAND JS, 1984, J CONSEIL, V41, P111; Simpfendorfer CA, 1999, FISH B-NOAA, V97, P978; Simpfendorfer CA, 2009, ENVIRON CONSERV, V36, P97, DOI 10.1017/S0376892909990191; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Smith WD, 2008, MAR FRESHWATER RES, V59, P575, DOI 10.1071/MF07020; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevenson DE, 2008, FISH B-NOAA, V106, P24; Stevenson DE, 2010, FISH B-NOAA, V108, P208; Sulikowski JA, 2006, J FISH BIOL, V69, P1449, DOI 10.1111/j.1095-8649.2006.01207.x; Sulikowski JA, 2005, FISH B-NOAA, V103, P161; Thorsteinson LK, 2002, FISHES ALASKA; Tuljapurkar S., 1997, STRUCTURED POPULATIO; Walker PA, 1998, ICES J MAR SCI, V55, P392, DOI 10.1006/jmsc.1997.0325; Wiegand J, 2011, MAR FRESHWATER RES, V62, P722, DOI 10.1071/MF10141; Winton M.V, 2011, AGE GROWTH DEMOGRAPH; [No title captured]	105	20	20	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65000	10.1371/journal.pone.0065000	http://dx.doi.org/10.1371/journal.pone.0065000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741442	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900155
J	Bonzano, L; Sormani, MP; Tacchino, A; Abate, L; Lapucci, C; Mancardi, GL; Uccelli, A; Bove, M				Bonzano, Laura; Sormani, Maria Pia; Tacchino, Andrea; Abate, Lucia; Lapucci, Caterina; Mancardi, Giovanni Luigi; Uccelli, Antonio; Bove, Marco			Quantitative Assessment of Finger Motor Impairment in Multiple Sclerosis	PLOS ONE			English	Article							SERIAL ADDITION TEST; BRAIN REORGANIZATION; DISABILITY; MOVEMENTS; INTEGRITY; SCALE; FMRI; MRI; MS	Objective: To address the disability impact on fine hand motor functions in patients with Multiple Sclerosis (MS) by quantitatively measuring finger opposition movements, with the aim of providing a new "score'' integrating current methods for disability assessment. Methods: 40 MS patients (Expanded Disability Status Scale (EDSS): 0-7) and 80 healthy controls (HC) performed a repetitive finger-to-thumb opposition sequence with their dominant hand at spontaneous and maximal velocity, and uni- and bi-manually metronome-paced. A sensor-engineered glove was used to measure finger motor performance. Twenty-seven HC were tested twice, one month apart, to assess test-retest reliability. Results: The motor parameters showed a good reproducibility in HC and demonstrated significantly worse performance in MS patients with respect to HC. A multivariate model revealed that rate of movement in the spontaneous velocity condition and inter-hand interval (IHI), indicating bimanual coordination, contributed independently to differentiate the two groups. A finger motor impairment score based on these two parameters was able to discriminate HC from MS patients with very low EDSS scores (p<0.001): a significant difference was already evident for patients with EDSS = 0. Further, in the MS group, some motor performance parameters correlated with the clinical scores. In particular, significant correlations were found between IHI and EDSS (r = 0.56; p<0.0001), MS Functional Composite (r = -0.40; p = 0.01), Paced Auditory Serial Addition (r = -0.38; p = 0.02). No motor performance parameter correlated with Timed 25-Foot Walk. Conclusions: A simple, quantitative, objective method measuring finger motor performance could be used to define a score discriminating healthy controls and MS patients, even with very low disability. This sensitivity might be of crucial importance for monitoring the disease course and the treatment effects in early MS patients, when changes in the EDSS are small or absent.	[Bonzano, Laura; Abate, Lucia; Lapucci, Caterina; Mancardi, Giovanni Luigi; Uccelli, Antonio] Univ Genoa, Dept Neurosci, Genoa, Italy; [Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy; [Tacchino, Andrea; Bove, Marco] Univ Genoa, Dept Expt Med, Sect Human Physiol, Genoa, Italy; [Tacchino, Andrea; Bove, Marco] Univ Genoa, Ctr Polifunz Sci Motorie, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa	Bove, M (corresponding author), Univ Genoa, Dept Expt Med, Sect Human Physiol, Genoa, Italy.	marco.bove@unige.it	Tacchino, Andrea/AAH-2597-2020; Lapucci, Caterina/ABA-9667-2021; Lapucci, Caterina/AAA-6723-2021; UCCELLI, Antonio/E-7343-2012; Sormani, Maria Pia/ABH-8756-2020; Mancardi, Giovanni Luigi/K-8656-2016	Tacchino, Andrea/0000-0002-2263-7315; Lapucci, Caterina/0000-0002-3527-6520; UCCELLI, Antonio/0000-0002-2008-6038; Mancardi, Giovanni Luigi/0000-0001-8427-118X; SORMANI, MARIA PIA/0000-0001-6892-104X; Bonzano, Laura/0000-0001-8186-2566	Italian Multiple Sclerosis Foundation (FISM) [2011/R/7, 2011/R/8]; Biogen Idec; Merck Serono; Synthon; Actelion; Allozyne; Bayer Schering; Sanofi-Aventis; Novartis; Allergan; Roche; Teva	Italian Multiple Sclerosis Foundation (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Biogen Idec(Biogen); Merck Serono(Merck & Company); Synthon; Actelion; Allozyne; Bayer Schering(Bayer AG); Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Allergan(AbbVieAllergan); Roche(Roche Holding); Teva(Teva Pharmaceutical Industries)	This work was partially supported by the Italian Multiple Sclerosis Foundation (FISM) with grants 2011/R/7 and 2011/R/8 to LB and MB respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The authors have read the journal's policy and have the following conflicts: Maria Pia Sormani received consulting fees from Biogen Idec, Merck Serono, Synthon, Actelion, Allozyne; payment for lectures from Merck Serono, Biogen Idec. Giovanni Luigi Mancardi received honoraria for lecturing, travel expenses for attending meetings and financial support for research from Bayer Schering, Biogen Idec, Sanofi-Aventis, Novartis and Merck Serono. Antonio Uccelli received consulting fees from Biogen Idec, Merck Serono, Allergan and Roche; payment for lectures from Merck Serono, Biogen Idec, Teva, Sanofi-Aventis, Novartis, Roche. Laura Bonzano, Andrea Tacchino, Lucia Abate, Caterina Lapucci, and Marco Bove have nothing to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arnould C, 2007, J REHABIL MED, V39, P708, DOI 10.2340/16501977-0111; Audoin B, 2005, HUM BRAIN MAPP, V24, P216, DOI 10.1002/hbm.20083; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Barkhof F, 2009, NAT REV NEUROL, V5, P182, DOI 10.1038/nrneurol.2009.31; Barrett L, 2012, MULT SCLER; BEATTY PA, 1977, J NERV MENT DIS, V164, P42, DOI 10.1097/00005053-197701000-00008; Bonzano L, 2011, NEUROIMAGE, V57, P495, DOI 10.1016/j.neuroimage.2011.04.037; Bonzano L, 2008, J NEUROSCI, V28, P3227, DOI 10.1523/JNEUROSCI.4076-07.2008; Bonzano L, 2011, HUM BRAIN MAPP, V32, P218, DOI 10.1002/hbm.21011; Bonzano L, 2009, NEUROIMAGE, V44, P9, DOI 10.1016/j.neuroimage.2008.08.015; Bove M, 2007, BRAIN RES, V1153, P84, DOI 10.1016/j.brainres.2007.03.063; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; GOLDSTEIN G, 1974, J NERV MENT DIS, V158, P280, DOI 10.1097/00005053-197404000-00006; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Larson EB, 2002, CORTEX, V38, P201, DOI 10.1016/S0010-9452(08)70650-6; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Nagels G, 2005, CLIN NEUROL NEUROSUR, V107, P218, DOI 10.1016/j.clineuro.2004.11.016; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pantano P, 2002, BRAIN, V125, P1607, DOI 10.1093/brain/awf164; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P471, DOI 10.1080/01688638908400907; Reddy H, 2002, BRAIN, V125, P2646, DOI 10.1093/brain/awf283; Rocca MA, 2005, LANCET NEUROL, V4, P618, DOI 10.1016/S1474-4422(05)70171-X	25	36	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65225	10.1371/journal.pone.0065225	http://dx.doi.org/10.1371/journal.pone.0065225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741485	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900198
J	Dyrba, M; Ewers, M; Wegrzyn, M; Kilimann, I; Plant, C; Oswald, A; Meindl, T; Pievani, M; Bokde, ALW; Fellgiebel, A; Filippi, M; Hampel, H; Kloppel, S; Hauenstein, K; Kirste, T; Teipel, SJ				Dyrba, Martin; Ewers, Michael; Wegrzyn, Martin; Kilimann, Ingo; Plant, Claudia; Oswald, Annahita; Meindl, Thomas; Pievani, Michela; Bokde, Arun L. W.; Fellgiebel, Andreas; Filippi, Massimo; Hampel, Harald; Kloeppel, Stefan; Hauenstein, Karlheinz; Kirste, Thomas; Teipel, Stefan J.		EDSD Study Grp	Robust Automated Detection of Microstructural White Matter Degeneration in Alzheimer's Disease Using Machine Learning Classification of Multicenter DTI Data	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DIFFUSION-TENSOR; DIAGNOSTIC UTILITY; TRACT INTEGRITY; WORK GROUP; MRI; DAMAGE; AD; BIOMARKERS; PROGRESSION	Diffusion tensor imaging (DTI) based assessment of white matter fiber tract integrity can support the diagnosis of Alzheimer's disease (AD). The use of DTI as a biomarker, however, depends on its applicability in a multicenter setting accounting for effects of different MRI scanners. We applied multivariate machine learning (ML) to a large multicenter sample from the recently created framework of the European DTI study on Dementia (EDSD). We hypothesized that ML approaches may amend effects of multicenter acquisition. We included a sample of 137 patients with clinically probable AD (MMSE 20.6 +/- 5.3) and 143 healthy elderly controls, scanned in nine different scanners. For diagnostic classification we used the DTI indices fractional anisotropy (FA) and mean diffusivity (MD) and, for comparison, gray matter and white matter density maps from anatomical MRI. Data were classified using a Support Vector Machine (SVM) and a Naive Bayes (NB) classifier. We used two cross-validation approaches, (i) test and training samples randomly drawn from the entire data set (pooled cross-validation) and (ii) data from each scanner as test set, and the data from the remaining scanners as training set (scanner-specific cross-validation). In the pooled cross-validation, SVM achieved an accuracy of 80% for FA and 83% for MD. Accuracies for NB were significantly lower, ranging between 68% and 75%. Removing variance components arising from scanners using principal component analysis did not significantly change the classification results for both classifiers. For the scanner-specific cross-validation, the classification accuracy was reduced for both SVM and NB. After mean correction, classification accuracy reached a level comparable to the results obtained from the pooled cross-validation. Our findings support the notion that machine learning classification allows robust classification of DTI data sets arising from multiple scanners, even if a new data set comes from a scanner that was not part of the training sample.	[Dyrba, Martin; Wegrzyn, Martin; Kilimann, Ingo; Teipel, Stefan J.] German Ctr Neurodegenerat Dis DZNE, Rostock, Germany; [Ewers, Michael] Ludwig Maximilians Univ Munchen, Inst Stroke & Dementia Res ISD, Munich, Germany; [Plant, Claudia] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Comp Sci, Neuherberg, Germany; [Plant, Claudia] Tech Univ Munich, Dept Database Syst, D-80290 Munich, Germany; [Oswald, Annahita] Ludwig Maximilians Univ Munchen, Inst Informat, Munich, Germany; [Meindl, Thomas] Ludwig Maximilians Univ Munchen, Inst Clin Radiol, Dept MRI, Munich, Germany; IRCCS Ctr San Giovanni Dio FBF, Lab Epidemiol Neuroimaging & Telemed LENITEM, Brescia, Italy; [Bokde, Arun L. W.] Trinity Coll Dublin, Sch Med, Cognit Syst Grp, Discipline Psychiat, Dublin, Ireland; [Bokde, Arun L. W.] Trinity Coll Dublin, TCIN, Dublin, Ireland; [Fellgiebel, Andreas] Univ Med Ctr Mainz, Dept Psychiat, Mainz, Germany; [Filippi, Massimo] Univ Vita Salute San Raffaele, Sci Inst, Div Neurosci, Neuroimaging Res Unit,Inst Expt Neurol, Milan, Italy; [Filippi, Massimo] Univ Vita Salute San Raffaele, Milan, Italy; [Hampel, Harald] Goethe Univ, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Kloeppel, Stefan] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg Brain Imaging, Freiburg, Germany; [Kloeppel, Stefan] Univ Med Ctr Freiburg, Dept Neurol, Freiburg, Germany; [Hauenstein, Karlheinz] Univ Rostock, Dept Radiol, D-18055 Rostock, Germany; [Kirste, Thomas] Univ Rostock, Mobile Multimedia Informat Syst Grp MMIS, D-18055 Rostock, Germany; [Teipel, Stefan J.] Univ Rostock, Clin Psychosomat & Psychotherapeut Med, D-18055 Rostock, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; Trinity College Dublin; Trinity College Dublin; Johannes Gutenberg University of Mainz; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; Goethe University Frankfurt; University of Freiburg; University of Freiburg; University of Rostock; University of Rostock; University of Rostock	Dyrba, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Rostock, Germany.	martin.dyrba@dzne.de	Dyrba, Martin/M-4454-2018; Frisoni, Giovanni B./K-1360-2016; Pievani, Michela/C-6021-2011; Filippi, Massimo/K-1755-2018; Agosta, Federica/J-9908-2016	Dyrba, Martin/0000-0002-3353-3167; Frisoni, Giovanni B./0000-0002-6419-1753; Pievani, Michela/0000-0002-1794-8987; Filippi, Massimo/0000-0002-5485-0479; Hampel, Harald/0000-0003-0894-8982; Bokde, Arun/0000-0003-0114-4914; Kloppel, Stefan/0000-0001-6452-9964; Agosta, Federica/0000-0003-3121-4979	Alexander von Humboldt-Foundation	Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	The work of Claudia Plant was supported by the Alexander von Humboldt-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir A, 2011, NEUROIMAGE, V58, P785, DOI 10.1016/j.neuroimage.2011.06.029; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bozzali M, 2001, NEUROLOGY, V57, P1135, DOI 10.1212/WNL.57.6.1135; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Canu E, 2010, J ALZHEIMERS DIS, V19, P963, DOI 10.3233/JAD-2010-1295; Chang Y. W., 2008, CAUSATION PREDICTION, V2, P47; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Clerx L, 2012, J ALZHEIMERS DIS, V29, P405, DOI 10.3233/JAD-2011-110797; Cohen J.E., 1988, STAT POWER ANAL BEHA; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; DUDA RO, 2001, PATTERN CLASSIFICATI; Ewers M, 2011, PROG NEUROBIOL, V95, P535, DOI 10.1016/j.pneurobio.2011.06.004; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Fayyad U., 1993, MULTIINTERVAL DISCRE; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friese U, 2010, J ALZHEIMERS DIS, V20, P477, DOI 10.3233/JAD-2010-1386; Gaser C, 1999, NEUROIMAGE, V10, P107, DOI 10.1006/nimg.1999.0458; Grana M, 2011, NEUROSCI LETT, V502, P225, DOI 10.1016/j.neulet.2011.07.049; Hall MA, 2003, IEEE T KNOWL DATA EN, V15, P1437, DOI 10.1109/TKDE.2003.1245283; Hampel H, 2000, ANN NY ACAD SCI, V903, P470, DOI 10.1111/j.1749-6632.2000.tb06401.x; Hardy M.A., 2009, HDB DATA ANAL; Huang JB, 2007, ANN NY ACAD SCI, V1097, P259, DOI 10.1196/annals.1379.021; Jack CR, 2011, NEUROBIOL AGING, V32, pS48, DOI 10.1016/j.neurobiolaging.2011.09.011; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Meng JZ, 2012, J CLIN NEUROSCI, V19, P1659, DOI 10.1016/j.jocn.2011.12.031; Mladenic D., 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P234, DOI 10.1145/1008992.1009034; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Muller MJ, 2007, NEUROBIOL AGING, V28, P398, DOI 10.1016/j.neurobiolaging.2006.01.009; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; Nakata Y, 2009, MAGN RESON IMAGING, V27, P347, DOI 10.1016/j.mri.2008.07.013; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Plant C, 2010, NEUROIMAGE, V50, P162, DOI 10.1016/j.neuroimage.2009.11.046; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rasmussen PM, 2011, NEUROIMAGE, V55, P1120, DOI 10.1016/j.neuroimage.2010.12.035; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Sander J, 1998, DATA MIN KNOWL DISC, V2, P169, DOI 10.1023/A:1009745219419; Scola E, 2010, J NEUROL NEUROSUR PS, V81, P798, DOI 10.1136/jnnp.2009.189639; Smith E. D, 2008, OPEN CYBERNETICS SYS, V2, P39, DOI DOI 10.2174/1874110X00802010039; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; Talairach J., 1988, COPLANAR STEREOTAXIC; Teipel SJ, 2007, NEUROIMAGE, V34, P985, DOI 10.1016/j.neuroimage.2006.07.047; Teipel SJ, 2011, PSYCHIAT RES-NEUROIM, V194, P363, DOI [10.1016/j.pscychresns2011.05.012, 10.1016/j.pscychresns.2011.05.012]; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Witten I.H., 2005, DATA MINING PRACTICA; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Yoshiura T, 2002, NEUROREPORT, V13, P2299, DOI 10.1097/00001756-200212030-00026; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zuendorf G, 2003, HUM BRAIN MAPP, V18, P13, DOI 10.1002/hbm.10069	65	76	77	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64925	10.1371/journal.pone.0064925	http://dx.doi.org/10.1371/journal.pone.0064925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741425	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900138
J	Jian, PY; Hu, FS; Wang, CP; Chiang, JM; Lin, TC				Jian, Pei-Yu; Hu, Feng Sheng; Wang, Chiao Ping; Chiang, Jyh-min; Lin, Teng-Chiu			Ecological Facilitation between Two Epiphytes through Drought Mitigation in a Subtropical Rainforest	PLOS ONE			English	Article							CLOUD FOREST; POSITIVE INTERACTIONS; ASPLENIUM-NIDUS; WATER RELATIONS; CLIMATE-CHANGE; CANOPY; DIVERSITY; BIOMASS; FERNS; BIOGEOGRAPHY	Positive species interactions (facilitation) play an important role in shaping the structures and species diversity of ecological communities, particularly under stressful environmental conditions. Epiphytes in rainforests often grow in multiple-species clumps, suggesting interspecies facilitation. However, little is known about the patterns and mechanisms of epiphyte co-occurrence. We assessed the interactions of two widespread epiphyte species, Asplenium antiquum and Haplopteris zosterifolia, by examining their co-occurrence and size-class association in the field. To elucidate factors controlling their interactions, we conducted reciprocal-removal and greenhouse-drought experiments, and nutrient and isotope analyses. Forty-five percent of H. zosterifolia co-occurred with A. antiquum, whereas only 17% of A. antiquum co-occurred with H. zosterifolia. Removing the fronds plus substrate of A. antiquum reduced the relative frond length and specific leaf area of H. zosterifolia, but removing fronds only had little effect. Removing H. zosterifolia had no significant effects on the growth of A. antiquum. H. zosterifolia co-occurring and not co-occurring with A. antiquum had similar foliar nutrient concentrations and delta N-15 values, suggesting that A. antiquum does not affect the nutrient status of H. zosterifolia. Reduced growth of H. zosterifolia with the removal of A. antiquum substrate, together with higher foliar delta C-13 for H. zosterifolia growing alone than those co-occurring with A. antiquum, suggest that A. antiquum enhances water availability to H. zosterifolia. This enhancement probably resulted from water storage in the substrate of A. antiquum, which could hold water up to 6.2 times its dry weight, and from reduced evapotranspiration due to shading of A. antiquum fronds. Greater water loss occurred in the frond-clipped group than the unclipped group between days 3-13 of the drought treatment. Our results imply that drought mitigation by substrate-forming epiphytes is important for maintaining epiphyte diversity in tropic and subtropic regions with episodic water limitations, especially in the context of anthropogenic climate change.	[Jian, Pei-Yu; Lin, Teng-Chiu] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Hu, Feng Sheng] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Wang, Chiao Ping] Taiwan Forestry Res Inst, Taipei, Taiwan; [Chiang, Jyh-min] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan	National Taiwan Normal University; University of Illinois System; University of Illinois Urbana-Champaign; Tunghai University	Lin, TC (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	tclin@ntnu.edu.tw		Chiang, Jyh-Min/0000-0002-6293-1551	National Science Council of Taiwan (NSC); National Science Council of Taiwan [NSC 98-2321-B-003-003, 98-2313-B-003-001-MY3]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council of Taiwan (NSC). This research was supported by grants from the National Science Council of Taiwan (NSC 98-2321-B-003-003, 98-2313-B-003-001-MY3) http://www.nsc.gov.tw. The funders had no role in the study design, data collecton and analysis, decision to publish, or preparation of the manuscript.	Andrade JL, 1997, BIOTROPICA, V29, P261, DOI 10.1111/j.1744-7429.1997.tb00427.x; Benner JW, 2007, ECOL LETT, V10, P628, DOI 10.1111/j.1461-0248.2007.01054.x; Benzing D., 1990, J TROP ECOL, V8, P55, DOI [10.1017/S0266467400006088, DOI 10.1017/S0266467400006088]; Benzing DH, 1998, CLIMATIC CHANGE, V39, P519, DOI 10.1023/A:1005312307709; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BERTNESS MD, 1994, AM NAT, V144, P363, DOI 10.1086/285681; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burns KC, 2010, ECOLOGY, V91, P377, DOI 10.1890/08-2004.1; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Condit R, 1998, CLIMATIC CHANGE, V39, P413, DOI 10.1023/A:1005395806800; Delta-T, 2000, HEMIVIEW CAN AN SOFT; Ellwood MDF, 2004, NATURE, V429, P549, DOI 10.1038/nature02560; Fayle TM, 2009, BIOTROPICA, V41, P676, DOI 10.1111/j.1744-7429.2009.00523.x; Freiberg M, 2007, AUSTRAL ECOL, V32, P70, DOI 10.1111/j.1442-9993.2007.01732.x; GENTRY AH, 1987, ANN MO BOT GARD, V74, P205, DOI 10.2307/2399395; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Hietz P, 2002, OECOLOGIA, V131, P350, DOI 10.1007/s00442-002-0896-6; Hietz P, 1998, OECOLOGIA, V114, P305, DOI 10.1007/s004420050452; Hsia Y. J., 1999, Q J CHIN FOR, V32, P39; Hsu CC, 2002, J TROP ECOL, V18, P659, DOI 10.1017/S0266467402002432; Hsu ChiaChun, 2007, Journal of the Experimental Forest of National Taiwan University, V21, P161; Kawai T, 2007, P R SOC B, V274, P2503, DOI 10.1098/rspb.2007.0871; Kohler L, 2007, PLANT ECOL, V193, P171, DOI 10.1007/s11258-006-9256-7; Kreft H, 2004, J BIOGEOGR, V31, P1463, DOI 10.1111/j.1365-2699.2004.01083.x; Lin TC, 2011, ECOSYSTEMS, V14, P127, DOI 10.1007/s10021-010-9399-1; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Marshall JD, 2003, CAN J FOREST RES, V33, P164, DOI 10.1139/X02-158; Martin C. E., 2010, Taiwan Journal of Forest Science, V25, P3; Martin CE, 2004, INT J PLANT SCI, V165, P65, DOI 10.1086/380982; Nadkarni NM, 2002, OECOLOGIA, V131, P580, DOI 10.1007/s00442-002-0899-3; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Rich P. M., 1990, Remote Sensing Reviews, V5, P13; Schuettpelz Eric, 2006, Selbyana, V27, P65; Stancato GC, 2001, PLANT PHYSIOL BIOCH, V39, P1009, DOI 10.1016/S0981-9428(01)01321-3; TFRI, 1989, LIST NAT PLANTS FUSH; Thomsen MS, 2010, INTEGR COMP BIOL, V50, P158, DOI 10.1093/icb/icq042; Turnbull MH, 2002, OECOLOGIA, V130, P515, DOI 10.1007/s00442-001-0842-z; Wang Hsueh-Ching, 2006, Taiwan Journal of Forest Science, V21, P281; Yen MH, 2007, THESIS NATL TAIWAN U; Yin CY, 2005, PHYSIOL PLANTARUM, V123, P445, DOI 10.1111/j.1399-3054.2005.00477.x; Zotz G, 2006, ANN BOT-LONDON, V97, P745, DOI 10.1093/aob/mcl026; Zotz G, 2004, J TROP ECOL, V20, P693, DOI 10.1017/S0266467404001889; Zotz G., 2009, V70, P147, DOI 10.1007/978-3-540-68421-3_7; Zotz G, 1999, J BIOGEOGR, V26, P761, DOI 10.1046/j.1365-2699.1999.00304.x	47	14	14	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64599	10.1371/journal.pone.0064599	http://dx.doi.org/10.1371/journal.pone.0064599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741346	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900059
J	Kulkarni, AA; Thatcher, TH; Hsiao, HM; Olsen, KC; Kottmann, RM; Morrissette, J; Wright, TW; Phipps, RP; Sime, PJ				Kulkarni, Ajit A.; Thatcher, Thomas H.; Hsiao, Hsi-Min; Olsen, Keith C.; Kottmann, Robert Matthew; Morrissette, Jason; Wright, Terry W.; Phipps, Richard P.; Sime, Patricia J.			The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; ACID; TOXICITY; DIFFERENTIATION; PATHOGENESIS; METHYL; DRUGS; MODEL	Pulmonary Fibrosis (PF) is a devastating progressive disease in which normal lung structure and function is compromised by scarring. Lung fibrosis can be caused by thoracic radiation, injury from chemotherapy and systemic diseases such as rheumatoid arthritis that involve inflammatory responses. CDDO-Me (Methyl 2-cyano-3,12-dioxooleana-1,9(11) dien-28-oate, Bardoxolone methyl) is a novel triterpenoid with anti-fibrotic and anti-inflammatory properties as shown by our in vitro studies. Based on this evidence, we hypothesized that CDDO-Me would reduce lung inflammation, fibrosis and lung function impairment in a bleomycin model of lung injury and fibrosis. To test this hypothesis, mice received bleomycin via oropharyngeal aspiration (OA) on day zero and CDDO-Me during the inflammatory phase from days -1 to 9 every other day. Bronchoalveolar lavage fluid (BALF) and lung tissue were harvested on day 7 to evaluate inflammation, while fibrosis and lung function were evaluated on day 21. On day 7, CDDO-Me reduced total BALF protein by 50%, alveolar macrophage infiltration by 40%, neutrophil infiltration by 90% (p <= 0.01), inhibited production of the inflammatory cytokines KC and IL-6 by over 90% (p <= 0.001), and excess production of the pro-fibrotic cytokine TGFb by 50%. CDDO-Me also inhibited alpha-smooth muscle actin and fibronectin mRNA by 50% (p <= 0.05). On day 21, CDDO-Me treatment reduced histological fibrosis, collagen deposition and alpha SMA production. Lung function was significantly improved at day 21 by treatment with CDDO-Me, as demonstrated by respiratory rate and dynamic compliance. These new findings reveal that CDDO-Me exhibits potent anti-fibrotic and anti-inflammatory properties in vivo. CDDO-Me is a potential new class of drugs to arrest inflammation and ameliorate fibrosis in patients who are predisposed to lung injury and fibrosis incited by cancer treatments (e.g. chemotherapy and radiation) and by systemic autoimmune diseases.	[Kulkarni, Ajit A.; Thatcher, Thomas H.; Olsen, Keith C.; Kottmann, Robert Matthew; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14627 USA; [Kulkarni, Ajit A.; Thatcher, Thomas H.; Olsen, Keith C.; Kottmann, Robert Matthew; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Lung Biol & Dis Program, Rochester, NY USA; [Hsiao, Hsi-Min] Univ Rochester, Dept Pathol, Rochester, NY 14627 USA; [Olsen, Keith C.; Wright, Terry W.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA; [Morrissette, Jason] Univ Rochester, Dept Biostatist & Computat Biol, Rochester, NY USA; [Wright, Terry W.; Phipps, Richard P.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Dept Environm Med, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Sime, PJ (corresponding author), Univ Rochester, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14627 USA.	Patricia_Sime@urmc.rochester.edu		Thatcher, Thomas/0000-0001-7177-3041; Hsiao, Hsi-Min Jim/0000-0003-1918-7381	University of Rochester Department of Medicine [KL2RR024136]; Empire Clinical Research Investigator Award; Greg Chandler and Guy F. Solimano Pulmonary Fibrosis Research Fund; Connor Fund; Pulmonary Fibrosis Foundation; National Center for Advancing Translational Sciences of the National Institutes of Health [8UL1TR000042-07];  [R01HL075432];  [T32HL066988];  [T32ES007026];  [R01EY017123];  [R01HL083761]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024136] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083761, R01HL075432, R01HL113495, T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026] Funding Source: NIH RePORTER	University of Rochester Department of Medicine; Empire Clinical Research Investigator Award; Greg Chandler and Guy F. Solimano Pulmonary Fibrosis Research Fund; Connor Fund; Pulmonary Fibrosis Foundation; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01HL075432, T32HL066988, T32ES007026, R01EY017123, R01HL083761, a Buswell Medicine Fellowship from the University of Rochester Department of Medicine, KL2RR024136, an Empire Clinical Research Investigator Award, the Greg Chandler and Guy F. Solimano Pulmonary Fibrosis Research Fund, the Connor Fund, and the Pulmonary Fibrosis Foundation. The project described in this publication was supported in part by Clinical Science and Translational Award number 8UL1TR000042-07 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auletta JJ, 2010, J INTERF CYTOK RES, V30, P497, DOI 10.1089/jir.2009.0100; Bhagwat SP, 2010, J IMMUNOL, V184, P497, DOI 10.4049/jimmunol.0901864; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Camus P, 2004, RESPIRATION, V71, P301, DOI 10.1159/000079633; CATANE R, 1979, INT J RADIAT ONCOL, V5, P1513, DOI 10.1016/0360-3016(79)90761-2; Deeb Dorrah, 2008, J Exp Ther Oncol, V7, P31; Dimopoulou I, 2006, ANN ONCOL, V17, P372, DOI 10.1093/annonc/mdj057; Ding Q, 2011, DRUGS, V71, P981, DOI 10.2165/11591490-000000000-00000; Ferguson HE, 2009, AM J RESP CELL MOL, V41, P722, DOI 10.1165/rcmb.2009-0006OC; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Heathcote Karen L, 2011, Can Respir J, V18, pe73; Hogan CM, 2011, PPAR RES, V2011, DOI 10.1155/2011/318134; Honda T, 2010, BIOORG MED CHEM LETT, V20, P2275, DOI 10.1016/j.bmcl.2010.02.007; JULESELYSEE K, 1990, CLIN CHEST MED, V11, P1; Kawashima M, 2002, LUNG, V180, P73, DOI 10.1007/PL00021246; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Kottmann RM, 2009, RESPIROLOGY, V14, P917, DOI 10.1111/j.1440-1843.2009.01624.x; KREISMAN H, 1992, SEMIN ONCOL, V19, P508; KULKARNI A, 2012, PPAR RES, V2012, P1; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Limper AH, 2004, CLIN CHEST MED, V25, P53, DOI 10.1016/S0272-5231(03)00123-0; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Nathan SD, 2007, AM J RESP CRIT CARE, V175, P875, DOI 10.1164/rccm.200608-1153CC; Nathan SD, 2011, CHEST, V140, P221, DOI 10.1378/chest.10-2572; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; PHAN SH, 1992, EXP LUNG RES, V18, P29, DOI 10.3109/01902149209020649; Place AE, 2003, CLIN CANCER RES, V9, P2798; Reddy NM, 2009, AM J RESP CRIT CARE, V180, P867, DOI 10.1164/rccm.200905-0670OC; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sogno I, 2009, RECENT RESULTS CANC, V181, P209; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Suh NJ, 1999, CANCER RES, V59, P336; Thatcher TH, 2008, AM J PHYSIOL-LUNG C, V295, pL412, DOI 10.1152/ajplung.00392.2007; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Wright TW, 1999, J CLIN INVEST, V104, P1307, DOI 10.1172/JCI6688; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	47	42	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e63798	10.1371/journal.pone.0063798	http://dx.doi.org/10.1371/journal.pone.0063798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741300	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900012
J	Miles-Chan, JL; Sarafian, D; Montani, JP; Schutz, Y; Dulloo, A				Miles-Chan, Jennifer L.; Sarafian, Delphine; Montani, Jean-Pierre; Schutz, Yves; Dulloo, Abdul			Heterogeneity in the Energy Cost of Posture Maintenance during Standing Relative to Sitting: Phenotyping According to Magnitude and Time-Course	PLOS ONE			English	Article							RESTING METABOLIC-RATE; STANDARD ACTIVITIES; EXPENDITURE; ADULTS; FOOD	Background: Reducing sitting-time may decrease risk of disease and increase life-span. In the search for approaches to reduce sitting-time, research often compares sitting to standing and ambulation, but the energetic cost of standing alone versus sitting is equivocal, with large variation in reported mean values (0% to >20% increase in energy expenditure (EE) during standing). Objective: To determine the magnitude and time-course of changes in EE and respiratory quotient (RQ) during steady-state standing versus sitting. Design: Min-by-min monitoring using a posture-adapted ventilated-hood indirect calorimetry system was conducted in 22 young adults with normal BMI during 10 min of steady-state standing versus sitting comfortably. Results: This study reveals three distinct phenotypes based on the magnitude and time-course of the EE response to steady-state standing. One-third of participants (8/22) showed little or no change in EE during standing relative to sitting (Delta EE <5%; below first quartile). Of the 14 responders (Delta EE 7-21%), 4 showed sustained, elevated EE during standing, while 10 decreased their EE to baseline sitting values during the second half of the standing period. These EE phenotypes were systematically mirrored by alterations in RQ (a proxy of substrate oxidation), with DEE inversely correlated with Delta RQ (r = 0.6-0.8, p<0.01). Conclusion: This study reveals different phenotypes pertaining to both energy cost and fuel utilization during standing, raising questions regarding standing as a strategy to increase EE and thermogenesis for weight control, and opening new avenues of research towards understanding the metabolic and psychomotor basis of variability in the energetics of standing and posture maintenance.	[Miles-Chan, Jennifer L.; Sarafian, Delphine; Montani, Jean-Pierre; Schutz, Yves; Dulloo, Abdul] Univ Fribourg, Dept Med Physiol, CH-1700 Fribourg, Switzerland	University of Fribourg	Dulloo, A (corresponding author), Univ Fribourg, Dept Med Physiol, CH-1700 Fribourg, Switzerland.	abdul.dulloo@unifr.ch	Miles-Chan, Jennifer/Q-2464-2019	Miles-Chan, Jennifer/0000-0003-0313-7048; DULLOO, Abdul/0000-0003-3877-6149				Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; EDHOLM OG, 1955, BRIT J NUTR, V9, P286, DOI 10.1079/BJN19550040; GEISSLER CA, 1985, ANN NUTR METAB, V29, P40, DOI 10.1159/000176952; Kanade AN, 2001, EUR J CLIN NUTR, V55, P708, DOI 10.1038/sj.ejcn.1601211; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Katzmarzyk PT, 1996, AM J PHYS ANTHROPOL, V99, P537, DOI 10.1002/ajpa.1330990402; LAWRENCE M, 1985, AM J CLIN NUTR, V42, P753, DOI 10.1093/ajcn/42.5.753; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 2000, AM J CLIN NUTR, V72, P1451; Oppert JM, 2012, NESTLE NUTR WORKS SE, V73, P113, DOI 10.1159/000341306; PASSMORE R, 1952, BRIT J NUTR, V6, P253, DOI 10.1079/BJN19520028; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Roffey DM, 2006, JPEN-PARENTER ENTER, V30, P426, DOI 10.1177/0148607106030005426; STRICKLAND SS, 1990, ANN HUM BIOL, V17, P133, DOI 10.1080/03014469000000882; Veerman JL, 2012, BRIT J SPORT MED, V46, P927, DOI [10.1136/bjsports-2011-085662, 10.1136/bjsm.2011.085662]	15	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65827	10.1371/journal.pone.0065827	http://dx.doi.org/10.1371/journal.pone.0065827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741514	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900227
J	Mukherjee, A; Walker, J; Weyant, KB; Schroeder, CM				Mukherjee, Arnab; Walker, Joshua; Weyant, Kevin B.; Schroeder, Charles M.			Characterization of Flavin-Based Fluorescent Proteins: An Emerging Class of Fluorescent Reporters	PLOS ONE			English	Article							BACILLUS-SUBTILIS; REGULATION NETWORK; ESCHERICHIA-COLI; BLUE; OXYGEN; DOMAIN; GFP; EXPRESSION; CELLS; NONBIOLUMINESCENT	Fluorescent reporter proteins based on flavin-binding photosensors were recently developed as a new class of genetically encoded probes characterized by small size and oxygen-independent maturation of fluorescence. Flavin-based fluorescent proteins (FbFPs) address two major limitations associated with existing fluorescent reporters derived from the green fluorescent protein (GFP)-namely, the overall large size and oxygen-dependent maturation of fluorescence of GFP. However, FbFPs are at a nascent stage of development and have been utilized in only a handful of biological studies. Importantly, a full understanding of the performance and properties of FbFPs as a practical set of biological probes is lacking. In this work, we extensively characterize three FbFPs isolated from Pseudomonas putida, Bacillus subtilis, and Arabidopsis thaliana, using in vitro studies to assess probe brightness, oligomeric state, maturation time, fraction of fluorescent holoprotein, pH tolerance, redox sensitivity, and thermal stability. Furthermore, we validate FbFPs as stable molecular tags using in vivo studies by constructing a series of FbFP-based transcriptional constructs to probe promoter activity in Escherichia coli. Overall, FbFPs show key advantages as broad-spectrum biological reporters including robust pH tolerance (4-11), thermal stability (up to 60 degrees C), and rapid maturation of fluorescence (<3 min.). In addition, the FbFP derived from Arabidopsis thaliana (iLOV) emerged as a stable and nonperturbative reporter of promoter activity in Escherichia coli. Our results demonstrate that FbFP-based reporters have the potential to address key limitations associated with the use of GFP, such as pH-sensitive fluorescence and slow kinetics of fluorescence maturation (10-40 minutes for half maximal fluorescence recovery). From this view, FbFPs represent a useful new addition to the fluorescent reporter protein palette, and our results constitute an important framework to enable researchers to implement and further engineer improved FbFP-based reporters with enhanced brightness and tighter flavin binding, which will maximize their potential benefits.	[Mukherjee, Arnab; Walker, Joshua; Weyant, Kevin B.; Schroeder, Charles M.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA; [Schroeder, Charles M.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Schroeder, Charles M.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL USA; [Schroeder, Charles M.] Univ Illinois, Dept Chem, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Schroeder, CM (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA.	cms@illinois.edu		Weyant, Kevin/0000-0002-6185-8743; Walker, Joshua/0000-0003-0787-0298; Mukherjee, Arnab/0000-0003-3571-8015	David and Lucile Packard Foundation; National Institutes of Health [4R00HG004183-03]; FMC Technologies, Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG004183] Funding Source: NIH RePORTER	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FMC Technologies, Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a Packard Fellowship from the David and Lucile Packard Foundation and an National Institutes of Health Pathway to Independence Award (4R00HG004183-03) to CMS. AM was supported by a fellowship from FMC Technologies, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Augustyniak W, 2012, PROTEIN SCI, V21, P487, DOI 10.1002/pro.2031; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Avila-Perez M, 2009, J BIOL CHEM, V284, P24958, DOI 10.1074/jbc.M109.033316; Bizzarri R, 2009, ANAL BIOANAL CHEM, V393, P1107, DOI 10.1007/s00216-008-2515-9; BUJARD H, 1987, METHOD ENZYMOL, V155, P416; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chapman KS, 1999, METHODS MOL BIOL FLA; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Chattopadhaya S, 2009, BIOORGAN MED CHEM, V17, P981, DOI 10.1016/j.bmc.2008.01.043; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Choi CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018499; Christie JM, 2012, J BIOL CHEM, V287, P22295, DOI 10.1074/jbc.M111.318881; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Coralli C, 2001, CANCER RES, V61, P4784; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; de Jong H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-55; DELAGRAVE S, 1995, BIO-TECHNOL, V13, P151, DOI 10.1038/nbt0295-151; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Herrou J, 2011, NAT REV MICROBIOL, V9, P713, DOI 10.1038/nrmicro2622; Holzer W, 2002, PHOTOCHEM PHOTOBIOL, V75, P479, DOI 10.1562/0031-8655(2002)075<0479:SCOFMB>2.0.CO;2; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; KHOSLA C, 1990, BIO-TECHNOL, V8, P554, DOI 10.1038/nbt0690-554; Lobo LA, 2011, FEMS MICROBIOL LETT, V317, P67, DOI 10.1111/j.1574-6968.2011.02212.x; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Mukherjee A, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-20; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nevoigt E, 2007, BIOTECHNOL BIOENG, V96, P550, DOI 10.1002/bit.21129; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Piekarski T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-265; Potzkei J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-28; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Regoes A, 2005, BIOTECHNIQUES, V39, P809, DOI 10.2144/000112054; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuttrigkeit TA, 2003, CHEM PHYS, V294, P501, DOI 10.1016/S0301-0104(03)00390-2; Scott KP, 1998, FEMS MICROBIOL ECOL, V26, P219, DOI 10.1111/j.1574-6941.1998.tb00507.x; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Siepert EM, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-65; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Tielker D, 2009, EUKARYOT CELL, V8, P913, DOI 10.1128/EC.00394-08; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vordermark D, 2001, NEOPLASIA, V3, P527, DOI 10.1038/sj.neo.7900192; Walter J, 2012, PLOS ONE, V7; Wiedenmann J, 2004, MAR BIOTECHNOL, V6, P270, DOI 10.1007/s10126-004-3006-4; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	63	78	79	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64753	10.1371/journal.pone.0064753	http://dx.doi.org/10.1371/journal.pone.0064753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741385	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900098
J	Neirinckx, V; Marquet, A; Coste, C; Rogister, B; Wislet-Gendebien, S				Neirinckx, Virginie; Marquet, Alice; Coste, Cecile; Rogister, Bernard; Wislet-Gendebien, Sabine			Adult Bone Marrow Neural Crest Stem Cells and Mesenchymal Stem Cells Are Not Able to Replace Lost Neurons in Acute MPTP-Lesioned Mice	PLOS ONE			English	Article							1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL; INDUCIBLE MIAMI CELLS; STROMAL CELLS; DOPAMINERGIC-NEURONS; INFLAMMATORY CYTOKINES; PROGENITOR CELLS; TIME-COURSE; TRANSPLANTATION; DIFFERENTIATION; EXPRESSION	Adult bone marrow stroma contains multipotent stem cells (BMSC) that are a mixed population of mesenchymal and neural-crest derived stem cells. Both cells are endowed with in vitro multi-lineage differentiation abilities, then constituting an attractive and easy-available source of material for cell therapy in neurological disorders. Whereas the in vivo integration and differentiation of BMSC in neurons into the central nervous system is currently matter of debate, we report here that once injected into the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice, pure populations of either bone marrow neural crest stem cells (NCSC) or mesenchymal stem cells (MSC) survived only transiently into the lesioned brain. Moreover, they do not migrate through the brain tissue, neither modify their initial phenotype, while no recovery of the dopaminergic system integrity was observed. Consequently, we tend to conclude that MSC/NCSC are not able to replace lost neurons in acute MPTP-lesioned dopaminergic system through a suitable integration and/or differentiation process. Altogether with recent data, it appears that neuroprotective, neurotrophic and anti-inflammatory features characterizing BMSC are of greater interest as regards CNS lesions management.	[Neirinckx, Virginie; Marquet, Alice; Coste, Cecile; Rogister, Bernard; Wislet-Gendebien, Sabine] Univ Liege, Unit Neurosci, Grp Interdisciplinaire Genoprote Appl, Liege, Belgium; [Rogister, Bernard] Univ Liege, Unit Dev Stem Cells & Regenerat Med, GIGA, Liege, Belgium; [Rogister, Bernard] Ctr Hosp Univ Liege, Dept Neurol, Liege, Belgium	University of Liege; University of Liege; University of Liege	Wislet-Gendebien, S (corresponding author), Univ Liege, Unit Neurosci, Grp Interdisciplinaire Genoprote Appl, Liege, Belgium.	s.wislet@ulg.ac.be	Rogister, Bernard/AAJ-9591-2020	wislet, sabine/0000-0003-4279-9669	Fonds National de la Recherche Scientifique (FNRS) of Belgium; Belgian League against Multiple Sclerosis associated with the Leon Fredericq Foundation; Fonds Speciaux a la Recherche of the University of Liege	Fonds National de la Recherche Scientifique (FNRS) of Belgium(Fonds de la Recherche Scientifique - FNRS); Belgian League against Multiple Sclerosis associated with the Leon Fredericq Foundation; Fonds Speciaux a la Recherche of the University of Liege	This work was supported by a grant from the Fonds National de la Recherche Scientifique (FNRS) of Belgium, by the Belgian League against Multiple Sclerosis associated with the Leon Fredericq Foundation and by the Fonds Speciaux a la Recherche of the University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2011, NEUROREHAB NEURAL RE, V25, P873, DOI 10.1177/1545968311416823; Blandini F, 2010, CELL TRANSPLANT, V19, P203, DOI 10.3727/096368909X479839; Chao YX, 2009, J NEUROIMMUNOL, V216, P39, DOI 10.1016/j.jneuroim.2009.09.003; Ciesielska A, 2003, ACTA NEUROBIOL EXP, V63, P117; Cova L, 2010, BRAIN RES, V1311, P12, DOI 10.1016/j.brainres.2009.11.041; Curtis KM, 2012, MOL CELL NEUROSCI, V49, P138, DOI 10.1016/j.mcn.2011.10.008; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; D'Ippolito G, 2006, EXP HEMATOL, V34, P1608, DOI 10.1016/j.exphem.2006.07.016; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Foudah D, 2011, ITALIAN J ANTOMY EMB, V16; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Gibrat C, 2009, J NEUROCHEM, V109, P1469, DOI 10.1111/j.1471-4159.2009.06072.x; Glejzer A, 2011, CELL MOL LIFE SCI, V68, P2101, DOI 10.1007/s00018-010-0558-5; HALL PA, 1989, DEVELOPMENT, V106, P619; Hebert G, 2003, NEUROSCI LETT, V349, P191, DOI 10.1016/S0304-3940(03)00832-2; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Khoo MLM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019025; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Levy YS, 2008, CYTOTHERAPY, V10, P340, DOI 10.1080/14653240802021330; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Liu J, 2012, INT J ARTIF ORGANS, V35, P323, DOI 10.5301/ijao.5000085; Lofrumento DD, 2011, NEUROIMMUNOMODULAT, V18, P79, DOI 10.1159/000320027; Malgrange B, 2011, CELL MOL LIFE SCI, V68, P635, DOI 10.1007/s00018-010-0557-6; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Neirinckx V, 2013, STEM CELL TRANSL MED, V2, P284, DOI 10.5966/sctm.2012-0147; Offen D, 2007, J NEURAL TRANSM-SUPP, P133; Park HW, 2012, CELL TRANSPLANT, V7; Park HJ, 2011, CELL TRANSPLANT, V20, P827, DOI 10.3727/096368910X540630; Patani R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1216; Phani S, 2010, BRAIN RES, V1343, P1, DOI 10.1016/j.brainres.2010.04.061; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Przedborski S, 2000, RESTOR NEUROL NEUROS, V16, P135; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tatard VM, 2007, BONE, V40, P360, DOI 10.1016/j.bone.2006.09.013; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Venkataramana NK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/931902; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; Verfaillie Catherine M., 2005, V265, P55; Verfaillie CM, 2005, NOVART FDN SYMP, V265, P92; Verfaillie CM, 2005, NOVART FDN SYMP, V265, P61; Wang JS, 2010, STEM CELLS DEV, V19, P1375, DOI 10.1089/scd.2009.0258; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Wislet-Gendebien S, 2012, CELL MOL LIFE SCI, V69, P2593, DOI 10.1007/s00018-012-0937-1; Wislet-Gendebien S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601560; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64723	10.1371/journal.pone.0064723	http://dx.doi.org/10.1371/journal.pone.0064723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741377	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900090
J	Tang, CD; Li, JF; Wei, XH; Min, R; Gao, SJ; Wang, JQ; Yin, X; Wu, MC				Tang, Cun-Duo; Li, Jian-Fang; Wei, Xi-Huan; Min, Rou; Gao, Shu-Juan; Wang, Jun-Qing; Yin, Xin; Wu, Min-Chen			Fusing a Carbohydrate-Binding Module into the Aspergillus usamii beta-Mannanase to Improve Its Thermostability and Cellulose-Binding Capacity by In Silico Design	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; PICHIA-PASTORIS; TRICHODERMA-REESEI; ENERGY ANALYSIS; CLONING; GENE; PROTEINS; STRAIN; DOMAIN	The AuMan5A, an acidophilic glycoside hydrolase (GH) family 5 beta-mannanase derived from Aspergillus usamii YL-01-78, consists of an only catalytic domain (CD). To perfect enzymatic properties of the AuMan5A, a family 1 carbohydrate-binding module (CBM) of the Trichoderma reesei cellobiohydrolase I (TrCBH I), having the lowest binding free energy with cellobiose, was selected by in silico design, and fused into its C-terminus forming a fusion beta-mannanase, designated as AuMan5A-CBM. Then, its encoding gene, Auman5A-cbm, was constructed as it was designed theoretically, and expressed in Pichia pastoris GS115. SDS-PAGE analysis displayed that both recombinant AuMan5A-CBM (reAuMan5A-CBM) and AuMan5A (reAuMan5A) were secreted into the cultured media with apparent molecular masses of 57.3 and 49.8 kDa, respectively. The temperature optimum of the reAuMan5A-CBM was 75 degrees C, being 5 degrees C higher than that of the reAuMan5A. They were stable at temperatures of 68 and 60 degrees C, respectively. Compared with reAuMan5A, the reAuMan5A-CBM showed an obvious decrease in K-m and a slight alteration in V-max. In addition, the fusion of a CBM of the TrCBH I into the AuMan5A contributed to its cellulose-binding capacity.	[Tang, Cun-Duo; Wang, Jun-Qing; Yin, Xin] Jiangnan Univ, Minist Educ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Tang, Cun-Duo; Wang, Jun-Qing; Yin, Xin] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Li, Jian-Fang; Wei, Xi-Huan] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Min, Rou; Gao, Shu-Juan] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi, Jiangsu, Peoples R China; [Wu, Min-Chen] Jiangnan Univ, Wuxi Med Sch, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan University	Wu, MC (corresponding author), Jiangnan Univ, Wuxi Med Sch, Wuxi, Jiangsu, Peoples R China.	biowmc@126.com			National Nature Science Foundation of China [31271811]; Jiangnan University, China [JUDCF11011]; Postgraduate Innovation Training Project of Jiangsu, China [CXZZ11_0480]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangnan University, China; Postgraduate Innovation Training Project of Jiangsu, China	This work was supported by National Nature Science Foundation of China (grant No. 31271811) (http://www.nsfc.gov.cn/); Doctoral Research Funds of Jiangnan University, China (grant No. JUDCF11011) (http://yjsb.jiangnan.edu.cn/); and Postgraduate Innovation Training Project of Jiangsu, China (grant No. CXZZ11_0480) (http://www.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benech RO, 2007, ENZYME MICROB TECH, V41, P740, DOI 10.1016/j.enzmictec.2007.06.012; Chen XL, 2007, J BIOTECHNOL, V128, P452, DOI 10.1016/j.jbiotec.2006.11.003; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Heck JX, 2005, ENZYME MICROB TECH, V37, P417, DOI 10.1016/j.enzmictec.2005.02.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JF, 2012, J AGR FOOD CHEM, V60, P765, DOI 10.1021/jf2041565; Li JF, 2011, J BIOSCI BIOENG, V111, P537, DOI 10.1016/j.jbiosc.2011.01.002; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; ORTIZ AR, 1995, J MED CHEM, V38, P2681, DOI 10.1021/jm00014a020; Perez C, 1998, J MED CHEM, V41, P836, DOI 10.1021/jm970535b; Phosrithong N, 2010, MED CHEM RES, V19, P817, DOI 10.1007/s00044-009-9233-5; Ravalason H, 2009, J BIOTECHNOL, V142, P220, DOI 10.1016/j.jbiotec.2009.04.013; Roth R, 2009, MOL BIOTECHNOL, V43, P112, DOI 10.1007/s12033-009-9187-3; Timmers LFSM, 2012, J MOL MODEL, V18, P467, DOI 10.1007/s00894-011-1045-0; Shi HL, 2012, J IND MICROBIOL BIOT, V39, P347, DOI 10.1007/s10295-011-1039-z; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; STALBRAND H, 1995, APPL ENVIRON MICROB, V61, P1090; Tan ZB, 2011, WORLD J MICROB BIOT, V27, P2767, DOI 10.1007/s11274-011-0752-0; Tang CD, 2011, WORLD J MICROB BIOT, V27, P2921, DOI 10.1007/s11274-011-0775-6; Thongekkaew J, 2012, BIOCHEM BIOPH RES CO, V420, P183, DOI 10.1016/j.bbrc.2012.02.139; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; Wu MC, 2011, CARBOHYD RES, V346, P2149, DOI 10.1016/j.carres.2011.06.035; Ye XH, 2011, APPL MICROBIOL BIOT, V92, P551, DOI 10.1007/s00253-011-3346-8; Zhang Y, 2010, APPL ENVIRON MICROB, V76, P6870, DOI 10.1128/AEM.00896-10; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200	26	8	19	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64766	10.1371/journal.pone.0064766	http://dx.doi.org/10.1371/journal.pone.0064766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741390	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900103
J	Ziebert, F; Aranson, IS				Ziebert, Falko; Aranson, Igor S.			Effects of Adhesion Dynamics and Substrate Compliance on the Shape and Motility of Crawling Cells	PLOS ONE			English	Article							LAMELLIPODIAL CONTRACTIONS; ACTIN CYTOSKELETON; CELLULAR MOTILITY; SELF-POLARIZATION; MODEL; LOCOMOTION; FORCE; ORGANIZATION; DIFFUSION; MIGRATION	Computational modeling of eukaryotic cells moving on substrates is an extraordinarily complex task: many physical processes, such as actin polymerization, action of motors, formation of adhesive contacts concomitant with both substrate deformation and recruitment of actin etc., as well as regulatory pathways are intertwined. Moreover, highly nontrivial cell responses emerge when the substrate becomes deformable and/or heterogeneous. Here we extended a computational model for motile cell fragments, based on an earlier developed phase field approach, to account for explicit dynamics of adhesion site formation, as well as for substrate compliance via an effective elastic spring. Our model displays steady motion vs. stick-slip transitions with concomitant shape oscillations as a function of the actin protrusion rate, the substrate stiffness, and the rates of adhesion. Implementing a step in the substrate's elastic modulus, as well as periodic patterned surfaces exemplified by alternating stripes of high and low adhesiveness, we were able to reproduce the correct motility modes and shape phenomenology found experimentally. We also predict the following nontrivial behavior: the direction of motion of cells can switch from parallel to perpendicular to the stripes as a function of both the adhesion strength and the width ratio of adhesive to non-adhesive stripes.	[Ziebert, Falko] Univ Freiburg, Inst Phys, D-79106 Freiburg, Germany; [Ziebert, Falko] Inst Charles Sadron, F-67083 Strasbourg, France; [Aranson, Igor S.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Aranson, Igor S.] Northwestern Univ, Evanston, IL USA	University of Freiburg; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University	Aranson, IS (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	aronson@anl.gov	Aranson, Igor/I-4060-2013		U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering, [DE-AC02-06CH11357]; DFG [IRTG 1642]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering,(United States Department of Energy (DOE)); DFG(German Research Foundation (DFG))	Supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering, under Contract DE-AC02-06CH11357 (ISA) and by the DFG via IRTG 1642 Soft Matter Science (FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017; Aranson IS, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125402; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Barnhart EL, 2010, BIOPHYS J, V98, P933, DOI 10.1016/j.bpj.2009.10.058; Bayly PV, 2012, J R SOC INTERFACE, V9, P1241, DOI 10.1098/rsif.2011.0627; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; BRUINSMA R, 1994, BIOPHYS J, V67, P746, DOI 10.1016/S0006-3495(94)80535-1; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carlsson AE, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073009; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Csucs G, 2007, CELL MOTIL CYTOSKEL, V64, P856, DOI 10.1002/cm.20230; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Doubrovinski K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.258103; Du XX, 2012, BIOPHYS J, V102, P1738, DOI 10.1016/j.bpj.2012.03.052; Erdmann T, 2004, J CHEM PHYS, V121, P8997, DOI 10.1063/1.1805496; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; JACOBSON K, 1987, ANNU REV PHYSIOL, V49, P163, DOI 10.1146/annurev.ph.49.030187.001115; KRISCHER K, 1994, PHYS REV LETT, V73, P3165, DOI 10.1103/PhysRevLett.73.3165; Kruse K, 2006, PHYS BIOL, V3, P130, DOI 10.1088/1478-3975/3/2/005; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; Kuusela E, 2009, J MATH BIOL, V58, P135, DOI 10.1007/s00285-008-0179-x; Ladoux B, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/11/116601; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Loosley AJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031908; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Persson BNJ, 2000, SLIDING FRICTION; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Rolli CG, 2012, BIOMATERIALS, V33, P2409, DOI 10.1016/j.biomaterials.2011.12.012; Sabass B, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194112; Sackmann E, 2002, CHEMPHYSCHEM, V3, P262, DOI 10.1002/1439-7641(20020315)3:3<262::AID-CPHC262>3.0.CO;2-U; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Shao DY, 2012, P NATL ACAD SCI USA, V109, P6851, DOI 10.1073/pnas.1203252109; Shao DY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.108104; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Shemesh T, 2012, BIOPHYS J, V102, P1746, DOI 10.1016/j.bpj.2012.03.006; Smith AS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061902; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Volfson D, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031302; Wolgemuth CW, 2005, BIOPHYS J, V89, P1643, DOI 10.1529/biophysj.105.066720; Ziebert F, 2012, J R SOC INTERFACE, V9, P1084, DOI 10.1098/rsif.2011.0433; Ziebert F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/421	49	71	71	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64511	10.1371/journal.pone.0064511	http://dx.doi.org/10.1371/journal.pone.0064511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741334	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900047
J	Willmann, CA; Hemeda, H; Pieper, LA; Lenz, M; Qin, J; Joussen, S; Sontag, S; Wanek, P; Denecke, B; Schuler, HM; Zenke, M; Wagner, W				Willmann, Charlotte A.; Hemeda, Hatim; Pieper, Lisa A.; Lenz, Michael; Qin, Jie; Joussen, Sylvia; Sontag, Stephanie; Wanek, Paul; Denecke, Bernd; Schueler, Herdit M.; Zenke, Martin; Wagner, Wolfgang			To Clone or Not to Clone? Induced Pluripotent Stem Cells Can Be Generated in Bulk Culture	PLOS ONE			English	Article							DNA-METHYLATION; FIBROBLASTS; INDUCTION; DIFFERENTIATION; SENESCENCE; MUTATIONS; EXPANSION; SELECTION; ESCAPE; SYSTEM	Induced pluripotent stem cells (iPSCs) are usually clonally derived. The selection of fully reprogrammed cells generally involves picking of individual colonies with morphology similar to embryonic stem cells (ESCs). Given that fully reprogrammed cells are highly proliferative and escape from cellular senescence, it is conceivable that they outgrow non-pluripotent and partially reprogrammed cells during culture expansion without the need of clonal selection. In this study, we have reprogrammed human dermal fibroblasts (HDFs) with episomal plasmid vectors. Colony frequency was higher and size was larger when using murine embryonic fibroblasts (MEFs) as stromal support instead of HDFs or human mesenchymal stromal cells (MSCs). We have then compared iPSCs which were either clonally derived by manual selection of a single colony, or derived from bulk-cultures of all initial colonies. After few passages their morphology, expression of pluripotency markers, and gene expression profiles did not reveal any significant differences. Furthermore, clonally-derived and bulk-cultured iPSCs revealed similar in vitro differentiation potential towards the three germ layers. Therefore, manual selection of individual colonies does not appear to be necessary for the generation of iPSCs - this is of relevance for standardization and automation of cell culture procedures.	[Willmann, Charlotte A.; Hemeda, Hatim; Pieper, Lisa A.; Joussen, Sylvia; Zenke, Martin; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Technol Stem Cell Biol & Ce, Aachen, Germany; [Lenz, Michael] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci AICES, Aachen, Germany; [Qin, Jie; Sontag, Stephanie; Wanek, Paul; Zenke, Martin] Rhein Westfal TH Aachen, Sch Med, Inst Biomed Engn Cell Biol, D-52062 Aachen, Germany; [Denecke, Bernd] Rhein Westfal TH Aachen, Sch Med, Interdisciplinary Ctr Clin Res, D-52062 Aachen, Germany; [Schueler, Herdit M.] Rhein Westfal TH Aachen, Sch Med, Inst Human Genet, D-52062 Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Wagner, W (corresponding author), Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Technol Stem Cell Biol & Ce, Aachen, Germany.	wwagner@ukaachen.de	Lenz, Michael/J-4401-2016	Lenz, Michael/0000-0002-6319-6480; Wagner, Wolfgang/0000-0002-1971-3217	StemCellFactory Project; Ziel2.NRW; Stem Cell Network NRW	StemCellFactory Project; Ziel2.NRW; Stem Cell Network NRW	This work was supported by the StemCellFactory Project funded by Ziel2.NRW (www.stemcellfactory.de), and by the Stem Cell Network NRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen HF, 2011, STEM CELL REV REP, V7, P722, DOI 10.1007/s12015-011-9233-y; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Chung HCY, 2012, STEM CELLS DEV, V21, P206, DOI 10.1089/scd.2010.0440; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Haupt S, 2009, NAT METHODS, V6, DOI 10.1038; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Koch CM, 2013, GENOME RES, V23, P248, DOI 10.1101/gr.141945.112; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Lohmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037839; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohnuki M., 2009, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC04A02S9]; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Okita K, 2010, EXP CELL RES, V316, P2565, DOI 10.1016/j.yexcr.2010.04.023; Pera MF, 2000, J CELL SCI, V113, P5; Pfannkuche K, 2010, PLOS ONE, V5, pA140, DOI 10.1371/journal.pone.0009580; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003788; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao KF, 2013, MOL THER, V21, P240, DOI 10.1038/mt.2012.207; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Veraitch FS, 2008, BIOTECHNOL BIOENG, V99, P1216, DOI 10.1002/bit.21673; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner W, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt145; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x	51	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65324	10.1371/journal.pone.0065324	http://dx.doi.org/10.1371/journal.pone.0065324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734247	gold, Green Submitted, Green Published			2022-12-27	WOS:000319725500019
J	Maso, G; Alberico, S; Monasta, L; Ronfani, L; Montico, M; Businelli, C; Soini, V; Piccoli, M; Gigli, C; Domini, D; Fiscella, C; Casarsa, S; Zompicchiatti, C; De Agostinis, M; D'Atri, A; Mugittu, R; La Valle, S; Di Leonardo, C; Adamo, V; Smiroldo, S; Del Frate, G; Olivuzzi, M; Giove, S; Parente, M; Bassini, D; Melazzini, S; Guaschino, S; De Seta, F; Demarini, S; Travan, L; Marchesoni, D; Rossi, A; Simon, G; Zicari, S; Tamburlini, G				Maso, Gianpaolo; Alberico, Salvatore; Monasta, Lorenzo; Ronfani, Luca; Montico, Marcella; Businelli, Caterina; Soini, Valentina; Piccoli, Monica; Gigli, Carmine; Domini, Daniele; Fiscella, Claudio; Casarsa, Sara; Zompicchiatti, Carlo; De Agostinis, Michela; D'Atri, Attilio; Mugittu, Raffaela; La Valle, Santo; Di Leonardo, Cristina; Adamo, Valter; Smiroldo, Silvia; Del Frate, Giovanni; Olivuzzi, Monica; Giove, Silvio; Parente, Maria; Bassini, Daniele; Melazzini, Simona; Guaschino, Secondo; De Seta, Francesco; Demarini, Sergio; Travan, Laura; Marchesoni, Diego; Rossi, Alberto; Simon, Giorgio; Zicari, Sandro; Tamburlini, Giorgio			The Application of the Ten Group Classification System (TGCS) in Caesarean Delivery Case Mix Adjustment. A Multicenter Prospective Study	PLOS ONE			English	Article							LOW-RISK PREGNANCIES; SECTION RATE; RATES	Background: Caesarean delivery (CD) rates are commonly used as an indicator of quality in obstetric care and risk adjustment evaluation is recommended to assess inter-institutional variations. The aim of this study was to evaluate whether the Ten Group classification system (TGCS) can be used in case-mix adjustment. Methods: Standardized data on 15,255 deliveries from 11 different regional centers were prospectively collected. Crude Risk Ratios of CDs were calculated for each center. Two multiple logistic regression models were herein considered by using: Model 1-maternal (age, Body Mass Index), obstetric variables (gestational age, fetal presentation, single or multiple, previous scar, parity, neonatal birth weight) and presence of risk factors; Model 2-TGCS either with or without maternal characteristics and presence of risk factors. Receiver Operating Characteristic (ROC) curves of the multivariate logistic regression analyses were used to assess the diagnostic accuracy of each model. The null hypothesis that Areas under ROC Curve (AUC) were not different from each other was verified with a Chi Square test and post hoc pairwise comparisons by using a Bonferroni correction. Results: Crude evaluation of CD rates showed all centers had significantly higher Risk Ratios than the referent. Both multiple logistic regression models reduced these variations. However the two methods ranked institutions differently: model 1 and model 2 (adjusted for TGCS) identified respectively nine and eight centers with significantly higher CD rates than the referent with slightly different AUCs (0.8758 and 0.8929 respectively). In the adjusted model for TGCS and maternal characteristics/presence of risk factors, three centers had CD rates similar to the referent with the best AUC (0.9024). Conclusions: The TGCS might be considered as a reliable variable to adjust CD rates. The addition of maternal characteristics and risk factors to TGCS substantially increase the predictive discrimination of the risk adjusted model.	[Maso, Gianpaolo; Alberico, Salvatore; Businelli, Caterina; Soini, Valentina; Piccoli, Monica; Guaschino, Secondo; De Seta, Francesco] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Obstet & Gynaecol, Trieste, Italy; [Monasta, Lorenzo; Ronfani, Luca; Montico, Marcella] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Epidemiol & Biostat Unit, Trieste, Italy; [Gigli, Carmine; Domini, Daniele] Hosp Gorizia, Dept Obstet & Gynaecol, Gorizia, Italy; [Fiscella, Claudio; Casarsa, Sara] Hosp Latisana, Dept Obstet & Gynaecol, Latisana, Italy; [Zompicchiatti, Carlo; De Agostinis, Michela] Hosp Palmanova, Dept Obstet & Gynaecol, Palmanova, Italy; [D'Atri, Attilio; Mugittu, Raffaela] Hosp Monfalcone, Dept Obstet & Gynaecol, Monfalcone, Italy; [La Valle, Santo; Di Leonardo, Cristina] San Giorgio Private Hosp, Dept Obstet & Gynaecol, Pordenone, Italy; [Adamo, Valter; Smiroldo, Silvia] S Maria Angeli Hosp, Dept Obstet & Gynaecol, Pordenone, Italy; [Del Frate, Giovanni; Olivuzzi, Monica] Hosp San Daniele del Friuli, Dept Obstet & Gynaecol, San Daniele Del Friuli, Italy; [Smiroldo, Silvia; Del Frate, Giovanni] S Maria dei Battuti Hosp, Dept Obstet & Gynaecol, San Vito Al Tagliamento, Italy; [Bassini, Daniele; Melazzini, Simona] S Antonio Abate Hosp, Dept Obstet & Gynaecol, Tolmezzo, Italy; [Demarini, Sergio; Travan, Laura] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Neonatal Intens Care Unit, Trieste, Italy; [Marchesoni, Diego; Rossi, Alberto] Univ Udine, Dept Obstet & Gynaecol, I-33100 Udine, Italy; [Simon, Giorgio] Reg Hlth Agcy, Friuli Venezia Giulia, Italy; [Zicari, Sandro] Univ Roma La Sapienza, Dept Epidemiol & Stat, I-00185 Rome, Italy; [Tamburlini, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Sci Comm, Trieste, Italy; [Gigli, Carmine; Domini, Daniele; Fiscella, Claudio; Casarsa, Sara; Zompicchiatti, Carlo; De Agostinis, Michela; D'Atri, Attilio; Mugittu, Raffaela; La Valle, Santo; Di Leonardo, Cristina; Adamo, Valter; Smiroldo, Silvia; Del Frate, Giovanni; Olivuzzi, Monica; Giove, Silvio; Parente, Maria; Bassini, Daniele; Melazzini, Simona; Guaschino, Secondo; De Seta, Francesco; Demarini, Sergio; Travan, Laura; Marchesoni, Diego; Rossi, Alberto; Simon, Giorgio; Zicari, Sandro; Tamburlini, Giorgio] Multictr Study Grp Mode Delivery Friuli Venezi, Venice, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; University of Udine; Sapienza University Rome; IRCCS Burlo Garofolo	Maso, G (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Obstet & Gynaecol, Trieste, Italy.	maso@burlo.trieste.it	Ronfani, Luca/B-6668-2013; De Seta, Francesco/AAC-1857-2022; Montico, Marcella/B-5290-2013; Travan, Laura/AAC-8957-2022; Monasta, Lorenzo/B-1388-2012	Ronfani, Luca/0000-0001-5710-3914; De Seta, Francesco/0000-0003-1611-0813; Montico, Marcella/0000-0003-0377-8232; Monasta, Lorenzo/0000-0001-7774-548X; Laura, Travan/0000-0001-9861-0832; Maso, Gianpaolo/0000-0003-4954-4968; simon, giorgio/0000-0003-3318-1509	Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste (Italy) [86/05]	Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste (Italy)	This study has been funded by the grant No. 86/05 of Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists Task Force on Caesarean Delivery, 2000, EV CAES DEL; [Anonymous], 1985, LANCET, V2, P436; Aron DC, 1998, JAMA-J AM MED ASSOC, V279, P1968, DOI 10.1001/jama.279.24.1968; Athukorala C, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-56; Bailit J, 2003, OBSTET GYNECOL, V102, P45, DOI 10.1016/S0029-7844(03)00356-9; BAILIT J, 2008, AM J OBSTET GYNECOL, V198; Bailit JL, 2007, J REPROD MED, V52, P194; Bailit JL, 2006, AM J OBSTET GYNECOL, V194, P402, DOI 10.1016/j.ajog.2005.07.045; Bailit JL, 2004, AM J OBSTET GYNECOL, V190, P395, DOI 10.1016/j.ajog.2003.07.024; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Bragg F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5065; Chescheir N, 2009, OBSTET GYNECOL, V114, P217, DOI 10.1097/AOG.0b013e3181ad9533; Colais P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-54; Cyr RM, 2006, AM J OBSTET GYNECOL, V194, P932, DOI 10.1016/j.ajog.2005.10.199; Delbaere I, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-3; Fuglenes D, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.021; Habiba M, 2006, BJOG-INT J OBSTET GY, V113, P647, DOI 10.1111/j.1471-0528.2006.00933.x; Hanley GE, 2010, OBSTET GYNECOL, V115, P1201, DOI 10.1097/AOG.0b013e3181dd918c; Italian Ministry of Health. National Agency for Regional Health Services, 2012, OUTC EV PROGR PNE HO; Johnson JA, 2012, J OBSTET GYNAECOL CA, V34, P80, DOI 10.1016/S1701-2163(16)35138-6; Jonsdottir G, 2009, ACTA OBSTET GYN SCAN, V88, P621, DOI 10.1080/00016340902818196; Kahn EB, 2009, OBSTET GYNECOL, V113, P33, DOI 10.1097/AOG.0b013e318190bb33; National Health Institute's National Guidelines System, 2010, CAES SECT APPR INF C; Porreco RP, 1996, AM J OBSTET GYNECOL, V175, P369, DOI 10.1016/S0002-9378(96)70148-5; Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156; Srinivas SK, 2010, OBSTET GYNECOL, V115, P1007, DOI 10.1097/AOG.0b013e3181d9f4b6; StataCorp, 2021, STATA STAT SOFTWARE; Stivanello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028060; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	30	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e62364	10.1371/journal.pone.0062364	http://dx.doi.org/10.1371/journal.pone.0062364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755097	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400002
J	Huang, XD; Grace, P; Hu, WB; Rowlings, D; Mengersen, K				Huang, Xiaodong; Grace, Peter; Hu, Wenbiao; Rowlings, David; Mengersen, Kerrie			Spatial Prediction of N2O Emissions in Pasture: A Bayesian Model Averaging Analysis	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; SOIL; UNCERTAINTY; VARIABILITY; CH4	Nitrous oxide (N2O) is one of the greenhouse gases that can contribute to global warming. Spatial variability of N2O can lead to large uncertainties in prediction. However, previous studies have often ignored the spatial dependency to quantify the N2O - environmental factors relationships. Few researches have examined the impacts of various spatial correlation structures (e.g. independence, distance-based and neighbourhood based) on spatial prediction of N2O emissions. This study aimed to assess the impact of three spatial correlation structures on spatial predictions and calibrate the spatial prediction using Bayesian model averaging (BMA) based on replicated, irregular point-referenced data. The data were measured in 17 chambers randomly placed across a 271 m(2) field between October 2007 and September 2008 in the southeast of Australia. We used a Bayesian geostatistical model and a Bayesian spatial conditional autoregressive (CAR) model to investigate and accommodate spatial dependency, and to estimate the effects of environmental variables on N2O emissions across the study site. We compared these with a Bayesian regression model with independent errors. The three approaches resulted in different derived maps of spatial prediction of N2O emissions. We found that incorporating spatial dependency in the model not only substantially improved predictions of N2O emission from soil, but also better quantified uncertainties of soil parameters in the study. The hybrid model structure obtained by BMA improved the accuracy of spatial prediction of N2O emissions across this study region.	[Huang, Xiaodong; Mengersen, Kerrie] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Huang, Xiaodong; Grace, Peter; Rowlings, David] Queensland Univ Technol, Inst Sustainable Resources, Brisbane, Qld 4001, Australia; [Hu, Wenbiao] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland	Huang, XD (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	xiaodong.huang@student.qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Mengersen, Kerrie/0000-0001-8625-9168; Grace, Peter/0000-0003-4136-4129; Hu, Wenbiao/0000-0001-6422-9240	Institute of Sustainable Resources (ISR); University of Technology (QUT); Australian Research Council (ARC)	Institute of Sustainable Resources (ISR); University of Technology (QUT); Australian Research Council (ARC)(Australian Research Council)	The authors thank the Institute of Sustainable Resources (ISR), Queensland University of Technology (QUT), and the Australian Research Council (ARC) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Ambus P, 2005, NUTR CYCL AGROECOSYS, V72, P189, DOI 10.1007/s10705-005-1269-4; Anselin L., 2003, GEODA 0 9 US GUID; Banerjee S., 2004, HIERARCHICAL MODELIN; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Best N, 2005, STAT METHODS MED RES, V14, P35, DOI 10.1191/0962280205sm388oa; Boone EL, 2008, J APPL STAT, V35, P967, DOI 10.1080/02664760802185845; Borgonovo E, 2006, RISK ANAL, V26, P1349, DOI 10.1111/j.1539-6924.2006.00806.x; BOUWMAN AF, 1995, J GEOPHYS RES-ATMOS, V100, P2785, DOI 10.1029/94JD02946; Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Bouwman AF, 1998, NATURE, V392, P866, DOI 10.1038/31809; Clyde M, 2000, ENVIRONMETRICS, V11, P745, DOI 10.1002/1099-095X(200011/12)11:6<745::AID-ENV431>3.0.CO;2-N; Cressie N., 2011, STAT SPATIO TEMPORAL; Davidson EA, 1991, MICROBIAL PRODUCTION; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; DRAPER D, 1995, J R STAT SOC B, V57, P45, DOI 10.1111/j.2517-6161.1995.tb02015.x; Gelman A, 2004, BAYESIAN DATA ANLYSI; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GOODROAD LL, 1984, SOIL BIOL BIOCHEM, V16, P39, DOI 10.1016/0038-0717(84)90123-8; Goovaerts P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-6; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Huang XD, 2013, SCI TOTAL ENVIRON, V454, P206, DOI 10.1016/j.scitotenv.2013.03.013; Huang XD, 2012, SOIL RES, V50, P596, DOI 10.1071/SR11100; Huang XD, 2011, SCI TOTAL ENVIRON, V409, P4572, DOI 10.1016/j.scitotenv.2011.07.044; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Jackson CH, 2009, J R STAT SOC A STAT, V172, P383, DOI 10.1111/j.1467-985X.2008.00573.x; Kamp T, 1998, BIOL FERT SOILS, V27, P307, DOI 10.1007/s003740050438; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Kelsall J., 1999, BAYESIAN STAT; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; Machefert SE, 2004, WATER AIR SOIL POLL, V4, P427, DOI DOI 10.1023/B:WAF0.0000028369.86947.9F; Robertson G, 2003, SOIL RES, V41, P65; Robertson G.P., 2008, GS GEOSTATISTICS ENV; Rowlings DW, 2012, GLOBAL CHANGE BIOL, V18, P726, DOI 10.1111/j.1365-2486.2011.02563.x; Saggar S, 2004, NUTR CYCL AGROECOSYS, V68, P243, DOI 10.1023/B:FRES.0000019463.92440.a3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thomas A, 2002, GEOBUGS US MAN VERS; Thomas A, 2004, GEOBUGS US MAN VERS; Wackerly D.D., 2008, MATH STAT APPL; Wall MM, 2004, J STAT PLAN INFER, V121, P311, DOI 10.1016/S0378-3758(03)00111-3; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124; Yan YP, 2008, J ENVIRON SCI, V20, P207, DOI 10.1016/S1001-0742(08)60033-9	45	3	3	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65039	10.1371/journal.pone.0065039	http://dx.doi.org/10.1371/journal.pone.0065039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750227	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900029
J	Vogler, S; Pannicke, T; Hollborn, M; Grosche, A; Busch, S; Hoffmann, S; Wiedemann, P; Reichenbach, A; Hammes, HP; Bringmann, A				Vogler, Stefanie; Pannicke, Thomas; Hollborn, Margrit; Grosche, Antje; Busch, Stephanie; Hoffmann, Sigrid; Wiedemann, Peter; Reichenbach, Andreas; Hammes, Hans-Peter; Bringmann, Andreas			Muller Cell Reactivity in Response to Photoreceptor Degeneration in Rats with Defective Polycystin-2	PLOS ONE			English	Article							RETINAL GLIAL-CELLS; OXIDATIVE STRESS; PHENOTYPIC IMPACT; MAMMALIAN RETINA; DIABETES ALTERS; MOUSE RETINA; NITRIC-OXIDE; IN-VITRO; APOPTOSIS; ISCHEMIA	Background: Retinal degeneration in transgenic rats that express a mutant cilia gene polycystin-2 (CMV-PKD2(1/ 703) HA) is characterized by initial photoreceptor degeneration and glial activation, followed by vasoregression and neuronal degeneration (Feng et al., 2009, PLoS One 4: e7328). It is unknown whether glial activation contributes to neurovascular degeneration after photoreceptor degeneration. We characterized the reactivity of Muller glial cells in retinas of rats that express defective polycystin-2. Methods: Age-matched Sprague-Dawley rats served as control. Retinal slices were immunostained for intermediate filaments, the potassium channel Kir4.1, and aquaporins 1 and 4. The potassium conductance of isolated Muller cells was recorded by whole-cell patch clamping. The osmotic swelling characteristics of Muller cells were determined by superfusion of retinal slices with a hypoosmotic solution. Findings: Muller cells in retinas of transgenic rats displayed upregulation of GFAP and nestin which was not observed in control cells. Whereas aquaporin-1 labeling of photoreceptor cells disappeared along with the degeneration of the cells, aquaporin-1 emerged in glial cells in the inner retina of transgenic rats. Aquaporin-4 was upregulated around degenerating photoreceptor cells. There was an age-dependent redistribution of Kir4.1 in retinas of transgenic rats, with a more even distribution along glial membranes and a downregulation of perivascular Kir4.1. Muller cells of transgenic rats displayed a slight decrease in their Kir conductance as compared to control. Muller cells in retinal tissues from transgenic rats swelled immediately under hypoosmotic stress; this was not observed in control cells. Osmotic swelling was induced by oxidativenitrosative stress, mitochondrial dysfunction, and inflammatory lipid mediators. Interpretation: Cellular swelling suggests that the rapid water transport through Muller cells in response to osmotic stress is altered as compared to control. The dislocation of Kir4.1 will disturb the retinal potassium and water homeostasis, and osmotic generation of free radicals and inflammatory lipids may contribute to neurovascular injury.	[Vogler, Stefanie; Pannicke, Thomas; Grosche, Antje; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Hollborn, Margrit; Wiedemann, Peter; Bringmann, Andreas] Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany; [Hollborn, Margrit; Wiedemann, Peter; Bringmann, Andreas] Univ Leipzig, Hosp Eye, D-04109 Leipzig, Germany; [Busch, Stephanie; Hammes, Hans-Peter] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, Mannheim, Germany; [Hoffmann, Sigrid] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany	Leipzig University; Leipzig University; Leipzig University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bringmann, A (corresponding author), Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany.	bria@medizin.uni-leipzig.de	Reichenbach, Andreas/B-2510-2017; Pannicke, Thomas/A-5078-2017; Hammes, Hans-Peter/S-3719-2019; Grosche, Antje/N-1978-2014	Pannicke, Thomas/0000-0001-7435-9540; Grosche, Antje/0000-0003-0338-7530	Deutsche Forschungsgemeinschaft [GRK 1097, RE 849/10-2, RE 849/12-2, PA615/2-1, GRK 880]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (GRK 1097, RE 849/10-2, and RE 849/12-2 to AR; PA615/2-1 to TP; GRK 880 to HPH). SB is medical graduate of GRK 880, project 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 1987, Acta Neurochir Suppl (Wien), V41, P85; Balboa MA, 2006, BBA-MOL CELL BIOL L, V1761, P385, DOI 10.1016/j.bbalip.2006.03.014; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beretta S, 2006, NEUROBIOL DIS, V24, P308, DOI 10.1016/j.nbd.2006.07.016; Bringmann A, 2005, ACTA OPHTHALMOL SCAN, V83, P528, DOI 10.1111/j.1600-0420.2005.00565.x; Bringmann A, 2004, OPHTHALMIC RES, V36, P241, DOI 10.1159/000081203; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; CROMPTON M, 1988, BIOCHEM J, V255, P357; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Deltas CC, 2001, HUM MUTAT, V18, P13, DOI 10.1002/humu.1145; Dmitriev AV, 1999, VISUAL NEUROSCI, V16, P1157, DOI 10.1017/S095252389916615X; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Felmy F, 2001, GLIA, V34, P190, DOI 10.1002/glia.1053; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Fuks B, 2005, EUR J PHARMACOL, V519, P24, DOI 10.1016/j.ejphar.2005.06.046; Fukuda M, 2010, EXP EYE RES, V90, P17, DOI 10.1016/j.exer.2009.09.003; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hansson MJ, 2010, J BIOL CHEM, V285, P741, DOI 10.1074/jbc.M109.017731; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Iandiev I, 2005, NEUROSCI LETT, V388, P96, DOI 10.1016/j.neulet.2005.06.046; Iandiev I, 2008, INVEST OPHTH VIS SCI, V49, P3559, DOI 10.1167/iovs.08-1723; Iandiev I, 2007, NEUROSCI LETT, V421, P132, DOI 10.1016/j.neulet.2007.04.076; Iandiev I, 2006, NEUROSCI LETT, V408, P108, DOI 10.1016/j.neulet.2006.08.084; Iandiev L, 2008, NEUROSCI LETT, V434, P317, DOI 10.1016/j.neulet.2008.02.026; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Karl A, 2011, GLIA, V59, P256, DOI 10.1002/glia.21095; Kaur C, 2007, J PATHOL, V212, P429, DOI 10.1002/path.2195; Kim IB, 2002, J COMP NEUROL, V452, P178, DOI 10.1002/cne.10359; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Kohno H, 2006, GRAEF ARCH CLIN EXP, V244, P90, DOI 10.1007/s00417-005-0030-7; Krugel K, 2011, EXP EYE RES, V92, P87, DOI 10.1016/j.exer.2010.11.007; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Landiev I, 2006, EXP EYE RES, V82, P449, DOI 10.1016/j.exer.2005.07.018; Landino LM, 1996, P NATL ACAD SCI USA, V93, P15069, DOI 10.1073/pnas.93.26.15069; LEES GJ, 1991, BRAIN RES REV, V16, P283, DOI 10.1016/0165-0173(91)90011-V; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Miller JW, 2010, JPN J OPHTHALMOL, V54, P523, DOI 10.1007/s10384-010-0863-4; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Owada S, 1999, J BIOL CHEM, V274, P2000, DOI 10.1074/jbc.274.4.2000; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, J NEUROIMMUNOL, V161, P145, DOI 10.1016/j.jneuroim.2005.01.003; Pannicke T, 2005, GLIA, V50, P1, DOI 10.1002/glia.20151; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Qin YW, 2009, EXP EYE RES, V89, P741, DOI 10.1016/j.exer.2009.06.020; STAUB F, 1994, J CEREBR BLOOD F MET, V14, P1030, DOI 10.1038/jcbfm.1994.135; Thanos S, 2001, GRAEF ARCH CLIN EXP, V239, P794, DOI 10.1007/s004170100362; Uckermann O, 2006, J NEUROSCI RES, V83, P538, DOI 10.1002/jnr.20760; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wurm A, 2011, PROG RETIN EYE RES, V30, P324, DOI 10.1016/j.preteyeres.2011.06.001; Xue LP, 2006, NEUROSCIENCE, V143, P117, DOI 10.1016/j.neuroscience.2006.07.044; Xue LP, 2011, INT J EXP PATHOL, V92, P377, DOI 10.1111/j.1365-2613.2011.00786.x; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Zheng Z, 2009, DIABETES, V58, P954, DOI 10.2337/db07-1524; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	62	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e61631	10.1371/journal.pone.0061631	http://dx.doi.org/10.1371/journal.pone.0061631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755094	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300002
J	Fritsche, M; Pandey, RB; Farmer, BL; Heermann, DW				Fritsche, Miriam; Pandey, Ras B.; Farmer, Barry L.; Heermann, Dieter W.			Variation in Structure of a Protein (H2AX) with Knowledge-Based Interactions	PLOS ONE			English	Article							PAIR POTENTIALS	The structure of a protein (H2AX) as a function of temperature is examined by three knowledge-based phenomenological interactions, MJ (Miyazawa and Jernigan), BT (Betancourt and Thirumalai), and BFKV (Bastolla et al.) to identify similarities and differences in results. Data from the BT and BFKV residue-residue interactions verify finding with the MJ interaction, i.e., the radius of gyration (R-g) of H2AX depends non-monotonically on temperature. The increase in R-g is followed by a decay on raising the temperature with a maximum at a characteristic value, T-c, which depends on the knowledge-based contact matrix, T-cBFKV <= T-cMJ <= T-cBT. The range (Delta T) of non-monotonic thermal response and its decay pattern with the temperature are sensitive to interaction. A rather narrow temperature range of Delta T-MJ approximate to 0.015-0.022 with the MJ interaction expands and shifts up to Delta T-BT approximate to 0.018-0.30 at higher temperatures with the BT interaction and shifts down with the BFKV interaction to Delta T-BFKV approximate to 0.011-0.018. The scaling of the structure factor with the wave vector reveals that the structure of the protein undergoes a transformation from a random coil at high temperature to a globular conformation at low temperatures.	[Fritsche, Miriam; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany; [Pandey, Ras B.] Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA; [Farmer, Barry L.] AF Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH USA	Ruprecht Karls University Heidelberg; University of Southern Mississippi; United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Pandey, RB (corresponding author), Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA.	ras.pandey@usm.edu			Air Force Research Laboratory	Air Force Research Laboratory	This work is supported by the Air Force Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagci Z, 2003, PROTEINS, V53, P56, DOI 10.1002/prot.10435; Bastolla U, 2001, PROTEINS, V44, P79, DOI 10.1002/prot.1075; Betancourt MR, 1999, PROTEIN SCI, V8, P361; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Freddolino PL, 2010, NAT PHYS, V6, P751, DOI 10.1038/NPHYS1713; Fritsche M, 2012, PLOS ONE, V7; Godzik A, 1996, STRUCTURE, V4, P363, DOI 10.1016/S0969-2126(96)00041-X; LIWO A, 1993, PROTEIN SCI, V2, P1697, DOI 10.1002/pro.5560021015; MAIOROV VN, 1992, J MOL BIOL, V227, P876, DOI 10.1016/0022-2836(92)90228-C; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Pandey RB, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3484241; Pandey RB, 2009, PHYS CHEM CHEM PHYS, V11, P1989, DOI 10.1039/b816187a; Pandey RB, 2012, PLOS ONE, V7; Skolnick J, 1997, PROTEIN SCI, V6, P676; TANAKA S, 1976, MACROMOLECULES, V9, P945, DOI 10.1021/ma60054a013	16	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64507	10.1371/journal.pone.0064507	http://dx.doi.org/10.1371/journal.pone.0064507			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741333	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900045
J	Han, Z; Yang, JL; Jiang, SSX; Hou, ST; Zheng, RY				Han, Zhao; Yang, Jin-Long; Jiang, Susan X.; Hou, Sheng-Tao; Zheng, Rong-Yuan			Fast, Non-Competitive and Reversible Inhibition of NMDA-Activated Currents by 2-BFI Confers Neuroprotection	PLOS ONE			English	Article							AGONIST CONCENTRATION-DEPENDENCY; CHANNEL BLOCKER MEMANTINE; CEREBRAL-ISCHEMIA; RAT-BRAIN; PARADIGM SHIFT; MEDIATED NEUROTOXICITY; RECEPTOR ANTAGONISTS; GLUTAMATE TOXICITY; DRUG DEVELOPMENT; CALPAIN ACTIVITY	Excessive activation of the N-methyl-D-aspartic acid (NMDA) type glutamate receptors (NMDARs) causes excitotoxicity, a process important in stroke-induced neuronal death. Drugs that inhibit NMDA receptor-mediated [Ca2+]i influx are potential leads for development to treat excitotoxicity-induced brain damage. Our previous studies showed that 2-(2-benzofu-ranyl)-2-imidazoline (2-BFI), an immidazoline receptor ligand, dose-dependently protects rodent brains from cerebral ischemia injury. However, the molecular mechanisms remain unclear. In this study, we found that 2-BFI transiently and reversibly inhibits NMDA, but not AMPA currents, in a dose-dependent manner in cultured rat cortical neurons. The mechanism of 2-BFI inhibition of NMDAR is through a noncompetitive fashion with a faster on (K-on = 2.19 +/- 0.33x10(-9) M-1 sec(-1)) and off rate (K-off = 0.67 +/- 0.02 sec(-1)) than those of memantine, a gold standard for therapeutic inhibition NMDAR-induced excitotoxicity. 2-BFI also transiently and reversibly blocked NMDA receptor-mediated calcium entry to cultured neurons and provided long-term neuroprotection against NMDA toxicity in vitro. Collectively, these studies demonstrated a potential mechanism of 2-BFI-mediated neuroprotection and indicated that 2-BFI is an excellent candidate for repositioning as a drug for stroke treatment.	[Han, Zhao; Yang, Jin-Long; Zheng, Rong-Yuan] Wenzhou Med Coll, Affiliated Hosp 1, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; [Han, Zhao; Yang, Jin-Long; Zheng, Rong-Yuan] Wenzhou Med Coll, Res Inst Expt Neurobiol, Wenzhou, Zhejiang, Peoples R China; [Jiang, Susan X.; Hou, Sheng-Tao] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Wenzhou Medical University; Wenzhou Medical University; National Research Council Canada	Hou, ST (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	sheng.hou@nrc-cnrc.gc.ca; ruzheng@yahoo.com	Hou, Sheng Tao/AAM-7756-2020; Hou, Sheng Tao/O-3202-2018	Hou, Sheng Tao/0000-0001-9736-342X	Chinese National Natural Science Foundation [81070960]; Zhejiang Provincial Natural Science Funding [Y2090932]; Building Funding of Zhejiang Key Subjects (Pharmacology and Biochemical Pharmaceutics); Wenzhou Medical College	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Funding; Building Funding of Zhejiang Key Subjects (Pharmacology and Biochemical Pharmaceutics); Wenzhou Medical College	This work was supported by grants from the Chinese National Natural Science Foundation (81070960), partly supported by Zhejiang Provincial Natural Science Funding (Y2090932) and the Building Funding of Zhejiang Key Subjects (Pharmacology and Biochemical Pharmaceutics). STH's contribution to this work was supported by a 3010 grant from Wenzhou Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 1997, N-S ARCH PHARMACOL, V356, P39, DOI 10.1007/PL00005026; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Culmsee C, 2004, STROKE, V35, P1197, DOI 10.1161/01.STR.0000125855.17686.6d; Dong CJ, 2008, INVEST OPHTH VIS SCI, V49, P4515, DOI 10.1167/iovs.08-2078; Du WL, 2010, J CLIN INVEST, V120, P3480, DOI 10.1172/JCI43165; Gilling KE, 2007, NEUROPHARMACOLOGY, V53, P415, DOI 10.1016/j.neuropharm.2007.05.022; Gilling KE, 2009, NEUROPHARMACOLOGY, V56, P866, DOI 10.1016/j.neuropharm.2009.01.012; Han Z, 2012, BIOCHEM BIOPH RES CO, V424, P544, DOI 10.1016/j.bbrc.2012.06.152; Han Z, 2010, BRAIN RES, V1361, P86, DOI 10.1016/j.brainres.2010.09.029; Han Z, 2009, NEUROL RES, V31, P390, DOI 10.1179/174313209X444116; Head G. A., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P17, DOI 10.2174/187152506775268758; Hewitt KE, 1998, J NEUROSCI RES, V54, P223, DOI 10.1002/(SICI)1097-4547(19981015)54:2<223::AID-JNR10>3.0.CO;2-5; Hou ST, 2008, INT REV CEL MOL BIO, V267, P125, DOI 10.1016/S1937-6448(08)00603-5; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hou ST, 2002, INT REV CYTOL, V221, P93; Jiang SX, 2010, EUR J PHARMACOL, V629, P12, DOI 10.1016/j.ejphar.2009.11.063; Jiang SX, 2005, J BIOL CHEM, V280, P33811, DOI 10.1074/jbc.M503113200; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2005, EXPERT OPIN THER TAR, V9, P427, DOI 10.1517/14728222.9.3.427; Lipton SA, 2004, CELL DEATH DIFFER, V11, P18, DOI 10.1038/sj.cdd.4401344; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Milhaud D, 2000, NEUROPHARMACOLOGY, V39, P2244, DOI 10.1016/S0028-3908(00)00085-X; Milhaud D, 2002, NEUROREPORT, V13, P1711, DOI 10.1097/00001756-200210070-00004; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Olmos G, 1996, EUR J PHARMACOL, V310, P273, DOI 10.1016/0014-2999(96)00519-5; Parsons CG, 2008, EUR J PHARMACOL, V587, P99, DOI 10.1016/j.ejphar.2008.03.053; Simon R, 2006, BIOCHEM SOC T, V34, P1356, DOI 10.1042/BST0341356; Smith RA, 2003, MOL BRAIN RES, V116, P70, DOI 10.1016/S0169-328X(03)00253-5; Stieg PE, 1999, EUR J PHARMACOL, V375, P115, DOI 10.1016/S0014-2999(99)00214-9; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Wang P, 2011, BIOCHEM BIOPH RES CO, V406, P152, DOI 10.1016/j.bbrc.2011.02.018; Wang XS, 2009, BRAIN RES, V1253, P198, DOI 10.1016/j.brainres.2008.11.059; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	37	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64894	10.1371/journal.pone.0064894	http://dx.doi.org/10.1371/journal.pone.0064894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741413	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900126
J	Klotz, JG; Heckel, R; Schober, S				Klotz, Johannes Georg; Heckel, Reinhard; Schober, Steffen			Bounds on the Average Sensitivity of Nested Canalizing Functions	PLOS ONE			English	Article							NOISE SENSITIVITY; BOOLEAN NETWORK; DYNAMICS	Nested canalizing Boolean functions (NCF) play an important role in biologically motivated regulatory networks and in signal processing, in particular describing stack filters. It has been conjectured that NCFs have a stabilizing effect on the network dynamics. It is well known that the average sensitivity plays a central role for the stability of (random) Boolean networks. Here we provide a tight upper bound on the average sensitivity of NCFs as a function of the number of relevant input variables. As conjectured in literature this bound is smaller than 4/3. This shows that a large number of functions appearing in biological networks belong to a class that has low average sensitivity, which is even close to a tight lower bound.	[Klotz, Johannes Georg; Schober, Steffen] Univ Ulm, Inst Commun Engn, D-89069 Ulm, Germany; [Heckel, Reinhard] ETH, Dept Informat Technol & Elect Engn, Zurich, Switzerland	Ulm University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Klotz, JG (corresponding author), Univ Ulm, Inst Commun Engn, D-89069 Ulm, Germany.	johannes.klotz@uni-ulm.de	Heckel, Reinhard/AAV-7904-2020		Deutsche Forschungsgemeinschaft [BO867/25-2, SPP 1395]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been funded by the Deutsche Forschungsgemeinschaft under grant BO867/25-2 in the priority program SPP 1395 "Informations- und Kommunikationstheorie in der Molekularbiologie (InKoMBio)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; Bahadur RR, 1961, STUDIES ITEM ANAL PR, V6, P158; Ben-Or M., 1985, 26th Annual Symposium on Foundations of Computer Science (Cat. No.85CH2224-4), P408, DOI 10.1109/SFCS.1985.15; Benjamini I, 1999, PUBL MATH, P5; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Bshouty NH, 1996, J ACM, V43, P747, DOI 10.1145/234533.234564; COOK S, 1986, SIAM J COMPUT, V15, P87, DOI 10.1137/0215006; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Friedgut E, 1996, P AM MATH SOC, V124, P2993, DOI 10.1090/S0002-9939-96-03732-X; FURST ML, 1991, PROCEEDINGS OF THE FOURTH ANNUAL WORKSHOP ON COMPUTATIONAL LEARNING THEORY, P317; GABBOUJ M, 1992, CIRC SYST SIGNAL PR, V11, P171, DOI 10.1007/BF01189226; Harris Stephen E., 2002, Complexity, V7, P23, DOI 10.1002/cplx.10022; Heckel R., 2013, EURASIP J B IN PRESS; Kahn, 1988, P 29 ANN S FDN COMP, P68, DOI [10.1109/SFCS.1988.21923, DOI 10.1109/SFCS.1988.21923]; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klotz JG, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-1; Li F, 2004, P NATL ACAD SCI USA, V101; Li Y, 2013, THEOR COMPUT SCI, V481, P24, DOI 10.1016/j.tcs.2013.02.020; Lynch JF, 2007, SER KNOTS EVERYTHING, V38, P15, DOI 10.1142/9789812706799_0002; Mossel E, 2003, RANDOM STRUCT ALGOR, V23, P333, DOI 10.1002/rsa.10097; Murrugarra D, 2011, J THEOR BIOL, V288, P66, DOI 10.1016/j.jtbi.2011.08.015; Peixoto TP, 2010, EUR PHYS J B, V78, P187, DOI 10.1140/epjb/e2010-10559-0; Schober S, 2007, ARXIV07040197; Shmulevich I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.048701; Shmulevich I, 2005, ARXIVMATH0507030; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64371	10.1371/journal.pone.0064371	http://dx.doi.org/10.1371/journal.pone.0064371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741321	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900033
J	Li, XM; Zhou, F; Marcus, DC; Wangemann, P				Li, Xiangming; Zhou, Fei; Marcus, Daniel C.; Wangemann, Philine			Endolymphatic Na+ and K+ Concentrations during Cochlear Growth and Enlargement in Mice Lacking Slc26a4/pendrin	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; VESTIBULAR AQUEDUCT; ELEMENTAL COMPOSITION; SENSORY TRANSDUCTION; PENDRED SYNDROME; SLC26A4 GENE; INNER-EAR; CELLS; HOMEOSTASIS; ABSORPTION	Slc26a4(Delta/Delta) mice are deaf, develop an enlarged membranous labyrinth, and thereby largely resemble the human phenotype where mutations of SLC26A4 cause an enlarged vestibular aqueduct and sensorineural hearing loss. The enlargement is likely caused by abnormal ion and fluid transport during the time of embryonic development, however, neither the mechanisms of ion transport nor the ionic composition of the luminal fluid during this time of development are known. Here we determine the ionic composition of inner ear fluids at the time at which the enlargement develops and the onset of expression of selected ion transporters. Concentrations of Na+ and K+ were measured with double-barreled ion-selective electrodes in the cochlea and the endolymphatic sac of Slc26a4(Delta/+), which develop normal hearing, and of Slc26a4(Delta/Delta) mice, which fail to develop hearing. The expression of specific ion transporters was examined by quantitative RT-PCR and immunohistochemistry. High Na+ (similar to 141 mM) and low K+ concentrations (similar to 11 mM) were found at embryonic day (E) 16.5 in cochlear endolymph of Slc26a4(Delta/+) and Slc26a4(Delta/Delta) mice. Shortly before birth the K+ concentration began to rise. Immediately after birth (postnatal day 0), the Na+ and K+ concentrations in cochlear endolymph were each similar to 80 mM. In Slc26a4(Delta/Delta) mice, the rise in the K+ concentration occurred with a similar to 3 day delay. K+ concentrations were also found to be low (similar to 15 mM) in the embryonic endolymphatic sac. The onset of expression of the K+ channel KCNQ1 and the Na+/2Cl(-)/K+ cotransporter SLC12A2 occurred in the cochlea at E19.5 in Slc26a4(Delta/+) and Slc26a4(Delta/)Delta mice. These data demonstrate that endolymph, at the time at which the enlargement develops, is a Na+-rich fluid, which transitions into a K+-rich fluid before birth. The data suggest that the endolymphatic enlargement caused by a loss of Slc26a4 is a consequence of disrupted Na+ transport.	[Li, Xiangming; Zhou, Fei; Marcus, Daniel C.; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	Kansas State University	Wangemann, P (corresponding author), Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA.	wange@vet.ksu.edu	Wangemann, Philine/N-2826-2013		National Institutes on Deafness and Other Communication Disorders [NIH-R01-DC012151]; Kansas City Area Life Sciences Institute; Patton Trust; Kansas State University - College of Veterinary Medicine; National Institutes of Health [NIH-P20-RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012151] Funding Source: NIH RePORTER	National Institutes on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Kansas City Area Life Sciences Institute; Patton Trust; Kansas State University - College of Veterinary Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant from the National Institutes on Deafness and Other Communication Disorders, NIH-R01-DC012151 (to PW) and by a grant from the Kansas City Area Life Sciences Institute (to PW) that was in turn funded by the Patton Trust. The Confocal Microscopy Core facility was supported by Kansas State University - College of Veterinary Medicine and a grant from the National Institutes of Health, NIH-P20-RR017686 (to DCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; ANNIKO M, 1980, ARCH OTO-RHINO-LARYN, V229, P281, DOI 10.1007/BF02565531; ANNIKO M, 1980, ACTA OTO-LARYNGOL, V90, P425, DOI 10.3109/00016488009131744; Anwar S, 2009, J HUM GENET, V54, P266, DOI 10.1038/jhg.2009.21; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Cheung CY, 2005, J SOC GYNECOL INVEST, V12, P558, DOI 10.1016/j.jsgi.2005.08.008; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Griffith AJ, 2011, HEARING RES, V281, P11, DOI 10.1016/j.heares.2011.05.009; JAYAKANNAN M, J PLANT PHYSL, V168, P1045; KELLEY MW, 2005, SPRINGER HDB AUDITOR, V26; Kim CH, 2009, NEUROREPORT, V20, P1275, DOI 10.1097/WNR.0b013e32833017eb; Kim HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017949; Kim HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014041; Kim SH, 2011, HEARING RES, V280, P21, DOI 10.1016/j.heares.2011.05.003; Kim SH, 2009, OTOL NEUROTOL, V30, P529, DOI 10.1097/MAO.0b013e31819a8e0e; Lee JH, 2003, NEUROSCIENCE, V119, P3, DOI 10.1016/S0306-4522(03)00104-0; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; Marcus DC, 1999, HEARING RES, V134, P48, DOI 10.1016/S0378-5955(99)00074-X; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; ROZEN S, 2013, BIOINFORMATICS METHO, P1365; SADANAGA M, 1995, HEARING RES, V89, P155, DOI 10.1016/0378-5955(95)00133-X; WANGEMANN P, 1995, HEARING RES, V90, P149, DOI 10.1016/0378-5955(95)00157-2; WANGEMANN P, HEAR RES, V84, P19; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009; Wu CC, 2010, AUDIOL NEURO-OTOL, V15, P57, DOI 10.1159/000231567; Yoo JC, 2012, ACTA OTO-LARYNGOL, V132, pS103, DOI 10.3109/00016489.2012.664285; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79	33	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65977	10.1371/journal.pone.0065977	http://dx.doi.org/10.1371/journal.pone.0065977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741519	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900232
J	Wegener, S; Artmann, J; Luft, AR; Buxton, RB; Weller, M; Wong, EC				Wegener, Susanne; Artmann, Judith; Luft, Andreas R.; Buxton, Richard B.; Weller, Michael; Wong, Eric C.			The Time of Maximum Post-Ischemic Hyperperfusion Indicates Infarct Growth Following Transient Experimental Ischemia	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; FOCAL ISCHEMIA; BLOOD-FLOW; PERFUSION; STROKE; REPERFUSION; RATS; DIFFUSION; MRI; INJURY	After recanalization, cerebral blood flow (CBF) can increase above baseline in cerebral ischemia. However, the significance of post-ischemic hyperperfusion for tissue recovery remains unclear. To analyze the course of post-ischemic hyperperfusion and its impact on vascular function, we used magnetic resonance imaging (MRI) with pulsed arterial spin labeling (pASL) and measured CBF quantitatively during and after a 60 minute transient middle cerebral artery occlusion (MCAO) in adult rats. We added a 5% CO2 - challenge to analyze vasoreactivity in the same animals. Results from MRI were compared to histological correlates of angiogenesis. We found that CBF in the ischemic area recovered within one day and reached values significantly above contralateral thereafter. The extent of hyperperfusion changed over time, which was related to final infarct size: early (day 1) maximal hyperperfusion was associated with smaller lesions, whereas a later (day 4) maximum indicated large lesions. Furthermore, after initial vasoparalysis within the ischemic area, vasoreactivity on day 14 was above baseline in a fraction of animals, along with a higher density of blood vessels in the ischemic border zone. These data provide further evidence that late post-ischemic hyperperfusion is a sequel of ischemic damage in regions that are likely to undergo infarction. However, it is transient and its resolution coincides with re-gaining of vascular structure and function.	[Wegener, Susanne; Artmann, Judith; Luft, Andreas R.; Weller, Michael] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Buxton, Richard B.; Wong, Eric C.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Wong, Eric C.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	University of Zurich; University Zurich Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego	Wegener, S (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	Susanne.Wegener@usz.ch		Weller, Michael/0000-0002-1748-174X	Deutsche Forschungsgemeinschaft; 6th Framework Program of the European Commission (Marie Curie Outgoing International Fellowship); Swiss National Science Foundation (NCCR Neural Plasticity and Repair); National Institute of Health [R01 EB002096]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002096] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 6th Framework Program of the European Commission (Marie Curie Outgoing International Fellowship)(European Commission); Swiss National Science Foundation (NCCR Neural Plasticity and Repair)(Swiss National Science Foundation (SNSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported by the Deutsche Forschungsgemeinschaft, the 6th Framework Program of the European Commission (Marie Curie Outgoing International Fellowship), the Swiss National Science Foundation (NCCR Neural Plasticity and Repair) (all to S.W.), and the National Institute of Health (R01 EB002096) (to E.C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Barber PA, 1998, STROKE, V29, P2522, DOI 10.1161/01.STR.29.12.2522; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Garcia JH, 1995, STROKE, V26, P635; GOURLEY JK, 1984, AM J PHYSIOL, V246, pH52, DOI 10.1152/ajpheart.1984.246.1.H52; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Kidwell CS, 2001, NEUROLOGY, V57, P2015, DOI 10.1212/WNL.57.11.2015; Koizumi J., 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; Lee SK, 2002, NEURORADIOLOGY, V44, P103, DOI 10.1007/s002340100705; Lee SK, 2004, AM J NEURORADIOL, V25, P1342; Li FH, 2000, NEUROLOGY, V54, P689, DOI 10.1212/WNL.54.3.689; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; MACFARLANE R, 1991, J NEUROSURG, V75, P845, DOI 10.3171/jns.1991.75.6.0845; Marchal G, 1996, BRAIN, V119, P409, DOI 10.1093/brain/119.2.409; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; Neumann-Haefelin T, 2004, STROKE, V35, P109, DOI 10.1161/01.STR.0000106482.31425.D1; OLSEN TS, 1981, STROKE, V12, P598, DOI 10.1161/01.STR.12.5.598; RAYNAUD C, 1989, STROKE, V20, P192, DOI 10.1161/01.STR.20.2.192; Shen Q, 2011, J CEREB BLOOD FLOW M; Soehle M, 1998, STROKE, V29, P1240, DOI 10.1161/01.STR.29.6.1240; Tran Dinh YR, 1997, J NUCL MED, V38, P602; van Dorsten FA, 2002, MAGN RESON MED, V47, P97, DOI 10.1002/mrm.10021; Wang L, 2002, J CEREBR BLOOD F MET, V22, P253, DOI 10.1097/00004647-200203000-00002; Wegener S, 2008, NMR BIOMED, V21, P696, DOI 10.1002/nbm.1243; Wegener S, 2007, J MAGN RESON IMAGING, V26, P855, DOI 10.1002/jmri.21045; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506	30	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65322	10.1371/journal.pone.0065322	http://dx.doi.org/10.1371/journal.pone.0065322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741488	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000319799900201
J	Yang, YL; Li, JJ; Ji, R; Wei, YY; Chen, J; Dou, KF; Wang, YY				Yang, Yan-Ling; Li, Jun-Jie; Ji, Ru; Wei, Yan-Yan; Chen, Jing; Dou, Ke-Feng; Wang, Ya-Yun			Abnormal Chloride Homeostasis in the Substancia Nigra Pars Reticulata Contributes to Locomotor Deficiency in a Model of Acute Liver Injury	PLOS ONE			English	Article							HEPATIC-ENCEPHALOPATHY; KCC2 EXPRESSION; MINI-ASTERIXIS; BASAL GANGLIA; IN-VIVO; RATS; COTRANSPORTERS; FAILURE; ACTIVATION; MECHANISM	Background: Altered chloride homeostasis has been thought to be a risk factor for several brain disorders, while less attention has been paid to its role in liver disease. We aimed to analyze the involvement and possible mechanisms of altered chloride homeostasis of GABAergic neurons within the substantia nigra pars reticulata (SNr) in the motor deficit observed in a model of encephalopathy caused by acute liver failure, by using glutamic acid decarboxylase 67 - green fluorescent protein knock-in transgenic mice. Methods: Alterations in intracellular chloride concentration in GABAergic neurons within the SNr and changes in the expression of two dominant chloride homeostasis-regulating genes, KCC2 and NKCC1, were evaluated in mice with hypolocomotion due to hepatic encephalopathy (HE). The effects of pharmacological blockade and/or activation of KCC2 and NKCC1 functions with their specific inhibitors and/or activators on the motor activity were assessed. Results: In our mouse model of acute liver injury, chloride imaging indicated an increase in local intracellular chloride concentration in SNr GABAergic neurons. In addition, the mRNA and protein levels of KCC2 were reduced, particularly on neuronal cell membranes; in contrast, NKCC1 expression remained unaffected. Furthermore, blockage of KCC2 reduced motor activity in the normal mice and led to a further deteriorated hypolocomotion in HE mice. Blockade of NKCC1 was not able to normalize motor activity in mice with liver failure. Conclusion: Our data suggest that altered chloride homeostasis is likely involved in the pathophysiology of hypolocomotion following HE. Drugs aimed at restoring normal chloride homeostasis would be a potential treatment for hepatic failure.	[Yang, Yan-Ling; Li, Jun-Jie; Ji, Ru; Wei, Yan-Yan; Chen, Jing; Wang, Ya-Yun] Fourth Mil Med Univ, Dept Anat, Xian 710032, Peoples R China; [Yang, Yan-Ling; Li, Jun-Jie; Ji, Ru; Wei, Yan-Yan; Chen, Jing; Wang, Ya-Yun] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Yang, Yan-Ling; Li, Jun-Jie; Ji, Ru; Dou, Ke-Feng] Fourth Mil Med Univ, Xi Jing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Dou, KF (corresponding author), Fourth Mil Med Univ, Xi Jing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China.	gdwk@fmmu.edu.cn; wangyy@fmmu.edu.cn	王, 亚/GXM-4793-2022; 王, 亚云/AAJ-7271-2020	wang, yayun/0000-0002-0397-0390	National Natural Science Foundation of China [81070327, 81071895, 30971174]; Excellent Project of the Fourth Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Project of the Fourth Military Medical University	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81070327, 81071895 and 30971174 (http://159.226.244.22/portal/ProjectDblDetail.asp?flag=true&name=???&orgcode=71003202&organization=%D6%D0%B9%FA%C8%CB%C3%F1%BD%E2%B7%C5%BE%FC%B5%DA%CB%C4%BE%FC%D2%BD%B4%F3%D1%A7)) and Excellent Project of the Fourth Military Medical University (for Ya-Yun Wang), http://jingpin.fmmu.edu.cn/jyrc/jyrc_1.jsp?urltype=tree.TreeTempUrl&wbtreeid=1187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Andres T, 1999, OXFORD TXB CLIN HEPA, P765; Avraham Y, 2006, NEUROBIOL DIS, V21, P237, DOI 10.1016/j.nbd.2005.07.008; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Bruck J, 2011, J HEPATOL, V54, P251, DOI 10.1016/j.jhep.2010.06.035; Busse S, 2005, BRAIN RES, V1046, P116, DOI 10.1016/j.brainres.2005.03.055; Cauli O, 2006, J HEPATOL, V45, P654, DOI 10.1016/j.jhep.2006.06.019; Chang Ching-Chih, 2006, J Chin Med Assoc, V69, P563; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; de Miranda AS, 2010, ARQ NEURO-PSIQUIAT, V68, P597, DOI 10.1590/S0004-282X2010000400022; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; DICHIARA G, 1978, LIFE SCI, V23, P2045, DOI 10.1016/0024-3205(78)90237-0; Farjam M, 2012, IRAN RED CRESCENT ME, V14, P164; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiegen RJ, 1997, HEPATOLOGY, V25, P1425, DOI 10.1002/hep.510250620; Galanopoulou AS, 2003, EXP NEUROL, V183, P628, DOI 10.1016/S0014-4886(03)00213-9; Gulacsi A, 2003, J NEUROSCI, V23, P8237; Hasbargen T, 2010, ANN NY ACAD SCI, V1198, P168, DOI 10.1111/j.1749-6632.2010.05462.x; Huang HC, 2008, J GASTROEN HEPATOL, V23, pE236, DOI 10.1111/j.1440-1746.2007.04988.x; Huang HC, 2012, EUR J CLIN INVEST, V42, P139, DOI 10.1111/j.1365-2362.2011.02566.x; Jayakumar AR, 2011, NEUROBIOL DIS, V41, P498, DOI 10.1016/j.nbd.2010.10.021; Jayakumar AR, 2011, J HEPATOL, V54, P272, DOI 10.1016/j.jhep.2010.06.041; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Jover R, 2005, J HEPATOL, V42, P659, DOI 10.1016/j.jhep.2004.12.030; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kawaguchi H, 2010, J BIOL CHEM, V285, P17277, DOI 10.1074/jbc.C110.132944; Kirmse K, 2006, EUR J NEUROSCI, V24, P2741, DOI 10.1111/j.1460-9568.2006.05179.x; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; Moy LY, 2000, J NEUROCHEM, V74, P1656, DOI 10.1046/j.1471-4159.2000.0741656.x; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Phongphanphanee P, 2011, J NEUROSCI, V31, P1949, DOI 10.1523/JNEUROSCI.2305-10.2011; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Scheel-Kruger J, 1981, Adv Biochem Psychopharmacol, V30, P165; Scheel-Kruger J, 1981, AMINO ACID NEUROTRAN; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Song L, 2005, BIOPHYS J, V88, P2350, DOI 10.1529/biophysj.104.053579; Spahr L, 1996, HEPATOLOGY, V24, P1116; STOLF AMS, 1976, BIOCHEM BIOPH RES CO, V72, P1576, DOI 10.1016/S0006-291X(76)80194-5; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Timmermann L, 2003, NEUROLOGY, V61, P689, DOI 10.1212/01.WNL.0000078816.05164.B1; Timmermann L, 2002, NEUROLOGY, V58, P295, DOI 10.1212/WNL.58.2.295; Wang YY, 2009, J CHEM NEUROANAT, V38, P75, DOI 10.1016/j.jchemneu.2009.04.003; Weissenborn K, 1998, METAB BRAIN DIS, V13, P261, DOI 10.1023/A:1020628607245; Weissenborn K, 2005, AIDS, V19, pS93, DOI 10.1097/01.aids.0000192076.03443.6d; WYSMYK U, 1992, NEUROCHEM RES, V17, P1187, DOI 10.1007/BF00968397; YURDAYDIN C, 1990, HEPATOLOGY, V12, P695, DOI 10.1002/hep.1840120413	54	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65194	10.1371/journal.pone.0065194	http://dx.doi.org/10.1371/journal.pone.0065194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741482	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900195
J	Zhang, JN; Chen, S; Liu, HB; Zhang, BK; Zhao, Y; Ma, K; Zhao, D; Wang, QS; Ma, HP; Zhang, ZR				Zhang, Jianing; Chen, Shuo; Liu, Huibin; Zhang, Bingkun; Zhao, Ying; Ma, Ke; Zhao, Dan; Wang, Qiushi; Ma, Heping; Zhang, Zhiren			Hydrogen Sulfide Prevents Hydrogen Peroxide-Induced Activation of Epithelial Sodium Channel through a PTEN/PI(3,4,5)P-3 Dependent Pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; TUMOR-SUPPRESSOR PTEN; SUPEROXIDE-PRODUCTION; TENSIN HOMOLOG; PROTECTS; INACTIVATION; BETA; H2S; HYPERTENSION; PHOSPHATASE	Sodium reabsorption through the epithelial sodium channel (ENaC) at the distal segment of the kidney plays an important role in salt-sensitive hypertension. We reported previously that hydrogen peroxide (H2O2) stimulates ENaC in A6 distal nephron cells via elevation of phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3) in the apical membrane. Here we report that H2S can antagonize H2O2-induced activation of ENaC in A6 cells. Our cell-attached patch-clamp data show that ENaC open probability (P-O) was significantly increased by exogenous H2O2, which is consistent with our previous finding. The aberrant activation of ENaC induced by exogenous H2O2 was completely abolished by H2S (0.1 mM NaHS). Pre-treatment of A6 cells with H2S slightly decreased ENaC P-O; however, in these cells H2O2 failed to elevate ENaC P-O. Confocal microscopy data show that application of exogenous H2O2 to A6 cells significantly increased intracellular reactive oxygen species (ROS) level and induced accumulation of PI(3,4,5)P-3 in the apical compartment of the cell membrane. These effects of exogenous H2O2 on intracellular ROS levels and on apical PI(3,4,5)P-3 levels were almost completely abolished by treatment of A6 cells with H2S. In addition, H2S significantly inhibited H2O2-induced oxidative inactivation of the tumor suppressor phosphatase and tensin homolog (PTEN) which is a negative regulator of PI(3,4,5)P-3. Moreover, BPV(pic), a specific inhibitor of PTEN, elevated PI(3,4,5)P-3 and ENaC activity in a manner similar to that of H2O2 in A6 cells. Our data show, for the first time, that H2S prevents H2O2-induced activation of ENaC through a PTEN-PI(3,4,5)P-3 dependent pathway.	Harbin Med Univ, Affiliated Hosp 2, Dept Clin Pharm, Minist Myocardial Ischemia Mech & Treatment,Key L, Harbin, Peoples R China; [Zhang, Jianing; Chen, Shuo; Liu, Huibin; Zhang, Bingkun; Zhao, Ying; Ma, Ke; Zhao, Dan; Wang, Qiushi; Zhang, Zhiren] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Minist Myocardial Ischemia Mech & Treatment,Key L, Harbin, Peoples R China; [Ma, Heping] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Harbin Medical University; Harbin Medical University; Emory University	Ma, HP (corresponding author), Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA.	heping.ma@emory.edu; zhirenz@yahoo.com	Liu, Hui-Bin/F-5841-2013	Liu, Hui-Bin/0000-0002-9535-3719	Key Project of the Chinese National Program for Fundamental Research and Development (973 Program) [2012CB517803]; National Natural Science Foundation of China [81270340, 81070217]; Postdoctoral Science Foundation of China [2012M520775]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067110] Funding Source: NIH RePORTER	Key Project of the Chinese National Program for Fundamental Research and Development (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Key Project of the Chinese National Program for Fundamental Research and Development (973 Program, 2012CB517803), the National Natural Science Foundation of China (81270340 and 81070217), and the Postdoctoral Science Foundation of China (2012M520775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Blazer-Yost BL, 2004, AM J PHYSIOL-CELL PH, V287, pC1569, DOI 10.1152/ajpcell.00226.2004; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Ha HL, 2010, WORLD J GASTROENTERO, V16, P4932, DOI 10.3748/wjg.v16.i39.4932; Henderson PW, 2010, J SURG RES, V159, P451, DOI 10.1016/j.jss.2009.05.010; Hu Y, 2008, PFLUG ARCH EUR J PHY, V455, P607, DOI 10.1007/s00424-007-0321-4; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Johansen D, 2006, BASIC RES CARDIOL, V101, P53, DOI 10.1007/s00395-005-0569-9; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lan AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025921; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Manna P, 2012, CELL PHYSIOL BIOCHEM, V30, P1363, DOI 10.1159/000343325; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mori T, 2007, HYPERTENSION, V49, P1336, DOI 10.1161/HYPERTENSIONAHA.106.085811; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Tang XQ, 2008, CLIN EXP PHARMACOL P, V35, P180, DOI 10.1111/j.1440-1681.2007.04799.x; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Taylor NE, 2005, AM J PHYSIOL-REG I, V289, pR1573, DOI 10.1152/ajpregu.00525.2005; Tripatara P, 2009, EUR J PHARMACOL, V606, P205, DOI 10.1016/j.ejphar.2009.01.041; Wang J, 2009, AM J PHYSIOL-RENAL, V296, pF284, DOI 10.1152/ajprenal.90647.2008; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Xu ZB, 2009, AM J PHYSIOL-RENAL, V297, pF27, DOI 10.1152/ajprenal.00096.2009; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF1666, DOI 10.1152/ajprenal.00444.2006; Zhang ZR, 2010, PFLUG ARCH EUR J PHY, V459, P377, DOI 10.1007/s00424-009-0733-4	41	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64304	10.1371/journal.pone.0064304	http://dx.doi.org/10.1371/journal.pone.0064304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741314	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900026
J	Loizzo, S; Rimondini, R; Travaglione, S; Fabbri, A; Guidotti, M; Ferri, A; Campana, G; Fiorentini, C				Loizzo, Stefano; Rimondini, Roberto; Travaglione, Sara; Fabbri, Alessia; Guidotti, Marco; Ferri, Alberto; Campana, Gabriele; Fiorentini, Carla			CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SPATIAL MEMORY PERFORMANCE; TOXIN-INDUCED ACTIVATION; BETA PRECURSOR PROTEIN; APOLIPOPROTEIN-E; RHO-GTPASES; APOE; RISK; MODULATION; MOUSE	Overexpression of pro-inflammatory cytokines and cellular energy failure are associated with neuroinflammatory disorders, such as Alzheimer's disease. Transgenic mice homozygous for human ApoE4 gene, a well known AD and atherosclerosis animal model, show decreased levels of ATP, increased inflammatory cytokines level and accumulation of beta amyloid in the brain. All these findings are considered responsible for triggering cognitive decline. We have demonstrated that a single administration of the bacterial E. coli protein toxin CNF1 to aged apoE4 mice, beside inducing a strong amelioration of both spatial and emotional memory deficits, favored the cell energy restore through an increment of ATP content. This was accompanied by a modulation of cerebral Rho and Rac1 activity. Furthermore, CNF1 decreased the levels of beta amyloid accumulation and interleukin-1 beta expression in the hippocampus. Altogether, these data suggest that the pharmacological modulation of Rho GTPases by CNF1 can improve memory performances in an animal model of Alzheimer's disease via a control of neuroinflammation and a rescue of systemic energy homeostasis.	[Loizzo, Stefano; Travaglione, Sara; Fabbri, Alessia; Fiorentini, Carla] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Rimondini, Roberto; Campana, Gabriele] Univ Bologna, Dept Pharmacol, Bologna, Italy; [Guidotti, Marco] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Ferri, Alberto] CNR, Inst Cellular Biol & Neurobiol, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Bologna; Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR)	Fiorentini, C (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	carla.fiorentini@iss.it	FERRI, ALBERTO/B-7660-2015; Travaglione, Sara/AAJ-2516-2021; roberto, rimondini/AAC-3525-2019; Campana, Gabriele/A-8285-2010; Fabbri, Alessia/AAA-4594-2019; Fiorentini, Carla/Q-2088-2015; Rimondini, Roberto/B-2500-2010; FIORENTINI, CARLA/AAG-8005-2019; Guidotti, Marco/D-2069-2015	FERRI, ALBERTO/0000-0002-4097-0605; roberto, rimondini/0000-0003-4099-513X; Campana, Gabriele/0000-0001-8978-0530; Fabbri, Alessia/0000-0002-3075-3367; Fiorentini, Carla/0000-0003-1707-6282; Rimondini, Roberto/0000-0003-4099-513X; FIORENTINI, CARLA/0000-0003-1707-6282; Loizzo, Stefano/0000-0001-6344-2613; Travaglione, Sara/0000-0002-2816-0490	"Italia-USA Collaboration Program" [Fascicolo 11US/1]; Cure_FXS project under the E-Rare program	"Italia-USA Collaboration Program"; Cure_FXS project under the E-Rare program	This work was partially supported by "Italia-USA Collaboration Program", Fascicolo 11US/1 (to CF) and by the Cure_FXS project (www.cure-fxs.eu) under the E-Rare program (to CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608; Armstrong R A, 2011, Int J Alzheimers Dis, V2011, P630865, DOI 10.4061/2011/630865; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Bedlack RS, 2000, ARCH NEUROL-CHICAGO, V57, P1561, DOI 10.1001/archneur.57.11.1561; Boyer L, 2006, MOL BIOL CELL, V17, P2489, DOI 10.1091/mbc.E05-09-0876; Buttini M, 2010, AM J PATHOL, V177, P563, DOI 10.2353/ajpath.2010.090973; Cedazo-Minguez A, 2007, J CELL MOL MED, V11, P1227, DOI 10.1111/j.1582-4934.2007.00130.x; Cerri C, 2011, J NEUROSCI, V31, P15163, DOI 10.1523/JNEUROSCI.2617-11.2011; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Chen Xi, 2006, Current Alzheimer Research, V3, P515, DOI 10.2174/156720506779025215; Chen X, 2006, IUBMB LIFE, V58, P686, DOI 10.1080/15216540601047767; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crawley JN, 2007, WHAT WRONG MY MOUSE, P110; De Filippis B, 2012, NEUROPSYCHOPHARMACOL, V37, P1152, DOI 10.1038/npp.2011.301; DENTI A, 1972, PHYSIOL BEHAV, V8, P611, DOI 10.1016/0031-9384(72)90083-2; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; Dolev I, 2006, J ALZHEIMERS DIS, V10, P291; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FALZANO L, 1993, MOL MICROBIOL, V9, P1247, DOI 10.1111/j.1365-2958.1993.tb01254.x; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Fiorentini C, 1998, EXP CELL RES, V242, P341, DOI 10.1006/excr.1998.4057; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Forloni G, 1993, Funct Neurol, V8, P211; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Gavillet M, 2008, GLIA, V56, P975, DOI 10.1002/glia.20671; Gibson GE, 2010, J ALZHEIMERS DIS, V20, pS591, DOI 10.3233/JAD-2010-100336; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Johnson LA, 2011, DIABETES, V60, P2285, DOI 10.2337/db11-0466; Jung ES, 2012, J NEUROSCI, V32, P3081, DOI 10.1523/JNEUROSCI.6357-11.2012; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Li YJ, 2004, NEUROLOGY, V62, P2005, DOI 10.1212/01.WNL.0000128089.53030.AC; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Malchiodi-Albedi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034115; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Michels A, 2012, J ALZHEIMERS DIS, V28, P25, DOI 10.3233/JAD-2011-110554; Miraglia AG, 2007, MOL BIOL CELL, V18, P2735, DOI 10.1091/mbc.E06-10-0910; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Musilli M, 2013, BEHAV BRAIN RES, V237, P223, DOI 10.1016/j.bbr.2012.09.043; O'Kane EM, 2003, J NEUROCHEM, V87, P1309, DOI 10.1046/j.1471-4159.2003.02102.x; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Pavone F, 2009, PAIN, V145, P219, DOI 10.1016/j.pain.2009.06.026; Paxinos G., 1998, MOUSE BRAIN STEREOTA; Perasso L, 2013, MED RES REV, V33, P336, DOI 10.1002/med.20255; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Prins ND, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt28; Raber Jacob, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/91236; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Roses Allen D., 1994, Current Opinion in Biotechnology, V5, P663, DOI 10.1016/0958-1669(94)90091-4; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Sawmiller DR, 2012, J NEUROCHEM, V123, P525, DOI 10.1111/j.1471-4159.2012.07923.x; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Tang BL, 2007, J NEUROCHEM, V100, P314, DOI 10.1111/j.1471-4159.2006.04215.x; Tashiro A, 2008, METHOD ENZYMOL, V439, P285, DOI 10.1016/S0076-6879(07)00421-1; Travaglione S, 2005, CELL DEATH DIFFER, V12, P78, DOI 10.1038/sj.cdd.4401522; Tu JL, 2009, BIOCHEM BIOPH RES CO, V384, P466, DOI 10.1016/j.bbrc.2009.04.153; Tuminello Elizabeth R, 2011, Int J Alzheimers Dis, V2011, P726197, DOI 10.4061/2011/726197; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Yao J, 2011, CURR PHARM DESIGN, V17, P3474, DOI 10.2174/138161211798072517; Yin JX, 2011, J ALZHEIMERS DIS, V27, P89, DOI 10.3233/JAD-2011-110479; Zhang HL, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/949072; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	81	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e65898	10.1371/journal.pone.0065898	http://dx.doi.org/10.1371/journal.pone.0065898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738020	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700081
J	Grant, SP; Mayo-Wilson, E; Melendez-Torres, GJ; Montgomery, P				Grant, Sean P.; Mayo-Wilson, Evan; Melendez-Torres, G. J.; Montgomery, Paul			Reporting Quality of Social and Psychological Intervention Trials: A Systematic Review of Reporting Guidelines and Trial Publications	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; HEALTH INTERVENTIONS; CONSORT STATEMENT; CLINICAL-TRIALS; EXTENSION; IMPLEMENTATION; CHALLENGES; IMPACT; TREND; WORK	Background: Previous reviews show that reporting guidelines have improved the quality of trial reports in medicine, yet existing guidelines may not be fully suited for social and psychological intervention trials. Objective/Design: We conducted a two-part study that reviewed (1) reporting guidelines for and (2) the reporting quality of social and psychological intervention trials. Data Sources: (1) To identify reporting guidelines, we systematically searched multiple electronic databases and reporting guideline registries. (2) To identify trials, we hand-searched 40 journals with the 10 highest impact factors in clinical psychology, criminology, education, and social work. Eligibility: (1) Reporting guidelines consisted of articles introducing a checklist of reporting standards relevant to social and psychological intervention trials. (2) Trials reported randomised experiments of complex interventions with psychological, social, or health outcomes. Results: (1) We identified 19 reporting guidelines that yielded 147 reporting standards relevant to social and psychological interventions. Social and behavioural science guidelines included 89 standards not found in CONSORT guidelines. However, CONSORT guidelines used more recommended techniques for development and dissemination compared to other guidelines. (2) Our review of trials (n = 239) revealed that many standards were poorly reported, such as identification as a randomised trial in titles (20% reported the information) and abstracts (55%); information about blinding (15%), sequence generation (23%), and allocation concealment (17%); and details about actual delivery of experimental (43%) and control interventions (34%), participant uptake (25%), and service environment (28%). Only 11 of 40 journals referenced reporting guidelines in "Instructions to Authors." Conclusion: Existing reporting guidelines have important limitations in content, development, and/or dissemination. Important details are routinely missing from trial publications; most leading journals in social and behavioural sciences do not ask authors to follow reporting standards. Findings demonstrate a need to develop a CONSORT extension with updated standards for social and psychological intervention trials.	[Grant, Sean P.; Melendez-Torres, G. J.; Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England; [Mayo-Wilson, Evan] UCL, Res Dept Clin Educ & Hlth Psychol, Ctr Outcomes Res & Effectiveness, London, England	University of Oxford; University of London; University College London	Grant, SP (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford, England.	sean.grant@spi.ox.ac.uk	Mayo-Wilson, Evan/J-6289-2019; Grant, Sean/L-9912-2016	Mayo-Wilson, Evan/0000-0001-6126-2459; Grant, Sean/0000-0002-7775-3022; Melendez-Torres, G.J./0000-0002-9823-4790; Montgomery, Paul/0000-0001-8008-1370	Clarendon Fund-Green Templeton College Annual Fund Scholarship; Economic and Social Research Council (ESRC); Marshall Scholarship; Economic and Social Research Council [ES/K00087X/1] Funding Source: researchfish; ESRC [ES/K00087X/1] Funding Source: UKRI	Clarendon Fund-Green Templeton College Annual Fund Scholarship; Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Marshall Scholarship; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	SG holds a linked Clarendon Fund-Green Templeton College Annual Fund Scholarship to support his studies and research. EMW and PM have accepted a grant (no reference number assigned at time of submission) from the Economic and Social Research Council (ESRC; http://www.esrc.ac.uk/) to develop a CONSORT extension for complex psychological and social interventions. GJMT holds a Marshall Scholarship to support his studies and research. The authors thank the Centre for Evidence Based Intervention (Oxford), the Centre for Outcomes Research and Effectiveness (UCL), and the National Collaborating Centre for Mental Health (NCCMH) for internal support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, WIDER RECOMMENDATION; Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; American Educational Research Association, 2006, EDUC RESEARCHER, V35, P33, DOI DOI 10.3102/0013189X035006033; ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; Armstrong R, 2008, J PUBLIC HEALTH-UK, V30, P103, DOI 10.1093/pubmed/fdm082; BALAS EA, 1995, MED CARE, V33, P687, DOI 10.1097/00005650-199507000-00005; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Bonell C, 2006, BMJ-BRIT MED J, V333, P346, DOI 10.1136/bmj.333.7563.346; Bonell CP, 2011, J EPIDEMIOL COMMUN H, V65, P582, DOI 10.1136/jech.2008.082602; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Cooper H, 2008, AM PSYCHOL, V63, P839, DOI 10.1037/0003-066X.63.9.839; Davidson KW, 2003, ANN BEHAV MED, V26, P161, DOI 10.1207/S15324796ABM2603_01; Dechartres A, 2011, J CLIN EPIDEMIOL, V64, P136, DOI 10.1016/j.jclinepi.2010.04.015; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Egan M, 2009, J EPIDEMIOL COMMUN H, V63, P4, DOI 10.1136/jech.2007.071233; Eisenstein Eric L, 2007, AMIA Annu Symp Proc, P211; Evans Tim, 2003, Inj Control Saf Promot, V10, P11, DOI 10.1076/icsp.10.1.11.14117; Fraser MW, 2009, INTERVENTION RES DEV; Gill CE, 2011, J EXP CRIMINOL, V7, P201, DOI 10.1007/s11292-011-9122-z; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Han C, 2009, CONTEMP CLIN TRIALS, V30, P116, DOI 10.1016/j.cct.2008.11.004; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Ladd BO, 2010, ADDICT BEHAV, V35, P660, DOI 10.1016/j.addbeh.2010.02.009; Medical Research Council, 2008, DEV EV COMPL INT NEW; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Moberg-Mogren E, 2006, AM J OCCUP THER, V60, P226, DOI 10.5014/ajot.60.2.226; Moher D, 2004, CAN MED ASSOC J, V171, P349, DOI 10.1503/cmaj.1040031; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Moore L, 2002, BUILDING RES CAPACIT, V1, P4; Moore L, 2011, J EPIDEMIOL COMMUN H, V65, P596, DOI 10.1136/jech.2009.093211; MOSTELLER F, 1980, CONTROL CLIN TRIALS, V1, P37, DOI 10.1016/S0197-2456(80)80006-7; Naleppa MJ, 2010, RES SOCIAL WORK PRAC, V20, P674, DOI 10.1177/1049731509352088; Nelson DL, 2004, AM J OCCUP THER, V58, P24, DOI 10.5014/ajot.58.1.24; Pawson R., 2004, REALIST SYNTHESIS IN; Perry A., 2008, J EXPT CRIMINOLOGY, V4, P165, DOI DOI 10.1007/S11292-008-9051-7; Perry AE, 2010, J EXP CRIMINOL, V6, P245, DOI 10.1007/s11292-010-9099-z; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Prescott RJ, 1999, HEALTH TECHNOL ASSES, V3, P1, DOI DOI 10.3310/hta3200; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shepperd S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000086; Simera I, 2008, PLOS MED, V5, P869, DOI 10.1371/journal.pmed.0050139; Stinson JN, 2003, J PEDIATR PSYCHOL, V28, P159, DOI 10.1093/jpepsy/jsg001; Tetzlaff JM, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-43; Torgerson CJ, 2005, BRIT EDUC RES J, V31, P761, DOI 10.1080/01411920500314919; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; van Aalst J, 2010, EDUC RESEARCHER, V39, P387, DOI 10.3102/0013189X10371120; Viera AJ, 2005, FAM MED, V37, P360; Wallace, 2005, FMHI PUBLICATION, V231; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	54	67	69	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65442	10.1371/journal.pone.0065442	http://dx.doi.org/10.1371/journal.pone.0065442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155DJ	23734256	Green Submitted, gold, Green Published			2022-12-27	WOS:000319725500010
J	Hoppe, S; Bier, FF; von Nickisch-Rosenegk, M				Hoppe, Sebastian; Bier, Frank F.; v. Nickisch-Rosenegk, Markus			Rapid Identification of Novel Immunodominant Proteins and Characterization of a Specific Linear Epitope of Campylobacter jejuni	PLOS ONE			English	Article							SWISS-MODEL; ESCHERICHIA-COLI; MESSENGER-RNA; CONFORMATIONAL EPITOPE; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; PROKARYOTIC RNA; RIBOSOMAL-RNA; PREDICTION; MICROARRAY	Campylobacter jejuni remains one of the major gut pathogens of our time. Its zoonotic nature and wide-spread distribution in industrialized countries calls for a quick and reliable diagnostic tool. Antibody-based detection presents a suitable means to identify pathogenic bacteria. However, the knowledge about immunodominant targets is limited. Thus, an approach is presented, which allows for the rapid screening of numerous cDNA derived expression clones to identify novel antigens. The deeper understanding of immunodominant proteins assists in the design of diagnostic tools and furthers the insight into the bacterium's pathogenicity as well as revealing potential candidates for vaccination. We have successfully screened 1536 clones of an expression library to identify 22 proteins that have not been described as immunodominant before. After subcloning the corresponding 22 genes and expression of full-length proteins, we investigated the immunodominant character by microarrays and ELISA. Subsequently, seven proteins were selected for epitope mapping. For cj0669 and cj0920c linear epitopes were identified. For cj0669, specificity assays revealed a specific linear epitope site. Consequently, an eleven amino acid residue sequence TLIKELKRLGI was analyzed via alanine scan, which revealed the glycine residue to be significant for binding of the antibody. The innovative approach presented herein of generating cDNAs of prokaryotes in combination with a microarray platform rendering time-consuming purification steps obsolete has helped to illuminate novel immunodominant proteins of C. jejuni. The findings of a specific linear epitope pave the way for a plethora of future research and the potential use in diagnostic applications such as serological screenings. Moreover, the current approach is easily adaptable to other highly relevant bacteria making it a formidable tool for the future discovery of antigens and potential biomarkers. Consequently, it is desirable to simplify the identification of structural epitopes, as this would extend the spectrum of novel epitopes to be detected.	[Hoppe, Sebastian; Bier, Frank F.; v. Nickisch-Rosenegk, Markus] Fraunhofer Inst Biomed Engn, Potsdam, Germany; [Bier, Frank F.] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	Fraunhofer Gesellschaft; University of Potsdam	Hoppe, S (corresponding author), Fraunhofer Inst Biomed Engn, Potsdam, Germany.	sebastian.hoppe@ibmt.fraunhofer.de	Bier, Frank/AAN-2532-2020	Bier, Frank/0000-0003-0375-9832	German Federal Ministry of Education and Research [03IS2201A]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 03IS2201A of the German Federal Ministry of Education and Research (www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubarak A, 2004, J VIROL, V78, P4806, DOI 10.1128/JVI.78.9.4806-4816.2004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andresen H, 2006, PROTEOMICS, V6, P1376, DOI 10.1002/pmic.200500343; [Anonymous], 2013, ROBERT KOCH I EPIDEM, V03; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bach HJ, 1999, J MICROBIOL METH, V37, P187, DOI 10.1016/S0167-7012(99)00066-4; Behringer M, 2011, J MICROBIOL METH, V84, P194, DOI 10.1016/j.mimet.2010.11.016; Benjamin DC, 1995, ADV EXP MED BIOL, V386, P95; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blaser MJ, 2005, PRINCIPLES PRACTICE, V6th, P2548; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Bogdanova EA, 2011, METHODS MOL BIOL, V729, P85, DOI 10.1007/978-1-61779-065-2_6; CAO GJ, 1992, P NATL ACAD SCI USA, V89, P10380, DOI 10.1073/pnas.89.21.10380; Carmona SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050748; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Drummond AJ, 2012, GENEIOUS V5 6 2012; Du LF, 2008, WORLD J GASTROENTERO, V14, P6244, DOI 10.3748/wjg.14.6244; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flower Darren R., 2007, V409, P1, DOI 10.1007/978-1-60327-118-9_1; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; Gao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040104; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gilbert M, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P219; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guthridge JM, 2001, J IMMUNOL, V167, P5758, DOI 10.4049/jimmunol.167.10.5758; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Hoppe S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-12; HORSFALL AC, 1991, IMMUNOL TODAY, V12, P211, DOI 10.1016/0167-5699(91)90029-S; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Legros V, 2000, PROTEIN SCI, V9, P1002, DOI 10.1110/ps.9.5.1002; List C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000771; Lodish H, 2000, MOL CELL BIOL; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lundardi C, 2000, INT IMMUNOL, V12, P647, DOI 10.1093/intimm/12.5.647; Malik-Kale P, 2007, APPL ENVIRON MICROB, V73, P3123, DOI 10.1128/AEM.01399-06; Miller RS, 2008, J CLIN MICROBIOL, V46, P3546, DOI 10.1128/JCM.01027-08; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; NAKAZATO H, 1975, NATURE, V256, P144, DOI 10.1038/256144a0; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Pawelec DP, 2000, FEMS MICROBIOL LETT, V185, P43, DOI 10.1111/j.1574-6968.2000.tb09038.x; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1598, DOI 10.1128/AEM.01508-07; RHODES G, 1990, J CLIN LAB ANAL, V4, P456, DOI 10.1002/jcla.1860040613; Ribot EM, 2001, J CLIN MICROBIOL, V39, P1889, DOI 10.1128/JCM.39.5.1889-1894.2001; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stahl M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00005; Su CL, 1998, MOL BIOTECHNOL, V10, P83, DOI 10.1007/BF02745865; TEBBE CC, 1995, APPL ENVIRON MICROB, V61, P4296, DOI 10.1128/AEM.61.12.4296-4303.1995; Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846; VANDAMME P, 1991, INT J SYST BACTERIOL, V41, P451, DOI 10.1099/00207713-41-3-451; Vinion-Dubiel AD, 2001, INFECT IMMUN, V69, P4329, DOI 10.1128/IAI.69.7.4329-4336.2001; Wissmueller S, 2011, PROTEINS, V79, P2365, DOI 10.1002/prot.23068; Wyszynska A, 2008, CURR MICROBIOL, V57, P181, DOI 10.1007/s00284-008-9171-3; Xu CX, 2005, INT IMMUNOPHARMACOL, V5, P1151, DOI 10.1016/j.intimp.2005.02.008; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Zhang R, 2001, 2 0 CRYSTAL STRUCTUR, DOI [10.2210/pdb1ji0/pdb, DOI 10.2210/PDB1JI0/PDB]; Zhou WZ, 2012, INT J MOL SCI, V13, P13150, DOI 10.3390/ijms131013150; Zhu H, 2006, P NATL ACAD SCI USA, V103, P4011, DOI 10.1073/pnas.0510921103	75	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65837	10.1371/journal.pone.0065837	http://dx.doi.org/10.1371/journal.pone.0065837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734261	Green Submitted, gold, Green Published			2022-12-27	WOS:000319725500005
J	Calizza, E; Rossi, L; Costantini, ML				Calizza, Edoardo; Rossi, Loreto; Costantini, Maria Letizia			Predators and Resources Influence Phosphorus Transfer along an Invertebrate Food Web through Changes in Prey Behaviour	PLOS ONE			English	Article							CHEMICAL STIMULI; BOTTOM-UP; RESPONSES; RISK; POPULATIONS; COEXISTENCE; COMPETITION; MECHANISMS; LANDSCAPE; STABILITY	Predators play a fundamental role in prey trophic behaviour, with indirect consequences for species coexistence and ecosystem functioning. Resource quality and availability also influence prey trophic behaviour, with potential effects on predator-prey dynamics. Although many studies have addressed these topics, little attention has been paid to the combined effects of predators and resources on prey species coexistence and nutrient transfer along food chains, especially in detritus-based systems. To determine the influence of predators and resource quality on the movement and P uptake of detritivores, we carried out a field experiment on the River Kelvin (Scotland) using P-32 to test the hypothesis of reduced prey vagility among resource patches as a strategy to avoid predation. Thirty leaf sacks containing alder leaves and two detritivore prey populations (Asellus aquaticus and Lymnaea peregra) were placed in cages, half of them with two predator species (Dendrocoelum lacteum and Erpobdella octoculata) and the other half without predators. Five alder leaf bags, each individually inoculated with a different fungus strain to simulate a patchy habitat, were placed inside each leaf sack. One bag in each sack was labelled with P-32, in order to assess the proportion of detritivores using it as food and thus their movement among the five resource patches. Three replicates for each labelled fungus and each predation treatment (i.e. with and without predators) were left on the riverbed for 7 days. The presence of predators had negligible effects on the number of detritivores in the leaf bags, but it did reduce the proportion of P-32-labelled detritivores and their P uptake. The most strongly affected species was A. aquaticus, whose vagility, trophic overlap with L. peregra and P uptake were all reduced. The results confirm the importance of bottom-up and top-down forces acting simultaneously to regulate nutrient transfer along food chains in patchy habitats.	[Calizza, Edoardo; Rossi, Loreto; Costantini, Maria Letizia] Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy	Sapienza University Rome	Rossi, L (corresponding author), Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy.	loreto.rossi@uniroma1.it		Calizza, Edoardo/0000-0002-9457-4229; ROSSI, LORETO/0000-0001-8014-5397; Costantini, Maria Letizia/0000-0001-6242-558X	National Academy of Lincei; PNRA (Ministero dell'istruzione, dell'universitae della ricerca); Provincia di Latina (Presidenza and Assessorato Ambiente)	National Academy of Lincei; PNRA (Ministero dell'istruzione, dell'universitae della ricerca); Provincia di Latina (Presidenza and Assessorato Ambiente)	Funding for experiment provided by National Academy of Lincei. Funding for numerical analysis provided by PNRA 2010 (Ministero dell'istruzione, dell'universitae della ricerca, http://www.istruzione.it/) and Provincia di Latina (Presidenza and Assessorato Ambiente) 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminot A, 1996, WATER RES, V30, P2805, DOI 10.1016/S0043-1354(96)00192-3; BASSET A, 1990, FUNCT ECOL, V4, P685, DOI 10.2307/2389737; Beisner BE, 2003, ECOLOGY, V84, P1563, DOI 10.1890/0012-9658(2003)084[1563:VOLOTL]2.0.CO;2; Bell AV, 2009, THEOR POPUL BIOL, V76, P52, DOI 10.1016/j.tpb.2009.03.008; BROWMAN HI, 1987, HOLARCTIC ECOL, V10, P163; Browman HI, 2011, MAR BIOL, V158, P2653, DOI 10.1007/s00227-011-1763-y; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Bundschuh M, 2012, ARCH ENVIRON CON TOX, V63, P77, DOI 10.1007/s00244-011-9743-2; Calizza E, 2012, FRESHWATER BIOL, V57, P2613, DOI 10.1111/fwb.12033; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Costantini ML, 2010, FRESHWATER BIOL, V55, P2281, DOI 10.1111/j.1365-2427.2010.02433.x; Costantini ML, 2005, MAR FRESHWATER RES, V56, P997, DOI 10.1071/MF04272; COSTANTINI ML, 1995, HYDROBIOLOGIA, V302, P81, DOI 10.1007/BF00006401; COVICH AP, 1994, J N AM BENTHOL SOC, V13, P283, DOI 10.2307/1467246; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Dahl J, 1998, OECOLOGIA, V117, P217, DOI 10.1007/s004420050651; Davis J, 2010, FRESHWATER BIOL, V55, P5, DOI 10.1111/j.1365-2427.2009.02376.x; DUSSART GBJ, 1979, HYDROBIOLOGIA, V67, P223, DOI 10.1007/BF00023179; Eroukhmanoff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006173; Faithfull CL, 2011, OIKOS, V120, P311, DOI 10.1111/j.1600-0706.2010.18683.x; Ferreira V, 2011, OECOLOGIA, V167, P279, DOI 10.1007/s00442-011-1976-2; Fry B., 2006, STABLE ISOTOPE ECOLO; Gessner M. O., 2007, P301; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; HAM L, 1995, ARCH ENVIRON CON TOX, V29, P358, DOI 10.1007/BF00212501; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Henry J.-P., 1983, Bulletin Mensuel de la Societe Linneenne de Lyon, V52, P319; HERRMANN J, 1984, HYDROBIOLOGIA, V114, P3, DOI 10.1007/BF00016595; HEWS DK, 1988, ANIM BEHAV, V36, P125, DOI 10.1016/S0003-3472(88)80255-0; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; LANCASTER J, 1991, J ANIM ECOL, V60, P625, DOI 10.2307/5302; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MACAN TT, 1977, BIOL REV, V52, P45, DOI 10.1111/j.1469-185X.1977.tb01345.x; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; Meissner K, 2009, ANN ZOOL FENN, V46, P193, DOI 10.5735/086.046.0304; Morrison LW, 1999, OECOLOGIA, V121, P113, DOI 10.1007/s004420050912; Mulder C, 2006, NATURWISSENSCHAFTEN, V93, P467, DOI 10.1007/s00114-006-0130-1; Mulder C, 2012, ADV ECOL RES, V46, P1, DOI 10.1016/B978-0-12-396992-7.00001-0; Mulder C, 2011, ADV ECOL RES, V44, P277, DOI 10.1016/B978-0-12-374794-5.00005-5; Orr MV, 2007, J EXP BIOL, V210, P4150, DOI 10.1242/jeb.010173; Orrock JL, 2008, ECOLOGY, V89, P2426, DOI 10.1890/07-1024.1; OSENBERG CW, 1988, THESIS MICHIGAN STAT; Palkovacs EP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018879; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Peckarsky BL, 1998, OECOLOGIA, V113, P565, DOI 10.1007/s004420050410; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Preisser EL, 2009, ECOL LETT, V12, P315, DOI 10.1111/j.1461-0248.2009.01290.x; REYNOLDSON TB, 1979, J ZOOL, V189, P459; REYNOLDSON TB, 1970, J ANIM ECOL, V39, P599, DOI 10.2307/2857; ROSSI L, 1983, MYCOLOGIA, V75, P887, DOI 10.2307/3792781; ROSSI L, 1985, OIKOS, V44, P175, DOI 10.2307/3544059; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; SEABY RMH, 1995, FRESHWATER BIOL, V34, P21, DOI 10.1111/j.1365-2427.1995.tb00419.x; SIH A, 1992, ECOLOGY, V73, P1418, DOI 10.2307/1940687; SIH A, 1979, J ANIM ECOL, V48, P79, DOI 10.2307/4101; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Thaler JS, 2012, P NATL ACAD SCI USA, V109, P12075, DOI 10.1073/pnas.1208070109; Tikkanen P, 1996, ANIM BEHAV, V51, P1391, DOI 10.1006/anbe.1996.0142; Verovnik R, 2005, MOL ECOL, V14, P4355, DOI 10.1111/j.1365-294X.2005.02745.x; Whittaker R, 1961, ECOL MONOGR, V1, P57; Wirsing AJ, 2010, ANIM BEHAV, V79, P531, DOI 10.1016/j.anbehav.2009.12.014; Wisenden BD, 1997, J CHEM ECOL, V23, P137, DOI 10.1023/B:JOEC.0000006350.66424.3d; Withers PJA, 2008, SCI TOTAL ENVIRON, V400, P379, DOI 10.1016/j.scitotenv.2008.08.002; WOOSTER D, 1995, OIKOS, V73, P3, DOI 10.2307/3545718; Wudkevich K, 1997, J CHEM ECOL, V23, P1163, DOI 10.1023/B:JOEC.0000006393.92013.36; YOUNG JO, 1980, HYDROBIOLOGIA, V68, P209, DOI 10.1007/BF00018828	75	26	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65186	10.1371/journal.pone.0065186	http://dx.doi.org/10.1371/journal.pone.0065186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750242	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900044
J	Teixeira-Silva, A; Silva, RM; Carneiro, J; Amorim, A; Azevedo, L				Teixeira-Silva, Ana; Silva, Raquel M.; Carneiro, Joao; Amorim, Antonio; Azevedo, Luisa			The Role of Recombination in the Origin and Evolution of Alu Subfamilies	PLOS ONE			English	Article							HUMAN GENOMIC DIVERSITY; GENE CONVERSION; HUMAN-DISEASE; HOT-SPOTS; ELEMENTS; DELETIONS; RETROTRANSPOSITION; REPEATS; HUMANS; REARRANGEMENTS	Alus are the most abundant and successful short interspersed nuclear elements found in primate genomes. In humans, they represent about 10% of the genome, although few are retrotransposition-competent and are clustered into subfamilies according to the source gene from which they evolved. Recombination between them can lead to genomic rearrangements of clinical and evolutionary significance. In this study, we have addressed the role of recombination in the origin of chimeric Alu source genes by the analysis of all known consensus sequences of human Alus. From the allelic diversity of Alu consensus sequences, validated in extant elements resulting from whole genome searches, distinct events of recombination were detected in the origin of particular subfamilies of AluS and AluY source genes. These results demonstrate that at least two subfamilies are likely to have emerged from ectopic Alu-Alu recombination, which stimulates further research regarding the potential of chimeric active Alus to punctuate the genome.	[Teixeira-Silva, Ana; Silva, Raquel M.; Carneiro, Joao; Amorim, Antonio; Azevedo, Luisa] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Teixeira-Silva, Ana; Carneiro, Joao; Amorim, Antonio] Univ Porto, FCUP Fac Sci, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Azevedo, L (corresponding author), Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lazevedo@ipatimup.pt	Carneiro, Joao/A-6289-2009; Silva, Raquel M/B-8337-2008; Azevedo, Luisa/J-4051-2013; Amorim, Antonio/A-7938-2008	Carneiro, Joao/0000-0002-5153-2395; Silva, Raquel M/0000-0001-5926-8042; Azevedo, Luisa/0000-0002-3157-7342; Amorim, Antonio/0000-0002-7518-6247; Teixeira-Silva, Ana/0000-0002-9011-9501	FCT (Portuguese governmental institution); MCTES national funding; European Social Fund;  [PTDC/BIA-PRO/099888/2008]	FCT (Portuguese governmental institution); MCTES national funding; European Social Fund(European Social Fund (ESF)); 	This work was supported by FCT (Portuguese governmental institution) through the program Ciencia2007 (Hiring of PhDs for the SCTN - financed by POPH - QREN - Tipology 4.2 - Promoting Scientific Employment, co-financed by MCTES national funding and The European Social Fund and the research project PTDC/BIA-PRO/099888/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Comeaux MS, 2009, GENOME RES, V19, P545, DOI 10.1101/gr.089789.108; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; DEININGER PL, 1986, TRENDS GENET, V2, P76, DOI 10.1016/0168-9525(86)90183-6; Dobrovolny R, 2011, HUM MUTAT, V32, P688, DOI 10.1002/humu.21474; Drummond AJ., 2011, GENEIOUS PRO 5 4; Franke G, 2009, HUM MUTAT, V30, P776, DOI 10.1002/humu.20948; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Johanning K, 2003, J MOL EVOL, V56, P658, DOI 10.1007/s00239-002-2433-y; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kapitonov V, 1996, J MOL EVOL, V42, P59, DOI 10.1007/BF00163212; Kuiper RP, 2011, HUM MUTAT, V32, P407, DOI 10.1002/humu.21446; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MATERA AG, 1990, NUCLEIC ACIDS RES, V18, P6019, DOI 10.1093/nar/18.20.6019; McVean G, 2010, PHILOS T R SOC B, V365, P1213, DOI 10.1098/rstb.2009.0299; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Nachman MW, 2000, GENETICS, V156, P297; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Park ES, 2005, GENES GENET SYST, V80, P415, DOI 10.1266/ggs.80.415; Pereira MC, 2012, GENET MED, V14, P143, DOI 10.1038/gim.2011.7; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Quental R, 2009, CLIN GENET, V75, P457, DOI 10.1111/j.1399-0004.2009.01172.x; Ray DA, 2005, BMC EVOLUTIONARY BIO, V5; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; Roy AM, 2000, GENOME RES, V10, P1485, DOI 10.1101/gr.152300; Roy-Engel AM, 2002, J MOL BIOL, V316, P1033, DOI 10.1006/jmbi.2001.5380; Salem AH, 2003, MOL BIOL EVOL, V20, P1349, DOI 10.1093/molbev/msg150; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Styles P, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-102; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WILLARD C, 1987, J MOL EVOL, V26, P180, DOI 10.1007/BF02099850; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Zhi DG, 2007, GENE, V390, P117, DOI 10.1016/j.gene.2006.09.030	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64884	10.1371/journal.pone.0064884	http://dx.doi.org/10.1371/journal.pone.0064884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750218	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900020
J	Luo, RB; Wong, T; Zhu, JQ; Liu, CM; Zhu, XQ; Wu, E; Lee, LK; Lin, HX; Zhu, WJ; Cheung, DW; Ting, HF; Yiu, SM; Peng, SL; Yu, C; Li, YR; Li, RQ; Lam, TW				Luo, Ruibang; Wong, Thomas; Zhu, Jianqiao; Liu, Chi-Man; Zhu, Xiaoqian; Wu, Edward; Lee, Lap-Kei; Lin, Haoxiang; Zhu, Wenjuan; Cheung, David W.; Ting, Hing-Fung; Yiu, Siu-Ming; Peng, Shaoliang; Yu, Chang; Li, Yingrui; Li, Ruiqiang; Lam, Tak-Wah			SOAP3-dp: Fast, Accurate and Sensitive GPU-Based Short Read Aligner	PLOS ONE			English	Article							ALIGNMENT; SEQUENCE; FRAMEWORK; EFFICIENT; ULTRAFAST; TOOL	To tackle the exponentially increasing throughput of Next-Generation Sequencing (NGS), most of the existing short-read aligners can be configured to favor speed in trade of accuracy and sensitivity. SOAP3-dp, through leveraging the computational power of both CPU and GPU with optimized algorithms, delivers high speed and sensitivity simultaneously. Compared with widely adopted aligners including BWA, Bowtie2, SeqAlto, CUSHAW2, GEM and GPU-based aligners BarraCUDA and CUSHAW, SOAP3-dp was found to be two to tens of times faster, while maintaining the highest sensitivity and lowest false discovery rate (FDR) on Illumina reads with different lengths. Transcending its predecessor SOAP3, which does not allow gapped alignment, SOAP3-dp by default tolerates alignment similarity as low as 60%. Real data evaluation using human genome demonstrates SOAP3-dp's power to enable more authentic variants and longer Indels to be discovered. Fosmid sequencing shows a 9.1% FDR on newly discovered deletions. SOAP3-dp natively supports BAM file format and provides the same scoring scheme as BWA, which enables it to be integrated into existing analysis pipelines. SOAP3-dp has been deployed on Amazon-EC2, NIH-Biowulf and Tianhe-1A.	[Luo, Ruibang; Wong, Thomas; Zhu, Jianqiao; Liu, Chi-Man; Wu, Edward; Lee, Lap-Kei; Cheung, David W.; Ting, Hing-Fung; Yiu, Siu-Ming; Lam, Tak-Wah] Univ Hong Kong, HKU BGI Bioinformat Algorithms & Core Technol Res, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Zhu, Xiaoqian; Peng, Shaoliang] Natl Univ Def Technol, Sch Comp Sci, Changsha, Hunan, Peoples R China; [Lin, Haoxiang; Zhu, Wenjuan; Yu, Chang; Li, Yingrui] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Li, Ruiqiang] Peking Univ, Peking Tsinghua Ctr Life Sci, Biodynam Opt Imaging Ctr, Sch Life Sci, Beijing 100871, Peoples R China; [Zhu, Jianqiao] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA	University of Hong Kong; National University of Defense Technology - China; Beijing Genomics Institute (BGI); Peking University; University of Wisconsin System; University of Wisconsin Madison	Li, YR (corresponding author), BGI Shenzhen, Shenzhen, Guangdong, Peoples R China.	liyr@genomics.cn; lirq@pku.edu.cn; twlam@cs.hku.hk	Yu, Chang/AAE-8538-2019; Yiu, Siu Ming/C-1843-2009; Li, Yingrui/K-1064-2015; Lee, Lap-Kei/AAT-7933-2020; Wong, Thomas/J-7623-2013	Yiu, Siu Ming/0000-0002-3975-8500; Lee, Lap-Kei/0000-0001-9619-6041; Wong, Thomas/0000-0002-0580-6324; Lam, Tak-Wah/0000-0003-4676-8587; Peng, Shaoliang/0000-0002-4647-2615; Luo, Ruibang/0000-0001-9711-6533	RGC General Research Fund [10612042]; Hong Kong ITF Grant [GHP/011/12]; GRF Grant [HKU-713512E]	RGC General Research Fund; Hong Kong ITF Grant; GRF Grant	TL was partially supported by RGC General Research Fund 10612042. R. Luo was partially supported by Hong Kong ITF Grant GHP/011/12. Both R. Luo and TL are partially supported by the GRF Grant HKU-713512E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; Klus Petr, 2012, BMC Res Notes, V5, P27, DOI 10.1186/1756-0500-5-27; Lam TW, 2009, IEEE INT C BIOINFORM, P31, DOI 10.1109/BIBM.2009.42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Liu C.-M., 2011, 3 WORKSH MASS DAT AL; Liu CM, 2012, BIOINFORMATICS, V28, P878, DOI 10.1093/bioinformatics/bts061; Liu YC, 2012, BIOINFORMATICS, V28, pI318, DOI 10.1093/bioinformatics/bts414; Liu YC, 2012, BIOINFORMATICS, V28, P1830, DOI 10.1093/bioinformatics/bts276; Liu Yongchao, 2009, BMC Res Notes, V2, P73, DOI 10.1186/1756-0500-2-73; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mu JC, 2012, BIOINFORMATICS, V28, P2366, DOI 10.1093/bioinformatics/bts450; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; *NVIDIA, 2012, BIOINF LIF SCI; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zaharia M, 2011, 11115572V1 ARXIV	27	69	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65632	10.1371/journal.pone.0065632	http://dx.doi.org/10.1371/journal.pone.0065632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741504	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900217
J	Manam, S; Chaganty, BKR; Evani, SJ; Zafiratos, MT; Ramasubramanian, AK; Arulanandam, BP; Murthy, AK				Manam, Srikanth; Chaganty, Bharat K. R.; Evani, Shankar Jaikishan; Zafiratos, Mark T.; Ramasubramanian, Anand K.; Arulanandam, Bernard P.; Murthy, Ashlesh K.			Intranasal Vaccination with Chlamydia pneumoniae Induces Cross-Species Immunity against Genital Chlamydia muridarum Challenge in Mice	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; PROTECTIVE IMMUNITY; OVIDUCT PATHOLOGY; INFECTION; IMMUNIZATION; ANTIBODIES; RESOLUTION; GAMMA	Chlamydia trachomatis is the most common bacterial sexually transmitted disease in the world and specifically in the United States, with the highest incidence in age-groups 14-19 years. In a subset of females, the C. trachomatis genital infection leads to serious pathological sequelae including pelvic inflammatory disease, ectopic pregnancy, and infertility. Chlamydia pneumoniae, another member of the same genus, is a common cause of community acquired respiratory infection with significant number of children aged 5-14 yr displaying sero-conversion. Since these bacteriae share several antigenic determinants, we evaluated whether intranasal immunization with live C. pneumoniae (1610 6 inclusion forming units; IFU) in 5 week old female C57BL/6 mice would induce cross-species protection against subsequent intravaginal challenge with Chlamydia muridarum (5x10(4) IFU), which causes a similar genital infection and pathology in mice as C. trachomatis in humans. Mice vaccinated intranasally with live C. pneumoniae, but not mock (PBS) immunized animals, displayed high levels of splenic cellular antigen-specific IFN-gamma production and serum antibody response against C. muridarum and C. trachomatis. Mice vaccinated with C. pneumoniae displayed a significant reduction in the vaginal C. muridarum shedding as early as day 12 after secondary i.vag. challenge compared to PBS (mock) immunized mice. At day 19 after C. muridarum challenge, 100% of C. pneumoniae vaccinated mice had cleared the infection compared to none (0%) of the mock immunized mice, which cleared the infection by day 27. At day 80 after C. muridarum challenge, C. pneumoniae vaccinated mice displayed a significant reduction in the incidence (50%) and degree of hydrosalpinx compared to mock immunized animals (100%). These results suggest that respiratory C. pneumoniae infection induces accelerated chlamydial clearance and reduction of oviduct pathology following genital C. muridarum challenge, and may have important implications to the C. trachomatis-induced reproductive disease in humans.	[Manam, Srikanth; Zafiratos, Mark T.; Murthy, Ashlesh K.] Midwestern Univ, Dept Pathol, Downers Grove, IL 60515 USA; [Chaganty, Bharat K. R.; Evani, Shankar Jaikishan; Ramasubramanian, Anand K.; Arulanandam, Bernard P.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, Dept Biol, San Antonio, TX USA	Midwestern University; University of Texas System; University of Texas at San Antonio (UTSA)	Murthy, AK (corresponding author), Midwestern Univ, Dept Pathol, Downers Grove, IL 60515 USA.	amurth@midwestern.edu	Arulanandam, Bernard P/O-9501-2014; Manam, Srikanth/K-6265-2019; evani, shankar jaikishan/Z-3198-2019	Manam, Srikanth/0000-0001-5682-1957; Chaganty, Bharat Kumar Reddy/0000-0003-3281-6218	NIH [1R03AI088342, 1RO1AI074860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL112629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074860, R03AI088342] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grant 1R03AI088342 to AKM, and NIH 1RO1AI074860 to BPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; CALDWELL HD, 1982, INFECT IMMUN, V38, P745, DOI 10.1128/IAI.38.2.745-754.1982; Campbell LA, 2005, INFECT IMMUN, V73, P3164, DOI 10.1128/IAI.73.5.3164-3165.2005; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Debattista J, 2003, FERTIL STERIL, V79, P1273, DOI 10.1016/S0015-0282(03)00396-0; Dong F, 2005, INFECT IMMUN, V73, P1868, DOI 10.1128/IAI.73.3.1868-1872.2005; Imtiaz MT, 2007, MICROBES INFECT, V9, P1561, DOI 10.1016/j.micinf.2007.08.010; Imtiaz MT, 2006, INFECT IMMUN, V74, P5513, DOI 10.1128/IAI.00730-06; Kelly KA, 2003, INT REV IMMUNOL, V22, P3, DOI 10.1080/08830180305229; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Li WD, 2008, J IMMUNOL, V180, P3375, DOI 10.4049/jimmunol.180.5.3375; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; Murthy AK, 2007, INFECT IMMUN, V75, P666, DOI 10.1128/IAI.01280-06; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Murthy AK, 2011, VACCINE, V29, P2519, DOI 10.1016/j.vaccine.2011.01.074; Murthy AK, 2009, J REPROD IMMUNOL, V83, P179, DOI 10.1016/j.jri.2009.05.007; Murthy AK, 2009, FEMS IMMUNOL MED MIC, V55, P271, DOI 10.1111/j.1574-695X.2008.00517.x; Pal S, 2006, VACCINE, V24, P766, DOI 10.1016/j.vaccine.2005.08.074; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Pal S, 2008, INFECT IMMUN, V76, P5581, DOI 10.1128/IAI.00574-08; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rekart ML, 2008, SEX TRANSM INFECT, V84, P87, DOI 10.1136/sti.2007.027938; Rockey DD, 2009, EXPERT REV VACCINES, V8, P1365, DOI 10.1586/ERV.09.98; Satterwhite C. L., 2011, Morbidity and Mortality Weekly Report, V60, P370; STEPHENS RS, 1988, J EXP MED, V167, P817, DOI 10.1084/jem.167.3.817; Yang X, 1998, J IMMUNOL, V161, P1439	27	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64917	10.1371/journal.pone.0064917	http://dx.doi.org/10.1371/journal.pone.0064917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741420	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900133
J	Oulidi, A; Bokhobza, A; Gkika, D; Vanden Abeele, F; Lehen'kyi, V; Ouafik, L; Mauroy, B; Prevarskaya, N				Oulidi, Agathe; Bokhobza, Alexandre; Gkika, Dimitra; Vanden Abeele, Fabien; Lehen'kyi, V'yacheslav; Ouafik, L'Houcine; Mauroy, Brigitte; Prevarskaya, Natalia			TRPV2 Mediates Adrenomedullin Stimulation of Prostate and Urothelial Cancer Cell Adhesion, Migration and Invasion	PLOS ONE			English	Article							CHANNEL; ANGIOGENESIS; PROGRESSION; ACTIVATION; PEPTIDE; GROWTH	Adrenomedullin (AM) is a 52-amino acid peptide initially isolated from human pheochromocytoma. AM is expressed in a variety of malignant tissues and cancer cell lines and was shown to be a mitogenic factor capable of stimulating growth of several cancer cell types. In addition, AM is a survival factor for certain cancer cells. Some data suggest that AM might be involved in the progression cancer metastasis via angiogenesis and cell migration and invasion control. The Transient Receptor Potential channel TRPV2 is known to promote in prostate cancer cell migration and invasive phenotype and is correlated with the stage and grade of bladder cancer. In this work we show that AM induces prostate and urothelial cancer cell migration and invasion through TRPV2 translocation to plasma membrane and the subsequent increase in resting calcium level.	[Oulidi, Agathe; Bokhobza, Alexandre; Gkika, Dimitra; Vanden Abeele, Fabien; Lehen'kyi, V'yacheslav; Mauroy, Brigitte; Prevarskaya, Natalia] Equipe Labellisee Ligue Natl Canc, INSERM U1003, Villeneuve Dascq, France; [Oulidi, Agathe; Bokhobza, Alexandre; Gkika, Dimitra; Vanden Abeele, Fabien; Lehen'kyi, V'yacheslav; Mauroy, Brigitte; Prevarskaya, Natalia] Univ Sci & Technol Lille, Lab Excellence Ion Channels Sci & Therapeut, Villeneuve Dascq, France; [Ouafik, L'Houcine] Fac Med Timone, Inserm UMR CRO2 911, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Gkika, D (corresponding author), Equipe Labellisee Ligue Natl Canc, INSERM U1003, Villeneuve Dascq, France.	dimitra.gkika@univ-lille1.fr	Vanden Abeele, Fabien/O-6012-2017; Gkika, Dimitra/S-3054-2019; LEHEN'KYI, V'yacheslav/AAJ-6008-2020	Gkika, Dimitra/0000-0001-8612-0836; LEHEN'KYI, V'yacheslav/0000-0003-0806-8766; Vanden Abeele, Fabien/0000-0001-7111-7220; Ouafik, L'Houcine/0000-0002-4848-1232; bokhobza, Alexandre/0000-0001-7953-4328; Prevarskaya, natacha/0000-0003-0316-197X	Institut National de la Sante et de la Recherche Medicale (INSERM); Ligue Nationale Contre le Cancer; Region Nord Pas de Calais; Universite Catholique de Lille	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Nord Pas de Calais(Region Hauts-de-France); Universite Catholique de Lille	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), Ligue Nationale Contre le Cancer, Region Nord Pas de Calais and Universite Catholique de Lille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodding M, 2007, CELL SIGNAL, V19, P617, DOI 10.1016/j.cellsig.2006.08.012; Boels K, 2001, J CELL SCI, V114, P3599; Caprodossi S, 2007, EUR UROL; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; FUJITA S, 1992, JPN J CANCER RES, V83, P1317, DOI 10.1111/j.1349-7006.1992.tb02764.x; Gkika D, 2010, ONCOGENE, V29, P4611, DOI 10.1038/onc.2010.210; Gkika D, 2011, ASIAN J ANDROL; HaywoodReid PL, 1997, PROSTATE, V31, P1, DOI 10.1002/(SICI)1097-0045(19970401)31:1<1::AID-PROS1>3.0.CO;2-S; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Ishikawa T, 2003, ONCOGENE, V22, P1238, DOI 10.1038/sj.onc.1206207; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Kuwasako K, 2011, PEPTIDES, V32, P1540, DOI 10.1016/j.peptides.2011.05.022; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Monet M, 2010, CANCER RES, V70, P1225, DOI 10.1158/0008-5472.CAN-09-2205; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Nakamura M, 2006, CURR CANCER DRUG TAR, V6, P635, DOI 10.2174/156800906778742442; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Pomorski Pawel, 2009, Postepy Biochem, V55, P163; Skryma R, 2011, NAT REV UROL, V8, P617, DOI 10.1038/nrurol.2011.142; Zudaire E, 2003, REGUL PEPTIDES, V112, P175, DOI 10.1016/S0167-0115(03)00037-5	20	34	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64885	10.1371/journal.pone.0064885	http://dx.doi.org/10.1371/journal.pone.0064885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741410	Green Published, gold			2022-12-27	WOS:000319799900123
J	Pierre, N; Deldicque, L; Barbe, C; Naslain, D; Cani, PD; Francaux, M				Pierre, Nicolas; Deldicque, Louise; Barbe, Caroline; Naslain, Damien; Cani, Patrice D.; Francaux, Marc			Toll-Like Receptor 4 Knockout Mice Are Protected against Endoplasmic Reticulum Stress Induced by a High-Fat Diet	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; UNFOLDED PROTEIN RESPONSE; SKELETAL-MUSCLE; INDUCED OBESITY; ADIPOSE-TISSUE; MESSENGER-RNA; INDUCED INFLAMMATION; WEIGHT-LOSS; ER STRESS; GLUCOSE	The purpose of this study was to investigate whether toll-like receptor 4 (TLR4) is implicated in the development of endoplasmic reticulum stress (ER stress) observed after a high-fat diet (HFD) in liver, skeletal muscle and adipose tissue. TLR4(-/-) and C57BL/6J wild-type mice (WT) were fed with chow or HFD (45% calories from fat) during 18 weeks. An oral glucose tolerance-test was performed. The animals were sacrificed in a fasted state and the tissues were removed. TLR4 deletion protected from body weight gain and glucose intolerance induced by HFD whereas energy intake was higher in transgenic mice suggesting larger energy expenditure. HFD induced an ER stress in skeletal muscle, liver and adipose tissue of WT mice as assessed by BiP, CHOP, spliced and unspliced XBP1 and phospho-eIF2 alpha. TLR4(-/-) mice were protected against HFD-induced ER stress. Then, we investigated the main signaling downstream of TLR4 namely the NF-kappa B pathway, expecting to identify the mechanism by which TLR4 is able to activate ER stress. The mRNA levels of cytokines regulated by NF-kappa B namely TNF alpha, IL-1 beta and IL-6, were not changed after HFD and phospho-I kappa B-alpha (ser 32) was not changed. Our results indicate that TLR4 is essential for the development of ER stress related to HFD. Nevertheless, the NF kappa-B pathway does not seem to be directly implicated. The reduced fat storage in TLR4(-/-) mice could explain the absence of an ER stress after HFD.	[Pierre, Nicolas; Barbe, Caroline; Naslain, Damien; Francaux, Marc] Catholic Univ Louvain, Inst Neurosci, B-1348 Louvain, Belgium; [Deldicque, Louise] Exercise Physiol Res Grp, Dept Kinesiol, Ku Louvain, Belgium; [Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Francaux, M (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1348 Louvain, Belgium.	marc.francaux@uclouvain.be	D., Cani Patrice/M-8055-2016	D., Cani Patrice/0000-0003-2040-2448; Deldicque, Louise/0000-0003-3393-5278; Francaux, Marc/0000-0001-8182-1588; Pierre, Nicolas/0000-0002-8324-0434	Fonds de la Recherche Scientifique Medicale [FRSM 3.4514]; Fonds Speciaux de Recherche from the Universite catholique de Louvain; SFD (Societe Francophone du Diabete); FSR (Fonds Speciaux de Recherche); UCL (Universite catholique de Louvain); FRSM (Fonds de la Recherche Scientifique Medicale)	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de Recherche from the Universite catholique de Louvain; SFD (Societe Francophone du Diabete); FSR (Fonds Speciaux de Recherche); UCL (Universite catholique de Louvain); FRSM (Fonds de la Recherche Scientifique Medicale)(Fonds de la Recherche Scientifique - FNRS)	This study was granted by the Fonds de la Recherche Scientifique Medicale (FRSM 3.4514. www.fnrs.be/) and by the Fonds Speciaux de Recherche (http://www.uclouvain.be/389.html) from the Universite catholique de Louvain. P. D. C. is a research associate from the FRS-FNRS (Fonds de la Recherche Scientifique) in Belgium and is the recipient of subsidies from SFD (Societe Francophone du Diabete, http://www.sfdiabete.org/), FSR (Fonds Speciaux de Recherche, UCL (Universite catholique de Louvain)) and the FRSM (Fonds de la Recherche Scientifique Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, SCAND J INFECT DIS, V35, P555, DOI 10.1080/00365540310015683; Alhusaini S, 2010, BIOCHEM BIOPH RES CO, V397, P472, DOI 10.1016/j.bbrc.2010.05.138; Beriault DR, 2011, ATHEROSCLEROSIS; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Boden G, 2009, DIABETES, V58, P518, DOI 10.2337/db08-1746; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Dutta R, 2001, DIABETES, V50, P1186, DOI 10.2337/diabetes.50.5.1186; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Frisard MI, 2010, AM J PHYSIOL-ENDOC M, V298, pE988, DOI 10.1152/ajpendo.00307.2009; Gao S, 2010, BIOCHEM BIOPH RES CO, V398, P619, DOI 10.1016/j.bbrc.2010.05.114; Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010; Greenberg AS, 2006, AM J CLIN NUTR, V83, p461S; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim J. J., 2010, GASTROENTEROL RES PR, V2010; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kozlov AV, 2009, BBA-MOL BASIS DIS, V1792, P521, DOI 10.1016/j.bbadis.2009.03.004; Kuribayashi JS, 2008, MOL IMMUNOL, V45, P2990, DOI 10.1016/j.molimm.2008.01.013; Lambert CP, 2008, J APPL PHYSIOL, V105, P473, DOI 10.1152/japplphysiol.00006.2008; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Omar B, 2012, NUTRIENTS, V4, P1367, DOI 10.3390/nu4101367; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PAGLIASSOTTI MJ, 1994, AM J PHYSIOL, V266, pR1637, DOI 10.1152/ajpregu.1994.266.5.R1637; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Roden M, 1999, DIABETES, V48, P358, DOI 10.2337/diabetes.48.2.358; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Sheikh-Ali M, 2010, NUTRITION, V26, P1146, DOI 10.1016/j.nut.2009.08.019; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Srinivasan V, 2009, MOL CELL BIOCHEM, V328, P217, DOI 10.1007/s11010-009-0092-7; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Tsiotra PC, 2006, ANN NY ACAD SCI, V1083, P63, DOI 10.1196/annals.1367.007; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Younce CW, 2010, CARDIOVASC RES, V87, P665, DOI 10.1093/cvr/cvq102; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang XB, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/247275	67	75	81	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65061	10.1371/journal.pone.0065061	http://dx.doi.org/10.1371/journal.pone.0065061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741455	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900168
J	Quintanilla, RA; Godoy, JA; Alfaro, I; Cabezas, D; von Bernhardi, R; Bronfman, M; Inestrosa, NC				Quintanilla, Rodrigo A.; Godoy, Juan A.; Alfaro, Ivan; Cabezas, Deny; von Bernhardi, Rommy; Bronfman, Miguel; Inestrosa, Nibaldo C.			Thiazolidinediones Promote Axonal Growth through the Activation of the JNK Pathway	PLOS ONE			English	Article							N-TERMINAL KINASE; C-JUN; RECEPTOR-GAMMA; NEURONAL POLARITY; PPAR-GAMMA; MITOCHONDRIAL DYSFUNCTION; TRANSCRIPTION FACTORS; MOUSE MODEL; CELLS; DIFFERENTIATION	The axon is a neuronal process involved in protein transport, synaptic plasticity, and neural regeneration. It has been suggested that their structure and function are profoundly impaired in neurodegenerative diseases. Previous evidence suggest that Peroxisome Proliferator-Activated Receptors-gamma (PPAR gamma promote neuronal differentiation on various neuronal cell types. In addition, we demonstrated that activation of PPAR gamma by thiazolidinediones (TZDs) drugs that selectively activate PPAR gamma prevent neurite loss and axonal damage induced by amyloid-beta (A beta). However, the potential role of TZDs in axonal elongation and neuronal polarity has not been explored. We report here that the activation of PPAR gamma by TZDs promoted axon elongation in primary hippocampal neurons. Treatments with different TZDs significantly increased axonal growth and branching area, but no significant effects were observed in neurite elongation compared to untreated neurons. Treatment with PPAR gamma antagonist (GW 9662) prevented TZDs-induced axonal growth. Recently, it has been suggested that the c-Jun N-terminal kinase (JNK) plays an important role regulating axonal growth and neuronal polarity. Interestingly, in our studies, treatment with TZDs induced activation of the JNK pathway, and the pharmacological blockage of this pathway prevented axon elongation induced by TZDs. Altogether, these results indicate that activation of JNK induced by PPAR gamma activators stimulates axonal growth and accelerates neuronal polarity. These novel findings may contribute to the understanding of the effects of PPAR gamma on neuronal differentiation and validate the use of PPAR gamma activators as therapeutic agents in neurodegenerative diseases.	[Quintanilla, Rodrigo A.; Godoy, Juan A.; Alfaro, Ivan; Cabezas, Deny; Bronfman, Miguel; Inestrosa, Nibaldo C.] Catholic Univ Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile; [Quintanilla, Rodrigo A.; von Bernhardi, Rommy] Pontificia Univ Catolica Chile, Lab Neurociencias, Dept Neurol, Escuela Med, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Inestrosa, NC (corresponding author), Catholic Univ Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile.	ninestrosa@bio.puc.cl	QUINTANILLA, RODRIGO/ABG-8829-2021; Godoy, Juan A/F-5398-2018	Godoy, Juan A/0000-0001-9920-6698; von Bernhardi, Rommy/0000-0002-9022-7676; Cabezas Bratesco, Deny/0000-0002-6217-1513	Basal Center of Excellence in Aging and Regeneration [CONICYT-PFB12/2007]	Basal Center of Excellence in Aging and Regeneration(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	This work was supported by Basal Center of Excellence in Aging and Regeneration (CONICYT-PFB12/2007) to NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Brodbeck J, 2008, P NATL ACAD SCI USA, V105, P1343, DOI 10.1073/pnas.0709906104; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Codocedo JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047073; Coffey ET, 2000, J NEUROSCI, V20, P7602; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Gartner A, 2009, EMBO J, V28, P173, DOI 10.1038/emboj.2008.296; Ghoochani A, 2012, DIFFERENTIATION, V83, P60, DOI 10.1016/j.diff.2011.08.009; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jung KM, 2003, MOL PHARMACOL, V63, P607, DOI 10.1124/mol.63.3.607; Kalinin S, 2009, CURR ALZHEIMER RES, V6, P431, DOI 10.2174/156720509789207949; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kita Y, 1998, J CELL SCI, V111, P907; Ledesma MD, 2003, INT REV CYTOL, V227, P183, DOI 10.1016/S0074-7696(03)01010-6; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; Lerner RP, 2012, BRAIN RES BULL, V87, P571, DOI 10.1016/j.brainresbull.2012.01.012; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lindwall C, 2004, MOL CELL NEUROSCI, V27, P267, DOI 10.1016/j.mcn.2004.07.001; Maekawa T, 2010, MOL CELL BIOL, V30, P613, DOI 10.1128/MCB.00685-09; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Miglio G, 2009, NEUROSCI LETT, V454, P134, DOI 10.1016/j.neulet.2009.03.014; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Park KS, 2004, EXP CELL RES, V297, P424, DOI 10.1016/j.yexcr.2004.03.034; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Quintanilla RA, 2012, ARCH MED RES, V43, P632, DOI 10.1016/j.arcmed.2012.10.016; Quintanilla RA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.007; Quintanilla RA, 2009, BRAIN RES BULL, V80, P242, DOI 10.1016/j.brainresbull.2009.07.010; Rodriguez-Rivera J, 2011, BEHAV BRAIN RES, V216, P255, DOI 10.1016/j.bbr.2010.08.002; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Shah SB, 2009, NEUROBIOL DIS, V36, P11, DOI 10.1016/j.nbd.2009.05.016; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; von Bernhardi R, 2012, ANTIOXID REDOX SIGN, V16, P974, DOI 10.1089/ars.2011.4082; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Yang GY, 2011, J BIOL CHEM, V286, P6566, DOI 10.1074/jbc.M110.196568; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	52	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65140	10.1371/journal.pone.0065140	http://dx.doi.org/10.1371/journal.pone.0065140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741474	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900187
J	Sovik, E; Cornish, JL; Barron, AB				Sovik, Eirik; Cornish, Jennifer L.; Barron, Andrew B.			Cocaine Tolerance in Honey Bees	PLOS ONE			English	Article							SOCIAL INSECTS; BEHAVIORAL SENSITIZATION; DROSOPHILA-MELANOGASTER; SEROTONIN TRANSPORTER; LOCOMOTOR-ACTIVITY; NEURAL MECHANISMS; TIME-COURSE; DOPAMINE; ETHANOL; OCTOPAMINE	Increasingly invertebrates are being used to investigate the molecular and cellular effects of drugs of abuse to explore basic mechanisms of addiction. However, in mammals the principle factors contributing to addiction are long-term adaptive responses to repeated drug use. Here we examined whether adaptive responses to cocaine are also seen in invertebrates using the honey bee model system. Repeated topical treatment with a low dose of cocaine rendered bees resistant to the deleterious motor effects of a higher cocaine dose, indicating the development of physiological tolerance to cocaine in bees. Cocaine inhibits biogenic amine reuptake transporters, but neither acute nor repeated cocaine treatments caused measurable changes in levels of biogenic amines measured in whole bee brains. Our data show clear short and long-term behavioural responses of bees to cocaine administration, but caution that, despite the small size of the bee brain, measures of biogenic amines conducted at the whole-brain level may not reveal neurochemical effects of the drug.	[Sovik, Eirik; Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Cornish, Jennifer L.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	Macquarie University; Macquarie University	Barron, AB (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	Andrew.Barron@mq.edu.au		Sovik, Eirik/0000-0002-9347-0831; Barron, Andrew/0000-0002-8135-6628; Cornish, Jennifer/0000-0002-9754-8069	Australian Research Council Discovery Projects [DP0986021]; iMQRES scholarship; Macquarie University	Australian Research Council Discovery Projects(Australian Research Council); iMQRES scholarship; Macquarie University	This work was supported by an Australian Research Council Discovery Projects grant no. DP0986021 to ABB and JLC. ES is funded by an iMQRES scholarship awarded by Macquarie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Abramson CI, 2005, ALCOHOL, V36, P187, DOI 10.1016/j.alcohol.2005.09.001; Abramson CI, 2004, PSYCHOL REP, V94, P1107, DOI 10.2466/pr0.94.3c.1107-1115; Abramson CI, 2004, PSYCHOL REP, V94, P227; Abramson CI, 2003, PSYCHOL REP, V92, P365; Ammons AD, 2008, ALCOHOL, V42, P129, DOI 10.1016/j.alcohol.2007.12.005; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Barron AB, 2005, J COMP PHYSIOL A, V191, P659, DOI 10.1007/s00359-005-0619-7; Barron AB, 2002, J COMP PHYSIOL A, V188, P603, DOI 10.1007/s00359-002-0335-5; Barron AB, 2007, J INSECT PHYSIOL, V53, P187, DOI 10.1016/j.jinsphys.2006.11.009; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; Barron AB, 2009, J EXP BIOL, V212, P163, DOI 10.1242/jeb.025361; BAUMANN MH, 1993, SYNAPSE, V14, P40, DOI 10.1002/syn.890140107; Borue X, 2010, J NEUROCHEM, V113, P188, DOI 10.1111/j.1471-4159.2010.06588.x; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; CARROLL FI, 1992, J MED CHEM, V35, P969, DOI 10.1021/jm00084a001; CASTELLANI SA, 1978, EUR J PHARMACOL, V47, P57, DOI 10.1016/0014-2999(78)90374-6; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; Chen YL, 2008, ARCH INSECT BIOCHEM, V68, P241, DOI 10.1002/arch.20259; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; DEMCHYSHYN LL, 1994, P NATL ACAD SCI USA, V91, P5158, DOI 10.1073/pnas.91.11.5158; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; Dimitrijevic N, 2004, J NEUROSCI METH, V137, P181, DOI 10.1016/j.jneumeth.2004.02.023; EMMETTOGLESBY MW, 1993, DRUG ALCOHOL DEPEN, V32, P247, DOI 10.1016/0376-8716(93)90089-9; EMMETTOGLESBY MW, 1992, BEHAV PHARMACOL, V3, P193; FRANK RA, 1992, PHARMACOL BIOCHEM BE, V42, P771, DOI 10.1016/0091-3057(92)90028-E; Gallant P, 2003, EUR J BIOCHEM, V270, P664, DOI 10.1046/j.1432-1033.2003.03417.x; GALLOWAY MP, 1990, SYNAPSE, V6, P63, DOI 10.1002/syn.890060108; Grignaschi G, 2004, EUR J NEUROSCI, V20, P2833, DOI 10.1111/j.1460-9568.2004.03712.x; HADFIELD MG, 1992, PHARMACOL BIOCHEM BE, V43, P395, DOI 10.1016/0091-3057(92)90168-F; Hammer RP, 1997, BEHAV BRAIN RES, V84, P225, DOI 10.1016/S0166-4328(97)83332-3; HARRIS JW, 1992, J INSECT PHYSIOL, V38, P29, DOI 10.1016/0022-1910(92)90019-A; Heberlein U, 2009, NEUROPHARMACOLOGY, V56, P97, DOI 10.1016/j.neuropharm.2008.07.023; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; INADA T, 1992, NEUROPHARMACOLOGY, V31, P701, DOI 10.1016/0028-3908(92)90149-J; KALIVAS PW, 1989, BIOL PSYCHIAT, V25, P913, DOI 10.1016/0006-3223(89)90271-0; KALIVAS PW, 1993, J NEUROSCI, V13, P266; KALIVAS PW, 1988, J PHARMACOL EXP THER, V245, P485; Kandel ER, 2007, SEARCH MEMORY EMERGE; Kaun KR, 2012, HUM GENET, V131, P959, DOI 10.1007/s00439-012-1146-6; KEZIC N, 1992, APIDOLOGIE, V23, P217, DOI 10.1051/apido:19920304; King GR, 2004, PHARMACOL BIOCHEM BE, V78, P293, DOI 10.1016/j.pbb.2004.04.011; KONOPKA RJ, 1987, ANNU REV GENET, V21, P227, DOI 10.1146/annurev.genet.21.1.227; Lasek AW, 2010, GENES BRAIN BEHAV, V9, P817, DOI 10.1111/j.1601-183X.2010.00620.x; MAISONNEUVE IM, 1995, J PHARMACOL EXP THER, V272, P652; Makos MA, 2010, ACS CHEM NEUROSCI, V1, P74, DOI 10.1021/cn900017w; MARTIN BR, 1989, J ANAL TOXICOL, V13, P158, DOI 10.1093/jat/13.3.158; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Mustard JA, 2008, NEUROBIOL LEARN MEM, V90, P633, DOI 10.1016/j.nlm.2008.07.017; Nathaniel TI, 2012, BRAIN RES BULL, V87, P328, DOI 10.1016/j.brainresbull.2011.11.022; Nathaniel TI, 2010, BEHAV BRAIN RES, V207, P310, DOI 10.1016/j.bbr.2009.10.010; NATHANSON JA, 1993, P NATL ACAD SCI USA, V90, P9645, DOI 10.1073/pnas.90.20.9645; PETTIT HO, 1994, BRAIN RES, V651, P261, DOI 10.1016/0006-8993(94)90705-6; Porzgen P, 2001, MOL PHARMACOL, V59, P83; R Development Core Team, 2012, R LANG ENV STAT COMP; REITH MEA, 1987, J PHARMACOL EXP THER, V243, P281; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Samaha AN, 2004, J NEUROSCI, V24, P6362, DOI 10.1523/JNEUROSCI.1205-04.2004; Samaha AN, 2005, TRENDS PHARMACOL SCI, V26, P82, DOI 10.1016/j.tips.2004.12.007; Samaha AN, 2002, J NEUROSCI, V22, P3244, DOI 10.1523/JNEUROSCI.22-08-03244.2002; SCAVONE C, 1994, INSECT BIOCHEM MOLEC, V24, P589, DOI 10.1016/0965-1748(94)90095-7; Schafer WR, 2004, NEUROPHARMACOLOGY, V47, P123, DOI 10.1016/j.neuropharm.2004.06.026; Schenk S, 1997, PHARMACOL BIOCHEM BE, V57, P543, DOI 10.1016/S0091-3057(96)00447-9; Schlussman SD, 1998, PHARMACOL BIOCHEM BE, V60, P593, DOI 10.1016/S0091-3057(98)00047-1; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Schulz DJ, 2002, BRAIN BEHAV EVOLUT, V60, P350, DOI 10.1159/000067788; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; Sloley BD, 2004, NEUROTOXICOLOGY, V25, P175, DOI 10.1016/S0161-813X(03)00096-2; Sokolowski MBC, 2012, ALCOHOL CLIN EXP RES, V36, P1568, DOI 10.1111/j.1530-0277.2012.01770.x; TOLLIVER BK, 1994, PHARMACOL BIOCHEM BE, V48, P733, DOI 10.1016/0091-3057(94)90340-9; Tung A, 2002, ANESTHESIOLOGY, V97, P906, DOI 10.1097/00000542-200210000-00024; Wagener-Hulme C, 1999, J COMP PHYSIOL A, V184, P471, DOI 10.1007/s003590050347; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; WOOD DM, 1986, J PHARMACOL EXP THER, V237, P120; Woyciechowski M, 2009, INSECT SOC, V56, P193, DOI 10.1007/s00040-009-0012-6; Wright GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032677; YU SJ, 1984, PESTIC BIOCHEM PHYS, V22, P360, DOI 10.1016/0048-3575(84)90029-4	79	17	17	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64920	10.1371/journal.pone.0064920	http://dx.doi.org/10.1371/journal.pone.0064920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741423	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900136
J	Chu, JYS; Cheng, CYY; Sekar, R; Chow, BKC				Chu, Jessica Y. S.; Cheng, Carrie Y. Y.; Sekar, Revathi; Chow, Billy K. C.			Vagal Afferent Mediates the Anorectic Effect of Peripheral Secretin	PLOS ONE			English	Article							GASTRIC-ACID-SECRETION; PANCREATIC-SECRETION; BLOOD-BRAIN; FOOD-INTAKE; CHOLECYSTOKININ; ACTIVATION; RECEPTORS; NUCLEUS; FIBERS; NERVE	Secretin (SCT) is a classical peptide hormone that is synthesized and released from the gastrointestinal tract after a meal. We have previously shown that it acts both as a central and peripheral anorectic peptide, and that its central effect is mediated via melanocortin system. As peripheral satiety signals from the gastrointestinal tract can be sent to the brain via the vagal afferent or by crossing the blood-brain barrier (BBB), we therefore sought to investigate the pathway by which peripheral SCT reduces appetite in this study. It is found that bilateral subdiaphragmatic vagotomy and treatment of capsaicin, an excitotoxin for primary afferent neurons, could both block the anorectic effect of peripherally injected SCT. These treatments are found to be capable of blunting i.p. SCT-induced Fos activation in pro-opiomelanocortin (POMC) neurons within the hypothalamic Arcuate Nucleus (Arc). Moreover, we have also found that bilateral midbrain transaction could block feeding reduction by peripheral SCT. Taken together, we conclude that the satiety signals of peripheral SCT released from the gastrointestinal tract are sent via the vagus nerves to the brainstem and subsequently Arc, where it controls central expression of other regulatory peptides to regulate food intake.	[Chu, Jessica Y. S.; Cheng, Carrie Y. Y.; Sekar, Revathi; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.	bkcc@hku.hk	Chow, Billy/D-3064-2009; Sekar, Revathi/AFE-8105-2022; Sekar, Revathi/AAE-9642-2022	Chow, Billy/0000-0003-3390-0307; Sekar, Revathi/0000-0002-6787-7742; /0000-0003-2167-6926	Hong Kong government RGC [GRF763809]	Hong Kong government RGC	This work was supported by Hong Kong government RGC grants GRF763809 to Billy K. C. Chow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2002, J PHARMACOL EXP THER, V302, P1062, DOI 10.1124/jpet.102.036129; Bayliss WM, 1902, J PHYSL LOND; Cheng CYY, 2011, NEUROPSYCHOPHARMACOL, V36, P459, DOI 10.1038/npp.2010.178; CHEY WY, 1978, AM J DIG DIS, V23, P981, DOI 10.1007/BF01263096; Chey WY, 2004, J PHYSL PHARM; Chu JYS, 2006, ANN NY ACAD SCI, V1070, P196, DOI 10.1196/annals.1317.012; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; CRAWLEY JN, 1984, BRAIN RES, V322, P316, DOI 10.1016/0006-8993(84)90124-0; Gerber JG, 1996, J PHARMACOL EXP THER, V279, P718; GRAY MA, 1988, J MEMBRANE BIOL, V105, P131, DOI 10.1007/BF02009166; JIN HO, 1994, AM J PHYSIOL-GASTR L, V267, pG702, DOI 10.1152/ajpgi.1994.267.4.G702; Kanno N, 2001, AM J PHYSIOL-GASTR L, V281, pG612, DOI 10.1152/ajpgi.2001.281.3.G612; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; KATADA N, 1983, AM J GASTROENTEROL, V78, P740; KIM MS, 1979, AM J PHYSIOL, V236, pE539, DOI 10.1152/ajpendo.1979.236.5.E539; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; Konturek SJ, 2003, EUR J PHARMACOL, V481, P1, DOI 10.1016/j.ejphar.2003.08.042; Kwon HY, 1999, AM J PHYSIOL-GASTR L, V276, pG1052, DOI 10.1152/ajpgi.1999.276.4.G1052; LEE KY, 1980, PEPTIDES, V1, P155, DOI 10.1016/0196-9781(80)90080-7; Li P, 1998, AM J PHYSIOL-GASTR L, V275, pG22, DOI 10.1152/ajpgi.1998.275.1.G22; LU YX, 1995, AM J PHYSIOL-GASTR L, V268, pG1012, DOI 10.1152/ajpgi.1995.268.6.G1012; Lutz TA, 1998, AM J; MIKHAILOVA SD, 1990, B EXP BIOL MED+, V109, P849; RICARDO JA, 1978, BRAIN RES, V153, P1, DOI 10.1016/0006-8993(78)91125-3; Ruttimann EB, 2009, ENDOCRINOLOGY, V150, P1174, DOI 10.1210/en.2008-1221; SHIRATORI K, 1992, DIGEST DIS SCI, V37, P397, DOI 10.1007/BF01307734; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Vaudry D, 2000, PHARMACOL REV, V52, P269; WANG LM, 1995, GASTROENTEROLOGY, V108, pA1015; Yang B, 2004, AM J PHYSIOL-REG I, V286, pR927, DOI 10.1152/ajpregu.00600.2003; Yang H, 2004, NEUROSCIENCE, V128, P131, DOI 10.1016/j.neuroscience.2004.06.027; YOU CH, 1987, DIGEST DIS SCI, V32, P466, DOI 10.1007/BF01296028; Zhang JC, 2012, AM J PHYSIOL-REG I, V302, pR264, DOI 10.1152/ajpregu.00114.2011	33	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64859	10.1371/journal.pone.0064859	http://dx.doi.org/10.1371/journal.pone.0064859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738005	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700066
J	Wu, W; Mast, TG; Ziembko, C; Breza, JM; Contreras, RJ				Wu, Wei; Mast, Thomas G.; Ziembko, Christopher; Breza, Joseph M.; Contreras, Robert J.			Statistical Analysis and Decoding of Neural Activity in the Rodent Geniculate Ganglion Using a Metric-Based Inference System	PLOS ONE			English	Article							TASTE DETECTION THRESHOLD; SALT TASTE; GUSTATORY NEURONS; ELECTRICAL-STIMULATION; RESPONSE VARIABILITY; IMPULSE DISCHARGES; SOLITARY TRACT; RAT; AMILORIDE; CELLS	We analyzed the spike discharge patterns of two types of neurons in the rodent peripheral gustatory system, Na specialists (NS) and acid generalists (AG) to lingual stimulation with NaCl, acetic acid, and mixtures of the two stimuli. Previous computational investigations found that both spike rate and spike timing contribute to taste quality coding. These studies used commonly accepted computational methods, but they do not provide a consistent statistical evaluation of spike trains. In this paper, we adopted a new computational framework that treated each spike train as an individual data point for computing summary statistics such as mean and variance in the spike train space. We found that these statistical summaries properly characterized the firing patterns (e. g. template and variability) and quantified the differences between NS and AG neurons. The same framework was also used to assess the discrimination performance of NS and AG neurons and to remove spontaneous background activity or "noise" from the spike train responses. The results indicated that the new metric system provided the desired decoding performance and noise-removal improved stimulus classification accuracy, especially of neurons with high spontaneous rates. In summary, this new method naturally conducts statistical analysis and neural decoding under one consistent framework, and the results demonstrated that individual peripheral-gustatory neurons generate a unique and reliable firing pattern during sensory stimulation and that this pattern can be reliably decoded.	[Wu, Wei; Mast, Thomas G.; Breza, Joseph M.; Contreras, Robert J.] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Wu, Wei] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Ziembko, Christopher] Florida State Univ, Dept Math, Tallahassee, FL 32306 USA; [Mast, Thomas G.; Breza, Joseph M.; Contreras, Robert J.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Contreras, RJ (corresponding author), Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA.	rcontreras@fsu.edu		Breza, Joseph/0000-0002-6729-4539	National Institute on Deafness and Communication Disorders [DC-004785]	National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The National Institute on Deafness and Communication Disorders, Grant DC-004785, supported this research. The funders (http://www.nih.gov) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov D, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061905; Avila-Akerberg O, 2011, EXP BRAIN RES, V210, P353, DOI [10.1007/s00221-011-2553-y, 10.1007/s00221-011-2639-6]; Bensmaia SJ, 2008, BEHAV BRAIN RES, V190, P165, DOI 10.1016/j.bbr.2008.02.044; BOUDREAU JC, 1983, CHEM SENSES, V8, P131, DOI 10.1093/chemse/8.2.131; Breza JM, 2006, J NEUROPHYSIOL, V95, P674, DOI 10.1152/jn.00793.2005; Breza JM, 2007, CHEM SENSES, V32, P833, DOI 10.1093/chemse/bjm052; Breza JM, 2012, J NEUROPHYSIOL, V108, P2405, DOI 10.1152/jn.00114.2012; Breza JM, 2012, J NEUROPHYSIOL, V107, P1632, DOI 10.1152/jn.00621.2011; Breza JM, 2010, J NEUROPHYSIOL, V103, P1771, DOI 10.1152/jn.00785.2009; Chalfant ML, 1999, AM J PHYSIOL-CELL PH, V276, pC477, DOI 10.1152/ajpcell.1999.276.2.C477; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Christen M, 2006, J NEUROSCI METH, V156, P342, DOI 10.1016/j.jneumeth.2006.02.023; Collinger JL, 2012, LANCET, P61816; Contreras RJ, 2000, PHYSIOL BEHAV, V69, P41, DOI 10.1016/S0031-9384(00)00187-6; Di Lorenzo PM, 2007, J NEUROPHYSIOL, V97, P1857, DOI 10.1152/jn.00910.2006; Di Lorenzo PM, 2009, J NEUROSCI, V29, P9227, DOI 10.1523/JNEUROSCI.5995-08.2009; Di Lorenzo PM, 2003, BEHAV NEUROSCI, V117, P1423, DOI 10.1037/0735-7044.117.6.1423; Di Lorenzo PM, 2003, J NEUROPHYSIOL, V90, P1418, DOI 10.1152/jn.00177.2003; DILORENZO PM, 1993, BEHAV NEUROSCI, V107, P130, DOI 10.1037/0735-7044.107.1.130; Doolin RE, 1996, J GEN PHYSIOL, V107, P545, DOI 10.1085/jgp.107.4.545; FISHMAN IY, 1957, J CELL COMPAR PHYSL, V49, P319, DOI 10.1002/jcp.1030490213; Frank ME, 2008, PROG NEUROBIOL, V86, P245, DOI 10.1016/j.pneurobio.2008.09.003; Geran LC, 2000, BEHAV NEUROSCI, V114, P623, DOI 10.1037/0735-7044.114.3.623; Geran LC, 1999, BEHAV NEUROSCI, V113, P185, DOI 10.1037/0735-7044.113.1.185; Golden GJ, 2012, PHYSIOL BEHAV, V105, P1214, DOI 10.1016/j.physbeh.2011.12.023; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; HILL DL, 1990, BEHAV NEUROSCI, V104, P734, DOI 10.1037/0735-7044.104.5.734; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Houghton C, 2008, NEURAL COMPUT, V20, P1495, DOI 10.1162/neco.2007.10-06-350; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Hunter JD, 2003, J NEUROPHYSIOL, V90, P387, DOI 10.1152/jn.00074.2003; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kinzeler NR, 2008, AM J PHYSIOL-REG I, V295, pR436, DOI 10.1152/ajpregu.00189.2008; Kreuz T, 2007, J NEUROSCI METH, V165, P151, DOI 10.1016/j.jneumeth.2007.05.031; Lawhern V, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00018; Lemon CH, 2006, J NEUROSCI, V26, P7433, DOI 10.1523/JNEUROSCI.0106-06.2006; LIM D, 1994, J NEUROSCI METH, V52, P203, DOI 10.1016/0165-0270(94)90131-7; Lundy RF, 1999, J NEUROPHYSIOL, V82, P2970, DOI 10.1152/jn.1999.82.6.2970; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Lyall V, 2002, J GEN PHYSIOL, V120, P793, DOI 10.1085/jgp.20028656; Mistretta CM, 1972, OLFACTION TASTE, P294; NAGAI T, 1981, J NEUROPHYSIOL, V45, P574, DOI 10.1152/jn.1981.45.3.574; OGAWA H, 1974, J NEUROPHYSIOL, V37, P443, DOI 10.1152/jn.1974.37.3.443; OGAWA H, 1973, PHYSIOL BEHAV, V11, P469, DOI 10.1016/0031-9384(73)90033-4; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Paiva ARC, 2010, NEURAL COMPUT APPL, V19, P405, DOI 10.1007/s00521-009-0307-6; Paiva ARC, 2009, NEURAL COMPUT, V21, P424, DOI 10.1162/neco.2008.09-07-614; Quiroga RQ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041904; Sadacca BF, 2012, J NEUROSCI, V32, P9999, DOI 10.1523/JNEUROSCI.6059-11.2012; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; SMITH DV, 1979, CHEM SENS FLAV, V4, P215, DOI 10.1093/chemse/4.3.215; Smith KR, 2012, AM J PHYSIOL-REG I, V303, pR1195, DOI 10.1152/ajpregu.00154.2012; Spector AC, 1996, J NEUROSCI, V16, P8115; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Wang MF, 2009, CHEM SENSES, V34, P653, DOI 10.1093/chemse/bjp047; Wu W, 2012, FRONT COMPU IN PRESS; Wu W, 2011, J COMPUT NEUROSCI, V31, P725, DOI 10.1007/s10827-011-0336-x; Yoshida R, 2009, NEUROSCIENCE, V159, P795, DOI 10.1016/j.neuroscience.2008.12.052	62	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e65439	10.1371/journal.pone.0065439	http://dx.doi.org/10.1371/journal.pone.0065439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738016	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700077
J	Ball, J; Carrington, MJ; Wood, KA; Stewart, S				Ball, Jocasta; Carrington, Melinda J.; Wood, Kathryn A.; Stewart, Simon		SAFETY Investigators	Women Versus Men with Chronic Atrial Fibrillation: Insights from the Standard Versus Atrial Fibrillation spEcific managemenT studY (SAFETY)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; MILD COGNITIVE IMPAIRMENT; RISK-FACTORS; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; SEX-DIFFERENCES; STROKE; PREVENTION; ANTICOAGULATION	Background: Gender-based clinical differences are increasingly being identified as having significant influence on the outcomes of patients with cardiovascular disease (CVD), including atrial fibrillation (AF). Objective: To perform detailed clinical phenotyping on a cohort of hospitalised patients with chronic forms of AF to understand if gender-based differences exist in the clinical presentation, thrombo-embolic risk and therapeutic management of high risk patients hospitalised with chronic AF. Methods: We are undertaking the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY) - a multi-centre, randomised controlled trial of an AF-specific management intervention versus usual care. Extensive baseline profiling of recruited patients was undertaken to identify gender-specific differences for risk delineation. Results: We screened 2,438 patients with AF and recruited 335 into SAFETY. Of these, 48.1% were women who were, on average, 5 years older than their male counterparts. Women and men displayed divergent antecedent profiles, with women having a higher thrombo-embolic risk but being prescribed similar treatment regimens. More women than men presented to hospital with co-morbid thyroid dysfunction, depression, renal impairment and obesity. In contrast, more men presented with coronary artery disease (CAD) and/or chronic obstructive pulmonary disease (COPD). Even when data was age-adjusted, women were more likely to live alone (odds ratio [OR] 2.33; 95% confidence interval [CI] 1.47 to 3.69), have non-tertiary education (OR 2.69; 95% CI 1.61 to 4.48) and be symptomatic (OR 1.93; 95% CI 1.06 to 3.52). Conclusion: Health care providers should be cognisant of gender-specific differences in an attempt to individualise and, hence, optimise the management of patients with chronic AF and reduce potential morbidity and mortality.	[Ball, Jocasta; Carrington, Melinda J.; Stewart, Simon] Baker IDI Heart & Diabet Inst, Ctr Res Excellence Reduce Inequal Heart Dis, Melbourne, Vic, Australia; [Ball, Jocasta; Carrington, Melinda J.; Stewart, Simon] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Wood, Kathryn A.] Duke Univ, Sch Nursing, Durham, NC USA	Baker Heart and Diabetes Institute; Monash University; Duke University	Stewart, S (corresponding author), Baker IDI Heart & Diabet Inst, Ctr Res Excellence Reduce Inequal Heart Dis, Melbourne, Vic, Australia.	Simon.Stewart@bakeridi.edu.au	Stewart, Simon/M-3316-2016; Ball, Jocasta/E-3297-2016	Stewart, Simon/0000-0001-9032-8998; Ball, Jocasta/0000-0002-1512-4255; Carrington, Melinda J/0000-0003-3865-1645; Wood, Kathryn/0000-0003-4671-2014	National Health and Medical Research Council of Australia Program Grant [519823]; National Health and Medical Research Council of Australia; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	SAFETY is funded by a National Health and Medical Research Council of Australia Program Grant (519823). In addition, JB, MJC and SS are supported by the National Health and Medical Research Council of Australia. This research is supported in part by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; Ball J, 2013, INT J CARDI IN PRESS; Ball J, 2013, HEART, V99, P542, DOI 10.1136/heartjnl-2012-303182; BEERY TA, 1995, HEART LUNG, V24, P427, DOI 10.1016/S0147-9563(95)80020-4; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Brown WJ, 2005, CHOOSE HLTH BE ACTIV, P1; Carrington MJ, 2011, INT J CARDI IN PRESS; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldberg RJ, 1998, AM HEART J, V136, P189, DOI 10.1053/hj.1998.v136.88874; Goli NM, 2012, PACE, V35, P1090, DOI 10.1111/j.1540-8159.2012.03482.x; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Hendriks JML, 2012, EUR HEART J, V33, P2692, DOI 10.1093/eurheartj/ehs071; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphries KH, 2001, CIRCULATION, V103, P2365; Inglis Sally, 2004, J Cardiovasc Nurs, V19, P118; Johnson JA, 1998, QUAL LIFE RES, V7, P155, DOI 10.1023/A:1008809610703; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Levy S, 1999, CIRCULATION, V99, P3028, DOI 10.1161/01.CIR.99.23.3028; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McSweeney JC, 2003, CIRCULATION, V108, P2619, DOI 10.1161/01.CIR.0000097116.29625.7C; Melloni C, 2010, CIRC-CARDIOVASC QUAL, V3, P135, DOI 10.1161/CIRCOUTCOMES.110.868307; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NHMRC, 2009, AUSTR GUID RED HLTH, pi; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rienstra M, 2005, J AM COLL CARDIOL, V46, P1298, DOI 10.1016/j.jacc.2005.05.078; Rosenfeld A G, 2001, AACN Clin Issues, V12, P29, DOI 10.1097/00044067-200102000-00005; Sliwa K, 2010, HEART, V96, P1878, DOI 10.1136/hrt.2010.206938; Stock EO, 2012, CURR PROB CARDIOLOGY, V37, P450, DOI 10.1016/j.cpcardiol.2012.07.001	35	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65795	10.1371/journal.pone.0065795	http://dx.doi.org/10.1371/journal.pone.0065795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734260	Green Published, gold, Green Submitted			2022-12-27	WOS:000319725500006
J	Chen, LF; Ho, HC; Su, YC; Lee, MS; Hung, SK; Chou, P; Lee, CCJ; Lin, LC; Lee, CC				Chen, Li-Fu; Ho, Hsu-Chueh; Su, Yu-Chieh; Lee, Moon-Sing; Hung, Shih-Kai; Chou, Pesus; Lee, Ching-Chieh J.; Lin, Li-Chu; Lee, Ching-Chih			Association between Provider Volume and Healthcare Expenditures of Patients with Oral Cancer in Taiwan: A Population-Based Study	PLOS ONE			English	Article							HOSPITAL VOLUME; 5-YEAR SURVIVAL; SURGEON; COSTS; EXPERIENCE; MORTALITY; OUTCOMES; BURDEN; RATES	Background: Oral cancer requires considerable utilization of healthcare services. Wide resection of the tumor and reconstruction with free flap are widely used. Due to high recurrence rate, close follow-up is mandatory. This study was conducted to explore the relationship between the healthcare expenditure of oncological surgery and one-year follow up and provider volume. Methods: From the National Health Insurance Research Database published by the Taiwanese National Health Research Institute, the authors selected a total of 1300 oral cancer patients who underwent tumor resection and free flap reconstruction in 2008. Hierarchical linear regression analysis was subsequently performed to explore the relationship between provider volume and expenditures of oncological surgery and one-year follow-up period. Emergency department (ED) visits and 30-day readmission rates were also analyzed. Results: The mean expenditure for oncological surgery was $11080 +/- 4645 (all costs are given in U. S. dollars) and $10129 +/- 9248 for one-year follow up. For oncological surgery expenditure, oral cancer patients treated by low-volume surgeons had an additional $845 than those in high-volume surgeons in mixed model. For one-year follow-up expenditure, patients in low-volume hospitals had an additional $3439 than those in high-volume hospitals; patient in low-volume surgeons and medium-volume surgeons incurred an additional expenditure of $2065 and $1811 than those in high-volume surgeons. Oral cancer patients treated in low-volume hospitals incurred higher risk of 30-day readmission rate (odds ratio, 6.6; 95% confidence interval, 1.6-27). Conclusions: After adjusting for physician, hospital, and patient characteristics, low-volume provider performing wide excision with reconstructive surgery in oral cancer patients incurred significantly higher expenditure for oncological surgery and one-year healthcare per patient than did others with higher volumes. Treatment strategies adapted by high-volume providers should be further analyzed.	[Chen, Li-Fu] Natl Yang Ming Univ Hosp, Dept Emergency, Ilan, Taiwan; [Ho, Hsu-Chueh; Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Lee, Moon-Sing; Hung, Shih-Kai] Buddhist Dalin Tzu Chi Gen Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Ho, Hsu-Chueh; Su, Yu-Chieh; Lee, Moon-Sing; Hung, Shih-Kai; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chieh J.] Municipal Hsiao Kang Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Lin, Li-Chu] Buddhist Dalin Tzu Chi Gen Hosp, Dept Med Res, Chiayi, Taiwan; [Lin, Li-Chu] Natl Chung Cheng Univ, Grad Inst Elder Educ, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tzu Chi University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Chung Cheng University	Lee, CC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan.	hematcd@hotmail.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017; Hung, Shih-Kai/0000-0002-4945-528X	Department of Health, The Executive Yuan, Taiwan [DOH98-TD-PH-01]; Buddhist Dain Tzu Chi General Hospital [DTCRD 100(2)-I-12]	Department of Health, The Executive Yuan, Taiwan; Buddhist Dain Tzu Chi General Hospital	Financial support for this work was provided by a research grant from the Department of Health, The Executive Yuan, Taiwan (number DOH98-TD-PH-01). This study is based on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health, Taiwan, and managed by the National Health Research Institute. The interpretations and conclusions contained herein do not represent those of the Bureau of National Health Insurance, the Department of Health, or the National Health Research Institute. This study was funded in part by the Buddhist Dain Tzu Chi General Hospital [DTCRD 100(2)-I-12]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040590; Cheng SH, 2004, QUAL SAF HEALTH CARE, V13, P98, DOI 10.1136/qshc.2003.006981; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gruen RL, 2009, CA-CANCER J CLIN, V59, P192, DOI 10.3322/caac.20018; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hammond JW, 2003, J BONE JOINT SURG AM, V85A, P2318, DOI 10.2106/00004623-200312000-00008; Ho TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050337; Lang K, 2004, ARCH OTOLARYNGOL, V130, P1269, DOI 10.1001/archotol.130.11.1269; Lee Jennifer M, 2004, Eur J Health Econ, V5, P70, DOI 10.1007/s10198-003-0204-3; Lin CC, 2008, SURGERY, V143, P343, DOI 10.1016/j.surg.2007.09.033; Lin CS, 2008, PLAST RECONSTR SURG, V122, P133, DOI 10.1097/PRS.0b013e3181773d71; Lin HC, 2007, STROKE, V38, P1565, DOI 10.1161/STROKEAHA.106.474841; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; LUFT HS, 1987, HEALTH SERV RES, V22, P157; Maetzel A, 2004, ANN RHEUM DIS, V63, P395, DOI 10.1136/ard.2003.006031; Mignogna MD, 2004, EUR J CANCER PREV, V13, P139, DOI 10.1097/00008469-200404000-00008; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Shook TL, 1996, AM J CARDIOL, V77, P331, DOI 10.1016/S0002-9149(97)89359-9; Yang YH, 2005, J ORAL PATHOL MED, V34, P596, DOI 10.1111/j.1600-0714.2005.00266.x	24	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65077	10.1371/journal.pone.0065077	http://dx.doi.org/10.1371/journal.pone.0065077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750234	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900036
J	Kunhi Mouvenchery, Y; Jaeger, A; Aquino, AJA; Tunega, D; Diehl, D; Bertmer, M; Schaumann, GE				Kunhi Mouvenchery, Yamuna; Jaeger, Alexander; Aquino, Adelia J. A.; Tunega, Daniel; Diehl, Doerte; Bertmer, Marko; Schaumann, Gabriele Ellen			Restructuring of a Peat in Interaction with Multivalent Cations: Effect of Cation Type and Aging Time	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; GAUSSIAN-BASIS SETS; MOLECULAR-STRUCTURE; NMR RELAXOMETRY; ATOMS LI; SORPTION; WATER; PARTICLES; KINETICS; SAMPLES	It is assumed to be common knowledge that multivalent cations cross-link soil organic matter (SOM) molecules via cation bridges (CaB). The concept has not been explicitly demonstrated in solid SOM by targeted experiments, yet. Therefore, the requirements for and characteristics of CaB remain unidentified. In this study, a combined experimental and molecular modeling approach was adopted to investigate the interaction of cations on a peat OM from physicochemical perspective. Before treatment with salt solutions of Al3+, Ca2+ or Na+, respectively, the original exchangeable cations were removed using cation exchange resin. Cation treatment was conducted at two different values of pH prior to adjusting pH to 4.1. Cation sorption is slower (>>2 h) than deprotonation of functional groups (<2 h) and was described by a Langmuir model. The maximum uptake increased with pH of cation addition and decreased with increasing cation valency. Sorption coefficients were similar for all cations and at both pH. This contradicts the general expectations for electrostatic interactions, suggesting that not only the interaction chemistry but also spatial distribution of functional groups in OM determines binding of cations in this peat. The reaction of contact angle, matrix rigidity due to water molecule bridges (WaMB) and molecular mobility of water (NMR analysis) suggested that cross-linking via CaB has low relevance in this peat. This unexpected finding is probably due to the low cation exchange capacity, resulting in low abundance of charged functionalities. Molecular modeling demonstrates that large average distances between functionalities (similar to 3 nm in this peat) cannot be bridged by CaB-WaMB associations. However, aging strongly increased matrix rigidity, suggesting successive increase of WaMB size to connect functionalities and thus increasing degree of cross-linking by CaB-WaMB associations. Results thus demonstrated that the physicochemical structure of OM is decisive for CaB and aging-induced structural reorganisation can enhance cross-link formation.	[Kunhi Mouvenchery, Yamuna; Jaeger, Alexander; Diehl, Doerte; Schaumann, Gabriele Ellen] Univ Koblenz Landau, Inst Environm Sci, Dept Environm & Soil Chem, Landau, Germany; [Jaeger, Alexander; Bertmer, Marko] Univ Leipzig, Inst Expt Phys 2, Fac Phys & Earth Sci, D-04109 Leipzig, Germany; [Aquino, Adelia J. A.; Tunega, Daniel] Univ Nat Resources & Life Sci, Vienna Inst Soil Res, Vienna, Austria	University of Koblenz & Landau; Leipzig University; University of Natural Resources & Life Sciences, Vienna	Schaumann, GE (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Dept Environm & Soil Chem, Landau, Germany.	schaumann@uni-landau.de	Aquino, Adelia J.A./F-3226-2016; Schaumann, Gabriele E/B-4283-2015	Schaumann, Gabriele E/0000-0003-1788-2751; Tunega, Daniel/0000-0003-0822-1580; Diehl, Doerte/0000-0001-6868-3627	DFG [SPP 1315];  [SCHA849/8];  [GE 1676/1]	DFG(German Research Foundation (DFG)); ; 	This work was supported by DFG within the priority programme SPP 1315 "Biogeochemical Interfaces in Soil'', projects SCHA849/8 and GE 1676/1 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson A. W., 1967, PHYS CHEM SURFACES; AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Aquino AJA, 2008, CHEM PHYS, V349, P69, DOI 10.1016/j.chemphys.2008.02.063; Aquino AJA, 2011, INT J QUANTUM CHEM, V111, P1531, DOI 10.1002/qua.22693; Aquino AJA, 2011, GEODERMA, V169, P20, DOI 10.1016/j.geoderma.2010.12.006; Aquino AJA, 2009, J PHYS CHEM C, V113, P16468, DOI 10.1021/jp9054796; BACHE BW, 1976, J SCI FOOD AGR, V27, P273, DOI 10.1002/jsfa.2740270313; Bayer J.V., 2010, OPEN MAGNETIC RESONA, V3, P15, DOI DOI 10.2174/1874769801003010015; BENDALL MR, 1983, J MAGN RESON, V53, P365, DOI 10.1016/0022-2364(83)90211-1; Diehl D, 2010, GEODERMA, V158, P375, DOI 10.1016/j.geoderma.2010.06.005; Diehl D, 2009, EUR J SOIL SCI, V60, P557, DOI 10.1111/j.1365-2389.2009.01150.x; Diehl D, 2009, ROLE ORGANIC MATTER; Frimmel FH, 2006, P 13 M INT HUM SUBST, P833; Huang PM, 2011, HDB SOIL SCI PROPERT; Hurrass J, 2005, ENVIRON SCI TECHNOL, V39, P9534, DOI 10.1021/es051588i; Iskrenova-Tchoukova E, 2010, LANGMUIR, V26, P15909, DOI 10.1021/la102535n; Jaeger A, 2011, ORGANIC GEOCHEMISTRY, V42, P917, DOI DOI 10.1016/J.ORGGEOCHEM.2011.03.021; Jaeger F., 2010, OPEN MAGN RESON J, V3, P27, DOI [10.2174/1874769801003020027, DOI 10.2174/1874769801003020027]; Jaeger F, 2008, SOIL SCI SOC AM J, V72, P1694, DOI 10.2136/sssaj2007.0427; Kunhi Mouvenchery Y, 2012, REV ENVIRON SCI BIO, V11, P41, DOI 10.1007/s11157-011-9258-3; Lu YF, 2004, J ENVIRON QUAL, V33, P1314, DOI 10.2134/jeq2004.1314; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; McBride M. B., 1994, ENV CHEM SOILS; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Schaumann GE, 2008, EUR J SOIL SCI, V59, P423, DOI 10.1111/j.1365-2389.2007.00959.x; Schaumann GE, 2011, GEODERMA, V169, P55, DOI 10.1016/j.geoderma.2011.11.001; Schaumann GE, 2000, J PLANT NUTR SOIL SC, V163, P523, DOI 10.1002/1522-2624(200010)163:5<523::AID-JPLN523>3.0.CO;2-J; Schaumann GE, 2006, J PLANT NUTR SOIL SC, V169, P145, DOI 10.1002/jpln.200521785; Schaumann GE, 2006, J PLANT NUTR SOIL SC, V169, P157, DOI 10.1002/jpln.200521791; Schaumann GE, 2005, PLANT SOIL, V275, P1, DOI 10.1007/s11104-005-1708-7; Schaumann GE, 2005, COLLOID SURFACE A, V265, P163, DOI 10.1016/j.colsurfa.2005.02.040; Schaumann GE, 2005, ENVIRON SCI TECHNOL, V39, P800, DOI 10.1021/es0490931; Schaumann GE, 2006, P 13 M INT HUM SUBST, P941; Schulten HR, 2000, BIOL FERT SOILS, V30, P399, DOI 10.1007/s003740050020; Soriano MCH, 2012, ROLE ALUMINUM ORGANO; Stewart R.E., 1971, CLASSIFICATION NATUR; Tipping E, 2004, CATION BINDING HUMIC; Volkov AG, 1997, BIOELECTROCH BIOENER, V42, P153, DOI 10.1016/S0302-4598(96)05097-0; Xing BS, 1996, ENVIRON SCI TECHNOL, V30, P2432, DOI 10.1021/es950350z; Xu X, 2006, GEOCHIM COSMOCHIM AC, V70, P4319, DOI 10.1016/j.gca.2006.06.1552; Yuan GS, 2001, SOIL SCI, V166, P107, DOI 10.1097/00010694-200102000-00004	42	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65359	10.1371/journal.pone.0065359	http://dx.doi.org/10.1371/journal.pone.0065359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750256	gold, Green Submitted, Green Published			2022-12-27	WOS:000319961900058
J	Benson, RBJ; Evans, M; Smith, AS; Sassoon, J; Moore-Faye, S; Ketchum, HF; Forrest, R				Benson, Roger B. J.; Evans, Mark; Smith, Adam S.; Sassoon, Judyth; Moore-Faye, Scott; Ketchum, Hilary F.; Forrest, Richard			A Giant Pliosaurid Skull from the Late Jurassic of England	PLOS ONE			English	Article							POLYCOTYLID PLESIOSAUR REPTILIA; TURONIAN TROPIC SHALE; CRANIAL ANATOMY; SOUTHERN UTAH; SAUROPTERYGIA; INTERRELATIONSHIPS; BRAINCASE; EVOLUTION; TAXONOMY; WESTBURY	Pliosaurids were a long-lived and cosmopolitan group of marine predators that spanned 110 million years and occupied the upper tiers of marine ecosystems from the Middle Jurassic until the early Late Cretaceous. A well-preserved giant pliosaurid skull from the Late Jurassic Kimmeridge Clay Formation of Dorset, United Kingdom, represents a new species, Pliosaurus kevani. This specimen is described in detail, and the taxonomy and systematics of Late Jurassic pliosaurids is revised. We name two additional new species, Pliosaurus carpenteri and Pliosaurus westburyensis, based on previously described relatively complete, well-preserved remains. Most or all Late Jurassic pliosaurids represent a globally distributed monophyletic group (the genus Pliosaurus, excluding 'Pliosaurus' andrewsi). Despite its high species diversity, and geographically widespread, temporally extensive occurrence, Pliosaurus shows relatively less morphological and ecological variation than is seen in earlier, multi-genus pliosaurid assemblages such as that of the Middle Jurassic Oxford Clay Formation. It also shows less ecological variation than the pliosaurid-like Cretaceous clade Polycotylidae. Species of Pliosaurus had robust skulls, large body sizes (with skull lengths of 1.7-2.1 metres), and trihedral or subtrihedral teeth suggesting macropredaceous habits. Our data support a trend of decreasing length of the mandibular symphysis through Late Jurassic time, as previously suggested. This may be correlated with increasing adaptation to feeding on large prey. Maximum body size of pliosaurids increased from their first appearance in the Early Jurassic until the Early Cretaceous (skull lengths up to 2360 mm). However, some reduction occurred before their final extinction in the early Late Cretaceous (skull lengths up to 1750 mm).	[Benson, Roger B. J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Evans, Mark] Leicester Arts & Museums Serv, New Walk Museum & Art Gallery, Leicester, Leics, England; [Smith, Adam S.] Nottingham Nat Hist Museum, Nottingham, England; [Sassoon, Judyth] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Moore-Faye, Scott] Wavecut Platform Ltd, Sevenoaks, England; [Ketchum, Hilary F.] Univ Cambridge, Univ Museum Zool, Cambridge, England; [Ketchum, Hilary F.] Univ Cambridge, Sedgwick Museum Earth Sci, Cambridge, England; [Forrest, Richard] Radcliffe On Trent, Trent, Notts, England	University of Oxford; University of Bristol; University of Cambridge; University of Cambridge	Benson, RBJ (corresponding author), Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England.	roger.benson@earth.ox.ac.uk		Ketchum, Hilary/0000-0001-7037-1411; Smith, Adam/0000-0002-8166-1139; Benson, Roger/0000-0001-8244-6177	Heritage Lottery Fund Collecting Cultures programme; Dorset County Council; Devon County Council	Heritage Lottery Fund Collecting Cultures programme; Dorset County Council; Devon County Council	The Heritage Lottery Fund Collecting Cultures programme (http://www.hlf.org.uk) and Dorset (http://www.dorsetforyou.com/county) and Devon (http://www.devon.gov.uk/) County Councils provided funding for purchase of DORCM G.13,675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright LB, 2007, J VERTEBR PALEONTOL, V27, P31, DOI 10.1671/0272-4634(2007)27[31:PFTUCC]2.0.CO;2; Albright LB, 2007, J VERTEBR PALEONTOL, V27, P41, DOI 10.1671/0272-4634(2007)27[41:PFTUCC]2.0.CO;2; Andrews CW, 1913, DESCRIPTIVE CATALO 2, Vxxiv; Andrews CW, 1910, DESCRIPTIVE CATALO 1; Bardet N., 1993, NEUES JB GEOLOGIE PA, P385; Benson R. B. J., 2012, J SYSTEMATIC PALAEON, V11, P233; Benson RBJ, 2014, BIOL REV, V89, P1, DOI 10.1111/brv.12038; Benson RBJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031838; Benson RBJ, 2011, J VERTEBR PALEONTOL, V31, P562, DOI 10.1080/02724634.2011.572937; Benson RBJ, 2011, PALAEONTOLOGY, V54, P547, DOI 10.1111/j.1475-4983.2011.01044.x; Birkelund T., 1983, Proceedings of the Geologists' Association, V94, P289; Brown D.S., 1981, Bulletin of the British Museum (Natural History) Geology, V35, P253; Buchy MC, 2003, B SOC GEOL FR, V174, P271, DOI 10.2113/174.3.271; Carpenter Kenneth, 1997, P191, DOI 10.1016/B978-012155210-7/50011-9; Carpenter Kenneth, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V201, P259; Cau A, 2014, ACTA PALAEONTOL POL, V59, P643, DOI 10.4202/app.2012.0117; Clarke JB, 1992, P DORSET NAT HIST AR, V113, P202; Conybeare WD, 1822, T GEOL SOC LOND, V2, P103, DOI [10.1144/transgslb.1.1.103, DOI 10.1144/TRANSGSLB.1.1.103]; Conybeare WD, 1824, T GEOLOGICAL SOC LON, VS2, P381, DOI [10.1144/transgslb.1.2.381, DOI 10.1144/TRANSGSLB.1.2.381]; Cox B.M., 1981, I GEOLOGICAL SCI REP, P1; CRUICKSHANK ARI, 1991, NATURE, V352, P62, DOI 10.1038/352062a0; Cruickshank ARI, 1996, J GEOL SOC LONDON, V153, P873, DOI 10.1144/gsjgs.153.6.0873; Cruickshank Arthur R. I., 1997, Annals of the South African Museum, V105, P207; de Blainville HD, 1835, NOUVELLES ANN MUSEUM, V4, P233; Dines HG, 1933, GEOLOGY COUNTRY REIG; Druckenmiller PS, 2008, PALAEONTOGR ABT A, V283, P1; Druckenmiller PS, 2008, ZOOTAXA, P1; Gasparini Z, 2009, PALAEONTOLOGY, V52, P661, DOI 10.1111/j.1475-4983.2009.00871.x; HALSTEAD L B, 1971, Palaeontology (Oxford), V14, P566; HALSTEAD LB, 1989, J GEOL SOC LONDON, V146, P37, DOI 10.1144/gsjgs.146.1.0037; Hampe O., 1992, COURIER FORSCHUNGSIN, V145, P1; Hampe O., 2005, GEOWISSENSCHAFTLICHE, V8, P37, DOI [DOI 10.5194/fr-8-37-2005, DOI 10.5194/FR-8-37-2005]; Hopson PM, 2005, RR0501 BRIT GEOL SUR, P1; Kear BP, 2006, BIOL LETTERS, V2, P615, DOI 10.1098/rsbl.2006.0504; Ketchum HF, 2011, SPEC PAP PALAEONTOL, P109, DOI 10.1111/j.1475-4983.2011.01083.x; Ketchum HF, 2011, PALAEONTOLOGY, V54, P639, DOI 10.1111/j.1475-4983.2011.01050.x; Ketchum HF, 2010, BIOL REV, V85, P361, DOI 10.1111/j.1469-185X.2009.00107.x; KNIGHT W. C., 1898, AM J SCI, V5, P378; Knutsen EM, 2012, NORW J GEOL, V92, P259; Knutsen EM, 2012, NORW J GEOL, V92, P235; Linder H., 1913, Geologische u Palaeontologische Abhandlungen Jena (N F), V11; Lydekker R, 1890, Q J GEOLOGICAL SOC, V46, P36; Lydekker R., 1889, CATALOGUE FOSSIL R 2; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Massare Judy A., 1997, P401, DOI 10.1016/B978-012155210-7/50021-1; McKean RS, 2012, CRETACEOUS RES, V34, P184, DOI 10.1016/j.cretres.2011.10.017; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Noe LF, 2004, P GEOLOGIST ASSOC, V115, P13, DOI 10.1016/S0016-7878(04)80031-2; Noe LF, 2003, GEOL MAG, V140, P479, DOI 10.1017/S0016756803007829; NOVOZHILOV N. I., 1964, OSNOVY PALEONTOLOGII, P309; NOVOZHILOV NI, 1948, DOKL AKAD NAUK SSSR+, V60, P115; NOVOZHILOV NI, 1948, DOKL AKAD NAUK SSSR+, V60, P285; O'Keefe FR, 2011, SCIENCE, V333, P870, DOI 10.1126/science.1205689; O'Keefe FR, 2008, J VERTEBR PALEONTOL, V28, P664, DOI 10.1671/0272-4634(2008)28[664:CAATOD]2.0.CO;2; O'Keefe FR, 2005, PALEOBIOLOGY, V31, P656; O'Keefe FR, 2002, PALEOBIOLOGY, V28, P101, DOI 10.1666/0094-8373(2002)028<0101:TEOPAP>2.0.CO;2; O'Keefe Frank Robin, 2001, Acta Zoologica Fennica, V213, P1; Owen R., 1860, REPORT BRIT ASS ADV, V29, P153; Owen R., 1841, ODONTOGRAPHY; Owen R, 1863, PALAEONTOGRAPHICAL S, V14, P27; Owen R, 1861, PALAEONTOGRAPHICAL S, V8, P15; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; OWEN R., 1869, PALAEONTOGRAPHICAL S, V22, P1; Owen R., 1840, REPORT BRIT ASS ADV, V9, P43; Owen R, 1861, PALAEONTOGRAPHICAL S, V12, P1; Owen R., 1860, Q J GEOLOGICAL SOC, V16, P262, DOI DOI 10.1144/GSL.JGS.1860.016.01-02.35; PHILLIPS J., 1871, GEOLOGY OXFORD VALLE; Rieppel OC, 1997, FIELDIANA, V36, P1; ROMER ALFRED S., 1959, BREVIORA MUS COMP ZOOL [HARVARD], V112, P1; Rozhdestvensky A. K., 1947, CR Acad Sci Moscow, V56, P197; Sassoon J, 2012, PALAEONTOLOGY, V55, P743, DOI 10.1111/j.1475-4983.2012.01151.x; Sato T, 2005, J PALEONTOL, V79, P969, DOI 10.1666/0022-3360(2005)079[0969:ANPPRS]2.0.CO;2; Sato T, 2011, J VERTEBR PALEONTOL, V31, P313, DOI 10.1080/02724634.2011.550358; Sauvage HE, 1902, B SOC ACAD ARRONDISS, V6, P380; SCHUMACHER B. A., J VERTEBRAT IN PRESS; Schumacher Bruce A., 2011, Transactions of the Kansas Academy of Science, V114, P1, DOI 10.1660/062.114.0101; Schumacher BA, 2007, GEOL SOC AM SPEC PAP, V427, P133, DOI 10.1130/2007.2427(09); SEELEY H. G., 1874, Q J GEOL SOC LOND, V30, P436, DOI DOI 10.1144/GSL.JGS.1874.030.01-04.48; SIKES D. S., 2001, BETA SOFTWARE VERSIO; Smith AS, 2008, NATURWISSENSCHAFTEN, V95, P975, DOI 10.1007/s00114-008-0402-z; Storrs Glenn W., 2000, P187; SUES HD, 1987, ZOOL J LINN SOC-LOND, V90, P109, DOI 10.1111/j.1096-3642.1987.tb01351.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TARLO L. B., 1959, PALAEONTOLOGY, V2, P39; TARLO L. B., 1959, PALAEONTOLOGY, V1, P283; TARLO L. B., 1960, B BRIT MUS NAT HIST, V4, P147; Tarlo LB, 1957, PALAEONTOLOGY, V1, P36; TAYLOR MA, 1993, PHILOS T ROY SOC B, V341, P399, DOI 10.1098/rstb.1993.0124; Vincent P, 2011, J VERTEBR PALEONTOL, V31, P340, DOI 10.1080/02724634.2011.550352; Wahl William R., 2007, Paludicola, V6, P94; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; WEGNER T., 1914, BRANCA FESTSCHRIFT, P235; White T. E., 1935, Occasional Papers of the Boston Society of Natural History, V8, P219; White T. E., 1940, Journal of Paleontology Menasha, V14, P451; Wilkinson M, 2003, J VERTEBR PALEONTOL, V23, P311, DOI 10.1671/0272-4634(2003)023[0311:MEAMTI]2.0.CO;2; Williston S. W., 1903, GEOLOGICAL SERIES, V2, P1; WILLISTON S. W., 1907, P US NATL MUS, V32, P477, DOI DOI 10.5479/SI.00963801.32-1540.477	97	57	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65989	10.1371/journal.pone.0065989	http://dx.doi.org/10.1371/journal.pone.0065989			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741520	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900233
J	Golla, U; Singh, V; Azad, GK; Singh, P; Verma, N; Mandal, P; Chauhan, S; Tomar, RS				Golla, Upendarrao; Singh, Vikash; Azad, Gajendra Kumar; Singh, Prabhat; Verma, Naveen; Mandal, Papita; Chauhan, Sakshi; Tomar, Raghuvir S.			Sen1p Contributes to Genomic Integrity by Regulating Expression of Ribonucleotide Reductase 1 (RNR1) in Saccharomyces cerevisiae	PLOS ONE			English	Article							RNA-POLYMERASE-II; CELL-CYCLE PROGRESSION; DNA-DAMAGE RESPONSE; TYPE-1 PROTEIN PHOSPHATASE; CHECKPOINT PATHWAYS; SMALL-SUBUNIT; RAD53 KINASE; TRANSCRIPTION; REPLICATION; REPAIR	Gene expression is a multi-step process which requires recruitment of several factors to promoters. One of the factors, Sen1p is an RNA/DNA helicase implicated in transcriptional termination and RNA processing in yeast. In the present study, we have identified a novel function of Sen1p that regulates the expression of ribonucleotide reductase RNR1 gene, which is essential for maintaining genomic integrity. Cells with mutation in the helicase domain or lacking N-terminal domain of Sen1p displayed a drastic decrease in the basal level transcription of RNR1 gene and showed enhanced sensitivity to various DNA damaging agents. Moreover, SEN1 mutants [Sen1-1 (G1747D), Sen1-2 (D1-975)] exhibited defects in DNA damage checkpoint activation. Surprisingly, CRT1 deletion in Sen1p mutants (Sen1-1, Sen1-2) was partly able to rescue the slow growth phenotype upon genotoxic stress. Altogether, our observations suggest that Sen1p is required for cell protection against DNA damage by regulating the expression of DNA repair gene RNR1. Thus, the misregulation of Sen1p regulated genes can cause genomic instability that may lead to neurological disorders and premature aging.	[Golla, Upendarrao; Singh, Vikash; Azad, Gajendra Kumar; Singh, Prabhat; Verma, Naveen; Mandal, Papita; Chauhan, Sakshi; Tomar, Raghuvir S.] Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Tomar, RS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India.	rst@iiserb.ac.in	Singh, Vikash/HCI-9902-2022; Azad, Gajendra Kumar/AAC-7014-2019; Golla, Upendar Rao/D-5933-2017; Azad, Gajendra/K-3381-2014; Verma, Naveen/AGI-5147-2022	Singh, Vikash/0000-0002-5325-1386; Golla, Upendar Rao/0000-0003-0519-7087; Azad, Gajendra/0000-0003-0338-3265; Verma, Naveen/0000-0003-4211-579X; Azad, Gajendra Kumar/0000-0001-5478-526X	Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported by the funds from Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1998, METHODS YEAST GENETI, Vxiv; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Andrews PD, 2000, J CELL SCI, V113, P507; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Brachmann CB, 1998, YEAST, V14, P115; Burgis NE, 2007, CHEM RES TOXICOL, V20, P1843, DOI 10.1021/tx700126e; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; Chen YZ, 2006, NEUROBIOL DIS, V23, P97, DOI 10.1016/j.nbd.2006.02.007; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; DEMARINI DJ, 1992, MOL CELL BIOL, V12, P2154, DOI 10.1128/MCB.12.5.2154; Dyavaiah M, 2011, MOL CANCER RES, V9, P462, DOI 10.1158/1541-7786.MCR-10-0473; ELLEDGE SJ, 1989, MOL CELL BIOL, V9, P4932, DOI 10.1128/MCB.9.11.4932; ELLEDGE SJ, 1993, BIOESSAYS, V15, P333, DOI 10.1002/bies.950150507; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; FENG ZH, 1991, J BIOL CHEM, V266, P23796; Finkel JS, 2010, GENETICS, V184, P107, DOI 10.1534/genetics.109.110031; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; HISAMOTO N, 1994, MOL CELL BIOL, V14, P3158, DOI 10.1128/MCB.14.5.3158; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; Klinkenberg LG, 2006, EUKARYOT CELL, V5, P1007, DOI 10.1128/EC.00045-06; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Minard LV, 2011, J BIOL CHEM, V286, P7082, DOI 10.1074/jbc.M110.193813; Minear S, 2011, EUKARYOT CELL, V10, P1574, DOI 10.1128/EC.05163-11; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Munshi A, 2009, J GENET GENOMICS, V36, P75, DOI 10.1016/S1673-8527(08)60094-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Rasmussen TP, 1999, MOL CELL BIOL, V19, P5235; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Shen CX, 2007, MOL CELL BIOL, V27, P7007, DOI 10.1128/MCB.00290-07; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Srividya I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031288; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tomar RS, 2008, EMBO J, V27, P1575, DOI 10.1038/emboj.2008.93; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wang Y, 2000, GENE DEV, V14, P927; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Yuce O, 2013, MOL CELL BIOL, V33, P406, DOI 10.1128/MCB.01195-12; Zaim J, 2005, J BIOL CHEM, V280, P28, DOI 10.1074/jbc.M404669200; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	70	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64798	10.1371/journal.pone.0064798	http://dx.doi.org/10.1371/journal.pone.0064798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741394	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900107
J	Hesse, JE; Liu, LW; Innes, CL; Cui, YX; Palii, SS; Paules, RS				Hesse, Jill E.; Liu, Liwen; Innes, Cynthia L.; Cui, Yuxia; Palii, Stela S.; Paules, Richard S.			Genome-Wide Small RNA Sequencing and Gene Expression Analysis Reveals a microRNA Profile of Cancer Susceptibility in ATM-Deficient Human Mammary Epithelial Cells	PLOS ONE			English	Article							PERIPHERAL-BLOOD DNA; ATAXIA-TELANGIECTASIA; PROTEIN-KINASE; VARIANTS; ONCOMIRS; BIOGENESIS; ENRICHMENT; REGULATORS; MIR-29; GALAXY	Deficiencies in the ATM gene are the underlying cause for ataxia telangiectasia, a syndrome characterized by neurological, motor and immunological defects, and a predisposition to cancer. MicroRNAs (miRNAs) are useful tools for cancer profiling and prediction of therapeutic responses to clinical regimens. We investigated the consequences of ATM deficiency on miRNA expression and associated gene expression in normal human mammary epithelial cells (HME-CCs). We identified 81 significantly differentially expressed miRNAs in ATM-deficient HME-CCs using small RNA sequencing. Many of these have been implicated in tumorigenesis and proliferation and include down-regulated tumor suppressor miRNAs, such as hsa-miR-29c and hsa-miR-16, as well as over-expressed pro-oncogenic miRNAs, such as hsa-miR-93 and hsa-miR-221. MicroRNA changes were integrated with genome wide gene expression profiles to investigate possible miRNA targets. Predicted mRNA targets of the miRNAs significantly regulated after ATM depletion included many genes associated with cancer formation and progression, such as SOCS1 and the proto-oncogene MAF. While a number of miRNAs have been reported as altered in cancerous cells, there is little understanding as to how these small RNAs might be driving cancer formation or how they might be used as biomarkers for cancer susceptibility. This study provides preliminary data for defining miRNA profiles that may be used as prognostic or predictive biomarkers for breast cancer. Our integrated analysis of miRNA and mRNA expression allows us to gain a better understanding of the signaling involved in breast cancer predisposition and suggests a mechanism for the breast cancer-prone phenotype seen in ATM-deficient patients.	[Hesse, Jill E.; Innes, Cynthia L.; Cui, Yuxia; Palii, Stela S.; Paules, Richard S.] NIEHS, Environm Stress & Canc Grp, Lab Toxicol & Pharmacol, Res Triangle Pk, NC 27709 USA; [Liu, Liwen; Paules, Richard S.] NIEHS, NIEHS Microarray Core, Lab Toxicol & Pharmacol, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Paules, RS (corresponding author), NIEHS, Environm Stress & Canc Grp, Lab Toxicol & Pharmacol, POB 12233, Res Triangle Pk, NC 27709 USA.	paules@niehs.nih.gov		Paules, Richard S/0000-0001-9106-7486	Intramural Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES021157]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, Z01ES021157, ZIAES021157] Funding Source: NIH RePORTER	Intramural Program of the National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Program of the National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES021157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2006, ONCOGENE, V25, P5906, DOI 10.1038/sj.onc.1209873; Arlander SJH, 2008, CANCER RES, V68, P89, DOI 10.1158/0008-5472.CAN-07-0675; Babashah S, 2011, EUR J CANCER, V47, P1127, DOI 10.1016/j.ejca.2011.02.008; BLANKENBERG D, 2011, CURR PROTOC MOL BIOL, P11; Brennan K, 2012, CANCER RES, V72, P2304, DOI 10.1158/0008-5472.CAN-11-3157; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Flanagan JM, 2009, HUM MOL GENET, V18, P1332, DOI 10.1093/hmg/ddp033; Fletcher O, 2010, CANCER EPIDEM BIOMAR, V19, P2143, DOI 10.1158/1055-9965.EPI-10-0374; Foley NH, 2011, CELL DEATH DIFFER, V18, P1089, DOI 10.1038/cdd.2010.172; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldgar DE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2919; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Iguchi Haruhisa, 2010, Curr Drug Discov Technol, V7, P95; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson N, 2007, HUM MOL GENET, V16, P1051, DOI 10.1093/hmg/ddm050; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-419; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Mobley AK, 2012, CANCER METAST REV, V31, P621, DOI 10.1007/s10555-012-9358-8; Munker R, 2011, CLIN SCI, V121, P141, DOI 10.1042/CS20110005; Perry JJP, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001961; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Shen XH, 2010, REPROD FERT DEVELOP, V22, P634, DOI 10.1071/RD09188; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; SWIFT M, 1983, LANCET, V1, P1049; Swift M, 1985, Kroc Found Ser, V19, P133; SWIFT M, 1986, AM J HUM GENET, V39, P573; Tavtigian SV, 2009, AM J HUM GENET, V85, P427, DOI 10.1016/j.ajhg.2009.08.018; Voorhoeve PM, 2010, BBA-REV CANCER, V1805, P72, DOI 10.1016/j.bbcan.2009.09.003; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147	48	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64779	10.1371/journal.pone.0064779	http://dx.doi.org/10.1371/journal.pone.0064779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741392	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900105
J	Pasinelli, G; Meichtry-Stier, K; Birrer, S; Baur, B; Duss, M				Pasinelli, Gilberto; Meichtry-Stier, Kim; Birrer, Simon; Baur, Bruno; Duss, Martin			Habitat Quality and Geometry Affect Patch Occupancy of Two Orthopteran Species	PLOS ONE			English	Article							GRYLLUS-CAMPESTRIS; POPULATION-SIZE; LANDSCAPE; CRICKET; FRAGMENTATION; DYNAMICS; AREA; CONNECTIVITY; BEHAVIOR	Impacts of habitat loss and fragmentation on distribution and population size of many taxa are well established. In contrast, less is known about the role of within-patch habitat quality for the spatial dynamics of species, even though within-patch habitat quality may substantially influence the dynamics of population networks. We studied occurrence patterns of two Orthopteran species in relation to size, isolation and quality of habitat patches in an intensively managed agricultural landscape (16.65 km(2)) in the Swiss lowland. Occurrence of field crickets (Gryllus campestris) was positively related to patch size and negatively to the distance to the nearest occupied patch, two measures of patch geometry. Moreover, field crickets were more likely to occur in extensively managed meadows, meadows used at low intensity and meadows dominated by Poa pratensis, three measures of patch quality. Occurrence of the large gold grasshopper (Chrysochraon dispar) was negatively related to two measures of patch geometry, distance to the nearest occupied patch and perimeter index (ratio of perimeter length to patch area). Further, large gold grasshoppers were more likely to occupy patches close to water and patches with vegetation left uncut over winter, two measures of patch quality. Finally, examination of patch occupancy dynamics of field crickets revealed that patches colonized in 2009 and patches occupied in both 2005 and 2009 were larger, better connected and of other quality than patches remaining unoccupied and patches from which the species disappeared. The strong relationships between Orthopteran occurrence and aspects of patch geometry found in this study support the "area-and-isolation paradigm". Additionally, our study reveals the importance of patch quality for occurrence patterns of both species, and for patch occupancy dynamics in the field cricket. An increased understanding of patch occupancy patterns may be gained if inference is based on variables related to both habitat geometry and quality.	[Pasinelli, Gilberto; Meichtry-Stier, Kim; Birrer, Simon; Duss, Martin] Swiss Ornithol Inst, Sempach, Switzerland; [Baur, Bruno; Duss, Martin] Univ Basel, Dept Environm Sci, Basel, Switzerland	Swiss Ornithological Institute; University of Basel	Pasinelli, G (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	gilberto.pasinelli@vogelwarte.ch	Birrer, Simon/AAW-6366-2021	Birrer, Simon/0000-0002-3665-8141	Vogelwarte	Vogelwarte	The Vogelwarte (http://www.vogelwarte.ch/home-en.html) paid the salaries of G. Pasinelli, S. Birrer and K. Meichtry-Stier. These three persons all contributed to analyzing and writing the article (as did B. Baur and M. Duss). The funders of Vogelwarte had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2011, NATURWISSENSCHAFTEN, V98, P163, DOI 10.1007/s00114-010-0750-3; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Bauerfeind SS, 2009, J INSECT CONSERV, V13, P271, DOI 10.1007/s10841-008-9166-1; Baur H, 2006, HEUSCHRECKEN SCHWEIZ; Bender DJ, 2003, LANDSCAPE ECOL, V18, P17, DOI 10.1023/A:1022937226820; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bradford DF, 2003, ECOLOGY, V84, P1012, DOI 10.1890/0012-9658(2003)084[1012:HPOBTB]2.0.CO;2; Brouwers NC, 2009, LANDSCAPE ECOL, V24, P199, DOI 10.1007/s10980-008-9298-4; DAMBACH M, 1983, ENTOMOL GEN, V8, P267; Detzel P, 1991, THESIS U TUBINGEN; Detzel P, 1998, HEUSCHRECKEN BADEN W; Didham RK, 1996, TRENDS ECOL EVOL, V11, P255, DOI 10.1016/0169-5347(96)20047-3; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Franken RJ, 2004, J ANIM ECOL, V73, P889, DOI 10.1111/j.0021-8790.2004.00865.x; Franzen M, 2010, P ROY SOC B-BIOL SCI, V277, P79, DOI 10.1098/rspb.2009.1584; Fricke M, 1992, SCHRIFTEN, V4, P59; Gaggiotti Oscar E., 2004, P337, DOI 10.1016/B978-012323448-3/50016-7; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Graf R, 2009, MONITORING NATURNAHE; GUSTAFSON EJ, 1994, LANDSCAPE URBAN PLAN, V29, P117, DOI 10.1016/0169-2046(94)90022-1; Hahn Steffen, 2005, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Oesterreich, V142, P1; Hames RS, 2001, J ANIM ECOL, V70, P182, DOI 10.1046/j.1365-2656.2001.00482.x; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I., 1999, METAPOPULATION ECOLO; Hjermann DO, 1996, J ANIM ECOL, V65, P768, DOI 10.2307/5675; Hobbs RJ, 2003, AUST J BOT, V51, P471, DOI 10.1071/BT03037; Humbert JY, 2012, BIOL CONSERV, V152, P96, DOI 10.1016/j.biocon.2012.03.015; Humbert JY, 2009, AGR ECOSYST ENVIRON, V130, P1, DOI 10.1016/j.agee.2008.11.014; Kajzer J, 2012, J BIOGEOGR, V39, P371, DOI 10.1111/j.1365-2699.2011.02604.x; KINDVALL O, 1992, CONSERV BIOL, V6, P520, DOI 10.1046/j.1523-1739.1992.06040520.x; LANDOLT E., 1977, OKOLOGISCHE ZEIGERWE; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Matter SF, 2005, OIKOS, V111, P359, DOI 10.1111/j.0030-1299.2005.14127.x; McGarigal K, 1995, PNW351 GTR; Monnerat C, 2007, ROTE LISTE HEUSCHREC; Mortelliti A, 2010, OECOLOGIA, V163, P535, DOI 10.1007/s00442-010-1623-3; Pavlacky DC, 2012, J ANIM ECOL, V81, P940, DOI 10.1111/j.1365-2656.2012.01975.x; Pellet J, 2007, BIOL CONSERV, V136, P483, DOI 10.1016/j.biocon.2006.12.020; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Rietze J., 1991, Articulata, V6, P91; Ritz Markus, 2000, Articulata, V15, P87; Robles H, 2012, CONSERV BIOL, V26, P284, DOI 10.1111/j.1523-1739.2011.01816.x; Roesti C, 2009, STIMMEN HEUSCHRECKEN; ROST R, 1987, BEHAV ECOL SOCIOBIOL, V21, P279, DOI 10.1007/BF00299965; Zuur Alain F., 2009, P1	48	8	8	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65850	10.1371/journal.pone.0065850	http://dx.doi.org/10.1371/journal.pone.0065850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741516	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900229
J	Saito, M; Koike, F				Saito, Masayuki; Koike, Fumito			Distribution of Wild Mammal Assemblages along an Urban-Rural-Forest Landscape Gradient in Warm-Temperate East Asia	PLOS ONE			English	Article							CARABID BEETLE ASSEMBLAGES; BADGERS MELES-MELES; HABITAT FRAGMENTATION; SPECIES RICHNESS; RELATIVE IMPORTANCE; FOOD-HABITS; LAND-USE; URBANIZATION; BIODIVERSITY; POPULATION	Urbanization may alter mammal assemblages via habitat loss, food subsidies, and other factors related to human activities. The general distribution patterns of wild mammal assemblages along urban-rural-forest landscape gradients have not been studied, although many studies have focused on a single species or taxon, such as rodents. We quantitatively evaluated the effects of the urban-rural-forest gradient and spatial scale on the distributions of large and mid-sized mammals in the world's largest metropolitan area in warm-temperate Asia using nonspecific camera-trapping along two linear transects spanning from the urban zone in the Tokyo metropolitan area to surrounding rural and forest landscapes. Many large and mid-sized species generally decreased from forest landscapes to urban cores, although some species preferred anthropogenic landscapes. Sika deer (Cervus nippon), Reeves' muntjac (Muntiacus reevesi), Japanese macaque (Macaca fuscata), Japanese squirrel (Sciurus lis), Japanese marten (Martes melampus), Japanese badger (Meles anakuma), and wild boar (Sus scrofa) generally dominated the mammal assemblage of the forest landscape. Raccoon (Procyon lotor), raccoon dog (Nyctereutes procyonoides), and Japanese hare (Lepus brachyurus) dominated the mammal assemblage in the intermediate zone (i.e., rural and suburban landscape). Cats (feral and free-roaming housecats; Felis catus) were common in the urban assemblage. The key spatial scales for forest species were more than 4000-m radius, indicating that conservation and management plans for these mammal assemblages should be considered on large spatial scales. However, small green spaces will also be important for mammal conservation in the urban landscape, because an indigenous omnivore (raccoon dog) had a smaller key spatial scale (500-m radius) than those of forest mammals. Urbanization was generally the most important factor in the distributions of mammals, and it is necessary to consider the spatial scale of management according to the degree of urbanization.	[Saito, Masayuki; Koike, Fumito] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 240, Japan	Yokohama National University	Saito, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	saito.ume@gmail.com	Koike, Fumito/F-5774-2011	Koike, Fumito/0000-0002-6588-6485	JSPS (Japan Society for the Promotion of Science) Global COE (Centers of Excellence) Program "Global eco-risk management from Asian viewpoints"; Joint Research Program C of the Research Institute of Environment and Information Sciences, Yokohama National University	JSPS (Japan Society for the Promotion of Science) Global COE (Centers of Excellence) Program "Global eco-risk management from Asian viewpoints"; Joint Research Program C of the Research Institute of Environment and Information Sciences, Yokohama National University	This study was supported in part by the JSPS (Japan Society for the Promotion of Science) Global COE (Centers of Excellence) Program "Global eco-risk management from Asian viewpoints" and Joint Research Program C of the Research Institute of Environment and Information Sciences, Yokohama National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2012, BIOL CONSERV, V145, P15, DOI 10.1016/j.biocon.2011.08.017; Asada M, 2009, REP CHIBA BIODIVERSI, V1, P21; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Bjerke T, 2004, ANTHROZOOS, V17, P109, DOI 10.2752/089279304786991783; Bjurlin Curtis D., 2005, Endangered Species Update, V22, P107; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Blair RB, 1999, ECOL APPL, V9, P164, DOI 10.1890/1051-0761(1999)009[0164:BABAAU]2.0.CO;2; Branton M, 2011, CONSERV BIOL, V25, P9, DOI 10.1111/j.1523-1739.2010.01606.x; BRIGHT PW, 1993, MAMMAL REV, V23, P101, DOI 10.1111/j.1365-2907.1993.tb00420.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Clout MN, 2006, ASSESSMENT CONTROL B, P127; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; DICKMAN CR, 1987, J APPL ECOL, V24, P337, DOI 10.2307/2403879; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; du Toit JT, 2010, ANIM CONSERV, V13, P229, DOI 10.1111/j.1469-1795.2010.00355.x; Fujita M, 2009, ECOSYSTEMS, V12, P391, DOI 10.1007/s10021-009-9230-z; Fukue Y., 2002, WILDLIFE CONSERVATIO, V7, P83; Germaine SS, 2001, BIOL CONSERV, V97, P229, DOI 10.1016/S0006-3207(00)00115-4; Gomes V, 2011, BIODIVERS CONSERV, V20, P3577, DOI 10.1007/s10531-011-0149-2; Gray TNE, 2010, ANIM CONSERV, V13, P324, DOI 10.1111/j.1469-1795.2010.00351.x; HARRIS S, 1987, J APPL ECOL, V24, P75, DOI 10.2307/2403788; Hemami MR, 2005, FOREST ECOL MANAG, V215, P224, DOI 10.1016/j.foreco.2005.05.013; Hirasawa Mizuho, 2006, Mammal Study, V31, P9, DOI 10.3106/1348-6160(2006)31[9:SFHOTR]2.0.CO;2; HOFFMANN CO, 1977, J MAMMAL, V58, P623, DOI 10.2307/1380010; Honda T, 2009, MAMM STUDY, V34, P107, DOI 10.3106/041.034.0206; Ichikawa K, 2006, LANDSCAPE URBAN PLAN, V78, P398, DOI 10.1016/j.landurbplan.2005.12.001; Ikeda Tohru, 2004, Global Environmental Research, V8, P125; Imaki H., 2006, BIOSPH CONSERV, V7, P87; Ishitani M, 2003, ECOGRAPHY, V26, P481, DOI 10.1034/j.1600-0587.2003.03436.x; Jansen A, 2007, EMERG INFECT DIS, V13, P739, DOI 10.3201/eid1305.061302; Kaneko Y, 2006, J ZOOL, V270, P78, DOI 10.1111/j.1469-7998.2006.00063.x; Kaneko Yayoi, 2005, Honyurui Kagaku, V45, P157; Kataoka Tomomi, 2005, Mammal Study, V30, P131, DOI 10.3106/1348-6160(2005)30[131:EOHFOT]2.0.CO;2; Kent R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025440; Lindsey Peter A., 2007, Journal of Ecotourism, V6, P19, DOI 10.2167/joe133.0; Luck M, 2002, LANDSCAPE ECOL, V17, P327, DOI 10.1023/A:1020512723753; Maestas JD, 2003, CONSERV BIOL, V17, P1425, DOI 10.1046/j.1523-1739.2003.02371.x; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Magura T, 2004, LANDSCAPE ECOL, V19, P747, DOI 10.1007/s10980-005-1128-4; McCleery RA, 2007, J WILDLIFE MANAGE, V71, P1149, DOI 10.2193/2006-282; Mccleery RA, 2009, LANDSCAPE ECOL, V24, P483, DOI 10.1007/s10980-009-9323-2; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Ministry of Internal Affairs and Communications, 2013, JAP STAT YB 2013; Ministry of the Environment, 2004, 6 7 NAT SURV NAT ENV; Ministry of the Environment, 2007, REP SPEC DIV SURV RA; Ministry of the Environment, 2010, AN DISTR ATL JAP; Miyawaki A., 1976, B I ENV SCI TECH YOK, V2, P95; Morrison M.L., 2002, SCI PRAC ECOL REST; Mortelliti A, 2010, MAMMAL REV, V40, P125, DOI 10.1111/j.1365-2907.2009.00157.x; National Institute for Environmental Studies, 2012, INV SPEC JAP; Natuhara Y, 1999, BIODIVERS CONSERV, V8, P239, DOI 10.1023/A:1008869410668; Natuhara Y, 1996, ECOL RES, V11, P1, DOI 10.1007/BF02347814; Ochimaru T, 2007, CAN J FOREST RES, V37, P247, DOI 10.1139/X06-293; Odell EA, 2001, CONSERV BIOL, V15, P1143, DOI 10.1046/j.1523-1739.2001.0150041143.x; Oehler JD, 1996, CAN J ZOOL, V74, P2070, DOI 10.1139/z96-235; OHDACHI S. D., 2009, WILD MAMMALS JAPAN; Okello MM, 2008, TOURISM MANAGE, V29, P751, DOI 10.1016/j.tourman.2007.08.003; Parker Tommy S., 2008, Urban Ecosystems, V11, P243, DOI 10.1007/s11252-008-0060-0; R Development Core Team, 2012, R LANG ENV STAT COMP; Randa LA, 2006, J MAMMAL, V87, P1154, DOI 10.1644/05-MAMM-A-224R2.1; Razgour O, 2011, BIOL CONSERV, V144, P2922, DOI 10.1016/j.biocon.2011.08.010; Riem JG, 2012, AM MIDL NAT, V168, P315; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Saeki M, 2007, J MAMMAL, V88, P1098, DOI 10.1644/06-MAMM-A-208R1.1; Saito M, 2012, WILDLIFE BIOL, V18, P383, DOI 10.2981/11-110; Saito M, 2012, INT J PEST MANAGE, V58, P65, DOI 10.1080/09670874.2011.648230; Saito M, 2011, CROP PROT, V30, P1048, DOI 10.1016/j.cropro.2011.02.017; Saito M, 2009, ACTA THERIOL, V54, P363, DOI 10.4098/j.at.0001-7051.061.2008; Sauvajot Raymond M., 1999, Urban Ecosystems, V2, P279, DOI 10.1023/A:1009588723665; Shimano K, 2006, J WILDLIFE MANAGE, V70, P1650, DOI 10.2193/0022-541X(2006)70[1650:HAADEF]2.0.CO;2; Soga M, 2012, ECOL RES, V27, P265, DOI 10.1007/s11284-011-0896-2; Sonoda Y., 2004, J JAPANESE I LANDSCA, V67, P779; Sonoda Youichi, 2008, Ecology and Civil Engineering, V11, P41, DOI 10.3825/ece.11.41; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Torii Harumi, 2009, P347, DOI 10.1007/978-4-431-09429-6_25; Totton SC, 2004, CAN FIELD NAT, V118, P65, DOI 10.22621/cfn.v118i1.884; United Nations, 2012, WORLD URB PROSP 2011; Uraguchi K, 2009, POPUL ECOL, V51, P271, DOI 10.1007/s10144-008-0125-1; van Langevelde F, 2009, ANIM CONSERV, V12, P540, DOI 10.1111/j.1469-1795.2009.00281.x; Virgos E, 2002, BIODIVERS CONSERV, V11, P1063, DOI 10.1023/A:1015856703786; Virgos E, 2002, CAN J ZOOL, V80, P430, DOI [10.1139/z02-028, 10.1139/Z02-028]; Virgos E, 2001, J BIOGEOGR, V28, P381, DOI 10.1046/j.1365-2699.2001.00552.x; Watanabe Shinichi, 2003, Mammal Study, V28, P47, DOI 10.3106/mammalstudy.28.47; Yamamoto Y., 1994, B KAWASAKI MUNICIPAL, V5, P29; Yasuda Masatoshi, 2004, Mammal Study, V29, P37, DOI 10.3106/mammalstudy.29.37; YATAKE H, 2003, MAMMALIAN SCI, V43, P99; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107	95	45	50	5	158	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65464	10.1371/journal.pone.0065464	http://dx.doi.org/10.1371/journal.pone.0065464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741495	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900208
J	Shimizu, N; Chikahisa, S; Nishi, Y; Harada, S; Iwaki, Y; Fujihara, H; Kitaoka, K; Shiuchi, T; Sei, H				Shimizu, Noriyuki; Chikahisa, Sachiko; Nishi, Yuina; Harada, Saki; Iwaki, Yohei; Fujihara, Hiroaki; Kitaoka, Kazuyoshi; Shiuchi, Tetsuya; Sei, Hiroyoshi			Maternal Dietary Restriction Alters Offspring's Sleep Homeostasis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PPAR-ALPHA; FOOD-INTAKE; AMP-KINASE; SYNTHASE; TRANSCRIPTION; METABOLISM; ADENOSINE; NUTRIENT; ENZYME	Nutritional state in the gestation period influences fetal growth and development. We hypothesized that undernutrition during gestation would affect offspring sleep architecture and/or homeostasis. Pregnant female mice were assigned to either control (fed ad libitum; AD) or 50% dietary restriction (DR) groups from gestation day 12 to parturition. After parturition, dams were fed AD chow. After weaning, the pups were also fed AD into adulthood. At adulthood (aged 8-9 weeks), we carried out sleep recordings. Although offspring mice displayed a significantly reduced body weight at birth, their weights recovered three days after birth. Enhancement of electroencephalogram (EEG) slow wave activity (SWA) during non-rapid eye movement (NREM) sleep was observed in the DR mice over a 24-hour period without changing the diurnal pattern or amounts of wake, NREM, or rapid eye movement (REM) sleep. In addition, DR mice also displayed an enhancement of EEG-SWA rebound after a 6-hour sleep deprivation and a higher threshold for waking in the face of external stimuli. DR adult offspring mice exhibited small but significant increases in the expression of hypothalamic peroxisome proliferator-activated receptor alpha (Ppar alpha) and brain-specific carnitine palmitoyltransferase 1 (Cpt1c) mRNA, two genes involved in lipid metabolism. Undernutrition during pregnancy may influence sleep homeostasis, with offspring exhibiting greater sleep pressure.	[Shimizu, Noriyuki; Chikahisa, Sachiko; Nishi, Yuina; Harada, Saki; Iwaki, Yohei; Fujihara, Hiroaki; Kitaoka, Kazuyoshi; Shiuchi, Tetsuya; Sei, Hiroyoshi] Univ Tokushima, Dept Integrat Physiol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Nishi, Yuina; Harada, Saki] Univ Tokushima, Student Lab, Fac Med, Tokushima 770, Japan	Tokushima University; Tokushima University	Sei, H (corresponding author), Univ Tokushima, Dept Integrat Physiol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.	sei@tokushima-u.ac.jp	Shiuchi, Tetsuya/AAG-7620-2020	Shiuchi, Tetsuya/0000-0002-3027-5465	Japan Society for the Promotion of Science (JSPS) [332 (22590224), 2373070600, 333]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research (C) 332 (22590224) to H. S. and Grants-in-Aid for Young Scientists (B) (2373070600) to S. C. 333 from Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bjorness TE, 2009, CURR NEUROPHARMACOL, V7, P238, DOI 10.2174/157015909789152182; Borbely AA, 2001, ARCH ITAL BIOL, V139, P53; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chikahisa S, 2008, ENDOCRINOLOGY, V149, P5262, DOI 10.1210/en.2008-0285; Chikahisa S, 2009, NEUROPHARMACOLOGY, V57, P369, DOI 10.1016/j.neuropharm.2009.07.015; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Dworak M, 2010, J NEUROSCI, V30, P9007, DOI 10.1523/JNEUROSCI.1423-10.2010; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Huang ZL, 2007, CURR OPIN PHARMACOL, V7, P33, DOI 10.1016/j.coph.2006.09.004; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Isganaitis E, 2009, DIABETES, V58, P1192, DOI 10.2337/db08-1266; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kostiuk MA, 2010, FASEB J, V24, P1914, DOI 10.1096/fj.09-149765; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2008, NUTRITION, V24, P786, DOI 10.1016/j.nut.2008.06.002; Porkka-Heiskanen T, 2011, SLEEP MED REV, V15, P123, DOI 10.1016/j.smrv.2010.06.005; Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Stenberg D, 2007, CELL MOL LIFE SCI, V64, P1187, DOI 10.1007/s00018-007-6530-3; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi Giulio, 2009, J Clin Sleep Med, V5, pS16; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wigren HKM, 2009, NEUROREPORT, V20, P97, DOI 10.1097/WNR.0b013e32831af03d	35	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64263	10.1371/journal.pone.0064263	http://dx.doi.org/10.1371/journal.pone.0064263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741310	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900022
J	Thullier, P; Avril, A; Mathieu, J; Behrens, CK; Pellequer, JL; Pelat, T				Thullier, Philippe; Avril, Arnaud; Mathieu, Jacques; Behrens, Christian K.; Pellequer, Jean-Luc; Pelat, Thibaut			Mapping the Epitopes of a Neutralizing Antibody Fragment Directed against the Lethal Factor of Bacillus anthracis and Cross-Reacting with the Homologous Edema Factor	PLOS ONE			English	Article							PROTECTIVE ANTIGEN; MONOCLONAL-ANTIBODIES; GERMLINE HUMANIZATION; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; HOT-SPOTS; BINDING; PREDICTION; RESIDUES; TOXIN	The lethal toxin (LT) of Bacillus anthracis, composed of the protective antigen (PA) and the lethal factor (LF), plays an essential role in anthrax pathogenesis. PA also interacts with the edema factor (EF, 20% identity with LF) to form the edema toxin (ET), which has a lesser role in anthrax pathogenesis. The first recombinant antibody fragment directed against LF was scFv 2LF; it neutralizes LT by blocking the interaction between PA and LF. Here, we report that scFv 2LF cross-reacts with EF and cross-neutralizes ET, and we present an in silico method taking advantage of this cross-reactivity to map the epitope of scFv 2LF on both LF and EF. This method identified five epitope candidates on LF, constituted of a total of 32 residues, which were tested experimentally by mutating the residues to alanine. This combined approach precisely identified the epitope of scFv 2LF on LF as five residues (H229, R230, Q234, L235 and Y236), of which three were missed by the consensus epitope candidate identified by pre-existing in silico methods. The homolog of this epitope on EF (H253, R254, E258, L259 and Y260) was experimentally confirmed to constitute the epitope of scFv 2LF on EF. Other inhibitors, including synthetic molecules, could be used to target these epitopes for therapeutic purposes. The in silico method presented here may be of more general interest.	[Thullier, Philippe; Avril, Arnaud; Pelat, Thibaut] Inst Rech Biomed Armees, Unite Biotechnol Anticorps & Toxines, La Tronche, France; [Mathieu, Jacques] Inst Rech Biomed Armees, Dept Microbiol, La Tronche, France; [Behrens, Christian K.] Lab Francais Fractionnement & Biotechnol, Les Ulis, France; [Pellequer, Jean-Luc] IBEB, CEA, Serv Biochim & Toxicol Nucl, Bagnols Sur Ceze, France	CEA	Pelat, T (corresponding author), Inst Rech Biomed Armees, Unite Biotechnol Anticorps & Toxines, La Tronche, France.	t.pelat@orange.fr	Pellequer, Jean-Luc/L-6855-2013	Pellequer, Jean-Luc/0000-0002-8944-2715; AVRIL, Arnaud/0000-0003-1759-7256; Pelat, thibaut/0000-0003-4312-1032	Direction Generale de l'Armement (DGA) [09co302-1]	Direction Generale de l'Armement (DGA)	This study was supported by Direction Generale de l'Armement (DGA) grant 09co302-1, http://www.defense.gouv.fr/dga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Albrecht MT, 2007, INFECT IMMUN, V75, P5425, DOI 10.1128/IAI.00261-07; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Baillie LWJ, 2006, J APPL MICROBIOL, V101, P594, DOI 10.1111/j.1365-2672.2006.03112.x; Brossier F, 2004, INFECT IMMUN, V72, P6313, DOI 10.1128/IAI.72.11.6313-6317.2004; Burnett JC, 2005, NAT REV DRUG DISCOV, V4, P281, DOI 10.1038/nrd1694; Chang HT, 2008, J MOL RECOGNIT, V21, P431, DOI 10.1002/jmr.910; Chen ZC, 2011, TOXINS, V3, P1004, DOI 10.3390/toxins3081004; Chen ZC, 2009, INFECT IMMUN, V77, P3902, DOI 10.1128/IAI.00200-09; Durmaz R, 2012, EUR J CLIN MICROBIOL, V31, P2783, DOI 10.1007/s10096-012-1628-4; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Fox JL, 2013, NAT BIOTECHNOL, V31, P8, DOI 10.1038/nbt0113-8; Froude JW, 2011, TOXINS, V3, P1433, DOI 10.3390/toxins3111433; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiao GS, 2010, BIOORG MED CHEM LETT, V20, P6850, DOI 10.1016/j.bmcl.2010.08.058; JIN L, 1994, PROTEIN SCI, V3, P2351, DOI 10.1002/pro.5560031219; JIN L, 1992, J MOL BIOL, V226, P851, DOI 10.1016/0022-2836(92)90636-X; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; Kulshreshtha P, 2011, MOL IMMUNOL, V48, P1958, DOI 10.1016/j.molimm.2011.05.024; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lightfoot N, 1990, SALISBURY MED B S68, V68; Lim NK, 2005, INFECT IMMUN, V73, P6547, DOI 10.1128/IAI.73.10.6547-6551.2005; LITTLE SF, 1990, INFECT IMMUN, V58, P1606, DOI 10.1128/IAI.58.6.1606-1613.1990; Little SF, 1997, INFECT IMMUN, V65, P5171, DOI 10.1128/IAI.65.12.5171-5175.1997; Ma BY, 2001, CURR OPIN STRUC BIOL, V11, P364, DOI 10.1016/S0959-440X(00)00216-5; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Patra G, 1998, J CLIN MICROBIOL, V36, P3412, DOI 10.1128/JCM.36.11.3412-3414.1998; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Pelat T, 2009, MABS-AUSTIN, V1, P377, DOI 10.4161/mabs.1.4.8635; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; PELLEQUER JL, 1993, MOL IMMUNOL, V30, P955, DOI 10.1016/0161-5890(93)90022-4; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Zhang Y, 2010, J BIOL CHEM, V285, P12078, DOI 10.1074/jbc.M109.092445; Zhao Ping, 2003, Human Antibodies, V12, P129	50	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65855	10.1371/journal.pone.0065855	http://dx.doi.org/10.1371/journal.pone.0065855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741517	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900230
J	Uddin, MJ; Khan, WA; Ismail, AIM				Uddin, Md. Jashim; Khan, Waqar A.; Ismail, A. I. Md.			MHD Forced Convective Laminar Boundary Layer Flow from a Convectively Heated Moving Vertical Plate with Radiation and Transpiration Effect	PLOS ONE			English	Article							STAGNATION-POINT FLOW; POWER-LAW FLUID; MASS-TRANSFER; SIMILARITY SOLUTIONS; VISCOUS DISSIPATION; VARIABLE VISCOSITY; SURFACE; SUCTION; WEDGE	A two-dimensional steady forced convective flow of a Newtonian fluid past a convectively heated permeable vertically moving plate in the presence of a variable magnetic field and radiation effect has been investigated numerically. The plate moves either in assisting or opposing direction to the free stream. The plate and free stream velocities are considered to be proportional to x(m) whilst the magnetic field and mass transfer velocity are taken to be proportional to x((m-1)/2)where xis the distance along the plate from the leading edge of the plate. Instead of using existing similarity transformations, we use a linear group of transformations to transform the governing equations into similarity equations with relevant boundary conditions. Numerical solutions of the similarity equations are presented to show the effects of the controlling parameters on the dimensionless velocity, temperature and concentration profiles as well as on the friction factor, rate of heat and mass transfer. It is found that the rate of heat transfer elevates with the mass transfer velocity, convective heat transfer, Prandtl number, velocity ratio and the magnetic field parameters. It is also found that the rate of mass transfer enhances with the mass transfer velocity, velocity ratio, power law index and the Schmidt number, whilst it suppresses with the magnetic field parameter. Our results are compared with the results existing in the open literature. The comparisons are satisfactory.	[Uddin, Md. Jashim] Amer Int Univ Bangladesh, Dhaka, Bangladesh; [Khan, Waqar A.] Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan; [Ismail, A. I. Md.] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia	American International University Bangladesh (AIUB); National University of Sciences & Technology - Pakistan; Universiti Sains Malaysia	Khan, WA (corresponding author), Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan.	wkhan_2000@yahoo.com	Khan, Waqar/H-3886-2013	Khan, Waqar/0000-0002-8328-850X				Abbasbandy S, 2009, COMMUN NONLINEAR SCI, V14, P3591, DOI 10.1016/j.cnsns.2009.01.030; Alam MS, 2008, INT J THERM SCI, V47, P758, DOI 10.1016/j.ijthermalsci.2007.06.006; Ali ME, 2006, INT J THERM SCI, V45, P60, DOI 10.1016/j.ijthermalsci.2005.04.006; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; Bakier AY, 2009, INT J FLUID MECH RES, V36, P489, DOI 10.1615/InterJFluidMechRes.v36.i6.10; Bararnia H, 2012, ADV ENG SOFTW, V43, P44, DOI 10.1016/j.advengsoft.2011.08.005; Bataller RC, 2008, APPL MATH COMPUT, V198, P333, DOI 10.1016/j.amc.2007.08.037; Belfiore L.A., 2003, TRANSPORT PHENOMENA; Brown NM, 2005, INT COMMUN HEAT MASS, V32, P1000, DOI 10.1016/j.icheatmasstransfer.2004.10.029; CEBECI T, 1998, PHYS COMPUTATIONAL A, P380; Chen CH, 2010, J HEAT TRANS-T ASME, V132, DOI 10.1115/1.4000946; Cortell R, 2008, PHYS LETT A, V372, P631, DOI 10.1016/j.physleta.2007.08.005; Cortell R, 2011, CHEM ENG RES DES, V89, P85, DOI 10.1016/j.cherd.2010.04.017; Duwairi HM, 2004, HEAT MASS TRANSFER, V41, P51, DOI 10.1007/s00231-004-0524-6; El-Kabeir SMM, 2010, INT J CHEM REACT ENG, V8; Hendi FA, 2012, J APPL MATH, DOI 10.1155/2012/123185; Herdrich G, 2006, VACUUM, V80, P1167, DOI 10.1016/j.vacuum.2006.01.043; Hoernel JD, 2008, COMMUN NONLINEAR SCI, V13, P1353, DOI 10.1016/j.cnsns.2006.10.010; Ishak A, 2007, CHINESE PHYS LETT, V24, P2274, DOI 10.1088/0256-307X/24/8/033; Ishak A, 2011, MECCANICA, V46, P795, DOI 10.1007/s11012-010-9338-4; Ishak A, 2010, APPL MATH COMPUT, V217, P837, DOI 10.1016/j.amc.2010.06.026; Ishak A, 2009, CHEM ENG J, V148, P63, DOI 10.1016/j.cej.2008.07.040; Jafar K, 2013, J AEROSPACE ENG, V26, P829, DOI 10.1061/(ASCE)AS.1943-5525.0000186; Kandasamy R, 2010, TRANSPORT POROUS MED, V84, P549, DOI 10.1007/s11242-009-9519-6; KLEMP JB, 1972, J FLUID MECH, V53, P177, DOI 10.1017/S0022112072000096; Magyar E, 2008, INT J THERM SCI, V47, P1436, DOI 10.1016/j.ijthermalsci.2007.12.010; Mahmoud MAA, 2009, CAN J CHEM ENG, V87, P47, DOI 10.1002/cjce.20135; Makinde OD, 2012, MECCANICA, V47, P1173, DOI 10.1007/s11012-011-9502-5; Makinde OD, 2010, CAN J CHEM ENG, V88, P983, DOI 10.1002/cjce.20369; Mukhopadhyay S, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/12/124706; Na T. Y., 1979, COMPUTATIONAL METHOD; Pal D, 2009, APPL MATH COMPUT, V212, P194, DOI 10.1016/j.amc.2009.02.013; Rahman MM, 2010, COMMUN NONLINEAR SCI, V15, P2073, DOI 10.1016/j.cnsns.2009.08.012; RAJAGOPAL KR, 1983, INT J NONLINEAR MECH, V18, P313, DOI 10.1016/0020-7462(83)90028-8; Seddeek MA, 2009, APPL APPL MATH, V4, P301; SHANG D, 2010, THEORY HEAT TRANSFER, pCH3; SUHIL K, 2010, ASME J HEAT TRANSFER, V132, P1; Uddin MJ, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/934964; Weidman PD, 2006, INT J ENG SCI, V44, P730, DOI 10.1016/j.ijengsci.2006.04.005; WHITE MF, 2006, VISCOUS FLOW; Yih KA, 1999, INT COMMUN HEAT MASS, V26, P819, DOI 10.1016/S0735-1933(99)00070-6; [No title captured]	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e62664	10.1371/journal.pone.0062664	http://dx.doi.org/10.1371/journal.pone.0062664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741295	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900007
J	van Grieken, A; Veldhuis, L; Renders, CM; Borsboom, GJ; van der Wouden, JC; Hirasing, RA; Raat, H				van Grieken, Amy; Veldhuis, Lydian; Renders, Carry M.; Borsboom, Gerard J.; van der Wouden, Johannes C.; Hirasing, Remy A.; Raat, Hein			Population-Based Childhood Overweight Prevention: Outcomes of the 'Be Active, Eat Right' Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; HEALTH-CARE; PARENTAL INVOLVEMENT; SUBGROUP ANALYSIS; BODY-MASS; OBESITY; CHILDREN; INTERVENTIONS; LINE	Objective: An overweight prevention protocol was used in the 'Be active, eat right' study; parents of overweight children (5 years) were offered healthy lifestyle counseling by youth health care professionals. Effects of the protocol on child BMI and waist circumference at age 7 years were evaluated. Methods: A cluster RCT was conducted among nine youth health care centers in the Netherlands. Parents of overweight, not obese, children received lifestyle counseling and motivational interviewing according to the overweight prevention protocol in the intervention condition (n = 349) and usual care in the control condition (n = 288). Measurements were made of child height, weight and waist circumference at baseline and at a two-year follow-up; parents completed questionnaires regarding demographic characteristics. Linear mixed models were applied; interaction terms were explored. Results: The analyzed population consisted of 38.1% boys; mean age 5.7 [sd: 0.4] years; mean BMI 18.1 [sd: 0.6], the median number of counseling sessions in the intervention condition was 2. The regression model showed no significant difference in BMI increase between the research conditions at follow-up (beta -0.16; 95% CI:-0.60 to 0.27; p = 0.463). There was a significant interaction between baseline BMI and research condition; children with a baseline BMI of 17.25 and 17.50 had a smaller increase in BMI at follow-up when allocated to the intervention condition compared to control condition (estimated adjusted mean difference -0.67 [se: 0.30] and -0.52 [se: 0.36]). Conclusion: Mildly overweight children (baseline BMI 17.25 and 17.50) in the intervention condition showed a significantly smaller increase in BMI at follow-up compared to the control condition; there was no overall difference between intervention and control condition. Future research may explore and evaluate improvements of the prevention protocol.	[van Grieken, Amy; Veldhuis, Lydian; Borsboom, Gerard J.; Raat, Hein] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Renders, Carry M.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Renders, Carry M.; van der Wouden, Johannes C.; Hirasing, Remy A.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van der Wouden, Johannes C.] Univ Med Ctr, Dept Gen Practice, Erasmus MC, Rotterdam, Netherlands; [van der Wouden, Johannes C.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands; [Hirasing, Remy A.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Raat, H (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl	van der Wouden, Johannes C/O-5109-2019; van Grieken, Amy/N-1583-2014	van der Wouden, Johannes C/0000-0001-6639-6050; van Grieken, Amy/0000-0001-6767-9159; Renders, Carry/0000-0001-6688-1312	ZonMw, the Netherlands Organization for Health Research and Development [50-50110-98-355]	ZonMw, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study is funded by a grant from the major funding body ZonMw, the Netherlands Organization for Health Research and Development (50-50110-98-355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman A, 2007, J HEALTH PSYCHOL, V12, P871, DOI 10.1177/1359105307082449; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Britt E, 2004, PATIENT EDUC COUNS, V53, P147, DOI 10.1016/S0738-3991(03)00141-1; Bulk-Bunschoten AMW, 2005, SIGNALERINGSPROTOCOL; BULKBUNSCHOTEN AMW, 2005, OVERBRUGGINGSPLAN KI; BURGMEIJER RJF, 1997, EVALUATION SCH HLTH; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Crawford D, 2006, PUBLIC HEALTH NUTR, V9, P889, DOI 10.1017/PHN2005917; Dalton WT, 2008, FAM COMMUNITY HEALTH, V31, P259, DOI 10.1097/01.FCH.0000336089.37280.f8; de Jonge G A, 2005, Ned Tijdschr Geneeskd, V149, P1273; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dietz WH, 1998, PEDIATRICS, V101, P518; Doolen J, 2009, J AM ACAD NURSE PRAC, V21, P160, DOI 10.1111/j.1745-7599.2008.00382.x; Edvardsson K, 2009, J ADV NURS, V65, P2542, DOI 10.1111/j.1365-2648.2009.05127.x; Emmons KM, 2001, AM J PREV MED, V20, P68, DOI 10.1016/S0749-3797(00)00254-3; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Golan M, 2004, OBES RES, V12, P357, DOI 10.1038/oby.2004.45; Hingle MD, 2010, PREV MED, V51, P103, DOI 10.1016/j.ypmed.2010.04.014; Lane C, 2005, PATIENT EDUC COUNS, V56, P166, DOI 10.1016/j.pec.2004.01.003; Lee YS, 2009, ANN ACAD MED SINGAP, V38, P75; MacDonell K, 2012, J ADOLESCENT HEALTH, V50, P201, DOI 10.1016/j.jadohealth.2011.04.018; McCallum Z, 2007, INT J OBESITY, V31, P630, DOI 10.1038/sj.ijo.0803509; *MIN HLTH WELF SPO, 2005, INT PUBL SER HLTH WE; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Prochaska J O, 1992, Prog Behav Modif, V28, P183; Renders CM, 2010, OBESITY FACTS, V3, P267, DOI 10.1159/000319426; Rollnick S, 2005, BMJ-BRIT MED J, V331, P961, DOI 10.1136/bmj.331.7522.961; Savoye M, 2007, JAMA-J AM MED ASSOC, V297, P2697, DOI 10.1001/jama.297.24.2697; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Schwartz RP, 2007, ARCH PEDIAT ADOL MED, V161, P495, DOI 10.1001/archpedi.161.5.495; Soderlund LL, 2011, PATIENT EDUC COUNS, V84, P16, DOI 10.1016/j.pec.2010.06.025; Statistics Netherlands, 2004, DUTCH STAND CLASS ED; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Summerbell CD, 2012, OBES REV, V13, P129, DOI 10.1111/j.1467-789X.2011.00940.x; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swertz O, 2004, STAT NETHERLANDS MIG; Tak NI, 2011, APPETITE, V56, P503, DOI 10.1016/j.appet.2011.01.013; Taveras EM, 2011, ARCH PEDIAT ADOL MED, V165, P714, DOI 10.1001/archpediatrics.2011.44; Twisk J, 2004, J CLIN EPIDEMIOL, V57, P223, DOI 10.1016/j.jclinepi.2003.07.009; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; van Stralen MM, 2011, INT J OBESITY, V35, P1251, DOI 10.1038/ijo.2011.68; Velde SJT, 2011, INT J PEDIATR OBES, V6, pE364, DOI 10.3109/17477166.2010.490264; Veldhuis L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-177; VERBRUGGE HP, 1990, PEDIATRICS, V86, P1044; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wake M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3308; WEINSTEIN ND, 1992, HEALTH PSYCHOL, V11, P170, DOI 10.1037/0278-6133.11.3.170; Whitlock EP, 2005, PEDIATRICS, V116, pE125, DOI 10.1542/peds.2005-0242; World Health Organization, OB OV; XIN S, 2010, BMJ, V340	52	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65376	10.1371/journal.pone.0065376	http://dx.doi.org/10.1371/journal.pone.0065376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741491	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900204
J	Vincenzi, F; Targa, M; Corciulo, C; Gessi, S; Merighi, S; Setti, S; Cadossi, R; Goldring, MB; Borea, PA; Varani, K				Vincenzi, Fabrizio; Targa, Martina; Corciulo, Carmen; Gessi, Stefania; Merighi, Stefania; Setti, Stefania; Cadossi, Ruggero; Goldring, Mary B.; Borea, Pier Andrea; Varani, Katia			Pulsed Electromagnetic Fields Increased the Anti-Inflammatory Effect of A(2A) and A(3) Adenosine Receptors in Human T/C-28a2 Chondrocytes and hFOB 1.19 Osteoblasts	PLOS ONE			English	Article							CARTILAGE MATRIX; RANKL EXPRESSION; BONE-FORMATION; UP-REGULATION; CELLS; DIFFERENTIATION; PROLIFERATION; ARTHRITIS; STIMULATION; HOMEOSTASIS	Adenosine receptors (ARs) have an important role in the regulation of inflammation and their activation is involved in the inhibition of pro-inflammatory cytokine release. The effects of pulsed electromagnetic fields (PEMFs) on inflammation have been reported and we have demonstrated that PEMFs increased A(2A) and A(3)AR density and functionality in different cell lines. Chondrocytes and osteoblasts are two key cell types in the skeletal system that play important role in cartilage and bone metabolism representing an interesting target to study the effect of PEMFs. The primary aim of the present study was to evaluate if PEMF exposure potentiated the anti-inflammatory effect of A(2A) and/or A(3)ARs in T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts. Immunofluorescence, mRNA analysis and saturation binding assays revealed that PEMF exposure up-regulated A(2A) and A(3)AR expression. A(2A) and A(3)ARs were able to modulate cAMP production and cell proliferation. The activation of A(2A) and A3ARs resulted in the decrease of some of the most relevant pro-inflammatory cytokine release such as interleukin (IL)-6 and IL-8, following the treatment with IL-1 beta as an inflammatory stimuli. In human chondrocyte and osteoblast cell lines, the inhibitory effect of A(2A) and A(3)AR stimulation on the release of prostaglandin E-2 (PGE(2)), an important lipid inflammatory mediator, was observed. In addition, in T/C-28a2 cells, the activation of A(2A) or A(3)ARs elicited an inhibition of vascular endothelial growth factor (VEGF) secretion. In hFOB 1.19 osteoblasts, PEMF exposure determined an increase of osteoprotegerin (OPG) production. The effect of the A(2A) or A(3)AR agonists in the examined cells was enhanced in the presence of PEMFs and completely blocked by using well-known selective antagonists. These results demonstrated that PEMF exposure significantly increase the anti-inflammatory effect of A(2A) or A(3)ARs suggesting their potential therapeutic use in the therapy of inflammatory bone and joint disorders.	[Vincenzi, Fabrizio; Targa, Martina; Corciulo, Carmen; Gessi, Stefania; Merighi, Stefania; Borea, Pier Andrea; Varani, Katia] Univ Ferrara, Dept Med Sci, Pharmacol Unit, I-44100 Ferrara, Italy; [Setti, Stefania; Cadossi, Ruggero] Igea Biophys Lab, Carpi, Italy; [Goldring, Mary B.] Weill Cornell Med Coll, Hosp Special Surg, Lab Cartilage Biol, New York, NY USA	University of Ferrara; Cornell University	Varani, K (corresponding author), Univ Ferrara, Dept Med Sci, Pharmacol Unit, I-44100 Ferrara, Italy.	vrk@unife.it	Vincenzi, Fabrizio/E-7925-2013; Gessi, Stefania/AAS-3844-2020	MERIGHI, STEFANIA/0000-0003-0839-6671; Vincenzi, Fabrizio/0000-0002-5027-1699; Gessi, Stefania/0000-0002-2197-5611; CORCIULO, CARMEN/0000-0002-1865-3494				Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088; Borsje MA, 2010, ANGLE ORTHOD, V80, P498, DOI 10.2319/060809-318.1; Campo GM, 2012, FEBS J, V279, P2120, DOI 10.1111/j.1742-4658.2012.08598.x; Carroll SH, 2012, J BIOL CHEM, V287, P15718, DOI 10.1074/jbc.M112.344994; Chalidis B, 2011, INT J IMMUNOPATH PH, V24, P17, DOI 10.1177/03946320110241S204; Claassen H, 2011, ANN ANAT, V193, P23, DOI 10.1016/j.aanat.2010.09.005; Confavreux CB, 2011, KIDNEY INT, V79, pS14, DOI 10.1038/ki.2011.25; De Mattei M, 2003, CONNECT TISSUE RES, V44, P154, DOI 10.1080/03008200390208546; De Mattei M, 2009, OSTEOARTHR CARTILAGE, V17, P252, DOI 10.1016/j.joca.2008.06.002; De Mattei M, 2001, CONNECT TISSUE RES, V42, P269; De Mattei M, 1999, BIOELECTROMAGNETICS, V20, P177, DOI 10.1002/(SICI)1521-186X(1999)20:3<177::AID-BEM4>3.0.CO;2-#; Malaspina TSD, 2008, J MOL HISTOL, V39, P627, DOI 10.1007/s10735-008-9203-0; Del Fattore Andrea, 2012, Front Biosci (Elite Ed), V4, P2302; Dong SW, 2012, BIOCHEM BIOPH RES CO, V418, P587, DOI 10.1016/j.bbrc.2012.01.075; Fini M, 2005, BIOMED PHARMACOTHER, V59, P388, DOI 10.1016/j.biopha.2005.02.002; Fishman P, 2009, Handb Exp Pharmacol, P399, DOI 10.1007/978-3-540-89615-9_14; Fraser A, 2003, ARTHRITIS RHEUM, V48, P3085, DOI 10.1002/art.11331; Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035; Gessi S, 2008, PHARMACOL THERAPEUT, V117, P123, DOI 10.1016/j.pharmthera.2007.09.002; Gessi S, 2011, ADV PHARMACOL, V61, P41, DOI 10.1016/B978-0-12-385526-8.00002-3; Gessi S, 2010, ARTERIOSCL THROM VAS, V30, P90, DOI 10.1161/ATVBAHA.109.194902; Goldring MB, 2004, METH MOLEC MED, V100, P37; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; He Wenjie, 2011, Front Biosci (Elite Ed), V3, P888; Kara FM, 2010, ARTHRITIS RHEUM-US, V62, P534, DOI 10.1002/art.27219; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Lin HY, 2011, BIOELECTROMAGNETICS, V32, P552, DOI 10.1002/bem.20668; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Ongaro A, 2012, J CELL PHYSIOL, V227, P2461, DOI 10.1002/jcp.22981; Petrov R, 2005, OSTEOARTHR CARTILAGE, V13, P250, DOI 10.1016/j.joca.2004.12.004; Pezzetti F, 1999, CALCIFIED TISSUE INT, V65, P396, DOI 10.1007/s002239900720; Rizzo A, 2011, CYTOKINE, V56, P450, DOI 10.1016/j.cyto.2011.06.027; Russell JM, 2007, CALCIFIED TISSUE INT, V81, P316, DOI 10.1007/s00223-007-9060-y; Schwartz Z, 2009, ANN BIOMED ENG, V37, P437, DOI 10.1007/s10439-008-9628-3; Seeman E, 2009, CRIT REV EUKAR GENE, V19, P219, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.40; Silva I, 2011, ACTA REUMATOL PORT, V36, P209; Sollazzo V, 2010, CLIN ORTHOP RELAT R, V468, P2260, DOI 10.1007/s11999-010-1341-5; Takedachi M, 2012, J CELL PHYSIOL, V227, P2622, DOI 10.1002/jcp.23001; Tesch AM, 2004, OSTEOARTHR CARTILAGE, V12, P349, DOI 10.1016/j.joca.2004.01.002; Tsai MT, 2007, BIOELECTROMAGNETICS, V28, P519, DOI 10.1002/bem.20336; Varani K, 2000, MOL PHARMACOL, V57, P968; Varani K, 2008, OSTEOARTHR CARTILAGE, V16, P292, DOI 10.1016/j.joca.2007.07.004; Varani K, 2006, AM J RESP CRIT CARE, V173, P398, DOI 10.1164/rccm.200506-869OC; Varani K, 2005, BIOCHEM PHARMACOL, V70, P1601, DOI 10.1016/j.bcp.2005.08.018; Varani K, 2003, BIOCHEM PHARMACOL, V66, P1897, DOI 10.1016/S0006-2952(03)00454-4; Varani K, 2002, BRIT J PHARMACOL, V136, P57, DOI 10.1038/sj.bjp.0704695; Varani K, 2010, BRIT J PHARMACOL, V160, P101, DOI 10.1111/j.1476-5381.2010.00667.x; Varani K, 2013, EUR J CANCER, V49, P482, DOI 10.1016/j.ejca.2012.06.005; Varani K, 2012, BIOELECTROMAGNETICS, V33, P279, DOI 10.1002/bem.20704; Varani K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3527; Varani K, 2011, AM J RESP CRIT CARE, V183, P522, DOI 10.1164/rccm.201006-0980OC; Varani K, 2010, FASEB J, V24, P587, DOI 10.1096/fj.09-141044; Varani K, 2009, ARTHRITIS RHEUM-US, V60, P2880, DOI 10.1002/art.24794; Vincenzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039317; Wang J, 2003, OSTEOARTHR CARTILAGE, V11, P801, DOI 10.1016/S1063-4584(03)00168-7; Xu JK, 2009, CYTOKINE GROWTH F R, V20, P7, DOI 10.1016/j.cytogfr.2008.11.007; ZHOU J, 2012, RHEUMATOL I IN PRESS; Zorzi C, 2007, KNEE SURG SPORT TR A, V15, P830, DOI 10.1007/s00167-007-0298-8	60	91	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65561	10.1371/journal.pone.0065561	http://dx.doi.org/10.1371/journal.pone.0065561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741498	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900211
J	Moda, LM; Vieira, J; Freire, ACG; Bonatti, V; Bomtorin, AD; Barchuk, AR; Simoes, ZLP				Moda, Livia Maria; Vieira, Joseana; Guimaraes Freire, Anna Claudia; Bonatti, Vanessa; Bomtorin, Ana Durvalina; Barchuk, Angel Roberto; Paulino Simoes, Zila Luz			Nutritionally Driven Differential Gene Expression Leads to Heterochronic Brain Development in Honeybee Castes	PLOS ONE			English	Article							APIS-MELLIFERA; BEE	The differential feeding regimes experienced by the queen and worker larvae of the honeybee Apis mellifera shape a complex endocrine response cascade that ultimately gives rise to differences in brain morphologies. Brain development analyzed at the morphological level from the third (L3) through fifth (L5) larval instars revealed an asynchrony between queens and workers. In the feeding phase of the last larval instar (L5F), two well-formed structures, pedunculi and calyces, are identifiable in the mushroom bodies of queens, both of which are not present in workers until a later phase (spinning phase, L5S). Genome-wide expression analyses and normalized transcript expression experiments monitoring specific genes revealed that this differential brain development starts earlier, during L3. Analyzing brains from L3 through L5S1 larvae, we identified 21 genes with caste-specific transcription patterns (e. g., APC-4, GlcAT-P, fax, kr-h1 and shot), which encode proteins that are potentially involved in the development of brain tissues through controlling the cell proliferation rate (APC4, kr-h1) and fasciculation (GlcAT-P, fax, and shot). Shot, whose expression is known to be required for axon extension and cell proliferation, was found to be transcribed at significantly higher levels in L4 queens compared with worker larvae. Moreover, the protein encoded by this gene was immunolocalized to the cytoplasm of cells near the antennal lobe neuropiles and proximal to the Kenyon cells in the brains of L4 queens. In conclusion, during the larval period, the brains of queens are larger and develop more rapidly than workers' brains, which represents a developmental heterochrony reflecting the effect of the differential feeding regime of the two castes on nervous system development. Furthermore, this differential development is characterized by caste-specific transcriptional profiles of a set of genes, thus pointing to a link between differential nutrition and differential neurogenesis via genes that control cell proliferation and fasciculation.	[Moda, Livia Maria; Bonatti, Vanessa; Bomtorin, Ana Durvalina] Univ SaPaulo FMRP, Dept Genet, Sao Paulo, Brazil; [Moda, Livia Maria; Vieira, Joseana; Guimaraes Freire, Anna Claudia; Bonatti, Vanessa; Barchuk, Angel Roberto] Univ Fed Alfenas, UNIFAL MG, Inst Ciencias Biomed, Dept Biol Celular Tecidual & Desenvolvimento, Alfenas, MG, Brazil; [Paulino Simoes, Zila Luz] Univ Sao Paulo FFCLRP, Dept Biol, Sao Paulo, Brazil	Universidade Federal de Alfenas	Barchuk, AR (corresponding author), Univ Fed Alfenas, UNIFAL MG, Inst Ciencias Biomed, Dept Biol Celular Tecidual & Desenvolvimento, Alfenas, MG, Brazil.	barchuk@unifal-mg.edu.br	Bomtorin, Ana/I-8817-2012; Simoes, Zila Luz Paulino/H-7314-2014; Moda, Livia M/I-6451-2012	Bomtorin, Ana/0000-0002-3331-7843; Moda, Livia M/0000-0001-6381-7788; Vieira, Joseana/0000-0003-0476-7359; Bonatti, Vanessa/0000-0001-7547-9149; Simoes, Zila Luz Paulino/0000-0003-2363-6178	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [APQ-01714-10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473748/2008-8, 473157/2010-1]; Financiadora de Estudos e Projetos [FINEP/PROINFRA 01/2008]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/03926-5]; FAPEMIG; CNPq; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPESP [Proc. 2009/05675-0, 2009/00810-7]	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by grants from Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG grant APQ-01714-10; http://www.fapemig.br/), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grants No 473748/2008-8; 473157/2010-1; http://www.cnpq.br/), and Financiadora de Estudos e Projetos (FINEP/PROINFRA 01/2008, LABSBIOEX UNIFAL-MG) to ARB; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant 2005/03926-5; http://www.fapesp.br/) to ZLPS. JV was an undergraduate recipient of a fellowship from FAPEMIG; VB was an undergraduate recipient of a fellowship from CNPq; ACGF was the recipient of a fellowship from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; http://www.capes.gov.br/), and ADB is supported by a FAPESP Doctoral fellowship (Proc. 2009/05675-0). LMRM was the recipient of a postdoctoral fellowship from FAPESP (2009/00810-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 1989, DROSOPHILA LAB HDB, Vi-xliii, P1; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Beck Y, 2004, DEV BIOL, V268, P64, DOI 10.1016/j.ydbio.2003.12.017; Bomtorin AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040111; Boyan GS, 2011, TRENDS NEUROSCIENCES, P34; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cox WG, 2004, BIOTECHNIQUES, V36, P114, DOI 10.2144/04361RR02; do Nascimento AM, 2004, INSECT BIOCHEM MOLEC, V34, P415, DOI 10.1016/j.ibmb.2003.12.003; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; FAHRBACH SE, 1995, NEUROSCI LETT, V197, P145, DOI 10.1016/0304-3940(95)11913-H; Fahrbach SE, 2006, ANN REV ENTOMOLOGY, P51; Fahrbach SE, 1996, DEV NEUROSCIENCE, V18; Farris SM, 2003, ARTHROPOD STRUCTURE, V32; Farris SM, 2001, J NEUROSCIENCE, V21; Farris SM, 1999, J COMP NEUROLOGY, P414; FRISTROM JW, 1965, GENETICS, V52, P297; Ganeshina O, 2000, J COMP NEUROLOGY, P417; Groh C, 2008, ARTHROPOD STRUCTURE, V37; Grozinger CM, 2007, J COMP PHYSL A, V193; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; HILL KK, 1995, GENETICS, V141, P595; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kraut R, 2001, CURRENT BIOL, V11; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lee S., 2002, DEVELOPMENT, V129; Lee S, 2000, J NEUROSCIENCE, V20; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Maestro JL, 2009, J BIOL CHEM, V284, P5506, DOI 10.1074/jbc.M807042200; Malun D, 1998, LEARNING MEMORY, P5; Malun D, 2003, J NEUROBIOLOGY, V57; Matos RJB, 2011, NEUROSCIENCE, V196, P16, DOI 10.1016/j.neuroscience.2011.08.071; Meijlink F, 1999, INT J DEV BIOL, V43, P651; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Michener CD, 1974, SOCIAL BEHAV BEES CO, Vi-xii, P1; Pandey R, 2011, PLOS ONE, V6; Rachinsky A, 1998, IN VITRO CELLULAR DE, V34; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Roat TC, 2008, MICRON, V39, P1171, DOI 10.1016/j.micron.2008.05.004; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saunders C, 1999, BIOTECHNIQUES, V26, P186, DOI 10.2144/99262bm01; Shi L, 2007, DEV NEUROBIOLOGY, V67; Stern A, 2007, J MOL EVOLUTION, V64; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Yang YM, 2010, J TAIWAN INST CHEM E, V41, P1, DOI 10.1016/j.jtice.2009.11.002; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200	52	21	21	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64815	10.1371/journal.pone.0064815	http://dx.doi.org/10.1371/journal.pone.0064815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738002	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700063
J	Dreon, MS; Frassa, MV; Ceolin, M; Ituarte, S; Qiu, JW; Sun, J; Fernandez, PE; Heras, H				Sebastian Dreon, Marcos; Victoria Frassa, Maria; Ceolin, Marcelo; Ituarte, Santiago; Qiu, Jian-Wen; Sun, Jin; Fernandez, Patricia E.; Heras, Horacio			Novel Animal Defenses against Predation: A Snail Egg Neurotoxin Combining Lectin and Pore-Forming Chains That Resembles Plant Defense and Bacteria Attack Toxins	PLOS ONE			English	Article							MUSSEL MYTILUS-GALLOPROVINCIALIS; POMACEA-CANALICULATA GASTROPODA; APPLE-SNAIL; PERIVITELLINE FLUID; AMPULLARIIDAE; MOLLUSCA; PROTEIN; LIPOPROTEINS; MECHANISMS; RETROSPECT	Although most eggs are intensely predated, the aerial egg clutches from the aquatic snail Pomacea canaliculata have only one reported predator due to unparalleled biochemical defenses. These include two storage-proteins: ovorubin that provides a conspicuous (presumably warning) coloration and has antinutritive and antidigestive properties, and PcPV2 a neurotoxin with lethal effect on rodents. We sequenced PcPV2 and studied whether it was able to withstand the gastrointestinal environment and reach circulation of a potential predator. Capacity to resist digestion was assayed using small-angle X-ray scattering (SAXS), fluorescence spectroscopy and simulated gastrointestinal proteolysis. PcPV2 oligomer is antinutritive, withstanding proteinase digestion and displaying structural stability between pH 4.0-10.0. cDNA sequencing and protein domain search showed that its two subunits share homology with membrane attack complex/perforin (MACPF)-like toxins and tachylectin-like lectins, a previously unknown structure that resembles plant Type-2 ribosomein-activating proteins and bacterial botulinum toxins. The protomer has therefore a novel AB toxin combination of a MACPF-like chain linked by disulfide bonds to a lectin-like chain, indicating a delivery system for the former. This was further supported by observing PcPV2 binding to glycocalix of enterocytes in vivo and in culture, and by its hemaggutinating, but not hemolytic activity, which suggested an interaction with surface oligosaccharides. PcPV2 is able to get into predator's body as evidenced in rats and mice by the presence of circulating antibodies in response to sublethal oral doses. To our knowledge, a lectin-pore-forming toxin has not been reported before, providing the first evidence of a neurotoxic lectin in animals, and a novel function for ancient and widely distributed proteins. The acquisition of this unique neurotoxic/antinutritive/storage protein may confer the eggs a survival advantage, opening new perspectives in the study of the evolution of animal defensive strategies.	[Sebastian Dreon, Marcos; Ituarte, Santiago; Heras, Horacio] UNLP, Consejo Nacl Invest Cient & Tecn CONICET CCT La P, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina; [Victoria Frassa, Maria; Ceolin, Marcelo] UNLP, CONICET CCT La Plata, Inst Invest Fis Quim Teor & Aplicadas INIFTA, La Plata, Buenos Aires, Argentina; [Sebastian Dreon, Marcos] UNLP, Catedra Bioquim & Biol Mol, Fac Ciencias, La Plata, Buenos Aires, Argentina; [Qiu, Jian-Wen; Sun, Jin] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Fernandez, Patricia E.] UNLP, Inst Patol B Epstein, Catedra Patol Gen Vet, Fac Cs Vet, La Plata, Buenos Aires, Argentina; [Heras, Horacio] UNLP, Fac Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA; National University of La Plata; Hong Kong Baptist University; National University of La Plata; National University of La Plata; Museo La Plata	Heras, H (corresponding author), UNLP, Consejo Nacl Invest Cient & Tecn CONICET CCT La P, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.	h-heras@med.unlp.edu.ar	Sun, Jin/C-1458-2010; Ceolin, Marcelo/T-9405-2017; Heras, Horacio/R-9555-2018	Sun, Jin/0000-0001-8002-6881; Qiu, Jian-Wen/0000-0002-1541-9627; Ceolin, Marcelo/0000-0002-2385-7803; Heras, Horacio/0000-0003-3379-0216; Ituarte, Santiago/0000-0002-3670-2843	Agencia Nacional de Promocion Cientifica y Tencnologica (ANPCyT) [2166, 1865]; Universidad de La Plata [PPID N545]	Agencia Nacional de Promocion Cientifica y Tencnologica (ANPCyT); Universidad de La Plata(National University of La Plata)	The work was funded by Agencia Nacional de Promocion Cientifica y Tencnologica (ANPCyT) grants PIP#2166 and PIP#1865 and PPID N545 from Universidad de La Plata to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht EA, 1996, VELIGER, V39, P142; Becerro MA, 2006, J CHEM ECOL, V32, P1491, DOI 10.1007/s10886-006-9064-5; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blount JD, 2009, P ROY SOC B-BIOL SCI, V276, P871, DOI 10.1098/rspb.2008.1407; Boraston AB, 2007, COMPREHENSIVE GLYCOS, V3, P661; Cabang AB, 2011, TOXICON, V58, P672, DOI 10.1016/j.toxicon.2011.09.001; Deutscher MP, 1990, METHOD ENZYMOL, P19; Dreon M, 2002, J EXP ZOOL, V292, P323, DOI 10.1002/jez.10043; Dreon MS, 2008, FEBS J, V275, P4522, DOI 10.1111/j.1742-4658.2008.06595.x; Dreon MS, 2004, MOL REPROD DEV, V68, P359, DOI 10.1002/mrd.20078; DUSSOURD DE, 1988, P NATL ACAD SCI USA, V85, P5992, DOI 10.1073/pnas.85.16.5992; Eisner T, 2000, P NATL ACAD SCI USA, V97, P1634, DOI 10.1073/pnas.030532797; Estebenet AL, 2002, BIOCELL, V26, P83; Estevez-Calvar N, 2011, DEV COMP IMMUNOL, V35, P1015, DOI 10.1016/j.dci.2011.03.023; Gabor F, 1998, J CONTROL RELEASE, V55, P131, DOI 10.1016/S0168-3659(98)00043-1; Galliano M, 2003, BIOCHEM J, V376, P433, DOI 10.1042/BJ20030413; Garin CF, 1996, J EXP ZOOL, V276, P307, DOI 10.1002/(SICI)1097-010X(19961201)276:5&lt;307::AID-JEZ1&gt;3.0.CO;2-S; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Gilbert RJ, 2012, CELL MOL LIFE SCI, P1, DOI DOI 10.1007/S00018-012-1153-8; Hammersley AP, 1997, FIT2D INTRO OVERVIEW; Heras H, 2007, COMP BIOCHEM PHYS C, V146, P158, DOI 10.1016/j.cbpc.2006.10.013; Heras H, 2002, BIOCELL, V26, P111; Heras H, 1998, J EXP ZOOL, V280, P375, DOI 10.1002/(SICI)1097-010X(19980415)280:6<375::AID-JEZ1>3.3.CO;2-V; Heras H, 2008, TOXICON, V52, P481, DOI 10.1016/j.toxicon.2008.06.022; Herlax V, 2005, CHEM PHYS LIPIDS, V135, P107, DOI 10.1016/j.chemphyslip.2005.02.009; Ituarte S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050115; Kawashima Y, 2003, TOXICON, V42, P491, DOI 10.1016/S0041-0101(03)00226-5; Lavelle EC, 2000, IMMUNOLOGY, V99, P30, DOI 10.1046/j.1365-2567.2000.00932.x; Lord JM, 2010, PLANT CELL MONOGR, V18, P1, DOI 10.1007/978-3-642-12176-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mah SA, 2004, BIOCHEM BIOPH RES CO, V316, P468, DOI 10.1016/j.bbrc.2004.02.073; Meinwald J, 2008, P NATL ACAD SCI USA, V105, P4539, DOI 10.1073/pnas.0800649105; Moreno FJ, 2005, FEBS J, V272, P341, DOI 10.1111/j.1742-4658.2004.04472.x; Nagai T, 1999, J BIOL CHEM, V274, P37673, DOI 10.1074/jbc.274.53.37673; Nation JI, 2002, INSECT PHYSL BIOCH, P27; National Research Council, 2011, GUIDE CARE USE LAB A; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; Odumosu O, 2010, TOXINS, V2, P1612, DOI 10.3390/toxins2071612; Olivera BM, 2001, TOXICON, V39, P7, DOI 10.1016/S0041-0101(00)00157-4; Oshiro N, 2004, TOXICON, V43, P225, DOI 10.1016/j.toxicon.2003.11.017; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; RANDALL D, 1997, ECKERT ANIMAL PHYSL, P683; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Schroder HC, 2003, J BIOL CHEM, V278, P32810, DOI 10.1074/jbc.M304116200; Schroeder FC, 1999, P NATL ACAD SCI USA, V96, P13620, DOI 10.1073/pnas.96.24.13620; Dreon MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015059; Sun J, 2012, MOL ECOL RESOUR, V12, P1133, DOI 10.1111/1755-0998.12014; Sun J, 2012, J PROTEOME RES, V11, P4240, DOI 10.1021/pr3003613; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tchernychev B, 1996, FEBS LETT, V397, P139, DOI 10.1016/S0014-5793(96)01154-4; UHLENBRUCK G, 1976, EXPERIENTIA, V32, P391, DOI 10.1007/BF01940857; Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005; Vasta GR, 2008, ANIMAL LECTINS FUNCT; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Frassa MV, 2010, BBA-PROTEINS PROTEOM, V1804, P1492, DOI 10.1016/j.bbapap.2010.02.013; Wang GD, 2008, FISH SHELLFISH IMMUN, V24, P346, DOI 10.1016/j.fsi.2007.12.008; Yusa Y, 2001, J MOLLUS STUD, V67, P275, DOI 10.1093/mollus/67.3.275	58	48	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63782	10.1371/journal.pone.0063782	http://dx.doi.org/10.1371/journal.pone.0063782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737950	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700013
J	Zeller, KS; Riaz, A; Sarve, H; Li, J; Tengholm, A; Johansson, S				Zeller, Kathrin S.; Riaz, Anjum; Sarve, Hamid; Li, Jia; Tengholm, Anders; Johansson, Staffan			The Role of Mechanical Force and ROS in Integrin-Dependent Signals	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ROTENONE INDUCES APOPTOSIS; IMAGE FORESTING TRANSFORM; MEDIATED CELL-ADHESION; TYROSINE PHOSPHORYLATION; STRUCTURAL BASIS; ASCORBIC-ACID; AFFINITY-CHROMATOGRAPHY; MITOCHONDRIAL-FUNCTION; HYDROGEN-PEROXIDE	Cells are exposed to several types of integrin stimuli, which generate responses generally referred to as "integrin signals", but the specific responses to different integrin stimuli are poorly defined. In this study, signals induced by integrin ligation during cell attachment, mechanical force from intracellular contraction, or cell stretching by external force were compared. The elevated phosphorylation levels of several proteins during the early phase of cell attachment and spreading of fibroblast cell lines were not affected by inhibition of ROCK and myosin II activity, i.e. the reactions occurred independently of intracellular contractile force acting on the adhesion sites. The contraction-independent phosphorylation sites included ERK1/2 T202/Y204, AKT S473, p130CAS Y410, and cofilin S3. In contrast to cell attachment, cyclic stretching of the adherent cells induced a robust phosphorylation only of ERK1/2 and the phosphorylation levels of the other investigated proteins were not or only moderately affected by stretching. No major differences between signaling via alpha 5 beta 1 or alpha v beta 3 integrins were detected. The importance of mitochondrial ROS for the integrin-induced signaling pathways was investigated using rotenone, a specific inhibitor of complex I in the respiratory chain. While rotenone only moderately reduced ATP levels and hardly affected the signals induced by cyclic cell stretching, it abolished the activation of AKT and reduced the actin polymerization rate in response to attachment in both cell lines. In contrast, scavenging of extracellular ROS with catalase or the vitamin C analog Asc-2P did not significantly influence the attachment-derived signaling, but caused a selective and pronounced enhancement of ERK1/2 phosphorylation in response to stretching. In conclusion, the results showed that "integrin signals" are composed of separate sets of reactions triggered by different types of integrin stimulation. Mitochondrial ROS and extracellular ROS had specific and distinct effects on the integrin signals induced by cell attachment and mechanical stretching.	[Zeller, Kathrin S.; Riaz, Anjum; Johansson, Staffan] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Sarve, Hamid] Swedish Univ Agr Sci, Ctr Image Anal, Uppsala, Sweden; [Li, Jia; Tengholm, Anders] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Uppsala University	Johansson, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	staffan.johansson@imbim.uu.se			Swedish Cancer Foundation; Swedish Research Council; Agnes och Mac Rudberg stiftelse; E Wesslers stiftelse for medical biochemical research; Higher Education Commission, Pakistan	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Agnes och Mac Rudberg stiftelse; E Wesslers stiftelse for medical biochemical research; Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	Economic support was obtained from the Swedish Cancer Foundation and the Swedish Research Council. KSZ was supported by scholarships from Agnes och Mac Rudberg stiftelse and E Wesslers stiftelse for medical biochemical research. AR was supported by scholarships from the Higher Education Commission, Pakistan and from Agnes och Mac Rudberg stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Ali MH, 2006, AM J PHYSIOL-LUNG C, V291, pL38, DOI 10.1152/ajplung.00287.2004; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Benov L, 1998, FREE RADICAL BIO MED, V25, P826, DOI 10.1016/S0891-5849(98)00163-4; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Chepda T, 2001, IN VITRO CELL DEV-AN, V37, P26; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Deng YT, 2010, MOL CARCINOGEN, V49, P141, DOI 10.1002/mc.20583; Dey T, 2011, BIOCHEM BIOPH RES CO, V413, P541, DOI 10.1016/j.bbrc.2011.08.133; Dib K, 2003, J BIOL CHEM, V278, P24181, DOI 10.1074/jbc.M302300200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duarte TL, 2007, TOXICOL LETT, V170, P57, DOI 10.1016/j.toxlet.2007.02.005; Falcao AX, 2004, IEEE T PATTERN ANAL, V26, P19, DOI 10.1109/TPAMI.2004.1261076; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Fiaschi Tania, 2012, J Signal Transduct, V2012, P754964, DOI 10.1155/2012/754964; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Frikke-Schmidt H, 2010, ANAL BIOCHEM, V397, P135, DOI 10.1016/j.ab.2009.09.040; Goitre L, 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/807682; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Gupta RK, 2012, HISTOCHEM CELL BIOL, V138, P881, DOI 10.1007/s00418-012-1003-7; Gustavsson A, 2002, J CELL SCI, V115, P2669; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Li J, 2013, DIABETOLOGI IN PRESS; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lorenz M, 2001, FREE RADICAL BIO MED, V31, P824, DOI 10.1016/S0891-5849(01)00664-5; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Malmberg F, 2009, LECT NOTES COMPUT SC, V5852, P201, DOI 10.1007/978-3-642-10210-3_16; MCKAY ND, 1983, BIOCHIM BIOPHYS ACTA, V762, P198, DOI 10.1016/0167-4889(83)90071-X; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Riaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032081; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Sai XR, 1999, J CELL SCI, V112, P1365; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; SMILENOV L, 1992, FEBS LETT, V302, P227, DOI 10.1016/0014-5793(92)80447-O; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Taddei ML, 2007, ANTIOXID REDOX SIGN, V9, P469, DOI 10.1089/ars.2006.1392; Takebayashi J, 2006, BIOL PHARM BULL, V29, P766, DOI 10.1248/bpb.29.766; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Taulet N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041342; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ulrich-Merzenich G, 2007, EUR J NUTR, V46, P87, DOI 10.1007/s00394-006-0636-5; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Vrablic AS, 2001, FASEB J, V15, P1739, DOI 10.1096/fj.00-0300com; Wang JG, 2001, BIOCHEM BIOPH RES CO, V288, P356, DOI 10.1006/bbrc.2001.5775; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005; Zhang Y, 2010, ANTIOXID REDOX SIGN, V13, P959, DOI 10.1089/ars.2009.2908; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	83	32	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64897	10.1371/journal.pone.0064897	http://dx.doi.org/10.1371/journal.pone.0064897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738008	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700069
J	Sprengelmeyer, R; Lewis, J; Hahn, A; Perrett, DI				Sprengelmeyer, Reiner; Lewis, Jennifer; Hahn, Amanda; Perrett, David I.			Aesthetic and Incentive Salience of Cute Infant Faces: Studies of Observer Sex, Oral Contraception and Menstrual Cycle	PLOS ONE			English	Article							GENDER-DIFFERENCES; FACIAL EXPRESSION; ADULTS RESPONSES; ATTRACTIVENESS; BEAUTIFUL	Infant cuteness can influence adult-infant interaction and has been shown to activate reward centres in the brain. In a previous study, we found men and women to be differentially sensitive to small differences in infant facial cuteness, with reproductive hormone status as the potential underlying cause. It is unclear, however, whether reproductive hormone status impacts on the aesthetic and incentive salience of infant faces. To address this question, we conducted two interlinked studies. We used static images of the same smiling and neutral-looking infant faces in both a rating task, in which participants had to rate the cuteness of infant faces (aesthetic salience - 'liking'), and a key-press task, in which participants could prolong or shorten viewing time of infant faces by rapid alternating key-presses (incentive salience - 'wanting'). In a first study, we compared the performance of men, women who are taking oral contraceptives, and regularly cycling women. In this study, we found a significant correlation between cuteness ratings within and between groups, which implies that participants had the same concept of cuteness. Cuteness ratings and effort to look at faces was linked regardless of sex and reproductive hormone status, in that cute faces were looked at for longer than less cute faces. A happy facial expression contributed only marginally to the incentive salience of the face. To explore the potential impact of reproductive hormone status in more detail, we followed a subset of regularly cycling women during the menstrual, follicular and luteal phases of their cycle. The aesthetic and incentive salience of infant faces did not change across the menstrual cycle. Our findings suggest that reproductive hormone status does not modulate the aesthetic and incentive value of infant faces.	[Sprengelmeyer, Reiner; Lewis, Jennifer; Hahn, Amanda; Perrett, David I.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of St Andrews	Sprengelmeyer, R (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	rhs3@st-and.ac.uk; dp@st-and.ac.uk	Hahn, Amanda C/H-8779-2013; Hahn, Amanda C/AAH-1106-2021; Lewis, Jennifer/HCH-4635-2022	Hahn, Amanda C/0000-0002-4555-7924; Hahn, Amanda C/0000-0002-4555-7924; Perrett, David/0000-0002-6025-0939; Sprengelmeyer, Reiner Heinrich/0000-0002-3083-5995	SINAPSE (Scottish Imaging Network: A Platform for Scientific Excellence)	SINAPSE (Scottish Imaging Network: A Platform for Scientific Excellence)	This study was funded by SINAPSE (Scottish Imaging Network: A Platform for Scientific Excellence) in form of a PhD studentship to Jennifer Lewis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Hahn AC, 2013, Q J EXP PSYCHOL, V66, P200, DOI 10.1080/17470218.2012.705860; Halbreich U, 2003, PSYCHONEUROENDOCRINO, V28, P1, DOI 10.1016/S0306-4530(03)00098-2; HILDEBRANDT KA, 1978, BEHAV PROCESS, V3, P159, DOI 10.1016/0376-6357(78)90042-6; KARRAKER KH, 1990, BASIC APPL SOC PSYCH, V11, P371, DOI 10.1207/s15324834basp1104_2; LANGLOIS JH, 1995, DEV PSYCHOL, V31, P464, DOI 10.1037/0012-1649.31.3.464; Levy B, 2008, LEARN MOTIV, V39, P136, DOI 10.1016/j.lmot.2007.09.002; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025897; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; POWER TG, 1982, INFANT BEHAV DEV, V5, P33, DOI 10.1016/S0163-6383(82)80015-5; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; STEPHAN CW, 1984, CHILD DEV, V55, P576, DOI 10.2307/1129969; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042	17	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65844	10.1371/journal.pone.0065844	http://dx.doi.org/10.1371/journal.pone.0065844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155DJ	23734262	Green Submitted, gold, Green Published			2022-12-27	WOS:000319725500004
J	Zhou, YH; Liao, SJ; Li, D; Luo, J; Wei, JJ; Yan, B; Sun, R; Shu, Y; Wang, Q; Zhang, GM; Feng, ZH				Zhou, Yuan-Hong; Liao, Sheng-Jun; Li, Dong; Luo, Jing; Wei, Jing-Jing; Yan, Bin; Sun, Rui; Shu, Yu; Wang, Qi; Zhang, Gui-Mei; Feng, Zuo-Hua			TLR4 Ligand/H2O2 Enhances TGF-beta 1 Signaling to Induce Metastatic Potential of Non-Invasive Breast Cancer Cells by Activating Non-Smad Pathways	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; GROWTH-FACTOR; PROLIFERATION; MIGRATION; DORMANCY; PROTEIN; ONCOGENESIS; EXPRESSION; RESISTANCE; ESTROGEN	TGF-beta 1 has the potential to activate multiple signaling pathways required for inducing metastatic potential of tumor cells. However, TGF-beta 1 was inefficient in inducing metastatic potential of many non-invasive human tumor cells. Here we report that the enhancement of TGF-beta 1 signaling is required for inducing metastatic potential of non-invasive breast cancer cells. TGF-beta 1 alone could not efficiently induce the sustained activation of Smad and non-Smad pathways in non-invasive breast cancer cells. TLR4 ligand (LPS) and H2O2 cooperated with TGF-beta 1 to enhance the sustained activation of non-Smad pathways, including p38MAPK, ERK, JNK, PI3K, and NF-kappa B. The activation of MAPK and PI3K pathways resulted in a positive feed-back effect on TGF-beta 1 signaling by down-regulating Nm23-H1 expression and up-regulating the expression of T beta RI and T beta RII, favoring further activation of multiple signaling pathways. Moreover, the enhanced TGF-beta 1 signaling induced higher expression of SNAI2, which also promoted T beta RII expression. Therefore, the sustained activation levels of both Smad and non-Smad pathways were gradually increased after prolonged stimulation with TGF-beta 1/H2O2/LPS. Consistent with the activation pattern of signaling pathways, the invasive capacity and anoikis-resistance of non-invasive breast cancer cells were gradually increased after prolonged stimulation with TGF-beta 1/H2O2/LPS. The metastatic potential induced by TGF-beta 1/H2O2/LPS was sufficient for tumor cells to extravasate and form metastatic foci in an experimental metastasis model in nude mice. The findings in this study suggested that the enhanced signaling is required for inducing higher metastatic capacity of tumor cells, and that targeting one of stimuli or signaling pathways might be potential approach in comprehensive strategy for tumor therapy.	[Zhou, Yuan-Hong; Liao, Sheng-Jun; Li, Dong; Luo, Jing; Wei, Jing-Jing; Yan, Bin; Sun, Rui; Shu, Yu; Wang, Qi; Zhang, Gui-Mei; Feng, Zuo-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zhang, GM (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China.	zhanggm58@163.com; fengzhg@public.wh.hb.cn	wei, jing/GXA-1455-2022		National Science Foundation of China [30830095, 81272314]; National Development Program (973) for Key Basic Research of China [2009CB521806]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Development Program (973) for Key Basic Research of China(National Basic Research Program of China)	This work was supported by National Science Foundation of China (No. 30830095 to ZHF, No. 81272314 to GMZ) (http://isisn.nsfc.gov.cn/egrantweb/main), and National Development Program (973) for Key Basic Research of China (No. 2009CB521806 to ZHF) (http://www.973.gov.cn/areamana.aspx). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Christeli E, 1996, ONCOL REP, V3, P1115; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Fortin CF, 2011, EUR J IMMUNOL, V41, P1709, DOI 10.1002/eji.201040945; Gallego MI, 2003, ONCOGENE, V22, P8498, DOI 10.1038/sj.onc.1207063; Horak CE, 2008, APMIS, V116, P586, DOI 10.1111/j.1600-0463.2008.01213.x; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Keller ET, 2011, CANCER RES, V71, P310, DOI 10.1158/0008-5472.CAN-10-2930; Krueger JS, 2001, ONCOGENE, V20, P4209, DOI 10.1038/sj.onc.1204541; Li Y, 2010, ENDOCRINOLOGY, V151, P5146, DOI 10.1210/en.2009-1506; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Liu LY, 2011, AUTOPHAGY, V7, P112, DOI 10.4161/auto.7.1.14005; Liu SL, 2002, ARCH BIOCHEM BIOPHYS, V406, P173, DOI 10.1016/S0003-9861(02)00430-7; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Marshall JCA, 2012, JNCI-J NATL CANCER I, V104, P1306, DOI 10.1093/jnci/djs319; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Mawson A, 2005, MOL CELL ENDOCRINOL, V229, P161, DOI 10.1016/j.mce.2004.08.002; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Okoh V, 2011, BBA-REV CANCER, V1815, P115, DOI 10.1016/j.bbcan.2010.10.005; Ozaki I, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00078; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Sato Y, 2009, CANCER MICROENVIRON, V2, pS205, DOI 10.1007/s12307-009-0022-y; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taniguchi F, 2003, J CLIN ENDOCR METAB, V88, P773, DOI 10.1210/jc.2002-021062; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Xiong T, 2012, HUM REPROD, V27, P3540, DOI 10.1093/humrep/des330; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoon SO, 2002, J BIOL CHEM, V277, P30271, DOI 10.1074/jbc.M202647200; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244; Zhang Y, 2001, Chin J Traumatol, V4, P139	40	63	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65906	10.1371/journal.pone.0065906	http://dx.doi.org/10.1371/journal.pone.0065906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734265	Green Submitted, Green Published, gold			2022-12-27	WOS:000319725500001
J	Ellis, JS; Turner, LM; Knight, ME				Ellis, Jonathan S.; Turner, Lucy M.; Knight, Mairi E.			Lack of Variation at Phosphoglucose Isomerase (Pgi) in Bumblebees: Implications for Conservation Genetics Studies	PLOS ONE			English	Article							BALANCING SELECTION; PHYSIOLOGICAL CONSEQUENCES; SELF-INCOMPATIBILITY; NATURAL-POPULATIONS; FITNESS DIFFERENCES; DNA POLYMORPHISM; BEES HYMENOPTERA; FLIGHT MUSCLES; NEST DENSITY; BOMBUS	Assessing genetic variation underlying ecologically important traits is increasingly of interest and importance in population and conservation genetics. For some groups generally useful markers exist for examining the relative role of selection and drift in shaping genetic diversity e.g. the major histocompatibility complex in vertebrates and self-incompatibility loci in plants. For invertebrates there is no such generally useful locus. However, phosphoglucose isomerase (Pgi) has been proposed as a useful functional marker in the conservation genetics of invertebrates. Where thermal microclimate varies, balanced polymorphisms may be maintained due to trade-offs between thermally stable and kinetically advantageous allelic forms. We here report very low levels of Pgi variation in bumblebees rendering this locus to be of little use as an adaptive marker in a conservation genetics context in this group. Potential explanations for this lack of variation are considered.	[Ellis, Jonathan S.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester, Greater Manches, England; [Turner, Lucy M.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Ellis, Jonathan S.; Knight, Mairi E.] Univ Plymouth, Sch Biomed & Biol Sci, Plymouth PL4 8AA, Devon, England	Manchester Metropolitan University; University of Plymouth; University of Plymouth	Ellis, JS (corresponding author), Manchester Metropolitan Univ, Sch Sci & Environm, Manchester, Greater Manches, England.	j.ellis@mmu.ac.uk	Turner, Lucy/B-8495-2013; Turner, Lucy/GRR-1515-2022	Turner, Lucy/0000-0002-9052-9498; Ellis, Jonathan/0000-0002-6655-4685	Leverhulme Trust [F/00 568/S]	Leverhulme Trust(Leverhulme Trust)	This work was funded by the Leverhulme Trust (F/00 568/S (http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Akashi H, 1997, GENETICS, V146, P295; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Castric V, 2004, MOL ECOL, V13, P2873, DOI 10.1111/j.1365-294X.2004.02267.x; CHAPPELL MA, 1983, OECOLOGIA, V56, P126, DOI 10.1007/BF00378228; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Charman TG, 2010, MOL ECOL, V19, P2661, DOI 10.1111/j.1365-294X.2010.04697.x; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Darvill B, 2006, MOL ECOL, V15, P601, DOI 10.1111/j.1365-294X.2006.02797.x; EDWARDS R, 2005, PROVISIONAL ATLAS 5; Edwards R., 2002, PROVISIONAL ATLAS 4; Ekblom R, 2010, GENETICA, V138, P453, DOI 10.1007/s10709-008-9335-x; Ellis JS, 2006, MOL ECOL, V15, P4375, DOI 10.1111/j.1365-294X.2006.03121.x; Ellis JS, 2012, GENETICA, V140, P205, DOI 10.1007/s10709-012-9672-7; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; ESTOUP A, 1995, MOL ECOL, V4, P89, DOI 10.1111/j.1365-294X.1995.tb00195.x; Fussell M., 1993, Entomologist's Monthly Magazine, V129, P1; FUSSELL M, 1991, J APICULT RES, V30, P87, DOI 10.1080/00218839.1991.11101239; Gillespie J. H., 2004, POPULATION GENETICS; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson Dave, 2001, British Journal of Entomology and Natural History, V14, P129; GRAUR D, 1985, EVOLUTION, V39, P190, DOI 10.1111/j.1558-5646.1985.tb04091.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hedrick AV, 2002, J COMP PHYSIOL A, V188, P799, DOI 10.1007/s00359-002-0368-9; Hedrick PW, 1997, ANNU REV ECOL SYST, V28, P55, DOI 10.1146/annurev.ecolsys.28.1.55; HEINRICH B, 1973, J EXP BIOL, V58, P677; HEINRICH B, 1976, J EXP BIOL, V64, P561; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hohenlohe PA, 2010, INT J PLANT SCI, V171, P1059, DOI 10.1086/656306; Kammer AE, 1968, J COMP PHYSIOL A, V68, P334; Karl I, 2009, ECOGRAPHY, V32, P488, DOI 10.1111/j.1600-0587.2008.05660.x; Katz LA, 1997, GENETICS, V147, P609; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Kohn MH, 2006, TRENDS ECOL EVOL, V21, P629, DOI 10.1016/j.tree.2006.08.001; Kraus FB, 2009, J ANIM ECOL, V78, P247, DOI 10.1111/j.1365-2656.2008.01479.x; Lawrence MJ, 2000, ANN BOT-LONDON, V85, P221, DOI 10.1006/anbo.1999.1044; Lozier JD, 2011, MOL ECOL, V20, P4870, DOI 10.1111/j.1365-294X.2011.05314.x; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; NEWSHOLME EA, 1972, BIOCHEM J, V128, P89, DOI 10.1042/bj1280089; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Oh HK, 2009, GENES GENOM, V31, P293, DOI 10.1007/BF03191202; Orsini L, 2009, J EVOLUTION BIOL, V22, P367, DOI 10.1111/j.1420-9101.2008.01653.x; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; PAMILO P, 1981, GENETICS, V98, P199; Piertney SB, 2010, GENETICA, V138, P419, DOI 10.1007/s10709-008-9322-2; Rank NE, 2002, EVOLUTION, V56, P2278, DOI 10.1111/j.0014-3820.2002.tb00151.x; RIDDOCH BJ, 1993, BIOL J LINN SOC, V50, P1, DOI 10.1111/j.1095-8312.1993.tb00915.x; ROSS KG, 1995, AM NAT, V146, P325, DOI 10.1086/285803; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saastamoinen M, 2008, AM NAT, V171, pE701, DOI 10.1086/587531; Saunders P., 2008, BOMBUS MUSCORUM BOMB; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; Staples JF, 2004, J EXP BIOL, V207, P749, DOI 10.1242/jeb.00825; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ujvari B, 2011, INT J MOL SCI, V12, P5168, DOI 10.3390/ijms12085168; WATT WB, 1983, GENETICS, V103, P691; Watt WB, 1992, P NATL ACAD SCI, V89, P01608; Wheat CW, 2010, CONSERV GENET, V11, P387, DOI 10.1007/s10592-009-0042-7; Wheat CW, 2010, MOL BIOL EVOL, V27, P267, DOI 10.1093/molbev/msp227; Wheat CW, 2006, MOL BIOL EVOL, V23, P499, DOI 10.1093/molbev/msj062; Widmer A, 1998, HEREDITY, V81, P563, DOI 10.1046/j.1365-2540.1998.00407.x; Widmer A, 1999, MOL ECOL, V8, P387, DOI 10.1046/j.1365-294X.1999.00584.x	67	2	2	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65600	10.1371/journal.pone.0065600	http://dx.doi.org/10.1371/journal.pone.0065600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750269	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900071
J	Fallon, BP; Curnutte, B; Maupin, KA; Partyka, K; Choi, S; Brand, RE; Langmead, CJ; Tembe, W; Haab, BB				Fallon, Brian P.; Curnutte, Bryan; Maupin, Kevin A.; Partyka, Katie; Choi, Sunguk; Brand, Randall E.; Langmead, Christopher J.; Tembe, Waibhav; Haab, Brian B.			The Marker State Space (MSS) Method for Classifying Clinical Samples	PLOS ONE			English	Article							CA-19-9 ANTIGEN; LUNG-CANCER; DIAGNOSIS; PROTEINS; CLASSIFICATION; BIOMARKERS; CELL; GLYCOSYLATION; SPECIFICITY; PREVALENCE	The development of accurate clinical biomarkers has been challenging in part due to the diversity between patients and diseases. One approach to account for the diversity is to use multiple markers to classify patients, based on the concept that each individual marker contributes information from its respective subclass of patients. Here we present a new strategy for developing biomarker panels that accounts for completely distinct patient subclasses. Marker State Space (MSS) defines "marker states'' based on all possible patterns of high and low values among a panel of markers. Each marker state is defined as either a case state or a control state, and a sample is classified as case or control based on the state it occupies. MSS was used to define multi-marker panels that were robust in cross validation and training-set/test-set analyses and that yielded similar classification accuracy to several other classification algorithms. A three-marker panel for discriminating pancreatic cancer patients from control subjects revealed subclasses of patients based on distinct marker states. MSS provides a straightforward approach for modeling highly divergent subclasses of patients, which may be adaptable for diverse applications.	[Fallon, Brian P.; Curnutte, Bryan; Maupin, Kevin A.; Partyka, Katie; Haab, Brian B.] Van Andel Inst, Lab Canc Immunodiagnost, Grand Rapids, MI USA; [Choi, Sunguk; Langmead, Christopher J.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Brand, Randall E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Tembe, Waibhav] Translat Genom Res Inst, Phoenix, AZ USA	Van Andel Institute; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Translational Genomics Research Institute	Haab, BB (corresponding author), Van Andel Inst, Lab Canc Immunodiagnost, Grand Rapids, MI USA.	Brian.haab@vai.org		Langmead, Christopher/0000-0001-7521-6736	National Institutes of Health [R33 CA122890, 1U01CA152653, 1U01CA168896]; Van Andel Institute; NATIONAL CANCER INSTITUTE [U01CA168896, U01CA152653, R33CA122890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Andel Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funding of this work is from the National Institutes of Health (R33 CA122890, 1U01CA152653, and 1U01CA168896) and the Van Andel Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alonzo Todd A., 2007, V404, P89, DOI 10.1007/978-1-59745-530-5_6; Baek S, 2009, BRIEF BIOINFORM, V10, P537, DOI 10.1093/bib/bbp016; Bergsma D, 2010, MOL CELL PROTEOMICS, V9, P446, DOI 10.1074/mcp.M900418-MCP200; Bouwman K, 2003, PROTEOMICS, V3, P2200, DOI 10.1002/pmic.200300611; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; CHEN S, 2007, CLIN PROTEOMICS; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; COOK EF, 1984, J CHRON DIS, V37, P721, DOI 10.1016/0021-9681(84)90041-9; DILLMAN RO, 1983, CANCER RES, V43, P417; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; GAIL MH, 1988, J NATL CANCER I, V80, P97, DOI 10.1093/jnci/80.2.97; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Haab BB, 2010, ANN SURG, V251, P937, DOI 10.1097/SLA.0b013e3181d7738d; Haab BB, 2010, EXPERT REV PROTEOMIC, V7, P9, DOI 10.1586/EPR.09.102; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Hoggatt J, 2011, MOL DIAGN THER, V15, P53, DOI 10.2165/11534880-000000000-00000; Kloppel G, 2009, ARCH PATHOL LAB MED, V133, P382, DOI 10.1043/1543-2165-133.3.382; Koziol JA, 2003, CLIN CANCER RES, V9, P5120; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; LOMBARDI C, 1990, CHEST, V97, P639, DOI 10.1378/chest.97.3.639; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Lukes M, 2001, FOLIA BIOL-PRAGUE, V47, P41; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Orchekowski R, 2005, CANCER RES, V65, P11193, DOI 10.1158/0008-5472.CAN-05-1436; Partyka K, 2012, PROTEOMICS, V12, P2212, DOI 10.1002/pmic.201100676; Porter A, 2010, GLYCOBIOLOGY, V20, P369, DOI 10.1093/glycob/cwp187; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang CY, 2010, BIOSTATISTICS, V11, P195, DOI 10.1093/biostatistics/kxp052; Wu YM, 2009, J PROTEOME RES, V8, P1876, DOI 10.1021/pr8008379; Yue TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029180; Yue TT, 2011, PROTEOMICS, V11, P3665, DOI 10.1002/pmic.201000827; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200; Zhang HP, 2003, P NATL ACAD SCI USA, V100, P4168, DOI 10.1073/pnas.0230559100	37	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65905	10.1371/journal.pone.0065905	http://dx.doi.org/10.1371/journal.pone.0065905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750276	Green Accepted, Green Published, gold			2022-12-27	WOS:000319961900078
J	Lincoln, S; Allen, M; Cox, CL; Walker, LP; Malphrus, K; Qiu, YS; Nguyen, T; Rowley, C; Kouri, N; Crook, J; Pankratz, VS; Younkin, S; Younkin, L; Carrasquillo, M; Zou, FG; Abdul-Hay, SO; Springer, W; Sando, SB; Aasly, JO; Barcikowska, M; Wszolek, ZK; Lewis, JM; Dickson, D; Graff-Radford, NR; Petersen, RC; Eckman, E; Younkin, SG; Ertekin-Taner, N				Lincoln, Sarah; Allen, Mariet; Cox, Claire L.; Walker, Louise P.; Malphrus, Kimberly; Qiu, Yushi; Thuy Nguyen; Rowley, Christopher; Kouri, Naomi; Crook, Julia; Pankratz, V. Shane; Younkin, Samuel; Younkin, Linda; Carrasquillo, Minerva; Zou, Fanggeng; Abdul-Hay, Samer O.; Springer, Wolfdieter; Sando, Sigrid B.; Aasly, Jan O.; Barcikowska, Maria; Wszolek, Zbigniew K.; Lewis, Jada M.; Dickson, Dennis; Graff-Radford, Neill R.; Petersen, Ronald C.; Eckman, Elizabeth; Younkin, Steven G.; Ertekin-Taner, Niluefer			LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer's Disease (LOAD)	PLOS ONE			English	Article							ALPHA-T-CATENIN; AMYLOID-PRECURSOR PROTEIN; GENETIC ASSOCIATION; BETA; LINKAGE; BRAIN; SUSCEPTIBILITY; CHROMOSOME-10; POLYMORPHISMS; EXPRESSION	Leucine rich repeat transmembrane protein 3 (LRRTM3) is member of a synaptic protein family. LRRTM3 is a nested gene within alpha-T catenin (CTNNA3) and resides at the linkage peak for late-onset Alzheimer's disease (LOAD) risk and plasma amyloid beta (Ab) levels. In-vitro knock-down of LRRTM3 was previously shown to decrease secreted Ab, although the mechanism of this is unclear. In SH-SY5Y cells overexpressing APP and transiently transfected with LRRTM3 alone or with BACE1, we showed that LRRTM3 co-localizes with both APP and BACE1 in early endosomes, where BACE1 processing of APP occurs. Additionally, LRRTM3 co-localizes with APP in primary neuronal cultures from Tg2576 mice transduced with LRRTM3-expressing adeno-associated virus. Moreover, LRRTM3 co-immunoprecipitates with both endogenous APP and overexpressed BACE1, in HEK293T cells transfected with LRRTM3. SH-SY5Y cells with knock-down of LRRTM3 had lower BACE1 and higher CTNNA3 mRNA levels, but no change in APP. Brain mRNA levels of LRRTM3 showed significant correlations with BACE1, CTNNA3 and APP in similar to 400 humans, but not in LRRTM3 knock-out mice. Finally, we assessed 69 single nucleotide polymorphisms (SNPs) within and flanking LRRTM3 in 1,567 LOADs and 2,082 controls and identified 8 SNPs within a linkage disequilibrium block encompassing 5'UTR-Intron 1 of LRRTM3 that formed multilocus genotypes (MLG) with suggestive global association with LOAD risk (p = 0.06), and significant individual MLGs. These 8 SNPs were genotyped in an independent series (1,258 LOADs and 718 controls) and had significant global and individual MLG associations in the combined dataset (p = 0.02-0.05). Collectively, these results suggest that protein interactions between LRRTM3, APP and BACE1, as well as complex associations between mRNA levels of LRRTM3, CTNNA3, APP and BACE1 in humans might influence APP metabolism and ultimately risk of AD.	[Lincoln, Sarah; Allen, Mariet; Cox, Claire L.; Walker, Louise P.; Malphrus, Kimberly; Qiu, Yushi; Thuy Nguyen; Rowley, Christopher; Kouri, Naomi; Younkin, Samuel; Younkin, Linda; Carrasquillo, Minerva; Zou, Fanggeng; Abdul-Hay, Samer O.; Springer, Wolfdieter; Dickson, Dennis; Eckman, Elizabeth; Younkin, Steven G.; Ertekin-Taner, Niluefer] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA; [Crook, Julia] Mayo Clin Florida, Biostat Unit, Jacksonville, FL USA; [Pankratz, V. Shane] Mayo Clin Minnesto, Dept Biostat, Rochester, MN USA; [Sando, Sigrid B.; Aasly, Jan O.] St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Sando, Sigrid B.; Aasly, Jan O.] Norwegian Univ Sci & Technol, NTNU, Dept Neurosci, N-7034 Trondheim, Norway; [Barcikowska, Maria] Polish Acad Sci, Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland; [Wszolek, Zbigniew K.; Graff-Radford, Neill R.; Ertekin-Taner, Niluefer] Mayo Clin Florida, Dept Neurol, Jacksonville, FL USA; [Lewis, Jada M.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Petersen, Ronald C.] Mayo Clin Minnesota, Dept Neurol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Polish Academy of Sciences; Mayo Clinic; State University System of Florida; University of Florida	Ertekin-Taner, N (corresponding author), Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA.	taner.nilufer@mayo.edu	Eckman, Elizabeth/AAL-7316-2021; Wszolek, Zbigniew K./AAB-1431-2019; Kouri, Naomi/G-6695-2013	Rowley, Christopher/0000-0002-5307-1748; Eckman, Elizabeth/0000-0002-5391-4960; Kouri, N/0000-0002-6841-9882; Springer, Wolfdieter/0000-0002-1178-3149; Barcikowska, Maria/0000-0001-5657-9670; Dickson, Dennis W/0000-0001-7189-7917	National Institutes of Health (NIH) grants: National Institute on Aging [R01 032990, R01 AG018023]; Mayo Alzheimer's Disease Research Center [P50 AG016574]; Mayo Alzheimer's Disease Patient Registry [U01 AG006576]; National Institute on Aging [AG025711, AG017216, AG003949]; NIH [KL2 RR024151]; Siragusa Foundation; GHR Foundation; Research Council of Norway [153487/V50]; Ministry of Science (Poland) [N N401 235134]; NIH/NINDS [P50 NS072187]; Mayo Clinic Florida Research Committee CR program; Dystonia Medical Research Foundation; Genentech, Inc; MMRC; Elan Pharmaceutical Research; Pfizer Pharmaceuticals; Medivation; Pfizer Incorporated; Janssen Alzheimer Immunotherapy; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017216, P01AG003949, P50AG016574, R01AG018023, P50AG025711] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grants: National Institute on Aging; Mayo Alzheimer's Disease Research Center; Mayo Alzheimer's Disease Patient Registry; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siragusa Foundation; GHR Foundation; Research Council of Norway(Research Council of Norway); Ministry of Science (Poland); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic Florida Research Committee CR program; Dystonia Medical Research Foundation; Genentech, Inc(Roche HoldingGenentech); MMRC; Elan Pharmaceutical Research; Pfizer Pharmaceuticals(Pfizer); Medivation; Pfizer Incorporated; Janssen Alzheimer Immunotherapy; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this research was provided by these National Institutes of Health (NIH) grants: National Institute on Aging (R01 032990 to NET and R01 AG018023 to NRG-R and SGY), Mayo Alzheimer's Disease Research Center (P50 AG016574 to RCP, DWD, NRG-R, SGY, and NET), Mayo Alzheimer's Disease Patient Registry (U01 AG006576 to RCP), National Institute on Aging (AG025711, AG017216, AG003949 to DWD). NET is the recipient of NIH (KL2 RR024151) and Siragusa Foundation grants. This project was also generously supported by the Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (to RCP, DWD, NRG-R, and SGY) and by the Palumbo Professorship in Alzheimer's Disease Research (to SGY). MMC and WS are supported partly by GHR Foundation grants. SBS was supported by the Research Council of Norway (153487/V50). MB is partly supported by Ministry of Science (Poland) grant (N N401 235134). ZKWis partially supported by the NIH/NINDS P50 NS072187, Mayo Clinic Florida Research Committee CR program, and Dystonia Medical Research Foundation. The mouse strain used for this research project, B6; 129S5-Lrrtm3tm1Lex/Mmcd, identification number 032451-UCD was donated to the Mutant Mouse Regional Resource Center MMRRC by Genentech, Inc. MMRC is a NCRR-NIH funded strain repository. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We have the following interests: N. Graff-Radford has served as a consultant to Codman and received grant support from Elan Pharmaceutical Research, Pfizer Pharmaceuticals, Medivation, and Forrest. R.C. Petersen has been a consultant to GE Healthcare and Elan Pharmaceuticals, has served on a data safety monitoring board in clinical trials sponsored by Pfizer Incorporated and Janssen Alzheimer Immunotherapy, and gave a CME lecture at Novartis Incorporated. The mouse strain used for this research project, B6; 129S5-Lrrtm3tm1Lex/Mmcd, identification number 032451-UCD was donated to the Mutant Mouse Regional Resource Center MMRRC by Genentech, Inc. MMRC is a NCRR-NIH-funded strain repository. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Allen M, 2012, NEUROLOGY, V79, P221, DOI 10.1212/WNL.0b013e3182605801; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertram L, 2007, J MED GENET, V44, DOI 10.1136/jmg.2005.039263; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blomqvist MEL, 2004, NEUROSCI LETT, V358, P220, DOI 10.1016/j.neulet.2004.01.032; Busby V, 2004, NEUROMOL MED, V5, P133, DOI 10.1385/NMM:5:2:133; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Cellini E, 2005, ALZ DIS ASSOC DIS, V19, P246, DOI 10.1097/01.wad.0000189030.50826.86; EDWARDS TL, 2008, AM J MED GENET B; Ertekin-Taner N, 2005, HUM MOL GENET, V14, P447, DOI 10.1093/hmg/ddi041; Ertekin-Taner N, 2003, HUM MOL GENET, V12, P3133, DOI 10.1093/hmg/ddg343; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jurinke C, 2004, MOL BIOTECHNOL, V26, P147, DOI 10.1385/MB:26:2:147; Kask M, 2011, BIOCHEM BIOPH RES CO, V411, P56, DOI 10.1016/j.bbrc.2011.06.085; Klimkowicz-Mrowiec A, 2009, DEMENT GERIATR COGN, V28, P461, DOI 10.1159/000259460; Laakso T, 2012, J ALZHEIMERS DIS, V31, P759, DOI 10.3233/JAD-2012-120193; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Martin ER, 2005, J MED GENET, V42, P787, DOI 10.1136/jmg.2004.029553; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyashita A, 2007, HUM MOL GENET, V16, P2854, DOI 10.1093/hmg/ddm244; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REITZ C, 2012, ARCH NEUROLOGY; Sando SB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-9; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Smith JD, 2011, CELL MOL LIFE SCI, V68, P2493, DOI 10.1007/s00018-011-0728-0; Sousa I, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-7; Thornton-Wells TA, 2008, GENET EPIDEMIOL, V32, P187, DOI 10.1002/gepi.20294; van Dijk M, 2010, J ALZHEIMERS DIS, V19, P673, DOI 10.3233/JAD-2010-1265; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zou F, 2010, NEUROLOGY, V74, P480, DOI 10.1212/WNL.0b013e3181d07654	36	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64164	10.1371/journal.pone.0064164	http://dx.doi.org/10.1371/journal.pone.0064164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750206	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900008
J	Pfitzner, R; Gorzelniak, L; Heinrich, J; von Berg, A; Klumper, C; Bauer, CP; Koletzko, S; Berdel, D; Horsch, A; Schulz, H				Pfitzner, Rebecca; Gorzelniak, Lukas; Heinrich, Joachim; von Berg, Andrea; Kluemper, Claudia; Bauer, Carl P.; Koletzko, Sibylle; Berdel, Dietrich; Horsch, Alexander; Schulz, Holger		GINIplus Study Grp	Physical Activity in German Adolescents Measured by Accelerometry and Activity Diary: Introducing a Comprehensive Approach for Data Management and Preliminary Results	PLOS ONE			English	Article							ECONOMIC COSTS; ILL HEALTH; CHILDREN; INACTIVITY; OBESITY; BURDEN; VALIDATION; TIME; LIFE	Introduction: Surveillance of physical activity (PA) is increasingly based on accelerometry. However, data management guidelines are lacking. We propose an approach for combining accelerometry and diary based PA information for assessment of PA in adolescents and provide an example of this approach using data from German adolescents. Methods: The 15-year-old participants comprised a subsample the GINIplus birth cohort (n = 328, 42.4% male). Data on PA was obtained from hip-worn accelerometers (ActiGraph GT3X) for seven consecutive days, combined with a prospective activity diary. Major aspects of data management were validity of wear time, handling of non-wear time and diary comments. After data cleaning, PA and percentage of adolescents meeting the recommendations for moderate-to-vigorous activity (MVPA) per day were determined. Results: From the 2224 recorded days 493 days (25%) were invalid, mainly due to uncertainties relating to non-wear time (322 days). Ultimately, 269 of 328 subjects (82%) with valid data for at least three weekdays and one weekend day were included in the analysis. Mean MVPA per day was 39.1 minutes (SD +/- 25.0), with boys being more active than girls (41.8 +/- 21.5 minutes vs. 37.1 +/- 27.8 minutes, p<0.001). Accordingly, 24.7% of boys and 17.2% of girls (p<0.01) met the WHO recommendations for PA. School sport accounted for only 6% of weekly MVPA. In fact, most MVPA was performed during leisure time, with the majority of adolescents engaging in ball sports (25.4%) and endurance sports (19.7%). Girls also frequently reported dancing and gymnastics (23%). Conclusion: For assessment of PA in adolescents, collecting both accelerometry and diary-based information is recommended. The diary is vital for the identification of invalid data and non-compliant participants. Preliminary results suggest that four out of five German adolescents do not meet WHO recommendations for PA and that school sport contributes only little to MVPA.	[Pfitzner, Rebecca; Heinrich, Joachim; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Gorzelniak, Lukas; Horsch, Alexander] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [von Berg, Andrea; Berdel, Dietrich] Marien Hosp, Dept Pediat, Wesel, Germany; [Kluemper, Claudia] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany; [Bauer, Carl P.] Tech Univ Munich, Dept Pediat, D-80290 Munich, Germany; [Koletzko, Sibylle] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; St. Marien Hospital; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Technical University of Munich; University of Munich	Schulz, H (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany.	schulz@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Horsch, Alexander/W-8322-2018; Schulz, Holger/J-5643-2015	Heinrich, Joachim/0000-0002-9620-1629; Horsch, Alexander/0000-0001-7745-0139; Schulz, Holger/0000-0002-1157-200X	Helmholtz Zentrum Munchen, German Research Center for Environmental Health; Graduate School of Information Science in Health (GSISH); TUM Graduate School	Helmholtz Zentrum Munchen, German Research Center for Environmental Health(Helmholtz Association); Graduate School of Information Science in Health (GSISH); TUM Graduate School	Accelerometers were funded by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health. The research was also supported by the Graduate School of Information Science in Health (GSISH) and the TUM Graduate School. All institutions are no external funding sources rather governmental run scientific institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807; Andrews F. M., 1976, SOCIAL INDICATORS WE; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Cain KL, J PHYS ACT IN PRESS; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Chung AE, 2012, CLIN PEDIATR, V51, P122, DOI 10.1177/0009922811417291; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Colley Rachel, 2010, Health Rep, V21, P63; Currie C, 2012, HLTH BEHAV SCH AGED; De Meester F, 2011, PUBLIC HEALTH NUTR, V14, P2124, DOI 10.1017/S1368980011001868; Esliger DW, 2007, APPL PHYSIOL NUTR ME, V32, pS195, DOI 10.1139/H07-107; Fox KR, 2000, P NUTR SOC, V59, P497, DOI 10.1017/S0029665100000720; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Guinhouya CB, 2006, OBESITY, V14, P774, DOI 10.1038/oby.2006.89; Heinrich J, 2012, BUNDESGESUNDHEITSBLA, V55, P864, DOI 10.1007/s00103-012-1485-4; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kahlert D, 2011, DEUT Z SPORTMED, V62, P36; Kaminsky LA, 2012, PHYSIOL MEAS, V33, P1869, DOI 10.1088/0967-3334/33/11/1869; Katzmarzyk PT, 2004, CAN J APPL PHYSIOL, V29, P90, DOI 10.1139/h04-008; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lampert T, 2007, BUNDESGESUNDHEITSBLA, V50, P634, DOI 10.1007/s00103-007-0224-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; National Cancer Institute, SAS PROGR AN NHANES; Olds T, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-43; Organization WH, 2009, GLOB HLTH RISKS MORT; Ottevaere C, 2011, J SPORT SCI, V29, P103, DOI 10.1080/02640414.2010.521169; R Core Team, 2018, R LANG ENV STAT COMP; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	42	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65192	10.1371/journal.pone.0065192	http://dx.doi.org/10.1371/journal.pone.0065192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750243	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000319961900045
J	Rao, JH; Qin, JJ; Qian, XF; Lu, L; Wang, P; Wu, ZS; Zhai, Y; Zhang, F; Li, GQ; Wang, XH				Rao, Jianhua; Qin, Jianjie; Qian, Xiaofeng; Lu, Ling; Wang, Ping; Wu, Zhengshan; Zhai, Yuan; Zhang, Feng; Li, Guoqiang; Wang, Xuehao			Lipopolysaccharide Preconditioning Protects Hepatocytes from Ischemia/Reperfusion Injury (IRI) through Inhibiting ATF4-CHOP Pathway in Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; LIVER ISCHEMIA; TNF-ALPHA; CELL-DEATH; ER STRESS; IL-6 PRODUCTION; ACTIVATION; APOPTOSIS	Background: Low-dose lipopolysaccharide (LPS) preconditioning-induced liver protection has been demonstrated during ischemia-reperfusion injury (IRI) in several organs but has not been sufficiently elucidated underlying causal mechanism. This study investigated the role of low-dose LPS preconditioning on ATF4-CHOP pathway as well as the effects of the pathway on tissue injury and inflammation in a mouse model of liver partial-warm IRI. Methods: LPS (100 mg/kg/d) was injected intraperitoneally two days before ischemia. Hepatic injury was evaluated based on serum alanine aminotransferase levels, histopathology, and caspase-3 activity. The ATF4-CHOP pathway and its related apoptotic molecules were investigated after reperfusion. The role of LPS preconditioning on apoptosis and ATF4-CHOP pathway was examined in vitro. Moreover, the effects of the ATF4-CHOP pathway on apoptosis, Caspase-12, and Caspase-3 were determined with ATF4 small interfering RNA (siRNA). Inflammatory cytokine expression was also checked after reperfusion. Inflammatory cytokines and related signaling pathways were analyzed in vitro in macrophages treated by LPS preconditioning or ATF4 siRNA. Results: LPS preconditioning significantly attenuated liver injury after IRI. As demonstrated by in vitro experiments, LPS preconditioning significantly reduced the upregulation of the ATF4-CHOP pathway and inhibited Caspase-12 and Caspase-3 activation after IRI. Later experiments showed that ATF4 knockdown significantly suppressed CHOP, cleaved caspase-12 and caspase-3 expression, as well as inhibited hepatocellular apoptosis. In addition, in mice pretreated with LPS, TNF-alpha and IL-6 were inhibited after reperfusion, whereas IL-10 was upregulated. Similarly, low-dose LPS significantly inhibited TNF-alpha, IL-6, ATF4-CHOP pathway, NF-kappa B pathway, and ERK1/2 in high-dose LPS-stimulated macrophages, whereas IL-10 and cytokine signaling (SOCS)-3 suppressor were induced. Importantly, ATF4 siRNA is consistent with results of LPS preconditioning in macrophages. Conclusions: This work is the first time to provide evidence for LPS preconditioning protects hepatocytes from IRI through inhibiting ATF4-CHOP pathway, which may be critical to reducing related apoptosis molecules and modulating innate inflammation.	[Zhang, Feng] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; Minist Publ Hlth, Key Lab Living Donor Liver Transplantat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhang, F (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	zhangf@njmu.edu.cn; liguoqiang@njmu.edu.cn; xuehaowang@hotmail.com	lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022		International Collaboration Foundation of Jiangsu Province [BZ2011041, BK2009439, ZX05 200904, WS2011106, W201201, BZ2012058]; Development of Innovative Research Team in the First Affiliated Hospital of NJMU; National Nature Science Foundation of China [81100270, 81070380, 81310108001, 81210108017, 81273261, 81270583]; Health Department of Jiangsu Province [ZX05200903]	International Collaboration Foundation of Jiangsu Province; Development of Innovative Research Team in the First Affiliated Hospital of NJMU; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Jiangsu Province	This study was supported by the International Collaboration Foundation of Jiangsu Province (BZ2011041, BK2009439, ZX05 200904, WS2011106, W201201, BZ2012058), Development of Innovative Research Team in the First Affiliated Hospital of NJMU and the National Nature Science Foundation of China (81100270, 81070380, 81310108001, 81210108017, 81273261, 81270583). Open project of the program of "Science and Education to Promote Health'' from Health Department of Jiangsu Province (ZX05200903). First Innovation Team Foundation of Jiangsu province Hospital (for Sun BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Azzolina A, 2003, BBA-MOL CELL RES, V1643, P75, DOI 10.1016/j.bbamcr.2003.09.003; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Blohmke CJ, 2012, J IMMUNOL, V189, P5467, DOI 10.4049/jimmunol.1103661; COLLETTI LM, 1994, J SURG RES, V57, P337, DOI 10.1006/jsre.1994.1152; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Franco PJ, 2008, INVEST OPHTH VIS SCI, V49, P4604, DOI 10.1167/iovs.08-2054; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Godet C, 2006, SHOCK, V25, P384, DOI 10.1097/01.shk.0000209528.35743.54; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; Hatano E, 2001, AM J PHYSIOL-GASTR L, V281, pG1357, DOI 10.1152/ajpgi.2001.281.6.G1357; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jeong HJ, 2002, CYTOKINE, V18, P252, DOI 10.1006/cyto.2002.0894; Ke BB, 2009, HUM GENE THER, V20, P1133, DOI 10.1089/hum.2009.049; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Korhonen L, 2005, MOL CELL NEUROSCI, V28, P85, DOI 10.1016/j.mcn.2004.08.015; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Liu J, 2012, TRANSPLANTATION, V94, P211, DOI 10.1097/TP.0b013e318259d38e; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moniz H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.88; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Obermaier R, 2003, PANCREAS, V27, pE51, DOI 10.1097/00006676-200310000-00020; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Que XY, 2004, J SURG RES, V116, P262, DOI 10.1016/j.jss.2003.07.005; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Rudiger HA, 2003, J INVEST SURG, V16, P149, DOI 10.1080/08941930390205764; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sano T, 2011, TRANSPLANTATION, V91, P1082, DOI 10.1097/TP.0b013e31821457cb; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Srinivasan K, 2012, LIFE SCI, V90, P154, DOI 10.1016/j.lfs.2011.10.017; SUZUKI S, 1991, TRANSPLANTATION, V52, P978, DOI 10.1097/00007890-199112000-00008; Urban P, 2012, MOL CELL BIOCHEM, V362, P133, DOI 10.1007/s11010-011-1135-4; Vekich JA, 2012, J MOL CELL CARDIOL, V53, P259, DOI 10.1016/j.yjmcc.2012.05.005; Vilatoba M, 2005, SURGERY, V138, P342, DOI 10.1016/j.surg.2005.04.019; Wang ZJ, 2009, CELL BIOL INT, V33, P665, DOI 10.1016/j.cellbi.2009.03.006; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wu CX, 2011, J SURG RES, V166, pE205, DOI 10.1016/j.jss.2010.10.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	51	42	47	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65568	10.1371/journal.pone.0065568	http://dx.doi.org/10.1371/journal.pone.0065568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750267	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900069
J	Zelazny, AM; Ding, L; Goldberg, JB; Mijares, LA; Conlan, S; Conville, PS; Stock, F; Ballentine, SJ; Olivier, KN; Sampaio, EP; Murray, PR; Holland, SM				Zelazny, Adrian M.; Ding, Li; Goldberg, Joanna B.; Mijares, Lilia A.; Conlan, Sean; Conville, Patricia S.; Stock, Frida; Ballentine, Samuel J.; Olivier, Kenneth N.; Sampaio, Elizabeth P.; Murray, Patrick R.; Holland, Steven M.			Adaptability and Persistence of the Emerging Pathogen Bordetella petrii	PLOS ONE			English	Article							O-ANTIGEN BIOSYNTHESIS; GENE-TRANSFER; SP NOV.; IDENTIFICATION; INFECTIONS	The first described, environmentally isolated, Bordetella petrii was shown to undergo massive genomic rearrangements in vitro. More recently, B. petrii was isolated from clinical samples associated with jaw, ear bone, cystic fibrosis and chronic pulmonary disease. However, the in vivo consequences of B. petrii genome plasticity and its pathogenicity remain obscure. B. petrii was identified from four sequential respiratory samples and a post-mortem spleen sample of a woman presenting with bronchiectasis and cavitary lung disease associated with nontuberculous mycobacterial infection. Strains were compared genetically, phenotypically and by antibody recognition from the patient and from inoculated mice. The successive B. petrii strains exhibited differences in growth, antibiotic susceptibility and recognition by the patient's antibodies. Antibodies from mice inoculated with these strains recapitulated the specificity and strain dependent response that was seen with the patient's serum. Finally, we characterize one strain that was poorly recognized by the patient's antibodies, due to a defect in the lipopolysaccharide O-antigen, and identify a mutation associated with this phenotype. We propose that B. petrii is remarkably adaptable in vivo, providing a possible connection between immune response and bacterial evasion and supporting infection persistence.	[Zelazny, Adrian M.; Ding, Li; Ballentine, Samuel J.; Olivier, Kenneth N.; Sampaio, Elizabeth P.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Zelazny, Adrian M.; Mijares, Lilia A.; Conville, Patricia S.; Stock, Frida; Murray, Patrick R.] NIH, Microbiol Serv, Ctr Clin, Bethesda, MD 20892 USA; [Goldberg, Joanna B.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [Conlan, Sean] NHGRI, NIH, Bethesda, MD 20892 USA; [Sampaio, Elizabeth P.] Fiocruz MS, Inst Oswaldo Cruz, Leprosy Lab, BR-21045900 Rio De Janeiro, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Virginia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fundacao Oswaldo Cruz	Zelazny, AM (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	azelazny@mail.nih.gov	Conlan, Sean/B-4401-2008	Conlan, Sean/0000-0001-6848-3465	Division of Intramural Research; National Human Genome Research Institute; Clinical Center at the National Institutes of Health; National Institute of Allergy and Infectious Diseases; CLINICAL CENTER [ZIACL080013] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Clinical Center at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	This work was financially supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute and Clinical Center at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Buboltz AM, 2009, INFECT IMMUN, V77, P3249, DOI 10.1128/IAI.01448-08; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; *CLIN LAB STAND I, 2011, M100S21 CLSI; Cunneen MM, 2007, MOL BIOL EVOL, V24, P1355, DOI 10.1093/molbev/msm058; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Fry NK, 2005, EMERG INFECT DIS, V11, P1131, DOI 10.3201/eid1107.050046; Goebel EM, 2008, INFECT IMMUN, V76, P1774, DOI 10.1128/IAI.01629-07; Gross R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-449; Iguchi A, 2008, MICROBIOL-SGM, V154, P559, DOI 10.1099/mic.0.2007/013334-0; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Ko KS, 2005, J CLIN MICROBIOL, V43, P2516, DOI 10.1128/JCM.43.5.2516-2519.2005; Le Coustumier A, 2011, EMERG INFECT DIS, V17, P612, DOI 10.3201/eid1704.101480; Lechner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-141; Lee MS, 2006, DIAGN MICR INFEC DIS, V56, P217, DOI 10.1016/j.diagmicrobio.2006.03.017; MacArthur L, 2007, J ENDOTOXIN RES, V13, P243, DOI 10.1177/0968051907082609; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Moissenet D, 2005, PATHOL BIOL, V53, P500, DOI 10.1016/j.patbio.2005.06.004; Mooi FR, 1997, TRENDS MICROBIOL, V5, P161, DOI 10.1016/S0966-842X(96)10086-X; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Shepard CW, 2004, CLIN INFECT DIS, V38, P799, DOI 10.1086/381888; Spilker T, 2008, CLIN MICROBIOL INFEC, V14, P504, DOI 10.1111/j.1469-0691.2008.01968.x; Stark D, 2007, J MED MICROBIOL, V56, P435, DOI 10.1099/jmm.0.46976-0; Tang YW, 1998, CLIN INFECT DIS, V26, P389, DOI 10.1086/516323; Vandamme P, 1996, INT J SYST BACTERIOL, V46, P849, DOI 10.1099/00207713-46-4-849; von Wintzingerode F, 2001, INT J SYST EVOL MICR, V51, P1257, DOI 10.1099/00207713-51-4-1257; WEISS AA, 1984, INFECT IMMUN, V43, P263, DOI 10.1128/IAI.43.1.263-269.1984; Zelazny AM, 2009, INFECT IMMUN, V77, P4337, DOI 10.1128/IAI.00259-09; Zhang XQ, 2009, INFECT IMMUN, V77, P5050, DOI 10.1128/IAI.00667-09	30	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65102	10.1371/journal.pone.0065102	http://dx.doi.org/10.1371/journal.pone.0065102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750235	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900037
J	Cui, C; Ge, XH; Zhou, YY; Li, MT; Li, ZY				Cui, Cheng; Ge, Xianhong; Zhou, Yingying; Li, Maoteng; Li, Zaiyun			Cytoplasmic and Genomic Effects on Non-Meiosis-Driven Genetic Changes in Brassica Hybrids and Allotetraploids from Pairwise Crosses of Three Cultivated Diploids	PLOS ONE			English	Article							CYTOSINE METHYLATION; EXPRESSION DOMINANCE; NAPUS; ALLOPOLYPLOIDY; HYBRIDIZATION; EVOLUTION; POLYPLOIDY; MECHANISMS; WHEAT; AFLP	Nuclear-cytoplasmic interactions are predicted to be important in shaping the genetic changes in early stage of allopolyploidization. Our previous study shows the specific role of genome and cytoplasm affecting the chromosome pairing in Brassica hybrids and allotetraploids from pairwise crosses between three cultivated diploids with A, B and C genomes, respectively. Herein, to address how parental genomes and cytoplasm affects genomic, epigenetic and gene expression changes prior to meiosis in these hybrids and allopolyploids, their patterns of AFLP (Amplified fragment length polymorphism), mAFLP (Methylation AFLP) and cDNA-AFLP were compared with the progenitors, revealing the major absent bands within each genome. These changes varied under various cytoplasm backgrounds and genome combinations, following the significant order of AFLP> mAFLP> cDNA -AFLP. The frequencies of AFLP bands lost were positively correlated with the divergence degrees of parental genomes, but not obvious for those of mAFLP and cDNA-AFLP absent bands, and methylation change showed least variations among hybrids and within each genome. These changes within each genome followed the A>B>C hierarchy, except the highest rate of cDNA loss in B genome. Among three changes, only overall AFLP bands were significantly correlated with cDNA-AFLP, and their correlations varied within each genome. These changes in allotetraploids were mainly caused by genome merger rather than doubling. Parental genomes altered differently at three levels, responded to the types of cytoplasm and genome and their interaction or divergence. The result provides new clues for instant non-meiosis-driven genome restructuring following genome merger and duplication.	[Cui, Cheng; Ge, Xianhong; Zhou, Yingying; Li, Zaiyun] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Ctr Oil Crop Improvement Wuhan, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China; [Li, Maoteng] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Wuhan 430074, Peoples R China	Huazhong Agricultural University; Huazhong University of Science & Technology	Ge, XH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Ctr Oil Crop Improvement Wuhan, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China.	gexianhong@gmail.com; lizaiyun@mail.hzau.edu.cn			Ministry of Science and Technology of China [2012BAD49G00]; National Natural Science Foundation of China [31171583]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the grant from Ministry of Science and Technology of China (2012BAD49G00) and National Natural Science Foundation of China (31171583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Adams KL, 2004, GENETICS, V147, P1381; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Bachem CWB, 1998, PLANT MOL BIOL REP, V16, P157, DOI 10.1023/A:1007468801806; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Bardil A, 2011, NEW PHYTOL, V192, P760, DOI 10.1111/j.1469-8137.2011.03833.x; Bento M, 2011, GENOME, V54, P175, DOI 10.1139/G10-107; Buggs RJA, 2011, CURR BIOL, V21, P551, DOI 10.1016/j.cub.2011.02.016; Buggs RJA, 2010, NEW PHYTOL, V186, P175, DOI 10.1111/j.1469-8137.2010.03205.x; Chelaifa H, 2010, NEW PHYTOL, V186, P161, DOI 10.1111/j.1469-8137.2010.03179.x; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Cifuentes M, 2010, PLANT CELL, V22, P2265, DOI 10.1105/tpc.109.072991; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Cui C, 2012, GENETICS, V191, P725, DOI 10.1534/genetics.112.140780; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Feldman M, 1997, GENETICS, V147, P1381; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Hegarty MJ, 2008, PHILOS T R SOC B, V363, P3055, DOI 10.1098/rstb.2008.0080; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; Hegarty MJ, 2011, MOL ECOL, V20, P105, DOI 10.1111/j.1365-294X.2010.04926.x; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu Bao, 2002, Current Genomics, V3, P489, DOI 10.2174/1389202023350255; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Marmagne A, 2010, NEW PHYTOL, V186, P216, DOI 10.1111/j.1469-8137.2009.03139.x; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Narayan RKJ, 1998, ANN BOT-LONDON, V82, P57, DOI 10.1006/anbo.1998.0752; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Rapp RA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-18; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Szadkowski E, 2010, NEW PHYTOL, V186, P102, DOI 10.1111/j.1469-8137.2010.03182.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 2000, MOL BREEDING, V6, P265, DOI 10.1023/A:1009656422272; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Xu YH, 2009, PLANTA, V229, P471, DOI 10.1007/s00425-008-0844-8; Zhao N, 2011, GENETICS, V188, P499, DOI 10.1534/genetics.111.127688; Zhou RC, 2011, P NATL ACAD SCI USA, V108, P16122, DOI 10.1073/pnas.1109551108	55	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65078	10.1371/journal.pone.0065078	http://dx.doi.org/10.1371/journal.pone.0065078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741462	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900175
J	Forman, OP; De Risio, L; Mellersh, CS				Forman, Oliver P.; De Risio, Luisa; Mellersh, Cathryn S.			Missense Mutation in CAPN1 Is Associated with Spinocerebellar Ataxia in the Parson Russell Terrier Dog Breed	PLOS ONE			English	Article							BETA-III SPECTRIN; HEREDITARY ATAXIA; CALPAIN ACTIVATION; NEUROMYOTONIA; DEGENERATION; PROTEOLYSIS; DISRUPTION; INHIBITORS; ALIGNMENT; MYOKYMIA	Spinocerebellar ataxia (SCA) in the Parson Russell Terrier (PRT) dog breed is a disease of progressive incoordination of gait and loss of balance. Clinical signs usually become notable between 6 and 12 months of age with affected dogs presenting with symmetric spinocerebellar ataxia particularly evident in the pelvic limbs. The degree of truncal ataxia, pelvic limb hypermetria and impaired balance is progressive, particularly during the initial months of disease. A certain degree of stabilisation as well as intermittent worsening may occur. At the later stages of the disease ambulation often becomes difficult, with owners often electing to euthanise affected dogs on welfare grounds. Using a GWAS approach and target-enriched massively-parallel sequencing, a strongly associated non-synonymous SNP in the CAPN1 gene, encoding the calcium dependent cysteine protease calpain1 (mu-calpain), was identified. The SNP is a missense mutation causing a cysteine to tyrosine substitution at residue 115 of the CAPN1 protein. Cysteine 115 is a highly conserved residue and forms a key part of a catalytic triad of amino acids that are crucial to the enzymatic activity of cysteine proteases. The CAPN1 gene shows high levels of expression in the brain and nervous system and roles for the protein in both neuronal necrosis and maintenance have been suggested. Given the functional implications and high level of conservation observed across species, the CAPN1 variant represents a provocative candidate for the cause of SCA in the PRT and a novel potential cause of ataxia in humans.	[Forman, Oliver P.; Mellersh, Cathryn S.] Anim Hlth Trust, Kennel Club Genet, Newmarket, Suffolk, England; [De Risio, Luisa] Anim Hlth Trust, Ctr Small Anim Studies, Neurol Neurosurg Serv, Newmarket, Suffolk, England	Animal Health Trust; Animal Health Trust	Forman, OP (corresponding author), Anim Hlth Trust, Kennel Club Genet, Newmarket, Suffolk, England.	oliver.forman@aht.org.uk	De Risio, Luisa/ABB-3561-2020	De Risio, Luisa/0000-0001-9005-4165	Kennel Club Charitable Trust; Animal Health Trust	Kennel Club Charitable Trust; Animal Health Trust	This study was funded by the Kennel Club Charitable Trust, the Animal Health Trust, and donations from individuals and breed clubs via the Animal Health Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Bauer P, 2006, BIOESSAYS, V28, P785, DOI 10.1002/bies.20443; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Bhatti SF, 2011, VET J, V189, P284, DOI 10.1016/j.tvjl.2010.07.011; BJORK G., 1957, Veterinary Record, V69, P871; BJORCK G., 1962, ACTA NEUROPATHOLOGICA SUPPL, V1, P45; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; Coates JR, 2002, J VET INTERN MED, V16, P680, DOI 10.1111/j.1939-1676.2002.tb02408.x; Demarchi F, 2007, CELL CYCLE, V6, P136; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Faddis BT, 1997, J NEUROSCI, V17, P951; Forman OP, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-55; Gao YZ, 2011, J NEUROSCI, V31, P16581, DOI 10.1523/JNEUROSCI.3332-11.2011; HARTLEY WJ, 1973, ACTA NEUROPATHOL, V26, P71, DOI 10.1007/BF00685524; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kyostila K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002759; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Perkins EM, 2010, J NEUROSCI, V30, P4857, DOI 10.1523/JNEUROSCI.6065-09.2010; Pignol B, 2006, J NEUROCHEM, V98, P1217, DOI 10.1111/j.1471-4159.2006.03952.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohdin C, 2010, VET REC, V166, P557, DOI 10.1136/vr.b4821; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Sakaguchi G, 1998, BIOCHEM BIOPH RES CO, V248, P846, DOI 10.1006/bbrc.1998.9067; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Touma E, 2007, EUR J NEUROSCI, V26, P3368, DOI 10.1111/j.1460-9568.2007.05943.x; Vanhaesebrouck A, 2012, VET REC, V171, P131, DOI 10.1136/vr.e5021; Wessmann A, 2004, J VET INTERN MED, V18, P515, DOI 10.1892/0891-6640(2004)18&lt;515:HAITJR&gt;2.0.CO;2; Zeng R, 2011, J VET INTERN MED, V25, P267, DOI 10.1111/j.1939-1676.2010.0666.x	40	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64627	10.1371/journal.pone.0064627	http://dx.doi.org/10.1371/journal.pone.0064627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741357	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900070
J	Fraser, KC; Silverio, C; Kramer, P; Mickle, N; Aeppli, R; Stutchbury, BJM				Fraser, Kevin C.; Silverio, Cassandra; Kramer, Patrick; Mickle, Nanette; Aeppli, Robert; Stutchbury, Bridget J. M.			A Trans-Hemispheric Migratory Songbird Does Not Advance Spring Schedules or Increase Migration Rate in Response to Record-Setting Temperatures at Breeding Sites	PLOS ONE			English	Article							CLIMATE-CHANGE; PHENOTYPIC PLASTICITY; ECOLOGICAL CONDITIONS; BIRD POPULATION; ARRIVAL DATE; DISTANCE; CONNECTIVITY; HERITABILITY; PHENOLOGY; DECLINES	The decline of long distance migratory songbirds has been linked to an increasing mismatch between spring arrival date and timing of food availability caused by climate change. It is unclear to what extent individuals can adjust migration timing or en route rate in response to annual variation in temperature at breeding sites. We tracked the ca. 7300 km spring migration of 52 purple martins Progne subis from the Amazon basin to two breeding sites in eastern North America. Spring 2012 was the warmest on record in eastern North America, but contrary to predictions, this did not result in earlier departure, faster migration, or earlier arrival at breeding areas compared with earlier years. Temperatures and rainfall in the Amazon basin at the time of departure were not higher in 2012, and conditions along migration routes did not give consistent signals of a warmer spring at the breeding site. Once in North America, individuals likely had limited opportunity to speed up their migration because this final portion of the journey was already very rapid ( 570 km/d; 4-5 d in duration). Migration timing over the entire journey was best predicted by breeding latitude and sex and was not sensitive to ecological cues (temperature and rainfall amount) at departure from South American overwintering sites or en route, in contrast to recent studies of other songbirds. Our results provide the first direct evidence for a mismatch between higher spring temperatures at breeding sites and departure schedules of individual songbirds, and suggest phenotypic responses to short-term climatic warming may be limited for some species. Further direct-tracking data with greater geographic and temporal scope is needed to test for individual plasticity in response to temperature and rainfall along migratory routes for this, and other, species.	[Fraser, Kevin C.; Silverio, Cassandra; Kramer, Patrick; Stutchbury, Bridget J. M.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Aeppli, Robert] Purple Martin Conservat Assoc, Erie, PA USA	York University - Canada	Fraser, KC (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	fraserkev@gmail.com			Natural Sciences and Engineering Research Council; National Geographic Society; Silence of the Songbirds (Walker Co.); North American Bluebird Society; Purple Martin Conservation Association	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Geographic Society(National Geographic Society); Silence of the Songbirds (Walker Co.); North American Bluebird Society; Purple Martin Conservation Association	Funding was provided by Natural Sciences and Engineering Research Council, National Geographic Society, proceeds from Silence of the Songbirds (2007, Walker & Co.), North American Bluebird Society, and the Purple Martin Conservation Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola M, 2004, GLOBAL CHANGE BIOL, V10, P1610, DOI 10.1111/j.1365-2486.2004.00823.x; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2010, CURR BIOL, V20, P243, DOI 10.1016/j.cub.2009.11.074; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Fraser KC, 2012, P ROY SOC B-BIOL SCI, V279, P4901, DOI 10.1098/rspb.2012.2207; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Huppop O, 2003, P ROY SOC B-BIOL SCI, V270, P233, DOI 10.1098/rspb.2002.2236; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; MacMynowski DP, 2007, INT J BIOMETEOROL, V51, P361, DOI 10.1007/s00484-006-0084-1; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; McKinnon EA, 2013, NEW DISCOVERIES LAND; Moller AP, 2001, P ROY SOC B-BIOL SCI, V268, P203; Nebel S, 2010, AVIAN CONSERV ECOL, V5; NOAA, 2012, STAT CLIM NAT OV MAY; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Przybylo R, 2000, J ANIM ECOL, V69, P395, DOI 10.1046/j.1365-2656.2000.00401.x; Pulido F, 2001, P ROY SOC B-BIOL SCI, V268, P953, DOI 10.1098/rspb.2001.1602; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robson D, 2011, J ANIM ECOL, V80, P320, DOI 10.1111/j.1365-2656.2010.01772.x; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2008, GLOBAL CHANGE BIOL, V14, P250, DOI 10.1111/j.1365-2486.2007.01488.x; Stanley CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040688; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548	27	27	29	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64587	10.1371/journal.pone.0064587	http://dx.doi.org/10.1371/journal.pone.0064587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741345	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900058
J	Johnstone, K; Wells, RE; Strutt, D; Zeidler, MP				Johnstone, Kirsty; Wells, Richard E.; Strutt, David; Zeidler, Martin P.			Localised JAK/STAT Pathway Activation Is Required for Drosophila Wing Hinge Development	PLOS ONE			English	Article							X-CHROMOSOME; GENE; MELANOGASTER; PROTEIN; EYE; IDENTIFICATION; MUTATIONS; RECEPTOR; ENCODES; PATTERN	Extensive morphogenetic remodelling takes place during metamorphosis from a larval to an adult insect body plan. These changes are particularly intricate in the generation of the dipteran wing hinge, a complex structure that is derived from an apparently simple region of the wing imaginal disc. Using the characterisation of original outstretched alleles of the unpaired locus as a starting point, we demonstrate the role of JAK/STAT pathway signalling in the process of wing hinge development. We show that differences in JAK/STAT signalling within the proximal most of three lateral folds present in the wing imaginal disc is required for fold morphology and the subsequent differentiation of the first and second auxiliary sclerites as well as the posterior notal wing process. Changes in these domains are consistent with the established fate map of the wing disc. We show that outstretched wing posture phenotypes arise from the loss of a region of Unpaired expression in the proximal wing fold and demonstrate that this results in a decrease in JAK/STAT pathway activity. Finally we show that reduction of JAK/STAT pathway activity within the proximal wing fold is sufficient to phenocopy the outstretched phenotype. Taken together, we suggest that localised Unpaired expression and hence JAK/STAT pathway activity, is required for the morphogenesis of the adult wing hinge, providing new insights into the link between signal transduction pathways, patterning and development.	[Zeidler, Martin P.] Univ Sheffield, MRC Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Zeidler, MP (corresponding author), Univ Sheffield, MRC Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England.	m.zeidler@sheffield.ac.uk	Strutt, David/E-6196-2010	Strutt, David/0000-0001-8185-4515; Johnstone, Kirsty/0000-0001-5296-7043; Zeidler, Martin/0000-0003-2942-1135	Cancer Research UK Senior Cancer Research Fellowship	Cancer Research UK Senior Cancer Research Fellowship(Cancer Research UK)	Funding has been provided by a Cancer Research UK Senior Cancer Research Fellowship to MPZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bach EA, 2003, GENETICS, V165, P1149; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; BRYANT PJ, 1975, J EXP ZOOL, V193, P49, DOI 10.1002/jez.1401930106; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; COHEN B, 1993, DEVELOPMENT, V117, P597; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; EBERL DF, 1992, GENETICS, V130, P569; GERGEN JP, 1986, ROUX ARCH DEV BIOL, V195, P49, DOI 10.1007/BF00444041; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Mukherjee T, 2005, ONCOGENE, V24, P2503, DOI 10.1038/sj.onc.1208487; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Muller HJ, 1935, DIS, V3, P29; Resende LP, 2012, CURR OPIN CELL BIOL; Taylor J, 2008, DEV BIOL, V313, P739, DOI 10.1016/j.ydbio.2007.11.009; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Wang YH, 2010, DEV DYNAM, V239, P2522, DOI 10.1002/dvdy.22394; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; Wright VM, 2011, CELL SIGNAL, V23, P920, DOI 10.1016/j.cellsig.2011.01.020; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342	27	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65076	10.1371/journal.pone.0065076	http://dx.doi.org/10.1371/journal.pone.0065076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741461	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000319799900174
J	Kunwar, P; Hawkins, N; Dinges, WL; Liu, Y; Gabriel, EE; Swan, DA; Stevens, CE; Maenza, J; Collier, AC; Mullins, JI; Hertz, T; Yu, XS; Horton, H				Kunwar, Pratima; Hawkins, Natalie; Dinges, Warren L.; Liu, Yi; Gabriel, Erin E.; Swan, David A.; Stevens, Claire E.; Maenza, Janine; Collier, Ann C.; Mullins, James I.; Hertz, Tomer; Yu, Xuesong; Horton, Helen			Superior Control of HIV-1 Replication by CD8+T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; CELLULAR IMMUNE-RESPONSES; LYMPHOCYTE RESPONSES; MAJOR DETERMINANTS; ENHANCED DETECTION; PRIMARY INFECTION; AUTOLOGOUS VIRUS; VIRAL LOAD; TYPE-1	A successful HIV vaccine will likely induce both humoral and cell-mediated immunity, however, the enormous diversity of HIV has hampered the development of a vaccine that effectively elicits both arms of the adaptive immune response. To tackle the problem of viral diversity, T cell-based vaccine approaches have focused on two main strategies (i) increasing the breadth of vaccine-induced responses or (ii) increasing vaccine-induced responses targeting only conserved regions of the virus. The relative extent to which set-point viremia is impacted by epitope-conservation of CD8(+) T cell responses elicited during early HIV-infection is unknown but has important implications for vaccine design. To address this question, we comprehensively mapped HIV-1 CD8(+) T cell epitope-specificities in 23 ART-naive individuals during early infection and computed their conservation score (CS) by three different methods (prevalence, entropy and conseq) on clade-B and group-M sequence alignments. The majority of CD8(+) T cell responses were directed against variable epitopes (p < 0.01). Interestingly, increasing breadth of CD8(+) T cell responses specifically recognizing conserved epitopes was associated with lower set-point viremia (r = -0.65, p = 0.009). Moreover, subjects possessing CD8(+) T cells recognizing at least one conserved epitope had 1.4 log(10) lower set-point viremia compared to those recognizing only variable epitopes (p = 0.021). The association between viral control and the breadth of conserved CD8(+) T cell responses may be influenced by the method of CS definition and sequences used to determine conservation levels. Strikingly, targeting variable versus conserved epitopes was independent of HLA type (p = 0.215). The associations with viral control were independent of functional avidity of CD8(+) T cell responses elicited during early infection. Taken together, these data suggest that the next-generation of T-cell based HIV-1 vaccines should focus on strategies that can elicit CD8(+) T cell responses to multiple conserved epitopes of HIV-1.	[Kunwar, Pratima; Dinges, Warren L.; Horton, Helen] Seattle Biomed Res Inst, Viral Vaccine Program, Seattle, WA 98109 USA; [Hawkins, Natalie; Gabriel, Erin E.; Swan, David A.; Hertz, Tomer; Yu, Xuesong] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV Res & Prevent, Seattle, WA 98104 USA; [Dinges, Warren L.] Polyclin Infect Dis, Seattle, WA USA; [Stevens, Claire E.; Maenza, Janine; Collier, Ann C.; Mullins, James I.; Horton, Helen] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Liu, Yi; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Kunwar, Pratima; Horton, Helen] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Horton, H (corresponding author), Seattle Biomed Res Inst, Viral Vaccine Program, 4 Nickerson St, Seattle, WA 98109 USA.	helen.horton@seattlebiomed.org	Hertz, Tomer/S-5744-2016	Hertz, Tomer/0000-0002-0561-1578; Gabriel, Erin/0000-0002-0504-8404	National Institute of Health [R01 AI090783, P01 AI57005]; University of Washington Center for AIDS Research, an National Institutes of Health (NIH) [P30 AI027757]; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institute of Mental Health; National Institute on Drug Abuse; National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institute on Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI087397, P01AI057005, P30AI027757, R01AI090783] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research, an National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health grants R01 AI090783 and P01 AI57005. This research was supported by the University of Washington Center for AIDS Research, an National Institutes of Health (NIH) funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute, National Institute on Aging). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Alimonti JB, 2006, IMMUNOL CELL BIOL, V84, P482, DOI 10.1111/j.1440-1711.2006.01455.x; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Altfeld M, 2006, TRENDS IMMUNOL, V27, P504, DOI 10.1016/j.it.2006.09.007; Bansal A, 2005, AIDS, V19, P241; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2000, J VIROL, V74, P9144, DOI 10.1128/JVI.74.19.9144-9151.2000; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brambilla D, 1998, J CLIN MICROBIOL, V36, P311, DOI 10.1128/JCM.36.1.311-314.1998; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; CAO J, J VIROL, V77, P6867; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Costa AIF, 2010, AIDS, V24, P211, DOI 10.1097/QAD.0b013e328334442e; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; Draenert R, 2004, J VIROL, V78, P630, DOI 10.1128/JVI.78.2.630-641.2004; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; FUKAZAWA Y, 2012, NAT MED; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Girard MP, 2012, CURR OPIN HIV AIDS, V7, P4, DOI 10.1097/COH.0b013e32834ddc96; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hertz T, 2011, J VIROL, V85, P1310, DOI 10.1128/JVI.01966-10; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Horton H, 2006, J VIROL, V80, P9779, DOI 10.1128/JVI.00794-06; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kern F, 1999, J VIROL, V73, P8179, DOI 10.1128/JVI.73.10.8179-8184.1999; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kristiansen TB, 2001, J IMMUNOL METHODS, V252, P147, DOI 10.1016/S0022-1759(01)00349-0; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Liu Y, 2009, J INFECT DIS, V200, P1825, DOI 10.1086/648401; Malhotra U, 2007, J VIROL, V81, P5225, DOI 10.1128/JVI.02564-06; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Niu LG, 2011, VACCINE, V29, P2110, DOI 10.1016/j.vaccine.2010.12.131; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Penn O, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000214; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Promadej N, 2003, J INFECT DIS, V187, P1053, DOI 10.1086/368127; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rowland-Jones SL, 1999, IMMUNOL LETT, V66, P9, DOI 10.1016/S0165-2478(98)00179-5; Rowland-Jones SL, 2001, IMMUNOL LETT, V79, P15, DOI 10.1016/S0165-2478(01)00261-9; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; Thobakgale CF, 2011, AIDS RES HUM RETROV, V27, P1005, DOI 10.1089/aid.2010.0227; Thomas MC, 2006, ELEMENTS INFORM THEO; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999	77	46	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64405	10.1371/journal.pone.0064405	http://dx.doi.org/10.1371/journal.pone.0064405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741326	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900038
J	Lin, CY; Chang, CH; Fan, PC; Tian, YC; Chang, MY; Jenq, CC; Hung, CC; Fang, JT; Yang, CW; Chen, YC				Lin, Chan-Yu; Chang, Chih-Hsiang; Fan, Pei-Chun; Tian, Ya-Chung; Chang, Ming-Yang; Jenq, Chang-Chyi; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang			Serum Interleukin-18 at Commencement of Renal Replacement Therapy Predicts Short-Term Prognosis in Critically Ill Patients with Acute Kidney Injury	PLOS ONE			English	Article							HOSPITAL MORTALITY; OUTCOME PREDICTION; CYSTATIN-C; SEPSIS; FAILURE; DISEASE; RISK; CARE; CLASSIFICATION; SYSTEM	Background: Acute kidney injury (AKI) requiring renal replacement therapy (RRT) in critically ill patients results in a high hospital mortality. Outcome prediction in this selected high-risk collective is challenging due to the lack of appropriate biomarkers. The aim of this study was to identify outcome-specific biomarkers in this patient population. Methodology/Principal Findings: Serum samples were collected from 101 critically ill patients with AKI at the initiation of RRT in intensive care units (ICUs) of a tertiary care university hospital between August 2008 and March 2011. Measurements of serum levels of cystatin C (CysC), neutrophil gelatinase-associated lipocalin, and interleukin-18 (IL-18) were performed. The primary outcome measure was hospital mortality. The observed overall mortality rate was 56.4% (57/101). Multiple logistic regression analysis indicated that the serum IL-18 and CysC concentrations and Acute Physiology and Chronic Health Evaluation III (ACPACHE III) scores determined on the first day of RRT were independent predictors of hospital mortality. The APACHE III score had the best discriminatory power (0.872 +/- 0.041, p<0.001), whereas serum IL-18 had the best Youden index (0.65) and the highest correctness of prediction (83%). Cumulative survival rates at 6-month follow-up following hospital discharge differed significantly (p<0.001) for serum IL-18 <1786 pg/ml vs. >= 1786 pg/ml in these critically ill patients. Conclusions: In this study, we confirmed the grave prognosis for critically ill patients at the commencement of RRT and found a strong correlation between serum IL-18 and the hospital mortality of ICU patients with dialysis-dependent AKI. In addition, we demonstrated that the APACHE III score has the best discriminative power for predicting hospital mortality in these critically ill patients.	[Lin, Chan-Yu; Chang, Chih-Hsiang; Fan, Pei-Chun; Tian, Ya-Chung; Chang, Ming-Yang; Jenq, Chang-Chyi; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang] Chang Gung Univ Coll Med, Chang Gung Mem Hosp, Dept Nephrol, Kidney Res Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, YC (corresponding author), Chang Gung Univ Coll Med, Chang Gung Mem Hosp, Dept Nephrol, Kidney Res Ctr, Taipei, Taiwan.	cyc2356@adm.cgmh.org.tw	Chang, Jason Chih-Hsiang/P-8662-2017; Chang, Ming-Yang/AGH-5397-2022	Chang, Jason Chih-Hsiang/0000-0002-7342-335X; Chang, Ming-Yang/0000-0001-8899-0376	Chang Gung Medical Research Fund [CMRPG-370591]; Chang Gung Memorial Hospital, Linkou, Taiwan	Chang Gung Medical Research Fund; Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital)	This work was supported by the Chang Gung Medical Research Fund CMRPG-370591, Chang Gung Memorial Hospital, Linkou, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chen TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032328; Chen YC, 2009, SHOCK, V31, P139, DOI 10.1097/SHK.0b013e31817d419e; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Davenport A, 2008, CLIN J AM SOC NEPHRO, V3, P869, DOI 10.2215/CJN.04821107; Fan PC, 2012, AM J MED SCI, V344, P83, DOI 10.1097/MAJ.0b013e3182373d36; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861; Lin CY, 2009, RESPIRATION, V77, P398, DOI 10.1159/000183756; Lin YF, 2009, AM J SURG, V198, P325, DOI 10.1016/j.amjsurg.2008.10.021; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Nejat M, 2010, CRIT CARE, V14, DOI 10.1186/cc9014; Ostermann M, 2009, CRIT CARE, V13, DOI 10.1186/cc8154; Perianayagam MC, 2009, AM J KIDNEY DIS, V54, P1025, DOI 10.1053/j.ajkd.2009.05.022; Ricci Z, 2009, BLOOD PURIFICAT, V27, P127, DOI 10.1159/000167019; Rocha E, 2009, NEPHROL DIAL TRANSPL, V24, P1925, DOI 10.1093/ndt/gfn750; Tiret L, 2005, CIRCULATION, V112, P643, DOI 10.1161/CIRCULATIONAHA.104.519702; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Westhuyzen J, 2006, ANN CLIN LAB SCI, V36, P387; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zimmerman JE, 2008, CURR OPIN CRIT CARE, V14, P491, DOI 10.1097/MCC.0b013e32830864c0	27	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e66028	10.1371/journal.pone.0066028	http://dx.doi.org/10.1371/journal.pone.0066028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741523	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900236
J	Martner, A; Ostman, S; Lundin, S; Rask, C; Bjornsson, V; Telemo, E; Collins, LV; Axelsson, L; Wold, AE				Martner, Anna; Ostman, Sofia; Lundin, Samuel; Rask, Carola; Bjornsson, Viktor; Telemo, Esbjorn; Collins, L. Vincent; Axelsson, Lars; Wold, Agnes E.			Stronger T Cell Immunogenicity of Ovalbumin Expressed Intracellularly in Gram-Negative than in Gram-Positive Bacteria	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INDUCIBLE GENE-EXPRESSION; HUMAN DENDRITIC CELLS; LACTIC-ACID BACTERIA; LACTOBACILLUS-PLANTARUM; CYTOKINE RESPONSES; DIFFERENT PATTERNS; HUMAN MONOCYTES; ANTIGEN; VECTORS	This study aimed to clarify whether Gram-positive (G+) and Gram-negative (G-) bacteria affect antigen-presenting cells differently and thereby influence the immunogenicity of proteins they express. Lactobacilli, lactococci and Escherichia coli strains were transformed with plasmids conferring intracellular ovalbumin (OVA) production. Murine splenic antigen presenting cells (APCs) were pulsed with washed and UV-inactivated OVA-producing bacteria, control bacteria, or soluble OVA. The ability of the APCs to activate OVA-specific DO11.10 CD4(+) T cells was assessed by measurments of T cell proliferation and cytokine (IFN-gamma, IL-13, IL-17, IL-10) production. OVA expressed within E. coli was strongly immunogenic, since 500 times higher concentrations of soluble OVA were needed to achieve a similar level of OVA-specific T cell proliferation. Furthermore, T cells responding to soluble OVA produced mainly IL-13, while T cells responding to E. coli-expressed OVA produced high levels of both IFN-gamma and IL-13. Compared to E. coli, G+ lactobacilli and lactococci were poor inducers of OVA-specific T cell proliferation and cytokine production, despite efficient intracellular expression and production of OVA and despite being efficiently phagocytosed. These results demonstrate a pronounced difference in immunogenicity of intracellular antigens in G+ and G- bacteria and may be relevant for the use of bacterial carriers in vaccine development.	[Martner, Anna; Ostman, Sofia; Rask, Carola; Bjornsson, Viktor; Wold, Agnes E.] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Lundin, Samuel] Univ Gothenburg, Dept Med Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden; [Telemo, Esbjorn; Collins, L. Vincent] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Inst Med, Gothenburg, Sweden; [Axelsson, Lars] Nofima Norwegian Inst Food Fisheries & Aquacultur, As, Norway	University of Gothenburg; University of Gothenburg; University of Gothenburg; Nofima	Martner, A (corresponding author), Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden.	anna.martner@microbio.gu.se		Martner, Anna/0000-0002-6598-5221; Wold, Agnes/0000-0001-9196-5040	European Commission (IMMUNOBIOTA project of the Marie Curie Transfer of Knowledge program); Swedish MRC [K200-06GX-14072-01]; Medical Faculty of Gothenburg [ALFGBG-11006]; Martina Wilhelm and Lundgren Foundation; Torsten and Ragnar Soderberg Foundation	European Commission (IMMUNOBIOTA project of the Marie Curie Transfer of Knowledge program); Swedish MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Faculty of Gothenburg; Martina Wilhelm and Lundgren Foundation; Torsten and Ragnar Soderberg Foundation	This study was supported by grants from the European Commission (IMMUNOBIOTA project of the Marie Curie Transfer of Knowledge program), the Swedish MRC (K200-06GX-14072-01), the Medical Faculty of Gothenburg (ALFGBG-11006), the Martina Wilhelm and Lundgren Foundation, and the Torsten and Ragnar Soderberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurkust TaH, 1992, FOOD RES INT, V25, P253; Barkman C, 2008, MICROBES INFECT, V10, P1484, DOI 10.1016/j.micinf.2008.08.011; Boele LCL, 2009, CELL IMMUNOL, V255, P17, DOI 10.1016/j.cellimm.2008.09.002; CATTERALL JF, 1978, NATURE, V275, P510, DOI 10.1038/275510a0; Chiba Y, 2010, IMMUNOLOGY, V130, P352, DOI 10.1111/j.1365-2567.2009.03204.x; CROWLEY M, 1990, J EXP MED, V172, P383, DOI 10.1084/jem.172.1.383; DAHLGREN UIH, 1991, IMMUNOLOGY, V73, P394; de Veer M, 2010, VACCINE, V28, P6597, DOI 10.1016/j.vaccine.2010.07.056; GASSON MJ, 1983, J BACTERIOL, V154, P1; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Hessle C, 2000, INFECT IMMUN, V68, P3581, DOI 10.1128/IAI.68.6.3581-3586.2000; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; Hessle CC, 2003, INFLAMMATION, V27, P329, DOI 10.1023/B:IFLA.0000006700.41614.21; Karlsson H, 2004, INFECT IMMUN, V72, P2671, DOI 10.1128/IAI.72.5.2671-2678.2004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; MERCEREAUPUIJALON O, 1978, NATURE, V275, P505, DOI 10.1038/275505a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nayak JV, 2006, J IMMUNOL, V177, P8493, DOI 10.4049/jimmunol.177.12.8493; PALIARD X, 1988, J IMMUNOL, V141, P849; Perez-Arellano I, 2001, PLASMID, V46, P106, DOI 10.1006/plas.2001.1531; Rud I, 2006, MICROBIOL-SGM, V152, P1011, DOI 10.1099/mic.0.28599-0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHILLINGER U, 1989, APPL ENVIRON MICROB, V55, P1901, DOI 10.1128/AEM.55.8.1901-1906.1989; Seledtsov VI, 2012, IMMUNOBIOLOGY, V217, P430, DOI 10.1016/j.imbio.2011.10.011; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Skovbjerg S, 2010, J INTERF CYTOK RES, V30, P23, DOI 10.1089/jir.2009.0033; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Sorvig E, 2005, MICROBIOL-SGM, V151, P2439, DOI 10.1099/mic.0.28084-0; Sorvig E, 2003, FEMS MICROBIOL LETT, V229, P119, DOI 10.1016/S0378-1097(03)00798-5; VANDEGUCHTE M, 1991, MOL GEN GENET, V227, P65, DOI 10.1007/BF00260708; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006	32	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65124	10.1371/journal.pone.0065124	http://dx.doi.org/10.1371/journal.pone.0065124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741469	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900182
J	Merlet, N; Piriou, N; Rozec, B; Grabherr, A; Lauzier, B; Trochu, JN; Gauthier, C				Merlet, Nolwenn; Piriou, Nicolas; Rozec, Bertrand; Grabherr, Amandine; Lauzier, Benjamin; Trochu, Jean-Noel; Gauthier, Chantal			Increased Beta2-Adrenoceptors in Doxorubicin-Induced Cardiomyopathy in Rat	PLOS ONE			English	Article							ADRIAMYCIN-INDUCED CARDIOMYOPATHY; SPRAGUE-DAWLEY; HEART-FAILURE; CELL-DEATH; FOLLOW-UP; IN-VITRO; ANTHRACYCLINE; ECHOCARDIOGRAPHY; DYSFUNCTION; MODEL	Background: The toxicity of doxorubicin, leading to an irreversible heart failure, limits its use as chemotherapeutic agent. The beneficial effects of early administration of beta-blocker were reported in patients with heart failure due to doxorubicin, suggesting an important role of beta-adrenoceptors (beta-ARs). This study aimed to identify a putative target (beta-AR and/or its effectors) at the early phase of a chronic doxorubicin-induced cardiomyopathy (Dox-CM) in a rat model. Methodology: Dox-CM was induced by six doxorubicin injections (cumulative dose: 15 mg.kg(-1)) and validated by echocardiography and left ventricle (LV) catheterization. The beta-AR protein expressions in LV were evaluated by western-blot at days 35 (d35) and 70 (d70) after the first doxorubicin injection. Ex vivo cardiac contractility (dP/dt(max), dP/dt(min)) was evaluated on isolated heart in response to specific beta-AR stimulations at d35. Results: At d35, Dox-CM hearts were characterized by mild LV systolic and diastolic dysfunctions, which were exacerbated at d70. In Dox-CM hearts, beta(3)-AR expression was only decreased at d70 (-37+/-8%). At d35, beta(1)-AR expression was decreased by 68+/-6%, but ex vivo beta(1)-AR function was preserved due to, at least in part, an increased adenylyl cyclase response assessed by forskolin. beta(2)-AR expression was increased both at d35 (+58+/-22%) and d70 (+174+/-35%), with an increase of ex vivo beta(2)-AR response at d35. Inhibition of Gi protein with pertussis toxin did not affect beta(2)-AR response in Dox-CM hearts, suggesting a decoupling of beta(2)-AR to Gi protein. Conclusion: This study highlights the beta(1)/beta(2)-AR imbalance in early Dox-CM and reveals the important role that beta(2)-AR/Gi coupling could play in this pathology. Our results suggest that beta(2)-AR could be an interesting target at early stage of DoxCM.	[Merlet, Nolwenn; Piriou, Nicolas; Rozec, Bertrand; Grabherr, Amandine; Lauzier, Benjamin; Trochu, Jean-Noel; Gauthier, Chantal] CNRS, UMR 6291, Unite Inserm UMR 1087, Inst Thorax, Nantes, France; [Merlet, Nolwenn; Lauzier, Benjamin; Trochu, Jean-Noel; Gauthier, Chantal] Univ Nantes, Nantes, France; [Piriou, Nicolas; Trochu, Jean-Noel] CHU Nantes, Inst Thorax, F-44035 Nantes 01, France; [Rozec, Bertrand] CHU Nantes, Dept Anaesthesiol, F-44035 Nantes 01, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Gauthier, C (corresponding author), CNRS, UMR 6291, Unite Inserm UMR 1087, Inst Thorax, Nantes, France.	chantal.gauthier@univ-nantes.fr	Lauzier, Benjamin/D-3570-2015; Lauzier, Benjamin/GSI-5091-2022; Trochu, Jean-Noel/D-6378-2015; Piriou, Nicolas/D-9154-2015; Rozec, Bertrand/AAA-8152-2021; Grabherr, Amandine/D-6563-2015; Gauthier, Chantal/D-6198-2015; Rozec, Bertrand/D-3542-2015; Nicolas, Piriou/CAH-2512-2022	Lauzier, Benjamin/0000-0002-1370-6155; Piriou, Nicolas/0000-0002-6677-6552; Nicolas, Piriou/0000-0002-6677-6552; Rozec, Bertrand/0000-0002-2226-3982	Association Francaise contre les Myopathies; Federation Francaise de Cardiologie; Fondation de France; Fondation Genavie	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Federation Francaise de Cardiologie; Fondation de France(Fondation de France); Fondation Genavie	This work was supported by the "Association Francaise contre les Myopathies", the "Federation Francaise de Cardiologie", the "Fondation de France" and the "Fondation Genavie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmet I, 2004, CIRCULATION, V110, P1083, DOI 10.1161/01.CIR.0000139844.15045.F9; Ahmet I, 2009, J PHARMACOL EXP THER, V331, P178, DOI 10.1124/jpet.109.157107; Ahmet I, 2008, J PHARMACOL EXP THER, V325, P491, DOI 10.1124/jpet.107.135335; Bernstein D, 2005, AM J PHYSIOL-HEART C, V289, pH2441, DOI 10.1152/ajpheart.00005.2005; Bian JS, 1998, J MOL CELL CARDIOL, V30, P2103, DOI 10.1006/jmcc.1998.0774; Brouwer CAJ, 2006, ANN ONCOL, V17, P1586, DOI 10.1093/annonc/mdl156; CALDERONE A, 1991, J MOL CELL CARDIOL, V23, P333, DOI 10.1016/0022-2828(91)90069-X; Cardinale D, 2010, J AM COLL CARDIOL, V55, P213, DOI 10.1016/j.jacc.2009.03.095; Chakir K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001909; Chakir K, 2009, CIRCULATION, V119, P1231, DOI 10.1161/CIRCULATIONAHA.108.774752; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Connors JM, 2005, J CLIN ONCOL, V23, P6400, DOI 10.1200/JCO.2005.05.016; Danelisen I, 2002, J MOL CELL CARDIOL, V34, P789, DOI 10.1006/jmcc.2002.2015; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; Dery AS, 2011, AM J HEALTH-SYST PH, V68, P879, DOI 10.2146/ajhp100309; Dhein S, 2006, J CARDIOTHORAC SURG, V1, DOI 10.1186/1749-8090-1-17; Fajardo G, 2006, J MOL CELL CARDIOL, V40, P375, DOI 10.1016/j.yjmcc.2005.12.004; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; FU LX, 1991, BASIC RES CARDIOL, V86, P117, DOI 10.1007/BF02190544; Georgakopoulos P, 2010, AM J HEMATOL, V85, P894, DOI 10.1002/ajh.21840; Ghibu S, 2012, BIOCHIMIE, V94, P932, DOI 10.1016/j.biochi.2011.02.015; Grimer Robert, 2010, Sarcoma, V2010, P1, DOI 10.1155/2010/506182; Ho E, 2010, HEART, V96, P701, DOI 10.1136/hrt.2009.173997; Iliskovic N, 1997, AM J PATHOL, V150, P727; Iliskovic N, 1997, MOL CELL BIOCHEM, V176, P235, DOI 10.1023/A:1006805229758; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Kalay N, 2006, J AM COLL CARDIOL, V48, P2258, DOI 10.1016/j.jacc.2006.07.052; Kaya MG, 2012, INT J CARDIOL; Kenk M, 2010, J NUCL CARDIOL, V17, P254, DOI 10.1007/s12350-009-9190-x; Kishida T, 2008, J TOXICOL SCI, V33, P447, DOI 10.2131/jts.33.447; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; Liu J, 2009, METHODS MOL BIOL, V573, P139, DOI 10.1007/978-1-60761-247-6_8; Lou H, 2004, J MOL CELL CARDIOL, V36, P683, DOI 10.1016/j.yjmcc.2004.03.004; Morishima I, 1998, LIFE SCI, V63, P511, DOI 10.1016/S0024-3205(98)00302-6; MULVAGH S, 1992, J AM COLL CARDIOL, V20, P112, DOI 10.1016/0735-1097(92)90146-E; Nagami K, 1997, JPN CIRC J, V61, P249, DOI 10.1253/jcj.61.249; Nagy AC, 2008, PATHOL ONCOL RES, V14, P69, DOI 10.1007/s12253-008-9013-4; Nakamura T, 2000, CIRCULATION, V102, P572; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Pavoine C, 2005, CELL SIGNAL, V17, P141, DOI 10.1016/j.cellsig.2004.09.001; Popovic ZB, 2007, AM J PHYSIOL-HEART C, V292, pH2809, DOI 10.1152/ajpheart.01176.2006; Rautureau Y, 2002, BRIT J PHARMACOL, V137, P153, DOI 10.1038/sj.bjp.0704867; Rozec B, 2009, J AM COLL CARDIOL, V53, P1532, DOI 10.1016/j.jacc.2008.11.057; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Senba M, 2011, ACTA VIROL, V55, P161, DOI 10.4149/av_2011_02_161; STEINHERZ LJ, 1991, JAMA-J AM MED ASSOC, V266, P1672, DOI 10.1001/jama.266.12.1672; STODDARD MF, 1992, J AM COLL CARDIOL, V20, P62, DOI 10.1016/0735-1097(92)90138-D; Sun JF, 2011, GEN COMP ENDOCR, V172, P518, DOI 10.1016/j.ygcen.2011.04.019; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Tassan-Mangina S, 2006, EUR J ECHOCARDIOGR, V7, P141, DOI 10.1016/j.euje.2005.04.009; TONG J, 1991, AM J PHYSIOL, V260, pH909, DOI 10.1152/ajpheart.1991.260.3.H909; Ueno M, 2006, J PHARMACOL SCI, V101, P151, DOI 10.1254/jphs.FP0050980; Xiao RP, 2006, TRENDS PHARMACOL SCI, V27, P330, DOI 10.1016/j.tips.2006.04.009; Zhu WZ, 2012, CIRC RES, V110, P265, DOI 10.1161/CIRCRESAHA.111.253260; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	55	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64711	10.1371/journal.pone.0064711	http://dx.doi.org/10.1371/journal.pone.0064711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741376	gold, Green Published			2022-12-27	WOS:000319799900089
J	Meybohm, P; Renner, J; Broch, O; Caliebe, D; Albrecht, M; Cremer, J; Haake, N; Scholz, J; Zacharowski, K; Bein, B				Meybohm, Patrick; Renner, Jochen; Broch, Ole; Caliebe, Dorothee; Albrecht, Martin; Cremer, Jochen; Haake, Nils; Scholz, Jens; Zacharowski, Kai; Bein, Berthold			Postoperative Neurocognitive Dysfunction in Patients Undergoing Cardiac Surgery after Remote Ischemic Preconditioning: A Double-Blind Randomized Controlled Pilot Study	PLOS ONE			English	Article							COGNITIVE DYSFUNCTION; REPERFUSION INJURY; PROTECTION; BYPASS; HEART; STATEMENT; OUTCOMES; HUMANS; TRIAL	Background: Remote ischemic preconditioning (RIPC) has been shown to enhance the tolerance of remote organs to cope with a subsequent ischemic event. We hypothesized that RIPC reduces postoperative neurocognitive dysfunction (POCD) in patients undergoing complex cardiac surgery. Methods: We conducted a prospective, randomized, double-blind, controlled trial including 180 adult patients undergoing elective cardiac surgery with cardiopulmonary bypass. Patients were randomized either to RIPC or to control group. Primary endpoint was postoperative neurocognitive dysfunction 5-7 days after surgery assessed by a comprehensive test battery. Cognitive change was assumed if the preoperative to postoperative difference in 2 or more tasks assessing different cognitive domains exceeded more than one SD (1 SD criterion) or if the combined Z score was 1.96 or greater (Z score criterion). Results: According to 1 SD criterion, 52% of control and 46% of RIPC patients had cognitive deterioration 5-7 days after surgery (p = 0.753). The summarized Z score showed a trend to more cognitive decline in the control group (2.16+/-5.30) compared to the RIPC group (1.14+/-4.02; p = 0.228). Three months after surgery, incidence and severity of neurocognitive dysfunction did not differ between control and RIPC. RIPC tended to decrease postoperative troponin T release at both 12 hours [0.60 (0.19-1.94) mg/L vs. 0.48 (0.07-1.84) mg/L] and 24 hours after surgery [0.36 (0.14-1.89) mg/L vs. 0.26 (0.07-0.90) mg/L]. Conclusions: We failed to demonstrate efficacy of a RIPC protocol with respect to incidence and severity of POCD and secondary outcome variables in patients undergoing a wide range of cardiac surgery. Therefore, definitive large-scale multicenter trials are needed.	[Meybohm, Patrick; Zacharowski, Kai] Univ Hosp Frankfurt, Clin Anaesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Meybohm, Patrick; Renner, Jochen; Broch, Ole; Caliebe, Dorothee; Albrecht, Martin; Scholz, Jens; Bein, Berthold] Univ Hosp Schleswig Holstein, Dept Anaesthesiol & Intens Care Med, Kiel, Germany; [Cremer, Jochen; Haake, Nils] Univ Hosp Schleswig Holstein, Dept Cardiovasc Surg, Kiel, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Meybohm, P (corresponding author), Univ Hosp Frankfurt, Clin Anaesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany.	patrick.meybohm@kgu.de	Albrecht, Martin/AAW-9303-2021; Meybohm, Patrick/K-4066-2017	Albrecht, Martin/0000-0003-2580-768X; Meybohm, Patrick/0000-0002-2666-8696	University of Kiel; International Anesthesia Research Society; German Society of Anesthesiology and Intensive Care Medicine	University of Kiel; International Anesthesia Research Society; German Society of Anesthesiology and Intensive Care Medicine	The study is funded by a junior research funding award of the University of Kiel (PM), a Clinical Scholar Research Award of the International Anesthesia Research Society (PM), and a Clinical Research Grant of the German Society of Anesthesiology and Intensive Care Medicine (PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0314-0; Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; Er F, 2012, CIRCULATION, V126, P296, DOI 10.1161/CIRCULATIONAHA.112.096370; Fudickar A, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-7; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Gunaydin B, 2000, PHARMACOL RES, V41, P493, DOI 10.1006/phrs.1999.0611; Hahn CD, 2011, STROKE, V42, P2960, DOI 10.1161/STROKEAHA.111.622340; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hocker J, 2009, ANESTHESIOLOGY, V110, P1068, DOI 10.1097/ALN.0b013e31819dad92; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Hudetz JA, 2009, ACTA ANAESTH SCAND, V53, P864, DOI 10.1111/j.1399-6576.2009.01978.x; Kloner RA, 2009, CIRCULATION, V119, P776, DOI 10.1161/CIRCULATIONAHA.108.832832; Koch S, 2011, STROKE, V42, P1387, DOI 10.1161/STROKEAHA.110.605840; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Lange M, 2009, ANESTHESIOLOGY, V110, P516, DOI 10.1097/ALN.0b013e318197ff62; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Loukogeorgakis SP, 2007, CIRCULATION, V116, P1386, DOI 10.1161/CIRCULATIONAHA.106.653782; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Meybohm P, 2012, EUR HEART J, V33, P1423; Moskowitz MA, 2011, CIRCULATION, V123, P709, DOI 10.1161/CIRCULATIONAHA.110.009688; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; Presta P, 2011, INT UROL NEPHROL, V43, P601, DOI 10.1007/s11255-011-9956-3; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rahman I, 2009, HEART, V95, P1553, DOI 10.1136/hrt.2008.159988; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Rasmussen LS, 2004, ACTA ANAESTH SCAND, V48, P1137, DOI 10.1111/j.1399-6576.2004.00502.x; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Rudolph JL, 2010, ACTA ANAESTH SCAND, V54, P663, DOI 10.1111/j.1399-6576.2010.02236.x; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Tropak MB, 2011, J THORAC CARDIOV SUR, V142, P233, DOI 10.1016/j.jtcvs.2011.04.003; Walsh SR, 2010, VASC ENDOVASC SURG, V44, P434, DOI 10.1177/1538574410369709; Young PJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0256-6; Zhao HG, 2007, NEUROCHEM RES, V32, P1919, DOI 10.1007/s11064-007-9381-2; ZHOU C, 2012, J CARDIOTHORAC VASC; Zitta K, 2012, MOL MED, V18, P29, DOI 10.2119/molmed.2011.00278	42	59	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64743	10.1371/journal.pone.0064743	http://dx.doi.org/10.1371/journal.pone.0064743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741380	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900093
J	Rivera, P; Perez-Martin, M; Pavon, FJ; Serrano, A; Crespillo, A; Cifuentes, M; Lopez-Avalos, MD; Grondona, JM; Vida, M; Fernandez-Llebrez, P; de Fonseca, FR; Suarez, J				Rivera, Patricia; Perez-Martin, Margarita; Pavon, Francisco J.; Serrano, Antonia; Crespillo, Ana; Cifuentes, Manuel; Lopez-Avalos, Maria-Dolores; Grondona, Jesus M.; Vida, Margarita; Fernandez-Llebrez, Pedro; Rodriguez de Fonseca, Fernando; Suarez, Juan			Pharmacological Administration of the Isoflavone Daidzein Enhances Cell Proliferation and Reduces High Fat Diet-Induced Apoptosis and Gliosis in the Rat Hippocampus	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DENTATE GYRUS; SOY PROTEIN; METABOLIC SYNDROME; ESTRADIOL; NEUROGENESIS; PHYTOESTROGENS; EXPRESSION; GENISTEIN; OBESITY	Soy extracts have been claimed to be neuroprotective against brain insults, an effect related to the estrogenic properties of isoflavones. However, the effects of individual isoflavones on obesity-induced disruption of adult neurogenesis have not yet been analyzed. In the present study we explore the effects of pharmacological administration of daidzein, a main soy isoflavone, in cell proliferation, cell apoptosis and gliosis in the adult hippocampus of animals exposed to a very high-fat diet. Rats made obese after 12-week exposure to a standard or high-fat (HFD, 60%) diets were treated with daidzein (50 mg kg(-1)) for 13 days. Then, plasma levels of metabolites and metabolic hormones, cell proliferation in the subgranular zone of the dentate gyrus (SGZ), and immunohistochemical markers of hippocampal cell apoptosis (caspase-3), gliosis (GFAP and Iba-1), food reward factor FosB and estrogen receptor alpha (ER alpha) were analyzed. Treatment with daidzein reduced food/caloric intake and body weight gain in obese rats. This was associated with glucose tolerance, low levels of HDL-cholesterol, insulin, adiponectin and testosterone, and high levels of leptin and 17 beta-estradiol. Daidzein increased the number of phospho-histone H3 and 5-bromo-2-deoxyuridine (BrdU)-ir cells detected in the SGZ of standard diet and HFD-fed rats. Daidzein reversed the HFD-associated enhanced immunohistochemical expression of caspase-3, FosB, GFAP, Iba-1 and ER alpha in the hippocampus, being more prominent in the dentate gyrus. These results suggest that pharmacological treatment with isoflavones regulates metabolic alterations associated with enhancement of cell proliferation and reduction of apoptosis and gliosis in response to high-fat diet.	[Rivera, Patricia; Pavon, Francisco J.; Serrano, Antonia; Crespillo, Ana; Vida, Margarita; Rodriguez de Fonseca, Fernando; Suarez, Juan] Complejo Hosp Malaga, Hosp Carlos Haya, Inst Invest Biomed IBIMA, Lab Med Regenerat UGC Salud Mental, Malaga, Spain; [Rivera, Patricia; Pavon, Francisco J.; Serrano, Antonia; Crespillo, Ana; Vida, Margarita; Rodriguez de Fonseca, Fernando; Suarez, Juan] Minist Ciencia & Innovac, Inst Salud Carlos III, CIBER OBN, Madrid, Spain; [Perez-Martin, Margarita; Cifuentes, Manuel; Lopez-Avalos, Maria-Dolores; Grondona, Jesus M.; Fernandez-Llebrez, Pedro] Univ Malaga, Fac Ciencias, Dept Biol Celular Genet & Fisiol, E-29071 Malaga, Spain; [Cifuentes, Manuel] Minist Ciencia & Innovac, Inst Salud Carlos III, CIBER BBN, Madrid, Spain	Hospital Carlos Haya; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III	de Fonseca, FR (corresponding author), Complejo Hosp Malaga, Hosp Carlos Haya, Inst Invest Biomed IBIMA, Lab Med Regenerat UGC Salud Mental, Malaga, Spain.	fernando.rodriguez@fundacionimabis.org; juan.suarez@fundacionimabis.org	Martin, Margarita Perez/L-1556-2017; Lopez-Avalos, Maria D./AAS-5327-2021; Martin, Margarita Perez/AAS-9326-2021; Grondona, Jesus M./F-1650-2011; Cifuentes, Manuel/I-6922-2018; Pavón Morón, Francisco Javier/AAG-9721-2020; Suarez, Juan/I-5188-2015; Fernandez-Llebrez del Rey, Pedro/H-6007-2015	Martin, Margarita Perez/0000-0001-8791-3862; Martin, Margarita Perez/0000-0001-8791-3862; Grondona, Jesus M./0000-0003-1781-1486; Cifuentes, Manuel/0000-0003-1414-469X; Pavón Morón, Francisco Javier/0000-0002-5256-8904; Suarez, Juan/0000-0001-5254-9802; Lopez Avalos, Maria de los Dolores/0000-0002-9022-2381; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Serrano, Antonia/0000-0002-8017-9754; Fernandez-Llebrez del Rey, Pedro/0000-0003-1409-5816; Rivera, Patricia/0000-0002-0478-6667	7th Framework Programme of European Union [REPROBESITY] [HEALTH-F2-2008-223713]; Ministerio de Ciencia e Innovacion [SAF2010-19087, SAF 2010-20521]; Instituto de Salud Carlos III del Ministerio de Ciencia e Innovacion, UE-ERDF, Red de Trastornos Adictivos [RD06/0001/0000]; Instituto de Salud Carlos III del Ministerio de Ciencia e Innovacion, UE-ERDF, CIBERobn; Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia, UE/ERDF [CTS-433, P07-CVI-03079, P-11-CVI-07637]; Consejeria de salud de la Junta de Andalucia [PI0232/2008, PI0029/2008]; National System of Health (Instituto de Salud Carlos III) [CP12/03109]	7th Framework Programme of European Union [REPROBESITY]; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III del Ministerio de Ciencia e Innovacion, UE-ERDF, Red de Trastornos Adictivos; Instituto de Salud Carlos III del Ministerio de Ciencia e Innovacion, UE-ERDF, CIBERobn; Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia, UE/ERDF; Consejeria de salud de la Junta de Andalucia(Junta de Andalucia); National System of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos III)	This work is supported by 7th Framework Programme of European Union [grant number HEALTH-F2-2008-223713, REPROBESITY]; Ministerio de Ciencia e Innovacion [grant numbers SAF2010-19087 and SAF 2010-20521]; Instituto de Salud Carlos III del Ministerio de Ciencia e Innovacion, UE-ERDF, Red de Trastornos Adictivos [grant number RD06/0001/0000]; Instituto de Salud Carlos III del Ministerio de Ciencia e Innovacion, UE-ERDF, CIBERobn; Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia, UE/ERDF [grant number CTS-433, P07-CVI-03079 and P-11-CVI-07637]; Consejeria de salud de la Junta de Andalucia [grant numbers PI0232/2008 and PI0029/2008]. JS is recipient of a "Miguel Servet" research contract from the National System of Health (Instituto de Salud Carlos III, grant number CP12/03109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Amateau SK, 2004, ENDOCRINOLOGY, V145, P2906, DOI 10.1210/en.2003-1363; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Azcoitia I, 2011, TRENDS ENDOCRIN MET, V22, P467, DOI 10.1016/j.tem.2011.08.002; Bagheri M, 2012, BRAIN RES, V1429, P145, DOI 10.1016/j.brainres.2011.10.020; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191; Cifuentes M, 2011, J NEUROSCI METH, V201, P307, DOI 10.1016/j.jneumeth.2011.08.006; Crespillo A, 2011, BRIT J PHARMACOL, V164, P1899, DOI 10.1111/j.1476-5381.2011.01477.x; Davis J, 2007, ANN NUTR METAB, V51, P42, DOI 10.1159/000100820; Demonty I, 2002, J NUTR BIOCHEM, V13, P671, DOI 10.1016/S0955-2863(02)00214-0; Saraceno GE, 2010, EXP NEUROL, V223, P615, DOI 10.1016/j.expneurol.2010.02.010; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Guo YQ, 2009, NUTR RES, V29, P656, DOI 10.1016/j.nutres.2009.09.005; Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x; Heyer A, 2005, J CEREBR BLOOD F MET, V25, P427, DOI 10.1038/sj.jcbfm.9600056; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hwang IK, 2008, BRAIN RES, V1241, P1, DOI 10.1016/j.brainres.2008.08.024; Kordower JH, 2010, EXP NEUROL, V224, P252, DOI 10.1016/j.expneurol.2010.03.027; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Li J, 2011, J CEREBR BLOOD F MET, V31, P413, DOI 10.1038/jcbfm.2010.181; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Little JP, 2012, J ALZHEIMERS DIS, V30, pS179, DOI 10.3233/JAD-2011-111262; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Mao Z, 2007, MOLECULES, V12, P1455, DOI 10.3390/12071455; Martinez-Cerdeno V, 2006, EUR J NEUROSCI, V24, P3475, DOI 10.1111/j.1460-9568.2006.05239.x; Mazzucco CA, 2006, NEUROSCIENCE, V141, P1793, DOI 10.1016/j.neuroscience.2006.05.032; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Morley JE, 2004, J GERONTOL A-BIOL, V59, P139; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; Nerurkar PV, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-64; Orgaard A, 2008, EXP BIOL MED, V233, P1066, DOI 10.3181/0712-MR-347; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perez-Martin M, 2005, EXP GERONTOL, V40, P450, DOI 10.1016/j.exger.2005.03.003; Perez-Martin M, 2003, EUR J NEUROSCI, V18, P923, DOI 10.1046/j.1460-9568.2003.02830.x; Prange-Kiel J, 2003, HIPPOCAMPUS, V13, P226, DOI 10.1002/hipo.10075; Prange-Kiel J, 2008, J CELL BIOL, V180, P417, DOI 10.1083/jcb.200707043; Richter DU, 2009, GYNECOL ENDOCRINOL, V25, P32, DOI 10.1080/09513590802485020; Rivera P, 2011, EUR J NEUROSCI, V33, P1577, DOI 10.1111/j.1460-9568.2011.07650.x; Schreihofer DA, 2009, NEUROSCIENCE, V158, P602, DOI 10.1016/j.neuroscience.2008.10.003; Sosic-Jurjevic B, 2007, EXP BIOL MED, V232, P1222, DOI 10.3181/0703-BC-82; Stangl D, 2009, GENES NUTR, V4, P271, DOI 10.1007/s12263-009-0134-5; Strandberg J, 2008, NEUROREPORT, V19, P1235, DOI 10.1097/WNR.0b013e32830a7109; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Teegarden SL, 2008, BIOL PSYCHIAT, V64, P941, DOI 10.1016/j.biopsych.2008.06.007; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Walker CD, 2008, ANN NY ACAD SCI, V1144, P189, DOI 10.1196/annals.1418.023; Wang P, 2008, BIOCHEM BIOPH RES CO, V366, P393, DOI 10.1016/j.bbrc.2007.11.147; Weigt C, 2012, MOL CELL ENDOCRINOL, V351, P227, DOI 10.1016/j.mce.2011.12.013; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Yu CJ, 2010, BEHAV PHARMACOL, V21, P283, DOI 10.1097/FBP.0b013e32833aec1a; Zhan SY, 2005, AM J CLIN NUTR, V81, P397; Zhao LX, 2002, EXP BIOL MED, V227, P509, DOI 10.1177/153537020222700716; Zhu BT, 2006, ENDOCRINOLOGY, V147, P4132, DOI 10.1210/en.2006-0113	56	49	50	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64750	10.1371/journal.pone.0064750	http://dx.doi.org/10.1371/journal.pone.0064750			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741384	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900097
J	Song, Y; Ahn, J; Suh, Y; Davis, ME; Lee, K				Song, Yan; Ahn, Jinsoo; Suh, Yeunsu; Davis, Michael E.; Lee, Kichoon			Identification of Novel Tissue-Specific Genes by Analysis of Microarray Databases: A Human and Mouse Model	PLOS ONE			English	Article							TRANSCRIPTS ENCODING MEMBRANE; ORGANIC ANION TRANSPORTER; RYANODINE RECEPTOR GENE; FAT-SPECIFIC PROTEIN-27; MOLECULAR-CLONING; CELL-DEATH; DIACYLGLYCEROL ACYLTRANSFERASE; ADIPOSE-TISSUE; KLOTHO GENE; ACYL-COA	Understanding the tissue-specific pattern of gene expression is critical in elucidating the molecular mechanisms of tissue development, gene function, and transcriptional regulations of biological processes. Although tissue-specific gene expression information is available in several databases, follow-up strategies to integrate and use these data are limited. The objective of the current study was to identify and evaluate novel tissue-specific genes in human and mouse tissues by performing comparative microarray database analysis and semi-quantitative PCR analysis. We developed a powerful approach to predict tissue-specific genes by analyzing existing microarray data from the NCBI's Gene Expression Omnibus (GEO) public repository. We investigated and confirmed tissue-specific gene expression in the human and mouse kidney, liver, lung, heart, muscle, and adipose tissue. Applying our novel comparative microarray approach, we confirmed 10 kidney, 11 liver, 11 lung, 11 heart, 8 muscle, and 8 adipose specific genes. The accuracy of this approach was further verified by employing semi-quantitative PCR reaction and by searching for gene function information in existing publications. Three novel tissue-specific genes were discovered by this approach including AMDHD1 (amidohydrolase domain containing 1) in the liver, PRUNE2 (prune homolog 2) in the heart, and ACVR1C (activin A receptor, type IC) in adipose tissue. We further confirmed the tissue-specific expression of these 3 novel genes by real-time PCR. Among them, ACVR1C is adipose tissue-specific and adipocyte-specific in adipose tissue, and can be used as an adipocyte developmental marker. From GEO profiles, we predicted the processes in which AMDHD1 and PRUNE2 may participate. Our approach provides a novel way to identify new sets of tissue-specific genes and to predict functions in which they may be involved.	[Song, Yan; Ahn, Jinsoo; Suh, Yeunsu; Davis, Michael E.; Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Ahn, Jinsoo; Lee, Kichoon] Ohio State Univ, Interdisciplinary PhD Program Nutr OSUN, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lee, K (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	Lee.2626@osu.edu	Davis, Michael/K-6300-2012	Davis, Mike/0000-0001-7666-4856	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2010-65206-20716]	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive grant number 2010-65206-20716 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2008, AM J PHYSIOL-RENAL, V295, pF165, DOI 10.1152/ajprenal.90257.2008; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Assie G, 2010, TRENDS ENDOCRIN MET, V21, P325, DOI 10.1016/j.tem.2009.12.009; Barrett T, 2007, NUCL ACIDS RES, V35; Bi S, 1997, J BIOL CHEM, V272, P30583, DOI 10.1074/jbc.272.48.30583; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BRAGA VMM, 1992, DEVELOPMENT, V115, P427; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Buist SCN, 2004, DRUG METAB DISPOS, V32, P620, DOI 10.1124/dmd.32.6.620; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Chang J, 2004, RNA BIOL, V1, P17; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chu PH, 2000, MECH DEVELOP, V95, P259, DOI 10.1016/S0925-4773(00)00341-5; Clarke RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004995; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; Deiuliis JA, 2006, COMP BIOCHEM PHYS B, V145, P50, DOI 10.1016/j.cbpb.2006.06.003; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Dobrzyn P, 2008, EUR J LIPID SCI TECH, V110, P93, DOI 10.1002/ejlt.200700249; Foroud T, 2005, NEUROLOGY, V65, P1936, DOI 10.1212/01.wnl.0000188872.28149.9a; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Geier C, 2003, CIRCULATION, V107, P1390, DOI 10.1161/01.CIR.0000056522.82563.5F; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Grover PK, 1999, EUR J BIOCHEM, V263, P50, DOI 10.1046/j.1432-1327.1999.00448.x; Harayama T, 2009, J LIPID RES, V50, P1824, DOI 10.1194/jlr.M800500-JLR200; Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141; HO SB, 1993, CANCER RES, V53, P641; Hosoyamada M, 1999, AM J PHYSIOL-RENAL, V276, pF122, DOI 10.1152/ajprenal.1999.276.1.F122; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hudkins KL, 1999, J AM SOC NEPHROL, V10, P444; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Iwama E, 2011, J MOL NEUROSCI, V44, P103, DOI 10.1007/s12031-010-9490-2; JOHNSON WJ, 1991, J LIPID RES, V32, P1993; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Komori H, 2008, ARTERIOSCL THROM VAS, V28, P1298, DOI 10.1161/ATVBAHA.108.165845; Li B, 2007, J ANIM SCI, V85, P1651, DOI 10.2527/jas.2006-755; Li B, 2009, ENDOCRINOLOGY, V150, P1217, DOI 10.1210/en.2008-0727; Li SM, 2012, BRAIN RES, V1488, P1, DOI 10.1016/j.brainres.2012.10.001; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Machida T, 2006, ONCOGENE, V25, P1931, DOI 10.1038/sj.onc.1209225; Magnusson B, 2008, METABOLISM, V57, P1307, DOI 10.1016/j.metabol.2008.04.028; Mastroianni N, 1996, GENOMICS, V35, P486, DOI 10.1006/geno.1996.0388; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Merikallio H, 2011, INT J CLIN EXP PATHO, V4, P667; Mologni L, 2005, BIOCHEM BIOPH RES CO, V329, P1001, DOI 10.1016/j.bbrc.2005.02.074; Mooslehner KA, 1999, MAMM GENOME, V10, P218, DOI 10.1007/s003359900976; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Niimi T, 2001, MOL CELL BIOL, V21, P7380, DOI 10.1128/MCB.21.21.7380-7390.2001; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ogasawara O, 2006, NUCLEIC ACIDS RES, V34, pD628, DOI 10.1093/nar/gkj137; Okada T, 2008, BIOCHEM BIOPH RES CO, V367, P370, DOI 10.1016/j.bbrc.2007.12.164; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Penisson-Besnier I, 2006, NEUROMUSCULAR DISORD, V16, P427, DOI 10.1016/j.nmd.2006.04.009; PERI A, 1993, J CLIN INVEST, V92, P2099, DOI 10.1172/JCI116810; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Price ND, 2007, P NATL ACAD SCI USA, V104, P3414, DOI 10.1073/pnas.0611373104; Priori SG, 2001, CIRCULATION, V103, P196; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Quraishe S, 2008, NEUROSCIENCE, V153, P483, DOI 10.1016/j.neuroscience.2008.01.058; RAUTH G, 1992, EUR J BIOCHEM, V204, P523, DOI 10.1111/j.1432-1033.1992.tb16663.x; Roberts HJ, 2003, BIOL REPROD, V68, P1719, DOI 10.1095/biolreprod.102.013045; SALIER JP, 1993, BIOCHEM J, V296, P85, DOI 10.1042/bj2960085; Salmikangas P, 1999, HUM MOL GENET, V8, P1329, DOI 10.1093/hmg/8.7.1329; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75; Sha Q, 2008, AM J PHYSIOL-RENAL, V295, pF91, DOI 10.1152/ajprenal.00519.2007; Shin J, 2009, J ANIM SCI, V87, P3923, DOI 10.2527/jas.2009-2124; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Sirotkin H, 1997, GENOMICS, V42, P245, DOI 10.1006/geno.1997.4734; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Soh UJK, 2008, J CELL SCI, V121, P1739, DOI 10.1242/jcs.021774; SRINIVAS PR, 1993, MOL ENDOCRINOL, V7, P1445, DOI 10.1210/me.7.11.1445; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tachibana T, 2009, CURR OPIN PULM MED, V15, P486, DOI 10.1097/MCP.0b013e32832d03bb; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Vos MJ, 2009, BBA-MOL CELL RES, V1793, P1343, DOI 10.1016/j.bbamcr.2009.05.005; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093; Zhao J, 2003, AM J PHYSIOL-REG I, V285, pR438, DOI 10.1152/ajpregu.00776.2002	96	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64483	10.1371/journal.pone.0064483	http://dx.doi.org/10.1371/journal.pone.0064483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741331	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900043
J	Vicente, WS; dos Reis, LM; Graciolli, RG; Graciolli, FG; Dominguez, WV; Wang, CC; Fonseca, TL; Velosa, AP; Roschel, H; Teodoro, WR; Gualano, B; Jorgetti, V				Vicente, Wagner S.; dos Reis, Luciene M.; Graciolli, Rafael G.; Graciolli, Fabiana G.; Dominguez, Wagner V.; Wang, Charles C.; Fonseca, Tatiana L.; Velosa, Ana P.; Roschel, Hamilton; Teodoro, Walcy R.; Gualano, Bruno; Jorgetti, Vanda			Bone Plasticity in Response to Exercise Is Sex-Dependent in Rats	PLOS ONE			English	Article							MECHANICAL STRAIN; DIMORPHISM; ESTROGEN; STRENGTH; DENSITY; SIZE; CHONDROCYTES; EXPRESSION; OSTEOCYTES; STEROIDS	Purpose: To characterize the potential sexual dimorphism of bone in response to exercise. Methods: Young male and female Wistar rats were either submitted to 12 weeks of exercise or remained sedentary. The training load was adjusted at the mid-trial (week 6) by the maximal speed test. A mechanical test was performed to measure the maximal force, resilience, stiffness, and fracture load. The bone structure, formation, and resorption were obtained by histomorphometric analyses. Type I collagen (COL I) mRNA expression and tartrate-resistant acid phosphatase (TRAP) mRNA expression were evaluated by quantitative real-time PCR (qPCR). Results: The male and female trained rats significantly improved their maximum speed during the maximal exercise test (main effect of training; p<0.0001). The male rats were significantly heavier than the females, irrespective of training (main effect of sex; p<0.0001). Similarly, both the weight and length of the femur were greater for the male rats when compared with the females (main effect of sex; p<0.0001 and p<0.0001, respectively). The trabecular volume was positively affected by exercise in male and female rats (main effect of training; p = 0.001), whereas the trabecular thickness, resilience, mineral apposition rate, and bone formation rate increased only in the trained males (within-sex comparison; p<0.05 for all parameters), demonstrating the sexual dimorphism in response to exercise. Accordingly, the number of osteocytes increased significantly only in the trained males (within-sex comparison; p<0.05). Pearson's correlation analyses revealed that the COL I mRNA expression and TRAP mRNA expression were positively and negatively, respectively, related to the parameters of bone remodeling obtained from the histomorphometric analysis (r = 0.59 to 0.85; p<0.05). Conclusion: Exercise yielded differential adaptations with respect to bone structure, biomechanical proprieties, and molecular signaling in male and female rats.	[Vicente, Wagner S.; dos Reis, Luciene M.; Graciolli, Rafael G.; Graciolli, Fabiana G.; Dominguez, Wagner V.; Jorgetti, Vanda] Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil; [Roschel, Hamilton; Gualano, Bruno] Univ Sao Paulo, Sch Phys Educ & Sport, Dept Sports, Sao Paulo, Brazil; [Fonseca, Tatiana L.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Velosa, Ana P.; Teodoro, Walcy R.] Univ Sao Paulo, Sch Med, Div Rheumatol, Sao Paulo, Brazil; [Wang, Charles C.] Univ Fed Sao Paulo, Dept Physiol Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Jorgetti, V (corresponding author), Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	vandajor@usp.br	Dominguez, Wagner/AAR-6693-2020; Vicente, Wilter R R/J-4984-2012; JORGETTI, VANDA/C-9470-2012; Roschel, Hamilton/D-4353-2012; Gualano, Bruno/C-7190-2012; Gualano, Bruno/ABA-9571-2020; Teodoro, Walcy/H-5133-2017; teodoro, walcy/J-7602-2018; dos Reis, Luciene M/C-7143-2013	Vicente, Wilter R R/0000-0001-7696-0962; JORGETTI, VANDA/0000-0002-4824-8879; Roschel, Hamilton/0000-0002-9513-6132; Gualano, Bruno/0000-0001-7100-8681; Gualano, Bruno/0000-0001-7100-8681; Teodoro, Walcy/0000-0001-7559-4542; teodoro, walcy/0000-0001-7559-4542; dos Reis, Luciene M/0000-0001-8476-6780; Pereira Velosa, Ana Paula/0000-0002-6465-0796				Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009; Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209; Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828; Capelo LP, 2008, BONE, V43, P921, DOI 10.1016/j.bone.2008.06.020; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Dy CJ, 2011, CLIN ORTHOP RELAT R, V469, P1906, DOI 10.1007/s11999-011-1849-3; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; ENGESAETER LB, 1978, ACTA ORTHOP SCAND, V49, P512, DOI 10.3109/17453677808993231; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gouveia CHA, 1997, J BONE MINER RES, V12, P2098, DOI 10.1359/jbmr.1997.12.12.2098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin AD, 1987, J SPORT SCI, V5, P155, DOI 10.1080/02640418708729773; McMillan J, 2006, BBA-MOL CELL RES, V1763, P381, DOI 10.1016/j.bbamcr.2006.02.010; Molgaard C, 1997, ARCH DIS CHILD, V76, P9, DOI 10.1136/adc.76.1.9; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PENG Z, 1994, BONE, V15, P523, DOI 10.1016/8756-3282(94)90276-3; Rautava E, 2007, OSTEOPOROSIS INT, V18, P915, DOI 10.1007/s00198-006-0312-x; Raz P, 2005, J CELL BIOCHEM, V95, P108, DOI 10.1002/jcb.20298; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Saxon LK, 2006, BONE, V39, P1261, DOI 10.1016/j.bone.2006.06.030; Schoenau E, 2001, J CLIN ENDOCR METAB, V86, P613, DOI 10.1210/jc.86.2.613; Seeman E, 2001, J CLIN ENDOCR METAB, V86, P4576, DOI 10.1210/jc.86.10.4576; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang XZ, 1999, J BONE MINER RES, V14, P802, DOI 10.1359/jbmr.1999.14.5.802	31	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64725	10.1371/journal.pone.0064725	http://dx.doi.org/10.1371/journal.pone.0064725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741378	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900091
J	DeRosse, P; Burdick, KE; Lencz, T; Siris, SG; Malhotra, AK				DeRosse, Pamela; Burdick, Katherine E.; Lencz, Todd; Siris, Samuel G.; Malhotra, Anil K.			Empirical Support for DSM-IV Schizoaffective Disorder: Clinical and Cognitive Validators from a Large Patient Sample	PLOS ONE			English	Article							NEGATIVE SYMPTOMS; SCHIZOPHRENIA; GENOTYPE; PSYCHOSIS; DIAGNOSIS; SPECTRUM; GENETICS; RISK; FORM	Objective: The diagnosis of schizoaffective disorder has long maintained an uncertain status in psychiatric nosology. Studies comparing clinical and biological features of patients with schizoaffective disorder to patients with related disorders [e. g., schizophrenia and bipolar disorder] can provide an evidence base for judging the validity of the diagnostic category. However, because most prior studies of schizoaffective disorder have only evaluated differences between groups at a static timepoint, it is unclear how these disorders may be related when the entire illness course is taken into consideration. Methods: We ascertained a large cohort [N = 993] of psychiatric patients with a range of psychotic diagnoses including schizophrenia with no history of major affective episodes [SZ-; N = 371], schizophrenia with a superimposed mood syndrome [SZ+; N = 224], schizoaffective disorder [SAD; N = 129] and bipolar I disorder with psychotic features [BPD+; N = 269]. Using cross-sectional data we designed key clinical and neurocognitive dependent measures that allowed us to test longitudinal hypotheses about the differences between these diagnostic entities. Results: Large differences between diagnostic groups on several demographic and clinical variables were observed. Most notably, groups differed on a putative measure of cognitive decline. Specifically, the SAD group demonstrated significantly greater post-onset cognitive decline compared to the BP+ group, with the SZ- and SZ+ group both exhibiting levels of decline intermediate to BPD+ and SAD. Conclusions: These results suggest that schizoaffective disorder may possess distinct features. Contrary to earlier formulations, schizoaffective disorder may be a more severe form of illness.	[DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.] Feinstein Inst Med Res, Ctr Translat Psychiat, Manhasset, NY USA; [DeRosse, Pamela; Lencz, Todd; Siris, Samuel G.; Malhotra, Anil K.] Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY USA; [Burdick, Katherine E.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Burdick, Katherine E.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Lencz, Todd; Malhotra, Anil K.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA	Northwell Health; Northwell Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Hofstra University; Northwell Health	DeRosse, P (corresponding author), Feinstein Inst Med Res, Ctr Translat Psychiat, Manhasset, NY USA.	pderosse@lij.edu	DeRosse, Pamela/H-1083-2012; Lencz, Todd/J-3418-2014; DeRosse, Pamela/X-1412-2019; Burdick, Katherine E/G-6124-2012	DeRosse, Pamela/0000-0003-0823-8163; Lencz, Todd/0000-0001-8586-338X; 	 [MH086756];  [MH077807];  [MH079800]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079800, K99MH086756, K23MH077807] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants MH086756 to PD, MH077807 to KEB, and MH079800 to AKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1952, DIAGN STAT MAN MENT; American Psychiatric Association, 1968, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Brewer WJ, 2005, AM J PSYCHIAT, V162, P71, DOI 10.1176/appi.ajp.162.1.71; Burdick KE, 2006, HUM MOL GENET, V163, P532; Cheniaux E, 2008, J AFFECT DISORDERS, V106, P209, DOI 10.1016/j.jad.2007.07.009; Craddock N, 2007, WORLD PSYCHIATRY, V6, P20; Craddock N, 2009, SCHIZOPHRENIA BULL, V35, P482, DOI 10.1093/schbul/sbp020; CUESTA MJ, 1995, COMPR PSYCHIAT, V36, P353, DOI 10.1016/S0010-440X(95)90116-7; Davidson M, 1999, AM J PSYCHIAT, V156, P1328; DeRosse P, 2006, AM J PSYCHIAT, V163, P532, DOI 10.1176/appi.ajp.163.3.532; DeRosse P, 2008, SCHIZOPHRENIA BULL, V34, P1047, DOI 10.1093/schbul/sbn076; DeRosse P, 2007, BIOL PSYCHIAT, V61, P1208, DOI 10.1016/j.biopsych.2006.07.023; DeRosse P, 2006, SCHIZOPHR RES, V87, P28, DOI 10.1016/j.schres.2006.06.008; Evans JD, 1999, J CLIN PSYCHIAT, V60, P874, DOI 10.4088/JCP.v60n1211; Fuller R, 2002, AM J PSYCHIAT, V159, P1183, DOI 10.1176/appi.ajp.159.7.1183; Kasanin J, 1933, AM J PSYCHIAT, V13, P97; Keefe RSE, 2007, SCHIZOPHRENIA BULL, V33, P912, DOI 10.1093/schbul/sbm046; Keefe RSE, 2005, BIOL PSYCHIAT, V57, P688, DOI 10.1016/j.biopsych.2005.01.003; KENDLER KS, 1995, AM J PSYCHIAT, V152, P755; Kremen WS, 2006, J CLIN EXP NEUROPSYC, V28, P208, DOI 10.1080/13803390500360414; LEVINSON DF, 1991, SCHIZOPHRENIA BULL, V17, P491, DOI 10.1093/schbul/17.3.491; Peralta V, 2008, J AFFECT DISORDERS, V108, P71, DOI 10.1016/j.jad.2007.09.009; Reichenberg A, 2005, ARCH GEN PSYCHIAT, V62, P1297, DOI 10.1001/archpsyc.62.12.1297; Salokangas RKR, 2003, EUR PSYCHIAT, V18, P274, DOI 10.1016/j.eurpsy.2003.03.001; Schwartz JE, 2000, ARCH GEN PSYCHIAT, V57, P593, DOI 10.1001/archpsyc.57.6.593	27	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63734	10.1371/journal.pone.0063734	http://dx.doi.org/10.1371/journal.pone.0063734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177SC	23737946	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700009
J	Evans, KK; Birdwell, RL; Wolfe, JM				Evans, Karla K.; Birdwell, Robyn L.; Wolfe, Jeremy M.			If You Don't Find It Often, You Often Don't Find It: Why Some Cancers Are Missed in Breast Cancer Screening	PLOS ONE			English	Article							COMPUTER-AIDED DETECTION; MAMMOGRAPHY; PERFORMANCE; PREVALENCE; CARCINOMA; RATES	Mammography is an important tool in the early detection of breast cancer. However, the perceptual task is difficult and a significant proportion of cancers are missed. Visual search experiments show that miss (false negative) errors are elevated when targets are rare (low prevalence) but it is unknown if low prevalence is a significant factor under real world, clinical conditions. Here we show that expert mammographers in a real, low-prevalence, clinical setting, miss a much higher percentage of cancers than are missed when the mammographers search for the same cancers under high prevalence conditions. We inserted 50 positive and 50 negative cases into the normal workflow of the breast cancer screening service of an urban hospital over the course of nine months. This rate was slow enough not to markedly raise disease prevalence in the radiologists' daily practice. Six radiologists subsequently reviewed all 100 cases in a session where the prevalence of disease was 50%. In the clinical setting, participants missed 30% of the cancers. In the high prevalence setting, participants missed just 12% of the same cancers. Under most circumstances, this low prevalence effect is probably adaptive. It is usually wise to be conservative about reporting events with very low base rates (Was that a flying saucer? Probably not.). However, while this response to low prevalence appears to be strongly engrained in human visual search mechanisms, it may not be as adaptive in socially important, low prevalence tasks like medical screening. While the results of any one study must be interpreted cautiously, these data are consistent with the conclusion that this behavioral response to low prevalence could be a substantial contributor to miss errors in breast cancer screening.	[Evans, Karla K.; Wolfe, Jeremy M.] Harvard Univ, Sch Med, Visual Attent Lab, Brigham & Womens Hosp, Cambridge, MA 02138 USA; [Birdwell, Robyn L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Evans, KK (corresponding author), Harvard Univ, Sch Med, Visual Attent Lab, Brigham & Womens Hosp, Cambridge, MA 02138 USA.	kevans@search.bwh.harvard.edu	Wolfe, Jeremy M/A-9248-2016; Evans, Karla K/S-5779-2018; Wolfe, Jeremy M/C-1621-2012	Wolfe, Jeremy M/0000-0002-6475-1984; Evans, Karla K/0000-0002-8440-1711; Wolfe, Jeremy M/0000-0002-6475-1984	NIH [EY017001]; ONR MURI [N000141010278]; NIH/NEI [1F32EY019819-01]; NATIONAL EYE INSTITUTE [R01EY017001, F32EY019819] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR MURI(MURIOffice of Naval Research); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH EY017001 and ONR MURI N000141010278 to J.M.W.; K. K. E. was supported by NIH/NEI 1F32EY019819-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlin L, 2007, AM J ROENTGENOL, V188, P1173, DOI 10.2214/AJR.06.1270; BIRD RE, 1992, RADIOLOGY, V184, P613, DOI 10.1148/radiology.184.3.1509041; Birdwell RL, 2001, RADIOLOGY, V219, P192, DOI 10.1148/radiology.219.1.r01ap16192; Boyer B, 2004, J RADIOL, V85, P2071, DOI 10.1016/S0221-0363(04)97784-0; COLQUHOUN WP, 1961, ERGONOMICS, V4, P41, DOI 10.1080/00140136108930506; COLQUHOUN WP, 1967, J EXP PSYCHOL, V73, P153, DOI 10.1037/h0024087; Evans K. K, 2010, ATTEN PERCEPT PSYCHO, V73, p[Does visual expertise improve visual recognition memory, 30], DOI DOI 10.3758/S13414-010-0022-5; Evans KK, 2011, ARCH PATHOL LAB MED, V135, P1557, DOI 10.5858/arpa.2010-0739-OA; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Gur D, 2003, RADIOLOGY, V228, P10, DOI 10.1148/radiol.2281020709; Gur D, 2008, RADIOLOGY, V249, P47, DOI 10.1148/radiol.2491072025; Hardesty LA, 2005, ACAD RADIOL, V12, P286, DOI 10.1016/j.acra.2004.11.026; HARVEY JA, 1993, AM J ROENTGENOL, V161, P1167, DOI 10.2214/ajr.161.6.8249720; HILLARD A, 1985, INVEST RADIOL, V20, P422, DOI 10.1097/00004424-198507000-00017; Kopans DB, 2011, RADIOLOGY, V260, P616, DOI 10.1148/radiol.11110716; Majid AS, 2003, RADIOGRAPHICS, V23, P881, DOI 10.1148/rg.234025083; Nodine CF, 1996, ACAD RADIOL, V3, P1000, DOI 10.1016/S1076-6332(96)80032-8; Nodine CF, 2001, RADIOLOGY, V221, P122, DOI 10.1148/radiol.2211001507; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Pisano ED, 2009, RADIOLOGY, V252, P348, DOI 10.1148/radiol.2522081457; Reed WM, 2011, RADIOLOGY, V258, P938, DOI 10.1148/radiol.10101090; Ryan JT, 2011, AM J ROENTGENOL, V197, pW985, DOI 10.2214/AJR.10.5859; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; Wolfe JM, 2007, J EXP PSYCHOL GEN, V136, P623, DOI 10.1037/0096-3445.136.4.623; Wolfe JM, 2010, CURR BIOL, V20, P121, DOI 10.1016/j.cub.2009.11.066; Wolfe JM, 2005, NATURE, V435, P439, DOI 10.1038/435439a	26	100	100	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64366	10.1371/journal.pone.0064366	http://dx.doi.org/10.1371/journal.pone.0064366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737980	gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700045
J	Lundberg, ME; Becker, EC; Choe, S				Lundberg, Matthew E.; Becker, Eric C.; Choe, Senyon			MstX and a Putative Potassium Channel Facilitate Biofilm Formation in Bacillus subtilis	PLOS ONE			English	Article							ESCHERICHIA-COLI; MASTER REGULATOR; MEMBRANE-PROTEIN; EXPRESSION; GENE; TRANSPORTERS; BISTABILITY; MUTAGENESIS; INITIATION; MICROBES	Biofilms constitute the predominant form of microbial life and a potent reservoir for innate antibiotic resistance in systemic infections. In the spore-forming bacterium Bacillus subtilis, the transition from a planktonic to sessile state is mediated by mutually exclusive regulatory pathways controlling the expression of genes required for flagellum or biofilm formation. Here, we identify mstX and yugO as novel regulators of biofilm formation in B. subtilis. We show that expression of mstX and the downstream putative K+ efflux channel, yugO, is necessary for biofilm development in B. subtilis, and that overexpression of mstX induces biofilm assembly. Transcription of the mstX-yugO operon is under the negative regulation of SinR, a transcription factor that governs the switch between planktonic and sessile states. Furthermore, mstX regulates the activity of Spo0A through a positive autoregulatory loop involving KinC, a histidine kinase that is activated by potassium leakage. The addition of potassium abrogated mstX-mediated biofilm formation. Our findings expand the role of Spo0A and potassium homeostasis in the regulation of bacterial development.	[Lundberg, Matthew E.; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Lundberg, Matthew E.; Becker, Eric C.; Choe, Senyon] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA.	choe@salk.edu			National Institutes of Health; Chapman foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chapman foundation	Funding provided by the National Institutes of Health and the Chapman foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chen Y, 2012, MOL MICROBIOL, V85, P418, DOI 10.1111/j.1365-2958.2012.08109.x; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; Cozy LM, 2012, MOL MICROBIOL, V83, P1210, DOI 10.1111/j.1365-2958.2012.08003.x; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Diethmaier C, 2011, J BACTERIOL, V193, P5997, DOI 10.1128/JB.05360-11; Dvir H, 2009, PROTEIN EXPRES PURIF, V68, P28, DOI 10.1016/j.pep.2009.06.007; Dvir H, 2009, PROTEIN SCI, V18, P1564, DOI 10.1002/pro.148; FERGUSON GP, 1995, MOL MICROBIOL, V17, P1025, DOI 10.1111/j.1365-2958.1995.mmi_17061025.x; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Hamon MA, 2004, MOL MICROBIOL, V52, P847, DOI 10.1111/j.1365-2958.2004.04023.x; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kefala Georgia, 2007, Journal of Structural and Functional Genomics, V8, P167, DOI 10.1007/s10969-007-9033-4; Kinsinger RF, 2005, J BACTERIOL, V187, P8462, DOI 10.1128/JB.187.24.8462-8469.2005; Kobayashi K, 2008, MOL MICROBIOL, V69, P1399, DOI 10.1111/j.1365-2958.2008.06369.x; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Liu XJ, 2008, BBA-PROTEINS PROTEOM, V1784, P1742, DOI 10.1016/j.bbapap.2008.06.018; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; McLoon AL, 2011, J BACTERIOL, V193, P679, DOI 10.1128/JB.01186-10; MUNRO AW, 1991, MOL MICROBIOL, V5, P607, DOI 10.1111/j.1365-2958.1991.tb00731.x; O'Toole GA, 2004, NATURE, V432, P680, DOI 10.1038/432680a; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Roosild TP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-10; Roosild TP, 2009, STRUCTURE, V17, P893, DOI 10.1016/j.str.2009.03.018; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Rubinstein SM, 2012, MOL MICROBIOL; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Ueda A, 2008, APPL MICROBIOL BIOT, V79, P843, DOI 10.1007/s00253-008-1483-5; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	44	40	40	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e60993	10.1371/journal.pone.0060993	http://dx.doi.org/10.1371/journal.pone.0060993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737939	gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700003
J	Wang, JS; Liu, LQ; Qiu, HJ; Zhang, XH; Guo, W; Chen, WB; Tian, Y; Fu, LY; Shi, DB; Cheng, JD; Huang, WL; Deng, WG				Wang, Jingshu; Liu, Liqun; Qiu, Huijuan; Zhang, Xiaohong; Guo, Wei; Chen, Wangbing; Tian, Yun; Fu, Lingyi; Shi, Dingbo; Cheng, Jianding; Huang, Wenlin; Deng, Wuguo			Ursolic Acid Simultaneously Targets Multiple Signaling Pathways to Suppress Proliferation and Induce Apoptosis in Colon Cancer Cells	PLOS ONE			English	Article							CYCLOOXYGENASE-2 INHIBITOR; DOWN-REGULATION; TUMOR-GROWTH; IN-VITRO; EXPRESSION; CELECOXIB; ANTITUMOR; COX-2; P300; DERIVATIVES	Ursolic acid (UA), a natural pentacyclic triterpenoid carboxylic acid distributed in medical herbs, exerts antitumor effects and is emerging as a promising compound for cancer prevention and therapy, but its excise mechanisms of action in colon cancer cells remains largely unknown. Here, we identified the molecular mechanisms by which UA inhibited cell proliferation and induced apoptosis in human colon cancer SW480 and LoVo cells. Treatment with UA led to significant inhibitions in cell viability and clone formation and changes in cell morphology and spreading. UA also suppressed colon cancer cell migration by inhibiting MMP9 and upregulating CDH1 expression. Further studies showed that UA inhibited the phosphorylation of Akt and ERK proteins. Pretreatment with an Akt or ERK-specific inhibitor considerably abrogated the proliferation inhibition by UA. UA also significantly inhibited colon cancer cell COX-2 expression and PGE2 production. Pretreatment with a COX-2 inhibitor (celecoxib) abrogated the UA-induced cell proliferation. Moreover, we found that UA effectively promoted NF-kappa B and p300 translocation from cell nuclei to cytoplasm, and attenuated the p300-mediated acetylation of NF-kappa B and CREB2. Pretreatment with a p300 inhibitor (roscovitine) abrogated the UA-induced cell proliferation, which is reversed by p300 overexpression. Furthermore, UA treatment induced colon cancer cell apoptosis, increased the cleavage of PARP, caspase-3 and 9, and trigged the release of cytochrome c from mitochondrial intermembrane space into cytosol. These results indicate that UA inhibits cell proliferation and induces apoptosis in colon cancer cells through simultaneous modulation of the multiple signaling pathways such as MMP9/CDH1, Akt/ERK, COX-2/PGE2, p300/NF-kappa B/CREB2, and cytochrome c/caspase pathways.	[Wang, Jingshu; Qiu, Huijuan; Chen, Wangbing; Tian, Yun; Fu, Lingyi; Shi, Dingbo; Huang, Wenlin; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xiaohong; Guo, Wei] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China; [Liu, Liqun] Sun Yat Sen Univ, Huangpu Hosp, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Cheng, Jianding] Sun Yat Sen Univ, Sch Med, Dept Forens Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Wenlin] Guangzhou Double Bioprod Inc, State Key Lab Targeted Drug Tumors Guangdong Prov, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Dalian Medical University; Sun Yat Sen University; Sun Yat Sen University	Cheng, JD (corresponding author), Sun Yat Sen Univ, Sch Med, Dept Forens Pathol, Guangzhou 510275, Guangdong, Peoples R China.	jdcheng2001@yahoo.com.cn; huangwl@sysucc.org.cn; dengwg@sysucc.org.cn			National Natural Science Foundation of China [81071687, 81272195]; State "863 Program" of China [SS2012AA020403]; Doctoral Programs Foundation of Ministry of Education of China [20110171110077]; State Key Laboratory of Oncology in Southern China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State "863 Program" of China(National High Technology Research and Development Program of China); Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Oncology in Southern China	This work was supported by the funds from the National Natural Science Foundation of China (81071687, 81272195), the State "863 Program" of China (SS2012AA020403), the Doctoral Programs Foundation of Ministry of Education of China (20110171110077), and the State Key Laboratory of Oncology in Southern China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarsha MA, 1998, PHYTOTHER RES, V12, P32, DOI 10.1002/(SICI)1099-1573(19980201)12:1&lt;32::AID-PTR185&gt;3.0.CO;2-4; Chattopadhyay D, 2005, CONTRACEPTION, V71, P372, DOI 10.1016/j.contraception.2004.11.006; Chen YF, 2012, EUR ARCH OT IN PRESS; Chiu WT, 2010, NEUROBIOL DIS, V37, P118, DOI 10.1016/j.nbd.2009.09.015; Cunha WR, 2010, PHARM BIOL, V48, P166, DOI 10.3109/13880200903062648; Dai ZJ, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-53; Damodharan U, 2011, APPL BIOCHEM BIOTECH, V165, P1245, DOI 10.1007/s12010-011-9342-8; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Deng WG, 2007, ARTERIOSCL THROM VAS, V27, P1752, DOI 10.1161/ATVBAHA.107.144352; Deng WG, 2006, BLOOD, V108, P518, DOI 10.1182/blood-2005-09-3691; Duan DP, 2012, ONCOL REP, V28, P1693, DOI 10.3892/or.2012.1992; Hegde P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026312; Hou X, 2012, EJSO-EUR J SURG ONC, V38, P523, DOI 10.1016/j.ejso.2012.02.180; Jin YR, 2012, PHARM BIOL, V50, P523, DOI 10.3109/13880209.2011.611143; Kawamori T, 2003, CARCINOGENESIS, V24, P985, DOI 10.1093/carcin/bgg033; Kazakova OB, 2010, BIOORG MED CHEM LETT, V20, P4088, DOI 10.1016/j.bmcl.2010.05.083; Leal AS, 2012, BIOORGAN MED CHEM, V20, P5774, DOI 10.1016/j.bmc.2012.08.010; Lee KM, 2010, J AGR FOOD CHEM, V58, P5815, DOI 10.1021/jf903698s; Li Q, 2011, EPIGENETICS-US, V6, P849, DOI 10.4161/epi.6.7.16314; Ling ZQ, 2011, INT J MOL MED, V27, P625, DOI 10.3892/ijmm.2011.640; Liu B, 2010, CELL BIOL INT, V34, P21, DOI 10.1042/CBI20090129; Liu WB, 2012, MOLECULES, V17, P9104, DOI 10.3390/molecules17089104; Messner B, 2011, ATHEROSCLEROSIS, V219, P402, DOI 10.1016/j.atherosclerosis.2011.05.025; Ninomiya I, 2012, ONCOL REP, V28, P777, DOI 10.3892/or.2012.1885; Rahman M, 2012, NEOPLASIA, V14, P624, DOI 10.1593/neo.12486; Roberts HR, 2011, CARCINOGENESIS, V32, P1741, DOI 10.1093/carcin/bgr210; Saini MK, 2009, J ENVIRON PATHOL TOX, V28, P39, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i1.40; Shanmugam MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032476; Sultana N, 2011, J ENZYM INHIB MED CH, V26, P616, DOI 10.3109/14756366.2010.546793; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Wang L., 2008, Experimental Oncology, V30, P42; Wang QE, 2012, NUCL ACIDS IN PRESS; Wang ZL, 2012, CARCINOGENE IN PRESS; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Xiao YT, 2012, ONCOL LETT, V4, P1219, DOI 10.3892/ol.2012.936; Yan F, 2010, J MED CHEM, V53, P5502, DOI 10.1021/jm1001698; Zheng QY, 2013, CELL SIGNAL, V25, P206, DOI 10.1016/j.cellsig.2012.09.012	39	63	68	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63872	10.1371/journal.pone.0063872	http://dx.doi.org/10.1371/journal.pone.0063872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737956	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700019
J	Albert, MV; McCarthy, C; Valentin, J; Herrmann, M; Kording, K; Jayaraman, A				Albert, Mark V.; McCarthy, Cliodhna; Valentin, Juliana; Herrmann, Megan; Kording, Konrad; Jayaraman, Arun			Monitoring Functional Capability of Individuals with Lower Limb Amputations Using Mobile Phones	PLOS ONE			English	Article							PATIENT ACTIVITY MONITOR; TRANSFEMORAL AMPUTEES; OSSEOINTEGRATED FIXATION; ACTIVITY RECOGNITION; LONG-TERM; QUESTIONNAIRE; ACCELEROMETRY; VALIDITY; WALKING; PERFORMANCE	To be effective, a prescribed prosthetic device must match the functional requirements and capabilities of each patient. These capabilities are usually assessed by a clinician and reported by the Medicare K-level designation of mobility. However, it is not clear how the K-level designation objectively relates to the use of prostheses outside of a clinical environment. Here, we quantify participant activity using mobile phones and relate activity measured during real world activity to the assigned K-levels. We observe a correlation between K-level and the proportion of moderate to high activity over the course of a week. This relationship suggests that accelerometry-based technologies such as mobile phones can be used to evaluate real world activity for mobility assessment. Quantifying everyday activity promises to improve assessment of real world prosthesis use, leading to a better matching of prostheses to individuals and enabling better evaluations of future prosthetic devices.	[Albert, Mark V.; Kording, Konrad] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Albert, Mark V.; Kording, Konrad; Jayaraman, Arun] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [McCarthy, Cliodhna] MIT, Cambridge, MA 02139 USA; [Valentin, Juliana] Boston Univ, Boston, MA 02215 USA; [Albert, Mark V.; McCarthy, Cliodhna; Valentin, Juliana; Herrmann, Megan; Jayaraman, Arun] Northwestern Univ, Rehabil Inst Chicago, Max Nader Ctr Rehabil Technol & Outcomes Res, Chicago, IL 60611 USA; [Albert, Mark V.; Herrmann, Megan; Jayaraman, Arun] Northwestern Univ, Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Massachusetts Institute of Technology (MIT); Boston University; Northwestern University; Shirley Ryan AbilityLab; Northwestern University; Shirley Ryan AbilityLab	Albert, MV (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	markvalbert@gmail.com	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	Max Nader Center for Rehabilitation Technologies and Outcomes; National Institutes of Health [R01NS057814, 1R01NS063399, 2P01NS044393]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057814, R01NS063399, P01NS044393] Funding Source: NIH RePORTER	Max Nader Center for Rehabilitation Technologies and Outcomes; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by philanthropic funds through the Max Nader Center for Rehabilitation Technologies and Outcomes. The authors also thank the National Institutes of Health (grants R01NS057814, 1R01NS063399 and 2P01NS044393) for their support of authors MVA and KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M., 2012, FRONTIERS NEUROLOGY, V3; Albert MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036556; Arya AP, 2008, J BONE JOINT SURG BR, V90B, P1414, DOI 10.1302/0301-620X.90B11.21131; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Boone DA., 2006, J PROSTHET ORTHOT, V18, P68, DOI DOI 10.1097/00008526-200601001-00008; Bourke AK, 2007, GAIT POSTURE, V26, P194, DOI 10.1016/j.gaitpost.2006.09.012; Brezmes T, 2009, LECT NOTES COMPUT SC, V5518, P796, DOI 10.1007/978-3-642-02481-8_120; Dourado KCC, 2010, REV SOC BRAS MED TRO, V43, P405, DOI 10.1590/S0037-86822010000400014; Condie E, 2006, PROCEEDINGS OF THE AMERICAN ACADEMY OF ORTHOTISTS AND PROSTHETISTS, pP13; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; Dijkstra B, 2008, AGE AGEING, V37, P436, DOI 10.1093/ageing/afn097; Dudek NL, 2008, J REHABIL RES DEV, V45, P577, DOI 10.1682/JRRD.2007.05.0069; Estrin D, 2009, AMBULATION TOOL MONI, P927; Fernandes HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020290; Frossard L, 2011, J PROSTHETICS ORTHOT, V23; Frossard L, 2010, J PROSTHET ORTHOT, V22, P11, DOI [10.1097/JPO.0b013-3181ccc53d, DOI 10.1097/JPO.0B013E3181CCC53D]; Frossard L., 2003, J PROSTHET ORTHOT, V15, P135, DOI DOI 10.1097/00008526-200310000-00005; Frossard L, 2009, IEEE T NEUR SYS REH, V17, P9, DOI 10.1109/TNSRE.2008.2010478; Frossard LA, 2010, PROSTHET ORTHOT INT, V34, P472, DOI 10.3109/03093646.2010.520057; Frossard LA, 2010, PROSTHET ORTHOT INT, V34, P85, DOI 10.3109/03093640903585024; Gailey RS, 2002, ARCH PHYS MED REHAB, V83, P613, DOI 10.1053/ampr.2002.32309; GAUTHIERGAGNON C, 1994, ARCH PHYS MED REHAB, V75, P1309; Grise MC, 2006, J PROSTHETICS ORTHOT, V18, P68; Gyorbiro N, 2009, MOBILE NETW APPL, V14, P82, DOI 10.1007/s11036-008-0112-y; Hafner BJ, 2007, ARCH PHYS MED REHAB, V88, P207, DOI 10.1016/j.apmr.2006.10.030; Hagberg K, 2004, J REHABIL RES DEV, V41, P695, DOI 10.1682/JRRD.2003.11.0167; Heinemann AW, 2003, PROSTHET ORTHOT INT, V27, P191, DOI 10.1080/03093640308726682; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Lee R, 2011, RUNNING THE WORLDS MARKETS: THE GOVERNANCE OF FINANCIAL INFRASTRUCTURE, P40; Lee WCC, 2008, MED ENG PHYS, V30, P825, DOI 10.1016/j.medengphy.2007.09.003; Lee WCC, 2007, CLIN BIOMECH, V22, P665, DOI 10.1016/j.clinbiomech.2007.02.005; Legro MW, 1998, ARCH PHYS MED REHAB, V79, P931, DOI 10.1016/S0003-9993(98)90090-9; MAHONEY F I, 1965, Md State Med J, V14, P61; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Mathie MJ, 2004, PHYSIOL MEAS, V25, pR1, DOI 10.1088/0967-3334/25/2/R01; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Meier MR, 2012, J REHABIL RES DEV, V49, P583, DOI 10.1682/JRRD.2010.05.0094; MUELLER MJ, 1985, PHYS THER, V65, P1037, DOI 10.1093/ptj/65.7.1037; Neumann E.S., 2012, J PROSTHET ORTHOT, V24, P160, DOI [DOI 10.1097/JP0.0B013E31826F66F0, 10.1097/JPO.0b013-31826f66f0, DOI 10.1097/JPO.0B013-31826F66F0]; Neumann ES, 2012, PROSTHET ORTHOT INT, V36, P203, DOI 10.1177/0309364612436408; Office UGP, HCFA COMM PROC COD S; Parker K, 2010, ARCH PHYS MED REHAB, V91, P543, DOI 10.1016/j.apmr.2009.12.009; Ramstrand N, 2007, PROSTHET ORTHOT INT, V31, P157, DOI 10.1080/03093640600988617; Ryall NH, 2003, DISABIL REHABIL, V25, P833, DOI 10.1080/0963828021000056460; SANDERS JE, 1995, J REHABIL RES DEV, V32, P210; Smeathers JE, 2005, CLASSIFICATION DAILY; Stepien JM, 2007, ARCH PHYS MED REHAB, V88, P896, DOI 10.1016/j.apmr.2007.03.016; Sup F, 2011, IEEE T NEUR SYS REH, V19, P71, DOI 10.1109/TNSRE.2010.2087360; Sup Frank, 2009, IEEE Int Conf Rehabil Robot, V2009, P638, DOI 10.1109/ICORR.2009.5209625; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	52	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65340	10.1371/journal.pone.0065340	http://dx.doi.org/10.1371/journal.pone.0065340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750254	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900056
J	Fragkias, M; Lobo, J; Strumsky, D; Seto, KC				Fragkias, Michail; Lobo, Jose; Strumsky, Deborah; Seto, Karen C.			Does Size Matter? Scaling of CO2 Emissions and US Urban Areas	PLOS ONE			English	Article							ENERGY-USE; METABOLISM; CITIES; URBANIZATION; INNOVATION; CITY; AGGLOMERATION; GROWTH; MODEL	Urban areas consume more than 66% of the world's energy and generate more than 70% of global greenhouse gas emissions. With the world's population expected to reach 10 billion by 2100, nearly 90% of whom will live in urban areas, a critical question for planetary sustainability is how the size of cities affects energy use and carbon dioxide (CO2) emissions. Are larger cities more energy and emissions efficient than smaller ones? Do larger cities exhibit gains from economies of scale with regard to emissions? Here we examine the relationship between city size and CO2 emissions for U.S. metropolitan areas using a production accounting allocation of emissions. We find that for the time period of 1999-2008, CO2 emissions scale proportionally with urban population size. Contrary to theoretical expectations, larger cities are not more emissions efficient than smaller ones.	[Fragkias, Michail] Boise State Univ, Dept Econ, Boise, ID 83725 USA; [Lobo, Jose] Arizona State Univ, Sch Sustainabil, Tempe, AZ USA; [Strumsky, Deborah] Univ N Carolina, Dept Geog & Earth Sci, Charlotte, NC 28223 USA; [Seto, Karen C.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT USA	Idaho; Boise State University; Arizona State University; Arizona State University-Tempe; University of North Carolina; University of North Carolina Charlotte; Yale University	Fragkias, M (corresponding author), Boise State Univ, Dept Econ, Boise, ID 83725 USA.	michailfragkias@boisestate.edu	Lobo, Jose/AAG-2746-2021; Seto, Karen C./C-2722-2008; Fragkias, Michail/B-5785-2008	Lobo, Jose/0000-0002-0814-7168; Seto, Karen C./0000-0002-4928-2446; 	Direct For Social, Behav & Economic Scie [1229429] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [0937777] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; Arbesman S, 2011, PHYSICA A, V390, P2155, DOI 10.1016/j.physa.2011.02.013; Baccini P, 1997, J URBAN TECHNOL, V4, P27, DOI 10.1080/10630739708724555; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Bettencourt LMA, 2012, 1209014 SANT FE I; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bonner J.T., 2006, WHY SIZE MATTERS; Brown JH, 2011, BIOSCIENCE, V61, P19, DOI 10.1525/bio.2011.61.1.7; Burger JR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001345; Carlino GA, 2007, J URBAN ECON, V61, P389, DOI 10.1016/j.jue.2006.08.003; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Ewing R, 2010, J AM PLANN ASSOC, V76, P265, DOI 10.1080/01944361003766766; Gabaix X., 2004, HDB REGIONAL URBAN E, P2341, DOI DOI 10.1016/S1574-0080(04)80010-5; Gandy M., 2004, CITY, V8, P363, DOI [DOI 10.1080/1360481042000313509, 10.1080/1360481042000313509]; Glaeser E.L., 2004, HDB REG URBAN EC, V4, P2481, DOI [DOI 10.1016/S1574-0080(04)80013-0, 10.1016/S1574-0080(04)80013-0]; Glaeser EL, 2010, J URBAN ECON, V67, P404, DOI 10.1016/j.jue.2009.11.006; Glaeser EL, 2010, J REGIONAL SCI, V50, P221, DOI 10.1111/j.1467-9787.2009.00635.x; Golubiewski N, 2012, AMBIO, V41, P751, DOI 10.1007/s13280-011-0232-7; Gurney KR, 2009, ENVIRON SCI TECHNOL, V43, P5535, DOI 10.1021/es900806c; Gurney KR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005373; IEA, 2012, WORLD EN OUTL 2012; Johansson TB, 2012, GLOBAL ENERGY ASSESS; JONES DW, 1991, ENERG POLICY, V19, P621, DOI 10.1016/0301-4215(91)90094-5; Katz JS, 2006, RES POLICY, V35, P893, DOI 10.1016/j.respol.2006.03.007; Kaya Y., 1990, INT PAN CLIM CHANG E; Kaya Y, 1990, INT PAN CLIM CHANG E; Kennedy C, 2007, J IND ECOL, V11, P43, DOI 10.1162/jie.2007.1107; Kennedy C, 2009, ENVIRON SCI TECHNOL, V43, P7297, DOI 10.1021/es900213p; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; Kuil P, 2017, P 24 ANN EUROPEAN RE; Lobo J, 2008, J URBAN ECON, V63, P871, DOI 10.1016/j.jue.2007.07.005; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Newman PWG, 1999, LANDSCAPE URBAN PLAN, V44, P219, DOI 10.1016/S0169-2046(99)00009-2; PARIKH J, 1995, GLOBAL ENVIRON CHANG, V5, P87, DOI 10.1016/0959-3780(95)00015-G; Payne JE, 2010, J ECON STUD, V37, P53, DOI 10.1108/01443581011012261; Puga D, 2010, J REGIONAL SCI, V50, P203, DOI 10.1111/j.1467-9787.2009.00657.x; Rappaport J, 2008, J URBAN ECON, V63, P715, DOI 10.1016/j.jue.2007.04.008; Rees W.E., 1996, OUR ECOLOGICAL FOOTP; Sedgley N, 2011, AM J ECON SOCIOL, V70, P86, DOI 10.1111/j.1536-7150.2010.00764.x; Seto K. C., 2012, P NATL ACAD SCI; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Seto KC, 2010, ANNU REV ENV RESOUR, V35, P167, DOI 10.1146/annurev-environ-100809-125336; Smil Vaclav, 2008, ENERGY NATURE SOC GE; SORNETTE D, 2004, SPRINGER SERIES SYNE, P1; Strumsky D, 2009, ENVIRON SCI TECHNOL; Thisse J.F., 2004, HDB REGIONAL URBAN E, V4, P2063, DOI [DOI 10.1016/S1574-0080(04)80006-3, 10.1016/S1574-0080(04)80006-3]; United Nations, 2012, WORLD URB PROSP 2011; USLANER EM, 1976, AM J POLIT SCI, V20, P125, DOI 10.2307/2110513; Weinzettel J, 2013, GLOBAL ENVIRON CHANG, V23, P433, DOI 10.1016/j.gloenvcha.2012.12.010; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wilson G., 2012, 2010 CENSUS SPECIAL; WOLMAN A, 1965, SCI AM, V213, P179; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	58	169	174	18	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64727	10.1371/journal.pone.0064727	http://dx.doi.org/10.1371/journal.pone.0064727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IE	23750213	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900015
J	Brown, BE; Nobecourt, E; Zeng, JM; Jenkins, AJ; Rye, KA; Davies, MJ				Brown, Bronwyn E.; Nobecourt, Estelle; Zeng, Jingmin; Jenkins, Alicia J.; Rye, Kerry-Anne; Davies, Michael J.			Apolipoprotein A-I glycation by Glucose and Reactive Aldehydes Alters Phospholipid Affinity but Not Cholesterol Export from Lipid-Laden Macrophages	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; DIABETIC-NEPHROPATHY; INHIBIT GLYCATION; VITRO FORMATION; END-PRODUCTS; EFFLUX; METHYLGLYOXAL; PROTEINS; GLYCOXIDATION; PREVENT	Increased protein glycation in people with diabetes may promote atherosclerosis. This study examined the effects of non-enzymatic glycation on the association of lipid-free apolipoproteinA-I (apoA-I) with phospholipid, and cholesterol efflux from lipid-loaded macrophages to lipid-free and lipid-associated apoA-I. Glycation of lipid-free apoA-I by methylglyoxal and glycolaldehyde resulted in Arg, Lys and Trp loss, advanced glycation end-product formation and protein cross-linking. The association of apoA-I glycated by glucose, methylglyoxal or glycolaldehyde with phospholipid multilamellar vesicles was impaired in a glycating agent dose-dependent manner, with exposure of apoA-I to both 30 mM glucose (42% decrease in k(slow)) and 3 mM glycolaldehyde (50% decrease in k(fast), 60% decrease in k(slow)) resulting is significantly reduced affinity. Cholesterol efflux to control or glycated lipid-free apoA-I, or discoidal reconstituted HDL containing glycated apoA-I (drHDL), was examined using cholesterol-loaded murine (J774A.1) macrophages treated to increase expression of ATP binding cassette transporters A1 (ABCA1) or G1 (ABCG1). Cholesterol efflux from J774A.1 macrophages to glycated lipid-free apoA-I via ABCA1 or glycated drHDL via an ABCG1-dependent mechanism was unaltered, as was efflux to minimally modified apoA-I from people with Type 1 diabetes, or controls. Changes to protein structure and function were prevented by the reactive carbonyl scavenger aminoguanidine. Overall these studies demonstrate that glycation of lipid-free apoA-I, particularly late glycation, modifies its structure, its capacity to bind phospholipids and but not ABCA1- or ABCG1-dependent cholesterol efflux from macrophages.	[Brown, Bronwyn E.; Nobecourt, Estelle; Zeng, Jingmin; Rye, Kerry-Anne; Davies, Michael J.] Heart Res Inst, Sydney, NSW, Australia; [Jenkins, Alicia J.; Rye, Kerry-Anne] Univ Melbourne, Dept Med St Vincents, Melbourne, Vic, Australia; [Brown, Bronwyn E.; Rye, Kerry-Anne; Davies, Michael J.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	University of Sydney; Heart Research Institute; University of Melbourne; University of Sydney	Davies, MJ (corresponding author), Heart Res Inst, Sydney, NSW, Australia.	daviesm@hri.org.au	Jenkins, Alicia/N-2482-2015; Davies, Michael/AGX-9184-2022; Davies, Michael J/H-4939-2011; Davies, Michael/GWV-2527-2022	Davies, Michael/0000-0002-5196-6919; Davies, Michael J/0000-0002-5196-6919; Jenkins, Alicia/0000-0003-0583-3717; Brown, Bronwyn/0000-0002-8980-7155	Diabetes Australia Research Trust; Australian Research Council; National Health and Medical Research Council	Diabetes Australia Research Trust; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Diabetes Australia Research Trust, the Australian Research Council, and the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BE, 2006, DIABETOLOGIA, V49, P775, DOI 10.1007/s00125-006-0137-3; Brown BE, 2005, DIABETOLOGIA, V48, P361, DOI 10.1007/s00125-004-1648-4; Brown BE, 2007, FEBS J, V274, P1530, DOI 10.1111/j.1742-4658.2007.05699.x; DUELL PB, 1991, DIABETES, V40, P377, DOI 10.2337/diabetes.40.3.377; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; HAIK GM, 1994, EXP EYE RES, V59, P497, DOI 10.1006/exer.1994.1135; Hoang A, 2007, DIABETOLOGIA, V50, P1770, DOI 10.1007/s00125-007-0718-9; Iborra RT, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-172; Imanaga Y, 2000, ATHEROSCLEROSIS, V150, P343, DOI 10.1016/S0021-9150(99)00396-2; Jang W, 2011, MOL CELLS, V31, P461, DOI 10.1007/s10059-011-1009-3; Jenkins AJ, 2004, DIABETES-METAB RES, V20, P349, DOI 10.1002/dmrr.491; Jenkins AJ, 2003, KIDNEY INT, V64, P817, DOI 10.1046/j.1523-1755.2003.00164.x; Knott HM, 2003, EUR J BIOCHEM, V270, P3572, DOI 10.1046/j.1432-1033.2003.03742.x; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Lewis GF, 1996, METABOLISM, V45, P1034, DOI 10.1016/S0026-0495(96)90276-0; LO TWC, 1994, J BIOL CHEM, V269, P32299; Machado AP, 2006, INT J BIOCHEM CELL B, V38, P392, DOI 10.1016/j.biocel.2005.09.016; Matsuki K, 2009, ATHEROSCLEROSIS, V206, P434, DOI 10.1016/j.atherosclerosis.2009.03.003; Nangaku M, 2003, J AM SOC NEPHROL, V14, P1212, DOI 10.1097/01.ASN.0000062961.76776.C1; Nanjee MN, 1996, ARTERIOSCL THROM VAS, V16, P1203, DOI 10.1161/01.ATV.16.9.1203; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nobecourt E, 2007, DIABETOLOGIA, V50, P643, DOI 10.1007/s00125-006-0574-z; Nobecourt E, 2010, ARTERIOSCL THROM VAS, V30, P766, DOI 10.1161/ATVBAHA.109.201715; Park KH, 2010, BIOCHEM BIOPH RES CO, V392, P295, DOI 10.1016/j.bbrc.2009.12.179; Passarelli M, 2000, CLIN CHIM ACTA, V301, P119, DOI 10.1016/S0009-8981(00)00336-3; Passarelli M, 2005, DIABETES, V54, P2198, DOI 10.2337/diabetes.54.7.2198; POWNALL HJ, 1978, BIOCHEMISTRY-US, V17, P1183, DOI 10.1021/bi00600a008; Rashduni DL, 1999, METABOLISM, V48, P139, DOI 10.1016/S0026-0495(99)90024-0; Rashid I, 2007, FEBS LETT, V581, P1067, DOI 10.1016/j.febslet.2007.01.082; RYE KA, 1993, BIOCHIM BIOPHYS ACTA, V1167, P316, DOI 10.1016/0005-2760(93)90235-2; Sakr SW, 1999, BBA-MOL CELL BIOL L, V1438, P85, DOI 10.1016/S1388-1981(99)00041-4; Segall ML, 2002, J LIPID RES, V43, P1688, DOI 10.1194/jlr.M200157-JLR200; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; Wang M, 2002, CHEM REV, V104, P119; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; World Health Organisation, 2002, DIABETES MELLITUS; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Zeng JM, 2005, CHEM RES TOXICOL, V18, P1232, DOI 10.1021/tx050074u	42	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65430	10.1371/journal.pone.0065430	http://dx.doi.org/10.1371/journal.pone.0065430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741493	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900206
J	Cronin, AL				Cronin, Adam L.			Conditional Use of Social and Private Information Guides House-Hunting Ants	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; LEARNING STRATEGIES; SITE SELECTION; NEST-SITE; CHEMICAL COMMUNICATION; PHEROMONE TRAILS; BEHAVIOR; ORIENTATION; RECRUITMENT; MODULATION	Social animals can use both social and private information to guide decision making. While social information can be relatively economical to acquire, it can lead to maladaptive information cascades if attention to environmental cues is supplanted by unconditional copying. Ants frequently employ pheromone trails, a form of social information, to guide collective processes, and this can include consensus decisions made when choosing a place to live. In this study, I examine how house-hunting ants balance social and private information when these information sources conflict to different degrees. Social information, in the form of pre-established pheromone trails, strongly influenced the decision process in choices between equivalent nests, and lead to a reduced relocation time. When trails lead to non-preferred types of nest, however, social information had less influence when this preference was weak and no influence when the preference was strong. These results suggest that social information is vetted against private information during the house-hunting process in this species. Private information is favoured in cases of conflict and this may help insure colonies against costly wrong decisions.	Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan	Iwate University	Cronin, AL (corresponding author), Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan.	adamcronin@gmail.com			United Graduate School of Agricultural Science, Iwate University	United Graduate School of Agricultural Science, Iwate University	This work was supported by funding from the United Graduate School of Agricultural Science, Iwate University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LR, 1997, AM ECON REV, V87, P847; Arbilly M, 2011, J R SOC INTERFACE, V8, P1604, DOI 10.1098/rsif.2011.0138; ARON S, 1993, INSECT SOC, V40, P369, DOI 10.1007/BF01253900; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Beekman M, 2009, CONTEMP TOP ENTOMOL, P115; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Boyd R., 1985, CULTURE EVOLUTIONARY; Cao TT, 2012, INSECT SOC, V59, P87, DOI 10.1007/s00040-011-0192-8; Chittka L, 2005, CURR BIOL, V15, pR869, DOI 10.1016/j.cub.2005.10.018; Cronin AL, 2012, ANIM BEHAV, V84, P1243, DOI 10.1016/j.anbehav.2012.08.036; Czaczkes TJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1009; Czaczkes TJ, 2013, J EXP BIOL, V216, P188, DOI 10.1242/jeb.076570; Czaczkes TJ, 2011, BIOL LETTERS, V7, P521, DOI 10.1098/rsbl.2011.0067; Detrain C, 2009, CONTEMP TOP ENTOMOL, P29; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Evison SEF, 2012, BEHAV ECOL SOCIOBIOL, V66, P711, DOI 10.1007/s00265-012-1319-2; Evison SEF, 2008, BEHAV ECOL SOCIOBIOL, V63, P261, DOI 10.1007/s00265-008-0657-6; Franks NR, 2003, ANIM BEHAV, V65, P215, DOI 10.1006/anbe.2002.2032; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Gruter C, 2008, P R SOC B, V275, P1321, DOI 10.1098/rspb.2008.0186; Gruter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044501; Gruter C, 2011, BEHAV ECOL SOCIOBIOL, V65, P141, DOI 10.1007/s00265-010-1020-2; Gruter C, 2010, CURR BIOL, V20, pR683, DOI 10.1016/j.cub.2010.06.052; HARRISON JF, 1989, ANIM BEHAV, V37, P869, DOI 10.1016/0003-3472(89)90076-6; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Holldobler B., 1990, pi; Jackson DE, 2007, ANIM BEHAV, V74, P463, DOI 10.1016/j.anbehav.2006.11.027; JEANNE RL, 1981, ANIM BEHAV, V29, P102, DOI 10.1016/S0003-3472(81)80157-1; Jeanson R, 2004, BEHAV ECOL SOCIOBIOL, V55, P388, DOI 10.1007/s00265-003-0716-y; Kendal J, 2009, J THEOR BIOL, V260, P210, DOI 10.1016/j.jtbi.2009.05.029; Kendal RL, 2004, BEHAV ECOL, V15, P269, DOI 10.1093/beheco/arh008; KENDAL RL, 2009, COGNITIVE ECOLOGY, V2; Laland KN, 2011, PHILOS T R SOC B, V366, P958, DOI 10.1098/rstb.2010.0328; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; Laland KN, 2004, LEARN BEHAV, V32, P4; Leadbeater E, 2009, CONTEMP TOP ENTOMOL, P135; List C, 2009, PHILOS T R SOC B, V364, P755, DOI 10.1098/rstb.2008.0277; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; Morgan TJH, 2012, P ROY SOC B-BIOL SCI, V279, P653, DOI 10.1098/rspb.2011.1172; Nocera JJ, 2006, P ROY SOC B-BIOL SCI, V273, P349, DOI 10.1098/rspb.2005.3318; Pratt S.C., 2010, ENCY ANIMAL BEHAV, V2, P534, DOI DOI 10.1016/B978-0-08-045337-8.00127-3; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; R Core Team, 2012, R LANG ENV STAT COMP; Rendell L, 2011, PHILOS T R SOC B, V366, P1118, DOI 10.1098/rstb.2010.0376; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rieucau G, 2011, PHILOS T R SOC B, V366, P949, DOI 10.1098/rstb.2010.0325; Rieucau G, 2009, BEHAV ECOL, V20, P1217, DOI 10.1093/beheco/arp121; Schmidt VM, 2006, ANIM BEHAV, V72, P1309, DOI 10.1016/j.anbehav.2006.03.023; Schorkopf DLP, 2011, J COMP PHYSIOL A, V197, P755, DOI 10.1007/s00359-011-0638-5; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Seeley TD, 2008, J EXP BIOL, V211, P3691, DOI 10.1242/jeb.021071; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Stroeymeyt N., 2010, PLOS ONE, V5; Stroeymeyt N, 2011, J EXP BIOL, V214, P3046, DOI 10.1242/jeb.059188; Stroeymeyt N, 2011, BEHAV ECOL, V22, P535, DOI 10.1093/beheco/arr007; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Webster MM, 2008, P ROY SOC B-BIOL SCI, V275, P2869, DOI 10.1098/rspb.2008.0817; Zuur Alain F., 2009, P1	64	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64668	10.1371/journal.pone.0064668	http://dx.doi.org/10.1371/journal.pone.0064668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741364	Green Published, gold			2022-12-27	WOS:000319799900077
J	Gaji, RY; Huynh, MH; Carruthers, VB				Gaji, Rajshekhar Y.; Huynh, My-Hang; Carruthers, Vern B.			A Novel High Throughput Invasion Screen Identifies Host Actin Regulators Required for Efficient Cell Entry by Toxoplasma gondii	PLOS ONE			English	Article							CYTOSKELETON; ASTROCYTES; ACTIVATION; SECRETION; INFECTION; PROMOTES; LAMININ; BINDING; CYCLE	Toxoplasma gondii critically relies on cell invasion as a survival strategy to evade immune clearance during infection. Although it was widely thought that Toxoplasma entry is parasite directed and that the host cell is largely a passive victim, recent studies have suggested that host components such as microfilaments and microtubules indeed contribute to entry. Hence to identify additional host factors, we performed a high-throughput siRNA screen of a human siRNA library targeting druggable proteins using a novel inducible luciferase based invasion assay. The top 100 hits from the primary screen that showed the strongest decreases in invasion were subjected to confirmation by secondary screening, revealing 24 proteins that are potentially involved in Toxoplasma entry into host cells. Interestingly, 6 of the hits appear to affect parasite invasion by modifying host cell actin dynamics, resulting in increased deposition of F-actin at the periphery of the cell. These findings support the emerging notion that host actin dynamics are important for Toxoplasma invasion along with identifying several novel host factors that potentially participate in parasite entry.	[Gaji, Rajshekhar Y.; Huynh, My-Hang; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu		Carruthers, Vern/0000-0001-6859-8895	National Institutes of Health [AI063263, AI076674]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063263, R21AI076674, R01AI046675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI063263 (VBC) and AI076674 (M-HH), and an American Heart Association Postdoctoral Fellowship (RYG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Barros JC, 2005, J CELL SCI, V118, P1663, DOI 10.1242/jcs.02308; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Delorme-Walker V, 2012, J CELL SCI, V125, P4333, DOI 10.1242/jcs.103648; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dubey JP, 1997, PARASITOLOGY, V115, P15, DOI 10.1017/S0031182097008949; Ek P, 2002, EUR J BIOCHEM, V269, P5016, DOI 10.1046/j.1432-1033.2002.03206.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FURTADO GC, 1992, INFECT IMMUN, V60, P2337, DOI 10.1128/IAI.60.6.2337-2342.1992; FURTADO GD, 1992, INFECT IMMUN, V60, P4925, DOI 10.1128/IAI.60.11.4925-4931.1992; Gaji RY, 2011, TRAFFIC, V12, P840, DOI 10.1111/j.1600-0854.2011.01192.x; Gaji RY, 2011, MOL MICROBIOL, V79, P192, DOI 10.1111/j.1365-2958.2010.07441.x; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; Halonen SK, 2001, INFECT IMMUN, V69, P5573, DOI 10.1128/IAI.69.9.5573-5576.2001; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Luder CGK, 1999, EXP PARASITOL, V93, P23, DOI 10.1006/expr.1999.4421; Martin S, 2001, Neonatal Netw, V20, P23; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; MORISAKI JH, 1995, J CELL SCI, V108, P2457; Ohnesorge N, 2010, J BIOL CHEM, V285, P26199, DOI 10.1074/jbc.M110.103127; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Ortega-Barria E, 1999, J BIOL CHEM, V274, P1267, DOI 10.1074/jbc.274.3.1267; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; Ramsay AK, 2011, BRIT J CANCER, V104, P664, DOI 10.1038/sj.bjc.6606062; ROBERTS T, 1994, PARASITOL TODAY, V10, P419, DOI 10.1016/0169-4758(94)90171-6; Schramp M, 2008, J CELL BIOL, V181, P1195, DOI 10.1083/jcb.200801078; SUMYUEN MH, 1995, J PARASITOL, V81, P327, DOI 10.2307/3283948; Sweeney KR, 2010, EUKARYOT CELL, V9, P1680, DOI 10.1128/EC.00079-10; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Xu AJ, 2010, LUNG CANCER, V67, P48, DOI 10.1016/j.lungcan.2009.03.005; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	42	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64693	10.1371/journal.pone.0064693	http://dx.doi.org/10.1371/journal.pone.0064693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741372	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900085
J	Green, DE; Adler, BJ; Chan, ME; Lennon, JJ; Acerbo, AS; Miller, LM; Rubin, CT				Green, Danielle E.; Adler, Benjamin J.; Chan, Meilin Ete; Lennon, James J.; Acerbo, Alvin S.; Miller, Lisa M.; Rubin, Clinton T.			Altered Composition of Bone as Triggered by Irradiation Facilitates the Rapid Erosion of the Matrix by Both Cellular and Physicochemical Processes	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MECHANICAL-PROPERTIES; TRABECULAR BONE; ALLOGRAFT BONE; SPECTROSCOPIC CHARACTERIZATION; BIOMECHANICAL PROPERTIES; MINERALIZED TISSUES; GAMMA-IRRADIATION; ELASTIC-MODULUS; CORTICAL BONE	Radiation rapidly undermines trabecular architecture, a destructive process which proceeds despite a devastated cell population. In addition to the 'biologically orchestrated' resorption of the matrix by osteoclasts, physicochemical processes enabled by a damaged matrix may contribute to the rapid erosion of bone quality. 8w male C57BL/6 mice exposed to 5 Gy of Cs-137 gamma-irradiation were compared to age-matched control at 2d, 10d, or 8w following exposure. By 10d, irradiation had led to significant loss of trabecular bone volume fraction. Assessed by reflection-based Fourier transform infrared imaging (FTIRI), chemical composition of the irradiated matrix indicated that mineralization had diminished at 2d by -4.3 +/- 4.8%, and at 10d by -5.8 +/- 3.2%. These data suggest that irradiation facilitates the dissolution of the matrix through a change in the material itself, a conclusion supported by a 13.7 +/- 4.5% increase in the elastic modulus as measured by nanoindentation. The decline in viable cells within the marrow of irradiated mice at 2d implies that the immediate collapse of bone quality and inherent increased risk of fracture is not solely a result of an overly-active biologic process, but one fostered by alterations in the material matrix that predisposes the material to erosion.	[Green, Danielle E.; Adler, Benjamin J.; Chan, Meilin Ete; Lennon, James J.; Acerbo, Alvin S.; Miller, Lisa M.; Rubin, Clinton T.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Acerbo, Alvin S.; Miller, Lisa M.] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Rubin, CT (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	clinton.rubin@stonybrook.edu	/D-8931-2011	/0000-0002-0909-6497	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; National Institutes of Health [AR43498, RR23782]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043498] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886. Funding for this research was also provided by National Institutes of Health AR43498 and RR23782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbo AS, 2012, ANAL CHEM, V84, P3607, DOI 10.1021/ac203375d; Akkus O, 2005, J ORTHOP RES, V23, P838, DOI 10.1016/j.orthres.2005.01.007; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Barth HD, 2010, BONE, V46, P1475, DOI 10.1016/j.bone.2010.02.025; Boivin G., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P538; Boskey Adele L, 2006, Curr Osteoporos Rep, V4, P71, DOI 10.1007/s11914-006-0005-6; Boskey AL, 2005, VIB SPECTROSC, V38, P107, DOI 10.1016/j.vibspec.2005.02.015; BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142, DOI 10.1210/endo-125-3-1142; Busa B, 2005, CALCIFIED TISSUE INT, V77, P386, DOI 10.1007/s00223-005-0148-y; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Christodouleas JP, 2011, NEW ENGL J MED, V364, P2334, DOI 10.1056/NEJMra1103676; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Currey JD, 1997, J ORTHOP RES, V15, P111, DOI 10.1002/jor.1100150116; Faibish D, 2005, BONE, V36, P6, DOI 10.1016/j.bone.2004.08.019; FIDELER BM, 1995, AM J SPORT MED, V23, P643, DOI 10.1177/036354659502300521; Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Halton JM, 1996, J BONE MINER RES, V11, P1774; Hamer AJ, 1999, J BONE JOINT SURG BR, V81B, P342, DOI 10.1302/0301-620X.81B2.9083; Hamer AJ, 1996, J BONE JOINT SURG BR, V78B, P363, DOI 10.1302/0301-620X.78B3.0780363; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Holt GE, 2005, J BONE JOINT SURG AM, V87A, P315, DOI 10.2106/JBJS.C.01714; Hubner W, 2005, INT J ARTIF ORGANS, V28, P66; Inagaki J, 2011, BONE MARROW TRANSPL, V46, P1057, DOI 10.1038/bmt.2010.253; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Kondo H, 2009, RADIAT RES, V171, P283, DOI 10.1667/RR1463.1; Longhi A, 2012, CANCER-AM CANCER SOC, V118, P5050, DOI 10.1002/cncr.27493; Lublinsky S, 2007, CALCIFIED TISSUE INT, V81, P285, DOI 10.1007/s00223-007-9063-8; Miller LM, 2007, J BONE MINER RES, V22, P1037, DOI 10.1359/JBMR.070402; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Ozcivici Engin, 2008, V455, P323, DOI 10.1007/978-1-59745-104-8_22; Paschalis EP, 2009, OSTEOPOROSIS INT, V20, P1043, DOI 10.1007/s00198-009-0857-6; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 1997, CALCIFIED TISSUE INT, V61, P480, DOI 10.1007/s002239900371; Savani BN, 2007, BIOL BLOOD MARROW TR, V13, P517, DOI 10.1016/j.bbmt.2007.01.085; Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241; van der Sluis IM, 2002, J PEDIATR-US, V141, P204, DOI 10.1067/mpd.2002.125728; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Willey JS, 2009, RADIAT RES, V170, P388; Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6	42	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64952	10.1371/journal.pone.0064952	http://dx.doi.org/10.1371/journal.pone.0064952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741433	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900146
J	Hepkema, H; Pouwels, KB; van der Ende, A; Westra, TA; Postma, MJ				Hepkema, Hiltsje; Pouwels, Koen B.; van der Ende, Arie; Westra, Tjalke A.; Postma, Maarten J.			Meningococcal Serogroup A, C, W-135 and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands	PLOS ONE			English	Article							DISEASE; IMMUNIZATION; IMPACT; CARRIAGE; ENGLAND; AGE	Background: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was introduced in the Netherlands for all children aged 14 months. Despite its success, herd immunity may wane over time. Recently, a serogroup A,C,W-135, Y meningococcal conjugate vaccine (MenACWY) was licensed for use in subjects of 12 months of age and above. Objectives: To evaluate the cost-effectiveness of meningococcal vaccination at 14 months and an additional vaccination at the age of 12 years, both with the MenACWY vaccine. Methods: A decision analysis cohort model, with 185,000 Dutch newborns, was used to evaluate the cost-effectiveness of different immunization strategies. For strategies including a vaccination at 12 years of age, an additional cohort with adolescents aged 12 years was followed. The incremental cost-effectiveness ratio (ICER) was estimated for the current disease incidence and for a scenario when herd immunity is lost. Results: Vaccination with MenACWY at 14 months is cost-saving. Vaccinating with MenACWY at 14 months and at 12 years would prevent 7 additional cases of meningococcal serogroup A, C, W-135, Y disease in the birth cohort and adolescent cohort followed for 99 years compared to the current vaccine schedule of a single vaccination with MenC at 14 months. With the current incidence, this strategy resulted in an ICER of (sic)635,334 per quality adjusted life year. When serogroup C disease incidence returns to pre-vaccination levels due to a loss of vaccine-induced herd-immunity, vaccination with MenACWY at 14 months and at 12 years would be cost-saving. Conclusions: Routine vaccination with MenACWY is cost-saving. With the current epidemiology, a booster-dose with MenACWY is not likely cost-effective. When herd immunity is lost, a booster-dose has the potential of being cost-effective. A dynamic model should be developed for more precise estimation of the cost-effectiveness of the prevention of disappearance of herd immunity.	[Hepkema, Hiltsje; Pouwels, Koen B.; Westra, Tjalke A.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands; [Westra, Tjalke A.] GlaxoSmithKline, Corp Affairs, Zeist, Netherlands	University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; GlaxoSmithKline	Postma, MJ (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	m.j.postma@rug.nl	Pouwels, Koen B./F-2081-2013	Pouwels, Koen B./0000-0001-7097-8950; Postma, Maarten/0000-0002-6306-3653	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was funded by a research grant from GlaxoSmithKline. GlaxoSmithKline had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P521; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Chen RT, 1996, EPIDEMIOL REV, V18, P99, DOI 10.1093/oxfordjournals.epirev.a017931; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; *COLL HLTH INS, PHARM PRIC MEN SER A; *COLL HLTH INS, PHARM PRIC MEN SER C; de Greeff SC, 2008, EUR J CLIN MICROBIOL, V27, P985, DOI 10.1007/s10096-008-0535-1; de Greeff SC, 2006, PEDIATR INFECT DIS J, V25, P79, DOI 10.1097/01.inf.0000195594.41449.c6; de Voer RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012144; De Wals P, 2006, VACCINE, V24, P3500, DOI 10.1016/j.vaccine.2006.02.010; De Wals P, 2007, VACCINE, V25, P5433, DOI 10.1016/j.vaccine.2007.04.071; DEVOER RM, 2010, MENINGOCOCCAL C SPEC; Drummond M, 2007, VACCINE, V25, P5945, DOI 10.1016/j.vaccine.2007.04.070; *DUTCH ASS HOSP, NUM GEN HOSP BED NUM; *DUTCH HEALTHC AUT, 2011, MED SPEC TREATM ITS; *DUTCH MIN ED CULT, 2012, KEY FIG 2007 2011; *EUR MED AG, 2013, EMA7558742012; *EUR MED AG, 2012, EMACHMP1363152012; *EUR UN INV BACT I, 2001, INV NEISS MEN EUR 20; Gill CJ, 2013, LANCET INFECT DIS, V13, P381, DOI 10.1016/S1473-3099(13)70037-9; Hakkaart-van Roijen L, 2010, GUIDELINES COSTING R; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Ishola DA, 2012, CLIN VACCINE IMMUNOL, V19, P1126, DOI 10.1128/CVI.05655-11; Kaaijk P, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-35; Kauf TL, 2010, PHARMACOECONOMICS, V28, P449, DOI 10.2165/11535280-000000000-00000; KIND P, 1999, 172 U YORK CTR HLTH; Knuf M, 2010, VACCINE, V28, P744, DOI 10.1016/j.vaccine.2009.10.064; Knuf M, 2011, VACCINE, V29, P4264, DOI 10.1016/j.vaccine.2011.03.009; Larrauri A, 2005, VACCINE, V23, P4097, DOI 10.1016/j.vaccine.2005.03.045; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; *MED CONTR AG, 2000, CURRENT PROBLEMS PHA, V26, P14; *MIN HLTH AUSTR, 2012, IMM SCHED AUSTR; NEPPELENBROEK SE, 2002, GOED GEDAAN WOORDVER; *NETH REF LAB BACT, ANN REP 2007 2011 U; Oostenbrink R, 2002, SCAND J INFECT DIS, V34, P379, DOI 10.1080/00365540110080179; Ortega-Sanchez IR, 2008, CLIN INFECT DIS, V46, P1, DOI 10.1086/524041; Pouwels KB, 2013, HUM VACC IMMUNOTHER, V9, P1129, DOI 10.4161/hv.23888; ROZENBAUM MH, 2010, BMJ-BRIT MED J, V304, pC2509; SCHOLTEN RJPM, 1994, EPIDEMIOL INFECT, V112, P115, DOI 10.1017/S0950268800057472; Shepard CW, 2005, PEDIATRICS, V115, P1220, DOI 10.1542/peds.2004-2514; SPANJAARD L, 1987, B WORLD HEALTH ORGAN, V65, P861; Stouthard MEA, 1997, DISABILITY WEIGHTS D; Trotter CL, 2006, LANCET INFECT DIS, V6, P616, DOI 10.1016/S1473-3099(06)70584-9; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; VANLIER EA, 2012, 2010010012012 RIVM; Vesikari T, 2013, LANCET, V381, P825, DOI 10.1016/S0140-6736(12)61961-8; Vesikari T, 2012, HUM VACC IMMUNOTHER, V8, P1892, DOI 10.4161/hv.22166; Vesikari T, 2011, VACCINE, V29, P4274, DOI 10.1016/j.vaccine.2011.03.043; Welte R, 2004, VACCINE, V23, P470, DOI 10.1016/j.vaccine.2004.06.019; *WHO, 2012, IMM SCHED SWITZ; World Health Organization, 2011, BACKGR PAP MEN VACC	54	24	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65036	10.1371/journal.pone.0065036	http://dx.doi.org/10.1371/journal.pone.0065036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741448	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900161
J	Mendel, TA; Clabough, EBD; Kao, DS; Demidova-Rice, TN; Durham, JT; Zotter, BC; Seaman, SA; Cronk, SM; Rakoczy, EP; Katz, AJ; Herman, IM; Peirce, SM; Yates, PA				Mendel, Thomas A.; Clabough, Erin B. D.; Kao, David S.; Demidova-Rice, Tatiana N.; Durham, Jennifer T.; Zotter, Brendan C.; Seaman, Scott A.; Cronk, Stephen M.; Rakoczy, Elizabeth P.; Katz, Adam J.; Herman, Ira M.; Peirce, Shayn M.; Yates, Paul A.			Pericytes Derived from Adipose-Derived Stem Cells Protect against Retinal Vasculopathy	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; SMOOTH-MUSCLE-CELLS; CONTRACTILE PHENOTYPE; STROMAL CELLS; MODEL; GROWTH; RETINOPATHY; ACTIVATION; TRANSPLANTATION; PROMOTE	Background: Retinal vasculopathies, including diabetic retinopathy (DR), threaten the vision of over 100 million people. Retinal pericytes are critical for microvascular control, supporting retinal endothelial cells via direct contact and paracrine mechanisms. With pericyte death or loss, endothelial dysfunction ensues, resulting in hypoxic insult, pathologic angiogenesis, and ultimately blindness. Adipose-derived stem cells (ASCs) differentiate into pericytes, suggesting they may be useful as a protective and regenerative cellular therapy for retinal vascular disease. In this study, we examine the ability of ASCs to differentiate into pericytes that can stabilize retinal vessels in multiple pre-clinical models of retinal vasculopathy. Methodology/Principal Findings: We found that ASCs express pericyte-specific markers in vitro. When injected intravitreally into the murine eye subjected to oxygen-induced retinopathy (OIR), ASCs were capable of migrating to and integrating with the retinal vasculature. Integrated ASCs maintained marker expression and pericyte-like morphology in vivo for at least 2 months. ASCs injected after OIR vessel destabilization and ablation enhanced vessel regrowth (16% reduction in avascular area). ASCs injected intravitreally before OIR vessel destabilization prevented retinal capillary dropout (53% reduction). Treatment of ASCs with transforming growth factor beta (TGF-beta 1) enhanced hASC pericyte function, in a manner similar to native retinal pericytes, with increased marker expression of smooth muscle actin, cellular contractility, endothelial stabilization, and microvascular protection in OIR. Finally, injected ASCs prevented capillary loss in the diabetic retinopathic Akimba mouse (79% reduction 2 months after injection). Conclusions/Significance: ASC-derived pericytes can integrate with retinal vasculature, adopting both pericyte morphology and marker expression, and provide functional vascular protection in multiple murine models of retinal vasculopathy. The pericyte phenotype demonstrated by ASCs is enhanced with TGF-beta 1 treatment, as seen with native retinal pericytes. ASCs may represent an innovative cellular therapy for protection against and repair of DR and other retinal vascular diseases.	[Mendel, Thomas A.; Clabough, Erin B. D.; Kao, David S.; Zotter, Brendan C.; Yates, Paul A.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22903 USA; [Mendel, Thomas A.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Demidova-Rice, Tatiana N.; Durham, Jennifer T.; Herman, Ira M.] Tufts Univ, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA; [Rakoczy, Elizabeth P.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Dept Mol Ophthalmol, Nedlands, WA 6009, Australia; [Katz, Adam J.] Univ Virginia, Dept Plast Surg, Charlottesville, VA USA; [Seaman, Scott A.; Cronk, Stephen M.; Peirce, Shayn M.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	University of Virginia; University of Virginia; Tufts University; University of Western Australia; University of Virginia; University of Virginia	Yates, PA (corresponding author), Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22903 USA.	pay2x@virginia.edu		Peirce, Shayn/0000-0001-5857-5606	Launchpad Translational Research Fund for Biomedical Innovation in Diabetes, Richmond Eye and Ear Foundation, National Institutes of Health (NIH) [T32GM08715, NIH HL082838-02, NIH K08 EY019533-02]; NATIONAL EYE INSTITUTE [R01EY022063, K08EY019533] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, T32GM008715] Funding Source: NIH RePORTER	Launchpad Translational Research Fund for Biomedical Innovation in Diabetes, Richmond Eye and Ear Foundation, National Institutes of Health (NIH); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Launchpad Translational Research Fund for Biomedical Innovation in Diabetes, Richmond Eye and Ear Foundation, National Institutes of Health (NIH) T32GM08715 to TAM, NIH HL082838-02 to SMP, and NIH K08 EY019533-02 to PAY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shabrawey M, 2011, DIABETES, V60, P614, DOI 10.2337/db10-0008; Altman AM, 2008, AESTHET PLAST SURG, V32, P56, DOI 10.1007/s00266-007-9008-7; Amos PJ, 2008, STEM CELLS; Aoki H, 2008, GRAEF ARCH CLIN EXP, V246, P255, DOI 10.1007/s00417-007-0710-6; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attinger CE, 2007, PLAST RECONSTR SURG, V120, P412, DOI 10.1097/01.prs.0000267697.74070.f7; Cetrulo CL, 2005, PLAST RECONSTR SURG, V116, P1053, DOI 10.1097/01.prs.0000178403.79051.70; Chan RK, 2007, PLAST RECONSTR SURG, V120, P409, DOI 10.1097/01.prs.0000267696.98789.66; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Chan-Ling T, 2006, AM J PATHOL, V168, P1031, DOI 10.2353/ajpath.2006.050697; Chen CW, 2009, CYTOKINE GROWTH F R, V20, P429, DOI 10.1016/j.cytogfr.2009.10.014; Cheng LN, 2011, AM J ROENTGENOL, V196, P1381, DOI 10.2214/AJR.10.5495; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Gruh I, 2006, CIRCULATION, V113, P1326, DOI 10.1161/CIRCULATIONAHA.105.559005; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hauger O, 2006, RADIOLOGY, V238, P200, DOI 10.1148/radiol.2381041668; HEALY AM, 1992, EUR J CELL BIOL, V59, P56; Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314; HERMAN IM, 1985, J CELL BIOL, V101, P43, DOI 10.1083/jcb.101.1.43; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Huang SD, 2006, J THORAC CARDIOV SUR, V132, P1329, DOI 10.1016/j.jtcvs.2006.08.021; Hughes S, 2007, INVEST OPHTH VIS SCI, V48, P1368, DOI 10.1167/iovs.06-0850; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kendirci M, 2010, J UROLOGY, V184, P1560, DOI 10.1016/j.juro.2010.05.088; Kicic A, 2003, J NEUROSCI, V23, P7742; Kielczewski JL, 2011, AM J PATHOL, V178, P1517, DOI 10.1016/j.ajpath.2010.12.031; Kotecki M, 2010, MICROVASC RES, V80, P339, DOI 10.1016/j.mvr.2010.07.012; Kutcher ME, 2007, AM J PATHOL, V171, P693, DOI 10.2353/ajpath.2007.070102; Lin GT, 2012, CYTOTHERAPY, V14, P240, DOI 10.3109/14653249.2011.627918; Lu F, 2008, PLAST RECONSTR SURG, V121, P50, DOI 10.1097/01.prs.0000293876.10700.b8; Lu F, 2009, PLAST RECONSTR SURG, V124, P1437, DOI 10.1097/PRS.0b013e3181babbb6; MacIsaac ZM, 2012, EXP CELL RES, V318, P416, DOI 10.1016/j.yexcr.2011.12.002; Mario S. P., 2010, GLOBAL DATA VISUAL I; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; NEWCOMB PM, 1993, J CELL PHYSIOL, V155, P385, DOI 10.1002/jcp.1041550220; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Papetti M, 2003, INVEST OPHTH VIS SCI, V44, P4994, DOI 10.1167/iovs.03-0291; Perdiguero EG, 2011, J BIOL CHEM, V286, P36841, DOI 10.1074/jbc.M111.220061; Rakoczy EP, 2010, AM J PATHOL, V177, P2659, DOI 10.2353/ajpath.2010.090883; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; Sengupta N, 2003, INVEST OPHTH VIS SCI, V44, P4908, DOI 10.1167/iovs.03-0342; Sieczkiewicz GJ, 2003, MICROVASC RES, V66, P190, DOI 10.1016/S0026-2862(03)00055-4; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Wong T, 2011, ASS RES VIS OPHTH AN; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108; Zhang SX, 2007, PROG RETIN EYE RES, V26, P1, DOI 10.1016/j.preteyeres.2006.09.002; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	62	105	110	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65691	10.1371/journal.pone.0065691	http://dx.doi.org/10.1371/journal.pone.0065691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741506	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900219
J	Modig, K; Andersson, T; Drefahl, S; Ahlbom, A				Modig, Karin; Andersson, Tomas; Drefahl, Sven; Ahlbom, Anders			Age-Specific Trends in Morbidity, Mortality and Case-Fatality from Cardiovascular Disease, Myocardial Infarction and Stroke in Advanced Age: Evaluation in the Swedish Population	PLOS ONE			English	Article							HEART-DISEASE; RISK; SURVIVAL; DYNAMICS; FUTURE; CANCER; EUROPE; SWEDEN; HEALTH; OLD	Background: It is not clear if the downward trend in cardiovascular disease (CVD) observed for ages up to 85 years can be extended to the oldest old, those 85 years and above. Methods and Findings: This nationwide cohort study presents age specific trends of CVD as well as for myocardial infarction (MI) and stroke separately for the period 1994 to 2010 for individuals 85 to 99 years old in Sweden. Data were extracted from national registries. All analyses were based on one-year age- and sex- specific figures. The risk for CVD increased with every age above 85 years although the rate of increase leveled off with age. Over time, the risk for CVD and MI decreased for all ages, and for stroke for ages up to 89 years. However, the risk of MI increased until around 2001 in all age groups and both sexes but decreased after that. The overall mortality improved for all outcomes over the period 1994 to 2010, so did the survival within 28 days from an event. The average annual decline in mortality over all ages, 85 and above was 3% for MI, 2% for stroke and for 2% CVD. Corresponding figures for ages 60-84 was 4% for each of MI, stroke and CVD. The results were similar for men and women. Conclusions: Improvements in CVD risks observed among ages up to 85 years appear to have extended also to ages above 85 years, even if the rate of improvement plateaued with age. The improvements in survival for all ages up to 99 years give no support to the hypothesis that more fragile individuals reach higher ages. Additional research is needed to find out if improvement in survival can be seen also for the second and third event of CVD, stroke and MI.	[Modig, Karin; Andersson, Tomas; Drefahl, Sven; Ahlbom, Anders] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Andersson, Tomas] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Drefahl, Sven] Stockholm Univ, Dept Sociol, Demog Unit, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Stockholm University	Modig, K (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	karin.modig@ki.se	Modig, Karin/H-1542-2014	Modig, Karin/0000-0002-5151-4867; Drefahl, Sven/0000-0003-4533-7558	Swedish Council for Working Life and Social Research; Swedish abbreviation	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish abbreviation	This study was funded by the Swedish Council for Working Life and Social Research, FAS by Swedish abbreviation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1995, SURVIVAL ANAL USING; Amiri M, 2011, J EPIDEMIOL COMMUN H, V65, P676, DOI 10.1136/jech.2010.109058; Arnold AM, 2005, J AM GERIATR SOC, V53, P211, DOI 10.1111/j.1532-5415.2005.53105.x; Cooper R, 2000, CIRCULATION, V102, P3137; Dickman PW, 2006, J INTERN MED, V260, P103, DOI 10.1111/j.1365-2796.2006.01677.x; Drefahl S, 2012, J INTERN MED, V272, P100, DOI 10.1111/j.1365-2796.2012.02518.x; Driver JA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2467; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hallstrom B, 2008, STROKE, V39, P10, DOI 10.1161/STROKEAHA.107.491779; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; Janssen F, 2005, J EPIDEMIOL COMMUN H, V59, P775, DOI 10.1136/jech.2004.028407; Kesteloot H, 2006, EUR HEART J, V27, P107, DOI 10.1093/eurheartj/ehi511; Koopman C, 2012, INT J CARDIOL; Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mannsverk J, 2012, EUR J PREV CARDIOL, V19, P927, DOI 10.1177/1741826711421081; Modig K, 2012, EUR J EPIDEMIOL, V27, P139, DOI 10.1007/s10654-012-9653-2; Modig KD S, 2013, INT J EPIDEMIOL, V2013, P1; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025; Peeters A, 2011, EUR J EPIDEMIOL, V26, P369, DOI 10.1007/s10654-011-9546-9; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Swedish National Board of Health and Welfare, 2011, HJART 1987 2010 MYOC; Vaartjes I, 2011, HEART, V97, P569, DOI 10.1136/hrt.2010.206565; Vaartjes I, 2012, STROKE; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	28	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64928	10.1371/journal.pone.0064928	http://dx.doi.org/10.1371/journal.pone.0064928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741426	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900139
J	Ovejero-Benito, MC; Frade, JM				Ovejero-Benito, Maria C.; Frade, Jose M.			Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CELL-CYCLE REENTRY; ALZHEIMERS-DISEASE; TYROSINE PHOSPHORYLATION; KINASE; DEATH; EXPRESSION; BDNF; APOPTOSIS; P34(CDC2)	Neurodegeneration is often associated with DNA synthesis in neurons, the latter usually remaining for a long time as tetraploid cells before dying by apoptosis. The molecular mechanism preventing G2/M transition in these neurons remains unknown, but it may be reminiscent of the mechanism that maintains tetraploid retinal ganglion cells (RGCs) in a G2-like state during normal development, thus preventing their death. Here we show that this latter process, known to depend on brain-derived neurotrophic factor (BDNF), requires the inhibition of cdk1 by TrkB. We demonstrate that a subpopulation of chick RGCs previously shown to become tetraploid co-expresses TrkB and cdk1 in vivo. By using an in vitro system that recapitulates differentiation and cell cycle re-entry of chick retinal neurons we show that BDNF, employed at concentrations specific for the TrkB receptor, reduces the expression of cdk1 in TrkB-positive, differentiating neurons. In this system, BDNF also inhibits the activity of both endogenous cdk1 and exogenously-expressed cdk1/cyclin B1 complex. This inhibition correlates with the phosphorylation of cdk1 at Tyr15, an effect that can be prevented with K252a, a tyrosine kinase inhibitor commonly used to prevent the activity of neurotrophins through their Trk receptors. The effect of BDNF on cdk1 activity is Tyr15-specific since BDNF cannot prevent the activity of a constitutively active form of cdk1 (Tyr15Phe) when expressed in differentiating retinal neurons. We also show that BDNF-dependent phosphorylation of cdk1 at Tyr15 could not be blocked with MK-1775, a Wee1-selective inhibitor, indicating that Tyr15 phosphorylation in cdk1 does not seem to occur through the canonical mechanism observed in proliferating cells. We conclude that the inhibition of both expression and activity of cdk1 through a BDNF-dependent mechanism contributes to the maintenance of tetraploid RGCs in a G2-like state.	[Ovejero-Benito, Maria C.; Frade, Jose M.] CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Frade, JM (corresponding author), CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain.	frade@cajal.csic.es	Frade, Jose M/E-7913-2013; Ovejero-Benito, María Carmen/AAY-5238-2020; Ovejero-Benito, Maria C/L-9218-2014	Frade, Jose M/0000-0001-7067-2505; Ovejero-Benito, Maria C/0000-0003-4082-5165	Secretaria de Estado de Investigacion, Desarrollo e Innovacion [BFU2009-07671, SAF2012-38316]; Fundacion Areces [CIVP16A1815]; Ministerio de Educacion, Cultura y Deporte [AP2008-04655]	Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Fundacion Areces; Ministerio de Educacion, Cultura y Deporte	This work was supported by grants from the "Secretaria de Estado de Investigacion, Desarrollo e Innovacion" (Refs. BFU2009-07671 and SAF2012-38316) (http://www.mineco.gob.es) and from the "Fundacion Areces" (Ref. CIVP16A1815) (http://www.fundacionareces.es). MCOB was supported by a FPU fellowship from the "Ministerio de Educacion, Cultura y Deporte" (Ref. AP2008-04655) (http://www.mecd.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allington C, 2001, CELL DEATH DIFFER, V8, P451, DOI 10.1038/sj.cdd.4400831; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Arendt T, 2010, AM J PATHOL, V177, P15, DOI 10.2353/ajpath.2010.090955; BERG MM, 1992, J BIOL CHEM, V267, P13; Bicknell KA, 2004, BIOCHEM J, V382, P411, DOI 10.1042/BJ20031481; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; BUCHKOVICH KJ, 1994, MOL BIOL CELL, V5, P1225, DOI 10.1091/mbc.5.11.1225; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; Dechant G, 2001, CELL TISSUE RES, V305, P229, DOI 10.1007/s004410100378; DELAROSA EJ, 1994, NEUROSCIENCE, V58, P347, DOI 10.1016/0306-4522(94)90041-8; Espanel X, 1997, INT J DEV BIOL, V41, P469; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Fletcher L, 2002, CANCER RES, V62, P241; Frade JM, 1996, EXP CELL RES, V222, P140, DOI 10.1006/excr.1996.0018; Frade JM, 2000, J CELL SCI, V113, P1139; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 2000, METH MOL B, V139, P257; Frade JM, 1997, DEVELOPMENT, V124, P3313; Frade JM, 1996, NATURE, V383, P166; Frade JN, 1996, DEVELOPMENT, V122, P2497; Frade JM, 2010, CELL CYCLE, V9, P1934, DOI 10.4161/cc.9.10.11582; Gannon JV, 1998, GENES CELLS, V3, P17, DOI 10.1046/j.1365-2443.1998.00163.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Herrup K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt37; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; Kimpinski K, 1999, NEUROSCIENCE, V93, P253, DOI 10.1016/S0306-4522(99)00156-6; KOBAYASHI H, 1992, MOL BIOL CELL, V3, P1279, DOI 10.1091/mbc.3.11.1279; Konishi Y, 2003, J NEUROSCI, V23, P1649; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; LEES E, 1995, CURR OPIN CELL BIOL, V7, P773, DOI 10.1016/0955-0674(95)80060-3; Liu DX, 2005, GENE DEV, V19, P719, DOI 10.1101/gad.1296405; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; Lopez-Sanchez N, 2007, PHYSIOL GENOMICS, V30, P156, DOI 10.1152/physiolgenomics.00249.2006; Lopez-Sanchez N, 2011, RESULTS PROBL CELL D, V53, P547, DOI 10.1007/978-3-642-19065-0_22; LOPEZSANCHEZ N, 2013, J NEUROSCI IN PRESS; MacPhee IJ, 1997, J BIOL CHEM, V272, P23547, DOI 10.1074/jbc.272.38.23547; Morillo SM, 2012, MOL CELL BIOL, V32, P2722, DOI 10.1128/MCB.00239-12; Morillo SM, 2010, P NATL ACAD SCI USA, V107, P109, DOI 10.1073/pnas.0906121107; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; Muller M, 2010, J CELL SCI, V123, P286, DOI 10.1242/jcs.058230; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; Ogawa O, 2003, ACTA NEUROPATHOL, V105, P524, DOI 10.1007/s00401-003-0684-3; PADGETT CS, 1960, ANAT REC, V137, P1, DOI 10.1002/ar.1091370102; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pei JJ, 2002, ACTA NEUROPATHOL, V104, P369, DOI 10.1007/s00401-002-0565-1; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; PRADA C, 1991, EUR J NEUROSCI, V3, P559, DOI 10.1111/j.1460-9568.1991.tb00843.x; Ray G, 2006, BIOCHEMISTRY-US, V45, P3703, DOI 10.1021/bi051570k; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; Santos AM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036243, 10.1371/journal.pone.0048332]; Skaper Stephen D, 2012, Methods Mol Biol, V846, P1, DOI 10.1007/978-1-61779-536-7_1; Suzuki S, 2002, ANAL BIOCHEM, V301, P65, DOI 10.1006/abio.2001.5495; Tomashevski A, 2001, J ALZHEIMERS DIS, V3, P195; Tsujioka Y, 1999, DEMENT GERIATR COGN, V10, P192, DOI 10.1159/000017119; Vincent I, 1997, J NEUROSCI, V17, P3588; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; WATANABE M, 1991, J NEUROBIOL, V22, P85, DOI 10.1002/neu.480220109; Wen Y, 2004, J BIOL CHEM, V279, P22684, DOI 10.1074/jbc.M311768200; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	67	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64890	10.1371/journal.pone.0064890	http://dx.doi.org/10.1371/journal.pone.0064890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741412	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900125
J	Sawford, K; Vollman, AR; Stephen, C				Sawford, Kate; Vollman, Ardene Robinson; Stephen, Craig			A Focused Ethnographic Study of Alberta Cattle Veterinarians' Decision Making about Diagnostic Laboratory Submissions and Perceptions of Surveillance Programs	PLOS ONE			English	Article							ANIMAL HEALTH; DISEASE SURVEILLANCE; MOUTH-DISEASE; SATURATION; EMERGENCE; OUTBREAK	The animal and public health communities need to address the challenge posed by zoonotic emerging infectious diseases. To minimize the impacts of future events, animal disease surveillance will need to enable prompt event detection and response. Diagnostic laboratory-based surveillance systems targeting domestic animals depend in large part on private veterinarians to submit samples from cases to a laboratory. In contexts where pre-diagnostic laboratory surveillance systems have been implemented, this group of veterinarians is often asked to input data. This scenario holds true in Alberta where private cattle veterinarians have been asked to participate in the Alberta Veterinary Surveillance Network-Veterinary Practice Surveillance, a platform to which pre-diagnostic disease and non-disease case data are submitted. Consequently, understanding the factors that influence these veterinarians to submit cases to a laboratory and the complex of factors that affect their participation in surveillance programs is foundational to interpreting disease patterns reported by laboratories and engaging veterinarians in surveillance. A focused ethnographic study was conducted with ten cattle veterinarians in Alberta. Individual in-depth interviews with participants were recorded and transcribed to enable thematic analysis. Laboratory submissions were biased toward outbreaks of unknown cause, cases with unusual mortality rates, and issues with potential herd-level implications. Decreasing cattle value and government support for laboratory testing have contributed to fewer submissions over time. Participants were willing participants in surveillance, though government support and collaboration were necessary. Changes in the beef industry and veterinary profession, as well as cattle producers themselves, present both challenges and opportunities in surveillance.	[Sawford, Kate] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia; [Sawford, Kate; Stephen, Craig] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada; [Sawford, Kate] Univ Calgary, Fac Med, Dept Med Sci, Calgary, AB, Canada; [Vollman, Ardene Robinson] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada	University of Sydney; University of Calgary; University of Calgary; University of Calgary	Sawford, K (corresponding author), Univ Sydney, Fac Vet Sci, Camden, NSW, Australia.	kate.sawford@sydney.edu.au	Sawford, Katherine/B-9095-2014		Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by a Strategic Project Grant from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezcua MD, 2010, CAN J VET RES, V74, P241; [Anonymous], 2009, SUSTAINING GLOBAL SU; Babcock S, 2008, JAVMA-J AM VET MED A, V233, P1556, DOI 10.2460/javma.233.10.1556; Baker E L Jr, 1996, J Public Health Manag Pract, V2, P58; Berezowski J, 2011, REV EPID SAN ANIM, V59-60, P32; Bloom Y, 2000, J Public Health Manag Pract, V6, P78; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX; Carpenter TE, 2011, J VET DIAGN INVEST, V23, P26, DOI 10.1177/104063871102300104; Christou L, 2011, CLIN MICROBIOL INFEC, V17, P326, DOI 10.1111/j.1469-0691.2010.03441.x; Coe JB, 2007, JAVMA-J AM VET MED A, V231, P1510, DOI 10.2460/javma.231.10.1510; Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6; Daszak P, 2009, ECOHEALTH, V6, P1, DOI 10.1007/s10393-009-0253-x; Doherr MG, 2001, PHILOS T R SOC B, V356, P1097, DOI 10.1098/rstb.2001.0898; Elbakidze L, 2006, J AGR APPL EC, V38; Field CJ, 2002, J LEUKOCYTE BIOL, V71, P16; Fudge RS, 1999, J BUS ETHICS, V18, P295, DOI 10.1023/A:1005801022353; Gibbens JC, 2008, VET REC, V162, P771, DOI 10.1136/vr.162.24.771; Given L, 2006, LIBR HI TECH, V24, P376, DOI 10.1108/07378830610692145; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Green LW, 1996, AM J HEALTH PROMOT, V10, P270, DOI 10.4278/0890-1171-10.4.270; Greger M, 2007, CRIT REV MICROBIOL, V33, P243, DOI 10.1080/10408410701647594; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hektoen L, 2004, VET REC, V155, P701, DOI 10.1136/vr.155.22.701; Hueston W D, 1993, Rev Sci Tech, V12, P1187; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; Kloeze H, 2010, TRANSBOUND EMERG DIS, V57, P414, DOI 10.1111/j.1865-1682.2010.01166.x; Liccione WJ, 2007, PERFORMANCE IMPROVEM, V46, P16; Ndiaye SM, 2003, HEALTH PROMOT INT, V18, P89, DOI 10.1093/heapro/18.2.89; Newcomb J., 2003, BIOL BORDERS SARS NE; Palmer S, 2009, SOCIOL RURALIS, V49, P360, DOI 10.1111/j.1467-9523.2009.00495.x; Pope Jeanette, 2005, Sex Health, V2, P97, DOI 10.1071/SH04052; Richards, 2002, README 1 USERS GUIDE; Rushton J, 2006, REV SCI TECH OIE, V25, P375, DOI 10.20506/rst.25.1.1671; Sawford K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048035; Scudamore JM, 2002, REV SCI TECH OIE, V21, P699, DOI 10.20506/rst.21.3.1351; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thobokwe G, 2004, NEW ZEAL VET J, V52, P90, DOI 10.1080/00480169.2004.36411; THURMOND MC, 1994, J VET DIAGN INVEST, V6, P269, DOI 10.1177/104063879400600224; UMALI DL, 1994, WORLD BANK RES OBSER, V9, P71, DOI 10.1093/wbro/9.1.71; Vaarst M, 2003, LIVEST PROD SCI, V80, P109, DOI 10.1016/S0301-6226(02)00310-X; Wagner M M, 2001, J Public Health Manag Pract, V7, P51; Wagner MM., 2006, HDB BIOSURVEILLANCE; Watson EN, 2008, VET REC, V163, P531, DOI 10.1136/vr.163.18.531; Wilkinson D, 2007, HEALTH SERV MANAG RE, V20, P211, DOI 10.1258/095148407782219058; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; World Health Organization, 2006, SEACD148 WHO	47	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64811	10.1371/journal.pone.0064811	http://dx.doi.org/10.1371/journal.pone.0064811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741397	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900110
J	Song, ZQ; Zhai, ZF; Zhong, H; Zhou, ZY; Chen, WC; Hao, F				Song, Zhiqiang; Zhai, Zhifang; Zhong, Hua; Zhou, Ziyuan; Chen, WenChieh; Hao, Fei			Evaluation of Autologous Serum Skin Test and Skin Prick Test Reactivity to House Dust Mite in Patients with Chronic Spontaneous Urticaria	PLOS ONE			English	Article							AUTOANTIBODIES; POSITIVITY; PREVALENCE; THERAPY	Background: Chronic spontaneous urticaria (CSU) is a common skin disorder with etiology that is not well understood. Methods: In this study, we evaluated the prevalence of autologous serum skin test (ASST) and skin prick testing (SPT) to house dust mite (HDM) in 862 CSU cases in China. Clinical features, courses and treatment responses were also recorded. Results: The prevalence of positive ASST was 46.3%, and patients aged 30-39 years had the highest positive rate (52.1%). Positive SPT to HDM was seen in 153 patients (17.7%) with the highest positive rate (34.2%) in patients aged 20 or less. Patients with positive ASST had higher urticaria activity scores (UAS) (4.18 +/- 0.65 vs. 3.67 +/- 0.53) but lower positive rates of HDM (24.6% vs. 37.6%), as compared with those with negative ASST (odds ratio (OR) 1.84, 95% CI 1.38-2.47). Patients could be categorized into four groups based on the results of ASST and SPT to HDM and patients with positive ASST and positive SPT to HDM had the highest disease activity scores, experienced higher frequencies of angioedema, diseases duration, and required higher dosage of loratadine every month, compared with other subgroups (P<0.0001). Conclusions: Patients with CSU showed varied responses of positive ASST and varied sensitivity to HDM, Patients with positive ASST and/or positive SPT had more disease activity compared with patients with negative ASST and/or negative SPT. Further classification can be made based on the result of SPT and ASST.	[Song, Zhiqiang; Zhai, Zhifang; Zhong, Hua; Hao, Fei] Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China; [Chen, WenChieh] Tech Univ Munich, Dept Dermatol & Allergy, D-80290 Munich, Germany; [Zhou, Ziyuan] Third Mil Med Univ, Prevent Coll, Dept Toxicol, Chongqing, Peoples R China	Army Medical University; Technical University of Munich; Army Medical University	Hao, F (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China.	swderma@126.com	zhai, zhifang/AAK-8284-2020	zhai, zhifang/0000-0003-2565-0272	Third Military Medical University [2010XLC11]; National Science Foundation of China [81072447]	Third Military Medical University; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Clinical Research Funding of the Third Military Medical University (2010XLC11) (http://www.tmmu.edu.cn) and National Science Foundation of China (81072447) (http://www.nsfc.gov.cn). These funders are used to pay for the expense of related test regents, data collection and analysis. The funders had no role in study design, decision to publish, or preparation of the manuscript. Dr. Zhiqiang Song, Dr. Zhifang Zhai, Dr. Hua Zhong, Dr. Ziyuan Zhou and Prof. Fei Hao are employed by Third Military Medical University.	Augey F, 2011, EUR J DERMATOL, V21, P349, DOI 10.1684/ejd.2011.1285; Bajaj AK, 2008, INDIAN J DERMATOL VE, V74, P109, DOI 10.4103/0378-6323.39691; Boguniewicz M, 2008, ALLERGY ASTHMA PROC, V29, P433, DOI 10.2500/aap.2008.29.3148; Buss Yiling Andrea, 2007, J Dtsch Dermatol Ges, V5, P22, DOI 10.1111/j.1610-0387.2007.06194.x; Caliskaner Z, 2004, J INVEST ALLERG CLIN, V14, P50; Chen S, 2012, CHINESE J DERMATOL, V45, P12; Daschner A, 2010, J DERMATOL, V37, P780, DOI 10.1111/j.1346-8138.2010.00869.x; Irinyi B, 2007, INT ARCH ALLERGY IMM, V144, P217, DOI 10.1159/000103995; Jariwala SP, 2009, ANN ALLERG ASTHMA IM, V102, P475, DOI 10.1016/S1081-1206(10)60120-2; Johansson SGO, 2001, ALLERGY, V56, P813, DOI 10.1034/j.1398-9995.2001.t01-1-00001.x; Kaplan AP, 2009, CLIN EXP ALLERGY, V39, P777, DOI 10.1111/j.1365-2222.2009.03256.x; Kasperska-Zajac A, 2009, VACCINE, V27, P7240, DOI 10.1016/j.vaccine.2009.08.076; Kocaturk E, 2011, J DERMATOL TREAT, V31, P1; Konstantinou GN, 2009, ALLERGY, V64, P1256, DOI 10.1111/j.1398-9995.2009.02132.x; Kulthanan K, 2008, ACTA DERM-VENEREOL, V88, P584, DOI 10.2340/00015555-0546; Kulthanan K, 2008, J DERMATOL, V35, P330, DOI 10.1111/j.1346-8138.2008.00477.x; Lennox RD, 2004, ANN ALLERG ASTHMA IM, V93, P142, DOI 10.1016/S1081-1206(10)61466-4; Mahesh P A, 2005, Indian J Dermatol Venereol Leprol, V71, P99; Maurer M, 2011, ALLERGY, V66, P317, DOI 10.1111/j.1398-9995.2010.02496.x; Mlynek A, 2008, CURR OPIN ALLERGY CL, V8, P433, DOI 10.1097/ACI.0b013e32830f9119; Najib U, 2009, ALLERGY ASTHMA PROC, V30, P1, DOI 10.2500/aap.2009.30.3191; NUMATA T, 1980, Journal of Dermatology (Tokyo), V7, P197, DOI 10.1111/j.1346-8138.1980.tb03532.x; Ronchetti R, 2003, PEDIAT ALLERG IMM-UK, V14, P201, DOI 10.1034/j.1399-3038.2003.00027.x; Sabroe RA, 1999, BRIT J DERMATOL, V140, P446; Sabroe RA, 1999, J AM ACAD DERMATOL, V40, P443, DOI 10.1016/S0190-9622(99)70495-0; Sheikh J, 2005, CURR OPIN ALLERGY CL, V5, P403, DOI 10.1097/01.all.0000182540.45348.bc; Song ZhiQiang, 2008, Journal of Clinical Dermatology, V37, P809; Staubach P, 2006, DERMATOLOGY, V212, P150, DOI 10.1159/000090656; Toubi E, 2004, ALLERGY, V59, P869, DOI 10.1111/j.1398-9995.2004.00473.x; Wedi B, 2008, J DTSCH DERMATOL GES, V6, P306, DOI 10.1111/j.1610-0387.2008.06661.x; Yildiz H, 2011, BRIT J DERMATOL, V165, P1205, DOI 10.1111/j.1365-2133.2011.10582.x; Zuberbier T, 2006, ALLERGY, V61, P316, DOI 10.1111/j.1398-9995.2005.00964.x; 周小芳, 2011, [临床皮肤科杂志, Journal of Clinical Dermatology], V40, P224	33	17	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64142	10.1371/journal.pone.0064142	http://dx.doi.org/10.1371/journal.pone.0064142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741306	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900018
J	Wong, PCM; Ettlinger, M; Zheng, J				Wong, Patrick C. M.; Ettlinger, Marc; Zheng, Jing			Linguistic Grammar Learning and DRD2-TAQ-IA Polymorphism	PLOS ONE			English	Article							DOPAMINE-RECEPTOR GENE; INDIVIDUAL-DIFFERENCES; DRD2 GENE; A1 ALLELE; LANGUAGE; ASSOCIATION; ENGLISH; IDENTIFICATION; EXPRESSION; PREDICTS	As research into the neurobiology of language has focused primarily on the systems level, fewer studies have examined the link between molecular genetics and normal variations in language functions. Because the ability to learn a language varies in adults and our genetic codes also vary, research linking the two provides a unique window into the molecular neurobiology of language. We consider a candidate association between the dopamine receptor D2 gene (DRD2) and linguistic grammar learning. DRD2-TAQ-IA polymorphism (rs1800497) is associated with dopamine receptor D2 distribution and dopamine impact in the human striatum, such that A1 allele carriers show reduction in D2 receptor binding relative to carriers who are homozygous for the A2 allele. The individual differences in grammatical rule learning that are particularly prevalent in adulthood are also associated with striatal function and its role in domain-general procedural memory. Therefore, we reasoned that procedurally-based grammar learning could be associated with DRD2-TAQ-IA polymorphism. Here, English-speaking adults learned artificial concatenative and analogical grammars, which have been respectively associated with procedural and declarative memory. Language learning capabilities were tested while learners' neural hemodynamic responses were simultaneously measured by fMRI. Behavioral learning and brain activation data were subsequently compared with the learners' DRD2 (rs1800497) genotype. Learners who were homozygous for the A2 allele were better at concatenative (but not analogical) grammar learning and had higher striatal responses relative to those who have at least one A1 allele. These results provide preliminary evidence for the neurogenetic basis of normal variations in linguistic grammar learning and its link to domain-general functions.	[Wong, Patrick C. M.] Chinese Univ Hong Kong, Dept Linguist & Modern Languages, Shatin, Hong Kong, Peoples R China; [Wong, Patrick C. M.; Ettlinger, Marc] Northwestern Univ, Sch Commun, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL USA; [Wong, Patrick C. M.; Zheng, Jing] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA; [Wong, Patrick C. M.; Zheng, Jing] Northwestern Univ, Hugh Knowles Ctr Clin & Basic Sci Hearing & Its D, Evanston, IL USA	Chinese University of Hong Kong; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University	Wong, PCM (corresponding author), Chinese Univ Hong Kong, Dept Linguist & Modern Languages, Shatin, Hong Kong, Peoples R China.	p.wong@cuhk.edu.hk	Zheng, Jing/F-5273-2017	Zheng, Jing/0000-0003-2790-1143; Wong, Patrick/0000-0002-6105-5027	National Science Foundation [BCS-1125144]; National Institutes of Health [R01DC008333, R21DC009652, ARRA R21DC009652-S1]; National Institutes of Health Institutional Training Grant [T32 NS047987]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008333, RC1DC010633, R21DC009652, R01DC011813] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by grants from the National Science Foundation (BCS-1125144) www.nsf.gov and the National Institutes of Health (R01DC008333, R21DC009652, & ARRA R21DC009652-S1) www.nih.gov awarded to P. W., the National Institutes of Health (ARRA RC1DC010633) awarded to J.Z., and a National Institutes of Health Institutional Training Grant (T32 NS047987; PI: Ken Paller) supporting M. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakovic Eric., 2005, PHONOLOGY, V22, P279; Beaver KM, 2010, J NEURAL TRANSM, V117, P827, DOI 10.1007/s00702-010-0421-8; BERKO J, 1958, WORD, V14, P150, DOI 10.1080/00437956.1958.11659661; Comings DE, 1996, PHARMACOGENETICS, V6, P73, DOI 10.1097/00008571-199602000-00006; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; ETTLINGER M, 2008, THESIS U CALIFORNIA; Ettlinger M, 2014, APPL PSYCHOLINGUIST, V35, P807, DOI 10.1017/S0142716412000586; Evans JL, 2009, J SPEECH LANG HEAR R, V52, P321, DOI 10.1044/1092-4388(2009/07-0189); Ferman S, 2009, J NEUROLINGUIST, V22, P384, DOI 10.1016/j.jneuroling.2008.12.002; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; GRANDY DK, 1993, HUM MOL GENET, V2, P2197, DOI 10.1093/hmg/2.12.2197-a; Gupta P, 1999, CARN S COGN, P447; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hoenicka J, 2010, BIOL PSYCHIAT, V67, P3, DOI 10.1016/j.biopsych.2009.08.012; JACKSON GM, 1995, NEUROPSYCHOLOGIA, V33, P577, DOI 10.1016/0028-3932(95)00010-Z; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kiparsky P., 1973, 3 DIMENSIONS LINGUIS, P57; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Klein TA, 2008, SCIENCE, V321, DOI 10.1126/science.1156079; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lamy MN, 2007, RES PRACT APPL LINGU, P1, DOI 10.1057/9780230592681; Lerman C, 2003, HEALTH PSYCHOL, V22, P541, DOI 10.1037/0278-6133.22.5.541; Levy M., 1997, COMPUT ASSIST LANG L; LIPHOLA M, 2001, ASPECTS PHONOLOGY MO; Lucht M, 2008, SCIENCE, V321, DOI 10.1126/science.1155372; McCarthy John, 2005, PARADIGMS PHONOLOGIC, P170; Mishkin M., 1984, NEUROBIOL LEARN MEM, P65, DOI DOI 10.1523/JNEUROSCI.0840-16.2016; Miyake A, 1998, FOREIGN LANGUAGE LEARNING, P339; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips LH, 1999, MEMORY, V7, P209, DOI 10.1080/741944066; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Robinson P., 2002, INDIVIDUAL DIFFERENC; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Taylor J, 2010, SCIENCE, V328, P512, DOI 10.1126/science.1186149; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tomasello M., 2003, CONSTRUCTING LANGUAG; Ullman MT, 2005, BRAIN LANG, V93, P185, DOI 10.1016/j.bandl.2004.10.001; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; WeberFox CM, 1996, J COGNITIVE NEUROSCI, V8, P231, DOI 10.1162/jocn.1996.8.3.231; Whitehouse AJO, 2011, GENES BRAIN BEHAV, V10, P451, DOI 10.1111/j.1601-183X.2011.00684.x; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wong PCM, 2007, APPL PSYCHOLINGUIST, V28, P565, DOI 10.1017/S0142716407070312; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Wong PCM, 2012, CORTEX, V48, P1091, DOI 10.1016/j.cortex.2012.03.017; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T; Yang BZ, 2007, HUM MOL GENET, V16, P2844, DOI 10.1093/hmg/ddm240; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	61	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64983	10.1371/journal.pone.0064983	http://dx.doi.org/10.1371/journal.pone.0064983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741438	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900151
J	Reznik, ON; Skvortsov, AE; Reznik, AO; Ananyev, AN; Tutin, AP; Kuzmin, DO; Bagnenko, SF				Reznik, Oleg N.; Skvortsov, Andrei E.; Reznik, Alexander O.; Ananyev, Alexey N.; Tutin, Alexey P.; Kuzmin, Denis O.; Bagnenko, Sergey F.			Uncontrolled Donors with Controlled Reperfusion after Sixty Minutes of Asystole: A Novel Reliable Resource for Kidney Transplantation	PLOS ONE			English	Article							CARDIAC DEATH DONORS; HEART-BEATING DONORS; EXTRACORPOREAL SUPPORT; CIRCULATORY DETERMINATION; RENAL PRESERVATION; COLD PRESERVATION; ORGAN DONATION; PERFUSION; LUNG; PROCUREMENT	Background: Organ shortage leads to usage of kidneys from donors after sudden cardiac death, or uncontrolled donors (UDCD). Ischemic injury due to cessation of circulation remains a crucial problem that limits adoption of UDCD. Our clinical investigation was to determine the applicability of kidneys obtained from UDCD and resuscitated by extracorporeal perfusion in situ after 60 minutes of asystole. Methods: In 2009-2011, organ procurement service of St. Petersburg, obtained kidneys from 22 UDCD with critically expanded warm ischemic time (WIT). No patients were considered as potential organ donors initially. All donors died after sudden irreversible cardiac arrest. Mean WIT was 61.4+/-4.5 minutes. For kidney resuscitation, the subnormothermic extracorporeal abdominal perfusion with thrombolytics and leukocyte depletion was employed. Grafts were transplanted into 44 recipients. The outcomes of transplantation of resuscitated kidneys were compared to outcomes of 87 KTx from 74 brain death donors (BDDs). Results: Immediate functioning of kidney grafts was observed in 21 of the 44 recipients, with no cases of primary non function. By the end of the first post-transplant year there was an acute rejection rate of 9.1% (4 episodes of rejection) in the UDCD group versus 14.2% (13 episodes of rejection) in the BDD group. The actual 1-year graft survival rate was 95.5% (n = 42) in UDCD group, and 94.6% (n = 87) in BDD group. Creatinine levels at the end of the first year were 0.116+/-0.008 and 0.115+/-0.004 mmol/l in UDCD and BDD groups, respectively. Conclusions: UDCD kidneys with critically expanded WIT could be succefully used for transplantation if in situ organ "resuscitation" perfusion is included into procurement protocol. The results of 1-year follow-up meet the generally accepted criteria for graft survival and function. In situ reperfusion may exert a therapeutic effect on grafts before procurement. This approach could substantially expand the organ donors' pool.	[Reznik, Oleg N.; Skvortsov, Andrei E.; Reznik, Alexander O.; Ananyev, Alexey N.; Bagnenko, Sergey F.] St Petersburg Pavlov State Med Univ, Organ Transplant Dept, St Petersburg, Russia; [Reznik, Alexander O.; Ananyev, Alexey N.; Tutin, Alexey P.; Kuzmin, Denis O.] St Petersburg State Res Inst Emergency, Organ Procurement Ctr, St Petersburg, Russia	Pavlov First Saint Petersburg State Medical University	Reznik, AO (corresponding author), St Petersburg Pavlov State Med Univ, Organ Transplant Dept, St Petersburg, Russia.	onreznik@gmail.com	Reznik, Oleg/ABH-1782-2020; Reznik, Aleksandr/R-7856-2016; Skvortsov, Andrey/P-2426-2015	Reznik, Aleksandr/0000-0002-5588-8735; Skvortsov, Andrey/0000-0001-5205-0331; Reznik, Oleg/0000-0003-2770-1432; Bagnenko, Sergey/0000-0002-6380-137X	Ministry of Education and Science of Russia [2012-1.1-12-000-2008-067, 8273]	Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation)	This work was supported by the application No. 2012-1.1-12-000-2008-067 for the grant of the Ministry of Education and Science of Russia (contract No. 8273, dated August 27, 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagul A, 2008, BRIT J SURG, V95, P111, DOI 10.1002/bjs.5909; Cypel M, 2009, AM J TRANSPLANT, V9, P2262, DOI 10.1111/j.1600-6143.2009.02775.x; Cypel M, 2008, J HEART LUNG TRANSPL, V27, P1319, DOI 10.1016/j.healun.2008.09.003; Dominguez-Gil B, 2011, TRANSPL INT, V24, P676, DOI 10.1111/j.1432-2277.2011.01257.x; Durandy Yves, 2010, Asian Cardiovasc Thorac Ann, V18, P386, DOI 10.1177/0218492310376675; Fan Y, 2010, EUR J CARDIO-THORAC, V37, P912, DOI 10.1016/j.ejcts.2009.09.030; Farney AC, 2008, J AM COLL SURGEONS, V206, P1028, DOI 10.1016/j.jamcollsurg.2007.12.029; Fondevila C, 2007, AM J TRANSPLANT, V7, P1849, DOI 10.1111/j.1600-6143.2007.01846.x; Fondevila C, 2012, AM J TRANSPLANT, V12, P162, DOI 10.1111/j.1600-6143.2011.03834.x; Fondevila C, 2010, AM J TRANSPLANT, V10, P1341, DOI 10.1111/j.1600-6143.2010.03134.x; Fondevila C, 2011, ANN SURG, V254, P1000, DOI 10.1097/SLA.0b013e31822b8b2f; Gagandeep S, 2006, AM J TRANSPLANT, V6, P1682, DOI 10.1111/j.1600-6143.2006.01386.x; Gok MA, 2003, TRANSPLANTATION, V76, P1714, DOI 10.1097/01.TP.0000093834.05766.FD; Gok MA, 2002, TRANSPLANTATION, V73, P1869, DOI 10.1097/00007890-200206270-00003; Hanto DW, 2011, AM J TRANSPLANT, V11, P1351, DOI 10.1111/j.1600-6143.2011.03583.x; Hoogland ERP, 2011, AM J TRANSPLANT, V11, P1427, DOI 10.1111/j.1600-6143.2011.03562.x; Ingemansson R, 2009, ANN THORAC SURG, V87, P255, DOI 10.1016/j.athoracsur.2008.09.049; IOM, 2009, ORG DON OPP ACT; Jacob Samuel, 2008, Interact Cardiovasc Thorac Surg, V7, P491, DOI 10.1510/icvts.2008.178343; Jassem W, 2002, TRANSPLANTATION, V73, P493, DOI 10.1097/00007890-200202270-00001; Kootstra G, 1997, TRANSPLANTATION, V63, P917, DOI 10.1097/00007890-199704150-00001; Magliocca JF, 2005, J TRAUMA, V58, P1095, DOI 10.1097/01.TA.0000169949.82778.DF; Manara AR, 2012, BRIT J ANAESTH, V108, pI108, DOI 10.1093/bja/aer357; Metcalfe MS, 2002, TRANSPLANT P, V34, P1473, DOI 10.1016/S0041-1345(02)02935-4; Miranda B, 2003, AM J TRANSPLANT, V3, P1189, DOI 10.1046/j.1600-6143.2003.00198.x; Moers C, 2012, TRANSPL INT, V25, P210, DOI 10.1111/j.1432-2277.2011.01383.x; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Moustafellos P, 2007, TRANSPL P, V39, P1323, DOI 10.1016/j.transproceed.2006.11.026; Punch J, 2009, ORGAN DONATION TRANS, P153; Punch JD, 2012, AM J TRANSPLANT, V12, P9, DOI 10.1111/j.1600-6143.2011.03835.x; Reid AWN, 2011, AM J TRANSPLANT, V11, P995, DOI 10.1111/j.1600-6143.2011.03474.x; Rhee JY, 2011, AM J TRANSPLANT, V11, P1719, DOI 10.1111/j.1600-6143.2011.03634.x; Roberts KJ, 2011, TRANSPL INT, V24, P477, DOI 10.1111/j.1432-2277.2011.01230.x; Rojas-Pena A, 2010, AM J TRANSPLANT, V10, P1365, DOI 10.1111/j.1600-6143.2010.03063.x; Rojas-Pena A, 2011, ASAIO J, V57, P368, DOI 10.1097/MAT.0b013e318227f8a2; Sanchez-Fructuoso AI, 2003, J NEPHROL, V16, P387; Sanchez-Fructuoso AI, 2006, ANN INTERN MED, V145, P157, DOI 10.7326/0003-4819-145-3-200608010-00003; Shoskes D, 2001, AM J TRANSPLANT, V1, P305, DOI 10.1034/j.1600-6143.2001.10402.x; Steen S, 2007, ANN THORAC SURG, V83, P2191, DOI 10.1016/j.athoracsur.2007.01.033; Talbot D., 2009, ORGAN DONATION TRANS, P103; Taylor MJ, 2010, CRYOBIOLOGY, V60, pS20, DOI 10.1016/j.cryobiol.2009.10.006; Toledo-Pereyra LH, 2011, J SURG RES, V169, P188, DOI 10.1016/j.jss.2010.09.048; Van Gelder F, 2010, J EUROPEAN TRANSPLAN, V13, P77; Verheijde Joseph L, 2007, Philos Ethics Humanit Med, V2, P8, DOI 10.1186/1747-5341-2-8; Verheijde Joseph L, 2009, Philos Ethics Humanit Med, V4, P15, DOI 10.1186/1747-5341-4-15; Wall SP, 2011, AM J TRANSPLANT, V11, P1417, DOI 10.1111/j.1600-6143.2011.03582.x; Warren O, 2007, EUR J CARDIO-THORAC, V31, P665, DOI 10.1016/j.ejcts.2006.12.034; Wierup P, 2006, ANN THORAC SURG, V81, P460, DOI 10.1016/j.athoracsur.2005.08.015; Zhai Y, 2011, AM J TRANSPLANT, DOI [10.1111/j.1600 6143.2011.03579.x, DOI 10.1111/J.1600]	49	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64209	10.1371/journal.pone.0064209	http://dx.doi.org/10.1371/journal.pone.0064209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737973	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700037
J	Zhao, HQ; Chen, C; Xiong, YW; Xu, XF; Lan, RT; Wang, HY; Yao, XY; Bai, XN; Liu, XT; Meng, Q; Zhang, XA; Sun, H; Zhao, AL; Bai, XM; Cheng, YL; Chen, Q; Ye, CY; Xu, JG				Zhao, Hongqing; Chen, Chen; Xiong, Yanwen; Xu, Xuefang; Lan, Ruiting; Wang, Haiyin; Yao, Xinyue; Bai, Xiangning; Liu, Xuetong; Meng, Qiong; Zhang, Xiaoai; Sun, Hui; Zhao, Ailan; Bai, Xuemei; Cheng, Yuli; Chen, Qiang; Ye, Changyun; Xu, Jianguo			Global Transcriptional and Phenotypic Analyses of Escherichia coli O157:H7 Strain Xuzhou21 and Its pO157_Sal Cured Mutant	PLOS ONE			English	Article							ADENINE METHYLASE MUTANTS; H-NS; GENE-EXPRESSION; RNA-SEQ; HEMOLYSIN OPERON; BIOFILM FORMATION; MINIMAL MEDIUM; SHOCK PROTEIN; O157-H7; STPA	Escherichia coli O157:H7 is an important food-borne pathogen that can cause hemorrhagic colitis and hemolytic-uremic syndrome in humans. pO157_Sal, a novel conjugative plasmid is present in a Chinese O157:H7 outbreak strain Xuzhou21. Here we investigated the phenotypic and transcriptional differences between the wild type strain Xuzhou21 and the pO157_Sal cured mutant strain Xuzhou21m. RNA-Seq analysis found that all 52 ORFs encoded on pO157_Sal were transcribed. One hundred and sixty eight chromosomal and pO157 genes were differentially expressed (>= 2 fold difference) between Xuzhou21 and Xuzhou21m. Sixty-seven and 101 genes were up-regulated and down-regulated respectively by pO157_Sal including genes related to stress response, adaption and virulence. The plasmid-cured mutant Xuzhou21m grew slower than wild type Xuzhou21 and pO157_Sal plasmid complemented strain Xuzhou21c in M9 medium under the condition of high NaCl or presence of sodium deoxycholate (NaDC), corroborating with the RNA-Seq data. Seven differentially expressed genes are associated with NaDC resistance, including the adenine-specific DNA-methyltransferase gene (dam), multidrug efflux system subunit gene mdtA, hyperosmotically inducible periplasmic protein gene osmY and oxidation-reduction related genes while two differentially expressed genes (osmY and pspD) are likely to be related to resistance to osmotic pressure. A number of differentially expressed genes were virulence associated including four genes encoding T3SS effectors from the chromosome and ehxD from pO157. Through complementation of Xuzhou21m with a plasmid construct carrying the pO157_Sal hha homolog we further showed that the pO157_Sal hha represses the expression of T3SS effectors. These findings demonstrated that the plasmid pO157_Sal affects the transcription of the chromosomal and pO157 plasmid genes and contributes to the enhanced ability to resist stress. We conclude that pO157_Sal plays an important role in regulating global gene expression and affects the virulence and adaptation of E. coli O157:H7.	[Zhao, Hongqing; Chen, Chen; Xiong, Yanwen; Xu, Xuefang; Wang, Haiyin; Yao, Xinyue; Bai, Xiangning; Liu, Xuetong; Meng, Qiong; Sun, Hui; Zhao, Ailan; Bai, Xuemei; Cheng, Yuli; Chen, Qiang; Ye, Changyun; Xu, Jianguo] Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Zhang, Xiaoai] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of New South Wales Sydney	Xu, JG (corresponding author), Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xujianguo@icdc.cn	chen, chen/AAQ-1805-2021; CHEN, CHEN/HDM-6657-2022	chen, chen/0000-0003-1765-8899; Meng, Qiong/0000-0002-8378-9021; Lan, Ruiting/0000-0001-9834-5258	National Basic Research Program of China [2011CB504901]; China Mega-Project for Infectious Disease Grant [2011ZX10004-001]; Chinese National Natural Science Foundation Grant [81271788]; State Key Laboratory for Infectious Disease Prevention and Control Development Grants [2012SKLID401, 2011SKLID203, 2008SKLID106]; Beijing Municipal Commission of Education Grant [YB20098450101]	National Basic Research Program of China(National Basic Research Program of China); China Mega-Project for Infectious Disease Grant; Chinese National Natural Science Foundation Grant(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Disease Prevention and Control Development Grants; Beijing Municipal Commission of Education Grant	This work was supported by the National Basic Research Program of China (2011CB504901), China Mega-Project for Infectious Disease Grant (2011ZX10004-001), Chinese National Natural Science Foundation Grant (81271788), State Key Laboratory for Infectious Disease Prevention and Control Development Grants (2012SKLID401, 2011SKLID203, 2008SKLID106) and Beijing Municipal Commission of Education Grant (YB20098450101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; Andrup L, 2008, PLASMID, V59, P139, DOI 10.1016/j.plasmid.2007.11.005; Bae WH, 1999, MOL MICROBIOL, V31, P1429, DOI 10.1046/j.1365-2958.1999.01284.x; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bernstein C, 1999, CURR MICROBIOL, V39, P68, DOI 10.1007/s002849900420; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; El-Mansi M, 2000, RES MICROBIOL, V151, P201, DOI 10.1016/S0923-2508(00)00140-6; Forns N, 2005, FEMS MICROBIOL LETT, V251, P75, DOI 10.1016/j.femsle.2005.07.027; Free A, 1997, J BACTERIOL, V179, P909, DOI 10.1128/jb.179.3.909-918.1997; Free A, 1998, J BACTERIOL, V180, P994, DOI 10.1128/JB.180.4.994-997.1998; Garcia-Contreras R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002394; Grant J, 2008, EMERG INFECT DIS, V14, P1633, DOI 10.3201/eid1410.071341; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Hansen AM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-231; HEEFNER DL, 1984, J BACTERIOL, V159, P460, DOI 10.1128/JB.159.2.460-464.1984; Heithoff DM, 2001, INFECT IMMUN, V69, P6725, DOI 10.1128/IAI.69.11.6725-6730.2001; Hong SH, 2010, MICROB BIOTECHNOL, V3, P717, DOI 10.1111/j.1751-7915.2010.00220.x; Isabella VM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-51; Jiang WN, 1997, J BIOL CHEM, V272, P196; Juarez A, 2000, ADV EXP MED BIOL, V485, P127; Kanamaru K, 2000, MOL MICROBIOL, V38, P805, DOI 10.1046/j.1365-2958.2000.02171.x; Koskenniemi K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002741; Kudva IT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-103; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Li HP, 2008, FEMS MICROBIOL LETT, V285, P257, DOI 10.1111/j.1574-6968.2008.01240.x; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nieto JM, 2000, MOL GEN GENET, V263, P349, DOI 10.1007/s004380051178; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Oh JT, 2000, BBA-BIOMEMBRANES, V1463, P43, DOI 10.1016/S0005-2736(99)00177-7; Paytubi S, 2004, MOL MICROBIOL, V54, P251, DOI 10.1111/j.1365-2958.2004.04268.x; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Pucciarelli MG, 2002, MICROBIOL-SGM, V148, P1171, DOI 10.1099/00221287-148-4-1171; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Sharma VK, 2013, APPL ENVIRON MICROB, V79, P2384, DOI 10.1128/AEM.02998-12; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sonnenfield JM, 2001, BIOCHIMIE, V83, P243, DOI 10.1016/S0300-9084(01)01232-9; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; TARR PI, 1995, CLIN INFECT DIS, V20, P1, DOI 10.1093/clinids/20.1.1; Wang P, 2011, J CLIN MICROBIOL, V49, P1594, DOI 10.1128/JCM.02530-10; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiong YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036144; Xu Jianguo, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P114; ZHANG AX, 1992, NUCLEIC ACIDS RES, V20, P6735, DOI 10.1093/nar/20.24.6735; Zhang AX, 1996, EMBO J, V15, P1340, DOI 10.1002/j.1460-2075.1996.tb00476.x; Zheng H, 2005, MICROBIOL IMMUNOL, V49, P1019, DOI 10.1111/j.1348-0421.2005.tb03698.x; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	63	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e65466	10.1371/journal.pone.0065466	http://dx.doi.org/10.1371/journal.pone.0065466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738017	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700078
J	Boattini, A; Martinez-Cruz, B; Sarno, S; Harmant, C; Useli, A; Sanz, P; Yang-Yao, D; Manry, J; Ciani, G; Luiselli, D; Quintana-Murci, L; Comas, D; Pettener, D				Boattini, Alessio; Martinez-Cruz, Begona; Sarno, Stefania; Harmant, Christine; Useli, Antonella; Sanz, Paula; Yang-Yao, Daniele; Manry, Jeremy; Ciani, Graziella; Luiselli, Donata; Quintana-Murci, Lluis; Comas, David; Pettener, Davide		Genographic Consortium	Uniparental Markers in Italy Reveal a Sex-Biased Genetic Structure and Different Historical Strata	PLOS ONE			English	Article							DNA; EUROPE; MTDNA; VARIABILITY; RESOLUTION; PATTERNS; PHYLOGEOGRAPHY; COLONIZATION; DIVERGENCE; DIVERSITY	Located in the center of the Mediterranean landscape and with an extensive coastal line, the territory of what is today Italy has played an important role in the history of human settlements and movements of Southern Europe and the Mediterranean Basin. Populated since Paleolithic times, the complexity of human movements during the Neolithic, the Metal Ages and the most recent history of the two last millennia (involving the overlapping of different cultural and demic strata) has shaped the pattern of the modern Italian genetic structure. With the aim of disentangling this pattern and understanding which processes more importantly shaped the distribution of diversity, we have analyzed the uniparentally-inherited markers in similar to 900 individuals from an extensive sampling across the Italian peninsula, Sardinia and Sicily. Spatial PCAs and DAPCs revealed a sex-biased pattern indicating different demographic histories for males and females. Besides the genetic outlier position of Sardinians, a North West-South East Y-chromosome structure is found in continental Italy. Such structure is in agreement with recent archeological syntheses indicating two independent and parallel processes of Neolithisation. In addition, date estimates pinpoint the importance of the cultural and demographic events during the late Neolithic and Metal Ages. On the other hand, mitochondrial diversity is distributed more homogeneously in agreement with older population events that might be related to the presence of an Italian Refugium during the last glacial period in Europe.	[Boattini, Alessio; Sarno, Stefania; Yang-Yao, Daniele; Ciani, Graziella; Luiselli, Donata; Pettener, Davide] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Lab Antropol Mol, Bologna, Italy; [Martinez-Cruz, Begona; Sanz, Paula; Comas, David] Univ Pompeu Fabra, Dept Ciencies Salut & Vida, Inst Biol Evolut CSIC UPF, Barcelona, Spain; [Harmant, Christine; Manry, Jeremy; Quintana-Murci, Lluis] Inst Pasteur, Human Evolutionary Genet Unit, Dept Genomes & Genet, Paris, France; [Harmant, Christine; Manry, Jeremy; Quintana-Murci, Lluis] CNRS, Paris, France; [Useli, Antonella] Univ Sassari, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy	University of Bologna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Sassari	Comas, D (corresponding author), Univ Pompeu Fabra, Dept Ciencies Salut & Vida, Inst Biol Evolut CSIC UPF, Barcelona, Spain.	david.comas@upf.edu; davide.pettener@unibo.it	Comas, David/D-5382-2014; Pettener, Davide/E-1576-2017; Balanovsky, Oleg/G-1549-2014; Santos, Fabrício Rodrigues/H-2370-2011; Haber, Marc/Y-5090-2019; Quintana-Murci, Lluis/AAB-7468-2022; Haak, Wolfgang/C-2362-2014; Haak, Wolfgang/Z-4947-2019; Clarke, Andrew/A-7635-2008; Bertranpetit, Jaume/F-8550-2012	Comas, David/0000-0002-5075-0956; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Haber, Marc/0000-0003-1000-1448; Haak, Wolfgang/0000-0003-2475-2007; Haak, Wolfgang/0000-0003-2475-2007; Clarke, Andrew/0000-0003-2293-1423; Manry, Jeremy/0000-0001-5998-2051; Bertranpetit, Jaume/0000-0003-0100-0590; merchant, nirav/0000-0002-1988-8180; Cooper, Alan/0000-0002-7738-7851; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Martinez-Cruz, Begona/0000-0003-1268-6620; Royyuru, Ajay/0000-0003-4440-4755; zalloua, pierre/0000-0002-8494-5081; Quintana-Murci, Lluis/0000-0003-2429-6320	University of Bologna; MIUR PRIN; Spanish Government [CGL2010-14944/BOS]	University of Bologna; MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Spanish Government(Spanish GovernmentEuropean Commission)	This study was supported by Strategic Project 2006-09 from the University of Bologna to DP and from MIUR PRIN 2007 and 2009 Grants to DP. The project was also supported by the Spanish Government grant CGL2010-14944/BOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Babalini C, 2005, EUR J HUM GENET, V13, P902, DOI 10.1038/sj.ejhg.5201439; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banks WE, 2008, J ARCHAEOL SCI, V35, P481, DOI 10.1016/j.jas.2007.05.011; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002; Boattini A, 2012, HUM BIOL, V84, P235, DOI 10.3378/027.084.0302; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brisighelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050794; Busby GB, 2011, P BIOL SCI, V279, P884; Calo C., 2008, INT J MODERN ANTHR, V1, P39; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Caramelli D, 2007, HUM GENET, V122, P327, DOI 10.1007/s00439-007-0403-6; Cavalli-Sforza L, 1994, HIST GEOGRAPHY HUMAN, P1088; Chio A, 2011, ARCH NEUROL-CHICAGO, V68, P594, DOI 10.1001/archneurol.2010.352; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; Cox MP, 2008, HUM BIOL, V80, P335, DOI 10.3378/1534-6617-80.4.335; Cunliffe B, 2001, OXFORD ILLUSTRATED H, P544; Di Gaetano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043759; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Grassi F, 2009, J PLANT RES, V122, P377, DOI 10.1007/s10265-009-0230-z; Grassi F, 2008, BIOL J LINN SOC, V95, P611, DOI 10.1111/j.1095-8312.2008.01081.x; Gusmao L, 2006, FORENSIC SCI INT, V157, P187, DOI 10.1016/j.forsciint.2005.04.002; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034288; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; King RJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-69; King TE, 2009, MOL BIOL EVOL, V26, P1093, DOI 10.1093/molbev/msp022; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Lacan M, 2011, P NATL ACAD SCI USA, V108, P18255, DOI 10.1073/pnas.1113061108; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Martinez-Cruz B, 2012, MOL BIOL EVOL, V29, P2211, DOI 10.1093/molbev/mss091; Martinez-Cruz Begona, 2011, Investig Genet, V2, P13, DOI 10.1186/2041-2223-2-13; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Ottoni C, 2009, ANN HUM BIOL, V36, P785, DOI 10.3109/03014460903198509; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pardo LM, 2012, EUR J HUM GENET, V20, P956, DOI 10.1038/ejhg.2012.22; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pesando F., 2005, ITALIA ANTICA CULTUR; Pessina A, 2008, ARCHEOLOGIA NEOLITIC, P375; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; R Development Core Team, 2008, R LANG ENV STAT COMP; Randi E, 2007, Phylogeography of Southern European Refugia, P101, DOI 10.1007/1-4020-4904-8_3; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2012, EUR J HUM GENET, V20, P1275, DOI 10.1038/ejhg.2012.86; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Turchi C, 2008, INT J LEGAL MED, V122, P199, DOI 10.1007/s00414-007-0207-1; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zecca G, 2011, ORG DIVERS EVOL, V11, P357, DOI 10.1007/s13127-011-0063-1; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	71	57	57	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65441	10.1371/journal.pone.0065441	http://dx.doi.org/10.1371/journal.pone.0065441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734255	gold, Green Published			2022-12-27	WOS:000319725500011
J	Biggs, BC				Biggs, Brendan C.			Harnessing Natural Recovery Processes to Improve Restoration Outcomes: An Experimental Assessment of Sponge-Mediated Coral Reef Restoration	PLOS ONE			English	Article							LONG-TERM; ECOLOGICAL INTERACTIONS; ARTIFICIAL SUBSTRATUM; SETTLEMENT-PATTERNS; REHABILITATION; RECRUITMENT; DIVERSITY; ABUNDANCE; GROWTH; MANAGEMENT	Background: Restoration is increasingly implemented to reestablish habitat structure and function following physical anthropogenic disturbance, but scientific knowledge of effectiveness of methods lags behind demand for guidelines. On coral reefs, recovery is largely dependent on coral reestablishment, and substratum stability is critical to the survival of coral fragments and recruits. Concrete is often used to immobilize rubble, but its ecological performance has not been rigorously evaluated, and restoration has generally fallen short of returning degraded habitat to pre-disturbance conditions. Fragments of erect branching sponges mediate reef recovery by facilitating rubble consolidation, yet such natural processes have been largely overlooked in restoring reefs. Methods: On two reefs in Curacao, four treatments - coral rubble alone, rubble seeded with sponge fragments, rubble bound by concrete, and concrete "rubble'' bound by concrete - were monitored over four years to investigate rubble consolidation with and without sponges and the ecological performance of treatments in terms of the number and diversity of coral recruits. Species specific rates of sponge fragment attachment to rubble, donor sponge growth and tissue replacement, and fragment survival inside rubble piles were also investigated to evaluate sponge species performance and determine rates for sustainably harvesting tissue. Findings/Significance: Rubble piles seeded with sponges retained height and shape to a significantly greater degree, lost fewer replicates to water motion, and were significantly more likely to be consolidated over time than rubble alone. Significantly more corals recruited to sponge-seeded rubble than to all other treatments. Coral diversity was also greatest for rubble with sponges and it was the only treatment to which framework building corals recruited. Differences in overall sponge species performance suggest species selection is important to consider. Employing organisms that jump start successional pathways and facilitate recovery can significantly improve restoration outcomes; however, best practices require techniques be tailored to each system.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Biggs, BC (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	Biggs@bio.fsu.edu			Royal Caribbean Cruise Lines (marine conservation grant); National Science Foundation [OCE-0550599]	Royal Caribbean Cruise Lines (marine conservation grant); National Science Foundation(National Science Foundation (NSF))	This research was supported by Royal Caribbean Cruise Lines (marine conservation grant to B. Biggs) and by the National Science Foundation under grant number OCE-0550599 (J. Wulff). Other than J. Wulff, the authors' major professor, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2008, MAR FRESHWATER RES, V59, P304, DOI 10.1071/MF07165; Aerts LAM, 1997, MAR ECOL PROG SER, V148, P125, DOI 10.3354/meps148125; Aerts LAM, 2000, DYNAMICS STANDOFF IN; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BINGHAM BL, 1991, MAR BIOL, V109, P19, DOI 10.1007/BF01320227; Bowden-Kerby A, 2001, B MAR SCI, V69, P915; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burt J, 2011, ECOL ENG, V37, P191, DOI 10.1016/j.ecoleng.2010.09.004; Burt J, 2009, J EXP MAR BIOL ECOL, V373, P72, DOI 10.1016/j.jembe.2009.03.009; Castro J, 2004, RESTOR ECOL, V12, P352, DOI 10.1111/j.1061-2971.2004.0316.x; CHANAS B, 1995, MAR ECOL PROG SER, V127, P195, DOI 10.3354/meps127195; Clark S, 1999, AQUAT CONSERV, V9, P5, DOI 10.1002/(SICI)1099-0755(199901/02)9:1<5::AID-AQC330>3.3.CO;2-L; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cote IM, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 0521671450; Crawley M.J., 2007, R BOOK; Curtis C, 1985, P 5 INT COR REEF C T, V6, P471; Diaz MC, 2001, B MAR SCI, V69, P535; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Epstein N, 2003, AQUAT CONSERV, V13, P387, DOI 10.1002/aqc.558; Fox HE, 2005, CONSERV BIOL, V19, P98, DOI 10.1111/j.1523-1739.2005.00261.x; Fox HE, 2004, MAR ECOL PROG SER, V269, P131, DOI 10.3354/meps269131; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; GOREAU TF, 1966, SCIENCE, V151, P343, DOI 10.1126/science.151.3708.343; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hilderbrand RH, 2005, ECOL SOC, V10; Hill MS, 1999, BIOL BULL, V202, P86; Hudson J.H., 1988, P231; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Irving AD, 2010, J APPL ECOL, V47, P1119, DOI 10.1111/j.1365-2664.2010.01852.x; Jaap WC, 2000, ECOL ENG, V15, P345, DOI 10.1016/S0925-8574(00)00085-9; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Leong W, 2010, MAR ECOL PROG SER, V406, P71, DOI 10.3354/meps08541; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Lirman D, 1997, J COASTAL RES, V13, P67; Lockwood Julie L., 1999, P363, DOI 10.1017/CBO9780511542237.014; Lutz Steven J., 2006, P25, DOI 10.1201/9781420003796.ch2; McGrath E, 2012, THESIS NOVA SE U; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Miller MW, 2009, MAR ECOL PROG SER, V387, P147, DOI 10.3354/meps08097; Miller MW, 2001, B MAR SCI, V69, P395; Miller MW, 2000, P 9 INT COR REEF S, V2, P977; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Palmer MA, 1997, RESTOR ECOL, V5, P291, DOI 10.1046/j.1526-100X.1997.00543.x; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Pile A.J., 1997, P1403; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; PORTER JW, 1988, BIOL BULL, V175, P230, DOI 10.2307/1541563; Precht WF, 2001, B MAR SCI, V69, P1001; Precht William F., 2006, P1, DOI 10.1201/9781420003796.ch1; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Pywell RF, 2003, J APPL ECOL, V40, P65, DOI 10.1046/j.1365-2664.2003.00762.x; RANDALL JE, 1968, MAR BIOL, V1, P216, DOI 10.1007/BF00347115; Rasser MW, 2002, CORAL REEFS, V21, P57, DOI 10.1007/s00338-001-0206-5; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Requena N, 2001, APPL ENVIRON MICROB, V67, P495, DOI 10.1128/AEM.67.2.495-498.2001; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Reyes MZ, 2001, B MAR SCI, V69, P559; Rinkevich B, 2000, MAR BIOL, V136, P807, DOI 10.1007/s002270000293; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Rogers CS, 2001, B MAR SCI, V69, P793; Schittone J, 2010, REV BIOL TROP, V58, P151; Smith RS, 2003, J APPL ECOL, V40, P51, DOI 10.1046/j.1365-2664.2003.00780.x; Spieler RE, 2001, B MAR SCI, V69, P1013; STODDART DR, 1965, NATURE, V207, P589, DOI 10.1038/207589a0; SULLIVAN B, 1983, SCIENCE, V221, P1175, DOI 10.1126/science.221.4616.1175; Sutton L, 2008, 11 INT COR REEF S FL, V24, P48; Van Duyl F. C, 1985, ATLAS LIVING REEFS C; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Weidenmeyer F, 1977, SHALLOW WATER SPONGE; Wilkinson C.R., 2008, STATUS CORAL REEFS W; Wulff J, 2001, B MAR SCI, V69, P831; Wulff JL, 2006, FUNCT ECOL, V20, P699, DOI 10.1111/j.1365-2435.2006.01143.x; Wulff J. L., 1985, P 5 INT COR REEF C, V5, P119; Wulff J, 2012, ADV MAR BIOL, V61, P273, DOI 10.1016/B978-0-12-387787-1.00003-9; Wulff JL, 2008, MAR ECOL-EVOL PERSP, V29, P193, DOI 10.1111/j.1439-0485.2008.00224.x; Wulff JL, 2008, AM NAT, V171, P597, DOI 10.1086/587067; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; WULFF JL, 1979, NATURE, V281, P474, DOI 10.1038/281474a0; Wulff JL, 1997, ECOLOGY, V78, P146; WULFF JL, 1995, CORAL REEFS, V14, P55, DOI 10.1007/BF00304073; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z; WULFF JL, 1994, SPONGES IN TIME AND SPACE, P265; WULFF JL, 1984, CORAL REEFS, V3, P157, DOI 10.1007/BF00301960; Zedler JB, 2001, BIOSCIENCE, V51, P1005, DOI 10.1641/0006-3568(2001)051[1005:DBWSMA]2.0.CO;2; Zhao HL, 2007, ECOL ENG, V31, P1, DOI 10.1016/j.ecoleng.2007.04.010; Zimmer Beth, 2006, P39; Zuur Alain F., 2009, P1	99	22	22	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64945	10.1371/journal.pone.0064945	http://dx.doi.org/10.1371/journal.pone.0064945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750219	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900021
J	Ito, H; Kawahara, T; Terao, H; Ogawa, T; Yao, M; Kubota, Y; Matsuzaki, J				Ito, Hiroki; Kawahara, Takashi; Terao, Hideyuki; Ogawa, Takehiko; Yao, Masahiro; Kubota, Yoshinobu; Matsuzaki, Junichi			Utility and Limitation of Cumulative Stone Diameter in Predicting Urinary Stone Burden at Flexible Ureteroscopy with Holmium Laser Lithotripsy: A Single-Center Experience	PLOS ONE			English	Article							PLAIN RADIOGRAPHY; CALCULI; SIZE; TOMOGRAPHY; CM	Purpose: To retrospectively assess the clinical utility in ureteroscopy (URS) planning of cumulative stone diameter (CSD), which does not account for stone width or depth, as a predictor of URS outcome and compare it with stone volume. Materials and Methods: Patients with renal stones treated at a single institute by flexible URS were retrospectively evaluated. To assess the clinical utility of CSD, relationships between stone-free (SF) status and stone burden (CSD and volume) were analyzed using the area under the receiver operating characteristics (AUROC) curve. To identify stone number impact on CSD, the AUROC of CSD divided by stone number was evaluated. Correlation coefficients of CSD and stone volume were also calculated for groups by stone number. Results: In cases with CSD <20.0 mm, CSD and stone volume revealed equal ability to predict SF status. In cases with CSD >= 20.0 mm, stone volume showed higher predictive ability. The ROC curves for cases with >= 4 stones showed that CSD was less predictive of SF status than stone volume. The correlation coefficients of CSD and stone volume by stone number were 0.922 for 1 stone, 0.900 for 2-3 stones, and 0.661 for >= 4 stones. Conclusions: In cases with CSD >= 20.0 mm or >= 4 stones, we should evaluate stone volume for a more predictive stone burden, and pretreatment non-contrast CT seems sufficient. In cases with CSD <20.0 mm or 1-3 stones, CSD was as valid a predictor of preoperative stone burden as stone volume, so preoperative kidney-ureter-bladder (KUB) films may be sufficient.	[Ito, Hiroki; Kawahara, Takashi; Terao, Hideyuki; Matsuzaki, Junichi] Ohguchi E Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Ito, Hiroki; Kawahara, Takashi; Ogawa, Takehiko; Yao, Masahiro; Kubota, Yoshinobu] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan	Yokohama City University	Ito, H (corresponding author), Ohguchi E Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan.	pug_daikichi@yahoo.co.jp						Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Breda A, 2009, EUR UROL, V55, P1190, DOI 10.1016/j.eururo.2008.06.019; Dundee P, 2006, J ENDOUROL, V20, P1005, DOI 10.1089/end.2006.20.1005; Eisner BH, 2009, J UROLOGY, V181, P1710, DOI 10.1016/j.juro.2008.11.116; Hyams ES, 2010, J ENDOUROL, V24, P1411, DOI 10.1089/end.2009.0645; Ito H, 2012, J ENDOUROL, V26, P1125, DOI 10.1089/end.2012.0154; Ito H, 2012, UROLOGY, V80, P524, DOI 10.1016/j.urology.2012.04.001; LAM HS, 1992, J UROLOGY, V147, P1219, DOI 10.1016/S0022-5347(17)37522-5; Mariani AJ, 2007, J UROLOGY, V177, P168, DOI 10.1016/j.juro.2006.08.066; Narepalem N, 2002, J UROLOGY, V167, P1235, DOI 10.1016/S0022-5347(05)65272-X; Parsons JK, 2003, J ENDOUROL, V17, P725, DOI 10.1089/089277903770802245; Preminger GM, 2007, J UROLOGY, V178, P2418, DOI 10.1016/j.juro.2007.09.107; Riley JM, 2009, J ENDOUROL, V23, P1395, DOI 10.1089/end.2009.0391; Tan P. K., 1995, Singapore Medical Journal, V36, P53; Tiselius HG, 2001, EUR UROL, V40, P362, DOI 10.1159/000049803	15	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65060	10.1371/journal.pone.0065060	http://dx.doi.org/10.1371/journal.pone.0065060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750229	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900031
J	Xu, YQ; Gu, L; Pan, YQ; Li, R; Gao, TY; Song, GQ; Nie, ZL; Chen, LP; Wang, SK; He, BS				Xu, Yeqiong; Gu, Ling; Pan, Yuqin; Li, Rui; Gao, Tianyi; Song, Guoqi; Nie, Zhenlin; Chen, Liping; Wang, Shukui; He, Bangshun			Different Effects of Three Polymorphisms in MicroRNAs on Cancer Risk in Asian Population: Evidence from Published Literatures	PLOS ONE			English	Article							COMMON GENETIC-VARIANTS; FUNCTIONAL POLYMORPHISM; GASTRIC-CANCER; PRE-MICRORNAS; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; LUNG-CANCER; SUSCEPTIBILITY; PRE-MIR-146A; PROLIFERATION	MicroRNAs (miRNAs) are a class of small non-protein-coding RNAs, which have emerged as integrated and important post-transcriptional regulators of gene expression. It has been demonstrated that single nucleotide polymorphisms (SNPs) exist in protein-coding genes. Accumulated studies have evaluated the association of miRNA SNPs with cancer risk, especially in Asian population, which included a series of related studies. However, the results remain controversial for the different genetic backgrounds, living habits and environment exposed. To evaluate the relationship between SNPs in miRNAs and cancer risk, 21 studies focused on Asian population were enrolled for the pooled analysis for three polymorphisms rs2910164, rs11614913, rs3746444 in three miRNAs miR-146aG>C, miR-196a2C>T, miR-499A>G using odds ratios (ORs) with 95% confidence intervals (CIs). For rs2910164 polymorphism, C allele was observed association with decreased overall cancer risk. In addition, subgroup analysis revealed of rs2910164 C allele decreased hepatocellular carcinoma (HCC), cervical cancer and prostate cancer risk among Chinese population. For rs11614913 polymorphism, TT genotype was observed to be associated with decreased cancer risk, especially for cancer type of colorectal cancer (CRC), lung cancer and country of Korea, North India. Whereas, rs3746444 G allele was an increased cancer risk factor in Chinese population, especially for breast cancer. In conclusion, this meta-analysis indicated that rs2910164 C allele was associated with decreased cancer risk in Chinese population. However, the association varied from different cancer types. Furthermore, TT genotype of rs11614913 was associated with decreased cancer risk. While different cancer types and countries contributed to different effects. Whereas, rs3746444 G allele was a risk factor in Chinese population, and the association varied from different cancer types.	[Xu, Yeqiong; Pan, Yuqin; Gao, Tianyi; Song, Guoqi; Nie, Zhenlin; Wang, Shukui; He, Bangshun] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China; [Gu, Ling; Li, Rui; Chen, Liping] Nanjing Normal Univ, Dept Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Normal University	Wang, SK (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China.	shukwang@163.com; hebangshun@163.com			National Nature Science Foundation of China [81172141, 81200401]; Jiangsu Provincial Key Medical Talents; Program of Healthy Talents' Cultivation for Nanjing City; Medical Science and technology development Foundation; Nanjing Department of Health [QYK11175]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Key Medical Talents; Program of Healthy Talents' Cultivation for Nanjing City; Medical Science and technology development Foundation; Nanjing Department of Health	This project was supported by grants from The National Nature Science Foundation of China (81172141, 81200401), Jiangsu Provincial Key Medical Talents to SK Wang, Program of Healthy Talents' Cultivation for Nanjing City to BS He, and Medical Science and technology development Foundation, Nanjing Department of Health (QYK11175) to BS He. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshatwi AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030049; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen H, 2012, INTERN MED J, V42, pE115, DOI 10.1111/j.1445-5994.2011.02434.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039777; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hong Young-Seoub, 2011, J Prev Med Public Health, V44, P125, DOI 10.3961/jpmph.2011.44.3.125; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; JAKOBOVITS A, 1986, P NATL ACAD SCI USA, V83, P7806, DOI 10.1073/pnas.83.20.7806; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Kim WH, 2012, GENE, V504, P92, DOI 10.1016/j.gene.2012.05.014; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Lung R.W., 2012, MOL CARCINOG; Min KT, 2012, MOL CARCINOGEN, V51, pE65, DOI 10.1002/mc.21849; Murakami A, 2001, NUCLEIC ACIDS RES, V29, P3347, DOI 10.1093/nar/29.16.3347; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Punj V, 2010, ONCOGENE, V29, P1835, DOI 10.1038/onc.2009.460; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wynter CVA, 2006, MED HYPOTHESES, V66, P612, DOI 10.1016/j.mehy.2005.10.024; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Yang YC, 2009, EUR J GASTROEN HEPAT, V21, P1016, DOI 10.1097/MEG.0b013e32831d7b9c; Zeng Y, 2010, WORLD J GASTROENTERO, V16, P3578, DOI 10.3748/wjg.v16.i28.3578; Zhan JF, 2011, ARCH MED RES, V42, P144, DOI 10.1016/j.arcmed.2011.04.001; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740; Zhou FY, 2012, DNA CELL BIOL, V31, P1290, DOI 10.1089/dna.2011.1596; Zhou J, 2012, DNA CELL BIOL, V31, P524, DOI 10.1089/dna.2011.1340; Zhu LJ, 2012, DNA CELL BIOL, V31, P349, DOI 10.1089/dna.2011.1348	42	29	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65123	10.1371/journal.pone.0065123	http://dx.doi.org/10.1371/journal.pone.0065123			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750236	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900038
J	Ammar, D; Nazari, EM; Muller, YMR; Allodi, S				Ammar, Dib; Nazari, Evelise M.; Mueller, Yara M. R.; Allodi, Silvana			On the Brain of a Crustacean: A Morphological Analysis of CaMKII Expression and Its Relation to Sensory and Motor Pathways	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; SUBSTANCE P-LIKE; CALMODULIN; LOCALIZATION; EVOLUTION; IMMUNOREACTIVITY; ORGANIZATION; PATTERNS; DENSITY; BINDING	Calcium/calmodulin kinase II (CaMKII) is a Ca2+-activated enzyme that is abundant in vertebrate and invertebrate brains. However, its characterization is poorly addressed in the nervous system of crustaceans, and, to our knowledge, no studies have determined the microanatomical location of CaMKII in a crustacean species. In this study, we found labeling of CaMKII in the eyestalk and brain of the prawn Macrobrachium acanthurus, by means of immunohistochemistry and Western blotting. Antibodies against neuron (beta tubulin III), glutamate receptor (GluA1), and FMRFamide were used in order to further characterize the CaMKII-labeled cells in the brain. In the eyestalk, strong labeling with CaMKII was observed in the photoreceptors. These cells, especially in the rhabdom, were also reactive to anti-beta tubulin III, whereas the pigment cells were labeled with anti-CaMKII. GluA1 co-located with CaMKII in the photoreceptors. Also, CaMKII appeared in the same sites as FMRFamide in the deutocerebrum, including the olfactory lobe, and in the tritocerebrum, specifically in the antennular neuropil, indicating that the synaptic areas in these regions may be related to sensory-motor processing. In the brain, the identification of cells and regions that express CaMKII contributes to the understanding of the processing of neural connections and the modulating role of CaMKII in decapod crustaceans.	[Ammar, Dib; Nazari, Evelise M.; Mueller, Yara M. R.] Univ Fed Santa Catarina, Dept Biol Celular Embriol & Genet, Programa Posgrad Biol Celular & Desenvolvimento, Ctr Ciencias Biol, BR-88040900 Florianopolis, SC, Brazil; [Ammar, Dib; Nazari, Evelise M.; Allodi, Silvana] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Morfol, Rio De Janeiro, Brazil; [Allodi, Silvana] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Posgrad Ciencias Biol Fisiol, BR-21941 Rio De Janeiro, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Allodi, S (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Morfol, Rio De Janeiro, Brazil.	sallodi@biof.ufrj.br	S, Allodi/AAR-7968-2020; Allodi, Silvana/G-1781-2012	Allodi, Silvana/0000-0002-3053-3866	FAPERJ, CNPq, N/A	FAPERJ, CNPq, N/A	The work was funded by FAPERJ, CNPq, N/A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allodi S, 2006, GLIA, V53, P612, DOI 10.1002/glia.20317; Ammar D, 2008, BRAIN BEHAV EVOLUT, V72, P27, DOI 10.1159/000139459; Arendt D, 2003, INT J DEV BIOL, V47, P563; Burkert P, 2006, EUR J NEUROSCI, V23, P335, DOI 10.1111/j.1460-9568.2005.04562.x; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chen N, 2003, NEUROSCIENCE, V120, P163, DOI 10.1016/S0306-4522(03)00259-8; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Derby CD, 2008, J CHEM ECOL, V34, P898, DOI 10.1007/s10886-008-9489-0; FINGERMAN M, 1985, CELL TISSUE RES, V241, P473; GuptaRoy B, 2000, MOL BRAIN RES, V80, P26, DOI 10.1016/S0169-328X(00)00115-7; GuptaRoy B, 1996, J BIOL CHEM, V271, P19846, DOI 10.1074/jbc.271.33.19846; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HARZSCH S, 1993, HELGOLANDER MEERESUN, V47, P61, DOI 10.1007/BF02366185; Hawkins RD, 2006, BIOL BULL-US, V210, P174, DOI 10.2307/4134556; HERGENHAHN HG, 1984, BIOCHIM BIOPHYS ACTA, V787, P196, DOI 10.1016/0167-4838(84)90080-3; Horner AJ, 2004, J EXP BIOL, V207, P3785, DOI 10.1242/jeb.01200; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; JOHANSSON KUI, 1992, ZOOMORPHOLOGY, V112, P81, DOI 10.1007/BF01673809; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Kazama H, 2003, NEUROSCIENCE, V117, P615, DOI 10.1016/S0306-4522(02)00923-5; Kleinlogel S, 2003, J COMP NEUROL, V467, P326, DOI 10.1002/cne.10922; Langworthy K, 1997, CELL TISSUE RES, V288, P191, DOI 10.1007/s004410050806; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Melzer RR, 1997, NATURWISSENSCHAFTEN, V84, P542, DOI 10.1007/s001140050442; Mercier AJ, 2002, CRUSTACEAN NERVOUS SYSTEM, P49; Meyer-Rochow VB, 2001, ZOOL SCI, V18, P1175, DOI 10.2108/zsj.18.1175; MICHAEL RH, 1992, LIFE SCI, V51, P1881, DOI 10.1016/0024-3205(92)90040-V; NORONHA KF, 1995, BRAIN RES, V673, P70, DOI 10.1016/0006-8993(94)01396-Y; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Sandeman D. C., 1995, NERVOUS SYSTEMS INVE, P329; SANDEMAN DC, 1993, J EXP ZOOL, V265, P112, DOI 10.1002/jez.1402650204; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; Schmidt M, 2005, J EXP BIOL, V208, P233, DOI 10.1242/jeb.01357; Schmidt M, 1997, BRAIN RES, V746, P71, DOI 10.1016/S0006-8993(96)01187-0; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Sombke A, 2011, CHEM SENSES, V36, P43, DOI 10.1093/chemse/bjq096; Sullivan JM, 2004, J COMP NEUROL, V470, P25, DOI 10.1002/cne.11026; Tsvileneva V.A., 1985, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V113, P217; Withers Michelle D., 1998, Invertebrate Neuroscience, V3, P335, DOI 10.1007/BF02577693; Zhang Y, 2009, DEV NEUROBIOL, V69, P415, DOI 10.1002/dneu.20717	43	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64855	10.1371/journal.pone.0064855	http://dx.doi.org/10.1371/journal.pone.0064855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741406	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900119
J	Falola, MI; Wiener, HW; Wineinger, NE; Cutter, GR; Kimberly, RP; Edberg, JC; Arnett, DK; Kaslow, RA; Tang, JM; Shrestha, S				Falola, Michael I.; Wiener, Howard W.; Wineinger, Nathan E.; Cutter, Gary R.; Kimberly, Robert P.; Edberg, Jeffrey C.; Arnett, Donna K.; Kaslow, Richard A.; Tang, Jianming; Shrestha, Sadeep			Genomic Copy Number Variants: Evidence for Association with Antibody Response to Anthrax Vaccine Adsorbed	PLOS ONE			English	Article							HEPATITIS-B-VACCINE; INHALATIONAL ANTHRAX; IMMUNE-RESPONSES; WIDE ASSOCIATION; UNITED-STATES; GENES; HLA; EXPRESSION; IMMUNOGENICITY; SUSCEPTIBILITY	Background: Anthrax and its etiologic agent remain a biological threat. Anthrax vaccine is highly effective, but vaccine-induced IgG antibody responses vary widely following required doses of vaccinations. Such variation can be related to genetic factors, especially genomic copy number variants (CNVs) that are known to be enriched among genes with immunologic function. We have tested this hypothesis in two study populations from a clinical trial of anthrax vaccination. Methods: We performed CNV-based genome-wide association analyses separately on 794 European Americans and 200 African-Americans. Antibodies to protective antigen were measured at week 8 (early response) and week 30 (peak response) using an enzyme-linked immunosorbent assay. We used DNA microarray data (Affymetrix 6.0) and two CNV detection algorithms, hidden markov model (PennCNV) and circular binary segmentation (GeneSpring) to determine CNVs in all individuals. Multivariable regression analyses were used to identify CNV-specific associations after adjusting for relevant non-genetic covariates. Results: Within the 22 autosomal chromosomes, 2,943 non-overlapping CNV regions were detected by both algorithms. Genomic insertions containing HLA-DRB5, DRB1 and DQA1/DRA genes in the major histocompatibility complex (MHC) region (chromosome 6p21.3) were moderately associated with elevated early antibody response (beta = 0.14, p = 1.78x10(-3)) among European Americans, and the strongest association was observed between peak antibody response and a segmental insertion on chromosome 1, containing NBPF4, NBPF5, STXMP3, CLCC1, and GPSM2 genes (beta = 1.66, p = 6.06x10(-5)). For African-Americans, segmental deletions spanning PRR20, PCDH17 and PCH68 genes on chromosome 13 were associated with elevated early antibody production (beta = 0.18, p = 4.47x10(-5)). Population-specific findings aside, one genomic insertion on chromosome 17 (containing NSF, ARL17 and LRRC37A genes) was associated with elevated peak antibody response in both populations. Conclusion: Multiple CNV regions, including the one consisting of MHC genes that is consistent with earlier research, can be important to humoral immune responses to anthrax vaccine adsorbed.	[Falola, Michael I.; Wiener, Howard W.; Arnett, Donna K.; Kaslow, Richard A.; Shrestha, Sadeep] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Wineinger, Nathan E.] Scripps Translat Sci Inst, La Jolla, CA USA; [Cutter, Gary R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Kimberly, Robert P.; Edberg, Jeffrey C.; Tang, Jianming] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Scripps Research Institute; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shrestha, S (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	sshrestha@uab.edu	Tang, Jianming "James"/O-4980-2019; Cutter, Gary/AAY-5392-2021	Tang, Jianming "James"/0000-0003-0137-7486; Cutter, Gary/0000-0002-8455-980X; Kimberly, Robert/0000-0002-5330-3086	National Institute of Allergy and Infectious Diseases [N01-AI40068, 272201000023C-0-0-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040068] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases through contracts N01-AI40068 and 272201000023C-0-0-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG TECHN INC, GENESPRING US MAN; Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; BRACHMAN PS, 1962, AM J PUBLIC HEALTH N, V52, P632, DOI 10.2105/AJPH.52.4.632; *CDCP, 2002, JAMA-J AM MED ASSOC, V288, P2681; Chauncey KM, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-33; Chen J, 2009, IEEE ACM T COMPUT BI, V6, P529, DOI 10.1109/TCBB.2008.129; Cherkasskiy BL, 1999, J APPL MICROBIOL, V87, P192, DOI 10.1046/j.1365-2672.1999.00868.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desombere I, 1998, TISSUE ANTIGENS, V51, P593, DOI 10.1111/j.1399-0039.1998.tb03001.x; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Garman L, 2012, TOXINS, V4, P1451, DOI 10.3390/toxins4121451; GIANNUZZI G, 2012, GENOME RES; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Irvin MR, 2011, PHARMACOGENET GENOM, V21, P798, DOI 10.1097/FPC.0b013e32834b68f9; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Kim Soon-Young, 2012, Genomics & Informatics, V10, P194, DOI 10.5808/GI.2012.10.3.194; Latourelle JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046199; Lee YC, 2006, VACCINE, V24, P5335, DOI 10.1016/j.vaccine.2006.04.021; Maillard JM, 2002, EMERG INFECT DIS, V8, P1035, DOI 10.3201/eid0810.020389; Marano N, 2008, JAMA-J AM MED ASSOC, V300, P1532, DOI 10.1001/jama.300.13.1532; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; Nagasawa M, 2001, J BIOL CHEM, V276, P20413, DOI 10.1074/jbc.M100366200; Newport MJ, 2005, EXPERT REV VACCINES, V4, P739, DOI 10.1586/14760584.4.5.739; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Ovsyannikova IG, 2006, J INFECT DIS, V193, P655, DOI 10.1086/500144; Ovsyannikova IG, 2006, EXPERT REV VACCINES, V5, P33, DOI 10.1586/14760584.5.1.33; Pajewski NM, 2011, GENES IMMUN, V12, P457, DOI 10.1038/gene.2011.15; Pajewski NM, 2012, VACCINE, V30, P4778, DOI 10.1016/j.vaccine.2012.05.032; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Png E, 2011, HUM MOL GENET, V20, P3893, DOI 10.1093/hmg/ddr302; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Regnstrom K, 2003, VACCINE, V21, P2307, DOI 10.1016/S0264-410X(03)00103-8; Semenova VA, 2012, J IMMUNOL METHODS, V376, P97, DOI 10.1016/j.jim.2011.12.002; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Thielmann Y, 2009, PROTEINS, V77, P637, DOI 10.1002/prot.22477; Traeger MS, 2002, EMERG INFECT DIS, V8, P1029, DOI 10.3201/eid0810.020354; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Wineinger Nathan E., 2008, International Journal of Computational Biology and Drug Design, V1, P368, DOI 10.1504/IJCBDD.2008.022208	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64813	10.1371/journal.pone.0064813	http://dx.doi.org/10.1371/journal.pone.0064813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741398	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900111
J	Hoorelbeke, B; Xue, J; LiWang, PJ; Balzarini, J				Hoorelbeke, Bart; Xue, Jie; LiWang, Patricia J.; Balzarini, Jan			Role of the Carbohydrate-Binding Sites of Griffithsin in the Prevention of DC-SIGN-Mediated Capture and Transmission of HIV-1	PLOS ONE			English	Article							ANTIVIRAL PROTEIN GRIFFITHSIN; HUMAN-IMMUNODEFICIENCY-VIRUS; ENTRY INHIBITOR GRIFFITHSIN; DENDRITIC CELLS; T-LYMPHOCYTES; CROSS-LINKING; INFECTION; LECTIN; GLYCANS; GP120	Background: The glycan-targeting C-type DC-SIGN lectin receptor is implicated in the transmission of the human immunodeficiency virus (HIV) by binding the virus and transferring the captured HIV-1 to CD4(+) T lymphocytes. Carbohydrate binding agents (CBAs) have been reported to block HIV-1 infection. We have now investigated the potent mannose-specific anti-HIV CBA griffithsin (GRFT) on its ability to inhibit the capture of HIV-1 to DC-SIGN, its DC-SIGN-directed transmission to CD4(+) T-lymphocytes and the role of the three carbohydrate-binding sites (CBS) of GRFT in these processes. Findings: GRFT inhibited HIV-1(IIIB) infection of CEM and HIV-1(NL4.3) infection of C8166 CD4(+) T-lymphocytes at an EC50 of 0.059 and 0.444 nM, respectively. The single mutant CBS variants of GRFT (in which a key Asp in one of the CBS was mutated to Ala) were about similar to 20 to 60-fold less potent to prevent HIV-1 infection and similar to 20 to 90-fold less potent to inhibit syncytia formation in co-cultures of persistently HIV-1 infected HuT-78 and uninfected C8166 CD4(+) T-lymphocytes. GRFT prevents DC-SIGN-mediated virus capture and HIV-1 transmission to CD4(+) T-lymphocytes at an EC50 of 1.5 nM and 0.012 nM, respectively. Surface plasmon resonance (SPR) studies revealed that wild-type GRFT efficiently blocked the binding between DC-SIGN and immobilized gp120, whereas the point mutant CBS variants of GRFT were similar to 10-to 15-fold less efficient. SPR-analysis also demonstrated that wild-type GRFT and its single mutant CBS variants have the capacity to expel bound gp120 from the gp120-DC-SIGN complex in a dose dependent manner, a property that was not observed for HHA, another mannose-specific potent anti-HIV-1 CBA. Conclusion: GRFT is inhibitory against HIV gp120 binding to DC-SIGN, efficiently prevents DC-SIGN-mediated transfer of HIV-1 to CD4(+) T-lymphocytes and is able to expel gp120 from the gp120-DC-SIGN complex. Functionally intact CBS of GRFT are important for the optimal action of GRFT.	[Hoorelbeke, Bart; Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Xue, Jie; LiWang, Patricia J.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	KU Leuven; University of California System; University of California Merced	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.	jan.balzarini@rega.kuleuven.be	Xue, Jie/J-9778-2015		KU Leuven [GOA 10/14, PF 0/018]; Flemish "Fonds voor Wetenschappelijk Onderzoek" (FWO) [G-0528-12N]; European Community (CHAARM)	KU Leuven(KU Leuven); Flemish "Fonds voor Wetenschappelijk Onderzoek" (FWO)(FWO); European Community (CHAARM)(European Commission)	The research was funded by grants from the KU Leuven (GOA 10/14, PF 0/018), the Flemish "Fonds voor Wetenschappelijk Onderzoek" (FWO) (no. G-0528-12N) and the European Community (CHAARM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre KB, 2011, J VIROL, V85, P9039, DOI 10.1128/JVI.02675-10; Alexandre KB, 2012, VIROLOGY, P175; Balzarini J, 2005, MOL PHARMACOL, V67, P1556, DOI 10.1124/mol.104.005082; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; Balzarini J, 2007, J VIROL, V81, P362, DOI 10.1128/JVI.01404-06; Belardi B, 2012, J AM CHEM SOC, V134, P9549, DOI 10.1021/ja301694s; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Godula K, 2012, J AM CHEM SOC, V134, P15732, DOI 10.1021/ja302193u; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hoorelbeke B, 2010, ANTIMICROB AGENTS CH, V54, P3287, DOI 10.1128/AAC.00254-10; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Matei E, 2010, J BIOL CHEM, V285, P13057, DOI 10.1074/jbc.M109.094938; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Moulaei T, 2010, STRUCTURE, V18, P1104, DOI 10.1016/j.str.2010.05.016; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Ogata M, 2012, BIOCONJUGATE CHEM, V23, P97, DOI 10.1021/bc200440e; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Steinman RM, 2003, CURR TOP MICROBIOL, V276, P1; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Turville SG, 2005, J VIROL, V79, P13519, DOI 10.1128/JVI.79.21.13519-13527.2005; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Xue J, 2012, MOL PHARMACEUT, V9, P2613, DOI 10.1021/mp300194b; Ziolkowska NE, 2007, PROTEINS, V67, P661, DOI 10.1002/prot.21336; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	33	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64132	10.1371/journal.pone.0064132	http://dx.doi.org/10.1371/journal.pone.0064132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741304	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900016
J	Hosokawa, T; Hironaka, M; Inadomi, K; Mukai, H; Nikoh, N; Fukatsu, T				Hosokawa, Takahiro; Hironaka, Mantaro; Inadomi, Koichi; Mukai, Hiromi; Nikoh, Naruo; Fukatsu, Takema			Diverse Strategies for Vertical Symbiont Transmission among Subsocial Stinkbugs	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MATERNAL-CARE; TROPHIC-EGGS; EVOLUTION; HEMIPTERA; BACTERIA; BUG; HETEROPTERA; BEHAVIOR	Sociality may affect symbiosis and vice versa. Many plant-sucking stinkbugs harbor mutualistic bacterial symbionts in the midgut. In the superfamily Pentatomoidea, adult females excrete symbiont-containing materials from the anus, which their offspring ingest orally and establish vertical symbiont transmission. In many stinkbug families whose members are mostly non-social, females excrete symbiont-containing materials onto/beside eggs upon oviposition. However, exceptional cases have been reported from two subsocial species representing the closely related families Cydnidae and Parastrachiidae, wherein females remain nearby eggs for maternal care after oviposition, and provide their offspring with symbiont-containing secretions at later stages, either just before or after hatching. These observations suggested that sociality of the host stinkbugs may be correlated with their symbiont transmission strategies. However, we found that cydnid stinkbugs of the genus Adomerus, which are associated with gammaproteobacterial gut symbionts and exhibit elaborate maternal care over their offspring, smear symbiont-containing secretions onto eggs upon oviposition as many non-social stinkbugs do. Surface sterilization of the eggs resulted in aposymbiotic insects of slower growth, smaller size and abnormal body coloration, indicating vertical symbiont transmission via egg surface contamination and presumable beneficial nature of the symbiosis. The Adomerus symbionts exhibited AT-biased nucleotide compositions, accelerated molecular evolutionary rates and reduced genome size, while these degenerative genomic traits were less severe than those in the symbiont of a subsocial parastrachiid. These results suggest that not only sociality but also other ecological and evolutionary aspects of the host stinkbugs, including the host-symbiont co-evolutionary history, may have substantially affected their symbiont transmission strategies. (250 words).	[Hosokawa, Takahiro; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Hironaka, Mantaro] Hamamatsu Univ Sch Med, Dept Biol, Fac Med, Hamamatsu, Shizuoka 4313192, Japan; [Inadomi, Koichi] Saga Univ, Fac Agr, Dept Appl Biol Sci, Saga 840, Japan; [Mukai, Hiromi] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hamamatsu University School of Medicine; Saga University; Kagoshima University	Hosokawa, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	th-hosokawa@aist.go.jp	Hironaka, Mantaro/HGC-7443-2022	Hosokawa, Takahiro/0000-0001-7618-1774	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Society of the Promotion of Science [236923, 21370011]	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN), Grant-in-Aid for JSPS Fellows (236923), and Grant-in-Aid for Scientific Research (B) (21370011) from the Japan Society of the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1995, JPN J APPL ENTOMOL Z, V39, P109, DOI 10.1303/jjaez.39.109; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Costa J., 2006, OTHER INSECT SOC; Crawley MJ, 2005, STAT INTRO USING R; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Hosokawa T, 2008, BIOL LETTERS, V4, P45, DOI 10.1098/rsbl.2007.0510; Hosokawa T, 2007, MOL ECOL, V16, P5316, DOI 10.1111/j.1365-294X.2007.03592.x; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Hosokawa T, 2012, APPL ENVIRON MICROB, V78, P4758, DOI 10.1128/AEM.00867-12; Hosokawa T, 2012, ANIM BEHAV, V83, P293, DOI 10.1016/j.anbehav.2011.11.006; Hosokawa T, 2010, APPL ENVIRON MICROB, V76, P4130, DOI 10.1128/AEM.00616-10; Kaiwa N, 2010, APPL ENVIRON MICROB, V76, P3486, DOI 10.1128/AEM.00421-10; Kikuchi Y, 2008, MICROBIAL ECOLOGY RE, P39; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kikuchi Y, 2012, APPL ENTOMOL ZOOL, V47, P1, DOI 10.1007/s13355-011-0081-7; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koga R, 2012, P NATL ACAD SCI USA, V109, pE1230, DOI 10.1073/pnas.1119212109; KUDO S, 1989, J ETHOL, V7, P75, DOI 10.1007/BF02350027; KUDO S, 1990, APPL ENTOMOL ZOOL, V25, P431, DOI 10.1303/aez.25.431; Kudo S, 2004, OIKOS, V107, P28, DOI 10.1111/j.0030-1299.2004.13169.x; Kudo Shin-Ichi, 1993, Psyche (Cambridge), V100, P121, DOI 10.1155/1993/51480; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Mukai H, 2012, ANIM BEHAV, V84, P1443, DOI 10.1016/j.anbehav.2012.09.012; Mukai H, 2010, CAN ENTOMOL, V142, P52, DOI 10.4039/n09-045; NAKAHIRA T, 1994, NATURWISSENSCHAFTEN, V81, P413, DOI 10.1007/s001140050097; Nakahira T, 2008, J INSECT BEHAV, V21, P306, DOI 10.1007/s10905-008-9129-0; Nikoh N, 2011, GENOME BIOL EVOL, V3, P702, DOI 10.1093/gbe/evr064; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Prado SS, 2009, ENTOMOL EXP APPL, V132, P21, DOI 10.1111/j.1570-7458.2009.00863.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; ROSENKRANZ W., 1939, ZEITSCHR MORPH U OKOL TIERS, V36, P279, DOI 10.1007/BF00403148; Schorr H., 1957, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V45, P561, DOI 10.1007/BF00399596; Sweet MH, 2002, ANN ENTOMOL SOC AM, V95, P441, DOI 10.1603/0013-8746(2002)095[0441:PHCRTF]2.0.CO;2; Tada A, 2011, APPL ENTOMOL ZOOL, V46, P483, DOI 10.1007/s13355-011-0066-6; TSUKAMOTO L, 1992, J ETHOL, V10, P21, DOI 10.1007/BF02350183; Vega FE, 2005, INSECT FUNGAL ASS EC, P333; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; [No title captured]	54	53	54	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65081	10.1371/journal.pone.0065081	http://dx.doi.org/10.1371/journal.pone.0065081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741463	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900176
J	Jiang, LL; Perc, M; Szolnoki, A				Jiang, Luo-Luo; Perc, Matjaz; Szolnoki, Attila			If Cooperation Is Likely Punish Mildly: Insights from Economic Experiments Based on the Snowdrift Game	PLOS ONE			English	Article							ANTISOCIAL PUNISHMENT; ALTRUISTIC PUNISHMENT; HUMAN-BEHAVIOR; EVOLUTION; CARROT; REWARD; RECIPROCITY; SANCTIONS; EMERGENCE; DYNAMICS	Punishment may deter antisocial behavior. Yet to punish is costly, and the costs often do not offset the gains that are due to elevated levels of cooperation. However, the effectiveness of punishment depends not only on how costly it is, but also on the circumstances defining the social dilemma. Using the snowdrift game as the basis, we have conducted a series of economic experiments to determine whether severe punishment is more effective than mild punishment. We have observed that severe punishment is not necessarily more effective, even if the cost of punishment is identical in both cases. The benefits of severe punishment become evident only under extremely adverse conditions, when to cooperate is highly improbable in the absence of sanctions. If cooperation is likely, mild punishment is not less effective and leads to higher average payoffs, and is thus the much preferred alternative. Presented results suggest that the positive effects of punishment stem not only from imposed fines, but may also have a psychological background. Small fines can do wonders in motivating us to chose cooperation over defection, but without the paralyzing effect that may be brought about by large fines. The later should be utilized only when absolutely necessary.	[Jiang, Luo-Luo] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China; [Jiang, Luo-Luo] Wenzhou Univ, Financial Res Inst, Wenzhou, Peoples R China; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Szolnoki, Attila] Hungarian Acad Sci, Inst Tech Phys & Mat Sci, Res Ctr Nat Sci, Budapest, Hungary	Wenzhou University; Wenzhou University; University of Maribor; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Jiang, LL (corresponding author), Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China.	jiangluoluo@gmail.com	Perc, Matjaz/A-5148-2009; Szolnoki, Attila/A-6714-2010	Perc, Matjaz/0000-0002-3087-541X; Szolnoki, Attila/0000-0002-0907-0406	National Natural Science Foundation of China [61203145, 11047012]; Hungarian National Research Fund [K-101490]; Slovenian Research Agency [J1-4055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the National Natural Science Foundation of China (Grants 61203145 and 11047012), the Hungarian National Research Fund (Grant K-101490), and the Slovenian Research Agency (Grant J1-4055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor DR, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066115; Andreoni J, 2003, AM ECON REV, V93, P893, DOI 10.1257/000282803322157142; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Calder WA., 1984, SIZE FUNCTION LIFE H; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Choi JK, 2013, J ECON PSYCHOL, V35, P17, DOI 10.1016/j.joep.2013.01.001; Deng KY, 2012, THEOR POPUL BIOL, V81, P284, DOI 10.1016/j.tpb.2012.02.005; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Espin A, 2012, P R SOC B; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fowler JH, 2005, NATURE, V437, pE8, DOI 10.1038/nature04201; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gachter S, 2011, EUR ECON REV, V55, P193, DOI 10.1016/j.euroecorev.2010.04.003; Garcia J, 2012, J THEOR BIOL, V307, P168, DOI 10.1016/j.jtbi.2012.05.011; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Gracia-Lazaro C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00325; Grujic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047718; Grujic J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00638; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hauert C, 2010, J THEOR BIOL, V267, P22, DOI 10.1016/j.jtbi.2010.08.009; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2006, SCIENCE, V312, P60, DOI 10.1126/science.1126398; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hilbe C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00458; Hilbe C, 2010, P ROY SOC B-BIOL SCI, V277, P2427, DOI 10.1098/rspb.2010.0065; Hrdy S, 2011, MOTHERS OTHERS EVOLU; Isakov A, 2012, DYN GAMES APPL, V2, P97, DOI 10.1007/s13235-011-0020-9; Maynard Smith J., 1982, pi; Nowak M., 2011, SUPERCOOPERATORS ALT; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Perc M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043013; Perc M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00344; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Santos MD, 2012, J THEOR BIOL, V315, P81, DOI 10.1016/j.jtbi.2012.09.001; Sefton M, 2007, ECON INQ, V45, P671, DOI 10.1111/j.1465-7295.2007.00051.x; Sigmund K., 2010, CALCULUS SELFISHNESS; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Sutter M, 2010, REV ECON STUD, V77, P1540, DOI 10.1111/j.1467-937X.2010.00608.x; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/093016; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Traulsen A, 2012, P ROY SOC B-BIOL SCI, V279, P3716, DOI 10.1098/rspb.2012.0937; Vukov J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002868	58	38	38	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64677	10.1371/journal.pone.0064677	http://dx.doi.org/10.1371/journal.pone.0064677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741367	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000319799900080
J	Kammerer, CF; Frobisch, J; Angielczyk, KD				Kammerer, Christian F.; Froebisch, Joerg; Angielczyk, Kenneth D.			On the Validity and Phylogenetic Position of Eubrachiosaurus browni, a Kannemeyeriiform Dicynodont (Anomodontia) from Triassic North America	PLOS ONE			English	Article							THERAPSIDA; SYNAPSIDA; GENUS; EVOLUTION; REPTILIA; MOROCCAN; PATTERNS; ANATOMY; NAMIBIA; AFRICA	The large dicynodont Eubrachiosaurus browni from the Upper Triassic Popo Agie Formation of Wyoming is redescribed. Eubrachiosaurus is a valid taxon that differs from Placerias hesternus, with which it was previously synonymized, by greater anteroposterior expansion of the scapula dorsally and a very large, nearly rectangular humeral ectepicondyle with a broad supinator process. Inclusion of Eubrachiosaurus in a revised phylogenetic analysis of anomodont therapsids indicates that it is a stahleckeriid closely related to the South American genera Ischigualastia and Jachaleria. The recognition of Eubrachiosaurus as a distinct lineage of North American dicynodonts, combined with other recent discoveries in the eastern USA and Europe, alters our perception of Late Triassic dicynodont diversity in the northern hemisphere. Rather than being isolated relicts in previously therapsid-dominated regions, Late Triassic stahleckeriid dicynodonts were continuing to disperse and diversify, even in areas like western North America that were otherwise uninhabited by coeval therapsids (i.e., cynodonts).	[Kammerer, Christian F.; Froebisch, Joerg] Leibniz Inst Res Evolut & Biodivers, Museum Naturkunde, Berlin, Germany; [Angielczyk, Kenneth D.] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Field Museum of Natural History (Chicago)	Kammerer, CF (corresponding author), Leibniz Inst Res Evolut & Biodivers, Museum Naturkunde, Berlin, Germany.	christian.kammerer@mfn-berlin.de			Deutsche Forschungsgemeinschaft [FR 2457/3-1, FR 2457/4-1]; Alexander von Humboldt Foundation; Federal Ministry of Education and Research; Department of Geology of the Field Museum of Natural History	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Department of Geology of the Field Museum of Natural History	Research by CFK and JF was supported by the Deutsche Forschungsgemeinschaft (FR 2457/3-1 and FR 2457/4-1) and a Sofja Kovalevskaja-Award of the Alexander von Humboldt Foundation and the Federal Ministry of Education and Research to JF. Research by KDA was supported by the Department of Geology of the Field Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Angielczyk KD, 2002, J PALEONTOL, V76, P1047, DOI 10.1666/0022-3360(2002)076<1047:RPPASS>2.0.CO;2; Angielczyk KD, 2013, EARLY EVOLUTIONARY H; Angielczyk KD, 2008, J PALEONTOL, V82, P528, DOI 10.1666/07-051.1; Angielczyk KD, 2009, J VERTEBR PALEONTOL, V29, P1174, DOI 10.1671/039.029.0427; [Anonymous], 1961, TRAITE PALEONTOLOGIE; Baird D., 1968, Geological Society of America Special Paper, VNo. 115, P11; BANDYOPADHYAY S, 1988, PHILOS T ROY SOC B, V320, P185, DOI 10.1098/rstb.1988.0072; BENTON MJ, 1983, Q REV BIOL, V58, P29, DOI 10.1086/413056; Botha J, 2007, PALAEONTOLOGY, V50, P1175, DOI 10.1111/j.1475-4983.2007.00697.x; Botha J, 2006, J AFR EARTH SCI, V45, P502, DOI 10.1016/j.jafrearsci.2006.04.006; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Broom R., 1905, Records of the Albany Museum, Vi, P266; Broom R, 1912, P ZOOL SOC LOND, V1912, P859; Camp C.L., 1956, MEM U CALIF, V13, P255; Cisneros JC, 2011, SCIENCE, V331, P1603, DOI 10.1126/science.1200305; Cope ED, 1870, SYNOPSIS EXTINCT B 2, P105; Cox C.B., 1972, P173; COX CB, 1983, PALAEONTOLOGY, V26, P389; COX CB, 1965, PHILOS T ROY SOC B, V248, P457, DOI 10.1098/rstb.1965.0005; Damiani R, 2007, PALAEONTOLOGY, V50, P1531, DOI 10.1111/j.1475-4983.2007.00727.x; DUTUIT JM, 1989, CR ACAD SCI II, V309, P1267; DUTUIT JM, 1989, CR ACAD SCI II, V309, P303; Dzik J, 2008, ACTA PALAEONTOL POL, V53, P733, DOI 10.4202/app.2008.0415; Fiorillo AR, 2000, PALAIOS, V15, P373, DOI 10.2307/3515510; Frobisch J, 2007, ZOOL J LINN SOC-LOND, V150, P117, DOI 10.1111/j.1096-3642.2007.00285.x; Frobisch J, 2006, CAN J EARTH SCI, V43, P1297, DOI 10.1139/E06-031; Frobisch J, 2010, NATURWISSENSCHAFTEN, V97, P187, DOI 10.1007/s00114-009-0626-6; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; Govender Romala, 2009, Palaeontologia Africana, V44, P41; Green J, 2005, J VERTEBR PALEONTOL, V25, p65A; Green JL, 2011, FORERUNNERS MAMMALS, P178; Hancox PJ, 2013, J VERTEBR P IN PRESS; HUBER P, 1993, SE GEOL, V33, P171; Huene F, 1935, FOSSILEN REPTILIEN S; Huxley T.H., 1859, Q J GEOL SOC LOND, V15, P649, DOI DOI 10.1144/GSL.JGS.1859.015.01-02.63; Ivakhnenko M.F., 1997, Trudy Paleontologicheskogo Instituta, V268, P1; Kalandadze NN, 1985, PALEONTOL J, V19, P73; Kammerer CF, 2011, J VERTEBR PALEONTOL, V31, P1, DOI 10.1080/02724634.2011.627074; Kammerer CF, 2009, ZOOTAXA, P1; KEYSER A W, 1979, Transactions of the Geological Society of South Africa, V82, P81; King G.M., 1988, Handbuch der Palaeoherpetologie, V17C, P1; King G. M., 1990, DICYNODONTS STUDY PA; Li J, 2008, CHINESE FOSSIL REPTI; LI JL, 1980, VERTEBRAT PALASIATIC, V18, P94; Liu J, 2010, P ROY SOC B-BIOL SCI, V277, P285, DOI 10.1098/rspb.2009.0883; Long R.A., 1995, NEW MEXICO MUSEUM NA, V4, P1; Lucas F. A., 1904, Proceedings United States Museum, Vxxvii, P193; Lucas Spencer G., 2002, Bulletin of the New Mexico Museum of Natural History and Science, V21, P127; Lucas Spencer G., 1993, Bulletin of the New Mexico Museum of Natural History and Science, V3, P321; Maisch MW, 2001, NEUES JAHRB GEOL P-A, V220, P127, DOI 10.1127/njgpa/220/2001/127; Mueller B, 2007, J VERTEBR PALEONTOL, V27, p121A; Owen R., 1860, REPORT BRIT ASS ADV, V29, P153; Owen R., 1845, T GEOLOGICAL SOC LON, V2, P59, DOI DOI 10.1144/TRANSGSLB.7.59; Parker WG, 2010, EARTH ENV SCI T R SO, V101, P231, DOI 10.1017/S1755691011020020; Ray S, 2006, PALAEONTOLOGY, V49, P1263, DOI 10.1111/j.1475-4983.2006.00597.x; Schoch RR, 2012, NEUES JAHRB GEOL P-A, V263, P119, DOI 10.1127/0077-7749/2012/0216; Sidor CA, 1998, PALEOBIOLOGY, V24, P254; Strong EE, 1999, CLADISTICS, V15, P363, DOI 10.1111/j.1096-0031.1999.tb00272.x; Sullivan C, 2003, P ROY SOC B-BIOL SCI, V270, P173, DOI 10.1098/rspb.2002.2189; Sun A. L., 1963, Paleont Sinica NS, VC17, P1; Surkov MV, 2005, PALEONTOL J+, V39, P72; Surkov MV, 2004, PALAEONTOLOGY, V47, P619, DOI 10.1111/j.0031-0239.2004.00382.x; Surkov MV, 1998, PALEONTOL J, V32, P402; SURKOV MV, 1999, PALEONTOL J, V33, P302; Surkov MV, 1999, PALEONTOL J, V33, P420; Vega-Dias C, 2004, NEUES JAHRB GEOL P-A, V231, P145, DOI 10.1127/njgpa/231/2004/145; Vega-Dias Cristina, 2004, Paleobios, V24, P7; Vjuschkov V. P., 1969, Paleontologicheskii Zhurnal, V3, P237; Walter L.R., 1986, P89; Weithofer A, 1888, ANN K K NATURHISTORI, V3, P1; Whiteside JH, 2011, P NATL ACAD SCI USA, V108, P8972, DOI 10.1073/pnas.1102473108; Williston SW, 1904, J GEOL, V12, P688, DOI 10.1086/621190; YEH H. K., 1959, VERTE BRATA PALASISTICA [CHINA], V3, P187; Z-W Cheng, 1980, DI ZHI CHU BAN SHE, V2, P115	80	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64203	10.1371/journal.pone.0064203	http://dx.doi.org/10.1371/journal.pone.0064203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741307	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900019
J	Li, JM; Xiao, T; Zhang, Q; Dong, M				Li, Junmin; Xiao, Tao; Zhang, Qiong; Dong, Ming			Interactive Effect of Herbivory and Competition on the Invasive Plant Mikania micrantha	PLOS ONE			English	Article							SUCCESSFUL BIOLOGICAL-CONTROL; COMPENSATORY GROWTH; NATIVE GRASS; DEFOLIATION; RESPONSES; WEED; CARBON; BUNCHGRASSES; MYCORRHIZAE; INTENSITY	A considerable number of host-specific biological control agents fail to control invasive plants in the field, and exploring the mechanism underlying this phenomenon is important and helpful for the management of invasive plants. Herbivory and competition are two of the most common biotic stressors encountered by invasive plants in their recipient communities. We predicted that the antagonistic interactive effect between herbivory and competition would weaken the effect of herbivory on invasive plants and result in the failure of herbivory to control invasive plants. To examine this prediction, thus, we conducted an experiment in which both invasive Mikania micrantha and native Coix lacryma-jobi were grown together and subjected to herbivory-mimicking defoliation. Both defoliation and competition had significantly negative effects on the growth of the invader. However, the negative effect of 75% respective defoliation on the above-and below-ground biomass of Mikania micrantha was alleviated by presence of Coix lacryma-jobi. The negative effect of competition on the above-and below-ground biomass was equally compensated at 25%, 50% and 100% defoliation and overcompensated at 75% defoliation. The interactive effect was antagonistic and dependent on the defoliation intensity, with the maximum effect at 75% defoliation. The antagonistic interaction between defoliation and competition appears to be able to release the invader from competition, thus facilitating the invasiveness of Mikania, a situation that might make herbivory fail to inhibit the growth of invasive Mikania in the invaded community.	[Li, Junmin; Xiao, Tao; Zhang, Qiong; Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Junmin] Taizhou Univ, Inst Ecol, Linhai, Peoples R China; [Li, Junmin; Dong, Ming] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China	Hangzhou Normal University; Taizhou University; Chinese Academy of Sciences; Institute of Botany, CAS	Dong, M (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	dongming@hznu.edu.cn	李, 钧敏/L-7390-2019		National Natural Science Foundation of China [30800133, 39825106]; China Postdoctoral Science Foundation [20080440557]; National Natural Science Foundation of Zhejiang Province of China [Y5110227]; Innovative R & D Projects of Hangzhou Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of Zhejiang Province of China; Innovative R & D Projects of Hangzhou Normal University	Support for the project was provided through funding from National Natural Science Foundation of China (30800133 and 39825106), China Postdoctoral Science Foundation (20080440557), National Natural Science Foundation of Zhejiang Province of China (Y5110227) and the Innovative R & D Projects of Hangzhou Normal University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres E, 2007, FUNCT ECOL, V21, P256, DOI 10.1111/j.1365-2435.2006.01227.x; Bacilio-Jimenez M, 2001, SOIL BIOL BIOCHEM, V33, P167, DOI 10.1016/S0038-0717(00)00126-7; Barton J, 2007, BIOL CONTROL, V40, P370, DOI 10.1016/j.biocontrol.2006.09.010; Barton KE, 2008, OIKOS, V117, P917, DOI 10.1111/j.0030-1299.2008.16324.x; Boege K, 2010, ECOLOGY, V91, P2628, DOI 10.1890/09-0543.1; Callaway RM, 2006, BIOL INVASIONS, V8, P1389, DOI 10.1007/s10530-006-0003-8; Callaway RM, 1999, ECOLOGY, V80, P1196, DOI 10.1890/0012-9658(1999)080[1196:BCHMIC]2.0.CO;2; Callaway RM, 2001, ECOL LETT, V4, P429, DOI 10.1046/j.1461-0248.2001.00251.x; Carey EV, 2004, PLANT ECOL, V172, P133, DOI 10.1023/B:VEGE.0000026031.14086.f1; Charoenpakdee S, 2010, MYCOSPHERE, V1, P195; COCK MJW, 1982, B ENTOMOL RES, V72, P523, DOI 10.1017/S0007485300013705; Crawley MJ, 1997, SEEDS ECOLOGY REGENE, P401; Desmier de chenon R, 2003, EXOTIC PEST THEIR CO, P201; DETLING JK, 1979, OECOLOGIA, V41, P127, DOI 10.1007/BF00344997; Doyle R, 2007, BIOL CONTROL, V41, P327, DOI 10.1016/j.biocontrol.2007.03.004; Dray FA, 2001, BIOCONTROL SCI TECHN, V11, P301, DOI 10.1080/09583150120055718; DYER MI, 1991, ECOLOGY, V72, P1472, DOI 10.2307/1941120; Ferrero-Serrano A, 2008, RANGELAND ECOL MANAG, V61, P529, DOI 10.2111/07-142R.1; HAMID A, 1990, PHOTOSYNTHETICA, V24, P96; Johnson MTJ, 2011, FUNCT ECOL, V25, P305, DOI 10.1111/j.1365-2435.2011.01838.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lehtila K, 2004, ECOL STU AN, V173, P257; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Li Zhi-gang, 2004, Chinese Journal of Biological Control, V20, P170; Li Zhi-Gang, 2003, Entomological Knowledge, V40, P561; LONG SP, 1993, VEGETATIO, V104, P33, DOI 10.1007/BF00048143; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MCEVOY P, 1991, ECOL APPL, V1, P430, DOI 10.2307/1941900; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Newingham BA, 2006, OIKOS, V114, P397, DOI 10.1111/j.2006.0030-1299.14345.x; Pearson DE, 2003, TRENDS ECOL EVOL, V18, P456, DOI 10.1016/S0169-5347(03)00188-5; Puettmann KJ, 2001, OECOLOGIA, V129, P376, DOI 10.1007/s004420100741; RICHARDS JH, 1984, OECOLOGIA, V64, P21, DOI 10.1007/BF00377538; Ruiz-R N, 2008, PLANT ECOL, V198, P19, DOI 10.1007/s11258-007-9381-y; Ballina-Gomez HS, 2010, J TROP ECOL, V26, P163, DOI 10.1017/S0266467409990514; Schadler M, 2007, ECOLOGY, V88, P1490, DOI 10.1890/06-0647; Sciegienka JK, 2011, INVAS PLANT SCI MANA, V4, P151, DOI 10.1614/IPSM-D-10-00061.1; Sheppard AW, 2001, J APPL ECOL, V38, P291, DOI 10.1046/j.1365-2664.2001.00583.x; Suwa T, 2010, OECOLOGIA, V162, P91, DOI 10.1007/s00442-009-1432-8; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; TRUMBLE JT, 1993, ANNU REV ENTOMOL, V38, P93, DOI 10.1146/annurev.en.38.010193.000521; Turner PJ, 2010, BIOL CONTROL, V54, P322, DOI 10.1016/j.biocontrol.2010.06.005; VanderKlein DW, 1999, NEW PHYTOL, V144, P121, DOI 10.1046/j.1469-8137.1999.00496.x; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Walling SZ, 2006, APPL SOIL ECOL, V32, P111, DOI 10.1016/j.apsoil.2005.02.017; Waterhouse D.F., 1994, BIOL CONTROL WEEDS S; Watt MS, 2007, BIOL CONTROL, V43, P119, DOI 10.1016/j.biocontrol.2007.06.011; Yu LF, 2010, FLORA, V205, P449, DOI 10.1016/j.flora.2009.12.016; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x	53	7	9	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e62608	10.1371/journal.pone.0062608	http://dx.doi.org/10.1371/journal.pone.0062608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737942	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700006
J	Newsome, TM; Ballard, GA; Dickman, CR; Fleming, PJS; Howden, C				Newsome, Thomas M.; Ballard, Guy-Anthony; Dickman, Christopher R.; Fleming, Peter J. S.; Howden, Chris			Anthropogenic Resource Subsidies Determine Space Use by Australian Arid Zone Dingoes: An Improved Resource Selection Modelling Approach	PLOS ONE			English	Article							ESTIMATING EQUATIONS; TANAMI DESERT; WILD DOGS; ECOLOGY; FRAMEWORK; HABITAT	Dingoes (Canis lupus dingo) were introduced to Australia and became feral at least 4,000 years ago. We hypothesized that dingoes, being of domestic origin, would be adaptable to anthropogenic resource subsidies and that their space use would be affected by the dispersion of those resources. We tested this by analyzing Resource Selection Functions (RSFs) developed from GPS fixes (locations) of dingoes in arid central Australia. Using Generalized Linear Mixed-effect Models (GLMMs), we investigated resource relationships for dingoes that had access to abundant food near mine facilities, and for those that did not. From these models, we predicted the probability of dingo occurrence in relation to anthropogenic resource subsidies and other habitat characteristics over similar to 18,000 km(2). Very small standard errors and subsequent pervasively high P-values of results will become more important as the size of data sets, such as our GPS tracking logs, increases. Therefore, we also investigated methods to minimize the effects of serial and spatio-temporal correlation among samples and unbalanced study designs. Using GLMMs, we accounted for some of the correlation structure of GPS animal tracking data; however, parameter standard errors remained very small and all predictors were highly significant. Consequently, we developed an alternative approach that allowed us to review effect sizes at different spatial scales and determine which predictors were sufficiently ecologically meaningful to include in final RSF models. We determined that the most important predictor for dingo occurrence around mine sites was distance to the refuse facility. Away from mine sites, close proximity to human-provided watering points was predictive of dingo dispersion as were other landscape factors including palaeochannels, rocky rises and elevated drainage depressions. Our models demonstrate that anthropogenically supplemented food and water can alter dingo-resource relationships. The spatial distribution of such resources is therefore critical for the conservation and management of dingoes and other top predators.	[Newsome, Thomas M.; Dickman, Christopher R.] Univ Sydney, Sch Biol Sci, Inst Wildlife Res, Sydney, NSW 2006, Australia; [Newsome, Thomas M.] Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT 2601, Australia; [Ballard, Guy-Anthony] Univ New England, Vertebrate Pest Res Unit, NSW Dept Primary Ind, Armidale, NSW, Australia; [Fleming, Peter J. S.] NSW Dept Primary Ind, Vertebrate Pest Res Unit, Orange, NSW, Australia; [Howden, Chris] Tricky Solut, Sydney, NSW, Australia	University of Sydney; University of Canberra; NSW Department of Primary Industries; University of New England; NSW Department of Primary Industries	Newsome, TM (corresponding author), Univ Sydney, Sch Biol Sci, Inst Wildlife Res, Heydon Laurence Bldg, Sydney, NSW 2006, Australia.	tnew5216@uni.sydney.edu.au	Newsome, Thomas M/AET-0276-2022; Dickman, Christopher/Q-4662-2019; Newsome, Thomas M/ABE-8451-2021	Newsome, Thomas M/0000-0003-3457-3256; Dickman, Christopher/0000-0002-1067-3730; Newsome, Thomas M/0000-0003-3457-3256; Fleming, Peter/0000-0002-3490-6148	University of Sydney, NSW; Invasive Animals CRC; Newmont Pty Ltd; NSW Department of Primary Industries; Central Land Council	University of Sydney, NSW; Invasive Animals CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Newmont Pty Ltd; NSW Department of Primary Industries; Central Land Council	The work presented was funded by The University of Sydney, NSW (http://sydney.edu.au/), the Invasive Animals CRC (http://www.invasiveanimals.com/), Newmont Pty Ltd (http://www.newmont.com/), the NSW Department of Primary Industries (http://www.dpi.nsw.gov.au/) and the Central Land Council (http://www.clc.org.au/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than in the form of the authors being employees or students within one or two of the organisations.	Allen BL, 2012, AUST MAMMAL, V34, P251, DOI 10.1071/AM12012; Ardalan A, 2012, GENETICA, V140, P65, DOI 10.1007/s10709-012-9658-5; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bureau of Meteorology, 2010, RABB FLAT NO TERR SE; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calange C, 2009, STAT RULES THUMB; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; Claridge AW, 2009, FOREST ECOL MANAG, V258, P814, DOI 10.1016/j.foreco.2009.05.030; Corbett L. K., 1995, DINGO AUSTR ASIA; Dickman Chris R., 2009, P238, DOI 10.1002/9781444312034.ch11; Domahidy G, 1990, HYDROGEOLOGY GRANITE; Earth Observing System Data and Information System, 2008, EARTH OBS SYST CLEAR; Erickson Wallace P., 1998, Journal of Agricultural Biological and Environmental Statistics, V3, P296, DOI 10.2307/1400584; Faraday JJ, 2006, EXTENDING LINEAR MOD; Fieberg J, 2012, PHILOS T R SOC LON B, V365, P2233; Fieberg J, 2009, J APPL ECOL, V46, P1018, DOI 10.1111/j.1365-2664.2009.01692.x; Fleming P., 2001, MANAGING IMPACTS DIN; Geoscience Australia, 2006, GEODATA TOPO 250K 3, V3; Gibson LA, 2004, J APPL ECOL, V41, P213, DOI 10.1111/j.0021-8901.2004.00896.x; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Green R. H., 1979, Sampling design and statistical methods for environmental biologists.; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hurlbert SH, 2009, ANN ZOOL FENN, V46, P311, DOI 10.5735/086.046.0501; Jarvis A, 2008, HOLE FILLED SEAMLESS; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Kenward RE., 2000, MANUAL WILDLIFE RADI; Koper N, 2009, J APPL ECOL, V46, P590, DOI 10.1111/j.1365-2664.2009.01642.x; LUNDIEJENKINS G, 1993, WILDLIFE RES, V20, P495, DOI 10.1071/WR9930495; Manly B., 2007, RESOURCE SELECTION A; Manly B.F.J., 2002, RESOURCE SELECTION A; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Navman Wireless OEM Solutions, 2006, JUP 31 GPS REC MOD D; NEWSOME AE, 1983, AUST J ECOL, V8, P345, DOI 10.1111/j.1442-9993.1983.tb01332.x; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; Newsome TM, 2011, THESIS U SYDNEY SYDN; Purcell B, 2010, DINGO; R Core Team, 2021, R LANGUAGE ENV STAT; Robley Alan, 2010, Australian Mammalogy, V32, P23, DOI 10.1071/AM09030; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Southgate R, 2007, J ARID ENVIRON, V68, P438, DOI 10.1016/j.jaridenv.2006.06.006; STAFFORD SMITH DM, 1990, J ARID ENVIRON, V18, P255, DOI 10.1016/S0140-1963(18)30837-1; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; Van Belle G., 2008, STAT RULES THUMB; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J., 2002, R NEWS, V2, P12	50	31	33	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63931	10.1371/journal.pone.0063931	http://dx.doi.org/10.1371/journal.pone.0063931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23750191	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700021
J	Lin, YH; Ho, YC; Lin, SH; Yeh, YH; Liu, CY; Kuo, TBJ; Yang, CCH; Yang, AC				Lin, Yu-Hsuan; Ho, Yen-Cheng; Lin, Sheng-Hsuan; Yeh, Yao-Hsien; Liu, Chia-Yih; Kuo, Terry B. J.; Yang, Cheryl C. H.; Yang, Albert C.			On-Call Duty Effects on Sleep-State Physiological Stability in Male Medical Interns	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CIRCADIAN-RHYTHMS; DEPRIVATION; DURATION; HUMANS; ACTIGRAPHY; PHYSICIANS; WORK	Background: On-call duty among medical interns is characterized by sleep deprivation and stressful working conditions, both of which alter cardiac autonomic modulation. We hypothesized that sleep stability decreased in medical interns during on-call duty. We used cardiopulmonary-coupling (CPC) analysis to test our hypothesis. Methods: We used electrocardiogram (ECG)-based CPC analysis to quantify physiological parameters of sleep stability in 13 medical interns during on-call and on-call duty-free periods. There were ten 33.5-h on-call duty shifts per month for interns, each followed by 2 on-call duty-free days, over 3 months. Measurements during sleep were collected before, during, and after an on-call shift. Measurements were repeated 3 months later during an on-call duty-free period. Results: The medical interns had significantly reduced stable sleep, and displayed increased latency to the first epoch of stable sleep during the on-call night shift, compared to the pre-call and on-call duty-free nights. Interns also had significantly increased rapid-eye-movement (REM) sleep during the on-call night shift, compared to the pre-call and on-call duty-free nights. Conclusion: Medical interns suffer disrupted sleep stability and continuity during on-call night shifts. The ECG-based CPC analysis provides a straightforward means to quantify sleep quality and stability in medical staff performing shift work under stressful conditions.	[Lin, Yu-Hsuan] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Ho, Yen-Cheng; Liu, Chia-Yih] Chang Gung Univ, Sch Med, Taoyuan Cty, Taiwan; [Ho, Yen-Cheng; Liu, Chia-Yih] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan Cty, Taiwan; [Lin, Sheng-Hsuan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Yeh, Yao-Hsien] Taipei City Hosp, Ren Ai Branch, Dept Internal Med, Taipei, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Sleep Res Ctr, Taipei 112, Taiwan; [Yang, Albert C.] Natl Yang Ming Univ, Div Psychiat, Sch Med, Taipei 112, Taiwan; [Yang, Albert C.] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Chang Gung University; Chang Gung Memorial Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Yang, AC (corresponding author), Natl Yang Ming Univ, Div Psychiat, Sch Med, Taipei 112, Taiwan.	accyang@gmail.com		Lin, Sheng-Hsuan/0000-0003-0714-2354; Lin, Yu-Hsuan/0000-0001-9393-3886; Yang, Albert Chih-Chieh/0000-0003-2794-9649	NSC [NSC 100-2911-I-008-001, NSC101-2314-B-075-041-MY3]	NSC(Ministry of Science and Technology, Taiwan)	Funding was provided by NSC101-2314-B-075-041-MY3 (http://web1.nsc.gov.tw/), and NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 100-2911-I-008-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arora VM, 2008, JAMA-J AM MED ASSOC, V300, P1146, DOI 10.1001/jama.300.10.1146; Baldwin DC, 2004, SLEEP, V27, P217, DOI 10.1093/sleep/27.2.217; Carter JR, 2012, J APPL PHYSL; Dumont M, 2004, CLIN NEUROPHYSIOL, V115, P2031, DOI 10.1016/j.clinph.2004.04.007; Goldschmidt-Clermont PJ, 2012, NAT REV CARDIOL; Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3; Kang MY, 2012, J OCCUP ENVIRON MED, V54, P532, DOI 10.1097/JOM.0b013e31824fe192; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Kuo TBJ, 2008, SLEEP, V31, P311, DOI 10.1093/sleep/31.3.311; Kuo TBJ, 2010, ENDOCRINOLOGY, V151, P2613, DOI 10.1210/en.2009-1410; Kuo TBJ, 2009, EXP NEUROL, V217, P38, DOI 10.1016/j.expneurol.2009.01.012; Lin YH, 2012, STRESS, V15, P21, DOI 10.3109/10253890.2011.572208; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Liu CC, 2003, AM J PHYSIOL-HEART C, V285, pH2188, DOI 10.1152/ajpheart.00256.2003; Malmberg B, 2011, INT ARCH OCC ENV HEA, V84, P293, DOI 10.1007/s00420-010-0593-4; Mansukhani MP, 2012, POSTGRAD MED, V124, P241, DOI 10.3810/pgm.2012.07.2583; Moody G.B., 1986, COMPUT CARDIOL, V13, P507; Rauchenzauner M, 2009, EUR HEART J, V30, P2606, DOI 10.1093/eurheartj/ehp268; Sabanayagam C, 2010, SLEEP, V33, P1037, DOI 10.1093/sleep/33.8.1037; Shankar A, 2008, AM J EPIDEMIOL, V168, P1367, DOI 10.1093/aje/kwn281; Thomas RJ, 2005, SLEEP, V28, P1151, DOI 10.1093/sleep/28.9.1151; Thomas RJ, 2007, SLEEP, V30, P1756, DOI 10.1093/sleep/30.12.1756; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Weng WH, 2013, PSYCHOPHYSIOLOGY; Yang CCH, 2002, NEUROSCI LETT, V329, P213, DOI 10.1016/S0304-3940(02)00661-4; Yang CH, 2010, PSYCHOPHYSIOLOGY; Yeragani V, 2005, CARDIOVASC ENG, V5, P135; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004	29	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65072	10.1371/journal.pone.0065072	http://dx.doi.org/10.1371/journal.pone.0065072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750232	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900034
J	Olguin, CA; Landete-Castillejos, T; Ceacero, F; Garcia, AJ; Gallego, L				Olguin, Cesar A.; Landete-Castillejos, Tomas; Ceacero, Francisco; Garcia, Andres J.; Gallego, Laureano			Effects of Feed Supplementation on Mineral Composition, Mechanical Properties and Structure in Femurs of Iberian Red Deer Hinds (Cervus elaphus hispanicus)	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; PHYSIOLOGICAL EFFORT; ORGANIC MATRIX; KIDNEY FAT; BONE; ANTLER; CALCIUM; GROWTH; LACTATION; WEIGHT	Few studies in wild animals have assessed changes in mineral profile in long bones and their implications for mechanical properties. We examined the effect of two diets differing in mineral content on the composition and mechanical properties of femora from two groups each with 13 free-ranging red deer hinds. Contents of Ca, P, Mg, K, Na, S, Cu, Fe, Mn, Se, Zn, B and Sr, Young's modulus of elasticity (E), bending strength and work of fracture were assessed in the proximal part of the diaphysis (PD) and the mid-diaphysis (MD). Whole body measures were also recorded on the hinds. Compared to animals on control diets, those on supplemented diets increased live weight by 6.5 kg and their kidney fat index (KFI), but not carcass weight, body or organ size, femur size or cortical thickness. Supplemental feeding increased Mn content of bone by 23%, Cu by 9% and Zn by 6%. These differences showed a mean fourfold greater content of these minerals in supplemental diet, whereas femora did not reflect a 5.4 times greater content of major minerals (Na and P) in the diet. Lower content of B and Sr in supplemented diet also reduced femur B by 14% and Sr by 5%. There was a subtle effect of diet only on E and none on other mechanical properties. Thus, greater availability of microminerals but not major minerals in the diet is reflected in bone composition even before marked body effects, bone macro-structure or its mechanical properties are affected.	[Olguin, Cesar A.; Landete-Castillejos, Tomas; Garcia, Andres J.; Gallego, Laureano] IREC UCLM CSIC JCCM, IREC Sec Albacete, Appl Wildlife Management Res Grp, Albacete, Spain; [Olguin, Cesar A.; Landete-Castillejos, Tomas; Garcia, Andres J.; Gallego, Laureano] UCLM, IDR, Grp Recursos Cineget, Albacete, Spain; [Landete-Castillejos, Tomas; Garcia, Andres J.; Gallego, Laureano] UCLM, ETSIA, Dept Ciencia & Tecnol Agroforestal & Genet, Albacete, Spain; [Ceacero, Francisco] Czech Univ Life Sci, Fac Trop AgriSci, Dept Anim Sci & Food Proc Trop & Subtrop, Prague, Czech Republic	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Czech University of Life Sciences Prague	Landete-Castillejos, T (corresponding author), IREC UCLM CSIC JCCM, IREC Sec Albacete, Appl Wildlife Management Res Grp, Campus UCLM, Albacete, Spain.	tomas.landete@uclm.es	Ceacero, Francisco/C-1088-2009; Garcia Diaz, Andres Jose/A-9162-2012; Gallego, Laureano/G-9715-2015	Ceacero, Francisco/0000-0001-9014-147X; Landete Castillejos, Tomas/0000-0001-9753-5295; Garcia Diaz, Andres Jose/0000-0002-4662-2185; Gallego, Laureano/0000-0001-8219-087X	Consejo Nacional de Ciencia y Tecnologia (Mexico) [302198]; Czech University of Life Sciences (Czech Republic) [99830/1181/1822]; MINECO [CGL2011-24811, AGL2012-38898]	Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Czech University of Life Sciences (Czech Republic); MINECO(Spanish Government)	CAO was funded by the Postgraduate Scholarship 302198 of the Consejo Nacional de Ciencia y Tecnologia (Mexico). FC was supported by a post-doc grant at Czech University of Life Sciences no. 99830/1181/1822 (Czech Republic). This paper has been funded by projects MINECO CGL2011-24811 and AGL2012-38898. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gomez JA, 2008, WILDLIFE BIOL, V14, P331, DOI 10.2981/0909-6396(2008)14[331:LGIMCO]2.0.CO;2; [Anonymous], 2003, MINERALS ANIMAL HUMA, DOI DOI 10.1016/B978-0-444-51367-0.50006-4; *ASAB, 2009, ANIM BEHAV, V77, pR1; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P105, DOI 10.1016/0040-5809(78)90007-2; BLOOD DA, 1966, J WILDLIFE MANAGE, V30, P135, DOI 10.2307/3797893; Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3; Ceacero F, 2009, LIVEST SCI, V122, P345, DOI 10.1016/j.livsci.2008.08.002; Cook RC, 2003, WILDLIFE SOC B, V31, P536; Corah L, 1996, ANIM FEED SCI TECH, V59, P61, DOI 10.1016/0377-8401(95)00887-X; Currey J.D., 2002, BONES STRUCTURE MECH; CURREY JD, 2009, OPEN BONE J, V1, P38; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; DAUPHINE TC, 1975, J WILDLIFE MANAGE, V39, P379, DOI 10.2307/3799918; Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002; DESOUSA JC, 1978, J ANIM SCI S1, V47, P342; Estevez JA, 2010, ANIM PROD SCI, V50, P177, DOI 10.1071/AN09012; Estevez JA, 2009, ACTA THERIOL, V54, P235, DOI 10.4098/j.at.0001-7051.070.2008; FINGER SE, 1981, J WILDLIFE MANAGE, V45, P964, DOI 10.2307/3808104; Gaspar-Lopez E, 2008, EUR J WILDLIFE RES, V54, P753, DOI 10.1007/s10344-008-0185-8; Gomez JA, 2006, LIVEST SCI, V105, P27, DOI 10.1016/j.livsci.2006.04.028; Gomez S, 2013, BONE, V52, P506, DOI 10.1016/j.bone.2012.09.015; Grace ND, 2008, NEW ZEAL J AGR RES, V51, P439, DOI 10.1080/00288230809510473; Grace ND, 2002, NEW ZEAL VET J, V50, P252, DOI 10.1080/00480169.2002.36321; Gustafson MB, 1996, J BIOMECH, V29, P1191, DOI 10.1016/0021-9290(96)00020-6; Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466; Kelly R. W., 1975, Applied Animal Ethology, V1, P293, DOI 10.1016/0304-3762(75)90022-X; KIE JG, 1987, PSW106, P1; Kotha SP, 2007, J BIOMECH, V40, P36, DOI 10.1016/j.jbiomech.2005.11.016; Landete-Castilleijos T, 2007, BONE, V41, P794, DOI 10.1016/j.bone.2007.07.013; Landete-Castillejos T, 2007, BONE, V40, P1095, DOI 10.1016/j.bone.2006.11.022; Landete-Castillejos T, 2007, BONE, V40, P230, DOI 10.1016/j.bone.2006.07.009; Landete-Castillejos T, 2012, BONE, V50, P245, DOI 10.1016/j.bone.2011.10.026; Landete-Castillejos T, 2010, BONE, V47, P815, DOI 10.1016/j.bone.2010.07.021; Landete-Castillejos T, 2002, BIOL REPROD, V67, P1613, DOI 10.1095/biolreprod.102.004507; Landete-Castillejos Tomas, 2012, Front Biosci (Elite Ed), V4, P1385; MCCOY H, 1994, ENVIRON HEALTH PERSP, V102, P49, DOI 10.2307/3431962; McDowell LR, 1996, ANIM FEED SCI TECH, V60, P247, DOI 10.1016/0377-8401(96)00983-2; Minson D.J., 1990, FORAGE RUMINANT NUTR, P9, DOI [10.1016/b978-0-12-498310-6.50008-0, DOI 10.1016/B978-0-12-498310-6.50008-0]; Naghii MR, 2006, BIOFACTORS, V28, P195, DOI 10.1002/biof.5520280306; Nazarian A, 2009, J BIOMECH, V42, P82, DOI 10.1016/j.jbiomech.2008.09.037; Nicol AM, 2007, NZ SOC ANIMAL PRODUC, V14, P151; NORRIS LC, 1972, J NUTR, V102, P1085, DOI 10.1093/jn/102.8.1085; Paik I, 2001, ASIAN AUSTRAL J ANIM, V14, P191; Palacios C, 2006, CRIT REV FOOD SCI, V46, P621, DOI 10.1080/10408390500466174; PEEK JM, 2002, ELK N AM ECOLOGY MAN, P614; RINEY T, 1995, NZ J SCI B, V36, P429; Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361; RODRIGUEZBERROCAL J, 1978, ARCH ZOOTEC, V27, P73; Spears JW, 1996, ANIM FEED SCI TECH, V58, P151, DOI 10.1016/0377-8401(95)00881-0; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Varley PF, 2011, ANIM FEED SCI TECH, V165, P201, DOI 10.1016/j.anifeedsci.2011.02.017; Wysolmerski JJ, 2002, J MAMMARY GLAND BIOL, V7, P267, DOI 10.1023/A:1022800716196	52	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65461	10.1371/journal.pone.0065461	http://dx.doi.org/10.1371/journal.pone.0065461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750262	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900064
J	Danielsen, I; Granstrom, C; Haldorsson, T; Rytter, D; Bech, BH; Henriksen, TB; Vaag, AA; Olsen, SF				Danielsen, Inge; Granstrom, Charlotta; Haldorsson, Thorhallur; Rytter, Dorte; Bech, Bodil Hammer; Henriksen, Tine Brink; Vaag, Allan Arthur; Olsen, Sjurdur Frodi			Dietary Glycemic Index during Pregnancy Is Associated with Biomarkers of the Metabolic Syndrome in Offspring at Age 20 Years	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; BIRTH-WEIGHT; INSULIN-RESISTANCE; THRIFTY PHENOTYPE; LOAD VALUES; RISK; CARBOHYDRATE; WOMEN; METAANALYSIS; PREVALENCE	Objective: Growing evidence indicates that metabolic syndrome is rooted in fetal life with a potential key role of nutrition during pregnancy. The objective of the study was to assess the possible associations between the dietary glycemic index (GI) and glycemic load (GL) during pregnancy and biomarkers of the metabolic syndrome in young adult offspring. Methods: Dietary GI and GL were assessed by questionnaires and interviews in gestation week 30 and offspring were clinically examined at the age of 20 years. Analyses based on 428 mother-offspring dyads were adjusted for maternal smoking during pregnancy, height, pre-pregnancy body mass index (BMI), education, energy intake, and the offspring's ambient level of physical activity. In addition, possible confounding by gestational diabetes mellitus was taken into account. Outcome Measures: Waist circumference, blood pressure, HOMA insulin resistance (HOMA-IR) and plasma levels of fasting glucose, triglycerides, HDL cholesterol, LDL cholesterol, total cholesterol, insulin, and leptin were measured in the offspring. Results: Significant associations were found between dietary GI in pregnancy and HOMA-IR (the relative increase in HOMA-IR per 10 units' GI increase was 1.09 [95% CI: 1.01, 1.16], p = 0.02), insulin (1.09 [95% CI: 1.02, 1.16], p = 0.01) and leptin (1.21 [95% CI: 1.06, 1.38], p = 0.01) in the offspring; whereas no associations were detected for GL. Conclusions: Our data suggests that high dietary GI in pregnancy may affect levels of markers for the metabolic syndrome in young adult offspring in a potentially harmful direction.	[Danielsen, Inge; Granstrom, Charlotta; Haldorsson, Thorhallur; Olsen, Sjurdur Frodi] Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark; [Haldorsson, Thorhallur] Univ Iceland, Sch Hlth Sci, Fac Food Sci & Nutr, Unit Nutr Res, Reykjavik, Iceland; [Rytter, Dorte; Bech, Bodil Hammer] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Ctr Fetal Programming, Aarhus, Denmark; [Henriksen, Tine Brink] Aarhus Univ Hosp, Dept Paediat, Skejby, Denmark; [Vaag, Allan Arthur] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Vaag, Allan Arthur] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	Statens Serum Institut; University of Iceland; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen	Danielsen, I (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark.	ind@ssi.dk	Bech, Bodil Hammer/B-9646-2016	Bech, Bodil Hammer/0000-0002-0287-3687; Rytter, Dorte/0000-0003-1518-0975; Halldorsson, Thorhallur/0000-0002-3488-0777; Vaag, Allan Arthur/0000-0002-3690-2191; Olsen, Sjurdur/0000-0003-3017-7096	Danish Council for Strategic Research [09-067124, 09-063072, 2101-06-0005]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The study was supported by the Danish Council for Strategic Research (09-067124; 09-063072; 2101-06-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Beck B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00224; Brand-Miller J, 2012, CURR OPIN LIPIDOL, V23, P62, DOI 10.1097/MOL.0b013e32834ec705; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Clapp JF, 2002, P NUTR SOC, V61, P45, DOI 10.1079/PNS2001129; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Djiane J, 2008, J PHYSIOL PHARMACOL, V59, P55; Dong JY, 2012, AM J CARDIOL, V109, P1608, DOI 10.1016/j.amjcard.2012.01.385; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Frystyk J, 2005, DIABETOLOGIA, V48, P1911, DOI 10.1007/s00125-005-1850-z; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Gabory A, 2011, AM J CLIN NUTR, V94, p1943S, DOI 10.3945/ajcn.110.000927; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Garcia-Prieto MD, 2007, CLIN ENDOCRINOL, V66, P185, DOI 10.1111/j.1365-2265.2006.02705.x; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Grant SM, 2011, NUTRIENTS, V3, P330, DOI 10.3390/nu3030330; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Halldorsson TI, 2012, ENVIRON HEALTH PERSP, V120, P668, DOI 10.1289/ehp.1104034; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P1383, DOI 10.1067/S0002-9378(03)00601-X; Kanitz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052748; Keely EJ, 2008, PEDIATR DIABETES, V9, P53; Kim K, 2008, BRIT J NUTR, V100, P576, DOI 10.1017/S0007114508904372; Lauszus FF, 1999, ACTA OBSTET GYN SCAN, V78, P520, DOI 10.1034/j.1600-0412.1999.780608.x; Ma XY, 2012, ATHEROSCLEROSIS, V223, P491, DOI 10.1016/j.atherosclerosis.2012.05.028; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCCANCE DR, 1994, BRIT MED J, V308, P942, DOI 10.1136/bmj.308.6934.942; McGowan CA, 2010, BRIT J NUTR, V104, P153, DOI 10.1017/S0007114510000425; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Moses RG, 2006, AM J CLIN NUTR, V84, P807, DOI 10.1093/ajcn/84.4.807; O'Connell BA, 2013, PLACENTA, V34, P119, DOI 10.1016/j.placenta.2012.11.009; OLSEN SF, 1995, BRIT J NUTR, V73, P387, DOI 10.1079/BJN19950041; Otten W, 2013, J ANIM SCI, V91, P2680, DOI 10.2527/jas.2012-6080; PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V16, P330, DOI 10.1530/acta.0.0160330; Pettitt D J, 2001, Curr Diab Rep, V1, P78, DOI 10.1007/s11892-001-0014-x; Poston L, 2010, BEST PRACT RES CL EN, V24, P541, DOI 10.1016/j.beem.2010.05.007; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Scholl TO, 2004, AM J EPIDEMIOL, V159, P467, DOI 10.1093/aje/kwh068; Tzanetakou IP, 2011, OPEN CARDIOVASC MED, V5, P103, DOI 10.2174/1874192401105010103; Van Dijk AE, 2012, EARLY HUM DEV, V88, P351, DOI 10.1016/j.earlhumdev.2011.09.009; Walsh JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5605; Willet W, 1998, NUTR EPIDEMIOLOGY; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xita N, 2010, ANN NY ACAD SCI, V1205, P148, DOI 10.1111/j.1749-6632.2010.05658.x; Zheng X, 2012, EUR J CLIN NUTR, V66, P231, DOI 10.1038/ejcn.2011.161	48	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64887	10.1371/journal.pone.0064887	http://dx.doi.org/10.1371/journal.pone.0064887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741411	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900124
J	Ghosh, W; Alam, M; Roy, C; Pyne, P; George, A; Chakraborty, R; Majumder, S; Agarwal, A; Chakraborty, S; Majumdar, S; Das Gupta, SK				Ghosh, Wriddhiman; Alam, Masrure; Roy, Chayan; Pyne, Prosenjit; George, Ashish; Chakraborty, Ranadhir; Majumder, Saikat; Agarwal, Atima; Chakraborty, Sheolee; Majumdar, Subrata; Das Gupta, Sujoy Kumar			Genome Implosion Elicits Host-Confinement in Alcaligenaceae: Evidence from the Comparative Genomics of Tetrathiobacter kashmirensis, a Pathogen in the Making	PLOS ONE			English	Article							SP-NOV.; ACHROMOBACTER-XYLOSOXIDANS; BORDETELLA-PERTUSSIS; GEN. NOV.; SALMONELLA-ENTERICA; EMERGING PATHOGEN; CODON USAGE; SEQUENCE; SOIL; PARAPERTUSSIS	This study elucidates the genomic basis of the evolution of pathogens alongside free-living organisms within the family Alcaligenaceae of Betaproteobacteria. Towards that end, the complete genome sequence of the sulfur-chemolithoautotroph Tetrathiobacter kashmirensis WT001(T) was determined and compared with the soil isolate Achromobacter xylosoxidans A8 and the two pathogens Bordetella bronchiseptica RB50 and Taylorella equigenitalis MCE9. All analyses comprehensively indicated that the RB50 and MCE9 genomes were almost the subsets of A8 and WT001(T), respectively. In the immediate evolutionary past Achromobacter and Bordetella shared a common ancestor, which was distinct from the other contemporary stock that gave rise to Tetrathiobacter and Taylorella. The Achromobacter-Bordetella precursor, after diverging from the family ancestor, evolved through extensive genome inflation, subsequent to which the two genera separated via differential gene losses and acquisitions. Tetrathiobacter, meanwhile, retained the core characteristics of the family ancestor, and Taylorella underwent massive genome degeneration to reach an evolutionary dead-end. Interestingly, the WT001(T) genome, despite its conserved architecture, had only 85% coding density, besides which 578 out of its 4452 protein-coding sequences were found to be pseudogenized. Translational impairment of several DNA repair-recombination genes in the first place seemed to have ushered the rampant and indiscriminate frame-shift mutations across the WT001(T) genome. Presumably, this strain has just come out of a recent evolutionary bottleneck, representing a unique transition state where genome self-degeneration has started comprehensively but selective host-confinement has not yet set in. In the light of this evolutionary link, host-adaptation of Taylorella clearly appears to be the aftereffect of genome implosion in another member of the same bottleneck. Remarkably again, potent virulence factors were found widespread in Alcaligenaceae, corroborating which hemolytic and mammalian cell-adhering abilities were discovered in WT001(T). So, while WT001(T) relatives/derivatives in nature could be going the Taylorella way, the lineage as such was well-prepared for imminent host-confinement.	[Ghosh, Wriddhiman; Alam, Masrure; Roy, Chayan; Pyne, Prosenjit; Das Gupta, Sujoy Kumar] Bose Inst, Dept Microbiol, Kolkata, W Bengal, India; [George, Ashish; Agarwal, Atima] Invitrogen Bioserv India, Gurgaon, Haryana, India; [Chakraborty, Ranadhir] Univ N Bengal, Dept Biotechnol, Siliguri, W Bengal, India; [Majumder, Saikat; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, W Bengal, India; [Chakraborty, Sheolee] Bose Inst, Cent Instrument Facil, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute; University of North Bengal; Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Ghosh, W (corresponding author), Bose Inst, Dept Microbiol, Kolkata, W Bengal, India.	wriman@bic.boseinst.ernet.in	Roy, Chayan/GVS-7013-2022; CHAKRABORTY, RANADHIR/M-4439-2016; Ghosh, Wriddhiman/M-3467-2016; Majumder, Saikat/ABC-2194-2020	Majumder, Saikat/0000-0002-6591-9515; Roy, Chayan/0000-0003-1783-4514; Ghosh, Wriddhiman/0000-0002-4922-7404; Alam, Masrure/0000-0002-2226-8118; Pyne, Prosenjit/0000-0002-2339-8686	Council of Scientific and Industrial Research (CSIR), Government of India [37(1519)/11-EMR-II]; CSIR [09/015(0385)/10-EMR-I, 09/015(0405)/11-EMR-I]; University Grants Commission, Government of India [F.2-8/2002(SA-I)]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India)	This work was financed by the Council of Scientific and Industrial Research (CSIR), Government of India (http://rdpp.csir.res.in/csir_acsir/Home.aspx?MenuId = 1), through a grant-in-aid research scheme [37(1519)/11-EMR-II]. MA [09/015(0385)/10-EMR-I] and PP [09/015(0405)/11-EMR-I] were endowed with a fellowship by the CSIR, while CR [F.2-8/2002(SA-I)] received a fellowship from the University Grants Commission, Government of India (http://www.ugc.ac.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2009, CLIN NEPHROL, V71, P350; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Aisenberg G, 2004, CANCER-AM CANCER SOC, V101, P2134, DOI 10.1002/cncr.20604; Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bador J, 2011, ANTIMICROB AGENTS CH, V55, P4912, DOI 10.1128/AAC.00341-11; Baida GE, 1996, BBA-BIOMEMBRANES, V1284, P122, DOI 10.1016/S0005-2736(96)00168-X; Brickman TJ, 2011, J BACTERIOL, V193, P4798, DOI 10.1128/JB.05136-11; CARSIOTIS M, 1989, INFECT IMMUN, V57, P3276, DOI 10.1128/IAI.57.11.3276-3280.1989; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Dam B, 2009, APPL ENVIRON MICROB, V75, P4362, DOI 10.1128/AEM.02521-08; Deveryshetty J, 2010, FEMS MICROBIOL LETT, V311, P93, DOI 10.1111/j.1574-6968.2010.02079.x; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; Essam T, 2010, J HAZARD MATER, V173, P783, DOI 10.1016/j.jhazmat.2009.09.006; Ghosh W, 2006, INT J SYST EVOL MICR, V56, P91, DOI 10.1099/ijs.0.63967-0; Ghosh W, 2005, INT J SYST EVOL MICR, V55, P1779, DOI 10.1099/ijs.0.63595-0; Ghosh W, 2011, J BACTERIOL, V193, P5553, DOI 10.1128/JB.05781-11; Ghosh W, 2009, RES MICROBIOL, V160, P409, DOI 10.1016/j.resmic.2009.07.003; Gibello A, 2009, INT J SYST EVOL MICR, V59, P1914, DOI 10.1099/ijs.0.007443-0; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Hebert L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029953; Hebert L, 2011, J BACTERIOL, V193, P1785, DOI 10.1128/JB.01547-10; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Jang SS, 2001, INT J SYST EVOL MICR, V51, P971, DOI 10.1099/00207713-51-3-971; Kampfer P, 2010, INT J SYST EVOL MICR, V60, P1537, DOI 10.1099/ijs.0.016576-0; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Traglia GM, 2012, CURR MICROBIOL, V65, P673, DOI 10.1007/s00284-012-0213-5; Matsuda M, 2003, VET MICROBIOL, V97, P111, DOI 10.1016/j.vetmic.2003.08.001; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Mehdizadeh SN, 2011, WATER SCI TECHNOL, V64, P1239, DOI 10.2166/wst.2011.756; Meidanis J, 2002, MICROBIOL MOL BIOL R, V66, P272, DOI 10.1128/MMBR.66.2.272-299.2002; Nakamura MM, 2006, INFECT IMMUN, V74, P5537, DOI 10.1128/IAI.00781-06; O'Connell KP, 1998, MICROBIOL-SGM, V144, P2607, DOI 10.1099/00221287-144-9-2607; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11; Remenant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024356; Robert PY, 2008, OPHTHAL SURG LAS IM, V39, P500, DOI 10.3928/15428877-20081101-15; Rudnick PA, 2001, J BACTERIOL, V183, P2682, DOI 10.1128/JB.183.8.2682-2685.2001; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Sebaihia M, 2006, J BACTERIOL, V188, P6002, DOI 10.1128/JB.01927-05; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shi SY, 2005, ACTA BIOCH BIOPH SIN, V37, P561, DOI 10.1111/j.1745-7270.2005.00075.x; Spilker T, 2012, J CLIN MICROBIOL, V50, P3010, DOI 10.1128/JCM.00814-12; Srinivasan S, 2010, INT J SYST EVOL MICR, V60, P1783, DOI 10.1099/ijs.0.018358-0; Stolz A, 2005, INT J SYST EVOL MICR, V55, P1077, DOI 10.1099/ijs.0.63466-0; Strnad H, 2011, J BACTERIOL, V193, P791, DOI 10.1128/JB.01299-10; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Uhlik O, 2009, APPL ENVIRON MICROB, V75, P6471, DOI 10.1128/AEM.00466-09; VanderZee A, 1997, J BACTERIOL, V179, P6609, DOI 10.1128/jb.179.21.6609-6617.1997; Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x	60	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64856	10.1371/journal.pone.0064856	http://dx.doi.org/10.1371/journal.pone.0064856			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741407	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900120
J	Kurotani, K; Kochi, T; Nanri, A; Tsuruoka, H; Kuwahara, K; Pham, NM; Kabe, I; Mizoue, T				Kurotani, Kayo; Kochi, Takeshi; Nanri, Akiko; Tsuruoka, Hiroko; Kuwahara, Keisuke; Ngoc Minh Pham; Kabe, Isamu; Mizoue, Tetsuya			Plant Oils Were Associated with Low Prevalence of Impaired Glucose Metabolism in Japanese Workers	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; DIET HISTORY QUESTIONNAIRES; INSULIN SENSITIVITY; ADIPOSE-TISSUE; RISK; PLASMA; INFLAMMATION; METAANALYSIS; CONSUMPTION; TOLERANCE	Fatty acid has been suggested to be involved in development of diabetes. However, its association is unclear among Japanese populations, which consume large amounts of fish rich in n-3 polyunsaturated fatty acids. The present cross-sectional study examined the association of individual dietary fatty acids and dietary fatty acid patterns with abnormal glucose metabolism among 1065 Japanese employees, aged 18-69 years. Impaired glucose metabolism is defined if a person has a history of diabetes, current use of anti-diabetic drug, fasting plasma glucose of 110 mg/dl (>= 6.1 mmol/L) or greater, or hemoglobin A1C of 6.0% (>= 42 mmol/mol) or greater. Dietary intake was assessed with a self-administered diet history questionnaire. Dietary fatty acid patterns were extracted by principal component analysis. Odds ratios of impaired glucose metabolism according to tertile categories of each fatty acids and dietary fatty acid patterns were estimated using logistic regression with adjustment for potential confounding variables. A higher intake of polyunsaturated fatty acid, n-6 fatty acid, linoleic acid, and oleic acid were significantly associated with a decreased prevalence of impaired glucose metabolism (P for trend = 0.03, 0.01, 0.02, and 0.04, respectively). Alpha-linolenic acid was marginally significantly associated with a decreased prevalence of impaired glucose metabolism (P for trend = 0.12). Of three fatty acid patterns identified, a higher plant oil pattern score, which characterized by high intake of alpha-linolenic acid, linoleic acid, and oleic acid, was associated with a decreased prevalence of impaired glucose metabolism (P for trend = 0.03). No association was observed for other patterns. In conclusion, plant source fatty acids might be protectively associated with development of diabetes in Japanese adults.	[Kurotani, Kayo; Nanri, Akiko; Kuwahara, Keisuke; Ngoc Minh Pham; Kabe, Isamu; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Clin Res Ctr, Dept Epidemiol & Prevent, Tokyo, Japan; [Kochi, Takeshi; Tsuruoka, Hiroko] Furukawa Elect Corp, Dept Hlth Adm, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Furukawa Electric	Kurotani, K (corresponding author), Natl Ctr Global Hlth & Med, Clin Res Ctr, Dept Epidemiol & Prevent, Tokyo, Japan.	kkurotani@ri.ncgm.go.jp		Kochi, Takeshi/0000-0002-3411-1070; Kuwahara, Keisuke/0000-0002-7503-1333	Japan Society for the Promotion of Science [21390213]; Grants-in-Aid for Scientific Research [25702006, 25871168] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (B)(21390213) from Japan Society for the Promotion of Science (to TM). The funding body had no role in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; Clarke SD, 2004, CURR OPIN LIPIDOL, V15, P13, DOI 10.1097/00041433-200402000-00004; FAO, 2012, FAO STAT YB WORLD FO; FESKENS EJM, 1995, DIABETES CARE, V18, P1104, DOI 10.2337/diacare.18.8.1104; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Ibrahim A, 2005, METABOLISM, V54, P240, DOI 10.1016/j.metabol.2004.08.019; JHY WU, 2012, BRIT J NUTR, V107, pS214; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3; Lottenberg AM, 2012, J NUTR BIOCHEM, V23, P1027, DOI 10.1016/j.jnutbio.2012.03.004; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Melanson EL, 2009, ANN NUTR METAB, V55, P229, DOI 10.1159/000229004; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Muramatsu T, 2010, PREV MED, V50, P272, DOI 10.1016/j.ypmed.2010.02.014; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Pelikanova T, 2001, METABOLISM, V50, P1472, DOI 10.1053/meta.2001.27195; Perez-Jimenez F, 2001, DIABETOLOGIA, V44, P2038, DOI 10.1007/s001250100009; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; Sacks FM, 2006, J CLIN ENDOCR METAB, V91, P398, DOI 10.1210/jc.2005-2459; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Storlien LH, 1996, LIPIDS, V31, pS261, DOI 10.1007/BF02637087; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; TREVISAN M, 1990, JAMA-J AM MED ASSOC, V263, P688, DOI 10.1001/jama.263.5.688; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Wang L, 2003, AM J CLIN NUTR, V78, P91	36	9	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64758	10.1371/journal.pone.0064758	http://dx.doi.org/10.1371/journal.pone.0064758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741386	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900099
J	Le Tacon, F; Zeller, B; Plain, C; Hossann, C; Brechet, C; Robin, C				Le Tacon, Francois; Zeller, Bernd; Plain, Caroline; Hossann, Christian; Brechet, Claude; Robin, Christophe			Carbon Transfer from the Host to Tuber melanosporum Mycorrhizas and Ascocarps Followed Using a C-13 Pulse-Labeling Technique	PLOS ONE			English	Article							HIGH TEMPORAL RESOLUTION; NITROGEN-FERTILIZATION; CARBOHYDRATE RESERVES; SEASONAL-CHANGES; ALLOCATION; STORAGE; STARCH; PLANTS; FIELD; TRANSLOCATION	Truffles ascocarps need carbon to grow, but it is not known whether this carbon comes directly from the tree (heterotrophy) or from soil organic matter (saprotrophy). The objective of this work was to investigate the heterotrophic side of the ascocarp nutrition by assessing the allocation of carbon by the host to Tuber melanosporum mycorrhizas and ascocarps. In 2010, a single hazel tree selected for its high truffle (Tuber melanosporum) production and situated in the west part of the Vosges, France, was labeled with (CO2)-C-13. The transfer of C-13 from the leaves to the fine roots and T. melanosporum mycorrhizas was very slow compared with the results found in the literature for herbaceous plants or other tree species. The fine roots primarily acted as a carbon conduit; they accumulated little C-13 and transferred it slowly to the mycorrhizas. The mycorrhizas first formed a carbon sink and accumulated C-13 prior to ascocarp development. Then, the mycorrhizas transferred C-13 to the ascocarps to provide constitutive carbon (1.7 mg of C-13 per day). The ascocarps accumulated host carbon until reaching complete maturity, 200 days after the first labeling and 150 days after the second labeling event. This role of the Tuber ascocarps as a carbon sink occurred several months after the end of carbon assimilation by the host and at low temperature. This finding suggests that carbon allocated to the ascocarps during winter was provided by reserve compounds stored in the wood and hydrolyzed during a period of frost. Almost all of the constitutive carbon allocated to the truffles (1% of the total carbon assimilated by the tree during the growing season) came from the host.	[Le Tacon, Francois] INRA, UMR 1136, Interact Arbres Microorganismes, Ctr INRA Nancy, Champenoux, France; [Le Tacon, Francois] Univ Lorraine, UMR 1136, Interact Arbres Microorganisme, Fac Sci, Vandoeuvre Les Nancy, France; [Zeller, Bernd] INRA, UR 1138, Biogeochimie Ecosyst Forestiers, Ctr INRA Nancy, Champenoux, France; [Plain, Caroline; Hossann, Christian; Brechet, Claude] INRA, UMR 1137, Ecol & Ecophysiol Forestieres, Ctr INRA Nancy, Champenoux, France; [Plain, Caroline; Hossann, Christian; Brechet, Claude] Univ Lorraine, UMR 1137, Ecol & Ecophysiol Forestieres, Fac Sci, Vandoeuvre Les Nancy, France; [Robin, Christophe] Univ Lorraine, UMR Agron & Environm Nancy Colmar 1121, Vandoeuvre Les Nancy, France; [Robin, Christophe] INRA, UMR Agron & Environm Nancy Colmar 1121, Vandoeuvre Les Nancy, France	INRAE; Universite de Lorraine; Universite de Lorraine; INRAE; INRAE; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Universite de Lorraine; INRAE	Zeller, B (corresponding author), INRA, UR 1138, Biogeochimie Ecosyst Forestiers, Ctr INRA Nancy, Champenoux, France.	zeller@nancy.inra.fr	ROBIN, Christophe/C-7323-2013	ROBIN, Christophe/0000-0001-8117-806X; plain, caroline/0000-0002-3624-1127	INRA; Regional Council of Lorraine; SYSTRUF programme (An integrated approach for sustainable management of ecosystems producing Black Truffle, Tuber melanosporum); French ANR (Agence Nationale de la Recherche) [ANR-09-STRA-10-02]	INRA; Regional Council of Lorraine(Region Grand-Est); SYSTRUF programme (An integrated approach for sustainable management of ecosystems producing Black Truffle, Tuber melanosporum); French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	For this work, the authors utilized the online continuous flow CN analyzer (Carlo Erba NA1500) coupled with an isotope ratio mass spectrometer (Finnigan delta S) and DNA sequencing facilities at INRA-Nancy financed by INRA and the Regional Council of Lorraine. The pulse-labeling experiment was supported by the SYSTRUF programme (An integrated approach for sustainable management of ecosystems producing Black Truffle, Tuber melanosporum) financed by the French ANR (Agence Nationale de la Recherche; programme SYSTERRA, ANR-09-STRA-10-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY D, 1994, CAN J BOT, V72, P317, DOI 10.1139/b94-041; Bollmark L, 1999, CAN J FOREST RES, V29, P85, DOI 10.1139/cjfr-29-1-85; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Callot G, 1999, TRUFFE TERRE VIE QUA; CHEVALIER G, 1990, AGR ECOSYST ENVIRON, V28, P75, DOI 10.1016/0167-8809(90)90017-8; Ek H, 1997, NEW PHYTOL, V135, P133, DOI 10.1046/j.1469-8137.1997.00621.x; Epron D, 2011, BIOGEOSCIENCES, V8, P1153, DOI 10.5194/bg-8-1153-2011; ESSIAMAH S, 1985, IAWA BULL, V6, P97, DOI 10.1163/22941932-90000921; FINLAY RD, 1986, NEW PHYTOL, V103, P143, DOI 10.1111/j.1469-8137.1986.tb00603.x; GODBOUT C, 1992, CAN J BOT, V70, P181, DOI 10.1139/b92-024; Hobbie EA, 2013, BIOGEOCHEMISTRY, V114, P381, DOI 10.1007/s10533-012-9779-z; Hogberg P, 2008, NEW PHYTOL, V177, P220, DOI 10.1111/j.1469-8137.2007.02238.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; HORWATH WR, 1994, TREE PHYSIOL, V14, P1163, DOI 10.1093/treephys/14.10.1163; JOHANSSON T, 1993, SCAND J FOREST RES, V8, P94, DOI 10.1080/02827589309382758; Johnson D, 2002, NEW PHYTOL, V153, P327, DOI 10.1046/j.0028-646X.2001.00316.x; Kagawa A, 2006, NEW PHYTOL, V171, P793, DOI 10.1111/j.1469-8137.2006.01780.x; Kagawa A, 2006, PLANT CELL ENVIRON, V29, P1571, DOI 10.1111/j.1365-3040.2006.01533.x; Kuikka K, 2003, ECOLOGY, V84, P2051, DOI 10.1890/02-0359; LAMHAMEDI MS, 1994, CAN J FOREST RES, V24, P1797, DOI 10.1139/x94-232; Landhausser SM, 2003, TREES-STRUCT FUNCT, V17, P471, DOI 10.1007/s00468-003-0263-1; LAST FT, 1979, NATURE, V280, P168, DOI 10.1038/280168a0; Leake JR, 2006, APPL SOIL ECOL, V33, P152, DOI 10.1016/j.apsoil.2006.03.001; Leake JR, 2001, TREE PHYSIOL, V21, P71, DOI 10.1093/treephys/21.2-3.71; MAMOUN M, 1991, AGRONOMIE, V11, P521, DOI 10.1051/agro:19910609; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Maurel K, 2004, TREE PHYSIOL, V24, P579, DOI 10.1093/treephys/24.5.579; MILLER SL, 1989, TREE PHYSIOL, V5, P239, DOI 10.1093/treephys/5.2.239; Murat C, 2013, NEW PHYTOL, V199, P176, DOI 10.1111/nph.12264; Nguyen C, 1999, PLANT SOIL, V212, P191, DOI 10.1023/A:1004681528074; NORTON JM, 1990, SOIL BIOL BIOCHEM, V22, P449, DOI 10.1016/0038-0717(90)90177-2; Olivier J.-M., 2012, TRUFFE TRUFFICULTURE; Ostle N, 2003, SOIL BIOL BIOCHEM, V35, P877, DOI 10.1016/S0038-0717(03)00117-2; Palonen P, 2000, PHYSIOL PLANTARUM, V110, P393, DOI 10.1034/j.1399-3054.2000.1100314.x; Paolocci F, 1999, FEMS MICROBIOL ECOL, V28, P23, DOI 10.1111/j.1574-6941.1999.tb00557.x; Paolocci F, 2006, APPL ENVIRON MICROB, V72, P2390, DOI 10.1128/AEM.72.4.2390-2393.2006; Pestana M, 2011, OECOLOGIA, V165, P723, DOI 10.1007/s00442-010-1760-8; Philip LJ, 2008, PLANT SOIL, V308, P23, DOI 10.1007/s11104-008-9603-7; Plain C, 2009, TREE PHYSIOL, V29, P1433, DOI 10.1093/treephys/tpp072; Riccioni C, 2008, NEW PHYTOL, V180, P466, DOI 10.1111/j.1469-8137.2008.02560.x; ROBIN C, 1990, PLANT PHYSIOL BIOCH, V28, P343; ROUQUEROLLE T, 1975, REV MYCOL, V29, P213; Rubini A, 1998, FEMS MICROBIOL LETT, V164, P7, DOI 10.1016/S0378-1097(98)00183-9; RYGIEWICZ PT, 1994, NATURE, V369, P58, DOI 10.1038/369058a0; SAUTER JJ, 1994, TREES-STRUCT FUNCT, V8, P297, DOI 10.1007/BF00202674; Simard SW, 1997, PLANT SOIL, V191, P41, DOI 10.1023/A:1004205727882; Subke JA, 2009, NEW PHYTOL, V183, P349, DOI 10.1111/j.1469-8137.2009.02883.x; Teramoto M, 2012, MYCORRHIZA, V22, P219, DOI 10.1007/s00572-011-0395-x; Treseder KK, 2006, SOIL BIOL BIOCHEM, V38, P1077, DOI 10.1016/j.soilbio.2005.09.006; Zeller B, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008037	50	66	65	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64626	10.1371/journal.pone.0064626	http://dx.doi.org/10.1371/journal.pone.0064626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741356	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900069
J	O'Malley, MP; Lee-Brooks, K; Medd, HB				O'Malley, Mary P.; Lee-Brooks, Katie; Medd, Hannah B.			The Global Economic Impact of Manta Ray Watching Tourism	PLOS ONE			English	Article							SHARK; CONSERVATION; ECOTOURISM; INDUSTRY; BIOLOGY	As manta rays face increased threats from targeted and bycatch fisheries, manta ray watching tourism, if managed properly, may present an attractive economic alternative to consumptive use of these species. Both species in the genus Manta (Manta alfredi and Manta birostris) are classified by the International Union for the Conservation of Nature Red List as species Vulnerable to extinction in the wild, and are considered unsustainable as fisheries resources due to their conservative life history characteristics, which considerably reduce their ability to recover population numbers when depleted. Utilising dive operator surveys, Internet research, and a literature review, this study provides the first global estimate of the direct economic impact of manta ray watching tourism and examines the potential socio-economic benefits of non-consumptive manta ray watching operations relative to consumptive use of manta rays as a fishery resource. In the 23 countries in which manta ray watching operations meeting our criteria were identified, we estimated direct revenue to dive operators from manta ray dives and snorkels at over US$73 million annually and direct economic impact, including associated tourism expenditures, of US$140 million annually. Ten countries account for almost 93% of the global revenue estimate, specifically Japan, Indonesia, the Maldives, Mozambique, Thailand, Australia, Mexico, United States, Federated States of Micronesia and Palau. In many of the areas where directed fisheries for manta rays are known to occur, these activities overlap with manta ray tourism sites or the migratory range of the mantas on which these sites depend, and are likely to be unsustainable and detrimental to manta ray watching tourism.	[O'Malley, Mary P.] WildAid, San Francisco, CA USA; [O'Malley, Mary P.; Lee-Brooks, Katie] Manta Trust, Dorchester, England; [O'Malley, Mary P.; Medd, Hannah B.] Shark Savers, New York, NY USA		O'Malley, MP (corresponding author), WildAid, San Francisco, CA USA.	maryomalley@mac.com						Alava ERZ, 2002, ELASMOBRACH BIODIVER; Anderson Charles, 2001, Shark News, V13, P1; Anderson R. C., 2010, Tourism in Marine Environments, V7, P15, DOI 10.3727/154427310X12826772784793; Anderson R.C., 1993, SHARK FISHERIES MALD; Angermeier PL, 2000, CONSERV BIOL, V14, P373, DOI 10.1046/j.1523-1739.2000.98362.x; [Anonymous], 2012, UNWTO TOURISM HIGHLI; [Anonymous], 2007, INT VISITOR ARRIVALS; [Anonymous], 2009, VALUE CORAL REEFS MA; [Anonymous], 1981, TOURISM MULTIPLIERS; Brand Matrix Research, 2011, FIN REP STAT OUTL DI; Brander LM, 2007, ECOL ECON, V63, P209, DOI 10.1016/j.ecolecon.2006.11.002; Brunnschweiler JM, 2010, J SUSTAIN TOUR, V18, P29, DOI 10.1080/09669580903071987; Burke L., 2004, REEFS RISK CARIBBEAN; Camhi M. D., 2009, IUCN SHARK SPEC GROU; Catlin J, 2013, BIOL CONSERV, V157, P93, DOI 10.1016/j.biocon.2012.07.022; Catlin J, 2010, INT J TOUR RES, V12, P134, DOI 10.1002/jtr.742; Cesar H., 2003, EC WORLDWIDE CORAL R; Chen VY, 2002, MANAGEMENT TRADE WHA; Cisneros-Montemayor A. M., 2010, J BIOECONOMICS, V12, P245, DOI DOI 10.1007/S10818-010-9092-7; Cisneros-Montemayor AM, 2012, 201204 FISH CTR, P1; Cisneros-Montemayor AM, 2011, TOO PRECIOUS DRILL M; Clua E, 2011, MAR FRESHWATER RES, V62, P764, DOI 10.1071/MF10163; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Daw B, 2008, 2008 JOINT M ICHTH H; De La Cruz Modino R, 2011, REV TURISMO PATRIMON, V9, P467; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; Dearden P, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P66; Dewar H., 2002, PRELIMINARY REPORT M; Dicken ML, 2009, AFR J MAR SCI, V31, P227, DOI 10.2989/AJMS.2009.31.2.10.882; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Fernando D, 2011, STUDY SRI LANKAS MAN; Gallagher AJ, 2011, CURR ISSUES TOUR, V14, P797, DOI 10.1080/13683500.2011.585227; Garrod B., 2004, Journal of Sustainable Tourism, V12, P95, DOI 10.1080/09669580408667227; Graham Rachel T., 2004, Shark News, V16, P8; Graham Rachel T., 2007, Gulf and Caribbean Research, V19, P149; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hara M, 2003, MARINE BASED TOURISM; Haskell PJ, 2012, IS WHALE SHARK TOURI; Heinrichs S., 2011, GLOBAL THREAT MANTA; Higham J, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P1, DOI 10.1079/9781845933456.0001; Homma K, 1999, INDOPACIFIC FISH BIO; Hoyt E., 2001, WHALE WATCHING WORLD; Jones T., 2009, Journal of Ecotourism, V8, P32, DOI 10.1080/14724040802517922; Justus J, 2009, TRENDS ECOL EVOL, V24, P187, DOI 10.1016/j.tree.2008.11.011; Kahn B, 2003, P PUBL WORLD C AQ PR; Lack M., 2009, TRENDS GLOBAL SHARK; Marshall A, 2011, IUCN 2011 IUCN RED L; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall Andrea D., 2009, Zootaxa, V2301, P1; Martin R A, 2006, MALDIVES MARINE RES, V8, P1; Mau R., 2008, Journal of Ecotourism, V7, P208, DOI 10.2167/joe0232.0; McCauley DJ, 2006, NATURE, V443, P27, DOI 10.1038/443027a; Norman B., 2007, EC IMPORTANCE CONSER; Notarbartolo di Sciara G, 1995, SHARK NEWS, V5, P1; O'Connor S., 2009, WHALE WATCHING WORLD; Orams MB, 2002, COAST MANAGE, V30, P361, DOI 10.1080/089207502900264; Pet-Soede L, 2002, SOLOR ALOR ISLANDS E; Priyambodo RH, 2012, ANTARA NEWS     1029; Quiros AL, 2007, FISH RES, V84, P102, DOI 10.1016/j.fishres.2006.11.017; Rohner CA, 2013, MARINE ECOL IN PRESS; Rowat D, 2007, FISH RES, V84, P109, DOI 10.1016/j.fishres.2006.11.018; Sirakaya E., 1999, Journal of Travel Research, V38, P168, DOI 10.1177/004728759903800210; Sorice MG, 2003, COAST MANAGE, V31, P319, DOI 10.1080/08920750390232983; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Stoeckl N., 2005, Journal of Tourism Studies, V16, P69; Stoeckl N, 2010, TOURISM ECON, V16, P995, DOI 10.5367/te.2010.0005; Tapsuwan S, 2008, COAST MANAGE, V36, P431, DOI 10.1080/08920750802412908; Tibirica Y., 2011, TOURISM MARINE ENV, V7, P141, DOI DOI 10.3727/154427311X13195453162732; Topelko Karen N., 2005, Journal of Ecotourism, V4, P108, DOI 10.1080/14724040409480343; Vianna G., 2011, SOCIOECONOMIC VALUE; Vianna G, 2010, WANTED DEAD ALIVE RE; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Waheed A, 1998, BAY BENGAL NEWS, V12, P23; White L, 2008, THESIS DUKE U N CARO; White WT, 2006, FISH RES, V82, P65, DOI 10.1016/j.fishres.2006.08.008; Zeppel H., 2008, TOURISM MARINE ENV, V5, P215	76	90	91	1	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65051	10.1371/journal.pone.0065051	http://dx.doi.org/10.1371/journal.pone.0065051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741450	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900163
J	Trumpp, NM; Traub, F; Kiefer, M				Trumpp, Natalie M.; Traub, Felix; Kiefer, Markus			Masked Priming of Conceptual Features Reveals Differential Brain Activation during Unconscious Access to Conceptual Action and Sound Information	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TIME-COURSE; ATTENTIONAL SENSITIZATION; NEUROPHYSIOLOGICAL DISTINCTION; ACTION WORDS; MOTOR; REPETITION; REPRESENTATION; PERCEPTION; KNOWLEDGE	Previous neuroimaging studies suggested an involvement of sensory-motor brain systems during conceptual processing in support of grounded cognition theories of conceptual memory. However, in these studies with visible stimuli, contributions of strategic imagery or semantic elaboration processes to observed sensory-motor activity cannot be entirely excluded. In the present study, we therefore investigated the electrophysiological correlates of unconscious feature-specific priming of action- and sound-related concepts within a novel feature-priming paradigm to specifically probe automatic processing of conceptual features without the contribution of possibly confounding factors such as orthographic similarity or response congruency. Participants were presented with a masked subliminal prime word and a subsequent visible target word. In the feature-priming conditions primes as well as targets belonged to the same conceptual feature dimension ( action or sound, e.g., typewriter or radio) whereas in the two non-priming conditions, either the primes or the targets consisted of matched control words with low feature relevance (e.g., butterfly or candle). Event-related potential analyses revealed unconscious feature-specific priming effects at fronto-central electrodes within 100 to 180 ms after target stimulus onset that differed with regard to topography and underlying neural generators. In congruency with previous findings under visible stimulation conditions, these differential subliminal ERP feature-priming effects demonstrate an unconscious automatic access to action versus sound features of concepts. The present results therefore support grounded cognition theory suggesting that activity in sensory and motor areas during conceptual processing can also occur unconsciously and is not mandatorily accompanied by a vivid conscious experience of the conceptual content such as in imagery.	[Trumpp, Natalie M.; Traub, Felix; Kiefer, Markus] Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany	Ulm University	Kiefer, M (corresponding author), Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany.	Markus.Kiefer@uni-ulm.de		Trumpp, Natalie/0000-0001-9975-4870	German Research Foundation [DFG Ki804/5-1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by grants of the German Research Foundation to MK (DFG Ki804/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, COGNITIVE SCI SERIES; Ansorge Ulrich, 2011, Adv Cogn Psychol, V7, P108, DOI 10.2478/v10053-008-0087-z; Ansorge U, 2010, COGNITION, V116, P303, DOI 10.1016/j.cognition.2010.05.010; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2012, NEUROIMAGE, V59, P3502, DOI 10.1016/j.neuroimage.2011.11.011; Chatterjee A, 2010, LANG COGN, V2, P79, DOI 10.1515/LANGCOG.2010.004; Damasio AR, 1989, NEURAL COMPUT, V1, P123, DOI 10.1162/neco.1989.1.1.123; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Eddy M, 2006, PSYCHOPHYSIOLOGY, V43, P564, DOI 10.1111/j.1469-8986.2006.00455.x; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gerlach C, 2007, J COGNITIVE NEUROSCI, V19, P296, DOI 10.1162/jocn.2007.19.2.296; Green DM, 1966, SIGNAL DETECTION THE; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Hauk O, 2008, J PHYSIOL-PARIS, V102, P50, DOI 10.1016/j.jphysparis.2008.03.013; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Hauk O, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00050; Helbig HB, 2006, EXP BRAIN RES, V174, P221, DOI 10.1007/s00221-006-0443-5; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Hoenig K, 2008, J COGNITIVE NEUROSCI, V20, P1799, DOI 10.1162/jocn.2008.20123; Hoenig K, 2011, NEUROIMAGE, V56, P1714, DOI 10.1016/j.neuroimage.2011.02.065; Holcomb PJ, 2006, J COGNITIVE NEUROSCI, V18, P1631, DOI 10.1162/jocn.2006.18.10.1631; HUMPHREYS GW, 1988, COGNITIVE NEUROPSYCH, V5, P67, DOI 10.1080/02643298808252927; James TW, 2003, CURR BIOL, V13, P1792, DOI 10.1016/j.cub.2003.09.039; Kherif F, 2011, CEREB CORTEX, V21, P103, DOI 10.1093/cercor/bhq063; Kiefer M, 2001, MEM COGNITION, V29, P100, DOI 10.3758/BF03195745; Kiefer M, 2005, J COGNITIVE NEUROSCI, V17, P199, DOI 10.1162/0898929053124938; Kiefer M, 2000, NEUROREPORT, V11, P2401, DOI 10.1097/00001756-200008030-00013; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; Kiefer M, 2002, COGNITIVE BRAIN RES, V13, P27, DOI 10.1016/S0926-6410(01)00085-4; Kiefer M., 2013, ACTION SCI FDN EMERG; Kiefer Markus, 2008, Adv Cogn Psychol, V3, P289, DOI 10.2478/v10053-008-0032-2; Kiefer M, 2007, CEREB CORTEX, V17, P1516, DOI 10.1093/cercor/bhl062; Kiefer M, 2007, J COGNITIVE NEUROSCI, V19, P525, DOI 10.1162/jocn.2007.19.3.525; Kiefer M, 2012, BRAIN LANG, V122, P120, DOI 10.1016/j.bandl.2012.05.007; Kiefer M, 2012, CORTEX, V48, P805, DOI 10.1016/j.cortex.2011.04.006; Kiefer M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00061; Kiefer M, 2012, ADV COGN PSYCHOL, V8, P50, DOI [10.2478/v10053-008-0102-4, 10.5709/acp-0102-4]; Kiefer Markus, 2011, Adv Cogn Psychol, V7, P55, DOI 10.2478/v10053-008-0090-4; Kiefer M, 2011, J COGNITIVE NEUROSCI, V23, P1864, DOI 10.1162/jocn.2010.21543; Kiefer M, 2010, J EXP PSYCHOL GEN, V139, P464, DOI 10.1037/a0019561; Kiefer M, 2008, J NEUROSCI, V28, P12224, DOI 10.1523/JNEUROSCI.3579-08.2008; Kunde W, 2012, ADV COGN PSYCHOL, V8, P9, DOI [10.2478/v10053-008-0097-x, 10.5709/acp-0097-x]; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Machery E, 2007, COGNITION, V104, P19, DOI 10.1016/j.cognition.2006.05.002; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mosher JC, 1998, IEEE T BIO-MED ENG, V45, P1342, DOI 10.1109/10.725331; Naatanen R., 2018, ATTENTION BRAIN FUNC; Neininger B, 2003, NEUROPSYCHOLOGIA, V41, P53, DOI 10.1016/S0028-3932(02)00126-4; Noppeney U, 2006, CEREB CORTEX, V16, P437, DOI 10.1093/cercor/bhi123; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pecher D, 2003, PSYCHOL SCI, V14, P119, DOI 10.1111/1467-9280.t01-1-01429; Pulvermuller F, 2010, J COGNITIVE NEUROSCI, V22, P2027, DOI 10.1162/jocn.2009.21339; Pulvermuller F, 2009, HUM BRAIN MAPP, V30, P3837, DOI 10.1002/hbm.20811; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; Pulvermuller F, 2000, NEUROREPORT, V11, P2789, DOI 10.1097/00001756-200008210-00036; Pulvermuller F, 2005, J COGNITIVE NEUROSCI, V17, P884, DOI 10.1162/0898929054021111; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Pylyshyn Z., 1984, COMPUTATION COGNITIO; QUILLIAN MR, 1969, COMMUN ACM, V12, P459, DOI 10.1145/363196.363214; Rugg MD, 1999, NEUROREPORT, V10, P2661, DOI 10.1097/00001756-199908200-00041; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; Schmidt Filipp, 2011, Adv Cogn Psychol, V7, P120, DOI 10.2478/v10053-008-0092-2; Simmons WK, 2007, NEUROPSYCHOLOGIA, V45, P2802, DOI 10.1016/j.neuropsychologia.2007.05.002; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Simmons WK, 2003, COGN NEUROPSYCHOL, V20, P451, DOI 10.1080/02643290342000032; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Trumpp NM, 2013, CORTEX, V49, P474, DOI 10.1016/j.cortex.2012.02.002; Trumpp NM, 2012, J COGNITIVE NE UNPUB; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Tyler LK, 2001, TRENDS COGN SCI, V5, P244, DOI 10.1016/S1364-6613(00)01651-X; Vorberg D, 2003, P NATL ACAD SCI USA, V100, P6275, DOI 10.1073/pnas.0931489100; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273	84	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65910	10.1371/journal.pone.0065910	http://dx.doi.org/10.1371/journal.pone.0065910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741518	Green Published, gold			2022-12-27	WOS:000319799900231
J	Zhang, JY; Chen, YL; Ji, GY; Fang, WY; Gao, ZW; Liu, Y; Wang, J; Ding, XY; Gao, F				Zhang, Juyong; Chen, Yue-Lei; Ji, Guanyu; Fang, Weiying; Gao, Zhaowei; Liu, Yi; Wang, Jun; Ding, Xiaoyan; Gao, Fei			Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells	PLOS ONE			English	Article							E-CADHERIN; TGF-BETA; HEPATOCELLULAR-CARCINOMA; TUMOR PROGRESSION; METHYLATION; COMBINATION; EXPRESSION; REPRESSION; SNAIL; GENE	The epithelial to mesenchymal transition (EMT) has been well recognized for many decades as an essential early step in the progression of primary tumors towards metastases. Widespread epigenetic reprogramming of DNA and histone modifications tightly regulates gene expression and cellular activity during carcinogenesis, and epigenetic therapy has been developed to design efficient strategies for cancer treatment. As the first oral agent approved for the clinical treatment of cancer, sorafenib has significant inhibitory effects on tumor growth and EMT. However, a detailed understanding of the underlying epigenetic mechanism remains elusive. In this manuscript, we performed a ChIP-seq assay to evaluate the activity of sorafenib on the genome-wide profiling of histone modifications. We demonstrate that sorafenib largely reverses the changes in histone modifications that occur during EMT in A549 alveolar epithelial cells. Sorafenib also significantly reduces the coordinated epigenetic switching of critical EMT-associated genes in accordance with their expression levels. Furthermore, we show that sorafenib potentiates histone acetylation by regulating the expression levels of histone-modifying enzymes. Collectively, these findings provide the first evidence that sorafenib inhibits the EMT process through an epigenetic mechanism, which holds enormous promise for identifying novel epigenetic candidate diagnostic markers and drug targets for the treatment of human malignancies.	[Zhang, Juyong; Ji, Guanyu; Gao, Zhaowei; Wang, Jun; Gao, Fei] BGI Shenzhen, Sci Technol Dept, Shenzhen, Peoples R China; [Chen, Yue-Lei; Fang, Weiying; Liu, Yi; Ding, Xiaoyan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Copenhagen; King Abdulaziz University; Novo Nordisk Foundation; University of Copenhagen	Ding, XY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China.	xyding@sunm.shcnc.ac.cn; gaofei@genomics.org.cn	Wang, Jun/A-7261-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Ji, Guanyu/0000-0001-9818-8694; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931	National High Technology Research and Development Program of China (863 Program) [2009AA022707]; National Basic Research Program of China [2009CB941103, 2011CBA01105, 2013CB967103]; National Science and Technology Major Projects [2011ZX09307-302-01]; National Natural Science Foundation of China [31000624, 81272396]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program, No. 2009AA022707); grants from the National Basic Research Program of China (2009CB941103 and 2011CBA01105) and the National Science and Technology Major Projects (2011ZX09307-302-01) to X. Ding; grants from the National Basic Research Program of China (2013CB967103) and the National Natural Science Foundation of China (31000624 and 81272396) to Y. L. Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Chen YL, 2011, HEPATOLOGY, V53, P1708, DOI 10.1002/hep.24254; Chen YL, 2009, J BIOL CHEM, V284, P23481, DOI 10.1074/jbc.M109.007864; Droufakou S, 2001, INT J CANCER, V92, P404, DOI 10.1002/ijc.1208; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Gahr S, 2012, J CANCER, V3, P158, DOI 10.7150/jca.4211; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Walker T, 2009, MOL PHARMACOL, V76, P342, DOI 10.1124/mol.109.056523; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang L, 2009, PLOS ONE, V6, P19144; Zhang Z, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-41	38	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64954	10.1371/journal.pone.0064954	http://dx.doi.org/10.1371/journal.pone.0064954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741434	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900147
J	Bondarenko, O; Ivask, A; Kakinen, A; Kurvet, I; Kahru, A				Bondarenko, Olesja; Ivask, Angela; Kaekinen, Aleksandr; Kurvet, Imbi; Kahru, Anne			Particle-Cell Contact Enhances Antibacterial Activity of Silver Nanoparticles	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESPIRATORY-CHAIN; IONS; NANOSILVER; BACTERIUM; TOXICITY; SURFACE; MICROSCOPY; PRODUCTS; EXPOSURE	Background: It is generally accepted that antibacterial properties of Ag nanoparticles (AgNPs) are dictated by their dissolved fraction. However, dissolution-based concept alone does not fully explain the toxic potency of nanoparticulate silver compared to silver ions. Methodology/Principal Findings: Herein, we demonstrated that the direct contact between bacterial cell and AgNPs' surface enhanced the toxicity of nanosilver. More specifically, cell-NP contact increased the cellular uptake of particle-associated Ag ions - the single and ultimate cause of toxicity. To prove that, we evaluated the toxicity of three different AgNPs (uncoated, PVP-coated and protein-coated) to six bacterial strains: Gram-negative Escherichia coli, Pseudomonas fluorescens, P. putida and P. aeruginosa and Gram-positive Bacillus subtilis and Staphylococcus aureus. While the toxicity of AgNO3 to these bacteria varied only slightly (the 4-h EC50 ranged from 0.3 to 1.2 mg Ag/l), the 4-h EC50 values of protein-coated AgNPs for various bacterial strains differed remarkably, from 0.35 to 46 mg Ag/l. By systematically comparing the intracellular and extracellular free Ag+ liberated from AgNPs, we demonstrated that not only extracellular dissolution in the bacterial test environment but also additional dissolution taking place at the particle-cell interface played an essential role in antibacterial action of AgNPs. The role of the NP-cell contact in dictating the antibacterial activity of Ag-NPs was additionally proven by the following observations: (i) separation of bacterial cells from AgNPs by particle-impermeable membrane (cut-off 20 kDa, similar to 4 nm) significantly reduced the toxicity of AgNPs and (ii) P. aeruginosa cells which tended to attach onto AgNPs, exhibited the highest sensitivity to all forms of nanoparticulate Ag. Conclusions/Significance: Our findings provide new insights into the mode of antibacterial action of nanosilver and explain some discrepancies in this field, showing that "Ag-ion" and "particle-specific" mechanisms are not controversial but, rather, are two faces of the same coin.	[Bondarenko, Olesja; Ivask, Angela; Kaekinen, Aleksandr; Kurvet, Imbi; Kahru, Anne] NICPB, Lab Environm Toxicol, Tallinn, Estonia; [Kaekinen, Aleksandr] Tallinn Univ Technol, Dept Chem & Mat Technol, EE-19086 Tallinn, Estonia	National Institute of Chemical Physics & Biophysics (NICPB); Tallinn University of Technology	Bondarenko, O (corresponding author), NICPB, Lab Environm Toxicol, Tallinn, Estonia.	olesja.bondarenko@kbfi.ee	Bondarenko, Olesja/AAP-7679-2020; Ivask, Angela/G-5180-2011; Kakinen, Aleksandr/J-8417-2017; Bondarenko, Olesja/AGE-4475-2022; Kahru, Anne/C-4927-2008; Ivask, Angela/AAH-5777-2021	Ivask, Angela/0000-0003-3451-7211; Kakinen, Aleksandr/0000-0003-1547-2855; Bondarenko, Olesja/0000-0001-8767-1365; Kahru, Anne/0000-0002-4944-4900; 	Estonian target funding project [SF0690063s08, ETF8561, ETF9347]; European Social Fund; EU [263147]	Estonian target funding project; European Social Fund(European Social Fund (ESF)); EU(European Commission)	This research was supported by the Estonian target funding project SF0690063s08, ETF8561 and ETF9347 grants, European Social Fund and EU 7th Framework Programme under grant agreement no. 263147 (NanoValid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinova I, 2012, ENVIRON SCI POLLUT R, P1; BOGDANCHIKOVA NE, 1992, REACT KINET CATAL L, V48, P475, DOI 10.1007/BF02162697; BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135; Cerkez I, 2012, J APPL POLYM SCI, V124, P4230, DOI 10.1002/app.35402; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Cleveland D, 2012, SCI TOTAL ENVIRON, V421, P267, DOI 10.1016/j.scitotenv.2012.01.025; Dallas P, 2011, ADV COLLOID INTERFAC, V166, P119, DOI 10.1016/j.cis.2011.05.008; Dror-Ehre A, 2012, DESALIN WATER TREAT, V48, P130, DOI 10.1080/19443994.2012.698804; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Fung MC, 1996, J TOXICOL-CLIN TOXIC, V34, P119, DOI 10.3109/15563659609020246; George S, 2012, ACS NANO, V6, P3745, DOI 10.1021/nn204671v; Gunawan C, 2009, SMALL, V5, P341, DOI 10.1002/smll.200801202; Henglein A, 1998, CHEM MATER, V10, P444, DOI 10.1021/cm970613j; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Hutchison ML, 1999, MICROBES INFECT, V1, P1005, DOI 10.1016/S1286-4579(99)80518-8; Ivask A., 2012, NANO ANTIMICROBIALS, P253; Ivask A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-41; Jin X, 2010, ENVIRON SCI TECHNOL, V44, P7321, DOI 10.1021/es100854g; Kahru A, 2013, ACCOUNTS CHEM RES, V46, P823, DOI 10.1021/ar3000212; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; McQuillan JS, 2012, NANOTOXICOLOGY, V6, P857, DOI 10.3109/17435390.2011.626532; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Nowack B, 2011, ENVIRON SCI TECHNOL, V45, P1177, DOI 10.1021/es103316q; O'Reilly JP, 2005, J AM CHEM SOC, V127, P1632, DOI 10.1021/ja0443326; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sotiriou GA, 2012, LANGMUIR, V28, P15929, DOI 10.1021/la303370d; Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s; Stefan M, 2011, J MATER SCI-MATER M, V22, P789, DOI 10.1007/s10856-011-4281-z; Taglietti A, 2012, LANGMUIR, V28, P8140, DOI 10.1021/la3003838; Tsao TM, 2009, SOIL SCI SOC AM J, V73, P1808, DOI 10.2136/sssaj2008.0376; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Zook JM, 2011, ANAL BIOANAL CHEM, V401, P1993, DOI 10.1007/s00216-011-5266-y	45	173	178	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64060	10.1371/journal.pone.0064060	http://dx.doi.org/10.1371/journal.pone.0064060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737965	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700029
J	Ding, ST; Wang, CL; Huang, YH; Shu, CC; Tseng, YT; Huang, CT; Hsu, NC; Lin, YF; Tsai, HB; Yang, MC; Ko, WJ				Ding, Shih-Tan; Wang, Chuan-Lan; Huang, Yu-Han; Shu, Chin-Chung; Tseng, Yu-Tzu; Huang, Chun-Ta; Hsu, Nin-Chieh; Lin, Yu-Feng; Tsai, Hung-Bin; Yang, Ming-Chin; Ko, Wen-Je			Demand and Predictors for Post-Discharge Medical Counseling in Home Care Patients: A Prospective Cohort Study	PLOS ONE			English	Article							HEALTH-CARE; INFORMATION-TRANSFER; HOSPITALIST SYSTEM; INTERNAL-MEDICINE; CONTINUITY; DISCHARGE; READMISSION; PREVALENCE; PHYSICIANS; PNEUMONIA	Rationale: Post-discharge care is challenging due to the high rate of adverse events after discharge. However, details regarding post-discharge care requirements remain unclear. Post-discharge medical counseling (PDMC) by telephone service was set-up to investigate its demand and predictors. Methods: This prospective study was conducted from April 2011 to March 2012 in a tertiary referral center in northern Taiwan. Patients discharged for home care were recruited and educated via telephone hotline counseling when needed. The patient's characteristics and call-in details were recorded, and predictors of PDMC use and worsening by red-flag sign were analyzed. Results: During the study period, 224 patients were enrolled. The PDMC was used 121 times by 65 patients in an average of 8.6 days after discharge. The red-flag sign was noted in 17 PDMC from 16 patients. Of the PDMC used, 50% (n = 60) were for symptom change and the rest were for post-discharge care problems and issues regarding other administrative services. Predictors of PDMC were underlying malignancy and lower Barthel index (BI). On the other hand, lower BI, higher adjusted Charlson co-morbidity index (CCI), and longer length of hospital stay were associated with PDMC and red-flag sign. Conclusions: Demand for PDMC may be as high as 29% in home care patients within 30 days after discharge. PDMC is needed more by patients with malignancy and lower BI. More focus should also be given to those with lower BI, higher CCI, and longer length of hospital stay, as they more frequently have red flag signs.	[Ding, Shih-Tan; Shu, Chin-Chung; Tseng, Yu-Tzu; Huang, Chun-Ta; Hsu, Nin-Chieh; Lin, Yu-Feng; Tsai, Hung-Bin; Ko, Wen-Je] Natl Taiwan Univ Hosp, Div Hosp Med, Dept Traumatol, Taipei, Taiwan; [Wang, Chuan-Lan; Huang, Yu-Han] Natl Taiwan Univ Hosp, Dept Nursing, Taipei, Taiwan; [Shu, Chin-Chung; Tseng, Yu-Tzu; Huang, Chun-Ta; Lin, Yu-Feng] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Hsu, Nin-Chieh; Yang, Ming-Chin] Natl Taiwan Univ, Inst Hlth Policy & Management, Coll Publ Hlth, Taipei 10764, Taiwan; [Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Shu, CC (corresponding author), Natl Taiwan Univ Hosp, Div Hosp Med, Dept Traumatol, Taipei, Taiwan.	ccshu139@ntu.edu.tw	Tsai, Hung-Bin/G-3761-2011	HSU, NIN-CHIEH/0000-0002-4997-1081; Tsai, Hung-Bin/0000-0002-0689-8339; YANG, MING-CHIN/0000-0001-7326-8671; SHU, CHIN-CHUNG/0000-0003-0311-5148; HUANG, CHUN-TA/0000-0002-5234-4986; LIN, YU-FENG/0000-0002-4350-7755	Bureau of National Health Insurance, Department of Health, Executive Yuan, Taiwan [DOH100-NH-1008]	Bureau of National Health Insurance, Department of Health, Executive Yuan, Taiwan	The authors thank the Bureau of National Health Insurance, Department of Health, Executive Yuan, Taiwan for funding support (DOH100-NH-1008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Cabre M, 2010, AGE AGEING, V39, P39, DOI 10.1093/ageing/afp100; Chaudhry SI, 2007, CIRCULATION, V116, P1549, DOI 10.1161/CIRCULATIONAHA.107.690768; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Giannella M, 2012, CLIN MICROBIOL INFEC, V18, P786, DOI 10.1111/j.1469-0691.2011.03757.x; Hsien CCM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001799; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jerng JS, 2008, J FORMOS MED ASSOC, V107, P396, DOI 10.1016/S0929-6646(08)60105-9; Karapinar-Carkit F, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-39; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Leong IYO, 2009, ANN ACAD MED SINGAP, V38, P113; Li JYZ, 2013, J EVAL CLIN PRACT, V19, P76, DOI 10.1111/j.1365-2753.2011.01772.x; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; Ling Wang Y-ML, 2009, TAIWAN EC FORUM, V7, P36; Peterson MC, 2009, MAYO CLIN PROC, V84, P248, DOI 10.1016/S0025-6196(11)61142-7; Rennke S, 2012, AM J MED, V125, P28, DOI 10.1016/j.amjmed.2011.05.011; Sackley C, 2008, STROKE, V39, P3329, DOI 10.1161/STROKEAHA.108.518563; Sainsbury A, 2005, AGE AGEING, V34, P228, DOI 10.1093/ageing/afi063; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Shu CC, 2012, INTERN MED J, V42, P677, DOI 10.1111/j.1445-5994.2011.02562.x; Shu CC, 2011, J HOSP MED, V6, P378, DOI [10.1002/Thm.896, 10.1002/jhm.896]; Shu CC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-96; Stinson JN, 2006, PAIN, V125, P143, DOI 10.1016/j.pain.2006.05.006; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; van Walraven C, 2010, J CLIN EPIDEMIOL, V63, P1000, DOI 10.1016/j.jclinepi.2010.01.023; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Wang Han-Yi, 2007, Chang Gung Med J, V30, P437; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64274	10.1371/journal.pone.0064274	http://dx.doi.org/10.1371/journal.pone.0064274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737976	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700040
J	Guo, AJ; Cai, JP; Gong, W; Yan, HB; Luo, XN; Tian, GF; Zhang, SH; Zhang, HL; Zhu, G; Cai, XP				Guo, Aijiang; Cai, Jianping; Gong, Wei; Yan, Hongbin; Luo, Xuenong; Tian, Guangfu; Zhang, Shaohua; Zhang, Haili; Zhu, Guan; Cai, Xuepeng			Transcriptome Analysis in Chicken Cecal Epithelia upon Infection by Eimeria tenella In Vivo	PLOS ONE			English	Article							INTESTINAL IMMUNE-RESPONSES; GENE-EXPRESSION; ANTICOCCIDIAL DRUGS; 2ND-GENERATION SCHIZONTS; MAXIMA INFECTION; CELLS; VACCINATION; IDENTIFICATION; SENSITIVITY; ACERVULINA	Coccidiosis, caused by various Eimeria species, is a major parasitic disease in chickens. However, our understanding on how chickens respond to coccidian infection is highly limited at both molecular and cellular levels. The present study employed the Affymetrix chicken genome array and performed transcriptome analysis on chicken cecal epithelia in response to infection for 4.5 days in vivo by the cecal-specific species E. tenella. By Significance Analysis of Microarrays (SAM), we have identified 7,099 probe sets with q-values at <0.05, in which 4,033 and 3,066 genes were found to be up-or down-regulated in response to parasite infection. The reliability of the microarray data were validated by real-time qRT-PCR of 20 genes with varied fold changes in expression (i.e., correlation coefficient between microarray and qRT-PCR datasets: R-2 = 0.8773, p<0.0001). Gene ontology analysis, KEGG pathway mapping and manual annotations of regulated genes indicated that up-regulated genes were mainly involved in immunity/defense, responses to various stimuli, apoptosis/cell death and differentiation, signal transduction and extracellular matrix (ECM), whereas down-regulated genes were mainly encoding general metabolic enzymes, membrane components, and some transporters. Chickens mustered complex cecal eipthelia molecular and immunological responses in response to E. tenella infection, which included pathways involved in cytokine production and interactions, natural killer cell mediated cytotoxicity, and intestinal IgA production. In response to the pathogenesis and damage caused by infection, chicken cecal epithelia reduced general metabolism, DNA replication and repair, protein degradation, and mitochondrial functions.	[Guo, Aijiang; Cai, Jianping; Gong, Wei; Yan, Hongbin; Luo, Xuenong; Tian, Guangfu; Zhang, Shaohua; Cai, Xuepeng] China Acad Agr Sci, State Key Lab Vet Etiol Biol, Lanzhou Inst Vet Res, Lanzhou, Peoples R China; [Zhang, Haili; Zhu, Guan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Zhu, Guan] Zhejiang Univ, Inst Genet, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Texas A&M University System; Texas A&M University College Station; Zhejiang University	Zhu, G (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA.	gzhu@cvm.tamu.edu; caixp@vip.163.com	Zhu, Guan/AFJ-2945-2022; ZHU, GUAN/GQB-0299-2022	Zhu, Guan/0000-0003-3888-0659; ZHU, GUAN/0000-0003-3888-0659	Chinese National Natural Science Fund [30872369]	Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National Natural Science Fund (Grant # 30872369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake DP, 2006, PARASITE IMMUNOL, V28, P305, DOI 10.1111/j.1365-3024.2006.00831.x; Buza TJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S2; CHAPMAN HD, 1994, POULTRY SCI, V73, P1404, DOI 10.3382/ps.0731404; CHAPMAN HD, 1989, RES VET SCI, V47, P125, DOI 10.1016/S0034-5288(18)31243-8; Dalloul RA, 2005, AVIAN DIS, V49, P1, DOI 10.1637/7306-11150R; Dalloul RA, 2007, MOL IMMUNOL, V44, P558, DOI 10.1016/j.molimm.2006.02.004; Denney CF, 1999, INFECT IMMUN, V67, P1547; FERNANDO M A, 1974, International Journal for Parasitology, V4, P267, DOI 10.1016/0020-7519(74)90082-4; FERNANDO MA, 1977, PARASITOLOGY, V74, P19, DOI 10.1017/S0031182000047491; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P259, DOI 10.1016/j.vetimm.2006.08.006; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P209, DOI 10.1016/j.vetimm.2006.07.007; Innes EA, 2006, PARASITOLOGY, V133, pS145, DOI 10.1017/S0031182006001855; JEFFERS TK, 1981, AVIAN DIS, V25, P395, DOI 10.2307/1589931; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Kim CH, 2008, VET IMMUNOL IMMUNOP, V124, P341, DOI 10.1016/j.vetimm.2008.04.013; Kim Chul-Hong, 2011, BMC Proc, V5 Suppl 4, pS12, DOI 10.1186/1753-6561-5-S4-S12; Kim DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027712; Laurent F, 2001, INFECT IMMUN, V69, P2527, DOI 10.1128/IAI.69.4.2527-2534.2001; Laurent F, 1998, FASEB J, V12, pA362; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Lillehoj HS, 2004, POULTRY SCI, V83, P611, DOI 10.1093/ps/83.4.611; Lillehoj HS, 1996, CLIN MICROBIOL REV, V9, P349, DOI 10.1128/CMR.9.3.349; Lillehoj HS, 2000, AVIAN DIS, V44, P408, DOI 10.2307/1592556; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; Lopez-Bernad F, 1998, PARASITOL RES, V84, P132, DOI 10.1007/s004360050369; MATHIS GF, 1982, POULTRY SCI, V61, P38, DOI 10.3382/ps.0610038; Mauzy MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031715; Min W, 2003, APPL MICROBIOL BIOT, V62, P392, DOI 10.1007/s00253-003-1303-x; Min WG, 2005, MOL BIOTECHNOL, V30, P143, DOI 10.1385/MB:30:2:143; Palmgren S, 2002, J CELL SCI, V115, P881; Reinecker HC, 1996, GASTROENTEROLOGY, V111, P1706, DOI 10.1016/S0016-5085(96)70036-7; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SAMPSON JR, 1972, J PARASITOL, V58, P311, DOI 10.2307/3278095; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; STOTISH RL, 1975, J PARASITOL, V61, P700, DOI 10.2307/3279469; Van Immerseel F, 2004, AVIAN DIS, V48, P384, DOI 10.1637/7094; Williams RB, 2002, AVIAN PATHOL, V31, P317, DOI 10.1080/03079450220148988; Yun CH, 2000, INFECT IMMUN, V68, P1282, DOI 10.1128/IAI.68.3.1282-1288.2000; Zhang HL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-647; ZHU G, 1992, J PARASITOL, V78, P1067, DOI 10.2307/3283231	42	26	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64236	10.1371/journal.pone.0064236	http://dx.doi.org/10.1371/journal.pone.0064236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737974	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700038
J	Hong, XQ; Bu, LP; Wang, Y; Xu, J; Wu, J; Huang, YF; Liu, J; Suo, HY; Yang, LM; Shi, YC; Lou, Y; Sun, ZL; Zhu, GQ; Behnisch, T; Yu, M; Jia, JG; Hai, WX; Meng, HP; Liang, S; Huang, F; Zou, YZ; Ge, JB				Hong, Xiaoqi; Bu, Liping; Wang, Yi; Xu, Jing; Wu, Jian; Huang, Yufang; Liu, Jie; Suo, Haiyun; Yang, Lumeng; Shi, Yuncen; Lou, Yi; Sun, Zhengliang; Zhu, Guoqi; Behnisch, Thomas; Yu, Mei; Jia, Jianguo; Hai, Wangxi; Meng, Hongping; Liang, Sheng; Huang, Fang; Zou, Yunzeng; Ge, Junbo			Increases in the Risk of Cognitive Impairment and Alterations of Cerebral beta-amyloid Metabolism in Mouse Model of Heart Failure	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-FLOW; WATER-MAZE; DEMENTIA; MICE; BRAIN; PET; MECHANISMS; INHIBITION	Epidemiological and clinico-pathological studies indicate a causal relationship between heart disease and Alzheimer's disease (AD). To learn whether heart disease causes an onset of AD, mice with myocardial infarction (MI) and congestive heart failure (HF) were used to test neuropsychiatric and cognitive behaviors as well as for measurements of AD related protein markers. To this end, adult mice were subjected to ligation of left anterior descending artery (LAD) and about two weeks later high-frequency echocardiography was performed to exam the resulting cardiac structure and function. Three months after successful induction of chronic heart failure (CHF) these mice showed an impairment of learning in the Morris Water Maze task. In addition, the expression of selected molecules, which are involved in beta-amyloid metabolism, apoptosis and inflammation on the level of gene transcription and translation, was altered in CHF mice. Our findings provide a plausible explanation that CHF increases the risk of cognitive impairments and alters cerebral beta-amyloid metabolism. In addition, our data indicate that the cerebral compensatory mechanisms in response to CHF are brain area and gender specific.	[Hong, Xiaoqi; Wang, Yi; Xu, Jing; Huang, Yufang; Liu, Jie; Suo, Haiyun; Yang, Lumeng; Shi, Yuncen; Lou, Yi; Sun, Zhengliang; Zhu, Guoqi; Behnisch, Thomas; Yu, Mei; Huang, Fang] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Hong, Xiaoqi; Wang, Yi; Xu, Jing; Huang, Yufang; Liu, Jie; Suo, Haiyun; Yang, Lumeng; Shi, Yuncen; Lou, Yi; Sun, Zhengliang; Zhu, Guoqi; Behnisch, Thomas; Yu, Mei; Huang, Fang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Bu, Liping; Wu, Jian; Jia, Jianguo; Zou, Yunzeng; Ge, Junbo] Fudan Univ, Dept Cardiol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Bu, Liping; Wu, Jian; Jia, Jianguo; Zou, Yunzeng; Ge, Junbo] Fudan Univ, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China; [Bu, Liping; Wu, Jian; Jia, Jianguo; Zou, Yunzeng; Ge, Junbo] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Huang, Fang] Fudan Univ, Key Lab Smart Drug Delivery, Minist Educ, Shanghai 200433, Peoples R China; [Huang, Fang] Fudan Univ, PLA, Shanghai 200433, Peoples R China; [Hai, Wangxi] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Meng, Hongping; Liang, Sheng] Shanghai Jiao Tong Univ, Dept Nucl Med, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, F (corresponding author), Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	huangf@shmu.edu.cn; zou.yunzeng@zs-hospital.sh.cn; ge.junbo2@zs-hospital.sh.cn	Behnisch, Thomas/G-3688-2018; SUO, HAIYUN/AAO-3344-2020; Hay, Vincent/AAW-1791-2020	Behnisch, Thomas/0000-0002-7842-3252; Wu, Jian/0000-0003-4259-8322	Ministry of Science and Technology of China [2012CB966300]; National Natural Science Foundation of China [81171188, 31271197, J1210041]; Specialized Research Fund for the Doctoral Program of Higher Education [20110071110039]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Ministry of Science and Technology of China (2012CB966300); the National Natural Science Foundation of China (81171188 and 31271197) to FH and TB, respectively; and the National Natural Science Foundation of China (J1210041) and the Specialized Research Fund for the Doctoral Program of Higher Education (20110071110039) to FH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevic D, 2010, EUR J HEART FAIL, V12, P1282, DOI 10.1093/eurjhf/hfq174; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bian MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039953; Busche MN, 2010, GER MED SCI, V8; Chatterjee K, 2007, J CARD FAIL, V13, P569, DOI 10.1016/j.cardfail.2007.04.006; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; de la Torre JC, 2008, NEURODEGENER DIS, V5, P126, DOI 10.1159/000113681; de la Torre JC, 2006, NEUROL RES, V28, P637, DOI 10.1179/016164106X130362; Alves TCDF, 2006, NEUROL RES, V28, P579, DOI 10.1179/016164106X130416; Alves TCDF, 2010, J ALZHEIMERS DIS, V20, P749, DOI 10.3233/JAD-2010-091561; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Freedland KE, 2003, PSYCHOSOM MED, V65, P119, DOI 10.1097/01.PSY.0000038938.67401.85; Furukawa K, 2010, J NEUROL, V257, P721, DOI 10.1007/s00415-009-5396-8; Grubb N R, 2000, Am Heart J, V140, pE1, DOI 10.1067/mhj.2000.106647; Gruhn N, 2001, STROKE, V32, P2530, DOI 10.1161/hs1101.098360; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jefferson AL, 2011, AM J CARDIOL, V108, P1346, DOI 10.1016/j.amjcard.2011.06.056; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Jeschke E, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-99; Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Langston RF, 2010, BEHAV BRAIN RES, V215, P275, DOI 10.1016/j.bbr.2010.07.006; Laudisio A, 2009, DRUG AGING, V26, P103, DOI 10.2165/0002512-200926020-00002; Lund GK, 2003, RADIOLOGY, V227, P209, DOI 10.1148/radiol.2271012156; Manabe I, 2011, CIRC J, V75, P2739, DOI 10.1253/circj.CJ-11-1184; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Mazza M, 2011, J ALZHEIMERS DIS, V23, P375, DOI 10.3233/JAD-2010-090700; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Polidori MC, 2006, NEUROL RES, V28, P588, DOI 10.1179/016164106X130489; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Qiu CX, 2006, ARCH INTERN MED, V166, P1003, DOI 10.1001/archinte.166.9.1003; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rattinger GB, 2012, AM J GERIATR PHARMAC, V10, P69, DOI 10.1016/j.amjopharm.2011.11.003; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Seok J, 2013, P NATL ACAD SCI US; Shin J, 2010, NEUROIMAGE, V52, P488, DOI 10.1016/j.neuroimage.2010.04.013; Silverman DHS, 2001, MOL GENET METAB, V74, P128, DOI 10.1006/mgme.2001.3236; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Vogels RLC, 2007, J AM GERIATR SOC, V55, P1764, DOI 10.1111/j.1532-5415.2007.01395.x; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; Yu M, 2013, NEUROBIOL AGING, V34, P916, DOI 10.1016/j.neurobiolaging.2012.06.002; Zhang T, 2009, NEUROSCIENCE, V161, P1045, DOI 10.1016/j.neuroscience.2009.04.032; Zuccala G, 1997, J NEUROL NEUROSUR PS, V63, P509, DOI 10.1136/jnnp.63.4.509	49	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63829	10.1371/journal.pone.0063829	http://dx.doi.org/10.1371/journal.pone.0063829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737953	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700016
J	Luttich, A; Brunke, S; Hube, B; Jacobsen, ID				Luettich, Anja; Brunke, Sascha; Hube, Bernhard; Jacobsen, Ilse D.			Serial Passaging of Candida albicans in Systemic Murine Infection Suggests That the Wild Type Strain SC5314 Is Well Adapted to the Murine Kidney	PLOS ONE			English	Article							DRUG-RESISTANCE; EXPERIMENTAL POPULATIONS; FUNGAL PATHOGEN; EVOLUTION; MICE; FLUCONAZOLE; MUTATIONS; MICROEVOLUTION; SUSCEPTIBILITY; EPIDEMIOLOGY	The opportunistic fungal pathogen Candida albicans has a remarkable ability to adapt to unfavorable environments by different mechanisms, including microevolution. For example, a previous study has shown that passaging through the murine spleen can cause new phenotypic characteristics. Since the murine kidney is the main target organ in murine Candida sepsis and infection of the spleen differs from the kidney in several aspects, we tested whether C. albicans SC5314 could evolve to further adapt to infection and persistence within the kidney. Therefore, we performed a long-term serial passage experiment through the murine kidney of using a low infectious dose. We found that the overall virulence of the commonly used wild type strain SC5314 did not change after eight passages and that the isolated pools showed only very moderate changes of phenotypic traits on the population level. Nevertheless, the last passage showed a higher phenotypic variability and a few individual strains exhibited phenotypic alterations suggesting that microevolution has occurred. However, the majority of the tested single strains were phenotypically indistinguishable from SC5314. Thus, our findings indicate that characteristics of SC5314 which are important to establish and maintain kidney infection over a prolonged time are already well developed.	[Luettich, Anja; Brunke, Sascha; Hube, Bernhard; Jacobsen, Ilse D.] Hans Knoell Inst Jena HKI, Dept Microbial Pathogen Mech, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Brunke, Sascha; Hube, Bernhard] Ctr Sepsis Control & Care, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Jacobsen, ID (corresponding author), Hans Knoell Inst Jena HKI, Dept Microbial Pathogen Mech, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.	Ilse.jacobsen@hki-jena.de	Brunke, Sascha/G-1486-2012; Jacobsen, Ilse/B-3155-2011	Brunke, Sascha/0000-0001-7740-4570; Jacobsen, Ilse/0000-0002-6033-9984; Hube, Bernhard/0000-0002-6028-0425	excellence graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft [Hu 528 17-1]	excellence graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	AL was supported by the excellence graduate school Jena School for Microbial Communication (JSMC; www.jsmc.uni-jena.de). BH and AL were also supported by the Deutsche Forschungsgemeinschaft (Hu 528 17-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andes D, 2006, ANTIMICROB AGENTS CH, V50, P2374, DOI 10.1128/AAC.01053-05; Ashman RB, 2008, FRONT BIOSCI-LANDMRK, V13, P3334; Asticcioli S, 2007, NEW MICROBIOL, V30, P303; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Brown DH, 1999, LICHENOLOGIST, V31, P1; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Cheng SJ, 2007, CELL MICROBIOL, V9, P492, DOI 10.1111/j.1462-5822.2006.00805.x; Cowen LE, 2001, J BACTERIOL, V183, P2971, DOI 10.1128/JB.183.10.2971-2978.2001; Cowen LE, 2000, J BACTERIOL, V182, P1515, DOI 10.1128/JB.182.6.1515-1522.2000; DJEU JY, 1990, DIAGN MICR INFEC DIS, V13, P383, DOI 10.1016/0732-8893(90)90007-I; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Eggimann P, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-37; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Ensminger AW, PLOS PATHOG, V8; Forche A, 2009, GENETICS, V182, P799, DOI 10.1534/genetics.109.103325; Franzot SP, 1998, INFECT IMMUN, V66, P89, DOI 10.1128/IAI.66.1.89-97.1998; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Laupland KB, 2005, J ANTIMICROB CHEMOTH, V56, P532, DOI 10.1093/jac/dki258; Levin BR, 2000, GENETICS, V154, P985; Lin Y, 1996, CAN J VET RES, V60, P145; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MacCallum DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006420; Natarajan U, 1998, J MED MICROBIOL, V47, P359, DOI 10.1099/00222615-47-4-359; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; PAPADIMITRIOU JM, 1986, J PATHOL, V150, P257, DOI 10.1002/path.1711500405; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; SCHROPPEL K, 1994, J CLIN MICROBIOL, V32, P2646; Selmecki A, 2010, EUKARYOT CELL, V9, P991, DOI 10.1128/EC.00060-10; Shin JH, 2004, J CLIN MICROBIOL, V42, P4025, DOI 10.1128/JCM.42.9.4025-4031.2004; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Van Enckevort FHJ, 1999, MED MYCOL, V37, P419, DOI 10.1046/j.1365-280X.1999.00247.x; Vonk AG, 2006, EXPERT OPIN BIOL TH, V6, P891, DOI 10.1517/14712598.6.9.891; White T C, 1997, Oral Dis, V3 Suppl 1, pS102; Yan L, 2008, ACTA BIOCH BIOPH SIN, V40, P1048, DOI 10.1111/j.1745-7270.2008.00483.x	44	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64482	10.1371/journal.pone.0064482	http://dx.doi.org/10.1371/journal.pone.0064482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737985	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700050
J	Nicol, C; Cesur, O; Forrest, S; Belyaeva, TA; Bunka, DHJ; Blair, GE; Stonehouse, NJ				Nicol, Clare; Cesur, Oezlem; Forrest, Sophie; Belyaeva, Tamara A.; Bunka, David H. J.; Blair, G. Eric; Stonehouse, Nicola J.			An RNA Aptamer Provides a Novel Approach for the Induction of Apoptosis by Targeting the HPV16 E7 Oncoprotein	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; RETINOBLASTOMA GENE-PRODUCT; CERVICAL-CARCINOMA CELLS; HAMMERHEAD RIBOZYMES; PROTEIN; DNA; E6; POLYMERASE; SELECTION; BINDING	Background: Human papillomavirus 16 (HPV16) is a high-risk DNA tumour virus, which is a major causative agent of cervical cancer. Cellular transformation is associated with deregulated expression of the E6 and E7 oncogenes. E7 has been shown to bind a number of cellular proteins, including the cell cycle control protein pRb. In this study, RNA aptamers (small, single-stranded oligonucleotides selected for high-affinity binding) to HPV16 E7 were employed as molecular tools to further investigate these protein-protein interactions. Methodology/Principal Findings: This study is focused on one aptamer (termed A2). Transfection of this molecule into HPV16-transformed cells resulted in inhibition of cell proliferation (shown using real-time cell electronic sensing and MTT assays) due to the induction of apoptosis (as demonstrated by Annexin V/propidium iodide staining). GST-pull down and bead binding assays were used to demonstrate that the binding of A2 required N-terminal residues of E7 known to be involved in interaction with the cell cycle control protein, pRb. Using a similar approach, A2 was shown to disrupt the interaction between E7 and pRb in vitro. Furthermore, transfection of HPV16-transformed cells with A2 appeared to result in the loss of E7 and rise in pRb levels, as observed by immunoblotting. Conclusions/Significance: This paper includes the first characterisation of the effects of an E7 RNA aptamer in a cell line derived from a cervical carcinoma. Transfection of cells with A2 was correlated with the loss of E7 and the induction of apoptosis. Aptamers specific for a number of cellular and viral proteins have been documented previously; one aptamer (Macugen) is approved for clinical use and several others are in clinical trials. In addition to its role as a molecular tool, A2 could have further applications in the future.	[Stonehouse, Nicola J.] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England; Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Stonehouse, NJ (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England.	n.j.stonehouse@leeds.ac.uk	Blair, George Eric/A-5906-2008	Blair, George Eric/0000-0003-0440-1795; Stonehouse, Nicola/0000-0003-1146-5519	Yorkshire Cancer Research [L333]; BBSRC	Yorkshire Cancer Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly supported by Yorkshire Cancer Research (L333) (http://www.yorkshirecancerresearch.org.uk/) and by a BBSRC studentship to CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; AUERSPERG N, 1964, J NATL CANCER I, V32, P135; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; BEIGELMAN L, 1995, J BIOL CHEM, V270, P25702, DOI 10.1074/jbc.270.43.25702; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernat A, 2003, ONCOGENE, V22, P7871, DOI 10.1038/sj.onc.1206896; Biroccio A, 2002, J VIROL, V76, P3688, DOI 10.1128/JVI.76.8.3688-3696.2002; Blank M, 2005, CURR OPIN CHEM BIOL, V9, P336, DOI 10.1016/j.cbpa.2005.06.011; Bottley G, 2008, ONCOGENE, V27, P1794, DOI 10.1038/sj.onc.1210798; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourgo RJ, 2009, MOL CARCINOGEN, V48, P45, DOI 10.1002/mc.20456; Boyd JM, 2008, ANAL CHIM ACTA, V615, P80, DOI 10.1016/j.aca.2008.03.047; Boyer SN, 1996, CANCER RES, V56, P4620; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Bunka DHJ, 2010, CURR OPIN PHARMACOL, V10, P557, DOI 10.1016/j.coph.2010.06.009; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Cheng CS, 2008, BIOCHEM BIOPH RES CO, V366, P670, DOI 10.1016/j.bbrc.2007.11.183; COULDWELL WT, 1994, FEBS LETT, V345, P43, DOI 10.1016/0014-5793(94)00415-3; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; EDMONDS C, 1989, J VIROL, V63, P2650, DOI 10.1128/JVI.63.6.2650-2656.1989; Ellingham M, 2006, RNA, V12, P1970, DOI 10.1261/rna.161006; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; Fukuda K, 2004, BIOCHEM BIOPH RES CO, V325, P670, DOI 10.1016/j.bbrc.2004.10.089; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; GEY GO, 1952, CANCER RES, V12, P264; Gopinath SCB, 2007, ARCH VIROL, V152, P2137, DOI 10.1007/s00705-007-1014-1; Guo CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017734; Guo CP, 2011, APOPTOSIS, V16, P606, DOI 10.1007/s10495-011-0594-0; He XY, 2009, J MICROBIOL METH, V78, P97, DOI 10.1016/j.mimet.2009.04.007; James W, 2007, J GEN VIROL, V88, P351, DOI 10.1099/vir.0.82442-0; Jang KJ, 2008, BIOCHEM BIOPH RES CO, V366, P738, DOI 10.1016/j.bbrc.2007.12.020; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; JONES RE, 1990, J BIOL CHEM, V265, P12782; Kirstein SL, 2006, ASSAY DRUG DEV TECHN, V4, P545, DOI 10.1089/adt.2006.4.545; LECHNER MS, 1994, J VIROL, V68, P4262, DOI 10.1128/JVI.68.7.4262-4273.1994; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Massimi P, 1997, J GEN VIROL, V78, P2607, DOI 10.1099/0022-1317-78-10-2607; Mayer G, 2009, ANGEW CHEM INT EDIT, V48, P2672, DOI 10.1002/anie.200804643; MINCHEVA A, 1987, MED MICROBIOL IMMUN, V176, P245, DOI 10.1007/bf00190531; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Nauenburg S, 2001, FASEB J, V15, P592; Ni X, 2011, CURR MED CHEM, V18, P4206, DOI 10.2174/092986711797189600; Nicol C, 2011, BIOCHEM BIOPH RES CO, V405, P417, DOI 10.1016/j.bbrc.2011.01.044; Oh KJ, 2004, J VIROL, V78, P5338, DOI 10.1128/JVI.78.10.5338-5346.2004; Ohlenschlager O, 2006, ONCOGENE, V25, P5953, DOI 10.1038/sj.onc.1209584; Padilla R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf138; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Robinson MA, 2006, NUCLEIC ACIDS RES, V34, P2698, DOI 10.1093/nar/gkl318; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Toscano-Garibay JD, 2011, ARCH MED RES, V42, P88, DOI 10.1016/j.arcmed.2011.02.005; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Xing JZ, 2006, TOXICOL IN VITRO, V20, P995, DOI 10.1016/j.tiv.2005.12.008; Yamato K, 2008, CANCER GENE THER, V15, P140, DOI 10.1038/sj.cgt.7701118; YEE C, 1985, AM J PATHOL, V119, P361; Yu SL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3803; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	69	24	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64781	10.1371/journal.pone.0064781	http://dx.doi.org/10.1371/journal.pone.0064781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738000	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700062
J	Starzynski, RR; Laarakkers, CMM; Tjalsma, H; Swinkels, DW; Pieszka, M; Stys, A; Mickiewicz, M; Lipinski, P				Starzynski, Rafal R.; Laarakkers, Coby M. M.; Tjalsma, Harold; Swinkels, Dorine W.; Pieszka, Marek; Stys, Agnieszka; Mickiewicz, Michal; Lipinski, Pawel			Iron Supplementation in Suckling Piglets: How to Correct Iron Deficiency Anemia without Affecting Plasma Hepcidin Levels	PLOS ONE			English	Article							DEXTRAN; HEMOGLOBIN; HEMATOLOGY; EXPRESSION	The aim of the study was to establish an optimized protocol of iron dextran administration to pig neonates, which better meets the iron demand for erythropoiesis. Here, we monitored development of red blood cell indices, plasma iron parameters during a 28-day period after birth (till the weaning), following intramuscular administration of different concentrations of iron dextran to suckling piglets. To better assess the iron status we developed a novel mass spectrometry assay to quantify pig plasma levels of the iron-regulatory peptide hormone hepcidin-25. This hormone is predominantly secreted by the liver and acts as a negative regulator of iron absorption and reutilization. The routinely used protocol with high amount of iron resulted in the recovery of piglets from iron deficiency but also in strongly elevated plasma hepcidin-25 levels. A similar protocol with reduced amounts of iron improved hematological status of piglets to the same level while plasma hepcidin-25 levels remained low. These data show that plasma hepcidin-25 levels can guide optimal dosing of iron treatment and pave the way for mixed supplementation of piglets starting with intramuscular injection of iron dextran followed by dietary supplementation, which could be efficient under condition of very low plasma hepcidin-25 level.	[Starzynski, Rafal R.; Stys, Agnieszka; Lipinski, Pawel] Inst Genet & Anim Breeding, Jastrzebiec, Poland; [Laarakkers, Coby M. M.; Tjalsma, Harold; Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med LGEM 830, NL-6525 ED Nijmegen, Netherlands; [Laarakkers, Coby M. M.; Tjalsma, Harold; Swinkels, Dorine W.] Hepcidinanalysis Com, Nijmegen, Netherlands; [Pieszka, Marek] Natl Res Inst Anim Prod, Balice, Poland; [Mickiewicz, Michal] Mifarmex Ltd, Michalow Grabina, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Radboud University Nijmegen; National Research Institute of Animal Production	Lipinski, P (corresponding author), Inst Genet & Anim Breeding, Jastrzebiec, Poland.	p.lipinski@ighz.pl	Swinkels, Dorine W./H-8098-2014	Swinkels, Dorine W./0000-0002-1040-9446; , Rafal/0000-0002-7470-0507	National Science Centre [2012/05/E/NZ5/02126]; Mifarmex Ltd	National Science Centre(National Science Centre, Poland); Mifarmex Ltd	This work was supported by The National Science Centre grant No 2012/05/E/NZ5/02126 (http://www.ncn.gov.pl/) and Mifarmex Ltd (http://mifarmex.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beaumont C, 2010, HAEMATOL-HEMATOL J, V95, P1233, DOI 10.3324/haematol.2010.025585; Blachier F, 2007, CAN J PHYSIOL PHARM, V85, P185, DOI 10.1139/Y07-007; Clark SF, 2009, CURR OPIN GASTROEN, V25, P122, DOI 10.1097/MOG.0b013e32831ef1cd; Collard KJ, 2009, PEDIATRICS, V123, P1208, DOI 10.1542/peds.2008-1047; COOK JD, 1994, ADV EXP MED BIOL, V356, P219; Csapo J, 1996, INT DAIRY J, V6, P881, DOI 10.1016/0958-6946(95)00072-0; Egeli AK, 1999, RES VET SCI, V66, P179, DOI 10.1053/rvsc.1998.0223; Egeli AK, 1998, J VET MED A, V45, P53, DOI 10.1111/j.1439-0442.1998.tb00800.x; Egeli AK, 1998, ACTA VET SCAND, V39, P381; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; GEISSER P, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1439; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kleinbeck SN, 1999, J ANIM SCI, V77, P2384; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Lipinski P, 2013, CELL MOL LIFE SCI, V70, P23, DOI 10.1007/s00018-012-1018-1; Lipinski P, 2010, AM J PATHOL, V177, P1233, DOI 10.2353/ajpath.2010.091020; Maes D, 2011, VET REC, V168, P188, DOI 10.1136/vr.c7033; MILLER ER, 1961, J ANIM SCI, V20, P890, DOI 10.2527/jas1961.204890x; Rincker MJ, 2005, J ANIM SCI, V83, P2137; Svoboda M., 2005, Folia Veterinaria, V49, P104; Svoboda M, 2007, ACTA VET BRNO, V76, pS11, DOI 10.2754/avb200776S8S011; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Szabo P, 2002, J VET MED A, V49, P390, DOI 10.1046/j.1439-0442.2002.00448.x; Tjalsma H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016762; VENN JAJ, 1947, J COMP PATHOL THERAP, V57, P314, DOI 10.1016/S0368-1742(47)80037-2; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012	29	45	45	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64022	10.1371/journal.pone.0064022	http://dx.doi.org/10.1371/journal.pone.0064022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737963	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700027
J	Tong, R; Shen, LP; Yin, WJ; Zhou, WM; Lu, J; Zheng, MQ; Bi, SL; Lou, YL; Tan, WJ				Tong, Rui; Shen, Liping; Yin, Wenjiao; Zhou, Weimin; Lu, Jian; Zheng, Meiqin; Bi, Shengli; Lou, Yongliang; Tan, Wenjie			Prevalence of Human Parvovirus B19, Bocavirus, and PARV4 in Blood Samples from the General Population of China and Lack of a Correlation between Parvovirus and Hepatitis B Co-Infection	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; FREQUENT DETECTION; CHILDREN; TRANSMISSION; PARTICLES; VIRUSES; PLASMA; DNA	Few comprehensive studies have investigated viraemia caused by human parvoviruses (HPAVs) in China. A total of 1626 of blood samples were collected from non-HBV and HBV infected Chinese subjects (adults, N = 1279; children, N = 347) from south-western and south-eastern China. DNA from three HPAVs was detected in blood samples using PCR-based assays. The epidemiological profiles and association with HBV co-infection were also analysed. Of the 1626 blood samples tested, 138 (8.49%) were found to exhibit HPAV viraemia, including 3.51% with B19, 3.75% with HBoV and 2.52% with PARV4. The presence of B19 DNA in both child and adult, as well as that of PARV4 DNA in adult, from the south-western region was significantly higher than that from the south-eastern region (P = 0.006 for B19 in children; P = 0.026 for B19 in adults; and P = 0.014 for PARV4 in adult). However, the frequency of HBoV DNA in adults from the south-western region was significantly lower than that observed in adults from the south-eastern region (P = 0.001). Furthermore, HBoV was more prevalence in male (4.9%) than in female (1.4%) individuals. In addition, no significant correlation between HBV and HPAV co-infection was found using serum samples from Chinese adults. In conclusions, the molecular prevalence of three HPAVs in blood samples exhibited variation among different populations depending on area, age and gender; No association between HPAV and HBV infection in adults was found. Our data provide a basis for improving blood safety and preventing HPAV infection in China.	[Tong, Rui; Lou, Yongliang; Tan, Wenjie] Wenzhou Med Coll, Inst Med Virol, Hangzhou, Zhejiang, Peoples R China; [Tong, Rui; Shen, Liping; Yin, Wenjiao; Zhou, Weimin; Lu, Jian; Bi, Shengli; Tan, Wenjie] China CDC, Key Lab Med Virol, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zheng, Meiqin] Wenzhou Med Coll, Hosp Eye, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Wenzhou Medical University	Lou, YL (corresponding author), Wenzhou Med Coll, Inst Med Virol, Hangzhou, Zhejiang, Peoples R China.	lyl@wzmc.edu.cn; tanwj28@yahoo.cn		Bi, Shengli/0000-0002-0380-5790	State Megaproject for Infectious Disease Research of China [2011ZX10004-001, 2013ZX10004601]; National 863 Project of China [2007AA02Z464]	State Megaproject for Infectious Disease Research of China; National 863 Project of China	This work was supported by grants from the State Megaproject for Infectious Disease Research of China (2011ZX10004-001; 2013ZX10004601) and National 863 Project of China (2007AA02Z464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Kenji, 2007, Int J Med Sci, V4, P105; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Botto S, 2009, NEW MICROBIOL, V32, P189; Brown KE, 2010, REV MED VIROL, V20, P231, DOI 10.1002/rmv.648; COSSART YE, 1975, LANCET, V1, P72; Doyle S, 2011, METHODS MOL BIOL, V665, P213, DOI 10.1007/978-1-60761-817-1_13; Fauquet CM, 2005, 8 REPORT INT COMM TA, P353; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Karalar L, 2010, CLIN MICROBIOL INFEC, V16, P633, DOI 10.1111/j.1469-0691.2009.02889.x; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Lin F, 2008, J VIROL METHODS, V149, P110, DOI 10.1016/j.jviromet.2007.12.016; Ma YY, 2012, VOX SANG, V103, P183, DOI 10.1111/j.1423-0410.2012.01605.x; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Manning A, 2007, J INFECT DIS, V195, P1345, DOI 10.1086/513280; Norja P, 2012, BRIT J HAEMATOL, V159, P385, DOI 10.1111/bjh.12060; Opaleye OO, 2011, J MED VIROL, V83, P710, DOI 10.1002/jmv.22008; Panning M, 2010, EMERG INFECT DIS, V16, P1143, DOI 10.3201/eid1607.100025; Parsyan A, 2007, TRANSFUSION MED, V17, P263, DOI 10.1111/j.1365-3148.2007.00765.x; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Simmonds P, 2007, EMERG INFECT DIS, V13, P1386, DOI 10.3201/eid1309.070428; Simmons R, 2012, J INFECT DIS, V205, P1816, DOI 10.1093/infdis/jis291; Toan NL, 2006, J HEPATOL, V45, P361, DOI 10.1016/j.jhep.2006.03.013; Touinssi M, 2010, EMERG INFECT DIS, V16, P165, DOI 10.3201/eid1601.090517; Tozer SJ, 2009, J MED VIROL, V81, P488, DOI 10.1002/jmv.21409; Weissbrich B, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-109; Yu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029474	30	10	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64391	10.1371/journal.pone.0064391	http://dx.doi.org/10.1371/journal.pone.0064391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737981	gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700046
J	van Loenen, MM; Hagedoorn, RS; de Boer, R; Falkenburg, JHF; Heemskerk, MHM				van Loenen, Marleen M.; Hagedoorn, Renate S.; de Boer, Renate; Falkenburg, J. H. Frederik; Heemskerk, Mirjam H. M.			Extracellular Domains of CD8 alpha and CD8ss Subunits Are Sufficient for HLA Class I Restricted Helper Functions of TCR-Engineered CD4(+) T Cells	PLOS ONE			English	Article							DONOR LEUKOCYTE INFUSIONS; TYROSINE KINASE P56LCK; RECEPTOR GENE-TRANSFER; CORECEPTOR FUNCTION; MARROW-TRANSPLANTATION; ANTITUMOR REACTIVITY; CANCER REGRESSION; LYMPHOCYTES; EXPRESSION; CD8(+)	T-cells as well as helper T-cells can be generated. Since most HLA-I-TCRs function best in the presence of the CD8 coreceptor, the CD8 alpha ss molecule has to be co-transferred into the CD4(+) T-cells to engineer optimal helper T-cells. In this study, we set out to determine the minimal part of CD8 alpha beta needed for optimal co-receptor function in HLA-I-TCR transduced CD4(+) T-cells. For this purpose, we transduced human peripheral blood derived CD4(+) T-cells with several HLA-class I restricted TCRs either with or without co-transfer of different CD8 subunits. We demonstrate that the co-transduced CD8ab coreceptor in HLA-I-TCR transduced CD4(+) T-cells behaves as an adhesion molecule, since for optimal antigen-specific HLA class I restricted CD4(+) T-cell reactivity the extracellular domains of the CD8 alpha and ss subunits are sufficient.	[van Loenen, Marleen M.; Hagedoorn, Renate S.; de Boer, Renate; Falkenburg, J. H. Frederik; Heemskerk, Mirjam H. M.] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Loenen, MM (corresponding author), Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands.	m.m.van_loenen@lumc.nl	Heemskerk, Mirjam H.M./ABI-2336-2020	Heemskerk, Mirjam H.M./0000-0001-6320-9133	Dutch Cancer Society [NKB 2007-3927]; ZonMw [ZonMw 433.00.001]	Dutch Cancer Society(KWF Kankerbestrijding); ZonMw(Netherlands Organization for Health Research and Development)	This work was supported by the Dutch Cancer Society (NKB 2007-3927) and ZonMw (grant ZonMw 433.00.001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Amir AL, 2011, CLIN CANCER RES, V17, P5615, DOI 10.1158/1078-0432.CCR-11-1066; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BAUME DM, 1990, CELL IMMUNOL, V131, P352, DOI 10.1016/0008-8749(90)90260-X; Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Burrows SR, 2000, J IMMUNOL, V165, P6229, DOI 10.4049/jimmunol.165.11.6229; Clay TM, 1999, J IMMUNOL, V163, P507; Collins RH, 1997, J CLIN ONCOL, V15, P433, DOI 10.1200/JCO.1997.15.2.433; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; FUNGLEUNG WP, 1993, EUR J IMMUNOL, V23, P2834, DOI 10.1002/eji.1830231117; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; IRIE HY, 1995, J EXP MED, V181, P1267, DOI 10.1084/jem.181.4.1267; ITANO A, 1994, IMMUNITY, V1, P287, DOI 10.1016/1074-7613(94)90080-9; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kessels HWHG, 2006, J IMMUNOL, V177, P976, DOI 10.4049/jimmunol.177.2.976; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; KOLB HJ, 1990, BLOOD, V76, P2462, DOI 10.1182/blood.V76.12.2462.2462; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; McKinney DM, 1999, J IMMUNOL, V163, P861; McNicol AM, 2007, EUR J IMMUNOL, V37, P1634, DOI 10.1002/eji.200636900; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Porter DL, 2000, BLOOD, V95, P1214; Renard V, 1996, J EXP MED, V184, P2439, DOI 10.1084/jem.184.6.2439; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; Scholten KBJ, 2006, CLIN IMMUNOL, V119, P135, DOI 10.1016/j.clim.2005.12.009; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; van Loenen MM, 2011, HAEMATOL-HEMATOL J, V96, P477, DOI 10.3324/haematol.2010.025916; van Loenen MM, 2009, CANCER RES, V69, P2034, DOI 10.1158/0008-5472.CAN-08-2523; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; Witte T, 1999, CELL IMMUNOL, V191, P90, DOI 10.1006/cimm.1998.1412; ZAMOYSKA R, 1994, IMMUNITY, V1, P243, DOI 10.1016/1074-7613(94)90075-2; Zandvliet ML, 2011, J IMMUNOTHER, V34, P307, DOI 10.1097/CJI.0b013e318213cb90	46	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e65212	10.1371/journal.pone.0065212	http://dx.doi.org/10.1371/journal.pone.0065212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738014	gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700075
J	Stephenson, R; Finneran, C				Stephenson, Rob; Finneran, Catherine			The IPV-GBM Scale: A New Scale to Measure Intimate Partner Violence among Gay and Bisexual Men	PLOS ONE			English	Article							PROBABILITY-BASED SAMPLE; SAME-SEX; HEALTH OUTCOMES; URBAN MEN; YOUNG MEN; RISK; ABUSE; VICTIMIZATION; BEHAVIORS; CONFLICT	Objectives: The paper describes the creation of a new scale to measure intimate partner violence (IPV) among gay and bisexual men. Methods: Seven focus group discussions were held with gay and bisexual men, focusing on defining intimate partner violence: 30 forms of IPV were identified. A venue-recruited sample of 912 gay and bisexual men was surveyed, examining definitional understanding and recent experiences of each of the 30 forms of IPV. Participants were also asked questions from the CDC definition of intimate partner violence and the short-form of the Conflicts Tactics Scale (CTS2S). Factor analysis of responses to the definitional questions was used to create the IPV-GBM scale, and the prevalence of intimate partner violence was compared with that identified by the CDC and CTS2S measures of intimate partner violence. Results: A 23-item scale, with 5 unique domains, was created, with strong internal reliability (Cronbach Alpha > .90). The IPV-GBM scale mirrored both the CDC and CTS2S definitions of intimate partner violence, but contained additional domains such as controlling violence, monitoring behaviors, emotional violence, and HIV-related violence. The new scale identified a significantly higher prevalence of IPV than either of the more commonly used measures. Conclusions: The results presented here provide encouraging evidence for a new, more accurate measure of intimate partner violence among gay and bisexual men in the U.S.	[Stephenson, Rob; Finneran, Catherine] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Finneran, C (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	cafinne@emory.edu			Eunice Kennedy Shriver National Insitute of Child Health & Human Development [5R21HD066306-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Insitute of Child Health & Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This original research was supported by funding from the Eunice Kennedy Shriver National Insitute of Child Health & Human Development, grant #5R21HD066306-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsam KF, 2005, J CONSULT CLIN PSYCH, V73, P477, DOI 10.1037/0022-006X.73.3.477; Bimbi D. S., 2008, J LGBT HLTH RES, V3, P1, DOI DOI 10.1300/J463V03N02_01; Blosnich JR, 2009, AM J PUBLIC HEALTH, V99, P2182, DOI 10.2105/AJPH.2008.139535; Bonomi AE, 2006, INJURY PREV, V12, P121, DOI 10.1136/ip.2005.009563; Conron KJ, 2010, AM J PUBLIC HLTH AJP; Craft SM, 2005, J INTERPERS VIOLENCE, V20, P777, DOI 10.1177/0886260505277101; DAHLSTROM WG, 1990, J PERS ASSESS, V55, P224, DOI 10.1207/s15327752jpa5501&2_22; Feldman Matthew B, 2007, J LGBT Health Res, V3, P9, DOI 10.1300/J463v03n02_02; Finneran C, TRAUMA VIOL IN PRESS; Friedman MS, 2008, AIDS BEHAV, V12, P891, DOI 10.1007/s10461-007-9319-3; Ghanem A, 2011, AIDS BEHAV, P1; Greenwood GL, 2002, AM J PUBLIC HEALTH, V92, P1964, DOI 10.2105/AJPH.92.12.1964; Houston E, 2007, J URBAN HEALTH, V84, P681, DOI 10.1007/s11524-007-9188-0; KALICHMAN SC, 1995, J SEX RES, V32, P45, DOI 10.1080/00224499509551773; Kalichman SC, 2001, J SEX RES, V38, P1, DOI 10.1080/00224490109552065; Klitzman RL, 2000, AM J PSYCHIAT, V157, P1162, DOI 10.1176/appi.ajp.157.7.1162; Koblin BA, 2006, AIDS CARE, V18, P961, DOI 10.1080/09540120500467182; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; Messinger AM, 2011, J INTERPERS VIOLENCE, V26, P2228, DOI 10.1177/0886260510383023; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Murray CE, 2009, J HOMOSEXUAL, V56, P361, DOI 10.1080/00918360902728848; Nieves-Rosa L. E., 2000, Journal of Gay & Lesbian Social Services, V11, P77, DOI 10.1300/J041v11n01_04; Pantalone D. W., 2011, AIDS BEHAV, P1; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Relf M V, 2001, J Assoc Nurses AIDS Care, V12, P41, DOI 10.1016/S1055-3290(06)60143-X; Relf MV, 2004, J ASSOC NURSE AIDS C, V15, P14, DOI 10.1177/1055329003261965; Rhodes SD, 2009, J HOMOSEXUAL, V56, P1083, DOI 10.1080/00918360903275500; Saltzman L. E., 2002, INTIMATE PARTNER VIO; Skogan WG, 1981, ISSUES MEASUREMENT V; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Stephenson R, 2011, WEST J EMERG MED, V12, P343; Stephenson R, 2011, WEST J EMERG MED, V12, P324; Stephenson R, 2010, WEST J EMERG MED, V11, P242; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Straus Murray A, 2004, Violence Vict, V19, P507; Tjaden P, 1999, Violence Vict, V14, P413; Welles S. L., 2010, J COMMUNITY HLTH, P1	38	79	80	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e62592	10.1371/journal.pone.0062592	http://dx.doi.org/10.1371/journal.pone.0062592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755098	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400003
J	Keane, BP; Lu, HJ; Papathomas, TV; Silverstein, SM; Kellman, PJ				Keane, Brian P.; Lu, Hongjing; Papathomas, Thomas V.; Silverstein, Steven M.; Kellman, Philip J.			Reinterpreting Behavioral Receptive Fields: Lightness Induction Alters Visually Completed Shape	PLOS ONE			English	Article							ILLUSORY CONTOUR; CLASSIFICATION IMAGES; BRIGHTNESS; TRANSPARENCY; PERCEPTION; MECHANISMS; CONTRAST; POLARITY	Background: A classification image (CI) technique has shown that static luminance noise near visually completed contours affects the discrimination of fat and thin Kanizsa shapes. These influential noise regions were proposed to reveal "behavioral receptive fields'' of completed contours-the same regions to which early cortical cells respond in neurophysiological studies of contour completion. Here, we hypothesized that 1) influential noise regions correspond to the surfaces that distinguish fat and thin shapes (hereafter, key regions); and 2) key region noise biases a "fat'' response to the extent that its contrast polarity (lighter or darker than background) matches the shape's filled-in surface color. Results: To test our hypothesis, we had observers discriminate fat and thin noise-embedded rectangles that were defined by either illusory or luminance-defined contours (Experiment 1). Surrounding elements ("inducers'') caused the shapes to appear either lighter or darker than the background-a process sometimes referred to as lightness induction. For both illusory and luminance-defined rectangles, key region noise biased a fat response to the extent that its contrast polarity (light or dark) matched the induced surface color. When lightness induction was minimized, luminance noise had no consistent influence on shape discrimination. This pattern arose when pixels immediately adjacent to the discriminated boundaries were excluded from the analysis (Experiment 2) and also when the noise was restricted to the key regions so that the noise never overlapped with the physically visible edges (Experiment 3). The lightness effects did not occur in the absence of enclosing boundaries (Experiment 4). Conclusions: Under noisy conditions, lightness induction alters visually completed shape. Moreover, behavioral receptive fields derived in CI studies do not correspond to contours per se but to filled-in surface regions contained by those contours. The relevance of lightness to two-dimensional shape completion supplies a new constraint for models of object perception.	[Keane, Brian P.; Papathomas, Thomas V.] Rutgers State Univ, Ctr Cognit Sci, Piscataway, NJ 08855 USA; [Keane, Brian P.; Silverstein, Steven M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ 08854 USA; [Keane, Brian P.; Silverstein, Steven M.] Univ Med & Dent New Jersey, Univ Behav HealthCare, Piscataway, NJ 08854 USA; [Keane, Brian P.; Lu, Hongjing; Kellman, Philip J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Papathomas, Thomas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California Los Angeles; Rutgers State University New Brunswick	Keane, BP (corresponding author), Rutgers State Univ, Ctr Cognit Sci, Piscataway, NJ 08855 USA.	Brian.Keane@gmail.com		Keane, Brian/0000-0002-7011-3380; Silverstein, Steven/0000-0002-0699-0960	UCLA Dissertation Year Fellowship; NIMH National Research Service Award [F32MH094102];  [NSF BCS-0843880]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH094102] Funding Source: NIH RePORTER	UCLA Dissertation Year Fellowship; NIMH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a UCLA Dissertation Year Fellowship and NIMH National Research Service Award (F32MH094102) to BPK, and also by a grant award (NSF BCS-0843880) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Ahumada AJ, 1996, PERCEPTION, V25, P18; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bressan P, 2006, PSYCHOL REV, V113, P526, DOI 10.1037/0033-295X.113.3.526; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Dillenburger B, 2010, J NEUROPHYSIOL, V103, P55, DOI 10.1152/jn.00001.2009; Field DJ, 2000, SPATIAL VISION, V13, P51, DOI 10.1163/156856800741018; Gold JM, 2006, J VISION, V6, P356, DOI 10.1167/6.4.5; Gold JM, 2000, CURR BIOL, V10, P663, DOI 10.1016/S0960-9822(00)00523-6; Green DM, 1966, SIGNAL DETECTION THE; Grossberg S, 2005, VISION RES, V45, P1725, DOI 10.1016/j.visres.2005.01.006; Heitger F, 1998, IMAGE VISION COMPUT, V16, P407, DOI 10.1016/S0262-8856(97)00083-8; HERSHBERGER W, 1984, PERCEPT PSYCHOPHYS, V36, P92, DOI 10.3758/BF03206358; KEANE BP, 2007, J VISION, V7, P603; Keane BP, 2007, VISION RES, V47, P3460, DOI 10.1016/j.visres.2007.10.003; Keane BP, 2012, COGNITION, V123, P404, DOI 10.1016/j.cognition.2012.02.004; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Matthews N, 1997, PERCEPTION, V26, P1431, DOI 10.1068/p261431; Murray RF, 2005, J VISION, V5, P139, DOI 10.1167/5.2.5; Murray RF, 2011, J VISION, V11, DOI 10.1167/11.5.2; Nagai M, 2008, J VISION, V8, DOI 10.1167/8.7.25; Palmer EM, 2006, J EXP PSYCHOL GEN, V135, P513, DOI 10.1037/0096-3445.135.4.513; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pereverzeva M, 2009, J VISION, V9, DOI 10.1167/9.2.19; Pillow J, 2002, NEURON, V33, P805, DOI 10.1016/S0896-6273(02)00605-0; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Ringach DL, 1996, VISION RES, V36, P3037, DOI 10.1016/0042-6989(96)00062-4; Rossi AF, 1996, VISION RES, V36, P1391, DOI 10.1016/0042-6989(95)00206-5; TAKEICHI H, 1992, PERCEPTION, V21, P313, DOI 10.1068/p210313; TJAN BS, 1995, VISION RES, V35, P3053, DOI 10.1016/0042-6989(95)00070-G; Tse PU, 2005, VISION RES, V45, P1095, DOI 10.1016/j.visres.2004.11.001; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Williams LR, 1997, NEURAL COMPUT, V9, P837, DOI 10.1162/neco.1997.9.4.837; Zhou JW, 2008, J VISION, V8, DOI 10.1167/8.12.2	35	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e62505	10.1371/journal.pone.0062505	http://dx.doi.org/10.1371/journal.pone.0062505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IE	23750200	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900002
J	Ma, J; Xue, Y; Liu, WC; Yue, CX; Bi, F; Xu, JQ; Zhang, J; Li, Y; Zhong, CP; Chen, Y				Ma, Ji; Xue, Yan; Liu, Wenchao; Yue, Caixia; Bi, Feng; Xu, Junqing; Zhang, Jian; Li, Yan; Zhong, Cuiping; Chen, Yan			Role of Activated Rac1/Cdc42 in Mediating Endothelial Cell Proliferation and Tumor Angiogenesis in Breast Cancer	PLOS ONE			English	Article							RHO-GTPASES; IN-VITRO; RAC1; P53; INHIBITION; EXPRESSION; CDC42; DEGRADATION; SUPPRESSOR; BIOMARKERS	Angiogenesis is a well-established target in anti-cancer therapy. Although vascular endothelial growth factor (VEGF)mediated angiogenesis apparently requires the Rho GTPases Rac1 and Cdc42, the relevant mechanisms are unclear. Here, we determined that activated Rac1/Cdc42 in MCF-7 breast cancer cells could decrease p53 protein levels and increase VEGF secretion to promote proliferation and tube formation of human umbilical vein endothelial cells (HUVECs). However, these effects are reversed after ubiquitin-proteasome breakage. In exploring potential mechanisms for this relationship, we confirmed that activated Rac1/Cdc42 could enhance p53 protein ubiquitination and weaken p53 protein stability to increase VEGF expression. Furthermore, in a xenograft model using nude mice that stably express active Rac1/Cdc42 protein, active Rac1/Cdc42 decreased p53 levels and increased VEGF expression. Additionally, tumor angiogenesis was inhibited, and p53 protein levels were augmented, by intratumoral injection of the ubiquitin-proteasome inhibitor MG132. Finally in 339 human breast cancer tissues, our analyses indicated that Rac1/Cdc42 expression was related to advanced TNM staging, high proliferation index, ER status, and positive invasive features. In particular, our data suggests that high Rac1/Cdc42 expression is correlated with low wt-p53 and high VEGF expression. We conclude that activated Rac1/Cdc42 is a vascular regulator of tumor angiogenesis and that it may reduce stability of the p53 protein to promote VEGF expression by enhancing p53 protein ubiquitin.	[Ma, Ji; Xue, Yan; Liu, Wenchao; Chen, Yan] Fourth Mil Med Univ, Xijing Hosp, Dept Oncol, Xian 710032, Shannxi, Peoples R China; [Ma, Ji] Peoples Liberat Army, Lanzhou Gen Hosp, Dept Breast Surg, Lanzhou, Gansu, Peoples R China; [Yue, Caixia; Bi, Feng] Sichuan Univ, West China Hosp, Lab Signal Transduct & Mol Targeted Therapy, Chengdu 610064, Sichuan, Peoples R China; [Xu, Junqing] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Shannxi, Peoples R China; [Zhang, Jian; Li, Yan] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Shannxi, Peoples R China; [Zhong, Cuiping] Peoples Liberat Army, Lanzhou Gen Hosp, Dept Ear Nose Throat Surg, Lanzhou, Gansu, Peoples R China	Air Force Military Medical University; Sichuan University; Air Force Military Medical University; Air Force Military Medical University	Xue, Y (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Oncol, Xian 710032, Shannxi, Peoples R China.	xueyan2011@yahoo.com.cn	Li, Yan/A-7115-2018; Li, Yan/AAA-6908-2021	Li, Yan/0000-0002-7465-7705; Li, Yan/0000-0002-7465-7705; Li, Yan/0000-0003-0096-0813	National Natural Science Foundation of China [81202085, 81201209, 30770823]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (nos. 81202085, 81201209 and 30770823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang C, 2010, CAN J NEUROL SCI, V37, P625, DOI 10.1017/S0317167100010805; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bijman MNA, 2006, MOL CANCER THER, V5, P2348, DOI 10.1158/1535-7163.MCT-06-0242; Bond M, 2008, CARDIOVASC RES, V80, P290, DOI 10.1093/cvr/cvn188; Cascone I, 2003, J BIOL CHEM, V278, P50702, DOI 10.1074/jbc.M307234200; de Toledo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048344; Fiedler LR, 2009, CELL ADHES MIGR, V3, P3, DOI 10.4161/cam.3.1.7275; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hoang MV, 2011, BLOOD, V117, P1751, DOI 10.1182/blood-2010-05-286831; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Jain RK, 2012, CELL, V149, P1408, DOI 10.1016/j.cell.2012.05.025; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Ma J, 2012, CANCER-AM CANCER SOC, V118, P4105, DOI 10.1002/cncr.27393; Ma J, 2012, MED ONCOL, V29, P119, DOI 10.1007/s12032-010-9774-y; Meng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048393; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Pal S, 2001, CANCER RES, V61, P6952; Sawada N, 2010, CURR OPIN PHARMACOL, V10, P116, DOI 10.1016/j.coph.2009.11.004; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Su LF, 2001, J BIOL CHEM, V276, P3231, DOI 10.1074/jbc.M005547200; Takata K, 2008, MOL CANCER THER, V7, P1551, DOI 10.1158/1535-7163.MCT-07-0428; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Xue Y, 2004, BIOCHEM BIOPH RES CO, V320, P1309, DOI 10.1016/j.bbrc.2004.06.088; Xue Y, 2006, INT J CANCER, V118, P2965, DOI 10.1002/ijc.21763; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972; Zhao W, 2008, GRAEF ARCH CLIN EXP, V246, P1413, DOI 10.1007/s00417-008-0858-8; Zietz C, 1998, AM J PATHOL, V153, P1425, DOI 10.1016/S0002-9440(10)65729-X	33	23	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66275	10.1371/journal.pone.0066275	http://dx.doi.org/10.1371/journal.pone.0066275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750283	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900085
J	Tramacere, F; Beccai, L; Kuba, M; Gozzi, A; Bifone, A; Mazzolai, B				Tramacere, Francesca; Beccai, Lucia; Kuba, Michael; Gozzi, Alessandro; Bifone, Angelo; Mazzolai, Barbara			The Morphology and Adhesion Mechanism of Octopus vulgaris Suckers	PLOS ONE			English	Article							CEPHALOPODS	The octopus sucker represents a fascinating natural system performing adhesion on different terrains and substrates. Octopuses use suckers to anchor the body to the substrate or to grasp, investigate and manipulate objects, just to mention a few of their functions. Our study focuses on the morphology and adhesion mechanism of suckers in Octopus vulgaris. We use three different techniques (MRI, ultrasonography, and histology) and a 3D reconstruction approach to contribute knowledge on both morphology and functionality of the sucker structure in O. vulgaris. The results of our investigation are two-fold. First, we observe some morphological differences with respect to the octopus species previously studied (i.e., Octopus joubini, Octopus maya, Octopus bimaculoides/bimaculatus and Eledone cirrosa). In particular, in O. vulgaris the acetabular chamber, that is a hollow spherical cavity in other octopuses, shows an ellipsoidal cavity which roof has an important protuberance with surface roughness. Second, based on our findings, we propose a hypothesis on the sucker adhesion mechanism in O. vulgaris. We hypothesize that the process of continuous adhesion is achieved by sealing the orifice between acetabulum and infundibulum portions via the acetabular protuberance. We suggest this to take place while the infundibular part achieves a completely flat shape; and, by sustaining adhesion through preservation of sucker configuration. In vivo ultrasonographic recordings support our proposed adhesion model by showing the sucker in action. Such an underlying physical mechanism offers innovative potential cues for developing bioinspired artificial adhesion systems. Furthermore, we think that it could possibly represent a useful approach in order to investigate any potential difference in the ecology and in the performance of adhesion by different species.	[Tramacere, Francesca; Beccai, Lucia; Mazzolai, Barbara] Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy; [Tramacere, Francesca] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy; [Kuba, Michael] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel; [Kuba, Michael] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neuronal Computat, Jerusalem, Israel; [Gozzi, Alessandro; Bifone, Angelo] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst, Rovereto, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Istituto Italiano di Tecnologia - IIT	Tramacere, F (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy.	francesca.tramacere@iit.it; barbara.mazzolai@iit.it	Mazzolai, Barbara/I-8876-2016; Kuba, Michael J/AAE-7934-2022; Kuba, Michael/ABH-8394-2020; Gozzi, Alessandro/K-6342-2016	Mazzolai, Barbara/0000-0003-0722-8350; Kuba, Michael J/0000-0003-2688-736X; Gozzi, Alessandro/0000-0002-5731-4137; Beccai, Lucia/0000-0002-8754-5155				BERENGUERES J, 2007, 2007 IEEE INT C ROB, P1256; Boyle PR, 1991, UFAW HDB CARE MANAGE; De Laoaze-Duthiers H, 1884, ARCH ZOOLOGIE EXPT G, P379; Grasso FW, 2008, AM MALACOL BULL, V24, P13, DOI 10.4003/0740-2783-24.1.13; Grasso FW, 2007, BIOINSPIR BIOMIM, V2, pS170, DOI 10.1088/1748-3182/2/4/S06; GRAZIADEI P, 1962, NATURE, V195, P57, DOI 10.1038/195057a0; GRAZIADEI PPC, 1976, TISSUE CELL, V8, P229, DOI 10.1016/0040-8166(76)90049-5; GRAZIADEI PPC, 1976, J MORPHOL, V150, P639, DOI 10.1002/jmor.1051500304; Guerin J, 1908, ARCH ZOOLOGIE EXPT G, P1; KIER W M, 1992, P205; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Kier WM, 2002, INTEGR COMP BIOL, V42, P1146, DOI 10.1093/icb/42.6.1146; KIER WM, 1990, BIOL BULL, V178, P126, DOI 10.2307/1541971; Kuba M.J., 2006, INT J COMP PSYCHOL, V19, P426; MESSENGER JB, 1985, COMP BIOCHEM PHYS C, V82, P203, DOI 10.1016/0742-8413(85)90230-0; Nachtigall W., 1974, BIOL MECH ATTACHMENT; Naef A, 1972, FAUNA FLORA BAY NAPL; Niemiec J, 1885, RECHERCHES MORPHOLOG; NIXON M, 1977, S ZOOL SOC LOND, V38, P447; Packard A., 1988, P37; Rossi F, 1958, NOUVELLES CONTRIBUTI, P1; SMITH AM, 1991, J EXP BIOL, V157, P257; Varenberg M, 2008, J R SOC INTERFACE, V5, P383, DOI 10.1098/rsif.2007.1171; Varenberg M, 2007, J R SOC INTERFACE, V4, P721, DOI 10.1098/rsif.2007.0222; Wells M.J., 1978, OCTOPUS PHYSL BEHAV, V1st; WELLS MJ, 1964, J EXP BIOL, V41, P433; Young J. Z., 1971, ANATOMY NERVOUS SYST	27	72	74	8	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65074	10.1371/journal.pone.0065074	http://dx.doi.org/10.1371/journal.pone.0065074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750233	Green Published, gold			2022-12-27	WOS:000319961900035
J	Attig, L; Brisard, D; Larcher, T; Mickiewicz, M; Guilloteau, P; Boukthir, S; Niamba, CN; Gertler, A; Djiane, J; Monniaux, D; Abdennebi-Najar, L				Attig, Linda; Brisard, Daphne; Larcher, Thibaut; Mickiewicz, Michal; Guilloteau, Paul; Boukthir, Samir; Niamba, Claude-Narcisse; Gertler, Arieh; Djiane, Jean; Monniaux, Danielle; Abdennebi-Najar, Latifa			Postnatal Leptin Promotes Organ Maturation and Development in IUGR Piglets	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; BIRTH-WEIGHT; RECEPTOR EXPRESSION; OVARIAN DEVELOPMENT; OOCYTE MATURATION; SMALL-INTESTINE; DUODENAL JUICE; PORCINE; FETAL; ONTOGENY	Babies with intra-uterine growth restriction (IUGR) are at increased risk for experiencing negative neonatal outcomes due to their general developmental delay. The present study aimed to investigate the effects of a short postnatal leptin supply on the growth, structure, and functionality of several organs at weaning. IUGR piglets were injected from day 0 to day 5 with either 0.5 mg/kg/d leptin (IUGRLep) or saline (IUGRSal) and euthanized at day 21. Their organs were collected, weighed, and sampled for histological, biochemical, and immunohistochemical analyses. Leptin induced an increase in body weight and the relative weights of the liver, spleen, pancreas, kidneys, and small intestine without any changes in triglycerides, glucose and cholesterol levels. Notable structural and functional changes occurred in the ovaries, pancreas, and secondary lymphoid organs. The ovaries of IUGRLep piglets contained less oogonia but more oocytes enclosed in primordial and growing follicles than the ovaries of IUGRSal piglets, and FOXO3A staining grade was higher in the germ cells of IUGRLep piglets. Within the exocrine parenchyma of the pancreas, IUGRLep piglets presented a high rate of apoptotic cells associated with a higher trypsin activity. In the spleen and the Peyer's patches, B lymphocyte follicles were much larger in IUGRLep piglets than in IUGRSal piglets. Moreover, IUGRLep piglets showed numerous CD79(+) cells in well-differentiated follicle structures, suggesting a more mature immune system. This study highlights a new role for leptin in general developmental processes and may provide new insight into IUGR pathology.	[Attig, Linda; Niamba, Claude-Narcisse; Abdennebi-Najar, Latifa] UPSP, EGEAL, Inst Polytech LaSalle Beauvais, Beauvais, France; [Brisard, Daphne; Monniaux, Danielle] INRA, Physiol Reprod & Comportements UMR85, Nouzilly, France; [Brisard, Daphne; Monniaux, Danielle] CNRS, UMR7247, Nouzilly, France; [Brisard, Daphne; Monniaux, Danielle] Univ Francois Rabelais Tours, Tours, France; [Brisard, Daphne; Monniaux, Danielle] IFCE, Nouzilly, France; [Larcher, Thibaut] INRA, UMR 703, Ecole Natl Vet, Nantes, France; [Mickiewicz, Michal; Guilloteau, Paul] INRA, Unite 1341, Nutr & Adaptat Digest Nerveuses & Comportementale, St Gilles, France; [Boukthir, Samir] Tunis El Manar Univ, Fac Med Tunis, Childrens Hosp, Dept Pediat C, Tunis RU12SP09, Tunisia; [Gertler, Arieh] Robert H Smith Fac Agr Food & Environm, IL-7610001 Rehovot, Israel; [Djiane, Jean] INRA, Ctr Rech Jouy En Josas, F-78350 Jouy En Josas, France	UniLaSalle; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; INRAE; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Abdennebi-Najar, L (corresponding author), UPSP, EGEAL, Inst Polytech LaSalle Beauvais, Beauvais, France.	latifa.najar@lasalle-beauvais.fr	Larcher, Thibaut/M-9160-2013; Larcher, Thibaut/X-8500-2019; Abdennebi-Najar, Latifa/AAG-3231-2021	Larcher, Thibaut/0000-0002-0396-3190; Abdennebi-Najar, latifa/0000-0003-3070-2639	Institut Polytechnique LaSalle Beauvais; INRA institute of France	Institut Polytechnique LaSalle Beauvais; INRA institute of France	This study was funded by Institut Polytechnique LaSalle Beauvais and INRA institute of France. LaSalle is an education institute "Grande Ecole" which offers outstanding scientific education to the future engineers in Nutrition and Health, Agriculture and Geology. INRA is a National institute of research in Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdennebi-Najar L, 2011, J MATERN-FETAL NEO M, V24, P1486, DOI 10.3109/14767058.2010.547638; Abir R, 2005, FERTIL STERIL, V84, P1779, DOI 10.1016/j.fertnstert.2005.05.067; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Albertsson-Wikland K, 1998, HORM RES, V49, P7, DOI 10.1159/000053080; Aquila S, 2008, REPRODUCTION, V136, P23, DOI 10.1530/REP-07-0304; Attig L, 2008, AM J PHYSIOL-ENDOC M, V295, pE1117, DOI 10.1152/ajpendo.90542.2008; Attig L, 2011, ORGANOGENESIS, V7, P88, DOI 10.4161/org.7.2.14871; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Bock T, 2003, J ENDOCRINOL, V179, P245, DOI 10.1677/joe.0.1790245; BOEHM G, 1990, BIOMED BIOCHIM ACTA, V49, P369; BOEHM G, 1991, J PEDIATR GASTR NUTR, V12, P324, DOI 10.1097/00005176-199104000-00006; Bouret SG, 2010, BRAIN RES, V1350, P2, DOI 10.1016/j.brainres.2010.04.011; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cioffi JA, 1997, MOL HUM REPROD, V3, P467, DOI 10.1093/molehr/3.6.467; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Craig J, 2004, ENDOCRINOLOGY, V145, P5355, DOI 10.1210/en.2004-0783; Da Silva-Buttkus P, 2003, REPRODUCTION, V126, P249, DOI 10.1530/rep.0.1260249; de Bruin JP, 1998, EARLY HUM DEV, V51, P39, DOI 10.1016/S0378-3782(97)00073-X; Ding W, 2010, J REPROD DEVELOP, V56, P162, DOI 10.1262/jrd.09-094H; Djiane J, 2008, J PHYSIOL PHARMACOL, V59, P55; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fattal-Valevski A, 2005, J PEDIATR ENDOCR MET, V18, P671; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Hales CN, 1997, ACTA PAEDIATR, V86, P184; HINCHLIFFE SA, 1992, BRIT J OBSTET GYNAEC, V99, P296, DOI 10.1111/j.1471-0528.1992.tb13726.x; Hoggard N, 1997, P NATL ACAD SCI USA, V94, P11073, DOI 10.1073/pnas.94.20.11073; Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x; Ibanez L, 2006, HORM RES, V65, P112, DOI 10.1159/000091515; Jaquet D, 1998, J CLIN ENDOCR METAB, V83, P1243, DOI 10.1210/jc.83.4.1243; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; Joo JK, 2010, ANIM REPROD SCI, V119, P329, DOI 10.1016/j.anireprosci.2010.02.002; Kilby MD, 1998, J CLIN ENDOCR METAB, V83, P2964, DOI 10.1210/jc.83.8.2964; KOLACEK S, 1990, ARCH DIS CHILD, V65, P178, DOI 10.1136/adc.65.2.178; LAINE J, 1993, PANCREAS, V8, P383, DOI 10.1097/00006676-199305000-00016; Litten JC, 2005, BIOL NEONATE, V87, P1, DOI 10.1159/000080107; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; MAROUX S, 1973, BIOCHIM BIOPHYS ACTA, V321, P282, DOI 10.1016/0005-2744(73)90083-1; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Mickiewicz M, 2012, J PHYSIOL PHARMACOL, V63, P225; OXENDER WD, 1979, BIOL REPROD, V21, P715, DOI 10.1095/biolreprod21.3.715; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; PIERZYNOWSKI SG, 1993, J PEDIATR GASTR NUTR, V16, P287, DOI 10.1097/00005176-199304000-00012; Poore KR, 2004, J PHYSIOL-LONDON, V558, P295, DOI 10.1113/jphysiol.2004.061390; Poore KR, 2002, J PHYSIOL-LONDON, V539, P969, DOI 10.1113/jphysiol.2001.012926; Poore KR, 2002, DIABETOLOGIA, V45, P1247, DOI 10.1007/s00125-002-0849-y; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; Ramsay TG, 2005, J ANIM SCI, V83, P2501; Raver N, 2000, PROTEIN EXPRES PURIF, V19, P30, DOI 10.1006/prep.2000.1202; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Rothkotter HJ, 2009, DEV COMP IMMUNOL, V33, P267, DOI 10.1016/j.dci.2008.06.016; ROTHKOTTER HJ, 1989, IMMUNOLOGY, V67, P103; Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324; Ryan NK, 2002, BIOL REPROD, V66, P1548, DOI 10.1095/biolreprod66.5.1548; Schnapper A, 2003, ANAT HISTOL EMBRYOL, V32, P297, DOI 10.1046/j.1439-0264.2003.00487.x; SHANKLIN DR, 1993, BIOL NEONATE, V64, P76; SINGH M, 1978, INDIAN PEDIATR, V15, P563; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P3871, DOI 10.1210/en.139.9.3871; Uddin S, 2011, INT J CLIN EXP PATHO, V4, P637; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Wang D, J BIOSCI, V37, P91; Wolinski J, 2003, J ENDOCRINOL, V177, P215, DOI 10.1677/joe.0.1770215; XANTHOU M, 1985, ACTA PAEDIATR SCAND, P143; XU RJ, 1992, J DEV PHYSIOL, V18, P161; Ye YH, 2009, REPROD BIOMED ONLINE, V19, P181, DOI 10.1016/S1472-6483(10)60070-3	71	22	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64616	10.1371/journal.pone.0064616	http://dx.doi.org/10.1371/journal.pone.0064616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741353	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900066
J	Beltran, NC; Horvathova, L; Jedelsky, PL; Sedinova, M; Rada, P; Marcincikova, M; Hrdy, I; Tachezy, J				Beltran, Neritza Campo; Horvathova, Lenka; Jedelsky, Petr L.; Sedinova, Miroslava; Rada, Petr; Marcincikova, Michaela; Hrdy, Ivan; Tachezy, Jan			Iron-Induced Changes in the Proteome of Trichomonas vaginalis Hydrogenosomes	PLOS ONE			English	Article							COMPLEX-I; TRANSCRIPTIONAL REGULATION; PROTEINS; GENE; IDENTIFICATION; EUKARYOTES; METABOLISM; PEROXIREDOXIN; MITOCHONDRIA; ACTIVATION	Iron plays a crucial role in metabolism as a key component of catalytic and redox cofactors, such as heme or iron-sulfur clusters in enzymes and electron-transporting or regulatory proteins. Limitation of iron availability by the host is also one of the mechanisms involved in immunity. Pathogens must regulate their protein expression according to the iron concentration in their environment and optimize their metabolic pathways in cases of limitation through the availability of respective cofactors. Trichomonas vaginalis, a sexually transmitted pathogen of humans, requires high iron levels for optimal growth. It is an anaerobe that possesses hydrogenosomes, mitochondrion-related organelles that harbor pathways of energy metabolism and iron-sulfur cluster assembly. We analyzed the proteomes of hydrogenosomes obtained from cells cultivated under iron-rich and iron-deficient conditions employing two-dimensional peptide separation combining IEF and nano-HPLC with quantitative MALDI-MS/MS. We identified 179 proteins, of which 58 were differentially expressed. Iron deficiency led to the upregulation of proteins involved in iron-sulfur cluster assembly and the downregulation of enzymes involved in carbohydrate metabolism. Interestingly, iron affected the expression of only some of multiple protein paralogues, whereas the expression of others was iron independent. This finding indicates a stringent regulation of differentially expressed multiple gene copies in response to changes in the availability of exogenous iron.	[Beltran, Neritza Campo; Horvathova, Lenka; Jedelsky, Petr L.; Sedinova, Miroslava; Rada, Petr; Marcincikova, Michaela; Hrdy, Ivan; Tachezy, Jan] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic	Charles University Prague	Tachezy, J (corresponding author), Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic.	tachezy@natur.cuni.cz	Jedelsky, Petr/C-5879-2009; Tachezy, Jan/R-4945-2017; Hrdý, Ivan/K-8931-2017; Rada, Petr/M-5289-2017; Horváthová, Lenka/AAC-3119-2021	Jedelsky, Petr/0000-0003-3813-2343; Tachezy, Jan/0000-0001-6976-8446; Hrdý, Ivan/0000-0002-5595-9177; Rada, Petr/0000-0001-6241-969X; Horváthová, Lenka/0000-0001-7618-8669	Czech Ministry of Education [MSM 0021620858]; Charles University in Prague [UNCE 204017]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague	This work was supported by the Czech Ministry of Education (MSM 0021620858) and Charles University in Prague (UNCE 204017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Coombs GH, 2004, J BIOL CHEM, V279, P5249, DOI 10.1074/jbc.M304359200; Crichton RR., 2009, IRON METABOLISM MOL; De Jesus JB, 2007, PROTEOMICS, V7, P1961, DOI 10.1002/pmic.200600797; De Jesus JB, 2006, PARASITOL INT, V55, P285, DOI 10.1016/j.parint.2006.08.002; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; Drmota T, 1996, MOL BIOCHEM PARASIT, V83, P221, DOI 10.1016/S0166-6851(96)02777-6; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; GORRELL TE, 1985, J BACTERIOL, V161, P1228, DOI 10.1128/JB.161.3.1228-1230.1985; Hjort K, 2010, PHILOS T R SOC B, V365, P713, DOI 10.1098/rstb.2009.0224; Horvathova L, 2012, GENOME BIOL EVOL, V4, P1017, DOI 10.1093/gbe/evs078; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; HRDY I, 2008, MICROBIOL MONOGR, V9, P113, DOI DOI 10.1007/7171_2007_110; Hsu HM, 2009, EUKARYOT CELL, V8, P362, DOI 10.1128/EC.00317-08; Huang PJ, 2012, GENOMICS, V99, P101, DOI 10.1016/j.ygeno.2011.11.002; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; LEHKER MW, 1992, MOL MICROBIOL, V6, P123, DOI 10.1111/j.1365-2958.1992.tb00844.x; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Nagele E, 2004, EXPERT REV PROTEOMIC, V1, P37, DOI 10.1586/14789450.1.1.37; Ong SJ, 2007, J BIOL CHEM, V282, P6716, DOI 10.1074/jbc.M610484200; Ong SJ, 2006, EUKARYOT CELL, V5, P391, DOI 10.1128/EC.5.2.391-399.2006; Pandey A, 2011, J BIOL CHEM, V286, P38242, DOI 10.1074/jbc.M111.288522; PETERSON KM, 1984, J EXP MED, V160, P398, DOI 10.1084/jem.160.2.398; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; Putz S, 2005, MOL BIOCHEM PARASIT, V142, P212, DOI 10.1016/j.molbiopara.2005.04.003; Rada P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024428; Schneider RE, 2011, INT J PARASITOL, V41, P1421, DOI 10.1016/j.ijpara.2011.10.001; Smid O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000243; Smutna T, 2009, EUKARYOT CELL, V8, P47, DOI 10.1128/EC.00276-08; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Sutak R, 2008, TRENDS MICROBIOL, V16, P261, DOI 10.1016/j.tim.2008.03.005; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Vanacova S, 2001, MICROBIOL-UK, V147, P53; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; WHO, 2011, GLOB PREV INC SEL CU; Zimorski V, 2013, J EUKARYOT MICROBIOL, V60, P89, DOI 10.1111/jeu.12012	39	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65148	10.1371/journal.pone.0065148	http://dx.doi.org/10.1371/journal.pone.0065148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741475	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900188
J	Brandariz-Fontes, C; Leonard, JA; Vega-Pla, JL; Backstrom, N; Lindgren, G; Lippold, S; Rico, C				Brandariz-Fontes, Claudia; Leonard, Jennifer A.; Luis Vega-Pla, Jose; Backstrom, Niclas; Lindgren, Gabriella; Lippold, Sebastian; Rico, Ciro			Y-Chromosome Analysis in Retuertas Horses	PLOS ONE			English	Article							NUCLEOTIDE DIVERSITY; HAPLOTYPE ANALYSIS; MITOCHONDRIAL-DNA; AMPLIFICATION; DOMESTICATION; POLYMERASE; ORIGINS; EQUUS	Several studies based on a variety of genetic markers have attempted to establish the origins of horse domestication. Thus far a discrepancy between the results of mitochondrial DNA analysis, which show high levels of diversity, and results from the Y-chromosome, with almost no genetic variability, has been identified. Most previous work on the horse Y-chromosome has focused on widespread, popular breeds or local Asian breeds. It is possible that these breeds represent a reduced set of the genetic variation present in the species. Additional genetic variation may be present in local breeds and ancient feral populations, such as the Retuertas horse in Spain. In this study we analyzed the Y-chromosome of the Retuertas horse, a feral horse population on the Iberian Peninsula that is at least several hundred years old, and whose genetic diversity and morphology suggests that it has been reproductively isolated for a long time. Data from the Retuertas horse was compared to another 11 breeds from the region (Portugal, Spain and France) or likely of Iberian origin, and then to data from 15 more breeds from around the globe. We sequenced 31 introns, Zinc finger Y-chromosomal protein (ZFY) and anonymous Y-linked fragments and genotyped 6 microsatellite loci found on the Y-chromosome. We found no sequence variation among all individuals and all breeds studied. However, fifteen differences were discovered between our data set and reference sequences in GenBank. We show that these likely represent errors within the deposited sequences, and suggest that they should not be used as comparative data for future projects.	[Brandariz-Fontes, Claudia; Rico, Ciro] EBD CSIC, Seville, Spain; [Brandariz-Fontes, Claudia] Univ Panama, Fac Med Vet, Panama City, Panama; [Leonard, Jennifer A.] EBD CSIC, Conservat & Evolutionary Genet Grp, Seville, Spain; [Luis Vega-Pla, Jose] Lab Invest Aplicada, Cordoba, Spain; [Backstrom, Niclas] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden; [Lindgren, Gabriella] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Lippold, Sebastian] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad de Panama; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Uppsala University; Swedish University of Agricultural Sciences; Max Planck Society	Leonard, JA (corresponding author), EBD CSIC, Conservat & Evolutionary Genet Grp, Seville, Spain.	ciro@ebd.csic.es	Vega-Pla, Jose Luis/ABB-5125-2020; Rico, Ciro/K-5725-2015; Rico, Ciro/P-9750-2019; Leonard, Jennifer/A-7894-2010	Rico, Ciro/0000-0002-0822-336X; Rico, Ciro/0000-0002-0822-336X; Lindgren, Gabriella/0000-0001-6046-9669; Leonard, Jennifer/0000-0003-0291-7819; Vega-Pla, Jose Luis/0000-0003-0916-9876	University of Panama; Fundacion Carolina	University of Panama; Fundacion Carolina	This project had no direct funding, but was supported with technical and logistical assistance by Fernando Hiraldo, Juan Calderon and Juan Jose Negro from EBD; the technical assistance from the Donana Natural Park staff for sample collection; Laboratorio Ecologia Molecular, Estacion Biologica de Donana-CSIC; Laboratorio de Investigacion Aplicada, Cria Caballar de las Fuerzas Armadas for sample collection and Hans Niclas Backstrom for his assistance optimizing laboratory procedures. CB-F was supported by the University of Panama and Fundacion Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bannasch DL, 2005, MAMM GENOME, V16, P273, DOI 10.1007/s00335-004-2435-8; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Ellegren H, 2009, TRENDS GENET, V25, P278, DOI 10.1016/j.tig.2009.04.005; Ginja C, 2009, J HERED, V100, P148, DOI 10.1093/jhered/esn080; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hasegawa T, 1999, J VET MED SCI, V61, P97, DOI 10.1292/jvms.61.97; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; ISHIDA N, 1995, J MOL EVOL, V41, P180, DOI 10.1007/BF00170671; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Kavar T, 2008, LIVEST SCI, V116, P1, DOI 10.1016/j.livsci.2008.03.002; Keohavong P, 1993, PCR Methods Appl, V2, P288; Lau AN, 2009, MOL BIOL EVOL, V26, P199, DOI 10.1093/molbev/msn239; Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326; Ling YH, 2010, J HERED, V101, P639, DOI 10.1093/jhered/esq047; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lippold S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1447; Lister A.M., 1998, ANCIENT BIOMOLECULES, V2, P267; Liu WS, 2003, CYTOGENET GENOME RES, V102, P53, DOI 10.1159/000075725; LOEWEN PC, 1995, GENE, V164, P59, DOI 10.1016/0378-1119(95)00383-H; Meadows JRS, 2004, ANIM GENET, V35, P379, DOI 10.1111/j.1365-2052.2004.01180.x; Olsen SL, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P245; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Rafeie F, 2011, AFR J BIOTECHNOL, V10, P17347, DOI 10.5897/AJB11.1430; Santani AB, 2004, THESIS TEXAS A M U U; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358; Vega Pla JL, 2005, EAAP PUBLICATION, P167; Vega-Pla JL, 2006, ANIM GENET, V37, P571, DOI 10.1111/j.1365-2052.2006.01533.x; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Vila C, 2006, DOCUMENTING DOMESTIC, P245; Wallner B, 2003, ANIM GENET, V34, P453, DOI 10.1046/j.0268-9146.2003.01044.x; Wallner B, 2004, J HERED, V95, P158, DOI 10.1093/jhered/esh020; Wallner B, 2001, THESIS VET MED U WIE; Warmuth V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018194	38	7	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64985	10.1371/journal.pone.0064985	http://dx.doi.org/10.1371/journal.pone.0064985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741439	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900152
J	Gao, J; Zhou, LJ; Ge, YL; Lin, SY; Du, J				Gao, Ju; Zhou, Luojing; Ge, Yali; Lin, Shunyan; Du, Jin			Effects of Different Resuscitation Fluids on Pulmonary Expression of Aquaporin1 and Aquaporin5 in a Rat Model of Uncontrolled Hemorrhagic Shock and Infection	PLOS ONE			English	Article							KAPPA-B ACTIVATION; HYDROXYETHYL STARCH; DOWN-REGULATION; WATER CHANNELS; MOUSE LUNG; TRANSPORT; EPIDEMIOLOGY; SEPSIS; INJURY	Background: To investigate the effects of fluids resuscitation on pulmonary expression of aquaporin1 and aquaporin5 in a rat model of uncontrolled hemorrhagic shock and infection. Methods: Sixty Sprague-Dawley rats were randomly assigned to five groups, sham operation group (Group C) and four treated groups: no fluid resuscitation group (Group NF), groups resuscitated with Lactated Ringer's (LR), 7.5% NaCl (HTS) and Hydroxyl ethyl starch (HES) respectively. Three-phased uncontrolled hemorrhagic shock and infection model was used. Phase I: Massive hemorrhage with a mean arterial pressure of 35-40 mmHg for 60 min, and followed by infection of lipopolysaccharide. Then some animals were resuscitated with solutions mentioned above, until 90 min. Phase II: At hemorrhagic shock 90 minutes, phase II of 60 minutes began with hemostasis and returning of all the initial shed blood. Phase III: Observation phase for 3.5 hours. After phase III, arterial blood gas analysis and the survival rates of the rats were recorded, Wet-to-dry lung weight ratio, BALF protein, pulmonary permeability index, and expressions of aquaporin1 and aquaporin5 were tested. Results: The expressions of aquaporin1 and aquaporin5 were decreased in treatment groups comparing with sham operation group. Group HES and Group HTS decreased pulmonary vascular permeability and Wet-to-dry lung weight ratio, improved arterial blood gas analysis and survival rates, and attenuated the decreased pulmonary expression of aquaporin1 and aquaporin5 after the "two-hit'', comparing with groups NF and LR, but these beneficial effects were blunted in group HTS. Conclusion: The expression of aquaporin1 and aquaporin5 may play important roles in formation of pulmonary edema. Resuscitation with HTS and HES, especially HES can reduce lung injury after hemorrhagic shock, partly by up-regulating the expressions of aquaporin1 and aquaporin5.	[Gao, Ju; Ge, Yali; Lin, Shunyan; Du, Jin] Yangzhou Univ, Clin Med Coll, Subei Peoples Hosp, Dept Anesthesiol, Yangzhou, Jiangsu, Peoples R China; [Zhou, Luojing] Yangzhou Univ, Clin Med Coll, Subei Peoples Hosp, Dept Sci Res, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Gao, J (corresponding author), Yangzhou Univ, Clin Med Coll, Subei Peoples Hosp, Dept Anesthesiol, Yangzhou, Jiangsu, Peoples R China.	happygezi81@163.com			National Natural Science Fund, China [81171838]	National Natural Science Fund, China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Fund, China (81171838). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablove RH, 2006, ORTHOPEDICS, V29, P443, DOI 10.3928/01477447-20060501-07; Auwerda JJA, 2002, ANN INTERN MED, V137, P1013, DOI 10.7326/0003-4819-137-12-200212170-00037; Bork K, 2005, BRIT J DERMATOL, V152, P3, DOI 10.1111/J.1365-2133.2004.06272.X; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; Chen HZ, 2006, J TRAUMA, V60, P701, DOI 10.1097/01.ta.0000203699.91475.f6; Cheng IW, 2003, CRIT CARE CLIN, V19, P693, DOI 10.1016/S0749-0704(03)00050-2; Costantini TW, 2010, CLINICS, V65, P621, DOI 10.1590/S1807-59322010000600010; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Dart AB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub2; Feng XM, 2006, J SURG RES, V135, P129, DOI 10.1016/j.jss.2006.02.028; Gao J, 2009, J TRAUMA, V67, P1213, DOI 10.1097/TA.0b013e31818cc1e4; Gurfinkel V, 2003, J TRAUMA, V54, P1137, DOI 10.1097/01.TA.0000064452.37534.29; Hoffert JD, 2000, J BIOL CHEM, V275, P9070, DOI 10.1074/jbc.275.12.9070; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Lehmann GL, 2008, AM J PHYSIOL-GASTR L, V294, pG567, DOI 10.1152/ajpgi.00232.2007; Ma TH, 2000, J CLIN INVEST, V105, P93, DOI 10.1172/JCI8258; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Madigan MC, 2008, J TRAUMA, V64, P280, DOI 10.1097/TA.0b013e3181622bb6; Saadia R, 1999, J ACCID EMERG MED, V16, P163; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; Sato H, 2007, SHOCK, V28, P291, DOI 10.1097/SHK.0b013e3180326e3d; Song LL, 2000, J GEN PHYSIOL, V115, P17, DOI 10.1085/jgp.115.1.17; Song YL, 2001, J GEN PHYSIOL, V117, P573, DOI 10.1085/jgp.117.6.573; Towne JE, 2000, AM J RESP CELL MOL, V22, P34, DOI 10.1165/ajrcmb.22.1.3818; Towne JE, 2001, J BIOL CHEM, V276, P18657, DOI 10.1074/jbc.M100322200; Tsai MC, 2007, SHOCK, V27, P527, DOI 10.1097/01.shk.0000245032.31859.f2; Verkman AS, 2000, AM J PHYSIOL-LUNG C, V278, pL867, DOI 10.1152/ajplung.2000.278.5.L867; Wang F, 2010, HEPATO-GASTROENTEROL, V57, P1553; WANG P, 2006, INT IMMUNOPHARMACOL, V9, P347; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Xie Yan-ping, 2005, Zhonghua Jiehe He Huxi Zazhi, V28, P385; Zarychanski Ryan, 2009, Open Med, V3, pe196; Zhang YW, 2009, CLIN EXP PHARMACOL P, V36, P734, DOI 10.1111/j.1440-1681.2009.05156.x	35	13	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64390	10.1371/journal.pone.0064390	http://dx.doi.org/10.1371/journal.pone.0064390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741323	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900035
J	Krajewski, SS; Nagel, M; Narberhaus, F				Krajewski, Stefanie S.; Nagel, Miriam; Narberhaus, Franz			Short ROSE-Like RNA Thermometers Control IbpA Synthesis in Pseudomonas Species	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; THERMOSENSOR CONTROLS EXPRESSION; ESCHERICHIA-COLI; MESSENGER-RNA; SECONDARY STRUCTURE; PUTIDA KT2440; QUANTITATIVE-ANALYSIS; GENE-EXPRESSION; SIGMA-FACTORS; TRANSLATION	The bacterial small heat shock protein IbpA protects client proteins from aggregation. Due to redundancy in the cellular chaperone network, deletion of the ibpA gene often leads to only a mild or no phenotypic defect. In this study, we show that a Pseudomonas putida ibpA deletion mutant has a severe growth defect under heat stress conditions and reduced survival during recovery revealing a critical role of IbpA in heat tolerance. Transcription of the ibpA gene depends on the alternative heat shock sigma factor sigma(32). Production of IbpA protein only at heat shock temperatures suggested additional translational control. We conducted a comprehensive structural and functional analysis of the 5' untranslated regions of the ibpA genes from P. putida and Pseudomonas aeruginosa. Both contain a ROSE-type RNA thermometer that is substantially shorter and simpler than previously reported ROSE elements. Comprised of two hairpin structures only, they inhibit translation at low temperature and permit translation initiation after a temperature upshift. Both elements regulate reporter gene expression in Escherichia coli and ribosome binding in vitro in a temperature-dependent manner. Structure probing revealed local melting of the second hairpin whereas the first hairpin remained unaffected. High sequence and structure conservation of pseudomonal ibpA untranslated regions and their ability to confer thermoregulation in vivo suggest that short ROSE-like thermometers are commonly used to control IbpA synthesis in Pseudomonas species.	[Krajewski, Stefanie S.; Nagel, Miriam; Narberhaus, Franz] Ruhr Univ Bochum, Bochum, Germany	Ruhr University Bochum	Narberhaus, F (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	franz.narberhaus@rub.de	Taylor, Graham/A-4027-2012	Narberhaus, Franz/0000-0002-8552-5310	German Research Foundation (DFG priority program) [SPP 1258]	German Research Foundation (DFG priority program)(German Research Foundation (DFG))	This work was financially supported by a grant from the German Research Foundation (DFG priority program SPP 1258: Sensory and regulatory RNAs in Prokaryotes) to FN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; Babst M, 1996, MOL MICROBIOL, V19, P827, DOI 10.1046/j.1365-2958.1996.438968.x; Balsiger S, 2004, J BACTERIOL, V186, P6824, DOI 10.1128/JB.186.20.6824-6829.2004; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; BRANTL S, 1994, EMBO J, V13, P3599, DOI 10.1002/j.1460-2075.1994.tb06667.x; BUKAU B, 1993, MOL MICROBIOL, V9, P671, DOI 10.1111/j.1365-2958.1993.tb01727.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chowdhury S, 2003, J BIOL CHEM, V278, P47915, DOI 10.1074/jbc.M306874200; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Crabbe A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-282; DESMIT MH, 1990, PROG NUCLEIC ACID RE, V38, P1; DESMIT MH, 1994, J MOL BIOL, V244, P144, DOI 10.1006/jmbi.1994.1714; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; DESMIT MH, 1994, J MOL BIOL, V235, P173, DOI 10.1016/S0022-2836(05)80024-5; Dominguez-Cuevas P, 2006, J BIOL CHEM, V281, P11981, DOI 10.1074/jbc.M509848200; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Filiatrault MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029335; Frank S, 2011, ENVIRON MICROBIOL, V13, P1309, DOI 10.1111/j.1462-2920.2011.02430.x; Gaubig LC, 2011, MICROBIOL-SGM, V157, P66, DOI 10.1099/mic.0.043802-0; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gross C. A., 1996, ESCHERICHIA COLI SAL, P1334; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HIRATA H, 1986, J BACTERIOL, V166, P722, DOI 10.1128/jb.166.3.722-727.1986; Huntzinger E, 2005, HDB RNA BIOCH, P163; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; KING EO, 1954, J LAB CLIN MED, V44, P301; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; Klinkert B, 2012, J BIOTECHNOL, V160, P55, DOI 10.1016/j.jbiotec.2012.01.007; Kobayashi Y, 2011, ENVIRON MICROBIOL, V13, P2007, DOI 10.1111/j.1462-2920.2010.02344.x; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Kortmann J, 2011, NUCLEIC ACIDS RES, V39, P2855, DOI 10.1093/nar/gkq1252; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim B, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P93; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Nocker A, 2001, NUCLEIC ACIDS RES, V29, P4800, DOI 10.1093/nar/29.23.4800; Nocker A, 2001, ARCH MICROBIOL, V176, P44, DOI 10.1007/s002030100294; O'Brien HE, 2011, ANNU REV PHYTOPATHOL, V49, P269, DOI 10.1146/annurev-phyto-072910-095242; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Rinnenthal J, 2011, NUCLEIC ACIDS RES, V39, P8258, DOI 10.1093/nar/gkr314; Rinnenthal J, 2010, NUCLEIC ACIDS RES, V38, P3834, DOI 10.1093/nar/gkq124; Sambrook J., 2001, MOL CLONING LAB MANU; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Studer SM, 2006, MOL CELL, V22, P105, DOI 10.1016/j.molcel.2006.02.014; Thomas JG, 1998, J BACTERIOL, V180, P5165, DOI 10.1128/JB.180.19.5165-5172.1998; Timmis KN, 2002, ENVIRON MICROBIOL, V4, P779, DOI 10.1046/j.1462-2920.2002.00365.x; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Waldminghaus T, 2005, BIOL CHEM, V386, P1279, DOI 10.1515/BC.2005.145; Waldminghaus T, 2007, MOL MICROBIOL, V65, P413, DOI 10.1111/j.1365-2958.2007.05794.x; Waldminghaus T, 2009, RNA BIOL, V6, P455, DOI 10.4161/rna.6.4.9014; Willkomm DK, 2005, NUCLEIC ACIDS RES, V33, P1949, DOI 10.1093/nar/gki334; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3	56	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65168	10.1371/journal.pone.0065168	http://dx.doi.org/10.1371/journal.pone.0065168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741480	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900193
J	Nur, H; Fostier, K; Aspeslagh, S; Renmans, W; Bertrand, E; Leleu, X; Favreau, M; Breckpot, K; Schots, R; De Waele, M; Van Valckenborgh, E; De Bruyne, E; Facon, T; Elewaut, D; Vanderkerken, K; Menu, E				Nur, Haneen; Fostier, Karel; Aspeslagh, Sandrine; Renmans, Wim; Bertrand, Elisabeth; Leleu, Xavier; Favreau, Meredis; Breckpot, Karine; Schots, Rik; De Waele, Marc; Van Valckenborgh, Els; De Bruyne, Elke; Facon, Thierry; Elewaut, Dirk; Vanderkerken, Karin; Menu, Eline			Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model	PLOS ONE			English	Article							MATURE DENDRITIC CELLS; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; CANCER-PATIENTS; IN-VIVO; ADAPTIVE IMMUNITY; INNATE; ACTIVATION; MOUSE; CD1D	Immunomodulators have been used in recent years to reactivate host anti-tumor immunity in several hematological malignancies. This report describes the effect of activating natural killer T (NKT) cells by alpha-Galactosylceramide (alpha-GalCer) in the 5T33MM model of multiple myeloma (MM). NKT cells are T lymphocytes, co-expressing T and NK receptors, while invariant NKT cells (iNKTs) also express a unique semi-invariant TCR alpha-chain. We followed iNKT numbers during the development of the disease in both 5T33MM mice and MM patients and found that their numbers dropped dramatically at the end stage of the disease, leading to a loss of total IFN-gamma secretion. We furthermore observed that alpha-GalCer treatment significantly increased the survival of 5T33MM diseased mice. Taken together, our data demonstrate for the first time the possibility of using a preclinical murine MM model to study the effects of a-GalCer and show promising results of alpha-GalCer treatment in a low tumor burden setting.	[Nur, Haneen; Favreau, Meredis; Van Valckenborgh, Els; De Bruyne, Elke; Vanderkerken, Karin; Menu, Eline] Vrije Univ Brussel VUB, Dept Hematol & Immunol, Myeloma Ctr Brussels, Brussels, Belgium; [Nur, Haneen] Hebron Univ, Fac Sci & Technol, Dept Biol, Hebron, Israel; [Fostier, Karel; Schots, Rik] Univ Ziekenhuis Brussel, Dept Clin Hematol, Brussels, Belgium; [Aspeslagh, Sandrine; Favreau, Meredis; Elewaut, Dirk] Univ Ghent, Dept Rheumatol, Lab Mol Immunol & Inflammat, B-9000 Ghent, Belgium; [Renmans, Wim; De Waele, Marc] Univ Ziekenhuis Brussel, Dept Lab Hematol, Brussels, Belgium; [Bertrand, Elisabeth; Leleu, Xavier; Facon, Thierry] CHRU, Hop Huriez, Serv Malad Sang, Lille, France; [Breckpot, Karine] Vrije Univ Brussel VUB, Lab Mol & Cellular Therapy, Brussels, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Ghent University; University Hospital Brussels; Vrije Universiteit Brussel; Universite de Lille - ISITE; CHU Lille; Vrije Universiteit Brussel	Menu, E (corresponding author), Vrije Univ Brussel VUB, Dept Hematol & Immunol, Myeloma Ctr Brussels, Brussels, Belgium.	Eline.Menu@vub.ac.be	Breckpot, Karine RP/A-4298-2008; Menu, Eline/K-2856-2015; Vanderkerken, Karin/I-3513-2013; De Bruyne, Elke/R-2145-2019; Elewaut, Dirk/K-6831-2014; De Bruyne, Elke/Z-3215-2019; Van Valckenborgh, Els/GRO-7224-2022	Breckpot, Karine RP/0000-0003-4331-3480; Menu, Eline/0000-0002-0805-6581; De Bruyne, Elke/0000-0003-4012-4617; Vanderkerken, Karin/0000-0002-2137-7179; Elewaut, Dirk/0000-0002-7468-974X	International Myeloma Foundation; Vlaams Liga tegen Kanker (VLK); FWO-VI; European Commission Framework of the Erasmus Mundus External Cooperation Window [2009-1642/001-001-ECW]	International Myeloma Foundation; Vlaams Liga tegen Kanker (VLK); FWO-VI(FWO); European Commission Framework of the Erasmus Mundus External Cooperation Window	This work was financially supported by the International Myeloma Foundation, Vlaams Liga tegen Kanker (VLK), FWO-VI and the European Commission Framework of the Erasmus Mundus External Cooperation Window under grant agreement 2009-1642/001-001-ECW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu Y, 2002, JPN J CANCER RES, V93, P397, DOI 10.1111/j.1349-7006.2002.tb01270.x; Ali Tahir SM, 2001, J IMMUNOL, V167, P4046; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Bontkes HJ, 2010, CLIN IMMUNOL, V136, P364, DOI 10.1016/j.clim.2010.04.019; Breckpot K, 2003, J GENE MED, V5, P654, DOI 10.1002/jgm.400; Broxmeyer HE, 2012, BLOOD, V119, P5731, DOI 10.1182/blood-2012-01-404012; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Chang YJ, 2007, P NATL ACAD SCI USA, V104, P10299, DOI 10.1073/pnas.0703824104; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Fang XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010288; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fujii SI, 2007, IMMUNOL REV, V220, P183, DOI 10.1111/j.1600-065X.2007.00561.x; Fujii SI, 2006, P NATL ACAD SCI USA, V103, P11252, DOI 10.1073/pnas.0604812103; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Iyoda T, 2010, INT IMMUNOL, V22, P905, DOI 10.1093/intimm/dxq444; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kobayashi E, 1995, ONCOL RES, V7, P529; Mattarollo SR, 2012, BLOOD, V120, P3019, DOI 10.1182/blood-2012-04-426643; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Neparidze N, 2009, ANN NY ACAD SCI, V1174, P61, DOI 10.1111/j.1749-6632.2009.04931.x; Pilones KA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/720803; RADL J, 1979, J IMMUNOL, V122, P609; Richter J, 2012, BLOOD; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Song WH, 2008, CLIN CANCER RES, V14, P6955, DOI 10.1158/1078-0432.CCR-07-5290; Spanoudakis E, 2009, BLOOD, V113, P2498, DOI 10.1182/blood-2008-06-161281; Tamura Y, 2008, BIOCHEM BIOPH RES CO, V369, P485, DOI 10.1016/j.bbrc.2008.02.037; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; Tyznik AJ, 2011, CHEM BIOL, V18, P1620, DOI 10.1016/j.chembiol.2011.10.015; van der Vliet HJJ, 2008, J IMMUNOL, V180, P7287, DOI 10.4049/jimmunol.180.11.7287; Vanderkerken K, 1997, BRIT J CANCER, V76, P451, DOI 10.1038/bjc.1997.409; Vanderkerken K, 2003, IMMUNOL REV, V194, P196, DOI 10.1034/j.1600-065X.2003.00035.x; Vanderkerken Karin, 2005, V113, P191, DOI 10.1385/1-59259-916-8:191; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; Wu L, 2009, TISSUE ANTIGENS, V73, P535, DOI 10.1111/j.1399-0039.2009.01256.x; Wu L, 2009, CURR MOL MED, V9, P4, DOI 10.2174/156652409787314534; Yanagisawa K, 2002, J IMMUNOL, V168, P6494, DOI 10.4049/jimmunol.168.12.6494	41	22	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65075	10.1371/journal.pone.0065075	http://dx.doi.org/10.1371/journal.pone.0065075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741460	Green Published, gold			2022-12-27	WOS:000319799900173
J	Simsek-Duran, F; Li, F; Ford, W; Swanson, RJ; Jones, HW; Castora, FJ				Simsek-Duran, Fatma; Li, Fang; Ford, Wentia; Swanson, R. James; Jones, Howard W., Jr.; Castora, Frank J.			Age-Associated Metabolic and Morphologic Changes in Mitochondria of Individual Mouse and Hamster Oocytes	PLOS ONE			English	Article							ADENOSINE-TRIPHOSPHATE CONTENT; IN-VITRO FERTILIZATION; DNA COPY NUMBER; DEVELOPMENTAL COMPETENCE; ATP CONTENT; PREIMPLANTATION EMBRYOS; MAMMALIAN OOCYTES; MURINE OOCYTES; BOVINE OOCYTES; MATURATION	Background: In human oocytes, as in other mammalian ova, there is a significant variation in the pregnancy potential, with approximately 20% of oocyte-sperm meetings resulting in pregnancies. This frequency of successful fertilization decreases as the oocytes age. This low proportion of fruitful couplings appears to be influenced by changes in mitochondrial structure and function. In this study, we have examined mitochondrial biogenesis in both hamster (Mesocricetus auratus) and mouse (Mus musculus) ova as models for understanding the effects of aging on mitochondrial structure and energy production within the mammalian oocyte. Methodology/Principal Findings: Individual metaphase II oocytes from a total of 25 young and old mice and hamsters were collected from ovarian follicles after hormone stimulation and prepared for biochemical or structural analysis. Adenosine triphosphate levels and mitochondrial DNA number were determined within individual oocytes from young and old animals. In aged hamsters, oocyte adenosine triphosphate levels and mitochondrial DNA molecules were reduced 35.4% and 51.8%, respectively. Reductions of 38.4% and 44% in adenosine triphosphate and mitochondrial genomes, respectively, were also seen in aged mouse oocytes. Transmission electron microscopic (TEM) analysis showed that aged rodent oocytes had significant alterations in mitochondrial and cytoplasmic lamellae structure. Conclusions/Significance: In both mice and hamsters, decreased adenosine triphosphate in aged oocytes is correlated with a similar decrease in mtDNA molecules and number of mitochondria. Mitochondria in mice and hamsters undergo significant morphological change with aging including mitochondrial vacuolization, cristae alterations, and changes in cytoplasmic lamellae.	[Simsek-Duran, Fatma; Castora, Frank J.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA; [Li, Fang; Ford, Wentia; Swanson, R. James] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Jones, Howard W., Jr.] Eastern Virginia Med Sch, Jones Inst Reprod Med, Dept Obstet & Gynecol, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Old Dominion University; Eastern Virginia Medical School	Castora, FJ (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA.	castorfj@evms.edu		Simsek-Duran, Fatma/0000-0001-8653-764X	Jones Institute Foundation [572831]	Jones Institute Foundation	This work was supported in part by funding from The Jones Institute Foundation (Grant #572831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGGERS J. D., 1971, Methods in mammalian embryology, P86; BRITTON AP, 1991, J MICROSC-OXFORD, V161, P497, DOI 10.1111/j.1365-2818.1991.tb03107.x; Castora FJ, 2008, MOL BIOL CELL S, V19, P2296; de Bruin JP, 2004, BIOL REPROD, V70, P419, DOI 10.1095/biolreprod.103.015784; Dumollard R, 2009, SEMIN CELL DEV BIOL, V20, P346, DOI 10.1016/j.semcdb.2008.12.013; Dvorak M, 1985, SCR MED-BRNO, V58, P161; El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551; Ge HS, 2012, REPROD FERT DEVELOP, V24, P945, DOI 10.1071/RD11212; Hamatani T, 2008, REPRODUCTION, V135, P581, DOI 10.1530/REP-07-0430; Hao ZD, 2009, REPROD FERT DEVELOP, V21, P323, DOI 10.1071/RD08157; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Igarashi H, 2005, BIOL REPROD, V72, P1256, DOI 10.1095/biolreprod.104.034926; Iwata H, 2011, REPROD FERT DEVELOP, V23, P424, DOI 10.1071/RD10133; Jimenez-Movilla M, 2009, HISTOL HISTOPATHOL, V24, P599, DOI 10.14670/HH-24.599; Kushnir VA, 2012, J ASSIST REPROD GEN, V29, P637, DOI 10.1007/s10815-012-9771-5; Nagai Seiichiro, 2004, Hum Cell, V17, P195; PELUSO JJ, 1974, FERTIL STERIL, V25, P494; QUINN P, 1973, J REPROD FERTIL, V35, P301, DOI 10.1530/jrf.0.0350301; Sathananthan A H, 1997, Hum Cell, V10, P21; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Simsek-Duran F, 2009, FASEB J, V855, P10; Sirard MA, 2001, THERIOGENOLOGY, V55, P1241, DOI 10.1016/S0093-691X(01)00480-0; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; Stojkovic M, 2001, BIOL REPROD, V64, P904, DOI 10.1095/biolreprod64.3.904; Sun QY, 2008, BIOL REPROD, V79, P1014, DOI 10.1095/biolreprod.108.070409; Suzuki H., 2005, J MAMM OVA RES, V22, P163; Svoboda P, 2008, CURR TOP MICROBIOL, V320, P225; Tamassia M, 2004, BIOL REPROD, V71, P697, DOI 10.1095/biolreprod.103.026104; Tarin JJ, 1996, MOL HUM REPROD, V2, P717, DOI 10.1093/molehr/2.10.717; Tatone C, 2008, GYNECOL ENDOCRINOL, V24, P59, DOI 10.1080/09513590701733504; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Van Blerkom J, 2008, REPROD BIOMED ONLINE, V16, P553, DOI 10.1016/S1472-6483(10)60463-4; Van Blerkom J, 2006, REPRODUCTION, V131, P961, DOI 10.1530/rep.1.00458; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wang C, 2007, ENDOCRINOLOGY, V148, P1707, DOI 10.1210/en.2006-1193; Wang LY, 2009, J ZHEJIANG UNIV-SC B, V10, P483, DOI 10.1631/jzus.B0820379; Wang LY, 2009, BIOSCIENCE REP, V29, P315, DOI 10.1042/BSR20080104; WEAKLEY BS, 1982, CELL TISSUE RES, V223, P127, DOI 10.1007/BF00221504; WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23; Zeng HT, 2007, HUM REPROD, V22, P1681, DOI 10.1093/humrep/dem070; Zeng HT, 2009, FERTIL STERIL, V91, P900, DOI 10.1016/j.fertnstert.2007.12.008	42	72	80	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64955	10.1371/journal.pone.0064955	http://dx.doi.org/10.1371/journal.pone.0064955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741435	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900148
J	Wang, L; Lin, J; Zhang, TT; Xu, K; Ren, CH; Zhang, ZY				Wang, Ling; Lin, Juan; Zhang, Tingting; Xu, Kun; Ren, Chonghua; Zhang, Zhiying			Simultaneous Screening and Validation of Effective Zinc Finger Nucleases in Yeast	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; TARGETED GENE DISRUPTION; SELECTION; CELLS; RECOMBINATION; EFFICIENCY; MUTANTS; REPAIR	Zinc finger nucleases (ZFNs) have been successfully used for genome modification in various cell types and species. However, construction of an effective ZFN remained challenging. Previous studies all focused on obtaining specific zinc finger proteins (ZFPs) first via bacterial 2-hybrid approach, and then fusing selected ZFPs to FokI nuclease domain. These assembled ZFNs have high rate of failing to cleave target sites in vivo. In this study, we developed a simultaneous screening and validation system to obtain effective ZFNs directly in yeast AH109. This system is based on Gal4 reporter system carrying a unique intermediate reporter plasmid with two 30-bp Gal4 homology arms and a ZFN target site. DNA double strand breaks introduced on target sequence by ZFNs were repaired by single strand annealing (SSA) mechanism, and the restored Gal4 drove reporter genes expression. Taking the advantage of OPEN (Oligomerized Pool ENgineering) selection, we constructed 3 randomized ZFNs libraries and 9 reporter strains for each target gene. We tested this system by taking goat alpha s1-casein as target gene following three-step selection. Consequently, 3 efficient pairs of ZFNs were obtained from positive colonies on selective medium. The ZFNs achieved a 15.9% disruption frequency in goat mammary epithelial cells. In conclusion, we created a novel system to obtain effective ZFNs directly with simultaneous screening and validation.	[Wang, Ling; Lin, Juan; Zhang, Tingting; Xu, Kun; Ren, Chonghua; Zhang, Zhiying] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, ZY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zhangzhy@nwsuaf.edu.cn	Ren, Chonghua/E-3870-2018	Ren, Chonghua/0000-0001-8221-0957; Zhang, Zhiying/0000-0001-6012-0889	National Natural Science Foundation of China [31172186]; 973 program [2011CBA01002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) grant number 31172186 and 973 program (http://www.973.gov.cn, grant number 2011CBA01002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Cannon P, 2011, CURR OPIN HIV AIDS, V6, P74, DOI 10.1097/COH.0b013e32834122d7; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Elrod-Erickson M, 1999, J BIOL CHEM, V274, P19281, DOI 10.1074/jbc.274.27.19281; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Herrmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020913; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Karathanasis E, 2002, GENETICS, V161, P1015; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056476; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ross JW, 2010, TRANSGENIC RES, V19, P611, DOI 10.1007/s11248-009-9345-1; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Shieh JC, 2010, METHODS MOL BIOL, V649, P51, DOI 10.1007/978-1-60761-753-2_3; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Tschulena U, 2009, NAT STRUCT MOL BIOL, V16, P1195, DOI 10.1038/nsmb.1677; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang W, 2012, GENE, V505, P114, DOI 10.1016/j.gene.2012.05.028; Wilson TE, 2002, GENETICS, V162, P677; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045169; Zhu C, 2013, NUCLEIC ACIDS RES, V41, P2455, DOI 10.1093/nar/gks1357	44	11	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64687	10.1371/journal.pone.0064687	http://dx.doi.org/10.1371/journal.pone.0064687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741369	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900082
J	Conseil, M; Carr, J; Molinari, N; Coisel, Y; Cisse, M; Belafia, F; Delay, JM; Jung, B; Jaber, S; Chanques, G				Conseil, Mathieu; Carr, Julie; Molinari, Nicolas; Coisel, Yannael; Cisse, Moussa; Belafia, Fouad; Delay, Jean-Marc; Jung, Boris; Jaber, Samir; Chanques, Gerald			A Simple Widespread Computer Help Improves Nutrition Support Orders and Decreases Infection Complications in Critically Ill Patients	PLOS ONE			English	Article							ENTERAL NUTRITION; PARENTERAL-NUTRITION; ENERGY-EXPENDITURE; INFORMATION-SYSTEM; ADULT PATIENTS; CALORIC-INTAKE; CARE; GUIDELINES; IMPACT; IMPLEMENTATION	Aims: To assess the impact of a simple computer-based decision-support system (computer help) on the quality of nutrition support orders and patients' outcome in Intensive-Care Unit (ICU). Methods: This quality-improvement study was carried out in a 16-bed medical-surgical ICU in a French university hospital. All consecutive patients who stayed in ICU more than 10 days with non-oral feeding for more than 5 days were retrospectively included during two 12-month periods. Prescriptions of nutrition support were collected and compared to French national guidelines as a quality-improvement process. A computer help was constructed using a simple Excel-sheet (Microsoft(TM)) to guide physicians' prescriptions according to guidelines. This computer help was displayed in computers previously used for medical orders. Physicians were informed but no systematic protocol was implemented. Patients included during the first (control group) and second period (computer help group) were compared for achievement of nutrition goals and ICU outcomes. Results: The control and computer help groups respectively included 71 and 95 patients. Patients' characteristics were not significantly different between groups. In the computer help group, prescriptions achieved significantly more often 80% of nutrition goals for calorie (45% vs. 79% p<0.001) and nitrogen intake (3% vs. 37%, p<0.001). Incidence of nosocomial infections decreased significantly between the two groups (59% vs. 41%, p = 0.03). Mortality did not significantly differ between control (21%) and computer help groups (15%, p = 0.30). Conclusions: Use of a widespread inexpensive computer help is associated with significant improvements in nutrition support orders and decreased nosocomial infections in ICU patients. This computer-help is provided in electronic supplement.	[Conseil, Mathieu; Carr, Julie; Coisel, Yannael; Cisse, Moussa; Belafia, Fouad; Delay, Jean-Marc; Jung, Boris; Jaber, Samir; Chanques, Gerald] Univ Montpellier Hosp, St Eloi Hosp, Intens Care & Anesthesiol Dept, Montpellier, France; [Conseil, Mathieu; Coisel, Yannael; Jung, Boris; Jaber, Samir; Chanques, Gerald] Univ Montpellier 2, Univ Montpellier 1, INSERM, Unite U1046, Montpellier, France; [Molinari, Nicolas] Univ Montpellier, Lapeyronie Hosp, Dept Stat, F-34059 Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Chanques, G (corresponding author), Univ Montpellier Hosp, St Eloi Hosp, Intens Care & Anesthesiol Dept, Montpellier, France.	g-chanques@chu-montpellier.fr	Jung, Boris/AAK-5066-2021; molinari, nicolas/Y-9681-2019	Jung, Boris/0000-0003-2522-1531; 	University of Montpellier Hospitals	University of Montpellier Hospitals	This study is part of the authors' own work at the University of Montpellier Hospitals which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attof Y, 2007, ANN FR ANESTH, V26, P1031, DOI 10.1016/j.annfar.2007.09.026; Barr J, 2004, CHEST, V125, P1446, DOI 10.1378/chest.125.4.1446; Berger MM, 1997, NUTRITION, V13, P870, DOI 10.1016/S0899-9007(97)00270-0; Berger MM, 2006, NUTRITION, V22, P221, DOI 10.1016/j.nut.2005.04.017; Blaser AR, 2012, INTENS CARE MED, V38, P384, DOI 10.1007/s00134-011-2459-y; Bosman RJ, 2003, INTENS CARE MED, V29, P83, DOI 10.1007/s00134-002-1542-9; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Chambrier C, 2010, FRENCH CLIN GUIDELIN; Conference de Consensus, 1998, NUTR CLIN METAB, V12, P2; Conference de Consensus, 1995, NUTR CLIN METABOL S1, V9, P1; Conseil M, 2006, REANIMATION, V15, pS58; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; De Jonghe B, 2001, CRIT CARE MED, V29, P8, DOI 10.1097/00003246-200101000-00002; Doig GS, 2008, JAMA-J AM MED ASSOC, V300, P2731, DOI 10.1001/jama.2008.826; Fowler S, 2007, J ANTIMICROB CHEMOTH, V59, P990, DOI 10.1093/jac/dkm014; Giner M, 1996, NUTRITION, V12, P23, DOI 10.1016/0899-9007(95)00015-1; Glynn CC, 1999, JPEN-PARENTER ENTER, V23, P147, DOI 10.1177/0148607199023003147; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Heyland DK, 2011, CLIN NUTR, V30, P148, DOI 10.1016/j.clnu.2010.09.011; Heyland DK, 2004, CRIT CARE MED, V32, P2260, DOI 10.1097/01.CCM.0000145581.54571.32; Howard JP, 1999, CLIN NUTR, V18, P379, DOI 10.1016/S0261-5614(99)80020-X; Kiser Kim, 2011, Minn Med, V94, P22; Klein CJ, 1998, J AM DIET ASSOC, V98, P795, DOI 10.1016/S0002-8223(98)00179-5; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Krishnan JA, 2003, CHEST, V124, P297, DOI 10.1378/chest.124.1.297; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MacDonald A, 2003, NUTRITION, V19, P233, DOI 10.1016/S0899-9007(02)01033-X; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; Martindale RG, 2009, CRIT CARE MED, V37, P1757, DOI 10.1097/CCM.0b013e3181a40116; Mowe M, 2008, CLIN NUTR, V27, P196, DOI 10.1016/j.clnu.2007.10.014; Nightingale PG, 2000, BMJ-BRIT MED J, V320, P750, DOI 10.1136/bmj.320.7237.750; Pulcini C, 2011, MED MALADIES INFECT, V41, P546, DOI 10.1016/j.medmal.2011.07.003; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Rubinson L, 2004, CRIT CARE MED, V32, P350, DOI 10.1097/01.CCM.0000089641.06306.68; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Societe francaise d'anesthesie et de reanimation, 2009, Ann Fr Anesth Reanim, V28, P912, DOI 10.1016/j.annfar.2009.09.007; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63771	10.1371/journal.pone.0063771	http://dx.doi.org/10.1371/journal.pone.0063771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737948	Green Published, gold			2022-12-27	WOS:000321394700011
J	Cui, C; Filla, MB; Jones, EAV; Lansford, R; Cheuvront, T; Al-Roubaie, S; Rongish, BJ; Little, CD				Cui, Cheng; Filla, Michael B.; Jones, Elizabeth A. V.; Lansford, Rusty; Cheuvront, Tracey; Al-Roubaie, Sarah; Rongish, Brenda J.; Little, Charles D.			Embryogenesis of the First Circulating Endothelial Cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PROGENITOR CELLS; STEM-CELLS; MONONUCLEAR-CELLS; AVIAN EMBRYOS; ORIGIN; NEOVASCULARIZATION; TRANSPLANTATION; VASCULOGENESIS; REGENERATION	Prior to this study, the earliest appearance of circulating endothelial cells in warm-blooded animals was unknown. Time-lapse imaging of germ-line transformed Tie1-YFP reporter quail embryos combined with the endothelial marker antibody QH1 provides definitive evidence for the existence of circulating endothelial cells - from the very beginning of blood flow. Blood-smear counts of circulating cells from Tie1-YFP embryos showed that up to 30% of blood-borne cells are Tie1 positive; though cells expressing low levels of YFP were also positive for benzidine, a hemoglobin stain, suggesting that these cells were differentiating into erythroblasts. Electroporation-based time-lapse experiments, exclusively targeting the intra-embryonic mesoderm were combined with QH1 immunostaining. The latter antibody marks quail endothelial cells. Together the optical data provide conclusive evidence that endothelial cells can enter blood flow from vessels of the embryo proper, as well as from extra-embryonic areas. When Tie1-YFP positive cells and tissues are transplanted to wild type host embryos, fluorescent cells emigrate from such transplants and join host vessels; subsequently a few YFP cells are shed into circulation. These data establish that entering circulation is a commonplace activity of embryonic vascular endothelial cells. We conclude that in the class of vertebrates most closely related to mammals a normal component of primary vasculogenesis is production of endothelial cells that enter circulation from all vessels, both intra-and extra-embryonic.	[Cui, Cheng; Filla, Michael B.; Cheuvront, Tracey; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Jones, Elizabeth A. V.; Al-Roubaie, Sarah] McGill Univ, Dept Chem Engn, Montreal, PQ, Canada; [Lansford, Rusty] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	University of Kansas; University of Kansas Medical Center; McGill University; California Institute of Technology	Little, CD (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.	clittle@kumc.edu	Jones, Elizabeth/B-3827-2010; Lansford, Rusty/C-6956-2014; Rongish, Brenda/G-7637-2016; Jones, Elizabeth AV/I-2180-2018	Jones, Elizabeth/0000-0002-2006-7064; Rongish, Brenda/0000-0002-1559-2876; Jones, Elizabeth AV/0000-0002-2006-7064; Lansford, Rusty/0000-0002-2159-3699	National Institutes of Health [HL085694, HL068855]; G. Harold & Leila Y. Mathers Charitable Foundation; NSERC [342134]; American Heart Assoc [0620105Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068855, R01HL085694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold & Leila Y. Mathers Charitable Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Heart Assoc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health R01 grants HL085694 (BJR), HL068855 (CDL) (http://www.nih.gov/); the G. Harold & Leila Y. Mathers Charitable Foundation (BJR and CDL) (http://www.mathersfoundation.org/); a NSERC Discovery 342134 (EAVJ) (http://www.nserc-crsng.gc.ca); and an American Heart Assoc, postdoctoral fellowship (0620105Z) to CC (http://www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Roubaie S, 2012, DEV DYNAM, V241, P1423, DOI 10.1002/dvdy.23835; ARCINIEGAS E, 1992, J CELL SCI, V103, P521; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; CUADROS MA, 1992, DEVELOPMENT, V115, P157; Cui C, 2006, DEV DYNAM, V235, P2802, DOI 10.1002/dvdy.20895; Cui C, 2009, DEV BIOL, V332, P212, DOI 10.1016/j.ydbio.2009.05.570; Cui C, 2009, ANAT REC, V292, P557, DOI 10.1002/ar.20872; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Erbs S, 2005, CIRC RES, V97, P756, DOI 10.1161/01.RES.0000185811.71306.8b; Fischer-Rasokat U, 2009, CIRC-HEART FAIL, V2, P417, DOI 10.1161/CIRCHEARTFAILURE.109.855023; GARCIAMARTINEZ V, 1993, DEV BIOL, V159, P706, DOI 10.1006/dbio.1993.1276; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Krenning G, 2008, BIOMATERIALS, V29, P3703, DOI 10.1016/j.biomaterials.2008.05.034; LaRue AC, 2003, DEV BIOL, V262, P162, DOI 10.1016/S0012-1606(03)00358-0; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Pardanaud L, 2006, DEVELOPMENT, V133, P2596, DOI 10.1242/dev.02461; Pardanaud L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025889; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; POOLE TJ, 1988, SCANNING MICROSCOPY, V2, P443; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Rodewald HR, 1996, ONCOGENE, V12, P397; Rupp PA, 2004, DEVELOPMENT, V131, P2887, DOI 10.1242/dev.01160; Rupp PA, 2003, BIOTECHNIQUES, V34, P274, DOI 10.2144/03342st01; Rupp PA, 2008, METHOD ENZYMOL, V445, P107, DOI 10.1016/S0076-6879(08)03005-X; Sato Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012674, 10.1371/journal.pone.0015119, 10.1371/journal.pone.0013109]; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Tendera M, 2009, EUR HEART J, V30, P1313, DOI 10.1093/eurheartj/ehp073; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Zentilin L, 2006, BLOOD, V107, P3546, DOI 10.1182/blood-2005-08-3215; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	40	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e60841	10.1371/journal.pone.0060841	http://dx.doi.org/10.1371/journal.pone.0060841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737938	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700002
J	Huang, XF; Xiang, P; Chen, J; Xing, DJ; Huang, N; Min, QJ; Gu, F; Tong, Y; Pang, CP; Qu, J; Jin, ZB				Huang, Xiu-Feng; Xiang, Ping; Chen, Jie; Xing, Dong-Jun; Huang, Na; Min, Qingjie; Gu, Feng; Tong, Yi; Pang, Chi-Pui; Qu, Jia; Jin, Zi-Bing			Targeted Exome Sequencing Identified Novel USH2A Mutations in Usher Syndrome Families	PLOS ONE			English	Article							SYNDROME TYPE-II; SHORT READ ALIGNMENT; RETINITIS-PIGMENTOSA; SYNDROME TYPE-2; GENE; SPECTRUM; JAPANESE; DISEASE	Usher syndrome (USH) is a leading cause of deaf-blindness in autosomal recessive trait. Phenotypic and genetic heterogeneities in USH make molecular diagnosis much difficult. This is a pilot study aiming to develop an approach based on next-generation sequencing to determine the genetic defects in patients with USH or allied diseases precisely and effectively. Eight affected patients and twelve unaffected relatives from five unrelated Chinese USH families, including 2 pseudo-dominant ones, were recruited. A total of 144 known genes of inherited retinal diseases were selected for deep exome resequencing. Through systematic data analysis using established bioinformatics pipeline and segregation analysis, a number of genetic variants were released. Eleven mutations, eight of them were novel, in the USH2A gene were identified. Biparental mutations in USH2A were revealed in 2 families with pseudo-dominant inheritance. A proband was found to have triple mutations, two of them were supposed to locate in the same chromosome. In conclusion, this study revealed the genetic defects in the USH2A gene and demonstrated the robustness of targeted exome sequencing to precisely and rapidly determine genetic defects. The methodology provides a reliable strategy for routine gene diagnosis of USH.	[Huang, Xiu-Feng; Xiang, Ping; Xing, Dong-Jun; Huang, Na; Jin, Zi-Bing] Wenzhou Med Coll, Hosp Eye, Div Ophthalm Genet, Lab Stem Cell & Retinal Regenerat, Wenzhou, Peoples R China; [Huang, Xiu-Feng; Xiang, Ping; Xing, Dong-Jun; Huang, Na; Gu, Feng; Qu, Jia; Jin, Zi-Bing] Minist Hlth PR China, State Key Lab Cultivat Base, Wenzhou, Peoples R China; [Huang, Xiu-Feng; Xiang, Ping; Xing, Dong-Jun; Huang, Na; Gu, Feng; Qu, Jia; Jin, Zi-Bing] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Peoples R China; [Chen, Jie; Jin, Zi-Bing] Wenzhou Med Coll, Hosp Eye, Ctr Excellence Low Vis & Visual Rehabil, Wenzhou, Peoples R China; [Min, Qingjie] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China; [Tong, Yi] Fuzhou Southeastern Eye Hosp, Fuzhou, Peoples R China; [Pang, Chi-Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Chinese University of Hong Kong	Jin, ZB (corresponding author), Wenzhou Med Coll, Hosp Eye, Div Ophthalm Genet, Lab Stem Cell & Retinal Regenerat, Wenzhou, Peoples R China.	jinzb@mail.eye.ac.cn	Pang, Chi P/I-5388-2014; Xiang, Ping/I-7695-2013; Jin, Zi-Bing/AAE-4106-2019; Jin, Zi-Bing/J-6810-2014	Xiang, Ping/0000-0002-0870-8551; Jin, Zi-Bing/0000-0003-0515-698X; Jin, Zi-Bing/0000-0003-0515-698X; Huang, Xiu-Feng/0000-0002-7852-6358	National Natural Science Foundation of China [H1208/81170879]; National Key Basic Research Program [2013CB967502]; MOST Major Projects [2012YQ12008004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); MOST Major Projects	This study was supported by the National Natural Science Foundation of China (H1208/81170879), the National Key Basic Research Program (2013CB967502), and the MOST Major Projects (2012YQ12008004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besnard T, 2012, HUM MUTAT, V33, P504, DOI 10.1002/humu.22004; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Bowne SJ, 2011, INVEST OPHTH VIS SCI, V52, P494, DOI 10.1167/iovs.10-6180; Bras J, 2012, NAT REV NEUROSCI, V13, P453, DOI 10.1038/nrn3271; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dreyer B, 2008, HUM MUTAT, V29, P451, DOI 10.1002/humu.9524; He J, 2011, ONCOTARGET, V2, P178; Hou HB, 2010, NUCLEIC ACIDS RES, V38, pW732, DOI 10.1093/nar/gkq302; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Nakanishi H, 2009, CLIN GENET, V76, P383, DOI 10.1111/j.1399-0004.2009.01257.x; Nakanishi H, 2011, J HUM GENET, V56, P484, DOI 10.1038/jhg.2011.45; van Wijk E, 2004, AM J HUM GENET, V74, P738, DOI 10.1086/383096; WLELBER RG, 2006, RETINA, P395; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Xu WJ, 2011, MOL VIS, V17, P1537	19	45	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63832	10.1371/journal.pone.0063832	http://dx.doi.org/10.1371/journal.pone.0063832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737954	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700017
J	Kunkle, BW; Yoo, C; Roy, D				Kunkle, Brian W.; Yoo, Changwon; Roy, Deodutta			Reverse Engineering of Modified Genes by Bayesian Network Analysis Defines Molecular Determinants Critical to the Development of Glioblastoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL-CYCLE; HIGH-GRADE; EXPRESSION; CANCER; GLIOMA; PROLIFERATION; ANGIOGENESIS; INHIBITION; MUTATIONS	In this study we have identified key genes that are critical in development of astrocytic tumors. Meta-analysis of microarray studies which compared normal tissue to astrocytoma revealed a set of 646 differentially expressed genes in the majority of astrocytoma. Reverse engineering of these 646 genes using Bayesian network analysis produced a gene network for each grade of astrocytoma (Grade I-IV), and 'key genes' within each grade were identified. Genes found to be most influential to development of the highest grade of astrocytoma, Glioblastoma multiforme were: COL4A1, EGFR, BTF3, MPP2, RAB31, CDK4, CD99, ANXA2, TOP2A, and SERBP1. All of these genes were up-regulated, except MPP2 (down regulated). These 10 genes were able to predict tumor status with 96-100% confidence when using logistic regression, cross validation, and the support vector machine analysis. Markov genes interact with NFk beta, ERK, MAPK, VEGF, growth hormone and collagen to produce a network whose top biological functions are cancer, neurological disease, and cellular movement. Three of the 10 genes - EGFR, COL4A1, and CDK4, in particular, seemed to be potential 'hubs of activity'. Modified expression of these 10 Markov Blanket genes increases lifetime risk of developing glioblastoma compared to the normal population. The glioblastoma risk estimates were dramatically increased with joint effects of 4 or more than 4 Markov Blanket genes. Joint interaction effects of 4, 5, 6, 7, 8, 9 or 10 Markov Blanket genes produced 9, 13, 20.9, 26.7, 52.8, 53.2, 78.1 or 85.9%, respectively, increase in lifetime risk of developing glioblastoma compared to normal population. In summary, it appears that modified expression of several 'key genes' may be required for the development of glioblastoma. Further studies are needed to validate these 'key genes' as useful tools for early detection and novel therapeutic options for these tumors.	[Kunkle, Brian W.; Roy, Deodutta] Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA; [Yoo, Changwon] Florida Int Univ, Dept Biostat, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Roy, D (corresponding author), Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA.	Droy@fiu.edu		Yoo, Changwon/0000-0003-0969-7468	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM096948] Funding Source: NIH RePORTER; NIGMS NIH HHS [SC3 GM096948] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An JH, 2009, J PROTEOME RES, V8, P2873, DOI 10.1021/pr900020q; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banjo, BAYES NETW INF JAV O; Bansal M, 2007, IET SYST BIOL, V1, P306, DOI 10.1049/iet-syb:20060079; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; CHARNIAK E, 1991, AI MAG, V12, P50; Dawany NB, 2011, INT J CANCER, V128, P2881, DOI 10.1002/ijc.25854; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Druzdzel M.J., 1999, SMILE STRUCTURAL MOD; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Glez-Pena D, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-147; Guerreiro AS, 2011, MOL CANCER RES, V9, P925, DOI 10.1158/1541-7786.MCR-10-0200; Guillamo JS, 2009, CLIN CANCER RES, V15, P3697, DOI 10.1158/1078-0432.CCR-08-2042; Gutmann DH, 2002, CANCER RES, V62, P2085; Hartemink AJ, 2005, NAT BIOTECHNOL, V23, P554, DOI 10.1038/nbt0505-554; Howlader N, 2011, SEER CANC STAT REV 1; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Idbaih A, 2009, NEUROPATH APPL NEURO, V35, P208, DOI 10.1111/j.1365-2990.2008.00977.x; Ishizawa K, 2008, CLIN NEUROPATHOL, V27, P118; Koensgen D, 2007, GYNECOL ONCOL, V107, P266, DOI 10.1016/j.ygyno.2007.06.023; Kusumawidjaja G, 2007, CANCER BIOL THER, V6, P367, DOI 10.4161/cbt.6.3.3704; Ladha J, 2010, CANCER RES, V70, P6437, DOI 10.1158/0008-5472.CAN-10-0819; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu Y, 2010, J NEURO-ONCOL, V99, P13, DOI 10.1007/s11060-009-0105-0; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nakahara Y, 2004, NEURO-ONCOLOGY, V6, P281, DOI 10.1215/S1152851703000632; Ng EL, 2009, J CELL PHYSIOL, V221, P716, DOI 10.1002/jcp.21911; Nobusawa S, 2010, BRAIN PATHOL, V20, P936, DOI 10.1111/j.1750-3639.2010.00395.x; Odreman F, 2005, J PROTEOME RES, V4, P698, DOI 10.1021/pr0498180; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rickman DS, 2001, CANCER RES, V61, P6885; Ruano Y, 2009, AM J CLIN PATHOL, V131, P257, DOI 10.1309/AJCP64YBDVCTIRWV; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Yoo C, 2002, Pac Symp Biocomput, P498; Yoo C, 2009, ANN NY ACAD SCI, V1158, P93, DOI 10.1111/j.1749-6632.2008.03749.x; Yu J, 2002, USING BAYESIAN NETWO; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	50	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64140	10.1371/journal.pone.0064140	http://dx.doi.org/10.1371/journal.pone.0064140			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737970	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700034
J	Scally, A; Yngvadottir, B; Xue, YL; Ayub, Q; Durbin, R; Tyler-Smith, C				Scally, Aylwyn; Yngvadottir, Bryndis; Xue, Yali; Ayub, Qasim; Durbin, Richard; Tyler-Smith, Chris			A Genome-Wide Survey of Genetic Variation in Gorillas Using Reduced Representation Sequencing	PLOS ONE			English	Article							ALLELE FREQUENCY-SPECTRUM; EVOLUTIONARY HISTORY; DEMOGRAPHIC HISTORY; ECOLOGY; DIVERSITY; TAXONOMY; INSIGHTS; COMPLEX	All non-human great apes are endangered in the wild, and it is therefore important to gain an understanding of their demography and genetic diversity. Whole genome assembly projects have provided an invaluable foundation for understanding genetics in all four genera, but to date genetic studies of multiple individuals within great ape species have largely been confined to mitochondrial DNA and a small number of other loci. Here, we present a genome-wide survey of genetic variation in gorillas using a reduced representation sequencing approach, focusing on the two lowland subspecies. We identify 3,006,670 polymorphic sites in 14 individuals: 12 western lowland gorillas (Gorilla gorilla gorilla) and 2 eastern lowland gorillas (Gorilla beringei graueri). We find that the two species are genetically distinct, based on levels of heterozygosity and patterns of allele sharing. Focusing on the western lowland population, we observe evidence for population substructure, and a deficit of rare genetic variants suggesting a recent episode of population contraction. In western lowland gorillas, there is an elevation of variation towards telomeres and centromeres on the chromosomal scale. On a finer scale, we find substantial variation in genetic diversity, including a marked reduction close to the major histocompatibility locus, perhaps indicative of recent strong selection there. These findings suggest that despite their maintaining an overall level of genetic diversity equal to or greater than that of humans, population decline, perhaps associated with disease, has been a significant factor in recent and long-term pressures on wild gorilla populations.	[Scally, Aylwyn; Yngvadottir, Bryndis; Xue, Yali; Ayub, Qasim; Durbin, Richard; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Scally, Aylwyn] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Yngvadottir, Bryndis] Univ Cambridge, Div Biol Anthropol, Cambridge, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England.	cts@sanger.ac.uk	Durbin, Richard/AAE-7178-2019	Durbin, Richard/0000-0002-9130-1006; Ayub, Qasim/0000-0003-3291-0917	Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust (grant number 098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2010, EVOLUTION, V64, P271, DOI 10.1111/j.1558-5646.2009.00858.x; Alexander DH, 2009, GENOME RES, P1664; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anthony NM, 2007, P NATL ACAD SCI USA, V104, P20432, DOI 10.1073/pnas.0704816105; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Becquet C, 2009, EVOLUTION, V63, P2547, DOI 10.1111/j.1558-5646.2009.00662.x; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Brelsford A, 2012, MOL ECOL; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Clifford SL, 2004, MOL ECOL, V13, P1551, DOI 10.1111/j.1365-294X.2004.02140.x; De Groot NG, 2008, MOL ECOL, V17, P2074, DOI 10.1111/j.1365-294X.2008.03716.x; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dupont LM, 2000, PALAEOGEOGR PALAEOCL, V155, P95, DOI 10.1016/S0031-0182(99)00095-4; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Fossey Diane, 1983, GORILLAS IN THE MIST; Garner KJ, 1996, MOL PHYLOGENET EVOL, V6, P39, DOI 10.1006/mpev.1996.0056; Gautier M, 2012, MOL ECOL; GROVES CP, 1967, NATURE, V213, P890, DOI 10.1038/213890a0; IUCN, 2012, IUCN RED LIST THREAT; Jensen-Seaman MI, 2001, MOL ECOL, V10, P2241, DOI 10.1046/j.0962-1083.2001.01365.x; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lie BA, 2005, CURR OPIN IMMUNOL, V17, P526, DOI 10.1016/j.coi.2005.07.001; Luca F, 2011, GENOME RES, V21, P1087, DOI 10.1101/gr.119792.110; Lukas D, 2004, MOL ECOL, V13, P3389, DOI 10.1111/j.1365-294X.2004.02353.x; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pilbrow V, 2010, J HUM EVOL, V59, P16, DOI 10.1016/j.jhevol.2010.01.009; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sarmiento EE, 2003, CAM S BIO EVOL ANTHR, V35, P432; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; Sepil I, 2012, MOL ECOL; Thalmann O, 2005, MOL ECOL, V14, P179, DOI 10.1111/j.1365-294X.2004.02382.x; Thalmann OH, 2007, MOL BIOL EVOL, V24, P146, DOI 10.1093/molbev/msl160; Thalmann O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-85; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566	39	15	15	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65066	10.1371/journal.pone.0065066	http://dx.doi.org/10.1371/journal.pone.0065066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750230	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900032
J	Papafragkou, E; Hewitt, J; Park, GW; Greening, G; Vinje, J				Papafragkou, Efstathia; Hewitt, Joanne; Park, Geun Woo; Greening, Gail; Vinje, Jan			Challenges of Culturing Human Norovirus in Three-Dimensional Organoid Intestinal Cell Culture Models	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; BLOOD-GROUP ANTIGEN; NORWALK VIRUS; DENDRITIC CELLS; UNITED-STATES; REPLICATION; BINDING; CACO-2; TISSUE; AMPLIFICATION	Human noroviruses are the most common cause of acute gastroenteritis worldwide. Recently, cell culture systems have been described using either human embryonic intestinal epithelial cells (Int-407) or human epithelial colorectal adenocarcinoma cells (Caco-2) growing on collagen-I porous micro carrier beads in a rotating bioreactor under conditions of physiological fluid shear. Here, we describe the efforts from two independent laboratories to implement this three dimensional (3D) cell culture system for the replication of norovirus. Int-407 and Caco-2 were grown in a rotating bioreactor for up to 28 days. Prior to infection, cells were screened for the presence of microvilli by electron microscopy and stained for junction proteins (zonula occludens-1, claudin-1, and b-catenin). Differentiated 3D cells were transferred to 24-well plates and infected with bacteria-free filtrates of various norovirus genotypes (GI. 1, GI. 3, GI. 8, GII. 2, GII. 4, GII. 7, and GII. 8). At 12 h, 24 h, and 48 h post inoculation, viral RNA from both cells and supernatants were collected and analyzed for norovirus RNA by real-time reverse transcription PCR. Despite observations of high expression of junction proteins and microvilli development in stained thin sections, our data suggest no significant increase in viral titer based on norovirus RNA copy number during the first 48 h after inoculation for the different samples and virus culture conditions tested. Our combined efforts demonstrate that 3D cell culture models using Int-407 or Caco-2 cells do not support norovirus replication and highlight the complexity and difficulty of developing a reproducible in vitro cell culture system for human norovirus.	[Papafragkou, Efstathia; Park, Geun Woo; Vinje, Jan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA; [Papafragkou, Efstathia] US FDA, Ctr Food Safety & Appl Nutr, Div Mol Biol, Laurel, MD USA; [Hewitt, Joanne; Greening, Gail] Inst Environm Sci & Res Ltd, Kenepuru Sci Ctr, Porirua, New Zealand	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); Institute of Environmental Science & Research (ESR) - New Zealand	Vinje, J (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA.	jvinje@cdc.gov	Vinje, Jan/ABE-6336-2020	Vinje, Jan/0000-0002-1530-3675; Hewitt, Joanne/0000-0003-0370-6394	ASM/CDC Fellowship Program in Infectious Disease and Public Health Microbiology; ESR Capability Fund	ASM/CDC Fellowship Program in Infectious Disease and Public Health Microbiology; ESR Capability Fund	This research was funded in part by the ASM/CDC Fellowship Program in Infectious Disease and Public Health Microbiology for EP. The New Zealand study was funded by the ESR Capability Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano J, 1999, J BIOL CHEM, V274, P21209, DOI 10.1074/jbc.274.30.21209; Ando T, 1997, J CLIN MICROBIOL, V35, P570, DOI 10.1128/JCM.35.3.570-577.1997; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; DAGAN R, 1986, J MED VIROL, V19, P219, DOI 10.1002/jmv.1890190304; DOLIN R, 1975, AM J MED, V59, P761, DOI 10.1016/0002-9343(75)90461-1; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Herbst-Kralovetz MM, 2013, EMERG INFECT DIS, V19, P431, DOI 10.3201/eid1903.121029; Howell JC, 2011, REGEN MED, V6, P743, DOI [10.2217/RME.11.90, 10.2217/rme.11.90]; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Hughes JH, 1996, NASA BIOT C HOUST TX; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; Lelkes PI, 1997, IN VITRO CELL DEV-AN, V33, P344; Leung WK, 2010, HONG KONG MED J, V16, pS8; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu PB, 2010, J MED VIROL, V82, P1612, DOI 10.1002/jmv.21851; Long JP, 1998, AVIAT SPACE ENVIR MD, V69, P851; Metcalfe MG, 2008, MICROSC MICROANAL, V14, P1548; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Park GW, 2010, J FOOD PROTECT, V73, P2232, DOI 10.4315/0362-028X-73.12.2232; PINTO RM, 1994, J MED VIROL, V44, P310, DOI 10.1002/jmv.1890440317; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Straub TM, 2011, J WATER HEALTH, V9, P225, DOI 10.2166/wh.2010.106; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; White LJ, 1996, J VIROL, V70, P6589, DOI 10.1128/JVI.70.10.6589-6597.1996; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wu SC, 2002, BIOTECHNOL PROGR, V18, P124, DOI 10.1021/bp010120q; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	39	82	88	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63485	10.1371/journal.pone.0063485	http://dx.doi.org/10.1371/journal.pone.0063485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755105	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300010
J	Bultmann, I; Conradi, A; Kretschmer, C; Sterner-Kock, A				Bultmann, Insa; Conradi, Anne; Kretschmer, Celine; Sterner-Kock, Anja			Latent Transforming Growth Factor beta-Binding Protein 4 Is Downregulated in Esophageal Cancer via Promoter Methylation	PLOS ONE			English	Article							TGF-BETA; BINDING-PROTEIN-4 LTBP-4; EXTRACELLULAR-MATRIX; LUNG DEVELOPMENT; CELL-CYCLE; IN-VITRO; EXPRESSION; E2F4; TRANSCRIPTION; ACTIVATION	Latent transforming growth factor beta-binding protein 4 (LTBP4) is an extracellular matrix molecule that is a member of important connective tissue networks and is needed for the correct folding and the secretion of TGF-beta 1. LTBP4 is downregulated in carcinomas of various tissues. Here we show that LTBP4 is also downregulated in adenocarcinomas and squamous cell carcinomas of the esophagus in vitro and in vivo. Re-expression of LTBP4 in esophageal cancer cell lines reduced cell migration ability, whereas cell viability and cell proliferation remained unchanged. Hypermethylation of the promoter regions of the two main human LTBP4 transcriptional forms, LTBP4L and LTBP4S, was found to be involved in LTBP4 silencing. Detailed investigations of the methylation patterns of the promoter regions of LTBP4L and LTBP4S identified GATA1, SP1, E2F4 and SMAD3 as potential transcription factors involved in LTBP4 expression. In in vitro transcription factor activity studies we discovered E2F4 as novel powerful regulator for LTBP4S expression.	[Bultmann, Insa; Conradi, Anne; Sterner-Kock, Anja] Univ Cologne, Fac Med, Ctr Med Expt, D-50931 Cologne, Germany; [Kretschmer, Celine] Charite, Med Klin Hepatol & Gastroenterol, Berlin, Germany	University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sterner-Kock, A (corresponding author), Univ Cologne, Fac Med, Ctr Med Expt, D-50931 Cologne, Germany.	anja.sterner-kock@uk-koeln.de			Maria Pesch-Foundation (National Science Funding Organisation)	Maria Pesch-Foundation (National Science Funding Organisation)	This work was supported by the Maria Pesch-Foundation (National Science Funding Organisation). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrol ED, 2011, J IMMUNOL, V186, P2329, DOI 10.4049/jimmunol.1002402; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chan SHK, 2011, INT J CANCER, V129, P565, DOI 10.1002/ijc.25698; CHAUDHRY A, 1994, ANTICANCER RES, V14, P2085; Chen H, 2012, CANCER LETT, V325, P89, DOI 10.1016/j.canlet.2012.06.005; Dabovic B, 2009, J CELL PHYSIOL, V219, P14, DOI 10.1002/jcp.21643; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; Danielian PS, 2007, DEV BIOL, V305, P564, DOI 10.1016/j.ydbio.2007.02.037; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gavin AT, 2012, CANC EPIDEMIOL; Groblewska M, 2012, FOLIA HISTOCHEM CYTO, V50, P12, DOI [10.5603/FHC.2012.0002, 10.2478/18691]; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HENRIKSEN R, 1995, LAB INVEST, V73, P213; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Kantola AK, 2005, GENE, V363, P142, DOI 10.1016/j.gene.2005.07.042; Kantola AK, 2010, J CELL PHYSIOL, V223, P727, DOI 10.1002/jcp.22082; Kaz AM, 2012, CANC LETT; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klopfleisch R, 2010, VET J, V186, P379, DOI 10.1016/j.tvjl.2009.09.014; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Koli K, 2001, MICROSC RES TECHNIQ, V52, P354, DOI 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G; Koski C, 1999, J BIOL CHEM, V274, P32619, DOI 10.1074/jbc.274.46.32619; Kretschmer C, 2011, CELL ONCOL, V34, P419, DOI 10.1007/s13402-011-0023-y; Landsberg RL, 2003, P NATL ACAD SCI USA, V100, P2456, DOI 10.1073/pnas.0138064100; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Mauel S, 2007, APMIS, V115, P687, DOI 10.1111/j.1600-0463.2007.apm_453.x; Miller ES, 2010, CELL CYCLE, V9, P2620, DOI 10.4161/cc.9.13.12108; Monticelli S, 2004, J BIOL CHEM, V279, P36210, DOI 10.1074/jbc.M406354200; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Roth-Eichhorn S, 2001, SCAND J GASTROENTERO, V36, P1204; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Tycko B, 2000, J CLIN INVEST, V105, P401, DOI 10.1172/JCI9462; Urban Z, 2009, AM J HUM GENET, V85, P593, DOI 10.1016/j.ajhg.2009.09.013; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zhang XS, 2002, LIFE SCI, V71, P3005, DOI 10.1016/S0024-3205(02)02164-1	46	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65614	10.1371/journal.pone.0065614	http://dx.doi.org/10.1371/journal.pone.0065614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741501	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900214
J	Jin, Q; Han, HL; Hu, XM; Li, XH; Zhu, CD; Ho, SYW; Ward, RD; Zhang, AB				Jin, Qian; Han, Huilin; Hu, XiMin; Li, XinHai; Zhu, ChaoDong; Ho, Simon Y. W.; Ward, Robert D.; Zhang, Ai-bing			Quantifying Species Diversity with a DNA Barcoding-Based Method: Tibetan Moth Species (Noctuidae) on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; RAPID BIODIVERSITY ASSESSMENT; PARASITOID FLIES DIPTERA; FUNCTIONAL DIVERSITY; PARTITIONING DIVERSITY; IDENTIFICATION; LEPIDOPTERA; POPULATION; MEMBERSHIP; SEQUENCES	With the ongoing loss of biodiversity, there is a great need for fast and effective ways to assess species richness and diversity: DNA barcoding provides a powerful new tool for this. We investigated this approach by focusing on the Tibetan plateau, which is one of the world's top biodiversity hotspots. There have been few studies of its invertebrates, although they constitute the vast majority of the region's diversity. Here we investigated species diversity of the lepidopteran family Noctuidae, across different environmental gradients, using measurements based on traditional morphology as well as on DNA barcoding. The COI barcode showed an average interspecific K2P distance of 9.45 +/- 2.08%, which is about four times larger than the mean intraspecific distance (1.85 +/- 3.20%). Using six diversity indices, we did not detect any significant differences in estimated species diversity between measurements based on traditional morphology and on DNA barcoding. Furthermore, we found strong positive correlations between them, indicating that barcode-based measures of species diversity can serve as a good surrogate for morphology-based measures in most situations tested. Eastern communities were found to have significantly higher diversity than Western ones. Among 22 environmental factors tested, we found that three (precipitation of driest month, precipitation of driest quarter, and precipitation of coldest quarter) were significantly correlated with species diversity. Our results indicate that these factors could be the key ecological factors influencing the species diversity of the lepidopteran family Noctuidae on the Tibetan plateau.	[Jin, Qian; Hu, XiMin; Zhang, Ai-bing] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Han, Huilin] Northeast Forestry Univ, Sch Forestry, Expt Ctr, Haerbin, Peoples R China; [Li, XinHai; Zhu, ChaoDong] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Ward, Robert D.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia	Capital Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zhang, AB (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	zhangab2008@mail.cnu.edu.cn	ZHU, Chao-Dong/E-5961-2011; Ho, Simon YW/A-8417-2008; Han, Hui-Lin/HHC-4823-2022; Li, Xinhai/G-9111-2011; Ward, Robert D/A-2319-2012	ZHU, Chao-Dong/0000-0002-9347-3178; Ho, Simon YW/0000-0002-0361-2307; Li, Xinhai/0000-0003-4514-0149; ZHANG, Ai-bing/0000-0003-3450-5421; zhang, ai bing/0000-0002-6580-5462	Beijing Municipal Natural Science Foundation [KZ201010028028]; Natural Science Foundation of China [31071963, 31272340, 30700641]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality [PHR201107120]; Research Fund for the Doctoral Program of Higher Education [20101108120002]; Ministry of Argriculture, China [201103024]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Ministry of Argriculture, China	This study was supported by Beijing Municipal Natural Science Foundation Key Projects (KZ201010028028 to ZHANG) and by Natural Science Foundation of China (to ZHANG, grants 31071963 and 31272340, to HAN, grant 30700641), by Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality (to ZHANG, grant PHR201107120), by The Research Fund for the Doctoral Program of Higher Education (to ZHANG, grant 20101108120002), and partially by PublicWelfare Project from th403 e Ministry of Argriculture, China (grant 201103024 to Chaodong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; Boursin C., 1963, ForschBer Nordrhein-Westf Koln & Opladen, Vno. 1170, P1; Bradford T, 2010, MOL ECOL RESOUR, V10, P41, DOI 10.1111/j.1755-0998.2009.02706.x; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Cabaret J, 2001, PARASITOL RES, V87, P311, DOI 10.1007/PL00008584; CHEN Y, 1999, FAUNA SINICA, V16; CHEN YX, 1991, NOCTUIDS FAUNA XIZAN; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Dai QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032544; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; DRAUDT M, 1950, MITTEILUNGEN MUNCHNE; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Fernandez-Gomez MJ, 2011, BIORESOURCE TECHNOL, V102, P9638, DOI 10.1016/j.biortech.2011.07.113; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gomez-Alvarez V, 2007, FEMS MICROBIOL ECOL, V60, P60, DOI 10.1111/j.1574-6941.2006.00253.x; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Gudelj I, 2010, ECOL LETT, V13, P1073, DOI 10.1111/j.1461-0248.2010.01507.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HARUTA T, 1995, TINEA, V2; HARUTA T, 1993, TINEA, V2; HARUTA T, 1998, TINEA S1, V15; HARUTA T, 1994, TINEA S1, V14; HARUTA T, 1992, TINEA S1, V13; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEPPNER J, 1992, LEPIDOPTERA TAIWAN 2, V11; Herrera A, 2007, EUR J SOIL BIOL, V43, P130, DOI 10.1016/j.ejsobi.2006.12.001; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hrcek J, 2011, MOL ECOL RESOUR, V11, P786, DOI 10.1111/j.1755-0998.2011.03016.x; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; HUDSON R, 1990, GENE GENEALOGIES COA; JAGERSMA GC, ENV MICROBIOL, V11, P3223; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L., 2009, ECOL ECON, V68, P925, DOI DOI 10.1016/J.ECOLECON.2008.10.015; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Justel A, 1997, STAT PROBABIL LETT, V35, P251, DOI 10.1016/S0167-7152(97)00020-5; KOLLAR V, 1844, KASCHMIR REICH SIEK, V4, P393; KONONENKO V, 2007, ATLAS GENITALIA NOCT; KONONENKO VS, 2010, NOCTUIDAE SIBIRICAE; Kononenko VS, 2005, NOCTUIDAE SIBIRICAE, V1; KRISTENSEN NP, 2007, ZOOTAXA, V1668; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Larsen PE, 2012, FEMS MICROBIOL LETT, V332, P91, DOI 10.1111/j.1574-6968.2012.02588.x; Leray M, 2012, CORAL REEFS, V31, P383, DOI 10.1007/s00338-011-0845-0; Liao B, 2005, CHEM PHYS LETT, V414, P296, DOI 10.1016/j.cplett.2005.08.079; Liu ZJ, 2009, MOL ECOL, V18, P3831, DOI 10.1111/j.1365-294X.2009.04330.x; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Magurran A.E, 2004, MEASURING BIOL DIVER; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Magurran Anne E., 2011, P85; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Medihala PG, 2012, CAN J MICROBIOL, V58, P1135, DOI [10.1139/w2012-087, 10.1139/W2012-087]; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Muturi EJ, 2006, J VECTOR ECOL, V31, P129, DOI 10.3376/1081-1710(2006)31[129:MSDAAI]2.0.CO;2; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Nye I. Y. B., 1975, GENERIC NAMES MOTHS, V1; Oline DK, 2006, APPL ENVIRON MICROB, V72, P6965, DOI 10.1128/AEM.00690-06; Ovreas L, 1998, MICROB ECOL, V36, P303, DOI 10.1007/s002489900117; Ovreas L, 2000, ECOL LETT, V3, P236, DOI 10.1046/j.1461-0248.2000.00148.x; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Quicke DLJ, 2012, MOL ECOL RESOUR, V12, P676, DOI 10.1111/j.1755-0998.2012.03143.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rougerie R, 2011, MOL ECOL, V20, P179, DOI 10.1111/j.1365-294X.2010.04918.x; Ru Wenming, 2006, Yingyong Shengtai Xuebao, V17, P561; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Shen Xiao-Cheng, 2007, Acta Entomologica Sinica, V50, P709; Silva-Brandao KL, 2009, NEOTROP ENTOMOL, V38, P441, DOI 10.1590/S1519-566X2009000400001; Sirohi SK, 2012, APPL MICROBIOL BIOT, V95, P1135, DOI 10.1007/s00253-012-4262-2; Slabbert E, 2010, MOL ECOL, V19, P1031, DOI 10.1111/j.1365-294X.2009.04517.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014424; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stahlhut JK, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-2; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Tang RWK, 2010, MOL ECOL RESOUR, V10, P439, DOI 10.1111/j.1755-0998.2009.02794.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vivas A, 2009, BIORESOURCE TECHNOL, V100, P1319, DOI 10.1016/j.biortech.2008.08.014; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; WILSON JB, 1991, J VEG SCI, V2, P35, DOI 10.2307/3235896; WITT T, 2008, WITT CATALOGUE TAXON, V3; WITT T, 2008, WITT CATALOGUE TAXON, V2; WITT T, 2008, WITT CATALOGUE TAXON, V1; WITT T, 2008, WITT CATALOGUE TAXON, V5; WITT T, 2008, WITT CATALOGUE TAXON, V4; Xu YJ, 2011, ENVIRON MONIT ASSESS, V177, P681, DOI 10.1007/s10661-010-1665-3; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Yu Siqin, 1998, Entomotaxonomia, V20, P44; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x; Zhang AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030986; Zhang ZJ, 2009, BIOINFORMATICS, V25, P1112, DOI 10.1093/bioinformatics/btp130	126	14	23	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64428	10.1371/journal.pone.0064428	http://dx.doi.org/10.1371/journal.pone.0064428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741330	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900042
J	Sahlender, DA; Kozik, P; Miller, SE; Peden, AA; Robinson, MS				Sahlender, Daniela A.; Kozik, Patrycja; Miller, Sharon E.; Peden, Andrew A.; Robinson, Margaret S.			Uncoupling the Functions of CALM in VAMP Sorting and Clathrin-Coated Pit Formation	PLOS ONE			English	Article							MYELOID-LEUKEMIA CALM; MEDIATED ENDOCYTOSIS; MOLECULAR-BASIS; SNARE VAMP7; PROTEIN; LOCALIZATION; ARABIDOPSIS; BINDING; AP180; SYNAPTOBREVIN	CALM (clathrin assembly lymphoid myeloid leukemia protein) is a cargo-selective adaptor for the post-Golgi R-SNAREs VAMPs 2, 3, and 8, and it also regulates the size of clathrin-coated pits and vesicles at the plasma membrane. The present study has two objectives: to determine whether CALM can sort additional VAMPs, and to investigate whether VAMP sorting contributes to CALM-dependent vesicle size regulation. Using a flow cytometry-based endocytosis efficiency assay, we demonstrate that CALM is also able to sort VAMPs 4 and 7, even though they have sorting signals for other clathrin adaptors. CALM homologues are present in nearly every eukaryote, suggesting that the CALM family may have evolved as adaptors for retrieving all post-Golgi VAMPs from the plasma membrane. Using a knockdown/rescue system, we show that wild-type CALM restores normal VAMP sorting in CALM-depleted cells, but that two non-VAMP-binding mutants do not. However, when we assayed the effect of CALM depletion on coated pit morphology, using a fluorescence microscopy-based assay, we found that the two mutants were as effective as wild-type CALM. Thus, we can uncouple the sorting function of CALM from its structural role.	[Sahlender, Daniela A.; Kozik, Patrycja; Miller, Sharon E.; Peden, Andrew A.; Robinson, Margaret S.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England	University of Cambridge	Robinson, MS (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.	msr12@mole.bio.cam.ac.uk		Kozik, Patrycja/0000-0001-8596-843X; Sahlender, Daniela Andrea/0000-0002-0510-9529; Peden, Andrew/0000-0003-0144-7712	Wellcome Trust [086598]; MRC [G120/952] Funding Source: UKRI; Medical Research Council [G120/952] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the Wellcome Trust, grant number 086598 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth M, 2004, J CELL SCI, V117, P2051, DOI 10.1242/jcs.01062; Besteiro S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-250; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Burston HE, 2009, J CELL BIOL, V185, P1097, DOI 10.1083/jcb.200811116; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Field MC, 2007, ADV EXP MED BIOL, V607, P84; Gordon DE, 2009, EMBO REP, V10, P851, DOI 10.1038/embor.2009.96; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hirst J, 2008, TRAFFIC, V9, P1354, DOI 10.1111/j.1600-0854.2008.00764.x; Holstein SEH, 2005, PROTOPLASMA, V226, P13, DOI 10.1007/s00709-005-0105-7; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Maritzen T, 2012, BIOL CELL, V104, P588, DOI 10.1111/boc.201200008; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Scotland PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044252; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Suzuki M, 2012, PLOS ONE; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; TIWARI RK, 1987, EMBO J, V6, P3373, DOI 10.1002/j.1460-2075.1987.tb02659.x; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Vivona S, 2010, J BIOL CHEM, V285, P17965, DOI 10.1074/jbc.M110.120972; Wen YJ, 2009, MOL BIOL CELL, V20, P4278, DOI 10.1091/mbc.E09-03-0243; Wiederhold K, 2010, J BIOL CHEM, V285, P21549, DOI 10.1074/jbc.M110.105148; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhuo Y, 2010, J MOL BIOL, V404, P274, DOI 10.1016/j.jmb.2010.09.044	41	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64514	10.1371/journal.pone.0064514	http://dx.doi.org/10.1371/journal.pone.0064514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741335	Green Accepted, Green Published, gold			2022-12-27	WOS:000319799900048
J	Top, J; Paganelli, FL; Zhang, XL; van Schaik, W; Leavis, HL; van Luit-Asbroek, M; van der Poll, T; Leendertse, M; Bonten, MJM; Willems, RJL				Top, Janetta; Paganelli, Fernanda L.; Zhang, Xinglin; van Schaik, Willem; Leavis, Helen L.; van Luit-Asbroek, Miranda; van der Poll, Tom; Leendertse, Masja; Bonten, Marc J. M.; Willems, Rob J. L.			The Enterococcus faecium Enterococcal Biofilm Regulator, EbrB, Regulates the esp Operon and Is Implicated in Biofilm Formation and Intestinal Colonization	PLOS ONE			English	Article							SURFACE PROTEIN ESP; EXPRESSION; GENE; FSR; IDENTIFICATION; PATHOGENESIS; CONTRIBUTES; GELATINASE; SYSTEM; FAMILY	Nowadays, Enterococcus faecium is one of the leading nosocomial pathogens worldwide. Strains causing clinical infections or hospital outbreaks are enriched in the enterococcal surface protein (Esp) encoding ICEEfm1 mobile genetic element. Previous studies showed that Esp is involved in biofilm formation, endocarditis and urinary tract infections. In this study, we characterized the role of the putative AraC type of regulator (locus tag EfmE1162_2351), which we renamed ebrB and which is, based on the currently available whole genome sequences, always located upstream of the esp gene, and studied its role in Esp surface exposure during growth. A markerless deletion mutant of ebrB resulted in reduced esp expression and complete abolishment of Esp surface exposure, while Esp cell-surface exposure was restored when this mutant was complemented with an intact copy of ebrB. This demonstrates a role for EbrB in esp expression. However, during growth, ebrB expression levels did not change over time, while an increase in esp expression at both RNA and protein level was observed during mid-log and late-log phase. These results indicate the existence of a secondary regulation system for esp, which might be an unknown quorum sensing system as the enhanced esp expression seems to be cell density dependent. Furthermore, we determined that esp is part of an operon of at least 3 genes putatively involved in biofilm formation. A semi-static biofilm model revealed reduced biofilm formation for the EbrB deficient mutant, while dynamics of biofilm formation using a flow cell system revealed delayed biofilm formation in the ebrB mutant. In a mouse intestinal colonization model the ebrB mutant was less able to colonize the gut compared to wild-type strain, especially in the small intestine. These data indicate that EbrB positively regulates the esp operon and is implicated in biofilm formation and intestinal colonization.	[Top, Janetta; Paganelli, Fernanda L.; Zhang, Xinglin; van Schaik, Willem; Leavis, Helen L.; van Luit-Asbroek, Miranda; Bonten, Marc J. M.; Willems, Rob J. L.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [van der Poll, Tom; Leendertse, Masja] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Top, J (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	j.top@umcutrecht.nl	Willems, Rob JL/E-3681-2010	Willems, Rob JL/0000-0002-7370-0812; Top, Janetta/0000-0002-4620-8128; van Schaik, Willem/0000-0001-5832-0988	European Union Seventh Framework Programme (FP7-HEALTH) [282004]	European Union Seventh Framework Programme (FP7-HEALTH)	J.T.'s, W.v.S.'s and R.J.L.W.'s research leading to these results has received funding from the European Union Seventh Framework Programme (FP7-HEALTH-2011-single-stage) under grant agreement no. 282004, EvoTAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunne WM, 1997, J CLIN MICROBIOL, V35, P388, DOI 10.1128/JCM.35.2.388-392.1997; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Heikens E, 2007, J BACTERIOL, V189, P8233, DOI 10.1128/JB.01205-07; Heikens E, 2011, MICROBES INFECT, V13, P1185, DOI 10.1016/j.micinf.2011.08.006; Heikens E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-19; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hendrickx APA, 2007, J BACTERIOL, V189, P8321, DOI 10.1128/JB.00664-07; Hendrickx APA, 2009, INFECT IMMUN, V77, P5097, DOI 10.1128/IAI.00275-09; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; Leavis H, 2004, J BACTERIOL, V186, P672, DOI 10.1128/JB.186.3.672-682.2004; Lebreton F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002834; Leendertse M, 2009, J INFECT DIS, V200, P1162, DOI 10.1086/605609; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Loo CY, 2004, J BACTERIOL, V186, P8193, DOI 10.1128/JB.186.24.8193-8206.2004; Maddox SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034398; Manzanera M, 2000, FEBS LETT, V476, P312, DOI 10.1016/S0014-5793(00)01749-X; MICHEL JL, 1992, P NATL ACAD SCI USA, V89, P10060, DOI 10.1073/pnas.89.21.10060; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051; Muscholl-Silberhorn A, 2000, SPRING LAB MAN, P134; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002; Singh KV, 2005, INFECT IMMUN, V73, P4888, DOI 10.1128/IAI.73.8.4888-4894.2005; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; Thurlow LR, 2010, INFECT IMMUN, V78, P4936, DOI 10.1128/IAI.01118-09; Top J, 2011, J BACTERIOL, V193, P1003, DOI 10.1128/JB.00952-10; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; van Schaik W, 2010, CLIN MICROBIOL INFEC, V16, P527, DOI 10.1111/j.1469-0691.2010.03201.x; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Van Wamel WJB, 2007, INFECT IMMUN, V75, P924, DOI 10.1128/IAI.00941-06; Wastfelt M, 1996, J BIOL CHEM, V271, P18892, DOI 10.1074/jbc.271.31.18892; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Wilson AC, 2007, J MICROBIOL METH, V71, P332, DOI 10.1016/j.mimet.2007.09.006; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001; Zhang XL, 2013, J INFECT DIS, V207, P1780, DOI 10.1093/infdis/jit076; Zhang XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002804; Zhang XL, 2011, ENVIRON MICROBIOL, V13, P518, DOI 10.1111/j.1462-2920.2010.02355.x	48	22	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65224	10.1371/journal.pone.0065224	http://dx.doi.org/10.1371/journal.pone.0065224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741484	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900197
J	Chen, YJ; Lee, LY; Chao, YK; Chang, JT; Lu, YC; Li, HF; Chiu, CC; Li, YC; Li, YL; Chiou, JF; Cheng, AJ				Chen, Yin-Ju; Lee, Li-Yu; Chao, Yin-Ka; Chang, Joseph T.; Lu, Ya-Ching; Li, Hsiao-Fang; Chiu, Ching-Chi; Li, Yi-Chen; Li, Yan-Liang; Chiou, Jeng-Fong; Cheng, Ann-Joy			DSG3 Facilitates Cancer Cell Growth and Invasion through the DSG3-Plakoglobin-TCF/LEF-Myc/Cyclin D1/MMP Signaling Pathway	PLOS ONE			English	Article							HUMAN BREAST-CANCER; HEAD NECK-CANCER; BETA-CATENIN; ORAL-CANCER; PLAKOGLOBIN EXPRESSION; ADHERENS JUNCTIONS; MOLECULAR TARGET; GAMMA-CATENIN; LUNG-CANCER; CARCINOMA	Desmoglein 3 (DSG3) is a component of the desmosome, which confers strong cell-cell adhesion. Previously, an oncogenic function of DSG3 has been found in head neck cancer (HNC). Here, we investigated how this molecule contributes to the malignant phenotype. Because DSG3 is associated with plakoglobin, we examined whether these phenotypic alterations were mediated through the plakoglobin molecule. Immunoprecipitation and immunofluorescence staining revealed that DSG3 silencing disrupted its interaction with plakoglobin and induced plakoglobin translocation from the cytoplasm to the nucleus. Knockdown of DSG3 significantly increased the interaction of plakoglobin with the transcriptional factor TCF and suppressed the TCF/LEF transcriptional activity. These effects further conferred to reduced expression of the TCF/LEF downstream target genes, including c-myc, cyclin D1, and MMP-7. Functional analyses showed that DSG3 silencing reduced cell growth and arrested cells at G0/G1 phase. Besides, cell migration and invasion abilities were also decreased. These cellular results were confirmed using tumor xenografts in mice, as DSG3 silencing led to the suppressed tumor growth, plakoglobin translocation and reduced expression of TCF/LEF target genes in tumors. Therefore, our study shows that the desmosomal protein DSG3 additionally functions to regulate malignant phenotypes via nuclear signaling. In conclusion, we found that DSG3 functions as an oncogene and facilitates cancer growth and invasion in HNC cells through the DSG3-plakoglobin-TCF/LEF pathway.	[Chen, Yin-Ju; Chiou, Jeng-Fong] Taipei Med Univ Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chen, Yin-Ju; Chiou, Jeng-Fong] Taipei Med Univ Hosp, Translat Res Lab, Taipei, Taiwan; [Chen, Yin-Ju; Lu, Ya-Ching; Li, Hsiao-Fang; Chiu, Ching-Chi; Li, Yi-Chen; Li, Yan-Liang; Cheng, Ann-Joy] Chang Gung Univ, Dept Med Biotechnol, Tao Yuan, Taiwan; [Lee, Li-Yu] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Chao, Yin-Ka] Chang Gung Mem Hosp, Dept Thorac Surg, Tao Yuan, Taiwan; [Chang, Joseph T.] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan; [Chiou, Jeng-Fong] Taipei Med Univ, Coll Med, Sch Med, Dept Radiol, Taipei, Taiwan; [Chiou, Jeng-Fong] Taipei Med Univ Hosp, Ctr Canc, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Cheng, AJ (corresponding author), Chang Gung Univ, Dept Med Biotechnol, Tao Yuan, Taiwan.	ajchen@mail.cgu.edu.tw	Li-yu, Lee/G-5055-2010; Chiu, Ching-Chi/AAB-3093-2020; Cheng, Ann-Joy/AAI-4374-2020; Chao, YinKai/ABE-7827-2020	Chiu, Ching-Chi/0000-0002-1827-8049; Li, Yi-Chen/0000-0002-5103-7642; Cheng, Ann-Joy/0000-0002-1317-0725; Chao, Yin Kai/0000-0001-8649-8783	Chang Gung Memorial Hospital [CMRPD1A0641, CMRPD190391-2]; Department of Health of Taiwan [DOH99-TD-C-111-006]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Department of Health of Taiwan	This work was supported by grants from Chang Gung Memorial Hospital (grant numbers CMRPD1A0641 and CMRPD190391-2) and from the Department of Health of Taiwan (grant number DOH99-TD-C-111-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Chang JTC, 2007, MOL CANCER THER, V6, P2271, DOI 10.1158/1535-7163.MCT-06-0801; Chang JT, 2006, BRIT J CANCER, V94, P870, DOI 10.1038/sj.bjc.6603008; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Chen YJ, 2011, HEAD NECK-J SCI SPEC, V33, P257, DOI 10.1002/hed.21442; Chen YJ, 2007, J STOMATOL INVEST, V1, P69; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Chiu CC, 2008, MOL CANCER THER, V7, P2788, DOI 10.1158/1535-7163.MCT-08-0172; Chiu CC, 2011, CLIN CANCER RES, V17, P4629, DOI 10.1158/1078-0432.CCR-10-2107; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Endo K, 2000, HUM PATHOL, V31, P558, DOI 10.1053/hp.2000.6683; Erin N, 2009, INT J CANCER, V124, P1503, DOI 10.1002/ijc.24131; Fukuoka J, 2007, HUM PATHOL, V38, P276, DOI 10.1016/j.humpath.2006.08.006; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Holen I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3201; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Hu PQ, 2003, J INVEST DERMATOL, V121, P242, DOI 10.1046/j.1523-1747.2003.12376.x; Kang CJ, 2009, CANCER LETT, V284, P131, DOI 10.1016/j.canlet.2009.04.014; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Khan K, 2006, BRIT J CANCER, V95, P1367, DOI 10.1038/sj.bjc.6603453; Kitajima Y, 1999, J INVEST DERM SYMP P, V4, P137, DOI 10.1038/sj.jidsp.5640197; Kolligs FT, 2000, GENE DEV, V14, P1319; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Lin CY, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-136; Lin TY, 2010, INT J RADIAT ONCOL, V78, P246, DOI 10.1016/j.ijrobp.2010.03.002; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Morgan RG, 2012, LEUKEMIA; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Pantel K, 1998, J CLIN ONCOL, V16, P1407, DOI 10.1200/JCO.1998.16.4.1407; Patel V, 2012, ORAL ONCOL; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; Robertson BW, 2010, EXP CELL RES, V316, P1, DOI 10.1016/j.yexcr.2009.10.012; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Simcha I, 1996, J CELL BIOL, V133, P199, DOI 10.1083/jcb.133.1.199; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; SOMMERS CL, 1994, CANCER RES, V54, P3544; Trojan L, 2005, ANTICANCER RES, V25, P183; Tsang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014211; Wang LH, 2007, VIRCHOWS ARCH, V451, P959, DOI 10.1007/s00428-007-0485-5; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418; Yashiro M, 2006, EUR J CANCER, V42, P2397, DOI 10.1016/j.ejca.2006.03.024; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	47	46	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64088	10.1371/journal.pone.0064088	http://dx.doi.org/10.1371/journal.pone.0064088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737966	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700030
J	Elbireer, AM; Jackson, JB; Sendagire, H; Opio, A; Bagenda, D; Amukele, TK				Elbireer, Ali M.; Jackson, J. Brooks; Sendagire, Hakim; Opio, Alex; Bagenda, Danstan; Amukele, Timothy K.			The Good, the Bad, and the Unknown: Quality of Clinical Laboratories in Kampala, Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ACCREDITATION; PHYSICIANS; ASSURANCE; FEEDBACK	Background: Clinical laboratories are crucial in addressing the high rates of communicable and non-communicable diseases seen in sub-Saharan Africa (SSA). However, the most basic information, such as the number and quality of clinical laboratories in SSA, is not available. The objective of this study was to create a practical method for obtaining this information in SSA towns and cities using an initial survey in Kampala, Uganda. Methods: Kampala city was divided into 5 partially-overlapping regions. Each region was assigned to 2-3 surveyors who identified and surveyed laboratories in their respective regions; in person and on foot. A modified version of the World Health Organization - African Region (WHO/AFRO) Laboratory Strengthening Checklist was used to obtain baseline measures of quality for all clinical laboratories within Kampala city. The surveyors also measured other attributes of each laboratory, such as their affiliation (government, private etc), designation (national hospital, district hospital, standalone etc), staff numbers, and type of staff. Results: The survey team identified and surveyed 954 laboratories in Kampala city. 96% of laboratories were private. Only 45 (5%) of the laboratories met or surpassed the lowest quality standards defined by the WHO/AFRO-derived laboratory strengthening tool (1-star). These 45 higher-quality laboratories were, on average, larger and had a higher number of laboratory-specific staff (technologists, phlebotomists etc) than the other 909 laboratories. 688 (72%) of the 954 laboratories were not registered with the Ministry of Health (MoH). Conclusions: This comprehensive evaluation of the number, scope, and quality of clinical laboratories in Kampala is the first published survey of its kind in sub-Saharan Africa. The survey findings demonstrated that laboratories in Kampala that had qualified personnel and those that had higher testing volumes, tended to be of higher-quality.	[Elbireer, Ali M.; Jackson, J. Brooks; Bagenda, Danstan; Amukele, Timothy K.] Johns Hopkins Univ, Makerere Univ, Clin Core Lab, Infect Dis Inst, Kampala, Uganda; [Elbireer, Ali M.; Jackson, J. Brooks; Amukele, Timothy K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Sendagire, Hakim; Opio, Alex] Minist Hlth, Cent Publ Hlth Lab, Kampala, Uganda; [Sendagire, Hakim; Bagenda, Danstan] Makerere Univ, Coll Hlth Sci, Kampala, Uganda	Makerere University; Johns Hopkins University; Makerere University	Elbireer, AM (corresponding author), Johns Hopkins Univ, Makerere Univ, Clin Core Lab, Infect Dis Inst, Kampala, Uganda.	aelbireer@idi.co.ug		jackson, brooks/0000-0001-9458-135X; Elbireer, Ali/0000-0002-2513-3497				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Amukele TK, 2012, AM J CLIN PATHOL, V138, P720, DOI 10.1309/AJCP8PCM4JVLEEQR; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Bunting PS, 2004, CLIN CHEM, V50, P321, DOI 10.1373/clinchem.2003.025098; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Elbireer AM, 2011, LABMEDICINE, V42, P719, DOI 10.1309/LM2OBNYY9D0UXZJO; Frean J, 2012, B WORLD HEALTH ORGAN, V90, P191, DOI 10.2471/BLT.11.091876; Gershy-Damet GM, 2010, AM J CLIN PATHOL, V134, P393, DOI 10.1309/AJCPTUUC2V1WJQBM; Holmes MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000244; Jamtvedt G, 2006, QUAL SAF HEALTH CARE, V15, P433, DOI 10.1136/qshc.2006.018549; KENNEY ML, 1987, CLIN CHEM, V33, P328; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; QMS, MOD LAB SERV GP26A4; Wattanasri N, 2010, AM J CLIN PATHOL, V134, P534, DOI 10.1309/AJCPZYY19WMKMAZT; World Health Organization, LAB QUAL MAN SYST TR; World Health Organization Department of Measurement and Health Information, 2006, PROJ MORT BURD DIS R	16	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64661	10.1371/journal.pone.0064661	http://dx.doi.org/10.1371/journal.pone.0064661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737993	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700057
J	Goh, XY; Newton, R; Wernisch, L; Fitzgerald, R				Goh, Xin Yi; Newton, Richard; Wernisch, Lorenz; Fitzgerald, Rebecca			Testing the Utility of an Integrated Analysis of Copy Number and Transcriptomics Datasets for Inferring Gene Regulatory Relationships	PLOS ONE			English	Article							PANCREATIC-CANCER; ARP2/3 COMPLEX; CELL-MIGRATION; BREAST-CANCER; HEART-DISEASE; C-MYC; EXPRESSION; INVASION; PROTEIN; CHEMOTHERAPY	Correlation patterns between matched copy number variation and gene expression data in cancer samples enable the inference of causal gene regulatory relationships by exploiting the natural randomization of such systems. The aim of this study was to test and verify experimentally the accuracy of a causal inference approach based on genomic randomization using esophageal cancer samples. Two candidates with strong regulatory effects emerging from our analysis are components of growth factor receptors, and implicated in cancer development, namely ERBB2 and FGFR2. We tested experimentally two ERBB2 and three FGFR2 regulated interactions predicted by the statistical analysis, all of which were confirmed. We also applied the method in a meta-analysis of 10 cancer datasets and tested 15 of the predicted regulatory interactions experimentally. Three additional predicted ERBB2 regulated interactions were confirmed, as well as interactions regulated by ARPC1A and FANCG. Overall, two thirds of experimentally tested predictions were confirmed.	[Goh, Xin Yi; Fitzgerald, Rebecca] MRC, Canc Cell Unit, Hutchison MRC Res Ctr, Cambridge, England; [Goh, Xin Yi] Univ Cambridge, Dept Oncol, Cambridge, England; [Newton, Richard; Wernisch, Lorenz] MRC, Biostat Unit, Cambridge CB2 2BW, England	University of Cambridge; MRC Biostatistics Unit	Newton, R (corresponding author), MRC, Biostat Unit, Cambridge CB2 2BW, England.	richard.newton@mrc-bsu.cam.ac.uk		Fitzgerald, Rebecca/0000-0002-3434-3568	Medical Research Council; Cambridge Experimental Cancer Medicine Centre; National Institute for Health Research, Cambridge Biomedical Research Centre; Malaysian Ministry of Higher Education; Advanced Medical and Dental Institute, Universiti Sains Malaysia; Medical Research Council Biostatistics Unit [U105260799]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Experimental Cancer Medicine Centre; National Institute for Health Research, Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Malaysian Ministry of Higher Education; Advanced Medical and Dental Institute, Universiti Sains Malaysia(Universiti Sains Malaysia); Medical Research Council Biostatistics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Medical Research Council (http://www.mrc.ac.uk), Cambridge Experimental Cancer Medicine Centre (http://www.ecmcnetwork.org.uk/network-centres/cambridge), National Institute for Health Research, Cambridge Biomedical Research Centre (http://cambridge-brc.org.uk/) [XYG and RF] and the Malaysian Ministry of Higher Education (http://www.mohe.gov.my/educationmsia/), the Advanced Medical and Dental Institute, Universiti Sains Malaysia (http://www.amdi.usm.edu.my) [XYG] and the Medical Research Council Biostatistics Unit (http://www.mrc-bsu.cam.ac.uk/), Unit Programme number U105260799 [RN and LW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bentley P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009136; Dancau AM, 2010, GENE CHROMOSOME CANC, V49, P1, DOI 10.1002/gcc.20713; Dudka AA, 2010, CANCER RES, V70, P3391, DOI 10.1158/0008-5472.CAN-09-3033; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; GRAY R, 1991, BONE MARROW TRANSPL, V7, P9; Gu TL, 2007, BLOOD, V110, P323, DOI 10.1182/blood-2006-10-052282; Kondo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019659; La Rosa P, 2006, BIOINFORMATICS, V22, P2066, DOI 10.1093/bioinformatics/btl359; Laurila E, 2009, GENE CHROMOSOME CANC, V48, P330, DOI 10.1002/gcc.20643; Lee H, 2008, BIOINFORMATICS, V24, P889, DOI 10.1093/bioinformatics/btn034; Leek JT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-150; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lewis SJ, 2010, CIRC-CARDIOVASC GENE, V3, P109, DOI 10.1161/CIRCGENETICS.109.880955; Li SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-186; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramberg H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-50; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; van Wieringen WN, 2006, BIOINFORMATICS, V22, P1919, DOI 10.1093/bioinformatics/btl269; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004; Walsh N, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-3; Yuan YY, 2012, IEEE ACM T COMPUT BI, V9, P947, DOI 10.1109/TCBB.2011.105; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63780	10.1371/journal.pone.0063780	http://dx.doi.org/10.1371/journal.pone.0063780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737949	gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700012
J	Jans, B; Schoevaerdts, D; Huang, TD; Berhin, C; Latour, K; Bogaerts, P; Nonhoff, C; Denis, O; Catry, B; Glupczynski, Y				Jans, Beatrice; Schoevaerdts, Didier; Huang, Te-Din; Berhin, Catherine; Latour, Katrien; Bogaerts, Pierre; Nonhoff, Claire; Denis, Olivier; Catry, Boudewijn; Glupczynski, Youri			Epidemiology of Multidrug-Resistant Microorganisms among Nursing Home Residents in Belgium	PLOS ONE			English	Article							TERM-CARE FACILITY; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; COLONIZATION; PREVALENCE; OMEPRAZOLE; HOSPITALS	Objectives: A national survey was conducted to determine the prevalence and risk factors of methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamases-producing Enterobacteriaceae (ESBLE) and vancomycin-resistant enterococci (VRE) among nursing home residents in Belgium. Methods: A random stratified, national prevalence survey was conducted in nursing home residents who were screened for carriage of ESBLE, MRSA and VRE by multisite enriched culture. Characteristics of nursing homes and residents were collected by a questionnaire survey and were analysed by multilevel logistic regression analysis. Results: Of 2791 screened residents in 60 participating nursing home, the weighted prevalence of ESBLE and MRSA carriage were 6.2% (range: 0 to 20%) and 12.2% (range: 0 to 36%), respectively. No cases of VRE were found. No relationship was found between ESBLE and MRSA prevalence rates within nursing homes and the rate of co-colonization was very low (0.8%). Geographical variations in prevalence of MRSA and ESBLE and in distribution of ESBL types in nursing home residents paralleled that of acute hospitals. Risk factors of ESBLE carriage included previously known ESBLE carriage, male gender, a low level of mobility and previous antibiotic exposure. Risk factors for MRSA colonization were: previously known MRSA carriage, skin lesions, a low functional status and antacid use. Conclusions: A low prevalence of ESBLE carriage was found in nursing home residents in Belgium. The prevalence of MRSA carriage decreased substantially in comparison to a similar survey conducted in 2005. A low functional status appeared as a common factor for ESBLE and MRSA carriage. Previous exposure to antibiotics was a strong predictor of ESBLE colonization while increased clustering of MRSA carriage suggested the importance of cross-transmission within nursing homes for this organism. These results emphasize the need for global coordination of the surveillance of MDRO within and between nursing homes and hospitals.	[Jans, Beatrice; Latour, Katrien; Catry, Boudewijn] Sci Inst Publ Hlth, Epidemiol Unit, Brussels, Belgium; [Schoevaerdts, Didier] CHU UCL Mt Godinne Dinant, Dept Geriatr Med, Yvoir, Belgium; [Schoevaerdts, Didier] Catholic Univ Louvain, Sch Publ Hlth, Inst Hlth & Soc, Brussels, Belgium; [Huang, Te-Din; Berhin, Catherine; Bogaerts, Pierre; Glupczynski, Youri] Catholic Univ Louvain, CHU UCL Mt Godinne Dinant, Dept Clin Microbiol, Natl Reference Lab Monitoring Antimicrobial Resis, Yvoir, Belgium; [Nonhoff, Claire; Denis, Olivier] Univ Libre Brussels, Hop Erasme, Natl Reference Lab MRSA & Staphylococci, Dept Clin Microbiol, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Libre de Bruxelles	Schoevaerdts, D (corresponding author), CHU UCL Mt Godinne Dinant, Dept Geriatr Med, Yvoir, Belgium.	didier.schoevaerdts@uclouvain.be		Catry, Boudewijn/0000-0002-8700-7138	Belgian Antibiotic Policy Coordination Committee (BAPCOC; Ministry of Public Health, Belgium); Belgian Infection Control Society (BICS); Mont-Godinne Foundation (Catholic University of Louvain); Chair DCF (Croix Rouge, Belgium)	Belgian Antibiotic Policy Coordination Committee (BAPCOC; Ministry of Public Health, Belgium); Belgian Infection Control Society (BICS); Mont-Godinne Foundation (Catholic University of Louvain); Chair DCF (Croix Rouge, Belgium)	This study was supported by grants from the Belgian Antibiotic Policy Coordination Committee (BAPCOC; Ministry of Public Health, Belgium) and from the Belgian Infection Control Society (BICS). The work is a part of a PhD thesis (DS) supported by a grant of the Mont-Godinne Foundation (Catholic University of Louvain) and Chair DCF (Croix Rouge, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agastya G, 2000, IMMUNOPHARM IMMUNOT, V22, P357, DOI 10.3109/08923970009016425; Andersson H, 2012, SCAND J INFECT DIS, V44, P641, DOI 10.3109/00365548.2012.671956; Belgian Infection Control Society, 2008, DET SURV PREV CONTR, P1; Benenson S, 2009, INFECT CONT HOSP EP, V30, P786, DOI 10.1086/598345; Bertrand X, 2012, AGE AGEING, V41, P233, DOI 10.1093/ageing/afr173; Bula CJ, 2004, J AM GERIATR SOC, V52, P700, DOI 10.1111/j.1532-5415.2004.52205.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chevalier P, 2008, GUIDE BELGE TRAITEME; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Costers M, 2012, EURO SURVEILL, V17; Denis O, 2005, J ANTIMICROB CHEMOTH, V56, P1103, DOI 10.1093/jac/dki379; Denis O, 2009, J ANTIMICROB CHEMOTH, V64, P1299, DOI 10.1093/jac/dkp345; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P1434, DOI 10.1128/JCM.33.5.1434-1434.1995; Gagliotti C, 2011, EURO SURVEILL, V16; GDEPIH-GOSPIZ, 2005, MES PREV TRANSM STAP; GDEPIH-GOSPIZ, 2003, REC CONTR PREV TRANS; Glupczynski Y, 2012, INT J ANTIMICROB AG, V39, P168, DOI 10.1016/j.ijantimicag.2011.10.005; Harris AD, 2007, AM J INFECT CONTROL, V35, P97, DOI 10.1016/j.ajic.2006.09.011; Jans B, 2013, EPI REPORTS; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lautenbach E, 2005, ANTIMICROB AGENTS CH, V49, P798, DOI 10.1128/AAC.49.2.798-800.2005; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Lautenbach E, 2008, J CLIN MICROBIOL, V46, P3094, DOI 10.1128/JCM.00945-08; Lautenbach E, 2006, ANTIMICROB AGENTS CH, V50, P3939, DOI 10.1128/AAC.00503-06; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; Mendelson G, 2005, EUR J CLIN MICROBIOL, V24, P17, DOI 10.1007/s10096-004-1264-8; Neal KR, 1996, BRIT MED J, V312, P414; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Nseir S, 2011, CLIN MICROBIOL INFEC, V17, P1201, DOI 10.1111/j.1469-0691.2010.03420.x; Pacio GA, 2003, INFECT CONT HOSP EP, V24, P246, DOI 10.1086/502201; Pop-Vicas A, 2008, J AM GERIATR SOC, V56, P1276, DOI 10.1111/j.1532-5415.2008.01787.x; Reddy P, 2007, CLIN INFECT DIS, V45, P846, DOI 10.1086/521260; Rodriguez-Villalobos H, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkq388; Rooney PJ, 2009, J ANTIMICROB CHEMOTH, V64, P635, DOI 10.1093/jac/dkp220; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; Trick WE, 2001, J AM GERIATR SOC, V49, P270, DOI 10.1046/j.1532-5415.2001.4930270.x; Van Gastel E, 2010, J ANTIMICROB CHEMOTH, V65, P576, DOI 10.1093/jac/dkp470; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026; Zekry D, 2012, J AM MED DIR ASSOC, V13, P272, DOI 10.1016/j.jamda.2010.11.011; Zirakzadeh A, 2008, BONE MARROW TRANSPL, V41, P385, DOI 10.1038/sj.bmt.1705912	42	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64908	10.1371/journal.pone.0064908	http://dx.doi.org/10.1371/journal.pone.0064908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738011	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700072
J	Ruiz, L; Motherway, MO; Lanigan, N; van Sinderen, D				Ruiz, Lorena; Motherway, Mary O'Connell; Lanigan, Noreen; van Sinderen, Douwe			Transposon Mutagenesis in Bifidobacterium breve: Construction and Characterization of a Tn5 Transposon Mutant Library for Bifidobacterium breve UCC2003	PLOS ONE			English	Article							METABOLIC-ACTIVITIES; SYSTEM; GENE; IDENTIFICATION; EXPRESSION; RESISTANCE; PROBIOTICS; MUTATIONS; DELIVERY; INSIGHTS	Bifidobacteria are claimed to contribute positively to human health through a range of beneficial or probiotic activities, including amelioration of gastrointestinal and metabolic disorders, and therefore this particular group of gastrointestinal commensals has enjoyed increasing industrial and scientific attention in recent years. However, the molecular mechanisms underlying these probiotic mechanisms are still largely unknown, mainly due to the fact that molecular tools for bifidobacteria are rather poorly developed, with many strains lacking genetic accessibility. In this work, we describe the generation of transposon insertion mutants in two bifidobacterial strains, B. breve UCC2003 and B. breve NCFB2258. We also report the creation of the first transposon mutant library in a bifidobacterial strain, employing B. breve UCC2003 and a Tn5-based transposome strategy. The library was found to be composed of clones containing single transposon insertions which appear to be randomly distributed along the genome. The usefulness of the library to perform phenotypic screenings was confirmed through identification and analysis of mutants defective in D-galactose, D-lactose or pullulan utilization abilities.	[van Sinderen, Douwe] Natl Univ Ireland, Dept Microbiol, Cork, Ireland; Natl Univ Ireland, Alimentary Pharmabiot Ctr, Cork, Ireland	University College Cork; University College Cork	van Sinderen, D (corresponding author), Natl Univ Ireland, Dept Microbiol, Cork, Ireland.	d.vansinderen@ucc.ie	Ruiz, Lorena/P-2860-2015; Van Sinderen, Douwe/A-6778-2015	Ruiz, Lorena/0000-0001-8199-5502; Van Sinderen, Douwe/0000-0003-1823-7957; O'Connell Motherway, Mary/0000-0001-9164-9320	Science Foundation Ireland (SFI) through the Irish Government's National Development Plan; SFI [02/CE/B124, 07/CE/B1368]; HRB [PDTM/20011/9]	Science Foundation Ireland (SFI) through the Irish Government's National Development Plan(Science Foundation Ireland); SFI(Science Foundation Ireland); HRB	The Alimentary Pharmabiotic Centre is a research centre funded by Science Foundation Ireland (SFI) through the Irish Government's National Development Plan. The authors and their work were supported by SFI (grants 02/CE/B124 and 07/CE/B1368) and an HRB postdoctoral fellowship (grant PDTM/20011/9) awarded to MOM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleya S, 2011, INT J FOOD MICROBIOL, V149, P28, DOI 10.1016/j.ijfoodmicro.2010.10.036; Arigoni F, 2008, International patent, Patent No. [WO 2008019886 A1, 2008019886]; Florez AB, 2006, APPL ENVIRON MICROB, V72, P7377, DOI 10.1128/AEM.00486-06; Chen CK, 2002, MICROBIOL-SGM, V148, P289, DOI 10.1099/00221287-148-1-289; Clarke G, 2012, ALIMENT PHARM THER, V35, P403, DOI 10.1111/j.1365-2036.2011.04965.x; Cronin M, 2011, INT J FOOD MICROBIOL, V149, P4, DOI 10.1016/j.ijfoodmicro.2011.01.019; Cronin M, 2010, MOL THER, V18, P1397, DOI 10.1038/mt.2010.59; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Fernandes PJ, 2001, MICROBIOL-SGM, V147, P2529, DOI 10.1099/00221287-147-9-2529; Food and Agriculture Organization of the United Nations and World Health Organization, 2001, HLTH NUTR PROP PROB; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fushinobu S, 2010, BIOSCI BIOTECH BIOCH, V74, P2374, DOI 10.1271/bbb.100494; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Goryshin IY, 2000, NAT BIOTECHNOL, V18, P97, DOI 10.1038/72017; Hirayama Y, 2012, APPL ENVIRON MICROB, V78, P4984, DOI 10.1128/AEM.00588-12; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Hu B, 2009, CANCER GENE THER, V16, P655, DOI 10.1038/cgt.2009.7; Ito M, 2010, J APPL MICROBIOL, V109, P657, DOI 10.1111/j.1365-2672.2010.04690.x; Judson N, 2000, TRENDS MICROBIOL, V8, P521, DOI 10.1016/S0966-842X(00)01865-5; Kawaguchi H, 2006, APPL ENVIRON MICROB, V72, P3418, DOI 10.1128/AEM.72.5.3418-3428.2006; Khatiwara A, 2012, APPL ENVIRON MICROB, V78, P3098, DOI 10.1128/AEM.06865-11; Laia ML, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-12; Laurent JP, 2003, J BACTERIOL, V185, P5003, DOI 10.1128/JB.185.16.5003-5006.2003; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liu HL, 2013, J BACTERIOL, V195, P629, DOI 10.1128/JB.01288-12; Ma YP, 2012, MICROBIOL-SGM, V158, P498, DOI 10.1099/mic.0.049932-0; MacConaill LE, 2003, APPL ENVIRON MICROB, V69, P6994, DOI 10.1128/AEM.69.12.6994-7001.2003; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P571, DOI 10.1128/AAC.49.2.571-577.2005; Maze A, 2007, APPL ENVIRON MICROB, V73, P545, DOI 10.1128/AEM.01496-06; Metchnikoff E., 1908, PROLONGATION LIFE OP, P161; Motherway MO, 2008, APPL ENVIRON MICROB, V74, P6271, DOI 10.1128/AEM.01169-08; Motherway MO, 2013, MICROB BIOTECHNOL, V6, P67, DOI 10.1111/1751-7915.12011; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Motherway MO, 2009, MICROB BIOTECHNOL, V2, P321, DOI 10.1111/j.1751-7915.2008.00071.x; Oram DM, 2002, J BACTERIOL, V184, P5723, DOI 10.1128/JB.184.20.5723-5732.2002; Petzke L, 2009, APPL MICROBIOL BIOT, V83, P979, DOI 10.1007/s00253-009-2047-z; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reznikoff William S., 2008, V416, P13, DOI 10.1007/978-1-59745-321-9_2; Reznikoff WS, 1999, BIOCHEM BIOPH RES CO, V266, P729, DOI 10.1006/bbrc.1999.1891; Reznikoff WS, 2004, METH MOL B, V260, P83, DOI 10.1385/1-59259-755-6:083; Ruiz L, 2012, APPL ENVIRON MICROB, V78, P1123, DOI 10.1128/AEM.06060-11; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; Sakaguchi K, 2012, APPL MICROBIOL BIOT, V95, P499, DOI 10.1007/s00253-012-4090-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez B, 2012, PHARM RES, V69, P127; Sangrador-Vegas A, 2007, PLASMID, V58, P140, DOI 10.1016/j.plasmid.2007.02.004; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Stanton C, 2005, CURR OPIN BIOTECH, V16, P198, DOI 10.1016/j.copbio.2005.02.008; Sun ZK, 2012, APPL ENVIRON MICROB, V78, P5035, DOI 10.1128/AEM.00551-12; Twiss E, 2005, MOL MICROBIOL, V57, P1593, DOI 10.1111/j.1365-2958.2005.04794.x; Ventura M, 2005, J BACTERIOL, V187, P8411, DOI 10.1128/JB.187.24.8411-8426.2005; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Ventura M, 2012, TRENDS MICROBIOL, V20, P467, DOI 10.1016/j.tim.2012.07.002; Ventura M, 2012, BIOENGINEERED, V3, P73, DOI 10.4161/bbug.18540; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Yamamoto S, 2010, VACCINE, V28, P6684, DOI 10.1016/j.vaccine.2010.08.007	59	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64699	10.1371/journal.pone.0064699	http://dx.doi.org/10.1371/journal.pone.0064699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737995	gold, Green Submitted, Green Published			2022-12-27	WOS:000321394700059
J	Agra, N; Cidre, F; Garcia-Garcia, L; de la Parra, J; Alonso, J				Agra, Noelia; Cidre, Florencia; Garcia-Garcia, Laura; de la Parra, Juan; Alonso, Javier			Lysyl Oxidase Is Downregulated by the EWS/FLI1 Oncoprotein and Its Propeptide Domain Displays Tumor Supressor Activities in Ewing Sarcoma Cells	PLOS ONE			English	Article							MESSENGER-RNA; CANCER-CELLS; MOLECULAR PATHOGENESIS; ONCOGENIC PHENOTYPE; SUPPRESSOR ACTIVITY; PROSTATE-CANCER; FUSION PROTEIN; BREAST-CANCER; DIRECT TARGET; GENE	Ewing sarcoma is the second most common bone malignancy in children and young adults. It is driven by oncogenic fusion proteins (i.e. EWS/FLI1) acting as aberrant transcription factors that upregulate and downregulate target genes, leading to cellular transformation. Thus, identificating these target genes and understanding their contribution to Ewing sarcoma tumorigenesis are key for the development of new therapeutic strategies. In this study we show that lysyl oxidase (LOX), an enzyme involved in maintaining structural integrity of the extracellular matrix, is downregulated by the EWS/FLI1 oncoprotein and in consequence it is not expressed in Ewing sarcoma cells and primary tumors. Using a doxycycline inducible system to restore LOX expression in an Ewing sarcoma derived cell line, we showed that LOX displays tumor suppressor activities. Interestingly, we showed that the tumor suppressor activity resides in the propeptide domain of LOX (LOX-PP), an N-terminal domain produced by proteolytic cleavage during the physiological processing of LOX. Expression of LOX-PP reduced cell proliferation, cell migration, anchorage-independent growth in soft agar and formation of tumors in immunodeficient mice. By contrast, the C-terminal domain of LOX, which contains the enzymatic activity, had the opposite effects, corroborating that the tumor suppressor activity of LOX is mediated exclusively by its propeptide domain. Finally, we showed that LOX-PP inhibits ERK/MAPK signalling pathway, and that many pathways involved in cell cycle progression were significantly deregulated by LOX-PP, providing a mechanistic explanation to the cell proliferation inhibition observed upon LOX-PP expression. In summary, our observations indicate that deregulation of the LOX gene participates in Ewing sarcoma development and identify LOX-PP as a new therapeutic target for one of the most aggressive paediatric malignancies. These findings suggest that therapeutic strategies based on the administration of LOX propeptide or functional analogues could be useful for the treatment of this devastating paediatric cancer.	[Agra, Noelia; Cidre, Florencia; Garcia-Garcia, Laura; de la Parra, Juan; Alonso, Javier] Inst Salud Carlos III, Inst Invest Enfermedades Raras, Unidad Tumores Solidos Infantiles, Area Genet Humana, Madrid, Spain	Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER)	Alonso, J (corresponding author), Inst Salud Carlos III, Inst Invest Enfermedades Raras, Unidad Tumores Solidos Infantiles, Area Genet Humana, Madrid, Spain.	fjalonso@isciii.es	Alonso, Javier/B-6012-2013	Alonso, Javier/0000-0002-6287-8391; Cidre Aranaz, Florencia/0000-0002-0246-7179; GARCIA, LAURA/0000-0002-8585-849X	Ministerio de Ciencia e Innovacion [SAF2009-10158]; Fundacion Cientifica de la Cientifica Espanola Contra el Cancer; Fundacion Maria Francisca de Roviralta; Fundacion General de la U.A.M.	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Cientifica de la Cientifica Espanola Contra el Cancer; Fundacion Maria Francisca de Roviralta; Fundacion General de la U.A.M.	This study was funded by grants of the Ministerio de Ciencia e Innovacion (SAF2009-10158), the Fundacion Cientifica de la Cientifica Espanola Contra el Cancer and the Fundacion Maria Francisca de Roviralta. N. Agra was supported by the Fundacion General de la U.A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Ban J, 2011, ONCOGENE, V30, P2173, DOI 10.1038/onc.2010.581; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Bouez C, 2006, CLIN CANCER RES, V12, P1463, DOI 10.1158/1078-0432.CCR-05-1456; Carrillo J, 2007, CLIN CANCER RES, V13, P2429, DOI 10.1158/1078-0432.CCR-06-1762; Csiszar K, 2002, INT J CANCER, V97, P636, DOI 10.1002/ijc.10035; De Vito C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023592; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; Garcia-Aragoncillo E, 2008, ONCOGENE, V27, P6034, DOI 10.1038/onc.2008.203; Giampuzzi M, 2001, J BIOL CHEM, V276, P29226, DOI 10.1074/jbc.M101695200; Grunewald TGP, 2012, MOL CANCER RES, V10, P52, DOI 10.1158/1541-7786.MCR-11-0524; Guo Y, 2007, AM J PHYSIOL-CELL PH, V292, pC2095, DOI 10.1152/ajpcell.00613.2006; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; HAJNAL A, 1993, CANCER RES, V53, P4670; HAMALAINEN ER, 1995, J BIOL CHEM, V270, P21590, DOI 10.1074/jbc.270.37.21590; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kovar H, 2010, GENOME MED, V2, DOI 10.1186/gm129; KUIVANIEMI H, 1986, FEBS LETT, V195, P261, DOI 10.1016/0014-5793(86)80172-7; Lessnick SL, 2011, ANN REV PATHOL; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Luo W, 2009, ONCOGENE, V28, P4126, DOI 10.1038/onc.2009.262; Mackintosh C, 2010, CANCER BIOL THER, V9, P655, DOI 10.4161/cbt.9.9.11511; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2010, J CELL BIOCHEM, V111, P1160, DOI 10.1002/jcb.22828; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Navarro D, 2010, CARCINOGENESIS, V31, P394, DOI 10.1093/carcin/bgp317; NAVARRO S, 1990, VIRCHOWS ARCH A, V416, P383, DOI 10.1007/BF01605142; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Potratz J, 2012, PEDIATR HEMAT ONCOL, V29, P1, DOI 10.3109/08880018.2011.622034; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Ren CZ, 1998, CANCER RES, V58, P1285; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Sankar S, 2012, ONCOGENE; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	58	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66281	10.1371/journal.pone.0066281	http://dx.doi.org/10.1371/journal.pone.0066281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750284	Green Published, gold			2022-12-27	WOS:000319961900086
J	Kitagawa, M; Fung, SYS; Onishi, N; Saya, H; Lee, SH				Kitagawa, Mayumi; Fung, Suet Yin Sarah; Onishi, Nobuyuki; Saya, Hideyuki; Lee, Sang Hyun			Targeting Aurora B to the Equatorial Cortex by MKlp2 Is Required for Cytokinesis	PLOS ONE			English	Article							CENTRAL SPINDLE; CELL-DIVISION; KINESIN; COMPLEX; CENTRALSPINDLIN; PHOSPHORYLATION; MIDZONE; MYOSIN; ACTIN; RHOA	Although Aurora B is important in cleavage furrow ingression and completion during cytokinesis, the mechanism by which kinase activity is targeted to the cleavage furrow and the molecule(s) responsible for this process have remained elusive. Here, we demonstrate that an essential mitotic kinesin MKlp2 requires myosin-II for its localization to the equatorial cortex, and this event is required to recruit Aurora B to the equatorial cortex in mammalian cells. This recruitment event is also required to promote the highly focused accumulation of active RhoA at the equatorial cortex and stable ingression of the cleavage furrow in bipolar cytokinesis. Specifically, in drug-induced monopolar cytokinesis, targeting Aurora B to the cell cortex by MKlp2 is essential for cell polarization and furrow formation. Once the furrow has formed, MKlp2 further recruits Aurora B to the growing furrow. This process together with continuous Aurora B kinase activity at the growing furrow is essential for stable furrow propagation and completion. In contrast, a MKlp2 mutant defective in binding myosin-II does not recruit Aurora B to the cell cortex and does not promote furrow formation during monopolar cytokinesis. This mutant is also defective in maintaining the ingressing furrow during bipolar cytokinesis. Together, these findings reveal that targeting Aurora B to the cell cortex (or the equatorial cortex) by MKlp2 is essential for the maintenance of the ingressing furrow for successful cytokinesis.	[Kitagawa, Mayumi; Fung, Suet Yin Sarah; Lee, Sang Hyun] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Onishi, Nobuyuki; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan	National University of Singapore; Keio University	Lee, SH (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.	sanghyun.lee@duke-nus.edu.sg	ONISHI, Nobuyuki/L-6296-2013; Saya, Hideyuki/J-4325-2013	Saya, Hideyuki/0000-0001-6610-1902; Fung, Suet Yin Sarah/0000-0002-9448-2826	National Research Foundation (NRF) Research Fellowship in Singapore [NRFRF2010-02]	National Research Foundation (NRF) Research Fellowship in Singapore	This work was supported by the National Research Foundation (NRF) Research Fellowship (NRFRF2010-02) in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Douglas ME, 2010, CURR BIOL, V20, P927, DOI 10.1016/j.cub.2010.03.055; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Lee SH, 2010, J CELL BIOL, V191, P1069, DOI 10.1083/jcb.201003095; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	18	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64826	10.1371/journal.pone.0064826	http://dx.doi.org/10.1371/journal.pone.0064826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750214	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900016
J	Sabbah, S; Zhu, CH; Hornsby, MAW; Kamermans, M; Hawryshyn, CW				Sabbah, Shai; Zhu, Changhai; Hornsby, Mark A. W.; Kamermans, Maarten; Hawryshyn, Craig W.			Feedback from Horizontal Cells to Cones Mediates Color Induction and May Facilitate Color Constancy in Rainbow Trout	PLOS ONE			English	Article							ULTRAVIOLET-POLARIZATION SENSITIVITY; 2-AMINO-4-PHOSPHONOBUTYRIC ACID; CHROMATIC ADAPTATION; SPECTRAL SENSITIVITY; ONCORHYNCHUS-MYKISS; OUTER RETINA; B-WAVE; GOLDFISH; PRIMATE; ORGANIZATION	Color vision is most beneficial when the visual system is color constant and can correct the excitations of photoreceptors for differences in environmental irradiance. A phenomenon related to color constancy is color induction, where the color of an object shifts away from the color of its surroundings. These two phenomena depend on chromatic spatial integration, which was suggested to originate at the feedback synapse from horizontal cells (HC) to cones. However, the exact retinal site was never determined. Using the electroretinogram and compound action potential recordings, we estimated the spectral sensitivity of the photoresponse of cones, the output of cones, and the optic nerve in rainbow trout. Recordings were performed before and following pharmacological inhibition of HC-cone feedback, and were repeated under two colored backgrounds to estimate the efficiency of color induction. No color induction could be detected in the photoresponse of cones. However, the efficiency of color induction in the cone output and optic nerve was substantial, with the efficiency in the optic nerve being significantly higher than in the cone output. We found that the efficiency of color induction in the cone output and optic nerve decreased significantly with the inhibition of HC-cone feedback. Therefore, our findings suggest not only that color induction originates as a result of HC-cone feedback, but also that this effect of HC-cone feedback is further amplified at downstream retinal elements, possibly through feedback mechanisms at the inner plexiform layer. This study provides evidence for an important role of HC-cone feedback in mediating color induction, and therefore, likely also in mediating color constancy.	[Sabbah, Shai; Zhu, Changhai; Hornsby, Mark A. W.; Hawryshyn, Craig W.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Kamermans, Maarten] Netherlands Inst Neurosci, Res Unit Retinal Signal Proc, Amsterdam, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands; [Hawryshyn, Craig W.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada	Queens University - Canada; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Queens University - Canada	Sabbah, S (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	shai_sabbah@brown.edu		Sabbah, Shai/0000-0002-4752-3832	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [106102-07]; NSERC Research Tools and Instrumentation Grant [359714-2008]; Ontario Innovation Trust [202821]; Canada Research Chair Program; Vanier Canada Graduate Scholarship from NSERC; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Research Tools and Instrumentation Grant; Ontario Innovation Trust; Canada Research Chair Program(Canada Research Chairs); Vanier Canada Graduate Scholarship from NSERC; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [106102-07], NSERC Research Tools and Instrumentation Grant [359714-2008], Canada Foundation for Innovation, Ontario Innovation Trust [202821], and the Canada Research Chair Program to CWH. SS was supported by a Vanier Canada Graduate Scholarship from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCAR VJ, 1972, J NEUROCHEM, V19, P2657, DOI 10.1111/j.1471-4159.1972.tb01325.x; BARON WS, 1975, J PHYSIOL-LONDON, V246, P311, DOI 10.1113/jphysiol.1975.sp010892; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; BLOOMFIELD SA, 1985, J NEUROPHYSIOL, V53, P699, DOI 10.1152/jn.1985.53.3.699; BROWMAN HI, 1992, VISION RES, V32, P2303, DOI 10.1016/0042-6989(92)90094-Y; BROWMAN HI, 1994, VISION RES, V34, P1397, DOI 10.1016/0042-6989(94)90139-2; BROWMAN HI, 1994, J EXP BIOL, V193, P191; Bush RA, 1996, J OPT SOC AM A, V13, P557, DOI 10.1364/JOSAA.13.000557; Connaughton VP, 2010, J NEUROPHYSIOL, V104, P2407, DOI 10.1152/jn.00644.2009; Dacey DM, 1996, SCIENCE, V271, P656, DOI 10.1126/science.271.5249.656; DAW NW, 1984, TRENDS NEUROSCI, V7, P330, DOI 10.1016/S0166-2236(84)80082-X; Dong CJ, 2002, VISION RES, V42, P1081, DOI 10.1016/S0042-6989(02)00032-9; Dong CJ, 2000, VISION RES, V40, P579, DOI 10.1016/S0042-6989(99)00203-5; Dorr S, 1997, VISION RES, V37, P1581, DOI 10.1016/S0042-6989(96)00320-3; Dorr S, 1996, PERCEPTION, V25, P243, DOI 10.1068/p250243; DOWLING JE, 1972, J GEN PHYSIOL, V60, P698, DOI 10.1085/jgp.60.6.698; Edgington E. S., 1995, RANDOMIZATION TESTS; Efron B., 1994, INTRO BOOTSTRAP; Fahrenfort I, 2004, VISUAL NEUROSCI, V21, P501, DOI 10.1017/S095252380421402X; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HAROSI FI, 1994, VISION RES, V34, P1359, DOI 10.1016/0042-6989(94)90134-1; Hawryshyn CW, 2010, J EXP BIOL, V213, P3187, DOI 10.1242/jeb.038760; HAWRYSHYN CW, 1994, VISION RES, V34, P1385, DOI 10.1016/0042-6989(94)90137-6; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; INGLE DJ, 1985, SCIENCE, V227, P651, DOI 10.1126/science.3969555; Joselevitch C, 2009, VISION RES, V49, P943, DOI 10.1016/j.visres.2008.07.019; Kamermans M, 1998, VISUAL NEUROSCI, V15, P787, DOI 10.1017/S0952523898154172; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; KAMERMANS M, 1991, J GEN PHYSIOL, V97, P819, DOI 10.1085/jgp.97.4.819; KANEKO A, 1986, J PHYSIOL-LONDON, V373, P463, DOI 10.1113/jphysiol.1986.sp016058; Klaassen LJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001107; Kraaij DA, 1998, VISUAL NEUROSCI, V15, P799, DOI 10.1017/S0952523898154184; Li P, 2005, J EXP BIOL, V208, P497, DOI 10.1242/jeb.01424; Li YN, 2009, J COMP NEUROL, V516, P442, DOI 10.1002/cne.22135; Liu X, J PHYSL; MASSEY SC, 1983, VISION RES, V23, P1607, DOI 10.1016/0042-6989(83)90174-8; NAKA K, 1971, J NEUROPHYSIOL, V34, P785, DOI 10.1152/jn.1971.34.5.785; NAKA K, 1972, J PHYSIOL-LONDON, V223, P449, DOI 10.1113/jphysiol.1972.sp009857; NAKA KI, 1977, J NEUROPHYSIOL, V40, P26, DOI 10.1152/jn.1977.40.1.26; Neumeyer C, 2002, PERCEPTION, V31, P171, DOI 10.1068/p05sp; NEUMEYER C, 1981, J COMP PHYSIOL, V144, P543, DOI 10.1007/BF01326839; NORTON AL, 1968, SCIENCE, V160, P1021, DOI 10.1126/science.160.3831.1021; NOVALESFLAMARIQUE I, 1992, J EXP BIOL, V169, P121; PARKYN DC, 1993, J COMP PHYSIOL A, V172, P493, DOI 10.1007/BF00213531; Parkyn DC, 2000, J EXP BIOL, V203, P1173; Ramsden SD, 2008, J EXP BIOL, V211, P1376, DOI 10.1242/jeb.015941; Rinner O, 2000, VISION RES, V40, P1813, DOI 10.1016/S0042-6989(00)00050-X; Sabbah S, 2010, BMC BIOL, V8, DOI [10.1186/1741-7007-1188-1133, DOI 10.1186/1741-7007-1188-1133]; Sabbah S, 2013, J NEUROSCI, V33, P7428, DOI 10.1523/JNEUROSCI.5815-12.2013; Sabbah S, 2012, J EXP BIOL, V215, P2684, DOI 10.1242/jeb.069922; Sabbah S, 2011, J EXP BIOL, V214, P487, DOI 10.1242/jeb.051284; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SPERLING HC, 1971, SCIENCE, V172, P180, DOI 10.1126/science.172.3979.180; STELL WK, 1975, J COMP NEUROL, V159, P473, DOI 10.1002/cne.901590404; STELL WK, 1975, SCIENCE, V190, P989, DOI 10.1126/science.1188380; SVAETICHIN G, 1958, ANN NY ACAD SCI, V74, P385, DOI 10.1111/j.1749-6632.1958.tb39560.x; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; THORESON WB, 1990, VISUAL NEUROSCI, V5, P571, DOI 10.1017/S0952523800000730; Vanleeuwen MT, 2007, VISUAL NEUROSCI, V24, P277, DOI 10.1017/S0952523807070058; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Verweij J, 2003, J NEUROSCI, V23, P10249; Vigh J, 1999, VISUAL NEUROSCI, V16, P159, DOI 10.1017/S095252389916111X; WAKABAYASHI K, 1988, INVEST OPHTH VIS SCI, V29, P1615; Winkler BS, 2003, EXP EYE RES, V77, P115, DOI 10.1016/S0014-4835(03)00085-X; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	65	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66216	10.1371/journal.pone.0066216	http://dx.doi.org/10.1371/journal.pone.0066216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750282	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900084
J	Choi, I; Carey, TS; Wilson, CA; Knott, JG				Choi, Inchul; Carey, Timothy S.; Wilson, Catherine A.; Knott, Jason G.			Evidence that Transcription Factor AP-2 gamma Is Not Required for Oct4 Repression in Mouse Blastocysts	PLOS ONE			English	Article							PREIMPLANTATION DEVELOPMENT; TROPHECTODERM; CDX2; EXPRESSION; EMBRYOS; DIFFERENTIATION; SPECIFICATION; BOVINE	In mouse blastocysts segregation of the inner cell mass (ICM) and the trophectoderm (TE) is regulated by the mutually antagonistic effects of the transcription factors Oct4 and Cdx2 expressed in the ICM and TE, respectively. In contrast, in other species such as bovine and human, Oct4 is not restricted to the ICM and continues to be expressed in the Cdx2-positive TE. A recent comparative study of the bovine and mouse Oct4 promoters revealed that additional mechanisms might act in conjunction with Cdx2 to downregulate Oct4 expression in the mouse TE lineage. For instance, the mouse Oct4 distal enhancer contains an AP-2 gamma (Tcfap2c) binding motif that is absent in the bovine and human Oct4 distal enhancer. Nonetheless, the functional relevance of Tcfap2c in Oct4 repression during mouse preimplantation development was not tested. To elucidate the role of Tcfap2c in Oct4 expression an RNA interference approach was utilized. Depletion of Tcfap2c triggered a decrease in Oct4 expression at the 8-cell and morula stage. Remarkably, at the blastocyst stage depletion of Tcfap2c and/or its family member Tcfap2a had no effect on Oct4 repression. To test whether Tcfap2c interacts with Oct4 to positively regulate Oct4 expression, chromatin immunoprecipitation and in situ co-immunoprecipitation analyses were performed. These experiments revealed Tcfap2c and Oct4 binding were enriched at the Oct4 distal enhancer in embryonic stem (ES) cells, but were rapidly lost during differentiation into trophoblast-like cells when Oct4 became repressed. Moreover, Tcfap2c and Oct4 interactions were detected at the morula stage, but were lost during blastocyst formation. In summary, these data demonstrate that Tcfap2c is not required for Oct4 silencing in mouse blastocysts, but may be necessary for the maintenance of Oct4 expression during the 8 cell-to-morula transition. These findings support the notion Cdx2 is the predominant negative regulator of Oct4 expression during blastocyst formation in mice.	[Choi, Inchul; Wilson, Catherine A.; Knott, Jason G.] Michigan State Univ, Dept Anim Sci, Dev Epigenet Lab, E Lansing, MI 48824 USA; [Carey, Timothy S.; Knott, Jason G.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Knott, JG (corresponding author), Michigan State Univ, Dept Anim Sci, Dev Epigenet Lab, E Lansing, MI 48824 USA.	knottj@msu.edu	Choi, Inchul/AAF-6264-2021	Choi, Inchul/0000-0001-5011-2658	National Institute of General Medical Sciences [R01GM095347]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095347] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grant R01GM095347 from the National Institute of General Medical Sciences to JGK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Cauffman G, 2005, MOL HUM REPROD, V11, P173, DOI 10.1093/molehr/gah155; Choi Inchul, 2012, Development, V139, P4623, DOI 10.1242/dev.086645; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Kurosaka S, 2004, BIOL REPROD, V71, P1578, DOI 10.1095/biolreprod.104.029322; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Wang K, 2010, PLOS ONE, V5; Winger Q, 2006, BIOL REPROD, V75, P324, DOI 10.1095/biolreprod.106.052407; Wu GM, 2010, DEVELOPMENT, V137, P4159, DOI 10.1242/dev.056630	17	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65771	10.1371/journal.pone.0065771	http://dx.doi.org/10.1371/journal.pone.0065771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741512	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900225
J	Henderson, JT; Puri, M; Blum, M; Harper, CC; Rana, A; Gurung, G; Pradhan, N; Regmi, K; Malla, K; Sharma, S; Grossman, D; Bajracharya, L; Satyal, I; Acharya, S; Lamichhane, P; Darney, PD				Henderson, Jillian T.; Puri, Mahesh; Blum, Maya; Harper, Cynthia C.; Rana, Ashma; Gurung, Geeta; Pradhan, Neelam; Regmi, Kiran; Malla, Kasturi; Sharma, Sudha; Grossman, Daniel; Bajracharya, Lata; Satyal, Indira; Acharya, Shridhar; Lamichhane, Prabhat; Darney, Philip D.			Effects of Abortion Legalization in Nepal, 2001-2010	PLOS ONE			English	Article							LEGAL-ABORTION; HOSPITAL ADMISSIONS; UNSAFE ABORTION; COMMUNICATION; COMPLICATIONS; WORLDWIDE; SERVICES; IMPACT; WOMEN	Background: Abortion was legalized in Nepal in 2002, following advocacy efforts highlighting high maternal mortality from unsafe abortion. We sought to assess whether legalization led to reductions in the most serious maternal health consequences of unsafe abortion. Methods: We conducted retrospective medical chart review of all gynecological cases presenting at four large public referral hospitals in Nepal. For the years 2001-2010, all cases of spontaneous and induced abortion complications were identified, abstracted, and coded to classify cases of serious infection, injury, and systemic complications. We used segmented Poisson and ordinary logistic regression to test for trend and risks of serious complications for three time periods: before implementation (2001-2003), early implementation (2004-2006), and later implementation (2007-2010). Results: 23,493 cases of abortion complications were identified. A significant downward trend in the proportion of serious infection, injury, and systemic complications was observed for the later implementation period, along with a decline in the risk of serious complications (OR 0.7, 95% CI 0.64, 0.85). Reductions in sepsis occurred sooner, during early implementation (OR 0.6, 95% CI 0.47, 0.75). Conclusion: Over the study period, health care use and the population of reproductive aged women increased. Total fertility also declined by nearly half, despite relatively low contraceptive prevalence. Greater numbers of women likely obtained abortions and sought hospital care for complications following legalization, yet we observed a significant decline in the rate of serious abortion morbidity. The liberalization of abortion policy in Nepal has benefited women's health, and likely contributes to falling maternal mortality in the country. The steepest decline was observed after expansion of the safe abortion program to include midlevel providers, second trimester training, and medication abortion, highlighting the importance of concerted efforts to improve access. Other countries contemplating changes to abortion policy can draw on the evidence and implementation strategies observed in Nepal.	[Henderson, Jillian T.; Blum, Maya; Harper, Cynthia C.; Darney, Philip D.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, San Francisco, CA 94143 USA; [Puri, Mahesh; Lamichhane, Prabhat] CREHPA, Kathmandu, Nepal; [Rana, Ashma; Gurung, Geeta; Pradhan, Neelam] Tribhuvan Univ, Teaching Hosp, Dept Gynecol & Obstet, Inst Med, Kathmandu, Nepal; [Regmi, Kiran] Bharatpur Dist Hosp, Chitwan, Nepal; [Malla, Kasturi] Medicare Natl Hosp & Res Ctr, Dept Gynecol & Obstet, Kathmandu, Nepal; [Sharma, Sudha] Minist Hlth & Populat, Kathmandu, Nepal; [Grossman, Daniel] Ibis Reprod Hlth, San Francisco, CA USA; [Grossman, Daniel] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Bajracharya, Lata] Capital Hosp, Kathmandu, Nepal; [Bajracharya, Lata; Satyal, Indira] Paropakar Matern & Womens Hosp, Kathmandu, Nepal; [Acharya, Shridhar] Lumbini Zonal Hosp, Butwal, Nepal	University of California System; University of California San Francisco; Tribhuvan University; Institute of Medicine (IoM) - Nepal; University of California System; University of California San Francisco	Henderson, JT (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, San Francisco, CA 94143 USA.	Jillian.T.Henderson@gmail.com		Lamichhane, Prabhat/0000-0002-5719-7129	National Center for Advancing Translational Sciences, National Institutes of Health (NIH), UCSF-CTSI [UL1 RR024131]; Richard and Rhoda Goldman Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health (NIH), UCSF-CTSI; Richard and Rhoda Goldman Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The publication benefited from resources available to Dr. JTH through the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), UCSF-CTSI Grant Number UL1 RR024131. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The authors wish to thank an anonymous donor and the Richard and Rhoda Goldman Fund for study support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee SK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-175; BARRETO T, 1992, STUD FAMILY PLANN, V23, P159, DOI 10.2307/1966725; Bingham A, 2011, J HEALTH COMMUN, V16, P245, DOI 10.1080/10810730.2010.529495; BRACKEN MB, 1982, AM J PUBLIC HEALTH, V72, P30, DOI 10.2105/AJPH.72.1.30; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; CATES W, 1978, AM J OBSTET GYNECOL, V132, P211, DOI 10.1016/0002-9378(78)90926-2; CATES W, 1982, SCIENCE, V215, P1586, DOI 10.1126/science.7071579; Collins S, 2006, LANCET, V368, P907, DOI 10.1016/S0140-6736(06)69353-7; Dahal K, 2004, LANCET, V363, P1905, DOI 10.1016/S0140-6736(04)16364-2; Dhakal S, 2007, LANCET, V370, P1301, DOI 10.1016/S0140-6736(07)61560-8; Fetters T, 2008, BJOG-INT J OBSTET GY, V115, P957, DOI 10.1111/j.1471-0528.2008.01765.x; FIGATALAMANCA I, 1986, INT J HEALTH SERV, V16, P375, DOI 10.2190/BJ4F-9KJN-MFAL-6X22; Ganatra Bela, 2002, J Am Med Womens Assoc (1972), V57, P159; Gebreselassie H, 2005, BJOG-INT J OBSTET GY, V112, P1229, DOI 10.1111/j.1471-0528.2004.00503.x; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Harris LH, 2011, INT J GYNECOL OBSTET, V115, P77, DOI 10.1016/j.ijgo.2011.05.018; Hussein J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019898; Jewkes R, 2005, BJOG-INT J OBSTET GY, V112, P355, DOI 10.1111/j.1471-0528.2004.00422.x; Jewkes R, 2002, BRIT MED J, V324, P1252, DOI 10.1136/bmj.324.7348.1252; Lamichhane P, 2011, WOMEN HEALTH ISS, V21, pS37, DOI 10.1016/j.whi.2011.02.001; Ministry of Health and Population (MOHP), 2007, NEP DEM HLTH SURV 20; Ministry of Health and Population (MOHP), 2012, NEP DEM HLTH SURV 20; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; Puri M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-297; Rocca CH, 2013, BJOG-INT J OBSTET GY, V120, P1075, DOI 10.1111/1471-0528.12242; Samandari G, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-7; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Sedgh G, 2011, PERSPECT SEX REPRO H, V43, P188, DOI 10.1363/4318811; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Singh S, 2006, LANCET, V368, P1887, DOI 10.1016/S0140-6736(06)69778-X; Thapa S, 2004, REPROD HEALTH MATTER, V12, P85, DOI 10.1016/S0968-8080(04)24006-X; WHO: World Health Organization United Nations Children's Fund United Nations Population Fund and The World Bank, 2011, TRENDS MAT MORT 1990; WITTER S, 2011, HLTH POLICY PLAN S2, P84; World Health Organization, 2013, UNS AB GLOB REG EST	34	31	33	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64775	10.1371/journal.pone.0064775	http://dx.doi.org/10.1371/journal.pone.0064775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741391	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900104
J	Jesan, T; Sarma, U; Halder, S; Saha, B; Sinha, S				Jesan, Tharmaraj; Sarma, Uddipan; Halder, Subhadra; Saha, Bhaskar; Sinha, Sitabhra			Branched Motifs Enable Long-Range Interactions in Signaling Networks through Retrograde Propagation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; KAPPA-B KINASE; MEK KINASE; INSULIN-RESISTANCE; NEGATIVE-FEEDBACK; MAP KINASE; P38; JNK; PATHWAYS; CD40	Branched structures arise in the intra-cellular signaling network when a molecule is involved in multiple enzyme-substrate reaction cascades. Such branched motifs are involved in key biological processes, e. g., immune response activated by T-cell and B-cell receptors. In this paper, we demonstrate long-range communication through retrograde propagation between branches of signaling pathways whose molecules do not directly interact. Our numerical simulations and experiments on a system comprising branches with JNK and p38MAPK as terminal molecules respectively that share a common MAP3K enzyme MEKK3/4 show that perturbing an enzyme in one branch can result in a series of changes in the activity levels of molecules "upstream" to the enzyme that eventually reaches the branch-point and affects other branches. In the absence of any evidence for explicit feedback regulation between the functionally distinct JNK and p38MAPK pathways, the experimentally observed modulation of phosphorylation amplitudes in the two pathways when a terminal kinase is inhibited implies the existence of long-range coordination through retrograde information propagation previously demonstrated in single linear reaction pathways. An important aspect of retrograde propagation in branched pathways that is distinct from previous work on retroactivity focusing exclusively on single chains is that varying the type of perturbation, e. g., between pharmaceutical agent mediated inhibition of phosphorylation or suppression of protein expression, can result in opposing responses in the other branches. This can have potential significance in designing drugs targeting key molecules which regulate multiple pathways implicated in systems-level diseases such as cancer and diabetes.	[Jesan, Tharmaraj; Sinha, Sitabhra] Inst Math Sci, Chennai 600113, Tamil Nadu, India; [Jesan, Tharmaraj] Bhabha Atom Res Ctr, Div Hlth Phys, Kalpakkam, Tamil Nadu, India; [Sarma, Uddipan; Halder, Subhadra; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Institute of Mathematical Sciences (IMSc) India; Bhabha Atomic Research Center (BARC); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sinha, S (corresponding author), Inst Math Sci, Chennai 600113, Tamil Nadu, India.	sitabhra@imsc.res.in		Sinha, Sitabhra/0000-0002-3004-1079	Department of Bio-Technology (DBT), Government of India [BT/PR7521/BRB/10/482/2006]; IMSc Complex Systems Project (XI Plan)	Department of Bio-Technology (DBT), Government of India(Department of Biotechnology (DBT) India); IMSc Complex Systems Project (XI Plan)	This study was supported by the Department of Bio-Technology (DBT), Government of India (BT/PR7521/BRB/10/482/2006) and IMSc Complex Systems Project (XI Plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2007, J BIOL CHEM, V282, P30476, DOI 10.1074/jbc.M705783200; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Chowdhury TA, 2010, QJM-INT J MED, V103, P905, DOI 10.1093/qjmed/hcq149; Cloutier M, 2011, INTEGR BIOL-UK, V3, P724, DOI 10.1039/c0ib00145g; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Deacon K, 1999, J BIOL CHEM, V274, P16604, DOI 10.1074/jbc.274.23.16604; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Gantke T, 2012, IMMUNOL REV, V246, P168, DOI 10.1111/j.1600-065X.2012.01104.x; Hagemann D, 1999, ONCOGENE, V18, P1391, DOI 10.1038/sj.onc.1202431; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Komarova NL, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100031; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lewin B., 2007, CELLS-BASEL; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Millat T, 2007, MATH BIOSCI, V207, P40, DOI 10.1016/j.mbs.2006.08.012; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Rub A, 2009, NAT IMMUNOL, V10, P273, DOI 10.1038/ni.1705; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Soyer OS, 2006, J THEOR BIOL, V238, P416, DOI 10.1016/j.jtbi.2005.05.030; Srivastava N, 2011, J IMMUNOL, V186, P5863, DOI 10.4049/jimmunol.1003957; Sudan R, 2012, J IMMUNOL, V188, P2328, DOI 10.4049/jimmunol.1101678; Sutherland CL, 1996, J IMMUNOL, V157, P3381; Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; YAN MH, 1994, NATURE, V372, P798; Zama T, 2002, J BIOL CHEM, V277, P23919, DOI 10.1074/jbc.M200838200	49	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64409	10.1371/journal.pone.0064409	http://dx.doi.org/10.1371/journal.pone.0064409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741327	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900039
J	Pouilly, M; Rejas, D; Perez, T; Duprey, JL; Molina, CI; Hubas, C; Guimaraes, JRD				Pouilly, Marc; Rejas, Danny; Perez, Tamara; Duprey, Jean-Louis; Molina, Carlos I.; Hubas, Cedric; Guimaraes, Jean-Remy D.			Trophic Structure and Mercury Biomagnification in Tropical Fish Assemblages, Itenez River, Bolivia	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; FOOD-CHAIN STRUCTURE; ENERGY-SOURCES; FLOODPLAIN; LAKE; METHANE; AMAZON; WEBS; BIOACCUMULATION; METHYLMERCURY	We examined mercury concentrations in three fish assemblages to estimate biomagnification rates in the Itenez main river, affected by anthropogenic activities, and two unperturbed rivers from the Itenez basin, Bolivian Amazon. Rivers presented low to moderate water mercury concentrations (from 1.25 ng L-1 to 2.96 ng L-1) and natural differences in terms of sediment load. Mercury biomagnification rates were confronted to trophic structure depicted by carbon and nitrogen stable isotopes composition (delta N-15; delta C-13) of primary trophic sources, invertebrates and fishes. Results showed a slight fish contamination in the Itenez River compared to the unperturbed rivers, with higher mercury concentrations in piscivore species (0.15 mu g g(-1) vs. 0.11 mu g g(-1) in the unperturbed rivers) and a higher biomagnification rate. Trophic structure analysis showed that the higher biomagnification rate in the Itenez River could not be attributed to a longer food chain. Nevertheless, it revealed for the Itenez River a higher contribution of periphyton to the diet of the primary consumers fish species; and more negative delta C-13 values for primary trophic sources, invertebrates and fishes that could indicate a higher contribution of methanotrophic bacteria. These two factors may enhance methylation and methyl mercury transfer in the food web and thus, alternatively or complementarily to the impact of the anthropogenic activities, may explain mercury differences observed in fishes from the Itenez River in comparison to the two other rivers.	[Pouilly, Marc] UPMC, IRD, CNRS, MNHN,Inst Rech Dev,UMR Borea Biol Organismes & Ec, Paris, France; [Rejas, Danny; Perez, Tamara] Univ Mayor San Simon, Unidad Limnol & Recursos Acuat, Cochabamba, Bolivia; [Duprey, Jean-Louis] Inst Rech Dev US Imago, La Paz, Bolivia; [Molina, Carlos I.] Univ Mayor San Andres, Inst Ecol, Unidad Limnol, La Paz, Bolivia; [Hubas, Cedric] UPMC, IRD, CNRS, Museum Natl Hist Nat UMR Borea MNHN, Paris, France; [Guimaraes, Jean-Remy D.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Tracadores, BR-21941 Rio De Janeiro, Brazil	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universidad Mayor de San Andres; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universidade Federal do Rio de Janeiro	Pouilly, M (corresponding author), UPMC, IRD, CNRS, MNHN,Inst Rech Dev,UMR Borea Biol Organismes & Ec, Paris, France.	pouilly@ird.fr	Guimaraes, Jean R D/B-6451-2013; Molina, Carlos/AAI-9839-2020; Hubas, Cédric/P-4200-2019; Pouilly, Marc/E-9119-2014; BOREA, UMR BOREA/C-6165-2008	Guimaraes, Jean R D/0000-0003-2584-0009; Hubas, Cédric/0000-0002-9110-9292; Pouilly, Marc/0000-0003-4209-3367; BOREA, UMR BOREA/0000-0002-9110-9292; Rejas, Danny/0000-0003-2561-1214; Molina, Carlos I./0000-0002-4191-7451	IRD; WWF Bolivia [KN10 WWF-IRD]	IRD; WWF Bolivia	This work was part of the IRD (http://www.ird.fr) funded project "Trophic Ecology of Amazonian Aquatic Systems" (JEAI-EMAA). Its also received financial support from a WWF Bolivia (http://bolivia.panda.org) funded project (KN10 WWF-IRD agreement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha D, 2011, CHEMOSPHERE, V82, P911, DOI 10.1016/j.chemosphere.2010.10.050; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ARAUJOLIMA CARM, 1986, SCIENCE, V234, P1256, DOI 10.1126/science.234.4781.1256; BARTLETT KB, 1988, J GEOPHYS RES-ATMOS, V93, P1571, DOI 10.1029/JD093iD02p01571; Bastviken D, 2003, ECOLOGY, V84, P969, DOI 10.1890/0012-9658(2003)084[0969:MAASOC]2.0.CO;2; Bowles KC, 2001, CAN J FISH AQUAT SCI, V58, P888, DOI 10.1139/cjfas-58-5-888; Brigham ME, 2009, ENVIRON SCI TECHNOL, V43, P2720, DOI 10.1021/es802694n; BUNN SE, 1993, OECOLOGIA, V96, P85, DOI 10.1007/BF00318034; CABANA G, 1994, CAN J FISH AQUAT SCI, V51, P381, DOI 10.1139/f94-039; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Coelho-Souza SA, 2006, SCI TOTAL ENVIRON, V364, P188, DOI 10.1016/j.scitotenv.2005.07.010; Coelho-Souza SA, 2011, SCI TOTAL ENVIRON, V409, P2746, DOI 10.1016/j.scitotenv.2011.03.028; Cremona F, 2009, BIOGEOCHEMISTRY, V94, P81, DOI 10.1007/s10533-009-9309-9; Da Silva DS, 2005, WATER AIR SOIL POLL, V165, P77, DOI 10.1007/s11270-005-4811-8; David N, 2009, ENVIRON TOXICOL CHEM, V28, P2091, DOI 10.1897/08-482.1; Dominique Y, 2007, ENVIRON TOXICOL CHEM, V26, P45, DOI 10.1897/05-649R.1; Gilmour CC, 1998, BIOGEOCHEMISTRY, V40, P327, DOI 10.1023/A:1005972708616; Guimaraes JRD, 2000, SCI TOTAL ENVIRON, V261, P99, DOI 10.1016/S0048-9697(00)00628-8; Hall BD, 1997, WATER AIR SOIL POLL, V100, P13; Hamelin S, 2011, ENVIRON SCI TECHNOL, V45, P7693, DOI 10.1021/es2010072; HAMILTON SK, 1992, OECOLOGIA, V89, P324, DOI 10.1007/BF00317409; Huguet L, 2010, SCI TOTAL ENVIRON, V408, P1338, DOI 10.1016/j.scitotenv.2009.10.058; Molina CI, 2010, SCI TOTAL ENVIRON, V408, P3382, DOI 10.1016/j.scitotenv.2010.04.019; Jepsen DB, 2007, ECOL FRESHW FISH, V16, P267, DOI 10.1111/j.1600-0633.2006.00218.x; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Jones RI, 2004, BOREAL ENVIRON RES, V9, P17; Kankaala P, 2006, LIMNOL OCEANOGR, V51, P2821, DOI 10.4319/lo.2006.51.6.2821; Martinez JM, 2007, REMOTE SENS ENVIRON, V108, P209, DOI 10.1016/j.rse.2006.11.012; Maurice-Bourgoin L, 2001, MERCUR AMAZ, P167, DOI [10.4000/books.irdeditions.2535, DOI 10.4000/BOOKS.IRDEDITIONS.2535]; Molina CI, 2011, HYDROBIOLOGIA, V663, P135, DOI 10.1007/s10750-010-0565-4; National Research Council, 2000, TOX EFF METH; Ovando AL, 2008, THESIS INT I GEOINFO; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Pouilly M, 2004, ECOL FRESHW FISH, V13, P245, DOI 10.1111/j.1600-0633.2004.00055.x; Pouilly M, 2012, ECOTOX ENVIRON SAFE, V83, P8, DOI 10.1016/j.ecoenv.2012.05.018; Rejas D, 2004, THESIS KATHOLIEKE U; Roulet M, 1999, WATER AIR SOIL POLL, V112, P297, DOI 10.1023/A:1005073432015; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Sanseverino AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042723; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Wantzen KM, 2002, AQUAT SCI, V64, P239, DOI 10.1007/PL00013196	42	32	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65054	10.1371/journal.pone.0065054	http://dx.doi.org/10.1371/journal.pone.0065054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741452	gold, Green Published			2022-12-27	WOS:000319799900165
J	Sahneh, FD; Scoglio, C; Riviere, J				Sahneh, Faryad Darabi; Scoglio, Caterina; Riviere, Jim			Dynamics of Nanoparticle-Protein Corona Complex Formation: Analytical Results from Population Balance Equations	PLOS ONE			English	Article							NANOMATERIALS; SYSTEMS	Background: Nanoparticle-protein corona complex formation involves absorption of protein molecules onto nanoparticle surfaces in a physiological environment. Understanding the corona formation process is crucial in predicting nanoparticle behavior in biological systems, including applications of nanotoxicology and development of nano drug delivery platforms. Method: This paper extends the modeling work in to derive a mathematical model describing the dynamics of nanoparticle corona complex formation from population balance equations. We apply nonlinear dynamics techniques to derive analytical results for the composition of nanoparticle-protein corona complex, and validate our results through numerical simulations. Results: The model presented in this paper exhibits two phases of corona complex dynamics. In the first phase, proteins rapidly bind to the free surface of nanoparticles, leading to a metastable composition. During the second phase, continuous association and dissociation of protein molecules with nanoparticles slowly changes the composition of the corona complex. Given sufficient time, composition of the corona complex reaches an equilibrium state of stable composition. We find analytical approximate formulae for metastable and stable compositions of corona complex. Our formulae are very well-structured to clearly identify important parameters determining corona composition. Conclusion: The dynamics of biocorona formation constitute vital aspect of interactions between nanoparticles and living organisms. Our results further understanding of these dynamics through quantitation of experimental conditions, modeling results for in vitro systems to better predict behavior for in vivo systems. One potential application would involve a single cell culture medium related to a complex protein medium, such as blood or tissue fluid.	[Sahneh, Faryad Darabi; Scoglio, Caterina; Riviere, Jim] Kansas State Univ, Inst Computat Comparat Med, Manhattan, KS 66506 USA; [Sahneh, Faryad Darabi; Scoglio, Caterina; Riviere, Jim] Kansas State Univ, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Scoglio, C (corresponding author), Kansas State Univ, Inst Computat Comparat Med, Manhattan, KS 66506 USA.	caterina@k-state.edu	Sahneh, Faryad Darabi/Y-6994-2019; Riviere, Jim/A-9210-2008	Sahneh, Faryad Darabi/0000-0003-2521-4331; Riviere, Jim/0000-0001-8412-9650; Scoglio, Caterina/0000-0003-4486-9229	Kansas Bioscience Authority	Kansas Bioscience Authority	This work was partially supported by Kansas Bioscience Authority funds to the Institute of Computational Comparative Medicine (ICCM) at Kansas State University. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	adler, 2012, J NANOPART RES, V14, P1; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Dell'Orco D, 2012, NANOMED-NANOTECHNOL, V8, P1271, DOI 10.1016/j.nano.2012.02.006; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Gasser M, 2010, J NANOBIOTECHNOL, V8, DOI 10.1186/1477-3155-8-31; Hill HD, 2009, ACS NANO, V3, P418, DOI 10.1021/nn800726e; Khalil H. K., 2002, NONLINEAR SYSTEMS 3, V3rd; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g; Milani S, 2012, ACS NANO, V6, P2532, DOI 10.1021/nn204951s; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Rocker C, 2009, NAT NANOTECHNOL, V4, P577, DOI [10.1038/NNANO.2009.195, 10.1038/nnano.2009.195]; Vilaseca P, 2013, ARXIV12023796V2; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Welsch N, 2012, SOFT MATTER, V8, P12043, DOI 10.1039/c2sm26798e; Xia XR, 2010, NAT NANOTECHNOL, V5, P671, DOI [10.1038/nnano.2010.164, 10.1038/NNANO.2010.164]; Yang ST, 2013, SMALL IN PRESS, DOI 101002/smll201201492	19	68	68	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64690	10.1371/journal.pone.0064690	http://dx.doi.org/10.1371/journal.pone.0064690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741371	Green Published, gold			2022-12-27	WOS:000319799900084
J	Sun, W; Wu, M; Qu, P; Lu, CM; Wang, L				Sun, Wei; Wu, Ming; Qu, Peng; Lu, Chunming; Wang, Lie			Quality of Life of People Living with HIV/AIDS under the New Epidemic Characteristics in China and the Associated Factors	PLOS ONE			English	Article							HIV; STIGMA; WOMEN; SUPPORT; INDIA; MEN	Background: Improvement of quality of life has been one of goals in health care for people living with HIV/AIDS (PLWHA). In China, the epidemic characteristics have changed and transmission is now most commonly sexual contact. However, the assessment of quality of life of PLWHA under new characteristics has limited reporting. This study was designed to assess the quality of life among PLWHA who contracted disease mainly via sexual contact and to clarify the associated factors. Methods: A cross-sectional study was performed in Liaoning Province. Sample size (800) was calculated based on the fatality rate and enlarged with consideration on the loss of response. Participants were sampled by tables of random numbers among all registered PLWHA. Questionnaires pertaining to quality of life (SF-36) and related factors (demographic characteristics, social support and network, HIV/AIDS awareness, and behavior factors) were distributed during December 2010-April 2011. 783 effective responses were obtained. Results: The average scores of physical component summary (PCS), mental component summary (MCS), and total score (TS) were 66.8 +/- 21.9 (Mean +/- SD), 62.2 +/- 20.9, and 64.5 +/- 20.2. General linear model analysis revealed that, in standardized estimate (b) sequence, PCS was significantly associated with monthly income, perceived social support, antiretroviral therapy, transmission, and ethnicity; MCS was associated with perceived social support, antiretroviral therapy, condom use, monthly income, transmission, ethnicity, and alcohol consumption; whereas TS was associated with perceived social support, antiretroviral therapy, monthly income, transmission, condom use, and ethnicity. Conclusions: Quality of life for PLWHA who contracted HIV mainly via sexual contact was worse and both physical conditions and social integration were impacted. Under current epidemic characteristics, efforts to increase social support and enhance the implementation of supporting policy are necessary to improve the quality of life of PLWHA.	[Sun, Wei] China Med Univ, Sch Publ Hlth, Dept Environm Hlth, Shenyang, Liaoning, Peoples R China; [Sun, Wei; Wang, Lie] China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang, Liaoning, Peoples R China; [Wu, Ming; Lu, Chunming] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning, Peoples R China; [Qu, Peng] Liaoning Women & Childrens Hlth, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Wang, L (corresponding author), China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang, Liaoning, Peoples R China.	liewang@mail.cmu.edu.cn		Sun, Wei/0000-0002-0241-6603	Global Fund AIDS Program in China	Global Fund AIDS Program in China	This study was supported by the Global Fund AIDS Program in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakrapani V, 2010, AIDS PATIENT CARE ST, V24, P49, DOI 10.1089/apc.2009.0214; Ding H, 2012, CHIN J AIDS STD, V18, P14; Dou Z, 2010, INT J EPIDEMIOL S2, pii56; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; Gibson K, 2011, AIDS PATIENT CARE ST, V25, P371, DOI 10.1089/apc.2010.0165; [宁南义 NING NanYi], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P501; Kowal J, 2008, J PAIN SYMPTOM MANAG, V36, P247, DOI 10.1016/j.jpainsymman.2007.10.012; [李进 Li Jin], 2004, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V4, P550; Lin Peng, 2013, Modern Preventive Medicine, V40, P463; Ma J, 2006, CHIN J PUBLIC HLTH, V22, P1307; Meng YJ, 2008, PUBLIC HEALTH, V122, P404, DOI 10.1016/j.puhe.2007.06.007; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Ochako R, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-11; Shamos S, 2009, QUAL HEALTH RES, V19, P1678, DOI 10.1177/1049732309353910; Shan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021839; Slade P, 2007, HUM REPROD, V22, P2309, DOI 10.1093/humrep/dem115; Song Q, 2010, CHIN J SCH HLTH, V31, P267; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; SUN X, 2010, INT J EPIDEMIOL S2, V39, P4, DOI DOI 10.1093/IJE/DYQ217; The Ministry of Health of the People's Republic of China, 2010, CHIN HAS MAD REM ACH; The Ministry of Health of the People's Republic of China, 2008, DIAGN CRIT HIV AIDS; The Ministry of Health of the People's Republic of China UNAIDS WHO, 2011, EST AIDS EP CHIN 201; Turner-Cobb JM, 2002, J BEHAV MED, V25, P337, DOI 10.1023/A:1015814431481; Wang H., 2001, CHINESE J PREVENTIVE, V35, P365; Wang X, 2011, CHIN J AIDS STD, V17, P499; *WHO UNAIDS, 2000, KEY EL HIV AIDS CAR; Wu Z.H., 2010, INT J SYST SCI, P1; Yan C, 2011, CHIN J AIDS STD, V17, P629; Yu Da, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P622	29	29	34	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64562	10.1371/journal.pone.0064562	http://dx.doi.org/10.1371/journal.pone.0064562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741340	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900053
J	Surges, R; Jordan, A; Elger, CE				Surges, Rainer; Jordan, Arthur; Elger, Christian E.			Ictal Modulation of Cardiac Repolarization, but Not of Heart Rate, Is Lateralized in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							SUDDEN UNEXPECTED DEATH; GENERALIZED SEIZURES; AUTONOMIC MODULATION; INSULAR INVOLVEMENT; RATE-VARIABILITY; POTENTIAL ROLE; QT-INTERVAL; STROKE; ABNORMALITIES; STIMULATION	Objectives: Human and animal studies provided controversial data on asymmetric cortical representation of cardiac function, which may partially be due to different study designs and inter-individual variability. Here, we investigated whether seizure-related changes in heart rate (HR) and cardiac repolarization depend on the side of seizure-activity in people with mesial temporal lobe epilepsy (mTLE). Methods: To account for inter-individual variability, EEG and ECG data were reviewed from patients with medically refractory mTLE undergoing pre-surgical video-EEG telemetry with at least 2 seizures arising from each hippocampus as assessed by bilateral hippocampal depths electrodes. RR and QT intervals were determined at different timepoints using a one-lead ECG. QT intervals were corrected for HR (QTc) using 4 established formulas. Results: Eighty-two seizures of 15 patients were analyzed. HR increased by similar to 30% during hippocampal activity irrespective of the side (p = 0.411). QTc intervals were lengthened to a significantly greater extent during left hippocampal seizures (e. g. difference of QT intervals between preictal and ictal state using Bazett's formula; left side 32.0 +/- 5.3 ms, right side 15.6 +/- 7.7 ms; p = 0.016). Abnormal QTc prolongation occurred in 7 of 41 left hippocampal seizures of 4 patients, and only in 2 of 37 right hippocampal seizures of 2 patients. Conclusions: Seizure-related modulation of cardiac repolarization, but not of HR, appears to depend on the side of ictal activity, strengthening the hypothesis of asymmetric cerebral representation of cardiac function. The clinical relevance of this is unclear, but may indicate an increased risk of abnormal ictal QT prolongation in people with left mTLE.	[Surges, Rainer; Jordan, Arthur; Elger, Christian E.] Univ Hosp Bonn, Dept Epileptol, Bonn, Germany	University of Bonn	Surges, R (corresponding author), Univ Hosp Bonn, Dept Epileptol, Bonn, Germany.	rainer.surges@gmail.com		Surges, Rainer/0000-0002-3177-8582	EISAI; National Institutes of Health [NBIH/NINDS - 1P20NS076965-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P20NS076965] Funding Source: NIH RePORTER	EISAI(Eisai Co Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. R. Surges has received support for congress participation and speaker fees from EISAI; had a consultancy agreement with UCB; is part of PRISM - the Prevention and Risk Identification of SUDEP Mortality Consortium which is funded by the National Institutes of Health (NBIH/NINDS - 1P20NS076965-01). A. Jordan has no financial disclosure to make. Prof. Dr. C. E. Elger is consultant for Desitin and Novartis and received honoraria for talks from Pfizer and Esai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GL, 2001, EPILEPSIA, V42, P912, DOI 10.1046/j.1528-1157.2001.042007912.x; Ansakorpi H, 2004, EPILEPSIA, V45, P933, DOI 10.1111/j.0013-9580.2004.65003.x; Aytemir K, 1999, PACE, V22, P1397, DOI 10.1111/j.1540-8159.1999.tb00635.x; Britton JW, 2006, EPILEPSIA, V47, P737, DOI 10.1111/j.1528-1167.2006.00509.x; Brotherstone R, 2010, EPILEPSIA, V51, P221, DOI 10.1111/j.1528-1167.2009.02281.x; Cheung RTF, 2000, ARCH NEUROL-CHICAGO, V57, P1685, DOI 10.1001/archneur.57.12.1685; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Critchley HD, 2005, BRAIN, V128, P75, DOI 10.1093/brain/awh324; EPSTEIN MA, 1992, NEUROLOGY, V42, P50, DOI 10.1212/WNL.42.1.50; Espinosa PS, 2009, NEUROLOGY, V72, P1702, DOI 10.1212/WNL.0b013e3181a55f90; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; HACHINSKI VC, 1992, ARCH NEUROL-CHICAGO, V49, P697, DOI 10.1001/archneur.1992.00530310039010; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; Jokeit H, 2000, NEUROLOGY, V54, P2347, DOI 10.1212/WNL.54.12.2347; Kawai M, 2006, NEUROLOGY, V66, P1279, DOI 10.1212/01.wnl.0000208519.40986.fb; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; Leung H, 2007, EPILEPTIC DISORD, V9, P77; Leutmezer F, 2003, EPILEPSIA, V44, P348, DOI 10.1046/j.1528-1157.2003.34702.x; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030; Moseley BD, 2011, EPILEPSY RES, V95, P237, DOI 10.1016/j.eplepsyres.2011.04.005; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Opherk C, 2002, EPILEPSY RES, V52, P117, DOI 10.1016/S0920-1211(02)00215-2; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Panchani J, 2011, EPILEPTIC DISORD, V13, P172, DOI 10.1684/epd.2011.0430; SANDER D, 1995, J NEUROL, V242, P313, DOI 10.1007/BF00878874; Schimpf R, 2012, HEART RHYTHM, V9, P776, DOI 10.1016/j.hrthm.2012.01.006; Seyal M, 2011, EPILEPSIA, V52, P2105, DOI 10.1111/j.1528-1167.2011.03262.x; Seyal M, 2009, EPILEPSIA, V50, P2557, DOI 10.1111/j.1528-1167.2009.02245.x; SPENCER SS, 1987, EPILEPSIA, V28, P479, DOI 10.1111/j.1528-1157.1987.tb03676.x; Surges R, 2012, CURR OPIN NEUROL, V25, P201, DOI 10.1097/WCO.0b013e3283506714; Surges R, 2010, EPILEPSIA, V51, P738, DOI 10.1111/j.1528-1167.2010.02571.x; Surges R, 2010, NEUROLOGY, V74, P421, DOI 10.1212/WNL.0b013e3181ccc706; Surges R, 2010, EPILEPSIA, V51, P233, DOI 10.1111/j.1528-1167.2009.02330.x; Tatschl C, 2006, CEREBROVASC DIS, V21, P47, DOI 10.1159/000089594; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408	35	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64765	10.1371/journal.pone.0064765	http://dx.doi.org/10.1371/journal.pone.0064765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741389	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900102
J	Wang, T; Xu, YN; Zhu, HY; Andrus, T; Ivanov, SB; Pan, C; Dolores, J; Dann, GC; Zhou, M; Forte, D; Yang, ZH; Holte, S; Corey, L; Zhu, TF				Wang, Tong; Xu, Younong; Zhu, Haiying; Andrus, Thomas; Ivanov, Sergei B.; Pan, Charlotte; Dolores, Jazel; Dann, Gregory C.; Zhou, Michael; Forte, Dominic; Yang, Zihuan; Holte, Sarah; Corey, Lawrence; Zhu, Tuofu			Successful Isolation of Infectious and High Titer Human Monocyte-Derived HIV-1 from Two Subjects with Discontinued Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; BLOOD-BRAIN-BARRIER; CD4(+) T-CELLS; REVERSE-TRANSCRIPTASE; TYPE-1 REPLICATION; TRANSENDOTHELIAL MIGRATION; PHENOTYPIC SUSCEPTIBILITY; CIRCULATING MONOCYTES; COMBINATION THERAPY	Background: HIV-1 DNA in blood monocytes is considered a viral source of various HIV-1 infected tissue macrophages, which is also known as "Trojan horse" hypothesis. However, whether these DNA can produce virions has been an open question for years, due to the inability of isolating high titer and infectious HIV-1 directly from monocytes. Results: In this study, we demonstrated successful isolation of two strains of M-HIV-1 (1690 M and 1175 M) from two out of four study subjects, together with their in vivo controls, HIV-1 isolated from CD4+ T-cells (T-HIV-1), 1690 T and 1175 T. All M- and T-HIV-1 isolates were detected CCR5-tropic. Both M-HIV-1 exhibited higher levels of replication in monocyte-derived macrophages (MDM) than the two T-HIV-1. Consistent with our previous reports on the subject 1175 with late infection, compartmentalized env C2-V3-C3 sequences were identified between 1175 M and 1175 T. In contrast, 1690 M and 1690 T, which were isolated from subject 1690 with relatively earlier infection, showed homogenous env C2-V3-C3 sequences. However, multiple reverse transcriptase (RT) inhibitor resistance-associated variations were detected in the Gag-Pol region of 1690 M, but not of 1690 T. By further measuring HIV DNA intracellular copy numbers post-MDM infection, 1690 M was found to have significantly higher DNA synthesis efficiency than 1690 T in macrophages, indicating a higher RT activity, which was confirmed by AZT inhibitory assays. Conclusions: These results suggested that the M- and T- HIV-1 are compartmentalized in the two study subjects, respectively. Therefore, we demonstrated that under in vitro conditions, HIV-1 infected human monocytes can productively release live viruses while differentiating into macrophages.	[Wang, Tong; Xu, Younong; Zhu, Haiying; Andrus, Thomas; Ivanov, Sergei B.; Pan, Charlotte; Dolores, Jazel; Dann, Gregory C.; Zhou, Michael; Forte, Dominic; Yang, Zihuan; Corey, Lawrence; Zhu, Tuofu] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Holte, Sarah] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Holte, Sarah] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Corey, Lawrence; Zhu, Tuofu] Fred Hutchinson Canc Res Ctr, Div Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Wang, Tong] Guangdong Higher Educ Inst, Key Lab Funct Prot Res, Guangzhou, Guangdong, Peoples R China; [Wang, Tong] Jinan Univ, Inst Life & Hlth Engn, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Jinan University	Zhu, TF (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	tzhu@u.washington.edu	Corey, Lawrence/AAE-1796-2020; Wang, Tong/A-2750-2011	Corey, Lawrence/0000-0002-2179-2436; Wang, Tong/0000-0002-5980-3380	National Institute of Health [AI 45402, AI 49109, AI 55336, AI 057005, NS060641-01A1]; University of Washington New Investigator Award (NIH) [P30 AI 027757]; Natural Science Foundation of China [NSFC 81000516, 81272185]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, P01AI057005, R01AI055336, R01AI049109, R01AI045402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060641] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington New Investigator Award (NIH); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health grants (AI 45402, AI 49109, AI 55336, AI 057005 and NS060641-01A1) to TZ; University of Washington New Investigator Award (NIH grant P30 AI 027757), as well as the Natural Science Foundation of China (NSFC 81000516 and 81272185) to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquaro S, 2001, J VIROL, V75, P4402, DOI 10.1128/JVI.75.9.4402-4406.2001; Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Aquaro S, 1997, J LEUKOCYTE BIOL, V62, P138, DOI 10.1002/jlb.62.1.138; Aquaro Stefano, 2008, Recent Pat CNS Drug Discov, V3, P23; Arfi V, 2008, J VIROL, V82, P6557, DOI 10.1128/JVI.02321-07; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Cavert W, 1998, SCIENCE, V280, P1865, DOI 10.1126/science.280.5371.1865; Cavert W, 1997, SCIENCE, V276, P960, DOI 10.1126/science.276.5314.960; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; Crowe SM, 2010, J LEUKOCYTE BIOL, V87, P589, DOI 10.1189/jlb.0809580; Cywin CL, 1998, J MED CHEM, V41, P2972, DOI 10.1021/jm9707030; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Delobel P, 2005, AIDS, V19, P1739, DOI 10.1097/01.aids.0000183125.93958.26; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOX CH, 1991, J INFECT DIS, V164, P1051, DOI 10.1093/infdis/164.6.1051; Fulcher JA, 2004, J VIROL, V78, P7883, DOI 10.1128/JVI.78.15.7883-7893.2004; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Gendelman HE, 2009, J NEUROIMMUNE PHARM, V4, P47, DOI 10.1007/s11481-008-9135-1; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Graham SM, 2009, AIDS RES HUM RETROV, V25, P433, DOI 10.1089/aid.2008.0267; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HO DD, 1986, J CLIN INVEST, V77, P1712, DOI 10.1172/JCI112491; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kagan RM, 2009, AIDS, V23, P1602, DOI 10.1097/QAD.0b013e32832d8771; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Llewellyn N, 2006, J LEUKOCYTE BIOL, V80, P1118, DOI 10.1189/jlb.0306144; Marsden MD, 2009, J ANTIMICROB CHEMOTH, V63, P7, DOI 10.1093/jac/dkn455; Muller WA, 1999, J LEUKOCYTE BIOL, V66, P698, DOI 10.1002/jlb.66.5.698; Natarajan V, 1999, LANCET, V353, P119, DOI 10.1016/S0140-6736(05)76156-0; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perno CF, 1998, J INFECT DIS, V178, P413, DOI 10.1086/515642; Persidsky Y, 1997, J IMMUNOL, V158, P3499; Persidsky Y, 1999, J NEUROVIROL, V5, P579, DOI 10.3109/13550289909021287; Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721; Polilli E, 2009, NEW MICROBIOL, V32, P205; Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058; Schrager LK, 1998, JAMA-J AM MED ASSOC, V280, P67, DOI 10.1001/jama.280.1.67; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Sonza S, 2001, AIDS, V15, P17, DOI 10.1097/00002030-200101050-00005; Soulie C, 2009, AIDS, V23, P1605, DOI 10.1097/QAD.0b013e32832d9031; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; Uhlmann EJ, 2004, J CLIN VIROL, V31, P198, DOI 10.1016/j.jcv.2004.03.012; Valcour VG, 2009, NEUROLOGY, V72, P992, DOI 10.1212/01.wnl.0000344404.12759.83; Valcour VG, 2010, J LEUKOCYTE BIOL, V87, P621, DOI 10.1189/jlb.0809571; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Wang T, 2008, J NEUROIMMUNE PHARM, V3, P173, DOI 10.1007/s11481-008-9110-x; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Westhorpe CLV, 2009, J LEUKOCYTE BIOL, V85, P1027, DOI 10.1189/jlb.0808501; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Wind-Rotolo M, 2009, J INFECT DIS, V199, P1301, DOI 10.1086/597759; Xu YN, 2008, J INFECT DIS, V197, P309, DOI 10.1086/524847; Yi YJ, 1998, J VIROL, V72, P772, DOI 10.1128/JVI.72.1.772-777.1998; Yi YJ, 2005, J VIROL, V79, P1480, DOI 10.1128/JVI.79.3.1480-1486.2005; Zhang ZQ, 1999, P NATL ACAD SCI USA, V96, P5169, DOI 10.1073/pnas.96.9.5169; Zhu T, 2002, J ANTIMICROB CHEMOTH, V50, P309, DOI 10.1093/jac/dkf143; Zhu TF, 2003, J VIROL, V77, P6108, DOI 10.1128/JVI.77.11.6108-6116.2003; Zhu TF, 2000, J LEUKOCYTE BIOL, V68, P338; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	87	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65071	10.1371/journal.pone.0065071	http://dx.doi.org/10.1371/journal.pone.0065071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741458	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900171
J	Mejia, M; Heghinian, MD; Mari, F; Godenschwege, TA				Mejia, Monica; Heghinian, Mari D.; Mari, Frank; Godenschwege, Tanja A.			New Tools for Targeted Disruption of Cholinergic Synaptic Transmission in Drosophila melanogaster	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; LONG-TERM-MEMORY; L-GLUTAMATE; FIBER; EXPRESSION; D-ALPHA-7; IDENTIFY; SUBUNITS; ABLATION	Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels. The alpha 7 subtype of nAChRs is involved in neurological pathologies such as Parkinson's disease, Alzheimer's disease, addiction, epilepsy and autism spectrum disorders. The Drosophila melanogaster alpha 7 (D alpha 7) has the closest sequence homology to the vertebrate alpha 7 subunit and it can form homopentameric receptors just as the vertebrate counterpart. The D alpha 7 subunits are essential for the function of the Giant Fiber circuit, which mediates the escape response of the fly. To further characterize the receptor function, we generated different missense mutations in the D alpha 7 nAChR's ligand binding domain. We characterized the effects of targeted expression of two UAS-constructs carrying a single mutation, D197A and Y195T, as well as a UAS-construct carrying a triple D77T, L117Q, I196P mutation in a D alpha 7 null mutant and in a wild type background. Expression of the triple mutation was able to restore the function of the circuit in D alpha 7 null mutants and had no disruptive effects when expressed in wild type. In contrast, both single mutations severely disrupted the synaptic transmission of D alpha 7-dependent but not glutamatergic or gap junction dependent synapses in wild type background, and did not or only partially rescued the synaptic defects of the null mutant. These observations are consistent with the formation of hybrid receptors, consisting of D197A or Y195T subunits and wild type D alpha 7 subunits, in which the binding of acetylcholine or acetylcholine-induced conformational changes of the D alpha 7 receptor are altered and causes inhibition of cholinergic responses. Thus targeted expression of D197A or Y195T can be used to selectively disrupt synaptic transmission of D alpha 7-dependent synapses in neuronal circuits. Hence, these constructs can be used as tools to study learning and memory or addiction associated behaviors by allowing the manipulation of neuronal processing in the circuits without affecting other cellular signaling.	[Mejia, Monica] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA; [Heghinian, Mari D.; Mari, Frank] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Godenschwege, Tanja A.] Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Godenschwege, TA (corresponding author), Florida Atlantic Univ, Dept Biol Sci, John D Mac Arthur Campus, Jupiter, FL USA.	godensch@fau.edu	Godenschwege, Tanja A/A-2830-2010	Godenschwege, Tanja A/0000-0003-3322-4134	National Institute for Neurological Disorders and Stroke [R21NS06637]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD050725]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066371] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institute for Neurological Disorders and Stroke grant R21NS06637 to F.M. and T.A.G. and the Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD050725 to T.A.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M.J., 2010, COLD SPRING HARB PRO, V2010; Allen MJ, 2007, EUR J NEUROSCI, V26, P439, DOI 10.1111/j.1460-9568.2007.05686.x; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Allen MJ, 1999, J NEUROSCI, V19, P9374; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; BAIRD DH, 1990, GENETICS, V126, P1045; Blagburn JM, 1999, J COMP NEUROL, V404, P449; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Ellison M, 2004, BIOCHEMISTRY-US, V43, P16019, DOI 10.1021/bi048918g; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Grauso M, 2002, GENETICS, V160, P1519; Gu HY, 2006, J NEUROSCI, V26, P265, DOI 10.1523/JNEUROSCI.4109-05.2006; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hou JM, 2004, J NEUROBIOL, V60, P249, DOI 10.1002/neu.20021; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Kasuya J, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.011.2009; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lansdell SJ, 2004, J NEUROCHEM, V90, P479, DOI 10.1111/j.1471-4159.2004.02499.x; Lansdell SJ, 2008, J NEUROCHEM, V105, P1573, DOI 10.1111/j.1471-4159.2008.05235.x; Lansdell SJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-73; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee D, 1999, J NEUROSCI, V19, P5311; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; LEVINE J, 1973, J COMP PHYSIOL, V87, P213, DOI 10.1007/BF00696043; LEVINE JD, 1973, P NATL ACAD SCI USA, V70, P1050, DOI 10.1073/pnas.70.4.1050; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Mejia M, 2012, JOVE-J VIS EXP, DOI 10.3791/3597; Mejia M, 2010, TOXICON, V56, P1398, DOI 10.1016/j.toxicon.2010.08.005; Mershin A, 2004, LEARN MEMORY, V11, P277, DOI 10.1101/lm.70804; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ping Y, 2012, FLY AUSTIN, V6; Quiram PA, 1999, J BIOL CHEM, V274, P19517, DOI 10.1074/jbc.274.28.19517; Taly A, 2012, CURR DRUG TARGETS, V13, P695, DOI 10.2174/138945012800398919; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; THOMAS JB, 1984, J NEUROSCI, V4, P530; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; USHERWOO.PN, 1968, NATURE, V219, P1169, DOI 10.1038/2191169a0; Valles AS, 2012, BBA-BIOMEMBRANES, V1818, P718, DOI 10.1016/j.bbamem.2011.10.012	49	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64685	10.1371/journal.pone.0064685	http://dx.doi.org/10.1371/journal.pone.0064685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737994	gold, Green Submitted, Green Published			2022-12-27	WOS:000321394700058
J	Qing, YF; Zhou, JG; Zhang, QB; Wang, DS; Li, M; Yang, QB; Huang, CP; Yin, L; Pan, SY; Xie, WG; Zhang, MY; Pu, MJ; Zeng, M				Qing, Yu-Feng; Zhou, Jing-Guo; Zhang, Quan-Bo; Wang, Dong-Sheng; Li, Min; Yang, Qi-Bin; Huang, Cui-Ping; Yin, Ling; Pan, Shu-Yue; Xie, Wen-Guang; Zhang, Meng-Yun; Pu, Meng-Jun; Zeng, Mei			Association of TLR4 Gene rs2149356 Polymorphism with Primary Gouty Arthritis in a Case-Control Study	PLOS ONE			English	Article							QUANTITATIVE PCR; HYPERURICEMIA; VARIANTS; PREVALENCE; DISEASE; MICE	Background: The toll-like receptor (TLR) 4-interleukin1 beta (IL1 beta) signaling pathway is involved in the monosodium urate (MSU)-mediated inflammation. The aim of this present study was to determine whether the TLR4 gene rs2149356 SNP is associated with gouty arthritis (GA) susceptibility and whether rs2149356 SNP impacts the TLR4-IL1 beta signaling pathway molecules expression. Methods and Findings: The rs2149356 SNP was detected in 459 GA patients and 669 control subjects (containing 459 healthy and 210 hyperuricemic subjects). Peripheral blood mononuclear cells (PBMCs) TLR4 mRNA and serum IL1 beta were measured in different genotype carriers, and correlations between TLR4 gene SNP and TLR4 mRNA, IL1 beta were investigated. The frequencies of the genotype and allele were significantly different between the GA and control groups (P < 0.01, respectively). The TT genotype was associated with a significantly increased risk of GA (OR = 1.88); this finding was not influenced by making adjustments for the components of possible confounders (adjusted OR = 1.96). TLR4 mRNA and IL1 beta were significantly increased in the TT genotype from acute GA patients (P < 0.05, respectively), and lipids were significantly different among three genotypes in the GA patients (P < 0.05, respectively). Conclusions: The TLR4 gene rs2149356 SNP might be associated with GA susceptibility, and might participate in regulating immune, inflammation and lipid metabolism. Further studies are required to confirm these findings.	[Zhang, Quan-Bo] North Sichuan Med Coll, Affiliated Hosp, Dept Geriatr, Nanchang, Peoples R China; [Wang, Dong-Sheng] North Sichuan Med Coll, Affiliated Hosp, Dept Clin Lab, Nanchang, Peoples R China; [Zeng, Mei] North Sichuan Med Coll, Dept Genet, Nanchang, Peoples R China	North Sichuan Medical University; North Sichuan Medical University; North Sichuan Medical University		jgzhou@nsmc.edu.cn			Natural Science Foundation of China [81271643]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (81271643). (Website: http://www.nsfc.gov.cn.) The funders had no role in study design, data collecton and analysis, decision to publish, or preparation of the manuscript.	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Ahmad-Nejad P, 2004, J ALLERGY CLIN IMMUN, V113, P565, DOI 10.1016/j.jaci.2003.12.583; Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; Baker JF, 2010, INT J CLIN PRACT, V64, P371, DOI 10.1111/j.1742-1241.2009.02188.x; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Dalbeth N, 2009, RHEUMATOLOGY, V48, P222, DOI 10.1093/rheumatology/ken460; Ghaemi-Oskouie F, 2011, CURR RHEUMATOL REP, V13, P160, DOI 10.1007/s11926-011-0162-1; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Lindstrom S, 2010, CANCER EPIDEM BIOMAR, V19, P873, DOI 10.1158/1055-9965.EPI-09-0618; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miao Z.M, 2006, CHIN J ENDOCRINOL ME, V22, P421, DOI DOI 10.3760/J.ISSN:1000-6699.2006.05.005; Miao ZM, 2008, J RHEUMATOL, V35, P1859; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Radstake TR, ARTHRITIS RHEUM, V50, P999; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen XY, 2010, DIGESTION, V81, P69, DOI 10.1159/000260417; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Stark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001948; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Weaver Arthur L, 2008, Cleve Clin J Med, V75 Suppl 5, pS9; Werner M, 2003, J ALLERGY CLIN IMMUN, V112, P323, DOI 10.1067/mai.2003.1648	27	44	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64845	10.1371/journal.pone.0064845	http://dx.doi.org/10.1371/journal.pone.0064845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738004	gold, Green Submitted, Green Published			2022-12-27	WOS:000321394700065
J	Schnell, JK; Harris, GM; Pimm, SL; Russell, GJ				Schnell, Jessica K.; Harris, Grant M.; Pimm, Stuart L.; Russell, Gareth J.			Quantitative Analysis of Forest Fragmentation in the Atlantic Forest Reveals More Threatened Bird Species than the Current Red List	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; HABITAT FRAGMENTATION; COMMUNITY DYNAMICS; LOCAL EXTINCTIONS; LANDSCAPE; RISK; DEFORESTATION; POPULATIONS; ABUNDANCE; PATTERNS	Habitat loss and attendant fragmentation threaten the existence of many species. Conserving these species requires a straightforward and objective method that quantifies how these factors affect their survival. Therefore, we compared a variety of metrics that assess habitat fragmentation in bird ranges, using the geographical ranges of 127 forest endemic passerine birds inhabiting the Atlantic Forest of Brazil. A common, non-biological metric - cumulative area of size-ranked fragments within a species range - was misleading, as the least threatened species had the most habitat fragmentation. Instead, we recommend a modified version of metapopulation capacity. The metric links detailed spatial information on fragment sizes and spatial configuration to the birds' abilities to occupy and disperse across large areas (100,000+ km(2)). In the Atlantic Forest, metapopulation capacities were largely bimodal, in that most species' ranges had either low capacity (high risk of extinction) or high capacity (very small risk of extinction). This pattern persisted within taxonomically and ecologically homogenous groups, indicating that it is driven by fragmentation patterns and not differences in species ecology. Worryingly, we found IUCN considers some 28 of 58 species in the low metapopulation capacity cluster to not be threatened. We propose that assessing the effect of fragmentation will separate species more clearly into distinct risk categories than does a simple assessment of remaining habitat.	[Schnell, Jessica K.; Russell, Gareth J.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Schnell, Jessica K.; Russell, Gareth J.] New Jersey Inst Technol, Dept Biol Sci, Newark, NJ 07102 USA; [Harris, Grant M.] US Fish & Wildlife Serv, Albuquerque, NM USA; [Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Rutgers State University Newark; Rutgers State University New Brunswick; New Jersey Institute of Technology; United States Department of the Interior; US Fish & Wildlife Service; Duke University	Schnell, JK (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA.	schnell@orn.mpg.de	pimm, stuart/ABF-1082-2020; Russell, Gareth/C-3061-2011	Schnell, Jessica/0000-0002-6636-1162; Russell, Gareth/0000-0003-2149-9456				ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Antongiovanni M, 2005, BIOL CONSERV, V122, P441, DOI 10.1016/j.biocon.2004.09.005; BIERREGAARD R O JR, 1989, Acta Amazonica, V19, P215; BIERREGAARD RO, 1992, BIOSCIENCE, V42, P859, DOI 10.2307/1312085; BirdLife International, 2011, IUCN RED LIST BIRDS; Bogaert J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001075; Borgella R, 2005, ECOL APPL, V15, P1062, DOI 10.1890/04-0352; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brooke M de L, 2009, AVIAN CONSERV ECOL, V4, P1; Brooks T, 1996, NATURE, V380, P115, DOI 10.1038/380115a0; Brooks T, 1999, ANIM CONSERV, V2, P211, DOI 10.1111/j.1469-1795.1999.tb00067.x; Brooks TM, 1997, CONSERV BIOL, V11, P382, DOI 10.1046/j.1523-1739.1997.95493.x; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; CLARK CW, 1994, AM NAT, V143, P583, DOI 10.1086/285621; Crooks KR, 2001, CONSERV BIOL, V15, P159, DOI 10.1046/j.1523-1739.2001.99379.x; DAFONSECA GAB, 1985, BIOL CONSERV, V34, P17, DOI 10.1016/0006-3207(85)90055-2; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; ESTRADA A, 1993, VEGETATIO, V108, P245; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Feeley KJ, 2007, ANIM CONSERV, V10, P493, DOI 10.1111/j.1469-1795.2007.00140.x; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Foppen R, 1999, ARDEA, V87, P113; Foppen RPB, 2000, CONSERV BIOL, V14, P1881, DOI 10.1111/j.1523-1739.2000.99022.x; Franklin AB, 2002, STUD AVIAN BIOL-SER, P20; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GALLI AE, 1976, AUK, V93, P356; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Goerck JM, 1997, CONSERV BIOL, V11, P112, DOI 10.1046/j.1523-1739.1997.95314.x; Hagan JM, 1996, CONSERV BIOL, V10, P188, DOI 10.1046/j.1523-1739.1996.10010188.x; Hansbauer MM, 2008, J TROP ECOL, V24, P291, DOI 10.1017/S0266467408005002; Hansbauer MM, 2008, BIOL CONSERV, V141, P782, DOI 10.1016/j.biocon.2008.01.002; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I, 2001, NATURWISSENSCHAFTEN, V88, P372, DOI 10.1007/s001140100246; Hanski I, 1999, METAPOPULATION ECOLO; HARPER L H, 1989, Acta Amazonica, V19, P249; Harris GM, 2004, CONSERV BIOL, V18, P1607, DOI 10.1111/j.1523-1739.2004.00157.x; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Hinsley SA, 1996, P ROY SOC B-BIOL SCI, V263, P307, DOI 10.1098/rspb.1996.0047; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; LECK CF, 1979, AUK, V96, P343; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; Marini MA, 2010, STUD NEOTROP FAUNA E, V45, P1, DOI 10.1080/01650521003656606; MAURER BA, 1993, CONSERV BIOL, V7, P501, DOI 10.1046/j.1523-1739.1993.07030501.x; McGarigal K., 1995, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEWMARK WD, 1991, CONSERV BIOL, V5, P67, DOI 10.1111/j.1523-1739.1991.tb00389.x; PIMM SL, 1993, P NATL ACAD SCI USA, V90, P10871, DOI 10.1073/pnas.90.22.10871; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ribon R, 2003, CONSERV BIOL, V17, P1827, DOI 10.1111/j.1523-1739.2003.00377.x; Russell GJ, 2006, J ANIM ECOL, V75, P324, DOI 10.1111/j.1365-2656.2006.01052.x; RUSSELL GJ, 1995, J ANIM ECOL, V64, P628, DOI 10.2307/5805; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schnell JK, 2013, CONSERV BIOL, V27, P520, DOI 10.1111/cobi.12047; Sekercioglu CH, 2007, CURR BIOL, V17, pR283, DOI 10.1016/j.cub.2007.02.019; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Stouffer PC, 2006, CONSERV BIOL, V20, P1212, DOI 10.1111/j.1523-1739.2006.00427.x; Stouffer PC, 2009, DIVERS DISTRIB, V15, P88, DOI 10.1111/j.1472-4642.2008.00497.x; Stratford JA, 1999, CONSERV BIOL, V13, P1416, DOI 10.1046/j.1523-1739.1999.98494.x; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Therivel R., 2012, STRATEGIC ENV ASSESS; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Van Houtan K. S., 2007, ECOL LETT, V9, P1; Verboom J, 2001, BIOL CONSERV, V100, P89, DOI 10.1016/S0006-3207(00)00210-X; Verboom J, 1996, SCI CONTRIBUTION I F; Vos CC, 2001, AM NAT, V157, P24, DOI 10.1086/317004; VUILLEUMIER F, 1970, AM NAT, V104, P373, DOI 10.1086/282671; WILCOVE DS, 1985, ECOLOGY, V66, P1211, DOI 10.2307/1939174; WILLIS EO, 1974, ECOL MONOGR, V44, P153, DOI 10.2307/1942309	80	28	28	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65357	10.1371/journal.pone.0065357	http://dx.doi.org/10.1371/journal.pone.0065357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734248	gold, Green Published, Green Submitted			2022-12-27	WOS:000319725500018
J	Srivastava, P; Moorthy, GS; Gross, R; Barrett, JS				Srivastava, Praveen; Moorthy, Ganesh S.; Gross, Robert; Barrett, Jeffrey S.			A Sensitive and Selective Liquid Chromatography/Tandem Mass Spectrometry Method for Quantitative Analysis of Efavirenz in Human Plasma	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITOR; HIV-PROTEASE INHIBITORS; ANTIRETROVIRAL AGENTS; RITONAVIR; QUANTIFICATION; AMPRENAVIR; SAQUINAVIR; LOPINAVIR; DRUGS; SERUM	A selective and a highly sensitive method for the determination of the non-nucleoside reverse transcriptase inhibitor (NNRTI), efavirenz, in human plasma has been developed and fully validated based on high performance liquid chromatography tandem mass spectrometry (LC-MS/MS). Sample preparation involved protein precipitation followed by one to one dilution with water. The analyte, efavirenz was separated by high performance liquid chromatography and detected with tandem mass spectrometry in negative ionization mode with multiple reaction monitoring. Efavirenz and C-13(6)-efavirenz (Internal Standard), respectively, were detected via the following MRM transitions: m/z 314.20243.90 and m/z 320.20249.90. A gradient program was used to elute the analytes using 0.1% formic acid in water and 0.1% formic acid in acetonitrile as mobile phase solvents, at a flow-rate of 0.3 mL/min. The total run time was 5 min and the retention times for the internal standard (C-13(6)-efavirenz) and efavirenz was approximately 2.6 min. The calibration curves showed linearity (coefficient of regression, r>0.99) over the concentration range of 1.0-2,500 ng/mL. The intraday precision based on the standard deviation of replicates of lower limit of quantification (LLOQ) was 9.24% and for quality control (QC) samples ranged from 2.41% to 6.42% and with accuracy from 112% and 100-111% for LLOQ and QC samples. The inter day precision was 12.3% and 3.03-9.18% for LLOQ and quality controls samples, and the accuracy was 108% and 95.2-108% for LLOQ and QC samples. Stability studies showed that efavirenz was stable during the expected conditions for sample preparation and storage. The lower limit of quantification for efavirenz was 1 ng/mL. The analytical method showed excellent sensitivity, precision, and accuracy. This method is robust and is being successfully applied for therapeutic drug monitoring and pharmacokinetic studies in HIV-infected patients.	[Srivastava, Praveen; Moorthy, Ganesh S.; Barrett, Jeffrey S.] Childrens Hosp Philadelphia, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA; [Gross, Robert; Barrett, Jeffrey S.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gross, Robert; Barrett, Jeffrey S.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gross, Robert; Barrett, Jeffrey S.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Moorthy, GS (corresponding author), Childrens Hosp Philadelphia, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA.	moorthyg@email.chop.edu		Barrett, Jeff/0000-0003-0879-1743	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been funded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JC, 1998, DRUGS, V56, P1055, DOI 10.2165/00003495-199856060-00014; [Anonymous], 2001, FDA GUID IND BIOAN M; Aymard G, 2000, J CHROMATOGR B, V744, P227, DOI 10.1016/S0378-4347(00)00225-5; Choi SO, 2007, J PHARMACEUT BIOMED, V43, P1562, DOI 10.1016/j.jpba.2006.11.017; D'Avolio A, 2007, J CHROMATOGR B, V859, P234, DOI 10.1016/j.jchromb.2007.10.003; D'Avolio A, 2010, J PHARMACEUT BIOMED, V52, P774, DOI 10.1016/j.jpba.2010.02.026; De Meulder M, 2008, J CHROMATOGR B, V870, P8, DOI 10.1016/j.jchromb.2008.04.041; Gross R, 2008, JAIDS-J ACQ IMM DEF, V49, P336, DOI 10.1097/QAI.0b013e31817c1ed0; Kappelhoff BS, 2003, J CHROMATOGR B, V792, P353, DOI 10.1016/S1570-0232(03)00325-8; Langmann P, 2001, J CHROMATOGR B, V755, P151, DOI 10.1016/S0378-4347(01)00059-7; Marzolini C, 2000, J CHROMATOGR B, V740, P43, DOI 10.1016/S0378-4347(99)00573-3; Matthews CZ, 2002, J PHARMACEUT BIOMED, V28, P925, DOI 10.1016/S0731-7085(01)00709-9; Mogatle S, 2009, J PHARMACEUT BIOMED, V49, P1308, DOI 10.1016/j.jpba.2009.03.008; Nirogi R, 2009, BIOMED CHROMATOGR, V23, P371, DOI 10.1002/bmc.1125; Notari S, 2006, J CHROMATOGR B, V831, P258, DOI 10.1016/j.jchromb.2005.12.016; Pereira EA, 2005, J CHROMATOGR A, V1091, P169, DOI 10.1016/j.chroma.2005.07.031; Ramachandran G, 2006, J CHROMATOGR B, V835, P131, DOI 10.1016/j.jchromb.2006.03.014; Rezk NL, 2004, J CHROMATOGR B, V805, P241, DOI 10.1016/j.jchromb.2004.03.002; Rouzes A, 2004, J CHROMATOGR B, V813, P209, DOI 10.1016/j.jchromb.2004.09.041; Sailaja AL, 2007, CHROMATOGRAPHIA, V65, P359, DOI 10.1365/s10337-006-0170-x; Sarasa-Nacenta M, 2001, J CHROMATOGR B, V763, P53, DOI 10.1016/S0378-4347(01)00357-7; Simon VA, 2001, J CHROMATOGR A, V913, P447, DOI 10.1016/S0021-9673(00)01092-X; Theron A, 2010, J CHROMATOGR B, V878, P2886, DOI 10.1016/j.jchromb.2010.08.051; Titier K, 2002, THER DRUG MONIT, V24, P417, DOI 10.1097/00007691-200206000-00015; Turner ML, 2003, J CHROMATOGR B, V784, P331, DOI 10.1016/S1570-0232(02)00822-X; Usami Y, 2003, CHEM PHARM BULL, V51, P715; Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003; Veldkamp AI, 1999, J CHROMATOGR B, V734, P55, DOI 10.1016/S0378-4347(99)00336-9; Villani P, 1999, THER DRUG MONIT, V21, P346, DOI 10.1097/00007691-199906000-00018; Weller DR, 2007, J CHROMATOGR B, V848, P369, DOI 10.1016/j.jchromb.2006.10.022; YOUNG SD, 1995, ANTIMICROB AGENTS CH, V39, P2602, DOI 10.1128/AAC.39.12.2602	31	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e63305	10.1371/journal.pone.0063305	http://dx.doi.org/10.1371/journal.pone.0063305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755102	gold, Green Submitted, Green Published			2022-12-27	WOS:000320579400004
J	Liu, Y; Guo, YL; Jiang, GL; Zhou, SJ; Sun, Q; Chen, X; Chang, XJ; Xing, AY; Du, FJ; Jia, HY; Zhang, ZD				Liu, Yang; Guo, Yan-Ling; Jiang, Guang-Lu; Zhou, Shi-Jie; Sun, Qi; Chen, Xi; Chang, Xiu-Jun; Xing, Ai-Ying; Du, Feng-Jiao; Jia, Hong-Yan; Zhang, Zong-De			Application of Hyperbranched Rolling Circle Amplification for Direct Detection of Mycobacterium Tuberculosis in Clinical Sputum Specimens	PLOS ONE			English	Article								Background: Global tuberculosis (TB) control is encumbered by the lack of a rapid and simple detection method for diagnosis, especially in low-resource areas. An isothermal amplification method, hyperbranched rolling circle amplification (HRCA), was optimized to detect Mycobacterium tuberculosis (Mtb) in clinical sputum specimens. Methods: A clinical validation study was performed to assess the diagnostic accuracy of HRCA. In order to analyze the detection limit of HRCA under optimal conditions, the method was initially used to detect purified H37Rv strain DNA and culture suspensions. Next, three strains of Mycobacterium tuberculosis complex (MTC) and eight strains of non-tuberculosis mycobacterium (NTM) were analyzed in order to evaluate specificity. Sputum specimens from 136 patients with diagnosed pulmonary TB, 38 lung cancer patients, and 34 healthy donors were tested by HRCA to validate the clinical application of HRCA for the rapid detection of Mtb. Results: The detection limit of HRCA for purified H37Rv DNA and culture suspensions was 740 aM and 200cfu/ml, respectively. The results of all MTC strains were positive in contrast to the NTM specimens which were all negative. The detection sensitivity for the 136 sputum specimens from TB patients was 77.2% (105/136), which was slightly lower than that of quantitative real-time PCR(79.4%, 108/136) and culture (80.9%, 110/136). The sensitivity of all three methods was statistically higher than smear microscopy (44.9%, 61/136). The overall specificity of HRCA was 98.6% (71/72) which was similar to that of quantitative real-time PCR (qRT-PCR) and smear/culture methods (100%, 72/72). Conclusions: Use of the HRCA assay for detection of Mtb within clinical sputum specimens was demonstrated to be highly sensitive and specific. Moreover, the performance of HRCA is simple and cost-effective compared with qRT-PCR and is less time consuming than culture. Therefore, HRCA is a promising TB diagnostic tool that can be used routinely in low-resource clinical settings.	[Liu, Yang; Guo, Yan-Ling; Jiang, Guang-Lu; Zhou, Shi-Jie; Sun, Qi; Chen, Xi; Chang, Xiu-Jun; Xing, Ai-Ying; Du, Feng-Jiao; Jia, Hong-Yan; Zhang, Zong-De] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Lab Mol Biol TB, Beijing, Peoples R China	Capital Medical University	Zhang, ZD (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Lab Mol Biol TB, Beijing, Peoples R China.	zzd417@163.com			Beijing new star project of science and technology [2008A40]; Beijing talents project [2012D003034000006]; cooperation program of basic and clinical research at Capital Medical University [11JL64]	Beijing new star project of science and technology; Beijing talents project; cooperation program of basic and clinical research at Capital Medical University	This work was supported by Beijing new star project of science and technology (No. 2008A40), Beijing talents project (2012D003034000006), and the cooperation program of basic and clinical research at Capital Medical University (No. 11JL64). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras SC, 2001, MOL BIOTECHNOL, V19, P29, DOI 10.1385/MB:19:1:029; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; George G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021007; HOFMANNTHIEL S, 2010, BMC MICROBIOL, V31, P10; Kaocharoen S, 2008, ELECTROPHORESIS, V29, P3183, DOI 10.1002/elps.200700903; Kim JH, 2011, J CLIN MICROBIOL, V49, P173, DOI 10.1128/JCM.00694-10; Lighter Jennifer, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P61, DOI 10.1016/j.cppeds.2008.12.003; Nyendak MR, 2009, CURR OPIN INFECT DIS, V22, P174, DOI 10.1097/QCO.0b013e3283262fe9; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; *ROCH MOL SYST INC, 2007, COBAS TAQMAN MTB TES; Scherer LC, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-15; Sohn H, 2009, EXPERT REV ANTI-INFE, V7, P723, DOI [10.1586/eri.09.52, 10.1586/ERI.09.52]; WHO, 2009, WHO TECH REP SER, V958, P1; World Health Organization, 1998, LAB SERV TUB CONTR; Yang YC, 2011, J CLIN MICROBIOL, V49, P797, DOI 10.1128/JCM.01839-10; Yi JZ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl261; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	17	7	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64583	10.1371/journal.pone.0064583	http://dx.doi.org/10.1371/journal.pone.0064583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750210	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900012
J	Pietraszewska-Bogiel, A; Lefebvre, B; Koini, MA; Klaus-Heisen, D; Takken, FLW; Geurts, R; Cullimore, JV; Gadella, TWJ				Pietraszewska-Bogiel, Anna; Lefebvre, Benoit; Koini, Maria A.; Klaus-Heisen, Doerte; Takken, Frank L. W.; Geurts, Rene; Cullimore, Julie V.; Gadella, Theodorus W. J.			Interaction of Medicago truncatula Lysin Motif Receptor-Like Kinases, NFP and LYK3, Produced in Nicotiana benthamiana Induces Defence- Like Responses	PLOS ONE			English	Article							PHOSPHOLIPID SIGNALING PATHWAYS; PLANT INNATE IMMUNITY; NOD FACTOR PERCEPTION; ROOT HAIRS; CELL-DEATH; FLUORESCENT PROTEINS; ARABIDOPSIS-THALIANA; MOLECULAR-PATTERNS; CA2+ SPIKING; NODULATION	Receptor(-like) kinases with Lysin Motif (LysM) domains in their extracellular region play crucial roles during plant interactions with microorganisms; e.g. Arabidopsis thaliana CERK1 activates innate immunity upon perception of fungal chitin/chitooligosaccharides, whereas Medicago truncatula NFP and LYK3 mediate signalling upon perception of bacterial lipo-chitooligosaccharides, termed Nod factors, during the establishment of mutualism with nitrogen-fixing rhizobia. However, little is still known about the exact activation and signalling mechanisms of MtNFP and MtLYK3. We aimed at investigating putative molecular interactions of MtNFP and MtLYK3 produced in Nicotiana benthamiana. Surprisingly, heterologous co-production of these proteins resulted in an induction of defence-like responses, which included defence-related gene expression, accumulation of phenolic compounds, and cell death. Similar defence-like responses were observed upon production of AtCERK1 in N. benthamiana leaves. Production of either MtNFP or MtLYK3 alone or their co-production with other unrelated receptor(-like) kinases did not induce cell death in N. benthamiana, indicating that a functional interaction between these LysM receptor-like kinases is required for triggering this response. Importantly, structure-function studies revealed that the MtNFP intracellular region, specific features of the MtLYK3 intracellular region (including several putative phosphorylation sites), and MtLYK3 and AtCERK1 kinase activity were indispensable for cell death induction, thereby mimicking the structural requirements of nodulation or chitin-induced signalling. The observed similarity of N. benthamiana response to MtNFP and MtLYK3 co-production and AtCERK1 production suggests the existence of parallels between Nod factor-induced and chitin-induced signalling mediated by the respective LysM receptor(-like) kinases. Notably, the conserved structural requirements for MtNFP and MtLYK3 biological activity in M. truncatula (nodulation) and in N. benthamiana (cell death induction) indicates the relevance of the latter system for studies on these, and potentially other symbiotic LysM receptor-like kinases.	[Pietraszewska-Bogiel, Anna; Koini, Maria A.; Gadella, Theodorus W. J.] Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, Amsterdam, Netherlands; [Lefebvre, Benoit; Klaus-Heisen, Doerte; Cullimore, Julie V.] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Lefebvre, Benoit; Klaus-Heisen, Doerte; Cullimore, Julie V.] CNRS, LIPM, UMR2594, F-31326 Castanet Tolosan, France; [Takken, Frank L. W.] Univ Amsterdam, Swammerdam Inst Life Sci, Sect Plant Pathol, Amsterdam, Netherlands; [Geurts, Rene] Wageningen Univ, Mol Biol Lab, Dept Plant Sci, NL-6700 AP Wageningen, Netherlands	University of Amsterdam; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; University of Amsterdam; Wageningen University & Research	Gadella, TWJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, Amsterdam, Netherlands.	Th.W.J.Gadella@uva.nl	lefebvre, benoit/G-2028-2012; Takken, Frank/C-8051-2012	Takken, Frank/0000-0003-2655-3108; Lefebvre, Benoit/0000-0002-3810-605X; Gadella, Theodorus/0000-0002-7639-219X; Cullimore, Julie/0000-0001-8804-4849	European Community [MRTN-CT-2006-035546]; French National Research Agency (ANR) [ANR-10-LABX-41]	European Community(European Commission); French National Research Agency (ANR)(French National Research Agency (ANR))	This work was supported by the European Community Marie Curie Research Training Network Programme through contract MRTN-CT-2006-035546 "NODPERCEPTION''. Work in Toulouse was supported by the French National Research Agency (ANR) through contracts "NodBindsLysM", "SYMPASIGNAL" and "LCOinNONLEGUMES", and has been done as part of the Laboratoire d'Excellence (LABEX) entitled TULIP (ANR-10-LABX-41). FLWT acknowledges the Centre for BioSystems Genomics and Netherlands Genomics Initiative program. RG acknowledges the Dutch Science Organisation NWO (VIDI 864.06.007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Bensmihen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026114; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Broghammer A, 2012, P NATL ACAD SCI USA, V109, P13859, DOI 10.1073/pnas.1205171109; Bueno P, 2001, NEW PHYTOL, V152, P91, DOI 10.1046/j.0028-646x.2001.00246.x; Capoen W, 2010, NEW PHYTOL, V186, P340, DOI 10.1111/j.1469-8137.2009.03124.x; Cardenas L, 2008, PLANT J, V56, P802, DOI 10.1111/j.1365-313X.2008.03644.x; Charron D, 2004, PLANT PHYSIOL, V136, P3582, DOI 10.1104/pp.104.051110; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; CORNELISSEN BJC, 1987, NUCLEIC ACIDS RES, V15, P6799, DOI 10.1093/nar/15.17.6799; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; den Hartog M, 2003, PLANT PHYSIOL, V132, P311, DOI 10.1104/pp.102.017954; den Hartog M, 2001, PLANT J, V25, P55, DOI 10.1046/j.1365-313x.2001.00931.x; Ditt RF, 2006, MOL PLANT MICROBE IN, V19, P665, DOI 10.1094/MPMI-19-0665; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Frey NFD, 2012, PLANT PHYSIOL, V159, P798, DOI 10.1104/pp.111.192575; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Gust AA, 2012, TRENDS PLANT SCI, V17, P495, DOI 10.1016/j.tplants.2012.04.003; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Han Z, 2012, SCIENCE, V336, P221; Haney CH, 2011, PLANT CELL, V23, P2774, DOI 10.1105/tpc.111.086389; Hayashi T, 2010, PLANT J, V63, P141, DOI 10.1111/j.1365-313X.2010.04228.x; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Ke DX, 2012, PLANT PHYSIOL, V159, P131, DOI 10.1104/pp.112.197269; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; Klaus-Heisen D, 2011, J BIOL CHEM, V286, P11202, DOI 10.1074/jbc.M110.186171; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kwaaitaal M, 2011, BIOCHEM J, V440, P355, DOI 10.1042/BJ20111112; Lefebvre B, 2012, J BIOL CHEM, V287, P10812, DOI 10.1074/jbc.M111.281634; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; Liu B, 2012, PLANT CELL, V24, P3406, DOI 10.1105/tpc.112.102475; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Martinez-Abarca F, 1998, MOL PLANT MICROBE IN, V11, P153, DOI 10.1094/MPMI.1998.11.2.153; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Miwa H, 2006, MOL PLANT MICROBE IN, V19, P914, DOI 10.1094/MPMI-19-0914; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Murray J, 2006, MOL PLANT MICROBE IN, V19, P1082, DOI 10.1094/MPMI-19-1082; Nakagawa T, 2011, PLANT J, V65, P169, DOI 10.1111/j.1365-313X.2010.04411.x; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Oh CS, 2010, TRENDS PLANT SCI, V16, P1360; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Peleg-Grossman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008399; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Serna-Sanz A, 2011, MOL PLANT MICROBE IN, V24, P932, DOI 10.1094/MPMI-09-10-0222; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw SL, 2003, PLANT PHYSIOL, V131, P976, DOI 10.1104/pp.005546; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Sieberer BJ, 2009, PLANT PHYSIOL, V151, P1197, DOI 10.1104/pp.109.142851; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Streng A, 2011, PLANT SIGNAL BEHAV, V6, P1510, DOI 10.4161/psb.6.10.17444; Taguchi F, 2009, PHYSIOL MOL PLANT P, V74, P11, DOI 10.1016/j.pmpp.2009.08.001; Takahashi Y, 2007, PLANT J, V49, P1030, DOI 10.1111/j.1365-313X.2006.03022.x; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wan JR, 2012, PLANT PHYSIOL, V160, P396, DOI 10.1104/pp.112.201699; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183	84	63	66	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65055	10.1371/journal.pone.0065055	http://dx.doi.org/10.1371/journal.pone.0065055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750228	Green Published, gold			2022-12-27	WOS:000319961900030
J	Hessle, L; Stordalen, GA; Wenglen, C; Petzold, C; Tanner, EK; Brorson, SH; Baekkevold, ES; Onnerfjord, P; Reinholt, FP; Heinegard, D				Hessle, Lovisa; Stordalen, Gunhild A.; Wenglen, Christina; Petzold, Christiane; Tanner, Elizabeth K.; Brorson, Sverre-Henning; Baekkevold, Espen S.; Onnerfjord, Patrik; Reinholt, Finn P.; Heinegard, Dick			The Skeletal Phenotype of Chondroadherin Deficient Mice	PLOS ONE			English	Article							BONE SIALOPROTEIN; OSTEOBLAST DIFFERENTIATION; PROTEIN CHONDROADHERIN; TARGETED DISRUPTION; MATRIX PROTEINS; INDIAN HEDGEHOG; SKIN FRAGILITY; IN-VITRO; OSTEOPONTIN; CARTILAGE	Chondroadherin, a leucine rich repeat extracellular matrix protein with functions in cell to matrix interactions, binds cells via their alpha 2b1 integrin as well as via cell surface proteoglycans, providing for different sets of signals to the cell. Additionally, the protein acts as an anchor to the matrix by binding tightly to collagens type I and II as well as type VI. We generated mice with inactivated chondroadherin gene to provide integrated studies of the role of the protein. The null mice presented distinct phenotypes with affected cartilage as well as bone. At 3-6 weeks of age the epiphyseal growth plate was widened most pronounced in the proliferative zone. The proteome of the femoral head articular cartilage at 4 months of age showed some distinct differences, with increased deposition of cartilage intermediate layer protein 1 and fibronectin in the chondroadherin deficient mice, more pronounced in the female. Other proteins show decreased levels in the deficient mice, particularly pronounced for matrilin-1, thrombospondin-1 and notably the members of the alpha 1-antitrypsin family of proteinase inhibitors as well as for a member of the bone morphogenetic protein growth factor family. Thus, cartilage homeostasis is distinctly altered. The bone phenotype was expressed in several ways. The number of bone sialoprotein mRNA expressing cells in the proximal tibial metaphysic was decreased and the osteoid surface was increased possibly indicating a change in mineral metabolism. Micro-CT revealed lower cortical thickness and increased structure model index, i.e. the amount of plates and rods composing the bone trabeculas. The structural changes were paralleled by loss of function, where the null mice showed lower femoral neck failure load and tibial strength during mechanical testing at 4 months of age. The skeletal phenotype points at a role for chondroadherin in both bone and cartilage homeostasis, however, without leading to altered longitudinal growth.	[Hessle, Lovisa; Wenglen, Christina; Onnerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Clin Sci Lund, Sect Mol Skeletal Biol, Lund, Sweden; [Hessle, Lovisa; Wenglen, Christina; Onnerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden; [Stordalen, Gunhild A.; Brorson, Sverre-Henning; Baekkevold, Espen S.; Reinholt, Finn P.] Univ Oslo, Dept Pathol, Oslo, Norway; [Stordalen, Gunhild A.; Brorson, Sverre-Henning; Baekkevold, Espen S.; Reinholt, Finn P.] Oslo Univ Hosp, Rikshosp, N-0027 Oslo, Norway; [Petzold, Christiane] Univ Oslo, Fac Odontol, Oslo, Norway; [Tanner, Elizabeth K.] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland; [Tanner, Elizabeth K.] Lund Univ, Dept Clin Sci Lund, Sect Orthopaed, Lund, Sweden	Lund University; Lund University; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Glasgow; Lund University	Stordalen, GA (corresponding author), Univ Oslo, Dept Pathol, Oslo, Norway.	gunhild@stordalenfoundation.no	Tanner, Elizabeth/E-9242-2010; Onnerfjord, Patrik/R-3131-2019	Tanner, Elizabeth/0000-0003-2257-0218; Onnerfjord, Patrik/0000-0002-2345-2937	European Union (OSTEOGENE) [FP6-502491]; Swedish Research Council, Konung Gustaf V's 80-A rsfond, Sweden; South-Eastern Regional Health Authority, Norway	European Union (OSTEOGENE); Swedish Research Council, Konung Gustaf V's 80-A rsfond, Sweden; South-Eastern Regional Health Authority, Norway	Grants were obtained from the European Union (OSTEOGENE, FP6-502491), the Swedish Research Council, Konung Gustaf V's 80-A rsfond, Sweden, and South-Eastern Regional Health Authority, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P193, DOI 10.1177/41.2.8419459; BRORSON SH, 1994, MICRON, V25, P453, DOI 10.1016/0968-4328(94)00035-2; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Franzen A, 2008, J ORTHOP RES, V26, P721, DOI 10.1002/jor.20544; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Haglund L, 2010, J BIOL CHEM; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HEINEGARD D, 1999, DYNAMICS BONE CARTIL, P59; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; HULTENBY K, 1991, MATRIX, V11, P206, DOI 10.1016/S0934-8832(11)80160-5; HULTENBY K, 1994, EUR J CELL BIOL, V63, P230; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Johnson J, 2006, MOL VIS, V12, P1057; Kojima H, 2004, J BIOCHEM, V136, P377, DOI 10.1093/jb/mvh136; Landgren C, 1998, GENOMICS, V47, P84, DOI 10.1006/geno.1997.5085; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LARSSON T, 1991, J BIOL CHEM, V266, P20428; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Mizuno M, 1996, CALCIFIED TISSUE INT, V59, P163, DOI 10.1007/s002239900103; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Shen ZX, 1998, BIOCHEM J, V330, P549, DOI 10.1042/bj3300549; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SOMMARIN Y, 1989, EXP CELL RES, V184, P181, DOI 10.1016/0014-4827(89)90376-5; Sommarin Y, 1998, J BIOL CHEM, V273, P16723, DOI 10.1074/jbc.273.27.16723; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023	36	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63080	10.1371/journal.pone.0063080	http://dx.doi.org/10.1371/journal.pone.0063080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755099	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000319872300005
J	Anton, J; Lucio, M; Pena, A; Cifuentes, A; Brito-Echeverria, J; Moritz, F; Tziotis, D; Lopez, C; Urdiain, M; Schmitt-Kopplin, P; Rossello-Mora, R				Anton, Josefa; Lucio, Marianna; Pena, Arantxa; Cifuentes, Ana; Brito-Echeverria, Jocelyn; Moritz, Franco; Tziotis, Dimitrios; Lopez, Cristina; Urdiain, Mercedes; Schmitt-Kopplin, Philippe; Rossello-Mora, Ramon			High Metabolomic Microdiversity within Co-Occurring Isolates of the Extremely Halophilic Bacterium Salinibacter ruber	PLOS ONE			English	Article							SP-NOV.; HYPERSALINE ENVIRONMENT; DIVERSITY; EVOLUTION; SALTERN; MEMBER; PONDS; LAKE	Salinibacter ruber is an extremely halophilic member of the Bacteroidetes that thrives in crystallizer ponds worldwide. Here, we have analyzed two sets of 22 and 35 co-occurring S. ruber strains, newly isolated respectively, from 100 microliters water samples from crystalizer ponds in Santa Pola and Mallorca, located in coastal and inland Mediterranean Spain and 350 km apart from each other. A set of old strains isolated from the same setting were included in the analysis. Genomic and taxonomy relatedness of the strains were analyzed by means of PFGE and MALDI-TOF, respectively, while their metabolomic potential was explored with high resolution ion cyclotron resonance Fourier transform mass spectrometry (ICR-FT/MS). Overall our results show a phylogenetically very homogeneous species expressing a very diverse metabolomic pool. The combination of MALDI-TOF and PFGE provides, for the newly isolated strains, the same scenario presented by the previous studies of intra-specific diversity of S. ruber using a more restricted number of strains: the species seems to be very homogeneous at the ribosomal level while the genomic diversity encountered was rather high since no identical genome patterns could be retrieved from each of the samples. The high analytical mass resolution of ICR-FT/MS enabled the description of thousands of putative metabolites from which to date only few can be annotated in databases. Some metabolomic differences, mainly related to lipid metabolism and antibiotic-related compounds, provided enough specificity to delineate different clusters within the co-occurring strains. In addition, metabolomic differences were found between old and new strains isolated from the same ponds that could be related to extended exposure to laboratory conditions.	[Anton, Josefa; Pena, Arantxa; Lopez, Cristina] Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain; [Lucio, Marianna; Moritz, Franco; Tziotis, Dimitrios] Helmholtz Zentrum Munich, German Res Ctr Environm Hlth, Analyt BioGeoChem, Neuherberg, Germany; [Cifuentes, Ana; Brito-Echeverria, Jocelyn; Urdiain, Mercedes; Schmitt-Kopplin, Philippe; Rossello-Mora, Ramon] Inst Mediterrani Estudis Avancats IMEDEA CSIC UIB, Dept Ecol & Marine Resources, Marine Microbiol Grp, Esporles, Illes Balears, Spain; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany	Universitat d'Alacant; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Technical University of Munich	Pena, A (corresponding author), Univ Balearic Isl, Dept Biol Microbiol, Palma de Mallorca, Illes Balears, Spain.	a.pena@uib.es	Peña, Arantxa/K-9693-2014; Rossello-Mora, Ramon/L-4650-2014; Peña, Aranzazu/S-1758-2018; Anton, Josefa/L-5283-2014; Schmitt-Kopplin, Philippe/H-6271-2011	Rossello-Mora, Ramon/0000-0001-8253-3107; Peña, Aranzazu/0000-0003-3456-9281; Anton, Josefa/0000-0002-5823-493X; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lucio, Marianna/0000-0002-5844-0098	Spanish Ministry of Science and Innovation [CLG2009-12651-C02-01, CLG2009-12651-C02-02, CE-CSD2007-0005]; FEDER from European Union; Government of the Balearic Islands; Ministry of Economy and Finances	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER from European Union; Government of the Balearic Islands; Ministry of Economy and Finances	This work was supported by the projects CLG2009-12651-C02-01 and 02; and CE-CSD2007-0005 of the Spanish Ministry of Science and Innovation, and all three projects were also co-financed with FEDER support from the European Union. JBE was financed by the Government of the Balearic Islands, Ministry of Economy and Finances. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton J, 2002, INT J SYST EVOL MICR, V52, P485, DOI 10.1099/00207713-52-2-485; Anton J, 2000, APPL ENVIRON MICROB, V66, P3052, DOI 10.1128/AEM.66.7.3052-3057.2000; Anton Josefa, 2008, Saline Syst, V4, P15, DOI 10.1186/1746-1448-4-15; Bardavid RE, 2007, HYDROBIOLOGIA, V576, P3, DOI 10.1007/s10750-006-0288-8; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Boujelben I, 2012, ANTON LEEUW INT J G, V101, P845, DOI 10.1007/s10482-012-9701-7; Brito-Echeverria J, 2011, EXTREMOPHILES, V15, P379, DOI 10.1007/s00792-011-0366-3; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; Eriksson L., 1999, INTRO MULTI MEGAVARI; Ghai R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00135; Goering RV, 2010, INFECT GENET EVOL, V10, P866, DOI 10.1016/j.meegid.2010.07.023; Gomariz M, 2012, THESIS U M HERNANDEZ; Hein EM, 2012, METABOLITES, V2, P254, DOI 10.3390/metabo2010254; Hertkorn N, 2007, ANAL BIOANAL CHEM, V389, P1311, DOI 10.1007/s00216-007-1577-4; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Kallow W, 2010, MASS SPECTROMETRY MI, P255; Krajewski M, 2012, PHYTOCHEMIS IN PRESS; Krug D, 2008, APPL ENVIRON MICROB, V74, P3058, DOI 10.1128/AEM.02863-07; Lucio M, 2010, HDB MOL MICROBIAL EC; Makhdoumi-Kakhki A, 2012, INT J SYST EVOL MICR, V62, P1521, DOI 10.1099/ijs.0.031971-0; Malfatti F, 2009, AQUAT MICROB ECOL, V58, P1, DOI 10.3354/ame01355; Matte-Tailliez O, 2002, MOL BIOL EVOL, V19, P631, DOI 10.1093/oxfordjournals.molbev.a004122; Maturrano L, 2006, APPL ENVIRON MICROB, V72, P3887, DOI 10.1128/AEM.02214-05; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Munoz R, 2011, SYST APPL MICROBIOL, V34, P69, DOI 10.1016/j.syapm.2010.11.012; Mutlu MB, 2008, FEMS MICROBIOL ECOL, V65, P474, DOI 10.1111/j.1574-6941.2008.00510.x; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Pena A, 2005, EXTREMOPHILES, V9, P151, DOI 10.1007/s00792-005-0430-y; Pena A, 2010, ISME J, V4, P882, DOI 10.1038/ismej.2010.6; Rossello-Mora R, 2008, ISME J, V2, P242, DOI 10.1038/ismej.2007.93; Santos F, 2011, ISME J, V5, P1621, DOI 10.1038/ismej.2011.34; Schloter M, 2000, FEMS MICROBIOL REV, V24, P647, DOI 10.1111/j.1574-6976.2000.tb00564.x; Smirnova GV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1199, DOI 10.1007/s10541-005-0248-3; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Tang J, 2011, CURR GENOMICS, V12, P391, DOI 10.2174/138920211797248619; Traxler MF, 2012, P NATL ACAD SCI USA, V109, P10128, DOI 10.1073/pnas.1207725109; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J, 2003, J CHEMOMETR, V17, P53, DOI 10.1002/cem.775; Tziotis D, 2011, EUR J MASS SPECTROM, V17, P415, DOI 10.1255/ejms.1135; Vaisman N, 2009, INT J SYST EVOL MICR, V59, P2571, DOI 10.1099/ijs.0.010892-0; Wagele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039860; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Zhaxybayeva O, 2013, EXTREMOPHILES, V17, P265, DOI 10.1007/s00792-013-0514-z	49	29	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64701	10.1371/journal.pone.0064701	http://dx.doi.org/10.1371/journal.pone.0064701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741374	Green Published, gold			2022-12-27	WOS:000319799900087
J	Baragli, I; Grande, C; Gesmundo, I; Settanni, F; Taliano, M; Gallo, D; Gargantini, E; Ghigo, E; Granata, R				Baragli, Iessandra; Grande, Cristina; Gesmundo, Iacopo; Settanni, Fabio; Taliano, Marina; Gallo, Davide; Gargantini, Eleonora; Ghigo, Ezio; Granata, Riccarda			Obestatin Enhances In Vitro Generation of Pancreatic Islets through Regulation of Developmental Pathways	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ADULT-MOUSE PANCREAS; TO-MESENCHYMAL TRANSITION; BETA-CELLS; PRECURSOR CELLS; UNACYLATED GHRELIN; ENDOCRINE-CELLS; RAT PANCREAS; INSULIN; PROLIFERATION	Availability of large amounts of in vitro generated beta-cells may support replacement therapy in diabetes. However, methods to obtain beta-cells from stem/progenitor cells are limited by inefficient endocrine differentiation. We have recently shown that the ghrelin gene product obestatin displays beneficial effects on pancreatic beta-cell survival and function. Obestatin prevents beta-cell apoptosis, preserves beta-cell mass and stimulates insulin secretion in vitro and in vivo, in both normal and diabetic conditions. In the present study, we investigated whether obestatin may promote in vitro beta-cell generation from mouse pancreatic islet-derived precursor cells. Treatment of cultured islets of Langerhans with obestatin (i) enriched cells expressing the mesenchymal/neuronal marker nestin, which is associated with pancreatic precursors; (ii) increased cell survival and reduced apoptosis during precursor selection; (iii) promoted the generation of islet-like cell clusters (ICCs) with increased insulin gene expression and C-peptide secretion. Furthermore, obestatin modulated the expression of fibroblast growth factor receptors (FGFRs), Notch receptors and neurogenin 3 (Ngn3) during islet-derived precursor cell selection and endocrine differentiation. These results indicate that obestatin improves the generation of functional beta-cells/ICCs in vitro, suggesting implications for cell-based replacement therapy in diabetes. Moreover, obestatin may play a role in regulating pathways involved in pancreas development and regeneration.	[Baragli, Iessandra; Grande, Cristina; Gesmundo, Iacopo; Settanni, Fabio; Taliano, Marina; Gallo, Davide; Gargantini, Eleonora; Ghigo, Ezio; Granata, Riccarda] Univ Turin, Dept Med Sci, Div Endocrinol Diabetol & Metab, Turin, Italy	University of Turin	Granata, R (corresponding author), Univ Turin, Dept Med Sci, Div Endocrinol Diabetol & Metab, Turin, Italy.	riccarda.granata@unito.it	Granata, Riccarda/K-7775-2016; Gesmundo, Iacopo/K-5131-2016	Granata, Riccarda/0000-0003-4164-7313; Gesmundo, Iacopo/0000-0003-4901-4764	Regione Piemonte; Brain Drain University of Turin; PRIN; Compagnia di San Paolo; Studio delle Malattie Endocrino Metaboliche (SMEM) Foundation (Turin, Italy); NIT (Neuroscience Institute of Turin); GISNe (Italian Group of Neuroendocrine Sciences)	Regione Piemonte(Regione Piemonte); Brain Drain University of Turin; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Compagnia di San Paolo(Compagnia di San Paolo); Studio delle Malattie Endocrino Metaboliche (SMEM) Foundation (Turin, Italy); NIT (Neuroscience Institute of Turin); GISNe (Italian Group of Neuroendocrine Sciences)	This work was supported by the following grants: Regione Piemonte 2008, Brain Drain University of Turin 2008, PRIN 2008 (to R. G.); Compagnia di San Paolo 2008 (to E. G.) and 2011 (to R. G.); Studio delle Malattie Endocrino Metaboliche (SMEM) Foundation (Turin, Italy); NIT (Neuroscience Institute of Turin), and GISNe (Italian Group of Neuroendocrine Sciences). There are no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Arnaud-Dabernat S, 2007, DIABETES, V56, P96, DOI 10.2337/db05-1073; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Chandra V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020615; Chanoine JP, 2006, HORM RES, V66, P81, DOI 10.1159/000093585; Chartrel N, 2007, SCIENCE, V315, DOI 10.1126/science.1135047; Chen W, 2009, ENDOCRINOLOGY, V150, P570, DOI 10.1210/en.2008-1009; Choi Y, 2004, STEM CELLS, V22, P1070, DOI 10.1634/stemcells.22-6-1070; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Davani B, 2007, STEM CELLS, V25, P3215, DOI 10.1634/stemcells.2007-0323; Egido EM, 2009, REGUL PEPTIDES, V152, P61, DOI 10.1016/j.regpep.2008.08.003; Elghazi L, 2002, P NATL ACAD SCI USA, V99, P3884, DOI 10.1073/pnas.062321799; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gouzi M, 2011, DEV DYNAM, V240, P589, DOI 10.1002/dvdy.22544; Granata R, 2008, DIABETES, V57, P967, DOI 10.2337/db07-1104; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Granata R, 2012, FASEB J, V26, P3393, DOI 10.1096/fj.11-201343; Granata R, 2010, J MOL ENDOCRINOL, V45, P107, DOI 10.1677/JME-10-0019; Granata R, 2010, J MOL ENDOCRINOL, V45, P9, DOI 10.1677/JME-09-0141; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Kim W, 2010, BIOCHEM BIOPH RES CO, V392, P247, DOI 10.1016/j.bbrc.2009.12.115; Kodama S, 2005, BIOCHEM BIOPH RES CO, V327, P1170, DOI 10.1016/j.bbrc.2004.12.120; Kordowich S, 2010, MOL CELL ENDOCRINOL, V323, P62, DOI 10.1016/j.mce.2009.12.016; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Le Bras S, 1998, DIABETES, V47, P1236, DOI 10.2337/diabetes.47.8.1236; Li HY, 2010, J PHARMACOL EXP THER, V335, P817, DOI 10.1124/jpet.110.169284; Liu DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021793; Liu H, 2010, ENDOCRINOLOGY, V151, P520, DOI 10.1210/en.2009-0992; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Miller K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007739; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Miyatsuka T, 2011, P NATL ACAD SCI USA, V108, P185, DOI 10.1073/pnas.1004842108; Morton RA, 2007, MOL CELL ENDOCRINOL, V270, P87, DOI 10.1016/j.mce.2007.02.005; Mutskov V, 2007, STEM CELLS, V25, P3223, DOI 10.1634/stemcells.2007-0325; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; RUBENSTE.AH, 1972, DIABETES, V21, P661, DOI 10.2337/diab.21.2.S661; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Shewade YM, 1999, TRANSPL P, V31, P1721, DOI 10.1016/S0041-1345(99)00077-9; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Ta M, 2006, STEM CELLS, V24, P1738, DOI 10.1634/stemcells.2005-0367; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Treff NR, 2006, STEM CELLS, V24, P2529, DOI 10.1634/stemcells.2006-0082; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	50	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64374	10.1371/journal.pone.0064374	http://dx.doi.org/10.1371/journal.pone.0064374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741322	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900034
J	Gilkeson, GS; Mashmoushi, AK; Ruiz, P; Caza, TN; Perl, A; Oates, JC				Gilkeson, Gary S.; Mashmoushi, Ahmad K.; Ruiz, Phillip; Caza, Tiffany N.; Perl, Andras; Oates, Jim C.			Endothelial Nitric Oxide Synthase Reduces Crescentic and Necrotic Glomerular Lesions, Reactive Oxygen Production, and MCP1 Production in Murine Lupus Nephritis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SUPEROXIDE-PRODUCTION; OXIDATIVE STRESS; REDOX REGULATION; GENETIC-ANALYSIS; MICE; ERYTHEMATOSUS; CELLS; TETRAHYDROBIOPTERIN; INHIBITION	Systemic lupus erythematosus, in both animal models and in humans, is characterized by autoantibody production followed by immune complex deposition in target tissues. Ensuing target organ damage is modulated by reactive intermediates, including reactive nitrogen and oxygen species, through as of now incompletely understood mechanisms. Endothelial nitric oxide synthase is known to impact vascular reactivity; however its impact on reactive intermediate production and inflammatory renal disease is less well defined. In this study, we assessed the impact of endothelial nitric oxide synthase (eNOS) on disease in lupus prone MRL/lpr mice. Mice lacking eNOS developed earlier more severe disease with decreased survival. eNOS deficient mice died sooner and developed significantly more glomerular crescents, necrosis, inflammatory infiltrates and vasculitis, indicating a role for eNOS in modulating these renal lesions. Immune complex deposition was similar between groups, indicating the impact of eNOS is distal to antibody/complement glomerular deposition. Urinary nitric oxide production was decreased in the eNOS deficient mice, while proteinuria was increased. Urinary monocyte chemotactic protein-1 was also increased in the knockout mice. CD4+ T cells from MRL/lpr mice demonstrated mitochondrial hyperpolarization, increased nitric oxide and superoxide production and increased calcium flux compared to B6 control mice. Deficiency of eNOS resulted in decreased nitric oxide and mitochondrial calcium levels but had no effect on mitochondrial hyperpolarization. Renal cortices from MRL/lpr mice that are eNOS deficient demonstrated increased superoxide production, which was blocked by both nitric oxide synthase and NADPH oxidase inhibitors. These studies thus demonstrate a key role for eNOS in modulating renal disease in lupus prone MRL/lpr mice. The impact appears to be mediated by effects on superoxide production in the kidney, impacting downstream mediators such as monocyte chemotactic protein-1. These results suggest that modulation of eNOS may be a novel therapeutic approach to treating lupus nephritis.	[Gilkeson, Gary S.; Mashmoushi, Ahmad K.; Oates, Jim C.] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Gilkeson, Gary S.; Oates, Jim C.] Ralph H Johnson VA Med Ctr, Med Serv, Charleston, SC USA; [Ruiz, Phillip] Univ Miami, Miller Sch Med, Dept Surg & Pathol, Transplant Labs & Immunopathol, Miami, FL 33136 USA; [Caza, Tiffany N.; Perl, Andras] SUNY Upstate Med Univ, Dept Med, Div Rheumatol, Syracuse, NY 13210 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Miami; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Oates, JC (corresponding author), Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	oatesjc@musc.edu		Perl, Andras/0000-0002-5017-1348; Oates, Jim/0000-0002-5426-1359; Caza, Tiffany/0000-0001-8988-8998	Medical University of SC Clinical and Translational Science Award (NIH) [UL1TR000062]; National Institutes of Health [R01-AR045476, T32-GM008716, AI048079, AI072648]; Alliance for Lupus Research; Central New York Community Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048079, R56AI048079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	Medical University of SC Clinical and Translational Science Award (NIH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Central New York Community Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Medical University of SC Clinical and Translational Science Award (NIH grant UL1TR000062) and National Institutes of Health grant numbers R01-AR045476 and T32-GM008716. This work was supported in part by grants AI048079 and AI072648 from the National Institutes of Health, the Alliance for Lupus Research, and the Central New York Community Foundation (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; [Anonymous], 2012, CHAMPION CHIP TRANSC; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Bollain YGJJ, 2009, INFLAMM RES, V58, P61; Brunner HI, 2012, ARTHRITIS RHEUM-US, V64, P2687, DOI 10.1002/art.34426; Chatterjee S, 2009, FREE RADICAL BIO MED, V46, P454, DOI 10.1016/j.freeradbiomed.2008.10.046; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; El-Magadmi M, 2004, CIRCULATION, V110, P399, DOI 10.1161/01.CIR.0000136807.78534.50; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Furusu A, 1998, KIDNEY INT, V53, P1760, DOI 10.1046/j.1523-1755.1998.00907.x; Gupte SA, 2006, J MOL CELL CARDIOL, V41, P340, DOI 10.1016/j.yjmcc.2006.05.003; Hagiwara M, 2008, AM J PHYSIOL-RENAL, V295, pF1735, DOI 10.1152/ajprenal.90427.2008; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kiss E, 2006, J AUTOIMMUN, V27, P211, DOI 10.1016/j.jaut.2006.09.008; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Marks SD, 2008, NEPHROL DIAL TRANSPL, V23, P3521, DOI 10.1093/ndt/gfn270; Moens AL, 2006, ARTERIOSCL THROM VAS, V26, P2439, DOI 10.1161/01.ATV.0000243924.00970.cb; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nagy G, 2006, CLIN IMMUNOL, V118, P145, DOI 10.1016/j.clim.2005.10.016; Nagy G, 2004, J IMMUNOL, V173, P3676, DOI 10.4049/jimmunol.173.6.3676; Njoku C, 2008, J INVEST MED, V56, P911, DOI 10.2310/JIM.0b013e3181889e13; Njoku CJ, 2005, J INVEST MED, V53, P347, DOI 10.2310/6650.2005.53705; Noris M, 1995, LAB INVEST, V73, P804; Oates JC, 1997, CLIN IMMUNOL IMMUNOP, V83, P86, DOI 10.1006/clin.1997.4332; Oates JC, 2010, AUTOIMMUNITY, V43, P56, DOI 10.3109/08916930903374683; Perl A, 2004, METH MOLEC MED, V102, P87; Pleskova M, 2005, FASEB J, V19, P139, DOI 10.1096/fj.05-3791fje; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Schoeb TR, 2012, ARTHRITIS RHEUM-US, V64, P4114, DOI 10.1002/art.37683; Selemidis S, 2007, CARDIOVASC RES, V75, P349, DOI 10.1016/j.cardiores.2007.03.030; Shah D, 2011, IMMUNOBIOLOGY, V216, P1010, DOI 10.1016/j.imbio.2011.04.001; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Stielow C, 2006, BIOCHEM BIOPH RES CO, V344, P200, DOI 10.1016/j.bbrc.2006.03.114; Sumiyoshi K, 2008, CARDIOVASC RES, V80, P463, DOI 10.1093/cvr/cvn206; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Taylor TP, 2012, BIOMARK INSIGHTS, V7, P1, DOI 10.4137/BMI.S8703; Tsao PS, 1997, CIRCULATION, V96, P934; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Volk T, 2000, MOL CELL BIOCHEM, V206, P105, DOI 10.1023/A:1007059616914; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645	43	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64650	10.1371/journal.pone.0064650	http://dx.doi.org/10.1371/journal.pone.0064650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741359	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900072
J	Kaplan, MB; Mooney, TA; McCorkle, DC; Cohen, AL				Kaplan, Maxwell B.; Mooney, T. Aran; McCorkle, Daniel C.; Cohen, Anne L.			Adverse Effects of Ocean Acidification on Early Development of Squid (Doryteuthis pealeii)	PLOS ONE			English	Article							LOLIGO-PEALEII; CARBONIC-ACID; SEA-WATER; GROWTH; CALCIFICATION; SEAWATER; CO2; STATOLITH; TEMPERATURE; SURVIVAL	Anthropogenic carbon dioxide (CO2) is being absorbed into the ocean, altering seawater chemistry, with potentially negative impacts on a wide range of marine organisms. The early life stages of invertebrates with internal and external aragonite structures may be particularly vulnerable to this ocean acidification. Impacts to cephalopods, which form aragonite cuttlebones and statoliths, are of concern because of the central role they play in many ocean ecosystems and because of their importance to global fisheries. Atlantic longfin squid (Doryteuthis pealeii), an ecologically and economically valuable taxon, were reared from eggs to hatchlings (paralarvae) under ambient and elevated CO2 concentrations in replicated experimental trials. Animals raised under elevated pCO(2) demonstrated significant developmental changes including increased time to hatching and shorter mantle lengths, although differences were small. Aragonite statoliths, critical for balance and detecting movement, had significantly reduced surface area and were abnormally shaped with increased porosity and altered crystal structure in elevated pCO(2)-reared paralarvae. These developmental and physiological effects could alter squid paralarvae behavior and survival in the wild, directly and indirectly impacting marine food webs and commercial fisheries.	[Kaplan, Maxwell B.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Kaplan, Maxwell B.; Mooney, T. Aran] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [McCorkle, Daniel C.; Cohen, Anne L.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	University of St Andrews; Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Mooney, TA (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	amooney@whoi.edu			WHOI Student Summer Fellowship; WHOI-MIT Joint Program; Penzance Endowed Fund; John E. and Anne W. Sawyer Endowed Fund; NSF [EF-1220034]; NOAA [NA10OAR4170083]; Emerging Frontiers [1220034] Funding Source: National Science Foundation	WHOI Student Summer Fellowship; WHOI-MIT Joint Program; Penzance Endowed Fund; John E. and Anne W. Sawyer Endowed Fund; NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by a WHOI Student Summer Fellowship and WHOI-MIT Joint Program, the Penzance Endowed Fund, the John E. and Anne W. Sawyer Endowed Fund and NSF Research Grant No. EF-1220034. Additional support came from NSF OCE 1041106 to ALC and DCM, and NOAA Sea Grant award #NA10OAR4170083 to ALC and DCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P573, DOI 10.1071/MF04158; Arkhipkin AI, 1999, J PLANKTON RES, V21, P401, DOI 10.1093/plankt/21.2.401; Arkhipkin AI, 2000, J ZOOL, V250, P31, DOI 10.1111/j.1469-7998.2000.tb00575.x; ARNOLD JM, 1976, AM ZOOL, V16, P421; BAILEY KM, 1984, MAR BIOL, V79, P303, DOI 10.1007/BF00393262; Baumann H, 2011, NAT CLIM CHANGE, P6; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Buresch KC, 2009, MAR ECOL PROG SER, V387, P197, DOI 10.3354/meps08052; Buresch KM, 2001, MAR ECOL PROG SER, V210, P161, DOI 10.3354/meps210161; CaCOFI, 2011, CACOFI REP REV SEL C; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Caldeira K., 2005, J GEOPHYS RES, V110, P1, DOI DOI 10.1029/2004JC002671; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; CLARKE MR, 1978, J MAR BIOL ASSOC UK, V58, P701, DOI 10.1017/S0025315400041345; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; COLMERS WF, 1984, CELL TISSUE RES, V236, P505; Comeau S, 2012, P ROY SOC B-BIOL SCI, V279, P732, DOI 10.1098/rspb.2011.0910; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dorey N, 2012, MAR BIOL; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Findlay HS, 2009, MAR ECOL PROG SER, V389, P193, DOI 10.3354/meps08141; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gilly WF, 2006, MAR ECOL PROG SER, V324, P1, DOI 10.3354/meps324001; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Gutowska MA, 2010, MAR BIOL, V157, P1653, DOI 10.1007/s00227-010-1438-0; Gutowska MA, 2008, MAR ECOL PROG SER, V373, P303, DOI 10.3354/meps07782; HANLON RT, 1989, J EXP BIOL, V141, P187; HANLON RT, 1983, BIOL BULL, V165, P637, DOI 10.2307/1541470; Hanlon RT, 1996, CEPHALOPOD BEHAV; Hatfield EMC, 2002, FISH B-NOAA, V100, P200; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holcomb M, 2010, J EXP MAR BIOL ECOL, V386, P27, DOI 10.1016/j.jembe.2010.02.007; Hoving HJT, 2012, P ROY SOC B-BIOL SCI, V279, P4559, DOI 10.1098/rspb.2012.1357; Hu MY, 2011, AM J PHYSIOL-REG I, V300, pR1100, DOI 10.1152/ajpregu.00653.2010; Huxham M, 2007, J FISH BIOL, V70, P1554, DOI 10.1111/j.1095-8649.2007.01443.x; Jacobson LD, 2005, LONGFIN INSHORE SQUI; Krief S, 2011, GEOCHIM COSMOCHIM AC; KRISTENSEN T K, 1980, Dana, V1, P39; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lacoue-Labarthe T, 2011, AQUAT TOXICOL, V105, P166, DOI 10.1016/j.aquatox.2011.05.021; Laine P, 1999, J EXP MAR BIOL ECOL, V237, P61, DOI 10.1016/S0022-0981(98)00213-5; Leis JM, 1997, MAR ECOL PROG SER, V159, P165, DOI 10.3354/meps159165; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; LIPINSKI MR, 1994, ANTARCT SCI, V6, P215, DOI 10.1017/S0954102094000337; Marshall AT, 1998, CORAL REEFS, V17, P37, DOI 10.1007/s003380050092; Maxwell MR, 2000, MAR ECOL PROG SER, V199, P159, DOI 10.3354/meps199159; McCorkle DC, 2012, TIME SERIES PCO2 PH; McCormick MI, 2003, OECOLOGIA, V136, P37, DOI 10.1007/s00442-003-1247-y; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Mooney TA, 2010, J EXP BIOL, V213, P3748, DOI 10.1242/jeb.048348; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; NMFS, 2011, 51 NE REG STOCK ASS; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Overholtz WJ, 2000, ICES J MAR SCI, V57, P1147, DOI 10.1006/jmsc.2000.0802; Paulsen H, 2009, J FISH BIOL, V75, P516, DOI 10.1111/j.1095-8649.2009.02301.x; Pierrot D., 2006, ORNLCDIAC105A US DEP, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Poruschi L, 2010, 10 YEARS ADV KNOWLED; Recksiek CW, 1978, BIOL OCEANOGRAPHIC A; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Ries JB, 2010, CORAL REEFS, V29, P661, DOI 10.1007/s00338-010-0632-3; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Robin JP, 1999, J APPL ECOL, V36, P101, DOI 10.1046/j.1365-2664.1999.00384.x; RODHOUSE PG, 1994, ANTARCT SCI, V6, P259, DOI 10.1017/S0954102094000398; Rodhouse PG, 2001, FISH RES, V54, P3, DOI 10.1016/S0165-7836(01)00370-8; Roger LM, 2012, ICES J MAR SCI, V69, P465, DOI 10.1093/icesjms/fsr171; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038282; Rosa R, 2010, PROG OCEANOGR, V86, P72, DOI 10.1016/j.pocean.2010.04.004; Rosas-Luis R, 2008, ECOL MODEL, V218, P149, DOI 10.1016/j.ecolmodel.2008.06.036; Ruiz-Cooley RI, 2006, J MAR BIOL ASSOC UK, V86, P437, DOI 10.1017/S0025315406013324; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Smith LW, 2007, CORAL REEFS, V26, P559, DOI 10.1007/s00338-007-0216-z; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Steer MA, 2004, J EXP MAR BIOL ECOL, V307, P73, DOI 10.1016/j.jembe.2004.01.017; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Vidal EAG, 2002, B MAR SCI, V71, P915; Villanueva R, 2000, MAR BIOL, V136, P449, DOI 10.1007/s002270050704; Waldbusser GG, 2010, MAR ECOL PROG SER, V417, P171, DOI 10.3354/meps08809; Walther K, 2010, MAR ECOL PROG SER, V417, P159, DOI 10.3354/meps08807; Waluda CM, 2001, MAR BIOL, V139, P671; Wang ZHA, 2013, LIMNOL OCEANOGR, V58, P325, DOI 10.4319/lo.2013.58.1.0325; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Xavier JC, 2003, IBIS, V145, P593, DOI 10.1046/j.1474-919X.2003.00196.x; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	97	53	53	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e63714	10.1371/journal.pone.0063714	http://dx.doi.org/10.1371/journal.pone.0063714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741298	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900010
J	Lee, HK; Tang, JWT; Kong, DHL; Koay, ESC				Lee, Hong Kai; Tang, Julian Wei-Tze; Kong, Debra Han-Lin; Koay, Evelyn Siew-Chuan			Simplified Large-Scale Sanger Genome Sequencing for Influenza A/H3N2 Virus	PLOS ONE			English	Article							A-VIRUS; EVOLUTIONARY DYNAMICS; PANDEMIC INFLUENZA; H1N1; AMPLIFICATION; GENE; HEMAGGLUTININ; SURVEILLANCE; VIRULENCE; SUBTYPES	Background: The advent of next-generation sequencing technologies and the resultant lower costs of sequencing have enabled production of massive amounts of data, including the generation of full genome sequences of pathogens. However, the small genome size of the influenza virus arguably justifies the use of the more conventional Sanger sequencing technology which is still currently more readily available in most diagnostic laboratories. Results: We present a simplified Sanger-based genome sequencing method for sequencing the influenza A/H3N2 virus in a large-scale format. The entire genome sequencing was completed with 19 reverse transcription-polymerase chain reactions (RT-PCRs) and 39 sequencing reactions. This method was tested on 15 native clinical samples and 15 culture isolates, respectively, collected between 2009 and 2011. The 15 native clinical samples registered quantification cycle values ranging from 21.0 to 30.56, which were equivalent to 2.4x10(3)-1.4x10(6) viral copies/mu L of RNA extract. All the PCR-amplified products were sequenced directly without PCR product purification. Notably, high quality sequencing data up to 700 bp were generated for all the samples tested. The completed sequence covered 408,810 nucleotides in total, with 13,627 nucleotides per genome, attaining 100% coding completeness. Of all the bases produced, an average of 89.49% were Phred quality value 40 (QV40) bases (representing an accuracy of circa one miscall for every 10,000 bases) or higher, and an average of 93.46% were QV30 bases (one miscall every 1000 bases) or higher. Conclusions: This sequencing protocol has been shown to be cost-effective and less labor-intensive in obtaining full influenza genomes. The constant high quality of sequences generated imparts confidence in extending the application of this non-purified amplicon sequencing approach to other gene sequencing assays, with appropriate use of suitably designed primers.	[Lee, Hong Kai; Koay, Evelyn Siew-Chuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Lee, Hong Kai; Kong, Debra Han-Lin; Koay, Evelyn Siew-Chuan] Natl Univ Hlth Syst, Natl Univ Hosp, Mol Diag Ctr, Dept Lab Med, Singapore, Singapore; [Tang, Julian Wei-Tze] Univ Alberta Hosp, Alberta Prov Lab Publ Hlth, Edmonton, AB T6G 2B7, Canada; [Tang, Julian Wei-Tze] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	National University of Singapore; National University of Singapore; University of Alberta; University of Alberta	Koay, ESC (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore.	evelyn_koay@nuhs.edu.sg	, Julian W Tang/H-2348-2014	Tang, Julian/0000-0002-4963-1028	National Medical Research Council [NMRC/1247/2010]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Medical Research Council grant funding (ref number: NMRC/1247/2010 to JWT and ESK; http://www.nmrc.gov.sg/content/nmrc_internet/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-77; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P83; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P351; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P421; Archer J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-47; Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Bell Jonathan, 2008, Biotechniques, V44, P834, DOI 10.2144/000112890; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; Chan CH, 2006, J VIROL METHODS, V136, P38, DOI 10.1016/j.jviromet.2006.03.027; Chen GW, 2004, EMERG INFECT DIS, V10, P630, DOI 10.3201/eid1004.030412; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Choi JS, 1999, EXP MOL MED, V31, P20, DOI 10.1038/emm.1999.3; DEOM CM, 1986, P NATL ACAD SCI USA, V83, P3771, DOI 10.1073/pnas.83.11.3771; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Dugan KA, 2002, J FORENSIC SCI, V47, P811; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fan XH, 2012, J VIROL, V86, P2375, DOI 10.1128/JVI.06824-11; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Krafft AE, 2005, J CLIN MICROBIOL, V43, P1768, DOI 10.1128/JCM.43.4.1768-1775.2005; Lee HK, 2012, J MED VIROL, V84, P1646, DOI 10.1002/jmv.23375; Lee HK, 2010, J MOL DIAGN, V12, P636, DOI 10.2353/jmoldx.2010.100010; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McHardy AC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000566; Narasaraju T, 2009, MICROBES INFECT, V11, P2, DOI 10.1016/j.micinf.2008.09.013; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Piralla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028332; Roy T, 2011, INFECT GENET EVOL, V11, P1595, DOI 10.1016/j.meegid.2011.05.022; Salzberg SL, 2004, PLOS BIOL, V2, P1273, DOI 10.1371/journal.pbio.0020285; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Tsai KN, 2011, MICROBES INFECT, V13, P479, DOI 10.1016/j.micinf.2011.01.013; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	40	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64785	10.1371/journal.pone.0064785	http://dx.doi.org/10.1371/journal.pone.0064785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741393	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900106
J	Ma, JC; Zhang, B; Liu, SX; Xie, ST; Yang, Y; Ma, J; Deng, YJ; Wang, WJ; Xu, LX; Li, RZ; Zhang, L; Yu, CP; Shi, W				Ma, Jianchao; Zhang, Bin; Liu, Shuangxin; Xie, Shaoting; Yang, Yun; Ma, Juan; Deng, Yujun; Wang, Wenjian; Xu, Lixia; Li, Ruizhao; Zhang, Li; Yu, Chunping; Shi, Wei			1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces Proteinuria	PLOS ONE			English	Article							SOLUBLE UROKINASE RECEPTOR; CHRONIC KIDNEY-DISEASE; VITAMIN-D-RECEPTOR; CATHEPSIN-L; D ANALOG; ALBUMINURIA; TARGET; PARICALCITOL; ACTIVATION; REDUCTION	Background: Accumulating studies have demonstrated that 1,25-Dihydroxyvitamin D(3) (1,25(OH)2D3) reduces proteinuria and protects podocytes from injury. Recently, urokinase receptor (uPAR) and its soluble form have been shown to cause podocyte injury and focal segmental glomerulosclerosis (FSGS). Here, our findings showed that 1,25(OH)2D3 did inhibit podocyte uPAR expression and attenuate proteinuria and podocyte injury. Methodology/Principal Findings: In this study, the antiproteinuric effect of 1,25(OH)2D3 was examined in the lipopolysaccharide mice model of transient proteinuria (LPS mice) and in the 5/6 nephrectomy rat FSGS model(NTX rats). uPAR protein expression were tested by flow cytometry, immune cytochemistry and western blot analysis, and uPAR mRNA expression by real-time quantitative PCR in cultured podocytes and kidney glomeruli isolated from mice and rats. Podocyte motility was observed by transwell migration assay and wound healing assay. Podocyte foot processes effacement was identified by transmission electron microscopy. We found that 1,25(OH)2D3 inhibited podocyte uPAR mRNA and protein synthesis in LPS-treated podocytes, LPS mice and NTX rats, along with 1,25(OH)2D3 reducing proteinuria in NTX rats and LPS mice. 1,25(OH)2D3 reduced glomerulosclerosis in NTX rats and alleviated podocyte foot processes effacement in LPS mice. Transwell migration assay and wound healing assay showed that LPS-induced podocyte motility, irrespective of random or directed motility, were substantially reduced by 1,25(OH)2D3. Conclusions/Significance: Our results demonstrated that 1,25(OH)2D3 inhibited podocyte uPAR expression in vitro and in vivo, which may be an unanticipated off target effect of 1,25(OH)2D3 and explain its antiproteinuric effect in the 5/6 nephrectomy rat FSGS model and the LPS mouse model of transient proteinuria.	[Ma, Jianchao] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Ma, Jianchao; Zhang, Bin; Liu, Shuangxin; Xie, Shaoting; Yang, Yun; Ma, Juan; Wang, Wenjian; Xu, Lixia; Li, Ruizhao; Zhang, Li; Yu, Chunping; Shi, Wei] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Deng, Yujun] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Emergency Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Shi, W (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	13929574215@139.com	liu, shuangxin/AAS-7429-2020		National Natural Science Foundation Committee of China [81270816, 81270784, 81100511]; Guangdong Science and Technology Department	National Natural Science Foundation Committee of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department	This work was supported by grants from National Natural Science Foundation Committee of China (81270816, 81270784, 81100511) and grants from the Guangdong Science and Technology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann K, 1996, NEPHROL DIAL TRANSPL, V11, P1003, DOI 10.1093/oxfordjournals.ndt.a027447; Arenas Jesus, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P221; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Barbosa EM, 2004, VIRCHOWS ARCH, V444, P175, DOI 10.1007/s00428-003-0929-5; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Cheng CC, 2013, LUPUS, V11; Cheng J, 2012, CLIN J AM SOC NEPHRO, V7, P391, DOI 10.2215/CJN.03000311; Comper WD, 2009, NAT MED, V15, P133, DOI 10.1038/nm0209-133a; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Deb DK, 2010, KIDNEY INT, V77, P1000, DOI 10.1038/ki.2010.22; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Jorgensen HS, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-102; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Kuhlmann A, 2004, AM J PHYSIOL-RENAL, V286, pF526, DOI 10.1152/ajprenal.00316.2003; Li YC, 2011, CURR DIABETES REV, V7, P35, DOI 10.2174/157339911794273964; Liu LJ, 2012, AM J KIDNEY DIS, V59, P67, DOI 10.1053/j.ajkd.2011.09.014; Luft FC, 2012, J MOL MED, V90, P1357, DOI 10.1007/s00109-012-0980-2; Ma YY, 2013, CANCER-AM CANCER SOC, V119, P563, DOI 10.1002/cncr.27531; Maas RJ, 2013, PEDIAT NEPHROL, V21; Migliori M, 2005, INT J IMMUNOPATH PH, V18, P779, DOI 10.1177/039463200501800422; Morath C, 2013, AM J THER, V20, P226, DOI 10.1097/MJT.0b013e3182811aca; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Reiser J, 2012, CURR OPIN NEPHROL HY, V21, P428, DOI 10.1097/MNH.0b013e328354a681; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Xiao HQ, 2009, AM J NEPHROL, V30, P34, DOI 10.1159/000200769; Zhang B, 2012, J MOL MED, V90, P1407, DOI 10.1007/s00109-012-0960-6; Zhang B, 2012, NEPHROL DIAL TRANSPL, V27, P1746, DOI 10.1093/ndt/gfr612; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zou MS, 2010, INTERNAL MED, V49, P2677, DOI 10.2169/internalmedicine.49.4174; Zou Min-shu, 2010, Int J Med Sci, V7, P290	40	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64912	10.1371/journal.pone.0064912	http://dx.doi.org/10.1371/journal.pone.0064912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741418	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900131
J	Marchiori, A; Capece, L; Giorgetti, A; Gasparini, P; Behrens, M; Carloni, P; Meyerhof, W				Marchiori, Alessandro; Capece, Luciana; Giorgetti, Alejandro; Gasparini, Paolo; Behrens, Maik; Carloni, Paolo; Meyerhof, Wolfgang			Coarse-Grained/Molecular Mechanics of the TAS2R38 Bitter Taste Receptor: Experimentally-Validated Detailed Structural Prediction of Agonist Binding	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; FAMILY; POCKET; SIMULATION; DYNAMICS; DOCKING; FPOCKET; MODEL; SITE	Bitter molecules in humans are detected by similar to 25 G protein-coupled receptors (GPCRs). The lack of atomic resolution structure for any of them is complicating an in depth understanding of the molecular mechanisms underlying bitter taste perception. Here, we investigate the molecular determinants of the interaction of the TAS2R38 bitter taste receptor with its agonists phenylthiocarbamide (PTC) and propylthiouracil (PROP). We use the recently developed hybrid Molecular Mechanics/Coarse Grained (MM/CG) method tailored specifically for GPCRs. The method, through an extensive exploration of the conformational space in the binding pocket, allows the identification of several residues important for agonist binding that would have been very difficult to capture from the standard bioinformatics/docking approach. Our calculations suggest that both agonists bind to Asn103, Phe197, Phe264 and Trp201, whilst they do not interact with the so-called extra cellular loop 2, involved in cis-retinal binding in the GPCR rhodopsin. These predictions are consistent with data sets based on more than 20 site-directed mutagenesis and functional calcium imaging experiments of TAS2R38. The method could be readily used for other GPCRs for which experimental information is currently lacking.	[Marchiori, Alessandro] Int Sch Adv Studies SISSA ISAS, Neurosci Sector, Trieste, Italy; [Capece, Luciana] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Marchiori, Alessandro; Capece, Luciana; Giorgetti, Alejandro; Carloni, Paolo] German Res Sch Simulat Sci, Julich, Germany; [Giorgetti, Alejandro] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Gasparini, Paolo] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Marchiori, Alessandro; Behrens, Maik; Meyerhof, Wolfgang] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Genet, Nuthetal, Germany; [Capece, Luciana; Carloni, Paolo] Forschungszentrum Julich, Inst Adv Simulat IAS 5, D-52425 Julich, Germany	International School for Advanced Studies (SISSA); International Center for Genetic Engineering & Biotechnology (ICGEB); University of Verona; IRCCS Burlo Garofolo; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Research Center Julich	Carloni, P (corresponding author), German Res Sch Simulat Sci, Julich, Germany.	p.carloni@grs-sim.de; meyerhof@dife.de	Gasparini, Paolo/B-6173-2014; Carloni, Paolo/H-8736-2013; Behrens, Maik/B-6753-2016	Behrens, Maik/0000-0003-2082-8860; Carloni, Paolo/0000-0002-9010-0149; Gasparini, Paolo/0000-0002-0859-0856; Giorgetti, Alejandro/0000-0001-8738-6150	German Research Foundation [Me 1024/2-3]; JARA-HPC on RWTH Compute Cluster [jara0023]	German Research Foundation(German Research Foundation (DFG)); JARA-HPC on RWTH Compute Cluster	The Me 1024/2-3 grant from the German Research Foundation and computer resources provided by JARA-HPC on RWTH Compute Cluster (project ID jara0023) are greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Almaula N, 1996, J BIOL CHEM, V271, P14672, DOI 10.1074/jbc.271.25.14672; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; BEHRENS M, 2012, SEMIN CELL DEV BIOL; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fox AL, 1932, P NATL ACAD SCI USA, V18, P115, DOI 10.1073/pnas.18.1.115; GO N, 1981, BIOPOLYMERS, V20, P991, DOI 10.1002/bip.1981.360200511; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m; Leguebe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047332; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Neri M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.218102; Neri M, 2008, BIOPHYS J, V94, P71, DOI 10.1529/biophysj.107.116301; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pei JM, 2007, NUCLEIC ACIDS RES, V35, pW649, DOI 10.1093/nar/gkm227; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Reichling C, 2008, J NEUROCHEM, V106, P1138, DOI 10.1111/j.1471-4159.2008.05453.x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Singh N, 2011, J BIOL CHEM, V286, P36032, DOI 10.1074/jbc.M111.246983; TAN J, 2012, J CHEM INF MODEL; UEDA T, 2005, J NEUROSCI, V23, P7376; Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	43	57	57	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64675	10.1371/journal.pone.0064675	http://dx.doi.org/10.1371/journal.pone.0064675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741366	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900079
J	Sinclair, D; Isba, R; Kredo, T; Zani, B; Smith, H; Garner, P				Sinclair, David; Isba, Rachel; Kredo, Tamara; Zani, Babalwa; Smith, Helen; Garner, Paul			World Health Organization Guideline Development: An Evaluation	PLOS ONE			English	Article								Background: Research in 2007 showed that World Health Organization (WHO) recommendations were largely based on expert opinion, rarely used systematic evidence-based methods, and did not follow the organization's own "Guidelines for Guidelines". In response, the WHO established a "Guidelines Review Committee'' (GRC) to implement and oversee internationally recognized standards. We examined the impact of these changes on WHO guideline documents and explored senior staff's perceptions of the new procedures. Methods and Findings: We used the AGREE II guideline appraisal tool to appraise ten GRC-approved guidelines from nine WHO departments, and ten pre-GRC guidelines matched by department and topic. We interviewed 20 senior staff across 16 departments and analyzed the transcripts using the framework approach. Average AGREE II scores for GRC-approved guidelines were higher across all six AGREE domains compared with pre-GRC guidelines. The biggest changes were noted for "Rigour of Development" (up 37.6%, from 30.7% to 68.3%) and "Editorial Independence" (up 52.7%, from 20.9% to 73.6%). Four main themes emerged from the interviews: (1) high standards were widely recognized as essential for WHO credibility, particularly with regard to conflicts of interest; (2) views were mixed on whether WHO needed a single quality assurance mechanism, with some departments purposefully bypassing the procedures; (3) staff expressed some uncertainties in applying the GRADE approach, with departmental staff concentrating on technicalities while the GRC remained concerned the underlying principles were not fully institutionalized; (4) the capacity to implement the new standards varied widely, with many departments looking to an overstretched GRC for technical support. Conclusions: Since 2007, WHO guideline development methods have become more systematic and transparent. However, some departments are bypassing the procedures, and as yet neither the GRC, nor the quality assurance standards they have set, are fully embedded within the organization.	[Sinclair, David; Isba, Rachel; Garner, Paul] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Kredo, Tamara; Zani, Babalwa] South African Cochrane Ctr, Cape Town, South Africa; [Smith, Helen] Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine; Liverpool School of Tropical Medicine	Sinclair, D (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.	sinclad@liverpool.ac.uk	Garner, Paul/HII-5856-2022; Garner, Paul/Y-8385-2019; smith, helen/F-4033-2014	Garner, Paul/0000-0002-0607-6941; Isba, Rachel/0000-0002-2896-4309; smith, helen/0000-0002-6252-3793; Kredo, Tamara/0000-0001-7115-9535	UK Department for International Development; World Health Organization; Liverpool School of Tropical Medicine	UK Department for International Development; World Health Organization(World Health Organization); Liverpool School of Tropical Medicine	This study was funded by the UK Department for International Development through a grant awarded to PG. Several small grants were received from the Agreements for Performance of Work grants between the World Health Organization and the Liverpool School of Tropical Medicine. The funding sources had no role in identifying the research topic, or in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appraisal of Guidelines for Research & Evaluation Instrument (AGREE), 2009, AGREE 2 INSTR; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hill S, 2007, LANCET, V369, P1842, DOI 10.1016/S0140-6736(07)60676-X; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P12, DOI 10.1186/1478-4505-4-12; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Ritchie J., 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.4135/9781452230108; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P13, DOI 10.1186/1478-4505-4-13; World Health Organization, 2003, GUID WHO GUID; World Health Organization, 2012, WHO HDB GUID DEV	12	40	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e63715	10.1371/journal.pone.0063715	http://dx.doi.org/10.1371/journal.pone.0063715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741299	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000319799900011
J	Svistoonoff, S; Benabdoun, FM; Nambiar-Veetil, M; Imanishi, L; Vaissayre, V; Cesari, S; Diagne, N; Hocher, V; de Billy, F; Bonneau, J; Wall, L; Ykhlef, N; Rosenberg, C; Bogusz, D; Franche, C; Gherbi, H				Svistoonoff, Sergio; Benabdoun, Faiza Meriem; Nambiar-Veetil, Mathish; Imanishi, Leandro; Vaissayre, Virginie; Cesari, Stella; Diagne, Nathalie; Hocher, Valerie; de Billy, Francoise; Bonneau, Jocelyne; Wall, Luis; Ykhlef, Nadia; Rosenberg, Charles; Bogusz, Didier; Franche, Claudine; Gherbi, Hassen			The Independent Acquisition of Plant Root Nitrogen-Fixing Symbiosis in Fabids Recruited the Same Genetic Pathway for Nodule Organogenesis	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; MEDICAGO-TRUNCATULA; DISCARIA-TRINERVIS; CASUARINA-GLAUCA; ALLOCASUARINA-VERTICILLATA; ACTINORHIZAL SYMBIOSES; CCAMK; EXPRESSION; NODULATION; FRANKIA	Only species belonging to the Fabid clade, limited to four classes and ten families of Angiosperms, are able to form nitrogen-fixing root nodule symbioses (RNS) with soil bacteria. This concerns plants of the legume family (Fabaceae) and Parasponia (Cannabaceae) associated with the Gram-negative proteobacteria collectively called rhizobia and actinorhizal plants associated with the Gram-positive actinomycetes of the genus Frankia. Calcium and calmodulin-dependent protein kinase (CCaMK) is a key component of the common signaling pathway leading to both rhizobial and arbuscular mycorrhizal symbioses (AM) and plays a central role in cross-signaling between root nodule organogenesis and infection processes. Here, we show that CCaMK is also needed for successful actinorhiza formation and interaction with AM fungi in the actinorhizal tree Casuarina glauca and is also able to restore both nodulation and AM symbioses in a Medicago truncatula ccamk mutant. Besides, we expressed auto-active CgCCaMK lacking the auto-inhibitory/CaM domain in two actinorhizal species: C. glauca (Casuarinaceae), which develops an intracellular infection pathway, and Discaria trinervis (Rhamnaceae) which is characterized by an ancestral intercellular infection mechanism. In both species, we found induction of nodulation independent of Frankia similar to response to the activation of CCaMK in the rhizobia-legume symbiosis and conclude that the regulation of actinorhiza organogenesis is conserved regardless of the infection mode. It has been suggested that rhizobial and actinorhizal symbioses originated from a common ancestor with several independent evolutionary origins. Our findings are consistent with the recruitment of a similar genetic pathway governing rhizobial and Frankia nodule organogenesis.	[Svistoonoff, Sergio; Benabdoun, Faiza Meriem; Nambiar-Veetil, Mathish; Imanishi, Leandro; Vaissayre, Virginie; Cesari, Stella; Diagne, Nathalie; Hocher, Valerie; Bonneau, Jocelyne; Bogusz, Didier; Franche, Claudine; Gherbi, Hassen] Inst Rech Dev, UMR DIADE IRD UM2, Equipe Rhizogenese, Montpellier, France; [Benabdoun, Faiza Meriem; Ykhlef, Nadia] Mentouri Univ, Dept Biol & Ecol, Constantine, Algeria; [Nambiar-Veetil, Mathish] Inst Forest Genet & Tree Breeding, Plant Biotechnol Div, Coimbatore, Tamil Nadu, India; [Imanishi, Leandro; Wall, Luis] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Lab Bioquim Microbol & Interacc Biol Suelo L, Bernal, Argentina; [Cesari, Stella] Biol & Genet Interact Plante Parasite INRA CIRAD, Montpellier, France; [Diagne, Nathalie] Lab Commun Microbiol IRD ISRA UCAD, Dakar, Senegal; [de Billy, Francoise; Rosenberg, Charles] INRA, CNRS, Lab Interact Plantes Microorganismes, UMR 2594 441, F-31326 Castanet Tolosan, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite Constantine; Indian Council of Forestry Research & Education (ICFRE); Institute of Forest Genetics & Tree Breeding (IFGTB); CIRAD; INRAE; University Cheikh Anta Diop Dakar; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Gherbi, H (corresponding author), Inst Rech Dev, UMR DIADE IRD UM2, Equipe Rhizogenese, Montpellier, France.	hassen.gherbi@ird.fr	Veetil, Mathish Nambiar/AAX-9738-2020; Bogusz, Didier/O-6055-2017; SVISTOONOFF, Sergio/X-9659-2019	Bogusz, Didier/0000-0002-9094-5870; SVISTOONOFF, Sergio/0000-0001-8554-2922; Cesari, Stella/0000-0001-8558-0371; GHERBI, Hassen/0000-0001-9473-9364	IRD; Agence Nationale de la Recherche Project NewNod; Agence Nationale de la Recherche Project SESAM [AN-06-BLAN-0095, 2010 BLAN 1708 01]; University of Quilmes; ECOS-SUD [A07B02]; European Union; Department of Biotechnology, Ministry of Science and Technology, Government of India; IRD Department of Capacity-Building for Southern Scientific Communities (IRD-DPF); Argentinean National Research Council (CONICET)	IRD; Agence Nationale de la Recherche Project NewNod(French National Research Agency (ANR)); Agence Nationale de la Recherche Project SESAM(French National Research Agency (ANR)); University of Quilmes; ECOS-SUD; European Union(European Commission); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); IRD Department of Capacity-Building for Southern Scientific Communities (IRD-DPF); Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Financial support was provided by IRD, grants from Agence Nationale de la Recherche Projects NewNod and SESAM (AN-06-BLAN-0095 and 2010 BLAN 1708 01), University of Quilmes and ECOS-SUD (A07B02). F. M. B. was funded by the European Union (Averroes program). M. N. V. was funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India. L. I. was funded by the IRD Department of Capacity-Building for Southern Scientific Communities (IRD-DPF) and the Argentinean National Research Council (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banba M, 2008, PLANT CELL PHYSIOL, V49, P1659, DOI 10.1093/pcp/pcn153; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; BRUNDRETT MC, 1984, CAN J BOT, V62, P2128, DOI 10.1139/b84-290; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Capoen W, 2009, PLANT CELL, V21, P1526, DOI 10.1105/tpc.109.066233; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Chaia E, 1998, PLANT SOIL, V205, P99, DOI 10.1023/A:1004305313480; Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; den Camp RO, 2011, SCIENCE, V331, P909, DOI 10.1126/science.1198181; DIOUF D, 1995, MOL PLANT MICROBE IN, V8, P532, DOI 10.1094/MPMI-8-0532; Doyle JJ, 2011, MOL PLANT MICROBE IN, V24, P1289, DOI 10.1094/MPMI-05-11-0114; Franche C, 1997, PLANT J, V11, P897, DOI 10.1046/j.1365-313X.1997.11040897.x; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayashi T, 2010, PLANT J, V63, P141, DOI 10.1111/j.1365-313X.2010.04228.x; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Hocher V, 2011, PLANT PHYSIOL, V156, P700, DOI 10.1104/pp.111.174151; Imanishi L, 2011, MOL PLANT MICROBE IN, V24, P1317, DOI 10.1094/MPMI-03-11-0078; JOUANIN L, 1986, PLASMID, V16, P124, DOI 10.1016/0147-619X(86)90071-5; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kumagai H, 2003, MOL PLANT MICROBE IN, V16, P663, DOI 10.1094/MPMI.2003.16.8.663; Laplaze L, 2000, MOL PLANT MICROBE IN, V13, P107, DOI 10.1094/MPMI.2000.13.1.107; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Liao JQ, 2012, PLANT J, V72, P572, DOI 10.1111/j.1365-313X.2012.05098.x; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Markmann K, 2009, TRENDS PLANT SCI, V14, P77, DOI 10.1016/j.tplants.2008.11.009; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Meilhoc E, 2010, MOL PLANT MICROBE IN, V23, P748, DOI 10.1094/MPMI-23-6-0748; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Pawlowski K, 2003, MOL PLANT MICROBE IN, V16, P796, DOI 10.1094/MPMI.2003.16.9.796; Perrine-Walker F, 2011, CURR PROTEIN PEPT SC, V12, P156, DOI 10.2174/138920311795684896; SAGAN M, 1995, PLANT SCI, V111, P63, DOI 10.1016/0168-9452(95)04229-N; Santi C, 2003, MOL PLANT MICROBE IN, V16, P808, DOI 10.1094/MPMI.2003.16.9.808; Shimoda Y, 2012, PLANT CELL, V24, P304, DOI 10.1105/tpc.111.092197; Singh S, 2012, CURR OPIN PLANT BIOL, V15, P444, DOI 10.1016/j.pbi.2012.04.002; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Svistoonoff S, 2003, MOL PLANT MICROBE IN, V16, P600, DOI 10.1094/MPMI.2003.16.7.600; Svistoonoff S, 2010, MOL PLANT MICROBE IN, V23, P740, DOI 10.1094/MPMI-23-6-0740; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; Tromas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044742; Valverde C, 1999, NEW PHYTOL, V141, P345, DOI 10.1046/j.1469-8137.1999.00345.x; Vessey JK, 2004, PLANT SOIL, V266, P205; Wang B, 2010, NEW PHYTOL, V186, P514, DOI 10.1111/j.1469-8137.2009.03137.x; NATURE, V344, P781	48	49	49	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64515	10.1371/journal.pone.0064515	http://dx.doi.org/10.1371/journal.pone.0064515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741336	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900049
J	Xiao, S; Li, R; Diao, HL; Zhao, F; Ye, XQ				Xiao, Shuo; Li, Rong; Diao, Honglu; Zhao, Fei; Ye, Xiaoqin			Progesterone Receptor-Mediated Regulation of N-Acetylneuraminate Pyruvate Lyase (NPL) in Mouse Uterine Luminal Epithelium and Nonessential Role of NPL in Uterine Function	PLOS ONE			English	Article							SIALIC-ACID METABOLISM; EMBRYO IMPLANTATION; ESCHERICHIA-COLI; GENE; EXPRESSION; ESTROGEN; PURIFICATION; ENZYMES; CLONING; UTERUS	N-acetylneuraminate pyruvate lyase (NPL) catalyzes N-acetylneuraminic acid, the predominant sialic acid. Microarray analysis of the periimplantation mouse uterine luminal epithelium (LE) revealed Npl being the most downregulated (35 x) gene in the LE upon embryo implantation. In natural pregnant mouse uterus, Npl expression increased 56 x from gestation day 0.5 (D0.5) to D2.5. In ovariectomized mouse uterus, Npl was significantly upregulated by progesterone (P4) but downregulated by 17 beta-estradiol (E2). Progesterone receptor (PR) antagonist RU486 blocked the upregulation of Npl in both preimplantation uterus and P4-treated ovariectomized uterus. Npl was specifically localized in the preimplantation D2.5 and D3.5 uterine LE. Since LE is essential for establishing uterine receptivity, it was hypothesized that NPL might play a critical role in uterine function, especially during embryo implantation. This hypothesis was tested in the Npl((-/-)) mice. No significant differences were observed in the numbers of implantation sites on D4.5, gestation periods, litter sizes, and postnatal offspring growth between wild type (WT) and Npl((-/-)) females from mating with WT males. Npl((-/-))xNpl((-/-)) crosses produced comparable little sizes as that from WTxWT crosses. Comparable mRNA expression levels of several genes involved in sialic acid metabolism were observed in D3.5 uterus and uterine LE between WT and Npl((-/-)), indicating no compensatory upregulation in the D3.5 Npl((-/-)) uterus and LE. This study demonstrates PR-mediated dynamic expression of Npl in the periimplantation uterus and dispensable role of Npl in uterine function and embryo development.	[Xiao, Shuo; Li, Rong; Diao, Honglu; Zhao, Fei; Ye, Xiaoqin] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Xiao, Shuo; Li, Rong; Zhao, Fei; Ye, Xiaoqin] Univ Georgia, Interdisciplinary Toxicol Program, Athens, GA 30602 USA; [Diao, Honglu] Hubei Univ Med, Renmin Hosp, Reprod Med Ctr, Shiyan, Hubei, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Hubei University of Medicine	Ye, XQ (corresponding author), Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA.	ye@uga.edu	Li, Rong/O-5558-2018		Graduate School at University of Georgia; Office of the Vice President for Research, Interdisciplinary Toxicology Program at University of Georgia; Department of Physiology & Pharmacology at University of Georgia; National Institutes of Health [NIH R15HD066301, NIH R01HD065939]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065939] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD066301] Funding Source: NIH RePORTER	Graduate School at University of Georgia; Office of the Vice President for Research, Interdisciplinary Toxicology Program at University of Georgia; Department of Physiology & Pharmacology at University of Georgia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Authors thank Dr. James N. Moore and Dr. Zhen Fu in the College of Veterinary Medicine, University of Georgia for access to the ABI 7900-Real-Time PCR machine and the imaging system, respectively; and the Graduate School, the Office of the Vice President for Research, Interdisciplinary Toxicology Program, and Department of Physiology & Pharmacology at University of Georgia, and National Institutes of Health (NIH R15HD066301 and NIH R01HD065939 to X.Y.) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank Dr. James N. Moore and Dr. Zhen Fu in the College of Veterinary Medicine, University of Georgia for access to the ABI 7900-Real-Time PCR machine and the imaging system, respectively; and the Graduate School, the Office of the Vice President for Research, Interdisciplinary Toxicology Program, and Department of Physiology & Pharmacology at University of Georgia, and National Institutes of Health for financial support.	AISAKA K, 1991, BIOCHEM J, V276, P541, DOI 10.1042/bj2760541; AISAKA K, 1986, APPL ENVIRON MICROB, V51, P562, DOI 10.1128/AEM.51.3.562-565.1986; ALVI MUH, 1988, OBSTET GYNECOL, V72, P171; Bagriacik EU, 1999, GLYCOBIOLOGY, V9, P267, DOI 10.1093/glycob/9.3.267; Bany BM, 2006, DEV BIOL, V294, P445, DOI 10.1016/j.ydbio.2006.03.006; Brown N, 2004, BIOL REPROD, V71, P2003, DOI 10.1095/biolreprod.104.031864; Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965; Chen Y, 2006, J MOL ENDOCRINOL, V37, P147, DOI 10.1677/jme.1.02009; COWELL TP, 1969, J REPROD FERTIL, V19, P239, DOI 10.1530/jrf.0.0190239; Crook M, 1997, J CLIN PATHOL, V50, P494, DOI 10.1136/jcp.50.6.494; DENKER HW, 1993, J EXP ZOOL, V266, P541, DOI 10.1002/jez.1402660606; Diao HL, 2011, FERTIL STERIL, V95, P2087, DOI 10.1016/j.fertnstert.2011.01.160; Diao HL, 2010, FERTIL STERIL, V94, P2808, DOI 10.1016/j.fertnstert.2010.06.034; Diao HL, 2010, FERTIL STERIL, V93, P2750, DOI 10.1016/j.fertnstert.2010.01.009; FROHMAN M, 1985, J IMMUNOL, V134, P2269; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Kleta R, 2003, AM J MED GENET A, V120A, P28, DOI 10.1002/ajmg.a.20024; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Meysick KC, 1996, MOL BIOCHEM PARASIT, V76, P289, DOI 10.1016/0166-6851(95)02544-8; OHTA Y, 1986, APPL MICROBIOL BIOT, V24, P386, DOI 10.1007/BF00294595; RAJAN R, 1983, EUR J OBSTET GYN R B, V16, P37, DOI 10.1016/0028-2243(83)90218-6; SCHAUER R, 1982, ADV CARBOHYD CHEM BI, V40, P131, DOI 10.1016/S0065-2318(08)60109-2; Schauer R, 1999, BIOSCIENCE REP, V19, P373, DOI 10.1023/A:1020256004616; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; SHANDILYA LN, 1977, J ENDOCRINOL, V73, P207, DOI 10.1677/joe.0.0730207; Sommer U, 1999, GLYCOCONJUGATE J, V16, P425, DOI 10.1023/A:1007030627948; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; VIMR ER, 1985, J BACTERIOL, V164, P854, DOI 10.1128/JB.164.2.854-860.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wang B, 2012, ADV NUTR, V3, p465S, DOI 10.3945/an.112.001875; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wickramasinghe S, 2011, BIOCHIMIE, V93, P1641, DOI 10.1016/j.biochi.2011.06.002; Wu MQ, 2005, DNA SEQUENCE, V16, P137, DOI 10.1080/10425170400020373; Ye XQ, 2011, FERTIL STERIL, V95, P2107, DOI 10.1016/j.fertnstert.2011.02.024; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yoshinaga K, 2012, J REPROD DEVELOP, V58, P196, DOI 10.1262/jrd.2011-027	42	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65607	10.1371/journal.pone.0065607	http://dx.doi.org/10.1371/journal.pone.0065607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741500	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900213
J	Yoshii, Y; Furukawa, T; Oyama, N; Hasegawa, Y; Kiyono, Y; Nishii, R; Waki, A; Tsuji, AB; Sogawa, C; Wakizaka, H; Fukumura, T; Yoshii, H; Fujibayashi, Y; Lewis, JS; Saga, T				Yoshii, Yukie; Furukawa, Takako; Oyama, Nobuyuki; Hasegawa, Yoko; Kiyono, Yasushi; Nishii, Ryuichi; Waki, Atsuo; Tsuji, Atsushi B.; Sogawa, Chizuru; Wakizaka, Hidekatsu; Fukumura, Toshimitsu; Yoshii, Hiroshi; Fujibayashi, Yasuhisa; Lewis, Jason S.; Saga, Tsuneo			Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; CELL-PROLIFERATION; EXPRESSION; APOPTOSIS; PET; INHIBITION; GROWTH; PROTEIN; CYTOSKELETON; METABOLISM	Fatty acid synthase (FASN) expression is elevated in several cancers, and this over-expression is associated with poor prognosis. Inhibitors of FASN, such as orlistat, reportedly show antitumor effects against cancers that over-express FASN, making FASN a promising therapeutic target. However, large variations in FASN expression levels in individual tumors have been observed, and methods to predict FASN-targeted therapy outcome before treatment are required to avoid unnecessary treatment. In addition, how FASN inhibition affects tumor progression remains unclear. Here, we showed the method to predict FASN-targeted therapy outcome using radiolabeled acetate uptake and presented mechanisms of FASN inhibition with human prostate cancer cell lines, to provide the treatment strategy of FASN-targeted therapy. We revealed that tumor uptake of radiolabeled acetate reflected the FASN expression levels and sensitivity to FASN-targeted therapy with orlistat in vitro and in vivo. FASN-targeted therapy was noticeably effective against tumors with high FASN expression, which was indicated by high acetate uptake. To examine mechanisms, we established FASN knockdown prostate cancer cells by transduction of short-hairpin RNA against FASN and investigated the characteristics by analyses on morphology and cell behavior and microarray-based gene expression profiling. FASN inhibition not only suppressed cell proliferation but prevented pseudopodia formation and suppressed cell adhesion, migration, and invasion. FASN inhibition also suppressed genes involved in production of intracellular second messenger arachidonic acid and androgen hormones, both of which promote tumor progression. Collectively, our data demonstrated that uptake of radiolabeled acetate is a useful predictor of FASN-targeted therapy outcome. This suggests that [1-C-11] acetate positron emission tomography (PET) could be a powerful tool to accomplish personalized FASN-targeted therapy by non-invasive visualization of tumor acetate uptake and selection of responsive tumors. FASN-targeted therapy could be an effective treatment to suppress multiple steps related to tumor progression in prostate cancers selected by [1-C-11] acetate PET.	[Yoshii, Yukie; Furukawa, Takako; Waki, Atsuo; Tsuji, Atsushi B.; Sogawa, Chizuru; Wakizaka, Hidekatsu; Fukumura, Toshimitsu; Fujibayashi, Yasuhisa; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Furukawa, Takako; Kiyono, Yasushi; Fujibayashi, Yasuhisa] Univ Fukui, Biomed Imaging Res Ctr, Fukui 910, Japan; [Oyama, Nobuyuki; Hasegawa, Yoko] Univ Fukui, Fac Med Sci, Fukui 910, Japan; [Nishii, Ryuichi] Univ Miyazaki Hosp, Dept Radiol, Miyazaki, Japan; [Yoshii, Hiroshi] Natl Inst Radiol Sci, Emergency Radiat Exposure Care Res Ctr, Chiba 260, Japan; [Lewis, Jason S.] Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiochem Serv, New York, NY 10021 USA	National Institutes for Quantum Science & Technology; University of Fukui; University of Fukui; University of Miyazaki; National Institutes for Quantum Science & Technology; Memorial Sloan Kettering Cancer Center	Yoshii, Y (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	yukiey@nirs.go.jp	Fukumura, Toshimitsu/E-2847-2012; TSUJI, Atsushi B/I-9922-2019	TSUJI, Atsushi B/0000-0003-2726-288X; Lewis, Jason/0000-0001-7065-4534; Oyama, Nobuyuki/0000-0001-9349-8909	Japan Society for the Promotion of Science, Japan (JSPS)	Japan Society for the Promotion of Science, Japan (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science, Japan (JSPS) (to YY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blann AD, 2011, PROSTATE, V71, P1047, DOI 10.1002/pros.21319; Canobbio I, 2001, J BIOL CHEM, V276, P26022, DOI 10.1074/jbc.M102639200; Carvalho MA, 2008, INT J CANCER, V123, P2557, DOI 10.1002/ijc.23835; Choi JI, 2011, KOREAN J UROL, V52, P461, DOI 10.4111/kju.2011.52.7.461; Czernin J, 2009, PET CLIN, V4, P163, DOI 10.1016/j.cpet.2009.05.001; Dai HZ, 2012, CARCINOGENESIS, V33, P30, DOI 10.1093/carcin/bgr232; De Schrijver E, 2003, CANCER RES, V63, P3799; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Gao Y, 2006, CANCER BIOL THER, V5, P978, DOI 10.4161/cbt.5.8.2883; Grassi I, 2012, AM J NUCL MED MOLEC, V2, P33; Guo NH, 1997, CANCER RES, V57, P1735; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Jelski W, 2008, CLIN CHIM ACTA, V395, P1, DOI 10.1016/j.cca.2008.05.001; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim DM, 2009, INT J CANCER, V125, P2520, DOI 10.1002/ijc.24617; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke JA, 2010, PROSTATE, V70, P239, DOI 10.1002/pros.21057; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Nagasaki S, 2009, CANCER RES, V69, P1392, DOI 10.1158/0008-5472.CAN-08-0821; Nakamura Y, 2005, ENDOCR-RELAT CANCER, V12, P101, DOI 10.1677/erc.1.00914; Oleksowicz L, 2012, PROSTATE, V72, P1140, DOI 10.1002/pros.22463; Oyama N, 2003, J NUCL MED, V44, P549; Oyama N, 2002, J NUCL MED, V43, P181; Oyama N, 2009, EUR J NUCL MED MOL I, V36, P422, DOI 10.1007/s00259-008-0981-0; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Ponde DE, 2007, J NUCL MED, V48, P420; Puig T, 2009, CLIN CANCER RES, V15, P7608, DOI 10.1158/1078-0432.CCR-09-0856; Qian XL, 2009, CANCER CELL, V16, P246, DOI 10.1016/j.ccr.2009.07.031; Ross RW, 2008, J CLIN ONCOL, V26, P842, DOI 10.1200/JCO.2007.13.6804; Rossi S, 2003, MOL CANCER RES, V1, P707; Salem N, 2011, MOL IMAGING BIOL, V13, P140, DOI 10.1007/s11307-010-0308-y; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Shou JY, 2002, P NATL ACAD SCI USA, V99, P2830, DOI 10.1073/pnas.052705299; Silina K, 2011, J IMMUNOTHER, V34, P28, DOI 10.1097/CJI.0b013e3181fb64fa; Smalley MJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1834; Soloviev D, 2006, APPL RADIAT ISOTOPES, V64, P995, DOI 10.1016/j.apradiso.2006.04.011; Tauber S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-200; Torti M, 1999, J BIOL CHEM, V274, P13690, DOI 10.1074/jbc.274.19.13690; Vavere AL, 2008, J NUCL MED, V49, P327, DOI 10.2967/jnumed.107.046672; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Watari A, 2003, APOPTOSIS, V8, P5, DOI 10.1023/A:1021639016300; WEISS L, 1986, BIOL CHEM H-S, V367, P905, DOI 10.1515/bchm3.1986.367.2.905; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xu W, 2010, LEUKEMIA LYMPHOMA, V51, P1962, DOI 10.3109/10428194.2010.514968; Yoshii Y, 2009, NUCL MED BIOL, V36, P771, DOI 10.1016/j.nucmedbio.2009.05.006; Yoshimoto M, 2001, NUCL MED BIOL, V28, P117, DOI 10.1016/S0969-8051(00)00195-5; Yun M, 2009, J NUCL MED, V50, P1222, DOI 10.2967/jnumed.109.062703; Zhao W, 2006, BRIT J CANCER, V95, P869, DOI 10.1038/sj.bjc.6603350	50	81	86	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64570	10.1371/journal.pone.0064570	http://dx.doi.org/10.1371/journal.pone.0064570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741342	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900055
J	Milutinovic, B; Stolpe, C; Peuss, R; Armitage, SAO; Kurtz, J				Milutinovic, Barbara; Stolpe, Clemens; Peuss, Robert; Armitage, Sophie A. O.; Kurtz, Joachim			The Red Flour Beetle as a Model for Bacterial Oral Infections	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS STRAINS; INSECTICIDAL CRYSTAL PROTEINS; TRIBOLIUM-CASTANEUM; NUCLEOTIDE-SEQUENCE; VAR TENEBRIONIS; CAENORHABDITIS-ELEGANS; DELTA-ENDOTOXINS; GENE; TOXIN; IDENTIFICATION	Experimental infection systems are important for studying antagonistic interactions and coevolution between hosts and their pathogens. The red flour beetle Tribolium castaneum and the spore-forming bacterial insect pathogen Bacillus thuringiensis (Bt) are widely used and tractable model organisms. However, they have not been employed yet as an efficient experimental system to study host-pathogen interactions. We used a high throughput oral infection protocol to infect T. castaneum insects with coleopteran specific B. thuringiensis bv. tenebrionis (Btt) bacteria. We found that larval mortality depends on the dietary spore concentration and on the duration of exposure to the spores. Furthermore, differential susceptibility of larvae from different T. castaneum populations indicates that the host genetic background influences infection success. The recovery of high numbers of infectious spores from the cadavers indicates successful replication of bacteria in the host and suggests that Btt could establish infectious cycles in T. castaneum in nature. We were able to transfer plasmids from Btt to a non-pathogenic but genetically well-characterised Bt strain, which was thereafter able to successfully infect T. castaneum, suggesting that factors residing on the plasmids are important for the virulence of Btt. The availability of a genetically accessible strain will provide an ideal model for more in-depth analyses of pathogenicity factors during oral infections. Combined with the availability of the full genome sequence of T. castaneum, this system will enable analyses of host responses during infection, as well as addressing basic questions concerning host-parasite coevolution.	[Milutinovic, Barbara; Stolpe, Clemens; Peuss, Robert; Armitage, Sophie A. O.; Kurtz, Joachim] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany	University of Munster	Milutinovic, B (corresponding author), Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany.	b.milutinovic@uni-muenster.de	Kurtz, Joachim/A-9678-2008; Armitage, Sophie AO/A-6961-2012	Kurtz, Joachim/0000-0002-7258-459X; Armitage, Sophie AO/0000-0002-5561-9543; Milutinovic, Barbara/0000-0002-8214-4758; Peuss, Robert/0000-0002-9716-6650	German Research Foundation (DFG) [KU 1929/4-1]; Volkswagen Foundation Postdoctoral Fellowship [1/83 516]	German Research Foundation (DFG)(German Research Foundation (DFG)); Volkswagen Foundation Postdoctoral Fellowship	BM, RP and JK were funded by a German Research Foundation (DFG) KU 1929/4-1 grant within SPP 1399. SAOA was funded by a Volkswagen Foundation Postdoctoral Fellowship, grant 1/83 516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Razek AS, 1999, CAN ENTOMOL, V131, P433, DOI 10.4039/Ent131433-4; AGAISSE H, 1995, J BACTERIOL, V177, P6027, DOI 10.1128/jb.177.21.6027-6032.1995; Ahmedani MS, 2008, PAK J BOT, V40, P2149; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; AMEEN M-U, 1973, International Journal of Insect Morphology and Embryology, V2, P137, DOI 10.1016/0020-7322(73)90014-7; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; ARONSON AI, 1986, MICROBIOL REV, V50, P1; Berenos C, 2009, J EVOLUTION BIOL, V22, P2049, DOI 10.1111/j.1420-9101.2009.01821.x; Borgonie G, 1996, FUND APPL NEMATOL, V19, P391; Bouillaut L, 2008, NUCLEIC ACIDS RES, V36, P3791, DOI 10.1093/nar/gkn149; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Brown SJ, 2003, GENET RES, V82, P155, DOI 10.1017/S0016672303006451; Bucher G, 2004, DEVELOPMENT, V131, P1729, DOI 10.1242/dev.01073; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; CAROZZI NB, 1991, APPL ENVIRON MICROB, V57, P3057, DOI 10.1128/AEM.57.11.3057-3061.1991; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; Chattopadhyay A, 2004, CRIT REV MICROBIOL, V30, P33, DOI 10.1080/10408410490270712; Chen J, 2005, APPL MICROBIOL BIOT, V67, P351, DOI 10.1007/s00253-004-1859-0; CHIANG AS, 1986, J INVERTEBR PATHOL, V48, P96, DOI 10.1016/0022-2011(86)90147-3; Contreras E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055330; Crickmore N, 2012, BACILLUS THURINGIENS; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Demuth JP, 2007, MOL ECOL NOTES, V7, P1189, DOI 10.1111/j.1471-8286.2007.01826.x; DONOVAN WP, 1988, MOL GEN GENET, V214, P365, DOI 10.1007/BF00330468; DONOVAN WP, 1992, APPL ENVIRON MICROB, V58, P3921, DOI 10.1128/AEM.58.12.3921-3927.1992; Dubois N. R., 1981, Journal of Arboriculture, V7, P233; FAUST RM, 1981, J INVERTEBR PATHOL, V37, P113, DOI 10.1016/0022-2011(81)90063-X; Fedhila S, 2003, J BACTERIOL, V185, P2820, DOI 10.1128/JB.185.9.2820-2825.2003; Fedhila S, 2002, J BACTERIOL, V184, P3296, DOI 10.1128/JB.184.12.3296-3304.2002; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Garbutt J, 2011, ECOL LETT, V14, P765, DOI 10.1111/j.1461-0248.2011.01638.x; Gill M, 2002, INSECT MOL BIOL, V11, P619, DOI 10.1046/j.1365-2583.2002.00373.x; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013; Grandvalet C, 2001, MICROBIOL-SGM, V147, P1805, DOI 10.1099/00221287-147-7-1805; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; HEIMPEL AM, 1960, BACTERIOL REV, V24, P266, DOI 10.1128/MMBR.24.3.266-288.1960; HERRNSTADT C, 1986, BIO-TECHNOL, V4, P305, DOI 10.1038/nbt0486-305; HOFTE H, 1989, MICROBIOL REV, V53, P242; HOFTE H, 1987, NUCLEIC ACIDS RES, V15, P7183, DOI 10.1093/nar/15.17.7183; Kho MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029122; Klingler M, 2004, CURR BIOL, V14, pR639, DOI 10.1016/j.cub.2004.08.004; KNOWLES BH, 1993, BIOESSAYS, V15, P469, DOI 10.1002/bies.950150706; KRIEG A, 1984, ANZ SCHADLINGSKD PFL, V57, P145, DOI 10.1007/BF01903233; KRIEG A, 1983, Z ANGEW ENTOMOL, V96, P500; Lagisz M, 2011, J APPL ENTOMOL, V135, P682, DOI 10.1111/j.1439-0418.2010.01593.x; LERECLUS D, 1995, BIO-TECHNOL, V13, P67, DOI 10.1038/nbt0195-67; LI RS, 1987, J INVERTEBR PATHOL, V50, P277, DOI 10.1016/0022-2011(87)90093-0; Little TJ, 2005, NAT IMMUNOL, V6, P651, DOI 10.1038/ni1219; LUTHY P, 1980, FEMS MICROBIOL LETT, V8, P1; MCPHERSON SA, 1988, BIO-TECHNOL, V6, P61, DOI 10.1038/nbt0188-61; MEADOWS MP, 1992, APPL ENVIRON MICROB, V58, P1344, DOI 10.1128/AEM.58.4.1344-1350.1992; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Obeidat M., 2008, World Journal of Agricultural Sciences, V4, P161; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Oppert B., 2010, Biopesticides International, V6, P67; Oppert B, 2011, PEST MANAG SCI, V67, P568, DOI 10.1002/ps.2099; Padin S, 2002, J STORED PROD RES, V38, P69, DOI 10.1016/S0022-474X(00)00046-1; Raymond B, 2007, J INVERTEBR PATHOL, V96, P151, DOI 10.1016/j.jip.2007.03.003; Raymond B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000905; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; Raymond B, 2009, BIOL LETTERS, V5, P218, DOI 10.1098/rsbl.2008.0610; Reyes-Ramirez A, 2005, APPL ENVIRON MICROB, V71, P1346, DOI 10.1128/AEM.71.3.1346-1355.2005; Reyes-Ramirez A, 2008, APPL ENVIRON MICROB, V74, P125, DOI 10.1128/AEM.02133-07; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Schulte RD, 2011, P ROY SOC B-BIOL SCI, V278, P2832, DOI 10.1098/rspb.2011.0019; SEKAR V, 1987, P NATL ACAD SCI USA, V84, P7036, DOI 10.1073/pnas.84.20.7036; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SHARPE ES, 1976, J INVERTEBR PATHOL, V27, P421, DOI 10.1016/0022-2011(76)90114-2; SICK A, 1990, NUCLEIC ACIDS RES, V18, P1305, DOI 10.1093/nar/18.5.1305; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Sokoloff A, 1972, BIOL TRIBOLIUM SPECI, V1; Sokoloff A., 1974, BIOL TRIBOLIUM SPECI, V2; Suzuki MT, 2004, CAN J MICROBIOL, V50, P973, DOI [10.1139/w04-087, 10.1139/W04-087]; Swadener C., 1994, Journal of Pesticide Reform, V14, P13; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Vilas-Boas GFLT, 1998, FEMS MICROBIOL ECOL, V25, P369, DOI 10.1016/S0168-6496(98)00005-1; Vlisidou I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000518; Whalon ME, 2003, ARCH INSECT BIOCHEM, V54, P200, DOI 10.1002/arch.10117; Younas M, 2008, J SUSTAIN AGR, V32, P181, DOI 10.1080/10440040802121601; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	92	53	53	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64638	10.1371/journal.pone.0064638	http://dx.doi.org/10.1371/journal.pone.0064638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737991	gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700055
J	Weimann, L; Ganzinger, KA; McColl, J; Irvine, KL; Davis, SJ; Gay, NJ; Bryant, CE; Klenerman, D				Weimann, Laura; Ganzinger, Kristina A.; McColl, James; Irvine, Kate L.; Davis, Simon J.; Gay, Nicholas J.; Bryant, Clare E.; Klenerman, David			A Quantitative Comparison of Single-Dye Tracking Analysis Tools Using Monte Carlo Simulations	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PARTICLE TRACKING; LATERAL DIFFUSION; MEMBRANE; RECEPTORS; MOLECULES; PROTEINS; ORGANIZATION; CHOLESTEROL; MICROSCOPY	Single-particle tracking (SPT) is widely used to study processes from membrane receptor organization to the dynamics of RNAs in living cells. While single-dye labeling strategies have the benefit of being minimally invasive, this comes at the expense of data quality; typically a data set of short trajectories is obtained and analyzed by means of the mean square displacements (MSD) or the distribution of the particles' displacements in a set time interval (jump distance, JD). To evaluate the applicability of both approaches, a quantitative comparison of both methods under typically encountered experimental conditions is necessary. Here we use Monte Carlo simulations to systematically compare the accuracy of diffusion coefficients (D-values) obtained for three cases: one population of diffusing species, two populations with different D-values, and a population switching between two D-values. For the first case we find that the MSD gives more or equally accurate results than the JD analysis (relative errors of D-values <6%). If two diffusing species are present or a particle undergoes a motion change, the JD analysis successfully distinguishes both species (relative error <5%). Finally we apply the JD analysis to investigate the motion of endogenous LPS receptors in live macrophages before and after treatment with methyl-beta-cyclodextrin and latrunculin B.	[Weimann, Laura; Ganzinger, Kristina A.; McColl, James; Klenerman, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Irvine, Kate L.; Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, MRC,Human Immunol Unit, Oxford OX3 9DU, England; [Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge; University of Oxford; University of Cambridge	Klenerman, D (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	dk10012@cam.ac.uk	Ganzinger, Kristina/AAD-5584-2020	Ganzinger, Kristina/0000-0001-9106-9406; Irvine, Katherine/0000-0002-8630-3250; McColl, James/0000-0002-6692-3663; Klenerman, David/0000-0001-7116-6954	Engineering and Physical Sciences Research Council (EPSRC); Studienstiftung des deutschen Volkes; Horserace Betting Levy Board (HBLB) scholarship; Medical Research Council (MRC); BBSRC [BB/H021930/1] Funding Source: UKRI; MRC [MC_UU_12010/4, G1000133, G0901545] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021930/1] Funding Source: researchfish; Medical Research Council [G0901545, G1000133, MC_UU_12010/4] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Studienstiftung des deutschen Volkes; Horserace Betting Levy Board (HBLB) scholarship; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	L.W. and K. A. G. are supported by fellowships from the Engineering and Physical Sciences Research Council (EPSRC). K. A. G is also funded by Studienstiftung des deutschen Volkes. K. L. I. is funded by a Horserace Betting Levy Board (HBLB) scholarship, and C. E. B. is a Biotechnology and Biological Sciences Research Council (BBSRC) Research Development Fellow. This work was funded by a Medical Research Council (MRC) program grant to N.J.G., C. E. B. and D. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; ANDERSON CM, 1992, J CELL SCI, V101, P415; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Baker A, 2007, EUR BIOPHYS J BIOPHY, V36, P849, DOI 10.1007/s00249-007-0214-7; BARAK LS, 1982, J CELL BIOL, V95, P846, DOI 10.1083/jcb.95.3.846; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bruckbauer A, 2007, BIOPHYS J, V93, P3120, DOI 10.1529/biophysj.107.104737; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Crank J., 1975, MATH DIFFUSION; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Deverall MA, 2005, BIOPHYS J, V88, P1875, DOI 10.1529/biophysj.104.050559; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Flier BMI, 2011, PHYS CHEM CHEM PHYS, V13, P1770, DOI 10.1039/c0cp01801e; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; GOLDMAN R, 2005, LIVE CELL IMAGING LA; Goulian M, 2000, BIOPHYS J, V79, P2188, DOI 10.1016/S0006-3495(00)76467-8; Grunwald D, 2008, BIOPHYS J, V94, P2847, DOI 10.1529/biophysj.107.115014; Guigas G, 2006, BIOPHYS J, V91, P2393, DOI 10.1529/biophysj.106.087031; HAZIOT A, 1988, J IMMUNOL, V141, P547; JAQAMAN K, 2009, COMPUTATIONAL IMAGE; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kalaidzidis Y, 2009, J MATH BIOL, V58, P57, DOI 10.1007/s00285-008-0180-4; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lommerse PHM, 2004, BBA-BIOMEMBRANES, V1664, P119, DOI 10.1016/j.bbamem.2004.05.005; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Saxton MJ, 2008, NAT METHODS, V5, P671, DOI 10.1038/nmeth0808-671; SAXTON MJ, 1994, BIOPHYS J, V67, P2110, DOI 10.1016/S0006-3495(94)80694-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Siebrasse JP, 2008, P NATL ACAD SCI USA, V105, P20291, DOI 10.1073/pnas.0810692105; Sonnleitner A, 1999, BIOPHYS J, V77, P2638, DOI 10.1016/S0006-3495(99)77097-9; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; VANVOORHIS WC, 1983, J EXP MED, V158, P126, DOI 10.1084/jem.158.1.126; Vrljic M, 2005, BIOPHYS J, V88, P334, DOI 10.1529/biophsj.104.045989; Wieser S, 2007, BIOPHYS J, V92, P3719, DOI 10.1529/biophysj.106.095398; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Wieser S, 2008, BIOPHYS J, V95, P5988, DOI 10.1529/biophysj.108.141655	47	39	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64287	10.1371/journal.pone.0064287	http://dx.doi.org/10.1371/journal.pone.0064287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737978	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000321394700042
J	Chu, C; Zhang, XJ; Ma, W; Li, L; Wang, W; Shang, L; Fu, P				Chu, Cheng; Zhang, Xinjiang; Ma, Wei; Li, Li; Wang, Wei; Shang, Lu; Fu, Peng			Induction of Autophagy by a Novel Small Molecule Improves A beta Pathology and Ameliorates Cognitive Deficits	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; IN-VITRO; RAPAMYCIN; NEURODEGENERATION; PROTEIN; TOXICITY; PEPTIDE; MTOR; AKT	Growing evidence has demonstrated a neuroprotective role of autophagy in Alzheimer's disease (AD). Thus, autophagy has been regarded as a potential therapeutic target, attracting increasing interest in pharmaceutical autophagy modulation by small molecules. We designed a two-cycle screening strategy on the basis of imaging high-throughout screening (HTS) and cellular toxicity assay, and have identified a novel autophagy inducer known as GTM-1. We further showed that GTM-1 exhibits dual activities, such as autophagy induction and antagonism against A beta-oligomer toxicity. GTM-1 modulates autophagy in an Akt-independent and mTOR-independent manner. In addition, we demonstrated that GTM-1 enhances autophagy clearance and reverses the downregulation of autophagy flux by thapsigargin and asparagine. Furthermore, administration of GTM-1 attenuated Ab pathology and ameliorated cognitive deficits in AD mice.	[Chu, Cheng; Zhang, Xinjiang; Wang, Wei] First Peoples Hosp Yangzhou, Dept Neurol, Yangzhou, Jiangsu, Peoples R China; [Chu, Cheng; Li, Li] Second Mil Med Univ, Changzheng Hosp, Dept Neurol, Shanghai, Peoples R China; [Ma, Wei] Mu Danjiang Med Coll, Heilongjiang, Peoples R China; [Shang, Lu] Shanghai Corps, Detachment Hlth Team CAPF 8, Shanghai, Jiangsu, Peoples R China; [Fu, Peng] Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Fu, P (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China.	fuajneg@163.com			First People's Hospital of Yangzhou and Changzheng Hospital	First People's Hospital of Yangzhou and Changzheng Hospital	This study was supported by the First People's Hospital of Yangzhou and Changzheng Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Anekonda TS, 2011, J ALZHEIMERS DIS, V23, P21, DOI 10.3233/JAD-2010-101287; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bonda DJ, 2010, CURR OPIN DRUG DISC, V13, P235; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Desplat V, 2010, J ENZYM INHIB MED CH, V25, P204, DOI 10.3109/14756360903169881; Florez-McClure ML, 2007, AUTOPHAGY, V3, P569, DOI 10.4161/auto.4776; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HOYVIK H, 1991, J CELL BIOL, V113, P1305, DOI 10.1083/jcb.113.6.1305; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Jekabsone A, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-24; Jeong JK, 2013, NEUROBIOL AGING, V34, P146, DOI 10.1016/j.neurobiolaging.2012.04.002; Jimenez-Sanchez M, 2012, PROG NEUROBIOL, V97, P67, DOI 10.1016/j.pneurobio.2011.08.013; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Ling DJ, 2009, AUTOPHAGY, V5, P738, DOI 10.4161/auto.5.5.8626; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Madeo F, 2009, GENE DEV, V23, P2253, DOI 10.1101/gad.1858009; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Smita M, 2011, POLS ONE, V6; Son SM, 2012, AUTOPHAGY, V8, P1842, DOI 10.4161/auto.21861; SOPHER BL, 1994, MOL BRAIN RES, V26, P207, DOI 10.1016/0169-328X(94)90092-2; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Wadsworth TL, 2008, J ALZHEIMERS DIS, V14, P225; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zheng L, 2006, NEUROSCI LETT, V394, P184, DOI 10.1016/j.neulet.2005.10.035; Zheng L, 2006, ANN NY ACAD SCI, V1067, P248, DOI 10.1196/annals.1354.032	44	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65367	10.1371/journal.pone.0065367	http://dx.doi.org/10.1371/journal.pone.0065367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750258	gold, Green Submitted, Green Published			2022-12-27	WOS:000319961900060
J	Delort, L; Lequeux, C; Dubois, V; Dubouloz, A; Billard, H; Mojallal, A; Damour, O; Vasson, MP; Caldefie-Chezet, F				Delort, Laetitia; Lequeux, Charlotte; Dubois, Virginie; Dubouloz, Alice; Billard, Hermine; Mojallal, Ali; Damour, Odile; Vasson, Marie-Paule; Caldefie-Chezet, Florence			Reciprocal Interactions between Breast Tumor and Its Adipose Microenvironment Based on a 3D Adipose Equivalent Model	PLOS ONE			English	Article							MAMMARY TUMORIGENESIS; CANCER CELLS; ADIPONECTIN; LEPTIN; GROWTH; EXPRESSION; ESTROGEN; TISSUE; ADIPOCYTES; PREADIPOCYTES	Breast cancer has become the most common cancer among women in industrialized countries. Obesity is well established as a risk factor, in particular owing to the attendant secretion of the entities called adipokines; there is growing evidence for a role of cells and factors present in the mammary tumor microenvironment such as fibroblasts, preadipocytes, adipocytes and their secretions. To study how the microenvironment influences breast cancer growth, we developed a novel tridimensional adipose model epithelialized with normal human keratinocytes or with breast cancer cell lines. These mimicked a breast tumor in contact with an adipose microenvironment and allowed monitoring of the interactions between the cells. Leptin and adiponectin, two major adipokines, and their respective receptors, ObRt and AdipoR1, were expressed in the model, but not the second adiponectin receptor, AdipoR2. The differentiation of preadipocytes into adipocytes was greater when they were in contact with the breast cancer cell lines. The contact of breast cancer cell lines with the microenvironment completely modified their transcriptional programs by increasing the expression of genes involved in cell proliferation (cyclinD1, MAPK), angiogenesis (MMP9, VEGF) and hormonal pathways (ESR1, IL6). This tridimensional adipose model provides new insights into the interactions between breast cancer cells and their adipose microenvironment, and provides a tool to develop new drugs for the treatment of both cancer and obesity.	[Delort, Laetitia; Dubois, Virginie; Billard, Hermine; Vasson, Marie-Paule; Caldefie-Chezet, Florence] Univ Auvergne, Clermont Univ, UFR Pharm, Lab SVFp, Clermont Ferrand, France; [Delort, Laetitia; Dubois, Virginie; Billard, Hermine; Vasson, Marie-Paule; Caldefie-Chezet, Florence] CRNH Auvergne, ECRIN, INRA, UMR 1019, Clermont Ferrand, France; [Vasson, Marie-Paule] Ctr Jean Perrin, Unite Nutr, Clermont Ferrand, France; [Lequeux, Charlotte; Dubouloz, Alice; Mojallal, Ali; Damour, Odile] Hop Edouard Herriot, Banque Tissus & Cellules, Lyon, France; [Mojallal, Ali] Hop Edouard Herriot, Serv Chirurg Plast Reconstruct & Esthet, Lyon, France	Universite Clermont Auvergne (UCA); INRAE; UNICANCER; Centre Jean Perrin; CHU Lyon; CHU Lyon	Delort, L (corresponding author), Univ Auvergne, Clermont Univ, UFR Pharm, Lab SVFp, Clermont Ferrand, France.	laetitia.delort@udamail.fr	delort, laetitia/C-3838-2014; FLORENCE, CALDEFIE-CHEZET FCC/U-3378-2018; vasson, marie-paule/ABA-2486-2021		Ligue Nationale contre le Cancer; French Ministry of Research and Technology fellowship	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); French Ministry of Research and Technology fellowship	This study received financial support from "Ligue Nationale contre le Cancer" (comite du Puy-de-Dome, Prof. F. Caldefie-Chezet) and "Canceropole Lyon-Auvergne-Rhone-Alpes". Virginie Dubois is supported by a French Ministry of Research and Technology fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Binai NA, 2010, INT J CANCER, V127, P55, DOI 10.1002/ijc.25010; BJORNTORP P, 1982, METABOLISM, V31, P366, DOI 10.1016/0026-0495(82)90112-3; Black AF, 2005, TISSUE ENG, V11, P723, DOI 10.1089/ten.2005.11.723; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; Caldefie-Chezet F, 2005, BIOCHEM BIOPH RES CO, V334, P737, DOI 10.1016/j.bbrc.2005.06.077; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cleary Margot P, 2009, Front Biosci (Schol Ed), V1, P329, DOI 10.2741/e30; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Dos Santos E, 2008, ONCOL REP, V20, P971, DOI 10.3892/or_00000098; Dubois V, 2010, ANTICANCER RES, V30, P2919; Ferlay J, 2010, INT J CANC; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; GODDEN J, 1992, ANTICANCER RES, V12, P1683; Guerrero J, 2010, BREAST CANCER RES TR, V119, P497, DOI 10.1007/s10549-009-0491-1; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Jarde T, 2008, HISTOPATHOLOGY, V53, P484, DOI 10.1111/j.1365-2559.2008.03121.x; Jarde T, 2009, ENDOCR-RELAT CANCER, V16, P1197, DOI 10.1677/ERC-09-0043; Jarde T, 2011, EUR J CANCER, V47, P33, DOI 10.1016/j.ejca.2010.09.005; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; La Vecchia C, 2006, EUR J CANCER PREV, V15, P117, DOI 10.1097/01.cej.0000179274.24200.9d; Lequeux C, 2009, BIO-MED MATER ENG, V19, P283, DOI 10.3233/BME-2009-0593; Maccio A, 2009, OBES REV, V10, P660, DOI 10.1111/j.1467-789X.2009.00592.x; Maccio A, 2010, J MOL MED, V88, P677, DOI 10.1007/s00109-010-0611-8; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; Mawson A, 2005, MOL CELL ENDOCRINOL, V229, P161, DOI 10.1016/j.mce.2004.08.002; Moinfar F, 2000, CANCER RES, V60, P2562; Mojallal A, 2008, BIO-MED MATER ENG, V18, P193, DOI 10.3233/BME-2008-0524; O'Brien SN, 1999, BIOCHEM BIOPH RES CO, V259, P695, DOI 10.1006/bbrc.1999.0843; Ozbay T, 2008, MOL CANCER RES, V6, P1052, DOI 10.1158/1541-7786.MCR-07-2126; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; Renehan AG, 2010, EUR J CANCER, V46, P2581, DOI 10.1016/j.ejca.2010.07.052; Takahata C, 2007, CANCER LETT, V250, P229, DOI 10.1016/j.canlet.2006.10.006; Tworoger SS, 2007, J CLIN ENDOCR METAB, V92, P1510, DOI 10.1210/jc.2006-1975; Vona-Davis L, 2007, OBES REV, V8, P395, DOI 10.1111/j.1467-789X.2007.00396.x; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Yee D, 2000, J MAMMARY GLAND BIOL, V5, P107, DOI 10.1023/A:1009575518338	39	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66284	10.1371/journal.pone.0066284	http://dx.doi.org/10.1371/journal.pone.0066284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750285	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900087
J	Hamilton, RT; Bhattacharya, A; Walsh, ME; Shi, Y; Wei, R; Zhang, YQ; Rodriguez, KA; Buffenstein, R; Chaudhuri, AR; Van Remmen, H				Hamilton, Ryan T.; Bhattacharya, Arunabh; Walsh, Michael E.; Shi, Yun; Wei, Rochelle; Zhang, Yiqiang; Rodriguez, Karl A.; Buffenstein, Rochelle; Chaudhuri, Asish R.; Van Remmen, Holly			Elevated Protein Carbonylation, and Misfolding in Sciatic Nerve from db/db and Sod1(-/-) Mice: Plausible Link between Oxidative Stress and Demyelination	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PERIPHERAL MYELIN PROTEIN-22; ALDOSE REDUCTASE INHIBITION; ALZHEIMERS-DISEASE BRAIN; DIABETIC-NEUROPATHY; LIPID-PEROXIDATION; SKELETAL-MUSCLE; CONDUCTION-VELOCITY; NITROSATIVE STRESS; ADVANCED GLYCATION	Diabetic peripheral polyneuropathy is associated with decrements in motor/sensory neuron myelination, nerve conduction and muscle function; however, the mechanisms of reduced myelination in diabetes are poorly understood. Chronic elevation of oxidative stress may be one of the potential determinants for demyelination as lipids and proteins are important structural constituents of myelin and highly susceptible to oxidation. The goal of the current study was to determine whether there is a link between protein oxidation/misfolding and demyelination. We chose two distinct models to test our hypothesis: 1) the leptin receptor deficient mouse (dbdb) model of diabetic polyneuropathy and 2) superoxide dismutase 1 knockout (Sod1 2/2) mouse model of in vivo oxidative stress. Both experimental models displayed a significant decrement in nerve conduction, increase in tail distal motor latency as well as reduced myelin thickness and fiber/axon diameter. Further biochemical studies demonstrated that oxidative stress is likely to be a potential key player in the demyelination process as both models exhibited significant elevation in protein carbonylation and alterations in protein conformation. Since peripheral myelin protein 22 (PMP22) is a key component of myelin sheath and has been found mutated and aggregated in several peripheral neuropathies, we predicted that an increase in carbonylation and aggregation of PMP22 may be associated with demyelination in dbdb mice. Indeed, PMP22 was found to be carbonylated and aggregated in sciatic nerves of dbdb mice. Sequence-driven hydropathy plot analysis and in vitro oxidation-induced aggregation of purified PMP22 protein supported the premise for oxidation-dependent aggregation of PMP22 in dbdb mice. Collectively, these data strongly suggest for the first time that oxidation-mediated protein misfolding and aggregation of key myelin proteins may be linked to demyelination and reduced nerve conduction in peripheral neuropathies.	[Hamilton, Ryan T.; Bhattacharya, Arunabh; Walsh, Michael E.; Shi, Yun; Zhang, Yiqiang; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Rodriguez, Karl A.; Buffenstein, Rochelle; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Chaudhuri, Asish R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Hamilton, Ryan T.; Bhattacharya, Arunabh; Shi, Yun; Wei, Rochelle; Zhang, Yiqiang; Rodriguez, Karl A.; Buffenstein, Rochelle; Chaudhuri, Asish R.; Van Remmen, Holly] Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX USA; [Chaudhuri, Asish R.; Van Remmen, Holly] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Chaudhuri, AR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	chaudhuria@uthscsa.edu; vanremmen@uthscsa.edu	Zhang, Yiqiang/AAA-3143-2019		National Service Research Award; Program project at the National Institute of Aging [AG20591]; University of Michigan Grant; Go Grant at the National institute of Aging project [RCA2AG036613]; Glenn Award (Research in Biological Mechanisms of Aging); Ellison Medical Foundation [AGSS-178006]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [P01AG020591, RC2AG036613, T32AG021890] Funding Source: NIH RePORTER	National Service Research Award; Program project at the National Institute of Aging; University of Michigan Grant; Go Grant at the National institute of Aging project; Glenn Award (Research in Biological Mechanisms of Aging); Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by T32 AG021890-08 (NIA) National Service Research Award to Postdoctoral Fellow Training Grant on the Biology of Aging to Steven N. Austad for trainees (RTH, KAR) AG20591 Program project at the National Institute of Aging (HV) (Project 2: Does Superoxide-Induced Mitochondrial Dysfunction Lead to Muscle Atrophy?) University of Michigan Grant (Subcontract), RCA2AG036613 Go Grant at the National institute of Aging project 8 (WW and HV) (Effect of rapa on removal of protein by the autophagic and/or proteasomal pathways) under (AR) (Can rapamycin retard aging?), Glenn Award (Research in Biological Mechanisms of Aging) (http://glennfoundation.org/), AGSS-178006 (RB is PI) Ellison Medical Foundation (Genomic Stability in the Naked Mole-Rat: A Role for Cancer Resistance and Extended Longevity) (http://www.ellisonfoundation.org/), and Glenn Foundation for Medical Research (RB is PI). (Comparative biological mechanisms of aging, insights from the longest lived rodent, the naked mole-rat) (http://glennfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraibar MA, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/919832; Bhattacharya A, 2011, AGING CELL, V10, P720, DOI 10.1111/j.1474-9726.2011.00712.x; Bizzozero OA, 2005, J NEUROSCI RES, V81, P687, DOI 10.1002/jnr.20587; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Coppey LJ, 2006, DIABETES, V55, P341, DOI 10.2337/diabetes.55.02.06.db05-0885; Delaney CL, 2001, J NEUROPATH EXP NEUR, V60, P147, DOI 10.1093/jnen/60.2.147; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Fortun J, 2006, NEUROBIOL DIS, V22, P153, DOI 10.1016/j.nbd.2005.10.010; Fortun J, 2005, J NEUROCHEM, V92, P1531, DOI 10.1111/j.1471-4159.2004.02987.x; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Grigsby J, 2012, CURR EYE RES, V37, P1045, DOI 10.3109/02713683.2012.713152; Gurpinar T, 2011, BIOTECH HISTOCHEM, V86, P373, DOI 10.3109/10520295.2010.506159; Ilnytska O, 2006, DIABETES, V55, P1686, DOI 10.2337/db06-0067; Jang YC, 2012, AGING CELL, V11, P770, DOI 10.1111/j.1474-9726.2012.00843.x; Jang YC, 2011, EXP GERONTOL, V46, P193, DOI 10.1016/j.exger.2010.08.029; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Juretic D, 1998, COMPUT CHEM, V22, P279, DOI 10.1016/S0097-8485(97)00070-3; Kalia LV, 2012, ANN NEUROL; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Miyata T, 2000, J AM SOC NEPHROL, V11, P1744, DOI 10.1681/ASN.V1191744; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Obrosova IG, 2005, DIABETES, V54, P234, DOI 10.2337/diabetes.54.1.234; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Oh SS, 2010, NEUROSCI LETT, V483, P127, DOI 10.1016/j.neulet.2010.07.076; Padua L, 2011, MUSCLE NERVE, V43, P652, DOI 10.1002/mus.21935; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Pierce A, 2006, BIOCHEMISTRY-US, V45, P3077, DOI 10.1021/bi052031i; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Pierce AP, 2007, FREE RADICAL BIO MED, V43, P1584, DOI 10.1016/j.freeradbiomed.2007.08.019; Pillon NJ, 2012, ENDOCRINOLOGY, V153, P2099, DOI 10.1210/en.2011-1957; Poon HF, 2005, FREE RADICAL BIO MED, V39, P453, DOI 10.1016/j.freeradbiomed.2005.03.030; Poon HF, 2005, NEUROBIOL DIS, V18, P492, DOI 10.1016/j.nbd.2004.12.009; Rangaraju S, 2008, NEUROBIOL DIS, V32, P105, DOI 10.1016/j.nbd.2008.06.015; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Rosso G, 2012, J MOL RECOGNIT, V25, P247, DOI 10.1002/jmr.2176; Salmon AB, 2009, FASEB J, V23, P2317, DOI 10.1096/fj.08-122523; Schmeichel AM, 2003, DIABETES, V52, P165, DOI 10.2337/diabetes.52.1.165; Shao CH, 2012, MOL PHARMACOL, V82, P383, DOI 10.1124/mol.112.078352; SHAW PJ, 1995, ANN NEUROL, V38, P691, DOI 10.1002/ana.410380424; Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012; SHIRASAKI N, 1991, J NEUROCYTOL, V20, P573, DOI 10.1007/BF01215265; Thomas PK, 1997, CLIN NEUROSCI, V4, P341; Tobler AR, 2002, P NATL ACAD SCI USA, V99, P483, DOI 10.1073/pnas.012593399; Vareniuk I, 2007, EXP NEUROL, V205, P425, DOI 10.1016/j.expneurol.2007.03.019; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Voziyan P, 2013, CLIN CHEM LAB MED, P1; Wang L, 2011, NEUROSCIENCE, V193, P399, DOI 10.1016/j.neuroscience.2011.07.039; Wei Q, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-13; Yamada K, 2003, J PEPT RES, V62, P78, DOI 10.1034/j.1399-3011.2003.00073.x; Yamamoto A, 2011, NEUROBIOL DIS, V43, P17, DOI 10.1016/j.nbd.2010.08.015	53	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65725	10.1371/journal.pone.0065725	http://dx.doi.org/10.1371/journal.pone.0065725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750273	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900075
J	Li, L; Ma, P; Liu, YJ; Huang, C; O, WS; Tang, F; Zhang, JV				Li, Lei; Ma, Ping; Liu, Yongjun; Huang, Chen; O, Wai-sum; Tang, Fai; Zhang, Jian V.			Intermedin Attenuates LPS-induced Inflammation in the Rat Testis	PLOS ONE			English	Article							OXIDATIVE STRESS; INTERMEDIN/ADRENOMEDULLIN 2; TESTICULAR MACROPHAGES; MALE-INFERTILITY; LEYDIG-CELLS; IN-VITRO; LIPOPOLYSACCHARIDE; PEPTIDE; SERTOLI; ADRENOMEDULLIN-2	First reported as a vasoactive peptide in the cardiovascular system, intermedin (IMD), also known as adrenomedullin 2 (ADM2), is a hormone with multiple potent roles, including its antioxidant action on the pulmonary, central nervous, cardiovascular and renal systems. Though IMD may play certain roles in trophoblast cell invasion, early embryonic development and cumulus cell-oocyte interaction, the role of IMD in the male reproductive system has yet to be investigated. This paper reports our findings on the gene expression of IMD, its receptor components and its protein localization in the testes. In a rat model, bacterial lippolysaccharide (LPS) induced atypical orchitis, and LPS treatment upregulated the expression of IMD and one of its receptor component proteins, i.e. receptor activity modifying protein 2 (RAMP2). IMD decreased both plasma and testicular levels of reactive oxygen species (ROS) production, attenuated the increase in the gene expression of the proinflammatory cytokines tumor necrosis factor alpha (TNF alpha), interleukin 6 (IL6) and interleukin 1 beta (IL1 beta), rescued spermatogenesis, and prevented the decrease in plasma testosterone levels caused by LPS. The restorative effect of IMD on steroidogenesis was also observed in hydrogen peroxide-treated rat primary Leydig cells culture. Our results indicate IMD plays an important protective role in spermatogenesis and steroidogenesis, suggesting therapeutic potential for IMD in pathological conditions such as orchitis.	[Li, Lei; Ma, Ping; Liu, Yongjun; Huang, Chen; Zhang, Jian V.] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Res Ctr Gene & Cell Engn, Shenzhen, Peoples R China; [O, Wai-sum] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Tang, Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Jian V.] Shenzhen Engn Lab Single Mol Detect & Instrument, Shenzhen, Peoples R China; [Zhang, Jian V.] Innovat Pharmacol & Biotherapy Preclin Test Publ, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Hong Kong; University of Hong Kong	Zhang, JV (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Res Ctr Gene & Cell Engn, Shenzhen, Peoples R China.	jian.zhang@siat.ac.cn		Li, Lei/0000-0002-4485-1937	One-hundred Talent Program of Chinese Academy Of Sciences of China; National Natural Science Foundation of China [31100850, 81200434]; Shenzhen City of China [SW201110059]; National Major Basic Research Program of China [2013CB945503]	One-hundred Talent Program of Chinese Academy Of Sciences of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen City of China; National Major Basic Research Program of China(National Basic Research Program of China)	JZ was supported by One-hundred Talent Program of Chinese Academy Of Sciences of China, Grant 31100850 from National Natural Science Foundation of China, Grant SW201110059 from Shenzhen City of China, and the National Major Basic Research Program of China 2013CB945503; LL was supported by Grant 81200434 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Allen JA, 2004, ENDOCRINE, V25, P265, DOI 10.1385/ENDO:25:3:265; Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704; Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; BOOCKFOR FR, 1994, ENDOCRINOLOGY, V134, P2150, DOI 10.1210/en.134.5.2150; Borahay M, 2013, J CLIN ENDOCRINOL ME; Bryniarski K, 2005, J IMMUNOL METHODS, V301, P186, DOI 10.1016/j.jim.2005.04.002; Chang CL, 2011, J BIOL CHEM, V286, P43193, DOI 10.1074/jbc.M111.297358; Chauhan M, 2011, BIOL REPROD, V85, P1232, DOI 10.1095/biolreprod.110.086835; Chauhan M, 2011, REGUL PEPTIDES, V170, P65, DOI 10.1016/j.regpep.2011.05.011; Chauhan M, 2009, BIOL REPROD, V81, P777, DOI 10.1095/biolreprod.108.074419; Chen L, 2006, BRAIN RES, V1086, P42, DOI 10.1016/j.brainres.2006.02.128; Cudicini C, 1997, ENDOCRINOLOGY, V138, P2863, DOI 10.1210/en.138.7.2863; DE SK, 1993, ENDOCRINOLOGY, V133, P389, DOI 10.1210/en.133.1.389; Hagiwara M, 2008, AM J PHYSIOL-RENAL, V295, pF1735, DOI 10.1152/ajprenal.90427.2008; KERN S, 1995, BIOL REPROD, V53, P1407, DOI 10.1095/biolreprod53.6.1407; Kuwasako K, 2004, MOL PHARMACOL, V65, P207, DOI 10.1124/mol.65.1.207; Li L, 2008, MOL CELL ENDOCRINOL, V283, P96, DOI 10.1016/j.mce.2007.11.028; McLachlan RI, 2001, MED J AUSTRALIA, V174, P116, DOI 10.5694/j.1326-5377.2001.tb143180.x; Muller-Redetzky HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035832; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Reddy MM, 2006, REPROD TOXICOL, V22, P493, DOI 10.1016/j.reprotox.2006.03.003; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Stephan JP, 1997, MOL CELL ENDOCRINOL, V134, P109, DOI 10.1016/S0303-7207(97)00172-X; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Taylor MM, 2005, AM J PHYSIOL-REG I, V288, pR919, DOI 10.1152/ajpregu.00744.2004; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132; Victor VM, 2003, PHYSIOL RES, V52, P789; WEI RQ, 1988, BIOL REPROD, V38, P830, DOI 10.1095/biolreprod38.4.830; Zhao L, 2012, PEPTIDES, V33, P329, DOI 10.1016/j.peptides.2011.12.016	31	22	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65278	10.1371/journal.pone.0065278	http://dx.doi.org/10.1371/journal.pone.0065278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750251	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900053
J	Valbuena-Urena, E; Amat, F; Carranza, S				Valbuena-Urena, Emilio; Amat, Felix; Carranza, Salvador			Integrative Phylogeography of Calotriton Newts (Amphibia, Salamandridae), with Special Remarks on the Conservation of the Endangered Montseny Brook Newt (Calotriton arnoldi)	PLOS ONE			English	Article							CLIMATIC OSCILLATIONS; GENETIC CONSEQUENCES; BIOGEOGRAPHY; MITOCHONDRIAL; RANGE; POPULATIONS; PHYLOGENETICS; COLONIZATION; EVOLUTION; LINEAGES	The genus Calotriton includes two species of newts highly adapted to live in cold and fast-flowing mountain springs. The Pyrenean brook newt (Calotriton asper), restricted to the Pyrenean region, and the Montseny brook newt (Calotriton arnoldi), endemic to the Montseny massif and one of the most endangered amphibian species in Europe. In the present manuscript, we use an integrative approach including species distribution modeling (SDM), molecular analyses of mitochondrial and nuclear DNA sequence data and morphology to unravel the historical processes that have contributed to shaping the biogeography and genetic structure of the genus Calotriton, with special emphasis on the conservation of C. arnoldi. The results of the molecular analyses confirm that, despite having originated recently, being ecologically similar and geographically very close, there is no signal of hybridization between C. asper and C. arnoldi. SDM results suggest that tough environmental conditions on mountains tops during glacial periods, together with subsequent warmer periods could have prevented the contact between the two species. Within the critically endangered C. arnoldi, a high genetic structure is revealed despite its extremely small distribution range compared to C. asper. Haplotype networks, AMOVA and SAMOVA analyses suggest that two distinct groups of populations can be clearly differentiated with absence of gene flow. This is in concordance with morphological differentiation and correlates with its geographical distribution, as the two groups are situated on the eastern and western sides of a river valley that acts as a barrier. The genetic and morphological results are highly important for the ongoing conservation program of C. arnoldi and strongly justify the management of this species into at least two independent evolutionary significant units (eastern and western sectors) to guarantee the long-term population viability.	[Valbuena-Urena, Emilio] Univ Autonoma Barcelona, Fac Biociencies, Unitat Zool, Cerdanyola Del Valles, Catalonia, Spain; [Valbuena-Urena, Emilio] Forestal Catalana, Ctr Fauna Salvatge Torreferrussa, Barcelona, Catalonia, Spain; [Amat, Felix] Museu Ciencies Nat Granollers, Area Herpetol, Granollers, Catalonia, Spain; [Carranza, Salvador] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Catalonia, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University	Valbuena-Urena, E (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Unitat Zool, Cerdanyola Del Valles, Catalonia, Spain.	emiliojavier.valbuena@uab.cat	Carranza, Salvador/A-2126-2012	Carranza, Salvador/0000-0002-5378-3008; Valbuena-Urena, Emilio/0000-0002-6771-4038	Forestal Catalana, S.A.; DAAM of the Generalitat de Catalunya; Miloca and Zoo de Barcelona [PRIC-2011]	Forestal Catalana, S.A.; DAAM of the Generalitat de Catalunya; Miloca and Zoo de Barcelona	This work was funded by Forestal Catalana, S.A., and DAAM of the Generalitat de Catalunya. Miloca and Zoo de Barcelona (PRIC-2011) also helped with the funding of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2012, J BIOGEOGR, V39, P970, DOI 10.1111/j.1365-2699.2011.02654.x; Amat F, 2007, CONSERVACIO TRITO MO, P1; Amat F, 2007, P 15 MED C CONTR AUT, P1; Amat F., 2005, 6 TROBADA ESTUDIOSOS, P119; Amat F, 2005, ESTUDI DEMOGRAFIC TR, P85; Amat F, 2004, DISTRIBUCIO TRITO PI, P90; [Anonymous], 1996, J APPL ECOL, DOI DOI 10.2307/2404927; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bardaji T, 2009, GEOMORPHOLOGY, V104, P22, DOI 10.1016/j.geomorph.2008.05.027; Beukema W, 2010, BIOL J LINN SOC, V101, P626, DOI 10.1111/j.1095-8312.2010.01506.x; Beukema W, 2008, ACTA HERPETOL, V3, P77; Bisconti R, 2011, MOL ECOL, V20, P5313, DOI 10.1111/j.1365-294X.2011.05363.x; Bosch J, 2009, IUCN 2012 IUCN RED L; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Carranza S, 2005, ZOOL J LINN SOC-LOND, V145, P555, DOI 10.1111/j.1096-3642.2005.00197.x; Carranza S, 2000, P ROY SOC B-BIOL SCI, V267, P637, DOI 10.1098/rspb.2000.1050; Carranza S, 2009, IUCN 2012 IUCN RED L; Carranza S, 2008, AMPHIBIA-REPTILIA, V29, P579, DOI 10.1163/156853808786230389; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; de Pous P, 2011, AMPHIBIA-REPTILIA, V32, P385, DOI 10.1163/017353711X587732; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Elith J, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P39; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garcia-Porta J, 2012, MOL PHYLOGENET EVOL, V63, P113, DOI 10.1016/j.ympev.2011.12.019; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Lecis R, 2004, BIOL CONSERV, V119, P263, DOI 10.1016/j.biocon.2003.11.011; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Llobet S., 1975, REV GEOGRAFIA, V9, P35; Lowe J.J., 2015, RECONSTRUCTING QUATE, V3rd ed.; Lopez-Garcia JM, 2010, NATURWISSENSCHAFTEN, V97, P753, DOI 10.1007/s00114-010-0695-6; Martinez-Rica J. P., 1980, STUDIA OECOLOGICA, V2, P135; Mattoccia M, 2011, BIOL J LINN SOC, V104, P903, DOI 10.1111/j.1095-8312.2011.01747.x; Mila B, 2010, MOL ECOL, V19, P108, DOI 10.1111/j.1365-294X.2009.04441.x; Montori A., 1991, B ASOC HERPETOL ESPA, V2, P10; Montori A., 1988, ESTUDIO BIOL ECOLOGI; Montori A., 2004, AMPHIBIA LISSAMPHIBI, P43; Montori A, 2008, AMPHIBIA-REPTILIA, V29, P371, DOI 10.1163/156853808785112048; Montori A, 2008, ZOOTAXA, P39, DOI 10.11646/zootaxa.1945.1.2; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Perera A, 2010, MOL PHYLOGENET EVOL, V54, P634, DOI 10.1016/j.ympev.2009.10.020; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Riberon A, 2001, MOL ECOL, V10, P2555, DOI 10.1046/j.1365-294X.2001.01373.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Serra-Cobo J, 2000, BELG J ZOOL, V130, P39; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Shepard DB, 2011, MOL PHYLOGENET EVOL, V59, P399, DOI 10.1016/j.ympev.2011.03.007; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; SPSS Inc, 2009, SPSS WIND REL 17 0; Steinfartz S, 2000, MOL ECOL, V9, P397, DOI 10.1046/j.1365-294x.2000.00870.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TEMPLETON AR, 1992, GENETICS, V132, P619; THIESMEIER B, 1990, Salamandra, V26, P63; Van Liedekerke M., 2006, EUROPEAN SOIL DATABA; Wake DB, 2006, ANN MO BOT GARD, V93, P8, DOI 10.3417/0026-6493(2006)93[8:PWSPAP]2.0.CO;2; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WEITZMAN ML, 1992, Q J ECON, V107, P363, DOI 10.2307/2118476; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wilson JS, 2012, DIVERS DISTRIB, V18, P1139, DOI 10.1111/j.1472-4642.2012.00902.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020	74	17	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e62542	10.1371/journal.pone.0062542	http://dx.doi.org/10.1371/journal.pone.0062542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750201	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900003
J	Del Re, AC; Spielmans, GI; Fluckiger, C; Wampold, BE				Del Re, A. C.; Spielmans, Glen I.; Flueckiger, Christoph; Wampold, Bruce E.			Efficacy of New Generation Antidepressants: Differences Seem Illusory	PLOS ONE			English	Article							REPORTING BIAS; METAANALYSIS; TRIALS; PUBLICATION; HYPOTHESIS	Background: Recently, Cipriani and colleagues examined the relative efficacy of 12 new-generation antidepressants on major depression using network meta-analytic methods. They found that some of these medications outperformed others in patient response to treatment. However, several methodological criticisms have been raised about network meta-analysis and Cipriani's analysis in particular which creates the concern that the stated superiority of some antidepressants relative to others may be unwarranted. Materials and Methods: A Monte Carlo simulation was conducted which involved replicating Cipriani's network meta-analysis under the null hypothesis (i.e., no true differences between antidepressants). The following simulation strategy was implemented: (1) 1000 simulations were generated under the null hypothesis (i.e., under the assumption that there were no differences among the 12 antidepressants), (2) each of the 1000 simulations were network meta-analyzed, and (3) the total number of false positive results from the network meta-analyses were calculated. Findings: Greater than 7 times out of 10, the network meta-analysis resulted in one or more comparisons that indicated the superiority of at least one antidepressant when no such true differences among them existed. Interpretation: Based on our simulation study, the results indicated that under identical conditions to those of the 117 RCTs with 236 treatment arms contained in Cipriani et al.'s meta-analysis, one or more false claims about the relative efficacy of antidepressants will be made over 70% of the time. As others have shown as well, there is little evidence in these trials that any antidepressant is more effective than another. The tendency of network meta-analyses to generate false positive results should be considered when conducting multiple comparison analyses.	[Del Re, A. C.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Del Re, A. C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Spielmans, Glen I.] Metropolitan State Univ, St Paul, MN USA; [Flueckiger, Christoph] Univ Zurich, Zurich, Switzerland; [Wampold, Bruce E.] Univ Wisconsin, Madison, WI USA; [Wampold, Bruce E.] Modum Bad Psychiat Ctr, Res Inst, Vikersund, Norway	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Minnesota State Colleges & Universities; Metropolitan State University; University of Zurich; University of Wisconsin System; University of Wisconsin Madison	Del Re, AC (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA USA.	acdelre@gmail.com	Del Re, A. C./N-2616-2014; Christoph, Flückiger/H-8169-2014	Del Re, A. C./0000-0002-9571-7623; Christoph, Flückiger/0000-0003-3058-5815	Center for Health Care Evaluation at the VA Palo Alto Health Care System; University of Zurich; Metropolitan State University; University of Wisconsin - Madison and Modum Bad Psychiatric Center	Center for Health Care Evaluation at the VA Palo Alto Health Care System; University of Zurich; Metropolitan State University; University of Wisconsin - Madison and Modum Bad Psychiatric Center	Dr. AD is supported by a postdoctoral affiliation with the Center for Health Care Evaluation at the VA Palo Alto Health Care System. Dr. CF is supported by the University of Zurich. Dr. GS is supported by Metropolitan State University. Dr. BW is supported by the University of Wisconsin - Madison and Modum Bad Psychiatric Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Del Re AC, 2013, RCMDRPLUGIN MA GRAPH; Del Re AC, 2012, MAD METAANALYSIS MEA; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Gartlehner G, 2009, LANCET, V373, P1761, DOI 10.1016/S0140-6736(09)60978-8; Howard GS, 2000, PSYCHOL METHODS, V5, P315, DOI 10.1037//1082-989X.5.3.315; Imberger G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028422; Ioannidis JPA, 2009, LANCET, V373, P1759, DOI 10.1016/S0140-6736(09)60974-0; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; ROSNOW RL, 1988, J COUNS PSYCHOL, V35, P203, DOI 10.1037/0022-0167.35.2.203; Svensson S, 2004, PSYCHOTHER PSYCHOSOM, V73, P10, DOI 10.1159/000074435; Trinquart L, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/JOURNAL.PONE.0035219; Trinquart L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-150; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Valkenhoef G, 2013, GEMTC GEMTC NETWORK; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WAMPOLD BE, 1990, J CONSULT CLIN PSYCH, V58, P360, DOI 10.1037/0022-006X.58.3.360; Wampold BE, 2013, QUALITY QUA IN PRESS, DOI DOI 10.1007/S11135-012-9800-6.IN	21	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63509	10.1371/journal.pone.0063509	http://dx.doi.org/10.1371/journal.pone.0063509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755107	gold, Green Published			2022-12-27	WOS:000319872300012
J	Ahler, E; Sullivan, WJ; Cass, A; Braas, D; York, AG; Bensinger, SJ; Graeber, TG; Christofk, HR				Ahler, Ethan; Sullivan, William J.; Cass, Ashley; Braas, Daniel; York, Autumn G.; Bensinger, Steven J.; Graeber, Thomas G.; Christofk, Heather R.			Doxycycline Alters Metabolism and Proliferation of Human Cell Lines	PLOS ONE			English	Article							CANCER-CELLS; GENE-EXPRESSION; IN-VITRO; TETRACYCLINE; ANTIBIOTICS; INHIBITION; CARCINOMA; APOPTOSIS	The tetracycline antibiotics are widely used in biomedical research as mediators of inducible gene expression systems. Despite many known effects of tetracyclines on mammalian cells-including inhibition of the mitochondrial ribosome-there have been few reports on potential off-target effects at concentrations commonly used in inducible systems. Here, we report that in human cell lines, commonly used concentrations of doxycycline change gene expression patterns and concomitantly shift metabolism towards a more glycolytic phenotype, evidenced by increased lactate secretion and reduced oxygen consumption. We also show that these concentrations are sufficient to slow proliferation. These findings suggest that researchers using doxycycline in inducible expression systems should design appropriate controls to account for potential confounding effects of the drug on cellular metabolism.	[Ahler, Ethan; Sullivan, William J.; Braas, Daniel; York, Autumn G.; Bensinger, Steven J.; Graeber, Thomas G.; Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Ahler, Ethan; Sullivan, William J.; Braas, Daniel; York, Autumn G.; Bensinger, Steven J.; Graeber, Thomas G.; Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA; [Cass, Ashley; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Bensinger, Steven J.; Graeber, Thomas G.; Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Christofk, HR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	hchristofk@mednet.ucla.edu		Graeber, Thomas/0000-0001-8574-9181; Christofk, Heather/0000-0002-8662-4425	Damon Runyon Cancer Research Foundation; Searle Scholars Program; National Institutes of Health [DP2 OD008454-01]; Caltech/UCLA Nanosystems Biology Cancer Center [NCI U54 CA151819]; NATIONAL CANCER INSTITUTE [U54CA151819] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008454] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Searle Scholars Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech/UCLA Nanosystems Biology Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H.R. Christofk is a Damon Runyon-Rachleff Innovation Awardee supported (in part) by the Damon Runyon Cancer Research Foundation, the Searle Scholars Program, the National Institutes of Health Director's New Innovator Award (DP2 OD008454-01), and the Caltech/UCLA Nanosystems Biology Cancer Center (NCI U54 CA151819). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Cohen BH, 2012, BBA-GENE REGUL MECH, V1819, P1067, DOI 10.1016/j.bbagrm.2012.02.023; Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05; Duivenvoorden WCM, 1997, INVAS METAST, V17, P312; FIFE RS, 1995, J LAB CLIN MED, V125, P407; Fife RS, 1998, CANCER LETT, V127, P37, DOI 10.1016/S0304-3835(98)00003-2; Fife RS, 1997, J LAB CLIN MED, V130, P530, DOI 10.1016/S0022-2143(97)90130-X; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RIESBECK K, 1990, ANTIMICROB AGENTS CH, V34, P167, DOI 10.1128/AAC.34.1.167; Roberts MC, 2003, CLIN INFECT DIS, V36, P462, DOI 10.1086/367622; Saikali Zeina, 2003, Anticancer Drugs, V14, P773; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Son K, 2009, ANTICANCER RES, V29, P3995; UITTO VJ, 1994, ANN NY ACAD SCI, V732, P140, DOI 10.1111/j.1749-6632.1994.tb24731.x	20	97	98	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64561	10.1371/journal.pone.0064561	http://dx.doi.org/10.1371/journal.pone.0064561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741339	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900052
J	Cao, CC; Zhu, YF; Chen, W; Li, LP; Qi, YC; Wang, XD; Zhao, Y; Wan, X; Chen, X				Cao, Changchun; Zhu, Yifan; Chen, Wen; Li, Liangpeng; Qi, Yongchao; Wang, Xiaodi; Zhao, Ye; Wan, Xin; Chen, Xin			IKK epsilon Knockout Prevents High Fat Diet Induced Arterial Atherosclerosis and NF-kappa B Signaling in Mice	PLOS ONE			English	Article							INFLAMMATION; INHIBITION; PATHWAYS; ACTIVATION; COMPLEX; OBESITY; TBK1; DNA	Aims: Atherosclerosis is a public health concern affecting many worldwide, but its pathogenesis remains unclear. In this study we investigated the role of IKK epsilon during the formation of atherosclerosis and its molecular mechanism in the mouse aortic vessel wall. Methods and Results: C57BL/6 wild-type or IKK epsilon knockout mice bred into the ApoE knockout genetic background were divided into 4 groups: (1) wild-type (WT), (2) ApoE knockout (AK), (3) IKK epsilon knockout (IK), (4) or both ApoE and IKK epsilon knockout (DK). Each group of mice were fed with a high fat diet (HFD) for 12 weeks from 8 weeks of age. Immunohistochemistry and Western blotting analysis demonstrated obvious increases in the expression of IKK epsilon in the AK group compared with the WT group, especially in the intima. Serum lipid levels were significantly higher in the AK and DK groups than in the other two groups. Staining with hematoxylin-eosin and Oil Red, as well as scanning electron microscopy revealed less severe atherosclerotic lesions in the DK group than in the AK group. Immunofluorescence and Western blot analysis demonstrated obvious increases in the expression of NF-kappa B pathway components and downstream factors in the AK group, especially in the intima, while these increases were blocked in the DK group. Conclusion: The knockout of IKK epsilon prevented significant atherosclerosis lesions in the mouse aorta from in both wild-type and ApoE knockout mice fed a HFD, suggesting that IKK epsilon may play a vital role in HFD-induced atherosclerosis and would be an important target for the treatment of atherosclerosis.	[Zhu, Yifan; Chen, Wen; Li, Liangpeng; Qi, Yongchao; Wang, Xiaodi; Chen, Xin] Nanjing Med Univ, Nanjing Hosp 1, Div Thorac & Cardiovasc Surg, Dept Surg, Nanjing, Jiangsu, Peoples R China; [Cao, Changchun; Zhao, Ye; Wan, Xin] Nanjing Med Univ, Nanjing Hosp 1, Div Nephrol, Dept Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Chen, X (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Div Thorac & Cardiovasc Surg, Dept Surg, Nanjing, Jiangsu, Peoples R China.	stevecx@njmu.edu.cn	Zhu, Yifan/GXH-6179-2022		National Natural Science Foundation of China [81070180]; Ministry of Human Resources and Social Security of China [412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Human Resources and Social Security of China	This study was supported by grants from the National Natural Science Foundation of China (81070180), and the Ministry of Human Resources and Social Security of China ([2010] 412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brand K, 1997, EXP PHYSIOL, V82, P297, DOI 10.1113/expphysiol.1997.sp004025; Chen FE, 1999, PROTEIN ENG, V12, P423, DOI 10.1093/protein/12.5.423; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Imai T, 2011, J ATHEROSCLER THROMB, V18, P1090, DOI 10.5551/jat.7567; Janjetovic Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005988; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kutuk O, 2003, TRENDS MOL MED, V9, P549, DOI 10.1016/j.molmed.2003.10.007; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Moser CV, 2011, J IMMUNOL, V187, P2617, DOI 10.4049/jimmunol.1004088; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Niederberger E, 2010, EXPERT REV PROTEOMIC, V7, P189, DOI 10.1586/EPR.10.1; Olefsky JM, 2009, CELL, V138, P834, DOI 10.1016/j.cell.2009.08.018; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Park SH, 2012, ARTERIOSCL THROM VAS, V32, P2869, DOI 10.1161/ATVBAHA.112.254573; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Qin B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2644; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Renner F, 2010, MOL CELL, V37, P503, DOI 10.1016/j.molcel.2010.01.018; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Scheja L, 2011, BIOCHEM BIOPH RES CO, V407, P288, DOI 10.1016/j.bbrc.2011.02.137; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sweeney SE, 2005, J IMMUNOL, V174, P6424, DOI 10.4049/jimmunol.174.10.6424; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; TOBY L, 2009, COLD SPRING HARB PER, V1, P1; URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang NZ, 2005, GENE, V353, P118, DOI 10.1016/j.gene.2005.04.013; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	38	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64930	10.1371/journal.pone.0064930	http://dx.doi.org/10.1371/journal.pone.0064930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741427	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900140
J	Caves, EM; Jennings, SB; HilleRisLambers, J; Tewksbury, JJ; Rogers, HS				Caves, Eleanor M.; Jennings, Summer B.; HilleRisLambers, Janneke; Tewksbury, Joshua J.; Rogers, Haldre S.			Natural Experiment Demonstrates That Bird Loss Leads to Cessation of Dispersal of Native Seeds from Intact to Degraded Forests	PLOS ONE			English	Article							RAIN-FOREST; FRUGIVOROUS BIRDS; ABANDONED PASTURE; SMALL MAMMALS; SUCCESSION; CONSEQUENCES; TREE; REGENERATION; ECOLOGY; RECRUITMENT	In healthy forests, vertebrate frugivores move seeds from intact to degraded forests, aiding in the passive regeneration of degraded forests. Yet vertebrate frugivores are declining around the world, and little is known about the impact of this loss on regeneration of degraded areas. Here, we use a unique natural experiment to assess how complete vertebrate frugivore loss affects native seed rain in degraded forest. All native vertebrate frugivores (which were primarily avian frugivores) have been functionally extirpated from the island of Guam by the invasive brown tree snake (Boiga irregularis), whereas the nearby island of Saipan has a relatively intact vertebrate frugivore community. We captured seed rain along transects extending from intact into degraded forest and compared the species richness, density and condition of the seed rain from native bird-dispersed tree species between the two islands. Considering seeds from native bird-dispersed species, approximately 1.66 seeds landed per 26 days in each square meter of degraded forest on Saipan, whereas zero seeds landed per 26 days per square meter in degraded forest on Guam. Additionally, on Saipan, 69% of native bird-dispersed seeds in intact forest and 77% of seeds in degraded forest lacked fleshy fruit pulp, suggesting ingestion by birds, compared to 0% of all seeds on Guam. Our results show an absence of seed rain in degraded forests on Guam, correlated with the absence of birds, whereas on Saipan, frugivorous birds regularly disperse seeds into degraded forests, providing a mechanism for re-colonization by native plants. These results suggest that loss of frugivores will slow regeneration of degraded forests on Guam.	[Caves, Eleanor M.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Jennings, Summer B.] Butte Community Coll, Dept Biol, Oroville, CA USA; [HilleRisLambers, Janneke; Tewksbury, Joshua J.; Rogers, Haldre S.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Rogers, Haldre S.] Rice Univ, Dept Ecol & Evolut Biol, Houston, TX USA; [Caves, Eleanor M.] Univ Cambridge, Dept Zool, Cambridge, England; [Jennings, Summer B.] So Oregon Univ, Dept Biol, Ashland, OR USA	Claremont Colleges; Pomona College; University of Washington; University of Washington Seattle; Rice University; University of Cambridge; Southern Oregon University	Rogers, HS (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	haldre@rice.edu	Caves, Eleanor/G-9958-2015	Caves, Eleanor/0000-0003-3497-5925; Tewksbury, Joshua/0000-0002-9786-1477; Rogers, Haldre/0000-0003-4763-5006	National Science Foundation Research Experience [DEB-0816465]	National Science Foundation Research Experience(National Science Foundation (NSF))	Funding for this research was provided by the National Science Foundation Research Experience for Undergraduates supplement to DEB-0816465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au AYY, 2006, PLANT ECOL, V186, P13, DOI 10.1007/s11258-006-9108-5; Bellingham PJ, 2010, NEW ZEAL J ECOL, V34, P115; Bianconi GV, 2012, RESTOR ECOL, V20, P211, DOI 10.1111/j.1526-100X.2010.00751.x; BROTHERS TS, 1992, CONSERV BIOL, V6, P91, DOI 10.1046/j.1523-1739.1992.610091.x; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camp RJ, 2009, BIRD CONSERV INT, V19, P323, DOI 10.1017/S0959270909008417; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Chimera CG, 2011, BIOL INVASIONS, V13, P1029, DOI 10.1007/s10530-010-9887-4; Chokkalingam U., 2001, International Forestry Review, V3, P19; Cole RJ, 2010, ECOL APPL, V20, P1255, DOI 10.1890/09-0714.1; CRAIG RJ, 1992, J FIELD ORNITHOL, V63, P436; Craig RJ, 1996, WILSON BULL, V108, P246; Craig Robert J., 1993, Micronesica, V26, P99; Crawley M.J., 2007, R BOOK; Culot L, 2010, INT J PRIMATOL, V31, P553, DOI 10.1007/s10764-010-9413-7; DaSilva JMC, 1996, CONSERV BIOL, V10, P491, DOI 10.1046/j.1523-1739.1996.10020491.x; DEBUSSCHE M, 1994, OIKOS, V69, P414, DOI 10.2307/3545854; del Castillo RF, 2008, J TROP ECOL, V24, P433, DOI 10.1017/S0266467408005142; DIAMOND JM, 1983, NATURE, V304, P586, DOI 10.1038/304586a0; Duncan RS, 1999, ECOL APPL, V9, P998, DOI 10.1890/1051-0761(1999)009[0998:SDAPFS]2.0.CO;2; Farwig N, 2012, BASIC APPL ECOL, V13, P109, DOI 10.1016/j.baae.2012.02.006; Fearnside PM, 2004, ECOL APPL, V14, P982, DOI 10.1890/03-5225; Galetti M, 2001, BIOTROPICA, V33, P723, DOI 10.1111/j.1744-7429.2001.tb00232.x; Gillies CS, 2010, J APPL ECOL, V47, P182, DOI 10.1111/j.1365-2664.2009.01756.x; GORCHOV DL, 1993, VEGETATIO, V108, P339; Griffiths CJ, 2011, CURR BIOL, V21, P762, DOI 10.1016/j.cub.2011.03.042; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; Holbrook KM, 2009, ECOLOGY, V90, P1449, DOI 10.1890/08-1332.1; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Holl KD, 2000, RESTOR ECOL, V8, P339, DOI 10.1046/j.1526-100x.2000.80049.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Ingle NR, 2003, OECOLOGIA, V134, P251, DOI 10.1007/s00442-002-1081-7; ITTO, 2002, ITTO POL DEV SER; Jenkins JH, 1983, ORNITHOLOGICAL MONOG, V31; Jong W. de, 2001, Journal of Tropical Forest Science, V13, P563; Kelly D, 2006, ECOL STUD-ANAL SYNTH, V186, P227; Kelly D, 2004, NEW ZEAL J BOT, V42, P89, DOI 10.1080/0028825X.2004.9512892; Kelly D, 2010, NEW ZEAL J ECOL, V34, P66; Kelm DH, 2008, CONSERV BIOL, V22, P733, DOI 10.1111/j.1523-1739.2008.00925.x; Kitamura S, 2004, J TROP ECOL, V20, P421, DOI 10.1017/S0266467404001555; Lamb D., 2003, REHABILITATION RESTO; Lander MA, 2003, 102 U GUAM GUAM I W; Lander MA, 2004, 103 U GUAM GUAM I W; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; LEVEY DJ, 1987, AM NAT, V129, P471, DOI 10.1086/284652; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Liu Z, 2006, GUAM VEGETATION MAPP; Liu Z., 2006, COMMONWEALTH NO MARI; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; MALMBORG PK, 1988, CONDOR, V90, P173, DOI 10.2307/1368446; MCCLANAHAN TR, 1993, CONSERV BIOL, V7, P279, DOI 10.1046/j.1523-1739.1993.07020279.x; Meyer JY, 2009, BIOL INVASIONS, V11, P1569, DOI 10.1007/s10530-008-9407-y; Mortensen HS, 2008, BIOL CONSERV, V141, P2146, DOI 10.1016/j.biocon.2008.06.014; Nascimento HEM, 2004, ECOL APPL, V14, pS127; Neilan W, 2006, BIOL CONSERV, V129, P393, DOI 10.1016/j.biocon.2005.11.007; Nepstad DC, 1996, OIKOS, V76, P25, DOI 10.2307/3545745; Nunez-Iturri G, 2008, BIOL CONSERV, V141, P1536, DOI 10.1016/j.biocon.2008.03.020; Nunez-Iturri G, 2007, BIOTROPICA, V39, P348, DOI 10.1111/j.1744-7429.2007.00276.x; Oliveira ACM, 2000, J TROP ECOL, V16, P709, DOI 10.1017/S0266467400001668; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4; Pejchar L, 2008, BIOL CONSERV, V141, P536, DOI 10.1016/j.biocon.2007.11.008; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; R Core Team, 2016, R FDN STAT COMP; Robertson AW, 2006, FUNCTIONAL ECOLOGY, V20; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Rodriguez-Perez J, 2010, PLANT ECOL, V207, P269, DOI 10.1007/s11258-009-9671-7; Sagarin R, 2010, FRONT ECOL ENVIRON, V8, P379, DOI 10.1890/090001; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sharam GJ, 2009, SCIENCE, V325, P51, DOI 10.1126/science.1173805; Shiels AB, 2011, BIOL INVASIONS, V13, P883, DOI 10.1007/s10530-010-9876-7; Teegalapalli K, 2010, J TROP ECOL, V26, P25, DOI 10.1017/S0266467409990344; Traveset A., 2007, Seed dispersal: theory and its application in a changing world, P78, DOI 10.1079/9781845931650.0078; Traveset A, 2001, PLANT ECOL, V155, P29, DOI 10.1023/A:1013282313035; Traveset A, 2012, P ROY SOC B-BIOL SCI, V279, P3298, DOI 10.1098/rspb.2012.0535; Traveset Anna, 2002, P339, DOI 10.1079/9780851995250.0339; UHL C, 1987, J ECOL, V75, P377, DOI 10.2307/2260425; US Fish and Wildlife Service, 2009, REC PLAN MA IN PRESS; VAZQUEZYANES C, 1993, ANNU REV ECOL SYST, V24, P69, DOI 10.1146/annurev.es.24.110193.000441; VIEIRA ICG, 1994, VEGETATIO, V115, P91; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Wiewel AS, 2009, PAC SCI, V63, P205, DOI 10.2984/049.063.0204; Wiles GJ, 2003, CONSERV BIOL, V17, P1350, DOI 10.1046/j.1523-1739.2003.01526.x; Williams PA, 2000, AUSTRAL ECOL, V25, P523, DOI 10.1046/j.1442-9993.2000.01078.x; Wotton DM, 2011, P ROY SOC B-BIOL SCI, V278, P3345, DOI 10.1098/rspb.2011.0185; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9	96	53	54	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65618	10.1371/journal.pone.0065618	http://dx.doi.org/10.1371/journal.pone.0065618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741503	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900216
J	Clark, NE; Boakes, EH; McGowan, PJK; Mace, GM; Fuller, RA				Clark, Natalie E.; Boakes, Elizabeth H.; McGowan, Philip J. K.; Mace, Georgina M.; Fuller, Richard A.			Protected Areas in South Asia Have Not Prevented Habitat Loss: A Study Using Historical Models of Land-Use Change	PLOS ONE			English	Article							ANDHARI TIGER RESERVE; GLOBAL BIODIVERSITY; FOREST LOSS; VEGETATION; DEFORESTATION; CONSERVATION; COVER; LOCATION; PARKS; IMPACTS	Habitat loss imperils species both locally and globally, so protection of intact habitat is critical for slowing the rate of biodiversity decline. Globally, more than 150,000 protected areas have been designated with a goal of protecting species and ecosystems, but whether they can continue to achieve this goal as human impacts escalate is unknown. Here we show that in South Asia, one of the world's major growth epicentres, the trajectory of habitat conversion rates inside protected areas is indistinguishable from that on unprotected lands, and habitat conversion rates do not decline following gazettement of a protected area. Moreover, a quarter of the land inside South Asia's protected areas is now classified as human modified. If the global community is to make significant progress towards the Convention on Biological Diversity's Aichi Target on protected areas, there is an urgent need both to substantially enhance management of these protected areas and to develop systematic conservation outside the formal protected area system.	[Clark, Natalie E.] Univ Reading, Sch Agr Policy & Dev, Ctr Agrienvironm Res, Reading, Berks, England; [Clark, Natalie E.; Boakes, Elizabeth H.; Mace, Georgina M.] Imperial Coll London, Ctr Populat Biol, Ascot, Berks, England; [Boakes, Elizabeth H.; Mace, Georgina M.] UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, London, England; [McGowan, Philip J. K.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fuller, Richard A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	University of Reading; Imperial College London; University of London; University College London; Newcastle University - UK; University of Queensland	Clark, NE (corresponding author), Univ Reading, Sch Agr Policy & Dev, Ctr Agrienvironm Res, Reading, Berks, England.	n.e.clark@pgr.reading.ac.uk	Fuller, Richard/B-7971-2008; Mace, Georgina M/I-3072-2016	Fuller, Richard/0000-0001-9468-9678; Mace, Georgina M/0000-0001-8965-5211	Leverhulme Trust [F/07058/AK]; NERC Centre for Population Biology, Imperial College London; World Pheasant Association; Australian Government's National Environmental Research Program; Australian Research Council	Leverhulme Trust(Leverhulme Trust); NERC Centre for Population Biology, Imperial College London; World Pheasant Association; Australian Government's National Environmental Research Program(Australian Government); Australian Research Council(Australian Research Council)	This work was funded by grant number F/07058/AK from the Leverhulme Trust to G.M.M. and P.J.K.M. Funding support was also received from the NERC Centre for Population Biology, Imperial College London, and the World Pheasant Association. R.A.F. is additionally funded through the Australian Government's National Environmental Research Program and a Future Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino O, 2007, INT GEOSCI REMOTE SE, P2412, DOI 10.1109/IGARSS.2007.4423328; Barr LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024707; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bertzky B., 2012, PROTECTED PLANET REP; Boitani L, 2008, PLOS BIOL, V6, P436, DOI 10.1371/journal.pbio.0060066; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cropper M, 2001, LAND ECON, V77, P172, DOI 10.2307/3147088; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Frondel M, 2005, ECOL ECON, V55, P515, DOI 10.1016/j.ecolecon.2004.12.013; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Jackson SF, 2008, GLOBAL CHANGE BIOL, V14, P2132, DOI 10.1111/j.1365-2486.2008.01628.x; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kanagaraj R, 2011, ECOGRAPHY, V34, P970, DOI 10.1111/j.1600-0587.2010.06482.x; Karanth KK, 2012, ENVIRON MANAGE, V49, P372, DOI 10.1007/s00267-011-9778-1; Kumar R, 2005, ENVIRON CONSERV, V32, P248, DOI 10.1017/S0376892905002316; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Loarie SR, 2007, TRENDS ECOL EVOL, V22, P630, DOI 10.1016/j.tree.2007.08.018; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; MATTHEWS E, 1983, J CLIM APPL METEOROL, V22, P474, DOI 10.1175/1520-0450(1983)022<0474:GVALUN>2.0.CO;2; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING HL; Mondal P, 2011, ENVIRON MANAGE, V48, P781, DOI 10.1007/s00267-011-9720-6; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Nagendra H, 2004, ENVIRON MANAGE, V34, P748, DOI 10.1007/s00267-004-0028-7; Nagendra H, 2006, APPL GEOGR, V26, P96, DOI 10.1016/j.apgeog.2005.11.002; Nagendra H, 2010, BIOL CONSERV, V143, P2900, DOI 10.1016/j.biocon.2010.04.050; Nath PC, 2005, BIODIVERS CONSERV, V14, P2109, DOI 10.1007/s10531-004-4361-1; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Pelkey NW, 2000, BIOL CONSERV, V94, P297, DOI 10.1016/S0006-3207(99)00195-0; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Persha L, 2010, BIOL CONSERV, V143, P2918, DOI 10.1016/j.biocon.2010.03.003; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Rayn D, 2011, BIODIVERS CONSERV, V20, P1625, DOI 10.1007/s10531-011-0051-y; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sagar R, 2004, ENVIRON CONSERV, V31, P55, DOI 10.1017/S0376892904001031; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Secretariat of the CBD, 2010, C PART 10 DEC X 2 X; Singh S., 1985, P1; Strassburg BBN, 2012, NAT CLIM CHANGE, V2, P350, DOI [10.1038/NCLIMATE1375, 10.1038/nclimate1375]; Thackway Richard, 2006, Ecological Management & Restoration, V7, pS53, DOI 10.1111/j.1442-8903.2006.00292.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; United Nations, 2009, WORLD POP PROSP 2008; United Nations Environment Programme and Development Alternatives, 2008, S AS ENV OUTL 2009; Vie J-C, 2009, WILDLIFE CHANGING WO; WDPA, 2020, WORLD DAT PROT AR	62	61	64	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65298	10.1371/journal.pone.0065298	http://dx.doi.org/10.1371/journal.pone.0065298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741486	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900199
J	Glass, K; Huttenhower, C; Quackenbush, J; Yuan, GC				Glass, Kimberly; Huttenhower, Curtis; Quackenbush, John; Yuan, Guo-Cheng			Passing Messages between Biological Networks to Refine Predicted Interactions	PLOS ONE			English	Article							GENE-EXPRESSION DATA; TRANSCRIPTIONAL NETWORKS; GENOMIC DATA; CHIP-CHIP; INFERENCE; INTEGRATION; DISCOVERY; MODULES; PHASE; RECONSTRUCTION	Regulatory network reconstruction is a fundamental problem in computational biology. There are significant limitations to such reconstruction using individual datasets, and increasingly people attempt to construct networks using multiple, independent datasets obtained from complementary sources, but methods for this integration are lacking. We developed PANDA (Passing Attributes between Networks for Data Assimilation), a message-passing model using multiple sources of information to predict regulatory relationships, and used it to integrate protein-protein interaction, gene expression, and sequence motif data to reconstruct genome-wide, condition-specific regulatory networks in yeast as a model. The resulting networks were not only more accurate than those produced using individual data sets and other existing methods, but they also captured information regarding specific biological mechanisms and pathways that were missed using other methodologies. PANDA is scalable to higher eukaryotes, applicable to specific tissue or cell type data and conceptually generalizable to include a variety of regulatory, interaction, expression, and other genome-scale data. An implementation of the PANDA algorithm is available at www.sourceforge.net/projects/panda-net.	[Glass, Kimberly; Quackenbush, John; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Glass, Kimberly; Huttenhower, Curtis; Quackenbush, John; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Yuan, GC (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	gcyuan@jimmy.harvard.edu		Huttenhower, Curtis/0000-0002-1110-0096; Quackenbush, John/0000-0002-2702-5879; Glass, Kimberly/0000-0003-4394-5779	National Heart, Lung and Blood Institute [1P01HL105339, R01HL111759]; National Science Foundation [NSF DBI-1053486]; Claudia Adams Barr Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111759, P01HL105339] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); Claudia Adams Barr Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by the grants 1P01HL105339 and R01HL111759 from the National Heart, Lung and Blood Institute as well as NSF DBI-1053486 from the National Science Foundation. This research was supported by a Claudia Adams Barr Award to GY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Altay G, 2010, BIOINFORMATICS, V26, P1738, DOI 10.1093/bioinformatics/btq259; Bailly-Bechet M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-355; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Bauer T, 2011, BIOINFORMATICS, V27, P2239, DOI 10.1093/bioinformatics/btr366; Beyer A, 2006, PLOS COMPUT BIOL, V2, P615, DOI 10.1371/journal.pcbi.0020070; Bonnet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010162; Braunstein A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030201; Butte A J, 2000, Pac Symp Biocomput, P418; Cao JG, 2012, METHODS MOL BIOL, V802, P185, DOI 10.1007/978-1-61779-400-1_12; Chang LW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r38; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Ernst J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000044; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Guthke R, 2005, BIOINFORMATICS, V21, P1626, DOI 10.1093/bioinformatics/bti226; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartemink AJ, 2005, NAT BIOTECHNOL, V23, P554, DOI 10.1038/nbt0505-554; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Hasegawa Y, 2008, RNA, V14, P2333, DOI 10.1261/rna.1016508; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kato T, 2005, BIOINFORMATICS, V21, P2488, DOI 10.1093/bioinformatics/bti339; KOCH C, 1994, CURR OPIN CELL BIOL, V6, P451, DOI 10.1016/0955-0674(94)90039-6; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Lemmens K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r37; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; MARBACH D, 2012, NAT METHODS; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; Ness F, 2001, EUR J BIOCHEM, V268, P1585, DOI 10.1046/j.1432-1033.2001.02029.x; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shaw OJ, 2004, BIOINFORMATICS, V20, P3638, DOI 10.1093/bioinformatics/bth395; Siegmund RF, 1996, MOL CELL BIOL, V16, P2647; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tuncbag Nurcan, 2012, Research in Computational Molecular Biology. Proceedings 16th Annual International Conference, RECOMB 2012, P287, DOI 10.1007/978-3-642-29627-7_31; Vu TT, 2009, GENOMICS, V93, P426, DOI 10.1016/j.ygeno.2009.01.006; Wilczynski B, 2009, BIOINFORMATICS, V25, P286, DOI 10.1093/bioinformatics/btn505; Yeang CH, 2004, J COMPUT BIOL, V11, P243, DOI 10.1089/1066527041410382; Youn A, 2010, BIOINFORMATICS, V26, P1879, DOI 10.1093/bioinformatics/btq289; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	58	90	91	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64832	10.1371/journal.pone.0064832	http://dx.doi.org/10.1371/journal.pone.0064832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741402	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900115
J	Itsumura, N; Inamo, Y; Okazaki, F; Teranishi, F; Narita, H; Kambe, T; Kodama, H				Itsumura, Naoya; Inamo, Yasuji; Okazaki, Fumiko; Teranishi, Fumie; Narita, Hiroshi; Kambe, Taiho; Kodama, Hiroko			Compound Heterozygous Mutations in SLC30A2/ZnT2 Results in Low Milk Zinc Concentrations: A Novel Mechanism for Zinc Deficiency in a Breast-Fed Infant	PLOS ONE			English	Article							TRANSPORT COMPLEXES; ALKALINE-PHOSPHATASES; CONFERS RESISTANCE; PREMATURE-INFANTS; MAMMALIAN ZINC; GENOME-WIDE; ACRODERMATITIS; EXPRESSION; PATHWAY; GENE	Zinc concentrations in breast milk are considerably higher than those of the maternal serum, to meet the infant's requirements for normal growth and development. Thus, effective mechanisms ensuring secretion of large amounts of zinc into the milk operate in mammary epithelial cells during lactation. ZnT2 was recently found to play an essential role in the secretion of zinc into milk. Heterozygous mutations of human ZnT2 (hZnT2), including H54R and G87R, in mothers result in low (>75% reduction) secretion of zinc into the breast milk, and infants fed on the milk develop transient neonatal zinc deficiency. We identified two novel missense mutations in the SLC30A2/ZnT2 gene in a Japanese mother with low milk zinc concentrations (>90% reduction) whose infant developed severe zinc deficiency; a T to C transition (c.454T>C) at exon 4, which substitutes a tryptophan residue with an arginine residue (W152R), and a C to T transition (c.887C>T) at exon 7, which substitutes a serine residue with a leucine residue (S296L). Biochemical characterization using zinc-sensitive DT40 cells indicated that the W152R mutation abolished the abilities to transport zinc and to form a dimer complex, indicating a loss-of-function mutation. The S296L mutation retained both abilities but was extremely destabilized. The two mutations were found on different alleles, indicating that the genotype of the mother with low milk zinc was compound heterozygous. These results show novel compound heterozygous mutations in the SLC30A2/ZnT2 gene causing zinc deficiency in a breast-fed infant.	[Itsumura, Naoya; Teranishi, Fumie; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan; [Inamo, Yasuji] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Okazaki, Fumiko; Narita, Hiroshi] Kyoto Womens Univ, Dept Food Sci, Kyoto, Japan; [Kodama, Hiroko] Teikyo Univ, Sch Med, Dept Pediat, Tokyo 173, Japan; [Kodama, Hiroko] Teikyo Heisei Univ, Fac Hlth & Med Sci, Dept Hlth & Dietet, Tokyo, Japan	Kyoto University; Nihon University; Kyoto Womens University; Teikyo University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan.	kambe1@kais.kyoto-u.ac.jp		Kambe, Taiho/0000-0001-9757-063X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Suzuken Memorial Foundation (to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland ML, 2006, GENES NUTR, V1, P41, DOI 10.1007/BF02829935; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; AGGETT PJ, 1980, ARCH DIS CHILD, V55, P547, DOI 10.1136/adc.55.7.547; Andrews GK, 2008, BIOCHEM SOC T, V36, P1242, DOI 10.1042/BST0361242; Barbarot S, 2010, PEDIATR DERMATOL, V27, P380, DOI 10.1111/j.1525-1470.2010.01174.x; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Dorea JG, 2002, J AM COLL NUTR, V21, P84, DOI 10.1080/07315724.2002.10719198; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Guo L, 2010, P NATL ACAD SCI USA, V107, P2818, DOI 10.1073/pnas.0914941107; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kambe Taiho, 2006, Genomics Proteomics & Bioinformatics, V4, P1, DOI 10.1016/S1672-0229(06)60010-7; Kambe T, 2012, CURR TOP MEMBR, V69, P199, DOI 10.1016/B978-0-12-394390-3.00008-2; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; Kelleher SL, 2009, GENES NUTR, V4, P83, DOI 10.1007/s12263-009-0119-4; Kiechl-Kohlendorfer U, 2007, PEDIATR DERMATOL, V24, P536, DOI 10.1111/j.1525-1470.2007.00512.x; Kienast A, 2007, EUR J PEDIATR, V166, P189, DOI 10.1007/s00431-006-0218-9; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KREBS NF, 1995, AM J CLIN NUTR, V61, P1030, DOI 10.1093/ajcn/61.5.1030; KRIEGER I, 1986, AM J CLIN NUTR, V43, P955, DOI 10.1093/ajcn/43.6.955; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lin HL, 2009, BIOCHEM J, V422, P273, DOI 10.1042/BJ20090853; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Lonnerdal B, 2007, ANNU REV NUTR, V27, P165, DOI 10.1146/annurev.nutr.27.061406.093809; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; McCormick N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011078; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; Michalczyk A, 2003, HUM GENET, V113, P202, DOI 10.1007/s00439-003-0952-2; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; Murthy Sambasiviah C, 2010, Dermatol Online J, V16, P3; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Park CH, 2010, J KOREAN MED SCI, V25, P1818, DOI 10.3346/jkms.2010.25.12.1818; PRASAD AS, 1995, NUTRITION, V11, P93; Qian LX, 2012, EARLY HUM DEV, V88, P663, DOI 10.1016/j.earlhumdev.2012.01.011; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; ROBERTS LJ, 1987, J AM ACAD DERMATOL, V16, P301, DOI 10.1016/S0190-9622(87)70039-5; Rovelet-Lecrux A, 2012, EUR J HUM GENET, V20, P613, DOI 10.1038/ejhg.2011.225; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471; ZIMMERMAN AW, 1982, PEDIATRICS, V69, P176	68	68	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64045	10.1371/journal.pone.0064045	http://dx.doi.org/10.1371/journal.pone.0064045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741301	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900013
J	Khamviwath, V; Hu, JF; Othmer, HG				Khamviwath, Varunyu; Hu, Jifeng; Othmer, Hans G.			A Continuum Model of Actin Waves in Dictyostelium discoideum	PLOS ONE			English	Article							TRAVELING-WAVES; ARP2/3 COMPLEX; MYOSIN-II; FILAMENT; DYNAMICS; NETWORK; PTEN; CORONIN; CELLS; WASP	Actin waves are complex dynamical patterns of the dendritic network of filamentous actin in eukaryotes. We developed a model of actin waves in PTEN-deficient Dictyostelium discoideum by deriving an approximation of the dynamics of discrete actin filaments and combining it with a signaling pathway that controls filament branching. This signaling pathway, together with the actin network, contains a positive feedback loop that drives the actin waves. Our model predicts the structure, composition, and dynamics of waves that are consistent with existing experimental evidence, as well as the biochemical dependence on various protein partners. Simulation suggests that actin waves are initiated when local actin network activity, caused by an independent process, exceeds a certain threshold. Moreover, diffusion of proteins that form a positive feedback loop with the actin network alone is sufficient for propagation of actin waves at the observed speed of similar to 6 mu m/min. Decay of the wave back can be caused by scarcity of network components, and the shape of actin waves is highly dependent on the filament disassembly rate. The model allows retraction of actin waves and captures formation of new wave fronts in broken waves. Our results demonstrate that a delicate balance between a positive feedback, filament disassembly, and local availability of network components is essential for the complex dynamics of actin waves.	[Khamviwath, Varunyu; Hu, Jifeng; Othmer, Hans G.] Univ Minnesota, Sch Math, Minneapolis, MN 55455 USA; [Othmer, Hans G.] Univ Minnesota, Digital Technol Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Othmer, HG (corresponding author), Univ Minnesota, Sch Math, Minneapolis, MN 55455 USA.	othmer@math.umn.edu			National Science Foundation [DMS-0517884, DMS-0817529, DMS-0956609]; National Institutes of Health [GM 29123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029123] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research is supported in part by Grants # DMS-0517884, DMS-0817529, and DMS-0956609 from the National Science Foundation (www.nsf.gov) and by Grant # GM 29123 from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Asano Y, 2008, CELL MOTIL CYTOSKEL, V65, P923, DOI 10.1002/cm.20314; Billadeau DD, 2008, NAT IMMUNOL, V9, P716, DOI 10.1038/ni0708-716; Bosgraaf L, 2006, EUR J CELL BIOL, V85, P969, DOI 10.1016/j.ejcb.2006.04.004; Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlsson AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228102; Case LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026631; Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701; Dai JW, 1999, BIOPHYS J, V77, P1168, DOI 10.1016/S0006-3495(99)76968-7; Dawes AT, 2006, J THEOR BIOL, V242, P265, DOI 10.1016/j.jtbi.2006.02.017; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; Diez S, 2005, P NATL ACAD SCI USA, V102, P7601, DOI 10.1073/pnas.0408546102; Doubrovinski K, 2010, EUR PHYS J E, V31, P95, DOI 10.1140/epje/i2010-10548-8; Doubrovinski K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228104; Doubrovinski K, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/18003; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gerisch G, 2012, BIOPHYS J, V103, P1170, DOI [10.1016/j.bpj.2012.08.004, 10.1016/j.bpj.2012.05.00.4]; Gerisch G, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-42; Gerisch G, 2009, CELL ADHES MIGR, V3, P373, DOI 10.4161/cam.3.4.9708; Gerisch Gunther, 2010, PMC Biophys, V3, P7, DOI 10.1186/1757-5036-3-7; Goehring NW, 2013, TRENDS CELL BIOL, V23, P72, DOI 10.1016/j.tcb.2012.10.009; Hecht I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158301; Hu JF, 2007, J STAT PHYS, V128, P111, DOI 10.1007/s10955-006-9204-x; Ideses Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003297; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569; KHAMVIWATH V, 2012, THESIS U MINNESOTA; KHAMVIWATH V, 2013, SIGNAL TRANSDU UNPUB; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Millius A, 2012, J CELL SCI, V125, P1165, DOI 10.1242/jcs.091157; Myers SA, 2005, MOL BIOL CELL, V16, P2191, DOI 10.1091/mbc.E04-09-0844; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pramanik MK, 2009, GENES CELLS, V14, P821, DOI 10.1111/j.1365-2443.2009.01312.x; Sackmann E, 2010, ANNU REV CONDEN MA P, V1, P257, DOI 10.1146/annurev-conmatphys-070909-104105; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Schroth-Diez B, 2009, HFSP J, V3, P412, DOI 10.2976/1.3239407; Stuhrmann B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014471; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Ura S, 2012, CURR BIOL, V22, P553, DOI 10.1016/j.cub.2012.02.020; Veltman DM, 2012, J CELL BIOL, V198, P501, DOI 10.1083/jcb.201205058; Vicker MG, 2002, EXP CELL RES, V275, P54, DOI 10.1006/excr.2001.5466; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Whitelam S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198103; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107	59	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64272	10.1371/journal.pone.0064272	http://dx.doi.org/10.1371/journal.pone.0064272			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741312	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900024
J	van de Waterbeemd, B; Zomer, G; Kaaijk, P; Ruiterkamp, N; Wijffels, RH; van den Dobbelsteen, GPJM; van der Pol, LA				van de Waterbeemd, Bas; Zomer, Gijsbert; Kaaijk, Patricia; Ruiterkamp, Nicole; Wijffels, Rene H.; van den Dobbelsteen, Germie P. J. M.; van der Pol, Leo A.			Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis	PLOS ONE			English	Article							B MENINGOCOCCAL VACCINE; ACELLULAR VACCINE; ADVERSE EVENTS; IMMUNOGENICITY; PROTEIN; STRAINS; SAFETY; PERTUSSIS; RESPONSES; DISEASE	An improved detergent-free process has been developed to produce vaccine based on native outer membrane vesicles (NOMV) against Neisseria meningitidis serogroup B. Performance was evaluated with the NonaMen vaccine concept, which provides broad coverage based on nine distinct PorA antigens. Scalable aseptic equipment was implemented, replacing undesirable steps like ultracentrifugation, inactivation with phenol, and the use of preservatives. The resulting process is more consistent and gives a higher yield than published reference processes, enabling NOMV production at commercial scale. Product quality met preliminary specifications for 9 consecutive batches, and an ongoing study confirmed real-time stability up to 12 months after production. As the NOMV had low endotoxic activity and induced high bactericidal titres in mice, they are expected to be safe and effective in humans. The production process is not limited to NonaMen and may be applicable for other N. meningitidis serogroups and other gram-negative pathogens. The current results therefore facilitate the late-stage development and clinical evaluation of NOMV vaccines.	[van de Waterbeemd, Bas; Zomer, Gijsbert; Kaaijk, Patricia; van den Dobbelsteen, Germie P. J. M.; van der Pol, Leo A.] Natl Inst Publ Hlth & Environm RIVM Vaccinol, Bilthoven, Netherlands; [Ruiterkamp, Nicole] Bilthoven Biol, Qual Control, Bilthoven, Netherlands; [Wijffels, Rene H.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	van de Waterbeemd, B (corresponding author), Natl Inst Publ Hlth & Environm RIVM Vaccinol, Bilthoven, Netherlands.	bas.van.de.waterbeemd@intravacc.nl		Wijffels, Rene/0000-0001-7630-4295; Kaaijk, Patricia/0000-0001-9165-1703	Ministry of Health, Welfare and Sport (The Netherlands)	Ministry of Health, Welfare and Sport (The Netherlands)	This work was funded by the Ministry of Health, Welfare and Sport (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigita C, 2004, VACCINE, V22, P629, DOI 10.1016/j.vaccine.2003.08.027; Baart GJE, 2008, BIOTECHNOL BIOENG, V101, P1022, DOI 10.1002/bit.22016; Baart GJE, 2007, VACCINE, V25, P6399, DOI 10.1016/j.vaccine.2007.06.008; Bai XL, 2011, EXPERT OPIN BIOL TH, V11, P969, DOI 10.1517/14712598.2011.585965; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Cartwright K, 1999, VACCINE, V17, P2612, DOI 10.1016/S0264-410X(99)00044-4; Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107; Claassen I, 1996, VACCINE, V14, P1001, DOI 10.1016/0264-410X(96)00020-5; Collins BS, 2011, DISCOV MED, V11, P7; de Kleijn E, 2001, VACCINE, V20, P352, DOI 10.1016/S0264-410X(01)00371-1; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; Fisseha M, 2005, INFECT IMMUN, V73, P4070, DOI 10.1128/IAI.73.7.4070-4080.2005; Frasch CE, 2001, METH MOLEC MED, V66, P81, DOI 10.1385/1-59259-148-5:81; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; FREDRIKSEN JH, 1991, NIPH ANN, V14, P79; Gerhardt P., 1994, METHODS GEN MOL BACT; Geurtsen J, 2006, INFECT IMMUN, V74, P5574, DOI 10.1128/IAI.00834-06; Girard MP, 2006, VACCINE, V24, P4692, DOI 10.1016/j.vaccine.2006.03.034; Gorringe A, 2006, W02006/008504 A1, Patent No. 2006008504; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; HOLTEN E, 1979, J CLIN MICROBIOL, V9, P186; Hou VC, 2005, J INFECT DIS, V192, P580, DOI 10.1086/432102; HOWSON CP, 1992, JAMA-J AM MED ASSOC, V267, P392, DOI 10.1001/jama.267.3.392; JANTZEN E, 1974, ACTA PATH MICRO IM B, VB 82, P767; Kaaijk P, 2013, VACCINE, V31, P1065, DOI 10.1016/j.vaccine.2012.12.031; Keiser PB, 2010, VACCINE; KEMPKEN R, 1995, J IND MICROBIOL, V14, P52, DOI 10.1007/BF01570067; Kesty NC, 2004, J BIOL CHEM, V279, P2069, DOI 10.1074/jbc.M307628200; KIM SH, 2009, BIOCH BIOPHYS ACTA; Koeberling O, 2008, CLIN VACCINE IMMUNOL; Koeberling O, 2011, VACCINE, V29, P4728, DOI 10.1016/j.vaccine.2011.04.095; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Luijkx T, 2006, VACCINE, V24, P1569, DOI 10.1016/j.vaccine.2005.10.003; Luijkx TA, 2003, INFECT IMMUN, V71, P6367, DOI 10.1128/IAI.71.11.6367-6371.2003; Martin DR, 2006, CLIN VACCINE IMMUNOL, V13, P486, DOI 10.1128/CVI.13.4.486-491.2006; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; Nieves W, 2011, VACCINE, V29, P8381, DOI 10.1016/j.vaccine.2011.08.058; Pajon R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001302; Pierson T, 2011, J PROTEOME RES, V10, P954, DOI 10.1021/pr1009756; PINTO VB, 2011, VACCINE; Roberts R, 2008, VACCINE, V26, P4639, DOI 10.1016/j.vaccine.2008.07.004; Rots NY., 2008, 16 INT PATH NEISS C; Roy K, 2011, CLIN VACCINE IMMUNOL, V18, P1803, DOI 10.1128/CVI.05217-11; Roy N, 2010, FEMS IMMUNOL MED MIC, V60, P18, DOI 10.1111/j.1574-695X.2010.00692.x; SAUKKONEN K, 1989, VACCINE, V7, P325, DOI 10.1016/0264-410X(89)90194-1; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; SNAPE MD, 2010, PEDIAT INFECT DIS J; Thornton V, 2006, VACCINE, V24, P1395, DOI 10.1016/j.vaccine.2005.09.043; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P101, DOI 10.1111/j.1574-6976.2006.00053.x; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; van de Waterbeemd B, 2012, VACCINE, V30, P3683, DOI 10.1016/j.vaccine.2012.03.028; van de Waterbeemd B, 2010, VACCINE, V28, P4810, DOI 10.1016/j.vaccine.2010.04.082; van den Dobbelsteen GPJM, 2007, VACCINE, V25, P2491, DOI 10.1016/j.vaccine.2006.09.025; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; van der Ley P, 2011, HUM VACCINES, V7, P886, DOI 10.4161/hv.7.8.16086; van der Maas N A T, 2007, Ned Tijdschr Geneeskd, V151, P2732; VANDERLEY P, 1995, VACCINE, V13, P401, DOI 10.1016/0264-410X(95)98264-B; VANHEMERT P, 1980, A VAN LEEUW J MICROB, V46, P501, DOI 10.1007/BF00395832; WELCH DF, 1991, CLIN MICROBIOL REV, V4, P422, DOI 10.1128/CMR.4.4.422-438.1991; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Zollinger WD, 2010, VACCINE; ZOLLINGER WD, 2003, Patent No. 6558677; Zollinger WD, 2011, EXPERT REV VACCINES, V10, P559, DOI [10.1586/erv.11.41, 10.1586/ERV.11.41]	68	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65157	10.1371/journal.pone.0065157	http://dx.doi.org/10.1371/journal.pone.0065157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741478	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900191
J	Jia, P; Teng, J; Zou, JZ; Fang, Y; Jiang, SH; Yu, XF; Kriegel, AJ; Liang, MY; Ding, XQ				Jia, Ping; Teng, Jie; Zou, Jianzhou; Fang, Yi; Jiang, Suhua; Yu, Xiaofang; Kriegel, Alison J.; Liang, Mingyu; Ding, Xiaoqiang			Intermittent Exposure to Xenon Protects against Gentamicin-Induced Nephrotoxicity	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; ELECTIVE SURGERY; RENAL-FAILURE; RAT KIDNEYS; EXPRESSION; INJURY; CELLS; AMINOGLYCOSIDES	Aminoglycoside antibiotics, especially gentamicin, are widely used to treat Gram-negative infections due to their efficacy and low cost. Nevertheless the use of gentamicin is limited by its major side effect, nephrotoxicity. Xenon (Xe) provided substantial organoprotective effects in acute injury of the brain and the heart and protected against renal ischemic-reperfusion injury. In this study, we investigated whether xenon could protect against gentamicin-induced nephrotoxicity. Male Wistar rats were intermittently exposed to either 70% xenon or 70% nitrogen (N-2) balanced with 30% oxygen before and during gentamicin administration at a dose of 100 mg/kg for 7 days to model gentamicin-induced kidney injury. We observed that intermittent exposure to Xe provided morphological and functional renoprotection, which was characterized by attenuation of renal tubular damage, apoptosis, and oxidative stress, but not a reduction in inflammation. We also found that Xe pretreatment upregulated hypoxia-inducible factor 2 alpha (HIF-2 alpha) and its downstream effector vascular endothelial growth factor, but not HIF-1 alpha. With regard to the three HIF prolyl hydroxylases, Xe pretreatment upregulated prolyl hydroxylase domain-containing protein-2 (PHD2), suppressed PHD1, and had no influence on PHD3 in the rat kidneys. Pretreatment with Xe also increased the expression of miR-21, a microRNA known to have anti-apoptotic effects. These results support Xe renoprotection against gentamicin-induced nephrotoxicity.	[Jia, Ping; Teng, Jie; Zou, Jianzhou; Fang, Yi; Jiang, Suhua; Yu, Xiaofang; Ding, Xiaoqiang] Fudan Univ, Div Nephrol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Kriegel, Alison J.; Liang, Mingyu] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Fudan University; Medical College of Wisconsin	Ding, XQ (corresponding author), Fudan Univ, Div Nephrol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	ding.xiaoqiang@zs-hospital.sh.cn	Liang, Mingyu/A-2331-2008		National Natural Science Foundation of China [30871176, 30971374]; Major Project of Basic Research of Technology Committee in Shanghai of China [12DJ1400200]; National Institutes of Health [HL082798, HL111580, HL029587]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL111580, P01HL029587, P01HL082798] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of Basic Research of Technology Committee in Shanghai of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants 30871176 and 30971374 (to XD) from the National Natural Science Foundation of China, 12DJ1400200 (to XD) from the Major Project of Basic Research of Technology Committee in Shanghai of China; and grants HL082798, HL111580, and HL029587 (to ML) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BH, 2011, BASIC CLIN PHARMACOL, V109, P225, DOI 10.1111/j.1742-7843.2011.00728.x; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Binswanger U, 1997, KIDNEY BLOOD PRESS R, V20, P163, DOI 10.1159/000174132; Bledsoe G, 2006, NEPHROL DIAL TRANSPL, V21, P624, DOI 10.1093/ndt/gfi225; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen LF, 2009, INFECT DIS CLIN N AM, V23, P1053, DOI 10.1016/j.idc.2009.06.004; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Cuzzocrea S, 2002, EUR J PHARMACOL, V450, P67, DOI 10.1016/S0014-2999(02)01749-1; Edwards Joshua R., 2007, BMC Physiology, V7, P1, DOI 10.1186/1472-6793-7-1; El Mouedden M, 2000, ANTIMICROB AGENTS CH, V44, P665, DOI 10.1128/AAC.44.3.665-675.2000; Faulkner SD, 2012, EUR J ANAESTH, V29, P577, DOI 10.1097/EJA.0b013e3283583c4b; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Goto T, 1998, BRIT J ANAESTH, V80, P255, DOI 10.1093/bja/80.2.255; Jankauskas SS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P666, DOI 10.1134/S0006297912060144; Jiang SH, 2009, AM J NEPHROL, V30, P440, DOI 10.1159/000239574; Kalayarasan S, 2009, EUR J PHARMACOL, V606, P162, DOI 10.1016/j.ejphar.2008.12.055; Karahan I, 2005, TOXICOLOGY, V215, P198, DOI 10.1016/j.tox.2005.07.007; Kojima I, 2007, J AM SOC NEPHROL, V18, P1218, DOI 10.1681/ASN.2006060639; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P259, DOI 10.1152/physiolgenomics.00173.2011; LACHMANN B, 1990, LANCET, V335, P1413; Li NJ, 2007, AM J PHYSIOL-RENAL, V292, pF207, DOI 10.1152/ajprenal.00457.2005; Liang MY, 2009, AM J PHYSIOL-RENAL, V297, pF553, DOI 10.1152/ajprenal.00045.2009; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Martinez-Salgado C, 2007, TOXICOL APPL PHARM, V223, P86, DOI 10.1016/j.taap.2007.05.004; Neukirchen M, 2012, BRIT J ANAESTH, V109, P887, DOI 10.1093/bja/aes303; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Plotnikov EY, 2011, BBA-MOL BASIS DIS, V1812, P77, DOI 10.1016/j.bbadis.2010.09.008; Preckel B, 2004, BRIT J ANAESTH, V92, P786, DOI 10.1093/bja/aeh137; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; Rizvi M, 2010, EXP BIOL MED, V235, P886, DOI 10.1258/ebm.2010.009366; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Rossaint R, 2003, ANESTHESIOLOGY, V98, P6, DOI 10.1097/00000542-200301000-00005; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Silachev DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051553; Steenhard BA, 2007, DEV DYNAM, V236, P1115, DOI 10.1002/dvdy.21106; Wang ZD, 2012, NEPHROL DIAL TRANSPL, V27, P929, DOI 10.1093/ndt/gfr379; Wang ZC, 2011, KIDNEY INT, V79, P300, DOI 10.1038/ki.2010.326; Wappler F, 2007, ANESTHESIOLOGY, V106, P463, DOI 10.1097/00000542-200703000-00010; Weber NC, 2005, BRIT J PHARMACOL, V146, P445, DOI 10.1038/sj.bjp.0706324; Weber NC, 2008, ANESTH ANALG, V107, P1807, DOI 10.1213/ane.Ob013e31818874bf; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241; Yagi K, 1998, Methods Mol Biol, V108, P101; Yaman I, 2010, EXP TOXICOL PATHOL, V62, P183, DOI 10.1016/j.etp.2009.03.006; Yang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037020; Yu X, 2012, NEPHROL DIAL TRANSPL, V0, P1	50	30	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64329	10.1371/journal.pone.0064329	http://dx.doi.org/10.1371/journal.pone.0064329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737979	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700044
J	Sun, HM; Xue, GH; Yan, C; Li, SL; Cao, L; Yuan, Y; Zhao, HQ; Feng, YL; Wang, LQ; Fan, ZY				Sun, Hongmei; Xue, Guanhua; Yan, Chao; Li, Shaoli; Cao, Ling; Yuan, Yi; Zhao, Hanqing; Feng, Yanling; Wang, Liqiong; Fan, Zhaoyang			Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Clinical Specimens and Proposal for Amendment of MLVA Nomenclature	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; P1 CYTADHESIN GENE; IDENTIFICATION; INFECTION; VARIANTS; SEQUENCE; JAPAN	Mycoplasma pneumoniae is one of the major respiratory bacterial pathogens that cause pneumonia in humans. Multiple-locus variable-number tandem-repeat analysis (MLVA) is currently the most discriminative method for typing M. pneumoniae strains. To better understand the epidemic of M. pneumoniae-related pneumonia in pediatric patients in Beijing, China, we performed MLVA analysis on 118 specimens collected during an epidemic from 2010-2012. Eleven distinct MLVA types were identified, including four novel types. There was no obvious association of macrolide resistance with any of the genotypes. Considering the instability of VNTR locus Mpn1, we propose an amended MLVA nomenclature system based on the remaining four VNTR loci.	[Sun, Hongmei; Xue, Guanhua; Yan, Chao; Li, Shaoli; Zhao, Hanqing; Feng, Yanling; Wang, Liqiong] Capital Inst Pediat, Dept Bacteriol, Beijing, Peoples R China; [Cao, Ling; Yuan, Yi] Capital Inst Pediat, Affiliated Childrens Hosp, Beijing, Peoples R China; [Fan, Zhaoyang] Capital Inst Pediat, Dept Integrated Early Childhood Dev, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Capital Institute of Pediatrics (CIP); Capital Institute of Pediatrics (CIP)	Sun, HM (corresponding author), Capital Inst Pediat, Dept Bacteriol, Beijing, Peoples R China.	s.hongmei@263.net	Sun, Hongmei/CAF-0999-2022		Beijing Natural Science Foundation [7112019]; Beijing City Talent Training Project Fund [20071A0303200118]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing City Talent Training Project Fund	This work was supported by Beijing Natural Science Foundation (7112019) and Beijing City Talent Training Project Fund (20071A0303200118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez AJ, 2012, J CLIN MICROBIOL, V50, P3620, DOI 10.1128/JCM.01755-12; Blystad H, 2012, EUROSURVEILLANCE, P17; Chalker V, 2011, EURO SURVEILL, V16; Chalker VJ, 2012, EURO SURVEILL, V17; DALLO SF, 1990, INFECT IMMUN, V58, P2017, DOI 10.1128/IAI.58.6.2017-2020.1990; Degrange S, 2009, J CLIN MICROBIOL, V47, P914, DOI 10.1128/JCM.01935-08; Dorigo-Zetsma JW, 2001, INFECT IMMUN, V69, P5612, DOI 10.1128/IAI.69.9.5612-5618.2001; Dumke R, 2010, EPIDEMIOL INFECT, V138, P1829, DOI 10.1017/S0950268810000622; Dumke R, 2006, J CLIN MICROBIOL, V44, P2567, DOI 10.1128/JCM.00495-06; Dumke R, 2011, J MICROBIOL METH, V86, P393, DOI 10.1016/j.mimet.2011.06.008; Eibach D, 2012, EUROSURVEILLANCE, V17; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jacobs E, 2012, EURO SURVEILL, V17; Kenri T, 1999, INFECT IMMUN, V67, P4557, DOI 10.1128/IAI.67.9.4557-4562.1999; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; Lenglet A, 2012, EURO SURVEILL, V17; Lin CY, 2010, J CLIN MICROBIOL, V48, P4567, DOI 10.1128/JCM.00400-10; Liu Y, 2012, J CLIN MICROBIOL, V50, P2793, DOI 10.1128/JCM.00678-12; Nir-Paz R., 2012, EURO SURVEILL, V17; Pereyre S, 2013, CLIN MICROBIOL INFEC, V19, pE212, DOI 10.1111/1469-0691.12107; Pereyre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038585; Polkowska A, 2012, EURO SURVEILL, V17, P20072; Rasmussen JN, 2010, EURO SURVEILL, V15, P19708; Sasaki T, 1996, J CLIN MICROBIOL, V34, P447, DOI 10.1128/JCM.34.2.447-449.1996; Schwartz SB, 2009, J CLIN MICROBIOL, V47, P4117, DOI 10.1128/JCM.01696-09; Spuesens EBM, 2010, J CLIN MICROBIOL, V48, P680, DOI 10.1128/JCM.02078-09; Thurman KA, 2009, CLIN INFECT DIS, V48, P1244, DOI 10.1086/597775; Vervloet LA, 2007, BRAZ J INFECT DIS, V11, P507, DOI 10.1590/S1413-86702007000500012; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Walter ND, 2008, J INFECT DIS, V198, P1365, DOI 10.1086/592281; Wang QN, 2008, J MED MICROBIOL, V57, P827, DOI 10.1099/jmm.0.47766-0; Youn You-Sook, 2012, Korean J Pediatr, V55, P42, DOI 10.3345/kjp.2012.55.2.42; Zhao F, 2013, J CLIN MICROBIOL, V51, P636, DOI 10.1128/JCM.02567-12; Zhao F, 2011, J CLIN MICROBIOL, V49, P3000, DOI 10.1128/JCM.00105-11	34	42	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64607	10.1371/journal.pone.0064607	http://dx.doi.org/10.1371/journal.pone.0064607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737989	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700053
J	Zhou, X; Ma, Y; Fang, Y; Gerile, W; Jaiseng, W; Yamada, Y; Kuno, T				Zhou, Xin; Ma, Yan; Fang, Yue; Gerile, Wugan; Jaiseng, Wurentuya; Yamada, Yuki; Kuno, Takayoshi			A Genome-Wide Screening of Potential Target Genes to Enhance the Antifungal Activity of Micafungin in Schizosaccharomyces pombe	PLOS ONE			English	Article							CELL-WALL INTEGRITY; FISSION YEAST; CANDIDA-ALBICANS; PROTEIN; KINASE; LOCALIZATION; MANNOSYLTRANSFERASE; MORPHOGENESIS; RESISTANCE; PATHWAYS	Micafungin is a non-reversible inhibitor of 1, 3-beta-D-glucan synthase and interferes with fungal cell wall synthesis. Clinically, micafungin has been shown to be efficacious for the treatment of invasive candidiasis and invasive aspergillosis. However, considering its relatively restricted antifungal spectrum, combination therapy with micafungin plus other agents should be considered in critically ill patients. To identify potential therapeutic targets for syncretic drug combinations that potentiate micafungin action, we carried out a genome-wide screen for altered sensitivity to micafungin by using the model yeast Schizosaccharomyces pombe mutant library. We confirmed that 159 deletion strains in the library are micafungin sensitive and classified them into various functional categories, including cell wall biosynthesis, gene expression and chromatin remodeling, membrane trafficking, signaling transduction, ubiquitination, ergosterol biosynthetic process and a variety of other known functions or still unknown functions. On the other hand, we also investigated the growth inhibitory activities of some well-known drugs in combination with micafungin including antifungal drug amphotericin B, fluconazole and immunosuppressive drug FK506. We found that amphotericin B in combination with micafungin showed a more potent inhibitory activity against wild-type cells than that of micafungin alone, whereas fluconazole in combination with micafungin did not. Also, the immunosuppressive drug FK506 showed synergistic inhibitory effect with micafungin on the growth of wild-type cells, whereas it decreased the inhibitory effect of micafungin in Delta pmk1 cells, a deletion mutant of the cell wall integrity mitogen-activated protein kinase (MAPK) Pmk1. Altogether, our findings provide useful information for new potential drug combinations in the treatment of fungal infections.	[Zhou, Xin] Liaoning Med Univ, Affiliated Hosp 1, Dept Oncol, Jinzhou, Peoples R China; [Zhou, Xin; Ma, Yan; Fang, Yue; Gerile, Wugan; Jaiseng, Wurentuya; Yamada, Yuki; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan; [Fang, Yue] China Med Univ, Sch Pharmaceut Sci, Dept Pharmacol, Shenyang, Peoples R China	Jinzhou Medical University; Kobe University; China Medical University	Zhou, X (corresponding author), Liaoning Med Univ, Affiliated Hosp 1, Dept Oncol, Jinzhou, Peoples R China.	xinzhoulmu@gmail.com			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by research grants from Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano M, 1996, EMBO J, V15, P4584, DOI 10.1002/j.1460-2075.1996.tb00836.x; Basquin J, 2012, MOL CELL, V48, P207, DOI 10.1016/j.molcel.2012.08.014; Sanz AB, 2012, MOL BIOL CELL, V23, P2805, DOI 10.1091/mbc.E12-04-0278; Blankenship Jill R, 2003, Curr Opin Investig Drugs, V4, P192; Brace JL, 2007, GENETICS, V175, P65, DOI 10.1534/genetics.106.064527; Brace JL, 2005, YEAST, V22, P641, DOI 10.1002/yea.1235; Carrillo-Munoz AJ, 2004, J CHEMOTHERAPY, V16, P468, DOI 10.1179/joc.2004.16.5.468; Chandrasekar PH, 2006, CLIN INFECT DIS, V42, P1171, DOI 10.1086/501020; Chen JQ, 2010, J BIOL CHEM, V285, P15786, DOI 10.1074/jbc.M110.101832; Espinel-Ingroff A, 2008, REV IBEROAM MICOL, V25, P101, DOI 10.1016/S1130-1406(08)70027-5; Fang Y, 2012, ANTIMICROB AGENTS CH, V56, P1949, DOI 10.1128/AAC.05126-11; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Garcia P, 2006, MOL BIOL CELL, V17, P1620, DOI 10.1091/mbc.E05-10-0933; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Ge WZ, 2005, MOL BIOL CELL, V16, P4124, DOI 10.1091/mbc.e04-11-0976; Giusiano G, 2005, J CHEMOTHERAPY, V17, P347, DOI 10.1179/joc.2005.17.3.347; Groenewald M, 2001, CURR GENET, V39, P222; HARDWICK KG, 1990, EMBO J, V9, P623, DOI 10.1002/j.1460-2075.1990.tb08154.x; Kaminska J, 2005, ACTA BIOCHIM POL, V52, P207; Kaneko Y, 2010, JPN J INFECT DIS, V63, P355; Karagiannis J, 1999, CURR GENET, V35, P593, DOI 10.1007/s002940050457; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lamagni TL, 2001, EPIDEMIOL INFECT, V126, P397, DOI 10.1017/S0950268801005507; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022421; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Miyatake M, 2007, GENETICS, V175, P1695, DOI 10.1534/genetics.107.070946; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morigasaki S, 2008, MOL CELL, V30, P108, DOI 10.1016/j.molcel.2008.01.017; Nakase M, 2010, J CELL SCI, V123, P1578, DOI 10.1242/jcs.059139; Oka T, 2004, MICROBIOL-SGM, V150, P1973, DOI 10.1099/mic.0.27005-0; Park JS, 2012, J CELL SCI, V125, P3004, DOI 10.1242/jcs.105114; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Rempola B, 2000, MOL GEN GENET, V262, P1081, DOI 10.1007/PL00008651; ROUSSOU I, 1994, MOL CELL BIOL, V14, P576, DOI 10.1128/MCB.14.1.576; SCHILD D, 1995, GENETICS, V140, P115; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P1664, DOI 10.1128/AAC.48.5.1664-1669.2004; Sucher AJ, 2009, ANN PHARMACOTHER, V43, P1647, DOI 10.1345/aph.1M237; Sugawara T, 2003, J ELECTRON MICROSC, V52, P237, DOI 10.1093/jmicro/52.2.237; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Toda T, 1996, MOL CELL BIOL, V16, P6752; Walsh TJ, 2004, CLIN MICROBIOL INFEC, V10, P48, DOI 10.1111/j.1470-9465.2004.00839.x; Yang PR, 2003, J BIOL CHEM, V278, P48821, DOI 10.1074/jbc.M306819200; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Zhang W, 2010, GENE DEV, V24, P502, DOI 10.1101/gad.1869110; Zimmermann J, 2010, BIOCHEM J, V431, P123, DOI 10.1042/BJ20100693	47	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e65904	10.1371/journal.pone.0065904	http://dx.doi.org/10.1371/journal.pone.0065904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738021	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700082
J	Brazeau, DA; Lesser, MP; Slattery, M				Brazeau, Daniel A.; Lesser, Michael P.; Slattery, Marc			Genetic Structure in the Coral, Montastraea cavernosa: Assessing Genetic Differentiation among and within Mesophotic Reefs	PLOS ONE			English	Article							LENGTH POLYMORPHISM AFLP; POPULATION ASSIGNMENT; SPECIES BOUNDARIES; CONNECTIVITY; DISPERSAL; MARKERS; DIVERGENCE; ALLOCATION; ADAPTATION; MIGRATION	Mesophotic coral reefs (30-150 m) have recently received increased attention as a potential source of larvae (e.g., the refugia hypothesis) to repopulate a select subset of the shallow water (<30 m) coral fauna. To test the refugia hypothesis we used highly polymorphic Amplified Fragment Length Polymorphism (AFLP) markers as a means to assess small-scale genetic heterogeneity between geographic locations and across depth clines in the Caribbean coral, Montastraea cavernosa. Zooxanthellae-free DNA extracts of coral samples (N = 105) were analyzed from four depths, shallow (3-10 m), medium (15-25 m), deep (30-50 m) and very deep (60-90 m) from Little Cayman Island (LCI), Lee Stocking Island (LSI), Bahamas and San Salvador (SS), Bahamas which range in distance from 170 to 1,600 km apart. Using AMOVA analysis there were significant differences in Phi(ST) values in pair wise comparisons between LCI and LSI. Among depths at LCI, there was significant genetic differentiation between shallow and medium versus deep and very deep depths in contrast there were no significant differences in Phi(ST) values among depths at LSI. The assignment program AFLPOP, however, correctly assigned 95.7% of the LCI and LSI samples to the depths from which they were collected, differentiating among populations as little as 10 to 20 m in depth from one another. Discriminant function analysis of the data showed significant differentiation among samples when categorized by collection site as well as collection depth. F-ST outlier analyses identified 2 loci under positive selection and 3 under balancing selection at LCI. At LSI 2 loci were identified, both showing balancing selection. This data shows that adult populations of M. cavernosa separated by depths of tens of meters exhibits significant genetic structure, indicative of low population connectivity among and within sites and are not supplying successful recruits to adjacent coral reefs less than 30 m in depth.	[Brazeau, Daniel A.] Univ New England, Dept Pharmaceut Sci, Portland, ME USA; [Lesser, Michael P.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Slattery, Marc] Univ Mississippi, Dept Pharmacognosy, University, MS 38677 USA	University of New England - Maine; University System Of New Hampshire; University of New Hampshire; University of Mississippi	Brazeau, DA (corresponding author), Univ New England, Dept Pharmaceut Sci, Portland, ME USA.	dbrazeau@une.edu						Amar KO, 2008, MAR BIOTECHNOL, V10, P350, DOI 10.1007/s10126-007-9069-2; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Atchison AD, 2008, J EXP MAR BIOL ECOL, V365, P1, DOI 10.1016/j.jembe.2008.07.002; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bernatchez L, 2000, CAN J FISH AQUAT SCI, V57, P1, DOI 10.1139/cjfas-57-1-1; Blears MJ, 1998, J IND MICROBIOL BIOT, V21, P99, DOI 10.1038/sj.jim.2900537; Bongaerts P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-303; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brazeau DA, 2005, MAR BIOL, V147, P1141, DOI 10.1007/s00227-005-0022-5; Budd AF, 2012, EVOL ECOL, V26, P265, DOI 10.1007/s10682-010-9460-8; Campbell D, 2003, MOL ECOL, V12, P1979, DOI 10.1046/j.1365-294X.2003.01856.x; Cornuet JM, 1999, GENETICS, V153, P1989; Davies N, 1999, TRENDS ECOL EVOL, V14, P17, DOI 10.1016/S0169-5347(98)01530-4; Diekmann OE, 2003, CORAL REEFS, V22, P29, DOI 10.1007/s00338-002-0273-2; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; EXCOFFIER L, 1992, GENETICS, V131, P479; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Hansen M, 1999, THEOR APPL GENET, V98, P845, DOI 10.1007/s001220051143; He TH, 2004, MOL ECOL, V13, P1099, DOI 10.1111/j.1365-294X.2004.02120.x; Hellberg ME, 2002, B MAR SCI, V70, P273; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jones OR, 2012, ECOL EVOL, V2, P1048, DOI 10.1002/ece3.237; Lee PLM, 2007, MOL ECOL, V16, P61, DOI 10.1111/j.1365-294X.2006.03115.x; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lopez JV, 1999, BIOL BULL-US, V196, P80, DOI 10.2307/1543170; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mechanda SM, 2004, GENOME, V47, P15, DOI 10.1139/G03-094; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Nunes F, 2009, MOL ECOL, V18, P4283, DOI 10.1111/j.1365-294X.2009.04347.x; Nunes FLD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022298; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Rivera MAJ, 2004, BIOL J LINN SOC, V81, P449, DOI 10.1111/j.1095-8312.2003.00304.x; Sammarco PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030144; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Stokes M. Dale, 2010, Atoll Research Bulletin, P1; Suazo A, 1999, BIOTECHNIQUES, V26, P704, DOI 10.2144/99264st07; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Thorrold SR, 2007, OCEANOGRAPHY, V20, P80, DOI 10.5670/oceanog.2007.31; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; VanToai TT, 1997, CROP SCI, V37, P1370, DOI 10.2135/cropsci1997.0011183X003700040056x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wares JP, 2007, MAR BIOL RES, V3, P168, DOI 10.1080/17451000701320572; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x; Wilkinson C, 2000, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W, V1	68	73	73	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65845	10.1371/journal.pone.0065845	http://dx.doi.org/10.1371/journal.pone.0065845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734263	Green Published, gold, Green Submitted			2022-12-27	WOS:000319725500003
J	Bryson, JL; Griffith, AV; Hughes, B; Saito, F; Takahama, Y; Richie, ER; Manley, NR				Bryson, Jerrod L.; Griffith, Ann V.; Hughes, Bernard, III; Saito, Fumi; Takahama, Yousuke; Richie, Ellen R.; Manley, Nancy R.			Cell-Autonomous Defects in Thymic Epithelial Cells Disrupt Endothelial-Perivascular Cell Interactions in the Mouse Thymus	PLOS ONE			English	Article							NEURAL CREST; GROWTH-FACTOR; PERICYTE LOSS; ADULT THYMUS; T-CELLS; VEGF-A; DIFFERENTIATION; MICE; MICROENVIRONMENTS; ORGANOGENESIS	The thymus is composed of multiple stromal elements comprising specialized stromal microenvironments responsible for the development of self-tolerant and self-restricted T cells. Here, we investigated the ontogeny and maturation of the thymic vasculature. We show that endothelial cells initially enter the thymus at E13.5, with PDGFR-beta(+) mesenchymal cells following at E14.5. Using an allelic series of the thymic epithelial cell (TEC) specific transcription factor Foxn1, we showed that these events are delayed by 1-2 days in Foxn1(Delta/Delta) mice, and this phenotype was exacerbated with reduced Foxn1 dosage. At subsequent stages there were fewer capillaries, leaky blood vessels, disrupted endothelium - perivascular cell interactions, endothelial cell vacuolization, and an overall failure of vascular organization. The expression of both VEGF-A and PDGF-B, which are both primarily expressed in vasculature-associated mesenchyme or endothelium in the thymus, were reduced at E13.5 and E15.5 in Foxn1(Delta/Delta) mice compared with controls. These data suggest that Foxn1 is required in TECs both to recruit endothelial cells and for endothelial cells to communicate with thymic mesenchyme, and for the differentiation of vascular-associated mesenchymal cells. These data show that Foxn1 function in TECs is required for normal thymus size and to generate the cellular and molecular environment needed for normal thymic vascularization. These data further demonstrate a novel TEC-mesenchyme-endothelial interaction required for proper fetal thymus organogenesis.	[Bryson, Jerrod L.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Griffith, Ann V.; Richie, Ellen R.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA; [Hughes, Bernard, III; Manley, Nancy R.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Saito, Fumi; Takahama, Yousuke] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 770, Japan	University System of Georgia; University of Georgia; University of Texas System; UTMD Anderson Cancer Center; University System of Georgia; University of Georgia; Tokushima University	Manley, NR (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	nmanley@uga.edu	Griffith, Ann/N-5624-2016; Takahama, Yousuke/A-5863-2010	Griffith, Ann/0000-0001-5345-0222; Takahama, Yousuke/0000-0002-4992-9174; Richie, Ellen/0000-0003-0786-973X	National Institutes of Health, National Institute of Allergy and Infectious Disease [AI055001, AI075244]; Grants-in-Aid for Scientific Research [24111004] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055001, R21AI075244] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health, National Institute of Allergy and Infectious Disease (AI055001 and AI075244) to NRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2000, INT IMMUNOL, V12, P1105, DOI 10.1093/intimm/12.7.1105; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bryson JL, 2011, JOVE-J VIS EXP, DOI 10.3791/3267; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Cuddihy AR, 2009, BLOOD, V113, P2723, DOI 10.1182/blood-2008-06-162040; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Griffith AV, 2009, DEV BIOL, V327, P216, DOI 10.1016/j.ydbio.2008.12.019; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jin SW, 2009, ARTERIOSCL THROM VAS, V29, P623, DOI 10.1161/ATVBAHA.107.161539; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; MOORE MAS, 1967, J EXP MED, V126, P715, DOI 10.1084/jem.126.4.715; Mori K, 2007, INT IMMUNOL, V19, P745, DOI 10.1093/intimm/dxm041; Mori K, 2010, CELL IMMUNOL, V260, P66, DOI 10.1016/j.cellimm.2009.09.007; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Muller SM, 2005, P NATL ACAD SCI USA, V102, P10587, DOI 10.1073/pnas.0502752102; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; USHIKI T, 1986, CELL TISSUE RES, V244, P285; Xiao SY, 2008, J IMMUNOL, V180, P914, DOI 10.4049/jimmunol.180.2.914; Xiao SY, 2007, J IMMUNOL, V179, P8153, DOI 10.4049/jimmunol.179.12.8153	50	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65196	10.1371/journal.pone.0065196	http://dx.doi.org/10.1371/journal.pone.0065196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750244	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900046
J	Oles, K; Gudowska-Nowak, E; Kleczkowski, A				Oles, Katarzyna; Gudowska-Nowak, Ewa; Kleczkowski, Adam			Efficient Control of Epidemics Spreading on Networks: Balance between Treatment and Recovery	PLOS ONE			English	Article							DISEASE SPREAD; COMPLEX; TRANSMISSION; STRATEGIES; INFECTION; LANDSCAPE; IMPACT; SCALE	We analyse two models describing disease transmission and control on regular and small-world networks. We use simulations to find a control strategy that minimizes the total cost of an outbreak, thus balancing the costs of disease against that of the preventive treatment. The models are similar in their epidemiological part, but differ in how the removed/recovered individuals are treated. The differences in models affect choice of the strategy only for very cheap treatment and slow spreading disease. However for the combinations of parameters that are important from the epidemiological perspective (high infectiousness and expensive treatment) the models give similar results. Moreover, even where the choice of the strategy is different, the total cost spent on controlling the epidemic is very similar for both models.	[Oles, Katarzyna; Gudowska-Nowak, Ewa] Jagiellonian Univ, M Kac Complex Syst Res Ctr, Krakow, Poland; [Oles, Katarzyna; Gudowska-Nowak, Ewa] Jagiellonian Univ, M Smoluchowski Inst Phys, Krakow, Poland; [Oles, Katarzyna; Kleczkowski, Adam] Univ Stirling, Dept Comp Sci & Math, Stirling FK9 4LA, Scotland	Jagiellonian University; Jagiellonian University; University of Stirling	Oles, K (corresponding author), Jagiellonian Univ, M Kac Complex Syst Res Ctr, Krakow, Poland.	kas@cs.stir.ac.uk	Kleczkowski, Adam/B-2016-2009; Gudowska-Nowak, Ewa/A-7622-2014; Oles, Katarzyna/AAH-1828-2021	Kleczkowski, Adam/0000-0003-1384-4352; Gudowska-Nowak, Ewa/0000-0001-5604-094X; Oles, Katarzyna/0000-0001-6821-9904	European Regional Development Fund covering [MPD/2009/6]; Jagiellonian University International Ph.D. Studies in Physics of Complex Systems; European Science Foundation (ESF)	European Regional Development Fund covering; Jagiellonian University International Ph.D. Studies in Physics of Complex Systems; European Science Foundation (ESF)(European Science Foundation (ESF))	Project operated within the Foundation for Polish Science International Ph.D. Projects Programme co-financed by the European Regional Development Fund covering, under the agreement no. MPD/2009/6, the Jagiellonian University International Ph.D. Studies in Physics of Complex Systems and was co-financed by the European Development Fund in the framework of the "Innovative Economy Programme'' and within the framework of "Exploring the Physics of Small Devices (EPSD)'' of European Science Foundation (ESF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksiejuk A, 2002, PHYSICA A, V310, P260, DOI 10.1016/S0378-4371(02)00740-9; Andersson H., 1999, MATH SCI, V24, P128; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Dybiec B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066145; Dybiec B, 2005, ACTA PHYS POL B, V36, P1509; Dye C, 2003, SCIENCE, V300, P1884, DOI 10.1126/science.1086925; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Filipe JAN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002328; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; Gersovitz M, 2004, ECON J, V114, P1, DOI 10.1046/j.0013-0133.2003.0174.x; Gilligan CA, 2007, J R SOC INTERFACE, V4, P925, DOI 10.1098/rsif.2007.1019; Gomez-Gardenes J, 2006, EUR PHYS J B, V49, P259, DOI 10.1140/epjb/e2006-00041-1; Gottwald TR, 2001, PHYTOPATHOLOGY, V91, P30, DOI 10.1094/PHYTO.2001.91.1.30; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Kao RR, 2002, TRENDS MICROBIOL, V10, P279, DOI 10.1016/S0966-842X(02)02371-5; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kleczkowski A, 2012, J R SOC INTERFACE, V9, P158, DOI 10.1098/rsif.2011.0216; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Meentemeyer RK, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00192.1; Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Oles K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036026; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Stacey AJ, 2004, PHYTOPATHOLOGY, V94, P209, DOI 10.1094/PHYTO.2004.94.2.209; Stoner BP, 2000, SEX TRANSM DIS, V27, P215, DOI 10.1097/00007435-200004000-00006; Verdasca J, 2005, J THEOR BIOL, V233, P553, DOI 10.1016/j.jtbi.2004.10.031; Watts Duncan J., 2003, SMALL WORLDS DYNAMIC; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661	40	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e63813	10.1371/journal.pone.0063813	http://dx.doi.org/10.1371/journal.pone.0063813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750205	Green Published, gold, Green Accepted			2022-12-27	WOS:000319961900007
J	Bonzheim, I; Irmler, M; Klier-Richter, M; Steinhilber, J; Anastasov, N; Schafer, S; Adam, P; Beckers, J; Raffeld, M; Fend, F; Quintanilla-Martinez, L				Bonzheim, Irina; Irmler, Martin; Klier-Richter, Margit; Steinhilber, Julia; Anastasov, Natasa; Schaefer, Sabine; Adam, Patrick; Beckers, Johannes; Raffeld, Mark; Fend, Falko; Quintanilla-Martinez, Leticia			Identification of C/EBP beta Target Genes in ALK plus Anaplastic Large Cell Lymphoma (ALCL) by Gene Expression Profiling and Chromatin Immunoprecipitation	PLOS ONE			English	Article							NF-KAPPA-B; BINDING-PROTEIN-BETA; RNA HELICASE-II/GU; SIGNALING PATHWAY; CYCLIN D1; II GU; TRANSCRIPTION; KINASE; SURVIVAL; DOMAINS	C/EBP beta (CCAAT enhancer binding protein) is a transcription factor that plays a crucial role in survival and transformation of ALK+ anaplastic large cell lymphoma (ALCL). The aim of this study was to identify the downstream targets of C/EBP beta responsible for ALK-mediated oncogenesis. C/EBP beta was knocked down in ALK+ ALCL cell lines with a C/EBP beta-shRNA, followed by gene expression profiling (GEP). GEP analysis revealed a reproducible signature of genes that were significantly regulated by C/EBP beta. Classification into biological categories revealed overrepresentation of genes involved in the immune response, apoptosis and cell proliferation. Transcriptional regulation by C/EBP beta was found in 6 of 11 (BCL2A1, G0S2, TRIB1, S100A9, DDX21 and DDIT4) genes investigated by chromatin immunoprecipitation. We demonstrated that BCL2A1, G0S2 and DDX21 play a crucial role in survival and proliferation of ALK+ ALCL cells. DDX21, a gene involved in rRNA biogenesis, was found differentially overexpressed in primary ALK+ ALCL cases. All three candidate genes were validated in primary ALCL cases by either immunohistochemistry or RT-qPCR. In conclusion, we identified and validated several key C/EBP beta-regulated genes with major impact on survival and cell growth in ALK+ ALCL, supporting the central role of C/EBP beta in ALK-mediated oncogenesis.	[Bonzheim, Irina; Klier-Richter, Margit; Steinhilber, Julia; Schaefer, Sabine; Adam, Patrick; Fend, Falko; Quintanilla-Martinez, Leticia] Univ Tubingen Hosp, Inst Pathol & Neuropathol, Tubingen, Germany; [Bonzheim, Irina; Klier-Richter, Margit; Steinhilber, Julia; Schaefer, Sabine; Adam, Patrick; Fend, Falko; Quintanilla-Martinez, Leticia] Univ Tubingen, Ctr Comprehens Canc, Tubingen, Germany; [Bonzheim, Irina; Klier-Richter, Margit; Anastasov, Natasa; Quintanilla-Martinez, Leticia] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen GmbH, Inst Pathol, Neuherberg, Germany; [Irmler, Martin; Beckers, Johannes] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen GmbH, Inst Expt Genet, Neuherberg, Germany; [Raffeld, Mark] NCI, Natl Inst Hlth, Bethesda, MD 20892 USA; [Beckers, Johannes] Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Technical University of Munich	Quintanilla-Martinez, L (corresponding author), Univ Tubingen Hosp, Inst Pathol & Neuropathol, Tubingen, Germany.	Leticia.Quintanilla-Fend@med.uni-tuebingen.de	Anastasov, Natasa/AAW-2478-2020; Beckers, Johannes/K-7237-2012; Anastasov, Natasa/M-9848-2014; Irmler, Martin/B-3317-2013	Anastasov, Natasa/0000-0002-4088-1119; Beckers, Johannes/0000-0001-7874-3822; Anastasov, Natasa/0000-0002-4088-1119; Irmler, Martin/0000-0003-3169-479X	University of Tubingen [SFB 685, TP B8]; IZKF fortune program, University of Tubingen; NATIONAL CANCER INSTITUTE [ZICBC011079] Funding Source: NIH RePORTER	University of Tubingen; IZKF fortune program, University of Tubingen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the SFB 685 "Immunotherapy" of the University of Tubingen, TP B8 (LQM and FF) and by the IZKF fortune program, University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Anastasov Natasa, 2009, J Hematop, V2, P9, DOI 10.1007/s12308-008-0020-x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Cheng YH, J MOL ENDOCRINOL; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cimino D, 2008, INT J CANCER, V123, P1327, DOI 10.1002/ijc.23660; Drexler HG, 2004, LEUKEMIA, V18, P1569, DOI 10.1038/sj.leu.2403465; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; Holmstrom TH, 2008, J BIOL CHEM, V283, P7046, DOI 10.1074/jbc.M709613200; Horie R, 2004, CANCER CELL, V5, P353, DOI 10.1016/S1535-6108(04)00084-4; Klier M, 2008, LEUKEMIA, V22, P2097, DOI 10.1038/leu.2008.213; Koch I, 2006, DIAGN MOL PATHOL, V15, P149, DOI 10.1097/01.pdm.0000213450.99655.54; Lamant L, 2007, BLOOD, V109, P2156, DOI 10.1182/blood-2006-06-028969; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mandal M, 2005, J EXP MED, V201, P603, DOI 10.1084/jem.20041924; Martinez-Delgado B, 2006, HEMATOL ONCOL, V24, P113, DOI 10.1002/hon.781; Martinez-Delgado B, 2005, LEUKEMIA, V19, P2254, DOI 10.1038/sj.leu.2403960; NUSSE M, 1994, METHOD CELL BIOL, V42, P149; Ou YC, 1999, EXP CELL RES, V247, P389, DOI 10.1006/excr.1998.4365; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Piva R, 2010, J CLIN ONCOL, V28, P1583, DOI 10.1200/JCO.2008.20.9759; Quintanilla-Martinez L, 2006, BLOOD, V108, P2029, DOI 10.1182/blood-2005-10-014258; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; SHIMAKAGE M, 1993, INTERVIROLOGY, V36, P215, DOI 10.1159/000150340; Specht K, 2002, CLIN CANCER RES, V8, P2902; Swerdlow SH, 2008, WHO CLASSIFICATION T; Valdez BC, 1997, EUR J BIOCHEM, V250, P800, DOI 10.1111/j.1432-1033.1997.00800.x; Welch C, 2009, CANCER RES, V69, P6782, DOI 10.1158/0008-5472.CAN-09-0128; Westermarck J, 2002, EMBO J, V21, P451, DOI 10.1093/emboj/21.3.451; Yang HS, 2005, FEBS J, V272, P3788, DOI 10.1111/j.1742-4658.2005.04811.x; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	46	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64544	10.1371/journal.pone.0064544	http://dx.doi.org/10.1371/journal.pone.0064544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741337	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900050
J	Garcia-Graells, C; van Cleef, BAGL; Larsen, J; Denis, O; Skov, R; Voss, A				Garcia-Graells, Cristina; van Cleef, Brigitte A. G. L.; Larsen, Jesper; Denis, Olivier; Skov, Robert; Voss, Andreas			Dynamic of Livestock-Associated Methicillin-Resistant Staphylococcus aureus CC398 in Pig Farm Households: A Pilot Study	PLOS ONE			English	Article							ST398	The aim of this study was to determine the long-term carriage rates and transmission dynamics of methicillin-resistant Staphylococcus aureus (MRSA) in pig farmers and their household members. During a 6-month period in 2009-2010, 4 pig farms in Denmark, Belgium, and the Netherlands, respectively, were studied for the presence of MRSA. The proportion of persistent carriers was significantly higher among farmers than among household members (87% vs. 11%) and significantly higher in household members from Belgium compared to those from Denmark and the Netherlands (29% vs. 0% vs. 6%). Determinant analysis of MRSA carriage revealed that pig contact was the most important determinant for MRSA carriage among household members and that the increased MRSA carriage rate observed among household members from Belgium is linked to country-specific differences in pig exposure. These findings demonstrated that even in pig farms with very high carriage rates of MRSA both in livestock and farmers, the risk for household members to acquire MRSA is limited and still depends strongly on pig exposure. By restricting access to the stables and exposure to pigs, MRSA acquisition by household members could be greatly reduced.	[Garcia-Graells, Cristina; Denis, Olivier] Univ Libre Bruxelles, Erasme Hosp, Dept Microbiol, Lab Reference MRSA Staphylocoques, Brussels, Belgium; [van Cleef, Brigitte A. G. L.] St Elizabeth Hosp, Lab Med Microbiol & Infect Prevent, Tilburg, Netherlands; [van Cleef, Brigitte A. G. L.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Larsen, Jesper; Skov, Robert] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Voss, Andreas] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Voss, Andreas] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands	Universite Libre de Bruxelles; Elisabeth-TweeSteden Ziekenhuis (ETZ); Netherlands National Institute for Public Health & the Environment; Statens Serum Institut; Radboud University Nijmegen; Canisius-Wilhelmina Hospital	Garcia-Graells, C (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Microbiol, Lab Reference MRSA Staphylocoques, Brussels, Belgium.	cgarcia-graells@gmail.com	Larsen, Jesper/AAJ-3161-2021; Voss, A./H-8111-2014; Skov, Robert/ABB-3105-2020	Larsen, Jesper/0000-0003-0582-0457; Skov, Robert/0000-0002-6079-5381	EU-HEALTH project PILGRIM of the 7th Framework Programme	EU-HEALTH project PILGRIM of the 7th Framework Programme	This study was supported by the EU-HEALTH project PILGRIM of the 7th Framework Programme (www.fp7-pilgrim.eu). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Bosch T, 2010, BMC MICROBIOL, V9, P40; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Denis O, 2003, MICROB DRUG RESIST, V9, P61, DOI 10.1089/107662903764736355; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; EFSA (European Food Safety Authority), 2010, EFSA J, V8, P1597, DOI [10.2903/j.efsa.2010.1597, DOI 10.2903/J.EFSA.2010.1597]; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Garcia-Graells C, 2012, EPIDEMIOL INFECT, V140, P383, DOI 10.1017/S0950268811002263; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Hallin M, 2011, INFECT GENET EVOL, V11, P290, DOI 10.1016/j.meegid.2010.10.021; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larsen AR, 2008, CLIN MICROBIOL INFEC, V14, P611, DOI 10.1111/j.1469-0691.2008.01995.x; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van de Giessen AW, 2009, PREV VET MED, V91, P270, DOI 10.1016/j.prevetmed.2009.05.016; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x	22	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65512	10.1371/journal.pone.0065512	http://dx.doi.org/10.1371/journal.pone.0065512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741497	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900210
J	Hamadneh, N; Khan, WA; Sathasivam, S; Ong, HC				Hamadneh, Nawaf; Khan, Waqar A.; Sathasivam, Saratha; Ong, Hong Choon			Design Optimization of Pin Fin Geometry Using Particle Swarm Optimization Algorithm	PLOS ONE			English	Article							MINIMUM ENTROPY GENERATION; LEAST-ENERGY OPTIMIZATION; HEAT-TRANSFER; GENETIC ALGORITHM; PERFORMANCE; SINKS	Particle swarm optimization (PSO) is employed to investigate the overall performance of a pin fin. The following study will examine the effect of governing parameters on overall thermal/fluid performance associated with different fin geometries, including, rectangular plate fins as well as square, circular, and elliptical pin fins. The idea of entropy generation minimization, EGM is employed to combine the effects of thermal resistance and pressure drop within the heat sink. A general dimensionless expression for the entropy generation rate is obtained by considering a control volume around the pin fin including base plate and applying the conservations equations for mass and energy with the entropy balance. Selected fin geometries are examined for the heat transfer, fluid friction, and the minimum entropy generation rate corresponding to different parameters including axis ratio, aspect ratio, and Reynolds number. The results clearly indicate that the preferred fin profile is very dependent on these parameters.	[Hamadneh, Nawaf; Sathasivam, Saratha; Ong, Hong Choon] Univ Sains Malaysia, Sch Math Sci, George Town 11800, Malaysia; [Khan, Waqar A.] Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan	Universiti Sains Malaysia; National University of Sciences & Technology - Pakistan	Khan, WA (corresponding author), Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan.	wkhan_2000@yahoo.com	Khan, Waqar/H-3886-2013; HAMADNEH, NAWAF N./Y-7759-2019; Ong, Hong Choon/D-9329-2012; sathasivam, saratha/B-1777-2018; Hamadneh, Nawaf N./AAW-7128-2021	Khan, Waqar/0000-0002-8328-850X; HAMADNEH, NAWAF N./0000-0002-2170-2074; Ong, Hong Choon/0000-0002-3253-0538; sathasivam, saratha/0000-0002-2843-7082; Hamadneh, Nawaf N./0000-0002-2170-2074	USM [304/PMATHS/6311126]	USM	This research is supported by the USM, short term grant number 304/PMATHS/6311126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarkish H, 2010, INT J THERM SCI, V49, P2222, DOI 10.1016/j.ijthermalsci.2010.06.023; Azarkish H, 2012, WORLD ACAD SCI ENG T, V61, P836; Bai Q., 2010, COMPUT INF SCI, DOI [10.5539/cis.v3n1p180, DOI 10.5539/CIS.V3N1P180]; Bar-Cohen A, 2003, IEEE T COMPON PACK T, V26, P16, DOI 10.1109/TCAPT.2003.811463; Bar-Cohen A, 2003, J ELECTRON PACKAGING, V125, P208, DOI 10.1115/1.1568361; Behnia M, 1998, COMP HEAT SINK GEOME, P310; Bejan A, 1996, J APPL PHYS, V79, P1191, DOI 10.1063/1.362674; Calcada D, 2010, COMP GA PSO PERFORMA, P1; CHAPMAN CL, 1994, TENTH ANNUAL IEEE SEMICONDUCTOR THERMAL MEASUREMENT AND MANAGEMENT SYMPOSIUM, P24, DOI 10.1109/STHERM.1994.288998; Chiang KT, 2006, INT COMMUN HEAT MASS, V33, P836, DOI 10.1016/j.icheatmasstransfer.2006.04.011; Copiello D, 2009, INT J HEAT MASS TRAN, V52, P1167, DOI 10.1016/j.ijheatmasstransfer.2008.09.012; Culham JR, 2001, IEEE T COMPON PACK T, V24, P159, DOI 10.1109/6144.926378; Eberhart Kennedy J, 1995, NEW OPTIMIZER USING, P39; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Eberhart RC, 2001, IEEE C EVOL COMPUTAT, P81, DOI 10.1109/CEC.2001.934374; Fabbri G, 1997, INT J HEAT MASS TRAN, V40, P2165, DOI 10.1016/S0017-9310(96)00294-3; Hajabdollahi F, 2012, APPL MATH MODEL, V36, P244, DOI 10.1016/j.apm.2011.05.048; Iyengar M, 2003, IEEE T COMPON PACK T, V26, P62, DOI 10.1109/TCAPT.2003.811484; Iyengar M, 2001, IEEE T COMPON PACK T, V24, P150, DOI 10.1109/6144.926377; Jha RK, 2005, P I MECH ENG C-J MEC, V219, P757, DOI 10.1243/095440605X31544; Jonsson H, 1996, ASME PUBLICATION; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Khan WA, 2006, J ELECTRON PACKAGING, V128, P324, DOI 10.1115/1.2351896; Khan W.A., 2004, MODELING FLUID FLOW; Lahiri SK, 2012, CHEM PROD PROCESS MO, V7, DOI 10.1515/1934-2659.1612; Laor K, 1992, I CHEM ENG S SER, V1, P335; Li QL, 1998, INT J HEAT FLUID FL, V19, P245, DOI 10.1016/S0142-727X(98)00003-4; Liu XY, 2010, LECT NOTES COMPUT SC, V6146, P92; Marinke R, 2005, PARTICLE SWARM OPTIM; Mokheimer EMA, 2002, INT J HEAT MASS TRAN, V45, P3631, DOI 10.1016/S0017-9310(02)00078-9; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Nenortaite J, 2008, EUROGR TECH REP SER, P88, DOI 10.1109/HSI.2008.4581414; OTA T, 1984, INT J HEAT MASS TRAN, V27, P1771, DOI 10.1016/0017-9310(84)90159-5; OTA T, 1983, B JSME, V26, P262, DOI 10.1299/jsme1958.26.262; Patel VK, 2010, APPL THERM ENG, V30, P1417, DOI 10.1016/j.applthermaleng.2010.03.001; Peng H, 2010, IND ENG CHEM RES, V49, P6144, DOI 10.1021/ie1002685; POULIKAKOS D, 1982, J HEAT TRANS-T ASME, V104, P616, DOI 10.1115/1.3245176; Rao RV, 2010, INT J THERM SCI, V49, P1712, DOI 10.1016/j.ijthermalsci.2010.04.001; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7; Wirtz RA, 1997, J ELECTRON PACKAGING, V119, P26, DOI 10.1115/1.2792197; Wong KKL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010331; Yousefi M, 2011, OPTIMAL DESIGN PLATE	44	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e66080	10.1371/journal.pone.0066080	http://dx.doi.org/10.1371/journal.pone.0066080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741525	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900238
J	Hase, Y; Tarusawa, T; Muto, A; Himeno, H				Hase, Yoichi; Tarusawa, Takefusa; Muto, Akira; Himeno, Hyouta			Impairment of Ribosome Maturation or Function Confers Salt Resistance on Escherichia coli Cells	PLOS ONE			English	Article							PEPTIDYL TRANSFERASE CENTER; TRANSFER-RNA-BINDING; SMALL-SUBUNIT; CRYOELECTRON MICROSCOPY; SIGMA(E) REGULON; BIOGENESIS; PROTEINS; METHYLTRANSFERASE; STRESS; SHOCK	We found that loss of integrity of the ribosome by removal of a putative ribosome maturation factor or a ribosomal protein conferred salt tolerance on Escherichia coli cells. Some protein synthesis inhibitors including kasugamycin and chloramphenicol also had a similar effect, although kasugamycin affected neither 16S rRNA maturation nor subunit association into a 70S ribosome. Thus, salt tolerance is a common feature of cells in which maturation or function of the ribosome is impaired. In these cells, premature induction of an alternative sigma factor, sigma(E), by salt stress was observed. These results suggest the existence of a yet-unknown stress response pathway mediated by the bacterial ribosome.	[Hase, Yoichi; Tarusawa, Takefusa; Muto, Akira; Himeno, Hyouta] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan; [Himeno, Hyouta] Hirosaki Univ, RNA Res Ctr, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Himeno, H (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan.	himeno@cc.hirosaki-u.ac.jp			Japan Society for the Promotion of Science [23380054, 24658066]; Grant for Hirosaki University Institutional Research; Grants-in-Aid for Scientific Research [24657114] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grant for Hirosaki University Institutional Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science to A.M. and H.H. (Nos. 23380054 and 24658066) and a Grant for Hirosaki University Institutional Research to H.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades SE, 2004, CURR OPIN MICROBIOL, V7, P157, DOI 10.1016/j.mib.2004.02.010; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bayfield MA, 2001, P NATL ACAD SCI USA, V98, P10096, DOI 10.1073/pnas.171319598; Bianchi AA, 1999, MOL MICROBIOL, V34, P1029, DOI 10.1046/j.1365-2958.1999.01664.x; Boehringer D, 2012, J BIOL CHEM, V287, P10453, DOI 10.1074/jbc.M111.318121; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Bylund GO, 1998, J BACTERIOL, V180, P73, DOI 10.1128/JB.180.1.73-82.1998; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Goto S, 2011, EMBO J, V30, P104, DOI 10.1038/emboj.2010.291; Guo Q, 2013, NUCLEIC ACIDS RES, V41, P2609, DOI 10.1093/nar/gks1256; Guo Q, 2011, P NATL ACAD SCI USA, V108, P13100, DOI 10.1073/pnas.1104645108; Hager J, 2004, J BACTERIOL, V186, P6634, DOI 10.1128/JB.186.19.6634-6642.2004; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hase Y, 2009, RNA, V15, P1766, DOI 10.1261/rna.1687309; HELD WA, 1974, J BIOL CHEM, V249, P3103; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Holmes KL, 2005, J MOL BIOL, V354, P340, DOI 10.1016/j.jmb.2005.09.056; ISONO K, 1978, P NATL ACAD SCI USA, V75, P6163, DOI 10.1073/pnas.75.12.6163; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Jomaa A, 2011, RNA, V17, P2026, DOI 10.1261/rna.2922311; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kimura T, 2008, J MOL BIOL, V381, P467, DOI 10.1016/j.jmb.2008.06.023; Lee SJ, 2004, MOL CELL, V14, P153, DOI 10.1016/S1097-2765(04)00202-3; Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656; Lovgren JM, 2004, RNA, V10, P1798, DOI 10.1261/rna.7720204; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Mutalik VK, 2009, J BACTERIOL, V191, P7279, DOI 10.1128/JB.01047-09; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Siibak T, 2011, MOL MICROBIOL, V80, P54, DOI 10.1111/j.1365-2958.2011.07555.x; Thompson KM, 2007, J BACTERIOL, V189, P4243, DOI 10.1128/JB.00020-07; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x	46	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65747	10.1371/journal.pone.0065747	http://dx.doi.org/10.1371/journal.pone.0065747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741511	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900224
J	Hummel, IB; Reinartz, MT; Kalble, S; Burhenne, H; Schwede, F; Buschauer, A; Seifert, R				Hummel, Irena Brunskole; Reinartz, Michael T.; Kaelble, Solveig; Burhenne, Heike; Schwede, Frank; Buschauer, Armin; Seifert, Roland			Dissociations in the Effects of beta(2)-Adrenergic Receptor Agonists on cAMP Formation and Superoxide Production in Human Neutrophils: Support for the Concept of Functional Selectivity	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; BETA(2) ADRENERGIC-RECEPTOR; FORMING NADPH OXIDASE; CYCLIC-AMP; SIGNAL-TRANSDUCTION; RESPIRATORY BURST; COUPLED RECEPTORS; ADENYLATE-CYCLASE; OXIDATIVE BURST; ACTIVATION	In neutrophils, activation of the beta(2)-adrenergic receptor (beta(2)AR), a G(s)-coupled receptor, inhibits inflammatory responses, which could be therapeutically exploited. The aim of this study was to evaluate the effects of various beta(2)AR ligands on adenosine-3',5'-cyclic monophosphate (cAMP) accumulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP)induced superoxide anion (O-2(center dot-)) production in human neutrophils and to probe the concept of ligand-specific receptor conformations (also referred to as functional selectivity or biased signaling) in a native cell system. This is an important question because so far, evidence for functional selectivity has been predominantly obtained with recombinant systems, due to the inherent difficulties to genetically manipulate human native cells. cAMP concentration was determined by HPLC/tandem mass spectrometry, and O-2(center dot-) formation was assessed by superoxide dismutase-inhibitable reduction of ferricytochrome c. beta(2)AR agonists were generally more potent in inhibiting fMLP-induced O-2(center dot-) production than in stimulating cAMP accumulation. (-)-Ephedrine and dichloroisoproterenol were devoid of any agonistic activity in the cAMP assay, but partially inhibited fMLP-induced O-2(center dot-) production. Moreover, (-)-adrenaline was equi-efficacious in both assays whereas the efficacy of salbutamol was more than two-fold higher in the O-2(center dot-) assay. Functional selectivity was visualized by deviations of ligand potencies and efficacies from linear correlations for various parameters. We obtained no evidence for involvement of protein kinase A in the inhibition of fMLP-induced O-2(center dot-) production after beta(2)AR-stimulation although cAMP-increasing substances inhibited O-2(center dot-) production. Taken together, our data corroborate the concept of ligand-specific receptor conformations with unique signaling capabilities in native human cells and suggest that the beta(2)AR inhibits O-2(center dot-) production in a cAMP-independent manner.	[Hummel, Irena Brunskole; Reinartz, Michael T.; Kaelble, Solveig; Burhenne, Heike; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Hummel, Irena Brunskole; Buschauer, Armin] Univ Regensburg, Dept Pharmaceut & Med Chem 2, D-93053 Regensburg, Germany; [Schwede, Frank] Biolog Life Sci Inst, Bremen, Germany	Hannover Medical School; University of Regensburg	Seifert, R (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	seifert.roland@mh-hannover.de	Bähre, Heike/AAL-7873-2021; Burhenne, Heike/G-4835-2013; Seifert, Roland/G-3189-2013		German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This work was supported by the Research Training Program GRK760 "Medicinal Chemistry: Molecular Recognition - Ligand-Receptor Interactions'' of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appl H, 2011, N-S ARCH PHARMACOL, V385, P145; Arruda MA, 2009, FRONT BIOSCI-LANDMRK, V14, P4546, DOI 10.2741/3547; Audet M, 2008, NAT CHEM BIOL, V4, P397, DOI 10.1038/nchembio.97; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2003, MOL PHARMACOL, V64, P679, DOI 10.1124/mol.64.3.679; Barnett CC, 1997, J SURG RES, V70, P166, DOI 10.1006/jsre.1997.5118; Beste KY, 2013, BIOL CHEM, V394, P261, DOI 10.1515/hsz-2012-0282; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; Brodde OE, 1995, PHARMACOL REV, V51, P651; BURDE R, 1989, N-S ARCH PHARMACOL, V340, P671, DOI 10.1007/BF00717743; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COSTA T, 1988, MOL PHARMACOL, V34, P744; Costantini TW, 2010, IMMUNOPHARM IMMUNOT, V32, P82, DOI 10.3109/08923970903183557; CRONSTEIN BN, 1988, BIOCHEM J, V252, P709, DOI 10.1042/bj2520709; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; El-Benna J, 2010, BIOCHEM PHARMACOL, V80, P778, DOI 10.1016/j.bcp.2010.05.020; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; GETHER U, 1995, J BIOL CHEM, V270, P28268; GIBSONBERRY KL, 1993, J NEUROIMMUNOL, V43, P59, DOI 10.1016/0165-5728(93)90075-A; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; Hourani SMO, 2001, BRIT J PHARMACOL, V133, P833, DOI 10.1038/sj.bjp.0704140; Jackson EK, 2004, ANNU REV PHYSIOL, V66, P571, DOI 10.1146/annurev.physiol.66.032102.111604; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; KAUKEL E, 1972, EUR J BIOCHEM, V27, P197, DOI 10.1111/j.1432-1033.1972.tb01826.x; Kaya AI, 2012, J BIOL CHEM, V287, P6362, DOI 10.1074/jbc.M111.301820; Kellenberger S, 1998, BONE, V22, P471, DOI 10.1016/S8756-3282(98)00026-X; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kinast L, 2012, N-S ARCH PHARMACOL, V385, P671, DOI 10.1007/s00210-012-0759-6; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; LAD PM, 1985, BIOCHIM BIOPHYS ACTA, V846, P286, DOI 10.1016/0167-4889(85)90076-X; Lazarovici P, 1996, ADV EXP MED BIOL, V391, P367; Liao CH, 2008, BIOCHEM PHARMACOL, V76, P1728, DOI 10.1016/j.bcp.2008.09.002; Liu FC, 2012, EUR J PHARMACOL, V688, P68, DOI 10.1016/j.ejphar.2012.05.006; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Madden KS, 2011, BREAST CANCER RES TR, V130, P747, DOI 10.1007/s10549-011-1348-y; Mirza ZN, 2002, ANN ALLERG ASTHMA IM, V88, P494, DOI 10.1016/S1081-1206(10)62388-5; MITSUYAMA T, 1995, MOL CELL BIOCHEM, V145, P19, DOI 10.1007/BF00925708; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; MUELLER H, 1988, MOL PHARMACOL, V34, P347; Mukhopadhyay S, 2005, MOL PHARMACOL, V67, P2016, DOI 10.1124/mol.104.003558; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Orlic T, 2002, AM J PHYSIOL-CELL PH, V282, pC1261, DOI 10.1152/ajpcell.00479.2001; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reher TM, 2012, BIOCHEM PHARMACOL, V84, P1174, DOI 10.1016/j.bcp.2012.08.014; Reher TM, 2012, BIOCHEM PHARMACOL, V84, P192, DOI 10.1016/j.bcp.2012.04.004; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; ROTHERMEL JD, 1984, J BIOL CHEM, V259, P8151; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; SEDGWICK JB, 1985, CLIN IMMUNOL IMMUNOP, V34, P205, DOI 10.1016/0090-1229(85)90025-X; SEIFERT R, 1991, J HYPERTENS, V9, P147, DOI 10.1097/00004872-199102000-00008; Seifert R, 1999, MOL PHARMACOL, V56, P348, DOI 10.1124/mol.56.2.348; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; SEIFERT R, 1991, REV PHYSIOL BIOCH P, V117, P1; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Seifert R, 2009, MOL PHARMACOL, V75, P13, DOI 10.1124/mol.108.052944; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Thomas RL, 2008, J PHARMACOL EXP THER, V327, P365, DOI 10.1124/jpet.108.141788; Tucek S, 1997, TRENDS PHARMACOL SCI, V18, P414; Uemura T, 2010, BONE, V47, P756, DOI 10.1016/j.bone.2010.07.008; Uzkeser H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/438912; Weitl N, 2008, J PHARMACOL EXP THER, V327, P760, DOI 10.1124/jpet.108.143412; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Wenzel-Seifert K, 1999, J BIOL CHEM, V274, P33259, DOI 10.1074/jbc.274.47.33259; WENZELSEIFERT K, 1991, N-S ARCH PHARMACOL, V344, P396; Werner K, 2011, N-S ARCH PHARMACOL, V384, P169, DOI 10.1007/s00210-011-0662-6; WONG K, 1981, CAN J PHYSIOL PHARM, V59, P915, DOI 10.1139/y81-141; Woo AYH, 2009, MOL PHARMACOL, V75, P158, DOI 10.1124/mol.108.051078	84	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64556	10.1371/journal.pone.0064556	http://dx.doi.org/10.1371/journal.pone.0064556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741338	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900051
J	Imam, SZ; Trickler, W; Kimura, S; Binienda, ZK; Paule, MG; Slikker, W; Li, SL; Clark, RA; Ali, SF				Imam, Syed Z.; Trickler, William; Kimura, Shinya; Binienda, Zbigniew K.; Paule, Merle G.; Slikker, William, Jr.; Li, Senlin; Clark, Robert A.; Ali, Syed F.			Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson's Disease Model	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; DOPAMINERGIC NEUROTOXICITY; IMATINIB; ACTIVATION; RESISTANCE; MUTATIONS; LEUKEMIA; GENE	Experimental evidence suggests that oxidative and nitrative mechanisms account for much of the dopaminergic neuronal injury in Parkinson's disease (PD). The ubiquitously expressed non-receptor tyrosine kinase c-Abl is activated by oxidative stress and thus, may play a role in redox-mediated neurodegeneration. Recently, we reported that c-Abl is activated in PD and that a c-Abl inhibitor mitigated neuronal damage in a PD animal model, suggesting a novel neuroprotective therapeutic approach. In the studies presented here, we evaluated the efficacy of a potent and clinically relevant second-generation irreversible Abl kinase inhibitor, INNO-406, as a therapeutic agent for PD. Our studies reveal that INNO-406 is capable of preventing the progression of dopaminergic neuronal damage in a toxin-induced C57 mouse model of PD. Using bovine brain microvessel endothelium as an in vitro blood-brain barrier (BBB) model, we detected rapid and significant transfer of INNO-406. Additionally, pharmacokinetic analyses demonstrated significant nanomolar concentrations of INNO-406 in brain in the presence or absence of MPTP administration, however, INNO-406 did not alter the brain levels of MPP+ in MPTP-treated mice. Finally, we showed that 10 mg/kg of INNO-406 given to C57 mice for one week before MPTP treatment (4620 mg/kg i.p., every 2 h) and then for one week after MPTP treatment decreased the loss of dopamine in the striatum by 45% and the loss of TH+ neurons in substantia nigra pars compacts by 40%. This treatment regimen also abrogated activation of c-Abl, tyrosine phosphorylation of the Abl substrate and E3-ubiquitin ligase parkin, and accumulation of the toxic parkin substrate AIMP2. We propose that compounds of the INNO-406 class of Abl inhibitors will be useful new neuroprotective drugs for the treatment of PD-like pathology in preclinical systems that should be easily translated to the clinic.	[Imam, Syed Z.; Trickler, William; Binienda, Zbigniew K.; Paule, Merle G.; Slikker, William, Jr.; Ali, Syed F.] US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Jefferson, AR 72079 USA; [Imam, Syed Z.; Li, Senlin; Clark, Robert A.] UT Hlth Sci Ctr, Dept Med, San Antonio, TX USA; [Imam, Syed Z.] Univ Arkansas Med Sci, Dept Geriatr, Little Rock, AR 72205 USA; [Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan	US Food & Drug Administration (FDA); University of Texas System; University of Texas Health San Antonio; University of Arkansas System; University of Arkansas Medical Sciences; Saga University	Imam, SZ (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Jefferson, AR 72079 USA.	syed.imam@fda.hhs.gov	Clark, Robert/Q-6764-2019	Clark, Robert/0000-0002-4892-3619	Michael J. Fox Foundation; Parkinson's Disease Foundation; San Antonio Area Foundation; American Parkinson Disease Association; Executive Research Council of UTHSCSA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25461425] Funding Source: KAKEN	Michael J. Fox Foundation; Parkinson's Disease Foundation; San Antonio Area Foundation; American Parkinson Disease Association; Executive Research Council of UTHSCSA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Michael J. Fox Foundation, Parkinson's Disease Foundation, San Antonio Area Foundation, American Parkinson Disease Association and Executive Research Council of UTHSCSA. The funders had no role in study design, data collection and analysis, decision to publish or presentation of the manuscript.	Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; AUDUS KL, 1987, ANN NY ACAD SCI, V507, P9, DOI 10.1111/j.1749-6632.1987.tb45787.x; Bachmeier CJ, 2004, J PHARM SCI-US, V93, P932, DOI 10.1002/jps.20018; Breedveld P, 2005, CANCER RES, V65, P2577, DOI 10.1158/0008-5472.CAN-04-2416; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Holcomb M, 2006, J BIOL CHEM, V281, P2430, DOI 10.1074/jbc.M508454200; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Imam SZ, 2001, J NEUROCHEM, V78, P952, DOI 10.1046/j.1471-4159.2001.00477.x; Kantarjian H, 2010, CANCER-AM CANCER SOC, V116, P2665, DOI 10.1002/cncr.25079; KARLSSON J, 1992, BIOCHIM BIOPHYS ACTA, V1111, P204, DOI 10.1016/0005-2736(92)90312-A; Kimura S, 2005, BLOOD, V106, P3948, DOI 10.1182/blood-2005-06-2209; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lozano AM, 1998, CURR OPIN NEUROBIOL, V8, P783, DOI 10.1016/S0959-4388(98)80122-0; Lozano AM, 1998, STEREOT FUNCT NEUROS, V71, P153, DOI 10.1159/000029659; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Santos FPS, 2010, CURR OPIN INVEST DR, V11, P1450; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Sherer TB, 2005, ANTIOXID REDOX SIGN, V7, P627, DOI 10.1089/ars.2005.7.627; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Trickler WJ, 2005, BRAIN RES, V1048, P24, DOI 10.1016/j.brainres.2005.04.028	26	53	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65129	10.1371/journal.pone.0065129	http://dx.doi.org/10.1371/journal.pone.0065129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741470	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900183
J	Liu, ZY; Liu, ZY; Walters, BJ; Owen, T; Kopan, R; Zuo, J				Liu, Zhiyong; Liu, Zhenyi; Walters, Bradley J.; Owen, Thomas; Kopan, Raphael; Zuo, Jian			In Vivo Visualization of Notch1 Proteolysis Reveals the Heterogeneity of Notch1 Signaling Activity in the Mouse Cochlea	PLOS ONE			English	Article							HAIR CELL-DEVELOPMENT; INNER-EAR; SENSORY EPITHELIA; PROSENSORY DOMAIN; FATE; DIFFERENTIATION; PILLAR; SPECIFICATION; EXPRESSION; SOX2	Mechanosensory hair cells (HCs) and surrounding supporting cells (SCs) in the mouse cochlea are important for hearing and are derived from the same prosensory progenitors. Notch1 signaling plays dual but contrasting and age-dependent roles in mouse cochlear development: early lateral induction and subsequent lateral inhibition. However, it has been difficult to directly visualize mouse cochlear cells experiencing various levels of Notch1 activity at single cell resolution. Here, we characterized two knock-in mouse lines, Notch1(Cre (Low)/+) and Notch1(Cre (High)/+), with different Cre recombinase activities, that can detect Notch1 receptor proteolysis or Notch1 activity at high and low thresholds, respectively. Using both lines together with a highly sensitive Cre reporter line, we showed that Notch1 activity is nearly undetectable during lateral induction but increases to medium and high levels during lateral inhibition. Furthermore, we found that within the neonatal organ of Corti, the vast majority of cells that experience Notch1 activity were SCs not HCs, suggesting that HCs kept undetectable Notch1 activity during the entire lineage development. Furthermore, among SC subtypes similar to 85-99% of Deiters' and outer pillar cells but only similar to 19-38% of inner pillar cells experience medium and high levels of Notch1 activity. Our results demonstrate that Notch1 activity is highly heterogeneous: 1) between lateral induction and inhibition; 2) between HC and SC lineages; 3) among different SC subtypes; 4) among different cells within each SC subtype. Such heterogeneity should elucidate how the development of the cochclear sensory epithelium is precisely controlled and how HC regeneration can be best achieved in postnatal cochleae.	[Liu, Zhiyong; Walters, Bradley J.; Owen, Thomas; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Liu, Zhiyong] Univ Tennessee, Ctr Hlth Sci, Integrated Program Biomed Sci, Memphis, TN 38163 USA; [Liu, Zhenyi; Kopan, Raphael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Liu, Zhenyi; Kopan, Raphael] Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA; [Owen, Thomas] Univ Bath, Bath BA2 7AY, Avon, England	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Washington University (WUSTL); Washington University (WUSTL); University of Bath	Zuo, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org	Kopan, Raphael/AAF-1357-2022; Kopan, Raphael/AFG-3275-2022	Kopan, Raphael/0000-0002-0350-2730	National Institutes of Health (NIH) [DC06471, CA21765, DK066408]; Office of Naval Research [N000140911014, N000141210191, N000141210775]; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; Hartwell Individual Biomedical Research Award; University of Tennessee Health Science Center; Academic Programs of St. Jude Children's Research Hospital; Society of Developmental Biology; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Hartwell Individual Biomedical Research Award; University of Tennessee Health Science Center; Academic Programs of St. Jude Children's Research Hospital; Society of Developmental Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (NIH): DC06471, CA21765 and DK066408; Office of Naval Research: N000140911014, N000141210191, and N000141210775; the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; The Hartwell Individual Biomedical Research Award (JZ); Travel Awards from University of Tennessee Health Science Center, Academic Programs of St. Jude Children's Research Hospital, and Society of Developmental Biology (Zhiyong Liu); HHF and NOHR (BW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Bok JW, 2007, INT J DEV BIOL, V51, P521, DOI 10.1387/ijdb.072381jb; Bok J, 2011, P NATL ACAD SCI USA, V108, P161, DOI 10.1073/pnas.1010547108; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Dolle P, 2010, DEV DYNAM, V239, P3260, DOI 10.1002/dvdy.22479; DRIVER EC, 2013, DEV BIOL; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Guentchev M, 2006, EUR J NEUROSCI, V23, P2289, DOI 10.1111/j.1460-9568.2006.04766.x; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hartman BH, 2009, JARO-J ASSOC RES OTO, V10, P321, DOI 10.1007/s10162-009-0162-2; Hayashi T, 2008, J NEUROSCI, V28, P5991, DOI 10.1523/JNEUROSCI.1690-08.2008; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Huh SH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001231; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly MC, 2009, CURR OPIN NEUROBIOL, V19, P395, DOI 10.1016/j.conb.2009.07.010; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Kwan T, 2009, ANN NY ACAD SCI, V1170, P28, DOI 10.1111/j.1749-6632.2009.04484.x; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Li SD, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-20; Liu ZY, 2011, J CLIN INVEST, V121, P800, DOI 10.1172/JCI43114; Liu ZY, 2009, GENOME RES, V19, P2081, DOI 10.1101/gr.093856.109; Liu ZY, 2012, J NEUROSCI, V32, P10530, DOI 10.1523/JNEUROSCI.0686-12.2012; Liu ZY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034123, 10.1371/journal.pone.0050367]; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Liu ZY, 2012, DEV DYNAM, V241, P684, DOI 10.1002/dvdy.23754; Liu ZY, 2010, DEV DYNAM, V239, P1674, DOI 10.1002/dvdy.22302; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Pan W, 2010, P NATL ACAD SCI USA, V107, P15798, DOI 10.1073/pnas.1003089107; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; TATEYA T, 2011, DEV BIOL; Vooijs M, 2007, DEVELOPMENT, V134, P535, DOI 10.1242/dev.02733; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yang H, 2010, GENESIS, V48, P407, DOI 10.1002/dvg.20633; Zhang N, 2000, CURR BIOL, V10, P659, DOI 10.1016/S0960-9822(00)00522-4	52	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64903	10.1371/journal.pone.0064903	http://dx.doi.org/10.1371/journal.pone.0064903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741415	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900128
J	Lu, L; Sun, HC; Zhang, W; Chai, ZT; Zhu, XD; Kong, LQ; Wang, WQ; Zhang, KZ; Zhang, YY; Zhang, QB; Ao, JY; Li, JQ; Wang, L; Wu, WZ; Tang, ZY				Lu, Lu; Sun, Hui-Chuan; Zhang, Wei; Chai, Zong-Tao; Zhu, Xiao-Dong; Kong, Ling-Qun; Wang, Wen-Quan; Zhang, Ke-Zhi; Zhang, Yuan-Yuan; Zhang, Qiang-Bo; Ao, Jian-Yang; Li, Jia-Qi; Wang, Lu; Wu, Wei-Zhong; Tang, Zhao-You			Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; LOW-DOSE ASPIRIN; IN-VIVO; TUMOR-GROWTH; ANTIANGIOGENIC THERAPY; ACETYLSALICYLIC-ACID; OXIDATIVE STRESS; CANCER INCIDENCE; LUNG METASTASIS; HEPATITIS-B	Background & Aims: We previously demonstrated the pro-metastasis effect of sorafenib in hepatocellular carcinoma (HCC), which is mediated by down-regulation of tumor suppressor HTATIP2. The aim of the present study was to determine whether aspirin minimizes this effect and improves survival. Methods: The effects of sorafenib, aspirin, and combined sorafenib and aspirin were observed in HCCLM3 and HepG2 xenograft nude mice. Tumor growth, intrahepatic metastasis (IHM), lung metastasis, and survival were assessed. Polymerase chain reaction (PCR) array, real-time (RT)-PCR, and Western blotting were used to examine gene expression. The antiinvasion and anti-metastasis effects of aspirin were studied in HTATIP2-knockdown and HTATIP2-overexpressing HCC cell lines. The molecular mechanism of HTATIP2 regulation by aspirin was explored. Results: Aspirin suppressed the pro-invasion and pro-metastasis effects of sorafenib in HCC and up-regulated HTATIP2 expression. Aspirin did not inhibit the proliferation of HCC cells, but it decreased the invasiveness of HCC with lower expression of HTATIP2 and increased expression of a set of markers, indicating a mesenchymal-to-epithelial transition in tumor cells. The up-regulation of HTATPI2 expression by aspirin is most likely mediated through inhibition of cyclooxygenase (COX) 2 expression. Conclusions: Aspirin minimized the pro-metastasis effect of sorafenib by up-regulating the tumor suppressor HTATIP2; this mechanism is mediated through inhibition of COX2.	[Lu, Lu; Sun, Hui-Chuan; Chai, Zong-Tao; Zhu, Xiao-Dong; Kong, Ling-Qun; Zhang, Ke-Zhi; Zhang, Yuan-Yuan; Zhang, Qiang-Bo; Ao, Jian-Yang; Li, Jia-Qi; Wang, Lu; Wu, Wei-Zhong; Tang, Zhao-You] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; [Lu, Lu; Sun, Hui-Chuan; Chai, Zong-Tao; Zhu, Xiao-Dong; Kong, Ling-Qun; Zhang, Ke-Zhi; Zhang, Yuan-Yuan; Zhang, Qiang-Bo; Ao, Jian-Yang; Li, Jia-Qi; Wang, Lu; Wu, Wei-Zhong; Tang, Zhao-You] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Lu, Lu; Sun, Hui-Chuan; Chai, Zong-Tao; Zhu, Xiao-Dong; Kong, Ling-Qun; Zhang, Ke-Zhi; Zhang, Yuan-Yuan; Zhang, Qiang-Bo; Ao, Jian-Yang; Li, Jia-Qi; Wang, Lu; Wu, Wei-Zhong; Tang, Zhao-You] Chinese Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Zhang, Wei] Tianjin Med Univ Canc Inst & Hosp TJCIH, Dept Hepatobiliary Surg, Tianjin, Peoples R China; [Zhang, Wei] Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Wang, Wen-Quan] Fudan Univ, Dept Hepatobiliary & Pancreat Surg, Inst Canc, Canc Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Tianjin Medical University; Fudan University	Tang, ZY (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China.	zytang88@163.com	Zhu, Xiao-Dong/A-8197-2010; zhang, yuanyuan/GYA-4428-2022	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Key Project for Infectious Diseases [2012ZX10002012-004]; National Natural Science Foundation of China [81101564, 81020108025]; Shanghai Natural Science Foundation [12ZR1442300]; National "211" Project for Higher Education	National Key Project for Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National "211" Project for Higher Education	This work was supported jointly by the National Key Project for Infectious Diseases (2012ZX10002012-004), the National Natural Science Foundation of China (No. 81101564, 81020108025), the Shanghai Natural Science Foundation (12ZR1442300), and the National "211" Project for Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru S, 2002, HEPATOLOGY, V35, P1117, DOI 10.1053/jhep.2002.32676; Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; Cacheux W, 2008, ANN ONCOL, V19, P1659, DOI 10.1093/annonc/mdn540; Carter CA, 2007, CANCER CHEMOTH PHARM, V59, P183, DOI 10.1007/s00280-006-0257-y; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; Desar IME, 2009, ACTA ONCOL, V48, P927, DOI 10.1080/02841860902974167; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Futakuchi M, 2004, CANCER SCI, V95, P18, DOI 10.1111/j.1349-7006.2004.tb03165.x; Futakuchi M, 2002, JPN J CANCER RES, V93, P1175, DOI 10.1111/j.1349-7006.2002.tb01220.x; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HIAL V, 1977, J PHARMACOL EXP THER, V202, P446; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Hossain MA, 2012, INT J ONCOL, V40, P1636, DOI 10.3892/ijo.2012.1359; Huang ES, 2011, AM J MED, V124, P426, DOI 10.1016/j.amjmed.2010.12.022; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Morgan G, 2009, PUBLIC HEALTH, V123, P787, DOI 10.1016/j.puhe.2009.10.007; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Powles T, 2011, EUR UROL, V60, P448, DOI 10.1016/j.eururo.2011.05.028; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Saad-Hossne R, 2007, ACTA CIR BRAS, V22, P299, DOI 10.1590/S0102-86502007000400012; Sahasrabuddhe VV, 2012, J NATL CANC I; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Tang ZY, 2005, J SURG ONCOL, V91, P95, DOI 10.1002/jso.20291; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yu CR, 2006, MOL CANCER THER, V5, P2378, DOI 10.1158/1535-7163.MCT-06-0235; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zhang W, 2012, GASTROENTEROLOGY; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Zhao J, 2008, HEPATOLOGY, V48, P265, DOI 10.1002/hep.22280; Zhao J, 2008, CANCER RES, V68, P4133, DOI 10.1158/0008-5472.CAN-08-0432; Zhao J, 2006, HEPATOLOGY, V44, P205, DOI 10.1002/hep.21213	50	32	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65023	10.1371/journal.pone.0065023	http://dx.doi.org/10.1371/journal.pone.0065023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741443	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900156
J	Ooba, N; Setoguchi, S; Ando, T; Sato, T; Yamaguchi, T; Mochizuki, M; Kubota, K				Ooba, Nobuhiro; Setoguchi, Soko; Ando, Takashi; Sato, Tsugumichi; Yamaguchi, Takuhiro; Mochizuki, Mayumi; Kubota, Kiyoshi			Claims-Based Definition of Death in Japanese Claims Database: Validity and Implications	PLOS ONE			English	Article								Background: For the pending National Claims Database in Japan, researchers will not have access to death information in the enrollment files. We developed and evaluated a claims-based definition of death. Methodology/Principal Findings: We used healthcare claims and enrollment data between January 2005 and August 2009 for 195,193 beneficiaries aged 20 to 74 in 3 private health insurance unions. We developed claims-based definitions of death using discharge or disease status and Charlson comorbidity index (CCI). We calculated sensitivity, specificity and positive predictive values (PPVs) using the enrollment data as a gold standard in the overall population and subgroups divided by demographic and other factors. We also assessed bias and precision in two example studies where an outcome was death. The definition based on the combination of discharge/disease status and CCI provided moderate sensitivity (around 60%) and high specificity (99.99%) and high PPVs (94.8%). In most subgroups, sensitivity of the preferred definition was also around 60% but varied from 28 to 91%. In an example study comparing death rates between two anticancer drug classes, the claims-based definition provided valid and precise hazard ratios (HRs). In another example study comparing two classes of anti-depressants, the HR with the claims-based definition was biased and had lower precision than that with the gold standard definition. Conclusions/Significance: The claims-based definitions of death developed in this study had high specificity and PPVs while sensitivity was around 60%. The definitions will be useful in future studies when used with attention to the possible fluctuation of sensitivity in some subpopulations.	[Ooba, Nobuhiro; Setoguchi, Soko; Sato, Tsugumichi; Kubota, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo, Japan; [Setoguchi, Soko] Duke Clin Res Inst, Durham, NC USA; [Ando, Takashi; Mochizuki, Mayumi] Keio Univ, Fac Pharm, Div Evaluat & Anal Drug Informat, Tokyo, Japan; [Sato, Tsugumichi] Drug Safety Res Unit Japan, Tokyo, Japan; [Yamaguchi, Takuhiro] Tohoku Univ, Sch Med, Dept Publ Hlth & Forens Med, Sendai, Miyagi 980, Japan	University of Tokyo; Duke University; Keio University; Tohoku University	Kubota, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo, Japan.	kubotape-tky@umin.ac.jp			Pfizer Health Research Foundation [11-2-021]	Pfizer Health Research Foundation	Dr. Kubota was supported by a grant from Pfizer Health Research Foundation (Grant No. 11-2-021, http://www.pfizer-zaidan.jp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mealing NM, 2012, PHARMACOEPIDEM DR S, V21, P742, DOI 10.1002/pds.2257; Ministry of Health Labour and Welfare (MHLW), NAT DAT GUID JAP; Ministry of Health Labour and Welfare (MHLW), NAT VIT STAT 2008; Sean H, 2006, BASIC CLIN PHARMACOL, V98, P311; Seong JM, 2011, PHARMACOEPIDEM DR S, V20, P344, DOI 10.1002/pds.2112; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Verdu B, 2008, DRUGS, V68, P2611, DOI 10.2165/0003495-200868180-00007	11	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e66116	10.1371/journal.pone.0066116	http://dx.doi.org/10.1371/journal.pone.0066116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741526	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900239
J	Prestori, F; Bonardi, C; Mapelli, L; Lombardo, P; Goselink, R; De Stefano, ME; Gandolfi, D; Mapelli, J; Bertrand, D; Schonewille, M; De Zeeuw, C; D'Angelo, E				Prestori, Francesca; Bonardi, Claudia; Mapelli, Lisa; Lombardo, Paola; Goselink, Rianne; De Stefano, Maria Egle; Gandolfi, Daniela; Mapelli, Jonathan; Bertrand, Daniel; Schonewille, Martijn; De Zeeuw, Chris; D'Angelo, Egidio			Gating of Long-Term Potentiation by Nicotinic Acetylcholine Receptors at the Cerebellum Input Stage	PLOS ONE			English	Article							GRANULE CELL SYNAPSES; SYNAPTIC PLASTICITY; DIFFERENTIALLY FACILITATE; NEUROTRANSMITTER RELEASE; SPATIAL-ORGANIZATION; RAT CEREBELLUM; TRANSMISSION; INDUCTION; GLUTAMATE; ACTIVATION	The brain needs mechanisms able to correlate plastic changes with local circuit activity and internal functional states. At the cerebellum input stage, uncontrolled induction of long-term potentiation or depression (LTP or LTD) between mossy fibres and granule cells can saturate synaptic capacity and impair cerebellar functioning, which suggests that neuromodulators are required to gate plasticity processes. Cholinergic systems innervating the cerebellum are thought to enhance procedural learning and memory. Here we show that a specific subtype of acetylcholine receptors, the alpha 7-nAChRs, are distributed both in cerebellar mossy fibre terminals and granule cell dendrites and contribute substantially to synaptic regulation. Selective alpha 7-nAChR activation enhances the postsynaptic calcium increase, allowing weak mossy fibre bursts, which would otherwise cause LTD, to generate robust LTP. The local microperfusion of alpha 7-nAChR agonists could also lead to in vivo switching of LTD to LTP following sensory stimulation of the whisker pad. In the cerebellar flocculus, alpha 7-nAChR pharmacological activation impaired vestibulo-ocular-reflex adaptation, probably because LTP was saturated, preventing the fine adjustment of synaptic weights. These results show that gating mechanisms mediated by specific subtypes of nicotinic receptors are required to control the LTD/LTP balance at the mossy fibre-granule cell relay in order to regulate cerebellar plasticity and behavioural adaptation.	[Prestori, Francesca; Mapelli, Jonathan; D'Angelo, Egidio] IRCCS, C Mondino Natl Inst Neurol Fdn, Brain Connect Ctr, Pavia, Italy; [Prestori, Francesca; Bonardi, Claudia; Mapelli, Lisa; Lombardo, Paola; Goselink, Rianne; Gandolfi, Daniela; D'Angelo, Egidio] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy; [Bonardi, Claudia; Goselink, Rianne; Schonewille, Martijn; De Zeeuw, Chris] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [De Stefano, Maria Egle] Charles Darwin Sapienza Univ Rome, Dept Biol & Biotechnol, Cenci Bolognetti Fdn, Inst Pasteur, Rome, Italy; [Bertrand, Daniel] Univ Geneva, Fac Med, Dept Neurosci, Geneva, Switzerland; [De Zeeuw, Chris] Royal Dutch Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Mapelli, Jonathan] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [De Stefano, Maria Egle] Univ Roma La Sapienza, Daniel Bovet Ctr Res Neurobiol, Rome, Italy	IRCCS Fondazione Casimiro Mondino; University of Pavia; University of Pavia; Erasmus University Rotterdam; Erasmus MC; Fondazione Cenci Bolognetti; University of Geneva; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Universita di Modena e Reggio Emilia; Sapienza University Rome	De Zeeuw, C (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl; dangelo@unipv.it	Goselink, Rianne/E-1795-2016; De Stefano, Maria Egle/A-8457-2010; Schonewille, Martijn/E-6170-2013; Mapelli, Lisa/J-9802-2019; Mapelli, Lisa/GSI-4507-2022; D'Angelo, Egidio/AAC-3846-2022	Goselink, Rianne/0000-0001-9640-6053; Mapelli, Lisa/0000-0002-5048-0458; D'Angelo, Egidio/0000-0002-6007-7187; mapelli, jonathan/0000-0002-0381-1576; De Stefano, Maria Egle/0000-0002-5730-2996; PRESTORI, FRANCESCA/0000-0002-0167-3309	European Union [CEREBNET FP7-ITN238686, REALNET FP7-ICT270434]; Italian Ministry of Health [RF-2008-1143418, RF-2009-1475845]	European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the European Union (CEREBNET FP7-ITN238686, REALNET FP7-ICT270434) and by a grant from the Italian Ministry of Health (RF-2008-1143418 and RF-2009-1475845) to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreescu CE, 2011, NEUROSCIENCE, V176, P274, DOI 10.1016/j.neuroscience.2010.12.024; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brown KL, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00166; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Churchland PS, 2017, COMPUT NEUROSCI-MIT; Clements JD, 2003, J NEUROSCI METH, V130, P115, DOI 10.1016/j.jneumeth.2003.09.019; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; D'Angelo E, 2011, BRAIN RES REV, V66, P5, DOI 10.1016/j.brainresrev.2010.10.002; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; D'Errico A, 2009, J PHYSIOL-LONDON, V587, P5843, DOI 10.1113/jphysiol.2009.177162; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DEAN P, 2011, J PHYSL; delToro ED, 1997, DEV BRAIN RES, V98, P125; Dittman JS, 2000, J NEUROSCI, V20, P1374; Fisher JL, 2000, NEUROPHARMACOLOGY, V39, P2756, DOI 10.1016/S0028-3908(00)00102-7; Fujii S, 1999, BRAIN RES, V846, P137, DOI 10.1016/S0006-8993(99)01982-4; Gall D, 2005, J NEUROSCI, V25, P4813, DOI 10.1523/JNEUROSCI.0410-05.2005; GERZANICH V, 1995, MOL PHARMACOL, V48, P774; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hirano S, 2008, MOVEMENT DISORD, V23, P1154, DOI 10.1002/mds.22056; HUNTER BE, 1994, NEUROSCI LETT, V168, P130, DOI 10.1016/0304-3940(94)90433-2; IRVING AJ, 1992, CELL CALCIUM, V13, P293, DOI 10.1016/0143-4160(92)90064-Y; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Lena C, 1997, J NEUROSCI, V17, P576; Lu H, 2005, J NEUROPHYSIOL, V94, P1849, DOI 10.1152/jn.01275.2004; Maloney KJ, 1999, J NEUROSCI, V19, P3057; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; Mapelli J, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00014; Mapelli J, 2010, J NEUROPHYSIOL, V103, P250, DOI 10.1152/jn.00642.2009; Mapelli L, 2009, J NEUROPHYSIOL, V101, P3089, DOI 10.1152/jn.91190.2008; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Martin-Ruiz CM, 2004, MOL BRAIN RES, V123, P81, DOI 10.1016/j.molbrainres.2004.01.003; Matsuyama S, 2000, EUR J NEUROSCI, V12, P3741, DOI 10.1046/j.1460-9568.2000.00259.x; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; McLachlan E M, 1978, Int Rev Physiol, V17, P49; Mielke JG, 2009, NEUROSCI RES, V65, P296, DOI 10.1016/j.neures.2009.08.003; Morissette J, 1996, EXP BRAIN RES, V109, P240; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Moser EI, 1999, NEUROSCI BIOBEHAV R, V23, P661, DOI 10.1016/S0149-7634(98)00060-8; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Nakauchi S, 2012, EUR J NEUROSCI, V35, P1381, DOI 10.1111/j.1460-9568.2012.08056.x; Nieus T, 2006, J NEUROPHYSIOL, V95, P686, DOI 10.1152/jn.00696.2005; Otnaess MK, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-24-j0007.1999; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Reno LAC, 2004, NEUROSCIENCE, V124, P647, DOI 10.1016/j.neuroscience.2003.12.023; Roggeri L, 2008, J NEUROSCI, V28, P6354, DOI 10.1523/JNEUROSCI.5709-07.2008; Rub U, 2008, CURR OPIN NEUROL, V21, P111, DOI 10.1097/WCO.0b013e3282f7673d; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Schweighofer N, 2004, BRAIN RES REV, V44, P103, DOI 10.1016/j.brainresrev.2003.10.004; Schweighofer N, 2001, NEUROSCIENCE, V103, P35, DOI 10.1016/S0306-4522(00)00548-0; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Sola E, 2004, J PHYSIOL-LONDON, V557, P843, DOI 10.1113/jphysiol.2003.060285; Turner JR, 2005, J NEUROSCI, V25, P9258, DOI 10.1523/JNEUROSCI.2112-05.2005; Wang BW, 2006, SYNAPSE, V59, P491, DOI 10.1002/syn.20267; Wang C, 2008, J NEUROSCI, V28, P1865, DOI 10.1523/JNEUROSCI.5417-07.2008; WARD JM, 1990, FEBS LETT, V270, P45, DOI 10.1016/0014-5793(90)81231-C; Welsby P, 2006, EUR J NEUROSCI, V24, P3109, DOI 10.1111/j.1460-9568.2006.05187.x; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Young JW, 2011, GENES BRAIN BEHAV	72	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64828	10.1371/journal.pone.0064828	http://dx.doi.org/10.1371/journal.pone.0064828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741401	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900114
J	Shahar-Gold, H; Gur, R; Wagner, S				Shahar-Gold, Hadar; Gur, Rotem; Wagner, Shlomo			Rapid and Reversible Impairments of Short- and Long-Term Social Recognition Memory Are Caused by Acute Isolation of Adult Rats via Distinct Mechanisms	PLOS ONE			English	Article							VASOPRESSIN; MICE; FACILITATION; HIPPOCAMPUS; LONELINESS; OXYTOCIN; PEPTIDES; MOUSE	Mammalian social organizations require the ability to recognize and remember individual conspecifics. This social recognition memory (SRM) can be examined in rodents using their innate tendency to investigate novel conspecifics more persistently than familiar ones. Here we used the SRM paradigm to examine the influence of housing conditions on the social memory of adult rats. We found that acute social isolation caused within few days a significant impairment in acquisition of short-term SRM of male and female rats. Moreover, SRM consolidation into long-term memory was blocked following only one day of social isolation. Both impairments were reversible, but with different time courses. Furthermore, only the impairment in SRM consolidation was reversed by systemic administration of arginine-vasopressin (AVP). In contrast to SRM, object recognition memory was not affected by social isolation. We conclude that acute social isolation rapidly induces reversible changes in the brain neuronal and molecular mechanisms underlying SRM, which hamper its acquisition and completely block its consolidation. These changes occur via distinct, AVP sensitive and insensitive mechanisms. Thus, acute social isolation of rats swiftly causes changes in their brain and interferes with their normal social behavior.	[Shahar-Gold, Hadar; Gur, Rotem; Wagner, Shlomo] Univ Haifa, Sagol Dept Neurobiol, IL-31999 Haifa, Israel	University of Haifa	Wagner, S (corresponding author), Univ Haifa, Sagol Dept Neurobiol, IL-31999 Haifa, Israel.	shlomow@research.haifa.ac.il		Wagner, Shlomo/0000-0002-7618-0752	Legacy Heritage Bio-Medical Program of the Israel Science Foundation [1901/08]; Autism Speaks Foundation [3613]; National Institute for Psychobiology in Israel [237-07-08]	Legacy Heritage Bio-Medical Program of the Israel Science Foundation; Autism Speaks Foundation; National Institute for Psychobiology in Israel	This research was supported by the Legacy Heritage Bio-Medical Program of the Israel Science Foundation (grant # 1901/08), by the Autism Speaks Foundation (grant # 3613) and by the National Institute for Psychobiology in Israel (grant # 237-07-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUTHE RM, 1992, BRAIN RES, V572, P261, DOI 10.1016/0006-8993(92)90480-W; BLUTHE RM, 1990, BRAIN RES, V535, P301, DOI 10.1016/0006-8993(90)91613-L; DANTZER R, 1988, BRAIN RES, V457, P143, DOI 10.1016/0006-8993(88)90066-2; ENGELMANN M, 1995, PHYSIOL BEHAV, V58, P315, DOI 10.1016/0031-9384(95)00053-L; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferguson JN, 2001, J NEUROSCI, V21, P8278; GHEUSI G, 1994, BEHAV PROCESS, V33, P59, DOI 10.1016/0376-6357(94)90060-4; Gusmao ID, 2012, BEHAV BRAIN RES, V228, P440, DOI 10.1016/j.bbr.2011.12.040; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; LEMOAL M, 1987, NEUROSCI LETT, V77, P353, DOI 10.1016/0304-3940(87)90527-1; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Macbeth AH, 2009, GENES BRAIN BEHAV, V8, P558, DOI 10.1111/j.1601-183X.2009.00506.x; Noack J, 2010, NEUROBIOL LEARN MEM, V94, P568, DOI 10.1016/j.nlm.2010.09.013; PARKES AS, 1961, SCIENCE, V134, P1049, DOI 10.1126/science.134.3485.1049; Popik P, 1998, PROG BRAIN RES, V119, P415; POPIK P, 1992, LIFE SCI, V50, P567, DOI 10.1016/0024-3205(92)90368-Y; POPIK P, 1991, PHYSIOL BEHAV, V49, P1031, DOI 10.1016/0031-9384(91)90327-K; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; SEKIGUCHI R, 1991, PHYSIOL BEHAV, V50, P1253, DOI 10.1016/0031-9384(91)90591-B; Sekiguchi R, 1991, Eur Neuropsychopharmacol, V1, P123, DOI 10.1016/0924-977X(91)90713-5; Squires AS, 2006, NEUROBIOL LEARN MEM, V85, P95, DOI 10.1016/j.nlm.2005.08.012; THOR DH, 1982, J COMP PHYSIOL PSYCH, V96, P1000, DOI 10.1037/0735-7036.96.6.1000; van Goethem NP, 2012, BEHAV BRAIN RES, V232, P323, DOI 10.1016/j.bbr.2012.03.023; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234	29	32	32	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65085	10.1371/journal.pone.0065085	http://dx.doi.org/10.1371/journal.pone.0065085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741464	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900177
J	Tam, DM; Shin, J; Li, A				Tam, Danny M.; Shin, Ji; Li, Andrea			Dominance of Orientation over Frequency in the Perception of 3-D Slant and Shape	PLOS ONE			English	Article							SURFACE ORIENTATION; 3-DIMENSIONAL SHAPE; 3D SHAPE; IDEAL OBSERVERS; TEXTURE; DISCRIMINATION; INHIBITION; STRATEGIES; CELLS	In images of textured three-dimensional surfaces, pattern changes can be characterized as changes in orientation and spatial frequency, features for which neurons in primary visual cortex are classically selective. Previously, we have demonstrated that correct 3-D shape perception is contingent on the visibility of orientation flows that run parallel to the surface curvature. We sought to determine the relative contributions of orientation modulations (OMs) and frequency modulations (FMs) for the detection of slant and shape from 3-D surfaces. Results show that 1) when OM and FM indicate inconsistent degrees of surface slant or curvature, observer responses were consistent with the slant or curvature specified by OM even if the FM indicated a slant or curvature in the opposite direction to the same degree. 2) For slanted surfaces, OM information dictates slant perception at both shallow and steep slants while FM information is effective only for steep slants. Together these results point to a dominant role of OM information in the perception of 3-D slant and shape.	[Tam, Danny M.; Li, Andrea] CUNY, Grad Ctr, Dept Psychol, New York, NY 10021 USA; [Tam, Danny M.; Shin, Ji; Li, Andrea] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Queens College NY (CUNY)	Tam, DM (corresponding author), CUNY, Grad Ctr, Dept Psychol, New York, NY 10021 USA.	danny.tam@qc.cuny.edu			NIH [R15 EY018951, R01 EY13312]; City University of New York PSC-CUNY Research Award Program [PSC-69450-00 38]; NATIONAL EYE INSTITUTE [R01EY013312, R15EY018951] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City University of New York PSC-CUNY Research Award Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH R15 EY018951 to A. Li, NIH R01 EY13312 to Q. Zaidi, and a grant from the City University of New York PSC-CUNY Research Award Program (PSC-69450-00 38) to A. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajcsy R., 1976, COMPUT GRAPHICS IMAG, V5, P52, DOI DOI 10.1016/S0146-664X(76)80005-6; Ben-Shahar O, 2002, LECT NOTES COMPUT SC, V2525, P189; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Clerc M, 2002, IEEE T PATTERN ANAL, V24, P536, DOI 10.1109/34.993560; CUMMING BG, 1993, VISION RES, V33, P827, DOI 10.1016/0042-6989(93)90201-7; CUTTING JE, 1984, J EXP PSYCHOL GEN, V113, P198, DOI 10.1037/0096-3445.113.2.198; Filangieri C, 2009, VISION RES, V49, P1465, DOI 10.1016/j.visres.2009.03.006; Fleming R., 2008, J VISION, V8, P76; Fleming RW, 2011, P NATL ACAD SCI USA, V108, P20438, DOI 10.1073/pnas.1114619109; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Garding J., 1992, Journal of Mathematical Imaging and Vision, V2, P327, DOI 10.1007/BF00121877; Georgieva SS, 2008, CEREB CORTEX, V18, P2416, DOI 10.1093/cercor/bhn002; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; JAMAR JHT, 1982, VISION RES, V22, P407, DOI 10.1016/0042-6989(82)90157-2; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; KNILL DC, 1992, J OPT SOC AM A, V9, P1449, DOI 10.1364/JOSAA.9.001449; Knill DC, 1998, VISION RES, V38, P2635, DOI 10.1016/S0042-6989(97)00415-X; Knill DC, 1998, VISION RES, V38, P1655, DOI 10.1016/S0042-6989(97)00324-6; Krumm John, 1994, Spatial Vision, V8, P281, DOI 10.1163/156856894X00369; Li A, 2004, J VISION, V4, P860, DOI 10.1167/4.10.3; Li A, 2003, VISION RES, V43, P2741, DOI 10.1016/j.visres.2003.07.001; Li A, 2001, VISION RES, V41, P2925, DOI 10.1016/S0042-6989(01)00257-7; Li A, 2000, VISION RES, V40, P217, DOI 10.1016/S0042-6989(99)00169-8; Li A, 2008, VISION RES, V48, P244, DOI 10.1016/j.visres.2007.11.009; Li A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008333; Liu Y, 2004, J NEUROSCI, V24, P3795, DOI 10.1523/JNEUROSCI.0150-04.2004; Malik J, 1997, INT J COMPUT VISION, V23, P149, DOI 10.1023/A:1007958829620; Massot C, 2008, INT J COMPUT VISION, V76, P165, DOI 10.1007/s11263-007-0048-x; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; SAKAI K, 1995, J OPT SOC AM A, V12, P1208, DOI 10.1364/JOSAA.12.001208; Saunders JA, 2006, J VISION, V6, P882, DOI 10.1167/6.9.3; Saunders JA, 2007, J VISION, V7, DOI 10.1167/7.6.7; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Todd J.T., 2010, Journal of Vision, V10, P1, DOI 10.1167/10.5.17.Introduction; Todd JT, 2005, VISION RES, V45, P1501, DOI 10.1016/j.visres.2005.01.003; Todd JT, 1987, J EXPT PSYCHOL HUMAN, V113, P221; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; TURNER MR, 1991, BIOL CYBERN, V65, P215, DOI 10.1007/BF00206219; Zaidi Q, 2002, VISION RES, V42, P815, DOI 10.1016/S0042-6989(01)00233-4; Zaidi Q, 2006, VISUAL NEUROSCI, V23, P323, DOI 10.1017/S0952523806233170	40	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64958	10.1371/journal.pone.0064958	http://dx.doi.org/10.1371/journal.pone.0064958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741436	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900149
J	Zampeli, E; Raftakis, I; Michelongona, A; Nikolaou, C; Elezoglou, A; Toutouzas, K; Siores, E; Sfikakis, PP				Zampeli, Evangelia; Raftakis, Ioannis; Michelongona, Archontoula; Nikolaou, Chara; Elezoglou, Antonia; Toutouzas, Konstantinos; Siores, Elias; Sfikakis, Petros P.			Detection of Subclinical Synovial Inflammation by Microwave Radiometry	PLOS ONE			English	Article							MUSCULOSKELETAL ULTRASOUND; KNEE-JOINT	Objective: Microwave Radiometry is a non-invasive method which determines within seconds the in vivo temperature of internal tissues at a depth of 3-7 cm with an accuracy of +/- 0.2 degrees C. In this proof-of-concept study, we tested the hypothesis that, in absence of relevant clinical signs, increased local temperature detected by microwave radiometry reflects subclinical synovial inflammation, using ultrasound as reference method. Methods: Knees of healthy controls, subjects with recent knee trauma and symptom-free patients with rheumatoid arthritis (RA) or osteoarthritis were examined by placing the microwave radiometry sensor, a) at the upper one third of the anterior surface of the thigh (control-point), and b) over the suprapatellar recess. Ultrasound was performed immediately after and the possible presence of fluid and/or synovitis was correlated with microwave radiometry findings. Results: In 30 healthy and 10 injured knees the temperature was always lower than thigh (32.3 +/- 1.1 and 31.8 +/- 1.4 versus 34.1 +/- 0.9 and 33.6 +/- 1.2 degrees C with a difference (Delta T) of -1.8 +/- 0.2 and -1.9 +/- 0.4 degrees C respectively). Of 40 RA and 20 osteoarthritis knees examined, ultrasound findings indicative of subclinical inflammation (fluid effusion and/or Doppler signal) were found in 24 and 12, respectively, in which the temperature was higher than healthy knees and Delta T was lower (20.9 +/- 0.7 in RA and -1.0 +/- 0.5 in osteoarthritis versus -1.8 +/- 0.2 degrees C, p<0.001). The 5 RA knees with power Doppler findings indicative of grade 2 inflammation had a Delta T 3 times lower compared to healthy (-0.6 +/- 0.6, p = 0.007), whereas the 9 RA and the 7 osteoarthritis knees with additionally fluid effusion, had even lower Delta T (-0.4 +/- 0.7, p<0.001). Conclusion: Using a safe, rapid and easy-to-perform method, such as microwave radiometry, thermal changes within the knee joint may reflect non-clinically apparent joint inflammation. Refinement of this method, including production of sensors for small joints, could result to the development of the ideal objective tool to detect subclinical synovitis in clinical practice.	[Zampeli, Evangelia; Sfikakis, Petros P.] Univ Athens, Sch Med, Dept Propedeut & Internal Med 1, GR-11527 Athens, Greece; [Raftakis, Ioannis; Elezoglou, Antonia] Asklep Gen Hosp, Dept Rheumatol, Athens, Greece; [Michelongona, Archontoula; Nikolaou, Chara; Toutouzas, Konstantinos] Univ Athens, Sch Med, Dept Cardiol 1, GR-11527 Athens, Greece; [Siores, Elias] Univ Bolton, Inst Mat Res & Innovat, Bolton, England	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; University of Bolton	Sfikakis, PP (corresponding author), Univ Athens, Sch Med, Dept Propedeut & Internal Med 1, GR-11527 Athens, Greece.	psfikakis@med.uoa.gr	Sfikakis, Petros/AAD-7289-2019	Zampeli, Evangelia/0000-0002-3668-4454				Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Barrett A H, 1975, Bibl Radiol, P45; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; DESILVA M, 1986, ANN RHEUM DIS, V45, P277, DOI 10.1136/ard.45.4.277; Fukae J, 2013, RHEUMATOLOGY, V52, P523, DOI 10.1093/rheumatology/kes310; Koski JM, 2006, ANN RHEUM DIS, V65, P1590, DOI 10.1136/ard.2005.051235; Naredo E, 2007, ARTHRIT RHEUM-ARTHR, V57, P116, DOI 10.1002/art.22461; SALISBURY RS, 1983, ANN RHEUM DIS, V42, P494, DOI 10.1136/ard.42.5.494; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Shaeffer J, 1982, Prog Clin Biol Res, V107, P509; Spalding SJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2360; TAMBORRINI G, 2011, US MUSCULOSKELETAL R, V1, P32; Toutouzas K, 2011, ATHEROSCLEROSIS, V215, P82, DOI 10.1016/j.atherosclerosis.2010.12.019; Toutouzas K, 2012, J AM COLL CARDIOL, V59, P1645, DOI 10.1016/j.jacc.2012.01.033; Wakefield RJ, 2005, J RHEUMATOL, V32, P2485; Walther M, 2001, ARTHRITIS RHEUM, V44, P331, DOI 10.1002/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0	16	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64606	10.1371/journal.pone.0064606	http://dx.doi.org/10.1371/journal.pone.0064606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741349	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900062
J	Case, CM; Sackett, DL; Wangsa, D; Karpova, T; McNally, JG; Ried, T; Camps, J				Case, Chanelle M.; Sackett, Dan L.; Wangsa, Danny; Karpova, Tatiana; McNally, James G.; Ried, Thomas; Camps, Jordi			CKAP2 Ensures Chromosomal Stability by Maintaining the Integrity of Microtubule Nucleation Sites	PLOS ONE			English	Article							MEROTELIC KINETOCHORE ORIENTATION; MAMMALIAN TISSUE-CELLS; HUMAN MITOTIC SPINDLE; DIFFERENT MECHANISMS; CANCER-CELLS; AURORA-A; IN-SITU; PROTEIN; PHOSPHORYLATION; INSTABILITY	Integrity of the microtubule spindle apparatus and intact cell division checkpoints are essential to ensure the fidelity of distributing chromosomes into daughter cells. Cytoskeleton-associated protein 2, CKAP2, is a microtubule-associated protein that localizes to spindle poles and aids in microtubule stabilization, but the exact function and mechanism of action are poorly understood. In the present study, we utilized RNA interference to determine the extent to which the expression of CKAP2 plays a role in chromosome segregation. CKAP2-depleted cells showed a significant increase of multipolar mitoses and other spindle pole defects. Notably, when interrogated for microtubule nucleation capacity, CKAP2-depleted cells showed a very unusual phenotype as early as two minutes after release from mitotic block, consisting of dispersal of newly polymerized microtubule filaments through the entire chromatin region, creating a cage-like structure. Nevertheless, spindle poles were formed after one hour of mitotic release suggesting that centrosome-mediated nucleation remained dominant. Finally, we showed that suppression of CKAP2 resulted in a higher incidence of merotelic attachments, anaphase lagging, and polyploidy. Based on these results, we conclude that CKAP2 is involved in the maintenance of microtubule nucleation sites, focusing microtubule minus ends to the spindle poles in early mitosis, and is implicated in maintaining genome stability.	[Case, Chanelle M.; Wangsa, Danny; Ried, Thomas; Camps, Jordi] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Case, Chanelle M.] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Sackett, Dan L.] NICHHD, Sect Cell Biophys, NIH, Bethesda, MD 20892 USA; [Karpova, Tatiana; McNally, James G.] NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ried, T (corresponding author), NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	riedt@mail.nih.gov; campsj@mail.nih.gov	Camps, Jordi/AAG-3080-2020	Camps, Jordi/0000-0002-3165-3640; Karpova, Tatiana/0000-0001-6025-2128	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NIH); Intramural Research Program of the Eunice Kennedy Shriver National Institute for Child Health and Human Development, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008765] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010833, ZICBC010571, ZIABC010835] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health (NIH); Intramural Research Program of the Eunice Kennedy Shriver National Institute for Child Health and Human Development, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NIH), and partially supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute for Child Health and Human Development, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae CD, 2003, J CANCER RES CLIN, V129, P621, DOI 10.1007/s00432-003-0484-0; Camps J, 2005, FASEB J, V19, P828, DOI 10.1096/fj.04-2276fje; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; De Luca M, 2008, ONCOGENE, V27, P6539, DOI 10.1038/onc.2008.252; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Haren Laurence, 2009, BMC Res Notes, V2, P64, DOI 10.1186/1756-0500-2-64; Heselmeyer-Haddad K, 2012, AM J PATHOL, V181, P1807, DOI 10.1016/j.ajpath.2012.07.012; Hong KU, 2008, EXP MOL MED, V40, P377, DOI 10.3858/emm.2008.40.4.377; Hong KU, 2007, MOL CELL BIOL, V27, P3667, DOI 10.1128/MCB.01386-06; Hong KU, 2009, EXP MOL MED, V41, P832, DOI 10.3858/emm.2009.41.11.089; Hong KU, 2009, J BIOL CHEM, V284, P16501, DOI 10.1074/jbc.M900257200; Hong KU, 2009, CELL CYCLE, V8, P314, DOI 10.4161/cc.8.2.7597; Jin Y, 2004, CANCER SCI, V95, P815, DOI 10.1111/j.1349-7006.2004.tb02187.x; Kang DS, 2012, BIOCHEM BIOPH RES CO, V420, P822, DOI 10.1016/j.bbrc.2012.03.081; Khodjakov A, 2010, NAT CELL BIOL, V12, P919, DOI 10.1038/ncb1010-919; Kim HJ, 2010, CELL CYCLE, V9, P2027, DOI 10.4161/cc.9.10.11753; Kufer TA, 2003, CHROMOSOMA, V112, P159, DOI 10.1007/s00412-003-0265-1; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Maouche-Chretien L, 1998, ONCOGENE, V17, P1245, DOI 10.1038/sj.onc.1202048; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 1997, J CELL BIOL, V138, P953, DOI 10.1083/jcb.138.5.953; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Padilla-Nash HM, 2006, NAT PROTOC, V1, P3129, DOI 10.1038/nprot.2006.358; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Ried T, 2012, BBA-GENE REGUL MECH, V1819, P784, DOI 10.1016/j.bbagrm.2012.02.020; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Seki A, 2007, J BIOL CHEM, V282, P15103, DOI 10.1074/jbc.M701688200; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tsuchihara K, 2005, CANCER RES, V65, P6685, DOI 10.1158/0008-5472.CAN-04-4223; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637	41	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64575	10.1371/journal.pone.0064575	http://dx.doi.org/10.1371/journal.pone.0064575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737987	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700051
J	Li, C; Yin, ZH; Wu, W; Li, XL; Ren, YW; Zhou, BS				Li, Cheng; Yin, Zhihua; Wu, Wei; Li, Xuelian; Ren, Yangwu; Zhou, Baosen			Genetic Variations in TERT-CLPTM1L Genes and Risk of Lung Cancer in Chinese Women Nonsmokers	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN TELOMERASE; SEQUENCE VARIANTS; SUSCEPTIBILITY; 5P15.33; ORGANIZATION; LOCUS	Background: The TERT gene is the reverse transcriptase component of telomerase and is essential for the maintenance of telomere DNA length, chromosomal stability and cellular immortality. CLPTM1L gene encodes a protein linked to cisplatin resistance, and it is well conserved and express in various normal or malignant tissues, including lung. Methods: To test this hypothesis, we genotyped for two significant SNPs TERT-rs2736098 and CLPTM1L-rs4016981 in a case-control study with 501 cancer cases and 576 cancer-free controls in Chinese nonsmoking population. Information concerning demographic and risk factors was obtained for each case and control by a trained interviewer. Gene polymorphisms were determined by TaqMan methodology. Results: We found that the homozygous variant genetic model of TERT gene was associated with a significantly increased risk of lung cancer with adjusted OR of 1.72(95%CI = 1.19-2.51, P = 0.004 for heterogeneity). The joint effect of TERT and CLPTM1L increased risk for lung cancer with adjusted OR is 1.31(95%CI = 1.00-1.74, P = 0.052 for heterogeneity). Conclusion: Genetic variants in TERT and CLPTM1L may affect the susceptibility of lung cancer, especially adenocarcinoma in Chinese women nonsmokers.	[Li, Cheng; Yin, Zhihua; Wu, Wei; Li, Xuelian; Ren, Yangwu; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Peoples R China; [Li, Cheng; Yin, Zhihua; Wu, Wei; Li, Xuelian; Ren, Yangwu; Zhou, Baosen] Univ Liaoning Prov, Key Lab Canc Etiol & Intervent, Dalian, Peoples R China	China Medical University	Zhou, BS (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Peoples R China.	bszhou@cmu.edu.cn			National Natural Science Foundation of China [81272293, 81102194]; Liaoning Provincial Department of Education [LS2010168]; China Medical Board [00726]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Provincial Department of Education; China Medical Board	This study was supported by grant no.81272293 from National Natural Science Foundation of China, grant no.81102194 from National Natural Science Foundation of China, grant no.LS2010168 from Liaoning Provincial Department of Education, and grant no.00726 from China Medical Board.	Bae EY, 2008, RESPIROLOGY; Chanock SJ, 2008, NATURE, V452, P537, DOI 10.1038/452537a; Chen HY, 2011, AM J EPIDEMIOL, V173, P915, DOI 10.1093/aje/kwq457; Chen XF, 2012, GENET MOL RES, V11, P370, DOI 10.4238/2012.February.16.2; Choi JE, 2009, CANCER EPIDEM BIOMAR, V18, P2773, DOI 10.1158/1055-9965.EPI-09-0323; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Gago-Dominguez M, 2011, CARCINOGENESIS, V32, P197, DOI 10.1093/carcin/bgq233; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Lam WK, 2005, RESPIROLOGY, V10, P408, DOI 10.1111/j.1440-1843.2005.00723.x; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Pande M, 2011, CARCINOGENESIS, V32, P1493, DOI 10.1093/carcin/bgr136; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yin JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050650; Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	24	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64988	10.1371/journal.pone.0064988	http://dx.doi.org/10.1371/journal.pone.0064988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738012	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700073
J	Wang, HM; Liang, XB; Wang, X; Luo, DZ; Jia, J; Wang, XM				Wang, Haomin; Liang, Xibin; Wang, Xuan; Luo, Dingzhen; Jia, Jun; Wang, Xiaomin			Electro-Acupuncture Stimulation Improves Spontaneous Locomotor Hyperactivity in MPTP Intoxicated Mice	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; PARKINSONS-DISEASE; MOUSE MODEL; SUBSTANTIA-NIGRA; TRANSECTED RATS; MESSENGER-RNA; ACUPUNCTURE; NEURONS; DEGENERATION; SYMPTOMS	Bradykinesia is one of the major clinical symptoms of Parkinson's disease (PD) for which treatment is sought. In most mouse models of PD, decreased locomotor activity can be reflected in an open field behavioral test. Therefore the open field test provides a useful tool to study the clinic symptoms of PD patients. Our previous work demonstrated that 100 Hz electro-acupuncture (EA) stimulation at ZUSANLI and SANYINJIAO protected the dopaminergic nigrostriatal system of C57BL/6 mice from MPTP toxicity, indicating that acupuncture might be an effective therapy for PD sufferers. In the present study, we investigated the effects of 100 Hz EA stimulation on the spontaneous locomotor activity in MPTP injured mice. Here we found that, in MPTP treated mice, the total movements significantly decreased and the movement time, velocity and distance dramatically increased, although the dopaminergic nigrostriatal system was devastated, revealed by immunohistochemistry and HPLC-ECD. After 12 sessions of 100 Hz EA stimulation, the total movements elevated and the movement time, velocity and distance decreased, in MPTP mice. 100 Hz EA increased striatal dopamine content in MPTP mice by 35.9%, but decreased its striatal dopamine turnover. We assumed that the injury of other regions in the brain, such as the A11 group in diencephalon, might be involved in the hypermotility in MPTP mice. The effects of 100 Hz EA on spontaneous locomotor activity in MPTP mice might not relate with the striatal dopamine, but with its neuroprotective and regulatory effects on motor circuits in the brain. Our study suggests that EA might be a promising treatment for neurological disorders including PD.	[Wang, Haomin] Peking Univ, Neurosci Res Inst, Key Lab Neurosci, Minist Educ, Beijing 100871, Peoples R China; [Liang, Xibin] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Wang, Xuan; Luo, Dingzhen; Jia, Jun; Wang, Xiaomin] Capital Med Univ, Dept Physiol, Key Lab Neurodegenerat Disorders, Minist Educ, Beijing, Peoples R China	Peking University; Stanford University; Capital Medical University	Wang, XM (corresponding author), Capital Med Univ, Dept Physiol, Key Lab Neurodegenerat Disorders, Minist Educ, Beijing, Peoples R China.	xmwang@ccmu.edu.cn			National Basic Research Program of China [2011CB504100]; National Natural Science Foundation of China [30472245]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2011CB504100, http://www.973.gov.cn) and the National Natural Science Foundation of China ( 30472245, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Chen L, 1998, J Tradit Chin Med, V18, P23; Connor JR, 2009, BRAIN, V132, P2403, DOI 10.1093/brain/awp125; Cristian A, 2005, MOVEMENT DISORD, V20, P1185, DOI 10.1002/mds.20503; Huang Y, 2010, INT J NEUROSCI, V120, P150, DOI 10.3109/00207450903316527; Huo LR, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/908439; Jeon S, 2008, PROTEOMICS, V8, P4822, DOI 10.1002/pmic.200700955; Jia J, 2010, BEHAV NEUROSCI, V124, P305, DOI 10.1037/a0018931; Jia J, 2009, BEHAV BRAIN RES, V205, P214, DOI 10.1016/j.bbr.2009.06.024; Kang JM, 2007, BRAIN RES, V1131, P211, DOI 10.1016/j.brainres.2006.10.089; Kim SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027566; Lam YC, 2008, J ALTERN COMPLEM MED, V14, P662, DOI 10.1089/acm.2007.0011; Lee MS, 2008, MOVEMENT DISORD, V23, P1505, DOI 10.1002/mds.21993; Liang XB, 2003, NEUROREPORT, V14, P1177, DOI 10.1097/00001756-200306110-00015; Liang XB, 2002, MOL BRAIN RES, V108, P51, DOI 10.1016/S0169-328X(02)00513-2; Liu XY, 2004, EXP NEUROL, V189, P189, DOI 10.1016/j.expneurol.2004.05.028; Luo DZ, 2009, EUR J PHARMACOL, V617, P33, DOI 10.1016/j.ejphar.2009.06.015; Paulus W, 2007, MOVEMENT DISORD, V22, P1451, DOI 10.1002/mds.21533; Qu S, 2006, EXP BRAIN RES, V168, P152, DOI 10.1007/s00221-005-0075-1; Qu S, 2007, J NEUROPATH EXP NEUR, V66, P383, DOI 10.1097/nen.0b013e3180517b5f; Rabinstein AA, 2003, NEUROLOGIST, V9, P137, DOI 10.1097/00127893-200305000-00002; Ren Xiao-ming, 2008, J Tradit Chin Med, V28, P255; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Rousselet E, 2003, NEUROBIOL DIS, V14, P218, DOI 10.1016/S0969-9961(03)00108-6; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; Shulman LM, 2002, MOVEMENT DISORD, V17, P799, DOI 10.1002/mds.10134; Wang HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019790; Zhao F, 2010, J NEUROSCI METH, V192, P199, DOI 10.1016/j.jneumeth.2010.07.016; Zhuang X, 2000, J Tradit Chin Med, V20, P265	30	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64403	10.1371/journal.pone.0064403	http://dx.doi.org/10.1371/journal.pone.0064403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737982	gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700047
J	Franzi, S; Salajegheh, M; Nazareno, R; Greenberg, SA				Franzi, Sara; Salajegheh, Mohammad; Nazareno, Remedios; Greenberg, Steven A.			Type 1 Interferons Inhibit Myotube Formation Independently of Upregulation of Interferon-Stimulated Gene 15	PLOS ONE			English	Article							TUBULORETICULAR INCLUSIONS; DISEASE-ACTIVITY; I INTERFERON; DERMATOMYOSITIS; EXPRESSION; CELLS; ISG15; CONJUGATION; MUSCLE; BETA	Introduction: Type 1 interferon (IFN)-inducible genes and their inducible products are upregulated in dermatomyositis muscle. Of these, IFN-stimulated gene 15 (ISG15) is one of the most upregulated, suggesting its possible involvement in the pathogenesis of this disease. To test this postulate, we developed a model of type 1 IFN mediated myotube toxicity and assessed whether or not downregulation of ISG15 expression prevents this toxicity. Methods: Mouse myoblasts (C2C12 cell line) were cultured in the presence of type 1 or type 2 IFNs and ISG15 expression assessed by microarray analysis. The morphology of newly formed myotubes was assessed by measuring their length, diameter, and area on micrographs using imaging software. ISG15 expression was silenced through transfection with small interference RNA. Results: Type 1 IFNs, especially IFN-beta, increased ISG15 expression in C2C12 cells and impaired myotube formation. Silencing of ISG15 resulted in knockdown of ISG15 protein, but without phenotypic rescue of myotube formation. Discussion: IFN-beta affects myoblast differentiation ability and myotube morphology in vitro. These studies provide evidence that ISG15, which is highly upregulated in dermatomyositis muscle, does not appear to play a key role in IFN-betamediated C2C12 myoblast cell fusion.	[Franzi, Sara; Salajegheh, Mohammad; Greenberg, Steven A.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Franzi, Sara] Fdn Ist Neurol Carlo Besta, Dept Neurol Neuromuscular Dis & Neuroimmunol 4, Milan, Italy; [Salajegheh, Mohammad; Nazareno, Remedios; Greenberg, Steven A.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Salajegheh, Mohammad; Greenberg, Steven A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; IRCCS Istituto Neurologico Besta; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Greenberg, SA (corresponding author), Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA.	sagreenberg@partners.org	Franzi, Sara/AAB-7683-2020	Franzi, Sara/0000-0003-1767-3431	Muscular Dystrophy Association [MDA56979]	Muscular Dystrophy Association(Muscular Dystrophy Association)	This study was sponsored by the Muscular Dystrophy Association (grant MDA56979 to Dr. Greenberg). No additional external funding was received for this study. The named funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Dr. Franzi, Dr. Salajegheh, Mrs. Nazareno, and Dr. Greenberg report no further financial disclosures in regards to this study.	Cappelletti C, 2011, NEUROLOGY, V76, P2079, DOI 10.1212/WNL.0b013e31821f440a; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; de Padilla CML, 2007, ARTHRITIS RHEUM, V56, P1658, DOI 10.1002/art.22558; FELDMAN D, 1988, LAB INVEST, V58, P584; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Greenberg SA, 2012, GENES IMMUN, V13, P207, DOI 10.1038/gene.2011.61; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; GRIMLEY PM, 1984, CANCER RES, V44, P3480; KUYAMA J, 1986, ULTRASTRUCT PATHOL, V10, P77, DOI 10.3109/01913128609015565; Liao AP, 2011, ANN RHEUM DIS, V70, P831, DOI 10.1136/ard.2010.139949; Magro CM, 2010, J CUTAN PATHOL, V37, P659, DOI 10.1111/j.1600-0560.2009.01443.x; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; RICH SA, 1983, LANCET, V1, P127; Salaiegheh M, 2010, ANN NEUROL, V67, P53, DOI 10.1002/ana.21805; Schirmer SH, 2010, J BIOL CHEM, V285, P34677, DOI 10.1074/jbc.M110.164350; Shrestha S, 2010, ARTHRITIS RHEUM-US, V62, P2813, DOI 10.1002/art.27529; Slaton JW, 1999, CLIN CANCER RES, V5, P2726; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tezak Z, 2002, J IMMUNOL, V168, P4154, DOI 10.4049/jimmunol.168.8.4154; Walsh RJ, 2007, ARTHRITIS RHEUM, V56, P3784, DOI 10.1002/art.22928; Wong D, 2011, PLOS ONE, V7; Xiao HB, 2011, GENE THER; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	25	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65362	10.1371/journal.pone.0065362	http://dx.doi.org/10.1371/journal.pone.0065362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750257	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900059
J	Loggi, E; Bihl, FK; Cursaro, C; Granieri, C; Galli, S; Brodosi, L; Furlini, G; Bernardi, M; Brander, C; Andreone, P				Loggi, Elisabetta; Bihl, Florian K.; Cursaro, Carmela; Granieri, Camilla; Galli, Silvia; Brodosi, Lucia; Furlini, Giuliano; Bernardi, Mauro; Brander, Christian; Andreone, Pietro			Virus-Specific Immune Response in HBeAg-Negative Chronic Hepatitis B: Relationship with Clinical Profile and HBsAg Serum Levels	PLOS ONE			English	Article							CD8(+) T-CELLS; SURFACE-ANTIGEN; CORE; QUANTIFICATION	Background & Aims: The immune impairment characterizing chronic hepatitis B (cHBV) infection is thought to be the consequence of persistent exposure to viral antigens. However, the immune correlates of different clinical stages of cHBV and their relation with different levels of HBsAg have not been investigated. The aim of the present study was to evaluate the relationship between HBV-specific T cells response and the degree of in vivo HBV control and HBsAg serum levels in HBeAg-HBeAb+ cHBV. Methods: Peripheral blood mononuclear cells from 42 patients with different clinical profiles (treatment-suppressed, inactive carriers and active hepatitis) of cHBV, 6 patients with resolved HBV infection and 10 HBV-uninfected individuals were tested with overlapping peptides spanning the entire HBV proteome. The frequency and magnitude of HBV-specific T cell responses was assessed by IFN gamma ELISPOT assay. Serum HBsAg was quantified with a chemiluminescent immunoassay. Results: The total breadth and magnitude of HBV-specific T cell responses did not differ significantly between the four groups. However, inactive carriers targeted preferentially the core region. In untreated patients, the breadth of the anti-core specific T cell response was inversely correlated with serum HBsAg concentrations as well as HBV-DNA and ALT levels and was significantly different in patients with HBsAg levels either above or below 1000 IU/mL. The same inverse association between anti-core T cell response and HBsAg levels was found in treated patients. Conclusions: Different clinical outcomes of cHBV infection are associated with the magnitude, breadth and specificity of the HBV-specific T cell response. Especially, robust anti-core T cell responses were found in the presence of reduced HBsAg serum levels, suggesting that core-specific T cell responses can mediate a protective effect on HBV control.	[Loggi, Elisabetta; Cursaro, Carmela; Granieri, Camilla; Brodosi, Lucia; Bernardi, Mauro; Andreone, Pietro] Univ Bologna, Dept Med & Surg Scinces, Bologna, Italy; [Bihl, Florian K.] EOC, Osped Reg Bellinzona & Valli, Gastroenterol Sect, Bellinzona, Switzerland; [Galli, Silvia; Furlini, Giuliano] Univ Bologna, Microbiol Sect, Dept Clin & Expt Med, Bologna, Italy; [Brander, Christian] Autonomous Univ Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa HIVACAT, Barcelona, Spain; [Brander, Christian] ICREA, Barcelona, Spain	University of Bologna; Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Bologna; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA	Andreone, P (corresponding author), Univ Bologna, Dept Med & Surg Scinces, Bologna, Italy.	pietro.andreone@unibo.it	Furlini, Giuliano/ABB-1290-2020; Brodosi, Lucia/ABF-6692-2020; Andreone, Pietro/K-8050-2016; Loggi, Elisabetta/K-7848-2016	Brodosi, Lucia/0000-0002-7735-7847; Andreone, Pietro/0000-0002-4794-9809; Loggi, Elisabetta/0000-0003-4985-9783; Cursaro, Carmela/0000-0002-5644-2508; Brander, Christian/0000-0002-0548-5778	Focused Fundamental Research by the Ministry of Education, University and Research, Italy; ICREA Funding Source: Custom	Focused Fundamental Research by the Ministry of Education, University and Research, Italy; ICREA(ICREA)	Partial support by Focused Fundamental Research by the Ministry of Education, University and Research, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Bihl FK, 2005, J TRANSL MED, V3; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; FERRARI C, 1991, J CLIN INVEST, V88, P214, DOI 10.1172/JCI115280; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Gehring AJ, 2007, J VIROL, V81, P2940, DOI 10.1128/JVI.02415-06; Heeg MHJ, 2007, J HEPATOL, V46, pS294, DOI 10.1016/S0168-8278(07)62380-0; Hsu CW, 2011, HEPATOLOGY, V54, P101, DOI 10.1002/hep.24363; Liaw YF, 2011, HEPATOLOGY, V54, pE1, DOI 10.1002/hep.24473; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Maini MK, 2010, J HEPATOL, V52, P616, DOI 10.1016/j.jhep.2009.12.017; Manesis EK, 2011, J HEPATOL, V55, P61, DOI 10.1016/j.jhep.2010.10.027; Menne S, 2002, J VIROL, V76, P1769, DOI 10.1128/JVI.76.4.1769-1780.2002; Milich DR, 1998, J IMMUNOL, V160, P2013; Moucari R, 2011, LIVER INT, V31, P122, DOI 10.1111/j.1478-3231.2010.02390.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pollicino T, 2012, HEPATOLOGY, V56, P434, DOI 10.1002/hep.25592; Rodella A, 2006, J CLIN VIROL, V37, P206, DOI 10.1016/j.jcv.2006.06.011; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; TSAI SL, 1992, J CLIN INVEST, V89, P87, DOI 10.1172/JCI115590; Volz T, 2007, GASTROENTEROLOGY, V133, P843, DOI 10.1053/j.gastro.2007.06.057; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	30	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65327	10.1371/journal.pone.0065327	http://dx.doi.org/10.1371/journal.pone.0065327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750252	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900054
J	Lv, XZ; Tang, SW; Xia, YY; Wang, XM; Yuan, YL; Hu, DY; Liu, FY; Wu, SS; Zhang, Y; Yang, ZR; Tu, DH; Chen, YX; Deng, PY; Ma, Y; Chen, R; Zhan, SY				Lv, Xiaozhen; Tang, Shaowen; Xia, Yinyin; Wang, Xiaomeng; Yuan, Yanli; Hu, Daiyu; Liu, Feiying; Wu, Shanshan; Zhang, Yuan; Yang, Zhirong; Tu, Dehua; Chen, Yixin; Deng, Peiyuan; Ma, Yu; Chen, Ru; Zhan, Siyan			Adverse Reactions Due to Directly Observed Treatment Strategy Therapy in Chinese Tuberculosis Patients: A Prospective Study	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUGS; HOSPITALIZED-PATIENTS; RISK-FACTORS; PYRAZINAMIDE	Background: More than 1 million tuberculosis (TB) patients are receiving directly observed treatment strategy (DOTS) therapy in China every year. As to the profile of adverse drug reactions (ADRs) due to DOTS therapy, no consensus has been reached. There is no report regarding ADRs due to DOTS therapy with a large Chinese TB population. This study aimed to determine the incidence and prognosis of ADRs due to DOTS therapy, and to evaluate their impact on anti-TB treatment in China. Methods: A prospective population-based cohort study was performed during 2007-2008. Sputum smear positive pulmonary TB patients who received DOTS therapy were included and followed up for six to nine months in 52 counties of four regions in China. The suspected ADRs were recorded and reviewed by Chinese State Food and Drug Administration. Results: A total of 4304 TB patients were included in this study. 649 patients (15.08%) showed at least one ADR and 766 cases in total were detected. The incidence (count) of ADR based on affected organ was: liver dysfunction 6.34% (273), gastrointestinal disorders 3.74% (161), arthralgia 2.51% (108), allergic reactions 2.35% (101), neurological system disorders 2.04% (88), renal impairment 0.07% (3) and others 0.05% (2). Most cases of ADRs (95%) had a good clinical outcome, while two with hepatotoxicity and one with renal impairment died. Compared with patients without ADRs, patients with ADRs were more likely to have positive smear test results at the end of the intensive phase (adjusted OR, 2.00; 95% CI, 1.44-2.78) and unsuccessful anti-TB outcomes (adjusted OR, 2.58; 95% CI, 1.43-4.68). Conclusions: The incidence of ADRs due to DOTS therapy was 15.08%. Those ADRs had a substantial impact on TB control in China. This highlighted the importance of developing strategies to ameliorate ADRs both to improve the quality of patient care and to control TB safely.	[Lv, Xiaozhen; Tang, Shaowen; Wu, Shanshan; Zhang, Yuan; Yang, Zhirong; Chen, Ru; Zhan, Siyan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Lv, Xiaozhen] Peking Univ, Inst Mental Hlth, Div Clin Res, Beijing 100871, Peoples R China; [Lv, Xiaozhen] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Tang, Shaowen] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Xia, Yinyin] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Wang, Xiaomeng] Ctr Dis Control & Prevent Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Yuan, Yanli] Ctr Dis Control & Prevent Jilin Prov, Changchun, Peoples R China; [Hu, Daiyu] Ctr Dis Control & Prevent Chongqing Municipal, Chongqing, Peoples R China; [Liu, Feiying] Ctr Dis Control & Prevent Guangxi Zhuang Autonomo, Nanning, Peoples R China; [Tu, Dehua] Beijing Inst TB Control, Beijing, Peoples R China; [Chen, Yixin] Ctr Drug Reassessment State Food & Drug Adm, Beijing, Peoples R China; [Deng, Peiyuan] Beijing Ctr Drug Reassessment, Beijing, Peoples R China; [Ma, Yu] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Peking University; Peking University; Nanjing Medical University; Chinese Center for Disease Control & Prevention	Zhan, SY (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	siyan-zhan@bjmu.edu.cn		Tang, Shaowen/0000-0001-5879-8594; Zhang, Yuan/0000-0002-4174-0641	National Natural Science Foundation of China [81072387]; Beijing Natural Science Foundation [7111006]; China Program for the Global Fund [TB07-030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); China Program for the Global Fund	This study was funded by National Natural Science Foundation of China (NO.81072387), Beijing Natural Science Foundation (NO.7111006) and China Program for the Global Fund to Fight TB (NO:TB07-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CHIN AIDS EP 2011; Arbex MA, 2010, J BRAS PNEUMOL, V36, P626, DOI 10.1590/S1806-37132010000500016; Awofeso N., 2008, B WHO, V86; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Chen XY, 2004, LANCET, V364, P417; Chhetri Anupa Khadka, 2008, J Pak Med Assoc, V58, P531; China Public Health Science Database Center, 2008, REP TUB MON 2008 DIS; Dhingra V. K., 2004, Journal of Communicable Diseases, V36, P251; DURAND F, 1995, HEPATOLOGY, V21, P929, DOI 10.1002/hep.1840210407; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Gholami Kheirollah, 2006, Pharmacy Pract (Granada), V4, P134, DOI 10.4321/s1885-642x2006000300006; Gulbay BE, 2006, RESP MED, V100, P1834, DOI 10.1016/j.rmed.2006.01.014; Javadi MR, 2007, PHARMACOEPIDEM DR S, V16, P1104, DOI 10.1002/pds.1468; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Marra F, 2007, INT J TUBERC LUNG D, V11, P868; MONTANER LJG, 1982, TUBERCLE, V63, P291, DOI 10.1016/S0041-3879(82)80018-4; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; Maciel ELN, 2010, J BRAS PNEUMOL, V36, P232, DOI 10.1590/S1806-37132010000200012; Ormerod LP, 1996, TUBERCLE LUNG DIS, V77, P37, DOI 10.1016/S0962-8479(96)90073-8; PATEL AM, 1995, DRUG SAFETY, V12, P1, DOI 10.2165/00002018-199512010-00001; Possuelo LG, 2008, EUR J CLIN PHARMACOL, V64, P673, DOI 10.1007/s00228-008-0484-8; Schaberg T, 1996, EUR RESPIR J, V9, P2026, DOI 10.1183/09031936.96.09102026; Shang P, 2011, PLOS ONE, V7; The UPPSALA MONITORING CENTRE, US WHO UMO SYST STAN; Tu DH, 2011, ANTITUBERCULOSIS DRU, P68; Vieira Denise Eri Onodera, 2008, J Bras Pneumol, V34, P1049; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, TREATM TUB GUID; World Health Organisation, 2007, TUB FACT SHEETS; World Health Organization, 2012, GLOB TUB REP 2012 TB; World Health Organization (WHO), 2002, STRAT PLAN VIS 2020, P1; Xia YY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-267; Xia Yin-Yin, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P419; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Zaka-Ur-Rehman Z, 2008, PAK J PHARM SCI, V21, P185	35	35	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65037	10.1371/journal.pone.0065037	http://dx.doi.org/10.1371/journal.pone.0065037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750225	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900027
J	Raja, H; Snyder, MR; Johnston, PB; O'Neill, BP; Caraballo, JN; Balsanek, JG; Peters, BE; Decker, PA; Pulido, JS				Raja, Harish; Snyder, Melissa R.; Johnston, Patrick B.; O'Neill, Brian P.; Caraballo, Juline N.; Balsanek, Joseph G.; Peters, Brian E.; Decker, Paul A.; Pulido, Jose S.			Effect of Intravitreal Methotrexate and Rituximab on Interleukin-10 Levels in Aqueous Humor of Treated Eyes with Vitreoretinal Lymphoma	PLOS ONE			English	Article							NERVOUS-SYSTEM LYMPHOMA; PRIMARY INTRAOCULAR LYMPHOMA; IL-10 MEASUREMENT; CYTOKINE; INJECTIONS	Intraocular cytokines are promising diagnostic biomarkers of vitreoretinal lymphoma. Here, we evaluate the utility of IL-10, IL-6 and IL-10/IL-6 for discriminating lymphoma from uveitis and report the effects of intraocular methotrexate and rituximab on aqueous cytokine levels in eyes with lymphoma. This is a retrospective case series including 10 patients with lymphoma and 7 patients with uveitis. Non-parametric Mann-Whitney analysis was performed to determine statistical significance of difference in interleukin levels between lymphoma and uveitis. Compared to eyes with uveitis, eyes with lymphoma had higher levels of IL-10 (U = 7.0; two-tailed p = 0.004) and IL-10/IL-6 (U = 6.0; two-tailed p = 0.003), whereas IL-6 levels were more elevated, although insignificant, in those patients with uveitis than in lymphoma (U = 15.0; two-tailed p = ns). Using a receiver operating characteristic analysis to identify threshold values diagnostic for lymphoma, optimal sensitivity and specificity improved to 80.0% and 100%, respectively, for IL-10.7.025 pg/ml and 90.0% and 100.0%, respectively, for IL-10/IL-6>0.02718. In patients in whom serial interleukin levels were available, regular intravitreal treatment with methotrexate and rituximab was associated with reduction in IL-10 levels over time. In conclusion, optimal IL-10 and IL-10/IL-6 threshold values are associated with a diagnostic sensitivity >= 80% and specificity of 100%. Therefore, these cytokines may serve as a useful adjunct in the diagnosis of lymphoma. While negative IL-10 and IL-10/IL-6 values do not exclude a diagnosis of lymphoma, elevated levels do appear to be consistent with lymphoma clinically. Moreover, elevated levels of IL-10 in the setting of a clinically quiet eye may point to impending disease recurrence. Lastly, once lymphoma is diagnosed, IL-10 levels can be monitored over time to assess disease activity and therapeutic response.	[Raja, Harish] Mayo Clin, Mayo Sch Grad Med Educ, Rochester, MN USA; [Snyder, Melissa R.] Mayo Clin, Antibody Immunol Lab, Dept Lab Med & Pathol, Rochester, MN USA; [Johnston, Patrick B.] Mayo Clin, Dept Hematol, Rochester, MN USA; [O'Neill, Brian P.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Caraballo, Juline N.; Pulido, Jose S.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; [Balsanek, Joseph G.; Peters, Brian E.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Decker, Paul A.] Mayo Clin, Dept Biomed Stat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Pulido, JS (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	pulido.jose@mayo.edu		O'NEILL, BRIAN PATRICK/0000-0001-7456-6152; Caraballo, Juline/0000-0001-9325-8550	Research to Prevent Blindness	Research to Prevent Blindness(Research to Prevent Blindness (RPB))	Support was provided by an unrestricted grant from Research to Prevent Blindness (NY) and by a gift from Terrance and Judith Paul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GRAPHPAD PRISM VERS; Cassoux N, 2000, OCUL IMMUNOL INFLAMM, V8, P243, DOI 10.1076/ocii.8.4.243.6463; Cassoux N, 2007, INVEST OPHTH VIS SCI, V48, P3253, DOI 10.1167/iovs.06-0031; CHAN CC, 1995, AM J OPHTHALMOL, V120, P671, DOI 10.1016/S0002-9394(14)72217-2; Fisson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052385; Grimm SA, 2007, ANN ONCOL, V18, P1851, DOI 10.1093/annonc/mdm340; Gunduz Kaan, 2006, Neurosurg Focus, V21, pE9; Itty S, 2009, RETINA-J RET VIT DIS, V29, P129, DOI 10.1097/IAE.0b013e318192f574; Kawamura H, 2009, OPHTHAL RES, V42, P172, DOI 10.1159/000230879; Ohguro N, 2008, ARCH OPHTHALMOL-CHIC, V126, P1002, DOI 10.1001/archopht.126.7.1002; Rajagopal R, 2011, RETINA-J RET VIT DIS, V31, P435, DOI 10.1097/IAE.0b013e31820a6743; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Salazar-Onfray F, 1999, MED ONCOL, V16, P86, DOI 10.1007/BF02785841; Saleh M, 2012, GRAEF ARCH CLIN EXP, V250, P761, DOI 10.1007/s00417-011-1718-5; Sen HN, 2008, OCUL IMMUNOL INFLAMM, V16, P29, DOI 10.1080/09273940801899764; Smith JR, 2002, OPHTHALMOLOGY, V109, P1709, DOI 10.1016/S0161-6420(02)01125-9; Sou R, 2008, JPN J OPHTHALMOL, V52, P167, DOI 10.1007/s10384-008-0519-9; Sugita S, 2009, JPN J OPHTHALMOL, V53, P209, DOI 10.1007/s10384-009-0662-y; van Kooij B, 2006, AM J OPHTHALMOL, V142, P192, DOI 10.1016/j.ajo.2006.02.052; Whitcup SM, 1997, ARCH OPHTHALMOL-CHIC, V115, P1157, DOI 10.1001/archopht.1997.01100160327010	20	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65627	10.1371/journal.pone.0065627	http://dx.doi.org/10.1371/journal.pone.0065627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750271	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900073
J	Tamburri, A; Dudilot, A; Licea, S; Bourgeois, C; Boehm, J				Tamburri, Albert; Dudilot, Anthony; Licea, Sara; Bourgeois, Catherine; Boehm, Jannic			NMDA-Receptor Activation but Not Ion Flux Is Required for Amyloid-Beta Induced Synaptic Depression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; REGULATED PROTEIN-KINASE; ALZHEIMERS-DISEASE; IN-VIVO; SIGNALING PATHWAY; PLASTICITY; OLIGOMERS; CA1; PHOSPHORYLATION; TRAFFICKING	Alzheimer disease is characterized by a gradual decrease of synaptic function and, ultimately, by neuronal loss. There is considerable evidence supporting the involvement of oligomeric amyloid-beta (A beta) in the etiology of Alzheimer's disease. Historically, AD research has mainly focused on the long-term changes caused by A beta rather than analyzing its immediate effects. Here we show that acute perfusion of hippocampal slice cultures with oligomeric A beta depresses synaptic transmission within 20 minutes. This depression is dependent on synaptic stimulation and the activation of NMDA-receptors, but not on NMDA-receptor mediated ion flux. It, therefore, appears that A beta dependent synaptic depression is mediated through a use-dependent metabotropic-like mechanism of the NMDA-receptor, but does not involve NMDA-receptor mediated synaptic transmission, i.e. it is independent of calcium flux through the NMDA-receptor.	[Tamburri, Albert; Dudilot, Anthony; Licea, Sara; Bourgeois, Catherine; Boehm, Jannic] Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Boehm, J (corresponding author), Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada.	jannic.boehm@umontreal.ca	Boehm, Jannic/AAK-8882-2020	Tamburri, Albert/0000-0001-8274-5089	CIHR; Alzheimer Society Canada	CIHR(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Canada	This work was funded by grants from the CIHR and the Alzheimer Society Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Cheng L, 2009, SYNAPSE, V63, P206, DOI 10.1002/syn.20599; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harney SC, 2006, J NEUROSCI, V26, P1128, DOI 10.1523/JNEUROSCI.2753-05.2006; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu NW, 2009, P NATL ACAD SCI USA, V106, P20504, DOI 10.1073/pnas.0908083106; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; Kessels HW, 2013, P NATL ACAD SCI USA, V110, P4033, DOI 10.1073/pnas.1219605110; Kim JH, 2001, J NEUROSCI, V21, P1327; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Mondragon-Rodriguez S, 2012, J BIOL CHEM, V287, P32040, DOI 10.1074/jbc.M112.401240; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; SAMUEL W, 1994, ARCH NEUROL-CHICAGO, V51, P772, DOI 10.1001/archneur.1994.00540200048015; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004	33	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65350	10.1371/journal.pone.0065350	http://dx.doi.org/10.1371/journal.pone.0065350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750255	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900057
J	Zhang, LL; Li, ZJ; Li, JF; Wang, AX				Zhang, Lili; Li, Zhenjun; Li, Jingfu; Wang, Aoxue			Ectopic Overexpression of SsCBF1, a CRT/DRE-Binding Factor from the Nightshade Plant Solanum lycopersicoides, Confers Freezing and Salt Tolerance in Transgenic Arabidopsis	PLOS ONE			English	Article							STRESS TRANSCRIPTION FACTORS; COLD-RESPONSE PATHWAY; CIS-ACTING ELEMENT; CBF GENE FAMILY; LOW-TEMPERATURE; DNA-BINDING; EXPRESSION PATTERN; DROUGHT; ACTIVATOR; REGULATOR	The C-repeat (CRT)/dehydration-responsive element (DRE) binding factor (CBF/ DREB1) transcription factors play a key role in cold response. However, the detailed roles of many plant CBFs are far from fully understood. A CBF gene (SsCBF1) was isolated from the cold-hardy plant Solanum lycopersicoides. A subcellular localization study using GFP fusion protein indicated that SsCBF1 is localized in the nucleus. We delimited the SsCBF1 transcriptional activation domain to the C-terminal segment comprising amino acid residues 193-228 (SsCBF1(193-228)). The expression of SsCBF1 could be dramatically induced by cold, drought and high salinity. Transactivation assays in tobacco leaves revealed that SsCBF1 could specifically bind to the CRT cis-elements in vivo to activate the expression of downstream reporter genes. The ectopic overexpression of SsCBF1 conferred increased freezing and high-salinity tolerance and late flowering phenotype to transgenic Arabidopsis. RNA-sequencing data exhibited that a set of cold and salt stress responsive genes were up-regulated in transgenic Arabidopsis. Our results suggest that SsCBF1 behaves as a typical CBF to contribute to plant freezing tolerance. Increased resistance to high-salinity and late flowering phenotype derived from SsCBF1 OE lines lend more credence to the hypothesis that plant CBFs participate in diverse physiological and biochemical processes related to adverse conditions.	[Zhang, Lili; Wang, Aoxue] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Li, Zhenjun] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China; [Zhang, Lili; Li, Jingfu; Wang, Aoxue] Northeast Agr Univ, Coll Hort, Harbin, Peoples R China; [Wang, Aoxue] Northeast Agr Univ, Heilongjiang Prov Key Univ Lab Agr Biol Funct Gen, Harbin, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Northeast Agricultural University - China; Northeast Agricultural University - China	Li, JF (corresponding author), Northeast Agr Univ, Coll Hort, Harbin, Peoples R China.	jfli_neau@yahoo.com.cn; aoxuewang@yahoo.com.cn			National Key Technology R D Program [2012BAD02B02-07]; Key Project of Chinese Ministry of Education [211043]; Research Fund for the Doctoral Program of Higher Education of China [20092325110001]; Trans-Century Training Programme Foundation for the Talents by Heilongjiang Provincial Education Department [1251-NCET-004]	National Key Technology R D Program(National Key Technology R&D Program); Key Project of Chinese Ministry of Education(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Trans-Century Training Programme Foundation for the Talents by Heilongjiang Provincial Education Department	This work was supported by National Key Technology R & D Program (No. 2012BAD02B02-07) from Jingfu Li, the Key Project of Chinese Ministry of Education (211043), the Research Fund for the Doctoral Program of Higher Education of China (20092325110001) and the Trans-Century Training Programme Foundation for the Talents by Heilongjiang Provincial Education Department (1251-NCET-004) from Aoxue Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Canella D, 2010, BBA-GENE REGUL MECH, V1799, P454, DOI 10.1016/j.bbagrm.2009.11.017; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Chetelat RT, 1997, EUPHYTICA, V95, P99, DOI 10.1023/A:1002958030799; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Choi DW, 2002, PLANT PHYSIOL, V129, P1781, DOI 10.1104/pp.003046; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doring P, 2000, PLANT CELL, V12, P265, DOI 10.1105/tpc.12.2.265; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; El Oirdi M, 2011, PLANT CELL, V23, P2405, DOI 10.1105/tpc.111.083394; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jiang C, 1996, PLANT MOL BIOL, V30, P679, DOI 10.1007/BF00049344; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; KURKELA S, 1992, PLANT MOL BIOL, V19, P689, DOI 10.1007/BF00026794; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lin CH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-85; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Owens CL, 2002, J AM SOC HORTIC SCI, V127, P489, DOI 10.21273/JASHS.127.4.489; Pino MT, 2008, PLANT CELL ENVIRON, V31, P393, DOI 10.1111/j.1365-3040.2008.01776.x; RAIKHEL N, 1992, PLANT PHYSIOL, V100, P1627, DOI 10.1104/pp.100.4.1627; RICK CM, 1988, THEOR APPL GENET, V76, P647, DOI 10.1007/BF00303508; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Sun JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002594; Tahtiharju S, 1997, PLANTA, V203, P442, DOI 10.1007/s004250050212; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; TREUTER E, 1993, MOL GEN GENET, V240, P113, DOI 10.1007/BF00276890; Vagujfalvi A, 2003, MOL GENET GENOMICS, V269, P60, DOI 10.1007/s00438-003-0806-6; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang ZB, 2005, PLANT MOL BIOL, V58, P543, DOI 10.1007/s11103-005-6760-4; WOLF S, 1986, J AM SOC HORTIC SCI, V111, P960; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; Xue GP, 2003, PLANT J, V33, P373, DOI 10.1046/j.1365-313X.2003.01630.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yang LA, 2010, J EXP BOT, V61, P2519, DOI 10.1093/jxb/erq084; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhou Y, 2012, PLANT CELL, V24, P1034, DOI 10.1105/tpc.111.094383	69	13	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e61810	10.1371/journal.pone.0061810	http://dx.doi.org/10.1371/journal.pone.0061810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755095	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300003
J	Naher, H; Abdullah, FA; Akbar, MA				Naher, Hasibun; Abdullah, Farah Aini; Akbar, M. Ali			Generalized and Improved (G '/G)-Expansion Method for (3+1)-Dimensional Modified KdV-Zakharov-Kuznetsev Equation	PLOS ONE			English	Article							EXP-FUNCTION METHOD; SOLITARY WAVE SOLUTIONS; ELLIPTIC FUNCTION SOLUTIONS; EXPANSION METHOD; F-EXPANSION	The generalized and improved (G'/G)-expansion method is a powerful and advantageous mathematical tool for establishing abundant new traveling wave solutions of nonlinear partial differential equations. In this article, we investigate the higher dimensional nonlinear evolution equation, namely, the (3+1)-dimensional modified KdV-Zakharov-Kuznetsev equation via this powerful method. The solutions are found in hyperbolic, trigonometric and rational function form involving more parameters and some of our constructed solutions are identical with results obtained by other authors if certain parameters take special values and some are new. The numerical results described in the figures were obtained with the aid of commercial software Maple.	[Naher, Hasibun; Abdullah, Farah Aini] Univ Sains Malaysia, Sch Mat Sci, George Town, Malaysia; [Abdullah, Farah Aini] BRAC Univ, Dept Math & Nat Sci, Dhaka, Bangladesh; [Akbar, M. Ali] Rajshahi Univ, Dept Appl Math, Rajshahi 6205, Bangladesh	Universiti Sains Malaysia; Bangladesh Rural Advancement Committee BRAC; BRAC University; University of Rajshahi	Naher, H (corresponding author), Univ Sains Malaysia, Sch Mat Sci, George Town, Malaysia.	hasibun06tasauf@gmail.com	Akbar, Prof. Ali/G-8025-2011; Abdullah, Farah Aini Binti/J-1711-2016	Akbar, Prof. Ali/0000-0001-5688-6259; Naher, Dr. Hasibun/0000-0002-7669-2037	Universiti Sains Malaysia (USM) [304/PMATHS/6310072]	Universiti Sains Malaysia (USM)(Universiti Sains Malaysia)	This work was supported by Universiti Sains Malaysia (USM) short term grant (Ref. No. 304/PMATHS/6310072). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abazari R, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/424801; Abdou MA, 2007, CHAOS SOLITON FRACT, V31, P95, DOI 10.1016/j.chaos.2005.09.030; Ablowitz M.J, 1991, SOLITONS NONLINEAR E; Akbar MA, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/459879; Aslan I, 2011, MATH METHOD APPL SCI, V34, P1707, DOI 10.1002/mma.1476; Bekir A, 2009, COMMUN NONLINEAR SCI, V14, P1804, DOI 10.1016/j.cnsns.2008.07.004; Chen Y, 2005, CHAOS SOLITON FRACT, V24, P745, DOI 10.1016/j.chaos.2004.09.014; Feng JH, 2011, APPL MATH COMPUT, V217, P5860, DOI 10.1016/j.amc.2010.12.071; Hamad Y. S., 2011, J MODERN METHODS NUM, V2, P32; He JH, 2006, CHAOS SOLITON FRACT, V30, P700, DOI 10.1016/j.chaos.2006.03.020; HIROTA R, 1971, PHYS REV LETT, V27, P1192, DOI 10.1103/PhysRevLett.27.1192; KUDRYASHOV NA, 1990, PHYS LETT A, V147, P287, DOI 10.1016/0375-9601(90)90449-X; Liu SK, 2001, PHYS LETT A, V289, P69, DOI 10.1016/S0375-9601(01)00580-1; Lu D, 2005, CHAOS SOLITON FRACT, V24, P1373, DOI 10.1016/j.chaos.2004.09.085; Ma WX, 2012, APPL MATH COMPUT, V218, P11871, DOI 10.1016/j.amc.2012.05.049; MALFLIET W, 1992, AM J PHYS, V60, P650, DOI 10.1119/1.17120; Mimura MR, 1978, BACKLUND TRANSFORMAT; Mohyud-Din S.T., 2010, J KING SAUD UNIV SCI, V22, P213, DOI DOI 10.1016/j.jksus.2010.04.015; Naher H., 2011, INT J PHYS SCI, V6, P6706; Naher H, 2012, WORLD APPL SCI J, V16, P11; Naher H, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/871724; Naher H, 2012, J APPL MATH, DOI 10.1155/2012/575387; Naher H, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/218216; Nofel TA, 2011, ANN FUZZY MATH INFOR, V3, P9; Noor M, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/250184; Rogers C., 1982, BACKLUND TRANSFORMAT; Soliman A. A., 2009, INT J NONLINEAR SCI, V7, P274; Triki H, 2011, WAVE RANDOM COMPLEX, V21, P151, DOI 10.1080/17455030.2010.539632; Wang ML, 2008, PHYS LETT A, V372, P417, DOI 10.1016/j.physleta.2007.07.051; Wang ML, 2005, CHAOS SOLITON FRACT, V24, P1257, DOI 10.1016/j.chaos.2004.09.044; Wazwaz AM, 2007, APPL MATH COMPUT, V188, P1467, DOI 10.1016/j.amc.2006.11.013; Wazwaz AM, 2011, PHYS SCRIPTA, DOI 10.1088/031-8949/84/03/035010; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021934; WEISS J, 1983, J MATH PHYS, V24, P522, DOI 10.1063/1.525721; Xu GQ, 2006, CHAOS SOLITON FRACT, V29, P942, DOI 10.1016/j.chaos.2005.08.058; Yan ZY, 2001, PHYS LETT A, V285, P355, DOI 10.1016/S0375-9601(01)00376-0; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Yildirim A, 2010, COMPUT MATH APPL, V60, P1873, DOI 10.1016/j.camwa.2010.07.020; Zayed E. M. E., 2010, Journal of Applied Mathematics and Informatics, V28, P383; Zayed EME, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/768573; Zhang JA, 2010, INT J COMPUT MATH, V87, P1716, DOI 10.1080/00207160802450166; Zhao YM, 2011, APPL MATH SCI, V5, P2855	42	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64618	10.1371/journal.pone.0064618	http://dx.doi.org/10.1371/journal.pone.0064618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741355	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900068
J	Quartuccio, SM; Lantvit, DD; Bosland, MC; Burdette, JE				Quartuccio, Suzanne M.; Lantvit, Daniel D.; Bosland, Maarten C.; Burdette, Joanna E.			Conditional Inactivation of p53 in Mouse Ovarian Surface Epithelium Does Not Alter MIS Driven Smad2-Dominant Negative Epithelium-Lined Inclusion Cysts or Teratomas	PLOS ONE			English	Article							FALLOPIAN-TUBE; SEROUS CARCINOMA; TUMOR-MARKERS; CANCER; PATHWAY; MODELS; BRCA1; CELLS; MICE; LEIOMYOSARCOMAS	Epithelial ovarian cancer is the most lethal gynecological malignancy among US women. The etiology of this disease, although poorly understood, may involve the ovarian surface epithelium or the epithelium of the fallopian tube fimbriae as the progenitor cell. Disruptions in the transforming growth factor beta (TGF beta) pathway and p53 are frequently found in chemotherapy-resistant serous ovarian tumors. Transgenic mice expressing a dominant negative form of Smad2 (Smad2DN), a downstream transcription factor of the TGF beta signaling pathway, targeted to tissues of the reproductive tract were created on a FVB background. These mice developed epithelium-lined inclusion cysts, a potential precursor lesion to ovarian cancer, which morphologically resembled oviductal epithelium but exhibited protein expression more closely resembling the ovarian surface epithelium. An additional genetic "hit" of p53 deletion was predicted to result in ovarian tumors. Tissue specific deletion of p53 in the ovaries and oviducts alone was attempted through intrabursal or intraoviductal injection of Cre-recombinase expressing adenovirus (AdCreGFP) into p53(flox/flox) mice. Ovarian bursal cysts were detected in some mice 6 months after intrabursal injection. No pathological abnormalities were detected in mice with intraoviductal injections, which may be related to decreased infectivity of the oviductal epithelium with adenovirus as compared to the ovarian surface epithelium. Bitransgenic mice, expressing both the Smad2DN transgene and p53(flox/flox), were then exposed to AdCreGFP in the bursa and oviductal lumen. These mice did not develop any additional phenotypes. Exposure to AdCreGFP is not an effective methodology for conditional deletion of floxed genes in oviductal epithelium and tissue specific promoters should be employed in future mouse models of the disease. In addition, a novel phenotype was observed in mice with high expression of the Smad2DN transgene as validated through qPCR analysis, characterized by teratoma-like lesions implicating Smad signaling in teratoma development.	[Quartuccio, Suzanne M.; Lantvit, Daniel D.; Burdette, Joanna E.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA; [Bosland, Maarten C.] Univ Illinois, Dept Pathol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Burdette, JE (corresponding author), Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.	joannab@uic.edu		, Suzanne/0000-0002-7568-5871	UIC College of Pharmacy Hans W. Vahlteich Scholar Award; American Cancer Society Illinois Division Research Scholar Grant [RSG-12-230-01-TBG]; Ovarian Cancer Research Fund Liz Tilberis [L/T/UIC/0.1.2011];  [R03CA139492]	UIC College of Pharmacy Hans W. Vahlteich Scholar Award; American Cancer Society Illinois Division Research Scholar Grant; Ovarian Cancer Research Fund Liz Tilberis; 	This manuscript was funded by the UIC College of Pharmacy Hans W. Vahlteich Scholar Award, an American Cancer Society Illinois Division Research Scholar Grant RSG-12-230-01-TBG, R03CA139492, and by the Ovarian Cancer Research Fund Liz Tilberis L/T/UIC/0.1.2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2012, BJOG-INT J OBSTET GY, V119, P134, DOI 10.1111/j.1471-0528.2011.03149.x; [Anonymous], 2011, CANC FACTS FIG; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bristol-Gould SK, 2005, ENDOCRINOLOGY, V146, P5228, DOI 10.1210/en.2005-0697; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Burdette JE, 2007, ENDOCRINOLOGY, V148, P3595, DOI 10.1210/en.2007-0030; Carey MS, 2010, CLIN CANCER RES, V16, P2852, DOI 10.1158/1078-0432.CCR-09-2502; Cherchi PL, 2002, EUR J GYNAECOL ONCOL, V23, P163; Clark-Knowles KV, 2007, EXP CELL RES, V313, P133, DOI 10.1016/j.yexcr.2006.09.026; Clark-Knowles KV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008534; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Drapkin R, 2004, HUM PATHOL, V35, P1014, DOI 10.1016/j.humpath.2004.04.014; Feeley BT, 2006, J ORTHOP RES, V24, P1709, DOI 10.1002/jor.20229; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Gamwell LF, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100347; Garson K, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-39; Ghosh M, 2008, FERTIL STERIL, V89, P1497, DOI 10.1016/j.fertnstert.2007.05.023; Gordeeva O F, 2009, Ontogenez, V40, P403; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Jackson KS, 2009, ENDOCRINOLOGY, V150, P3921, DOI 10.1210/en.2008-1674; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; King SM, 2011, ENDOCRINE RELATED CA; KRUK PA, 1990, LAB INVEST, V63, P132; Kumar TR, 2007, ENDOCRINOLOGY, V148, P3591, DOI 10.1210/en.2007-0574; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Li J, 2011, MOD PATHOL; Li QL, 2011, PLOS GENET, P7; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; MITTAL KR, 1993, INT J GYNECOL PATHOL, V12, P59, DOI 10.1097/00004347-199301000-00008; Moustakas A, 2001, J CELL SCI, V114, P4359; Ness RB, 2000, EPIDEMIOLOGY, V11, P111, DOI 10.1097/00001648-200003000-00006; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Quinn BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008404; Sabol M, 2012, INT J ONCOL, V41, P1411, DOI 10.3892/ijo.2012.1554; Sanghera P., 2006, Archives of Gynecology and Obstetrics, V274, P178, DOI 10.1007/s00404-006-0139-x; Schlosshauer PW, 2003, CANCER, V98, P2599, DOI 10.1002/cncr.11848; SCULLY RE, 1987, ENVIRON HEALTH PERSP, V73, P15, DOI 10.2307/3430594; SERRERO G, 1991, J CELL PHYSIOL, V149, P503, DOI 10.1002/jcp.1041490321; Szabova L, 2012, CANC RES; Toh MF, 2012, STEROIDS, V77, P765, DOI 10.1016/j.steroids.2012.03.013	45	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65067	10.1371/journal.pone.0065067	http://dx.doi.org/10.1371/journal.pone.0065067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741457	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900170
J	Silva-Ramos, M; Silva, I; Oliveira, O; Ferreira, S; Reis, MJ; Oliveira, JC; Correia-de-Sa, P				Silva-Ramos, Miguel; Silva, Isabel; Oliveira, Olga; Ferreira, Sonia; Reis, Maria Julia; Oliveira, Jose Carlos; Correia-de-Sa, Paulo			Urinary ATP May Be a Dynamic Biomarker of Detrusor Overactivity in Women with Overactive Bladder Syndrome	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ADENOSINE-TRIPHOSPHATE; NEUROTROPHIC FACTOR; TRACT SYMPTOMS; RELEASE; UROTHELIUM; INCONTINENCE; MICTURITION; PAIN	Background: Nowadays, there is a considerable bulk of evidence showing that ATP has a prominent role in the regulation of human urinary bladder function and in the pathophysiology of detrusor overactivity. ATP mediates nonadrenergic-noncholinergic detrusor contractions in overactive bladders. In vitro studies have demonstrated that uroepithelial cells and cholinergic nerves from overactive human bladder samples (OAB) release more ATP than controls. Here, we compared the urinary ATP concentration in samples collected non-invasively from OAB women with detrusor overactivity and age-matched controls. Methods: Patients with neurologic diseases, history of malignancy, urinary tract infections or renal impairment (creatinine clearance <70 ml/min) were excluded. All patients completed a 3-day voiding diary, a 24 h urine collection and blood sampling to evaluate creatinine clearance. Urine samples collected during voluntary voids were immediately freeze-preserved for ATP determination by the luciferin-luciferase bioluminescence assay; for comparison purposes, samples were also tested for urinary nerve growth factor (NGF) by ELISA. Results: The urinary content of ATP, but not of NGF, normalized to patients' urine creatinine levels (ATP/Cr) or urinary volume (ATP. Vol) were significantly (P<0.05) higher in OAB women with detrusor overactivity (n = 34) than in healthy controls (n = 30). Significant differences between the two groups were still observed by boosting urinary ATP/Cr content after water intake, but these were not detected for NGF/Cr. In OAB patients, urinary ATP/Cr levels correlated inversely with mean voided volumes determined in a 3-day voiding diary. Conclusion: A high area under the receiver operator characteristics (ROC) curve (0.741; 95% CI 0.62-0.86; P<0.001) is consistent with urinary ATP/Cr being a highly sensitive dynamic biomarker for assessing detrusor overactivity in women with OAB syndrome.	[Silva-Ramos, Miguel; Silva, Isabel; Oliveira, Olga; Ferreira, Sonia; Correia-de-Sa, Paulo] Univ Porto, Inst Ciencias Biomed Abel Salazar, UMIB, Lab Farmacol & Neurobiol, P-4100 Oporto, Portugal; [Silva-Ramos, Miguel; Oliveira, Olga; Ferreira, Sonia] Ctr Hosp Porto, Serv Urol, Oporto, Portugal; [Reis, Maria Julia; Oliveira, Jose Carlos] Ctr Hosp Porto, Serv Quim Clin, Oporto, Portugal	Universidade do Porto	Correia-de-Sa, P (corresponding author), Univ Porto, Inst Ciencias Biomed Abel Salazar, UMIB, Lab Farmacol & Neurobiol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	farmacol@icbas.up.pt	Correia-De-Sá, P./F-1079-2015; Correia-de-Sá, Paulo/AAG-5901-2019; Silva-Ramos, Miguel/N-4077-2013; Silva, Isabel SD/K-9890-2014; Silva, Isabel/AAD-8548-2020	Correia-De-Sá, P./0000-0002-6114-9189; Correia-de-Sá, Paulo/0000-0002-6114-9189; Silva-Ramos, Miguel/0000-0002-1232-3232; Silva, Isabel SD/0000-0001-7244-4792; Silva, Isabel/0000-0001-7244-4792; Oliveira, Jose Carlos/0000-0003-2142-6839	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU-OSM/104369/2008, Pest/OE/UI0215/2011]; Associacao Portuguesa de Urologia and University of Porto/Caixa Geral de Depositos (Investigacao Cientifica na Pre-Graduacao)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Associacao Portuguesa de Urologia and University of Porto/Caixa Geral de Depositos (Investigacao Cientifica na Pre-Graduacao)	The research was partially supported by Fundacao para a Ciencia e a Tecnologia (FCT projects PTDC/SAU-OSM/104369/2008 and Pest/OE/UI0215/2011), Associacao Portuguesa de Urologia and University of Porto/Caixa Geral de Depositos (Investigacao Cientifica na Pre-Graduacao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Antunes-Lopes T, 2011, ADV UROL, V2011, DOI 10.1155/2011/382431; BATES C P, 1970, British Journal of Urology, V42, P714, DOI 10.1111/j.1464-410X.1970.tb06796.x; Brostrom S, 2002, NEUROUROL URODYNAM, V21, P457, DOI 10.1002/nau.10019; Burnstock G, 2011, BJU INT, V107, P192, DOI 10.1111/j.1464-410X.2010.09926.x; Cartwright R, 2011, NAT REV UROL, V8, P139, DOI 10.1038/nrurol.2011.7; Castren E, 2010, CNS DRUGS, V24, P1, DOI 10.2165/11530010-000000000-00000; Cheng Y, 2013, NEUROUROL URODYNAM, V32, P969, DOI 10.1002/nau.22344; Cheng Y, 2010, J UROLOGY, V183, P1082, DOI 10.1016/j.juro.2009.11.028; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Coyne KS, 2011, BJU INT, V108, P1459, DOI 10.1111/j.1464-410X.2010.10013.x; EGAN JP, 1975, SERIES COGNITITION P; Farag FF, 2011, NEUROUROL URODYNAM, V30, P1422, DOI 10.1002/nau.21155; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fry CH, 2007, NEUROUROL URODYNAM, V26, P914, DOI 10.1002/nau.20483; Harvey RA, 2002, J UROLOGY, V168, P1235, DOI 10.1016/S0022-5347(05)64632-0; Hashim H, 2006, J UROLOGY, V175, P191, DOI 10.1016/S0022-5347(05)00067-4; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Ito K, 2008, N-S ARCH PHARMACOL, V377, P483, DOI 10.1007/s00210-007-0197-z; Keiding R, 1974, SCAND J CLIN LAB INV, V1, P271; Khera M, 2004, NEUROCHEM INT, V45, P987, DOI 10.1016/j.neuint.2004.06.001; Kim JC, 2006, J UROLOGY, V175, P1773, DOI 10.1016/S0022-5347(05)00992-4; Kumar V, 2004, J UROLOGY, V172, P744, DOI 10.1097/01.ju.0000131244.67160.f4ABSTRACT; Kumar V, 2010, EUR UROL, V57, P1087, DOI 10.1016/j.eururo.2009.11.042; Kuo HC, 2010, NEUROUROL URODYNAM, V29, P482, DOI 10.1002/nau.20741; Liu HT, 2010, J FORMOS MED ASSOC, V109, P862, DOI 10.1016/S0929-6646(10)60133-7; MOORE KH, 1992, BRIT J UROL, V70, P370, DOI 10.1111/j.1464-410X.1992.tb15790.x; Moore KH, 1990, NEUROUROL URODYNAM, V9, P331; Munoz A, 2011, NEUROCHEM INT, V58, P295, DOI 10.1016/j.neuint.2010.12.002; Munoz A, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-10; Nitti VW, 2010, BJU INT, V105, P1268, DOI 10.1111/j.1464-410X.2009.09037.x; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Pandita RK, 2002, J UROLOGY, V168, P1230, DOI 10.1016/S0022-5347(05)64631-9; Rovner E, 2011, NEUROUROL URODYNAM, V30, P556, DOI 10.1002/nau.21021; Ruggieri MR, 2006, NAT CLIN PRACT UROL, V3, P206, DOI 10.1038/ncpuro0456; Sadananda P, 2009, BRIT J PHARMACOL, V158, P1655, DOI 10.1111/j.1476-5381.2009.00431.x; Silva I, 2011, AUTON NEUROSCI-BASIC, V163, P49; Silva-Ramos M, 2010, BASIC CLIN PHARMACOL, V107, P2397; Smith CP, 2005, NEUROCHEM INT, V47, P291, DOI 10.1016/j.neuint.2005.04.021; Sugaya K, 2009, BIOMED RES-TOKYO, V30, P287, DOI 10.2220/biomedres.30.287; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; Yu YB, 2012, GUT, V61, P685, DOI 10.1136/gutjnl-2011-300265	42	49	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64696	10.1371/journal.pone.0064696	http://dx.doi.org/10.1371/journal.pone.0064696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741373	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900086
J	Stanton-Geddes, J; Paape, T; Epstein, B; Briskine, R; Yoder, J; Mudge, J; Bharti, AK; Farmer, AD; Zhou, P; Denny, R; May, GD; Erlandson, S; Yakub, M; Sugawara, M; Sadowsky, MJ; Young, ND; Tiffin, P				Stanton-Geddes, John; Paape, Timothy; Epstein, Brendan; Briskine, Roman; Yoder, Jeremy; Mudge, Joann; Bharti, Arvind K.; Farmer, Andrew D.; Zhou, Peng; Denny, Roxanne; May, Gregory D.; Erlandson, Stephanie; Yakub, Mohammed; Sugawara, Masayuki; Sadowsky, Michael J.; Young, Nevin D.; Tiffin, Peter			Candidate Genes and Genetic Architecture of Symbiotic and Agronomic Traits Revealed by Whole-Genome, Sequence-Based Association Genetics in Medicago truncatula	PLOS ONE			English	Article							MODEL LEGUME; WIDE ASSOCIATION; COMPLEX TRAITS; NODULATION; FAMILY; EXPRESSION; NITROGEN; VARIANTS; CALCIUM; KINASES	Genome-wide association study (GWAS) has revolutionized the search for the genetic basis of complex traits. To date, GWAS have generally relied on relatively sparse sampling of nucleotide diversity, which is likely to bias results by preferentially sampling high-frequency SNPs not in complete linkage disequilibrium (LD) with causative SNPs. To avoid these limitations we conducted GWAS with >6 million SNPs identified by sequencing the genomes of 226 accessions of the model legume Medicago truncatula. We used these data to identify candidate genes and the genetic architecture underlying phenotypic variation in plant height, trichome density, flowering time, and nodulation. The characteristics of candidate SNPs differed among traits, with candidates for flowering time and trichome density in distinct clusters of high linkage disequilibrium (LD) and the minor allele frequencies (MAF) of candidates underlying variation in flowering time and height significantly greater than MAF of candidates underlying variation in other traits. Candidate SNPs tagged several characterized genes including nodulation related genes SERK2, MtnodGRP3, MtMMPL1, NFP, CaML3, MtnodGRP3A and flowering time gene MtFD as well as uncharacterized genes that become candidates for further molecular characterization. By comparing sequence-based candidates to candidates identified by in silico 250K SNP arrays, we provide an empirical example of how reliance on even high-density reduced representation genomic makers can bias GWAS results. Depending on the trait, only 30-70% of the top 20 in silico array candidates were within 1 kb of sequence-based candidates. Moreover, the sequence-based candidates tagged by array candidates were heavily biased towards common variants; these comparisons underscore the need for caution when interpreting results from GWAS conducted with sparsely covered genomes.	[Stanton-Geddes, John; Paape, Timothy; Epstein, Brendan; Yoder, Jeremy; Erlandson, Stephanie; Yakub, Mohammed; Young, Nevin D.; Tiffin, Peter] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Briskine, Roman] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Mudge, Joann; Bharti, Arvind K.; Farmer, Andrew D.; May, Gregory D.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Zhou, Peng; Denny, Roxanne; Young, Nevin D.] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Sugawara, Masayuki; Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, Dept Soil Water & Climate, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Center for Genome Resources (NCGR); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Tiffin, P (corresponding author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.	ptiffin@umn.edu	Yoder, Jeremy B./A-8087-2008; Sugawara, Masayuki/AAV-6030-2021; Sadowsky, Michael/J-2507-2016	Yoder, Jeremy B./0000-0002-5630-0921; Sugawara, Masayuki/0000-0002-3058-4348; Sadowsky, Michael/0000-0001-8779-2781; Young, Nevin/0000-0001-6463-4772; Tiffin, Peter/0000-0003-1975-610X; Briskine, Roman/0000-0002-6831-3914; Mudge, Joann/0000-0002-2972-1640; Paape, Timothy/0000-0002-3595-2875; Stanton-Geddes, John/0000-0003-4667-2542	National Science Foundation Grant [0820005]; Direct For Biological Sciences [1237993] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1062432] Funding Source: National Science Foundation	National Science Foundation Grant(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was funded by National Science Foundation Grant 0820005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Beavis William D., 1998, P145; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BHUVANESWARI TV, 1981, PLANT PHYSIOL, V68, P1144, DOI 10.1104/pp.68.5.1144; Bonnin I, 2001, MOL ECOL, V10, P1371, DOI 10.1046/j.1365-294X.2001.01278.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Branca A, 2011, P NATL ACAD SCI USA, V108, pE864, DOI 10.1073/pnas.1104032108; Capoen W, 2011, P NATL ACAD SCI USA, V108, P14348, DOI 10.1073/pnas.1107912108; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Combier JP, 2007, PLANT PHYSIOL, V144, P703, DOI 10.1104/pp.106.092585; CREGAN PB, 1989, APPL ENVIRON MICROB, V55, P2532, DOI 10.1128/AEM.55.10.2532-2536.1989; DeRose-Wilson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022832; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833; Ferrario S, 2004, PLANT CELL, V16, P1490, DOI 10.1105/tpc.019679; Fisher RA, 1930, GENETICAL THEORY NAT; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Gubry-Rangin C, 2010, P ROY SOC B-BIOL SCI, V277, P1947, DOI 10.1098/rspb.2009.2072; Heath KD, 2007, P ROY SOC B-BIOL SCI, V274, P1905, DOI 10.1098/rspb.2007.0495; Huang X, 2011, NAT GENET, P1; Hudson M, 1999, GENE DEV, V13, P2017, DOI 10.1101/gad.13.15.2017; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kevei Z, 2002, MOL PLANT MICROBE IN, V15, P922, DOI 10.1094/MPMI.2002.15.9.922; Kevei Z, 2007, PLANT CELL, V19, P3974, DOI 10.1105/tpc.107.053975; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Long AD, 1999, GENOME RES, V9, P720; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Morere-Le Paven MC, 2011, J EXP BOT, V62, P5595, DOI 10.1093/jxb/err243; Nolan KE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-44; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Pierre JB, 2011, MOL BREEDING, V28, P25, DOI 10.1007/s11032-010-9457-6; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; R Core Team, 2020, R LANG ENV STAT COMP; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Ronfort J, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-28; Salzer P, 2004, PLANTA, V219, P626, DOI 10.1007/s00425-004-1268-8; Siol M, 2008, HEREDITY, V100, P517, DOI 10.1038/hdy.2008.5; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TRIPLETT EW, 1992, ANNU REV MICROBIOL, V46, P399, DOI 10.1146/annurev.mi.46.100192.002151; Venables WN., 2002, MODERN APPL STAT S 4; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu SZ, 2003, GENETICS, V165, P2259; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Young ND, 2009, CURR OPIN PLANT BIOL, V12, P193, DOI 10.1016/j.pbi.2008.11.005; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	59	107	108	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65688	10.1371/journal.pone.0065688	http://dx.doi.org/10.1371/journal.pone.0065688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741505	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900218
J	Hung, PS; Kuo, YC; Chen, HG; Chiang, HHK; Lee, OKS				Hung, Pei-San; Kuo, Yi-Chun; Chen, He-Guei; Chiang, Hui-Hua Kenny; Lee, Oscar Kuang-Sheng			Detection of Osteogenic Differentiation by Differential Mineralized Matrix Production in Mesenchymal Stromal Cells by Raman Spectroscopy	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IN-VIVO; OCTACALCIUM PHOSPHATE; PERIPHERAL-BLOOD; CORD BLOOD; BONE; TISSUE; HYDROXYAPATITE; MICROSPECTROSCOPY; PROLIFERATION	Mesenchymal stromal cells (MSCs) hold great potential in skeletal tissue engineering and regenerative medicine. However, conventional methods that are used in molecular biology to evaluate osteogenic differentiation of MSCs require a relatively large amount of cells. Cell lysis and cell fixation are also required and all these steps are time-consuming. Therefore, it is imperative to develop a facile technique which can provide real-time information with high sensitivity and selectivity to detect the osteogenic maturation of MSCs. In this study, we use Raman spectroscopy as a biosensor to monitor the production of mineralized matrices during osteogenic induction of MSCs. In summary, Raman spectroscopy is an excellent biosensor to detect the extent of maturation level during MSCs-osteoblast differentiation with a non-disruptive, real-time and label free manner. We expect that this study will promote further investigation of stem cell research and clinical applications.	[Hung, Pei-San; Chen, He-Guei; Chiang, Hui-Hua Kenny] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Kuo, Yi-Chun] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chiang, Hui-Hua Kenny] Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan; [Lee, Oscar Kuang-Sheng] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lee, OKS (corresponding author), Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan.	kslee@vghtpe.gov.tw			UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council I-RiCE Program [NSC100-2911-I-009-101]; Taipei Veterans General Hospital [VGH101E1-012, VGH101C-015, VN101-07]; National Science Council, Taiwan [NSC100-2120-M-010-001, NSC100-2314-B-010-030-MY3, NSC100-2321-B-010-019, NSC 101-2911-I-010-503, NSC 99-3114-B-002-005]; Ministry of Economic Affairs, Taiwan [101-EC-17-A-17-S1-203]; National Research Program for Biopharmaceuticals [DOH101-TD-PB-111-NSC014]; National Yang-Ming University/Cheng Hsin General Hospital Grant [101F195CY07]; Aim for the Top University Plan from the Ministry of Education	UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council I-RiCE Program; Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan); National Research Program for Biopharmaceuticals; National Yang-Ming University/Cheng Hsin General Hospital Grant; Aim for the Top University Plan from the Ministry of Education	This work was supported in part by the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC100-2911-I-009-101. The authors also acknowledge financial support from the Taipei Veterans General Hospital (VGH101E1-012, VGH101C-015 and VN101-07), the National Science Council, Taiwan (NSC100-2120-M-010-001, NSC100-2314-B-010-030-MY3, NSC100-2321-B-010-019, NSC 101-2911-I-010-503, and NSC 99-3114-B-002-005), the Ministry of Economic Affairs, Taiwan (101-EC-17-A-17-S1-203), and a Grant from National Research Program for Biopharmaceuticals (DOH101-TD-PB-111-NSC014), as well as the National Yang-Ming University/Cheng Hsin General Hospital Grant (101F195CY07). This study was also supported by the Aim for the Top University Plan from the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager JW, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1924668; Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Alge DL, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025016; Alt KW, 2002, HOMO, V53, P191; Anada T, 2008, TISSUE ENG PT A, V14, P965, DOI [10.1089/ten.tea.2007.0339, 10.1089/tea.2007.0339]; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; BOSKEY AL, 1992, CLIN ORTHOP RELAT R, P244; Brkovic BMB, 2012, CLIN ORAL INVEST, V16, P581, DOI 10.1007/s00784-011-0531-1; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carey DM, 1998, J CHEM PHYS, V108, P2669, DOI 10.1063/1.475659; Chan JW, 2008, ANAL CHEM, V80, P2180, DOI 10.1021/ac7022348; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Cheng MT, 2009, TISSUE ENG PT A, V15, P3979, DOI [10.1089/ten.tea.2009.0172, 10.1089/ten.TEA.2009.0172]; Chiang HK, 2009, J RAMAN SPECTROSC, V40, P546, DOI 10.1002/jrs.2161; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Eppert K, 2005, MODERN PATHOL, V18, P388, DOI 10.1038/modpathol.3800265; Fu SZ, 2012, BIOMATERIALS, V33, P8363, DOI 10.1016/j.biomaterials.2012.08.023; Fulmer MT, 1998, J MATER SCI-MATER M, V9, P197, DOI 10.1023/A:1008832006277; Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/NMAT2505, 10.1038/nmat2505]; Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053; Huang ZW, 2003, INT J CANCER, V107, P1047, DOI 10.1002/ijc.11500; Hughes C, 2010, ANALYST, V135, P3133, DOI 10.1039/c0an00574f; Jain R, 2013, BIOMATERIALS, V34, P340, DOI 10.1016/j.biomaterials.2012.09.055; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JOHNSSON MSA, 1992, CRIT REV ORAL BIOL M, V3, P61, DOI 10.1177/10454411920030010601; Kawai T, 2009, TISSUE ENG PT A, V15, P23, DOI 10.1089/ten.tea.2008.0141; Kuo SW, 2012, BIOMATERIALS, V33, P5013, DOI 10.1016/j.biomaterials.2012.03.080; Kuo TK, 2009, CELL TRANSPLANT, V18, P1013, DOI 10.3727/096368909X471206; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li QB, 2005, WORLD J GASTROENTERO, V11, P327, DOI 10.3748/wjg.v11.i3.327; Liu GH, 2012, BIOMATERIALS AND STEM CELLS IN REGENERATIVE MEDICINE, P419; Masse PG, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-2; Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8; MCCULLOCH CAG, 1986, ANAT RECORD, V215, P397, DOI 10.1002/ar.1092150410; McManus LL, 2012, ANALYST, V137, P1559, DOI 10.1039/c2an16209a; McManus LL, 2011, ANALYST, V136, P2471, DOI 10.1039/c1an15167c; Mok P L, 2008, Malays J Pathol, V30, P11; Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y; Murase M, 2009, BRIT J CANCER, V101, P1425, DOI 10.1038/sj.bjc.6605330; Nemecek D, 2013, CURR PROTOC PROTEIN, V17, P18; Neugebauer U, 2010, ANALYST, V135, P3178, DOI 10.1039/c0an00608d; Nishimura R, 2008, J BONE MINER METAB, V26, P203, DOI 10.1007/s00774-007-0824-2; Notingher I, 2004, J CELL BIOCHEM, V92, P1180, DOI 10.1002/jcb.20136; Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720; Ohgushi H, 2005, BIOMATERIALS, V26, P4654, DOI 10.1016/j.biomaterials.2004.11.055; Panetta NJ, 2009, PANMINERVA MED, V51, P25; Penel G, 1999, BONE, V25, p81S, DOI 10.1016/S8756-3282(99)00139-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; SAUER GR, 1994, CALCIFIED TISSUE INT, V54, P414, DOI 10.1007/BF00305529; Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006; Schulze HG, 2010, ANAL CHEM, V82, P5020, DOI 10.1021/ac902697q; Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253; Stewart S, 2002, J RAMAN SPECTROSC, V33, P536, DOI 10.1002/jrs.892; Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118; Tondreau T, 2005, STEM CELLS, V23, P1105, DOI 10.1634/stemcells.2004-0330; Vani R, 2009, J MATER SCI-MATER M, V20, P43, DOI 10.1007/s10856-008-3480-8; Villaron EM, 2004, HAEMATOLOGICA, V89, P1421; Walsh MJ, 2008, STEM CELLS, V26, P108, DOI 10.1634/stemcells.2007-0196; Yu YP, 2010, CHEM COMMUN, V46, P6909, DOI 10.1039/c0cc02141e; Zhao R, 2010, ANALYST, V135, P53, DOI 10.1039/b914311d; Zou XH, 2009, CELL TRANSPLANT, V18, P433, DOI 10.3727/096368909788809839; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	67	31	31	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65438	10.1371/journal.pone.0065438	http://dx.doi.org/10.1371/journal.pone.0065438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734254	gold, Green Published, Green Submitted			2022-12-27	WOS:000319725500012
J	Jensen, B; van den Berg, G; van den Doel, R; Oostra, RJ; Wang, T; Moorman, AFM				Jensen, Bjarke; van den Berg, Gert; van den Doel, Rick; Oostra, Roelof-Jan; Wang, Tobias; Moorman, Antoon F. M.			Development of the Hearts of Lizards and Snakes and Perspectives to Cardiac Evolution	PLOS ONE			English	Article							OUTFLOW TRACT; BULBUS-CORDIS; CONDUCTION SYSTEM; VERTEBRATE HEART; ARTERIAL POLE; HISTOLOGICAL SECTIONS; VENTRICULAR SEPTUM; PRIMARY MYOCARDIUM; MOLECULAR ANALYSIS; CHAMBER FORMATION	Birds and mammals both developed high performance hearts from a heart that must have been reptile-like and the hearts of extant reptiles have an unmatched variability in design. Yet, studies on cardiac development in reptiles are largely old and further studies are much needed as reptiles are starting to become used in molecular studies. We studied the growth of cardiac compartments and changes in morphology principally in the model organism corn snake (Pantherophis guttatus), but also in the genotyped anole (Anolis carolinenis and A. sagrei) and the Philippine sailfin lizard (Hydrosaurus pustulatus). Structures and chambers of the formed heart were traced back in development and annotated in interactive 3D pdfs. In the corn snake, we found that the ventricle and atria grow exponentially, whereas the myocardial volumes of the atrioventricular canal and the muscular outflow tract are stable. Ventricular development occurs, as in other amniotes, by an early growth at the outer curvature and later, and in parallel, by incorporation of the muscular outflow tract. With the exception of the late completion of the atrial septum, the adult design of the squamate heart is essentially reached halfway through development. This design strongly resembles the developing hearts of human, mouse and chicken around the time of initial ventricular septation. Subsequent to this stage, and in contrast to the squamates, hearts of endothermic vertebrates completely septate their ventricles, develop an insulating atrioventricular plane, shift and expand their atrioventricular canal toward the right and incorporate the systemic and pulmonary venous myocardium into the atria.	[Jensen, Bjarke; Wang, Tobias] Aarhus Univ, Dept Biosci Zoophysiol, Aarhus, Denmark; [Jensen, Bjarke; van den Berg, Gert; van den Doel, Rick; Oostra, Roelof-Jan; Moorman, Antoon F. M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	Aarhus University; University of Amsterdam; Academic Medical Center Amsterdam	Jensen, B (corresponding author), Aarhus Univ, Dept Biosci Zoophysiol, Aarhus, Denmark.	bjarke.jensen@biology.au.dk	Jensen, Bjarke/I-7490-2019; Wang, Tobias/I-7946-2013; Jensen, Bjarke/GQI-3989-2022	Jensen, Bjarke/0000-0002-7750-8035; Wang, Tobias/0000-0002-4350-3682; Oostra, Roelof-Jan/0000-0002-2452-8307	Danish Council for Independent Research \ Natural Sciences	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	Bjarke Jensen and Tobias Wang were supported by The Danish Council for Independent Research vertical bar Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanhaanen WTJ, 2011, J CLIN INVEST, V121, P534, DOI 10.1172/JCI44350; Aanhaanen WTJ, 2009, CIRC RES, V104, P1267, DOI 10.1161/CIRCRESAHA.108.192450; Acolat LM, 1943, THESIS FS NANCY; Agassiz L., 1857, CONTRIBUTIONS NATURA, VII, P451; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; ARBEL ER, 1977, AM J PHYSIOL, V232, pH24, DOI 10.1152/ajpheart.1977.232.1.H24; Benninghoff A., 1933, HDB VERGLEICHENDEN A, V6, P467; Benninghoff A, 1921, MORPH JB, V51, P355; Bertens LMF, 2010, ANAT REC, V293, P1101, DOI 10.1002/ar.21162; Bezuidenhout AJ, 1981, ANATOMY HEART OSTRIC; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Boas JEV., 1882, MORPH JB, V7, P488; Boixel C, 2003, J AM COLL CARDIOL, V42, P336, DOI 10.1016/S0735-1097(03)00578-3; Boukens BJ, 2012, PEDIATR CARDIOL, V33, P900, DOI 10.1007/s00246-012-0237-4; Brucke E., 1852, DENKSCHR AKAD WISS W, V3, P335; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; BUCHANAN J. G., 1956, TRANS ROY SOC NEW ZEALAND, V84, P103; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; BUGGE JORGEN, 1961, VIDENSK MEDDEL DANSK FORENING I KOBENHAVN, V123, P193; BURGGREN W, 1998, COMPREHENSIVE PHYSL, P215; Butcher JT, 2007, DEV DYNAM, V236, P802, DOI 10.1002/dvdy.20962; Castoe TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-406; Christoffels VM, 2009, CIRC-ARRHYTHMIA ELEC, V2, P195, DOI 10.1161/CIRCEP.108.829341; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Cousins KL, 1997, J EXP BIOL, V200, P1351; Crossley DA, 2009, J MORPHOL, V270, P1400, DOI 10.1002/jmor.10764; DAVIES F, 1946, BIOL REV, V21, P173, DOI 10.1111/j.1469-185X.1946.tb00323.x; Davies F, 1931, J ANAT, V65, P339; DAVIES F, 1952, J ANAT, V86, P152; de Boer BA, 2012, DEV BIOL, V368, P203, DOI 10.1016/j.ydbio.2012.05.001; De Boer BA, 2010, IMAGE ANAL STEREOL, V29, P53, DOI 10.5566/ias.v29.p53-60; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; DOWD DA, 1969, ACTA ANAT, V74, P547; Farrell A. P., 1998, V19, P375; Farrell AP, 2007, FISH PHYSIOL, V26, P53, DOI 10.1016/S1546-5098(07)26002-9; Ferguson MWJ, 1985, BIOL REPTILIA, P331; Fuchs F., 1924, Zs ges Anat Miinchen Abt 1, V75, P1, DOI 10.1007/BF02117102; Gallego A, 1997, ANAT REC, V248, P224; Gasch FR, 1888, ARCH NATURGESCH, V54, P119; Gegenbaur C., 1878, ELEMENTS COMP ANATOM; Goodrich ES, 1930, STUDIES STRUCTURE DE, P536; GOOR DA, 1972, CIRCULATION, V46, P375, DOI 10.1161/01.CIR.46.2.375; Gregory JA, 2004, COMP BIOCHEM PHYS A, V138, P203, DOI 10.1016/j.cbpb.2004.03.014; Greil A., 1903, Morphologisches Jahrbuch, Vxxxi, P123; Grimes AC, 2009, J FISH BIOL, V74, P983, DOI 10.1111/j.1095-8649.2008.02125.x; Grimes AC, 2006, DEV BIOL, V290, P265, DOI 10.1016/j.ydbio.2005.11.042; Grimes AC, 2010, EVOL DEV, V12, P552, DOI 10.1111/j.1525-142X.2010.00441.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; HART NH, 1968, J MORPHOL, V125, P1, DOI 10.1002/jmor.1051250102; HAYES JA, 1966, CIRCULATION, V33, P450, DOI 10.1161/01.CIR.33.3.450; Heine H, 1972, ANAT EMBRYOL, V137, P86; Hicks James W., 2012, P207; Hicks James W., 1998, V19, P425; Ho SY, 2000, HEART, V83, P444, DOI 10.1136/heart.83.4.444; HOLMES EB, 1975, J MORPHOL, V147, P209, DOI 10.1002/jmor.1051470207; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Icardo JM, 2005, J MORPHOL, V265, P43, DOI 10.1002/jmor.10340; ICARDO JM, 1993, J ANAT, V182, P87; Icardo JM, 2006, ANAT REC PART A, V288A, P900, DOI 10.1002/ar.a.20361; Icardo JM, 2011, ANAT REC, V294, P236, DOI 10.1002/ar.21320; Jahr M, 2011, DEV DYNAM, V240, P1518, DOI 10.1002/dvdy.22611; Jensen B, 2012, BIOCH BIOPHYS ACTA M, P783; Jensen B, 2011, COMP BIOCHEM PHYS A, V160, P35, DOI 10.1016/j.cbpa.2011.04.018; Jensen B, 2010, J MORPHOL, V271, P1066, DOI 10.1002/jmor.10854; Jensen B, 2010, J EXP BIOL, V213, P1611, DOI 10.1242/jeb.030999; JOHANSEN K, 1987, J EXP BIOL, V130, P1; JOHANSEN K, 1968, Z VERGL PHYSIOL, V59, P157; JOHANSEN KJELL, 1965, ANN N Y ACAD SCI, V127, P414, DOI 10.1111/j.1749-6632.1965.tb49417.x; Keith A, 1924, LANCET, V2, P1267; Keith A, 1907, J ANAT PHYSIOL, V41, P172; KLITGAARD T, 1978, ACTA ZOOL-STOCKHOLM, V59, P187, DOI 10.1111/j.1463-6395.1978.tb01033.x; KNAAPEN MWM, 1995, ANAT REC, V243, P93, DOI 10.1002/ar.1092430111; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; Kulbs F, 1910, Z EXPER PATHOL THERA, V8, P313; Lai NC, 2004, COMP BIOCHEM PHYS A, V137, P505, DOI 10.1016/j.cbpb.2003.11.011; LAMERS WH, 1995, CIRCULATION, V91, P111, DOI 10.1161/01.CIR.91.1.111; Lamers WH, 2002, CIRC RES, V91, P93, DOI 10.1161/01.RES.0000027135.63141.89; LANGER A, 1894, MORPHOL JB, V21, P40; Lankester E.R., 1882, P ZOOL SOC LOND, V50, P549; LAWSON R, 1966, J ZOOL, V149, P320; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; MACKINNON MR, 1981, J MORPHOL, V170, P1, DOI 10.1002/jmor.1051700102; MARCH HW, 1961, AM J PHYSIOL, V201, P1109, DOI 10.1152/ajplegacy.1961.201.6.1109; Meinertz T., 1966, MORPHOL JB, V108, P568; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Moorman AFM, 2012, HEART DEV REGENERATI, P219; MULLEN RK, 1967, PHYSIOL ZOOL, V40, P114, DOI 10.1086/physzool.40.2.30152446; MULLEN RK, 1973, COPEIA, P802; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Netter FH, 2003, NETTER PRESENTER HUM; O'Donoghue CH, 1912, P ZOOL SOC LOND, V1912, P612; Parsons CW, 1929, Q J MICROSC SCI, V73, P145; Pek M, 1997, J EXP BIOL, V200, P1913; Pernkopf E., 1933, ANAT ENTWICKLUNGSGES, V100, P563; Pettigrew JB., 1864, PHILOS T R SOC LOND, V154, P445, DOI DOI 10.1098/RSTL.1864.0014; PUTNAM JL, 1977, COPEIA, P476; Ramaswami LS, 1944, P ZOOL SOC LOND, V114, P117; Rana MS, 2007, CIRC RES, V100, P1000, DOI 10.1161/01.RES.0000262688.14288.b8; Rathke H, 1839, ENTWICKELUNGSGESCHIC; Robertson JI, 1913, Q J MICROSC SCI, V59, P53; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; ROWLATT U, 1990, ZOOL J LINN SOC-LOND, V98, P73, DOI 10.1111/j.1096-3642.1990.tb01220.x; ROWLATT U, 1975, J MORPHOL, V146, P479, DOI 10.1002/jmor.1051460405; SANCHEZQUINTANA D, 1987, ANAT REC, V217, P263, DOI 10.1002/ar.1092170307; Sandblom E, 2007, COMP BIOCHEM PHYS A, V148, P785, DOI 10.1016/j.cbpa.2007.08.036; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; SHANER RF, 1962, ANAT RECORD, V142, P519, DOI 10.1002/ar.1091420409; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; SIMONS J. R., 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P451; Sissman N J, 1970, Am J Cardiol, V25, P141, DOI 10.1016/0002-9149(70)90575-8; Sizarov A, 2012, J ANAT, V220, P336, DOI 10.1111/j.1469-7580.2012.01474.x; Sizarov A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P532, DOI 10.1161/CIRCEP.111.963421; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Soufan AT, 2003, PHYSIOL GENOMICS, V13, P187, DOI 10.1152/physiolgenomics.00182.2002; Syme DA, 2002, J EXP BIOL, V205, P1843; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644; Valentinuzzi M E, 1969, J Electrocardiol, V2, P39, DOI 10.1016/S0022-0736(69)80048-8; van den Berg G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022055; van den Berg G, 2009, CIRC RES, V104, P179, DOI 10.1161/CIRCRESAHA.108.185843; van den Hoff MJB, 2004, BIOESSAYS, V26, P248, DOI 10.1002/bies.20006; Van Mierop L H, 1985, Heart Vessels, V1, P114; Van Mierop L.H.S., 1981, VENTRICULAR SEPTUM H, P35; van Mierop L. H. S., 1985, A BENZON S, P38; Van Mierop LHS, 1984, CONGENITAL HEART DIS, P459; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; VIRAGH S, 1977, DEV BIOL, V56, P382, DOI 10.1016/0012-1606(77)90278-0; VISCOR G, 1985, COMP BIOCHEM PHYS A, V82, P597, DOI 10.1016/0300-9629(85)90439-6; WEATHERS WW, 1974, J COMP PHYSIOL, V93, P127, DOI 10.1007/BF00696267; WEBB GJW, 1979, J MORPHOL, V161, P221, DOI 10.1002/jmor.1051610209; WEBB GJW, 1974, J MORPHOL, V142, P1, DOI 10.1002/jmor.1051420102; WHITE FC, 1981, BASIC RES CARDIOL, V76, P189, DOI 10.1007/BF01907957; WHITE FN, 1959, ANAT REC, V135, P129, DOI 10.1002/ar.1091350208; Wilkinson M, 1996, ZOOL J LINN SOC-LOND, V118, P135, DOI 10.1111/j.1096-3642.1996.tb00223.x; Wyneken Jeanette, 2009, Veterinary Clinics of North America Exotic Animal Practice, V12, P51, DOI 10.1016/j.cvex.2008.08.001; Yelbuz TM, 2003, DEV DYNAM, V228, P152, DOI 10.1002/dvdy.10364; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE	143	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e63651	10.1371/journal.pone.0063651	http://dx.doi.org/10.1371/journal.pone.0063651			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755108	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400005
J	Lamontagne, A; Long, RE; Comunale, MA; Hafner, J; Rodemich-Betesh, L; Wang, MJ; Marrero, J; Di Bisceglie, AM; Block, T; Mehta, A				Lamontagne, Anne; Long, Ronald E.; Comunale, Mary Ann; Hafner, Julie; Rodemich-Betesh, Lucy; Wang, Mengjun; Marrero, Jorge; Di Bisceglie, Adrian M.; Block, Timothy; Mehta, Anand			Altered Functionality of Anti-Bacterial Antibodies in Patients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							IMMUNOGLOBULIN-G; FUCOSYLATED GLYCOPROTEINS; IGG ANTIBODIES; LIVER FIBROSIS; COMPLEMENT; BINDING; ACTIVATION; ENDOTOXIN; MODULATE	Background: Using comparative glycoproteomics, we have previously identified a glycoprotein that is altered in both amount and glycosylation as a function of liver cirrhosis. The altered glycoprotein is an agalactosylated (G0) immunoglobulin G molecule (IgG) that recognizes the heterophilic alpha-gal epitope. Since the alpha gal epitope is found on gut enterobacteria, it has been hypothesized that anti-gal antibodies are generated as a result of increased bacterial exposure in patients with liver disease. Methods: The N-linked glycosylation of anti-gal IgG molecules from patients with fibrosis and cirrhosis was determined and the effector function of anti-bacterial antibodies from over 100 patients examined. In addition, markers of microbial exposure were determined. Results: Surprisingly, the subset of agalactosylated anti-gal antibodies described here, was impaired in their ability to mediate complement mediated lysis and inhibited the complement-mediated destruction of common gut bacteria. In an analysis of serum from more than 100 patients with liver disease, we have shown that those with increased levels of this modified anti-gal antibody had increased levels of markers of bacterial exposure. Conclusions: Anti-gal antibodies in patients with liver cirrhosis were reduced in their ability to mediate complement mediated lysis of target cells. As bacterial infection is a major complication in patients with cirrhosis and bacterial products such as LPS are thought to play a major role in the development and progression of liver fibrosis, this finding has many clinical implications in the etiology, prognosis and treatment of liver disease.	[Lamontagne, Anne; Long, Ronald E.; Comunale, Mary Ann; Rodemich-Betesh, Lucy; Wang, Mengjun; Block, Timothy; Mehta, Anand] Drexel Univ, Coll Med, Doylestown, PA USA; [Lamontagne, Anne; Long, Ronald E.; Comunale, Mary Ann; Rodemich-Betesh, Lucy; Wang, Mengjun; Block, Timothy; Mehta, Anand] Dept Microbiol & Immunol, Doylestown, PA USA; [Lamontagne, Anne; Long, Ronald E.; Comunale, Mary Ann; Rodemich-Betesh, Lucy; Wang, Mengjun; Block, Timothy; Mehta, Anand] Drexel Inst Biotechnol & Virol, Doylestown, PA USA; [Hafner, Julie] Immunotope Inc, Doylestown, PA USA; [Marrero, Jorge] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA	Drexel University; Drexel University; University of Michigan System; University of Michigan; Saint Louis University; Saint Louis University	Lamontagne, A (corresponding author), Drexel Univ, Coll Med, Doylestown, PA USA.	anne.lamontagne@drexelmed.edu; asm54@me.com			National Cancer Institute (NCI) [R01 CA120206-01, R42 CA121506-02]; NCI's Early Research Detection Network (EDRN) [UO1 CA084951-06]; Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA120206, U01CA168856, R42CA121506, U01CA084951] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI's Early Research Detection Network (EDRN); Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01 CA120206-01 and R42 CA121506-02 from the National Cancer Institute (NCI), and grant UO1 CA084951-06 from the NCI's Early Research Detection Network (EDRN), the Hepatitis B Foundation, and an appropriation from The Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Comunale MA, 2006, J PROTEOME RES, V5, P308, DOI 10.1021/pr050328x; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Friedman SL, 2007, GASTROEN CLIN BIOL, V31, P812, DOI 10.1016/S0399-8320(07)73970-2; Friedman SL, 2007, NAT MED, V13, P1281, DOI 10.1038/nm1107-1281; Friedman SL, 2007, HEPATOLOGY, V45, P242, DOI 10.1002/hep.21459; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Galili U, 1999, Subcell Biochem, V32, P79; GALILI U, 1993, BLOOD, V82, P2485, DOI 10.1182/blood.V82.8.2485.bloodjournal8282485; Galili U, 1998, TRANSPLANTATION, V65, P1129, DOI 10.1097/00007890-199804270-00020; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; GALILI U, 1993, SPRINGER SEMIN IMMUN, V15, P155; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; HAMADEH RM, 1992, J CLIN INVEST, V89, P1223, DOI 10.1172/JCI115706; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; LaTemple DC, 1996, CANCER RES, V56, P3069; Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552; Mehta A, 2008, DIS MARKERS, V25, P259, DOI 10.1155/2008/264594; Mehta AS, 2008, J VIROL, V82, P1259, DOI 10.1128/JVI.01600-07; Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104; NOLAN JP, 1989, HEPATOLOGY, V10, P887, DOI 10.1002/hep.1840100523; NOLAN JP, 1981, HEPATOLOGY, V1, P458, DOI 10.1002/hep.1840010516; Papp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012957; Parker W, 1999, GLYCOBIOLOGY, V9, P865, DOI 10.1093/glycob/9.9.865; Parker W, 2001, TRANSPLANTATION, V71, P440, DOI 10.1097/00007890-200102150-00018; Posekany KJ, 2002, INFECT IMMUN, V70, P6215, DOI 10.1128/IAI.70.11.6215-6222.2002; POTTER BJ, 1973, GUT, V14, P451, DOI 10.1136/gut.14.6.451; Rudd PM, 1997, NATURE, V388, P205, DOI 10.1038/40677; Rudd PM, 1999, BIOTECHNOL GENET ENG, V16, P1; Rudd PM, 1997, CURR OPIN BIOTECH, V8, P488, DOI 10.1016/S0958-1669(97)80073-0; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Shao BM, 2007, J BIOL CHEM, V282, P13726, DOI 10.1074/jbc.M609462200; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; Yu PB, 1996, J IMMUNOL, V157, P5163	43	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64992	10.1371/journal.pone.0064992	http://dx.doi.org/10.1371/journal.pone.0064992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750224	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900026
J	Liu, C; Ma, N; Wang, PY; Fu, N; Shen, HL				Liu, Chen; Ma, Ning; Wang, Ping-Yong; Fu, Nan; Shen, Huo-Lin			Transcriptome Sequencing and De Novo Analysis of a Cytoplasmic Male Sterile Line and Its Near-Isogenic Restorer Line in Chili Pepper (Capsicum annuum L.)	PLOS ONE			English	Article							HONGLIAN CMS LINE; GENE-EXPRESSION; OF-FERTILITY; PARTIAL RESTORATION; OXIDATIVE STRESS; NUCLEAR GENES; MITOCHONDRIAL; MARKERS; WHEAT; RICE	Background: The use of cytoplasmic male sterility (CMS) in F-1 hybrid seed production of chili pepper is increasingly popular. However, the molecular mechanisms of cytoplasmic male sterility and fertility restoration remain poorly understood due to limited transcriptomic and genomic data. Therefore, we analyzed the difference between a CMS line 121A and its near-isogenic restorer line 121C in transcriptome level using next generation sequencing technology (NGS), aiming to find out critical genes and pathways associated with the male sterility. Results: We generated approximately 53 million sequencing reads and assembled de novo, yielding 85,144 high quality unigenes with an average length of 643 bp. Among these unigenes, 27,191 were identified as putative homologs of annotated sequences in the public protein databases, 4,326 and 7,061 unigenes were found to be highly abundant in lines 121A and 121C, respectively. Many of the differentially expressed unigenes represent a set of potential candidate genes associated with the formation or abortion of pollen. Conclusions: Our study profiled anther transcriptomes of a chili pepper CMS line and its restorer line. The results shed the lights on the occurrence and recovery of the disturbances in nuclear-mitochondrial interaction and provide clues for further investigations.	[Liu, Chen; Ma, Ning; Wang, Ping-Yong; Fu, Nan; Shen, Huo-Lin] China Agr Univ, Beijing 100094, Peoples R China	China Agricultural University	Shen, HL (corresponding author), China Agr Univ, Beijing 100094, Peoples R China.	shl1606@cau.edu.cn	Shen, Huolin/AAI-1644-2019		National Natural Science Foundation of China [31171972]; National "Twelfth Five-Year" Plan for Science & Technology Support [2012BA02B02]; Beijing key laboratory of growth and developmental regulation for protected vegetable crops	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science & Technology Support; Beijing key laboratory of growth and developmental regulation for protected vegetable crops	This project was supported by the National Natural Science Foundation of China(31171972); the National "Twelfth Five-Year" Plan for Science & Technology Support(2012BA02B02); the Beijing key laboratory of growth and developmental regulation for protected vegetable crops. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi H, 2004, THEOR APPL GENET, V108, P1449, DOI 10.1007/s00122-004-1591-2; Alfonso AA, 2003, PHILIPP AGRIC SCI, V86, P303; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; BEGU D, 1990, PLANT CELL, V2, P1283, DOI 10.1105/tpc.2.12.1283; Bennett MD, 2005, ANN BOT-LONDON, V95, P45, DOI 10.1093/aob/mci003; Bentolila S, 2012, PLANT PHYSIOL, V158, P996, DOI 10.1104/pp.111.190231; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Bosland P. W., 1992, HortTechnology, V2, P6; Bosland PW, 2012, CROP PROD SCI HORTIC, V22, P1, DOI 10.1079/9781845938253.0000; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Budar F, 2001, CR ACAD SCI III-VIE, V324, P543, DOI 10.1016/S0764-4469(01)01324-5; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Chen CM, 2012, MOL BIOL REP, V39, P737, DOI 10.1007/s11033-011-0793-3; Chen CM, 2012, PLANT MOL BIOL REP, V30, P403, DOI 10.1007/s11105-011-0358-6; Chen Xian-Feng, 1992, Acta Botanica Sinica, V34, P416; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; De AK., 2003, CAPSICUM GENUS CAPSI; Deng MH, 2012, SCI HORTIC-AMSTERDAM, V134, P232, DOI 10.1016/j.scienta.2011.10.027; Duan Jun, 1996, Plant Physiology Communications, V32, P331; Ekman DR, 2003, PLANT PHYSIOL, V133, P1397, DOI 10.1104/pp.103.028019; Gongora-Castillo E, 2012, BIOINFORMATION, V8, P43; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan JX, 1981, CHINA VEGETABLES, V1, P9; Gulyas G, 2006, BREEDING SCI, V56, P331, DOI 10.1270/jsbbs.56.331; Guo S, 2011, AGR SCI CHINA, V10, P1010, DOI 10.1016/S1671-2927(11)60088-6; Guo ShuAng, 2009, Acta Horticulturae Sinica, V36, P1443; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hong Sung-Tae, 1998, Journal of Plant Biology, V41, P116; Huang JinLing, 2004, Cotton Science, V16, P229; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P567, DOI 10.1016/j.tplants.2006.10.008; IWABUCHI M, 1993, EMBO J, V12, P1437, DOI 10.1002/j.1460-2075.1993.tb05787.x; Jin JK, 1984, RUPR ACTA HORTICULTU, V11, P182; Jo YD, 2010, MOL BREEDING, V25, P187, DOI 10.1007/s11032-009-9318-3; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim BS, 2012, KOREAN J HORTIC SCI, V30, P73, DOI 10.7235/hort.2012.11104; Kim DH, 2006, CURR GENET, V49, P59, DOI 10.1007/s00294-005-0032-3; Kim DH, 2005, MOL CELLS, V20, P416; Kim DH, 2007, PLANT MOL BIOL, V63, P519, DOI 10.1007/s11103-006-9106-y; Kim DS, 2006, MOL CELLS, V21, P135; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Lee J, 2008, THEOR APPL GENET, V117, P383, DOI 10.1007/s00122-008-0782-7; Lee JD, 2008, MOL BREEDING, V21, P95, DOI 10.1007/s11032-007-9111-0; Li Li, 2010, Agricultural Science & Technology - Hunan, V11, P9; Li SQ, 2004, FUNCT PLANT BIOL, V31, P369, DOI 10.1071/FP03224; [李莹莹 Li Yingying], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P134; Linke B, 2005, MITOCHONDRION, V5, P389, DOI 10.1016/j.mito.2005.10.001; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu SQ, 2012, PLANT CELL TISS ORG, V110, P111, DOI 10.1007/s11240-012-0135-8; LIU Y, 1988, Acta Genetica Sinica, V15, P348; Liu Z. S., 1990, Oil Crops of China, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Lu FH, 2011, SCI HORTIC-AMSTERDAM, V129, P38, DOI 10.1016/j.scienta.2011.03.003; Ma JH, 1984, CHINA VEGETABLES, V3, P1; Min WK, 2008, MOL CELLS, V25, P20; MONEGER F, 1994, EMBO J, V13, P8, DOI 10.1002/j.1460-2075.1994.tb06230.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUEHLBAUER GJ, 1988, CROP SCI, V28, P729, DOI 10.2135/cropsci1988.0011183X002800050002x; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Palloix A, 2012, GENET MOL RES, V11, P43; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; PETERSON PA, 1958, AM NAT, V92, P111, DOI 10.1086/282017; Qiu WM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-397; RICARD B, 1986, PLANT SCI, V43, P141, DOI 10.1016/0168-9452(86)90155-X; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; Shen H. L., 1994, Acta Agriculturae Universitatis Pekinensis, V20, P25; SINGH M, 1991, PLANT CELL, V3, P1349, DOI 10.1105/tpc.3.12.1349; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Teixeira RT, 2005, J EXP BOT, V56, P1245, DOI 10.1093/jxb/eri120; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Wan CX, 2007, PLANT CELL REP, V26, P373, DOI 10.1007/s00299-006-0234-2; Wang G, 2012, ACTA PHYSIOL PLANT, V34, P107, DOI 10.1007/s11738-011-0809-6; Wang LH, 2004, THEOR APPL GENET, V109, P1058, DOI 10.1007/s00122-004-1715-8; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; [王述彬 WANG Shubin], 2007, [华北农学报, Acta Agriculturae Boreali-Sinica], V22, P86; Wang Wen, 2011, China Cucurbits and Vegetables, V24, P1, DOI 10.1080/17544750.2011.544079; Wang X. Z., 1986, Acta Agronomica Sinica, V12, P177; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; YOUNG EG, 1987, CELL, V50, P41, DOI 10.1016/0092-8674(87)90660-X; YOUNG ND, 1988, GENETICS, V120, P579; Zhang BX, 2000, EUPHYTICA, V113, P155, DOI 10.1023/A:1003945723196; Zhang JianKui, 2001, Journal of Triticeae Crops, V21, P26; Zhang JuPing, 2007, Journal of Northwest A & F University - Natural Science Edition, V35, P153; Zhang MingYong, 1997, Acta Agronomica Sinica, V23, P603; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhang ZiXue, 2005, Acta Botanica Boreali-Occidentalia Sinica, V25, P799; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758; Zhou RH, 2005, THEOR APPL GENET, V110, P640, DOI 10.1007/s00122-004-1889-0	92	53	64	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65209	10.1371/journal.pone.0065209	http://dx.doi.org/10.1371/journal.pone.0065209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750245	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900047
J	Yoshida, W; Saito, T; Yokoyama, T; Ferri, S; Ikebukuro, K				Yoshida, Wataru; Saito, Taiki; Yokoyama, Tomomi; Ferri, Stefano; Ikebukuro, Kazunori			Aptamer Selection Based on G4-Forming Promoter Region	PLOS ONE			English	Article							QUADRUPLEX-FORMING REGION; DNA APTAMERS; VEGF; EVOLUTION; INSULIN; BIND; RECOGNITION; INHIBITION; ALGORITHM; MOLECULES	We developed a method for aptamer identification without in vitro selection. We have previously obtained several aptamers, which may fold into the G-quadruplex (G4) structure, against target proteins; therefore, we hypothesized that the G4 structure would be an excellent scaffold for aptamers to recognize the target protein. Moreover, the G4-forming sequence contained in the promoter region of insulin can reportedly bind to insulin. We thus expected that G4 DNAs, which are contained in promoter regions, could act as DNA aptamers against their gene products. We designated this aptamer identification method as "G4 promoter-derived aptamer selection (G4PAS).'' Using G4PAS, we identified vascular endothelial growth factor (VEGF) 165, platelet-derived growth factor-AA (PDGF)-AA, and RB1 DNA aptamers. Surface plasmon resonance (SPR) analysis revealed that the dissociation constant (K-d) values of VEGF165, PDGF-AA, and RB1 DNA aptamers were 1.76 x 10(-7) M, 6.3 x 10(-9) M, and 4.4 x 10(-7) M, respectively. G4PAS is a simple and rapid method of aptamer identification because it involves only binding analysis of G4 DNAs to the target protein. In the human genome, over 40% of promoters contain one or more potential G4 DNAs. G4PAS could therefore be applied to identify aptamers against target proteins that contain G4 DNAs on their promoters.	[Yoshida, Wataru; Saito, Taiki; Yokoyama, Tomomi; Ferri, Stefano; Ikebukuro, Kazunori] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Ferri, Stefano; Ikebukuro, Kazunori] Japan Sci & Technol Agcy, CREST, Koganei, Tokyo, Japan	Tokyo University of Agriculture & Technology; Japan Science & Technology Agency (JST)	Ikebukuro, K (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan.	ikebu@cc.tuat.ac.jp	Yoshida, Wataru/AAI-9404-2020; Ferri, Stefano/G-1166-2013; Ikebukuro, Kazunori/B-9957-2013	Yoshida, Wataru/0000-0001-9828-0896; Ikebukuro, Kazunori/0000-0003-2838-0562	JSPS KAKENHI [24760647]; TUAT Next Gen.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); TUAT Next Gen.	This work was supported by JSPS KAKENHI (Grant Number 24760647) to WY; and TUAT Next Gen. Grant 2012 to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chushak Y, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp408; Citartan M, 2012, BIOSENS BIOELECTRON, V34, P1, DOI 10.1016/j.bios.2012.01.002; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Connor AC, 2006, J AM CHEM SOC, V128, P4986, DOI 10.1021/ja056097c; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gatto B, 2009, CURR MED CHEM, V16, P1248, DOI 10.2174/092986709787846640; Hasegawa H, 2008, BIOTECHNOL LETT, V30, P829, DOI 10.1007/s10529-007-9629-6; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Ikebukuro K, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni108; Ikebukuro K, 2006, BIOTECHNOL LETT, V28, P1933, DOI 10.1007/s10529-006-9174-8; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; Li WL, 2000, J CELL SCI, V113, P1525; Matylla-Kulinska K, 2012, WIRES RNA, V3, P73, DOI 10.1002/wrna.105; Morita Y, 2011, BIOSENS BIOELECTRON, V26, P4837, DOI 10.1016/j.bios.2011.05.050; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Noma T, 2006, BIOCHEM BIOPH RES CO, V347, P226, DOI 10.1016/j.bbrc.2006.06.083; Noma T, 2006, BIOTECHNOL LETT, V28, P1939, DOI 10.1007/s10529-006-9178-4; Nonaka Y, 2010, MOLECULES, V15, P215, DOI 10.3390/molecules15010215; Osawa Y, 2009, ELECTROANAL, V21, P1303, DOI 10.1002/elan.200804559; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Qin Y, 2010, BIOCHEMISTRY-US, V49, P4208, DOI 10.1021/bi100330w; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Savory N, 2010, BIOSENS BIOELECTRON, V26, P1386, DOI 10.1016/j.bios.2010.07.057; Seenisamy J, 2004, J AM CHEM SOC, V126, P8702, DOI 10.1021/ja040022b; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tsukakoshi K, 2012, ANAL CHEM, V84, P5542, DOI 10.1021/ac300330g; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vinkenborg JL, 2011, NAT CHEM BIOL, V7, P519, DOI [10.1038/NCHEMBIO.609, 10.1038/nchembio.609]; Xiao JF, 2009, J AM SOC MASS SPECTR, V20, P1974, DOI 10.1016/j.jasms.2009.08.002; Xiao JF, 2009, J SEP SCI, V32, P1654, DOI 10.1002/jssc.200900060; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Yoshida W, 2009, BIOSENS BIOELECTRON, V24, P1116, DOI 10.1016/j.bios.2008.06.016; Zhang R, 2008, NUCLEIC ACIDS RES, V36, pD372, DOI 10.1093/nar/gkm787	49	23	25	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65497	10.1371/journal.pone.0065497	http://dx.doi.org/10.1371/journal.pone.0065497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750264	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900066
J	Baniwal, SK; Chimge, NO; Jordan, VC; Tripathy, D; Frenkel, B				Baniwal, Sanjeev K.; Chimge, Nyam-Osor; Jordan, V. Craig; Tripathy, Debu; Frenkel, Baruch			Prolactin-Induced Protein (PIP) Regulates Proliferation of Luminal A Type Breast Cancer Cells in an Estrogen-Independent Manner	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR PORTRAITS; TUMORS; DNA; PHOSPHORYLATION; TAMOXIFEN; SUBTYPES; CULTURE; LINES	Prolactin-induced Protein (PIP), an aspartyl protease unessential for normal mammalian cell function, is required for the proliferation and invasion of some breast cancer (BCa) cell types. Because PIP expression is particularly high in the Luminal A BCa subtype, we investigated the roles of PIP in the related T47D BCa cell line. Nucleic acid and antibody arrays were employed to screen effects of PIP silencing on global gene expression and activation of receptor tyrosine kinases (RTKs), respectively. Expression of PIP-stimulated genes, as defined in the T47D cell culture model, was well correlated with the expression of PIP itself across a cohort of 557 mRNA profiles of diverse BCa tumors, and bioinformatics analysis revealed cJUN and cMYC as major nodes in the PIP-dependent gene network. Among 71 RTKs tested, PIP silencing resulted in decreased phosphorylation of focal adhesion kinase (FAK), ephrin B3 (EphB3), FYN, and hemopoietic cell kinase (HCK). Ablation of PIP also abrogated serum-induced activation of the downstream serine/threonine kinases AKT, ERK1/2, and JNK1. Consistent with these results, PIP-depleted cells exhibited defects in adhesion to fibronectin, cytoskeletal stress fiber assembly and protein secretion. In addition, PIP silencing abrogated the mitogenic response of T47D BCa cells to estradiol (E2). The dependence of BCa cell proliferation was unrelated, however, to estrogen signaling because: 1) PIP silencing did not affect the transcriptional response of estrogen target genes to hormone treatment, and 2) PIP was required for the proliferation of tamoxifen-resistant BCa cells. Pharmacological inhibition of PIP may therefore serve the bases for both augmentation of existing therapies for hormone-dependent tumors and the development of novel therapeutic approaches for hormone-resistant BCa.	[Baniwal, Sanjeev K.; Frenkel, Baruch] Univ So Calif, Keck Sch Med, Dept Orthoped Surg, Los Angeles, CA 90033 USA; [Baniwal, Sanjeev K.; Chimge, Nyam-Osor; Frenkel, Baruch] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Chimge, Nyam-Osor; Frenkel, Baruch] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Jordan, V. Craig] Georgetown Univ, Med Ctr, Georgetown Lombardi Comprehens Canc Ctr, Dept Oncol,Breast Canc Program, Washington, DC 20007 USA; [Tripathy, Debu] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; Georgetown University; University of Southern California	Baniwal, SK (corresponding author), Univ So Calif, Keck Sch Med, Dept Orthoped Surg, Los Angeles, CA 90033 USA.	Baniwal@usc.edu	Jordan, V. Craig/H-4491-2011; JORDAN, V.Craig/AAX-3562-2020		National Institutes of Health [DK071122, DK071122S1, SC CTSI UL1 RR03986]; Zumberge Fund Individual Grant; NIH [30CA051008]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031986, S10RR003986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071122, R56DK071122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zumberge Fund Individual Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK071122, DK071122S1, and SC CTSI UL1 RR03986 from the National Institutes of Health (NIH) to BF, Zumberge Fund Individual Grant to SKB, and NIH grant 30CA051008 to the Lombardi Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Baniwal SK, 2009, MOL ENDOCRINOL, V23, P1203, DOI 10.1210/me.2008-0470; Baniwal SK, J CELL PHYSL, V227, P2276; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Boureux A, 2005, J CELL SCI, V118, P3717, DOI 10.1242/jcs.02491; Caputo E, 2000, J BIOL CHEM, V275, P7935, DOI 10.1074/jbc.275.11.7935; CASSONI P, 1995, INT J CANCER, V60, P216; CHALBOS D, 1987, CANCER RES, V47, P2787; Clark JW, 1999, BRIT J CANCER, V81, P1002, DOI 10.1038/sj.bjc.6690799; DEJARDIN L, 1991, J MOL ENDOCRINOL, V7, P105, DOI 10.1677/jme.0.0070105; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Ghosh MG, 2000, CANCER RES, V60, P6367; Graf T, 1992, CURR OPIN GENET DEV, V2, P249, DOI 10.1016/S0959-437X(05)80281-3; HAAGENSEN DE, 1990, ANN NY ACAD SCI, V586, P161, DOI 10.1111/j.1749-6632.1990.tb17804.x; HAAGENSEN DE, 1992, BREAST CANCER RES TR, V23, P77, DOI 10.1007/BF01831479; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Kim J, 2000, J STEROID BIOCHEM, V74, P157, DOI 10.1016/S0960-0760(00)00119-9; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lee Dong Min, 2005, Korean J Gastroenterol, V46, P388; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; MURPHY CS, 1989, EUR J CANCER CLIN ON, V25, P1777, DOI 10.1016/0277-5379(89)90348-9; MURPHY LC, 1987, J BIOL CHEM, V262, P15236; Naderi A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3232; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Park WC, 2005, INT J ONCOL, V27, P1459; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; SHIU RPC, 1985, J BIOL CHEM, V260, P1307; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; TREISMAN JE, 1995, GENE DEV, V9, P1709, DOI 10.1101/gad.9.14.1709; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593	36	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e62361	10.1371/journal.pone.0062361	http://dx.doi.org/10.1371/journal.pone.0062361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755096	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300004
J	Belcheva, A; Green, B; Weiss, A; Streutker, C; Martin, A				Belcheva, Antoaneta; Green, Blerta; Weiss, Ashley; Streutker, Catherine; Martin, Alberto			Elevated Incidence of Polyp Formation in APC(Min/+)Msh2(-/-) Mice Is Independent of Nitric Oxide-Induced DNA Mutations	PLOS ONE			English	Article							MISMATCH REPAIR; SOMATIC HYPERMUTATION; COLON CARCINOGENESIS; INCREASED EXPRESSION; DAMAGE; SYNTHASE; CANCER; APOPTOSIS; CELLS; INHIBITION	Gut microbiota has been linked to a number of human diseases including colon cancer. However, the mechanism through which gut bacteria influence colon cancer development and progression remains unclear. Perturbation of the homeostasis between the host immune system and microbiota leads to inflammation and activation of macrophages which produce large amounts of nitric oxide that acts as a genotoxic effector molecule to suppress bacterial growth. However, nitric oxide also has genotoxic effects to host cells by producing mutations that can predispose to colon cancer development. The major DNA lesions caused by nitric oxide are 8oxoG and deamination of deoxycytosine bases. Cellular glycosylases that belong to the base excision repair pathway have been demonstrated to repair these mutations. Recent evidence suggests that the mismatch repair pathway (MMR) might also repair nitric oxide-induced DNA damage. Since deficiency in MMR predisposes to colon cancer, we hypothesized that MMR-deficient colon epithelial cells are incapable of repairing nitric-oxide induced genetic lesions that can promote colon cancer. Indeed, we found that the MMR pathway repairs nitric oxide-induced DNA mutations in cell lines. To test whether nitric oxide promotes colon cancer, we genetically ablated the inducible nitric oxide synthase (iNOS) or inhibited iNOS activity in the APC(Min/+)Msh2(-/-) mouse model of colon cancer. However, despite the fact that nitric oxide production was strongly reduced in the colon using both approaches, colon cancer incidence was not affected. These data show that nitric oxide and iNOS do not promote colon cancer in APC(Min/+)Msh2(-/-) mice.	[Belcheva, Antoaneta; Green, Blerta; Weiss, Ashley; Martin, Alberto] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Streutker, Catherine] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Martin, A (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	alberto.martin@utoronto.ca		Belcheva, Antoaneta/0000-0001-5061-7533; Martin, Alberto/0000-0002-0795-0418	Canadian Research Society grant [MOP66965]; Canada Research Chair tier II award	Canadian Research Society grant; Canada Research Chair tier II award	This research is supported by a Canadian Research Society grant (MOP66965) to A.M., who is supported by a Canada Research Chair tier II award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn B, 2001, CANCER RES, V61, P8357; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; Bardwell PD, 2003, J IMMUNOL, V170, P1620, DOI 10.4049/jimmunol.170.4.1620; Blasko E, 2002, J BIOL CHEM, V277, P295, DOI 10.1074/jbc.M105691200; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P419, DOI 10.1016/S0952-7915(00)00111-4; Burney S, 1999, CHEM RES TOXICOL, V12, P513, DOI 10.1021/tx980254m; Cadet J, 2000, MUTAT RES-REV MUTAT, V462, P121, DOI 10.1016/S1383-5742(00)00022-3; DEROJASWALKER T, 1995, CHEM RES TOXICOL, V8, P473, DOI 10.1021/tx00045a020; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Frieder D, 2009, MOL CELL BIOL, V29, P5148, DOI 10.1128/MCB.00647-09; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Green B, 2011, BLOOD, V118, P3013, DOI 10.1182/blood-2011-03-345991; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hallinan EA, 2002, J MED CHEM, V45, P1686, DOI 10.1021/jm010420e; Hewish M, 2010, NAT REV CLIN ONCOL; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Jaiswal M, 2000, CANCER RES, V60, P184; Jaiswal M, 2001, CANCER RES, V61, P6388; Jaiswal M, 2001, GASTROENTEROLOGY, V120, P190, DOI 10.1053/gast.2001.20875; Kimura H, 1998, GUT, V42, P180, DOI 10.1136/gut.42.2.180; KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; MIDDLETON SJ, 1993, LANCET, V341, P465, DOI 10.1016/0140-6736(93)90211-X; Nepal RM, 2008, ONCOGENE, V27, P4752, DOI 10.1038/onc.2008.111; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; Nishino H, 1996, ENVIRON MOL MUTAGEN, V28, P299; OHSHIMA H, 1994, MUTAT RES, V305, P253, DOI 10.1016/0027-5107(94)90245-3; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Peters AC, 2003, DNA REPAIR, V2, P427, DOI 10.1016/S1568-7864(03)00003-X; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Rao CV, 1999, CARCINOGENESIS, V20, P641, DOI 10.1093/carcin/20.4.641; Rao CV, 2004, MUTAT RES-FUND MOL M, V555, P107, DOI 10.1016/j.mrfmmm.2004.05.022; Rao CV, 2002, CANCER RES, V62, P165; Richardson AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000451; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Scott DJ, 2001, GASTROENTEROLOGY, V121, P889, DOI 10.1053/gast.2001.27994; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shi Q, 2000, CANCER RES, V60, P2579; Sobko T, 2005, NITRIC OXIDE-BIOL CH, V13, P272, DOI 10.1016/j.niox.2005.08.002; Southan GJ, 1996, BIOCHEM PHARMACOL, V51, P383, DOI 10.1016/0006-2952(95)02099-3; Takahashi M, 1997, CANCER RES, V57, P1233; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tamir S, 1996, CHEM RES TOXICOL, V9, P821, DOI 10.1021/tx9600311; Weigert A, 2008, NITRIC OXIDE-BIOL CH, V19, P95, DOI 10.1016/j.niox.2008.04.021; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Xaus J, 2000, BLOOD, V95, P3823; Yerushalmi HF, 2006, MOL CARCINOGEN, V45, P93, DOI 10.1002/mc.20168	57	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65204	10.1371/journal.pone.0065204	http://dx.doi.org/10.1371/journal.pone.0065204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741483	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900196
J	Meng, XL; Liu, M; Jiang, KY; Wang, BJ; Tian, X; Sun, SJ; Luo, ZY; Qiu, CW; Wang, L				Meng, Xiao-lin; Liu, Mei; Jiang, Ke-yong; Wang, Bao-jie; Tian, Xue; Sun, Shu-juan; Luo, Zuo-yong; Qiu, Chu-wen; Wang, Lei			De Novo Characterization of Japanese Scallop Mizuhopecten yessoensis Transcriptome and Analysis of Its Gene Expression following Cadmium Exposure	PLOS ONE			English	Article							PATINOPECTEN-YESSOENSIS; LIPID-PEROXIDATION; RNA-SEQ; ENVIRONMENTAL-POLLUTION; HEAVY-METAL; CYTOCHROME-P450; CONTAMINATION; TRANSPORTERS; POLYMORPHISM; POPULATION	Background: Japanese scallop has been cultured on a large-scale in China for many years. However, serious marine pollution in recent years has resulted in considerable loss to this industry. Moreover, due to the lack of genomic resources, limited research has been carried out on this species. To facilitate the understanding at molecular level immune and stress response mechanism, an extensive transcriptomic profiling and digital gene expression (DGE) database of Japanese scallop upon cadmium exposure was carried out using the Illumina sequencing platform. Results: RNA-seq produced about 112 million sequencing reads from the tissues of adult Japanese scallops. These reads were assembled into 194,839 non-redundant sequences with open reading frame (ORF), of which 14,240 putative amino acid sequences were assigned biological function annotation and were annotated with gene ontology and eukaryotic orthologous group terms. In addition, we identified 720 genes involved in response to stimulus and 302 genes involved in immune-response pathways. Furthermore, we investigated the transcriptomic changes in the gill and digestive gland of Japanese scallops following cadmium exposure using a tag-based DGE system. A total of 7,556 and 3,002 differentially expressed genes were detected, respectively, and functionally annotated with KEGG pathway annotations. Conclusion: This study provides a comprehensive transcripts sequence resource for the Japanese scallop and presents a survey of gene expression in response to heavy metal exposure in a non-model marine invertebrate via the Illumina sequencing platform. These results may contribute to the in-depth elucidation of the molecular mechanisms involved in bivalve responses to marine pollutants.	[Meng, Xiao-lin; Liu, Mei; Jiang, Ke-yong; Wang, Bao-jie; Sun, Shu-juan; Luo, Zuo-yong; Qiu, Chu-wen; Wang, Lei] Chinese Acad Sci, Inst Oceanol, R&D Ctr Marine, Qingdao, Peoples R China; [Meng, Xiao-lin; Luo, Zuo-yong; Qiu, Chu-wen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Meng, Xiao-lin; Tian, Xue] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanxi Agricultural University	Wang, L (corresponding author), Chinese Acad Sci, Inst Oceanol, R&D Ctr Marine, Qingdao, Peoples R China.	wanglei@ms.qdio.ac.cn	wang, jie/GRS-0942-2022; Jiang, Keyong/A-6512-2015; WANG, JINGYI/GSJ-1241-2022	Jiang, Keyong/0000-0003-4505-0979; 	Chinese Academy of Sciences [KZCX2-EW-Q215]	Chinese Academy of Sciences(Chinese Academy of Sciences)	Financial support for this study was provided by the Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences (KZCX2-EW-Q215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMY S, 2009, MALARIA J, V8, P53; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BUCHELI TD, 1995, CRIT REV ENV SCI TEC, V25, P201, DOI 10.1080/10643389509388479; CHELOMIN VP, 1995, COMP BIOCHEM PHYS C, V110, P329, DOI 10.1016/0742-8413(95)95345-C; CHELOMIN VP, 1992, COMP BIOCHEM PHYS C, V103, P419, DOI 10.1016/0742-8413(92)90031-2; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Company R, 2004, MAR ENVIRON RES, V58, P377, DOI 10.1016/j.marenvres.2004.03.083; Escobedo-Fregoso C, 2010, ARCH ENVIRON CON TOX, V59, P255, DOI 10.1007/s00244-010-9484-7; EVTUSHENKO ZS, 1990, MAR BIOL, V104, P247, DOI 10.1007/BF01313265; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Haynes D, 2000, MAR POLLUT BULL, V41, P267, DOI 10.1016/S0025-326X(00)00134-X; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Hou R., 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021560, DOI 10.1371/J0URNAL.P0NE.0021560]; HUANG XY, 2012, FISH SHELLFISH IMMUN, V61; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kingtong S, 2007, AQUAT TOXICOL, V85, P124, DOI 10.1016/j.aquatox.2007.08.006; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; LESLEY JC, 2008, GENOME INFORM, V21, P3; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li Q, 2007, AQUACULTURE, V269, P211, DOI 10.1016/j.aquaculture.2007.04.017; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu WD, 2011, J WORLD AQUACULT SOC, V42, P456, DOI 10.1111/j.1749-7345.2011.00486.x; Liu WD, 2010, AQUAC RES, V41, P1602, DOI 10.1111/j.1365-2109.2010.02484.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckenbach T, 2008, AM J PHYSIOL-REG I, V294, pR1919, DOI 10.1152/ajpregu.00563.2007; LUKYANOVA ON, 1995, COMP BIOCHEM PHYS B, V110, P371, DOI 10.1016/0305-0491(94)00154-M; Maria VL, 2011, COMP BIOCHEM PHYS C, V154, P56, DOI 10.1016/j.cbpc.2011.02.004; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Moore MN, 2006, AUTOPHAGY, V2, P217, DOI 10.4161/auto.2663; Moreira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035009; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagashima K, 2005, MAR BIOTECHNOL, V7, P1, DOI 10.1007/s10126-004-3046-9; Owen J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-266; Peng S T, 2009, J WATERWAY HARBOR, V30, P57; REGOLI F, 1995, AQUAT TOXICOL, V31, P143, DOI 10.1016/0166-445X(94)00064-W; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sakurai I, 2000, AQUACULTURE, V181, P269, DOI 10.1016/S0044-8486(99)00242-2; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sasaki YF, 1997, MUTAT RES-GEN TOX EN, V393, P133, DOI 10.1016/S1383-5718(97)00098-3; Sato M, 2005, MAR BIOTECHNOL, V7, P713, DOI 10.1007/s10126-004-0127-8; Sato M, 2001, MAR BIOTECHNOL, V3, P370, DOI 10.1007/s10126001-0015-4; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shan ZG, 2011, COMP BIOCHEM PHYS B, V159, P1, DOI 10.1016/j.cbpb.2011.01.003; Slobodskova Valentina V., 2012, Ocean Science Journal, V47, P95, DOI 10.1007/s12601-012-0010-x; Snyder MJ, 2000, AQUAT TOXICOL, V48, P529, DOI 10.1016/S0166-445X(00)00085-0; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; TAINER JA, 1995, CURR OPIN STRUC BIOL, V5, P20, DOI 10.1016/0959-440X(95)80005-L; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Torres MA, 2008, ECOTOX ENVIRON SAFE, V71, P1, DOI 10.1016/j.ecoenv.2008.05.009; Ueng YF, 1996, B ENVIRON CONTAM TOX, V57, P125, DOI 10.1007/s001289900165; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang X, 2012, COMM COM INF SC, V350, P1; Wang XL, 2009, CONSERV GENET, V10, P1129, DOI 10.1007/s10592-008-9726-7; Wepener V, 2005, PHYS CHEM EARTH, V30, P751, DOI 10.1016/j.pce.2005.08.018; Wong CKC, 2000, ARCH ENVIRON CON TOX, V38, P486, DOI 10.1007/s002449910064; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xu KF, 2008, AQUAC RES, V40, P35, DOI 10.1111/j.1365-2109.2008.02058.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zorita I, 2007, ENVIRON POLLUT, V148, P236, DOI 10.1016/j.envpol.2006.10.022	68	43	44	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64485	10.1371/journal.pone.0064485	http://dx.doi.org/10.1371/journal.pone.0064485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741332	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900044
J	Nairismagi, ML; Fuchtbauer, A; Labouriau, R; Bramsen, JB; Fuchtbauer, EM				Nairismagi, Maarja-Liisa; Fuchtbauer, Annette; Labouriau, Rodrigo; Bramsen, Jesper Bertram; Fuchtbauer, Ernst-Martin			The Proto-Oncogene TWIST1 Is Regulated by MicroRNAs	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; SAETHRE-CHOTZEN SYNDROME; CERVICAL-CANCER CELLS; THROMBOPOIETIN RECEPTOR; DROSOPHILA EMBRYOS; TUMOR-METASTASIS; BREAST-CANCER; EXPRESSION; PROTEIN; GENE	Upregulation of the proto-oncogene Twist1 is highly correlated with acquired drug resistance and poor prognosis in human cancers. Altered expression of this multifunctional transcription factor is also associated with inherited skeletal malformations. The mammalian Twist1 3'UTRs are highly conserved and contain a number of potential regulatory elements including miRNA target sites. We analyzed the translational regulation of TWIST1 using luciferase reporter assays in a variety of cell lines. Among several miRNAs tested, miR-145a-5p, miR-151-5p and a combination of miR-145a-5p + miR-151-5p and miR-151-5p + miR-337-3p were able to significantly repress Twist1 translation. This phenomena was confirmed with both exogenous and endogenous miRNAs and was dependent on the presence of the predicted target sites in the 3'UTR. Furthermore, the repression was sensitive to LNA-modified miRNA antagonists and resulted in decreased migratory potential of murine embryonic fibroblast cells. Understanding the in vivo mechanisms of this oncogene's regulation might open up a possibility for therapeutic interference by gene specific cancer therapies.	[Nairismagi, Maarja-Liisa; Fuchtbauer, Annette; Labouriau, Rodrigo; Bramsen, Jesper Bertram; Fuchtbauer, Ernst-Martin] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University	Fuchtbauer, EM (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	emf@mb.au.dk	Labouriau, Rodrigo/H-3890-2014; Labouriau, Rodrigo/AAD-2576-2020	Labouriau, Rodrigo/0000-0001-8713-6864; 	Danish Cancer Society [DP08036]	Danish Cancer Society(Danish Cancer Society)	This work was supported by The Danish Cancer Society grant DP08036 (www.cancer.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annalisa Palmieri, 2008, J Oral Sci, V50, P301, DOI 10.2334/josnusd.50.301; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bramsen JB, 2010, NUCLEIC ACIDS RES, V38, P5761, DOI 10.1093/nar/gkq341; Burns TF, 2013, MOL CANC RE IN PRESS; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Chang TM, 2012, FEBS LETT, V586, P3746, DOI 10.1016/j.febslet.2012.08.034; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Davison A, 1997, BOOTSTRAP METHODS TH, P161; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; ElGhouzzi V, 1997, NAT GENET, V15, P42; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Fuchtbauer A, 2011, BIOL CHEM, V392, P769, DOI 10.1515/BC.2011.088; FUCHTBAUER EM, 1995, DEV DYNAM, V204, P316; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hebrok M, 1997, EXP CELL RES, V232, P295, DOI 10.1006/excr.1997.3541; Hornik C, 2004, ANAT EMBRYOL, V209, P31, DOI 10.1007/s00429-004-0412-3; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Kapinas K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3325; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Krebs I, 1997, HUM MOL GENET, V6, P1079, DOI 10.1093/hmg/6.7.1079; Laursen KB, 2007, J BIOL CHEM, V282, P34623, DOI 10.1074/jbc.M707085200; Li B, 2012, FEBS J, V279, P2393, DOI 10.1111/j.1742-4658.2012.08618.x; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; MURRAY SS, 1992, J BONE MINER RES, V7, P1131; Nairismagi ML, 2012, ONCOGENE, V31, P4960, DOI 10.1038/onc.2011.650; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pramanik D, 2011, MOL CANCER THER, V10, P1470, DOI 10.1158/1535-7163.MCT-11-0152; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Scaal M, 2001, ANAT EMBRYOL, V203, P1, DOI 10.1007/PL00008244; Shi M, 2012, J PATHOL, V228, P148, DOI 10.1002/path.3997; Shih KK, 2011, GYNECOL ONCOL, V121, P444, DOI 10.1016/j.ygyno.2011.01.025; SIMPSON P, 1983, GENETICS, V105, P615; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; Villavicencio EH, 2002, GENESIS, V32, P247, DOI 10.1002/gene.10078; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhu KX, 2012, ONCOL REP, V27, P1027, DOI 10.3892/or.2012.1633	61	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e66070	10.1371/journal.pone.0066070	http://dx.doi.org/10.1371/journal.pone.0066070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741524	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900237
J	Valente, GT; Acencio, ML; Martins, C; Lemke, N				Valente, Guilherme T.; Acencio, Marcio L.; Martins, Cesar; Lemke, Ney			The Development of a Universal In Silico Predictor of Protein-Protein Interactions	PLOS ONE			English	Article							LINK-PREDICTION; INTEGRATION; PRINCIPLES; NETWORKS; FEATURES; SITES	Protein-protein interactions (PPIs) are essential for understanding the function of biological systems and have been characterized using a vast array of experimental techniques. These techniques detect only a small proportion of all PPIs and are labor intensive and time consuming. Therefore, the development of computational methods capable of predicting PPIs accelerates the pace of discovery of new interactions. This paper reports a machine learning-based prediction model, the Universal In Silico Predictor of Protein-Protein Interactions (UNISPPI), which is a decision tree model that can reliably predict PPIs for all species (including proteins from parasite-host associations) using only 20 combinations of amino acids frequencies from interacting and non-interacting proteins as learning features. UNISPPI was able to correctly classify 79.4% and 72.6% of experimentally supported interactions and non-interacting protein pairs, respectively, from an independent test set. Moreover, UNISPPI suggests that the frequencies of the amino acids asparagine, cysteine and isoleucine are important features for distinguishing between interacting and non-interacting protein pairs. We envisage that UNISPPI can be a useful tool for prioritizing interactions for experimental validation.	[Valente, Guilherme T.; Martins, Cesar] Univ Estadual Paulista, UNESP, Dept Morphol, Botucatu, SP, Brazil; [Acencio, Marcio L.; Lemke, Ney] Univ Estadual Paulista, UNESP, Dept Phys & Biophys, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Valente, GT (corresponding author), Univ Estadual Paulista, UNESP, Dept Morphol, Botucatu, SP, Brazil.	valentegt@gmail.com	Valente, Guilherme T Targino/J-3682-2012; Lemke, Ney/L-6761-2019; Martins, Cesar/A-2594-2008; Valente, Guilherme/AAO-7253-2021; Lemke, Ney/A-8213-2008; Acencio, Marcio L/D-9264-2012; Acencio, Marcio Luis/ABH-1930-2020	Valente, Guilherme T Targino/0000-0001-5355-3424; Lemke, Ney/0000-0001-7463-4303; Martins, Cesar/0000-0003-3534-974X; Valente, Guilherme/0000-0001-5355-3424; Lemke, Ney/0000-0001-7463-4303; Acencio, Marcio L/0000-0002-8278-240X; Acencio, Marcio Luis/0000-0002-8278-240X	FAPESP [2009/05234-4, 2013/02018-4]; CNPq [475147/2010-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work received financial support from FAPESP, grant numbers 2009/05234-4 and 2013/02018-4, and from CNPq, grant number 475147/2010-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anashkina A, 2007, PROTEINS, V67, P1060, DOI 10.1002/prot.21363; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Archakov AI, 2003, PROTEOMICS, V3, P380, DOI 10.1002/pmic.200390053; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; BAHADUR RP, 2010, PROTEIN PROTEIN COMP, P25; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Chen XW, 2009, BIOINFORMATICS, V25, P585, DOI 10.1093/bioinformatics/btp039; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; CSERMELY P, 2013, PHARM THERA IN PRESS; De Bodt S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-288; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Guo Yanzhi, 2010, BMC Res Notes, V3, P145, DOI 10.1186/1756-0500-3-145; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Hue M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-144; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kingsford C, 2008, NAT BIOTECHNOL, V26, P1011, DOI 10.1038/nbt0908-1011; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030938; Lo SL, 2005, PROTEOMICS, V5, P876, DOI 10.1002/pmic.200401118; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Martin S, 2005, BIOINFORMATICS, V21, P218, DOI 10.1093/bioinformatics/bth483; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Nanni L, 2006, BIOINFORMATICS, V22, P1207, DOI 10.1093/bioinformatics/btl055; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; PADLAN EA, 1990, PROTEINS, V7, P112, DOI 10.1002/prot.340070203; Park Y, 2011, BIOINFORMATICS, V27, P3024, DOI 10.1093/bioinformatics/btr514; Pitre S, 2008, ADV BIOCHEM ENG BIOT, V110, P247, DOI 10.1007/10_2007_089; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Ren XW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-409; Res I, 2005, BIOINFORMATICS, V21, P2496, DOI 10.1093/bioinformatics/bti340; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shi MG, 2010, AMINO ACIDS, V38, P891, DOI 10.1007/s00726-009-0295-y; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Skrabanek L, 2008, MOL BIOTECHNOL, V38, P1, DOI 10.1007/s12033-007-0069-2; Smialowski P, 2010, NUCLEIC ACIDS RES, V38, pD540, DOI 10.1093/nar/gkp1026; Smith GR, 2002, CURR OPIN STRUC BIOL, V12, P28, DOI 10.1016/S0959-440X(02)00285-3; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Swaisgood HE, 2005, BIOTECHNOL ADV, V23, P71, DOI 10.1016/j.biotechadv.2004.09.004; Visa S., 2005, P 16 MIDW ART INT CO, P67; WILCOXON F, 1947, BIOMETRICS, V3, P119, DOI 10.2307/3001946; Witten IH, 2011, MOR KAUF D, P1; Yu CY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-167; Yu JT, 2010, BIOINFORMATICS, V26, P2610, DOI 10.1093/bioinformatics/btq483; Zaki N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-150; Zhang LV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-38; Zhou Y, 2012, MOL BIOSYST, V8, P1396, DOI 10.1039/c2mb05427b	55	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65587	10.1371/journal.pone.0065587	http://dx.doi.org/10.1371/journal.pone.0065587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741499	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900212
J	Zakharchenko, O; Cojoc, M; Dubrovska, A; Souchelnytskyi, S				Zakharchenko, Olena; Cojoc, Monica; Dubrovska, Anna; Souchelnytskyi, Serhiy			A Role of TGF beta 1 Dependent 14-3-3 sigma Phosphorylation at Ser69 and Ser74 in the Regulation of Gene Transcription, Stemness and Radioresistance	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; CELL-CYCLE; PROTEOMIC ANALYSIS; BETA; P53; EXPRESSION; PHOSPHOPROTEOMICS; 14-3-3-PROTEINS; PROTEINS	Transforming growth factor-beta (TGF beta) is a potent regulator of tumorigenesis, although mechanisms defining its tumor suppressing and tumor promoting activities are not understood. Here we describe phosphoproteome profiling of TGF beta signaling in mammary epithelial cells, and show that 60 identified TGF beta-regulated phosphoproteins form a network with scale-free characteristics. The network highlighted interactions, which may distribute signaling inputs to regulation of cell proliferation, metabolism, differentiation and cell organization. In this report, we identified two novel and TGF beta-dependent phosphorylation sites of 14-3-3 sigma, i.e. Ser69 and Ser74. We observed that 14-3-3 sigma phosphorylation is a feed-forward mechanism in TGF beta/Smad3-dependent transcription. TGF beta-dependent 14-3-3 sigma phosphorylation may provide a scaffold for the formation of the protein complexes which include Smad3 and p53 at the Smad3-specific CAGA element. Furthermore, breast tumor xenograft studies in mice and radiobiological assays showed that phosphorylation of 14-3-3 sigma at Ser69 and Ser74 is involved in regulation of cancer progenitor population and radioresistance in breast cancer MCF7 cells. Our data suggest that TGF beta-dependent phosphorylation of 14-3-3 sigma orchestrates a functional interaction of TGF beta/Smad3 with p53, plays a role in the maintenance of cancer stem cells and could provide a new potential target for intervention in breast cancer.	[Zakharchenko, Olena; Souchelnytskyi, Serhiy] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Karolinska Biom Ctr, Stockholm, Sweden; [Cojoc, Monica; Dubrovska, Anna] Tech Univ Dresden, Med Fac Dresden Carl Gustav Carus, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany	Karolinska Institutet; Karolinska University Hospital; Technische Universitat Dresden	Dubrovska, A (corresponding author), Tech Univ Dresden, Med Fac Dresden Carl Gustav Carus, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany.	anna.dubrovska@oncoray.de; serhiy.souchelnytskyi@ki.se	Souchelnytskyi, Serhiy/J-9446-2014; Dubrovska, Anna/AAE-8514-2019; Souchelnytskyi, Serhiy/G-6491-2011	Dubrovska, Anna/0000-0002-3375-1500; Souchelnytskyi, Serhiy/0000-0001-8243-9276	Karolinska Biomics Center; Dep. of Oncology-Pathology; Karolinska Institute; Radiumhemmet Research Funds; Karolinska University Hospital; Swedish Cancer Society; Swedish Research Council; INTAS; FEBS; EU RTN EpiPlast Carcinoma; Eurocan Platform; UICC; German Federal Ministry of Education and Research [03Z1NN11]; Susan G. Komen for the Cure Grant [PDF0707903]	Karolinska Biomics Center; Dep. of Oncology-Pathology; Karolinska Institute(Karolinska Institutet); Radiumhemmet Research Funds; Karolinska University Hospital(Karolinska Institutet); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); INTAS(INTASEuropean Commission); FEBS; EU RTN EpiPlast Carcinoma; Eurocan Platform; UICC; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Susan G. Komen for the Cure Grant(Susan G. Komen Breast Cancer Foundation)	Works in Souchelnytskyi group are supported by Karolinska Biomics Center, Dep. of Oncology-Pathology, Karolinska Institute, Radiumhemmet Research Funds, Karolinska University Hospital, the Swedish Cancer Society (CF), the Swedish Research Council (VR), INTAS, FEBS, EU RTN EpiPlast Carcinoma, Eurocan Platform and UICC. Works in Dubrovska group are supported by the German Federal Ministry of Education and Research (Grant-No. 03Z1NN11). This study was supported in part by Susan G. Komen for the Cure Grant PDF0707903 (to A.D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Atfi A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.126pe33; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Bosl WJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-13; Bruna A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2039; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Deeds EJ, 2006, P NATL ACAD SCI USA, V103, P311, DOI 10.1073/pnas.0509715102; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desrivieres S, 2003, MOL CELL PROTEOMICS, V2, P1039, DOI 10.1074/mcp.M300032-MCP200; Dubrovska A, 2005, PROTEOMICS, V5, P4678, DOI 10.1002/pmic.200500002; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hondermarck H, 2001, PROTEOMICS, V1, P1216, DOI 10.1002/1615-9861(200110)1:10<1216::AID-PROT1216>3.0.CO;2-P; Hu PZ, 2007, NAT REV CANCER, V7, P23, DOI 10.1038/nrc2036; Imamura T, 2012, BREAST CANCER-TOKYO, V19, P118, DOI 10.1007/s12282-011-0321-2; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Lim YP, 2003, MOL CANCER THER, V2, P1369; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Mukherji M, 2005, EXPERT REV PROTEOMIC, V2, P117, DOI 10.1586/14789450.2.1.117; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Sandhu C, 2005, J PROTEOME RES, V4, P674, DOI 10.1021/pr0498842; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schumacher B, 2010, FEBS LETT, V584, P1443, DOI 10.1016/j.febslet.2010.02.065; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Souchelnytskyi S, 2005, PROTEOMICS, V5, P4123, DOI 10.1002/pmic.200500135; Stasyk T, 2005, MOL BIOL CELL, V16, P4765, DOI 10.1091/mbc.E05-03-0257; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034079; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yap DBS, 2004, CANCER RES, V64, P4749, DOI 10.1158/0008-5472.CAN-1305-2; Yin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024080	52	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65163	10.1371/journal.pone.0065163	http://dx.doi.org/10.1371/journal.pone.0065163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741479	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900192
J	Gazave, E; Lavrov, DV; Cabrol, J; Renard, E; Rocher, C; Vacelet, J; Adamska, M; Borchiellini, C; Ereskovsky, AV				Gazave, Eve; Lavrov, Dennis V.; Cabrol, Jory; Renard, Emmanuelle; Rocher, Caroline; Vacelet, Jean; Adamska, Maja; Borchiellini, Carole; Ereskovsky, Alexander V.			Systematics and Molecular Phylogeny of the Family Oscarellidae (Homoscleromorpha) with Description of Two New Oscarella Species	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ORDER HAPLOSCLERIDA; CRYPTIC SPECIATION; CLASS DEMOSPONGIAE; MEDITERRANEAN SEA; SPONGES PORIFERA; RIBOSOMAL DNA; HALISARCA-DUJARDINI; MAXIMUM-LIKELIHOOD; CALCAREOUS SPONGES	The family Oscarellidae is one of the two families in the class Homoscleromorpha (phylum Porifera) and is characterized by the absence of a skeleton and the presence of a specific mitochondrial gene, tatC. This family currently encompasses sponges in two genera: Oscarella with 17 described species and Pseudocorticium with one described species. Although sponges in this group are relatively well-studied, phylogenetic relationships among members of Oscarellidae and the validity of genus Pseudocorticium remain open questions. Here we present a phylogenetic analysis of Oscarellidae using four markers (18S rDNA, 28S rDNA, atp6, tatC), and argue that it should become a mono-generic family, with Pseudocorticium being synonymized with Oscarella, and with the transfer of Pseudocorticium jarrei to Oscarella jarrei. We show that the genus Oscarella can be subdivided into four clades, each of which is supported by either a small number of morphological characters or by molecular synapomorphies. In addition, we describe two new species of Oscarella from Norwegian fjords: O. bergenensis sp. nov. and O. nicolae sp. nov., and we compare their morphology, anatomy, and cytology with other species in this genus. Internal anatomical characters are similar in both species, but details of external morphology and particularly of cytological characters provide diagnostic features. Our study also confirms that O. lobularis and O. tuberculata are two distinct polychromic sibling species. This study highlights the difficulties of species identification in skeleton-less sponges and, more generally, in groups where morphological characters are scarce. Adopting a multi-marker approach is thus highly suitable for these groups.	[Gazave, Eve] Univ Paris Diderot, Inst Jacques Monod, Sorbonne Paris Cite, CNRS,UMR 7592, Paris, France; [Gazave, Eve; Cabrol, Jory; Renard, Emmanuelle; Rocher, Caroline; Vacelet, Jean; Borchiellini, Carole; Ereskovsky, Alexander V.] Aix Marseille Univ, CNRS, UMR 7263, Mediterranean Inst Biodivers & Ecol IMBE, Marseille, France; [Lavrov, Dennis V.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Adamska, Maja] Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Ereskovsky, Alexander V.] St Petersburg State Univ, Fac Biol & Soil Sci, Dept Embryol, St Petersburg 199034, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Iowa State University; Saint Petersburg State University	Gazave, E (corresponding author), Univ Paris Diderot, Inst Jacques Monod, Sorbonne Paris Cite, CNRS,UMR 7592, Paris, France.	gazave.eve@ijm.univ-paris-diderot.fr	Adamska, Maja/M-4128-2014; Adamska, Maja/L-3306-2015; Ereskovsky, Alexander/W-1504-2019; Lavrov, Dennis/V-3699-2019; Gazave, Eve/F-2665-2010; Ereskovsky, Alexander/B-3136-2013	Adamska, Maja/0000-0002-4223-8450; Lavrov, Dennis/0000-0002-2745-1704; Ereskovsky, Alexander/0000-0003-1079-7204; Gazave, Eve/0000-0002-4647-6640; Renard, Emmanuelle/0000-0002-4184-5507	Centre National de Recherche Scientifique, Aix-Marseille Universite; National Science Foundation [DEB-0828783]	Centre National de Recherche Scientifique, Aix-Marseille Universite; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Centre National de Recherche Scientifique, Aix-Marseille Universite and by the National Science Foundation [DEB-0828783]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2011, ZOOLOGY, V114, P1, DOI 10.1016/j.zool.2010.10.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez B, 2000, ZOOL SCR, V29, P169, DOI 10.1046/j.1463-6409.2000.00029.x; ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; Bergquist PR, 2004, NEW ZEAL J MAR FRESH, V38, P51, DOI 10.1080/00288330.2004.9517217; Blanquer A, 2007, MOL PHYLOGENET EVOL, V45, P392, DOI 10.1016/j.ympev.2007.03.004; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x; Boury-Esnault N., 1997, THESAURUS SPONGE MOR; BOURYESNAULT N, 1995, OPHELIA, V43, P25, DOI 10.1080/00785326.1995.10430575; BOURYESNAULT N, 1992, J NAT HIST, V26, P271, DOI 10.1080/00222939200770131; Calderon I, 2006, J EXP MAR BIOL ECOL, V336, P184, DOI 10.1016/j.jembe.2006.05.006; Cardenas P, 2012, ADV MAR BIOL, V61, P79, DOI 10.1016/B978-0-12-387787-1.00010-6; Cardenas P, 2010, ZOOL SCR, V39, P89, DOI 10.1111/j.1463-6409.2009.00402.x; Carranza S, 1996, MOL BIOL EVOL, V13, P824, DOI 10.1093/oxfordjournals.molbev.a025643; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; de Cook S.C., 2002, SYSTEMA PORIFERA GUI, P1051, DOI [10.1007/978-1-4615-0747-5, DOI 10.1007/978-1-4615-0747-5]; Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ereskovsky AV, 2007, J MORPHOL, V268, P529, DOI 10.1002/jmor.10481; Ereskovsky AV, 2006, ZOOTAXA, P37, DOI 10.11646/zootaxa.1376.1.2; Ereskovsky AV, 2013, MAR BIOL, V160, P423, DOI 10.1007/s00227-012-2100-9; Ereskovsky AV, 2013, DEV GENES EVOL, V223, P5, DOI 10.1007/s00427-012-0399-3; Ereskovsky AV, 2011, ZOOTAXA, P5, DOI 10.11646/zootaxa.2768.1.2; Ereskovsky AV, 2009, CAH BIOL MAR, V50, P369; Ereskovsky AV, 2009, BIOESSAYS, V31, P89, DOI 10.1002/bies.080058; Ereskovsky AV, 2013, J MAR BIOL ASS UK; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gazave E, 2008, DEV GENES EVOL, V218, P479, DOI 10.1007/s00427-008-0242-z; Gazave E, 2012, HYDROBIOLOGIA, V687, P3, DOI 10.1007/s10750-011-0842-x; Gazave E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014290; Gazave E, 2010, MOL PHYLOGENET EVOL, V57, P35, DOI 10.1016/j.ympev.2010.05.028; Gloeckner V, 2013, MAR BIOL, V160, P781, DOI 10.1007/s00227-012-2133-0; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajdu E, 1998, P BIOL SOC WASH, V111, P737; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanitsch Richard, 1890, Proceedings of the Liverpool Biological Society, Viv, P192; Hey J, 2012, EVOLUTION, V66, P1413, DOI 10.1111/j.1558-5646.2011.01542.x; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HOOPER JNA, 2002, SYSTEMA PORIFERA GUI, P9; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Ivanisevic J, 2011, METABOLOMICS, V7, P289, DOI 10.1007/s11306-010-0239-2; Kelly-Borges Michelle, 1994, Molecular Marine Biology and Biotechnology, V3, P87; Lapebie P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005823; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Levi C., 1956, Archives de Zoologie Experimentale et Generale, V93, P1; Li C, 2007, J HERED, V98, P51, DOI 10.1093/jhered/esl037; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Legentil S, 2010, SCI MAR, V74, P445, DOI 10.3989/scimar.2010.74n3445; Maddison W., 2018, MESQUITE MODULAR SYS; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; McCormack GP, 2002, J ZOOL SYST EVOL RES, V40, P237, DOI 10.1046/j.1439-0469.2002.00204.x; Miller K, 2001, MAR BIOL, V139, P235; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Muricy G, 1996, CAN J ZOOL, V74, P881, DOI 10.1139/z96-102; Muricy G, 1998, ZOOL J LINN SOC-LOND, V124, P169, DOI 10.1111/j.1096-3642.1998.tb00572.x; Muricy G, 1996, MAR ECOL PROG SER, V138, P181, DOI 10.3354/meps138181; Muricy G., 2002, SYSTEMA PORIFERA GUI, P71, DOI [10.1007/978-1-4615-0747-5_6, DOI 10.1007/978-1-4615-0747-5_6]; Muricy Guilherme, 2004, Proceedings of the California Academy of Sciences, V55, P598; Nylander JAA., 2004, BIOINFORMATICS; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Perez T, 2011, MAR ECOL-EVOL PERSP, V32, P174, DOI 10.1111/j.1439-0485.2011.00435.x; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2010, FIGTREE 1 3 1; Redmond NE, 2007, MOL PHYLOGENET EVOL, V43, P344, DOI 10.1016/j.ympev.2006.10.021; Redmond NE, 2008, MOL PHYLOGENET EVOL, V47, P1090, DOI 10.1016/j.ympev.2008.02.018; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rua CPJ, 2011, J MAR BIOL ASSOC UK, V91, P1015, DOI 10.1017/S0025315410002122; Schmidt O., 1862, SPONGIEN ADRIATISCHE; Schmidt O., 1870, GRUNDZUGE SPONGIEN F; Sole-Cava Antonio M., 2007, V28, P603; SOLECAVA AM, 1986, MAR BIOL, V93, P247, DOI 10.1007/BF00508262; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Topsent E., 1897, Revue Suisse de Zoologie, Viv, P421; van Soest R.W.M., 2013, WORLD PORIFERA DATAB; Vishnyakov AE, 2009, MAR BIOL, V156, P1625, DOI 10.1007/s00227-009-1198-x; Voigt O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-69; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	89	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63976	10.1371/journal.pone.0063976	http://dx.doi.org/10.1371/journal.pone.0063976			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737959	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700023
J	Bhowmick, P; Pancsa, R; Guharoy, M; Tompa, P				Bhowmick, Pallab; Pancsa, Rita; Guharoy, Mainak; Tompa, Peter			Functional Diversity and Structural Disorder in the Human Ubiquitination Pathway	PLOS ONE			English	Article							PROTEIN-PROTEIN; MOLECULAR RECOGNITION; INTRINSIC DISORDER; HUB PROTEINS; NORMAL-MODES; RING DOMAIN; WEB SERVER; BINDING; LIGASE; DEGRADATION	The ubiquitin-proteasome system plays a central role in cellular regulation and protein quality control (PQC). The system is built as a pyramid of increasing complexity, with two E1 (ubiquitin activating), few dozen E2 (ubiquitin conjugating) and several hundred E3 (ubiquitin ligase) enzymes. By collecting and analyzing E3 sequences from the KEGG BRITE database and literature, we assembled a coherent dataset of 563 human E3s and analyzed their various physical features. We found an increase in structural disorder of the system with multiple disorder predictors (IUPred - E1: 5.97%, E2: 17.74%, E3: 20.03%). E3s that can bind E2 and substrate simultaneously (single subunit E3, ssE3) have significantly higher disorder (22.98%) than E3s in which E2 binding (multi RING-finger, mRF, 0.62%), scaffolding (6.01%) and substrate binding (adaptor/substrate recognition subunits, 17.33%) functions are separated. In ssE3s, the disorder was localized in the substrate/adaptor binding domains, whereas the E2-binding RING/HECT-domains were structured. To demonstrate the involvement of disorder in E3 function, we applied normal modes and molecular dynamics analyses to show how a disordered and highly flexible linker in human CBL (an E3 that acts as a regulator of several tyrosine kinase-mediated signalling pathways) facilitates long-range conformational changes bringing substrate and E2-binding domains towards each other and thus assisting in ubiquitin transfer. E3s with multiple interaction partners (as evidenced by data in STRING) also possess elevated levels of disorder (hubs, 22.90% vs. non-hubs, 18.36%). Furthermore, a search in PDB uncovered 21 distinct human E3 interactions, in 7 of which the disordered region of E3s undergoes induced folding (or mutual induced folding) in the presence of the partner. In conclusion, our data highlights the primary role of structural disorder in the functions of E3 ligases that manifests itself in the substrate/adaptor binding functions as well as the mechanism of ubiquitin transfer by long-range conformational transitions.	[Bhowmick, Pallab; Pancsa, Rita; Guharoy, Mainak; Tompa, Peter] Vrije Univ Brussel, VIB Dept Struct Biol, Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Tompa, P (corresponding author), Vrije Univ Brussel, VIB Dept Struct Biol, Brussels, Belgium.	ptompa@vub.ac.be	Bhowmick, Pallab/P-9871-2016	Bhowmick, Pallab/0000-0001-7267-8601; Tompa, Peter/0000-0001-8042-9939; Guharoy, Mainak/0000-0003-1354-2872	Research Foundation Flanders (FWO) Odysseus grant [G.0029.12]; Marie Curie Initial Training Network project (IDPbyNMR) from the European Commission [264257]	Research Foundation Flanders (FWO) Odysseus grant(FWO); Marie Curie Initial Training Network project (IDPbyNMR) from the European Commission	This work was supported by the Research Foundation Flanders (FWO) Odysseus grant G.0029.12, and the Marie Curie Initial Training Network project 264257 (IDPbyNMR) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Arrigoni A, 2012, J STRUCT BIOL, V178, P245, DOI 10.1016/j.jsb.2012.04.003; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Clerici M, 2009, EMBO J; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Cox CJ, 2002, FEBS LETT, V527, P303, DOI 10.1016/S0014-5793(02)03246-5; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Fishbain S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1194; Fong JH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000316; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Hagai T, 2011, J MOL BIOL, V412, P319, DOI 10.1016/j.jmb.2011.07.024; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hildebrand PW, 2009, NUCLEIC ACIDS RES, V37, pW571, DOI 10.1093/nar/gkp338; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kiss R, 2008, FEBS LETT, V582, P2149, DOI 10.1016/j.febslet.2008.05.032; Leung DW, 2005, P NATL ACAD SCI USA, V102, P5685, DOI 10.1073/pnas.0406472102; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000527; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Ryan PE, 2010, J BIOL CHEM, V285, P23687, DOI 10.1074/jbc.M109.091157; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shimizu H, 2003, TRENDS BIOCHEM SCI, V28, P346, DOI 10.1016/S0968-0004(03)00140-3; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Sowa ME, 2006, ACS CHEM BIOL, V1, P20, DOI 10.1021/cb0600020; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Tama F, 2000, PROTEINS, V41, P1; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Tompa P, 2010, J MOL BIOL, V403, P346, DOI 10.1016/j.jmb.2010.07.044; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; von Ossowski I, 2005, BIOPHYS J, V88, P2823, DOI 10.1529/biophysj.104.050146; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yang L, 2007, BIOPHYS J, V93, P920, DOI 10.1529/biophysj.106.095927; Zhao ML, 2010, J BIOL CHEM, V285, P4771, DOI 10.1074/jbc.M109.060095; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	103	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65443	10.1371/journal.pone.0065443	http://dx.doi.org/10.1371/journal.pone.0065443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734257	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000319725500009
J	Chizhov, I; Hartmann, FK; Hundt, N; Tsiavaliaris, G				Chizhov, Igor; Hartmann, Falk K.; Hundt, Nikolas; Tsiavaliaris, Georgios			Global Fit Analysis of Myosin-5b Motility Reveals Thermodynamics of Mg2+-Sensitive Acto-Myosin-ADP States	PLOS ONE			English	Article							IN-VITRO; MUSCLE; BINDING; MECHANISM; MAGNESIUM; COOPERATIVITY; DISSOCIATION; NUCLEOTIDE; KINETICS; INSIGHTS	Kinetic and thermodynamic studies of the mechanochemical cycle of myosin motors are essential for understanding the mechanism of energy conversion. Here, we report our investigation of temperature and free Mg2+-ion dependencies of sliding velocities of a high duty ratio class-5 myosin motor, myosin-5b from D. discoideum using in vitro motility assays. Previous studies have shown that the sliding velocity of class-5 myosins obeys modulation by free Mg2+-ions. Free Mg2+-ions affect ADP release kinetics and the dwell time of actin-attached states. The latter determines the maximal velocity of actin translocation in the sliding filament assay. We measured the temperature dependence of sliding velocity in the range from 5 to 55 degrees C at two limiting free Mg2+-ion concentrations. Arrhenius plots demonstrated non-linear behavior. Based on this observation we propose a kinetic model, which explains both sensitivity towards free Mg2+-ions and non-linearity of the temperature dependence of sliding velocity. According to this model, velocity is represented as a simple analytical function of temperature and free Mg2+-ion concentrations. This function has been applied to global non-linear fit analysis of three data sets including temperature and magnesium (at 20 degrees C) dependence of sliding velocity. As a result we obtain thermodynamic parameters (Delta H-Mg and Delta S-Mg) of a fast equilibrium between magnesium free (AM center dot D) and magnesium bound acto-myosin-ADP (AM center dot Mg2+D) states and the corresponding enthalpic barriers associated with ADP release (Delta H-1(double dagger) and Delta H-2(double dagger)). The herein presented integrative approach of data analysis based on global fitting can be applied to the remaining steps of the acto-myosin ATPase cycle facilitating the determination of energetic parameters and thermodynamics of actomyosin interactions.	[Chizhov, Igor; Hartmann, Falk K.; Hundt, Nikolas; Tsiavaliaris, Georgios] Hannover Med Sch, Inst Biophys Chem, Hannover, Germany	Hannover Medical School	Tsiavaliaris, G (corresponding author), Hannover Med Sch, Inst Biophys Chem, OE 4350, Hannover, Germany.	tsiavaliaris.georgios@mh-hannover.de		Hundt, Nikolas/0000-0001-8217-671X	Deutsche Forschungsgemeinschaft [TS 169/3-1, TS 169/3-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschungsgemeinschaft to Georgios Tsiavaliaris (Grant number TS 169/3-1,2) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrute-Nayak M, 2010, ANGEW CHEM INT EDIT, V49, P312, DOI 10.1002/anie.200905200; ANSON M, 1992, J MOL BIOL, V224, P1029, DOI 10.1016/0022-2836(92)90467-X; Bierbaum V, 2011, BIOPHYS J, V100, P1747, DOI 10.1016/j.bpj.2011.02.012; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Chizhov I, 1996, BIOPHYS J, V71, P2329, DOI 10.1016/S0006-3495(96)79475-4; Conibear PB, 1998, BIOPHYS J, V75, P926, DOI 10.1016/S0006-3495(98)77581-2; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Farruggia G, 2006, J AM CHEM SOC, V128, P344, DOI 10.1021/ja056523u; Geeves MA, 2005, CELL MOL LIFE SCI, V62, P1462, DOI 10.1007/s00018-005-5015-5; GEEVES MA, 1986, BIOCHEMISTRY-US, V25, P8454, DOI 10.1021/bi00374a020; Greenberg MJ, 2012, P NATL ACAD SCI USA, V109, pE2433, DOI 10.1073/pnas.1207811109; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Jacobs DJ, 2011, J MOL BIOL, V407, P716, DOI 10.1016/j.jmb.2011.02.001; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Mansson A, 2010, BIOPHYS J, V98, P1237, DOI 10.1016/j.bpj.2009.12.4285; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Nagy NT, 2010, FASEB J, V24, P4480, DOI 10.1096/fj.10-163998; Preller M, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P118, DOI 10.1016/B978-0-12-374920-8.00410-0; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; SHEETZ MP, 1984, J CELL BIOL, V99, P1867, DOI 10.1083/jcb.99.5.1867; Sundberg M, 2003, ANAL BIOCHEM, V323, P127, DOI 10.1016/j.ab.2003.07.022; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; SWEENEY HL, 1985, AM J PHYSIOL, V249, pC362, DOI 10.1152/ajpcell.1985.249.3.C362; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Takagi Y, 2004, PHILOS T R SOC B, V359, P1913, DOI 10.1098/rstb.2004.1561; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Truhlar DG, 2001, P NATL ACAD SCI USA, V98, P848, DOI 10.1073/pnas.98.3.848; UYEDA TQP, 1991, NATURE, V352, P307, DOI 10.1038/352307a0; VanBrederode ME, 1996, BIOPHYS J, V71, P365, DOI 10.1016/S0006-3495(96)79234-2; Xie P, 2006, BIOPHYS CHEM, V120, P225, DOI 10.1016/j.bpc.2005.11.008; Yengo CM, 2012, J MUSCLE RES CELL M, V33, P385, DOI 10.1007/s10974-012-9316-7; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	39	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e64797	10.1371/journal.pone.0064797	http://dx.doi.org/10.1371/journal.pone.0064797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23738001	gold, Green Published, Green Submitted			2022-12-27	WOS:000319435600077
J	Demeyer, I; De Raedt, R				Demeyer, Ineke; De Raedt, Rudi			Attentional Bias for Emotional Information in Older Adults: The Role of Emotion and Future Time Perspective	PLOS ONE			English	Article							SOCIAL PREFERENCES; AGE-DIFFERENCES; NEGATIVE AFFECT; ANXIETY; VALIDATION; MEMORY; REAPPRAISAL; COGNITION; THREAT; FACES	Objectives: Research suggests that older adults display a positivity bias at the level of information processing. However, because studies investigating attentional bias for emotional information in older adults have produced mixed findings, research identifying inter-individual differences that may explain these inconsistent results is necessary. Therefore, we investigated whether mood, symptoms of depression, symptoms of anxiety and future time perspective are related to attentional bias in older adults. Method: Thirty-seven healthy older adults and 25 healthy middle-aged adults completed questionnaires to assess mood, symptoms of depression, symptoms of anxiety and future time perspective. Attentional bias towards happy, sad and neutral information was measured using a modified exogenous cueing paradigm with long cue presentations, to measure maintained attention versus avoidance of emotional stimuli. Results: Older adults showed attentional avoidance for all emotional faces, whereas no attentional biases were found in the middle-aged group. Moreover, in the older adult group, avoidance for negative information was related to anxiety. Future time perspective was unrelated to attentional bias. Discussion: These findings suggest that anxiety may lead to inter-individual differences in attentional bias in older adults, and that avoidance from negative information may be an emotion regulation strategy.	[Demeyer, Ineke; De Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University	Demeyer, I (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	Ineke.Demeyer@UGent.be	De Raedt, Rudi/AAL-4093-2021; De Raedt, Rudi/A-3269-2012	De Raedt, Rudi/0000-0001-6781-4808; De Raedt, Rudi/0000-0001-6781-4808	Special Research Fund (BOF) of Ghent University [B/09916/02]	Special Research Fund (BOF) of Ghent University(Ghent University)	This work was supported by a Grant of the Special Research Fund (BOF) of Ghent University (B/09916/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Beck AT., 1996, MANUAL BECK DEPRESSI; Brown LA, 2011, EXP AGING RES, V37, P330, DOI 10.1080/0361073X.2011.568833; Bryant C, 2008, J AFFECT DISORDERS, V109, P233, DOI 10.1016/j.jad.2007.11.008; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; De Raedt R, 2013, J GERONTOL B-PSYCHOL, V68, P41, DOI 10.1093/geronb/gbs047; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Fox LS, 2005, AGING MENT HEALTH, V9, P585, DOI 10.1080/13607860500294282; Fung HH, 2010, PSYCHOL AGING, V25, P321, DOI 10.1037/a0019079; Fung HH, 1999, PSYCHOL AGING, V14, P595, DOI 10.1037/0882-7974.14.4.595; Fung HH, 2001, PSYCHOL AGING, V16, P351, DOI 10.1037//0882-7974.16.2.351; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Isaacowitz DM, 2008, PSYCHOL SCI, V19, P848, DOI 10.1111/j.1467-9280.2008.02167.x; Isaacowitz DM, 2006, EMOTION, V6, P511, DOI 10.1037/1528-3542.6.3.511; Isaacowitz DM, 2009, J GERONTOL B-PSYCHOL, V64, P188, DOI 10.1093/geronb/gbn036; Kessler EM, 2009, PSYCHOL AGING, V24, P349, DOI 10.1037/a0015352; Lee LO, 2009, PSYCHOL AGING, V24, P741, DOI 10.1037/a0016409; Leyman L, 2007, PSYCHOL MED, V37, P393, DOI 10.1017/S003329170600910X; Li TY, 2011, J GERONTOL B-PSYCHOL, V66, P56, DOI 10.1093/geronb/gbq074; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Mather M, 2006, J GERONTOL B-PSYCHOL, V61, pP54, DOI 10.1093/geronb/61.1.P54; Murphy NA, 2008, PSYCHOL AGING, V23, P263, DOI 10.1037/0882-7974.23.2.263; Nolen-Hoeksema S, 2011, PERS INDIV DIFFER, V51, P704, DOI 10.1016/j.paid.2011.06.012; Olatunji BO, 2010, BEHAV RES THER, V48, P435, DOI 10.1016/j.brat.2009.11.014; Orgeta V, 2011, J ANXIETY DISORD, V25, P1019, DOI 10.1016/j.janxdis.2011.06.010; Peeters F.P.M.L., 1996, TIJDSCHR PSYCHIAT, V38, P240; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Price RB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.46; Price RB, 2012, AM J GERIAT PSYCHIAT, V20, P798, DOI 10.1097/JGP.0b013e318230340d; Scheibe S, 2010, J GERONTOL B-PSYCHOL, V65, P135, DOI 10.1093/geronb/gbp132; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Steinmetz KRM, 2010, PSYCHOL AGING, V25, P239, DOI 10.1037/a0018297; Van der Does A, 2002, NEDERLANDSE VERSIE B; Van der Ploeg HM, 2000, HANDLEIDING BIJ ZELF; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	45	21	21	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65429	10.1371/journal.pone.0065429	http://dx.doi.org/10.1371/journal.pone.0065429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IE	23750261	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900063
J	Kennaway, DJ; Varcoe, TJ; Voultsios, A; Boden, MJ				Kennaway, David John; Varcoe, Tamara Jayne; Voultsios, Athena; Boden, Michael James			Global Loss of Bmal1 Expression Alters Adipose Tissue Hormones, Gene Expression and Glucose Metabolism	PLOS ONE			English	Article							CLOCK MUTANT MICE; REV-ERB-ALPHA; HIGH-FAT DIET; CIRCADIAN CLOCK; ADIPOCYTE DIFFERENTIATION; LIVER; RHYTHMICITY; HOMEOSTASIS; MUTATION; OBESITY	The close relationship between circadian rhythm disruption and poor metabolic status is becoming increasingly evident, but role of adipokines is poorly understood. Here we investigated adipocyte function and the metabolic status of mice with a global loss of the core clock gene Bmal1 fed either a normal or a high fat diet (22% by weight). Bmal1 null mice aged 2 months were killed across 24 hours and plasma adiponectin and leptin, and adipose tissue expression of Adipoq, Lep, Retn and Nampt mRNA measured. Glucose, insulin and pyruvate tolerance tests were conducted and the expression of liver glycolytic and gluconeogenic enzyme mRNA determined. Bmal1 null mice displayed a pattern of increased plasma adiponectin and plasma leptin concentrations on both control and high fat diets. Bmal1 null male and female mice displayed increased adiposity (1.8 fold and 2.3 fold respectively) on the normal diet, but the high fat diet did not exaggerate these differences. Despite normal glucose and insulin tolerance, Bmal1 null mice had increased production of glucose from pyruvate, implying increased liver gluconeogenesis. The Bmal1 null mice had arrhythmic clock gene expression in epigonadal fat and liver, and loss of rhythmic transcription of a range of metabolic genes. Furthermore, the expression of epigonadal fat Adipoq, Retn, Nampt, AdipoR1 and AdipoR2 and liver Pfkfb3 mRNA were down-regulated. These results show for the first time that global loss of Bmal1, and the consequent arrhythmicity, results in compensatory changes in adipokines involved in the cellular control of glucose metabolism.	[Kennaway, David John; Varcoe, Tamara Jayne; Voultsios, Athena; Boden, Michael James] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Kennaway, DJ (corresponding author), Univ Adelaide, Robinson Inst, Adelaide, SA, Australia.	david.kennaway@adelaide.edu.au	Kennaway, David J/B-8955-2009; Varcoe, Tamara/H-2785-2014; Boden, Michael/L-9884-2013	Kennaway, David J/0000-0002-5864-3514; Varcoe, Tamara/0000-0002-9462-1830	National Health and Medical Research Council of Australia [399131]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the National Health and Medical Research Council of Australia, Grant #399131 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden MJ, 2010, REPRODUCTION, V139, P1077, DOI 10.1530/REP-09-0523; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Guo BY, 2012, FASEB J, V26, P3453, DOI 10.1096/fj.12-205781; Hemmeryckx B, 2011, OBESITY, V19, P659, DOI 10.1038/oby.2010.266; Kennaway DJ, 2007, AM J PHYSIOL-REG I, V293, pR1528, DOI 10.1152/ajpregu.00018.2007; Kennaway DJ, 2006, AM J PHYSIOL-REG I, V291, pR1172, DOI 10.1152/ajpregu.00223.2006; Kennaway DJ, 2012, OBESITY, V20, P295, DOI 10.1038/oby.2011.276; Kennaway DJ, 2003, AM J PHYSIOL-REG I, V284, pR1231, DOI 10.1152/ajpregu.00697.2002; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kudo T, 2008, AM J PHYSIOL-ENDOC M, V294, pE120, DOI 10.1152/ajpendo.00061.2007; Kudo T, 2007, J BIOL RHYTHM, V22, P312, DOI 10.1177/0748730407302625; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; LEE JHW, 2011, J HYDRO-ENVIRON RES, V5, P1, DOI DOI 10.1016/J.JHER.2011.02.001; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Ratajczak CK, 2009, ENDOCRINOLOGY, V150, P1879, DOI 10.1210/en.2008-1021; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Shi SQ, 2010, CURR BIOL, V20, P316, DOI 10.1016/j.cub.2009.12.034; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; VANCAUTER E, 1989, J CLIN ENDOCR METAB, V69, P604; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07	37	56	63	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65255	10.1371/journal.pone.0065255	http://dx.doi.org/10.1371/journal.pone.0065255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750248	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900050
J	Nagaoka, K; Zhang, HL; Watanabe, G; Taya, K				Nagaoka, Kentaro; Zhang, Haolin; Watanabe, Gen; Taya, Kazuyoshi			Epithelial Cell Differentiation Regulated by MicroRNA-200a in Mammary Glands	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MIR-200 FAMILY; E-CADHERIN; REPRESSORS ZEB1; MORPHOGENESIS; CANCER; POLARITY; EXPRESSION; MOUSE; MAINTENANCE	Mammary gland epithelial cells undergo periodic cycles of proliferation, differentiation, and involution. Many studies have reported that miRNAs, which are small, non-coding RNAs, influence a variety of biological processes during posttranscriptional regulation. Here, we found that one miRNA, miR-200a, was relatively highly expressed in epithelial cell-rich organs such as mammary glands, lung, and kidney in mice. In mammary glands, miR-200a expression increased during mid-pregnancy through lactation; its expression was stimulated by lactogenic hormone treatment of mammary epithelial cells. Lactogenic hormone also induced the expression of milk protein beta-casein mRNA (a marker of cell differentiation) and E-cadherin mRNA (a marker of epithelial cells). However, knockdown of miR-200a prevented increases in beta-casein and E-cadherin mRNA expression. Protein analysis revealed that E-cadherin signal was decreased and ZEB1 (a marker of EMT) was increased following miR-200a knockdown. Finally, in a three-dimensional culture system modeling lumen-containing mammary ducts, miR-200a knockdown decreased the cavity formation rate and suppressed claudin-3 and par-6b expression, indicating reduced epithelial cell polarity. These observations suggest that miR-200a is important for maintaining the epithelial cell phenotype, which contributes to lactogenic hormone induction of cellular differentiation in mammary glands.	[Nagaoka, Kentaro; Zhang, Haolin; Watanabe, Gen; Taya, Kazuyoshi] Tokyo Univ Agr & Technol, Dept Vet Med, Vet Physiol Lab, Tokyo, Japan	Tokyo University of Agriculture & Technology	Nagaoka, K (corresponding author), Tokyo Univ Agr & Technol, Dept Vet Med, Vet Physiol Lab, Tokyo, Japan.	nagaokak@cc.tuat.ac.jp	张(Zhang), 浩林 (Haolin)/AGP-9653-2022; Watanabe/G-1134-2013; Nagaoka, Kentaro/C-2019-2013	张(Zhang), 浩林 (Haolin)/0000-0001-6178-7431; Watanabe/0000-0001-7611-4678; Nagaoka, Kentaro/0000-0003-1038-1380	Japan Society for the Promotion of Science [24780268]; Grants-in-Aid for Scientific Research [24780268] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to K.N., 24780268) http://kaken.nii.ac.jp/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai JX, 2013, ENDOCRINOLOGY, V154, P635, DOI 10.1210/en.2012-1607; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchard AAA, 2006, DNA CELL BIOL, V25, P79, DOI 10.1089/dna.2006.25.79; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Chilton BS, 2005, CURR TOP DEV BIOL, V68, P1, DOI 10.1016/S0070-2153(05)68001-5; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Eades G, J BIOL CHEM, V286, P40725; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Galio L, PHYSL GENOM IN PRESS; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kobayashi K, 2011, HISTOCHEM CELL BIOL, V136, P587, DOI 10.1007/s00418-011-0863-6; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lelievre SA, 2010, J MAMMARY GLAND BIOL, V15, P49, DOI 10.1007/s10911-010-9168-y; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Nagaoka K, 2007, EXP CELL RES, V313, P2937, DOI 10.1016/j.yexcr.2007.04.017; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Piao HL, 2012, J MAMMARY GLAND BIOL, V17, P33, DOI 10.1007/s10911-012-9245-5; Reginato MJ, 2006, J MAMMARY GLAND BIOL, V11, P205, DOI 10.1007/s10911-006-9030-4; Sana J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-103; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Xu R, 2010, CELL CYCLE, V9, P4315, DOI 10.4161/cc.9.21.13578; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021	37	31	34	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65127	10.1371/journal.pone.0065127	http://dx.doi.org/10.1371/journal.pone.0065127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750238	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900040
J	Smit, AJ; Smit, JM; Botterblom, GJ; Mulder, DJ				Smit, Andries J.; Smit, Jitske M.; Botterblom, Gijs J.; Mulder, Douwe J.			Skin Autofluorescence Based Decision Tree in Detection of Impaired Glucose Tolerance and Diabetes	PLOS ONE			English	Article							LIFE-STYLE; FOLLOW-UP; TYPE-2; RISK; PREVENTION; MELLITUS; MARKER	Aim: Diabetes (DM) and impaired glucose tolerance (IGT) detection are conventionally based on glycemic criteria. Skin autofluorescence (SAF) is a noninvasive proxy of tissue accumulation of advanced glycation endproducts (AGE) which are considered to be a carrier of glycometabolic memory. We compared SAF and a SAF-based decision tree (SAF-DM) with fasting plasma glucose (FPG) and HbA1c, and additionally with the Finnish Diabetes Risk Score (FINDRISC) questionnaire +/- FPG for detection of oral glucose tolerance test (OGTT)- or HbA1c-defined IGT and diabetes in intermediate risk persons. Methods: Participants had >= 1 metabolic syndrome criteria. They underwent an OGTT, HbA1c, SAF and FINDRISC, in adition to SAF-DM which includes SAF, age, BMI, and conditional questions on DM family history, antihypertensives, renal or cardiovascular disease events (CVE). Results: 218 persons, age 56 yr, 128M/90F, 97 with previous CVE, participated. With OGTT 28 had DM, 46 IGT, 41 impaired fasting glucose, 103 normal glucose tolerance. SAF alone revealed 23 false positives (FP), 34 false negatives (FN) (sensitivity (S) 68%; specificity (SP) 86%). With SAF-DM, FP were reduced to 18, FN to 16 (5 with DM) (S 82%; SP 89%). HbA1c scored 48 FP, 18 FN (S 80%; SP 75%). Using HbA1c-defined DM-IGT/suspicion >= 6%/42 mmol/mol, SAF-DM scored 33 FP, 24 FN (4 DM) (S76%; SP72%), FPG 29 FP, 41 FN (S71%; SP80%). FINDRISC >= 10 points as detection of HbA1c-based diabetes/suspicion scored 79 FP, 23 FN (S 69%; SP 45%). Conclusion: SAF-DM is superior to FPG and non-inferior to HbA1c to detect diabetes/IGT in intermediate-risk persons. SAF-DM's value for diabetes/IGT screening is further supported by its established performance in predicting diabetic complications.	[Smit, Andries J.; Botterblom, Gijs J.; Mulder, Douwe J.] Univ Med Ctr Groningen, Dept Med, NL-9713 AV Groningen, Netherlands; [Smit, Andries J.; Botterblom, Gijs J.; Mulder, Douwe J.] Univ Groningen, Groningen, Netherlands; [Smit, Jitske M.] Gelre Ziekenhuis, Dept Med, Apeldoorn, Netherlands	University of Groningen; University of Groningen; Gelre Hospitals	Smit, AJ (corresponding author), Univ Med Ctr Groningen, Dept Med, NL-9713 AV Groningen, Netherlands.	a.j.smit@umcg.nl			Diagnoptics Technologies, Groningen, the Netherlands; University Medical Center Groningen; Diagnoptics Technologies	Diagnoptics Technologies, Groningen, the Netherlands(Netherlands Government); University Medical Center Groningen; Diagnoptics Technologies	The study was partly funded by Diagnoptics Technologies, Groningen, the Netherlands. The study was also partly funded by the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by Diagnoptics Technologies. AJS is founder and shareholder, and JMS is also shareholder of Diagnoptics Technologies B.V., the Netherlands. Diagnoptics Technologies is the company that developed the AGE Reader, which is used in the present article. AJS was also the first inventor in the patent used for the AGE reader technology. He was inventor as employee of the University Medical Center Groningen (UMCG), which was co-owner of it. Later the patent was sold to Diagnoptics Technologies, so the UMCG has no financial interests anymore. AJS now works 80% of his time as as employee of the University Medical Center Groningen, but is also the scientific director of Diagnoptics technologies. As such, he has an interest in development and validation of possible further future applications of the AGE reader, such as described in the present paper. The other authors have declared that no competing interests exist; the personnel involved in the two participating hospitals in the study also had no competing interests. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	*AM ASS CLIN END, ENDOCR PRACT, V16, P155; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Christensen J, 2004, DIABETOLOGIA, V47, P1566, DOI 10.1007/s00125-004-1496-2; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Hische M, 2010, EUR J ENDOCRINOL, V163, P565, DOI 10.1530/EJE-10-0649; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; *INT EXP COMM REP, DIABETES CARE, V32, P1327; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113; Koetsier M, 2010, OPT EXPRESS, V18, P14416, DOI 10.1364/OE.18.014416; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414; Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173; Maynard JD, 2007, DIABETES CARE, V30, P1120, DOI 10.2337/dc06-2377; Meerwaldt R, 2005, ANN NY ACAD SCI, V1043, P290, DOI 10.1196/annals.1333.036; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Mulder DJ, 2009, NETH HEART J, V17, P162, DOI 10.1007/BF03086239; Nienhuis HLA, 2009, AUTOIMMUNITY, V42, P302, DOI 10.1080/08916930902831746; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Sliventoinen K, 2005, EUR J CARDIOV PREV R, V12, P451, DOI 10.1097/01.hjr.0000174793.31812.21; Smit AJ, 2010, CURR OPIN NEPHROL HY, V19, P527, DOI 10.1097/MNH.0b013e32833e9259; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; von Eckardstein A, 2000, J CLIN ENDOCR METAB, V85, P3101, DOI 10.1210/jc.85.9.3101	27	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65592	10.1371/journal.pone.0065592	http://dx.doi.org/10.1371/journal.pone.0065592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750268	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900070
J	Chabas, JF; Stephan, D; Marqueste, T; Garcia, S; Lavaut, MN; Nguyen, C; Legre, R; Khrestchatisky, M; Decherchi, P; Feron, F				Chabas, Jean-Francois; Stephan, Delphine; Marqueste, Tanguy; Garcia, Stephane; Lavaut, Marie-Noelle; Catherine Nguyen; Legre, Regis; Khrestchatisky, Michel; Decherchi, Patrick; Feron, Francois			Cholecalciferol (Vitamin D-3) Improves Myelination and Recovery after Nerve Injury	PLOS ONE			English	Article							TIBIALIS-ANTERIOR MUSCLE; 1,25-DIHYDROXYVITAMIN D-3; GROWTH-FACTOR; AFFERENT ACTIVITIES; MESSENGER-RNA; D DEFICIENCY; D-RECEPTOR; RAT; BRAIN; PROTEIN	Previously, we demonstrated i) that ergocalciferol (vitamin D-2) increases axon diameter and potentiates nerve regeneration in a rat model of transected peripheral nerve and ii) that cholecalciferol (vitamin D-3) improves breathing and hyper-reflexia in a rat model of paraplegia. However, before bringing this molecule to the clinic, it was of prime importance i) to assess which form - ergocalciferol versus cholecalciferol - and which dose were the most efficient and ii) to identify the molecular pathways activated by this pleiotropic molecule. The rat left peroneal nerve was cut out on a length of 10 mm and autografted in an inverted position. Animals were treated with either cholecalciferol or ergocalciferol, at the dose of 100 or 500 IU/kg/day, or excipient (Vehicle), and compared to unlesioned rats (Control). Functional recovery of hindlimb was measured weekly, during 12 weeks, using the peroneal functional index. Ventilatory, motor and sensitive responses of the regenerated axons were recorded and histological analysis was performed. In parallel, to identify the genes regulated by vitamin D in dorsal root ganglia and/or Schwann cells, we performed an in vitro transcriptome study. We observed that cholecalciferol is more efficient than ergocalciferol and, when delivered at a high dose (500 IU/kg/day), cholecalciferol induces a significant locomotor and electrophysiological recovery. We also demonstrated that cholecalciferol increases i) the number of preserved or newly formed axons in the proximal end, ii) the mean axon diameter in the distal end, and iii) neurite myelination in both distal and proximal ends. Finally, we found a modified expression of several genes involved in axogenesis and myelination, after 24 hours of vitamin supplementation. Our study is the first to demonstrate that vitamin D acts on myelination via the activation of several myelin-associated genes. It paves the way for future randomised controlled clinical trials for peripheral nerve or spinal cord repair.	[Chabas, Jean-Francois; Stephan, Delphine; Khrestchatisky, Michel; Feron, Francois] Aix Marseille Univ, CNRS, NICN UMR 7259, Marseille, France; [Chabas, Jean-Francois; Legre, Regis] Hop Conception, APHM, Serv Chirurg Main, Marseille, France; [Marqueste, Tanguy; Decherchi, Patrick] Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France; [Garcia, Stephane; Lavaut, Marie-Noelle] Aix Marseille Univ, Assistance Publ Hop Marseille, Serv Hosp Anat & Cytol Pathol Humaines, Marseille, France; [Garcia, Stephane; Lavaut, Marie-Noelle] Aix Marseille Univ, INSERM, U1068, Marseille, France; [Catherine Nguyen] Aix Marseille Univ, INSERM, TAGC UMR U1090, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Decherchi, P (corresponding author), Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France.	patrick.decherchi@univ-amu.fr; francois.feron@univ-amu.fr	DECHERCHI, Patrick/AAE-7756-2019; Feron, Francois/J-5639-2014; Marqueste, Tanguy/AAM-9751-2021; Nguyen, Catherine/M-4119-2016	DECHERCHI, Patrick/0000-0001-5639-852X; Marqueste, Tanguy/0000-0002-2620-1551; Nguyen, Catherine/0000-0001-9376-6360; Khrestchatisky, Michel/0000-0003-4797-8332	Aix-Marseille University, CNRS (Centre National de la Recherche Scientifique); DGA (Delegation Generale des Armees); Association Libre d'Aide a la Recherche sur la Moelle Epiniere; Demain Debout; Combattre la Paralysie; Avenir; Intermarche	Aix-Marseille University, CNRS (Centre National de la Recherche Scientifique); DGA (Delegation Generale des Armees); Association Libre d'Aide a la Recherche sur la Moelle Epiniere; Demain Debout; Combattre la Paralysie; Avenir; Intermarche	This work was financially supported by public grants from Aix-Marseille University, CNRS (Centre National de la Recherche Scientifique), DGA (Delegation Generale des Armees), and by private grants from various associations (Association Libre d'Aide a la Recherche sur la Moelle Epiniere, Demain Debout, Combattre la Paralysie) and foundations (Avenir, Intermarche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; Baas D, 2000, GLIA, V31, P59, DOI 10.1002/(SICI)1098-1136(200007)31:1<59::AID-GLIA60>3.0.CO;2-Y; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Barger-Lux MJ, 1998, OSTEOPOROSIS INT, V8, P222, DOI 10.1007/s001980050058; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BIRGE SJ, 1975, J CLIN INVEST, V56, P1100, DOI 10.1172/JCI108184; Birling MC, 1999, J NEUROCHEM, V73, P2600, DOI 10.1046/j.1471-4159.1999.0732600.x; Brouwer DAJ, 1998, BRIT J NUTR, V79, P527, DOI 10.1079/BJN19980091; Brown J, 2003, NEUROSCI LETT, V343, P139, DOI 10.1016/S0304-3940(03)00303-3; Burne THJ, 2005, BEHAV BRAIN RES, V157, P299, DOI 10.1016/j.bbr.2004.07.008; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Cannell JJ, 2009, MED SCI SPORT EXER, V41, P1102, DOI 10.1249/MSS.0b013e3181930c2b; CARONI P, 1994, J CELL BIOL, V125, P893, DOI 10.1083/jcb.125.4.893; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chabas JF, 2008, J NEUROTRAUM, V25, P1247, DOI 10.1089/neu.2008.0593; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Cornet A, 1998, J NEUROSCI RES, V53, P742, DOI 10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#; Darques JL, 1997, BRAIN RES, V750, P147, DOI 10.1016/S0006-8993(96)01341-8; Decherchi P, 1998, J PERIPHER NERV SYST, V3, P267; Decherchi P, 2001, MUSCLE NERVE, V24, P59, DOI 10.1002/1097-4598(200101)24:1<59::AID-MUS7>3.0.CO;2-S; Decherchi P, 2007, EXP BRAIN RES, V183, P299, DOI 10.1007/s00221-007-1044-7; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; ESAU SA, 1983, J APPL PHYSIOL, V54, P1353, DOI 10.1152/jappl.1983.54.5.1353; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Fernes de Abreu DA., 2009, PSYCHONEUROENDOCR S1, V34, pS265, DOI DOI 10.1016/J.PSYNEUEN.2009.05.023; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; Gao WQ, 1999, J NEUROBIOL, V39, P142, DOI 10.1002/(SICI)1097-4695(199904)39:1<142::AID-NEU11>3.0.CO;2-H; Garcion E, 1999, J NEUROCHEM, V73, P859, DOI 10.1046/j.1471-4159.1999.0730859.x; Garcion E, 1998, GLIA, V22, P282, DOI 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7; Heaney RP, 2011, J CLIN ENDOCR METAB, V96, pE447, DOI 10.1210/jc.2010-2230; HORST RL, 1982, BIOCHEM J, V204, P185, DOI 10.1042/bj2040185; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibi M, 2001, NEUROPHARMACOLOGY, V40, P761, DOI 10.1016/S0028-3908(01)00009-0; Ilahi M, 2008, AM J CLIN NUTR, V87, P688, DOI 10.1093/ajcn/87.3.688; Kimball S, 2008, ANN CLIN BIOCHEM, V45, P106, DOI 10.1258/acb.2007.007074; Langub MC, 2001, NEUROSCIENCE, V104, P49, DOI 10.1016/S0306-4522(01)00049-5; Marchesi C, 2010, NEUROLOGY, V75, P1830, DOI 10.1212/WNL.0b013e3181fd6314; Marini F, 2010, HIPPOCAMPUS, V20, P696, DOI 10.1002/hipo.20670; Moreira-Pfrimer LDF, 2009, ANN NUTR METAB, V54, P291, DOI 10.1159/000235874; Naveilhan P, 1996, NEUROREPORT, V7, P2171, DOI 10.1097/00001756-199609020-00023; NEVEU I, 1994, MOL BRAIN RES, V24, P70, DOI 10.1016/0169-328X(94)90119-8; NEVEU I, 1994, NEUROREPORT, V6, P124, DOI 10.1097/00001756-199412300-00032; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Norman P, 2002, CARDIOVASC RES, V55, P369, DOI 10.1016/S0008-6363(02)00444-3; Roder J D, 1999, Vet Hum Toxicol, V41, P343; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Sanchez B, 2009, J NEUROSCI RES, V87, P723, DOI 10.1002/jnr.21878; SAPORITO MS, 1994, BRAIN RES, V633, P189, DOI 10.1016/0006-8993(94)91539-3; Sato Y, 2005, CEREBROVASC DIS, V20, P187, DOI 10.1159/000087203; Selvaraju R, 2004, MOL CELL NEUROSCI, V25, P707, DOI 10.1016/j.mcn.2003.12.014; Shinpo K, 2000, J NEUROSCI RES, V62, P374, DOI 10.1002/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7; SORENSEN OH, 1979, CLIN SCI, V56, P157, DOI 10.1042/cs0560157; STUMPF WE, 1987, HISTOCHEMISTRY, V87, P393, DOI 10.1007/BF00496810; STUMPF WE, 1982, SCIENCE, V215, P1403, DOI 10.1126/science.6977846; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Terada N, 2002, GLIA, V40, P350, DOI 10.1002/glia.10134; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Veenstra TD, 1998, BRAIN RES, V804, P193, DOI 10.1016/S0006-8993(98)00565-4; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Walbert T, 2001, HORM METAB RES, V33, P525, DOI 10.1055/s-2001-17210; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; WASSNER SJ, 1983, J CLIN INVEST, V72, P102, DOI 10.1172/JCI110947; Zhao C, 2008, NEUROBIOL DIS, V31, P209, DOI 10.1016/j.nbd.2008.04.007; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104	68	93	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65034	10.1371/journal.pone.0065034	http://dx.doi.org/10.1371/journal.pone.0065034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741446	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900159
J	Gao, P; Zhang, J; He, XY; Hao, YQ; Wang, K; Gibson, PG				Gao, Peng; Zhang, Jie; He, Xiaoyan; Hao, Yuqiu; Wang, Ke; Gibson, Peter G.			Sputum Inflammatory Cell-Based Classification of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							IDENTIFICATION; EOSINOPHILIA; BRONCHITIS; MARKERS; ASTHMA; COPD	Background: Patients with chronic obstructive pulmonary disease (COPD) commonly suffer from acute exacerbations (AECOPD) and display varying disease severity. However, there is no available biomarker for the classification of AECOPD. This study is aimed at investigating the sputum cellular profiles to classify patients with AECOPD. Methods: A total of 83 patients with AECOPD and 26 healthy controls were recruited. Their demographic and clinical characteristics were recorded, and their lung function was examined. The phenotypes of sputum inflammatory cells were characterised, and the concentrations of sputum and serum amyloid-A (SAA), C-reactive protein (CRP), interleukin-6 (IL-6), and matrix metalloproteinase-9 (MMP-9) were measured. Based on the sputum inflammatory cell profiles, individual patients were categorized into one of the four subgroups with inflammatory eosinophilic, neutrophilic, paucigranulocytic, and mixed granulocytic AECOPD. Most AECOPD patients were reevaluated within 12-14 months after discharge. Results: There were 10 (12%) eosinophilic, 36 (43%) neutrophilic, 5 (6%) mixed granulocytic, and 32 (39%) paucigranulocytic AECOPD patients. The patients with mixed granulocytic or neutrophilic AECOPD had a higher BODE score, more sputum inflammatory cells, lower lung function, and longer hospital stay, accompanied by higher concentrations of sputum MMP-9, IL-6 and CRP, and serum SAA, IL-6 and CRP. Notably, 83% of patients with neutrophilic AECOPD displayed evidence of bacterial infection and many of them responded poorly to standard therapies. In addition, patients with mixed granulocytic or neutrophilic stable COPD remained at lower lung functions and higher levels of inflammation. Conclusion: Patients with AECOPD display heterogeneous inflammation, and the profiles of sputum inflammatory cells may be used as valuable biomarkers for the classification of AECOPD patients.	[Gao, Peng; Zhang, Jie; Hao, Yuqiu; Wang, Ke] Jilin Univ, Affiliated Hosp 2, Dept Resp Med, Changchun, Jilin, Peoples R China; [He, Xiaoyan; Gibson, Peter G.] John Hunter Hosp, Hunter Med Res Inst, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Gao, Peng; Zhang, Jie; He, Xiaoyan; Hao, Yuqiu; Wang, Ke; Gibson, Peter G.] Jilin Univ, Jilin Univ Woolcock Joint Res Ctr Airway Dis, Changchun, Jilin, Peoples R China; [Gao, Peng] Changchun Cent Hosp, Changchun, Jilin, Peoples R China	Jilin University; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; Jilin University	Zhang, J (corresponding author), Jilin Univ, Affiliated Hosp 2, Dept Resp Med, Changchun, Jilin, Peoples R China.	doctorzhangj@sina.com; Peter.gibson@hnehealth.nsw.gov.au	gibson, peter/G-6194-2014	gibson, peter/0000-0001-5865-489X	Jilin Province Science Research Foundation, China [ZJ201007300]	Jilin Province Science Research Foundation, China	This study was supported by the unrestricted grant of Jilin Province Science Research Foundation, China (number: ZJ201007300). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Berim Ilya, 2011, Ther Adv Respir Dis, V5, P207, DOI 10.1177/1753465811398372; Bisgaard H, 2005, AM J RESP CRIT CARE, V171, P315, DOI 10.1164/rccm.200407-894OC; Bozinovski S, 2008, AM J RESP CRIT CARE, V177, P269, DOI 10.1164/rccm.200705-678OC; Butorac-Petanjek B, 2010, J CHEMOTHERAPY, V22, P291, DOI 10.1179/joc.2010.22.5.291; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Confalonieri M, 1998, THORAX, V53, P583, DOI 10.1136/thx.53.7.583; Cowburn AS, 2008, CHEST, V134, P606, DOI 10.1378/chest.08-0422; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; D'silva L, 2011, CAN RESPIR J, V18, P144, DOI 10.1155/2011/430317; Fireman E, 2002, CLIN EXP IMMUNOL, V130, P331, DOI 10.1046/j.1365-2249.2002.t01-1-02001.x; Franciosi LG, 2006, PULM PHARMACOL THER, V19, P189, DOI 10.1016/j.pupt.2005.05.001; Gao P, 2013, CLIN RESPIR J, V7, P101, DOI 10.1111/j.1752-699X.2012.00291.x; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; King PT, 2007, RESP MED, V101, P1633, DOI 10.1016/j.rmed.2007.03.009; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; O'Donnell RA, 2004, THORAX, V59, P837, DOI 10.1136/thx.2003.019349; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Pizzichini E, 1998, AM J RESP CRIT CARE, V158, P1511, DOI 10.1164/ajrccm.158.5.9804028; SAETTA M, 1994, AM J RESP CRIT CARE, V150, P1646, DOI 10.1164/ajrccm.150.6.7952628; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x	23	39	49	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e57678	10.1371/journal.pone.0057678	http://dx.doi.org/10.1371/journal.pone.0057678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741289	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900001
J	Han, XX; An, MH; Zhao, B; Duan, S; Yang, SM; Xu, JJ; Zhang, M; McGoogan, JM; Takebe, Y; Shang, H				Han, Xiaoxu; An, Minghui; Zhao, Bin; Duan, Song; Yang, Shaomin; Xu, Junjie; Zhang, Min; McGoogan, Jennifer M.; Takebe, Yutaka; Shang, Hong			High Prevalence of HIV-1 Intersubtype B '/C Recombinants among Injecting Drug Users in Dehong, China	PLOS ONE			English	Article							YUNNAN-PROVINCE; INFECTION; FORMS; STRAINS; GENOMES; RUILI; AIDS	Objective: To examine the distribution of HIV-1 genotypes among injecting drug users (IDUs) from Dehong, Yunnan province. Materials and Methods: Blood samples from a total of 95 HIV-positive IDUs were retrospectively analyzed. Samples were collected between 2005 and 2009 from four cities in Dehong prefecture, western Yunnan province, the geographical origin of the HIV epidemic in China. HIV-1 gag, partial pol, vpr-env fragment, half-genome, or near-full-length sequences were analyzed to determine the HIV-1 genotypes of each subject. Results were compared with findings from past studies of IDUs in Dehong and in neighboring Myanmar. Results: We observed a high prevalence of B'/C recombinants (82.4%) among IDUs in Dehong, the structural profiles of which do not match those previously reported in Dehong or in Myanmar. Furthermore, statistically significant differences in geographical and temporal distributions of HIV-1 genotypes were characterized by a predominance of HIV-1 B'/C recombinant forms among older subjects(p = 0.034), subjects from Longchuan district (p = 0.022), and subjects diagnosed between 2000 and 2004 (p = 0.004). Conclusions: The increasing prevalence of multiple, new B'/C recombinant forms suggest that HIV-1 intersubtype recombination is substantial and ongoing in western Yunnan. This reflects the high-risk behavior of IDUs in this region and argues the need for stronger monitoring and prevention measures in Dehong and other high-prevalence areas around China.	[Han, Xiaoxu; An, Minghui; Zhao, Bin; Xu, Junjie; Zhang, Min; Takebe, Yutaka; Shang, Hong] China Med Univ, Affiliated Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang, Liaoning, Peoples R China; [Duan, Song] Dehong Prefecture Ctr Dis Control & Prevent, Mangshi, Yunnan, Peoples R China; [Yang, Shaomin] Yunnan Prov Hosp Infect Dis, AIDS Care Ctr, Kunming, Yunnan, Peoples R China; [McGoogan, Jennifer M.] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan	China Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; National Institute of Infectious Diseases (NIID)	Shang, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang, Liaoning, Peoples R China.	hongshang100@hotmail.com			National Science Research [2012ZX10001006, 2012ZX10001-002]	National Science Research	This study was funded by support from the mega projects of the National Science Research for the 12th Five-Year Plan (2012ZX10001006 and 2012ZX10001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GUAN YJ, 1997, CHIN J EXP CLIN VIRO, V11, P8; Han XX, 2007, AIDS RES HUM RETROV, V23, P357, DOI 10.1089/aid.2006.0094; Li D Q, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P337; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ma Y., 1990, CHINESE J EPIDEMIOLO, V11, P184, DOI DOI 10.1007/S10461-010-9797-6; Motomura K, 2000, AIDS RES HUM RETROV, V16, P1831, DOI 10.1089/08892220050195793; Pang W, 2012, AIDS, V26, P1121, DOI 10.1097/QAD.0b013e3283522c97; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qiu ZZ, 2005, AIDS RES HUM RETROV, V21, P1051, DOI 10.1089/aid.2005.21.1051; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shao Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P109; SHAO Y, 1995, CHINESE J VIROL, V12, P10; Shao YM, 1994, CHINESE J VIROL, V4, P291; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Takebe Y, 2003, AIDS, V17, P2077, DOI 10.1097/00002030-200309260-00009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang Bin, 1998, Virologica Sinica, V13, P226; Yang RG, 2002, AIDS, V16, P1401, DOI 10.1097/00002030-200207050-00012; Yu ESH, 1996, AM J PUBLIC HEALTH, V86, P1116, DOI 10.2105/AJPH.86.8_Pt_1.1116; ZENG YS, 1991, CHINESE J EPIDEMIOLO, V12, P129; Zhang M, 2008, JPN J INFECT DIS, V61, P361; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; ZHAO B, 2011, AIDS RES HUM RETROVI; Zheng Xi-Wen, 1993, Biomedical and Environmental Sciences, V6, P348; ZHENG XW, 1989, CHINESE J EPIDEMIOLO, V10, P65; 张家鹏, 1991, 中华流行病学杂志, V12, P9; 1991, ZHONGHUA LIU XING BI, V12, P12	28	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65337	10.1371/journal.pone.0065337	http://dx.doi.org/10.1371/journal.pone.0065337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741489	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900202
J	Sanchez, M; Bousquet, J; Le Moual, N; Jacquemin, B; Clavel-Chapelon, F; Humbert, M; Kauffmann, F; Tubert-Bitter, P; Varraso, R				Sanchez, Margaux; Bousquet, Jean; Le Moual, Nicole; Jacquemin, Benedicte; Clavel-Chapelon, Francoise; Humbert, Marc; Kauffmann, Francine; Tubert-Bitter, Pascale; Varraso, Raphaelle			Temporal Asthma Patterns Using Repeated Questionnaires over 13 Years in a Large French Cohort of Women	PLOS ONE			English	Article							ONSET; E3N; ADULTHOOD; CHILDHOOD; RISK; AGE	Variable expression is one aspect of the heterogeneity of asthma. We aimed to define a variable pattern, which is relevant in general health epidemiological cohorts. Our objectives were to assess whether: 1) asthma patterns defined using simple asthma questions through repeated measurements could reflect disease variability 2) these patterns may further be classified according to asthma severity/control. Among 70,428 French women, we used seven questionnaires (1992-2005) and a comprehensive reimbursement database (2004-2009) to define three reliable asthma patterns based on repeated positive answers to the ever asthma attack question: "never asthma'' (n = 64,061); "inconsistent'' ("yes'' followed by "no'', n = 3,514); "consistent'' (fully consistent positive answers, n = 2,853). The "Inconsistent'' pattern was related to both long-term (childhood-onset asthma with remission in adulthood) and short-term (reported asthma attack in the last 12 months, associated with asthma medication) asthma variability, showing that repeated questions are relevant markers of the variable expression of asthma. Furthermore, in this pattern, the number of positive responses (1992-2005) predicted asthma drug consumption in subsequent years, a marker of disease severity. The "Inconsistent'' pattern is a phenotype that may capture the variable expression of asthma. Repeated answers, even to a simple question, are too often neglected.	[Sanchez, Margaux; Bousquet, Jean; Le Moual, Nicole; Jacquemin, Benedicte; Kauffmann, Francine; Varraso, Raphaelle] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Resp & Environm Epidemiol Team, F-94807 Villejuif, France; [Sanchez, Margaux; Le Moual, Nicole; Jacquemin, Benedicte; Clavel-Chapelon, Francoise; Kauffmann, Francine; Tubert-Bitter, Pascale; Varraso, Raphaelle] Univ Paris Sud, UMRS1018, F-94807 Villejuif, France; [Bousquet, Jean] Univ Hosp, Dept Resp Dis, Hop Arnaud Villeneuve, Montpellier, France; [Jacquemin, Benedicte] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Clavel-Chapelon, Francoise] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Nutr Hormones & Womens Hlth Team, F-94807 Villejuif, France; [Humbert, Marc] Hop Bicetre, Assistance Publ Ho Paris, DHU Thorax Innovat Serv Pneumol & Reanimat Respir, Le Kremlin Bicetre, France; [Humbert, Marc] Ctr Chirurg Marie Lannelongue, INSERM U999, LabEX LERMIT, F-92350 Le Plessis Robinson, France; [Humbert, Marc] Univ Paris Sud, Fac Med, F-94276 Le Kremlin Bicetre, France; [Tubert-Bitter, Pascale] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Biostat Team, F-94807 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier; Pompeu Fabra University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Sanchez, M (corresponding author), INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Resp & Environm Epidemiol Team, F-94807 Villejuif, France.	margaux.sanchez@inserm.fr	Tubert-Bitter, Pascale/E-6118-2016; Humbert, Marc/ABD-5112-2021; Le Moual, Nicole/R-8976-2016; Jacquemin, Benedicte/D-8948-2018; Varraso, Raphaelle/R-8740-2016; Clavel-Chapelon, Francoise/G-6733-2014; Le Moual, Nicole/GNP-5114-2022; Bousquet, Jean/O-4221-2019; Humbert, Marc/AAC-8459-2019	Le Moual, Nicole/0000-0002-2723-5569; Jacquemin, Benedicte/0000-0003-1273-9892; Varraso, Raphaelle/0000-0002-3338-7825; Le Moual, Nicole/0000-0002-2723-5569; Humbert, Marc/0000-0003-0703-2892; /0000-0002-1923-6393	Mutuelle Generale de l'Education Nationale (MGEN); European Community; French League against Cancer (LNCC); Gustave Roussy Institute (IGR); National Institute for Health and Medical Research (Inserm); General Councils of France; Fonds de dotation "Recherche en Sante Respiratoire''	Mutuelle Generale de l'Education Nationale (MGEN); European Community(European Commission); French League against Cancer (LNCC); Gustave Roussy Institute (IGR); National Institute for Health and Medical Research (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); General Councils of France; Fonds de dotation "Recherche en Sante Respiratoire''	The E3N study is supported by the Mutuelle Generale de l'Education Nationale (MGEN), the European Community, the French League against Cancer (LNCC), the Gustave Roussy Institute (IGR), the National Institute for Health and Medical Research (Inserm) and General Councils of France. The specific respiratory health survey in the E3N study was supported by the Fonds de dotation "Recherche en Sante Respiratoire''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x; Brille D, 1971, COMMENTAIRES RELATIF; Burgess JA, 2006, J ASTHMA, V43, P727, DOI 10.1080/02770900601028587; Clavel-Chapelon F, 1997, EUR J CANCER PREV, V6, P473, DOI 10.1097/00008469-199710000-00007; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; OSBORNE ML, 1995, J CLIN EPIDEMIOL, V48, P1393, DOI 10.1016/0895-4356(95)00065-8; Pattaro C, 2007, J CLIN EPIDEMIOL, V60, P704, DOI 10.1016/j.jclinepi.2006.10.010; Romieu I, 2010, THORAX, V65, P292, DOI 10.1136/thx.2009.116079; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Toren K, 2006, J CLIN EPIDEMIOL, V59, P90, DOI 10.1016/j.jclinepi.2005.03.019; Varraso R, 2009, EUR RESPIR J, V33, P33, DOI 10.1183/09031936.00130807; Varraso R, 2012, EUR RESPIR J, V39, P67, DOI 10.1183/09031936.00115010; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A	19	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65090	10.1371/journal.pone.0065090	http://dx.doi.org/10.1371/journal.pone.0065090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741466	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900179
J	Wang, LJ; Jiang, YZ; Yuan, L; Lu, WX; Yang, L; Karim, A; Luo, KM				Wang, Lijun; Jiang, Yuanzhong; Yuan, Li; Lu, Wanxiang; Yang, Li; Karim, Abdul; Luo, Keming			Isolation and Characterization of cDNAs Encoding Leucoanthocyanidin Reductase and Anthocyanidin Reductase from Populus trichocarpa	PLOS ONE			English	Article							PROANTHOCYANIDIN SYNTHESIS; FLAVONOID BIOSYNTHESIS; TRANSCRIPTION FACTOR; MOLECULAR-CLONING; CONDENSED TANNINS; EXPRESSION; GENE; BIOCHEMISTRY; MODEL; SEED	Proanthocyanidins (PAs) contribute to poplar defense mechanisms against biotic and abiotic stresses. Transcripts of PA biosynthetic genes accumulated rapidly in response to infection by the fungus Marssonina brunnea f.sp. multigermtubi, treatments of salicylic acid (SA) and wounding, resulting in PA accumulation in poplar leaves. Anthocyanidin reductase (ANR) and leucoanthocyanidin reductase (LAR) are two key enzymes of the PA biosynthesis that produce the main subunits: (+)-catechin and (-)-epicatechin required for formation of PA polymers. In Populus, ANR and LAR are encoded by at least two and three highly related genes, respectively. In this study, we isolated and functionally characterized genes PtrANR1 and PtrLAR1 from P. trichocarpa. Phylogenetic analysis shows that Populus ANR1 and LAR1 occurr in two distinct phylogenetic lineages, but both genes have little difference in their tissue distribution, preferentially expressed in roots. Overexpression of PtrANR1 in poplar resulted in a significant increase in PA levels but no impact on catechin levels. Antisense down-regulation of PtrANR1 showed reduced PA accumulation in transgenic lines, but increased levels of anthocyanin content. Ectopic expression of PtrLAR1 in poplar positively regulated the biosynthesis of PAs, whereas the accumulation of anthocyanin and flavonol was significantly reduced (P<0.05) in all transgenic plants compared to the control plants. These results suggest that both PtrANR1 and PtrLAR1 contribute to PA biosynthesis in Populus.	[Wang, Lijun; Jiang, Yuanzhong; Yuan, Li; Yang, Li; Karim, Abdul; Luo, Keming] Southwest Univ, Sch Life Sci, Inst Resources Bot, Minist Educ,Key Lab Ecoenvironm Three Gorges Rese, Chongqing, Peoples R China; [Wang, Lijun; Lu, Wanxiang; Luo, Keming] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Lu, Wanxiang; Luo, Keming] Chinese Acad Sci, NorthWest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China	Southwest University - China; Southwest University - China; Chinese Academy of Sciences	Luo, KM (corresponding author), Southwest Univ, Sch Life Sci, Inst Resources Bot, Minist Educ,Key Lab Ecoenvironm Three Gorges Rese, Chongqing, Peoples R China.	kemingl@swu.edu.cn	wang, lijun/GWZ-6960-2022	wang, lijun/0000-0002-8511-7181	National Natural Science Foundation of China [31171620]; program for New Century Excellent Talents in University [NCET-11-0700]; Research Fund for the Doctoral Program of Higher Education [20110182110004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the National Natural Science Foundation of China (31171620), the program for New Century Excellent Talents in University (NCET-11-0700) and The Research Fund for the Doctoral Program of Higher Education (20110182110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2003, PLANT J, V35, P624, DOI 10.1046/j.1365-313X.2003.01834.x; Aron PM, 2008, MOL NUTR FOOD RES, V52, P79, DOI 10.1002/mnfr.200700137; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Bohm B. A., 1998, INTRO FLAVONOIDS; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Cos P, 2004, CURR MED CHEM, V11, P1345, DOI 10.2174/0929867043365288; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Dixon RA, 1996, GENE, V179, P61, DOI 10.1016/S0378-1119(96)00327-7; Dixon RA, 2005, CURR OPIN PLANT BIOL, V8, P329, DOI 10.1016/j.pbi.2005.03.008; Douglas GB, 1999, NEW ZEAL J AGR RES, V42, P55, DOI 10.1080/00288233.1999.9513353; FEUCHT W, 1990, ANN BOT-LONDON, V65, P225, DOI 10.1093/oxfordjournals.aob.a087928; Feucht W, 2004, PLANT CELL REP, V22, P430, DOI 10.1007/s00299-003-0705-7; Gagne S, 2009, PLANT PHYSIOL BIOCH, V47, P282, DOI 10.1016/j.plaphy.2008.12.004; Han YP, 2012, J EXP BOT, V63, P2437, DOI 10.1093/jxb/err415; Harborne J. B., 1994, FLAVONOIDS ADV RES 1; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Joseph R, 1998, AUST J PLANT PHYSIOL, V25, P271, DOI 10.1071/PP97068; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LARSON P R, 1971, Canadian Journal of Forest Research, V1, P1, DOI 10.1139/x71-001; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li XX, 2010, BIOTECHNOL LETT, V32, P1333, DOI [10.1007/s10529-010-0297-6, 10.1007/s10529-010-0281-1]; Li YG, 1996, J SCI FOOD AGR, V70, P89, DOI 10.1002/(SICI)1097-0010(199601)70:1&lt;89::AID-JSFA470&gt;3.0.CO;2-N; Lloyd G, 1980, P INT PLANT PROP SOC, V30, P421; Luo KM, 2006, PLANT CELL REP, V25, P403, DOI 10.1007/s00299-005-0051-z; Marles MAS, 2003, PHYTOCHEMISTRY, V64, P367, DOI 10.1016/S0031-9422(03)00377-7; McMahon LR, 2000, CAN J PLANT SCI, V80, P469, DOI 10.4141/P99-050; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Paolocci F, 2007, PLANT PHYSIOL, V143, P504, DOI 10.1104/pp.106.090886; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; PORTER L J, 1986, Phytochemistry (Oxford), V25, P223; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Stafford HA, 1990, FLAVONOID METABOLISM, P63; Stevens MT, 2005, OECOLOGIA, V145, P298, DOI 10.1007/s00442-005-0128-y; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Yuan L, 2012, J EXP BOT, V63, P2513, DOI 10.1093/jxb/err425	45	16	21	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64664	10.1371/journal.pone.0064664	http://dx.doi.org/10.1371/journal.pone.0064664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741362	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900075
J	Zhang, YG; Jin, ML; Li, L; Zhao, HY; Zeng, X; Jiang, L; Wei, P; Diao, XL; Li, X; Cao, Q; Tian, XX				Zhang, Yun-Gang; Jin, Mu-Lan; Li, Li; Zhao, Hong-Ying; Zeng, Xuan; Jiang, Lei; Wei, Ping; Diao, Xiao-Li; Li, Xue; Cao, Qing; Tian, Xin-Xia			Evaluation of ALK Rearrangement in Chinese Non-Small Cell Lung Cancer Using FISH, Immunohistochemistry, and Real-Time Quantitative RT- PCR on Paraffin-Embedded Tissues	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; EML4-ALK FUSION GENE; IDENTIFICATION; FEATURES	Patients with ALK gene rearrangements often manifest dramatic responses to crizotinib, an ALK inhibitor. Accurate identification of patients with ALK-positive non-small cell lung cancer (NSCLC) is essential for the clinical application of ALK-targeted therapy. However, assessing EML4-ALK rearrangement in NSCLC remains challenging in routine pathology practice. The aim of this study was to compare the diagnostic accuracy of FISH, immunohistochemistry (IHC), and real-time quantitative RT-PCR (QPCR) methodologies for detection of EML4-ALK rearrangement in NSCLC and to appraise immunohistochemistry as a pre-screening tool. In this study, a total of 473 paraffin-embedded NSCLC samples from surgical resections and biopsies were analyzed by IHC with ALK antibody. ALK rearrangement was further confirmed by FISH and QPCR. ALK protein expression was detected in twenty patients (20/473, 4.2%). Of the 20 ALK-positive cases by IHC, 15 cases were further confirmed as ALK rearrangement by FISH, and 5 cases were not interpretable. Also, we evaluated 13 out of the 20 IHC-positive tissues by QPCR in additional to FISH, and found that 9 cases were positive and 2 cases were equivocal, whereas 2 cases were negative although they were positive by both IHC and FISH. The ALK status was concordant in 5 out of 8 cases that were interpretable by three methods. Additionally, none of the 110 IHC-negative cases with adenocarcinoma histology showed ALK rearrangements by FISH. Histologically, almost all the ALK-rearranged cases were adenocarcinoma, except that one case was sarcomatoid carcinoma. A solid signet-ring cell pattern or mucinous cribriform pattern was presented at least focally in all ALK-positive tumors. In conclusion, our findings suggested that ALK rearrangement was associated with ALK protein expression. The conventional IHC assay is a valuable tool for the pre-screening of patients with ALK rearrangement in clinical practice and a combination of FISH and QPCR is required for further confirmation.	[Zhang, Yun-Gang; Jin, Mu-Lan; Li, Li; Zhao, Hong-Ying; Jiang, Lei; Wei, Ping; Diao, Xiao-Li; Li, Xue; Cao, Qing] Capital Med Univ, Beijing Chao Yang Hosp, Dept Pathol, Beijing, Peoples R China; [Zeng, Xuan] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100021, Peoples R China; [Zeng, Xuan] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Tian, Xin-Xia] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100871, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking University	Jin, ML (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Pathol, Beijing, Peoples R China.	kinmokuran@163.com			National Natural Science Foundation of China [81050015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NO. 81050015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; GIUSEPPE G, 2002, LUNG CANCER, V38, pS292; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Salido M, 2011, J THORAC ONCOL, V6, P21, DOI 10.1097/JTO.0b013e3181fb7cd6; Shaw AT, 2011, J NATL COMPR CANC NE, V9, P1335, DOI 10.6004/jnccn.2011.0115; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon B, 2009, J THORAC ONCOL, V4, P1450, DOI 10.1097/JTO.0b013e3181c4dedb; Subramanian J, 2010, J THORAC ONCOL, V5, P23, DOI 10.1097/JTO.0b013e3181c41e8d; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9	23	33	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64821	10.1371/journal.pone.0064821	http://dx.doi.org/10.1371/journal.pone.0064821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741400	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900113
J	Karen, T; Schlager, GW; Bendix, I; Sifringer, M; Herrmann, R; Pantazis, C; Enot, D; Keller, M; Kerner, T; Felderhoff-Mueser, U				Karen, Tanja; Schlager, Gerald W.; Bendix, Ivo; Sifringer, Marco; Herrmann, Ralf; Pantazis, Christos; Enot, David; Keller, Matthias; Kerner, Thoralf; Felderhoff-Mueser, Ursula			Effect of Propofol in the Immature Rat Brain on Short- and Long-Term Neurodevelopmental Outcome	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; INTENSIVE-CARE UNITS; CELL-DEATH; OBJECT RECOGNITION; ANESTHETIC AGENTS; NEUROCOGNITIVE FUNCTION; NEURODEGENERATION; RECEPTORS; INJURY; NEUROAPOPTOSIS	Background: Propofol is commonly used as sedative in newborns and children. Recent experimental studies led to contradictory results, revealing neurodegenerative or neuroprotective properties of propofol on the developing brain. We investigated neurodevelopmental short- and long-term effects of neonatal propofol treatment. Methods: 6-day-old Wistar rats (P6), randomised in two groups, received repeated intraperitoneal injections (0, 90, 180 min) of 30 mg/kg propofol or normal saline and sacrificed 6, 12 and 24 hrs following the first injection. Cortical and thalamic areas were analysed by Western blot and quantitative real-time PCR (qRT-PCR) for expression of apoptotic and neurotrophin-dependent signalling pathways. Long-term effects were assessed by Open-field and Novel-Object-Recognition at P30 and P120. Results: Western blot analyses revealed a transient increase of activated caspase-3 in cortical, and a reduction of active mitogen-activated protein kinases (ERK1/2, AKT) in cortical and thalamic areas. qRT-PCR analyses showed a down-regulation of neurotrophic factors (BDNF, NGF, NT-3) in cortical and thalamic regions. Minor impairment in locomotive activity was observed in propofol treated adolescent animals at P30. Memory or anxiety were not impaired at any time point. Conclusion: Exposing the neonatal rat brain to propofol induces acute neurotrophic imbalance and neuroapoptosis in a region- and time-specific manner and minor behavioural changes in adolescent animals.	[Karen, Tanja; Schlager, Gerald W.; Bendix, Ivo; Herrmann, Ralf; Pantazis, Christos; Enot, David; Keller, Matthias; Felderhoff-Mueser, Ursula] Univ Duisburg Essen, Dept Paediat 1, Univ Hosp Essen, Essen, Germany; [Sifringer, Marco] Charite, Dept Anaesthesiol & Intens Care Med Berlin, D-13353 Berlin, Germany; [Kerner, Thoralf] Asklepios Klin Harburg, Dept Anaesthesiol & Intens Care Med, Hamburg, Germany	University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Karen, T (corresponding author), Univ Duisburg Essen, Dept Paediat 1, Univ Hosp Essen, Essen, Germany.	tanja.karen@uk-essen.de	Felderhoff-Müser, Ursula/AAU-9682-2020	Bendix, Ivo/0000-0002-9751-3640	German Research Council [DFG KE 1159/2-1]	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council: DFG KE 1159/2-1. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegaert K, 2007, BRIT J ANAESTH, V99, P864, DOI 10.1093/bja/aem294; Anand KJS, 2007, PEDIATR RES, V62, P283, DOI 10.1203/PDR.0b013e3180986d2f; Anand KJS, 1999, PHYSIOL BEHAV, V66, P627, DOI 10.1016/S0031-9384(98)00338-2; Anand KJS, 2004, ANESTHESIOLOGY, V101, P527, DOI 10.1097/00000542-200408000-00033; Bercker S, 2009, NEUROTOX RES, V16, P140, DOI 10.1007/s12640-009-9063-8; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Cai JS, 2011, NEUROCHEM RES, V36, P1724, DOI 10.1007/s11064-011-0487-1; Carbajal R, 2008, JAMA-J AM MED ASSOC, V300, P60, DOI 10.1001/jama.300.1.60; Cattano D, 2008, ANESTH ANALG, V106, P1712, DOI 10.1213/ane.0b013e318172ba0a; Cheung ECC, 2005, J NEUROSCI, V25, P1324, DOI 10.1523/JNEUROSCI.4261-04.2005; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dumont C, 2000, BLOOD, V96, P1030, DOI 10.1182/blood.V96.3.1030.015k21_1030_1038; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; Ennaceur A, 2005, BEHAV BRAIN RES, V159, P247, DOI 10.1016/j.bbr.2004.11.006; Felderhoff-Mueser U, 2004, NEUROBIOL DIS, V17, P273, DOI 10.1016/j.nbd.2004.07.019; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Fredriksson A, 2004, BEHAV BRAIN RES, V153, P367, DOI 10.1016/j.bbr.2003.12.026; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Gelb AW, 2002, ANESTHESIOLOGY, V96, P1183, DOI 10.1097/00000542-200205000-00023; Gerstner B, 2007, ANN NEUROL, V61, P562, DOI 10.1002/ana.21118; Grunau RE, 2009, PAIN, V143, P138, DOI 10.1016/j.pain.2009.02.014; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Henschel O, 2008, CNS NEUROL DISORD-DR, V7, P211, DOI 10.2174/187152708784083812; HOLM S, 1979, SCAND J STAT, V6, P65; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Johnston CC, 1997, CLIN J PAIN, V13, P308, DOI 10.1097/00002508-199712000-00008; Kornblum HI, 1997, MOL BRAIN RES, V44, P219, DOI 10.1016/S0169-328X(96)00224-0; Kozinn J, 2006, ANESTHESIOLOGY, V105, P1182, DOI 10.1097/00000542-200612000-00018; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loepke AW, 2008, ANESTH ANALG, V106, P1681, DOI 10.1213/ane.0b013e318167ad77; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Mammen A, 2011, NEUROCHEM RES, V36, P746, DOI 10.1007/s11064-010-0394-x; Milanovic D, 2010, DEV NEUROSCI-BASEL, V32, P288, DOI 10.1159/000316970; Motsch J, 2004, ANAESTHESIST, V53, P1009, DOI 10.1007/s00101-004-0756-3; Olney JW, 2000, ENVIRON HEALTH PERSP, V108, P383, DOI 10.2307/3454524; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Pesic V, 2009, INT J DEV NEUROSCI, V27, P279, DOI 10.1016/j.ijdevneu.2008.12.005; R Development Core Team, 2005, R LANG ENV STAT COMP; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; Schlager GW, 2011, EXP NEUROL, V230, P67, DOI 10.1016/j.expneurol.2010.11.021; Shah PS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007248.pub2; Sitar SM, 1999, ANESTHESIOLOGY, V90, P1446, DOI 10.1097/00000542-199905000-00030; Straiko MMW, 2009, ANESTHESIOLOGY, V110, P862, DOI 10.1097/ALN.0b013e31819b5eab; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Sutcliffe JS, 2007, BEHAV BRAIN RES, V177, P117, DOI 10.1016/j.bbr.2006.10.029; Tu SF, 2011, BRAIN RES BULL, V86, P29, DOI 10.1016/j.brainresbull.2011.06.017; Vutskits L, 2005, ANESTHESIOLOGY, V102, P970, DOI 10.1097/00000542-200505000-00016; Vutskits L, 2012, PEDIATR ANESTH, V22, P973, DOI 10.1111/pan.12015; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Ward CG, 2012, PHARMACOL RES, V65, P271, DOI 10.1016/j.phrs.2011.10.001; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Young Y, 1997, EUR J ANAESTH, V14, P320, DOI 10.1046/j.1365-2346.1997.00130.x; Zacharias R, 2010, BRAIN RES, V1343, P14, DOI 10.1016/j.brainres.2010.04.081; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x; Zuur AF, 2009, STAT BIOL HLTH, P269	67	43	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64480	10.1371/journal.pone.0064480	http://dx.doi.org/10.1371/journal.pone.0064480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737984	gold, Green Published, Green Submitted			2022-12-27	WOS:000321394700049
J	Srivastava, SK; Ruigrok, VJB; Thompson, NJ; Trilling, AK; Heck, AJR; van Rijn, C; Beekwilder, J; Jongsma, MA				Srivastava, Saurabh K.; Ruigrok, Vincent J. B.; Thompson, Natalie J.; Trilling, Anke K.; Heck, Albert J. R.; van Rijn, Cees; Beekwilder, Jules; Jongsma, Maarten A.			16 kDa Heat Shock Protein from Heat-Inactivated Mycobacterium tuberculosis Is a Homodimer - Suitability for Diagnostic Applications with Specific Llama VHH Monoclonals	PLOS ONE			English	Article							HIV-ASSOCIATED TUBERCULOSIS; IMMUNOLOGICAL DIAGNOSIS; MASS-SPECTROMETRY; ANTIGEN; RESPONSES; EPITOPES	Background: The 16 kDa heat shock protein (HSP) is an immuno-dominant antigen, used in diagnosis of infectious Mycobacterium tuberculosis (M.tb.) causing tuberculosis (TB). Its use in serum-based diagnostics is limited, but for the direct identification of M.tb. bacteria in sputum or cultures it may represent a useful tool. Recently, a broad set of twelve 16 kDa specific heavy chain llama antibodies (VHH) has been isolated, and their utility for diagnostic applications was explored. Methodology/Principal Findings: To identify the epitopes recognized by the nine (randomly selected from a set of twelve 16 kDa specific VHH antibodies) distinct VHH antibodies, 14 overlapping linear epitopes (each 20 amino acid long) were characterized using direct and sandwich ELISA techniques. Seven out of 14 epitopes were recognized by 8 out of 9 VHH antibodies. The two highest affinity binders B-F10 and A-23 were found to bind distinct epitopes. Sandwich ELISA and SPR experiments showed that only B-F10 was suitable as secondary antibody with both B-F10 and A-23 as anchoring antibodies. To explain this behavior, the epitopes were matched to the putative 3D structure model. Electrospray ionization time-of-flight mass spectrometry and size exclusion chromatography were used to determine the higher order conformation. A homodimer model best explained the differential immunological reactivity of A-23 and B-F10 against heat-treated M.tb. lysates. Conclusions/Significance: The concentrations of secreted antigens of M.tb. in sputum are too low for immunological detection and existing kits are only used for identifying M.tb. in cultures. Here we describe how specific combinations of VHH domains could be used to detect the intracellular HSP antigen. Linked to methods of pre-concentrating M.tb. cells prior to lysis, HSP detection may enable the development of protein-based diagnostics of sputum samples and earlier diagnosis of diseases.	[Srivastava, Saurabh K.; Trilling, Anke K.; Beekwilder, Jules; Jongsma, Maarten A.] Plant Res Int, Wageningen, Netherlands; [Srivastava, Saurabh K.; Trilling, Anke K.; van Rijn, Cees] Univ Wageningen & Res Ctr, Organ Chem Lab, Wageningen, Netherlands; [Ruigrok, Vincent J. B.] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands; [Thompson, Natalie J.; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Thompson, Natalie J.; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Phamaceut Sci, Utrecht, Netherlands; [Thompson, Natalie J.; Heck, Albert J. R.] Netherlands Prote Ctr, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Utrecht University; Utrecht University	Jongsma, MA (corresponding author), Plant Res Int, Wageningen, Netherlands.	maarten.jongsma@wur.nl	Beekwilder, Jules/A-6802-2011; Jongsma, Maarten A/A-2118-2010; Heck, Albert/D-7098-2011; Schütz-Trilling, Anke/GWV-0828-2022; Van Rijn, Cees J.M./A-3869-2012	Beekwilder, Jules/0000-0003-3238-4427; Jongsma, Maarten A/0000-0001-5799-2301; Heck, Albert/0000-0002-2405-4404; Van Rijn, Cees J.M./0000-0001-8380-3834; Srivastava, Saurabh Kumar/0000-0003-2305-5525	Dutch Technology Foundation STW under the STW Project [10055]; Graduate school VLAG	Dutch Technology Foundation STW under the STW Project; Graduate school VLAG	The authors would like to thank the Dutch Technology Foundation STW for financial support under the STW Project 10055 and Graduate school VLAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/282574; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Chan ED, 2000, TUBERCLE LUNG DIS, V80, P131, DOI 10.1054/tuld.2000.0243; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; Devi KRU, 2002, PROTEIN EXPRES PURIF, V24, P188, DOI 10.1006/prep.2001.1569; Doebler RW, 2009, JALA-J LAB AUTOM, V14, P119, DOI 10.1016/j.jala.2009.02.010; FRISCIA G, 1995, CLIN EXP IMMUNOL, V102, P53; Gennaro ML, 2000, CLIN INFECT DIS, V30, pS243, DOI 10.1086/313868; Grabau JC, 1995, PUBLIC HEALTH REP, V110, P703; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Landowski CP, 2001, J CLIN MICROBIOL, V39, P2418, DOI 10.1128/JCM.39.7.2418-2424.2001; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; LI YT, 1993, J AM CHEM SOC, V115, P8409, DOI 10.1021/ja00071a058; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Ormerod LP, 2005, BRIT MED BULL, V73-74, P17, DOI 10.1093/bmb/ldh047; Pazehoski KO, 2008, J INORG BIOCHEM, V102, P522, DOI 10.1016/j.jinorgbio.2007.10.027; Pottumarthy S, 2000, J CLIN MICROBIOL, V38, P2227; Pottumarthy S, 1999, J CLIN MICROBIOL, V37, P3229, DOI 10.1128/JCM.37.10.3229-3232.1999; Raja A, 2002, CLIN DIAGN LAB IMMUN, V9, P308, DOI 10.1128/CDLI.9.2.308-312.2002; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Strokappe N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033298; Swaminathan S, 2010, CLIN INFECT DIS, V50, P1377, DOI 10.1086/652147; Toussaint C H, 1944, Postgrad Med J, V20, P143; Trilling AK, 2012, BIOSENS BIOELECTRON; Trilling AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026754; Tsara V, 2009, HIPPOKRATIA, V13, P20; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; VERBON A, 1992, CLIN EXP IMMUNOL, V89, P395; VORDERMEIER HM, 1991, J IMMUNOL, V147, P1023; Watterson SA, 2000, J CLIN PATHOL, V53, P727, DOI 10.1136/jcp.53.10.727; Wilson S, 2010, INT J TUBERC LUNG D, V14, P1164; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	36	8	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64040	10.1371/journal.pone.0064040	http://dx.doi.org/10.1371/journal.pone.0064040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737964	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700028
J	Webster, GD; Agdas, D; Masters, FJ; Cook, CL; Gesselman, AN				Webster, Gregory D.; Agdas, Duzgun; Masters, Forrest J.; Cook, Corey L.; Gesselman, Amanda N.			Prior Storm Experience Moderates Water Surge Perception and Risk	PLOS ONE			English	Article							MEDIATION; FRAMEWORK; FLOODS	Background: How accurately do people perceive extreme water speeds and how does their perception affect perceived risk? Prior research has focused on the characteristics of moving water that can reduce human stability or balance. The current research presents the first experiment on people's perceptions of risk and moving water at different speeds and depths. Methods: Using a randomized within-person 2 (water depth: 0.45, 0.90 m) x3 (water speed: 0.4, 0.8, 1.2 m/s) experiment, we immersed 76 people in moving water and asked them to estimate water speed and the risk they felt. Results: Multilevel modeling showed that people increasingly overestimated water speeds as actual water speeds increased or as water depth increased. Water speed perceptions mediated the direct positive relationship between actual water speeds and perceptions of risk; the faster the moving water, the greater the perceived risk. Participants' prior experience with rip currents and tropical cyclones moderated the strength of the actual-perceived water speed relationship; consequently, mediation was stronger for people who had experienced no rip currents or fewer storms. Conclusions: These findings provide a clearer understanding of water speed and risk perception, which may help communicate the risks associated with anticipated floods and tropical cyclones.	[Webster, Gregory D.; Gesselman, Amanda N.] Univ Florida, Dept Psychol, Coll Liberal Arts & Sci, Gainesville, FL 32611 USA; [Agdas, Duzgun; Masters, Forrest J.] Univ Florida, Coll Engn, Engn Sch Sustainable Infrastruct & Environm, Gainesville, FL 32611 USA; [Cook, Corey L.] Skidmore Coll, Dept Psychol, Saratoga Springs, NY USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Skidmore College	Webster, GD (corresponding author), Univ Florida, Dept Psychol, Coll Liberal Arts & Sci, Gainesville, FL 32611 USA.	gdwebs@gmail.com	Masters, Forrest James/AAS-8723-2021; Agdas, Duzgun/E-2209-2014; Cook, Corey/J-7685-2019; Masters, Forrest J/D-1287-2011	Masters, Forrest James/0000-0001-8203-9846; Agdas, Duzgun/0000-0002-3703-914X; Masters, Forrest J/0000-0001-8203-9846	Federal Alliance for Safe Homes (FLASH); University of Florida Open-Access Publishing Fund	Federal Alliance for Safe Homes (FLASH); University of Florida Open-Access Publishing Fund	The authors thank the Federal Alliance for Safe Homes (FLASH; http://www.flash.org) for supporting the research. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABT SR, 1989, WATER RESOUR BULL, V25, P881; Agdas D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049944; Aiken L. S., 1991, MULTIPLE REGRESSION; Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142; CNN [Cable News Network], 2005, FEMA CHIEF VICT BEAR; Crysel LC, 2013, PERS INDIV DIFFER, V54, P35, DOI 10.1016/j.paid.2012.07.029; Jonkman SN, 2008, J AM WATER RESOUR AS, V44, P1208, DOI 10.1111/j.1752-1688.2008.00217.x; Karvonen R.A., 2000, USE PHYS MODELS DAM; Muller D, 2005, J PERS SOC PSYCHOL, V89, P852, DOI 10.1037/0022-3514.89.6.852; Muthen L.K., 2010, MPLUS USERS GUIDE; NOAA [National Oceanic and Atmospheric Administration], NWS NAT WEATH SERV F; Penning-Rowsell E, 2005, NAT HAZARDS, V36, P43, DOI 10.1007/s11069-004-4538-7; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Raudenbush SW, 2004, SSI; Shao WY, 2010, J ZHEJIANG UNIV-SC A, V11, P668, DOI 10.1631/jzus.A1000137; Sommer A., 1972, LANCET, V299, P1030, DOI [10.1016/S0140-6736(72)91218-4, DOI 10.1016/S0140-6736(72)91218-4]; Webster GD, 2012, J RES PERS, V46, P591, DOI 10.1016/j.jrp.2012.07.001; Zhai GF, 2006, J AM WATER RESOUR AS, V42, P863, DOI 10.1111/j.1752-1688.2006.tb04500.x	18	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e62477	10.1371/journal.pone.0062477	http://dx.doi.org/10.1371/journal.pone.0062477			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177SC	23737941	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700005
J	Toniolo, A; Warden, EA; Nassi, A; Cignarella, A; Bolego, C				Toniolo, Alice; Warden, Erica Alessia; Nassi, Alberto; Cignarella, Andrea; Bolego, Chiara			Regulation of SIRT1 in Vascular Smooth Muscle Cells from Streptozotocin-Diabetic Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; OXIDATIVE STRESS; DEACETYLASE; MICE; AMPK; OVEREXPRESSION; PERSPECTIVES; MACROPHAGES; MECHANISMS; EXPRESSION	Sirtuins enzymes are a conserved family of nicotinamide adenine dinucleotide (NAD)-dependent deacetylases and ADP-ribosyltransferases that mediate responses to oxidative stress, fasting and dietary restriction in mammals. Vascular smooth muscle cells (VSMCs) are involved in many mechanisms that regulate vascular biology in vivo but the role of SIRT1 has not been explored in much detail. Therefore, we investigated the regulation of SIRT1 in cultured VSMCs under various stress conditions including diabetes. Sprague-Dawley rats were made diabetic by injecting a single dose of streptozotocin (65 mg/Kg), and aortic VSMCs were isolated after 4 weeks. Immunocytochemistry showed that SIRT1 was localized predominantly in the nucleus, with lower staining in VSMCs from STZ-diabetic as compared with normoglycemic rats. Previous diabetes induction in vivo and high glucose concentrations in vitro significantly downregulated SIRT1 amounts as detected in Western blot assays, whereas TNF-alpha (30 ng/ml) stimulation failed to induce significant changes. Because estrogen signaling affects several pathways of oxidative stress control, we also investigated SIRT1 modulation by 17 beta-estradiol. Treatment with the hormone (10 nM) or a selective estrogen receptor-alpha agonist decreased SIRT1 levels in VSMCs from normoglycemic but not in those from STZ-diabetic animals. 17 beta-estradiol treatment also enhanced activation of AMP-dependent kinase, which partners with SIRT1 in a signaling axis. SIRT1 downregulation by 17 beta-estradiol could be observed as well in human peripheral blood mononuclear cells, a cell type in which SIRT1 downregulation is associated with insulin resistance and subclinical atherosclerosis. These data suggest that SIRT1 protein levels are regulated by diverse cellular stressors to a variable extent in VSMCs from diabetic and normoglycemic rats, warranting further investigation on SIRT1 as a modulator of VSMC activity in settings of vascular inflammation.	[Toniolo, Alice; Warden, Erica Alessia; Nassi, Alberto; Cignarella, Andrea; Bolego, Chiara] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy	University of Padua	Cignarella, A (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	andrea.cignarella@unipd.it		Cignarella, Andrea/0000-0002-4820-4876	University of Padova [60A04-9531/10, 60A04-5504/11]	University of Padova	This study was supported by the University of Padova (grants 60A04-9531/10 and 60A04-5504/11 to AC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Fernandes CA, 2012, BIOCHEM BIOPH RES CO, V420, P857, DOI 10.1016/j.bbrc.2012.03.088; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Gurd BJ, 2009, J PHYSIOL-LONDON, V587, P1817, DOI 10.1113/jphysiol.2008.168096; Idel S, 2002, J BIOL CHEM, V277, P49319, DOI 10.1074/jbc.M204639200; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lempiainen J, 2012, BRIT J PHARMACOL, V166, P1905, DOI 10.1111/j.1476-5381.2012.01895.x; Li L, 2011, CIRC RES, V108, P1180, DOI 10.1161/CIRCRESAHA.110.237875; Maggi A, 2003, CIRCULATION, V108, P211, DOI 10.1161/01.CIR.0000079311.39939.94; Miyazaki R, 2008, ARTERIOSCL THROM VAS, V28, P1263, DOI 10.1161/ATVBAHA.108.166991; Moore RL, 2012, J ENDOCRINOL, V213, P37, DOI 10.1530/JOE-11-0217; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Ortmann J, 2011, J CLIN ENDOCR METAB, V96, P220, DOI 10.1210/jc.2010-0943; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Sastre-Serra J, 2013, FREE RADIC BIOL MED, DOI DOI 10.1016/J; Schulz E, 2005, CIRCULATION, V111, P3473, DOI 10.1161/CIRCULATIONAHA.105.546812; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Tajbakhsh N, 2012, MICROCIRCULATION, V19, P336, DOI 10.1111/j.1549-8719.2012.00167.x; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Wei Michael, 2003, Heart Lung Circ, V12, P44, DOI 10.1046/j.1444-2892.2003.00160.x; Wu AG, 2006, EUR J NEUROSCI, V23, P2573, DOI 10.1111/j.1460-9568.2006.04807.x; Yao HW, 2012, BIOCHEM PHARMACOL, V84, P1332, DOI 10.1016/j.bcp.2012.06.031; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zancan V, 1999, ENDOCRINOLOGY, V140, P2004, DOI 10.1210/en.140.5.2004; Zhang HN, 2010, BIOCHEM BIOPH RES CO, V397, P569, DOI 10.1016/j.bbrc.2010.05.160	36	16	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65666	10.1371/journal.pone.0065666	http://dx.doi.org/10.1371/journal.pone.0065666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734259	Green Published, gold, Green Submitted			2022-12-27	WOS:000319725500007
J	Cui, LL; Murikinati, SR; Wang, DL; Zhang, XJ; Duan, WM; Zhao, LR				Cui, Lili; Murikinati, Sasidhar R.; Wang, Dongliang; Zhang, Xiangjian; Duan, Wei-Ming; Zhao, Li-Ru			Reestablishing Neuronal Networks in the Aged Brain by Stem Cell Factor and Granulocyte-Colony Stimulating Factor in a Mouse Model of Chronic Stroke	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; LONG-TERM POTENTIATION; IN-VIVO; MATURE RAT; PERIINFARCT CORTEX; CA1 DENDRITES; PLASTICITY; MICE; DISEASE; SYNAPSE	Stroke has a high incidence in the elderly. Stroke enters the chronic phase 3 months after initial stroke onset. Currently, there is no pharmaceutical treatment available for chronic stroke. We have demonstrated the therapeutic effects of the combination of stem cell factor (SCF) and granulocyte-colony stimulating factor (G-CSF) (SCF+G-CSF) on chronic stroke. However, it remains unclear how SCF+G-CSF repairs the brain in chronic stroke. In this study, we determined the effects of SCF+G-CSF on neuronal network remodeling in the aged brain of chronic stroke. Cortical brain ischemia was produced in 16-18 month-old transgenic mice expressing yellow fluorescent protein in layer V pyramidal neurons. SCF+G-CSF was subcutaneously injected for 7 days beginning at 3.5 months post-ischemia. Using both live brain imaging and immunohistochemistry, we observed that SCF+G-CSF increased the mushroom-type spines on the apical dendrites of layer V pyramidal neurons adjacent to the infarct cavities 2 and 6 weeks after treatment. SCF+G-CSF also augmented dendritic branches and post-synaptic density protein 95 puncta in the peri-infarct cortex 6 weeks after treatment. These data suggest that SCF+G-CSF treatment in chronic stroke remodels neural circuits in the aged brain. This study provides evidence to support the development of a new therapeutic strategy for chronic stroke.	[Cui, Lili; Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA; [Murikinati, Sasidhar R.; Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA; [Duan, Wei-Ming; Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Wang, Dongliang] SUNY Upstate Med Univ, Dept Publ Hlth & Prevent Med, Syracuse, NY 13210 USA; [Cui, Lili; Zhang, Xiangjian] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei, Peoples R China; [Duan, Wei-Ming] Capital Med Univ, Dept Anat, Beijing, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Hebei Medical University; Capital Medical University	Zhao, LR (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA.	ZHAOL@upstate.edu	Wang, Dongliang/A-1395-2014	Wang, Dongliang/0000-0003-4713-3516; Zhang, Xiangjian/0000-0003-0114-1668	National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) in the USA [R01 NS060911]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060911] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) in the USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) in the USA, R01 NS060911 to L.R.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2007, HIPPOCAMPUS, V17, P1, DOI 10.1002/hipo.20238; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Brown CE, 2010, J CEREBR BLOOD F MET, V30, P783, DOI 10.1038/jcbfm.2009.241; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARA H, 1993, BRAIN RES, V618, P251, DOI 10.1016/0006-8993(93)91273-U; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HIRATA T, 1993, DEVELOPMENT, V119, P49; Katafuchi T, 2000, LEARN MEMORY, V7, P383, DOI 10.1101/lm.33900; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MCNIECE IK, 1995, J LEUKOCYTE BIOL, V58, P14, DOI 10.1002/jlb.58.1.14; Mostany R, 2011, J NEUROSCI, V31, P1734, DOI 10.1523/JNEUROSCI.4386-10.2011; Mostany R, 2010, J NEUROSCI, V30, P14116, DOI 10.1523/JNEUROSCI.3908-10.2010; Motro B, 1996, P NATL ACAD SCI USA, V93, P1808, DOI 10.1073/pnas.93.5.1808; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Parsons MW, 2000, NEUROLOGY, V55, P498, DOI 10.1212/WNL.55.4.498; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Sigler A, 2010, STROKE, V41, pS117, DOI 10.1161/STROKEAHA.110.594648; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Tackenberg C, 2009, J NEUROSCI, V29, P14439, DOI 10.1523/JNEUROSCI.3590-09.2009; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Zhao LR, 2007, STROKE, V38, P2804, DOI 10.1161/STROKEAHA.107.486217; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	40	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64684	10.1371/journal.pone.0064684	http://dx.doi.org/10.1371/journal.pone.0064684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750212	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900014
J	Li, P; Grgurevic, S; Liu, ZM; Harris, D; Rozovski, U; Calin, GA; Keating, MJ; Estrov, Z				Li, Ping; Grgurevic, Srdana; Liu, Zhiming; Harris, David; Rozovski, Uri; Calin, George A.; Keating, Michael J.; Estrov, Zeev			Signal Transducer and Activator of Transcription-3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							B-CELL LYMPHOMAS; STAT3; MIR-155; RESISTANCE; RESIDUES; SURVIVAL; REVEALS; PATHWAY; HODGKIN; CANCER	MicroRNA (miR) abnormalities play a key role in the pathogenesis of chronic lymphocytic leukemia (CLL). High levels of miR-155 have been detected in human neoplasms, and overexpression of miR-155 has been found to induce lymphoma in mice. High levels of miR-155 were detected in CLL cells and STAT3, which is known to induce miR-21 and miR-181b-1 expression, is constitutively activated in CLL. Given these findings, we hypothesized that STAT3 induces miR-155. Sequence analysis revealed that the miR-155 promoter harbors two putative STAT3 binding sites. Therefore, truncated miR-155 promoter constructs and STAT3 small interfering RNA (siRNA) were co-transfected into MM1 cells. Of the two putative binding sites, STAT3-siRNA reduced the luciferase activity of the construct containing the 700-709 bp STAT3 binding site, suggesting that this site is involved in STAT3-induced transcription. Electrophoretic mobility shift assay confirmed that STAT3 bound to the miR-155 promoter in CLL cells, and chromatin immunoprecipitation and luciferase assay confirmed that STAT3 bound to the 700-709 bp but not the 615-624 bp putative STAT3 binding site in CLL cells. Finally, STAT3-small hairpin RNA downregulated miR-155 gene expression, suggesting that constitutively activated STAT3 binds to the miR-155 gene promoter. Together, these results suggest that STAT3 activates miR-155 in CLL cells.	[Li, Ping; Grgurevic, Srdana; Liu, Zhiming; Harris, David; Rozovski, Uri; Keating, Michael J.; Estrov, Zeev] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Estrov, Z (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	zestrov@mdanderson.org	Calin, George/E-9390-2011	Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615	CLL Global Research Foundation; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	CLL Global Research Foundation; National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the CLL Global Research Foundation and the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazargan A, 2012, EXPERT REV ANTICANC, V12, P393, DOI [10.1586/era.12.2, 10.1586/ERA.12.2]; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Calin GA, 2009, BLOOD, V114, P4761, DOI 10.1182/blood-2009-07-192740; Calin GA, 2009, BLOOD, V113, P3652, DOI 10.1182/blood-2008-11-189795; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Huang X, 2012, AM J PATHOL, V181, P26, DOI 10.1016/j.ajpath.2012.03.013; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kutty RK, 2010, BIOCHEM BIOPH RES CO, V402, P390, DOI 10.1016/j.bbrc.2010.10.042; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Leng RX, 2011, RHEUMATOL INT, V31, P699, DOI 10.1007/s00296-010-1466-6; Li P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011859; Li SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016956; Liu ZM, 2011, MOL CANCER RES, V9, P507, DOI 10.1158/1541-7786.MCR-10-0559; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tam CS, 2010, NAT REV CLIN ONCOL, V7, P521, DOI 10.1038/nrclinonc.2010.101; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Wickremasinghe RG, 2001, BRIT J HAEMATOL, V114, P608, DOI 10.1046/j.1365-2141.2001.02978.x	34	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64678	10.1371/journal.pone.0064678	http://dx.doi.org/10.1371/journal.pone.0064678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750211	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900013
J	Panagopoulos, DJ; Johansson, O; Carlo, GL				Panagopoulos, Dimitris J.; Johansson, Olle; Carlo, George L.			Evaluation of Specific Absorption Rate as a Dosimetric Quantity for Electromagnetic Fields Bioeffects	PLOS ONE			English	Article							DIELECTRIC-PROPERTIES; IN-VITRO; CELL-PROLIFERATION; MICROWAVE EXPOSURE; BIOLOGICAL TISSUES; ELECTRIC-FIELDS; CEREBRAL TISSUE; STRAND BREAKS; BRAIN-TUMORS; RADIATION	Purpose: To evaluate SAR as a dosimetric quantity for EMF bioeffects, and identify ways for increasing the precision in EMF dosimetry and bioactivity assessment. Methods: We discuss the interaction of man-made electromagnetic waves with biological matter and calculate the energy transferred to a single free ion within a cell. We analyze the physics and biology of SAR and evaluate the methods of its estimation. We discuss the experimentally observed non-linearity between electromagnetic exposure and biological effect. Results: We find that: a) The energy absorbed by living matter during exposure to environmentally accounted EMFs is normally well below the thermal level. b) All existing methods for SAR estimation, especially those based upon tissue conductivity and internal electric field, have serious deficiencies. c) The only method to estimate SAR without large error is by measuring temperature increases within biological tissue, which normally are negligible for environmental EMF intensities, and thus cannot be measured. Conclusions: SAR actually refers to thermal effects, while the vast majority of the recorded biological effects from man-made non-ionizing environmental radiation are non-thermal. Even if SAR could be accurately estimated for a whole tissue, organ, or body, the biological/health effect is determined by tiny amounts of energy/power absorbed by specific biomolecules, which cannot be calculated. Moreover, it depends upon field parameters not taken into account in SAR calculation. Thus, SAR should not be used as the primary dosimetric quantity, but used only as a complementary measure, always reporting the estimating method and the corresponding error. Radiation/field intensity along with additional physical parameters (such as frequency, modulation etc) which can be directly and in any case more accurately measured on the surface of biological tissues, should constitute the primary measure for EMF exposures, in spite of similar uncertainty to predict the biological effect due to non-linearity.	[Panagopoulos, Dimitris J.] Univ Athens, Dept Biol, GR-15701 Athens, Greece; [Panagopoulos, Dimitris J.] Radiat & Environm Biophys Res Ctr, Athens, Greece; [Johansson, Olle] Karolinska Inst, Dept Neurosci, Expt Dermatol Unit, Stockholm, Sweden; [Carlo, George L.] Inst Healthful Adaptat, Sci & Publ Policy Inst, Washington, DC USA	National & Kapodistrian University of Athens; Karolinska Institutet	Panagopoulos, DJ (corresponding author), Univ Athens, Dept Biol, GR-15701 Athens, Greece.	dpanagop@biol.uoa.gr			University of Athens, Greece; Swedish Allergy, Cancer and Diabetes Foundation; Karolinska Institute, Stockholm, Sweden	University of Athens, Greece; Swedish Allergy, Cancer and Diabetes Foundation; Karolinska Institute, Stockholm, Sweden(Karolinska Institutet)	This study was supported by the University of Athens, Greece, the Swedish Allergy, Cancer and Diabetes Foundation, and the Karolinska Institute, Stockholm, Sweden. The contribution of Prof. A. R. Liboff with remarks and suggestions on the manuscript is gratefully acknowledged. The Irish Doctors Environmental Association, the Alliance for Irish Radiation Protection, Daryl Vernon, and Brian Stein, are gratefully acknowledged for their general support.	ADAIR RK, 1991, HLTH PHYS, V61; Agarwal A, 2008, FERTIL STERIL, V89, P124, DOI 10.1016/j.fertnstert.2007.01.166; Agarwal A, 2009, FERTIL STERIL, V92, P1318, DOI 10.1016/j.fertnstert.2008.08.022; Ahlbom A, 1998, HEALTH PHYS, V74, P494; Alberts B., 1994, MOL BIOL CELL; AVERBECK D, 2010, MUTAT RES, P7; BAWIN SM, 1975, ANN NY ACAD SCI, V247, P74, DOI 10.1111/j.1749-6632.1975.tb35984.x; BAWIN SM, 1976, P NATL ACAD SCI USA, V73, P1999, DOI 10.1073/pnas.73.6.1999; BAWIN SM, 1978, P NATL ACAD SCI USA, V75, P6314, DOI 10.1073/pnas.75.12.6314; BLACKMAN C F, 1980, Bioelectromagnetics, V1, P35, DOI 10.1002/bem.2250010104; BLACKMAN CF, 1989, BIOELECTROMAGNETICS, V10, P115, DOI 10.1002/bem.2250100202; BOLSHAKOV MA, 1992, BIOELECTROMAGNETICS, V13, P119, DOI 10.1002/bem.2250130206; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; Campisi A, 2010, NEUROSCI LETT, V473, P52, DOI 10.1016/j.neulet.2010.02.018; Carlo G L, 2000, MedGenMed, V2, pE40; CARLO GL, 1998, WIRELESS PHONES HLTH, V13; CARLO GL, 2001, WIRELESS PHONES HLTH, V12; CARPENTER RL, 1971, IEEE T MICROW THEORY, VMT19, P173, DOI 10.1109/TMTT.1968.1127480; Christ A, 2010, PHYS MED BIOL, V55, P1767, DOI 10.1088/0031-9155/55/7/001; Coggle JE., 1983, BIOL EFFECTS RAD, V2; Dawe AS, 2006, BIOELECTROMAGNETICS, V27, P88, DOI 10.1002/bem.20192; De Iuliis GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006446; Dertinger H, 1970, MOL RAD BIOL; Detlavs I, 1996, SCI TOTAL ENVIRON, V180, P35, DOI 10.1016/0048-9697(95)04917-7; Eberhardt JL, 2008, ELECTROMAGN BIOL MED, V27, P215, DOI 10.1080/15368370802344037; Elder JA, 2003, BIOELECTROMAGNETICS, pS162, DOI 10.1002/bem.10163; Fear EC, 1998, PHYS MED BIOL, V43, P1439, DOI 10.1088/0031-9155/43/6/005; Flyckt VMM, 2007, PHYS MED BIOL, V52, P2691, DOI 10.1088/0031-9155/52/10/004; FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25; Franzellitti S, 2010, MUTAT RES-FUND MOL M, V683, P35, DOI 10.1016/j.mrfmmm.2009.10.004; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; GOODMAN EM, 1995, INT REV CYTOL, V158, P279; Haemmerich D, 2005, PHYSIOL MEAS, V26, P59, DOI 10.1088/0967-3334/26/1/006; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hardell L, 2007, OCCUP ENVIRON MED, V64, P626, DOI 10.1136/oem.2006.029751; Hardell Lennart, 2009, Pathophysiology, V16, P113, DOI 10.1016/j.pathophys.2009.01.003; Hinrikus H, 2008, INT J RADIAT BIOL, V84, P69, DOI 10.1080/09553000701691679; Hoyto A, 2008, RADIAT RES, V170, P235, DOI 10.1667/RR1322.1; *IEEE, 2002, C953TM2002R2008 IEEE, P22002; Johansson O, 2006, ELECTROMAGN BIOL MED, V25, P245, DOI 10.1080/15368370601044150; Johansson Olle, 2009, Pathophysiology, V16, P157, DOI 10.1016/j.pathophys.2009.03.004; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; KRUGLIKOV IL, 1994, BIOELECTROMAGNETICS, V15, P539, DOI 10.1002/bem.2250150607; Kundrat P, 2012, INT J RADIAT BIOL, V88, P743, DOI 10.3109/09553002.2012.698029; Kwee S, 1998, BIOELECTROCH BIOENER, V44, P251, DOI 10.1016/S0302-4598(97)00095-0; La Vignera S, 2012, J ANDROL, V33, P350, DOI 10.2164/jandrol.111.014373; Lai H, 1996, INT J RADIAT BIOL, V69, P513, DOI 10.1080/095530096145814; LAI H, 1995, BIOELECTROMAGNETICS, V16, P207, DOI 10.1002/bem.2250160309; Lai H, 1997, BIOELECTROMAGNETICS, V18, P446, DOI 10.1002/(SICI)1521-186X(1997)18:6<446::AID-BEM7>3.0.CO;2-2; LEDNEV VV, 1991, BIOELECTROMAGNETICS, V12, P71, DOI 10.1002/bem.2250120202; Lenie S, 2008, MUTAT RES-GEN TOX EN, V651, P71, DOI 10.1016/j.mrgentox.2007.10.017; LEONARD JB, 1984, IEEE T BIO-MED ENG, V31, P533, DOI 10.1109/TBME.1984.325296; Levitt BB, 2010, ENVIRON REV, V18, P369, DOI 10.1139/A10-018; Liboff A.R., 1985, INTERACTIONS ELECTRO; LIBOFF AR, 1988, BIOELECTROMAGNETICS, V9, P39, DOI 10.1002/bem.2250090104; Liboff AR., 2003, BIOL EFFECTS ELECTRO, P76; LINLIU S, 1982, BIOELECTROMAGNETICS, V3, P309, DOI 10.1002/bem.2250030303; MANDL F, 1988, STAT PHYS, P2; Markova E, 2005, ENVIRON HEALTH PERSP, V113, P1172, DOI 10.1289/ehp.7561; Mitchel R. E. J., 2006, Dose-Response, V4, P75, DOI 10.2203/dose-response.04-002.Mitchel; Moulder JE, 1999, RADIAT RES, V151, P513, DOI 10.2307/3580028; Navarro EA, 2003, ELECTROMAGN BIOL MED, V22, P161, DOI 10.1081/JBC-120024625; *NCRP, 1981, 67 NCRP MEAS; Neher E., 1992, SCI AM, V266, P28; OM PG, 2012, ELECTROMAGN BIOL MED, V31, P34; Panagopoulos D. J., 2011, MOBILE PHONES TECHNO; Panagopoulos DJ, 2007, MUTAT RES-GEN TOX EN, V626, P69, DOI 10.1016/j.mrgentox.2006.08.008; Panagopoulos DJ, 2012, CELL BIOCHEM BIOPHYS, V63, P121, DOI 10.1007/s12013-012-9347-0; Panagopoulos DJ, 2010, INT J RADIAT BIOL, V86, P358, DOI 10.3109/09553000903567979; Panagopoulos DJ, 2010, INT J RADIAT BIOL, V86, P345, DOI 10.3109/09553000903567961; Panagopoulos DJ, 2000, BIOCHEM BIOPH RES CO, V272, P634, DOI 10.1006/bbrc.2000.2746; Panagopoulos DJ, 2002, BIOCHEM BIOPH RES CO, V298, P95, DOI 10.1016/S0006-291X(02)02393-8; Panagopoulos DJ., 2003, BIOL EFFECTS ELECTRO, P5; Panagopoulos DJ, 2011, ADV MED BIOL, V17; Panagopoulos DJ., 2018, MOBILE TELEPHONES, P107; Penafiel LM, 1997, BIOELECTROMAGNETICS, V18, P132, DOI 10.1002/(SICI)1521-186X(1997)18:2<132::AID-BEM6>3.0.CO;2-3; Peyman A, 2001, PHYS MED BIOL, V46, P1617, DOI 10.1088/0031-9155/46/6/303; Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005; Samoilov M O, 2003, Neurosci Behav Physiol, V33, P1, DOI 10.1023/A:1021119112927; SOMOSY Z, 1991, SCANNING MICROSCOPY, V5, P1145; Spottorno J, 2012, BIOELECTROMAGNETICS, V33, P612, DOI 10.1002/bem.21718; Stam R, 2010, BRAIN RES REV, V65, P80, DOI 10.1016/j.brainresrev.2010.06.001; Stryer L, 1996, BIOCHEMISTRY; Thuroczy G., 1994, Reviews on Environmental Health, V10, P135; Velizarov S, 1999, BIOELECTROCH BIOENER, V48, P177, DOI 10.1016/S0302-4598(98)00238-4; Verschaeve L, 2010, MUTAT RES-REV MUTAT, V705, P252, DOI 10.1016/j.mrrev.2010.10.001; VEYRET B, 1991, BIOELECTROMAGNETICS, V12, P47, DOI 10.1002/bem.2250120107; Wang JQ, 2006, PHYS MED BIOL, V51, P4119, DOI 10.1088/0031-9155/51/17/001	89	45	47	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e62663	10.1371/journal.pone.0062663	http://dx.doi.org/10.1371/journal.pone.0062663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750202	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900004
J	Sharon, D; Schumann, M; MacLeod, S; McPherson, R; Chaurasiya, S; Shaw, A; Hitt, MM				Sharon, David; Schuemann, Michael; MacLeod, Sheena; McPherson, Robyn; Chaurasiya, Shyambabu; Shaw, Andrew; Hitt, Mary M.			2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; TUMOR-SUPPRESSOR P53; IMMEDIATE-EARLY PROMOTER; HERPES-SIMPLEX VIRUS-1; E1B 55-KILODALTON; MRE11 COMPLEX; GAMMA(1)34.5 PROTEIN; DELETED ADENOVIRUS; VIRAL-INFECTION	Adenoviruses with deletions of viral genes have been extensively studied as potential cancer therapeutics. Although a high degree of cancer selectivity has been demonstrated with these conditionally replicating adenoviruses, low levels of virus replication can be detected in normal cells. Furthermore, these mutations were also found to reduce the activity of the replicating viruses in certain cancer cells. Recent studies have shown that co-administration of chemotherapeutic drugs may increase the activity of these viruses without affecting their specificity. We constructed an adenovirus with deletions of both the E1b and the VA-RNA genes and found that replication of this virus was selective for human hepatocellular carcinoma (HCC) cell lines when compared to normal cell lines. Furthermore, we show that 2-aminopurine (2'AP) treatment selectively enhanced virus replication and virus-mediated death of HCC cells. 2'AP did not compensate for the loss of VA-RNA activities, but rather the loss of an E1b-55K activity, such as the DNA damage response, suggesting that co-administration of 2'AP derivatives that block host DNA damage response, may increase the oncolytic activity of Ad Delta E1b Delta VA without reducing its selectivity for HCC cells.	[Sharon, David; MacLeod, Sheena; McPherson, Robyn; Chaurasiya, Shyambabu; Shaw, Andrew; Hitt, Mary M.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Schuemann, Michael] Klinikum Philipps Univ Marburg, Inst Virol, Marburg, Germany	University of Alberta; Philipps University Marburg	Hitt, MM (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	mary.hitt@albertahealthservices.ca	Chaurasiya, Shyambabu/AAM-3822-2020	Chaurasiya, Shyambabu/0000-0002-9543-5458	Canadian Institutes of Health Research [MOP-81203]; Canadian Breast Cancer Foundation/Prairies Chapter [24956]; Queen Elizabeth II Graduate Scholarship through the University of Alberta	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation/Prairies Chapter; Queen Elizabeth II Graduate Scholarship through the University of Alberta	This work was supported by the Canadian Institutes of Health Research (grant #MOP-81203, www.cihr-irsc.gc.ca) and the Canadian Breast Cancer Foundation/Prairies Chapter (grant #24956, www.cbcf.org/prairies). DS was supported by a Queen Elizabeth II Graduate Scholarship through the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 1997, J GEN VIROL, V78, P1653, DOI 10.1099/0022-1317-78-7-1653; Araujo FD, 2005, J VIROL, V79, P11382, DOI 10.1128/JVI.79.17.11382-11391.2005; ARMBRUST KE, 1946, J PHARMACOL EXP THER, V88, P382; BABISS LE, 1984, J VIROL, V50, P202, DOI 10.1128/JVI.50.1.202-212.1984; BARBER GN, 1993, P NATL ACAD SCI USA, V90, P4621, DOI 10.1073/pnas.90.10.4621; BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; BETT AJ, 1995, VIRUS RES, V39, P75; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Cascallo M, 2003, CANCER RES, V63, P5544; Cascallo M, 2006, HUM GENE THER, V17, P929, DOI 10.1089/hum.2006.17.929; Celis JE, 2006, CELL BIOL LAB HDB, P435; Cheng GF, 2003, J VIROL, V77, P10154, DOI 10.1128/JVI.77.18.10154-10161.2003; Cheng GF, 2001, VIROLOGY, V290, P115, DOI 10.1006/viro.2001.1148; CHOU J, 1994, P NATL ACAD SCI USA, V91, P5247, DOI 10.1073/pnas.91.12.5247; COGAN JD, 1992, J VIROL, V66, P3833, DOI 10.1128/JVI.66.6.3833-3845.1992; Connell CM, 2011, J CLIN INVEST, V121, P1283, DOI 10.1172/JCI43976; Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Geoerger B, 2002, CANCER RES, V62, P764; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Goodrum FD, 1999, J VIROL, V73, P7474, DOI 10.1128/JVI.73.9.7474-7488.1999; Goodrum FD, 1998, J VIROL, V72, P9479, DOI 10.1128/JVI.72.12.9479-9490.1998; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRAND RJA, 1994, VIROLOGY, V203, P229, DOI 10.1006/viro.1994.1480; Hartl B, 2008, ONCOGENE, V27, P3673, DOI 10.1038/sj.onc.1211039; Hasegawa T, 2000, BIOCHEM J, V352, P795, DOI 10.1042/0264-6021:3520795; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639; HU YH, 1993, J INTERFERON RES, V13, P323, DOI 10.1089/jir.1993.13.323; Huang S, 2003, ONCOGENE, V22, P3721, DOI 10.1038/sj.onc.1206490; JIMENEZGARCIA LF, 1993, J CELL SCI, V106, P11; KALVAKOLANU DVR, 1991, J BIOL CHEM, V266, P873; KAUFMAN RJ, 1987, MOL CELL BIOL, V7, P1568, DOI 10.1128/MCB.7.4.1568; Kim J, 2002, CANCER GENE THER, V9, P725, DOI 10.1038/sj.cgt.7700494; Kim J, 2009, GENE THER, V16, P1111, DOI 10.1038/gt.2009.72; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; Lavin MF, 2004, DNA REPAIR, V3, P1515, DOI 10.1016/j.dnarep.2004.07.001; Leitner S, 2009, CLIN CANCER RES, V15, P1730, DOI 10.1158/1078-0432.CCR-08-2008; Li Z, 2004, CANCER RES, V64, P9080, DOI 10.1158/0008-5472.CAN-04-2419; Liu BL, 2003, GENE THER, V10, P292, DOI 10.1038/sj.gt.3301885; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; MARAN A, 1988, VIROLOGY, V164, P106, DOI 10.1016/0042-6822(88)90625-3; Matskevich AA, 2009, J INNATE IMMUN, V1, P389, DOI 10.1159/000191408; McCormick F, 2000, ONCOGENE, V19, P6670, DOI 10.1038/sj.onc.1204096; McCormick F, 2000, SEMIN CANCER BIOL, V10, P453, DOI 10.1006/scbi.2000.0336; METCALF JP, 1994, AM J RESP CELL MOL, V10, P448, DOI 10.1165/ajrcmb.10.4.8136160; Miller DL, 2009, J VIROL, V83, P3591, DOI 10.1128/JVI.02269-08; Mohammadi ES, 2004, NUCLEIC ACIDS RES, V32, P2652, DOI 10.1093/nar/gkh593; MUNDSCHAU LJ, 1992, J BIOL CHEM, V267, P23092; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nakajima T, 1998, J BIOL CHEM, V273, P20036, DOI 10.1074/jbc.273.32.20036; O'Shea CC, 2005, CANCER CELL, V8, P61, DOI 10.1016/j.ccr.2005.06.009; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; OLIVE DM, 1990, ARCH VIROL, V112, P67, DOI 10.1007/BF01348986; OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5; RICE AP, 1989, J BIOL CHEM, V264, P20632; Ries SJ, 2000, NAT MED, V6, P1128, DOI 10.1038/80466; Sanchez TA, 2000, AM J RESP CELL MOL, V23, P670, DOI 10.1165/ajrcmb.23.5.3675; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; Schumann M, 2006, CELL CYCLE, V5, P315, DOI 10.4161/cc.5.3.2411; Schwartz RA, 2008, J VIROL, V82, P9043, DOI 10.1128/JVI.00925-08; Shen YQ, 2001, J VIROL, V75, P4297, DOI 10.1128/JVI.75.9.4297-4307.2001; Spurgeon ME, 2009, J VIROL, V83, P9970, DOI 10.1128/JVI.01113-09; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Steegenga WT, 1998, ONCOGENE, V16, P349, DOI 10.1038/sj.onc.1201540; Stracker TH, 2005, J VIROL, V79, P6664, DOI 10.1128/JVI.79.11.6664-6673.2005; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; TIWARI RK, 1988, MOL CELL BIOL, V8, P4289, DOI 10.1128/MCB.8.10.4289; Vollmer CM, 1999, CANCER RES, V59, P4369; Wang YH, 2005, CANCER RES, V65, P1523, DOI 10.1158/0008-5472.CAN-04-3113; WEIDEN MD, 1994, P NATL ACAD SCI USA, V91, P153, DOI 10.1073/pnas.91.1.153; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Yoon AR, 2006, HUM GENE THER, V17, P379, DOI 10.1089/hum.2006.17.379; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; ZHANG Y, 1994, J VIROL, V68, P2544, DOI 10.1128/JVI.68.4.2544-2555.1994; ZHANG Y, 1994, J VIROL, V68, P7040, DOI 10.1128/JVI.68.11.7040-7050.1994; Zheng XY, 2005, CANCER BIOL THER, V4, P1255, DOI 10.4161/cbt.4.11.2137; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	81	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65222	10.1371/journal.pone.0065222	http://dx.doi.org/10.1371/journal.pone.0065222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750246	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900048
J	Waithman, J; Zanker, D; Xiao, K; Oveissi, S; Wylie, B; Ng, R; Togel, L; Chen, WS				Waithman, Jason; Zanker, Damien; Xiao, Kun; Oveissi, Sara; Wylie, Ben; Ng, Royce; Toegel, Lars; Chen, Weisan			Resident CD8(+) and Migratory CD103(+) Dendritic Cells Control CD8 T Cell Immunity during Acute Influenza Infection	PLOS ONE			English	Article							MHC CLASS-I; ANTIGEN PRESENTATION; LYMPH-NODE; VIRUS; MOUSE; POPULATION; INDUCTION; SUBSETS; REVEALS; SURFACE	The identification of the specific DC subsets providing a critical role in presenting influenza antigens to naive T cell precursors remains contentious and under considerable debate. Here we show that CD8(+) T lymphocyte (TCD8+) responses are severely hampered in C57BL/6 mice deficient in the transcription factor Batf3 after intranasal challenge with influenza A virus (IAV). This transcription factor is required for the development of lymph node resident CD8(+) and migratory CD103(+) CD11b(-) DCs and we found both of these subtypes could efficiently stimulate anti-IAV TCD8+. Using a similar ex vivo approach, many publications on this subject matter excluded a role for resident, non-migratory CD8(+) DC. We postulate the differences reported can partially be explained by how DC are phenotyped, namely the use of MHC class II to segregate subtypes. Our results show that resident CD8(+) DC upregulate this marker during IAV infection and we advise against its use when isolating DC subtypes.	[Waithman, Jason; Wylie, Ben; Ng, Royce] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Waithman, Jason; Wylie, Ben; Ng, Royce] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Waithman, Jason; Zanker, Damien; Xiao, Kun; Oveissi, Sara; Toegel, Lars; Chen, Weisan] Ludwig Inst Canc Res, Melbourne Austin Branch, Melbourne, Vic 3050, Australia; [Zanker, Damien; Xiao, Kun; Oveissi, Sara; Chen, Weisan] La Trobe Univ, Sch Mol Sci, Melbourne, Vic, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; Ludwig Institute for Cancer Research; La Trobe University	Waithman, J (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	jwaithman@ichr.uwa.edu.au	Chen, Weisan/E-7828-2012; Oveissi, Sara/W-9426-2019; Wylie, Ben/GXM-4602-2022; Wylie, Ben/AAR-6292-2021	Chen, Weisan/0000-0002-5221-9771; Oveissi, Sara/0000-0002-7353-5108; Zanker, Damien/0000-0003-1163-9902; Wylie, Ben/0000-0001-8781-8611; Waithman, Jason/0000-0003-4940-0155	National Health and Medical Research Council Australia: Biomedical Training Fellowship [603100, 567122, 603104]	National Health and Medical Research Council Australia: Biomedical Training Fellowship	This work was partly supported by the National Health and Medical Research Council Australia: Biomedical Training Fellowship (603100) to JW; Senior Research Fellowship to WC (603104); and program grant to WC (567122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Hashimoto D, 2012, J CLIN INVEST; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; Ingulli E, 2009, J IMMUNOL, V182, P29, DOI 10.4049/jimmunol.182.1.29; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Langlois RA, 2012, P NATL ACAD SCI USA, V109, P12117, DOI 10.1073/pnas.1206039109; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; NUSSENZWEIG MC, 1981, J EXP MED, V154, P168, DOI 10.1084/jem.154.1.168; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Tussiwand R., 2012, NATURE; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Waithman J, 2012, VIRULENCE, V3, P603, DOI 10.4161/viru.21864; Zanker D, 2012, J IMMUNOL METHODS	27	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66136	10.1371/journal.pone.0066136	http://dx.doi.org/10.1371/journal.pone.0066136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750278	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900080
J	Griffeth, RJ; Carretero, J; Burks, DJ				Griffeth, Richard J.; Carretero, Jose; Burks, Deborah J.			Insulin Receptor Substrate 2 Is Required for Testicular Development	PLOS ONE			English	Article							GROWTH-FACTOR-I; SERTOLI-CELLS; IGF-1 RECEPTOR; TESTIS; MICE; RAT; SYSTEM; PHOSPHORYLATION; PROLIFERATION; REPRODUCTION	Insulin receptor substrate (IRS) proteins are key mediators of insulin and insulin-like growth factor (IGF) signalling. In mice, deletion of Irs1 is associated with profound growth retardation and increased longevity whereas Irs2-deficiency causes diabetes and female infertility. Clinical studies suggest that diabetes and obesity diminish male fertility. However, the role of IRS proteins in male reproduction is unknown. We observed that testis weight is reduced by 45% in Irs2-deficient mice as compared with control males. The weight of these organs in Irs1(-/-) males was similar to controls; however, since Irs1-deficient mice are 50% smaller, testis weight: body weight was increased in this model. Neonatal Irs2(-/-) mice also exhibited reduced testicular size, suggesting that impairments in this model occur during development. Histological examination of testicular cross sections from Irs2(-/-) mice revealed normal cellular associations without obvious abnormalities in the seminiferous epithelium. Reduced testicular weight was associated with fewer Sertoli cells, spermatogonia, spermatocytes, elongated spermatids, and epididymal spermatozoa. However, Leydig cell number and the concentration of serum testosterone were equivalent between Irs2-deficient and control males. Testicular weight was reduced similarly in nondiabetic and diabetic Irs2(-/-) mice, indicating that hyperglycemia does not compound the effects of Irs2 deletion on impaired testis development. Expression of Irs1, Irs3, and Irs4 was comparable between experimental groups. Collectively, our results demonstrate that IRS2 plays a critical role in testicular development, potentially by mediating IGF1 signalling during embryonic and early postnatal development.	[Griffeth, Richard J.; Burks, Deborah J.] Ctr Invest Principe Felipe, Valencia, Spain; [Carretero, Jose] Univ Salamanca, Dept Anat, E-37008 Salamanca, Spain; [Burks, Deborah J.] Ctr Invest Biomed Red Diabet & Enfermedades, Valencia, Spain	Prince Felipe Research Center; University of Salamanca; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Burks, DJ (corresponding author), Ctr Invest Principe Felipe, Valencia, Spain.	dburks@cipf.es	Carretero, José J/L-6930-2014	Carretero, José J/0000-0003-3143-6512	CIBERDEM; Regenerative Medicine Program of the Instituto de Salud Carlos III; Ministerio de Economia y Competividad of Spain	CIBERDEM; Regenerative Medicine Program of the Instituto de Salud Carlos III; Ministerio de Economia y Competividad of Spain(Spanish Government)	This research was supported by CIBERDEM, The Regenerative Medicine Program of the Instituto de Salud Carlos III, and the Ministerio de Economia y Competividad of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbaje IM, 2007, HUM REPROD, V22, P1871, DOI 10.1093/humrep/dem077; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; BENAHMED M, 1987, MOL CELL ENDOCRINOL, V50, P69, DOI 10.1016/0303-7207(87)90078-5; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Carew RM, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-73; Carpino A, 2010, INT J ANDROL, V33, P554, DOI 10.1111/j.1365-2605.2009.00971.x; CE Zenick H, 1989, ASSESSMENT MALE REPR; Chandrashekar V, 2004, BIOL REPROD, V71, P17, DOI 10.1095/biolreprod.103.027060; Colon E, 2007, ENDOCRINOLOGY, V148, P128, DOI 10.1210/en.2006-0835; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Franca LR, 2000, BIOL REPROD, V63, P1629, DOI 10.1095/biolreprod63.6.1629; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kanzaki M, 2001, CELL BIOCHEM BIOPHYS, V35, P191, DOI 10.1385/CBB:35:2:191; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Laviola L, 2005, ENDOCRINOLOGY, V146, P1498, DOI 10.1210/en.2004-1332; LIN T, 1995, J ANDROL, V16, P193; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu SCH, 1999, J BIOL CHEM, V274, P18093, DOI 10.1074/jbc.274.25.18093; Mah PM, 2010, MOL CELL ENDOCRINOL, V316, P180, DOI 10.1016/j.mce.2009.06.007; Medhi B, 2005, BJU INT, V95, P452, DOI 10.1111/j.1464-410X.2005.05368_1.x; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Neganova I, 2007, BIOL REPROD, V76, P1045, DOI 10.1095/biolreprod.106.059360; ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Roser JF, 2001, ANIM REPROD SCI, V68, P139, DOI 10.1016/S0378-4320(01)00151-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Sharpe RM, 2010, PHILOS T R SOC B, V365, P1697, DOI 10.1098/rstb.2009.0206; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SMITH EP, 1987, ENDOCRINOLOGY, V120, P186, DOI 10.1210/endo-120-1-186; SmithHall J, 1997, BIOCHEMISTRY-US, V36, P8304, DOI 10.1021/bi9630974; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Thakur M, 2012, INT J IMPOT RES, V24, P31, DOI 10.1038/ijir.2011.43; Torley KJ, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-2; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; VANNELLI BG, 1988, FERTIL STERIL, V49, P666; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; Villalpando I, 2008, EXP BIOL MED, V233, P419, DOI 10.3181/0708-RM-212; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; WHITE MF, 1994, J BIOL CHEM, V269, P1; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	55	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e62103	10.1371/journal.pone.0062103	http://dx.doi.org/10.1371/journal.pone.0062103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741292	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900004
J	Horstmann, H; Vasileva, M; Kuner, T				Horstmann, Heinz; Vasileva, Mariya; Kuner, Thomas			Photooxidation-Guided Ultrastructural Identification and Analysis of Cells in Neuronal Tissue Labeled with Green Fluorescent Protein	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; SYNAPTIC-TRANSMISSION; CORRELATIVE LIGHT; RAT CALYX; PHOTOCONVERSION; ARCHITECTURE; EXPRESSION; CORTEX; GIANT; AXONS	The ultrastructural characterization of neuronal compartments in intact tissue labeled with green fluorescent protein (GFP) remains a frequently encountered challenge, despite work establishing photooxidation of GFP in cultured cells. However, most applications require the detection of GFP or GFP fusion proteins expressed in intact tissue. Here, we report that illumination of GFP variants in oxygen-enriched environment reliably generated electron-dense 3,39-diaminobenzidine (DAB) precipitates in slices from rat brain. The method is applicable to GFP variants tagged to presynaptic proteins as well as to soluble GFP in various brain regions. Serial section scanning electron microscopy was used to examine genetically labeled presynaptic terminals at high resolution and to generate three-dimensional representations of the synapses. Thus, we introduce a generally applicable correlative approach for the identification of presynaptic terminals genetically labeled with green fluorescent proteins in tissue slices and their ultrastructural characterization.	[Horstmann, Heinz; Vasileva, Mariya; Kuner, Thomas] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kuner, T (corresponding author), Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany.	kuner@uni-heidelberg.de			CellNetworks Cluster of Excellence [EXC81]	CellNetworks Cluster of Excellence	This work has been supported by the the CellNetworks Cluster of Excellence (EXC81). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boassa D, 2013, J NEUROSCI, V33, P2605, DOI 10.1523/JNEUROSCI.2898-12.2013; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Dondzillo A, 2010, J COMP NEUROL, V518, P1008, DOI 10.1002/cne.22260; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; Grabenbauer M, 2012, METHOD CELL BIOL, V111, P117, DOI 10.1016/B978-0-12-416026-2.00007-8; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Groh A, 2008, J NEUROSCI, V28, P9652, DOI 10.1523/JNEUROSCI.1554-08.2008; Gundelfinger ED, 2012, CURR OPIN NEUROBIOL, V22, P423, DOI 10.1016/j.conb.2011.10.005; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; HOOGLAND PV, 1991, EXP BRAIN RES, V87, P159, DOI 10.1007/BF00228517; Horstmann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035172; Jimenez-Banzo A, 2008, BIOPHYS J, V94, P168, DOI 10.1529/biophysj.107.107128; Kacza J, 1997, J NEUROSCI METH, V71, P225, DOI 10.1016/S0165-0270(96)00150-1; Keene DR, 2008, MICROSC MICROANAL, V14, P342, DOI 10.1017/S1431927608080306; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Meisslitzer-Ruppitsch C, 2008, HISTOCHEM CELL BIOL, V130, P407, DOI 10.1007/s00418-008-0429-4; Meisslitzer-Ruppitsch Claudia, 2013, Methods Mol Biol, V931, P423, DOI 10.1007/978-1-62703-056-4_21; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Polishchuk Elena V, 2013, Methods Mol Biol, V931, P413, DOI 10.1007/978-1-62703-056-4_20; Satzler K, 2002, J NEUROSCI, V22, P10567; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Schwenger DB, 2010, EUR J NEUROSCI, V32, P974, DOI 10.1111/j.1460-9568.2010.07391.x; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Spiegelhalter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009014; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Wimmer VC, 2004, PFLUG ARCH EUR J PHY, V449, P319, DOI 10.1007/s00424-004-1327-9; Wimmer VC, 2010, J COMP NEUROL, V518, P4629, DOI 10.1002/cne.22483; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068	34	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64764	10.1371/journal.pone.0064764	http://dx.doi.org/10.1371/journal.pone.0064764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741388	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900101
J	John, SG; Sigrist, MK; Taal, MW; McIntyre, CW				John, Stephen G.; Sigrist, Mhairi K.; Taal, Maarten W.; McIntyre, Christopher W.			Natural History of Skeletal Muscle Mass Changes in Chronic Kidney Disease Stage 4 and 5 Patients: An Observational Study	PLOS ONE			English	Article							MAINTENANCE HEMODIALYSIS-PATIENTS; QUALITY-OF-LIFE; LEAN BODY-MASS; RENAL-DISEASE; PHYSICAL PERFORMANCE; DIABETES-MELLITUS; INSULIN-RESISTANCE; PROTEIN BREAKDOWN; DIALYSIS PATIENTS; CONTROLLED-TRIAL	Cross-sectional studies in dialysis demonstrate muscle wasting associated with loss of function, increased morbidity and mortality. The relative drivers are poorly understood. There is a paucity of data regarding interval change in muscle in pre-dialysis and dialysis-dependant patients. This study aimed to examine muscle and fat mass change and elucidate associations with muscle wasting in advanced CKD. 134 patients were studied (60 HD, 28 PD, 46 CKD 4-5) and followed up for two years. Groups were similar in age, sex and diabetes prevalence. Soft tissue cross-sectional area (CSA) was measured annually on 3 occasions by a standardised multi-slice CT thigh. Potential determinants of muscle and fat CSA were assessed. Functional ability was assessed by sit-to-stand testing. 88 patients completed follow-up (40 HD, 16 PD, 32 CKD). There was a significant difference in percentage change in muscle CSA (MCSA) over year 1, dependant on treatment modality (chi(2) = 6.46; p = 0.039). Muscle loss was most pronounced in pre-dialysis patients. Muscle loss during year 1 was partially reversed in year 2 in 39%. Incident dialysis patients significantly lost MCSA during the year which they commenced dialysis, but not the subsequent year. Baseline MCSA, change in MCSA during year 1 and dialysis modality predicted year 2 change in MCSA (adjusted R-2 = 0.77, p<0.001). There was no correlation between muscle or fat CSA change and any other factors. MCSA correlated with functional testing, although MCSA change correlated poorly with change in functional ability. These data demonstrate marked variability in MCSA over 2 years. Loss of MCSA in both pre-dialysis and established dialysis patients is reversible. Factors previously cross-sectionally shown to correlate with MCSA did not correlate with wasting progression. The higher rate of muscle loss in undialysed CKD patients, and its reversal after dialysis commencement, suggests that conventional indicators may not result in optimal timing of dialysis initiation.	[John, Stephen G.; Sigrist, Mhairi K.; Taal, Maarten W.; McIntyre, Christopher W.] Royal Derby Hosp, Dept Renal Med, Derby, England; [McIntyre, Christopher W.] Univ Nottingham, Sch Grad Entry Med & Hlth, Derby, England	University of Nottingham; University of Nottingham	McIntyre, CW (corresponding author), Royal Derby Hosp, Dept Renal Med, Derby, England.	chris.mcintyre@nottingham.ac.uk	McIntyre, Christopher W/O-8927-2014	Taal, Maarten/0000-0002-9065-212X; Sigrist, Mhairi/0000-0003-0138-386X	British Renal Society; Kidney Research UK	British Renal Society; Kidney Research UK(Kidney Research UK (KRUK))	This was funded by the British Renal Society and Kidney Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson J, 2006, CONTRIB NEPHROL, V151, P165, DOI 10.1159/000095327; Bailey JL, 2006, J AM SOC NEPHROL, V17, P1388, DOI 10.1681/ASN.2004100842; Blake C, 2004, NEPHROL DIAL TRANSPL, V19, P3124, DOI 10.1093/ndt/gfh538; Campistol JM, 2002, KIDNEY INT, V62, P1901, DOI 10.1046/j.1523-1755.2002.00614.x; Castaneda C, 2001, ANN INTERN MED, V135, P965, DOI 10.7326/0003-4819-135-11-200112040-00008; Cheema B, 2007, J AM SOC NEPHROL, V18, P1594, DOI 10.1681/ASN.2006121329; Desmeules S, 2004, NEPHROL DIAL TRANSPL, V19, P1182, DOI 10.1093/ndt/gfh016; Du J, 2005, EUR J CLIN INVEST, V35, P157, DOI 10.1111/j.1365-2362.2005.01473.x; Fouque D, 2011, KIDNEY INT, V80, P348, DOI 10.1038/ki.2011.118; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Harrison AP, 2006, NEPHRON PHYSIOL, V103, P33, DOI 10.1159/000090221; Hedayati SS, 2006, SEMIN DIALYSIS, V19, P323, DOI 10.1111/j.1525-139X.2006.00180.x; Huang CX, 2010, KIDNEY INT, V77, P624, DOI 10.1038/ki.2009.524; Johansen KL, 2006, J AM SOC NEPHROL, V17, P2307, DOI 10.1681/ASN.2006010034; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Johansen KL, 2001, KIDNEY INT, V60, P1586, DOI 10.1046/j.1523-1755.2001.00972.x; Kalantar-Zadeh K, 2006, AM J CLIN NUTR, V83, P202; Kaysen GA, 2003, SEMIN DIALYSIS, V16, P438, DOI 10.1046/j.1525-139X.2003.16096.x; Kemp GJ, 2004, NEPHROL DIAL TRANSPL, V19, P1520, DOI 10.1093/ndt/gfh189; Koufaki P, 2002, CLIN PHYSIOL FUNCT I, V22, P115, DOI 10.1046/j.1365-2281.2002.00405.x; Kouidi E, 1998, NEPHROL DIAL TRANSPL, V13, P685, DOI 10.1093/ndt/13.3.685; Lecker SH, 2011, J AM SOC NEPHROL, V22, P821, DOI 10.1681/ASN.2010090958; Lee SW, 2007, NEPHROL DIAL TRANSPL, V22, P2554, DOI 10.1093/ndt/gfm204; Leikis MJ, 2006, CLIN J AM SOC NEPHRO, V1, P488, DOI 10.2215/CJN.01501005; McIntyre CW, 2006, NEPHROL DIAL TRANSPL, V21, P2210, DOI 10.1093/ndt/gfl064; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P2258, DOI 10.2215/CJN.02080310; Ohkawa S, 2005, NEPHROL DIAL TRANSPL, V20, P945, DOI 10.1093/ndt/gfh643; Ohkawa S, 2000, AM J CLIN NUTR, V71, P485; Penninx BWJH, 2000, J GERONTOL A-BIOL, V55, pM691, DOI 10.1093/gerona/55.11.M691; Pupim LB, 2005, KIDNEY INT, V68, P2368, DOI 10.1111/j.1523-1755.2005.00699.x; Pupim LB, 2005, KIDNEY INT, V68, P1857, DOI 10.1111/j.1523-1755.2005.00605.x; Raj DSC, 2004, AM J PHYSIOL-ENDOC M, V286, pE136, DOI 10.1152/ajpendo.00352.2003; Sakkas GK, 2006, AM J KIDNEY DIS, V47, P862, DOI 10.1053/j.ajkd.2006.01.013; Selby NM, 2007, NEPHROL DIAL TRANSPL, V22, P870, DOI 10.1093/ndt/gfl654; Siew ED, 2007, KIDNEY INT, V71, P146, DOI 10.1038/sj.ki.5001984; Storer TW, 2005, NEPHROL DIAL TRANSPL, V20, P1429, DOI 10.1093/ndt/gfh784; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B	38	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65372	10.1371/journal.pone.0065372	http://dx.doi.org/10.1371/journal.pone.0065372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741490	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900203
J	Petersen, A; Alvarez, C; DeClaire, S; Tintle, NL				Petersen, Ashley; Alvarez, Carolina; DeClaire, Scott; Tintle, Nathan L.			Assessing Methods for Assigning SNPs to Genes in Gene-Based Tests of Association Using Common Variants	PLOS ONE			English	Article							DISEASES	Gene-based tests of association are frequently applied to common SNPs (MAF>5%) as an alternative to single-marker tests. In this analysis we conduct a variety of simulation studies applied to five popular gene-based tests investigating general trends related to their performance in realistic situations. In particular, we focus on the impact of non-causal SNPs and a variety of LD structures on the behavior of these tests. Ultimately, we find that non-causal SNPs can significantly impact the power of all gene-based tests. On average, we find that the "noise" from 6-12 non-causal SNPs will cancel out the "signal" of one causal SNP across five popular gene-based tests. Furthermore, we find complex and differing behavior of the methods in the presence of LD within and between non-causal and causal SNPs. Ultimately, better approaches for a priori prioritization of potentially causal SNPs (e. g., predicting functionality of non-synonymous SNPs), application of these methods to sequenced or fully imputed datasets, and limited use of window-based methods for assigning inter-genic SNPs to genes will improve power. However, significant power loss from non-causal SNPs may remain unless alternative statistical approaches robust to the inclusion of non-causal SNPs are developed.	[Petersen, Ashley] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Alvarez, Carolina] Florida Int Univ, Dept Biostat, Miami, FL 33199 USA; [DeClaire, Scott] Hope Coll, Dept Math, Holland, MI 49423 USA; [Tintle, Nathan L.] Dordt Coll, Sioux Ctr, Dept Math Stat & Comp, Iowa City, IA USA	University of Washington; University of Washington Seattle; State University System of Florida; Florida International University; Hope College	Tintle, NL (corresponding author), Dordt Coll, Sioux Ctr, Dept Math Stat & Comp, Iowa City, IA USA.	nathantintle@dordt.edu		Tintle, Nathan/0000-0003-1447-9107; Petersen, Ashley/0000-0001-7711-9657	National Human Genome Research Institute [R15HG004543, R15HG006915]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG006915, R15HG004543] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the National Human Genome Research Institute (R15HG004543; R15HG006915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; BALLARD DH, 2009, GENOME WIDE RHEUMATO, V8, P1, DOI DOI 10.1186/1753-6561-3-S7-S91; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; PETERSEN A, 2013, GENOME WIDE ASS STUD; Qaqish BF, 2003, BIOMETRIKA, V90, P455, DOI 10.1093/biomet/90.2.455; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	20	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e62161	10.1371/journal.pone.0062161	http://dx.doi.org/10.1371/journal.pone.0062161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741293	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900005
J	Yamamoto, T; Oishi, T; Higo, N; Murayama, S; Sato, A; Takashima, I; Sugiyama, Y; Nishimura, Y; Murata, Y; Yoshino-Saito, K; Isa, T; Kojima, T				Yamamoto, Tatsuya; Oishi, Takao; Higo, Noriyuki; Murayama, Shigeo; Sato, Akira; Takashima, Ichiro; Sugiyama, Yoko; Nishimura, Yukio; Murata, Yumi; Yoshino-Saito, Kimika; Isa, Tadashi; Kojima, Toshio			Differential Expression of Secreted Phosphoprotein 1 in the Motor Cortex among Primate Species and during Postnatal Development and Functional Recovery	PLOS ONE			English	Article							OSTEOPONTIN MESSENGER-RNA; SPINAL-CORD-INJURY; CORTICOSPINAL PROJECTIONS; PYRAMIDAL NEURONS; LATERAL SURFACE; FRONTAL-LOBE; RED NUCLEUS; BRAIN-STEM; IN-VIVO; ORGANIZATION	We previously reported that secreted phosphoprotein 1 (SPP1) mRNA is expressed in neurons whose axons form the corticospinal tract (CST) of the rhesus macaque, but not in the corresponding neurons of the marmoset and rat. This suggests that SPP1 expression is involved in the functional or structural specialization of highly developed corticospinal systems in certain primate species. To further examine this hypothesis, we evaluated the expression of SPP1 mRNA in the motor cortex from three viewpoints: species differences, postnatal development, and functional/structural changes of the CST after a lesion of the lateral CST (l-CST) at the mid-cervical level. The density of SPP1-positive neurons in layer V of the primary motor cortex (M1) was much greater in species with highly developed corticospinal systems (i.e., rhesus macaque, capuchin monkey, and humans) than in those with less developed corticospinal systems (i.e., squirrel monkey, marmoset, and rat). SPP1-positive neurons in the macaque monkey M1 increased logarithmically in layer V during postnatal development, following a time course consistent with the increase in conduction velocity of the CST. After an l-CST lesion, SPP1-positive neurons increased in layer V of the ventral premotor cortex, in which compensatory changes in CST function/structure may occur, which positively correlated with the extent of finger dexterity recovery. These results further support the concept that the expression of SPP1 may reflect functional or structural specialization of highly developed corticospinal systems in certain primate species.	[Yamamoto, Tatsuya; Higo, Noriyuki; Takashima, Ichiro; Sugiyama, Yoko; Murata, Yumi] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Yamamoto, Tatsuya; Takashima, Ichiro; Sugiyama, Yoko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Yamamoto, Tatsuya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Oishi, Takao; Higo, Noriyuki; Sato, Akira; Yoshino-Saito, Kimika; Isa, Tadashi; Kojima, Toshio] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Oishi, Takao] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Inuyama, Aichi 484, Japan; [Higo, Noriyuki; Nishimura, Yukio] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan; [Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Itabashi Ku, Tokyo, Japan; [Sato, Akira; Kojima, Toshio] RIKEN, Adv Sci Inst, Computat Syst Biol Res Grp, Yokohama, Kanagawa, Japan; [Nishimura, Yukio; Yoshino-Saito, Kimika; Isa, Tadashi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan; [Kojima, Toshio] Hamamatsu Univ Sch Med, Res Equipment Ctr, Hamamatsu, Shizuoka 4313192, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST); Kyoto University; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Gerontology; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Hamamatsu University School of Medicine	Higo, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan.	n.higo@aist.go.jp	Takashima, Ichiro/M-6105-2016; Yamamoto, Tatsuya/CAF-7029-2022; Yamamoto, Tatsuya/N-6861-2016; Murata, Yumi/M-7663-2016	Takashima, Ichiro/0000-0003-0272-5075; Yamamoto, Tatsuya/0000-0002-0231-9694; Yamamoto, Tatsuya/0000-0002-0231-9694; Murata, Yumi/0000-0002-6318-2951; Oishi, Takao/0000-0003-1067-3746	Core Research for Evolutionary Science and Technology (CREST) of JST; Precursory Research for Embryonic Science and Technology (PRESTO) of JST; Ministry of Education, Culture, Sports, Science and Technology of Japan [20019042, 17021041]	Core Research for Evolutionary Science and Technology (CREST) of JST; Precursory Research for Embryonic Science and Technology (PRESTO) of JST; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the following grant sponsors: the Core Research for Evolutionary Science and Technology (CREST) of JST (http://www.jst.go.jp/); the Precursory Research for Embryonic Science and Technology (PRESTO) of JST (http://www.jst.go.jp/); Grant-in-Aid for Scientific Research on Priority Areas - Integrative Brain Research - from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grant number 20019042 to N.H. and 17021041 to T.I. (http://www.togo-nou.nips.ac.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Al-Izki S, 2008, EXP NEUROL, V212, P118, DOI 10.1016/j.expneurol.2008.03.020; AMUNTS K, 1995, ANAT EMBRYOL, V192, P557; Baker SN, 2011, J PHYSIOL-LONDON, V589, P5603, DOI 10.1113/jphysiol.2011.215160; Belhaj-Saif A, 2000, J NEUROPHYSIOL, V83, P3147, DOI 10.1152/jn.2000.83.5.3147; Borra E, 2010, J COMP NEUROL, V518, P2570, DOI 10.1002/cne.22353; BORTOFF GA, 1993, J NEUROSCI, V13, P5105, DOI 10.1523/JNEUROSCI.13-12-05105.1993; BROWN LF, 1992, MOL BIOL CELL, V3, P1169, DOI 10.1091/mbc.3.10.1169; Burman KJ, 2008, J COMP NEUROL, V506, P860, DOI 10.1002/cne.21580; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; DAVIS RL, 1995, ANN NY ACAD SCI, V760, P279, DOI 10.1111/j.1749-6632.1995.tb44638.x; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; GALEA MP, 1995, CEREB CORTEX, V5, P518, DOI 10.1093/cercor/5.6.518; Gergen J.A., 1962, STEREOTAXIC ATLAS SQ, DOI [10.5962/bhl.title.114088, DOI 10.5962/BHL.TITLE.114088]; Ghazanfar AA, 1999, TRENDS COGN SCI, V3, P377, DOI 10.1016/S1364-6613(99)01379-0; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GONZALORUIZ A, 1990, BRAIN RES BULL, V25, P919, DOI 10.1016/0361-9230(90)90189-7; HARTMANNVONMONAKOW K, 1979, EXP BRAIN RES, V34, P91; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; HE SQ, 1993, J NEUROSCI, V13, P952; HEFFNER R, 1975, BRAIN BEHAV EVOLUT, V12, P161, DOI 10.1159/000124401; HEFFNER RS, 1983, BRAIN BEHAV EVOLUT, V23, P165, DOI 10.1159/000121494; Higo N, 2000, J NEUROSCI, V20, P6030, DOI 10.1523/JNEUROSCI.20-16-06030.2000; Higo N, 2010, J COMP NEUROL, V518, P2633, DOI 10.1002/cne.22356; Higo N, 2009, J COMP NEUROL, V516, P493, DOI 10.1002/cne.22121; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; Isa T, 2007, PHYSIOLOGY, V22, P145, DOI 10.1152/physiol.00045.2006; Iwaniuk AN, 1999, BEHAV BRAIN RES, V101, P173, DOI 10.1016/S0166-4328(98)00151-X; JONES EG, 1977, J COMP NEUROL, V175, P391, DOI 10.1002/cne.901750403; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; LAWRENCE DG, 1968, BRAIN, V91, P15, DOI 10.1093/brain/91.1.15; Lee MY, 2001, CELL TISSUE RES, V306, P179, DOI 10.1007/s004410100456; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Logothetis NK, 2007, COMBINED MRI HISTOLO; MARK MP, 1988, CELL TISSUE RES, V251, P23, DOI 10.1007/BF00215443; MARTINO AM, 1987, BRAIN RES, V404, P307, DOI 10.1016/0006-8993(87)91384-9; Misawa H, 2012, J NEUROSCIENCE RES; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Moura ACD, 2004, SCIENCE, V306, P1909, DOI 10.1126/science.1102558; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nishimura Y, 2009, BRAIN, V132, P709, DOI 10.1093/brain/awn338; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; NUDO RJ, 1995, J COMP NEUROL, V358, P181, DOI 10.1002/cne.903580203; Okada T, 2002, METHODS, V28, P237, DOI 10.1016/S1046-2023(02)00228-1; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Olivier E, 1997, J NEUROSCI, V17, P267, DOI 10.1523/JNEUROSCI.17-01-00267.1997; Olszewski J., 1967, CYTOARCHITECTURE HUM; OTABE JS, 1970, J COMP NEUROL, V138, P373, DOI 10.1002/cne.901380309; Palazzi X., 2008, MARMOSET BRAIN STERE; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pouydebat E, 2009, J BIOMECH, V42, P266, DOI 10.1016/j.jbiomech.2008.10.026; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; RODAN GA, 1995, ANN NY ACAD SCI, V760, P1, DOI 10.1111/j.1749-6632.1995.tb44614.x; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Selvaraju R, 2004, MOL CELL NEUROSCI, V25, P707, DOI 10.1016/j.mcn.2003.12.014; Shin SL, 1999, NEUROSCI LETT, V273, P73, DOI 10.1016/S0304-3940(99)00516-9; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; Takahata T, 2006, CEREB CORTEX, V16, P929, DOI 10.1093/cercor/bhj034; Takaji M, 2009, CEREB CORTEX, V19, P2865, DOI 10.1093/cercor/bhp062; TOYOSHIMA K, 1982, J HIRNFORSCH, V23, P257; Voelker CCJ, 2004, CEREB CORTEX, V14, P1276, DOI 10.1093/cercor/bhh089; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; WISE SP, 1979, NEUROSCIENCE, V4, P65, DOI 10.1016/0306-4522(79)90218-5; WOOLSEY CN, 1979, J NEUROSURG, V51, P476, DOI 10.3171/jns.1979.51.4.0476; Yamamoto T, 2010, NEUROSCI RES, V69, P81	75	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65701	10.1371/journal.pone.0065701	http://dx.doi.org/10.1371/journal.pone.0065701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741508	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900221
J	Goepfert, A; Stanger, FV; Dehio, C; Schirmer, T				Goepfert, Arnaud; Stanger, Frederic V.; Dehio, Christoph; Schirmer, Tilman			Conserved Inhibitory Mechanism and Competent ATP Binding Mode for Adenylyltransferases with Fic Fold	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; AMPYLATION; COMPLEX; KINASE; SITE	The ubiquitous FIC domain is evolutionarily conserved from bacteria to human and has been shown to catalyze AMP transfer onto protein side-chain hydroxyl groups. Recently, it was predicted that most catalytically competent Fic proteins are inhibited by the presence of an inhibitory helix alpha(inh) that is provided by a cognate anti-toxin (class I), or is part of the Nor C-terminal part of the Fic protein itself (classes II and III). In vitro, inhibition is relieved by mutation of a conserved glutamate of alpha(inh) to glycine. For the class III bacterial Fic protein NmFic from Neisseria meningitidis, the inhibitory mechanism has been elucidated. Here, we extend above study by including bacterial class I and II Fic proteins VbhT from Bartonella schoenbuchensis and SoFic from Shewanella oneidensis, respectively, and the respective E-> G mutants. Comparative enzymatic and crystallographic analyses show that, in all three classes, the ATP substrate binds to the wildtype FIC domains, but with the alpha-phosphate in disparate and non-competent orientations. In the E-> G mutants, however, the tri-phosphate moiety is found reorganized to the same tightly bound structure through a unique set of hydrogen bonds with Fic signature motif residues. The gamma-phosphate adopts the location that is taken by the inhibitory glutamate in wild-type resulting in an alpha-phosphate orientation that can be attacked in-line by a target side-chain hydroxyl group. The latter is properly registered to the Fic active center by main-chain beta-interactions with the beta-hairpin flap. These data indicate that the active site motif and the exposed edge of the flap are both required to form an adenylylation-competent Fic protein.	[Goepfert, Arnaud; Stanger, Frederic V.; Dehio, Christoph; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland; [Goepfert, Arnaud; Stanger, Frederic V.; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, Basel, Switzerland	University of Basel; University of Basel	Dehio, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.	christoph.dehio@unibas.ch; tilman.schirmer@unibas.ch	Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019	Dehio, Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052; Stanger, Frederic/0000-0002-9847-5084	Swiss National Science Foundation [31003A 312979, 3100 138414]; SystemsX.ch Swiss Initiative for Systems Biology [51RT 0_126008]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch Swiss Initiative for Systems Biology	This work was supported by grants 31003A 312979 and 3100 138414 from the Swiss National Science Foundation (to CD and TS, respectively) and grant 51RT 0_126008 (InfectX) in the frame of the SystemsX.ch Swiss Initiative for Systems Biology (to CD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227; Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	23	24	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64901	10.1371/journal.pone.0064901	http://dx.doi.org/10.1371/journal.pone.0064901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738009	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000321394700070
J	El-Shesheny, I; Hajeri, S; El-Hawary, I; Gowda, S; Killiny, N				El-Shesheny, Ibrahim; Hajeri, Subhas; El-Hawary, Ibrahim; Gowda, Siddarame; Killiny, Nabil			Silencing Abnormal Wing Disc Gene of the Asian Citrus Psyllid, Diaphorina citri Disrupts Adult Wing Development and Increases Nymph Mortality	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; CANDIDATUS LIBERIBACTER ASIATICUS; AUTONOMOUS LETHAL MUTATION; SPODOPTERA-EXIGUA; GREENING DISEASE; TUMOR-METASTASIS; AMINOPEPTIDASE-N; SYNTHASE GENE; INTERFERENCE; EXPRESSION	Huanglongbing (HLB) causes considerable economic losses to citrus industries worldwide. Its management depends on controlling of the Asian citrus Psyllid (ACP), the vector of the bacterium, Candidatus Liberibacter asiaticus (CLas), the causal agent of HLB. Silencing genes by RNA interference (RNAi) is a promising tool to explore gene functions as well as control pests. In the current study, abnormal wing disc (awd) gene associated with wing development in insects is used to interfere with the flight of psyllids. Our study showed that transcription of awd is development-dependent and the highest level was found in the last instar (5th) of the nymphal stage. Micro-application (topical application) of dsRNA to 5th instar of nymphs caused significant nymphal mortality and adult wing-malformation. These adverse effects in ACP were positively correlated with the amounts of dsRNA used. A qRT-PCR analysis confirmed the dsRNA-mediated transcriptional down-regulation of the awd gene. Significant down-regulation was required to induce a wing-malformed phenotype. No effect was found when dsRNA-gfp was used, indicating the specific effect of dsRNA-awd. Our findings suggest a role for awd in ACP wing development and metamorphosis. awd could serve as a potential target for insect management either via direct application of dsRNA or by producing transgenic plants expressing dsRNA-awd. These strategies will help to mitigate HLB by controlling ACP.	[El-Shesheny, Ibrahim; Killiny, Nabil] Univ Florida, IFAS, Citrus Res & Educ Ctr, Dept Entomol & Nematol, Lake Alfred, FL USA; [Hajeri, Subhas; Gowda, Siddarame] Univ Florida, IFAS, Citrus Res & Educ Ctr, Dept Plant Pathol, Lake Alfred, FL USA; [El-Shesheny, Ibrahim; El-Hawary, Ibrahim] Tanta Univ, Fac Agr, Dept Plant Protect, Tanta, Egypt	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Egyptian Knowledge Bank (EKB); Tanta University	Killiny, N (corresponding author), Univ Florida, IFAS, Citrus Res & Educ Ctr, Dept Entomol & Nematol, Lake Alfred, FL USA.	nabilkilliny@ufl.edu	El-Shesheny, Ibrahim/GPK-5883-2022; Hajeri, Subhas/E-8180-2018	El-Shesheny, Ibrahim/0000-0003-4318-1721; Hajeri, Subhas/0000-0002-5993-118X; Killiny, Nabil/0000-0002-3895-6943	Egyptian government	Egyptian government	Ibrahim El-Shesheny was supported with a scholarship from the Egyptian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Bill Dawson for the helpful discussion. We acknowledge our lab members for the technical assistance and the useful discussion. Ibrahim El-Shesheny was supported with a scholarship from the Egyptian government.	Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baldassari N, 1997, J APPL ENTOMOL, V121, P343, DOI 10.1111/j.1439-0418.1997.tb01417.x; Batool A, 2007, HORTIC SCI, V34, P159, DOI 10.17221/1897-HORTSCI; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Berg JM, 2002, BIOCHEMISTRY-US, V5th; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; Boucias D.G., 1998, PRINCIPLES INSECT PA, P177; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Dai H, 2008, ACTA BIOCH BIOPH SIN, V40, P790, DOI 10.1093/abbs/40.9.790; DEAROLF CR, 1988, DEV BIOL, V129, P169, DOI 10.1016/0012-1606(88)90171-6; DEAROLF CR, 1988, DEV BIOL, V129, P159, DOI 10.1016/0012-1606(88)90170-4; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Dudley R, 2007, ANNU REV ECOL EVOL S, V38, P179, DOI 10.1146/annurev.ecolsys.37.091305.110014; FIRE A, 1991, DEVELOPMENT, V113, P503; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garnier M, 2000, INT J SYST EVOL MICR, V50, P2119, DOI 10.1099/00207713-50-6-2119; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Halbert S.E., 2005, PEST ALERT CITRUS GR; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hodges A, 2012, EC IMPACTS CITRUS GR; Hossain M, 2008, INSECT BIOCHEM MOLEC, V38, P1001, DOI 10.1016/j.ibmb.2008.08.006; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Hull JJ, 2009, J BIOL CHEM, V284, P31200, DOI 10.1074/jbc.M109.044198; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; Jiang DF, 2010, AFR J BIOTECHNOL, V9, P7372; Khajuria C, 2010, INSECT BIOCHEM MOLEC, V40, P621, DOI 10.1016/j.ibmb.2010.06.003; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Koyama T, 2008, DEV BIOL, V324, P258, DOI 10.1016/j.ydbio.2008.09.017; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; LEWIN R, 1985, SCIENCE, V230, P428, DOI 10.1126/science.230.4724.428; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Liu WB, 2008, ARCH INSECT BIOCHEM, V69, P47, DOI 10.1002/arch.20261; Majumdar A, 2009, ALABAMA COOPERATIVE; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Masumoto M, 2009, DEV GENES EVOL, V219, P437, DOI 10.1007/s00427-009-0305-9; Matsumura F., 1975, TOXICOLOGY INSECTICI; Matsunaga TM, 2002, INSECT BIOCHEM MOLEC, V32, P691, DOI 10.1016/S0965-1748(01)00148-5; Mead FW, 1998, ASIAN CITRUS PSYLLID; Morera S, 1995, STRUCTURE, V3, P1307, DOI 10.1016/S0969-2126(01)00268-4; Nation, 2001, INSECT PHYSL BIOCH, DOI 10.1201/9781420058376; Noble-Nesbitt J, 1970, J PESTIC SCI, V1, P204; Ohnishi A, 2009, J BIOL CHEM, V284, P5128, DOI 10.1074/jbc.M806072200; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Rogers ME, 2007, FLORIDA CITRUS; Romoser W. S., 1998, SCI ENTOMOLOGY; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Sato K, 2008, GENETICS, V179, P875, DOI 10.1534/genetics.107.082784; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Skelley LH, 2004, BIOL CONTROL, V29, P14, DOI 10.1016/S1049-9644(03)00129-4; Takahashi T, 2009, J NEUROSCI METH, V179, P9, DOI 10.1016/j.jneumeth.2009.01.002; Tang B, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-65; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Timmons L, 2000, J BIOENERG BIOMEMBR, V32, P293, DOI 10.1023/A:1005545214937; Tomita S, 2009, DEV BIOL, V328, P403, DOI 10.1016/j.ydbio.2009.01.040; Tsuzuki S, 2005, MECH DEVELOP, V122, P189, DOI 10.1016/j.mod.2004.10.005; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Wang Y, 2012, INSECT BIOCHEM MOLEC, V42, P637, DOI 10.1016/j.ibmb.2012.04.009; Wang Z, 2006, PLANT PATHOL, V55, P630, DOI 10.1111/j.1365-3059.2006.01438.x; White I.M., 1985, Bulletin of the British Museum (Natural History) Entomology, V50, P153; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wikipedians B, 2011, INTRO INSECTS; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Yang YL, 2010, INSECT BIOCHEM MOLEC, V40, P592, DOI 10.1016/j.ibmb.2010.05.006; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang JZ, 2010, INSECT BIOCHEM MOLEC, V40, P824, DOI 10.1016/j.ibmb.2010.08.001; Zhao XN, 2009, B SERICULTURE, V40, P20; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	85	69	72	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65392	10.1371/journal.pone.0065392	http://dx.doi.org/10.1371/journal.pone.0065392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734251	Green Published, gold, Green Submitted			2022-12-27	WOS:000319725500015
J	Brown, SAN; Cheng, E; Williams, MS; Winkles, JA				Brown, Sharron A. N.; Cheng, Emily; Williams, Mark S.; Winkles, Jeffrey A.			TWEAK-Independent Fn14 Self-Association and NF-kappa B Activation Is Mediated by the C-Terminal Region of the Fn14 Cytoplasmic Domain	PLOS ONE			English	Article							NECROSIS-FACTOR-RECEPTOR; CYSTEINE-RICH DOMAIN; WEAK INDUCER; TUMOR-GROWTH; THERAPEUTIC TARGET; APOPTOSIS TWEAK; BREAST-CANCER; TNF; CELLS; PATHWAY	The tumor necrosis factor (TNF) superfamily member TNF-like weak inducer of apoptosis (TWEAK) is a pro-inflammatory and pro-angiogenic cytokine implicated in physiological tissue regeneration and wound repair. TWEAK binds to a 102-amino acid type I transmembrane cell surface receptor named fibroblast growth factor-inducible 14 (Fn14). TWEAK:Fn14 engagement activates several intracellular signaling cascades, including the NF-kappa B pathway, and sustained Fn14 signaling has been implicated in the pathogenesis of chronic inflammatory diseases and cancer. Although several groups are developing TWEAK- or Fn14-targeted agents for therapeutic use, much more basic science research is required before we fully understand the TWEAK/Fn14 signaling axis. For example, we and others have proposed that TWEAK-independent Fn14 signaling may occur in cells when Fn14 levels are highly elevated, but this idea has never been tested directly. In this report, we first demonstrate TWEAK-independent Fn14 signaling by showing that an Fn14 deletion mutant that is unable to bind TWEAK can activate the NF-kappa B pathway in transfected cells. We then show that ectopically-expressed, cell surface-localized Fn14 can self-associate into Fn14 dimers, and we show that Fn14 self-association is mediated by an 18-aa region within the Fn14 cytoplasmic domain. Endogenously-expressed Fn14 as well as ectopically-overexpressed Fn14 could also be detected in dimeric form when cell lysates were subjected to SDS-PAGE under non-reducing conditions. Additional experiments revealed that Fn14 dimerization occurs during cell lysis via formation of an intermolecular disulfide bond at cysteine residue 122. These findings provide insight into the Fn14 signaling mechanism and may aid current studies to develop therapeutic agents targeting this small cell surface receptor.	[Brown, Sharron A. N.; Cheng, Emily; Winkles, Jeffrey A.] Univ Maryland, Sch Med, Dept Surg, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Williams, Mark S.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Winkles, JA (corresponding author), Univ Maryland, Sch Med, Dept Surg, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	jwinkles@som.umaryland.edu			NIH [R01 AI070823, R01 NS055126, R01 CA130967]; NATIONAL CANCER INSTITUTE [P30CA134274, R01CA130967] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants R01 AI070823 (MSW), R01 NS055126 (JAW) and R01 CA130967 (JAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Brown SAN, 2010, J BIOL CHEM, V285, P17432, DOI 10.1074/jbc.M110.131979; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Chao DT, 2013, J CANCER RES CLIN, V139, P315, DOI 10.1007/s00432-012-1332-x; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Foley SF, 2008, ANAL BIOCHEM, V377, P95, DOI 10.1016/j.ab.2008.02.025; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Fortin SP, 2009, MOL CANCER RES, V7, P1871, DOI 10.1158/1541-7786.MCR-09-0194; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; He F, 2009, PROTEIN SCI, V18, P650, DOI 10.1002/pro.49; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Horie R, 2002, ONCOGENE, V21, P2493, DOI 10.1038/sj.onc.1205337; Huang MG, 2011, CARCINOGENESIS, V32, P1589, DOI 10.1093/carcin/bgr182; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Mehl AM, 2001, J IMMUNOL, V167, P6388, DOI 10.4049/jimmunol.167.11.6388; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Michaelson JS, 2012, CANCER BIOL THER, V13, P812, DOI 10.4161/cbt.20564; Michaelson JS, 2011, MABS-AUSTIN, V3, P362, DOI 10.4161/mabs.3.4.16090; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sanz AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008955; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Valley CC, 2012, J BIOL CHEM, V287, P21265, DOI 10.1074/jbc.M111.306480; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; Whitsett TG, 2012, AM J PATHOL, V181, P111, DOI 10.1016/j.ajpath.2012.03.026; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Winkles JA, 2007, FRONT BIOSCI-LANDMRK, V12, P2761, DOI 10.2741/2270; Yousaf N, 2005, ARTHRITIS RHEUM-US, V52, P2906, DOI 10.1002/art.21268; Zhou H, 2013, J INVEST DERMATOL, V133, P1052, DOI 10.1038/jid.2012.402; Zhou H, 2011, MOL CANCER THER, V10, P1276, DOI 10.1158/1535-7163.MCT-11-0161	54	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65248	10.1371/journal.pone.0065248	http://dx.doi.org/10.1371/journal.pone.0065248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750247	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900049
J	Falagas, ME; Tansarli, GS; Kapaskelis, A; Vardakas, KZ				Falagas, Matthew E.; Tansarli, Giannoula S.; Kapaskelis, Anastasios; Vardakas, Konstantinos Z.			Impact of Vacuum-Assisted Closure (VAC) Therapy on Clinical Outcomes of Patients with Sternal Wound Infections: A Meta-Analysis of Non-Randomized Studies	PLOS ONE			English	Article							TOPICAL NEGATIVE-PRESSURE; LONG-TERM SURVIVAL; SUCTION DRAINAGE; CARDIAC-SURGERY; MANAGEMENT; MEDIASTINITIS; MORTALITY; TRIAL; COST	Objective: To examine the impact of VAC therapy on mortality of patients with sternal wound infections after cardiothoracic surgery. Summary Background Data: Controversial results regarding mortality of patients with sternal wound infections were published. Methods: We performed a systematic search in PubMed and Scopus. Mortality was the primary outcome of the meta-analysis. Recurrences, complications and length of stay were secondary outcomes. Results: Twenty-two retrospective studies including 2467 patients were eligible for inclusion. Patients treated with VAC had significantly lower mortality compared to those treated without VAC [2233 patients, RR = 0.40, (95% CI 0.28, 0.57)]. This finding was consistent regardless of the study design, the exclusion of studies with positive findings, the criteria for establishment of the compared groups, the time of mortality assessment or the type of infections under study, provided that adequate data was available. VAC therapy was associated with fewer recurrences (RR = 0.34, 95% CI: 0.19-0.59). The meta-analysis did not show any difference in the length of stay (RR = -2.25, 95% CI: -7.52-3.02). Conclusions: VAC therapy was associated with lower mortality than other surgical techniques in retrospective cohorts of patients with DSWIs following cardiothoracic surgery.	[Falagas, Matthew E.; Tansarli, Giannoula S.; Kapaskelis, Anastasios; Vardakas, Konstantinos Z.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.; Kapaskelis, Anastasios; Vardakas, Konstantinos Z.] Mitera Hosp, Hygeia Grp, Dept Internal Med Infect Dis, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Vardakas, Konstantinos/M-5253-2019					Armstrong DG, 2005, LANCET, V366, P1704, DOI 10.1016/S0140-6736(05)67695-7; Assmann A, 2011, THORAC CARDIOV SURG, V59, P25, DOI 10.1055/s-0030-1250598; Baillot R, 2010, EUR J CARDIO-THORAC, V37, P880, DOI 10.1016/j.ejcts.2009.09.023; Berg HF, 2000, ANN THORAC SURG, V70, P924, DOI 10.1016/S0003-4975(00)01524-1; Biefer HRC, 2012, EUR J CARDIO-THORAC, V42, P306, DOI 10.1093/ejcts/ezr326; Bovill E, 2008, INT WOUND J, V5, P511, DOI 10.1111/j.1742-481X.2008.00437.x; Braakenburg A, 2006, PLAST RECONSTR SURG, V118, P390, DOI 10.1097/01.prs.0000227675.63744.af; Catarino PA, 2000, ANN THORAC SURG, V70, P1891, DOI 10.1016/S0003-4975(00)02173-1; Conquest AM, 2003, J SURG RES, V115, P209, DOI 10.1016/S0022-4804(03)00331-7; Damiani G, 2011, J PLAST RECONSTR AES, V64, P1119, DOI 10.1016/j.bjps.2010.11.022; De Feo Marisa, 2011, Asian Cardiovasc Thorac Ann, V19, P39, DOI 10.1177/0218492310395789; De Feo Marisa, 2010, Asian Cardiovasc Thorac Ann, V18, P360, DOI 10.1177/0218492310375854; Deniz H, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-67; Domkowski PW, 2003, J THORAC CARDIOV SUR, V126, P386, DOI 10.1016/S0022-5223(03)00352-0; Doss M, 2002, EUR J CARDIO-THORAC, V22, P934, DOI 10.1016/S1010-7940(02)00594-8; Eyileten Z, 2009, SURG TODAY, V39, P947, DOI 10.1007/s00595-008-3982-5; Flack S, 2008, J Wound Care, V17, P71; Fleck T, 2012, INT WOUND J; Fleck Tatjana, 2006, Int Wound J, V3, P273, DOI 10.1111/j.1742-481X.2006.00273.x; Fuchs U, 2005, ANN THORAC SURG, V79, P526, DOI 10.1016/j.athoracsur.2004.08.032; Gabriel A, 2008, INT WOUND J, V5, P399, DOI 10.1111/j.1742-481X.2007.00423.x; Immer FF, 2005, ANN THORAC SURG, V80, P957, DOI 10.1016/j.athoracsur.2005.03.035; Joseph E, 2000, WOUNDS, V12, P60; Kobayashi T, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-56; Landoni G, 2011, HEART LUNG VESSEL, V3, P9; Mokhtari A, 2008, SCAND CARDIOVASC J, V42, P85, DOI 10.1080/14017430701744469; Morisaki A, 2011, GEN THORAC CARDIOVAS, V59, P261, DOI 10.1007/s11748-010-0727-3; Othman Diaa, 2012, Plast Surg Int, V2012, P374398, DOI 10.1155/2012/374398; Petzina R, 2010, EUR J CARDIO-THORAC, V38, P110, DOI 10.1016/j.ejcts.2010.01.028; Risnes I, 2012, INT WOUND J; Segers Patrique, 2005, Interact Cardiovasc Thorac Surg, V4, P555, DOI 10.1510/icvts.2005.112714; Simek M, 2012, J CARDIOVASC SURG, V53, P113; Sjogren J, 2005, ANN THORAC SURG, V79, P2049, DOI 10.1016/j.athoracsur.2004.12.048; Sjogren J, 2005, ANN THORAC SURG, V80, P1270, DOI 10.1016/j.athoracsur.2005.04.010; Soares MO, 2012, MED DECIS MAKING; Sood Smita, 2012, Indian J Community Med, V37, P39, DOI 10.4103/0970-0218.94023; Steingrimsson S, 2012, INTERACT CARDIOV TH, V15, P406, DOI 10.1093/icvts/ivs254; Toumpoulis IK, 2005, CHEST, V127, P464, DOI 10.1378/chest.127.2.464; van Wingerden JJ, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-121; Vos RJ, 2012, EUR J CARDIOTHORAC S; Vuerstaek JDD, 2006, J VASC SURG, V44, P1029, DOI 10.1016/j.jvs.2006.07.030	41	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64741	10.1371/journal.pone.0064741	http://dx.doi.org/10.1371/journal.pone.0064741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741379	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900092
J	Gaibani, P; Cavrini, F; Gould, EA; Rossini, G; Pierro, A; Landini, MP; Sambri, V				Gaibani, Paolo; Cavrini, Francesca; Gould, Ernest A.; Rossini, Giada; Pierro, Anna; Landini, Maria Paola; Sambri, Vittorio			Comparative Genomic and Phylogenetic Analysis of the First Usutu Virus Isolate from a Human Patient Presenting with Neurological Symptoms	PLOS ONE			English	Article							WEST-NILE-VIRUS; RNA SECONDARY STRUCTURES; STEM-LOOP; DOMAIN-III; SYNONYMOUS MUTATIONS; CELL-PROTEINS; EMERGENCE; REGION; FLAVIVIRUSES; VIRULENCE	Usutu virus (USUV) is a mosquito-borne flavivirus, belonging to the Japanese encephalitis antigenic complex, that circulates among mosquitoes and birds. We describe and analyze the complete genome sequence of the first USUV strain isolated from an immunocompromised patient with neuroinvasive disease. This USUV isolate showed an overall nucleotide identity of 99% and 96%, respectively, with the genomes of isolates from Europe and Africa. Comparison of the human USUV complete polyprotein sequence with bird-derived strains, showed two unique amino acid substitutions. In particular, one substitution (S595G) was situated in the DIII domain of the viral Envelope protein that is recognized by flavivirus neutralizing antibodies. An additional amino acid substitution (D3425E) was identified in the RNA-dependent RNA polymerase (RdRp) domain of the NS5 protein. This substitution is remarkable since E3425 is highly conserved among the other USUV isolates that were not associated with human infection. However, a similar substitution was observed in Japanese encephalitis and in West Nile viruses isolated from humans. Phylogenetic analysis of the human USUV strain revealed a close relationship with an Italian strain isolated in 2009. Analysis of synonymous nucleotide substitutions (SNSs) among the different USUV genomes showed a specific evolutionary divergence among different countries. In addition, 15 SNSs were identified as unique in the human isolate. We also identified four specific nucleotide substitutions in the 59 and 39 untranslated regions (UTRs) in the human isolate that were not present in the other USUV sequences. Our analyses provide the basis for further experimental studies aimed at defining the effective role of these mutations in the USUV genome, their potential role in the development of viral variants pathogenic for humans and their evolution and dispersal out of Africa.	[Gaibani, Paolo; Cavrini, Francesca; Rossini, Giada; Pierro, Anna; Landini, Maria Paola] St Orsola Malpighi Univ Hosp, Reg Reference Ctr Microbiol Emergencies CRREM, Operat Unit Clin Microbiol, Bologna, Italy; [Gould, Ernest A.] Fac Med Marseille, Unite Virus Emergents, Emergence Pathol Virales UMR190, F-13385 Marseille, France; [Sambri, Vittorio] Cent Lab Area Vasta Romagna, Microbiol Unit, Pievesestina, Cesena, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD)	Gaibani, P (corresponding author), St Orsola Malpighi Univ Hosp, Reg Reference Ctr Microbiol Emergencies CRREM, Operat Unit Clin Microbiol, Bologna, Italy.	paolo.gaibani@unibo.it	gaibani, paolo/K-7690-2016; Pierro, Anna/AAC-7407-2022; Rossini, Giada/K-8815-2016; Sambri, Vittorio/H-5372-2019	gaibani, paolo/0000-0003-3791-8635; Pierro, Anna/0000-0001-9873-0367; Rossini, Giada/0000-0002-8917-6680; Sambri, Vittorio/0000-0002-5012-7355	University of Bologna; Ricerca Finalizzata from the Italian Ministry of Health [RF-2009-1539631]; "LAB P3" from Regione Emilia Romagna; Project "PREDEMICS" [278433]	University of Bologna; Ricerca Finalizzata from the Italian Ministry of Health(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); "LAB P3" from Regione Emilia Romagna; Project "PREDEMICS"	This work was partially supported by funds RFO 2010 from University of Bologna, Ricerca Finalizzata RF-2009-1539631 from the Italian Ministry of Health and "LAB P3" from Regione Emilia Romagna, to VS. Parts of this study were also supported under the Project "PREDEMICS" (7th Framework Programme - Grant Agreement no. 278433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLERING L, 2012, EURO SURVEILL, V17; Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005; Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457; Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7; Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058; Cavrini F, 2009, EURO SURVEILL, V14; Cavrini F, 2011, J CLIN VIROL, V50, P221, DOI 10.1016/j.jcv.2010.11.008; Cavrini F, 2009, J INFECT DEV COUNTR, V3, P744, DOI 10.3855/jidc.169; Chambers TJ, 1998, J GEN VIROL, V79, P2375, DOI 10.1099/0022-1317-79-10-2375; Chin JFL, 2007, MICROBES INFECT, V9, P1, DOI 10.1016/j.micinf.2006.09.009; Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0; Chvala S, 2004, J COMP PATHOL, V131, P176, DOI 10.1016/j.jcpa.2004.03.004; Cuevas JM, 2012, MOL BIOL EVOL, V29, P17, DOI 10.1093/molbev/msr179; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Domingo-Calap P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000742; Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10; Gaibani P, 2012, VECTOR-BORNE ZOONOT, V12, P431, DOI 10.1089/vbz.2011.0813; Gaibani P, 2010, J CLIN MICROBIOL, V48, P3338, DOI 10.1128/JCM.02501-09; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Hamano T, 2007, J VIROL, V81, P1528, DOI 10.1128/JVI.01596-06; Lelli R, 2008, ZOONOSES PUBLIC HLTH, V55, P361, DOI 10.1111/j.1863-2378.2008.01146.x; Manarolla G, 2010, VET MICROBIOL, V141, P159, DOI 10.1016/j.vetmic.2009.07.036; McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711; Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631; Novella IS, 2004, J MOL BIOL, V342, P1415, DOI 10.1016/j.jmb.2004.08.003; Pecorari M, 2009, EUROSURVEILLANCE, V14, P15; Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35; Proutski V, 1999, VIRUS RES, V64, P107, DOI 10.1016/S0168-1702(99)00079-9; Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez MD, 2005, VIROLOGY, V336, P70, DOI 10.1016/j.virol.2005.02.020; Savini G, 2011, VET MICROBIOL, V151, P264, DOI 10.1016/j.vetmic.2011.03.036; Shi PY, 1996, J VIROL, V70, P6278, DOI 10.1128/JVI.70.9.6278-6287.1996; Sironen T, 2008, J GEN VIROL, V89, P1309, DOI 10.1099/vir.0.83662-0; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Tamba M, 2011, VECTOR-BORNE ZOONOT, V11, P551, DOI 10.1089/vbz.2010.0055; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tuplin A, 2002, RNA, V8, P824, DOI 10.1017/S1355838202554066; Vazquez A, 2011, EUROSURVEILLANCE, V16, P22; Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191; Zhang SL, 2010, VIROLOGY, V403, P85, DOI 10.1016/j.virol.2010.03.038	51	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64761	10.1371/journal.pone.0064761	http://dx.doi.org/10.1371/journal.pone.0064761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741387	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900100
J	Kijima, T; Koga, F; Fujii, Y; Yoshida, S; Tatokoro, M; Kihara, K				Kijima, Toshiki; Koga, Fumitaka; Fujii, Yasuhisa; Yoshida, Soichiro; Tatokoro, Manabu; Kihara, Kazunori			Zoledronic Acid Sensitizes Renal Cell Carcinoma Cells to Radiation by Downregulating STAT1	PLOS ONE			English	Article							IN-VITRO; 3RD-GENERATION BISPHOSPHONATE; INTERFERON-ALPHA; BONE METASTASES; CANCER; RADIOTHERAPY; INHIBITION; ACTIVATION; RESISTANCE; MANAGEMENT	Zoledronic acid (ZOL), a third-generation bisphosphonate that strongly inhibits osteoclast activity, is widely used for the treatment of bone metastasis from a variety of malignancies, including renal cell carcinoma (RCC). We previously reported that zoledronic acid (ZOL) clinically potentiates antitumor effects of radiotherapy (RT) on bone metastases from RCC. To date, however, it remains unknown whether ZOL radiosensitizes RCC and if it does, how. Here, we demonstrated that ZOL directly radiosensitizes RCC cells independent of osteoclast activity by potentiating the caspase-3-mediated apoptosis pathway. The radiosensitization by ZOL was observed in 786-O, A-498, and ACHN cells but not in Caki-1 cells. As its underlying molecular mechanism, we found that the signal transducer and activator of transcription 1 (STAT1) plays a key role. The three RCC cell lines, in which ZOL exerted a radiosensitizing effect, expressed STAT1 abundantly but Caki-1 cells did not. ZOL downregulated endogenous STAT1 expression in 786-O, A-498, and ACHN cells by a post-transcriptional modification. We confirmed that knockdown of endogenous STAT1 by siRNA sensitized 786-O cells to RT equivalently to ZOL, and that introduction of exogenous STAT1 rendered Caki-1 cells more RT-resistant. This is the first study to clarify the molecular mechanism by which ZOL directly radiosensitizes tumor cells. Because tumor cells commonly overexpress STAT1 and ZOL reportedly radiosensitizes various types of tumor cells, ZOL warrants further clinical and translational studies as a potent radiosensitizer against RT-resistant tumors overexpressing STAT1.	[Kijima, Toshiki; Koga, Fumitaka; Fujii, Yasuhisa; Yoshida, Soichiro; Tatokoro, Manabu; Kihara, Kazunori] Tokyo Med & Dent Univ, Dept Urol, Grad Sch, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Koga, F (corresponding author), Tokyo Med & Dent Univ, Dept Urol, Grad Sch, Tokyo, Japan.	f-koga.uro@tmd.ac.jp	Koga, Fumitaka/AAO-4655-2021; KOGA, Fumitaka/AAM-8739-2021; , Fumitaka/AAO-2957-2021; Kijima, Toshiki/AAF-8264-2020; Koga, Fumitaka/AAO-2779-2021	KOGA, Fumitaka/0000-0001-7888-0085; , Fumitaka/0000-0001-7888-0085; Kijima, Toshiki/0000-0002-4380-9294; yoshida, soichiro/0000-0003-2757-8083	Ministry of Education, Culture, Sports, Science and Technology of Japan [23791745]; Grants-in-Aid for Scientific Research [23791745] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (23791745) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algur E, 2005, INT J RADIAT ONCOL, V61, P535, DOI 10.1016/j.ijrobp.2004.09.065; Alt AL, 2011, CANCER-AM CANCER SOC, V117, P2873, DOI 10.1002/cncr.25836; Bernhard EJ, 2000, CANCER RES, V60, P6597; Brunner TB, 2003, INT J RADIAT BIOL, V79, P569, DOI 10.1080/09553000310001610196; Chen TL, 2002, J CLIN PHARMACOL, V42, P1228, DOI 10.1177/009127002762491316; Clezardin P, 2003, CURR MED CHEM, V10, P173, DOI 10.2174/0929867033368529; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dhillon S, 2008, DRUGS, V68, P507, DOI 10.2165/00003495-200868040-00010; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Gupta AK, 2001, CANCER RES, V61, P4278; Hagan M, 2000, RADIAT RES, V153, P371, DOI 10.1667/0033-7587(2000)153[0371:IRIMAP]2.0.CO;2; Heymann D, 2004, TRENDS MOL MED, V10, P337, DOI 10.1016/j.molmed.2004.05.007; Hui ZG, 2009, INT J RADIAT ONCOL, V73, P288, DOI 10.1016/j.ijrobp.2008.08.043; Inamura K, 2005, BBA-MOL CELL RES, V1745, P401, DOI 10.1016/j.bbamcr.2005.06.003; KASID U, 1989, SCIENCE, V243, P1354, DOI 10.1126/science.2466340; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Kijima T, 2009, BJU INT, V103, P620, DOI 10.1111/j.1464-410X.2008.08124.x; KJAER M, 1987, INT J RADIAT ONCOL, V13, P665, DOI 10.1016/0360-3016(87)90283-5; Lei Y, 2010, MOL CELL BIOCHEM, V344, P23, DOI 10.1007/s11010-010-0525-3; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lipton A, 2003, CANCER, V98, P962, DOI 10.1002/cncr.11571; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Matsumoto S, 2005, LUNG CANCER, V47, P31, DOI 10.1016/j.lungcan.2004.06.003; Palayoor ST, 2004, CLIN CANCER RES, V10, P4158, DOI 10.1158/1078-0432.CCR-04-0005; Redman BG, 1998, CLIN CANCER RES, V4, P283; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Ryu K, 2010, ANTICANCER RES, V30, P2713; Shang D, 2007, CANCER SCI, V98, P1259, DOI 10.1111/j.1349-7006.2007.00526.x; Smyth A, 2007, INT J RADIAT BIOL, V83, P13, DOI 10.1080/09553000600983136; Ural AU, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1543; Vassiliou V, 2009, ANTI-CANCER AGENT ME, V9, P326, DOI 10.2174/1871520610909030326; Weiss HM, 2008, DRUG METAB DISPOS, V36, P2043, DOI 10.1124/dmd.108.021071; Yao RS, 2002, ONCOGENE, V21, P5814, DOI 10.1038/sj.onc.1205422; Yuasa T, 2005, CLIN CANCER RES, V11, P853; Zekri J, 2001, INT J ONCOL, V19, P379; ZHANG RD, 1992, AM J PATHOL, V141, P1115	38	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64615	10.1371/journal.pone.0064615	http://dx.doi.org/10.1371/journal.pone.0064615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741352	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900065
J	Nguyen, HB; Eshete, B; Lau, KHW; Sai, A; Villarin, M; Baylink, D				Nguyen, H. Bryant; Eshete, Blen; Lau, K. H. William; Sai, Adarsh; Villarin, Mark; Baylink, David			Serum 1,25-Dihydroxyvitamin D: An Outcome Prognosticator in Human Sepsis	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; SYSTEMIC INFLAMMATORY RESPONSE; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; ORGAN DYSFUNCTION; SEPTIC PATIENTS; D-3; EXPRESSION; STABILITY; MORTALITY; RADIOIMMUNOASSAY	In sepsis, the vitamin D active metabolite 1,25-dihydroxyvitamin D (1,25(OH)(2)D) may play a crucial role by its action to produce cathelicidin and improve endothelial barrier function, such that a deficiency in 1,25(OH)(2)D is associated with poor outcome. To test our hypothesis, we performed analysis of stored plasma samples from a prospective observational study in 91 patients with sepsis, age of 59.1+/22.0 years, 52.7% females, and 11.0% deaths at 30 days. Vitamin D status, including 25-hydroxyvitamin D (25(OH)D), 1,25(OH)(2)D, 24,25-dihydroxyvitamin D (24,25(OH)(2)D), and parathyroid hormone (PTH), were measured daily over 3 days after hospital admission. At baseline, 1,25(OH)(2)D was significantly different between survivors vs. non-survivors. But there was no significant difference in 25(OH)D, 24,25(OH)(2)D, and PTH. In a multivariable binomial logistic regression model, age, total calcium and 1,25(OH)(2)D were significant predictors of 30-day mortality. Kaplan Meier analysis showed that patients with mean 1,25(OH)(2)D measured over 3 days of < = 13.6 pg/mL had 57.1% 30-day survival compared to 91.7% in patients with 1,25 (OH)(2)D level.13.6 pg/mL (p < 0.01). From repeated measures regression analysis, there was significant increase in 1,25(OH)(2)D for increases in 25(OH)D in both survivors and non-survivors. However, compared to survivors, the low 25(OH)D in non-survivors was insufficient to account for the larger decrease in 1,25(OH)(2)D, indicating a dysfunctional 1 alpha-hydroxylase. Additionally, there was a significant negative correlation between PTH and 1,25(OH)(2)D in both survivors and non-survivors, suggesting a severe impairment in the effect of PTH to increase renal 1 alpha-hydroxylase activity. In conclusion, low 1,25(OH)(2)D levels are associated with increased 30-day mortality in sepsis patients, likely due to impaired 25(OH)D hydroxylation and PTH insensitivity. Our data also suggest that the active metabolite 1,25(OH)(2)D may be an important therapeutic target in the design of sepsis clinical trials.	[Nguyen, H. Bryant; Eshete, Blen; Lau, K. H. William; Sai, Adarsh; Baylink, David] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Nguyen, H. Bryant; Villarin, Mark] Loma Linda Univ, Dept Emergency Med, Loma Linda, CA 92350 USA; [Lau, K. H. William] Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA	Loma Linda University; Loma Linda University	Nguyen, HB (corresponding author), Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA.	hbnguyen@llu.edu	Sai, Adarsh/I-3204-2014	Sai, Adarsh/0000-0003-3695-962X; Lau, Kin-Hing/0000-0003-1109-5052				Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Anderson PH, 2010, J STEROID BIOCHEM, V121, P288, DOI 10.1016/j.jsbmb.2010.03.022; Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Antoniucci DM, 2005, CLIN CHEM, V51, P258; Arnson Y, 2012, QJM-INT J MED, V105, P633, DOI 10.1093/qjmed/hcs014; Asakura H, 2001, THROMB HAEMOSTASIS, V85, P287; BEILFUSS J, 2012, CYTOKINE; Borgermann J, 2012, CRIT CARE MED, V40, P2073, DOI 10.1097/CCM.0b013e31824e8c42; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Brinc D, 2012, CLIN BIOCHEM, V45, P816, DOI 10.1016/j.clinbiochem.2012.03.029; Cavalier E, 2009, CLIN J AM SOC NEPHRO, V4, P1988, DOI 10.2215/CJN.03970609; Cecchi A, 2011, MINERVA ANESTESIOL, V77, P1184; Chun RF, 2010, J CLIN ENDOCR METAB, V95, P3368, DOI 10.1210/jc.2010-0195; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; El-Khoury JM, 2012, CLIN BIOCHEM, V45, P707, DOI 10.1016/j.clinbiochem.2012.03.016; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Flynn L, 2012, AM J SURG, V203, P379, DOI 10.1016/j.amjsurg.2011.09.012; Fry DE, 2012, AM SURGEON, V78, P1; Ginde AA, 2011, ACAD EMERG MED, V18, P550, DOI 10.1111/j.1553-2712.2011.01047.x; Hewison M, 2004, MOL CELL ENDOCRINOL, V215, P31, DOI 10.1016/j.mce.2003.11.017; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Hoenderop JGJ, 2004, KIDNEY INT, V65, P531, DOI 10.1111/j.1523-1755.2004.00402.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 1996, CLIN CHEM, V42, P586; HOLLIS BW, 1993, CLIN CHEM, V39, P529; HORIUCHI H, 1991, AGENTS ACTIONS, V33, P343, DOI 10.1007/BF01986584; HORST RL, 1981, J CLIN INVEST, V67, P274, DOI 10.1172/JCI110023; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Krishnan A, 2010, CRIT CARE, V14, DOI 10.1186/cc9341; Kudo K, 2012, J STEROID BIOCHEM, V132, P290, DOI 10.1016/j.jsbmb.2012.07.003; Lind L, 2000, CRIT CARE MED, V28, P93, DOI 10.1097/00003246-200001000-00015; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lucas CE, 2010, SURGERY, V148, P135, DOI 10.1016/j.surg.2009.11.024; Martinesi M, 2006, CELL BIOL INT, V30, P365, DOI 10.1016/j.cellbi.2006.01.004; McKinney JD, 2011, J AM MED DIR ASSOC, V12, P208, DOI 10.1016/j.jamda.2010.04.004; MITLAK BH, 1992, J BONE MINER RES, V7, P479; Moller Soren, 2007, Int J Med Sci, V4, P190; Nizet V, 2003, SCAND J INFECT DIS, V35, P670, DOI 10.1080/00365540310015629; Pike JW, 2008, ENDOCRINOLOGY, V149, P3656, DOI 10.1210/en.2008-0042; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Shapiro NI, 2009, CRIT CARE MED, V37, P96, DOI 10.1097/CCM.0b013e318192fd9d; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P335, DOI 10.1081/IPH-120014721; Venkatram S, 2011, CRIT CARE, V15, DOI 10.1186/cc10585; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; WALDRON JL, 2013, J CLIN PATHOL; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Zhang QH, 2012, MOL CELL ENDOCRINOL, V355, P153, DOI 10.1016/j.mce.2012.02.006	51	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64348	10.1371/journal.pone.0064348	http://dx.doi.org/10.1371/journal.pone.0064348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741318	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900030
J	Jiang, FN; He, HC; Zhang, YQ; Yang, DL; Huang, JH; Zhu, YX; Mo, RJ; Chen, G; Yang, SB; Chen, YR; Zhong, WD; Zhou, WL				Jiang, Fu-neng; He, Hui-chan; Zhang, Yan-qiong; Yang, Deng-Liang; Huang, Jie-Hong; Zhu, Yun-xin; Mo, Ru-jun; Chen, Guo; Yang, Sheng-bang; Chen, Yan-ru; Zhong, Wei-de; Zhou, Wen-Liang			An Integrative Proteomics and Interaction Network-Based Classifier for Prostate Cancer Diagnosis	PLOS ONE			English	Article							UP-REGULATION; TUMOR; PTEN; 2D-DIGE; PROGRESSION; RECURRENCE; EXPRESSION; BIOMARKERS; PROTEIN	Aim: Early diagnosis of prostate cancer (PCa), which is a clinically heterogeneous-multifocal disease, is essential to improve the prognosis of patients. However, published PCa diagnostic markers share little overlap and are poorly validated using independent data. Therefore, we here developed an integrative proteomics and interaction network-based classifier by combining the differential protein expression with topological features of human protein interaction networks to enhance the ability of PCa diagnosis. Methods and Results: By two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) coupled with MS using PCa and adjacent benign tissues of prostate, a total of 60 proteins with the differential expression in PCa tissues were identified as the candidate markers. Then, their networks were analyzed by GeneGO Meta-Core software and three hub proteins (PTEN, SFPQ and HDAC1) were chosen. After that, a PCa diagnostic classifier was constructed by support vector machine (SVM) modeling based on the microarray gene expression data of the genes which encode the hub proteins mentioned above. Validations of diagnostic performance showed that this classifier had high predictive accuracy (85.96 similar to 90.18%) and area under ROC curve (approximating 1.0). Furthermore, the clinical significance of PTEN, SFPQ and HDAC1 proteins in PCa was validated by both ELISA and immunohistochemistry analyses. More interestingly, PTEN protein was identified as an independent prognostic marker for biochemical recurrence-free survival in PCa patients according to the multivariate analysis by Cox Regression. Conclusions: Our data indicated that the integrative proteomics and interaction network-based classifier which combines the differential protein expression and topological features of human protein interaction network may be a powerful tool for the diagnosis of PCa. We also identified PTEN protein as a novel prognostic marker for biochemical recurrence-free survival in PCa patients.	[Jiang, Fu-neng; Yang, Deng-Liang; Huang, Jie-Hong; Zhu, Yun-xin; Zhou, Wen-Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Fu-neng; He, Hui-chan; Mo, Ru-jun; Chen, Guo; Yang, Sheng-bang; Chen, Yan-ru; Zhong, Wei-de] Guangzhou Med Univ, Guangdong Key Lab Clin Mol Med & Diagnost, Guangzhou Peoples Hosp 1, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Zhang, Yan-qiong] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Zhong, WD (corresponding author), Guangzhou Med Univ, Guangdong Key Lab Clin Mol Med & Diagnost, Guangzhou Peoples Hosp 1, Dept Urol, Guangzhou, Guangdong, Peoples R China.	zhongwd2009@live.cn; lsszwl@yahoo.com.cn		Zhong, Weide/0000-0002-0430-2845	National Natural Science Foundation of China [81200550]; Chinese National Key Program of Basic Research [2010CB912700, 2011CB910601]; National ST Major Project [2008ZX10002-016, 2009ZX09301-002]; National Major Scientific and Technological Special Project [2011ZX09307-304]; Science and Technology Project of Guangdong Province [2010B060500003]; Guangzhou Municipal Science and Technology Key Project [2010Y1-C041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Program of Basic Research; National ST Major Project; National Major Scientific and Technological Special Project; Science and Technology Project of Guangdong Province; Guangzhou Municipal Science and Technology Key Project	This work was partly funded by National Natural Science Foundation of China (81200550), Chinese National Key Program of Basic Research (2010CB912700, 2011CB910601), National S&T Major Project (2008ZX10002-016, 2009ZX09301-002), National Major Scientific and Technological Special Project (2011ZX09307-304), Science and Technology Project of Guangdong Province (2010B060500003), Guangzhou Municipal Science and Technology Key Project (2010Y1-C041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis ES, 2012, CANCER-AM CANCER SOC, V118, P6063, DOI 10.1002/cncr.27689; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Chaux A, 2012, MODERN PATHOL, V25, P1543, DOI 10.1038/modpathol.2012.104; Chen JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040817; Chen L, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-161; Choucair K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-543; Collet B, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-16; Corona G, 2010, INT J ONCOL, V36, P93, DOI 10.3892/ijo_00000479; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Han ZD, 2012, MED ONCOL, V29, P2877, DOI 10.1007/s12032-011-0149-9; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kenfield SA, 2011, JAMA-J AM MED ASSOC, V305, P2548, DOI 10.1001/jama.2011.879; Klopfleisch R, 2010, J PROTEOME RES, V9, P6380, DOI 10.1021/pr100671c; Klotz Laurence, 2000, Cancer, V88, P3009, DOI 10.1002/1097-0142(20000615)88:12+<3009::AID-CNCR17>3.0.CO;2-E; Kurokawa K, 2012, J GASTROENTEROL, V47, P883, DOI 10.1007/s00535-012-0547-6; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Li XH, 2006, CANCER RES, V66, P9323, DOI 10.1158/0008-5472.CAN-06-1578; Muto T, 2011, J PROTEOMICS, V74, P858, DOI 10.1016/j.jprot.2011.02.030; Nishimori T, 2006, PROTEOMICS, V6, P1011, DOI 10.1002/pmic.200500262; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Orenes-Pinero E, 2007, J PROTEOME RES, V6, P4440, DOI 10.1021/pr070368w; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pang J, 2010, J PROTEOME RES, V9, P216, DOI 10.1021/pr900953s; Patra SK, 2001, BIOCHEM BIOPH RES CO, V287, P705, DOI 10.1006/bbrc.2001.5639; Rong YF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-68; Sinclair J, 2011, J PROTEOMICS, V74, P451, DOI 10.1016/j.jprot.2010.12.009; Tanaka M, 2009, AM J SURG PATHOL, V33, P1416, DOI 10.1097/PAS.0b013e3181a9cd6c; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Weeks ME, 2010, METHODS MOL BIOL, V658, P293, DOI 10.1007/978-1-60761-780-8_18; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Wu Z, 2012, PROSTATE IN PRESS; Xu YJ, 2011, BIOCHEM PHARMACOL, V82, P210, DOI 10.1016/j.bcp.2011.04.012; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022426; Zhong WD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-248	38	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63941	10.1371/journal.pone.0063941	http://dx.doi.org/10.1371/journal.pone.0063941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737958	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700022
J	Pathak, S; Lakhwani, D; Gupta, P; Mishra, BK; Shukla, S; Asif, MH; Trivedi, PK				Pathak, Sumya; Lakhwani, Deepika; Gupta, Parul; Mishra, Brij Kishore; Shukla, Sudhir; Asif, Mehar Hasan; Trivedi, Prabodh Kumar			Comparative Transcriptome Analysis Using High Papaverine Mutant of Papaver somniferum Reveals Pathway and Uncharacterized Steps of Papaverine Biosynthesis	PLOS ONE			English	Article							OPIUM POPPY; MORPHINE BIOSYNTHESIS; ALKALOID BIOSYNTHESIS; MOLECULAR-CLONING; GENE-EXPRESSION; ENZYME; SYNTHASE; SALUTARIDINE; METABOLISM; PART	The benzylisoquinoline alkaloid papaverine, synthesized in low amount in most of the opium poppy varieties of Papaver somniferum, is used as a vasodilator muscle relaxant and antispasmodic. Papaverine biosynthesis remains controversial as two different routes utilizing either (S)-coclaurine or (S)-reticuline have been proposed with uncharacterized intermediate steps. In an attempt to elucidate papaverine biosynthesis and identify putative genes involved in uncharacterized steps, we carried out comparative transcriptome analysis of high papaverine mutant (pap1) and normal cultivar (BR086) of P. somniferum. This natural mutant synthesizes more than 12-fold papaverine in comparison to BR086. We established more than 238 Mb transcriptome data separately for pap1 and BR086. Assembly of reads generated 127,342 and 106,128 unigenes in pap1 and BR086, respectively. Digital gene expression analysis of transcriptomes revealed 3,336 differentially expressing unigenes. Enhanced expression of (S)-norcoclaurine-6-O-methyltransferase (6OMT), (S)-3'-hydroxy-N-methylcoclaurine 4'-O-methyltransferase (4'OMT), norreticuline 7-O-methyltransferase (N7OMT) and down-regulation of reticuline 7-O-methyltransferase (7OMT) in pap1 in comparison to BR086 suggest (S)-coclaurine as the route for papaverine biosynthesis. We also identified several methyltransferases and dehydrogenases with enhanced expression in pap1 in comparison to BR086. Our analysis using natural mutant, pap1, concludes that (S)-coclaurine is the branch-point intermediate and preferred route for papaverine biosynthesis. Differentially expressing methyltransferases and dehydrogenases identified in this study will help in elucidating complete biosynthetic pathway of papaverine. The information generated will be helpful in developing strategies for enhanced biosynthesis of papaverine through biotechnological approaches.	[Pathak, Sumya; Lakhwani, Deepika; Gupta, Parul; Mishra, Brij Kishore; Shukla, Sudhir; Asif, Mehar Hasan; Trivedi, Prabodh Kumar] Natl Bot Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Trivedi, PK (corresponding author), Natl Bot Res Inst, CSIR, Rana Pratap Marg, Lucknow 226001, Uttar Pradesh, India.	prabodht@hotmail.com			Council of Scientific and Industrial Research, New Delhi, Government of India [NWP-08, BSC0107]	Council of Scientific and Industrial Research, New Delhi, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to the Council of Scientific and Industrial Research, New Delhi, Government of India, for providing the financial support to carry out this work under Network project (NWP-08 and BSC0107). SP acknowledges the Council of Scientific and Industrial Research, New Delhi, Government of India for a Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; Brisman JL, 2006, NEUROL RES, V28, P769, DOI 10.1179/016164106X152043; BROCHMAN.E, 1971, J PHARM SCI, V60, P1672, DOI 10.1002/jps.2600601118; Brochmann-Hanssen E, 1975, J CHEM SOC P1, V16, P1531; BROCHMANNHANSSEN E, 1980, J NAT PROD, V43, P736, DOI 10.1021/np50012a007; Damen L, 2006, CEPHALALGIA, V26, P497, DOI 10.1111/j.1468-2982.2005.01047.x; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; DellaPenna D, 2012, SCIENCE, V336, P1648, DOI 10.1126/science.1225473; Desgagne-Penix I, 2012, PLANT J, V72, P331, DOI 10.1111/j.1365-313X.2012.05084.x; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Facchini PJ, 2003, PHYTOCHEMISTRY, V64, P177, DOI 10.1016/S0031-9422(03)00292-9; GERARDY R, 1993, PHYTOCHEMISTRY, V32, P79, DOI 10.1016/0031-9422(92)80111-Q; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Gupta P, 2013, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0062714, DOI 10.1371/J0URNAL.-P0NE.0062714]; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Han X, 2010, PHYTOCHEMISTRY, V71, P1305, DOI 10.1016/j.phytochem.2010.04.022; Hirata K, 2004, PHYTOCHEMISTRY, V65, P1039, DOI 10.1016/j.phytochem.2004.02.015; KHANNA K R, 1991, Herba Hungarica, V30, P7; Lee EJ, 2010, PLANT CELL, V22, P3489, DOI 10.1105/tpc.110.077958; Liscombe DK, 2005, PHYTOCHEMISTRY, V66, P2500, DOI 10.1016/j.phytochem.2005.04.044; Menniti FS, 2007, CURR OPIN INVESTIG D, V8, P54; Millgate AG, 2004, NATURE, V431, P413, DOI 10.1038/431413a; Mishra BK, 2010, S AFR J BOT, V76, P447, DOI 10.1016/j.sajb.2010.02.090; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Ounaroon A, 2003, PLANT J, V36, P808, DOI 10.1046/j.1365-313X.2003.01928.x; Pathak S, 2012, PLANT GROWTH REGUL, V68, P17, DOI 10.1007/s10725-012-9689-z; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; Pienkny S, 2009, PLANT J, V60, P56, DOI 10.1111/j.1365-313X.2009.03937.x; Sato Y, 2007, BIOL PHARM BULL, V30, P145, DOI 10.1248/bpb.30.145; Shukla S, 1999, INDIAN J AGR SCI, V69, P44; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Thomas JA, 2002, JPN J PHARMACOL, V89, P101, DOI 10.1254/jjp.89.101; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Weid M, 2004, P NATL ACAD SCI USA, V101, P13957, DOI 10.1073/pnas.0405704101; Ziegler J, 2005, PLANTA, V222, P458, DOI 10.1007/s00425-005-1550-4; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x	41	29	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e65622	10.1371/journal.pone.0065622	http://dx.doi.org/10.1371/journal.pone.0065622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738019	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700080
J	Santana, IL; Goncalves, LM; de Vasconcellos, AA; da Silva, WJ; Cury, JA; Cury, AAD				Santana, Ivone Lima; Goncalves, Leticia Machado; de Vasconcellos, Andrea Araujo; da Silva, Wander Jose; Cury, Jaime Aparecido; Del Bel Cury, Altair Antoninha			Dietary Carbohydrates Modulate Candida albicans Biofilm Development on the Denture Surface	PLOS ONE			English	Article							CELL-WALL PROTEOME; DRUG-RESISTANCE; FREE-ENERGY; ORAL CANDIDOSIS; FUNGAL PATHOGEN; IN-SITU; ADHERENCE; SUCROSE; VIRULENCE; ADHESION	The purpose of this study was to investigate whether dietary carbohydrates can modulate the development of Candida albicans biofilms on the denture material surface. Poly (methyl methacrylate) acrylic resin discs were fabricated and had their surface roughness measured. Biofilms of C. albicans ATCC 90028 were developed on saliva-coated specimens in culture medium without (control) or with carbohydrate supplementation by starch, starch+sucrose, glucose, or sucrose for 72 h. The cell count, metabolic activity, biovolume, average thickness, and roughness coefficient were evaluated at the adhesion phase (1.5 h) and after 24, 48, and 72 h. The secretion of proteinases and phospholipases, cell surface energy, and production of extra/intracellular polysaccharides were analyzed after 72 h of biofilm development. Data were analyzed by one-and two-way ANOVA followed by Tukey's test at 5% significance level. In the early stages of colonization (adhesion and 24 h), the glucose group showed the highest cell counts and metabolic activity among the groups (p < 0.05). After maturation (48 and 72 h), biofilms exposed to glucose, sucrose, or starch+sucrose showed higher cell counts and metabolic activity than the control and starch groups (p < 0.001). Compared to the control group, biofilms developed on starch or starch+sucrose had more proteinase activity (p < 0.001), whereas biofilms developed on glucose or sucrose had more phospholipase activity (p < 0.05). Exposure to starch+sucrose increased the production of extracellular and intracellular polysaccharides (p < 0.05). Biofilms developed on starch or without carbohydrate supplementation presented cells with more hydrophobic behavior compared to the other groups. Confocal images showed hyphae forms on biofilms exposed to starch or starch+sucrose. Within the conditions studied, it can be concluded that dietary carbohydrates can modulate biofilm development on the denture surface by affecting virulence factors and structural features.	[Santana, Ivone Lima] Univ Fed Maranhao, Sch Dent, Dept Dent 1, Sao Luis, Maranhao, Brazil; [Goncalves, Leticia Machado; de Vasconcellos, Andrea Araujo; da Silva, Wander Jose; Del Bel Cury, Altair Antoninha] Univ Estadual Campinas, Dept Prosthodont & Periodontol, Piracicaba Dent Sch, Sao Paulo, Brazil; [Cury, Jaime Aparecido] Univ Estadual Campinas, Dept Physiol Sci, Piracicaba Dent Sch, Sao Paulo, Brazil	Universidade Federal do Maranhao; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Cury, AAD (corresponding author), Univ Estadual Campinas, Dept Prosthodont & Periodontol, Piracicaba Dent Sch, Sao Paulo, Brazil.	altcury@fop.unicamp.br	DEL BEL CURY, ALTAIR A/G-9022-2015; Del Bel Cury, Altair A/C-5191-2012; Cury, Jaime/AAV-6647-2021; da Silva, Wander José/C-7881-2012; Cury, Jaime/G-3607-2012	DEL BEL CURY, ALTAIR A/0000-0002-4329-0437; da Silva, Wander José/0000-0002-5613-5081; Cury, Jaime/0000-0003-1046-5605	Brazilian National Agency for Science and Technology [2006-7/308141]	Brazilian National Agency for Science and Technology	This work was supported by Brazilian National Agency for Science and Technology (grant number 2006-7/308141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x; Aires CP, 2008, CARIES RES, V42, P380, DOI 10.1159/000154783; Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980, DOI 10.1128/AEM.48.5.980-983.1984; Combe EC, 2004, DENT MATER, V20, P262, DOI 10.1016/S0109-5641(03)00102-7; Cury JA, 1997, CARIES RES, V31, P356, DOI 10.1159/000262418; Silva Wander José da, 2008, Braz. Dent. J., V19, P364, DOI 10.1590/S0103-64402008000400014; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Ene IV, 2012, PROTEOMICS, V12, P3164, DOI 10.1002/pmic.201200228; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Gocke Reinhard, 2002, Clin Oral Investig, V6, P227, DOI 10.1007/s00784-002-0176-1; Goncalves LM, 2012, J DENT RES, V91, P985, DOI 10.1177/0022034512458689; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Jayatilake JAMS, 2011, MYCOPATHOLOGIA, V171, P235, DOI 10.1007/s11046-010-9373-7; Jin Y, 2004, ARCH ORAL BIOL, V49, P789, DOI 10.1016/j.archoralbio.2004.04.011; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; Kang SH, 2012, ACTA ODONTOL SCAND; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Klein MI, 2009, APPL ENVIRON MICROB, V75, P837, DOI 10.1128/AEM.01299-08; Konno N, 2006, BIOL PHARM BULL, V29, P923, DOI 10.1248/bpb.29.923; Lingstrom P, 2000, CRIT REV ORAL BIOL M, V11, P366, DOI 10.1177/10454411000110030601; Lyon JP, 2006, ORAL SURG ORAL MED O, V102, P632, DOI 10.1016/j.tripleo.2005.12.015; MCCOURTIE J, 1984, INFECT IMMUN, V45, P6, DOI 10.1128/IAI.45.1.6-12.1984; MINAGI S, 1985, INFECT IMMUN, V47, P11, DOI 10.1128/IAI.47.1.11-14.1985; Moura JS, 2006, J PROSTHET DENT, V96, P205, DOI 10.1016/j.prosdent.2006.07.004; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; Nikawa H, 2001, ORAL MICROBIOL IMMUN, V16, P279, DOI 10.1034/j.1399-302x.2001.016005279.x; Ning Y, 2012, INT ENDOD J; Pande M, 2006, J AGR FOOD CHEM, V54, P10141, DOI 10.1021/jf062206a; QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x; SAMARANAYAKE LP, 1983, J ORAL PATHOL MED, V12, P84, DOI 10.1111/j.1600-0714.1983.tb00321.x; SAMARANAYAKE LP, 1984, SABOURAUDIA, V22, P201; SAMARANAYAKE LP, 1986, J ORAL PATHOL MED, V15, P61, DOI 10.1111/j.1600-0714.1986.tb00578.x; SAMARANAYAKE LP, 1985, FEMS MICROBIOL LETT, V27, P1, DOI 10.1111/j.1574-6968.1985.tb01627.x; SAMARANAYAKE LP, 1982, J MED MICROBIOL, V15, P511, DOI 10.1099/00222615-15-4-511; Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x; Seneviratne CJ, 2009, MYCOPATHOLOGIA, V167, P325, DOI 10.1007/s11046-009-9184-x; Sosinska GJ, 2008, MICROBIOL-SGM, V154, P510, DOI 10.1099/mic.0.2007/012617-0; Taniguchi L, 2009, J MICROBIOL METH, V78, P171, DOI 10.1016/j.mimet.2009.05.012; Tenuta LMA, 2006, CARIES RES, V40, P546, DOI 10.1159/000095656; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828	44	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64645	10.1371/journal.pone.0064645	http://dx.doi.org/10.1371/journal.pone.0064645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737992	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700056
J	Dickinson, JE; Bell, J; Badcock, DR				Dickinson, J. Edwin; Bell, Jason; Badcock, David R.			Near Their Thresholds for Detection, Shapes Are Discriminated by the Angular Separation of Their Corners	PLOS ONE			English	Article							POSTERIOR INFEROTEMPORAL CORTEX; HUMAN-VISION; AREA V4; RECOGNITION; MODEL; SELECTIVITY; PERCEPTION; PATTERNS; CONTOURS; CUES	Observers make sense of scenes by parsing images on the retina into meaningful objects. This ability is retained for line drawings, demonstrating that critical information is concentrated at object boundaries. Information theoretic studies argue for further concentration at points of maximum curvature, or corners, on such boundaries [1-3] suggesting that the relative positions of such corners might be important in defining shape. In this study we use patterns subtly deformed from circular, by a sinusoidal modulation of radius, in order to measure threshold sensitivity to shape change. By examining the ability of observers to discriminate between patterns of different frequency and/or number of cycles of modulation in a 2x2 forced choice task we were able to show, psychophysically, that difference in a single cue, the periodicity of the corners (specifically the polar angle between two points of maximum curvature) was sufficient to allow discrimination of two patterns near their thresholds for detection. We conclude that patterns could be considered as labelled for this measure. These results suggest that a small number of such labels might be sufficient to identify an object.	[Dickinson, J. Edwin; Bell, Jason; Badcock, David R.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Bell, Jason] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia	University of Western Australia; Australian National University	Dickinson, JE (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia.	edwin.dickinson@uwa.edu.au	Badcock, David R/A-4913-2008	Badcock, David R/0000-0002-4517-435X; Dickinson, Edwin/0000-0003-0834-4708; Bell, Jason/0000-0002-1583-5292	Australian reserch council [DP0666206, DP1097003, DP110104553, DP110101511]	Australian reserch council	Funding came from Australian reserch council grants DP0666206, DP1097003 and DP110104553 to DRB and DP110101511 to JB, www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Barlow HB, 2009, PERCEPTION, V38, P795, DOI 10.1068/pmkbar; Bell J, 2008, VISION RES, V48, P2336, DOI 10.1016/j.visres.2008.07.015; Bell J, 2008, VISION RES, V48, P2293, DOI 10.1016/j.visres.2008.07.003; Jason B, 2009, VISION RES, V49, P843, DOI 10.1016/j.visres.2009.03.001; BIEDERMAN I, 1991, COGNITIVE PSYCHOL, V23, P393, DOI 10.1016/0010-0285(91)90014-F; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carlson ET, 2011, CURR BIOL, V21, P288, DOI 10.1016/j.cub.2011.01.013; Connor C. E., 2004, VISUAL NEUROSCIENCES, P1080; Dickinson J. E., 2010, J VISION, V10; Dickinson JE, 2012, J VISION, V12; Feldman J, 2005, PSYCHOL REV, V112, P243, DOI 10.1037/0033-295X.112.1.243; FURCHNER CS, 1977, VISION RES, V17, P827, DOI 10.1016/0042-6989(77)90126-2; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; KLEIN SA, 1985, J OPT SOC AM A, V2, P1560, DOI 10.1364/JOSAA.2.001560; Loffler G, 2003, VISION RES, V43, P519, DOI 10.1016/S0042-6989(02)00686-7; NACHMIAS J, 1975, VISION RES, V15, P217, DOI 10.1016/0042-6989(75)90210-2; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Poirier FJAM, 2006, VISION RES, V46, P2443, DOI 10.1016/j.visres.2006.01.026; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Schmidtmann G, 2012, VISION RES, V62, P44, DOI 10.1016/j.visres.2012.03.001; SUTHERLAND NS, 1968, PROC R SOC SER B-BIO, V171, P297, DOI 10.1098/rspb.1968.0072; Wang YZ, 2005, VISION RES, V45, P1375, DOI 10.1016/j.visres.2004.12.003; WATSON AB, 1981, VISION RES, V21, P1115, DOI 10.1016/0042-6989(81)90014-6; Wilkinson F, 1998, VISION RES, V38, P3555, DOI 10.1016/S0042-6989(98)00039-X; WILSON HR, 1980, BIOL CYBERN, V38, P171, DOI 10.1007/BF00337406	31	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e66015	10.1371/journal.pone.0066015	http://dx.doi.org/10.1371/journal.pone.0066015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741521	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900234
J	Fuermaier, ABM; Tucha, L; Koerts, J; Aschenbrenner, S; Weisbrod, M; Lange, KW; Tucha, O				Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Aschenbrenner, Steffen; Weisbrod, Matthias; Lange, Klaus W.; Tucha, Oliver			Source Discrimination in Adults with Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							SOURCE MEMORY; SUSTAINED ATTENTION; ADHD; METHYLPHENIDATE; INTERFERENCE; PERFORMANCE; INHIBITION; CHILDREN	Objectives: The context of memory experiences is referred to as source memory and can be distinguished from the content of episodic item memory. Source memory represents a crucial part of biographic events and elaborate memory experiences. Whereas individuals with attention deficit hyperactivity disorder (ADHD) were shown to have inefficient item memory, little is known about the context of memory experiences. Methods: The present study compared 37 adult patients with a diagnosed ADHD with 40 matched healthy participants on a word list paradigm. Memory functions of encoding, retention and source discrimination were assessed. Furthermore, standardized measures of memory and executive control were applied in order to explore a qualitative differentiation of memory components. Results: Adult patients with ADHD showed impaired performance in encoding of new information whereas the retention of encoded items was found to be preserved. The most pronounced impairment of patients with ADHD was observed in source discrimination. Regression models of cognitive functions on memory components supported some qualitative differentiation. Conclusions: Data analysis suggests a differential pattern of memory impairment in adults suffering from ADHD with a particular deficit in source discrimination. Inefficient source discrimination in adults with ADHD can affect daily functioning by limiting biographic awareness and disturbing general cognitive processes.	[Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Aschenbrenner, Steffen] SRH Clin Karlsbad Langensteinbach, Dept Clin Psychol & Neuropsychol, Karlsbad, Germany; [Weisbrod, Matthias] SRH Clin Karlsbad Langensteinbach, Dept Psychiat & Psychotherapy, Karlsbad, Germany; [Weisbrod, Matthias] Heidelberg Univ, Sect Expt Psychopathol, Ctr Psychosocial Med, Heidelberg, Germany; [Lange, Klaus W.] Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany	University of Groningen; Ruprecht Karls University Heidelberg; University of Regensburg	Lange, KW (corresponding author), Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany.	klaus.lange@ur.de	Tucha, Oliver/AAD-1403-2019	Fuermaier, Anselm/0000-0002-2331-0840				ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2006, ATTENTION DEFICIT HY; BENSON DF, 1991, J CHILD NEUROL, V6, pS9, DOI 10.1177/0883073891006001S02; Benton AL., 1983, MULTILINGUAL APHASIA; Boonstra AM, 2010, NEUROPSYCHOLOGY, V24, P209, DOI 10.1037/a0017670; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Boucugnani LL, 1989, ARCH CLIN NEUROPSYCH, V4, P161, DOI DOI 10.1093/ARCLIN/4.2.161; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRAIK FIM, 1990, PSYCHOL AGING, V5, P148, DOI 10.1037/0882-7974.5.1.148; Davidson PSR, 2005, J CLIN EXP NEUROPSYC, V27, P915, DOI 10.1080/13803390490919335; Drag LL, 2009, J INT NEUROPSYCH SOC, V15, P399, DOI 10.1017/S1355617709090572; Duyck W, 2004, BEHAV RES METH INS C, V36, P488, DOI 10.3758/BF03195595; Fuermaier ABM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058338; Glisky EL, 2001, J EXP PSYCHOL LEARN, V27, P1131, DOI 10.1037//0278-7393.27.5.1131; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; HOUX PJ, 1993, EXP AGING RES, V19, P209, DOI 10.1080/03610739308253934; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Kaplan BJ, 1998, J CLIN EXP NEUROPSYC, V20, P518, DOI 10.1076/jcen.20.4.518.1477; Lange, 2000, WORD FLUENCY TEST; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; MAYES AR, 1991, NEUROPSYCHOLOGIA, V29, P771, DOI 10.1016/0028-3932(91)90071-F; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Muir-Broaddus JE, 2002, ARCH CLIN NEUROPSYCH, V17, P671, DOI 10.1016/S0887-6177(01)00170-6; Pollak Y, 2008, DEV NEUROPSYCHOL, V33, P62, DOI 10.1080/87565640701729789; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rosler M., 2008, HOMBURGER ADHS SKALE; SCHACTER DL, 1991, PSYCHOL AGING, V6, P559, DOI 10.1037/0882-7974.6.4.559; Schoechlin C, 2005, ARCH CLIN NEUROPSYCH, V20, P727, DOI 10.1016/j.acn.2005.04.005; Seidman LJ, 1998, BIOL PSYCHIAT, V44, P260, DOI 10.1016/S0006-3223(97)00392-2; SHIMAMURA AP, 1991, PSYCHOBIOLOGY, V19, P1; Storm BC, 2010, MEMORY, V18, P265, DOI 10.1080/09658210903547884; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tannock R, 1998, J CHILD PSYCHOL PSYC, V39, P65, DOI 10.1017/S0021963097001777; Tucha L, 2011, J ATTEN DISORD, V15, P161, DOI 10.1177/1087054709356391; Tucha L, 2009, J ATTEN DISORD, V12, P410, DOI 10.1177/1087054708315065; Tucha O, 2006, J NEURAL TRANSM, V113, P1575, DOI 10.1007/s00702-005-0437-7; Tucha Oliver, 2005, Cogn Neuropsychiatry, V10, P231, DOI 10.1080/13546800444000047; Wang B, 2010, NEUROBIOL LEARN MEM, V93, P572, DOI 10.1016/j.nlm.2010.02.005; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Wechsler D, 1987, WMS R WECHSLER MEMOR; White HA, 2004, PERS INDIV DIFFER, V37, P1453, DOI 10.1016/j.paid.2004.02.002; Woods SP, 2002, CLIN NEUROPSYCHOL, V16, P12, DOI 10.1076/clin.16.1.12.8336; Zeeuws I, 2010, HUM PSYCHOPHARM CLIN, V25, P326, DOI 10.1002/hup.1120	46	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65134	10.1371/journal.pone.0065134	http://dx.doi.org/10.1371/journal.pone.0065134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741472	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900185
J	Ma, S; Duan, GF; Chai, WG; Geng, CL; Tan, Y; Wang, LS; Le Sourd, F; Michel, G; Yu, WG; Han, F				Ma, Su; Duan, Gaofei; Chai, Wengang; Geng, Cunliang; Tan, Yulong; Wang, Lushan; Le Sourd, Frederic; Michel, Gurvan; Yu, Wengong; Han, Feng			Purification, Cloning, Characterization and Essential Amino Acid Residues Analysis of a New iota-Carrageenase from Cellulophaga sp QY3	PLOS ONE			English	Article							KAPPA-CARRAGEENASE; GLYCOSIDE HYDROLASES; LAMBDA-CARRAGEENAN; STRUCTURAL BASIS; PROTEIN; FAMILY; OLIGOSACCHARIDE; DEGRADATION; EVOLUTION	iota-Carrageenases belong to family 82 of glycoside hydrolases that degrade sulfated galactans in the red algae known as iota-carrageenans. The catalytic mechanism and some substrate-binding residues of family GH82 have been studied but the substrate recognition and binding mechanism of this family have not been fully elucidated. We report here the purification, cloning and characterization of a new iota-carrageenase CgiA_Ce from the marine bacterium Cellulophaga sp. QY3. CgiA_Ce was the most thermostable carrageenase described so far. It was most active at 50 degrees C and pH 7.0 and retained more than 70% of the original activity after incubation at 50 degrees C for 1 h at pH 7.0 or at pH 5.0-10.6 for 24 h. CgiA_Ce was an endo-type iota-carrageenase; it cleaved iota-carrageenan yielding neo-iota-carrabiose and neo-iota-carratetraose as the main end products, and neo-iota-carrahexaose was the minimum substrate. Sequence analysis and structure modeling showed that CgiA_Ce is indeed a new member of family GH82. Moreover, sequence analysis of iota-carrageenases revealed that the amino acid residues at subsites -1 and +1 were more conserved than those at other subsites. Site-directed mutagenesis followed by kinetic analysis identified three strictly conserved residues at subsites 21 and + 1 of iota-carrageenases, G228, Y229 and R254 in CgiA_Ce, which played important roles for substrate binding. Furthermore, our results suggested that Y229 and R254 in CgiA_Ce interacted specifically with the sulfate groups of the sugar moieties located at subsites -1 and + 1, shedding light on the mechanism of iota-carrageenan recognition in the family GH82.	[Ma, Su; Duan, Gaofei; Chai, Wengang; Tan, Yulong; Yu, Wengong; Han, Feng] Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Ma, Su; Duan, Gaofei; Tan, Yulong; Yu, Wengong; Han, Feng] Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Peoples R China; [Ma, Su; Duan, Gaofei; Tan, Yulong; Yu, Wengong; Han, Feng] Ocean Univ China, Lab Glycobiol, Sch Med & Pharm, Qingdao, Peoples R China; [Chai, Wengang] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London, England; [Geng, Cunliang; Wang, Lushan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Le Sourd, Frederic; Michel, Gurvan] Univ Paris 06, Paris, France; [Le Sourd, Frederic; Michel, Gurvan] CNRS, UMR Marine Plants & Biomol 7139, Stn Biol Roscoff, Brittany, France	Ocean University of China; Ocean University of China; Ocean University of China; Imperial College London; Shandong University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Han, F (corresponding author), Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China.	fhan@ouc.edu.cn	Han, Feng/AAX-3761-2021	Han, Feng/0000-0001-5706-7028; MICHEL, Gurvan/0000-0002-3009-6205; Ma, Su/0000-0003-2438-7222	National Natural Science Foundation of China [31070712]; Special Fund for Marine Scientific Research in the Public Interest [201005024, 201105027-3]; National High-tech RD Program [2011AA09070304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Marine Scientific Research in the Public Interest; National High-tech RD Program(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China, number 31070712 (www.nsfc.gov.cn); Special Fund for Marine Scientific Research in the Public Interest, numbers 201005024 and 201105027-3 (www.soa.gov.cn); National High-tech R&D Program, number 2011AA09070304 (www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Barbeyron T, 2000, J BIOL CHEM, V275, P35499, DOI 10.1074/jbc.M003404200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen HM, 2007, J AGR FOOD CHEM, V55, P6910, DOI 10.1021/jf070183+; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Guibet M, 2007, BIOCHEM J, V404, P105, DOI [10.1042//BJ20061359, 10.1042/BJ20061359]; Hatada Y, 2011, MAR BIOTECHNOL, V13, P411, DOI 10.1007/s10126-010-9312-0; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; Jouanneau D, 2010, CARBOHYD RES, V345, P547, DOI 10.1016/j.carres.2009.12.004; Kalitnik AA, 2013, J APPL PHYCOL, V25, P65, DOI 10.1007/s10811-012-9839-8; Kilor VA, 2010, AAPS PHARMSCITECH, V11, P336, DOI 10.1208/s12249-010-9389-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemoine M, 2009, BIOCHEM J, V419, P545, DOI 10.1042/BJ20080619; Li JB, 2007, CARBOHYD RES, V342, P1030, DOI 10.1016/j.carres.2007.02.008; Li SY, 2013, J OCEAN U CHINA, V12, P155, DOI 10.1007/s11802-013-1994-2; Ma CP, 2007, J BIOL CHEM, V282, P3747, DOI 10.1074/jbc.M607888200; Michel G, 2003, J MOL BIOL, V334, P421, DOI 10.1016/j.jmb.2003.09.056; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Rebuffet E, 2010, BIOCHEMISTRY-US, V49, P7590, DOI 10.1021/bi1003475; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Siepmann F, 2007, BIOMACROMOLECULES, V8, P3984, DOI 10.1021/bm7009587; Sun FX, 2010, CHIN J OCEANOL LIMN, V28, P1139, DOI 10.1007/s00343-010-9012-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang W, 2011, ANTIVIR RES, V92, P237, DOI 10.1016/j.antiviral.2011.08.010; Xu L, 2012, NEUROCHEM INT, V61, P689, DOI 10.1016/j.neuint.2012.06.019; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; Yang B, 2009, FEBS J, V276, P2125, DOI 10.1111/j.1742-4658.2009.06947.x; Yoshizawa T, 2012, J BIOL CHEM, V287, P18710, DOI 10.1074/jbc.M112.350520	31	50	50	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64666	10.1371/journal.pone.0064666	http://dx.doi.org/10.1371/journal.pone.0064666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741363	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900076
J	Mayor, DJ; Gray, NB; Elver-Evans, J; Midwood, AJ; Thornton, B				Mayor, Daniel J.; Gray, Nia B.; Elver-Evans, Joanna; Midwood, Andrew J.; Thornton, Barry			Metal-Macrofauna Interactions Determine Microbial Community Structure and Function in Copper Contaminated Sediments	PLOS ONE			English	Article							AMPHIPOD COROPHIUM-VOLUTATOR; MULTIPLE STRESSORS; ESTUARINE SEDIMENT; TRACE-ELEMENTS; FATTY-ACIDS; 2 SOILS; NITROGEN; CARBON; CADMIUM; TOXICITY	Copper is essential for healthy cellular functioning, but this heavy metal quickly becomes toxic when supply exceeds demand. Marine sediments receive widespread and increasing levels of copper contamination from antifouling paints owing to the 2008 global ban of organotin-based products. The toxicity of copper will increase in the coming years as seawater pH decreases and temperature increases. We used a factorial mesocosm experiment to investigate how increasing sediment copper concentrations and the presence of a cosmopolitan bioturbating amphipod, Corophium volutator, affected a range of ecosystem functions in a soft sediment microbial community. The effects of copper on benthic nutrient release, bacterial biomass, microbial community structure and the isotopic composition of individual microbial membrane [phospholipid] fatty acids (PLFAs) all differed in the presence of C. volutator. Our data consistently demonstrate that copper contamination of global waterways will have pervasive effects on the metabolic functioning of benthic communities that cannot be predicted from copper concentrations alone; impacts will depend upon the resident macrofauna and their capacity for bioturbation. This finding poses a major challenge for those attempting to manage the impacts of copper contamination on ecosystem services, e.g. carbon and nutrient cycling, across different habitats. Our work also highlights the paucity of information on the processes that result in isotopic fractionation in natural marine microbial communities. We conclude that the assimilative capacity of benthic microbes will become progressively impaired as copper concentrations increase. These effects will, to an extent, be mitigated by the presence of bioturbating animals and possibly other processes that increase the influx of oxygenated seawater into the sediments. Our findings support the move towards an ecosystem approach for environmental management.	[Mayor, Daniel J.; Elver-Evans, Joanna] Univ Aberdeen, Oceanlab, Inst Biol & Environm Sci, Aberdeen, Scotland; [Gray, Nia B.; Midwood, Andrew J.; Thornton, Barry] James Hutton Inst, Aberdeen, Scotland; [Gray, Nia B.] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland	University of Aberdeen; James Hutton Institute; University of Edinburgh	Mayor, DJ (corresponding author), Univ Aberdeen, Oceanlab, Inst Biol & Environm Sci, Aberdeen, Scotland.	dan.mayor@abdn.ac.uk	Midwood, Andrew/AAM-9525-2020; Mayor, Daniel/HDN-8520-2022	Mayor, Daniel/0000-0002-1295-0041; Midwood, Andrew/0000-0001-8803-3701; Gray-Wannell, Nia/0000-0002-8252-5382	NERC [NE/G014744/1]; Rural and Environmental Science and Analytical Services Division (RESAS) of the Scottish Government; NERC [NE/K002015/1] Funding Source: UKRI; Natural Environment Research Council [NE/K002015/1, NE/G014744/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Rural and Environmental Science and Analytical Services Division (RESAS) of the Scottish Government; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was funded by NERC (NE/G014744/1). BT, NG and AM received funding from the Rural and Environmental Science and Analytical Services Division (RESAS) of the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2007, ESTUAR COAST SHELF S, V73, P743, DOI 10.1016/j.ecss.2007.03.013; Alsterberg C, 2007, J EXP MAR BIOL ECOL, V351, P56, DOI 10.1016/j.jembe.2007.06.006; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Apitz SE, 2006, INTEGR ENVIRON ASSES, V2, P80, DOI 10.1002/ieam.5630020114; Barber WP, 2000, WATER RES, V34, P2423, DOI 10.1016/S0043-1354(99)00426-1; Bat L, 1998, J EXP MAR BIOL ECOL, V223, P167, DOI 10.1016/S0022-0981(97)00162-7; Bat Levent, 1998, Turkish Journal of Zoology, V22, P341; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; BINNERUP SJ, 1992, APPL ENVIRON MICROB, V58, P303, DOI 10.1128/AEM.58.1.303-313.1992; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boschker HTS, 2002, FEMS MICROBIOL ECOL, V40, P85, DOI 10.1111/j.1574-6941.2002.tb00940.x; Breitburg DL, 1999, LIMNOL OCEANOGR, V44, P837, DOI 10.4319/lo.1999.44.3_part_2.0837; BRINCHIVERSEN J, 1990, FEMS MICROBIOL ECOL, V74, P345; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Chander K, 2001, SOIL BIOL BIOCHEM, V33, P1811, DOI 10.1016/S0038-0717(01)00108-0; Conradi M, 1998, AQUAT TOXICOL, V44, P31, DOI 10.1016/S0166-445X(98)00069-1; De Laender F, 2011, ENVIRON TOXICOL CHEM, V30, P2892, DOI 10.1002/etc.698; Dean RJ, 2007, ENVIRON POLLUT, V145, P84, DOI 10.1016/j.envpol.2006.03.050; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; Durou C, 2005, ENVIRON TOXICOL, V20, P23, DOI 10.1002/tox.20074; FAO, 2006, 50 FAO; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Frostegard A, 1996, SOIL BIOL BIOCHEM, V28, P55, DOI 10.1016/0038-0717(95)00100-X; FROSTEGARD A, 1993, APPL ENVIRON MICROB, V59, P3605; GERDOL V, 1994, MAR ECOL PROG SER, V114, P109, DOI 10.3354/meps114109; Gilbertson WW, 2012, FEMS MICROBIOL ECOL, V82, P11, DOI 10.1111/j.1574-6941.2012.01400.x; GUCKERT JB, 1985, FEMS MICROBIOL ECOL, V31, P147, DOI 10.1111/j.1574-6968.1985.tb01143.x; Hawkins CM, 1985, NETH J SEA RES, V19, P165, DOI 10.1016/0077-7579(85)90020-1; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Hebel DK, 1997, ESTUAR COAST SHELF S, V44, P177, DOI 10.1006/ecss.1996.0209; ICELY JD, 1980, MAR BIOL, V57, P193, DOI 10.1007/BF00390737; JONAS RB, 1989, APPL ENVIRON MICROB, V55, P43, DOI 10.1128/AEM.55.1.43-49.1989; Jones DE, 2010, ESTUAR COAST SHELF S, V87, P399, DOI 10.1016/j.ecss.2010.01.018; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Laursen AE, 2002, ESTUARIES, V25, P57, DOI 10.1007/BF02696049; Laverock B, 2010, ISME J, V4, P1531, DOI 10.1038/ismej.2010.86; Lerch TZ, 2011, BIOGEOCHEMISTRY, V106, P5, DOI 10.1007/s10533-010-9432-7; Londry KL, 2004, APPL ENVIRON MICROB, V70, P745, DOI 10.1128/AEM.70.2.745-751.2004; LU JCS, 1977, ENVIRON SCI TECHNOL, V11, P174, DOI 10.1021/es60125a004; Manimaran K, 2012, B ENVIRON CONTAM TOX, V88, P30, DOI 10.1007/s00128-011-0427-4; Mayor DJ, 2009, MAR POLLUT BULL, V58, P552, DOI 10.1016/j.marpolbul.2008.11.015; Mayor DJ, 2008, AQUACULTURE, V285, P102, DOI 10.1016/j.aquaculture.2008.08.008; Mayor DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038582; Mayor DJ, 2011, ENVIRON RES, V111, P635, DOI 10.1016/j.envres.2011.03.013; Mayor DJ, 2010, ENVIRON SCI TECHNOL, V44, P2079, DOI 10.1021/es903073h; MURDOCH MH, 1986, J EXP MAR BIOL ECOL, V103, P235, DOI 10.1016/0022-0981(86)90143-7; Neser G, 2012, MAR POLLUT BULL, V64, P882, DOI 10.1016/j.marpolbul.2012.02.006; NEUMANNHENSEL H, 1995, ACTA HYDROCH HYDROB, V23, P72, DOI 10.1002/aheh.19950230205; Nicholls JC, 2009, AQUAT MICROB ECOL, V55, P105, DOI 10.3354/ame01285; Nixon SW, 1996, BIOGEOCHEMISTRY, V35, P141, DOI 10.1007/BF02179826; Ochoa-Herrera V, 2011, SCI TOTAL ENVIRON, V412, P380, DOI 10.1016/j.scitotenv.2011.09.072; Oksanen J., 2013, R PACKAGE VERSION 2, P292; OSPAR, 2009, OSPAR PUBL, V462/2009; Pancost RD, 2003, CHEM GEOL, V195, P29, DOI 10.1016/S0009-2541(02)00387-X; Parks R, 2010, MAR POLLUT BULL, V60, P1226, DOI 10.1016/j.marpolbul.2010.03.022; PELEGRI SP, 1994, MAR BIOL, V121, P253, DOI 10.1007/BF00346733; PELEGRI SP, 1994, MAR ECOL PROG SER, V105, P285, DOI 10.3354/meps105285; Petersen DG, 2004, ENVIRON TOXICOL CHEM, V23, P921, DOI 10.1897/03-196; Petersen K, 1998, MAR ENVIRON RES, V45, P403, DOI 10.1016/S0141-1136(98)00102-0; Porubsky WP, 2009, ESTUAR COAST SHELF S, V83, P392, DOI 10.1016/j.ecss.2009.04.012; Richards R, 2011, ECOL MODEL, V222, P3559, DOI 10.1016/j.ecolmodel.2011.08.017; Riisgard HU, 2007, MAR BIOL RES, V3, P421, DOI 10.1080/17451000701696302; Roberts DA, 2013, GLOBAL CHANGE BIOL, V19, P340, DOI 10.1111/gcb.12048; Schouten S, 2004, APPL ENVIRON MICROB, V70, P3785, DOI 10.1128/AEM.70.6.3785-3788.2004; Simpson SL, 2000, ENVIRON TOXICOL CHEM, V19, P1992, DOI 10.1002/etc.5620190806; Singh N, 2009, MAR POLLUT BULL, V58, P559, DOI 10.1016/j.marpolbul.2008.11.014; Sundback K, 2007, MAR ECOL PROG SER, V330, P13, DOI 10.3354/meps330013; TAYLOR J, 1983, J GEN MICROBIOL, V129, P3303; Teece MA, 1999, ORG GEOCHEM, V30, P1571, DOI 10.1016/S0146-6380(99)00108-4; Thornton B, 2011, RAPID COMMUN MASS SP, V25, P2433, DOI 10.1002/rcm.5148; Turner A, 2010, MAR POLLUT BULL, V60, P159, DOI 10.1016/j.marpolbul.2009.12.004; UNCTAD, 2012, REV MAR TRANSP; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Wiegner TN, 2003, ESTUARIES, V26, P352, DOI 10.1007/BF02695973; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001; Zetsche E, 2011, CONT SHELF RES, V31, P832, DOI 10.1016/j.csr.2011.02.006; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	81	23	25	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64940	10.1371/journal.pone.0064940	http://dx.doi.org/10.1371/journal.pone.0064940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741430	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900143
J	Rao, SP; Riederer, M; Lechleitner, M; Hermansson, M; Desoye, G; Hallstrom, S; Graier, WF; Frank, S				Rao, Shailaja P.; Riederer, Monika; Lechleitner, Margarete; Hermansson, Martin; Desoye, Gernot; Hallstroem, Seth; Graier, Wolfgang F.; Frank, Sasa			Acyl Chain-Dependent Effect of Lysophosphatidylcholine on Endothelium-Dependent Vasorelaxation	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; VASCULAR RELAXATION; PROSTANOID RECEPTORS; CONTRACTING FACTORS; RELAXING FACTOR; MOUSE ARTERIES; SMOOTH-MUSCLE; NITRIC-OXIDE; AORTA; PROSTACYCLIN	Previously we identified palmitoyl-, oleoyl-, linoleoyl-, and arachidonoyl- lysophosphatidylcholine (LPC 16:0, 18:1, 18:2 and 20:4) as the most prominent LPC species generated by endothelial lipase (EL). In the present study, we examined the impact of those LPC on acetylcholine (ACh)- induced vascular relaxation. All tested LPC attenuated ACh-induced relaxation, measured ex vivo, using mouse aortic rings and wire myography. The rank order of potency was as follows:18:2>20:4>16:0>18:1. The attenuating effect of LPC 16:0 on relaxation was augmented by indomethacin-mediated cyclooxygenase (COX)-inhibition and CAY10441, a prostacyclin (PGI(2))- receptor (IP) antagonist. Relaxation attenuated by LPC 20:4 and 18:2 was improved by indomethacin and SQ29548, a thromboxane A(2) (TXA(2))- receptor antagonist. The effect of LPC 20:4 could also be improved by TXA(2)- and PGI(2)-synthase inhibitors. As determined by EIA assays, the tested LPC promoted secretion of PGI(2), TXA(2), PGF(2 alpha), and PGE(2), however, with markedly different potencies. LPC 16:0 was the most potent inducer of superoxide anion production by mouse aortic rings, followed by LPC 18:2, 20:4 and 18:1, respectively. The strong antioxidant tempol recovered relaxation impairment caused by LPC 18:2, 18:1 and 20:4, but not by LPC 16:0. The tested LPC attenuate ACh-induced relaxation through induction of proconstricting prostanoids and superoxide anions. The potency of attenuating relaxation and the relative contribution of underlying mechanisms are strongly related to LPC acyl-chain length and degree of saturation.	[Rao, Shailaja P.; Riederer, Monika; Lechleitner, Margarete; Graier, Wolfgang F.; Frank, Sasa] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; [Hermansson, Martin] Univ Helsinki, Dept Biochem, Inst Biomed, Helsinki, Finland; [Desoye, Gernot] Med Univ Graz, Clin Obstet & Gynecol, Graz, Austria; [Hallstroem, Seth] Med Univ Graz, Inst Physiol Chem, Ctr Physiol Med, Graz, Austria; [Riederer, Monika] Univ Appl Sci Biomed Sci, Graz, Austria	Medical University of Graz; Finland National Institute for Health & Welfare; University of Helsinki; Medical University of Graz; Medical University of Graz	Frank, S (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria.	sasa.frank@medunigraz.at	Rao, Shailaja/P-8643-2019; Hermansson, Martin/B-7854-2008; Graier, Wolfgang F./B-7052-2008	Hermansson, Martin/0000-0003-3387-8365; Graier, Wolfgang F./0000-0003-1871-3298; Desoye, Gernot/0000-0002-5715-3230	Medical University of Graz; Austrian Science Fund FWF [P19473-B05]; Lanyar Foundation [369]; Ph.D. Program "Molecular Medicine'' at the Medical University of Graz	Medical University of Graz; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Lanyar Foundation; Ph.D. Program "Molecular Medicine'' at the Medical University of Graz	This work was supported by the Medical University of Graz (Ph.D. Program "Molecular Medicine''), the Austrian Science Fund FWF (Grant P19473-B05 to SF), and Lanyar Foundation Grant 369 (SF). SPR was funded by the Ph.D. Program "Molecular Medicine'' at the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brkic L, 2012, ATHEROSCLEROSIS, V224, P348, DOI 10.1016/j.atherosclerosis.2012.07.038; Chen L, 1997, J LIPID RES, V38, P546; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; DUDEK R, 1993, P SOC EXP BIOL MED, V203, P474; Feletou M, 2009, BRIT J PHARMACOL, V156, P563, DOI 10.1111/j.1476-5381.2008.00060.x; Froese DE, 1999, MOL CELL BIOCHEM, V197, P1, DOI 10.1023/A:1006847929334; Fujino T, 2002, BRIT J PHARMACOL, V136, P530, DOI 10.1038/sj.bjp.0704749; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Gauster M, 2005, J LIPID RES, V46, P1517, DOI 10.1194/jlr.M500054-JLR200; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gluais P, 2006, AM J PHYSIOL-HEART C, V291, pH2255, DOI 10.1152/ajpheart.01115.2005; Hristovska AM, 2007, HYPERTENSION, V50, P525, DOI 10.1161/HYPERTENSIONAHA.107.088948; Li H, 2000, J CHROMATOGR B, V746, P199, DOI 10.1016/S0378-4347(00)00328-5; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; MENON NK, 1991, P SOC EXP BIOL MED, V196, P461; Ojala PJ, 2007, J LEUKOCYTE BIOL, V82, P1501, DOI 10.1189/jlb.0507292; Ojala PJ, 2006, BIOCHEMISTRY-US, V45, P14021, DOI 10.1021/bi061657l; PARTHASARATHY S, 1985, P NATL ACAD SCI USA, V82, P3000, DOI 10.1073/pnas.82.9.3000; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; Riederer M, 2010, J LIPID RES, V51, P2957, DOI 10.1194/jlr.M006536; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Simonsen U, 2009, PHARMACOL THERAPEUT, V122, P109, DOI 10.1016/j.pharmthera.2009.02.002; Tang EHC, 2005, J CARDIOVASC PHARM, V46, P761, DOI 10.1097/01.fjc.0000187174.67661.67; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Tang EHC, 2009, PHARMACOL THERAPEUT, V122, P140, DOI 10.1016/j.pharmthera.2009.02.006; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Vuong TD, 2001, KIDNEY INT, V60, P1088, DOI 10.1046/j.1523-1755.2001.0600031088.x; WILLIAMS SP, 1994, AM J PHYSIOL, V267, pH796, DOI 10.1152/ajpheart.1994.267.2.H796; WOLF A, 1991, LIPIDS, V26, P223, DOI 10.1007/BF02543975; Wong MSK, 2010, ACTA PHARMACOL SIN, V31, P1095, DOI 10.1038/aps.2010.127; Zhang R, 2009, J MOL CELL CARDIOL, V47, P112, DOI 10.1016/j.yjmcc.2009.03.026; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005	38	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65155	10.1371/journal.pone.0065155	http://dx.doi.org/10.1371/journal.pone.0065155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741477	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900190
J	Schmidtke, D; Schulz, J; Hartung, J; Esser, KH				Schmidtke, Daniel; Schulz, Jochen; Hartung, Joerg; Esser, Karl-Heinz			Structure and Possible Functions of Constant-Frequency Calls in Ariopsis seemanni (Osteichthyes, Ariidae)	PLOS ONE			English	Article							SEA CATFISH; RESPONSE PROPERTIES; ELECTRIC FISH; HEARING; ECHOLOCATION; ORIENTATION; ORIGINS	In the 1970s, Tavolga conducted a series of experiments in which he found behavioral evidence that the vocalizations of the catfish species Ariopsis felis may play a role in a coarse form of echolocation. Based on his findings, he postulated a similar function for the calls of closely related catfish species. Here, we describe the physical characteristics of the predominant call-type of Ariopsis seemanni. In two behavioral experiments, we further explore whether A. seemanni uses these calls for acoustic obstacle detection by testing the hypothesis that the call-emission rate of individual fish should increase when subjects are confronted with novel objects, as it is known from other vertebrate species that use pulse-type signals to actively probe the environment. Audio-video monitoring of the fish under different obstacle conditions did not reveal a systematic increase in the number of emitted calls in the presence of novel objects or in dependence on the proximity between individual fish and different objects. These negative findings in combination with our current understanding of directional hearing in fishes (which is a prerequisite for acoustic obstacle detection) make it highly unlikely that A. seemanni uses its calls for acoustic obstacle detection. We argue that the calls are more likely to play a role in intra-or interspecific communication (e. g. in school formation or predator deterrence) and present results from a preliminary Y-maze experiment that are indicative for a positive phonotaxis of A. seemanni towards the calls of conspecifics.	[Schmidtke, Daniel; Esser, Karl-Heinz] Univ Vet Med, Inst Zool, Hannover, Germany; [Schmidtke, Daniel; Esser, Karl-Heinz] Univ Vet Med, Ctr Syst Neurosci, Hannover, Germany; [Schulz, Jochen; Hartung, Joerg] Univ Vet Med, Inst Anim Hyg Anim Welf & Farm Anim Behav, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Schmidtke, D (corresponding author), Univ Vet Med, Inst Zool, Hannover, Germany.	Daniel.Schmidtke@tiho-hannover.de	Schulz, Jochen/AAA-7340-2021	Schulz, Jochen/0000-0002-9747-6763	Studienstiftung des Deutschen Volkes	Studienstiftung des Deutschen Volkes	Funding for this study was provided by the Studienstiftung des Deutschen Volkes in form of a Ph.D. scholarship for DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2008, PRINCIPLES MARINE BI; BASS A, 1991, BRAIN BEHAV EVOLUT, V38, P240, DOI 10.1159/000114391; Bass AH, 2008, SCIENCE, V321, P417, DOI 10.1126/science.1157632; Betancur-R R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-175; Clark CW, 2004, POTENTIAL USE LOW FR, P564; COLES RB, 1987, J EXP BIOL, V129, P365; EVANS WE, 1973, J ACOUST SOC AM, V54, P191, DOI 10.1121/1.1913562; Fay Richard R., 2008, V32, P1; Fay RR, 1997, HEARING RES, V111, P1, DOI 10.1016/S0378-5955(97)00083-X; FLOCK A, 1964, J CELL BIOL, V22, P413, DOI 10.1083/jcb.22.2.413; Garilao CV, 2013, FISHBASE VERSION 01; Griffin DR, 1958, LISTENING DARK; Gunther A., 1864, CATALOGUE FISHES BRI, V5; Haddad V, 2006, TOXICON, V47, P838, DOI 10.1016/j.toxicon.2006.02.005; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; Kaatz IM, 2001, BIOL BULL, V201, P278, DOI 10.2307/1543365; Kailola P.J., 1995, GUIA FAO IDENTIFICAC, V3, P860; Kalmijn A.J., 1989, P187; Karleskint G., 2009, INTRO MARINE BIOL; KELLOGG WN, 1962, SCIENCE, V137, P399, DOI 10.1126/science.137.3528.399; KONISHI M, 1979, SCIENCE, V204, P425, DOI 10.1126/science.441731; Kuznetsov MY, 2009, ACOUST PHYS+, V55, P866, DOI 10.1134/S1063771009060219; LUGLI M, 1995, ENVIRON BIOL FISH, V43, P219, DOI 10.1007/BF00005853; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Mogdans J, 2012, BIOL CYBERN, V106, P627, DOI 10.1007/s00422-012-0525-3; MOHRES FP, 1956, Z VERGL PHYSIOL, V38, P1, DOI 10.1007/BF00338621; Moller P., 1995, ELECT FISHES HIST BE; Nakatani T, 2004, J ACOUST SOC AM, V116, P3690, DOI 10.1121/1.1787522; Norris KS, 1995, WHALES DOLPHINS PORP; Parvulescu A., 1967, MARINE BIOACOUSTICS, P7, DOI DOI 10.3354/MEPS331243.; POPPER A N, 1970, Animal Behaviour, V18, P552, DOI 10.1016/0003-3472(70)90052-7; Popper AN, 2004, ICES J MAR SCI, V61, P1057, DOI 10.1016/j.icesjms.2004.06.005; Popper Arthur N., 2003, P3, DOI 10.1007/978-0-387-22628-6_1; Post N, 1999, PHYSIOL BEHAV, V68, P115, DOI 10.1016/S0031-9384(99)00153-5; Reis RE, 2003, CHECKLIST FRESHWATER, P4; RENOUF D, 1982, NATURE, V300, P635, DOI 10.1038/300635a0; SAND O, 1974, J EXP BIOL, V60, P881; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Siemers BM, 2009, BIOL LETTERS, V5, P593, DOI 10.1098/rsbl.2009.0378; Speed MP, 2005, EVOLUTION, V59, P2499; Stimpert AK, 2007, BIOL LETTERS, V3, P467, DOI 10.1098/rsbl.2007.0281; Tavolga W.N., 1976, Developments Aquacult Fish Sci, V5, P185; TAVOLGA WN, 1982, J EXP BIOL, V96, P367; TAVOLGA WN, 1977, J EXP BIOL, V67, P97; TAVOLGA WN, 1971, ANN NY ACAD SCI, V188, P80, DOI 10.1111/j.1749-6632.1971.tb13091.x; Tovolga W.N., 1971, P135; VONCAMPENHAUSEN C, 1981, J COMP PHYSIOL, V143, P369, DOI 10.1007/BF00611175; VONDEREMDE G, 1992, ETHOLOGY, V91, P326; Wright JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-282; Zeddies DG, 2012, J EXP BIOL, V215, P152, DOI 10.1242/jeb.064998; Zelick Randy, 1999, Springer Handbook of Auditory Research, V11, P363	51	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64864	10.1371/journal.pone.0064864	http://dx.doi.org/10.1371/journal.pone.0064864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741408	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900121
J	Zhao, J; Si, YH; Cheng, M; Yang, Y; Niu, YQ; Li, X; Liu, XY; Yang, W				Zhao, Jin; Si, Youhui; Cheng, Min; Yang, Yang; Niu, Yuqiang; Li, Xiang; Liu, Xiuying; Yang, Wei			Albumin Fusion of Interleukin-28B: Production and Characterization of Its Biological Activities and Protein Stability	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; CHRONIC HEPATITIS-C; IMPROVED PHARMACOKINETICS; VIRUS-REPLICATION; INTERFERON-ALPHA; IL28B; MONKEYS; LAMBDA	The cytokine interleukin-28B (IL-28B) has potential antiviral properties and regulatory roles in adaptive cellular immunity. A genome-wide association study identified a single nucleotide polymorphism near the IL-28B gene that strongly predicts response to hepatitis C treatment with interferon and ribavirin. In this study, we produced human serum albumin (HSA) fused to interleukin-28B (HSA-IL28B) in an attempt to determine the effects of albumin fusion on anti-Hepatitis C virus (HCV) activity and protein stability. HSA-IL28B was expressed at high levels in the yeast expression system we used and was easily purified. The biological activities of IL-28B were only retained when HSA was fused at the N-terminus. Compared with the native IL-28B, HSA-IL28B showed improved protein stability. HSA-IL28B inhibited HCV infection through the membrane receptors IL28R1 and IL10R2. Additionally, we demonstrated that HSA-IL28B was able to induce interferon-stimulated genes, phosphorylate intracellular STAT1, and act in restricted cell types. Our findings highlight the potential clinical applications of the fusion protein during virus infection and for immune regulation.	[Si, Youhui] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Si, YH (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China.	siyouhui@ipbcams.ac.cn; wyang@ipb.pumc.edu.cn	Si, Youhui/O-6274-2017	Si, Youhui/0000-0001-8909-221X	Chinese Science and Technology Key Project [2012ZX10002007-003]; National Basic Research Program of China [2011CB504800]; National Natural Science Foundation of China [30970156, 81271831]	Chinese Science and Technology Key Project; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Science and Technology Key Project (2012ZX10002007-003), National Basic Research Program of China (2011CB504800) and National Natural Science Foundation of China (30970156 and 81271831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Cheng M, 2012, J ANTIMICROB CHEMOTH, V67, P1080, DOI 10.1093/jac/dks015; Chuang VTG, 2007, DRUG TODAY, V43, P547, DOI 10.1358/dot.2007.43.8.1067343; Duttaroy A, 2005, DIABETES, V54, P251, DOI 10.2337/diabetes.54.1.251; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Huang YS, 2007, EUR J PHARM BIOPHARM, V67, P301, DOI 10.1016/j.ejpb.2007.02.015; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Osborn BL, 2002, EUR J PHARMACOL, V456, P149, DOI 10.1016/S0014-2999(02)02644-4; Osborn BL, 2002, J PHARMACOL EXP THER, V303, P540, DOI 10.1124/jpet.102.037002; Pagliaccetti NE, 2010, VIROLOGY, V401, P197, DOI 10.1016/j.virol.2010.02.022; Park H, 2012, HEPATOLOGY; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pockros PJ, 2010, GASTROENTEROLOGY, V139, P1084, DOI 10.1053/j.gastro.2010.08.015; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019	21	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64301	10.1371/journal.pone.0064301	http://dx.doi.org/10.1371/journal.pone.0064301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741313	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900025
J	Zhou, LY; Ni, ED; Yang, JW; Zhou, H; Liang, H; Li, J; Jiang, DG; Wang, ZH; Liu, ZL; Zhuang, CX				Zhou, Lingyan; Ni, Erdong; Yang, Jiawei; Zhou, Hai; Liang, Hong; Li, Jing; Jiang, Dagang; Wang, Zhonghua; Liu, Zhenlan; Zhuang, Chuxiong			Rice OsGL1-6 Is Involved in Leaf Cuticular Wax Accumulation and Drought Resistance	PLOS ONE			English	Article							LIPID-TRANSFER PROTEINS; FATTY-ACID ELONGASE; ARABIDOPSIS ECERIFERUM1; ENDOPLASMIC-RETICULUM; ALKANE BIOSYNTHESIS; EPICUTICULAR WAXES; CUTICLE MEMBRANE; GENE; ENCODES; POLLEN	Cuticular wax is a class of organic compounds that comprises the outermost layer of plant surfaces. Plant cuticular wax, the last barrier of self-defense, plays an important role in plant growth and development. The OsGL1-6 gene, a member of the fatty aldehyde decarbonylase gene family, is highly homologous to Arabidopsis CER1, which is involved in cuticular wax biosynthesis. However, whether OsGL1-6 participates in cuticular wax biosynthesis remains unknown. In this study, an OsGL1-6 antisense-RNA vector driven by its own promoter was constructed and introduced into the rice variety Zhonghua11 by Agrobacterium-mediated transformation to obtain several independent transgenic plants with decreased OsGL1-6 expression. These OsGL1-6 antisense-RNA transgenic plants showed droopy leaves at the booting stage, significantly decreased leaf cuticular wax deposition, thinner cuticle membrane, increased chlorophyll leaching and water loss rates, and enhanced drought sensitivity. The OsGL1-6 gene was constitutively expressed in all examined organs and was very highly expressed in leaf epidermal cells and vascular bundles. The transient expression of OsGL1-6-GFP fusion indicated that OsGL1-6 is localized in the endoplasmic reticulum. Qualitative and quantitative analysis of the wax composition using gas chromatography-mass spectrometry revealed a significantly reduced total cuticular wax load on the leaf blades of the OsGL1-6 antisense-RNA transgenic plants as well as markedly decreased alkane and aldehyde contents. Their primary alcohol contents increased significantly compared with those in the wild type plants, suggesting that OsGL1-6 is associated with the decarbonylation pathways in wax biosynthesis. We propose that OsGL1-6 is involved in the accumulation of leaf cuticular wax and directly impacts drought resistance in rice.	[Zhou, Lingyan; Liang, Hong] Zhongkai Univ Agr & Engn, Lab Ctr Basic Biol & Biotechnol, Educ Dept Guangdong Prov, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhou, Lingyan; Ni, Erdong; Yang, Jiawei; Zhou, Hai; Li, Jing; Jiang, Dagang; Liu, Zhenlan; Zhuang, Chuxiong] South China Agr Univ, Coll Life Sci, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Wang, Zhonghua] Northwest A&F Univ, Coll Agron, Yangling, Shanxi, Peoples R China	Zhongkai University of Agriculture & Engineering; South China Agricultural University; Northwest A&F University - China	Liu, ZL (corresponding author), South China Agr Univ, Coll Life Sci, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	zhenlan_liu@scau.edu.cn; zhuangcx@scau.edu.cn	Zhou, Hai/AAY-8690-2020	Wang, Zhonghua/0000-0001-5470-3092	National High Technology Research and Development Program of China [2007AA10A144]; Genetically Modified Organisms Breeding Major Projects [2008ZX08001-004]; Team Project of the Natural Science Foundation of Guangdong Province [9351064201000002]; Natural Science Foundation of Guangdong Province [S2011040001653]; Open Foundation of State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources [KSL-CUSAb-2012-11]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201176]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Genetically Modified Organisms Breeding Major Projects; Team Project of the Natural Science Foundation of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Open Foundation of State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China)	This work was supported by the grants from the National High Technology Research and Development Program of China (2007AA10A144), Genetically Modified Organisms Breeding Major Projects (2008ZX08001-004), the Team Project of the Natural Science Foundation of Guangdong Province (9351064201000002), Natural Science Foundation of Guangdong Province (S2011040001653), and Open Foundation of State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources (KSL-CUSAb-2012-11). The funds of this experiment were supported by Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; Boevink P, 1996, PLANT J, V10, P935, DOI 10.1046/j.1365-313X.1996.10050935.x; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Boutrot F, 2007, PLANTA, V225, P843, DOI 10.1007/s00425-006-0397-7; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chen XB, 2003, PLANT CELL, V15, P1170, DOI 10.1105/tpc.010926; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; EIGENBRODE SD, 1995, ANNU REV ENTOMOL, V40, P171, DOI 10.1146/annurev.en.40.010195.001131; Feng JiuHuan, 2001, Chinese Journal of Rice Science, V15, P21; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; HANNOUFA A, 1993, PHYTOCHEMISTRY, V33, P851, DOI 10.1016/0031-9422(93)85289-4; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang ZY, 2011, MOL BIOL REP, V38, P4291, DOI 10.1007/s11033-010-0553-9; Islam MA, 2009, PLANT MOL BIOL, V70, P443, DOI 10.1007/s11103-009-9483-0; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; JEFFERSON PG, 1994, CROP SCI, V34, P367, DOI 10.2135/cropsci1994.0011183X003400020011x; Jeffree C. E, 1996, PLANT CUTICLES INTEG, P33; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; JENKS MA, 1994, PLANT PHYSIOL, V105, P1239, DOI 10.1104/pp.105.4.1239; Jenks Matthew A, 2002, Arabidopsis Book, V1, pe0016, DOI 10.1199/tab.0016; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kannangara R, 2007, PLANT CELL, V19, P1278, DOI 10.1105/tpc.106.047076; Kim DW, 2005, ELECTROPHORESIS, V26, P4521, DOI 10.1002/elps.200500334; Kolattukudy PE, 1996, PLANT CUTICLES INTEG, P83; Krauss P, 1997, PLANT CELL ENVIRON, V20, P1079, DOI 10.1111/j.1365-3040.1997.tb00684.x; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Kunst L, 2009, CURR OPIN PLANT BIOL, V12, P721, DOI 10.1016/j.pbi.2009.09.009; Kurata T, 2003, PLANT J, V36, P55, DOI 10.1046/j.1365-313X.2003.01854.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SB, 2009, PLANT PHYSIOL, V150, P42, DOI 10.1104/pp.109.137745; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017444; Li XM, 2011, J EXP BOT, V62, P4763, DOI 10.1093/jxb/err084; Mao BG, 2012, PLANTA, V235, P39, DOI 10.1007/s00425-011-1481-1; Markstadter C, 2000, CHEMOECOLOGY, V10, P33, DOI 10.1007/s000490050005; MCNEVIN JP, 1993, GENOME, V36, P610, DOI 10.1139/g93-082; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; MOLINA A, 1993, FEBS LETT, V316, P119, DOI 10.1016/0014-5793(93)81198-9; Nawrath C, 2006, CURR OPIN PLANT BIOL, V9, P281, DOI 10.1016/j.pbi.2006.03.001; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Qin BX, 2011, MOL PLANT, V4, P985, DOI 10.1093/mp/ssr028; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; Rowland O, 2007, FEBS LETT, V581, P3538, DOI 10.1016/j.febslet.2007.06.065; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; SOSSOUNTZOV L, 1991, PLANT CELL, V3, P923, DOI 10.1105/tpc.3.9.923; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Weng H, 2010, PLANTA, V231, P1089, DOI 10.1007/s00425-010-1110-4; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	63	23	30	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65139	10.1371/journal.pone.0065139	http://dx.doi.org/10.1371/journal.pone.0065139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741473	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900186
J	Poirault-Chassac, S; Nguyen, KA; Pietrzyk, A; Casari, C; Veyradier, A; Denis, CV; Baruch, D				Poirault-Chassac, Sonia; Kim Anh Nguyen; Pietrzyk, Audrey; Casari, Caterina; Veyradier, Agnes; Denis, Cecile V.; Baruch, Dominique			Terminal Platelet Production is Regulated by Von Willebrand Factor	PLOS ONE			English	Article							GLYCOPROTEIN-IB-ALPHA; DISEASE TYPE 2B; MOUSE MODEL; PROPLATELET FORMATION; THROMBUS FORMATION; MEGAKARYOCYTES; MICE; THROMBOCYTOPENIA; 5-FLUOROURACIL; VISUALIZATION	It is established that proplatelets are formed from mature megakaryocytes (MK) as intermediates before platelet production. Recently, the presence of proplatelets was described in blood incubated in static conditions. We have previously demonstrated that platelet and proplatelet formation is upregulated by MK exposure to high shear rates (1800 s(-1)) on immobilized von Willebrand factor (VWF). The purpose of the present study was to investigate whether VWF is involved in the regulation of terminal platelet production in blood. To this end, Vwf(-/-) mice, a model of severe von Willebrand disease, were used to create a situation in which blood cells circulate in a vascular tree that is completely devoid of VWF. Murine platelets were isolated from Vwf(-/-) and Vwf(+/+) blood, exposed to VWF at 1800 s(-1) in a microfluidic platform, and examined by means of videomicroscopy, as well as fluorescence and activation studies. Proplatelets became visible within 5 minutes, representing 38% of all platelets after 12 minutes and 46% after 28 min. The proportion of proplatelets was 1.8-fold higher in blood from Vwf(-/-) mice than from Vwf(+/+) mice, suggesting a role of VWF in vivo. Fragmentation of these proplatelets into smaller discoid platelets was also observed in real-time. Platelets remained fully activatable by thrombin. Compensation of plasmatic VWF following hydrodynamic gene transfer in Vwf(-/-) mice reduced the percentage of proplatelets to wild-type levels. A thrombocytopenic mouse model was studied in the flow system, 7 days after a single 5-FU injection. Compared to untreated mouse blood, a 2-fold increase in the percentage of proplatelets was detected following exposure to 1800 s(-1) on VWF of samples from mice treated with 5-FU. In conclusion, VWF and shear stress together appear to upregulate proplatelet reorganization and platelet formation. This suggests a new function for VWF in vivo as regulator of bloodstream thrombopoiesis.	[Poirault-Chassac, Sonia; Kim Anh Nguyen; Pietrzyk, Audrey; Baruch, Dominique] INSERM, UMR 765, Paris, France; [Poirault-Chassac, Sonia; Kim Anh Nguyen; Pietrzyk, Audrey; Baruch, Dominique] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Casari, Caterina; Veyradier, Agnes; Denis, Cecile V.] INSERM, UMR 770, F-94275 Le Kremlin Bicetre, France; [Casari, Caterina; Veyradier, Agnes; Denis, Cecile V.] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Veyradier, Agnes] Antoine Beclere Hosp, Clamart, France; [Veyradier, Agnes] Natl Reference Ctr von Willebrand Dis, Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Baruch, D (corresponding author), INSERM, UMR 765, Paris, France.	dominique.baruch@parisdescartes.fr	Denis, Cecile/A-7649-2011; Baruch, Dominique/ABA-1791-2020; casari, caterina/GXG-5273-2022; baruch, dominique/F-8189-2013; Casari, Caterina/O-7537-2019	Denis, Cecile/0000-0001-5152-9156; Baruch, Dominique/0000-0003-2835-5500; Casari, Caterina/0000-0002-8271-6795	ANR-Emergence Bio fellowship [09-EBIO-018]; "Region Ile de France DIM Stem Pole" PhD fellowship	ANR-Emergence Bio fellowship(French National Research Agency (ANR)); "Region Ile de France DIM Stem Pole" PhD fellowship(Region Ile-de-France)	DB and CD were supported by an ANR-Emergence Bio fellowship (09-EBIO-018) (http://www.agence-nationale-recherche.fr). AP is a recipient of "Region Ile de France DIM Stem Pole" PhD fellowship 2011 (http://www.dim-biotherapies.com/Appels%C3%A0projets/2011/Doctorants2011/tabid/227/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg N, 2000, BLOOD, V95, P3796; Anderson NM, 2012, EXP HEMATOL, V40, P48, DOI 10.1016/j.exphem.2011.09.007; Andre P, 2000, BLOOD, V96, P3322, DOI 10.1182/blood.V96.10.3322.h8003322_3322_3328; Bergmeier W, 2008, THROMB HAEMOSTASIS, V99, P264, DOI 10.1160/TH07-10-0638; Conant CG, 2009, JOVE-J VIS EXP, V32, P1644; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; DENIS C, 1993, ARTERIOSCLER THROMB, V13, P398, DOI 10.1161/01.ATV.13.3.398; Dunois-Larde C, 2009, BLOOD, V114, P1875, DOI 10.1182/blood-2009-03-209205; Federici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280; Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kaushansky Kenneth, 2009, Hematology Am Soc Hematol Educ Program, P147, DOI 10.1182/asheducation-2009.1.147; Kirito K, 2002, BLOOD, V99, P3220, DOI 10.1182/blood.V99.9.3220; Lenting PJ, 2010, THROMB HAEMOSTASIS, V104, P449, DOI 10.1160/TH09-11-0777; Levin J, 2001, BLOOD, V98, P1019, DOI 10.1182/blood.V98.4.1019; Marx I, 2008, BLOOD, V112, P603, DOI 10.1182/blood-2008-02-142943; Mendolicchio GL, 2005, SEMIN HEMATOL, V42, P5, DOI 10.1053/j.seminhematol.2004.09.006; Nurden AT, 2005, J THROMB HAEMOST, V3, P1773, DOI 10.1111/j.1538-7836.2005.01428.x; Nurden P, 2006, BLOOD, V108, P2587, DOI 10.1182/blood-2006-03-009449; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Patel-Hett S, 2008, BLOOD, V111, P4605, DOI 10.1182/blood-2007-10-118844; Pergolizzi RG, 2006, BLOOD, V108, P862, DOI 10.1182/blood-2005-06-2330; Rayes J, 2010, BLOOD, V115, P4870, DOI 10.1182/blood-2009-11-254193; SCHEININ TM, 1963, BLOOD, V22, P82, DOI 10.1182/blood.V22.1.82.82; Schwertz H, 2010, BLOOD, V115, P3801, DOI 10.1182/blood-2009-08-239558; Schwertz H, 2010, J CELL BIOL, V191, P699, DOI 10.1083/jcb.201010082; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Strassel C, 2009, HAEMATOL-HEMATOL J, V94, P800, DOI 10.3324/haematol.2008.001032; Thon JN, 2012, BLOOD; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; Zucker-Franklin D, 2000, AM J PATHOL, V157, P69, DOI 10.1016/S0002-9440(10)64518-X	35	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63810	10.1371/journal.pone.0063810	http://dx.doi.org/10.1371/journal.pone.0063810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737952	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700015
J	Strle, F; Wormser, GP; Mead, P; Dhaduvai, K; Longo, MV; Adenikinju, O; Soman, S; Tefera, Y; Maraspin, V; Lotric-Furlan, S; Ogrinc, K; Cimperman, J; Ruzic-Sabljic, E; Stupica, D				Strle, Franc; Wormser, Gary P.; Mead, Paul; Dhaduvai, Kanthi; Longo, Michael V.; Adenikinju, Omosalewa; Soman, Sandeep; Tefera, Yodit; Maraspin, Vera; Lotric-Furlan, Stanka; Ogrinc, Katarina; Cimperman, Joze; Ruzic-Sabljic, Eva; Stupica, Dasa			Gender Disparity between Cutaneous and Non-Cutaneous Manifestations of Lyme Borreliosis	PLOS ONE			English	Article							ACRODERMATITIS CHRONICA ATROPHICANS; ERYTHEMA MIGRANS; CEREBROSPINAL-FLUID; EPIDEMIOLOGIC FEATURES; SEROLOGICAL DIAGNOSIS; ORAL DOXYCYCLINE; SOUTHERN SWEDEN; IMMUNE-RESPONSE; ENDEMIC AREA; FOLLOW-UP	Cutaneous manifestations of Lyme borreliosis in Europe include erythema migrans (EM) and acrodermatitis chronica atrophicans (ACA); the most common non-cutaneous manifestations are Lyme neuroborreliosis (LNB) and Lyme arthritis. The purpose of this study was to evaluate the gender distribution of patients with these clinical manifestations of Lyme borreliosis. Data on gender were obtained from the clinical records of patients with Lyme borreliosis aged >= 15 years who had been evaluated at the University Medical Center Ljubljana, Ljubljana, Slovenia. Among 10,539 patients diagnosed with EM, 6,245 (59.3%) were female and among 506 ACA patients 347 (68.6%) were female. In contrast, among the 60 patients with Lyme arthritis only 15 (25%) were female (p<0.0001 for the comparison of gender with EM or ACA) and among the 130 patients with LNB only 51 (39.2%) were females (p<0.0001for the comparison of gender with EM or ACA). Although the proportion that was female in the LNB group was greater than that of patients with Lyme arthritis, this difference did not reach statistical significance (p = 0.10). Although older individuals are more likely to be female in the general Slovenian population, the age of patients with cutaneous versus non-cutaneous manifestations was not the explanation for the observed differences in gender. In conclusion, patients with cutaneous manifestations of Lyme borreliosis were predominantly female, whereas those with non-cutaneous manifestations were predominantly male. This provocative finding is unexplained but may have direct relevance to the pathogenesis of Lyme borreliosis.	[Strle, Franc; Maraspin, Vera; Lotric-Furlan, Stanka; Ogrinc, Katarina; Cimperman, Joze; Stupica, Dasa] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Wormser, Gary P.; Dhaduvai, Kanthi; Longo, Michael V.; Adenikinju, Omosalewa; Soman, Sandeep; Tefera, Yodit] New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA; [Mead, Paul] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA; [Ruzic-Sabljic, Eva] Univ Ljubljana Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia	University Medical Centre Ljubljana; New York Medical College; Centers for Disease Control & Prevention - USA; University of Ljubljana	Wormser, GP (corresponding author), New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA.	gary_wormser@nymc.edu		Stupica, Dasa/0000-0001-8927-2683	Slovenian Research Agency [J3-3636, P3-0296]; Centers for Disease Control and Prevention; National Institutes of Health; Immunetics, Inc.; BioRad; DiaSorin, Inc.; BioMerieux	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunetics, Inc.; BioRad; DiaSorin, Inc.; BioMerieux	This study was supported by research grants from Slovenian Research Agency (J3-3636, P3-0296) to FS and research grants from the Centers for Disease Control and Prevention, National Institutes of Health, Immunetics, Inc., BioRad, DiaSorin, Inc., and BioMerieux to GPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2005, EUR J IMMUNOL, V35, P3043, DOI 10.1002/eji.200526354; ASBRINK E, 1993, CLIN DERMATOL, V11, P369, DOI 10.1016/0738-081X(93)90092-Q; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Bennet L, 2006, EUR J CLIN MICROBIOL, V25, P426, DOI 10.1007/s10096-006-0167-2; Bennet L, 2002, SCAND J INFECT DIS, V34, P183, DOI 10.1080/00365540110080070; Bennet L, 2007, VECTOR-BORNE ZOONOT, V7, P34, DOI 10.1089/vbz.2006.0533; Benoit VM, 2010, INFECT IMMUN, V78, P586, DOI 10.1128/IAI.01216-09; BERGLUND J, 1995, J RHEUMATOL, V22, P695; Brehmer-Andersson E, 1998, ACTA DERM-VENEREOL, V78, P207; Brisson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022926; Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011; Ciceroni L, 2001, J CLIN MICROBIOL, V39, P2254, DOI 10.1128/JCM.39.6.2254-2260.2001; Fulop B, 2008, PARASITOL RES, V103, pS117, DOI 10.1007/s00436-008-1060-y; HUAUX JP, 1988, ANN RHEUM DIS, V47, P164, DOI 10.1136/ard.47.2.164; Hulshof MM, 1997, ARCH DERMATOL, V133, P33, DOI 10.1001/archderm.133.1.33; Institute of Public Health of the Republic of Slovenia, 2011, EP SURV COMM DIS SLO; Jarefors S, 2006, IMMUNOLOGY, V118, P224, DOI 10.1111/j.1365-2567.2006.02360.x; Karkkonen K, 2001, SCAND J INFECT DIS, V33, P259, DOI 10.1080/003655401300077225; Kirchner A, 2000, J NEUROL NEUROSUR PS, V68, P368, DOI 10.1136/jnnp.68.3.368; Leone M, 2004, J INFECT DIS, V189, P339, DOI 10.1086/380798; Ljostad U, 2008, LANCET NEUROL, V7, P690, DOI 10.1016/S1474-4422(08)70119-4; Logar M, 2004, INFECTION, V32, P15, DOI 10.1007/s15010-004-3042-z; Luczaj W, 2011, EUR J CLIN MICROBIOL, V30, P415, DOI 10.1007/s10096-010-1102-0; Marangoni A, 2008, EUR J CLIN MICROBIOL, V27, P349, DOI 10.1007/s10096-007-0445-7; Marangoni A, 2006, CLIN VACCINE IMMUNOL, V13, P525, DOI 10.1128/CVI.13.4.525-529.2006; Mehnert W H, 2005, Euro Surveill, V10, P83; Pancewicz S, 2009, SCAND J INFECT DIS, V41, P584, DOI 10.1080/00365540903036220; Panelius J, 2010, MICROB PATHOGENESIS, V49, P363, DOI 10.1016/j.micpath.2010.06.006; Pietruczuk A, 2006, INFECTION, V34, P158, DOI 10.1007/s15010-006-5013-z; Raoult D, 2000, MEDICINE, V79, P109, DOI 10.1097/00005792-200003000-00005; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Renaud I, 2004, JOINT BONE SPINE, V71, P39, DOI 10.1016/S1297-319X(03)00160-X; Selvin S., 1991, STAT ANAL EPIDEMIOLO, P375; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Strle F, 1999, ANN INTERN MED, V130, P32, DOI 10.7326/0003-4819-130-1-199901050-00006; Strle F, 2011, VECTOR-BORNE ZOONOT, V11, P1253, DOI 10.1089/vbz.2010.0230; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Tibbles CD, 2007, JAMA-J AM MED ASSOC, V297, P2617, DOI 10.1001/jama.297.23.2617; van Burgel ND, 2011, CLIN MICROBIOL INFEC, V17, P1495, DOI 10.1111/j.1469-0691.2011.03459.x; WILSKE B, 1984, INFECTION, V12, P331, DOI 10.1007/BF01651147; Woolson R F, 1982, Stat Med, V1, P37, DOI 10.1002/sim.4780010106; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2009, J WOMENS HEALTH, V18, P831, DOI 10.1089/jwh.2008.1193	44	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64110	10.1371/journal.pone.0064110	http://dx.doi.org/10.1371/journal.pone.0064110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737968	gold, Green Published			2022-12-27	WOS:000321394700032
J	Tjonna, AE; Leinan, IM; Bartnes, AT; Jenssen, BM; Gibala, MJ; Winett, RA; Wisloff, U				Tjonna, Arnt Erik; Leinan, Ingeborg Megaard; Bartnes, Anette Thoresen; Jenssen, Bjorn M.; Gibala, Martin J.; Winett, Richard A.; Wisloff, Ulrik			Low- and High-Volume of Intensive Endurance Training Significantly Improves Maximal Oxygen Uptake after 10-Weeks of Training in Healthy Men	PLOS ONE			English	Article							CONTINUOUS MODERATE EXERCISE; ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; ENDOTHELIAL FUNCTION; BLOOD-PRESSURE; WEIGHT-LOSS; CAPACITY; ARTERY; RISK; PREDICTOR	Regular exercise training improves maximal oxygen uptake (VO2max), but the optimal intensity and volume necessary to obtain maximal benefit remains to be defined. A growing body of evidence suggests that exercise training with low-volume but high-intensity may be a time-efficient means to achieve health benefits. In the present study, we measured changes in VO2max and traditional cardiovascular risk factors after a 10 wk. training protocol that involved three weekly high-intensity interval sessions. One group followed a protocol which consisted of 4 x 4 min at 90% of maximal heart rate (HRmax) interspersed with 3 min active recovery at 70% HRmax (4-AIT), the other group performed a single bout protocol that consisted of 1 x 4 min at 90% HRmax (1-AIT). Twenty-six inactive but otherwise healthy overweight men (BMI: 25-30, age: 35-45 y) were randomized to either 1-AIT (n = 11) or 4-AIT (n = 13). After training, VO2max increased by 10% (similar to 5.0 mL.kg(-1).min(-1)) and 13% (similar to 6.5 mL.kg(-1).min(-1)) after 1-AIT and 4-AIT, respectively (group difference, p = 0.08). Oxygen cost during running at a sub-maximal workload was reduced by 14% and 13% after 1-AIT and 4-AIT, respectively. Systolic blood pressure decreased by 7.1 and 2.6 mmHg after 1-AIT and 4-AIT respectively, while diastolic pressure decreased by 7.7 and 6.1 mmHg (group difference, p = 0.84). Both groups had a similar similar to 5% decrease in fasting glucose. Body fat, total cholesterol, LDL-cholesterol, and ox-LDL cholesterol only were significantly reduced after 4-AIT. Our data suggest that a single bout of AIT performed three times per week may be a time-efficient strategy to improve VO2max and reduce blood pressure and fasting glucose in previously inactive but otherwise healthy middle-aged individuals. The 1-AIT type of exercise training may be readily implemented as part of activities of daily living and could easily be translated into programs designed to improve public health.	[Tjonna, Arnt Erik; Wisloff, Ulrik] KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, Trondheim, Norway; [Leinan, Ingeborg Megaard; Bartnes, Anette Thoresen; Jenssen, Bjorn M.] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway; [Gibala, Martin J.] McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada; [Winett, Richard A.] Virginia Tech, Dept Psychol, Ctr Res Hlth Behav, Blacksburg, VA USA	Norwegian University of Science & Technology (NTNU); McMaster University; Virginia Polytechnic Institute & State University	Tjonna, AE (corresponding author), KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, Trondheim, Norway.	arnt.e.tjonna@ntnu.no	Wisloff, Ulrik/K-2899-2012; Jenssen, Bjorn Munro/O-3217-2019; Jenssen, Bjorn M/J-4830-2012	Jenssen, Bjorn Munro/0000-0002-7042-2191; Jenssen, Bjorn M/0000-0002-7042-2191; Wisloff, Ulrik/0000-0002-7211-3587	K.G Jebsen Foundation; Norwegian Council of Cardiovascular Disease; Norwegian Research Council; Eckbos Foundation, Oslo	K.G Jebsen Foundation; Norwegian Council of Cardiovascular Disease; Norwegian Research Council(Research Council of NorwayEuropean Commission); Eckbos Foundation, Oslo	The present study was supported by grants from the K.G Jebsen Foundation, Norwegian Council of Cardiovascular Disease, the Norwegian Research Council (Funding for Outstanding Young Investigators; Dr Wisloff), and funds for Cardiovascular and Medical Research at St Olav's University Hospital, Trondheim, and the Eckbos Foundation, Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSM, 2010, ACSMS GUID EX TEST P; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Barengo NC, 2004, EUR HEART J, V25, P2204, DOI 10.1016/j.ehj.2004.10.009; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Gaesser GA, 1999, MED SCI SPORT EXER, V31, P1118, DOI 10.1097/00005768-199908000-00007; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hunter GR, 1998, INT J OBESITY, V22, P489, DOI 10.1038/sj.ijo.0800629; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lutes LD, 2008, ANN BEHAV MED, V35, P351, DOI 10.1007/s12160-008-9033-z; Metcalfe RS, 2012, EUR J APPL PHYSIOL, V112, P2767, DOI 10.1007/s00421-011-2254-z; Moholdt TT, 2009, AM HEART J, V158, P1031, DOI 10.1016/j.ahj.2009.10.003; Molmen-Hansen HE, 2012, EUR J PREV CARDIOL, V19, P151, DOI 10.1177/1741826711400512; Moyna NM, 2004, ACTA PHYSIOL SCAND, V180, P113, DOI 10.1111/j.0001-6772.2003.01253.x; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Oliveira RB, 2009, EUR J CARDIOV PREV R, V16, P358, DOI 10.1097/HJR.0b013e3283292fe8; PATE RR, 1984, SPORTS MED, V1, P87, DOI 10.2165/00007256-198401020-00001; Pyke KE, 2005, J PHYSIOL-LONDON, V568, P357, DOI 10.1113/jphysiol.2005.089755; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Rognmo O, 2012, CIRCULATION, V126, P1436, DOI 10.1161/CIRCULATIONAHA.112.123117; Rognmo O, 2008, J STRENGTH COND RES, V22, P535, DOI 10.1519/JSC.0b013e31816354b1; Schjerve IE, 2008, CLIN SCI, V115, P283, DOI 10.1042/CS20070332; Skaug EA, 2012, EUR J PREV CARDIOL; Slordahl SA, 2005, SCAND CARDIOVASC J, V39, P244, DOI 10.1080/14017430510035844; Tan, 2008, SAMPLE SIZE TABLES C, P47, DOI DOI 10.1002/9781444300710.CH5; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Wisloff U, 2006, EUR J CARDIOV PREV R, V13, P798, DOI 10.1097/01.hjr.0000216548.84560.ac; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; World Health Organization, 1999, REP WHO CONS DEF MET	42	100	102	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65382	10.1371/journal.pone.0065382	http://dx.doi.org/10.1371/journal.pone.0065382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734250	gold, Green Published, Green Submitted			2022-12-27	WOS:000319725500016
J	Wang, M; Yang, JX; Chen, XY				Wang, Mo; Yang, Jun-Xing; Chen, Xiao-Yong			Molecular Phylogeny and Biogeography of Percocypris (Cyprinidae, Teleostei)	PLOS ONE			English	Article							TERMINALIA-FRANCHETII COMBRETACEAE; SCHIZOTHORACINE FISHES TELEOSTEI; MULTIPLE SEQUENCE ALIGNMENT; RIBOSOMAL-RNA GENE; STREAM STICKLEBACK; MORPHOLOGICAL DIVERGENCE; CYTOCHROME-B; THREESPINE STICKLEBACK; ADAPTIVE DIVERGENCE; YUNNAN PROVINCE	Fierce predatory freshwater fishes, the species of Percocypris (Cyprinidae, Teleostei) inhabit large rivers or lakes, and have a specific distribution pattern. Only a single species or subspecies occurs in each large-scale drainage basin of the Southeastern Tibetan Plateau. In this study, the molecular phylogenetic relationships for all but one of the described subspecies/species of Percocypris were investigated based on three mitochondrial genes (16S; COI; Cyt b) and one nuclear marker (Rag2). The results of Maximum Likelihood and Bayesian Inference analyses show that Percocypris is a strongly supported monophyletic group and that it is the sister group of Schizothorax. Combined with analyses of morphological characters, our results suggest that Percocypris needs to be reclassified, and we propose that six species be recognized, with corresponding distributions in five main drainages (including one lake). In addition, based on the results of the estimation of divergence times and ancestral drainages, we hypothesize that Percocypris likely originated in the early Miocene from a paleo-connected drainage system containing the contemporary main drainages of the Southeastern Tibetan Plateau. This study suggests that vicariance (due to the uplift of the Tibetan Plateau modifying the large-scale morphologies of drainage basins in the Southeastern Tibetan Plateau) has played an important role in the speciation of the genus. Furthermore, external morphological characters (such as the length of the fins) and an internal trait (the position of pterygiophore) appear to be correlated with different habitats in rivers and the lake.	[Wang, Mo; Yang, Jun-Xing; Chen, Xiao-Yong] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Wang, Mo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, JX (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	yangjx@mail.kiz.ac.cn; chenxy@mail.kiz.ac.cn			National Natural Science Foundation of China [30870288, 30730017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (No. 30870288, No. 30730017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2005, MOL BIOL EVOL, V22, P691, DOI 10.1093/molbev/msi050; Aguirre WE, 2009, BIOL J LINN SOC, V98, P139, DOI 10.1111/j.1095-8312.2009.01267.x; AMATO G, 1998, PHYLOGENY TIBETAN ST, P245; [Anonymous], 2002, GEOL CHINA; Bart HL, 2010, INT J MOL SCI, V11, P1090, DOI 10.3390/ijms11031090; BEACHAM TD, 1989, T AM FISH SOC, V118, P46, DOI 10.1577/1548-8659(1989)118<0046:AMABGV>2.3.CO;2; Berner D, 2008, J EVOLUTION BIOL, V21, P1653, DOI 10.1111/j.1420-9101.2008.01583.x; Berner D, 2011, J EVOLUTION BIOL, V24, P1975, DOI 10.1111/j.1420-9101.2011.02330.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Bohme M., 2003, FOSFARBASE; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BROOKS DR, 1985, ANN MO BOT GARD, V72, P660, DOI 10.2307/2399219; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Chen PF, 2010, J VERTEBR PALEONTOL, V30, P333, DOI 10.1080/02724631003620930; CHU XL, 1989, FISHES YUNNAN 1, P177; Chu Y.T., 1935, BIOL BULL+, V2, P1, DOI DOI 10.2307/1436747; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Collin H, 2011, MOL ECOL, V20, P4490, DOI 10.1111/j.1365-294X.2011.05284.x; CUI GH, 1990, DONG WU FEN LEI XUE, V15, P118; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drinan TJ, 2012, ECOL FRESHW FISH, V21, P420, DOI 10.1111/j.1600-0633.2012.00561.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang XM, 2002, SCI CHINA SER D, V45, P289, DOI 10.1360/02yd9031; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Franssen NR, 2011, EVOL APPL, V4, P791, DOI 10.1111/j.1752-4571.2011.00200.x; Guo XG, 2005, MOL PHYLOGENET EVOL, V35, P344, DOI 10.1016/j.ympev.2004.12.015; Haas TC, 2010, BIOL LETTERS, V6, P803, DOI 10.1098/rsbl.2010.0401; Harris PM, 2001, MOL PHYLOGENET EVOL, V20, P225, DOI 10.1006/mpev.2001.0980; He DK, 2007, CHINESE SCI BULL, V52, P777, DOI 10.1007/s11434-007-0123-2; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; He DK, 2004, CHINESE SCI BULL, V49, P39, DOI 10.1360/03wc0212; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Hendry AP, 2011, J EVOLUTION BIOL, V24, P23, DOI 10.1111/j.1420-9101.2010.02155.x; Hendry AP, 2002, EVOLUTION, V56, P1199; Hendry AP, 2004, EVOLUTION, V58, P2319; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kaeuffer R, 2012, EVOLUTION, V66, P402, DOI 10.1111/j.1558-5646.2011.01440.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kottelat Maurice, 2001, pi; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langerhans RB, 2003, BIOL J LINN SOC, V80, P689, DOI 10.1111/j.1095-8312.2003.00266.x; LAVIN PA, 1993, CAN J ZOOL, V71, P11, DOI 10.1139/z93-003; Levin BA, 2012, MOL PHYLOGENET EVOL, V62, P542, DOI 10.1016/j.ympev.2011.09.004; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; Liu J, 2009, SCI CHINA SER D, V52, P189, DOI 10.1007/s11430-009-0022-2; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; McGuigan K, 2003, EVOLUTION, V57, P104; Ming Q.Z., 2006, YUNNAN GEOG ENV RES, V18, P1, DOI [10.3969/j.issn.1001-7852.2006.04.001, DOI 10.3969/J.ISSN.1001-7852.2006.04.001]; Nanjing Institute of Geography and Limnology CAS Lanzhou Institute of Geology CAS Institute of Geochemistry CAS Nanjing Institute of Geology and Paleontology CAS, 1989, ENV SED FAULT LAK YU; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pavey SA, 2010, T AM FISH SOC, V139, P1584, DOI 10.1577/T09-182.1; Pellegrin J., 1936, B SOC ZOOLOGIQUE FRA, V61, P375; Peng ZG, 2006, MOL PHYLOGENET EVOL, V39, P568, DOI 10.1016/j.ympev.2005.10.016; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Rambaut A., 2007, TRACER V1 5; REIMCHEN TE, 1985, CAN J ZOOL, V63, P2944, DOI 10.1139/z85-441; Ripplinger J, 2008, SYST BIOL, V57, P76, DOI 10.1080/10635150801898920; Roesma Dewi Imelda, 2011, Biodiversitas, V12, P141; Ruber L, 2004, MOL PHYLOGENET EVOL, V32, P1010, DOI 10.1016/j.ympev.2004.04.020; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schonhuth S, 2012, ZOOTAXA, P281, DOI 10.11646/zootaxa.3586.1.27; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAN XH, 2000, FAUNA SINICA OSTEICH, P47; Sharpe DMT, 2008, EVOL ECOL RES, V10, P849; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; SUN HL, 1996, SCI MONOGRAPHIC SERI, P104; SWAIN DP, 1989, CAN J FISH AQUAT SCI, V46, P1406, DOI 10.1139/f89-180; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Tao WJ, 2013, MOL PHYLOGENET EVOL, V66, P603, DOI 10.1016/j.ympev.2012.09.024; Taylor EB, 2011, EVOL APPL, V4, P100, DOI 10.1111/j.1752-4571.2010.00136.x; Tchang T. L., 1935, Bulletin of the Fan Memorial Institute of Biology Zool Ser, V6, P60; TCHANG TCHUNG-LIN, 1930, BULL MUS NATION HIST NAT [PARIS], V2, P84; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsigenopoulos CS, 2003, BIOL J LINN SOC, V80, P207, DOI 10.1046/j.1095-8312.2003.00237.x; VOGLER AP, 1994, CONSERV BIOL, V8, P354, DOI 10.1046/j.1523-1739.1994.08020354.x; Wang XZ, 2007, MOL PHYLOGENET EVOL, V42, P157, DOI 10.1016/j.ympev.2006.06.014; WU XW, 1977, ZHONGGUO YULEI ZHI, P265; XiangHui K, 2007, SCI CHINA SER C, V50, P780, DOI 10.1007/s11427-007-0076-3; Yang J, 2012, J ZOOL SYST EVOL RES, V50, P184, DOI 10.1111/j.1439-0469.2012.00661.x; Yang ZH, 1996, J MOL EVOL, V42, P587, DOI 10.1007/BF02352289; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhang TC, 2011, J PLANT RES, V124, P63, DOI 10.1007/s10265-010-0360-3; Zhao Xitao, 2011, Dizhi Xuebao, V85, P1963; ZHAO Y, 2009, ENDEMIC FISHES SINOC, P255; Zwickl DJ., 2006, THESIS	98	15	17	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e61827	10.1371/journal.pone.0061827	http://dx.doi.org/10.1371/journal.pone.0061827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750199	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900001
J	Basu, M; Bhattacharyya, NP; Mohanty, PK				Basu, Mahashweta; Bhattacharyya, Nitai P.; Mohanty, Pradeep K.			Comparison of Modules of Wild Type and Mutant Huntingtin and TP53 Protein Interaction Networks: Implications in Biological Processes and Functions	PLOS ONE			English	Article							DISEASE GENE; DNA-REPAIR; RAT MODEL; P53; EXPRESSION; ACTIVATION; APOPTOSIS; MIGRATION; NEURONS; CANCER	Disease-causing mutations usually change the interacting partners of mutant proteins. In this article, we propose that the biological consequences of mutation are directly related to the alteration of corresponding protein protein interaction networks (PPIN). Mutation of Huntingtin (HTT) which causes Huntington's disease (HD) and mutations to TP53 which is associated with different cancers are studied as two example cases. We construct the PPIN of wild type and mutant proteins separately and identify the structural modules of each of the networks. The functional role of these modules are then assessed by Gene Ontology (GO) enrichment analysis for biological processes (BPs). We find that a large number of significantly enriched (p<0.0001) GO terms in mutant PPIN were absent in the wild type PPIN indicating the gain of BPs due to mutation. Similarly some of the GO terms enriched in wild type PPIN cease to exist in the modules of mutant PPIN, representing the loss. GO terms common in modules of mutant and wild type networks indicate both loss and gain of BPs. We further assign relevant biological function(s) to each module by classifying the enriched GO terms associated with it. It turns out that most of these biological functions in HTT networks are already known to be altered in HD and those of TP53 networks are altered in cancers. We argue that gain of BPs, and the corresponding biological functions, are due to new interacting partners acquired by mutant proteins. The methodology we adopt here could be applied to genetic diseases where mutations alter the ability of the protein to interact with other proteins.	[Basu, Mahashweta; Mohanty, Pradeep K.] Saha Inst Nucl Phys, Theoret Condensed Matter Phys Div, Kolkata, India; [Bhattacharyya, Nitai P.] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics	Mohanty, PK (corresponding author), Saha Inst Nucl Phys, Theoret Condensed Matter Phys Div, Kolkata, India.	pk.mohanty@saha.ac.in		Mohanty, Pradeep Kumar/0000-0002-5240-8396	DAE, Government of India	DAE, Government of India(Department of Atomic Energy (DAE))	The authors gratefully acknowledge the financial support obtained from DAE, Government of India, through Institutional grants to Saha Institute of Nuclear Physics, Kolkata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bano D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.112; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bode FJ, 2008, HUM MOL GENET, V17, P2595, DOI 10.1093/hmg/ddn159; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Ciarmiello A, 2012, EUR J NUCL MED MOL I, V39, P1030, DOI 10.1007/s00259-012-2114-z; Coffill CR, 2012, EMBO REP, V13, P638, DOI 10.1038/embor.2012.74; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Dong PX, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-103; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; GAMBERINO WC, 1994, J NEUROCHEM, V63, P1392; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; GOTTFRIED M, 1981, ACTA NEUROPATHOL, V55, P163, DOI 10.1007/BF00699242; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humbert S, 2010, EMBO REP, V11, P899, DOI 10.1038/embor.2010.182; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Jain AK, 2010, CANCER BIOL THER, V10, P665, DOI 10.4161/cbt.10.7.13445; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LEVINE AJ, 2009, NATURE REV, V9; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; MYERS RH, 1989, AM J HUM GENET, V45, P615; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; OLCH J, 2012, NEUROTOX RES, V22, P195; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Ozaki T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/603925; Pelegri C, 2008, INT J DEV NEUROSCI, V26, P665, DOI 10.1016/j.ijdevneu.2008.07.016; Perrin V, 2009, EXP NEUROL, V215, P191, DOI 10.1016/j.expneurol.2008.10.008; RIGAMONTI D, 2000, J BIOL CHEM, V276; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Selivanova G, 2009, CELL, V139, P1220, DOI 10.1016/j.cell.2009.12.016; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Seredenina T, 2012, NEUROBIOL DIS, V45, P83, DOI 10.1016/j.nbd.2011.07.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; SINHA M, 2012, NEUROMOL MED; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Sun SQ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1103; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tong YA, 2011, J NEUROSCI, V31, P14794, DOI 10.1523/JNEUROSCI.2774-11.2011; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-38	74	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64838	10.1371/journal.pone.0064838	http://dx.doi.org/10.1371/journal.pone.0064838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741403	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900116
J	Bruni, F; Gramegna, P; Oliveira, JMA; Lightowlers, RN; Chrzanowska-Lightowlers, ZMA				Bruni, Francesco; Gramegna, Pasqua; Oliveira, Jorge M. A.; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M. A.			REXO2 Is an Oligoribonuclease Active in Human Mitochondria	PLOS ONE			English	Article							POLYNUCLEOTIDE PHOSPHORYLASE; ESCHERICHIA-COLI; STRANDED-RNA; HUMAN-CELLS; AUG CODONS; DNA; DEGRADATION; NUCLEOIDS; COMPLEX; GENE	The Escherichia coli oligoribonuclease, ORN, has a 3' to 5' exonuclease activity specific for small oligomers that is essential for cell viability. The human homologue, REXO2, has hitherto been incompletely characterized, with only its in vitro ability to degrade small single-stranded RNA and DNA fragments documented. Here we show that the human enzyme has clear dual cellular localization being present both in cytosolic and mitochondrial fractions. Interestingly, the mitochondrial form localizes to both the intermembrane space and the matrix. Depletion of REXO2 by RNA interference causes a strong morphological phenotype in human cells, which show a disorganized network of punctate and granular mitochondria. Lack of REXO2 protein also causes a substantial decrease of mitochondrial nucleic acid content and impaired de novo mitochondrial protein synthesis. Our data constitute the first in vivo evidence for an oligoribonuclease activity in human mitochondria.	[Bruni, Francesco; Gramegna, Pasqua; Chrzanowska-Lightowlers, Zofia M. A.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lightowlers, Robert N.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Oliveira, Jorge M. A.] Univ Porto, Fac Pharm, Dept Drug Sci, REQUIMTE, P-4100 Oporto, Portugal	Newcastle University - UK; Newcastle University - UK; Universidade do Porto	Lightowlers, RN (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	robert.lightowlers@ncl.ac.uk; zofia.chrzanowska-lightowlers@ncl.ac.uk	Oliveira, Jorge M. A./D-4787-2013; Bruni, Francesco/I-4074-2018; REQUIMTE, PHYTO/M-4633-2013	Oliveira, Jorge M. A./0000-0002-6040-5355; Bruni, Francesco/0000-0001-5120-5936; Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152	Wellcome Trust [096919/Z/11/Z]; BBSRC [BB/F011520/1]; Biotechnology and Biological Sciences Research Council [BB/F011520/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RNL and ZMACL would like to thank The Wellcome Trust [096919/Z/11/Z], BBSRC [BB/F011520/1], http://www.wellcome.ac.uk/, http://www.bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Barni S, 1996, BIOTECH HISTOCHEM, V71, P66, DOI 10.3109/10520299609117135; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; Bruni F, 2012, BIOCHEM SOC T, V40, P865, DOI 10.1042/BST20120022; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; CHRZANOWSKALIGHTOWLERS ZMA, 1994, J BIOL CHEM, V269, P27322; Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P4372, DOI 10.1073/pnas.96.8.4372; Goldman SR, 2011, MOL CELL, V42, P817, DOI 10.1016/j.molcel.2011.06.005; Hanekamp T, 1999, CURR GENET, V34, P438, DOI 10.1007/s002940050418; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Koonin EV, 1997, CURR BIOL, V7, pR604, DOI 10.1016/S0960-9822(06)00311-3; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Lin CL, 2012, NUCLEIC ACIDS RES, V40, P4146, DOI 10.1093/nar/gkr1281; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5; Nguyen LH, 2000, J BIOL CHEM, V275, P25900, DOI 10.1074/jbc.M002672200; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; NIYOGI SK, 1975, J BIOL CHEM, V250, P7307; Oliveira JMA, 2011, CURR DRUG TARGETS, V12, P762; Ovcharenko D, 2005, RNA, V11, P985, DOI 10.1261/rna.7288405; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Szczesny RJ, 2012, BBA-GENE REGUL MECH, V1819, P1027, DOI 10.1016/j.bbagrm.2011.11.010; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Zhang XL, 1998, J BACTERIOL, V180, P2779, DOI 10.1128/JB.180.10.2779-2781.1998; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	50	39	40	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64670	10.1371/journal.pone.0064670	http://dx.doi.org/10.1371/journal.pone.0064670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741365	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900078
J	Fielding, R; Lam, WWT; Shun, SC; Okuyama, T; Lai, YH; Wada, M; Akechi, T; Li, WWY				Fielding, Richard; Lam, Wendy Wing Tak; Shun, Shiow Ching; Okuyama, Toru; Lai, Yeur Hur; Wada, Makoto; Akechi, Tatsuo; Li, Wylie Wai Yee		APPON	Attributing Variance in Supportive Care Needs during Cancer: Culture-Service, and Individual Differences, before Clinical Factors	PLOS ONE			English	Article							HONG-KONG CHINESE; BREAST-CANCER; SOCIAL SUPPORT; WOMEN; TRAJECTORIES; AMERICAN; PEOPLE; HEALTH	Background: Studies using the Supportive Care Needs Survey (SCNS) report high levels of unmet supportive care needs (SCNs) in psychological and less-so physical & daily living domains, interpreted as reflecting disease/treatment-coping deficits. However, service and culture differences may account for unmet SCNs variability. We explored if service and culture differences better account for observed SCNs patterns. Methods: Hong Kong (n = 180), Taiwanese (n = 263) and Japanese (n = 109) CRC patients' top 10 ranked SCNS-34 items were contrasted. Mean SCNS-34 domain scores were compared by sample and treatment status, then adjusted for sample composition, disease stage and treatment status using multivariate hierarchical regression. Results: All samples were assessed at comparable time-points. SCNs were most prevalent among Japanese and least among Taiwanese patients. Japanese patients emphasized Psychological (domain mean = 40.73) and Health systems and information (HSI) (38.61) SCN domains, whereas Taiwanese and Hong Kong patients emphasized HSI (27.41; 32.92) and Patient care & support (PCS) (19.70; 18.38) SCN domains. Mean Psychological domain scores differed: Hong Kong = 9.72, Taiwan = 17.84 and Japan = 40.73 (p<0.03-0.001, Bonferroni). Other SCN domains differed only between Chinese and Japanese samples (all p<0.001). Treatment status differentiated Taiwanese more starkly than Hong Kong patients. After adjustment, sample origin accounted for most variance in SCN domain scores (p, 0.001), followed by age (p = 0.01-0.001) and employment status (p = 0.01-0.001). Treatment status and Disease stage, though retained, accounted for least variance. Overall accounted variance remained low. Conclusions: Health service and/or cultural influences, age and occupation differences, and less so clinical factors, differentially account for significant variation in published studies of SCNs.	[Fielding, Richard; Lam, Wendy Wing Tak; Li, Wylie Wai Yee] Univ Hong Kong, Sch Publ Hlth, Ctr Psychooncol Res & Training, Pokfulam, Hong Kong, Peoples R China; [Shun, Shiow Ching; Lai, Yeur Hur] Natl Taiwan Univ, Dept Nursing, Taipei 10764, Taiwan; [Okuyama, Toru; Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Mizuho Ku, Nagoya, Aichi, Japan; [Wada, Makoto] Saitama Canc Ctr, Dept Psychooncol, Saitama, Japan	University of Hong Kong; National Taiwan University; Nagoya City University	Fielding, R (corresponding author), Univ Hong Kong, Sch Publ Hlth, Ctr Psychooncol Res & Training, Pokfulam, Hong Kong, Peoples R China.	fielding@hku.hk	Lam, Wendy Wing Tak/C-4319-2009	Lam, Wendy Wing Tak/0000-0003-2383-0149; Okuyama, Toru/0000-0003-0504-6406; SHUN, SHIOW-CHING/0000-0002-9883-4446; LAI, YEUR-HUR/0000-0003-0313-2634				Abrahamson K, 2010, PATIENT INTELL, V2, P45, DOI DOI 10.2147/PI.S9442; Akechi T, 2011, PSYCHO-ONCOLOGY, V20, P497, DOI 10.1002/pon.1757; ANTONUCCI TC, 1987, SEX ROLES, V17, P737, DOI 10.1007/BF00287685; Armes J, 2009, J CLIN ONCOL, V27, P6172, DOI 10.1200/JCO.2009.22.5151; Au A, 2011, PSYCHO-ONCOLOGY, V20, P1292, DOI 10.1002/pon.1851; Bachnik Jane M., 1994, SITUATED MEANING INS, P3; Bonevski B, 2000, CANCER, V88, P226; Boyes AW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-150; Bredart A, 2012, EUR J CANCER CARE, V21, P450, DOI 10.1111/j.1365-2354.2012.01356.x; Chen SC, 2008, THESIS TAIPEI MED U; Fielding R., 2011, CLIN PSYCHOONCOLOGY, P165; Goldstein D, 2012, J CLIN ONCOL S, V30; Harrison JD, 2011, COLORECTAL DIS, V13, P1400, DOI 10.1111/j.1463-1318.2010.02478.x; Harrison JD, 2009, SUPPORT CARE CANCER, V17, P1117, DOI 10.1007/s00520-009-0615-5; Jorgensen ML, 2012, SUPPORT CARE CANCER, V20, P1275, DOI 10.1007/s00520-011-1214-9; Jou YH, 2002, J SOC PSYCHOL, V142, P353, DOI 10.1080/00224540209603904; KAMITANI Y, 1993, PSYCHOL REP, V72, P855, DOI 10.2466/pr0.1993.72.3.855; Knobf MT, 2012, J CANCER SURVIV, V6, P1, DOI 10.1007/s11764-011-0198-2; Lai YH, 2006, UICC WORLD CANC C WA; Lam WWT, 2012, HEALTH EDUC RES, V27, P767, DOI 10.1093/her/cys087; Lam WWT, 2012, BREAST CANCER RES TR, V131, P957, DOI 10.1007/s10549-011-1798-2; Lam WWT, 2011, BREAST CANCER RES TR, V130, P531, DOI 10.1007/s10549-011-1592-1; Lam WWT, 2012, PSYCHO-ONCOLOGY, V21, P90, DOI 10.1002/pon.1876; Lam WWT, 2010, PSYCHO-ONCOLOGY, V19, P1044, DOI 10.1002/pon.1658; Lam WWT, 2003, PSYCHO-ONCOL, V12, P127, DOI 10.1002/pon.621; Li WWY, 2013, PSYCHO-ONCOLOGY, V22, P792, DOI 10.1002/pon.3068; Liao YC, 2011, SUPPORT CARE CANCER, V19, P1743, DOI 10.1007/s00520-010-1014-7; Makabe R, 2000, Oncol Nurs Forum, V27, P1381; Matsumoto D, 2008, J PERS SOC PSYCHOL, V94, P925, DOI 10.1037/0022-3514.94.6.925; McDowell ME, 2010, PSYCHO-ONCOLOGY, V19, P508, DOI 10.1002/pon.1604; Nemoto T, 1998, J COMMUNITY PSYCHOL, V26, P293, DOI 10.1002/(SICI)1520-6629(199807)26:4<293::AID-JCOP1>3.3.CO;2-K; Ng R, 2012, SUPPORT CARE CANCER, V20, P1049, DOI 10.1007/s00520-011-1181-1; Okuyama T, 2009, PSYCHO-ONCOL, V18, P1003, DOI 10.1002/pon.1482; Park BW, 2012, YONSEI MED J, V53, P118, DOI 10.3349/ymj.2012.53.1.118; Sanders SL, 2010, PSYCHO-ONCOLOGY, V19, P480, DOI 10.1002/pon.1577; Sanson-Fisher R, 2000, CANCER, V88, P226, DOI 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P; Suganda V., 2012, THESIS MCMASTER U; Tsai JL, 1997, J CROSS CULT PSYCHOL, V28, P600, DOI 10.1177/0022022197285006; Uchitomi Y, 1999, JPN J CLIN ONCOL, V29, P411, DOI 10.1093/jjco/29.9.411; Yen CL, 2012, INT J PSYCHOL	40	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65099	10.1371/journal.pone.0065099	http://dx.doi.org/10.1371/journal.pone.0065099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741467	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900180
J	Klaus, A; Zorman, S; Berthier, A; Polge, C; Ramirez, S; Michelland, S; Seve, M; Vertommen, D; Rider, M; Lentze, N; Auerbach, D; Schlattner, U				Klaus, Anna; Zorman, Sarah; Berthier, Alexandre; Polge, Cecile; Ramirez, Sacnicte; Michelland, Sylvie; Seve, Michel; Vertommen, Didier; Rider, Mark; Lentze, Nicolas; Auerbach, Daniel; Schlattner, Uwe			Glutathione S-Transferases Interact with AMP-Activated Protein Kinase: Evidence for S-Glutathionylation and Activation In Vitro	PLOS ONE			English	Article							ENERGY SENSOR; OXIDATIVE STRESS; CELL; PEROXIREDOXIN; PI; PROTECTION; COMPLEXES; REQUIRES; SUBUNITS; PATHWAY	AMP-activated protein kinase (AMPK) is a cellular and whole body energy sensor with manifold functions in regulating energy homeostasis, cell morphology and proliferation in health and disease. Here we apply multiple, complementary in vitro and in vivo interaction assays to identify several isoforms of glutathione S-transferase (GST) as direct AMPK binding partners: Pi-family member rat GSTP1 and Mu-family members rat GSTM1, as well as Schistosoma japonicum GST. GST/AMPK interaction is direct and involves the N-terminal domain of the AMPK beta-subunit. Complex formation of the mammalian GSTP1 and -M1 with AMPK leads to their enzymatic activation and in turn facilitates glutathionylation and activation of AMPK in vitro. GST-facilitated S-glutathionylation of AMPK may be involved in rapid, full activation of the kinase under mildly oxidative physiological conditions.	[Klaus, Anna; Zorman, Sarah; Berthier, Alexandre; Polge, Cecile; Ramirez, Sacnicte; Schlattner, Uwe] Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget, Grenoble, France; [Klaus, Anna; Zorman, Sarah; Berthier, Alexandre; Polge, Cecile; Ramirez, Sacnicte; Schlattner, Uwe] INSERM, Grenoble, France; [Michelland, Sylvie; Seve, Michel] CRI Inserm, Inst Albert Bonniot, Grenoble, France; [Michelland, Sylvie; Seve, Michel] Ctr Hosp Univ Grenoble, Inst Biol & Pathol, Grenoble, France; [Vertommen, Didier; Rider, Mark] Catholic Univ Louvain, Fac Med, B-1200 Brussels, Belgium; [Vertommen, Didier; Rider, Mark] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Lentze, Nicolas; Auerbach, Daniel] Dualsystems Biotech AG, Schlieren, Switzerland	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Catholique Louvain; Universite Catholique Louvain	Schlattner, U (corresponding author), Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget, Grenoble, France.	uwe.schlattner@ujf-grenoble.fr	Polge, Cécile/AAM-2467-2020; Schlattner, Uwe/D-1267-2009; Seve, Michel/M-2786-2013; Berthier, Alexandre/O-6566-2019	Polge, Cécile/0000-0002-8730-5776; Schlattner, Uwe/0000-0003-1159-5911; Berthier, Alexandre/0000-0003-4153-4810; SEVE, Michel/0000-0001-5503-9488; Vertommen, Didier/0000-0001-7648-8282	EU [LSHM-CT-2004-005272]; Fondation pour la Recherche Medicale; French Agence Nationale de Recherche ("chaire d'excellence")	EU(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Agence Nationale de Recherche ("chaire d'excellence")(French National Research Agency (ANR))	This work was supported by EU FP6 contract LSHM-CT-2004-005272 (EXGENESIS), the Fondation pour la Recherche Medicale (given to A. K.) and the French Agence Nationale de Recherche ("chaire d'excellence" given to U.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Anathy V, 2012, ANTIOXID REDOX SIGN, V16, P496, DOI 10.1089/ars.2011.4281; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Arbault S, 1997, CARCINOGENESIS, V18, P569, DOI 10.1093/carcin/18.3.569; Boireau W, 2009, BIOSENS BIOELECTRON, V24, P1121, DOI 10.1016/j.bios.2008.06.030; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; De Luca A, 2011, BIOCHEM J, V440, P175, DOI 10.1042/BJ20111333; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gilot D, 2002, J BIOL CHEM, V277, P49220, DOI 10.1074/jbc.M207325200; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3562, DOI 10.1021/bi00434a062; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hou XG, 2010, BIOCHEM BIOPH RES CO, V396, P199, DOI 10.1016/j.bbrc.2010.04.017; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Klaus A, 2012, J PROTEOMICS, V75, P3304, DOI 10.1016/j.jprot.2012.03.040; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Lo HW, 2004, CANCER RES, V64, P9131, DOI 10.1158/0008-5472.CAN-04-0283; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Mockli N, 2007, BIOTECHNIQUES, V42, P725, DOI 10.2144/000112455; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Nieslanik BS, 2000, J BIOL CHEM, V275, P17447, DOI 10.1074/jbc.M002083200; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Polge C, 2008, PLANT PHYSIOL, V148, P1570, DOI 10.1104/pp.108.123026; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Riek Uwe, 2009, Biotechniques, V46, pix, DOI 10.2144/000113130; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Smith DB, 2000, METHOD ENZYMOL, V326, P254; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tafelmeyer P, 2004, CHEM BIOL, V11, P681, DOI 10.1016/j.chembiol.2004.02.026; TEW KD, 2012, ANTIOXID REDOX SIGNA; Tew KD, 2011, FREE RADICAL BIO MED, V51, P299, DOI 10.1016/j.freeradbiomed.2011.04.013; Tew KD, 2011, DRUG METAB REV, V43, P179, DOI 10.3109/03602532.2011.552912; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Vincent O, 1999, EMBO J, V18, P6672, DOI 10.1093/emboj/18.23.6672; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Wetzelberger K, 2010, J BIOL CHEM, V285, P26135, DOI 10.1074/jbc.M110.146423; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Yin ZM, 2000, CANCER RES, V60, P4053; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	63	46	47	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e62497	10.1371/journal.pone.0062497	http://dx.doi.org/10.1371/journal.pone.0062497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741294	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900006
J	Liu, Y; Bai, R; Wang, L; Zhang, CT; Zhao, RF; Wan, DL; Chen, XS; Caceres, G; Barr, D; Barajas-Martinez, H; Antzelevitch, C; Hu, D				Liu, Yang; Bai, Rong; Wang, Lin; Zhang, Cuntai; Zhao, Ruifu; Wan, Deli; Chen, Xinshan; Caceres, Gabriel; Barr, Daniel; Barajas-Martinez, Hector; Antzelevitch, Charles; Hu, Dan			Identification of a Novel De Novo Mutation Associated with PRKAG2 Cardiac Syndrome and Early Onset of Heart Failure	PLOS ONE			English	Article							ACTIVATED-PROTEIN-KINASE; PARKINSON-WHITE-SYNDROME; CONDUCTION SYSTEM DISEASE; HYPERTROPHIC CARDIOMYOPATHY; VENTRICULAR PREEXCITATION; GAMMA(2) SUBUNIT; AMP BINDING; ENERGY; GAMMA-2-SUBUNIT; GLYCOGENOSIS	Introduction: The major structure elements of the AMP-activated protein kinase (AMPK) are alpha, beta, and gamma sunbunits. Mutations in gamma 2 subunit (PRKAG2) have been associated with a cardiac syndrome including inherited ventricular preexcitation, conduction disorder and hypertrophy mimicking hypertrophic cardiomyopathy. The aim of the present study was to identify PRKAG2 syndrome among patients presenting with left ventricular hypertrophy (LVH). Methods and Results: Nineteen unrelated subjects with unexplained LVH were clinically and genetically evaluated. Among 4 patients with bradycardia, manifestations of preexcitation were only found in a 19 year old male who also developed congestive heart failure 3 years later. Electrophysiological study of this case identified the coexistence of an AV accessory pathway and AV conduction defect. Histological analysis of his ventricular tissue isolated by biopsy confirmed excessive glycogen accumulation, prominent myofibrillar disarray and interstitial fibrosis. Direct sequencing of his DNA revealed a heterozygous mutation in PRKAG2 consisting of an A-to-G transition at nucleotide 1453 (c.1453A.G), predicting a substitution of a glutamic acid for lysine at highly-conserved residue 485 (p.Lys485Glu, K485E), which was absent in his unaffected family members and in 215 healthy controls. To assess the role of K485 in the structure and function of the protein, computational modeling calculations and conservation analyses were performed. Electrostatic calculations indicate that K485 forms a salt bridge with the conserved D248 residue in the AMPK b subunit, which is critical for proper regulation of the enzyme, and the K485E mutant disrupts the connection. Conclusions: Our study identifies a novel de novo PRKAG2 mutation in a young, in which progression of the disease warrants close medical attention. It also underlines the importance of molecular screening of PRKAG2 gene in patients with unexplained LVH, ventricular preexcitation, conduction defect, and/or early onset of heart failure.	[Liu, Yang; Bai, Rong; Wang, Lin; Zhao, Ruifu; Wan, Deli] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan 430074, Peoples R China; [Liu, Yang] Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China; [Zhang, Cuntai] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Geriatr, Wuhan 430074, Peoples R China; [Chen, Xinshan] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430074, Peoples R China; [Caceres, Gabriel; Barajas-Martinez, Hector; Antzelevitch, Charles; Hu, Dan] Masonic Med Res Lab, Dept Mol Genet & Expt Cardiol, Utica, NY USA; [Barr, Daniel] Utica Coll, Dept Chem & Biochem, Utica, NY 13502 USA	Huazhong University of Science & Technology; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Masonic Medical Research Laboratory	Hu, D (corresponding author), Masonic Med Res Lab, Dept Mol Genet & Expt Cardiol, Utica, NY USA.	dianah@mmrl.edu		Barr, Daniel/0000-0003-4660-5649; Antzelevitch, Charles/0000-0001-7349-1582; Antzelevitch, Charles/0000-0001-5215-4667; Hu, Dan/0000-0002-0994-8434	National Heart, Lung, and Blood Institute (NHLBI) [HL47678]; New York State Stem Cell Science (NYSTEM); Mason of New York State; Mason of Florida; Chinese programs for New Century Excellent Talents in University [NCET-09-0376]; National Natural Science Foundation [NSFC-30973601]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R55HL047678, R01HL047678] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York State Stem Cell Science (NYSTEM); Mason of New York State; Mason of Florida; Chinese programs for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant HL47678 from National Heart, Lung, and Blood Institute (NHLBI), grants from New York State Stem Cell Science (NYSTEM), the Masons of New York State and Florida to Dr. Charles Antzelevitch. The study was supported by the Chinese programs for New Century Excellent Talents in University (NCET-09-0376) and the National Natural Science Foundation (NSFC-30973601) to Dr. Rong Bai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman HO, 2007, PEDIATR RES, V62, P499, DOI 10.1203/PDR.0b013e3181462b86; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arad M, 2003, CIRCULATION, V107, P2850, DOI 10.1161/01.CIR.0000075270.13497.2B; Arad M, 2002, HUM MOL GENET, V11, P2499, DOI 10.1093/hmg/11.20.2499; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee SK, 2007, BIOCHEM BIOPH RES CO, V360, P381, DOI 10.1016/j.bbrc.2007.06.067; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Davies JK, 2006, AM J PHYSIOL-HEART C, V290, pH1942, DOI 10.1152/ajpheart.01020.2005; Gollob MH, 2002, CURR OPIN CARDIOL, V17, P229, DOI 10.1097/00001573-200205000-00004; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kelly BP, 2009, PEDIATR CARDIOL, V30, P1176, DOI 10.1007/s00246-009-9521-3; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lang TM, 2000, GENOMICS, V70, P258, DOI 10.1006/geno.2000.6376; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Murphy RT, 2005, J AM COLL CARDIOL, V45, P922, DOI 10.1016/j.jacc.2004.11.053; Pan Min, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P185; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sidhu JS, 2005, CIRCULATION, V111, P21, DOI 10.1161/01.CIR.0000151291.32974.D5; Sternick EB, 2011, HEART RHYTHM, V8, P58, DOI 10.1016/j.hrthm.2010.09.081; Van Belle Y, 2008, PACE, V31, P1358, DOI 10.1111/j.1540-8159.2008.01192.x; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yi Shao-hua, 2008, Chinese Medical Sciences Journal, V23, P239	30	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64603	10.1371/journal.pone.0064603	http://dx.doi.org/10.1371/journal.pone.0064603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741347	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900060
J	Zarranz-Ventura, J; Fernandez-Robredo, P; Recalde, S; Salinas-Alaman, A; Borras-Cuesta, F; Dotor, J; Garcia-Layana, A				Zarranz-Ventura, Javier; Fernandez-Robredo, Patricia; Recalde, Sergio; Salinas-Alaman, Angel; Borras-Cuesta, Francisco; Dotor, Javier; Garcia-Layana, Alfredo			Transforming Growth Factor-Beta Inhibition Reduces Progression of Early Choroidal Neovascularization Lesions in Rats: P17 and P144 Peptides	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; SYNTHETIC PEPTIDE; MESSENGER-RNA; EXPRESSION; MEMBRANES; VEGF; TGF-BETA-1; FIBROSIS	The purpose of this study was to assess the effects of transforming growth factor beta (TGF-beta) inhibitor peptides (P17 & P144) on early laser-induced choroidal neovascularization (LI-CNV) lesions in rats, two weeks after laser CNV induction. Seventy-one Long Evans rats underwent diode laser application in an established LI-CNV model. Baseline fluorescein angiography (FA) was performed 14 days following laser procedure, and treatments were administered 16 days post-laser application via different administration routes. Intravenous groups included control (IV-Control), P17 (IV-17), and P144 (IV-144) groups, whereas intravitreal groups included P17 (IVT-17), P144 (IVT-144), and a mixture of both peptides (IVT-17+144) (with fellow eyes receiving vehicle alone). CNV evolution was assessed using FA performed weekly for four weeks after treatment. Following sacrifice, VEGF, TGF-beta, COX-2, IGF-1, PAI-1, IL-6, MMP-2, MMP-9, and TNF-alpha gene expression was assessed using RT-PCR. VEGF and p-SMAD2 protein levels were also assessed by western-blot, while MMP-2 activity was assessed with gelatin zymography. Regarding the FA analysis, the mean CNV area was lower from the 3rd week in IVT-17 and IVT-144 groups, and also from the 2nd week in IVT-17+144. Biochemical analysis revealed that gene expression was lower for VEGF and COX-2 genes in IV-17 and IV-144 groups, VEGF gene in IVT-17+144 group and MMP-2 gene in IVT-17 and IVT-144 groups. VEGF protein expression was also decreased in IV-17, IV-144, IVT-17 and IVT-144, whereas pSMAD-2 levels were lower in IV-17, IV-144 and IVT-17+144 groups. Zymogram analysis revealed decreased MMP-2 activity in IV-17, IV-144, IVT-17 and IVT-144 groups. These data suggest that the use of TGF-beta inhibitor peptides (P17 & P144) decrease the development of early CNV lesions by targeting different mediators than those typically affected using current anti-angiogenic therapies. Its potential role in the treatment of early CNV appears promising as a single therapy or adjuvant to anti-VEGF drugs.	[Zarranz-Ventura, Javier; Fernandez-Robredo, Patricia; Recalde, Sergio; Garcia-Layana, Alfredo] Univ Navarra, Expt Ophthalmol Lab, E-31080 Pamplona, Spain; [Zarranz-Ventura, Javier; Salinas-Alaman, Angel; Garcia-Layana, Alfredo] Univ Navarra, Dept Ophthalmol, Univ Navarra Clin, E-31080 Pamplona, Spain; [Borras-Cuesta, Francisco] Univ Navarra, Div Hepatol & Gene Therapy, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Dotor, Javier] Digna Biotech, Madrid, Spain	University of Navarra; University of Navarra; University of Navarra	Garcia-Layana, A (corresponding author), Univ Navarra, Expt Ophthalmol Lab, E-31080 Pamplona, Spain.	aglayana@unav.es	Recalde, Sergio/D-1815-2017; Zarranz-Ventura, Javier/AAB-5390-2021	Recalde, Sergio/0000-0002-9328-9725; Zarranz-Ventura, Javier/0000-0003-2338-8143	Digna Biotech	Digna Biotech	This study was funded by Digna Biotech. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Javier Dotor is an employee of Digna Biotech, and he established the formulation of peptide solutions for intravitreal and intravenous injections employed in the study and reviewed the methods section of the manuscript.; Javier Dotor is employed by Digna Biotech, the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; Arnold JJ, 2000, BRIT MED J, V321, P741, DOI 10.1136/bmj.321.7263.741; Atherton E, 1989, J CHEM SOC PERKING T, V1, P538; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Bian ZM, 2007, EXP EYE RES, V84, P812, DOI 10.1016/j.exer.2006.12.016; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Brown DM, 2007, AM J OPHTHALMOL, V144, P627, DOI 10.1016/j.ajo.2007.06.039; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Dotor J, 2007, CYTOKINE, V39, P106, DOI 10.1016/j.cyto.2007.06.004; ELNER VM, 1990, AM J PATHOL, V136, P745; Ezquerro IJ, 2003, CYTOKINE, V22, P12, DOI 10.1016/S1043-4666(03)00101-7; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Garcia-Layana A, 2009, OPHTHALMIC RES, V42, P205, DOI 10.1159/000232946; Gil-Guerrero L, 2008, J IMMUNOL, V181, P126, DOI 10.4049/jimmunol.181.1.126; GREEN WR, 1991, RETINA-J RET VIT DIS, V11, P328, DOI 10.1097/00006982-199111030-00010; Grossniklaus HE, 2002, MOL VIS, V8, P119; GROSSNIKLAUS HE, 1992, RETINA-J RET VIT DIS, V12, P127, DOI 10.1097/00006982-199212020-00009; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hermida N, 2009, CARDIOVASC RES, V81, P601, DOI 10.1093/cvr/cvn315; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Ip MS, 2008, OPHTHALMOLOGY, V115, P1837, DOI 10.1016/j.ophtha.2008.08.012; Kim SJ, 2010, EXP EYE RES, V91, P537, DOI 10.1016/j.exer.2010.07.011; Klein R, 1998, ARCH OPHTHALMOL-CHIC, V116, P506, DOI 10.1001/archopht.116.4.506; Konstantinidis L, 2009, GRAEF ARCH CLIN EXP, V247, P311, DOI 10.1007/s00417-008-0995-0; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Lu Ming, 2006, Ophthalmol Clin North Am, V19, P323; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nagineni CN, 2003, J CELL PHYSIOL, V197, P453, DOI 10.1002/jcp.10378; Ogata N, 1997, CURR EYE RES, V16, P9, DOI 10.1076/ceyr.16.1.9.5121; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Recalde S, 2011, INVEST OPHTH VIS SCI, V52, P7090, DOI 10.1167/iovs.11-7300; Santiago B, 2005, J INVEST DERMATOL, V125, P450, DOI 10.1111/j.0022-202X.2005.23859.x; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; Serrati S, 2009, BIOCHEM PHARMACOL, V77, P813, DOI 10.1016/j.bcp.2008.10.036; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Tufail A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2459; Vicent S, 2008, CANCER RES, V68, P2275, DOI 10.1158/0008-5472.CAN-07-6493; Watanabe D, 2005, RETINA-J RET VIT DIS, V25, P911, DOI 10.1097/00006982-200510000-00015; Yoshida T, 2003, OPHTHALMOLOGY, V110, P1297, DOI 10.1016/S0161-6420(03)00461-5	42	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65434	10.1371/journal.pone.0065434	http://dx.doi.org/10.1371/journal.pone.0065434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741494	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900207
J	Huang, YC; Lin, KF; He, RY; Tu, PH; Koubek, J; Hsu, YC; Huang, JJT				Huang, Yi-Chen; Lin, Ku-Feng; He, Ruei-Yu; Tu, Pang-Hsien; Koubek, Jiri; Hsu, Yin-Chih; Huang, Joseph Jen-Tse			Inhibition of TDP-43 Aggregation by Nucleic Acid Binding	PLOS ONE			English	Article							PRION PROTEIN; TERMINAL FRAGMENTS; STRESS GRANULES; DNA; INSIGHTS; DOMAIN; NEURODEGENERATION; NEUROTOXICITY; DETERMINANTS; LOCALIZATION	The aggregation of TAR DNA-binding protein (TDP-43) has been shown as a hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) since 2006. While evidence has suggested that mutation or truncation in TDP-43 influences its aggregation process, nevertheless, the correlation between the TDP-43 aggregation propensity and its binding substrates has not been fully established in TDP-43 proteinopathy. To address this question, we have established a platform based on the in vitro protein expression system to evaluate the solubility change of TDP-43 in response to factors such as nucleotide binding and temperature. Our results suggest that the solubility of TDP-43 is largely influenced by its cognate single-strand DNA (ssDNA) or RNA (ssRNA) rather than hnRNP, which is known to associate with TDP-43 C-terminus. The direct interaction between the refolded TDP-43, purified from E. coli, and ssDNA were further characterized by Circular Dichroism (CD) as well as turbidity and filter binding assay. In addition, ssDNA or ssRNA failed to prevent the aggregation of the F147L/F149L double mutant or truncated TDP-43 (TDP208-414). Consistently, these two mutants form aggregates, in contrast with the wild-type TDP-43, when expressed in Neuro2a cells. Our results demonstrate an intimate relationship between the solubility of TDP-43 and its DNA or RNA binding affinity, which may shed light on the role of TDP-43 in ALS and FTLD.	[Huang, Yi-Chen; Huang, Joseph Jen-Tse] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Huang, Yi-Chen; Lin, Ku-Feng; He, Ruei-Yu; Koubek, Jiri; Hsu, Yin-Chih; Huang, Joseph Jen-Tse] Acad Sinica, Inst Chem, Taipei, Taiwan; [Tu, Pang-Hsien] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Huang, JJT (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	jthuang@gate.sinica.edu.tw	Huang, Joseph Jen-Tse/E-4918-2015	Huang, Joseph Jen-Tse/0000-0003-4847-7126; Tu, Pang-hsien/0000-0003-2821-7335; Koubek, Jiri/0000-0002-5117-6570	Academia Sinica; National Science Council, Taiwan [NSC 98-2113-M-001-015-MY2, NSC 100-2113-M-001-013-MY2]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the research grants from Academia Sinica and National Science Council, Taiwan (NSC 98-2113-M-001-015-MY2 and NSC 100-2113-M-001-013-MY2). Dr. K.-F.L. and Dr. R.-Y.H. were supported by the postdoctoral fellowship from Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Choi SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002677; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Furukawa Y, 2011, BBA-MOL BASIS DIS, V1812, P1577, DOI 10.1016/j.bbadis.2011.09.005; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Giraldo R, 2011, PRION, V5, P60, DOI 10.4161/pri.5.2.14913; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Hegde ML, 2010, FRONT BIOSCI-LANDMRK, V15, P418, DOI 10.2741/3628; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kang D, 2009, OPT EXPRESS, V17, P15239, DOI 10.1364/OE.17.015239; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Lin KF, 2012, BIOPHYS J, V102, P2818, DOI 10.1016/j.bpj.2012.04.048; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Rentzeperis D, 1999, NAT STRUCT BIOL, V6, P569; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sendtner M, 2011, NAT NEUROSCI, V14, P403, DOI 10.1038/nn.2784; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	50	40	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64002	10.1371/journal.pone.0064002	http://dx.doi.org/10.1371/journal.pone.0064002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737961	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700025
J	Puentes, F; Dickhaut, K; Hofstatter, M; Falk, K; Rotzschke, O				Puentes, Fabiola; Dickhaut, Katharina; Hofstaetter, Maria; Falk, Kirsten; Roetzschke, Olaf			Active Suppression Induced by Repetitive Self-Epitopes Protects against EAE Development	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NONOBESE DIABETIC MICE; CENTRAL-NERVOUS-SYSTEM; TGF-BETA; AUTOIMMUNE-DISEASE; B-CELLS; MULTIPLE-SCLEROSIS; MONOCLONAL-ANTIBODY	Background: Autoimmune diseases result from a breakdown in self-tolerance to autoantigens. Self-tolerance is induced and sustained by central and peripheral mechanisms intended to deviate harmful immune responses and to maintain homeostasis, where regulatory T cells play a crucial role. The use of self-antigens in the study and treatment of a range of autoimmune diseases has been widely described; however, the mechanisms underlying the induced protection by these means are unclear. This study shows that protection of experimental autoimmune disease induced by T cell self-epitopes in a multimerized form (oligomers) is mediated by the induction of active suppression. Principal Findings: The experimental autoimmune encephalomyelitis (EAE) animal model for multiple sclerosis was used to study the mechanisms of protection induced by the treatment of oligomerized T cell epitope of myelin proteolipid protein (PLP139-151). Disease protection attained by the administration of oligomers was shown to be antigen specific and effective in both prevention and treatment of ongoing EAE. Oligomer mediated tolerance was actively transferred by cells from treated mice into adoptive hosts. The induction of active suppression was correlated with the recruitment of cells in the periphery associated with increased production of IL-10 and reduction of the pro-inflammatory cytokine TNF-alpha. The role of suppressive cytokines was demonstrated by the reversion of oligomer-induced protection after in vivo blocking of either IL-10 or TGF-beta cytokines. Conclusions: This study strongly supports an immunosuppressive role of repeat auto-antigens to control the development of EAE with potential applications in vaccination and antigen specific treatment of autoimmune diseases.	[Puentes, Fabiola; Dickhaut, Katharina; Hofstaetter, Maria; Falk, Kirsten; Roetzschke, Olaf] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Roetzschke, Olaf] ASTAR, SIgN Singapore Immunol Network, Singapore, Singapore	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Puentes, F (corresponding author), Max Delbruck Ctr Mol Med MDC, Berlin, Germany.	f.puentes@qmul.ac.uk	Roetzschke, Olaf/GXH-0012-2022		Deutsche Forschungsgemeinschaft [SFB650]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft Grant SFB650. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; Aharoni R, 2002, J NEUROIMMUNOL, V126, P58, DOI 10.1016/S0165-5728(02)00053-X; Almeras L, 2002, EUR CYTOKINE NETW, V13, P200; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Aoki CA, 2005, AUTOIMMUN REV, V4, P450, DOI 10.1016/j.autrev.2005.03.006; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Carrier Y, 2007, J IMMUNOL, V178, P172, DOI 10.4049/jimmunol.178.1.172; Chung Y, 1999, J IMMUNOL, V163, P3692; Cottrez F, 2001, J IMMUNOL, V167, P773, DOI 10.4049/jimmunol.167.2.773; DASCH JR, 1989, J IMMUNOL, V142, P1536; Diener E, 1972, Transplant Rev, V8, P76; DiPaolo RJ, 2005, J IMMUNOL, V175, P7135, DOI 10.4049/jimmunol.175.11.7135; Falk K, 2000, J EXP MED, V191, P717, DOI 10.1084/jem.191.4.717; Falk K, 2000, EUR J IMMUNOL, V30, P3012, DOI 10.1002/1521-4141(200010)30:10<3012::AID-IMMU3012>3.0.CO;2-Q; Farina C, 2001, BRAIN, V124, P705, DOI 10.1093/brain/124.4.705; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Garg G, 2012, J IMMUNOL, V188, P4644, DOI 10.4049/jimmunol.1100272; Goodin DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022444; GROSS JA, 1992, J IMMUNOL, V149, P380; Hogan SP, 1998, P NATL ACAD SCI USA, V95, P2441, DOI 10.1073/pnas.95.5.2441; Huan JY, 2004, J IMMUNOL, V172, P4556, DOI 10.4049/jimmunol.172.7.4556; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Johnson KP, 2012, EXPERT REV NEUROTHER, V12, P371, DOI [10.1586/ern.12.25, 10.1586/ERN.12.25]; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; LIACOPOULOS P, 1971, European Journal of Immunology, V1, P359, DOI 10.1002/eji.1830010511; Liblau RS, 1996, P NATL ACAD SCI USA, V93, P3031, DOI 10.1073/pnas.93.7.3031; Liu ZR, 1995, AUTOIMMUNITY, V21, P173, DOI 10.3109/08916939509008014; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; Mack J, 2001, J PEPT SCI, V7, P338, DOI 10.1002/psc.327; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mekala DJ, 2005, P NATL ACAD SCI USA, V102, P11817, DOI 10.1073/pnas.0505445102; Miller SD, 2007, NAT REV IMMUNOL, V7, P665, DOI 10.1038/nri2153; Mizoguchi E, 2000, INT IMMUNOL, V12, P597, DOI 10.1093/intimm/12.5.597; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Paglinawan R, 2003, GLIA, V44, P219, DOI 10.1002/glia.10286; Piaggio E, 2007, P NATL ACAD SCI USA, V104, P9393, DOI 10.1073/pnas.0610423104; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; Rajagopalan G, 2006, CYTOKINE, V34, P85, DOI 10.1016/j.cyto.2006.04.006; Rotzschke O, 1997, P NATL ACAD SCI USA, V94, P14642, DOI 10.1073/pnas.94.26.14642; Ruiz PJ, 1999, J IMMUNOL, V162, P3336; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; SANTAMBROGIO L, 1993, J IMMUNOL, V151, P1116; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; SHARMA SD, 1991, P NATL ACAD SCI USA, V88, P11465, DOI 10.1073/pnas.88.24.11465; SNAPPER CM, 1995, J IMMUNOL, V154, P1177; Stienekemeier M, 2001, P NATL ACAD SCI USA, V98, P13872, DOI 10.1073/pnas.241504598; TEITELBAUM D, 1988, P NATL ACAD SCI USA, V85, P9724, DOI 10.1073/pnas.85.24.9724; van Herwijnen MJC, 2012, P NATL ACAD SCI USA, V109, P14134, DOI 10.1073/pnas.1206803109; Watanabe Kenichi, 2011, Inflammation & Allergy Drug Targets, V10, P218; Weinstock-Guttman B, 2012, J NEUROL, V259, P898, DOI 10.1007/s00415-011-6275-7; You S, 2004, J IMMUNOL, V173, P6777, DOI 10.4049/jimmunol.173.11.6777; Zinkernagel RM, 2001, SCIENCE, V293, P251, DOI 10.1126/science.1063005	57	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64888	10.1371/journal.pone.0064888	http://dx.doi.org/10.1371/journal.pone.0064888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738007	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000321394700068
J	Zarzycki-Siek, J; Norris, MH; Kang, Y; Sun, ZX; Bluhm, AP; McMillan, IA; Hoang, TT				Zarzycki-Siek, Jan; Norris, Michael H.; Kang, Yun; Sun, Zhenxin; Bluhm, Andrew P.; McMillan, Ian A.; Hoang, Tung T.			Elucidating the Pseudomonas aeruginosa Fatty Acid Degradation Pathway: Identification of Additional Fatty Acyl-CoA Synthetase Homologues	PLOS ONE			English	Article							COENZYME-A SYNTHETASE; ESCHERICHIA-COLI; BETA-OXIDATION; BURKHOLDERIA-THAILANDENSIS; LUNG SURFACTANT; SIGNATURE MOTIF; GENETIC TOOLS; FADD GENE; EXPRESSION; PROTEIN	The fatty acid (FA) degradation pathway of Pseudomonas aeruginosa, an opportunistic pathogen, was recently shown to be involved in nutrient acquisition during BALB/c mouse lung infection model. The source of FA in the lung is believed to be phosphatidylcholine, the major component of lung surfactant. Previous research indicated that P. aeruginosa has more than two fatty acyl-CoA synthetase genes (fadD; PA3299 and PA3300), which are responsible for activation of FAs using ATP and coenzyme A. Through a bioinformatics approach, 11 candidate genes were identified by their homology to the Escherichia coli FadD in the present study. Four new homologues of fadD (PA1617, PA2893, PA3860, and PA3924) were functionally confirmed by their ability to complement the E. coli fadD mutant on FA-containing media. Growth phenotypes of 17 combinatorial fadD mutants on different FAs, as sole carbon sources, indicated that the four new fadD homologues are involved in FA degradation, bringing the total number of P. aeruginosa fadD genes to six. Of the four new homologues, fadD4 (PA1617) contributed the most to the degradation of different chain length FAs. Growth patterns of various fadD mutants on plant-based perfumery substances, citronellic and geranic acids, as sole carbon and energy sources indicated that fadD4 is also involved in the degradation of these plant-derived compounds. A decrease in fitness of the sextuple fadD mutant, relative to the Delta fadD1D2 mutant, was only observed during BALB/c mouse lung infection at 24 h.	[Zarzycki-Siek, Jan; Kang, Yun; Sun, Zhenxin; Bluhm, Andrew P.; Hoang, Tung T.] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Norris, Michael H.; McMillan, Ian A.; Hoang, Tung T.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Hoang, TT (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	tongh@hawaii.edu	Sun, Zhenxin/V-3418-2019; Heacock-Kang, Yun/O-9767-2016	Sun, Zhenxin/0000-0003-3452-3881; Heacock-Kang, Yun/0000-0002-7304-9687; McMillan, Ian/0000-0002-8934-172X; Norris, Michael/0000-0002-5285-0432	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by grant number P20GM103516 from the National Institute of General Medical Sciences of the National Institutes of Health. The study design and content are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BALTCH AL, 1977, AM J MED SCI, V274, P119, DOI 10.1097/00000441-197709000-00002; Barrett AR, 2008, APPL ENVIRON MICROB, V74, P4498, DOI 10.1128/AEM.00531-08; Bernhard W, 2001, AM J RESP CELL MOL, V25, P725, DOI 10.1165/ajrcmb.25.6.4616; Bernhard W, 1997, THORAX, V52, P723, DOI 10.1136/thx.52.8.723; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; BLACK PN, 1992, J BIOL CHEM, V267, P25513; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; BLACK PN, 1988, J BACTERIOL, V170, P2850, DOI 10.1128/jb.170.6.2850-2854.1988; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; CANTWELL SG, 1978, J BACTERIOL, V135, P324, DOI 10.1128/JB.135.2.324-333.1978; Cho BK, 2006, MICROBIOL-SGM, V152, P2207, DOI 10.1099/mic.0.28912-0; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Cruickshank R., 1975, MED MICROBIOLOGY; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Doggett RG, 1979, PSEUDOMONAS AERUGINO; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Feng Y, 2009, J BACTERIOL, V191, P6320, DOI 10.1128/JB.00835-09; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Forster-Fromme K, 2006, APPL ENVIRON MICROB, V72, P4819, DOI 10.1128/AEM.00853-06; FULDA M, 1994, MOL GEN GENET, V242, P241, DOI 10.1007/BF00280412; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; Groot P H, 1976, Adv Lipid Res, V14, P75; HIGASHITANI A, 1993, MOL GEN GENET, V240, P339, DOI 10.1007/BF00280384; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Hoschle B, 2005, MICROBIOL-SGM, V151, P3649, DOI 10.1099/mic.0.28260-0; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; JENKINS LS, 1987, J BACTERIOL, V169, P42, DOI 10.1128/jb.169.1.42-52.1987; KAMEDA K, 1985, BIOCHIM BIOPHYS ACTA, V840, P29, DOI 10.1016/0304-4165(85)90158-8; Kang Y, 2008, MICROBIOL-SGM, V154, P1584, DOI 10.1099/mic.0.2008/018135-0; Kang Y, 2011, NAT PROTOC, V6, P1085, DOI 10.1038/nprot.2011.346; Kang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013557; Kang Y, 2009, MOL MICROBIOL, V73, P120, DOI 10.1111/j.1365-2958.2009.06757.x; Kang Y, 2009, APPL ENVIRON MICROB, V75, P4015, DOI 10.1128/AEM.02733-08; Lepow ML, 1994, PSEUDOMONAS AERUGINO, P421; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Nie L, 2008, BIOCHEMISTRY-US, V47, P7744, DOI 10.1021/bi800595f; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; PAULI G, 1974, J BACTERIOL, V117, P1178, DOI 10.1128/JB.117.3.1178-1183.1974; PRAMANIK A, 1979, J BACTERIOL, V137, P469, DOI 10.1128/JB.137.1.469-473.1979; Pruitt BA, 1998, WORLD J SURG, V22, P135; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Roos KL, 1994, PSEUDOMONAS AERUGINO, P257; Scheetz MH, 2009, DIAGN MICR INFEC DIS, V64, P311, DOI 10.1016/j.diagmicrobio.2009.02.006; Smith RP, 1994, PSEUDOMONAS AERUGINO, P327; Son MS, 2008, PLASMID, V59, P111, DOI 10.1016/j.plasmid.2007.12.002; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; White D, 2007, PHYSL BIOCH PROKARYO, P71; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Wilson R, 1998, THORAX, V53, P213, DOI 10.1136/thx.53.3.213; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861	60	29	31	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e64554	10.1371/journal.pone.0064554	http://dx.doi.org/10.1371/journal.pone.0064554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23737986	gold, Green Published, Green Submitted			2022-12-27	WOS:000319725500063
J	Hennings, JM; Kohli, MA; Czamara, D; Giese, M; Eckert, A; Wolf, C; Heck, A; Domschke, K; Arolt, V; Baune, BT; Horstmann, S; Bruckl, T; Klengel, T; Menke, A; Muller-Myhsok, B; Ising, M; Uhr, M; Lucae, S				Hennings, Johannes M.; Kohli, Martin A.; Czamara, Darina; Giese, Maria; Eckert, Anne; Wolf, Christiane; Heck, Angela; Domschke, Katharina; Arolt, Volker; Baune, Bernhard T.; Horstmann, Sonja; Brueckl, Tanja; Klengel, Torsten; Menke, Andreas; Mueller-Myhsok, Bertram; Ising, Marcus; Uhr, Manfred; Lucae, Susanne			Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach	PLOS ONE			English	Article							NEUROTROPHIC FACTOR GENE; MAJOR DEPRESSIVE DISORDER; GENOME-WIDE ASSOCIATION; TREATMENT RESPONSE; MOOD DISORDERS; BIPOLAR DISORDER; VAL66MET POLYMORPHISM; SEQUENCE VARIATIONS; MESSENGER-RNA; BRAIN	Background: Data from clinical studies and results from animal models suggest an involvement of the neurotrophin system in the pathology of depression and antidepressant treatment response. Genetic variations within the genes coding for the brain-derived neurotrophic factor (BDNF) and its key receptor Trkb (NTRK2) may therefore influence the response to antidepressant treatment. Methods: We performed a single and multi-marker association study with antidepressant treatment outcome in 398 depressed Caucasian inpatients participating in the Munich Antidepressant Response Signature (MARS) project. Two Caucasian replication samples (N = 249 and N = 247) were investigated, resulting in a total number of 894 patients. 18 tagging SNPs in the BDNF gene region and 64 tagging SNPs in the NTRK2 gene region were genotyped in the discovery sample; 16 nominally associated SNPs were tested in two replication samples. Results: In the discovery analysis, 7 BDNF SNPs and 9 NTRK2 SNPs were nominally associated with treatment response. Three NTRK2 SNPs (rs10868223, rs1659412 and rs11140778) also showed associations in at least one replication sample and in the combined sample with the same direction of effects (P-corr = .018, P-corr = .015 and P-corr = .004, respectively). We observed an across-gene BDNF-NTRK2 SNP interaction for rs4923468 and rs1387926. No robust interaction of associated SNPs was found in an analysis of BDNF serum protein levels as a predictor for treatment outcome in a subset of 93 patients. Conclusions/Limitations: Although not all associations in the discovery analysis could be unambiguously replicated, the findings of the present study identified single nucleotide variations in the BDNF and NTRK2 genes that might be involved in antidepressant treatment outcome and that have not been previously reported in this context. These new variants need further validation in future association studies.	[Hennings, Johannes M.; Kohli, Martin A.; Czamara, Darina; Wolf, Christiane; Heck, Angela; Horstmann, Sonja; Brueckl, Tanja; Klengel, Torsten; Menke, Andreas; Mueller-Myhsok, Bertram; Ising, Marcus; Uhr, Manfred; Lucae, Susanne] Max Planck Inst Psychiat, Munich, Germany; [Czamara, Darina; Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Giese, Maria; Eckert, Anne] Psychiat Univ Clin Basel, Neurobiol Lab Brain Aging & Mental Hlth, Basel, Switzerland; [Domschke, Katharina] Univ Wurzburg, Dept Psychiat, Wurzburg, Germany; [Arolt, Volker] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Baune, Bernhard T.] Univ Adelaide, Royal Adelaide Hosp, Dept Psychiat, Adelaide, SA, Australia	Max Planck Society; University of Munich; University of Basel; University of Wurzburg; University of Munster; Royal Adelaide Hospital; University of Adelaide	Hennings, JM (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	hennings@mpipsykl.mpg.de	Menke, Andreas/D-5939-2014; Klengel, Torsten/E-5629-2010; Domschke, Katharina/I-7921-2013	Menke, Andreas/0000-0002-1498-1992; Klengel, Torsten/0000-0001-7045-9229; Hennings, Johannes/0000-0003-3259-7991; Heck, Angela/0000-0002-1543-3197	German Federal Ministry for Education and Research (BMBF); NGFN-Plus and within the Molecular Diagnostics Program [FKZ 01GS0481, 01ES0811]; Astra-Zeneca; Lundbeck; Wyeth; Deutsche Forschungsgemeinschaft (German Research Foundation); Pfizer; Lilly; Bristol-Myers Squibb; Astra Zeneca	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NGFN-Plus and within the Molecular Diagnostics Program; Astra-Zeneca(AstraZeneca); Lundbeck(Lundbeck Corporation); Wyeth(Wyeth); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Pfizer(Pfizer); Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Astra Zeneca(AstraZeneca)	The study was supported in part by a research grant from the German Federal Ministry for Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN2 and NGFN-Plus, FKZ 01GS0481) and within the Molecular Diagnostics Program (01ES0811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Arolt is member of advisory boards and/or gave presentations for the following companies: Astra-Zeneca, Janssen-Organon, Eli Lilly, Lundbeck, Pfizer, Servier, and Wyeth. He also received grants from Astra-Zeneca, Lundbeck, and Wyeth. He chaired the committee for the "Wyeth Research Award Depression and Anxiety''. Czamara was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy). Domschke has received speaker fees from Pfizer, Lilly and Bristol-Myers Squibb; she is a consultant for Johnson & Johnson and has received funding by Astra Zeneca. Hennings has received travel support to scientific congresses from Eli Lilly, Bayer Vital and Novartis. Menke, Holsboer inventors: Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (TESI). European application number: 08016477.5. International application number: PCT/EP2009/061575. Uhr is patent holder of WO2005/108605A2 and WO2008/151803A2. Katharina Domschke is a PLOS ONE Editorial Board member. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adams JH, 2005, AM J MED GENET B, V132B, P90, DOI 10.1002/ajmg.b.30084; Alonso P, 2008, BIOL PSYCHIAT, V63, P619, DOI 10.1016/j.biopsych.2007.06.020; Angst J, 2005, J AFFECT DISORDERS, V84, P149, DOI 10.1016/S0165-0327(03)00195-2; [Anonymous], 1932, STAT METHODS RES WOR; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Baghai TC, 2006, MOL PSYCHIATR, V11, P1003, DOI 10.1038/sj.mp.4001884; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baune BT, 2008, NEUROPSYCHOPHARMACOL, V33, P924, DOI 10.1038/sj.npp.1301462; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Cozza A, 2008, J ALZHEIMERS DIS, V15, P61; Dong C, 2009, MOL PSYCHIATR, V14, P1105, DOI 10.1038/mp.2009.92; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dwivedi Y, 2006, NEUROSCIENCE, V139, P1017, DOI 10.1016/j.neuroscience.2005.12.058; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghaemi S N, 2001, J Psychiatr Pract, V7, P287, DOI 10.1097/00131746-200109000-00002; Gratacos M, 2008, PHARMACOGENOMICS J, V8, P101, DOI 10.1038/sj.tpj.6500460; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hennings JM, 2008, J PSYCHIATR RES, V43, P215, DOI 10.1016/j.jpsychires.2008.05.002; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Horstmann S, 2009, PSYCHONEUROENDOCRINO, V34, P238, DOI 10.1016/j.psyneuen.2008.09.004; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Ising M, 2009, ARCH GEN PSYCHIAT, V66, P966, DOI 10.1001/archgenpsychiatry.2009.95; KATO M, 2008, MOL PSYCHIAT; Knapman A, 2010, J PSYCHIATR RES, V44, P566, DOI 10.1016/j.jpsychires.2009.11.014; Kocabas NA, 2011, INT CLIN PSYCHOPHARM, V26, P1, DOI 10.1097/YIC.0b013e32833d18f8; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Kozisek ME, 2008, PHARMACOL THERAPEUT, V117, P30, DOI 10.1016/j.pharmthera.2007.07.001; Kunugi H, 2004, BIOL PSYCHIAT, V56, P376, DOI 10.1016/j.biopsych.2004.06.017; Licinio J, 2009, ARCH GEN PSYCHIAT, V66, P488, DOI 10.1001/archgenpsychiatry.2009.38; Lin E, 2009, REJUV RES, V12, P387, DOI 10.1089/rej.2009.0871; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Mitchell PB, 2008, BIPOLAR DISORD, V10, P144, DOI 10.1111/j.1399-5618.2007.00559.x; Nakata K, 2003, NEUROSCI LETT, V337, P17, DOI 10.1016/S0304-3940(02)01292-2; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; NIBUYA M, 1995, J NEUROSCI, V15, P7539; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; PERROUD N., 2009, NEUROPSYCHOPHARMACOL; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rantamaki T, 2006, NEUROPHARMACOLOGY, V50, P421, DOI 10.1016/j.neuropharm.2005.10.001; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Saarelainen T, 2003, J NEUROSCI, V23, P349; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Schumacher J, 2005, BIOL PSYCHIAT, V58, P307, DOI 10.1016/j.biopsych.2005.04.006; Sillaber I, 2008, PSYCHOPHARMACOLOGY, V200, P557, DOI 10.1007/s00213-008-1232-6; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Tadic A, 2011, PROG NEURO-PSYCHOPH, V35, P415, DOI 10.1016/j.pnpbp.2010.08.011; Taylor WD, 2010, PHARMACOGENOMICS J; Tsai SJ, 2008, PHARMACOGENOMICS, V9, P1353, DOI 10.2217/14622416.9.9.1353; Uher R, 2009, PHARMACOGENOMICS J, V9, P225, DOI 10.1038/tpj.2009.12; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wilkie MJV, 2007, PHARMACOGENET GENOM, V17, P207, DOI 10.1097/FPC.0b013e32801a3be6; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Wong M, 2009, J PSYCHOPHARMACOL OX; Yoshida K, 2007, J PSYCHOPHARMACOL, V21, P650, DOI 10.1177/0269881106072192; Young R, 2009, INT J NEUROPSYCHOPH, P1; Zou YF, 2010, NEUROPSYCHOBIOLOGY, V61, P71, DOI 10.1159/000265132	67	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64947	10.1371/journal.pone.0064947	http://dx.doi.org/10.1371/journal.pone.0064947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750220	Green Published, gold			2022-12-27	WOS:000319961900022
J	Larimore, J; Ryder, PV; Kim, KY; Ambrose, LA; Chapleau, C; Calfa, G; Gross, C; Bassell, GJ; Pozzo-Miller, L; Smith, Y; Talbot, K; Park, IH; Faundez, V				Larimore, Jennifer; Ryder, Pearl V.; Kim, Kun-Yong; Ambrose, L. Alex; Chapleau, Christopher; Calfa, Gaston; Gross, Christina; Bassell, Gary J.; Pozzo-Miller, Lucas; Smith, Yoland; Talbot, Konrad; Park, In-Hyun; Faundez, Victor			MeCP2 Regulates the Synaptic Expression of a Dysbindin-BLOC-1 Network Component in Mouse Brain and Human Induced Pluripotent Stem Cell-Derived Neurons	PLOS ONE			English	Article							SCHIZOPHRENIA SUSCEPTIBILITY GENE; RETT-SYNDROME; ORGANELLES COMPLEX-1; NEUROTROPHIC FACTOR; HIPPOCAMPAL-FORMATION; MESSENGER-RNA; MUTANT MICE; II-ALPHA; PROTEIN; BLOC-1	Clinical, epidemiological, and genetic evidence suggest overlapping pathogenic mechanisms between autism spectrum disorder (ASD) and schizophrenia. We tested this hypothesis by asking if mutations in the ASD gene MECP2 which cause Rett syndrome affect the expression of genes encoding the schizophrenia risk factor dysbindin, a subunit of the biogenesis of lysosome-related organelles complex-1 (BLOC-1), and associated interacting proteins. We measured mRNA and protein levels of key components of a dysbindin interaction network by, quantitative real time PCR and quantitative immunohistochemistry in hippocampal samples of wild-type and Mecp2 mutant mice. In addition, we confirmed results by performing immunohistochemistry of normal human hippocampus and quantitative qRT-PCR of human inducible pluripotent stem cells (iPSCs)-derived human neurons from Rett syndrome patients. We defined the distribution of the BLOC-1 subunit pallidin in human and mouse hippocampus and contrasted this distribution with that of symptomatic Mecp2 mutant mice. Neurons from mutant mice and Rett syndrome patients displayed selectively reduced levels of pallidin transcript. Pallidin immunoreactivity decreased in the hippocampus of symptomatic Mecp2 mutant mice, a feature most prominent at asymmetric synapses as determined by immunoelectron microcopy. Pallidin immunoreactivity decreased concomitantly with reduced BDNF content in the hippocampus of Mecp2 mice. Similarly, BDNF content was reduced in the hippocampus of BLOC-1 deficient mice suggesting that genetic defects in BLOC-1 are upstream of the BDNF phenotype in Mecp2 deficient mice. Our results demonstrate that the ASD-related gene Mecp2 regulates the expression of components belonging to the dysbindin interactome and these molecular differences may contribute to synaptic phenotypes that characterize Mecp2 deficiencies and ASD.	[Larimore, Jennifer; Ambrose, L. Alex] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA; [Ryder, Pearl V.; Gross, Christina; Bassell, Gary J.; Faundez, Victor] Emory Univ, Atlanta, GA 30322 USA; [Kim, Kun-Yong; Park, In-Hyun] Yale Univ, Sch Med, Dept Genet, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Chapleau, Christopher; Calfa, Gaston; Pozzo-Miller, Lucas] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Smith, Yoland] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Smith, Yoland] Emory Univ, Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA; [Talbot, Konrad] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	Emory University; Yale University; University of Alabama System; University of Alabama Birmingham; Emory University; Emory University; University of Pennsylvania; Pennsylvania Medicine	Faundez, V (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	vfaunde@emory.edu		Faundez, Victor/0000-0002-2114-5271; Pozzo-Miller, Lucas/0000-0001-6085-5527; Talbot, Konrad/0000-0003-4549-0835	National Institutes of Health (NIH) [GM077569, K12 GM000680, NS-065027, NS-40593, GM0099130-01]; Emory University Research Committee; IRSF award [2823]; NRSA [F31NS0765]; Neuronal Imaging Core of the Emory Neuroscience NINDS Core Facilities Grant [P30NS055077]; National Center for Research Resources [P51RR000165]; Office of Research Infrastructure Programs/OD [P51OD011132]; International Rett Syndrome Foundation [IRSF-0804]; CSCRF [12-SCB-YALE-11]; CTSA Grant from the National Center for Advancing Translational Science (NCATS), a component of the NIH [UL1 RR025750]; NIH roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169, R01GM077569, K12GM000680, P01GM099130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, R01NS065027, R01NS040593] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Research Committee; IRSF award; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuronal Imaging Core of the Emory Neuroscience NINDS Core Facilities Grant; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; International Rett Syndrome Foundation; CSCRF; CTSA Grant from the National Center for Advancing Translational Science (NCATS), a component of the NIH; NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) to VF. (GM077569), Emory University Research Committee to VF. JL was supported by NIH FIRST program Fellowship K12 GM000680 and IRSF award number 2823. PVR was supported by an NRSA fellowship F31NS0765 and supported in part by the Neuronal Imaging Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077 as well as by the National Center for Research Resources P51RR000165 and the Office of Research Infrastructure Programs/OD P51OD011132 to the Yerkes Primate Center. LP-M and GC acknowledge support from NIH grants NS-065027, NS-40593, and by Postdoctoral Fellowships IRSF-0804 from the International Rett Syndrome Foundation. IHP was partly supported by NIH (GM0099130-01), CSCRF (12-SCB-YALE-11), and by CTSA Grant UL1 RR025750 from the National Center for Advancing Translational Science (NCATS), a component of the NIH, and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. Thanks to Dr. Wei Li (UAB) for information on Mecp2 primer sequences for qRT-PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Ayalew M, 2012, MOL PSYCHIAT; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; Buizer-Voskamp JE, 2011, SCHIZOPHR RES, V129, P128, DOI 10.1016/j.schres.2011.03.021; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Calfa G, 2011, EXP BIOL MED, V236, P3, DOI 10.1258/ebm.2010.010261; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chapleau CA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/976164; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Cohen D, 2002, AM J PSYCHIAT, V159, P148, DOI 10.1176/appi.ajp.159.1.148-a; Consortium C-DGotPG, 2013, LANCET; Cristino A.S., 2013, MOL PSYCHIAT; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dean C, 2012, J NEUROSCI, V32, P5398, DOI 10.1523/JNEUROSCI.4515-11.2012; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Dickman DK, 2012, J NEUROSCI, V32, P8716, DOI 10.1523/JNEUROSCI.5465-11.2012; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038; Doherty JL, 2012, CLIN GENET, V81, P103, DOI 10.1111/j.1399-0004.2011.01773.x; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Ghiani CA, 2011, ASN NEURO, V3, DOI 10.1042/AN20110010; Gokhale A, 2012, J NEUROSCI, V32, P3697, DOI 10.1523/JNEUROSCI.5640-11.2012; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hamlyn J, 2012, NEUROBIOL DIS; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Iqbal Z., 2013, HUM MOL GENET; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Jokiranta E, 2013, PSYCHIAT RES; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; King BH, 2011, BRAIN RES, V1380, P34, DOI 10.1016/j.brainres.2010.11.031; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Korkmaz B, 2011, PEDIATR RES, V69, p101R, DOI 10.1203/PDR.0b013e318212c177; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; Larimore J, 2011, MOL BIOL CELL, V22, P4854, DOI 10.1091/mbc.E11-07-0592; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Li W, 2012, P NATL ACAD SCI USA, V109, P17087, DOI 10.1073/pnas.1205271109; Li XJ, 2006, METH MOL B, V331, P169; Lugnegard T, 2013, SCHIZOPHR RES, V143, P277, DOI 10.1016/j.schres.2012.12.001; Ma X, 2011, MOL PSYCHIATR, V16, P1105, DOI 10.1038/mp.2011.43; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; Mitchell EB, 2013, HUM MOL GENET; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Na ES, 2012, NEUROPSYCHOPHARMACOL; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Newell-Litwa K, 2010, J NEUROSCI, V30, P820, DOI 10.1523/JNEUROSCI.3400-09.2010; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Peters A., 1991, FINE STRUCTURE NERVO; Qiu ZL, 2012, J NEUROSCI, V32, P989, DOI 10.1523/JNEUROSCI.0175-11.2012; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Rodriguez-Fernandez IA, 2009, J INHERIT METAB DIS, V32, P190, DOI 10.1007/s10545-008-1014-7; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2005, MOL BIOL CELL, V16, P3692, DOI 10.1091/mbc.E05-01-0020; Schaaf CP, 2012, EUR J HUM GENET; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; Sullivan P, 2012, ARCH GEN PSYCHIAT, V2, P1; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2009, HANDBOOK OF NEUROCHEMISTRY AND MOLECULAR NEUROBIOLOGY: SCHIZOPHRENIA, THIRD EDITION, P107, DOI 10.1007/978-0-387-30410-6_2.2; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Talbot K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016886; Tang JX, 2009, HUM MOL GENET, V18, P3851, DOI 10.1093/hmg/ddp329; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Zoghbi HY, 2012, COLD SPRING HARB PER, V4	88	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65069	10.1371/journal.pone.0065069	http://dx.doi.org/10.1371/journal.pone.0065069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750231	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900033
J	Deng, Y; Zhao, YY; Liu, YB; Dai, QH				Deng, Yue; Zhao, Yanyu; Liu, Yebin; Dai, Qionghai			Differences Help Recognition: A Probabilistic Interpretation	PLOS ONE			English	Article								This paper presents a computational model to address one prominent psychological behavior of human beings to recognize images. The basic pursuit of our method can be concluded as that differences among multiple images help visual recognition. Generally speaking, we propose a statistical framework to distinguish what kind of image features capture sufficient category information and what kind of image features are common ones shared in multiple classes. Mathematically, the whole formulation is subject to a generative probabilistic model. Meanwhile, a discriminative functionality is incorporated into the model to interpret the differences among all kinds of images. The whole Bayesian formulation is solved in an Expectation-Maximization paradigm. After finding those discriminative patterns among different images, we design an image categorization algorithm to interpret how these differences help visual recognition within the bag-of-feature framework. The proposed method is verified on a variety of image categorization tasks including outdoor scene images, indoor scene images as well as the airborne SAR images from different perspectives.	[Deng, Yue; Zhao, Yanyu; Liu, Yebin; Dai, Qionghai] Tsinghua Univ, Dept Automat, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China	Tsinghua University	Dai, QH (corresponding author), Tsinghua Univ, Dept Automat, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China.	qhdai@tsinghua.edu.cn	Dai, Qionghai/ABD-5298-2021; Liu, Yebin/L-7393-2019	Dai, Qionghai/0000-0001-7043-3061; 	National Basic Research Project [2010CB731800]; Key Project of National Natural Science Foundation of China [60932007, U0935001, 61120106003, 61021063]	National Basic Research Project(National Basic Research Program of China); Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Project, No. 2010CB731800, (http://www.most.gov.cn/tztg/200910/t20091023_73804.htm) and the Key Project of National Natural Science Foundation of China, Nos. 60932007 (http://nsfc.pubmed.cn/2ce238a81), U0935001 (http://nsfc.pubmed.cn/9f9338686), 61120106003 (http://nsfc.pubmed.cn/2966dd309), 61021063 (http://nsfc.pubmed.cn/f8d1a7607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bishop C.M., 2006, PATTERN RECOGNITION, V4; Borman S, 2009, TECHNICAL REPORT; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; De Renzi E, 1969, NEUROLOGY; Deng Y, 2013, IEEE T NEUR NET LEAR, V24, P383, DOI 10.1109/TNNLS.2012.2235082; Deng Y, 2012, COMPUT VIS IMAGE UND, V116, P473, DOI 10.1016/j.cviu.2011.11.002; Deng Y, 2011, IEEE T IMAGE PROCESS, V20, P2329, DOI 10.1109/TIP.2011.2109729; Diwadkar VA, 1997, PSYCHOL SCI, V8, P302, DOI 10.1111/j.1467-9280.1997.tb00442.x; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Friedman J., 2001, SPRINGER SERIES STAT, V1; Fukunaga K., 2013, INTRO STAT PATTERN R; Graziano M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004909; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; Huang WL, 2012, IMAGE VISION COMPUT, V30, P355, DOI 10.1016/j.imavis.2012.03.004; Jiang ZL, 2011, PROC CVPR IEEE, P1697, DOI 10.1109/CVPR.2011.5995354; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Liu RS, 2010, PATTERN RECOGN, V43, P3298, DOI 10.1016/j.patcog.2010.05.009; Mairal J., 2008, P IEEE C COMP VIS PA, V2, P1, DOI DOI 10.1109/CVPR.2008.4587652; Pan LL, 2011, IEEE SIGNAL PROC LET, V18, P639, DOI 10.1109/LSP.2011.2166956; Quattoni A, 2009, PROC CVPR IEEE, P413, DOI 10.1109/CVPRW.2009.5206537; Schettino A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038064; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Tuytelaars T, 2011, IEEE I CONF COMP VIS, P1824, DOI 10.1109/ICCV.2011.6126449; van Gemert JC, 2010, IEEE T PATTERN ANAL, V32, P1271, DOI 10.1109/TPAMI.2009.132; Wang RXF, 1999, COGNITION, V70, P191; Yang JC, 2009, PROC CVPR IEEE, P1794, DOI 10.1109/CVPRW.2009.5206757; Yin HJ, 2010, INFORM SCIENCES, V180, P2649, DOI 10.1016/j.ins.2010.04.004	32	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63385	10.1371/journal.pone.0063385	http://dx.doi.org/10.1371/journal.pone.0063385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755104	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300009
J	Lynch, SJ; Zavadil, J; Pellicer, A				Lynch, Stephen J.; Zavadil, Jiri; Pellicer, Angel			In TCR-Stimulated T-cells, N-ras Regulates Specific Genes and Signal Transduction Pathways	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; H-RAS; K-RAS; MENTAL-RETARDATION; SILENT CHROMATIN; EXPRESSION; MOUSE; CHST1; MUTATIONS; ONCOGENES	It has been recently shown that N-ras plays a preferential role in immune cell development and function; specifically: N-ras, but not H-ras or K-ras, could be activated at and signal from the Golgi membrane of immune cells following a low level Tcell receptor stimulus. The goal of our studies was to test the hypothesis that N-ras and H-ras played distinct roles in immune cells at the level of the transcriptome. First, we showed via mRNA expression profiling that there were over four hundred genes that were uniquely differentially regulated either by N-ras or H-ras, which provided strong evidence in favor of the hypothesis that N-ras and H-ras have distinct functions in immune cells. We next characterized the genes that were differentially regulated by N-ras in T cells following a low-level T-cell receptor stimulus. Of the large pool of candidate genes that were differentially regulated by N-ras downstream of TCR ligation, four genes were verified in qRT-PCR-based validation experiments (Dntt, Slc9a6, Chst1, and Lars2). Finally, although there was little overlap between individual genes that were regulated by N-ras in unstimulated thymocytes and stimulated CD4(+) T-cells, there was a nearly complete correspondence between the signaling pathways that were regulated by N-ras in these two immune cell types.	[Lynch, Stephen J.; Pellicer, Angel] NYU, Dept Pathol, Langone Sch Med, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Dept Pathol, Langone Med Ctr, NYU Canc Inst, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Ctr Hlth Informat & Bioinformat, Langone Med Ctr, New York, NY 10016 USA; [Pellicer, Angel] NYU, Langone Sch Med, Inst Canc, New York, NY USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Pellicer, A (corresponding author), NYU, Dept Pathol, Langone Sch Med, 550 1St Ave, New York, NY 10016 USA.	Angel.Pellicer@nyumc.org	MARTINEZ, ANTONIO PELLICER/C-4832-2015; Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Pellicer, Angel/0000-0002-5062-0692	National Institutes of Health [CA36327]; NIH/NCI [P30 CA016087-30, 5 P30CA16087-33]; NYU Genome Technology; NYU Flow Cytometry facility; NATIONAL CANCER INSTITUTE [P30CA016087, R37CA036327, R01CA036327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYU Genome Technology; NYU Flow Cytometry facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health award CA36327 to AP. NIH/NCI P30 CA016087-30 supporting the NYU Genome Technology and JZ. NIH/NCI 5 P30CA16087-33 supporting the NYU Flow Cytometry facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOS JL, 1989, CANCER RES, V49, P4682; Castellano E, 2007, ONCOGENE, V26, P917, DOI 10.1038/sj.onc.1209845; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dustin ML, 2010, COLD SPRING HARB PER; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; Fruman DA, 2004, CURR OPIN IMMUNOL, V16, P314, DOI 10.1016/j.coi.2004.03.014; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Iida A, 2002, J HUM GENET, V47, P14, DOI 10.1007/s10038-002-8650-9; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Jutila MA, 1996, J IMMUNOL, V156, P289; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Li X, 2001, J LEUKOCYTE BIOL, V69, P565; Li XA, 1999, GENOMICS, V55, P345, DOI 10.1006/geno.1998.5653; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Mangues R, 1996, ONCOGENE, V13, P1053; Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041; Ohgaki R, 2011, BIOCHEMISTRY-US, V50, P443, DOI 10.1021/bi101082e; Ohgaki R, 2010, MOL BIOL CELL, V21, P1293, DOI 10.1091/mbc.E09-09-0767; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Perez de Castro I, 2003, CANCER RES, V63, P1615; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Su RC, 2005, SEMIN IMMUNOL, V17, P129, DOI 10.1016/j.smim.2005.01.003; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Tu LL, 1999, J IMMUNOL, V163, P5070; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Wang XD, 2001, GENE DEV, V15, P2922; Wiegers GJ, 2011, IMMUNOL CELL BIOL, V89, P33, DOI 10.1038/icb.2010.127; Wolfman JC, 2002, MOL CELL BIOL, V22, P1589, DOI 10.1128/MCB.22.5.1589-1606.2002; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Zhou W, 2009, ACTA BIOCH BIOPH SIN, V41, P54, DOI 10.1093/abbs/gmn006; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	43	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63193	10.1371/journal.pone.0063193	http://dx.doi.org/10.1371/journal.pone.0063193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755101	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300007
J	Brouwer, MC; Baas, F; van der Ende, A; van de Beek, D				Brouwer, Matthijs C.; Baas, Frank; van der Ende, Arie; van de Beek, Diederik			Genetic Variation and Cerebrospinal Fluid Levels of Mannose Binding Lectin in Pneumococcal Meningitis Patients	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CLINICAL-FEATURES; SUSCEPTIBILITY; ADULTS; COMPLEMENT; DISEASE; MBL; INFECTION; GENOTYPE; RECOVERY	It has been suggested that genetic variants in mannose binding lectin (MBL2) influence susceptibility and outcome of invasive pneumococcal disease. We assessed the influence of genetic variation in MBL2 on susceptibility, outcome and causative serotype of pneumococcal meningitis in a prospective nationwide cohort study including 299 white patients and 216 controls. We assessed functionality of the genetic polymorphisms by measuring levels of MBL, C3a, iC3b, C5a and sC5b-9 in cerebrospinal fluid. We also performed a meta-analysis of studies on MBL2 polymorphisms and susceptibility to invasive pneumococcal disease. The risk of contracting pneumococcal meningitis was substantially increased for white individuals homozygous with the defective MBL2 0/0 genotype (odds ratio [OR] 8.21, 95% confidence interval [CI] 1.05-64.1; p = 0.017). CSF MBL levels were significantly lower in patients with the A/0 and 0/0 genotype compared to homozygotes for the wild-type alleles (A/A; p<0.001). CSF MBL levels were positively correlated with C3a and iC3b levels, indicating complement activation by the lectin pathway. The effect of MBL2 genetic variants on susceptibility remained robust in a meta-analysis including 5 studies with 287 patients (OR 2.33, 99% CI 1.39-3.90). We conclude that MBL2 polymorphisms influence CSF MBL levels and substantially increase the risk of pneumococcal meningitis.	[Brouwer, Matthijs C.; van de Beek, Diederik] Ctr Infect & Immun Amsterdam CINIMA, Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Baas, Frank] Ctr Infect & Immun Amsterdam CINIMA, Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands; [van der Ende, Arie] Ctr Infect & Immun Amsterdam CINIMA, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [van der Ende, Arie] Ctr Infect & Immun Amsterdam CINIMA, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van de Beek, D (corresponding author), Ctr Infect & Immun Amsterdam CINIMA, Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	Baas, Frank/F-9574-2010; van de Beek, Diederik/Y-2713-2019	Baas, Frank/0000-0003-3912-5428; van de Beek, Diederik/0000-0002-4571-044X; van der Ende, Arie/0000-0003-1298-3086; Brouwer, Matthijs/0000-0001-7775-7843	Netherlands Organization for Health Research and Development (ZonMw; NWO-Veni grant) [916.76.023]; NWO-Vidi grant [016.116.358]; NWOVeni [916.130.78]; Academic Medical Center (AMC Fellowship); European Research Council (ERC Starting Grant)	Netherlands Organization for Health Research and Development (ZonMw; NWO-Veni grant); NWO-Vidi grant(Netherlands Organization for Scientific Research (NWO)); NWOVeni(Netherlands Organization for Scientific Research (NWO)); Academic Medical Center (AMC Fellowship); European Research Council (ERC Starting Grant)(European Research Council (ERC))	This study has been funded by grants from The Netherlands Organization for Health Research and Development (ZonMw; NWO-Veni grant 2006 [916.76.023], NWO-Vidi grant [016.116.358] to DvdB, NWOVeni grant 2012 [916.130.78] to MCB), the Academic Medical Center (AMC Fellowship 2008 to DvdB), and the European Research Council (ERC Starting Grant to DvdB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037618; Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Brouwer N, 2009, J IMMUNOL, V183, P3496, DOI 10.4049/jimmunol.0900445; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Eisen DP, 2006, FEMS IMMUNOL MED MIC, V48, P274, DOI 10.1111/j.1574-695X.2006.00144.x; Endeman H, 2008, CHEST, V134, P1135, DOI 10.1378/chest.08-0642; Garcia-Laorden MI, 2008, J ALLERGY CLIN IMMUN, V122, P368, DOI 10.1016/j.jaci.2008.05.037; Gardner P, 2006, NEW ENGL J MED, V355, P1466, DOI 10.1056/NEJMcp063561; Heckenberg SGB, 2012, CLIN MICROBIOL INFEC, V18, P849, DOI 10.1111/j.1469-0691.2011.03668.x; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Horcajada JP, 2009, CURR HIV RES, V7, P218, DOI 10.2174/157016209787581382; Garcia-Laorden MI, 2013, EUR RESPIR J, V41, P131, DOI 10.1183/09031936.00174111; Kronborg G, 2002, J INFECT DIS, V185, P1517, DOI 10.1086/340216; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Moens L, 2006, HUM IMMUNOL, V67, P605, DOI 10.1016/j.humimm.2006.04.014; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Thiel S, 2006, MOL IMMUNOL, V43, P86, DOI 10.1016/j.molimm.2005.06.018; Valdimarsson H, 1998, SCAND J IMMUNOL, V48, P116; Valles X, 2010, EUR RESPIR J, V36, P856, DOI 10.1183/09031936.00171409; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2002, J INFECT DIS, V186, P1047, DOI 10.1086/344229; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X; Woehrl B, 2011, J CLIN INVEST, V121, P3943, DOI 10.1172/JCI57522	33	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65151	10.1371/journal.pone.0065151	http://dx.doi.org/10.1371/journal.pone.0065151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741476	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900189
J	Koehler, NKU; Stransky, E; Shing, M; Gaertner, S; Meyer, M; Schreitmuller, B; Leyhe, T; Laske, C; Maetzler, W; Kahle, P; Celej, MS; Jovin, TM; Fallgatter, AJ; Batra, A; Buchkremer, G; Schott, K; Richartz-Salzburger, E				Koehler, Niklas K. U.; Stransky, Elke; Shing, Mona; Gaertner, Susanne; Meyer, Mirjam; Schreitmueller, Brigitte; Leyhe, Thomas; Laske, Christoph; Maetzler, Walter; Kahle, Phillipp; Celej, Maria S.; Jovin, Thomas M.; Fallgatter, Andreas J.; Batra, Anil; Buchkremer, Gerhard; Schott, Klaus; Richartz-Salzburger, Elke			Altered Serum IgG Levels to alpha-Synuclein in Dementia with Lewy Bodies and Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA; PARKINSONS-DISEASE; A-BETA; CEREBROSPINAL-FLUID; MOUSE MODEL; AUTOANTIBODY LEVELS; ANTIBODIES; PATHOLOGY; CLEARANCE; PLASMA	Natural self-reactive antibodies in the peripheral blood may play a considerable role in the control of potentially toxic proteins that may otherwise accumulate in the aging brain. The significance of serum antibodies reactive against alpha-synuclein is not well known. We explored serum IgG levels to monomeric alpha-synuclein in dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) with a novel and validated highly sensitive ELISA assay. Antibody levels revealed stark differences in patients compared to healthy subjects and were dependent on diagnosis, disease duration and age. Anti-alpha-synuclein IgG levels were increased in both patient groups, but in early DLB to a much greater extent than in AD. Increased antibody levels were most evident in younger patients, while with advanced age relatively low levels were observed, similar to healthy individuals, exhibiting stable antibody levels independent of age. Our data show the presence of differentially altered IgG levels against alpha-synuclein in DLB and AD, which may relate to a disturbed alpha-synuclein homeostasis triggered by the disease process. These observations may foster the development of novel, possibly preclinical biomarkers and immunotherapeutic strategies that target alpha-synuclein in neurodegenerative disease.	[Koehler, Niklas K. U.; Stransky, Elke; Shing, Mona; Gaertner, Susanne; Meyer, Mirjam; Schreitmueller, Brigitte; Leyhe, Thomas; Laske, Christoph; Fallgatter, Andreas J.; Batra, Anil; Buchkremer, Gerhard; Schott, Klaus; Richartz-Salzburger, Elke] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Maetzler, Walter] Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Kahle, Phillipp] Hertie Inst Clin Brain Res, Tubingen, Germany; [Celej, Maria S.; Jovin, Thomas M.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society	Koehler, NKU (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	niklaskoehler@yahoo.com	Maetzler, Walter/A-6796-2011; Demchuk, Andrew M/E-1103-2012; Maetzler, Walter/AAE-5831-2020; Celej, Maria Soledad/N-5709-2019	Maetzler, Walter/0000-0002-5945-4694; Demchuk, Andrew M/0000-0002-4930-7789; Maetzler, Walter/0000-0002-5945-4694; Celej, Maria Soledad/0000-0002-7831-9244	university of Tubingen	university of Tubingen	Financial support by the university of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONACI S, 1990, J CLIN LAB ANAL, V4, P16, DOI 10.1002/jcla.1860040106; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; Brendza RP, 2006, ALZ DIS ASSOC DIS, V20, P118, DOI 10.1097/01.wad.0000213810.89681.a5; Brettschneider S, 2005, BIOL PSYCHIAT, V57, P813, DOI 10.1016/j.biopsych.2004.12.008; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Dighiero G, 1999, IMMUNOL TODAY, V20, P423, DOI 10.1016/S0167-5699(99)01509-1; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Gruden MA, 2012, NEUROIMMUNOMODULAT, V19, P334, DOI 10.1159/000341400; Gruden MA, 2011, J NEUROIMMUNOL, V233, P221, DOI 10.1016/j.jneuroim.2010.12.001; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hyman BT, 2001, ANN NEUROL, V49, P808, DOI 10.1002/ana.1061; Jellinger KA, 2008, NEURODEGENER DIS, V5, P118, DOI 10.1159/000113679; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Lacroix-Desmazes S, 1999, J CLIN IMMUNOL, V19, P26, DOI 10.1023/A:1020510401233; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Miller G, 2008, SCIENCE, V320, P167, DOI 10.1126/science.320.5873.167a; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Morgan D, 2005, NEURODEGENER DIS, V2, P261, DOI 10.1159/000090366; Mori F, 2002, EXP NEUROL, V176, P98, DOI 10.1006/exnr.2002.7929; MORRIS JC, 1989, ARCH NEUROL-CHICAGO, V46, P651, DOI 10.1001/archneur.1989.00520420071025; Nasstrom T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027230; Nath A, 2003, NEUROMOL MED, V3, P29, DOI 10.1385/NMM:3:1:29; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Richartz E, 2005, J PSYCHIATR RES, V39, P535, DOI 10.1016/j.jpsychires.2004.12.005; Richartz E, 2005, DEMENT GERIATR COGN, V19, P184, DOI 10.1159/000083497; Richartz-Salzburger E, 2007, J PSYCHIATR RES, V41, P174, DOI 10.1016/j.jpsychires.2006.01.010; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4; Silverstein AM, 2001, NAT IMMUNOL, V2, P279, DOI 10.1038/86280; Smith LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052285; Spies PE, 2009, J ALZHEIMERS DIS, V16, P363, DOI 10.3233/JAD-2009-0955; Stefani A, 2012, J NEURAL TRANSM, V119, P861, DOI 10.1007/s00702-012-0820-0; Szabo P, 2008, AUTOIMMUN REV, V7, P415, DOI 10.1016/j.autrev.2008.03.007; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Tiraboschi P, 2006, BRAIN, V129, P729, DOI 10.1093/brain/awh725; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Wakabayashi K, 2010, ACTA NEUROPATHOL, V120, P1, DOI 10.1007/s00401-010-0706-x; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; Woulfe JM, 2002, NEUROLOGY, V58, P1435, DOI 10.1212/WNL.58.9.1435; Xu SH, 1997, MECH AGEING DEV, V94, P213, DOI 10.1016/S0047-6374(96)01861-1; Xu WH, 2008, BRAIN RES, V1219, P169, DOI 10.1016/j.brainres.2008.02.060; Yanamandra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018513	59	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64649	10.1371/journal.pone.0064649	http://dx.doi.org/10.1371/journal.pone.0064649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741358	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900071
J	Welmer, AK; Angleman, S; Rydwik, E; Fratiglioni, L; Qiu, CX				Welmer, Anna-Karin; Angleman, Sara; Rydwik, Elisabeth; Fratiglioni, Laura; Qiu, Chengxuan			Association of Cardiovascular Burden with Mobility Limitation among Elderly People: A Population-Based Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; APOLIPOPROTEIN-E; BLOOD-PRESSURE; GAIT SPEED; ALZHEIMERS-DISEASE; RISK-FACTORS; OLDER WOMEN; INFLAMMATION; CHOLESTEROL	Background: Cardiovascular risk factors (CRFs) such as smoking and diabetes have been associated with mobility limitations among older adults. We seek to examine to what extent individual and aggregated CRFs and cardiovascular diseases (CVDs) are associated with mobility limitation. Methods: The study sample included 2725 participants (age >= 60 years, mean age 72.7 years, 62% women) in the Swedish National Study on Aging and Care in the Kungsholmen district of central Stockholm, Sweden, who were living either at their own home or in institutions. Data on demographic features, CRFs, and CVDs were collected through interview, clinical examination, self-reported history, laboratory tests, and inpatient register. Mobility limitation was defined as walking speed <0.8 m/s. Data were analyzed using multiple logistic models controlling for potential confounders. Results: Of the 2725 participants, 581 (21.3%) had mobility limitation. The likelihood of mobility limitation increased linearly with the increasing number of CRFs (i.e., hypertension, high C-reactive protein, obesity, diabetes and smoking) (p for linear trend<0.010) and of CVDs (i.e., ischemic heart disease, atrial fibrillation, heart failure and stroke) (p for linear trend<0.001). There were statistical interactions of aggregated CRFs with age and APOE epsilon 4 allele on mobility limitation (p(interaction)<0.05), such that the association of mobility limitation with aggregated CRFs was statistically evident only among people aged <80 years and among carriers of the APOE epsilon 4 allele. Conclusion: Aggregations of multiple CRFs and CVDs are associated with an increased likelihood of mobility limitation among older adults; however the associations of CRFs with mobility limitation vary by age and genetic susceptibility.	[Welmer, Anna-Karin; Angleman, Sara; Rydwik, Elisabeth; Fratiglioni, Laura; Qiu, Chengxuan] Karolinska Inst, ARC, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Welmer, Anna-Karin; Angleman, Sara; Rydwik, Elisabeth; Fratiglioni, Laura; Qiu, Chengxuan] Stockholm Univ, S-10691 Stockholm, Sweden; [Welmer, Anna-Karin] Karolinska Univ Hosp, Stockholm, Sweden; [Rydwik, Elisabeth] Jakobsbergs Hosp, Res & Dev Unit, Jarfalla, Sweden; [Fratiglioni, Laura] Stockholm Gerontol Res Ctr, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Welmer, AK (corresponding author), Karolinska Inst, ARC, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	anna-karin.welmer@ki.se; chengxuan.qiu@ki.se	Welmer, Anna-Karin/AAL-3446-2021	Welmer, Anna-Karin/0000-0001-5819-8724; Angleman, Sara/0000-0002-9520-5716; Qiu, Chengxuan/0000-0003-1922-4912; Rydwik, Elisabeth/0000-0003-0550-1675	Swedish Ministry of Health and Social Affairs; Swedish Research Council in Medicine [K2008-69X-20821-01-3, K2009-69X-21166-01-3, K2012-99X-21967-01-3]; Swedish Council for Working Life and Social Research [2008-0512]; Stockholm County Council; Stohnes Foundation; Stiftelsen Ragnhild och Einar Lundstroms minne	Swedish Ministry of Health and Social Affairs; Swedish Research Council in Medicine; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stockholm County Council(Stockholm County Council); Stohnes Foundation; Stiftelsen Ragnhild och Einar Lundstroms minne	The SNAC-K was supported by the Swedish Ministry of Health and Social Affairs. Research grants were received from the Swedish Research Council in Medicine (http://www.vr.se/inenglish), Grant numbers: K2008-69X-20821-01-3, K2009-69X-21166-01-3 and K2012-99X-21967-01-3, the Swedish Council for Working Life and Social Research (http://www.fas.se/en/), Grant number 2008-0512, the Stockholm County Council (http://www.forskningsstod.sll.se/Ansokan/start.asp), the Stohnes Foundation and Stiftelsen Ragnhild och Einar Lundstroms minne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson HH, 2005, J AM GERIATR SOC, V53, P1197, DOI 10.1111/j.1532-5415.2005.53362.x; Basun H, 1996, STROKE, V27, P1310, DOI 10.1161/01.STR.27.8.1310; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P49; Bramell-Risberg E, 2005, DEMENT GERIATR COGN, V20, P298, DOI 10.1159/000088335; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Cedazo-Minguez A, 2001, J CELL MOL MED, V5, P254, DOI 10.1111/j.1582-4934.2001.tb00159.x; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Curb JD, 2004, J AM GERIATR SOC, V52, P1975, DOI 10.1111/j.1532-5415.2004.52551.x; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P1588, DOI 10.1001/jama.292.13.1588; Dore GA, 2009, DIABETOLOGIA, V52, P2551, DOI 10.1007/s00125-009-1497-2; Dumurgier J, 2010, J HYPERTENS, V28, P1506, DOI 10.1097/HJH.0b013e328338bbec; Figaro MK, 2006, DIABETES CARE, V29, P2039, DOI 10.2337/dc06-0245; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Ford ES, 2009, CIRCULATION, V120, P1181, DOI 10.1161/CIRCULATIONAHA.108.835728; Lagergren M, 2004, AGING CLIN EXP RES, V16, P158; Launer KJ, 1996, AGE AGEING, V25, P300, DOI 10.1093/ageing/25.4.300; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Onder G, 2006, J GERONTOL A-BIOL, V61, P736, DOI 10.1093/gerona/61.7.736; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P1105, DOI 10.1111/j.1532-5415.2004.52308.x; Phan HM, 2008, AM J GERIATR CARDIOL, V17, P101; Pugh KG, 2002, NEUROBIOL AGING, V23, P421, DOI 10.1016/S0197-4580(01)00319-0; Qiu C, 2012, EUR J NEUROL, V19, P876, DOI 10.1111/j.1468-1331.2011.03645.x; Rusanen M, 2010, DEMENT GERIATR COGN, V30, P277, DOI 10.1159/000320484; SEEMAN TE, 1994, J GERONTOL, V49, pM97, DOI 10.1093/geronj/49.3.M97; Solomon A, 2009, NEUROBIOL AGING, V30, P1006, DOI 10.1016/j.neurobiolaging.2007.09.012; Stenholm S, 2010, J GERONTOL A-BIOL, V65, P84, DOI 10.1093/gerona/glp150; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Taekema DG, 2011, AM J HYPERTENS, V24, P83, DOI 10.1038/ajh.2010.185; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Volpato S, 2002, DIABETES CARE, V25, P678, DOI 10.2337/diacare.25.4.678	34	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65815	10.1371/journal.pone.0065815	http://dx.doi.org/10.1371/journal.pone.0065815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741513	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900226
J	Lim, YW; Schmieder, R; Haynes, M; Furlan, M; Matthews, TD; Whiteson, K; Poole, SJ; Hayes, CS; Low, DA; Maughan, H; Edwards, R; Conrad, D; Rohwer, F				Lim, Yan Wei; Schmieder, Robert; Haynes, Matthew; Furlan, Mike; Matthews, T. David; Whiteson, Katrine; Poole, Stephen J.; Hayes, Christopher S.; Low, David A.; Maughan, Heather; Edwards, Robert; Conrad, Douglas; Rohwer, Forest			Mechanistic Model of Rothia mucilaginosa Adaptation toward Persistence in the CF Lung, Based on a Genome Reconstructed from Metagenomic Data	PLOS ONE			English	Article							CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; STOMATOCOCCUS-MUCILAGINOSUS; BACTERIAL DIVERSITY; ESCHERICHIA-COLI; SP-NOV; LACTATE; GENE; IDENTIFICATION; COMMUNITIES	The impaired mucociliary clearance in individuals with Cystic Fibrosis (CF) enables opportunistic pathogens to colonize CF lungs. Here we show that Rothia mucilaginosa is a common CF opportunist that was present in 83% of our patient cohort, almost as prevalent as Pseudomonas aeruginosa (89%). Sequencing of lung microbial metagenomes identified unique R. mucilaginosa strains in each patient, presumably due to evolution within the lung. The de novo assembly of a near-complete R. mucilaginosa (CF1E) genome illuminated a number of potential physiological adaptations to the CF lung, including antibiotic resistance, utilization of extracellular lactate, and modification of the type I restriction-modification system. Metabolic characteristics predicted from the metagenomes suggested R. mucilaginosa have adapted to live within the microaerophilic surface of the mucus layer in CF lungs. The results also highlight the remarkable evolutionary and ecological similarities of many CF pathogens; further examination of these similarities has the potential to guide patient care and treatment.	[Lim, Yan Wei; Haynes, Matthew; Furlan, Mike; Matthews, T. David; Whiteson, Katrine; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Schmieder, Robert; Edwards, Robert] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Poole, Stephen J.; Hayes, Christopher S.; Low, David A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.; Low, David A.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Maughan, Heather] Ronin Inst, Montclair, NJ USA; [Edwards, Robert] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Conrad, Douglas] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California San Diego	Lim, YW (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	ylim@rohan.sdsu.edu	Edwards, Robert/Q-1691-2019; Rohwer, Forest/AAC-5315-2019	Edwards, Robert/0000-0001-8383-8949; Whiteson, Katrine/0000-0002-5423-6014; Rohwer, Forest/0000-0003-1548-5429	National Institutes of Health [1 R01 GM095384-01]; Cystic Foundation Research Inc. (CFRI) [09-002];  [U54 AI065359]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Foundation Research Inc. (CFRI); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health and Cystic Foundation Research Inc. through grants (1 R01 GM095384-01 and CFRI #09-002) awarded to Forest Rohwer and grant U54 AI065359 awarded to Christopher Hayes and David Low. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, J MOL BIOL, V359, P455, DOI 10.1016/j.jmb.2006.03.053; Akhter S, 2012, NAR; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bensel T, 2011, J CYST FIBROS, V10, P37, DOI 10.1016/j.jcf.2010.09.004; BERGAN T, 1970, International Journal of Systematic Bacteriology, V20, P107; BERGAN T, 1982, INT J SYST BACTERIOL, V32, P374, DOI 10.1099/00207713-32-3-374; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; BOWDEN GH, 1969, ARCH ORAL BIOL, V14, P685, DOI 10.1016/0003-9969(69)90190-3; BRITIGAN BE, 1988, J CLIN INVEST, V81, P318, DOI 10.1172/JCI113323; Brown SA, 2007, J BACTERIOL, V189, P6407, DOI 10.1128/JB.00554-07; Carrolo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015678; Collins MD, 2000, INT J SYST EVOL MICR, V50, P661, DOI 10.1099/00207713-50-2-661; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; DeBacker D, 1997, AM J RESP CRIT CARE, V156, P1099, DOI 10.1164/ajrccm.156.4.9701048; Delgado S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-51; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Doel JJ, 2005, EUR J ORAL SCI, V113, P14, DOI 10.1111/j.1600-0722.2004.00184.x; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Goerke C, 2010, INT J MED MICROBIOL, V300, P520, DOI 10.1016/j.ijmm.2010.08.003; Gomes-Filho Isaac S, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5811; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guglielmetti S, 2010, APPL ENVIRON MICROB, V76, P3948, DOI 10.1128/AEM.00109-10; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Jimenez E, 2008, RES MICROBIOL, V159, P595, DOI 10.1016/j.resmic.2008.09.001; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kung VL, 2012, P NATL ACAD SCI USA, V109, P1275, DOI 10.1073/pnas.1109285109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; LEDERER F, 1974, EUR J BIOCHEM, V46, P393, DOI 10.1111/j.1432-1033.1974.tb03632.x; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lim YW, 2013, J CYST FIBROS, V12, P154, DOI 10.1016/j.jcf.2012.07.009; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Migula W, 1900, SYSTEM BAKTERIEN SPE; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Olsen Ingar, 2009, Microbial Ecology in Health and Disease, V21, P65, DOI 10.1080/08910600902907509; Ou G, 2009, AM J GASTROENTEROL, DOI DOI 10.1038/AJG.2009.524.ACCESSED; Palmer KL, 2011, J BACTERIOL, V193, P3431, DOI 10.1128/JB.05066-11; Philip K, 2009, PATHOGENIC BACTERIA; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; POTTER JL, 1967, AM REV RESPIR DIS, V96, P83; Preza D, 2009, EUR J CLIN MICROBIOL, V28, P1033, DOI 10.1007/s10096-009-0743-3; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Ready D, 2004, ANTIMICROB AGENTS CH, V48, P2883, DOI 10.1128/AAC.48.8.2883-2887.2004; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Sass A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-373; Schmieder R, MYMGDB; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmitz JE, 2010, APPL ENVIRON MICROB, V76, P7181, DOI 10.1128/AEM.00732-10; Smart CHM, 2006, J MED MICROBIOL, V55, P677, DOI 10.1099/jmm.0.46461-0; Smith H, 2007, INFECT IMMUN, V75, P4190, DOI 10.1128/IAI.00117-07; Stackebrandt E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P975, DOI 10.1007/0-387-30743-5_39; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; Willner D, 2010, VIRULENCE, V1, P309, DOI 10.4161/viru.1.4.12071; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Yamane K, 2010, SEQUENCING, V2010, DOI [10.1155/2010/457236, DOI 10.1155/2010/457236]	76	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64285	10.1371/journal.pone.0064285	http://dx.doi.org/10.1371/journal.pone.0064285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737977	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700041
J	Liu, JN; Xu, P; Collins, C; Liu, H; Zhang, JD; Keblesh, JP; Xiong, HG				Liu, Jianuo; Xu, Peng; Collins, Cory; Liu, Han; Zhang, Jingdong; Keblesh, James P.; Xiong, Huangui			HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POTASSIUM CHANNEL-BLOCKERS; CENTRAL-NERVOUS-SYSTEM; NEUROCOGNITIVE DISORDERS; THERAPEUTIC TARGETS; AUTOIMMUNE-DISEASES; NEURONAL INJURY; KV1.3 CHANNELS; RAT MICROGLIA; T-LYMPHOCYTES	Microglia plays a crucial role in the pathogenesis of HIV-1-associated neurocognitive disorders. Increasing evidence indicates the voltage-gated potassium (K-v) channels are involved in the regulation of microglia function, prompting us to hypothesize K-vv channels may also be involved in microglia-mediated neurotoxic activity in HIV-1-infected brain. To test this hypothesis, we investigated the involvement of K-v channels in the response of microglia to HIV-1 Tat protein. Treatment of rat microglia with HIV-1 Tat protein (200 ng/ml) resulted in pro-inflammatory microglial activation, as indicated by increases in TNF-alpha, IL-1 beta, reactive oxygen species, and nitric oxide, which were accompanied by enhanced outward K+ current and K(v)1.3 channel expression. Suppression of microglial K(v)1.3 channel activity, either with K(v)1.3 channel blockers Margatoxin, 5( 4-Phenoxybutoxy) psoralen, or broad-spectrum K+ channel blocker 4-Aminopyridine, or by knockdown of K(v)1.3 expression via transfection of microglia with K(v)1.3 siRNA, was found to abrogate the neurotoxic activity of microglia resulting from HIV-1 Tat exposure. Furthermore, HIV-1 Tat-induced neuronal apoptosis was attenuated with the application of supernatant collected from K+ channel blocker-treated microglia. Lastly, the intracellular signaling pathways associated with K(v)1.3 were investigated and enhancement of microglial K(v)1.3 was found to correspond with an increase in Erk1/ 2 mitogen-activated protein kinase activation. These data suggest targeting microglial K(v)1.3 channels may be a potential new avenue of therapy for inflammation-mediated neurological disorders.	[Liu, Jianuo; Xu, Peng; Collins, Cory; Liu, Han; Zhang, Jingdong; Keblesh, James P.; Xiong, Huangui] Univ Nebraska Med Ctr, Neurophysiol Lab, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Xiong, Huangui] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Liu, JN (corresponding author), Univ Nebraska Med Ctr, Neurophysiol Lab, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	jnliu@unmc.edu; hxiong@unmc.edu	Zhang, Jing/GWZ-7332-2022; Xu, Peng/AAE-2862-2020	Xu, Peng/0000-0003-1908-5828	National Institues of Health (NIH) [R01NS077873]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077873] Funding Source: NIH RePORTER	National Institues of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a research grant from National Institues of Health (NIH): R01NS077873 to HX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul M, 2003, ANTICANCER RES, V23, P3347; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Bonavia R, 2001, BIOCHEM BIOPH RES CO, V288, P301, DOI 10.1006/bbrc.2001.5743; Brevet M, 2008, HISTOL HISTOPATHOL, V23, P965, DOI 10.14670/HH-23.965; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Eder C, 1999, EUR J NEUROSCI, V11, P4251, DOI 10.1046/j.1460-9568.1999.00852.x; Eder C, 1998, AM J PHYSIOL-CELL PH, V275, pC327, DOI 10.1152/ajpcell.1998.275.2.C327; Esamai F, 2005, J TROP PEDIATRICS, V51, P17, DOI 10.1093/tropej/fmh069; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; FISCHER HG, 1995, NEUROSCIENCE, V64, P183, DOI 10.1016/0306-4522(94)00398-O; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Gendelman H.E., 1998, NEUROLOGY AIDS, P1; Gendelman HE, 2009, J NEUROIMMUNE PHARM, V4, P47, DOI 10.1007/s11481-008-9135-1; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Goffe B, 2005, CLIN THER, V27, P1912, DOI 10.1016/j.clinthera.2005.12.007; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Judge SIV, 2006, J REHABIL RES DEV, V43, P111, DOI 10.1682/JRRD.2004.09.0116; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Keblesh JP, 2009, J NEUROIMMUNE PHARM, V4, P317, DOI 10.1007/s11481-009-9161-7; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kielian T, 2004, FRONT BIOSCI-LANDMRK, V9, P732, DOI 10.2741/1266; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Lee YB, 2000, CYTOKINE, V12, P874, DOI 10.1006/cyto.2000.0688; Liu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.140; Lokensgard JR, 2001, J NEUROVIROL, V7, P481; Menteyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006770; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; NORENBERG W, 1994, J PHYSIOL-LONDON, V475, P15; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Schilling T, 2000, AM J PHYSIOL-CELL PH, V279, pC1123, DOI 10.1152/ajpcell.2000.279.4.C1123; Schilling T, 2011, J CELL PHYSIOL, V226, P3295, DOI 10.1002/jcp.22675; Spudich Serena S, 2011, Top Antivir Med, V19, P48; Strniskova M, 2002, GEN PHYSIOL BIOPHYS, V21, P231; Valverde P, 2005, J DENT RES, V84, P488, DOI 10.1177/154405910508400603; Vianna-Jorge R, 2004, BIODRUGS, V18, P329, DOI 10.2165/00063030-200418050-00005; Visentin S, 2001, GLIA, V33, P181, DOI 10.1002/1098-1136(200103)33:3<181::AID-GLIA1017>3.0.CO;2-Q; Walz W, 2001, MICROSC RES TECHNIQ, V54, P26, DOI 10.1002/jemt.1117; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wickenden AD, 2002, PHARMACOL THERAPEUT, V94, P157, DOI 10.1016/S0163-7258(02)00201-2; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Xu CS, 2011, GLIA, V59, P997, DOI 10.1002/glia.21171	61	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64904	10.1371/journal.pone.0064904	http://dx.doi.org/10.1371/journal.pone.0064904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738010	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700071
J	Thomas, R; Thomas, RS; Auerbach, SS; Portier, CJ				Thomas, Reuben; Thomas, Russell S.; Auerbach, Scott S.; Portier, Christopher J.			Biological Networks for Predicting Chemical Hepatocarcinogenicity Using Gene Expression Data from Treated Mice and Relevance across Human and Rat Species	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; N-ACETYLGLUCOSAMINYLTRANSFERASE; RISK-FACTORS; LIVER; CANCER; CARCINOGENICITY; MICROARRAY; INFECTION; PROFILES; PATHWAY	Background: Several groups have employed genomic data from subchronic chemical toxicity studies in rodents (90 days) to derive gene-centric predictors of chronic toxicity and carcinogenicity. Genes are annotated to belong to biological processes or molecular pathways that are mechanistically well understood and are described in public databases. Objectives: To develop a molecular pathway-based prediction model of long term hepatocarcinogenicity using 90-day gene expression data and to evaluate the performance of this model with respect to both intra-species, dose-dependent and cross-species predictions. Methods: Genome-wide hepatic mRNA expression was retrospectively measured in B6C3F1 mice following subchronic exposure to twenty-six (26) chemicals (10 were positive, 2 equivocal and 14 negative for liver tumors) previously studied by the US National Toxicology Program. Using these data, a pathway-based predictor model for long-term liver cancer risk was derived using random forests. The prediction model was independently validated on test sets associated with liver cancer risk obtained from mice, rats and humans. Results: Using 5-fold cross validation, the developed prediction model had reasonable predictive performance with the area under receiver-operator curve (AUC) equal to 0.66. The developed prediction model was then used to extrapolate the results to data associated with rat and human liver cancer. The extrapolated model worked well for both extrapolated species (AUC value of 0.74 for rats and 0.91 for humans). The prediction models implied a balanced interplay between all pathway responses leading to carcinogenicity predictions. Conclusions: Pathway-based prediction models estimated from sub-chronic data hold promise for predicting long-term carcinogenicity and also for its ability to extrapolate results across multiple species.	[Thomas, Reuben] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Thomas, Russell S.] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA; [Auerbach, Scott S.] Natl Inst Environm Hlth Sci, Natl Toxicol Program, Biomol Screening Branch, Res Triangle Pk, NC USA; [Portier, Christopher J.] US Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30329 USA; [Portier, Christopher J.] US Ctr Dis Control & Prevent, Agcy Tox Subst & Dis Registry, Atlanta, GA USA	University of California System; University of California Berkeley; The Hamner Institutes for Health Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Portier, CJ (corresponding author), US Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30329 USA.	cip7@cdc.gov	Portier, Christopher J/A-3160-2010	Portier, Christopher J/0000-0002-0954-0279; Thomas, Russell/0000-0002-2340-0301	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences; Hamner Institutes from the American Chemistry Council's Long-Range Research Initiative	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Hamner Institutes from the American Chemistry Council's Long-Range Research Initiative	This research was supported [in part] by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. The mouse studies and associated microarray analyses were supported by a grant to The Hamner Institutes from the American Chemistry Council's Long-Range Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; ALEXANDER DJ, 1995, HUM EXP TOXICOL, V14, P706, DOI 10.1177/096032719501400902; Ames BN, 1996, RISK ANAL, V16, P613, DOI 10.1111/j.1539-6924.1996.tb00810.x; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7772, DOI 10.1073/pnas.87.19.7772; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Auerbach SS, 2009, TOXICOLOGY APPL PHAR, V343, P300; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Ellinger-Ziegelbauer H, 2008, MUTAT RES-FUND MOL M, V637, P23, DOI 10.1016/j.mrfmmm.2007.06.010; FERNANDES B, 1991, CANCER RES, V51, P718; Fielden MR, 2005, TOXICOL PATHOL, V33, P675, DOI 10.1080/01926230500321213; FREEDMAN DA, 1993, RISK ANAL, V13, P265, DOI 10.1111/j.1539-6924.1993.tb01078.x; GOLD LS, 1992, RISK ANAL, V12, P579, DOI 10.1111/j.1539-6924.1992.tb00714.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hassan MM, 2002, J CLIN GASTROENTEROL, V35, P266, DOI 10.1097/00004836-200209000-00013; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hoenerhoff MJ, 2011, TOXICOL PATHOL, V39, P678, DOI 10.1177/0192623311407213; Huff J, 2006, ANN NY ACAD SCI, V895, P56; Ito Y, 2001, INT J CANCER, V91, P631, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1118>3.3.CO;2-6; Jiang Y, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-47; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546; Nakayama K, 2006, TOXICOL APPL PHARM, V217, P299, DOI 10.1016/j.taap.2006.09.008; National Research Council, 2007, TOXICITY TESTING 21; Nie AY, 2006, MOL CARCINOGEN, V45, P914, DOI 10.1002/mc.20205; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perrett L, 2010, DIABETES MOST COMMON; Polley E.C., 2010, SUPERLEARNER SUPER L; PORTIER CJ, 1989, FUND APPL TOXICOL, V12, P731, DOI 10.1016/0272-0590(89)90004-3; PORTIER CJ, 1986, CANCER RES, V46, P4372; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Regimbeau Jean M, 2004, Liver Transpl, V10, pS69, DOI 10.1002/lt.20033; Robin X, 2010, DISPLAY ANAL ROC CUR; Shi W, 2008, TOXICOL MECH METHOD, V18, P267, DOI 10.1080/15376510701857072; Somorjai RL, 2003, BIOINFORMATICS, V19, P1484, DOI 10.1093/bioinformatics/btg182; Tanaka T, 2005, CANCER SCI, V94, P965; Team RDC, 2009, R LANG ENV STAT COMP; Thomas R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r44; Thomas RS, 2001, MOL PHARMACOL, V60, P1189, DOI 10.1124/mol.60.6.1189; Thomas RS, 2007, TOXICOL SCI, V96, P40, DOI 10.1093/toxsci/kfl171; Thomas RS, 2009, TOXICOL SCI, V112, P311, DOI 10.1093/toxsci/kfp233; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Yamamoto H, 2000, CANCER RES, V60, P134; Yanagitani A, 2004, HEPATOLOGY, V40, P366, DOI 10.1002/hep.20335; Yao M, 1998, J CANCER RES CLIN, V124, P27, DOI 10.1007/s004320050129	57	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63308	10.1371/journal.pone.0063308	http://dx.doi.org/10.1371/journal.pone.0063308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737943	gold, Green Submitted, Green Published			2022-12-27	WOS:000321394700007
J	Wankhede, DP; Misra, M; Singh, P; Sinha, AK				Wankhede, Dhammaprakash Pandhari; Misra, Mohit; Singh, Pallavi; Sinha, Alok Krishna			Rice Mitogen Activated Protein Kinase Kinase and Mitogen Activated Protein Kinase Interaction Network Revealed by In-Silico Docking and Yeast Two-Hybrid Approaches	PLOS ONE			English	Article							ARABIDOPSIS MAPKS; SIGNALING PATHWAY; IDENTIFICATION; PERFORMANCE; CASCADE; BINDING; RDOCK; ZRANK; SITE	Protein-protein interaction is one of the crucial ways to decipher the functions of proteins and to understand their role in complex pathways at cellular level. Such a protein-protein interaction network in many crop plants remains poorly defined owing largely to the involvement of high costs, requirement for state of the art laboratory, time and labour intensive techniques. Here, we employed computational docking using ZDOCK and RDOCK programmes to identify interaction network between members of Oryza sativa mitogen activated protein kinase kinase (MAPKK) and mitogen activated protein kinase (MAPK). The 3-dimentional (3-D) structures of five MAPKKs and eleven MAPKs were determined by homology modelling and were further used as input for docking studies. With the help of the results obtained from ZDOCK and RDOCK programmes, top six possible interacting MAPK proteins were predicted for each MAPKK. In order to assess the reliability of the computational prediction, yeast two-hybrid (Y2H) analyses were performed using rice MAPKKs and MAPKs. A direct comparison of Y2H assay and computational prediction of protein interaction was made. With the exception of one, all the other MAPKK-MAPK pairs identified by Y2H screens were among the top predictions by computational dockings. Although, not all the predicted interacting partners could show interaction in Y2H, yet, the harmony between the two approaches suggests that the computational predictions in the present work are reliable. Moreover, the present Y2H analyses per se provide interaction network among MAPKKs and MAPKs which would shed more light on MAPK signalling network in rice.	[Wankhede, Dhammaprakash Pandhari; Misra, Mohit; Singh, Pallavi; Sinha, Alok Krishna] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Sinha, AK (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	alok@nipgr.ac.in		Singh, Pallavi/0000-0003-3694-6378	National Institute of Plant Genome Research, New Delhi, India from the Department of Biotechnology, New Delhi, Government of India	National Institute of Plant Genome Research, New Delhi, India from the Department of Biotechnology, New Delhi, Government of India	The work is supported by the core grant of National Institute of Plant Genome Research, New Delhi, India from the Department of Biotechnology, New Delhi, Government of India. DPW thanks University Grants Commission, India while PS thanks Council of Scientific and Industrial Research, India for fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Chen R, 2003, PROTEINS, V52, P88, DOI 10.1002/prot.10390; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Ding XD, 2009, PLANT PHYSIOL, V149, P1478, DOI 10.1104/pp.108.128298; Doczi R, 2012, TRENDS PLAN IN PRESS; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; Kumar K, 2008, PLANT PHYSIOL BIOCH, V46, P891, DOI 10.1016/j.plaphy.2008.05.014; Kumar Kundan, 2013, [Frontiers in Biology, 生物学前沿], V8, P109; Lee JS, 2008, PLANT SIGNAL BEHAV, V3, P1037, DOI 10.4161/psb.3.12.6848; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mizoguchi T, 1998, FEBS LETT, V437, P56, DOI 10.1016/S0014-5793(98)01197-1; Mody A, 2009, NAT CELL BIOL, V11, P484, DOI 10.1038/ncb1856; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pons C, 2010, PROTEINS, V78, P95, DOI 10.1002/prot.22564; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Rao KP, 2011, ARCH BIOCHEM BIOPHYS, V506, P73, DOI 10.1016/j.abb.2010.11.006; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schafferhans A, 2001, J MOL BIOL, V307, P407, DOI 10.1006/jmbi.2000.4453; Sharma Babita, 2008, In Silico Biology, V8, P193; Singh R, 2012, PLANT PHYSIOL, V160, P477, DOI 10.1104/pp.112.200071; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Sivasubramanian A, 2006, STRUCTURE, V14, P401, DOI 10.1016/j.str.2005.11.022; Tovchigrechko A, 2002, PROTEIN SCI, V11, P1888, DOI 10.1110/ps.4730102; Wen JQ, 2002, PLANT PHYSIOL, V129, P1880, DOI 10.1104/pp.006072; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Xie GS, 2012, BIOCHEM J, V443, P95, DOI 10.1042/BJ20111792	41	34	39	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e65011	10.1371/journal.pone.0065011	http://dx.doi.org/10.1371/journal.pone.0065011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738013	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700074
J	Weijerman, M; Fulton, EA; Parrish, FA				Weijerman, Mariska; Fulton, Elizabeth A.; Parrish, Frank A.			Comparison of Coral Reef Ecosystems along a Fishing Pressure Gradient	PLOS ONE			English	Article							MARINE PROTECTED AREAS; SMALL-SCALE FISHERIES; ECOLOGICAL INDICATORS; CLIMATE-CHANGE; WATER-COLUMN; MANAGEMENT; MODELS; ECOPATH; HABITAT; BAY	Three trophic mass-balance models representing coral reef ecosystems along a fishery gradient were compared to evaluate ecosystem effects of fishing. The majority of the biomass estimates came directly from a large-scale visual survey program; therefore, data were collected in the same way for all three models, enhancing comparability. Model outputs-such as net system production, size structure of the community, total throughput, production, consumption, production-to-respiration ratio, and Finn's cycling index and mean path length-indicate that the systems around the unpopulated French Frigate Shoals and along the relatively lightly populated Kona Coast of Hawai'i Island are mature, stable systems with a high efficiency in recycling of biomass. In contrast, model results show that the reef system around the most populated island in the State of Hawai'i, O'ahu, is in a transitional state with reduced ecosystem resilience and appears to be shifting to an algal-dominated system. Evaluation of the candidate indicators for fishing pressure showed that indicators at the community level (e. g., total biomass, community size structure, trophic level of the community) were most robust (i.e., showed the clearest trend) and that multiple indicators are necessary to identify fishing perturbations. These indicators could be used as performance indicators when compared to a baseline for management purposes. This study shows that ecosystem models can be valuable tools in identification of the system state in terms of complexity, stability, and resilience and, therefore, can complement biological metrics currently used by monitoring programs as indicators for coral reef status. Moreover, ecosystem models can improve our understanding of a system's internal structure that can be used to support management in identification of approaches to reverse unfavorable states.	[Weijerman, Mariska] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Weijerman, Mariska] Wageningen Univ, Wageningen Inst Environm & Climate Res, NL-6700 AP Wageningen, Netherlands; [Fulton, Elizabeth A.] Commonwealth Sci & Ind Res Org Hobart, Div Marine Res, Hobart, Tas, Australia; [Parrish, Frank A.] Pacific Isl Fisheries Sci Ctr, Protected Species Div, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa; Wageningen University & Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Weijerman, M (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	mariska.weijerman@noaa.gov	Fulton, Beth/A-2871-2008	Fulton, Beth/0000-0002-5904-7917	National Oceanic and Atmospheric Administration (NOAA): the Office of Habitat Conservation; National Oceanic and Atmospheric Administration (NOAA): the Habitat Conservation Division; National Oceanic and Atmospheric Administration (NOAA): the Pacific Islands Fisheries Science Centre	National Oceanic and Atmospheric Administration (NOAA): the Office of Habitat Conservation; National Oceanic and Atmospheric Administration (NOAA): the Habitat Conservation Division; National Oceanic and Atmospheric Administration (NOAA): the Pacific Islands Fisheries Science Centre	Funding for this study came from three National Oceanic and Atmospheric Administration (NOAA) offices: the Office of Habitat Conservation (http://www.nmfs.noaa.gov/habitat/); the Habitat Conservation Division (http://www.fpir.noaa.gov/HCD/hcd_index.html) and the Pacific Islands Fisheries Science Centre (http://www.pifsc.noaa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2008, ECOL MODEL, V214, P361, DOI 10.1016/j.ecolmodel.2008.02.039; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Arias-Gonzalez JE, 2004, ECOL MODEL, V172, P197, DOI 10.1016/j.ecolmodel.2003.09.007; Arreguin-Sanchez F, 2004, ECOL MODEL, V172, P421, DOI 10.1016/j.ecolmodel.2003.09.016; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BILGER RW, 1992, LIMNOL OCEANOGR, V37, P261, DOI 10.4319/lo.1992.37.2.0261; Brey T., 2001, POPULATION DYNAMICS; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bundy A, 2001, FISH RES, V53, P263, DOI 10.1016/S0165-7836(00)00295-2; Burke L, 2011, REEFS RISK REVISITED, P112; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chardy P, 1988, ATTEMPT ESTIMATE CAR, P541; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Christensen V., 2008, LEN OCE FUTS PROJ, P235; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeMartini EE, 2010, MAR FRESHWATER RES, V61, P532, DOI 10.1071/MF09141; Diaz-Uribe JG, 2007, ECOL MODEL, V201, P205, DOI 10.1016/j.ecolmodel.2006.09.015; Eakin CM, 2001, B MAR SCI, V69, P171; Everson A, 2004, STATUS HAWAIIS COAST, P110; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2000, MAR ECOL PROG SER, V196, P157, DOI 10.3354/meps196157; FABRICIUS KE, 1995, MAR ECOL PROG SER, V126, P145, DOI 10.3354/meps126145; Friedlander A., 2008, STATE CORAL REEF ECO, P222; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 1997, FISH RES, V32, P33, DOI 10.1016/S0165-7836(97)00038-6; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Friedlander AM, 2006, 23 NOAA NOS NCCOS; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Genin A, 2009, LIMNOL OCEANOGR, V54, P938, DOI 10.4319/lo.2009.54.3.0938; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Green A., 2009, MONITORING FUNCTIONA, P70; Gribble NA, 2003, FISH RES, V65, P493, DOI 10.1016/j.fishres.2003.09.035; Hall SJ, 2004, FISH FISH, V5, P1, DOI 10.1111/j.1467-2960.2004.00133.x; Hassett RP, 1999, MAR BIOL, V134, P571, DOI 10.1007/s002270050572; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoeke RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018038; Jorgensen SE, 2005, HDB ECOLOGICAL INDIC, P448; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Link JS, 2005, ICES J MAR SCI, V62, P569, DOI 10.1016/j.icesjms.2004.12.015; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2011, GLOBAL CHANGE BIOL, V17, P2023, DOI 10.1111/j.1365-2486.2011.02395.x; MCCLANAHAN TR, 1995, ECOL MODEL, V80, P1, DOI 10.1016/0304-3800(94)00042-G; McLeod K.L., 2005, SCI CONSENSUS STATEM; Metcalf SJ, 2011, ICES J MAR SCI, V68, P1417, DOI 10.1093/icesjms/fsr050; Morato T, 2009, DEEP-SEA RES PT II, V56, P2713, DOI 10.1016/j.dsr2.2008.12.029; Morissette L, 2007, COMPLEXITY COAST QUA, P278; Mumby PJ, 2006, ECOL MODEL, V196, P131, DOI 10.1016/j.ecolmodel.2005.11.035; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; ODUM E P, 1971, P574; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Opitz S, 1996, TROPHIC INTERACTIONS; Palomares MLD, 1998, MAR FRESHWATER RES, V49, P447, DOI 10.1071/MF98015; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parrish FA, 2004, MAR BIOL, V144, P1065, DOI 10.1007/s00227-003-1288-0; Parrish FA, 2011, MARINE MAMMAL SCI, V28, P552; PAULY D, 1980, J CONSEIL, V39, P175; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Paves HJ, 2008, ECOL MODEL, V212, P218, DOI 10.1016/j.ecolmodel.2007.10.004; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; POLOVINA JJ, 1984, CORAL REEFS, V3, P1, DOI 10.1007/BF00306135; Ribes M, 2003, MAR ECOL PROG SER, V257, P13, DOI 10.3354/meps257013; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; Samhouri JF, 2009, ECOSYSTEMS, V12, P1283, DOI 10.1007/s10021-009-9286-9; Sebens KP, 1996, MAR BIOL, V127, P303, DOI 10.1007/BF00942116; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Shin YJ, 2010, ICES J MAR SCI, V67, P717, DOI 10.1093/icesjms/fsp287; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; Stimson J, 2000, J EXP MAR BIOL ECOL, V252, P159, DOI 10.1016/S0022-0981(00)00230-6; Storlazzi CD, 2009, MAR GEOL, V264, P140, DOI 10.1016/j.margeo.2009.05.002; Tsehaye Y, 2008, ECOL MODEL, V212, P319, DOI 10.1016/j.ecolmodel.2007.10.044; Ulanowicz R.E., 1986, GROWTH DEV ECOSYSTEM, DOI [DOI 10.1007/978-1-4612-4916-0., 10.1007/978-1-4612-4916-0]; Vasconcellos M, 1997, ECOL MODEL, V100, P125, DOI 10.1016/S0304-3800(97)00150-6; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Walsh W, 2010, LONG TERM MONITORING, P133; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams ID, 2011, J MAR BIOL, DOI DOI 10.1155/2011/826234; Wilson SK, 2010, ECOL APPL, V20, P442, DOI 10.1890/08-2205.1; Wolanski E, 2004, J MARINE SYST, V46, P133, DOI 10.1016/j.jmarsys.2003.11.018; XIE LS, 1995, FISH OCEANOGR, V4, P52, DOI 10.1111/j.1365-2419.1995.tb00060.x; Xu SN, 2011, ESTUAR COAST, V34, P351, DOI 10.1007/s12237-010-9323-0; Zollner E, 2009, LIMNOL OCEANOGR, V54, P262, DOI 10.4319/lo.2009.54.1.0262	89	22	22	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63797	10.1371/journal.pone.0063797	http://dx.doi.org/10.1371/journal.pone.0063797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737951	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700014
J	Olsson, J; Bergstrom, L; Gardmark, A				Olsson, Jens; Bergstrom, Lena; Gardmark, Anna			Top-Down Regulation, Climate and Multi-Decadal Changes in Coastal Zoobenthos Communities in Two Baltic Sea Areas	PLOS ONE			English	Article							MONOPOREIA-AFFINIS; SPATIAL-DISTRIBUTION; SOFT BOTTOMS; FISH; POPULATION; PREDATION; ECOSYSTEM; FINLAND; ENTOMON; GULF	The structure of many marine ecosystems has changed substantially during recent decades, as a result of overexploitation, climate change and eutrophication. Despite of the apparent ecological and economical importance of coastal areas and communities, this aspect has received relatively little attention in coastal systems. Here we assess the temporal development of zoobenthos communities in two areas on the Swedish Baltic Sea coast during 30 years, and relate their development to changes in climate, eutrophication and top-down regulation from fish. Both communities show substantial structural changes, with a decrease in marine polychaetes and species sensitive to increased water temperatures. Concurrently, opportunistic species tolerant to environmental perturbation have increased in abundance. Species composition show a similar temporal development in both communities and significant changes in species composition occurred in both data sets in the late 1980s and early 1990s. The change in species composition was associated with large scale changes in climate (salinity and water temperature) and to the structure of the local fish community, whereas we found no effects of nutrient loading or ambient nutrient concentrations. Our results suggest that these coastal zoobenthos communities have gone through substantial structural changes over the last 30 years, resulting in communities of different species composition with potentially different ecological functions. We hence suggest that the temporal development of coastal zoobenthos communities should be assessed in light of prevailing climatic conditions considering the potential for top-down effects exerted by local fish communities.	[Olsson, Jens; Bergstrom, Lena; Gardmark, Anna] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Coastal Res, Oregrund, Sweden	Swedish University of Agricultural Sciences	Olsson, J (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Inst Coastal Res, Oregrund, Sweden.	Jens.Olsson@slu.se	Gårdmark, Anna/AAC-3909-2021	Bergstrom, Lena/0000-0002-8059-8764	Swedish Environmental Protection Agency; Swedish Board of Fisheries; Swedish University of Agricultural Sciences	Swedish Environmental Protection Agency; Swedish Board of Fisheries; Swedish University of Agricultural Sciences	This study is part of the project Integrated analyses of Baltic Sea ecosystems, financially supported by the Swedish Environmental Protection Agency, the Swedish Board of Fisheries and the Swedish University of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2008, HYDROBIOLOGIA, V614, P107, DOI 10.1007/s10750-008-9529-3; Anderson M.J., 2008, GUIDE SOFTWARE STAT; Bagge Ole, 1994, Dana, V10, P1; Beukema JJ, 2009, MAR ECOL PROG SER, V384, P135, DOI 10.3354/meps07952; Bonsdorff E, 2003, BOREAL ENVIRON RES, V8, P135; BONSDORFF E, 1995, J EXP MAR BIOL ECOL, V192, P125, DOI 10.1016/0022-0981(95)00067-2; Bonsdorff Erik, 1993, Oceanography and Marine Biology an Annual Review, V31, P153; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Casini M, 2012, P NATL ACAD SCI USA, V109, P8185, DOI 10.1073/pnas.1113286109; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Drouin A, 2011, BOREAL ENVIRON RES, V16, P101; Dulvy NK, 2002, J EXP MAR BIOL ECOL, V278, P1, DOI 10.1016/S0022-0981(02)00327-1; Dutertre M, 2013, ICES J MAR SCI, V70, P294, DOI 10.1093/icesjms/fss170; Eriksson BK, 2011, AMBIO, V40, P786, DOI 10.1007/s13280-011-0158-0; Eriksson BK, 2009, ECOL APPL, V19, P1975, DOI 10.1890/08-0964.1; Gorley C.K., 2006, GETTING STARTED PRIM; Grall J, 2002, GLOBAL CHANGE BIOL, V8, P813, DOI 10.1046/j.1365-2486.2002.00519.x; HAAHTELA I, 1990, ANN ZOOL FENN, V27, P269; Hakansson L, 2008, TOOLS CRITERIA SUSTA; HANSSON S, 1987, AMBIO, V16, P344; HELCOM, 1996, 64B BSEP HELCOM; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; ICES, 2010, 2010ACOM10 CM ICES H; Jarv L, 2011, ANN ZOOL FENN, V48, P129; Kanaya G, 2008, ESTUAR COAST SHELF S, V78, P674, DOI 10.1016/j.ecss.2008.02.005; Laine AO, 2003, ESTUAR COAST SHELF S, V57, P87, DOI 10.1016/S0272-7714(02)00333-5; Laine AO, 2007, J SEA RES, V57, P65, DOI 10.1016/j.seares.2006.08.003; Legendre P., 2012, NUMERICAL ECOLOGY; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; LEONARDSSON K, 1991, ECOLOGY, V72, P1273, DOI 10.2307/1941101; Leppakoski Erkki, 2000, Biological Invasions, V2, P151, DOI 10.1023/A:1010052809567; MATTILA J, 1989, NETH J SEA RES, V23, P69, DOI 10.1016/0077-7579(89)90044-6; MILLS A, 1980, MAR BIOL, V58, P153, DOI 10.1007/BF00396127; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Neuman E., 2000, FISK RAP, V2, P3; NEUMANN D, 1976, ANNU REV ENTOMOL, V21, P387, DOI 10.1146/annurev.en.21.010176.002131; Norkko A., 2008, MERI REP SER FINN I, V62, P73; OLIVER DR, 1971, ANNU REV ENTOMOL, V16, P211, DOI 10.1146/annurev.en.16.010171.001235; Olsson J, 2012, ICES J MAR SCI, V69, P961, DOI 10.1093/icesjms/fss072; Perus J, 2004, J SEA RES, V52, P45, DOI 10.1016/j.seares.2003.07.004; Pierscieniak K, 2010, OCEANOL HYDROBIOL ST, V39, P17, DOI 10.2478/v10009-010-0054-0; Rousi H, 2013, ICES J MAR SCI, V70, P440, DOI 10.1093/icesjms/fss197; Sandberg E, 1996, J SEA RES, V35, P345, DOI 10.1016/S1385-1101(96)90761-3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sieben K, 2011, J EXP MAR BIOL ECOL, V397, P79, DOI 10.1016/j.jembe.2010.11.020; SPARREVIK E, 1995, OECOLOGIA, V101, P177, DOI 10.1007/BF00317281; Stigzelius J, 1997, ANN ZOOL FENN, V34, P205; Swedish Board of Fisheries, 2005, REC VID KARNKR VID O, V2005, P8; Swedish Board of Fisheries, 2010, FINFO, V2010, P2; Thoresson G, 1996, GUIDELINES COASTAL F, P2; Thoresson G, 1992, HDB KUSTUNDERSOKNING, P4; Townsend CR, 2003, CONSERV BIOL, V17, P38, DOI 10.1046/j.1523-1739.2003.02017.x; von Storch H, 2008, GKSS SCH ENVIRONM, P1; Wiklund AKE, 2001, MAR ECOL PROG SER, V222, P131; Wiklund AKE, 2008, J EXP MAR BIOL ECOL, V367, P81, DOI 10.1016/j.jembe.2008.08.018; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	58	20	20	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e64767	10.1371/journal.pone.0064767	http://dx.doi.org/10.1371/journal.pone.0064767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23737998	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000319385300012
J	Li, YF; Hua, YM; Fang, J; Wang, C; Qiao, LN; Wan, CM; Mu, DZ; Zhou, KY				Li, Yifei; Hua, Yimin; Fang, Jie; Wang, Chuan; Qiao, Lina; Wan, Chaomin; Mu, Dezhi; Zhou, Kaiyu			Performance of Different Scan Protocols of Fetal Echocardiography in the Diagnosis of Fetal Congenital Heart Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SPATIOTEMPORAL IMAGE CORRELATION; LOW-RISK PREGNANCIES; ATRIOVENTRICULAR SEPTAL-DEFECT; INCREASED NUCHAL TRANSLUCENCY; OUTFLOW TRACT ABNORMALITIES; PRENATAL-DIAGNOSIS; 4-CHAMBER VIEW; CARDIAC ANOMALIES; ULTRASOUND EXAMINATION; 4-DIMENSIONAL ULTRASONOGRAPHY	Objective: The rapid progress in fetal echocardiography has lead to early detection of congenital heart diseases. Increasing evidences have shown that prenatal diagnosis could be life saving in certain cases. However, there is no agreement on which protocol is most adaptive diagnostic one. Thus, we use meta-analysis to conduct a pooled performance test on 5 diagnostic protocols. Methods: We searched PUBMED, EMBASE, the Cochrane Central Register of Controlled Trials and WHO clinical trails registry center to identify relevant studies up to August, 2012. We performed meta-analysis in a fixed/random-effect model using Meta-disc 1.4. We used STATA 11.0 to estimate the publication bias and SPSS 17.0 to evaluate variance. Results: We use results from 81 studies in 63 articles to analyze the pooled accuracy. The overall performance of pooled sensitivities of spatiotemporal image correlation (STIC), extend cardiac echography examination (ECEE) and 4 chambers view + outflow tract view + 3 vessels and trachea view (4 CV+OTV+3 VTV) were around 0.90, which was significant higher than that of 4 chambers view + outflow tract view or 3 vessels and trachea view (4 CV+OTV/3 VTV) and 4 chambers view (4 CV). Unfortunately the pooled specificity of STIC was 0.92, which was significant lower than that of other 4 protocols which reached at 1.00. The area under the summary receiver operating characteristic curves value of STIC, ECEE, 4 CV+OTV+3 VTV, 4 CV+OTV/3 VTV and 4 CV were 0.9700, 0.9971, 0.9983, 0.9929 and 0.9928 respectively. Conclusion: These results suggest a great diagnostic potential for fetal echocardiography detection as a reliable method of fetal congenital heart disease. But at least 3 sections view (4 CV, OTV and 3 VTV) should be included in scan protocol, while the STIC can be used to provide more information for local details of defects, and can not be used to make a definite diagnosis alone with its low specificity.	[Li, Yifei; Hua, Yimin; Wang, Chuan; Qiao, Lina; Wan, Chaomin; Mu, Dezhi; Zhou, Kaiyu] Sichuan Univ, West China Univ Hosp 2, Dept Pediat Cardiovasc Dis, Chengdu 610064, Sichuan, Peoples R China; [Li, Yifei; Hua, Yimin; Wang, Chuan; Qiao, Lina; Wan, Chaomin; Mu, Dezhi; Zhou, Kaiyu] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Women & Childrens Dis & Birth Defects, Chengdu 610064, Sichuan, Peoples R China; [Li, Yifei; Wang, Chuan] Sichuan Univ, West China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Hua, Yimin; Qiao, Lina; Wan, Chaomin; Mu, Dezhi; Zhou, Kaiyu] Sichuan Univ, West China Univ Hosp 2, Program Changjiang Scholars & Innovat Res Team Un, Chengdu 610064, Sichuan, Peoples R China; [Fang, Jie] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Zhou, KY (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat Cardiovasc Dis, Chengdu 610064, Sichuan, Peoples R China.	kaiyuzhou313@163.com			National Natural Science Foundation of China [81070136, 81270226]; Program for Yangtze River Scholars and Innovative Research Team in University [IRT0935]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Yangtze River Scholars and Innovative Research Team in University	This work was supported by grants from the National Natural Science Foundation of China (No. 81070136 and 81270226) and the Program for Yangtze River Scholars and Innovative Research Team in University (No. IRT0935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rustum RS, 2010, J ULTRAS MED, V29, P1445, DOI 10.7863/jum.2010.29.10.1445; Abu-Rustum RS, 2010, J ULTRAS MED, V29, P817, DOI 10.7863/jum.2010.29.5.817; ACHIRON R, 1992, BRIT MED J, V304, P671, DOI 10.1136/bmj.304.6828.671; ACHIRON R, 1994, J ULTRAS MED, V13, P783; ALLAN LD, 1989, INT J CARDIOL, V25, P279, DOI 10.1016/0167-5273(89)90218-0; Bakiler AR, 2007, FETAL DIAGN THER, V22, P241, DOI 10.1159/000100782; Becker R, 2006, ULTRASOUND OBST GYN, V27, P613, DOI 10.1002/uog.2709; Bennasar M, 2010, ULTRASOUND OBST GYN, V36, P458, DOI 10.1002/uog.7720; Bennasar M, 2009, ULTRASOUND OBST GYN, V33, P645, DOI 10.1002/uog.6374; Berghella V, 2001, FETAL DIAGN THER, V16, P407, DOI 10.1159/000053949; Bernard LS, 2009, ULTRASOUND OBST GYN, V33, P676, DOI 10.1002/uog.6302; BROMLEY B, 1992, AM J OBSTET GYNECOL, V166, P1473, DOI 10.1016/0002-9378(92)91622-H; Bronshtein M, 2003, AM J CARDIOL, V91, P903, DOI 10.1016/S0002-9149(03)00035-3; BRONSHTEIN M, 1993, OBSTET GYNECOL, V82, P225; Brown DL, 1997, J ULTRAS MED, V16, P95; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; Buskens E, 1996, OBSTET GYNECOL, V87, P423, DOI 10.1016/0029-7844(95)00439-4; Buskens E, 1996, CIRCULATION, V94, P67, DOI 10.1161/01.CIR.94.1.67; Carvalho JS, 2004, PRENATAL DIAG, V24, P1060, DOI 10.1002/pd.1063; Carvalho JS, 2004, HEART, V90, P921, DOI 10.1136/hrt.2003.015065; Carvalho JS, 2002, HEART, V88, P387, DOI 10.1136/heart.88.4.387; Carvalho JS, 1998, LANCET, V351, P1023, DOI 10.1016/S0140-6736(97)08406-7; Chew C, 2007, ULTRASOUND OBST GYN, V29, P619, DOI 10.1002/uog.4023; COPEL JA, 1987, AM J OBSTET GYNECOL, V157, P648, DOI 10.1016/S0002-9378(87)80022-4; Crane JM, 1997, ULTRASOUND OBST GYN, V10, P90, DOI 10.1046/j.1469-0705.1997.10020090.x; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Del Bianco A, 2006, J PERINAT MED, V34, P309, DOI 10.1515/JPM.2006.059; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; DeVore GR, 2005, J ULTRAS MED, V24, P1685, DOI 10.7863/jum.2005.24.12.1685; Divanovic A, 2011, J THORAC CARDIOV SUR, V141, P988, DOI 10.1016/j.jtcvs.2010.09.043; Duke C, 2001, AM J CARDIOL, V88, P1379, DOI 10.1016/S0002-9149(01)02117-8; EDWARDS MS, 1995, ULTRASOUND OBST GYN, V6, P43, DOI 10.1046/j.1469-0705.1995.06010043.x; Espinoza J, 2010, J ULTRAS MED, V29, P1573, DOI 10.7863/jum.2010.29.11.1573; Fernandez CO, 1998, CARDIOLOGY, V90, P202, DOI 10.1159/000006844; Gabriel CC, 2002, PRENATAL DIAG, V22, P586, DOI 10.1002/pd.372; Galindo A, 2003, J Matern Fetal Neonatal Med, V13, P163, DOI 10.1080/jmf.13.3.163.170; Garne E, 2005, ULTRASOUND OBST GYN, V25, P6, DOI 10.1002/uog.1784; Gelehrter Sarah, 2007, Congenit Heart Dis, V2, P32, DOI 10.1111/j.1747-0803.2007.00069.x; GEMBRUCH U, 1993, ULTRASOUND OBST GYN, V3, P310, DOI 10.1046/j.1469-0705.1993.03050310.x; Giancotti A., 1995, Clinical and Experimental Obstetrics and Gynecology, V22, P225; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Goncalves LF, 2006, J PERINAT MED, V34, P39, DOI 10.1515/JPM.2006.006; Goncalves LF, 2003, AM J OBSTET GYNECOL, V189, P1792, DOI 10.1016/S0002-9378(03)00913-X; Gottliebson WM, 2006, ULTRASOUND OBST GYN, V28, P15, DOI 10.1002/uog.2795; Grandjean H, 1999, AM J OBSTET GYNECOL, V181, P446, DOI 10.1016/S0002-9378(99)70577-6; Haak MC, 2002, ULTRASOUND OBST GYN, V20, P14, DOI 10.1046/j.1469-0705.2002.00739.x; Hafner E, 1998, PRENATAL DIAG, V18, P808, DOI 10.1002/(SICI)1097-0223(199808)18:8<808::AID-PD359>3.0.CO;2-K; Hartge DR, 2011, CARDIOL YOUNG, V21, P505, DOI 10.1017/S1047951111000345; Herberg U, 2011, ULTRASCHALL MED, V32, P293, DOI 10.1055/s-0029-1245281; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huggon IC, 2003, HEART, V89, P1071, DOI 10.1136/heart.89.9.1071; HUNG J-H, 1991, Fetal Diagnosis and Therapy, V6, P65; Khairy P, 2006, CIRCULATION, V113, P517, DOI 10.1161/CIRCULATIONAHA.105.589655; Khoo NS, 2008, AUST NZ J OBSTET GYN, V48, P559, DOI 10.1111/j.1479-828X.2008.00915.x; Kirk JS, 1997, OBSTET GYNECOL, V89, P227, DOI 10.1016/S0029-7844(96)00510-8; KIRK JS, 1994, OBSTET GYNECOL, V84, P427; Klein SK, 1999, PRENATAL DIAG, V19, P318, DOI 10.1002/(SICI)1097-0223(199904)19:4<318::AID-PD538>3.0.CO;2-X; Lagopoulos ME, 2010, AM HEART J, V160, P692, DOI 10.1016/j.ahj.2010.07.009; Leung MP, 1999, PRENATAL DIAG, V19, P305, DOI 10.1002/(SICI)1097-0223(199904)19:4<305::AID-PD535>3.3.CO;2-2; LEVI S, 1991, ULTRASOUND OBST GYN, V1, P102, DOI 10.1046/j.1469-0705.1991.01020102.x; Li H, 2007, CHINESE MED J-PEKING, V120, P1391, DOI 10.1097/00029330-200708020-00002; Machlitt A, 2004, ULTRASOUND OBST GYN, V24, P618, DOI 10.1002/uog.1750; Martin G R, 1990, J Am Soc Echocardiogr, V3, P4; McAuliffe FM, 2005, AM J OBSTET GYNECOL, V193, P1253, DOI 10.1016/j.ajog.2005.05.086; Meyer-Wittkopf M, 2001, ULTRASOUND OBST GYN, V17, P392, DOI 10.1046/j.1469-0705.2001.00381.x; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; NIMROD C, 1984, AM J OBSTET GYNECOL, V148, P516, DOI 10.1016/0002-9378(84)90738-5; Ogge G, 2006, ULTRASOUND OBST GYN, V28, P779, DOI 10.1002/uog.3830; OTT WJ, 1995, AM J OBSTET GYNECOL, V172, P1741, DOI 10.1016/0002-9378(95)91406-4; Ozkutlu S, 2005, TURKISH J PEDIATR, V47, P232; Ozkutlu S, 1999, TURKISH J PEDIATR, V41, P349; Ozkutlu S, 2010, ANADOLU KARDIYOL DER, V10, P263, DOI 10.5152/akd.2010.068; Paladini D, 2005, PRENATAL DIAG, V25, P403, DOI 10.1002/pd.1172; Paladini D, 2008, ULTRASOUND OBST GYN, V32, P865, DOI 10.1002/uog.6261; Parlakay AO, 2011, ANATOL J CARDIOL, V11, P627, DOI 10.5152/akd.2011.167; Pascal CJ, 2007, CARDIOL YOUNG, V17, P528, DOI 10.1017/S1047951107000728; Perolo A, 2001, ULTRASOUND OBST GYN, V18, P615, DOI 10.1046/j.0960-7692.2001.00586.x; Persico N, 2011, ULTRASOUND OBST GYN, V37, P296, DOI 10.1002/uog.8934; Plesinac Snezana, 2007, Int J Fertil Womens Med, V52, P89; Prakash A, 2010, CIRC-CARDIOVASC IMAG, V3, P112, DOI 10.1161/CIRCIMAGING.109.875021; Raboisson MJ, 2009, EUR J OBSTET GYN R B, V142, P18, DOI 10.1016/j.ejogrb.2008.09.001; Randall P, 2005, BJOG-INT J OBSTET GY, V112, P24, DOI 10.1111/j.1471-0528.2004.00295.x; Rasiah SV, 2006, ULTRASOUND OBST GYN, V28, P110, DOI 10.1002/uog.2803; Rizzo G, 2008, FETAL DIAGN THER, V24, P126, DOI 10.1159/000142142; Rizzo G, 2008, J ULTRAS MED, V27, P1071, DOI 10.7863/jum.2008.27.7.1071; Rizzo G, 2010, J ULTRAS MED, V29, P325, DOI 10.7863/jum.2010.29.2.325; RUSTICO MA, 1995, ULTRASOUND OBST GYN, V6, P313, DOI 10.1046/j.1469-0705.1995.06050313.x; Rustico MA, 2000, ULTRASOUND OBST GYN, V16, P614, DOI 10.1046/j.1469-0705.2000.00291.x; Rychik J, 1997, J Perinatol, V17, P183; Saxena Anita, 1995, Indian Journal of Pediatrics, V62, P575, DOI 10.1007/BF02761881; SHOLLER GF, 1986, MED J AUSTRALIA, V144, P250, DOI 10.5694/j.1326-5377.1986.tb115887.x; Simpson JM, 2000, BRIT J OBSTET GYNAEC, V107, P1492, DOI 10.1111/j.1471-0528.2000.tb11673.x; Skeels M, 2002, PEDIATR CARDIOL, V23, P594, DOI 10.1007/s00246-001-0073-4; Sklansky M, 2005, ULTRASOUND OBST GYN, V25, P435, DOI 10.1002/uog.1858; Sklansky MS, 2009, J ULTRAS MED, V28, P889, DOI 10.7863/jum.2009.28.7.889; SMITH RS, 1995, OBSTET GYNECOL, V85, P187, DOI 10.1016/0029-7844(94)00350-M; Smrcek JM, 2006, J ULTRAS MED, V25, P187, DOI 10.7863/jum.2006.25.2.187; Stefos T, 1999, J Matern Fetal Med, V8, P64; Strauss A, 2001, EUR J MED RES, V6, P66; Stumpflen I, 1996, LANCET, V348, P854, DOI 10.1016/S0140-6736(96)04069-X; Tegnander E, 2006, ULTRASOUND OBST GYN, V27, P252, DOI 10.1002/uog.2710; ter Heide H, 2004, HEART, V90, P916, DOI 10.1136/hrt.2003.018895; Todros T, 1997, PRENATAL DIAG, V17, P901, DOI 10.1002/(SICI)1097-0223(199710)17:10<901::AID-PD171>3.3.CO;2-Q; Tometzki AJP, 1999, J AM COLL CARDIOL, V33, P1696, DOI 10.1016/S0735-1097(99)00049-2; Tongsong T, 2010, PRENATAL DIAG, V30, P23, DOI 10.1002/pd.2404; Tworetzky W, 2001, CIRCULATION, V103, P1269, DOI 10.1161/01.cir.103.9.1269; Uittenbogaard LB, 2008, ULTRASOUND OBST GYN, V31, P625, DOI 10.1002/uog.5351; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; VERGANI P, 1992, AM J OBSTET GYNECOL, V167, P1000, DOI 10.1016/S0002-9378(12)80027-5; Verheijen PM, 2001, J THORAC CARDIOV SUR, V121, P798, DOI 10.1067/mtc.2001.112825; Vesel S, 2006, HEART, V92, P1501, DOI 10.1136/hrt.2005.083295; Vinals F, 2003, ULTRASOUND OBST GYN, V22, P388, DOI 10.1002/uog.883; Vinals F, 2002, ULTRASOUND OBST GYN, V19, P246, DOI 10.1046/j.1469-0705.2002.00651.x; Volpe P, 2006, ULTRASOUND OBST GYN, V28, P40, DOI 10.1002/uog.2818; Volpe P, 2010, ULTRASOUND OBST GYN, V35, P302, DOI 10.1002/uog.7530; Volpe P, 2012, J ULTRAS MED, V31, P563, DOI 10.7863/jum.2012.31.4.563; Wan AW, 2009, AM J CARDIOL, V104, P1276, DOI 10.1016/j.amjcard.2009.06.047; Weiner Z, 2002, J ULTRAS MED, V21, P23, DOI 10.7863/jum.2002.21.1.23; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WIGTON TR, 1993, OBSTET GYNECOL, V82, P219; WILSON NJ, 1994, NEW ZEAL MED J, V107, P258; Wong KKL, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412500248; Wong KKL, 2012, COMPUT MED IMAG GRAP, V36, P527, DOI 10.1016/j.compmedimag.2012.04.003; Wong KKL, 2009, J MECH MED BIOL, V9, P1, DOI 10.1142/S0219519409002894; Wong KKL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005688; Wong SF, 2007, ULTRASOUND OBST GYN, V30, P275, DOI 10.1002/uog.4105; Wong SF, 2003, ULTRASOUND OBST GYN, V21, P19, DOI 10.1002/uog.7; Wu HM, 2012, ECHOCARDIOGR-J CARD, V29, P614, DOI 10.1111/j.1540-8175.2011.01639.x; Wu QQ, 2009, J ULTRAS MED, V28, P1319, DOI 10.7863/jum.2009.28.10.1319; Yagel S, 2006, ULTRASOUND OBST GYN, V28, P266, DOI 10.1002/uog.2843; Yagel S, 2011, ULTRASOUND OBST GYN, V37, P432, DOI 10.1002/uog.8867; Yeu BK, 2008, FETAL DIAGN THER, V24, P241, DOI 10.1159/000151669; Zabadneh N, 2011, PEDIATR CARDIOL, V32, P724, DOI 10.1007/s00246-011-9977-9; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhou QC, 2005, CHINESE MED J-PEKING, V118, P1791; Zosmer N, 1999, BRIT J OBSTET GYNAEC, V106, P829, DOI 10.1111/j.1471-0528.1999.tb08405.x	137	25	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65484	10.1371/journal.pone.0065484	http://dx.doi.org/10.1371/journal.pone.0065484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750263	Green Submitted, Green Published, gold			2022-12-27	WOS:000319961900065
J	Wu, RD; Zhu, LL; Li, W; Tang, Q; Pan, FS; Wu, WB; Liu, J; Yao, C; Wang, SM				Wu, Ridong; Zhu, Liling; Li, Wen; Tang, Qing; Pan, Fushun; Wu, Weibin; Liu, Jie; Yao, Chen; Wang, Shenming			External Validation of a Nomogram That Predicts the Pathological Diagnosis of Thyroid Nodules in a Chinese Population	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; SONOGRAPHIC CRITERIA; GRAY-SCALE; MALIGNANCY; CANCER; MODEL; ULTRASONOGRAPHY; ULTRASOUND; US; PERFORMANCE	Introduction: Nomograms are statistical predictive models that can provide the probability of a clinical event. Nomograms have better performance for the estimation of individual risks because of their increased accuracy and objectivity relative to physicians' personal experiences. Recently, a nomogram for predicting the likelihood that a thyroid nodule is malignant was introduced by Nixon. The aim of this study was to determine whether Nixon's nomogram can be validated in a Chinese population. Materials and Methods: All consecutive patients with thyroid nodules who underwent surgery between January and June 2012 in our hospital were enrolled to validate Nixon's nomogram. Univariate and multivariate analyses were used to identify the risk factors for thyroid carcinoma. Discrimination and calibration were employed to evaluate the performance of Nixon's model in our population. Results: A total of 348 consecutive patients with 409 thyroid nodules were enrolled. Thyroid ultrasonographic characteristics, including shape, echo texture, calcification, margins, vascularity and number (solitary vs. multiple nodules), were associated with malignance in the multivariate analysis. The discrimination of all nodules group, the group with a low risk of malignancy (predictive proportion <50%) and the group with a high risk of malignancy (predictive proportion >= 50%) using Nixon's nomogram was satisfactory, and the area under the receiver operating characteristic curve of the three groups were 0.87, 0.75 and 0.72, respectively. However, the calibration was significant (p = 0.55) only in the high-risk group. Conclusion: Nixon's nomogram is a valuable predictive model for the Chinese population and has been externally validated. It has good performance for patients with a high risk of malignancy and may be more suitable for use with these patients in China.	[Wu, Ridong; Wu, Weibin; Yao, Chen; Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc & Thyroid Surg, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Liling] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Breast Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Li, Wen] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gen Surg Lab, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Qing; Liu, Jie] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Plast & Reconstruct Surg, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Fushun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Ultrason, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yao, C (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc & Thyroid Surg, Guangzhou 510275, Guangdong, Peoples R China.	skywalker_chenyao@yahoo.com.cn; shenmingwang@hotmail.com						Abu-Rustum NR, 2010, GYNECOL ONCOL, V116, P399, DOI 10.1016/j.ygyno.2009.11.027; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Appetecchia M, 2006, HORM RES, V66, P249, DOI 10.1159/000096013; Banks ND, 2008, THYROID, V18, P933, DOI 10.1089/thy.2008.0108; Boelaert K, 2006, J CLIN ENDOCR METAB, V91, P4295, DOI 10.1210/jc.2006-0527; Cappelli C, 2007, QJM-INT J MED, V100, P29, DOI 10.1093/qjmed/hcl121; Cappelli C, 2005, CLIN ENDOCRINOL, V63, P689, DOI 10.1111/j.1365-2265.2005.02406.x; Cong SZ, 2012, EUR J RADIOL, V81, P1806, DOI 10.1016/j.ejrad.2011.02.070; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Frates MC, 2006, J CLIN ENDOCR METAB, V91, P3411, DOI 10.1210/jc.2006-0690; Frates Mary C, 2006, Ultrasound Q, V22, P231; Gerschpacher M, 2010, THYROID, V20, P389, DOI 10.1089/thy.2009.0139; HAMBERGER B, 1982, AM J MED, V73, P381, DOI 10.1016/0002-9343(82)90731-8; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Lienart F, 2011, Rev Med Brux, V32, P445; Maia FFR, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-17; Moon HJ, 2012, RADIOLOGY, V262, P1002, DOI 10.1148/radiol.11110839; Moon HJ, 2010, RADIOLOGY, V255, P260, DOI 10.1148/radiol.09091284; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Nixon IJ, 2013, HEAD NECK-J SCI SPEC, V35, P1022, DOI 10.1002/hed.23075; Nixon IJ, 2010, SURGERY, V148, P1120, DOI 10.1016/j.surg.2010.09.030; Ozel A, 2012, MED ULTRASON, V14, P24; Paschke R, 2011, NAT REV ENDOCRINOL, V7, P354, DOI 10.1038/nrendo.2011.1; Phuttharak W, 2009, ASIAN PAC J CANCER P, V10, P759; Polterauer S, 2012, GYNECOL ONCOL, V125, P526, DOI 10.1016/j.ygyno.2012.03.030; Qiao LingYan, 2010, Journal of Shandong University (Health Sciences), V48, P5; Rago T, 2010, EUR J ENDOCRINOL, V162, P763, DOI 10.1530/EJE-09-0895; Rago T, 2001, J ENDOCRINOL INVEST, V24, P770, DOI 10.1007/BF03343926; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Sternberg CN, 2006, J CLIN ONCOL, V24, P3819, DOI 10.1200/JCO.2006.07.1290; Stojadinovic A, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-12; Tomei S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-396; Welker MJ, 2003, AM FAM PHYSICIAN, V67, P559; Yuan J, 2011, CHIN FOREIGN MED RES, V9, P74; Yunus M, 2010, J PAK MED ASSOC, V60, P848; Zhou S, 2011, CHIN J CLIN ELECT ED, V5, P903	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65162	10.1371/journal.pone.0065162	http://dx.doi.org/10.1371/journal.pone.0065162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750241	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900043
J	Yang, Y; Shiao, C; Hemingway, JF; Jorstad, NL; Shalloway, BR; Chang, R; Keene, CD				Yang, Yue; Shiao, Christine; Hemingway, Jake Frederick; Jorstad, Nikolas L.; Shalloway, Bryan Richard; Chang, Rubens; Keene, C. Dirk			Suppressed Retinal Degeneration in Aged Wild Type and APP swe/PS1 Delta E9 Mice by Bone Marrow Transplantation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BETA-AMYLOID DEPOSITION; RADIATION-INDUCED APOPTOSIS; ALZHEIMERS-DISEASE; TAU-HYPERPHOSPHORYLATION; COGNITIVE IMPAIRMENT; HEMATOPOIETIC-CELLS; PRECURSOR-PROTEIN; GANGLION-CELLS; MOUSE MODEL	Alzheimer's disease (AD) is an age-related condition characterized by accumulation of neurotoxic amyloid beta peptides (A beta) in brain and retina. Because bone marrow transplantation (BMT) results in decreased cerebral A beta in experimental AD, we hypothesized that BMT would mitigate retinal neurotoxicity through decreased retinal A beta. To test this, we performed BMT in APPswe/PS1 Delta E9 double transgenic mice using green fluorescent protein expressing wild type (wt) mice as marrow donors. We first examined retinas from control, non-transplanted, aged AD mice and found a two-fold increase in microglia compared with wt mice, prominent inner retinal A beta and paired helical filament-tau, and decreased retinal ganglion cell layer neurons. BMT resulted in near complete replacement of host retinal microglia with BMT-derived cells and normalized total AD retinal microglia to non-transplanted wt levels. A beta and paired helical filament-tau were reduced (61.0% and 44.1% respectively) in BMT-recipient AD mice, which had 20.8% more retinal ganglion cell layer neurons than non-transplanted AD controls. Interestingly, aged wt BMT recipients also had significantly more neurons (25.4%) compared with non-transplanted aged wt controls. Quantitation of retinal ganglion cell layer neurons in young mice confirmed age-related retinal degeneration was mitigated by BMT. We found increased MHC class II expression in BMT-derived microglia and decreased oxidative damage in retinal ganglion cell layer neurons. Thus, BMT is neuroprotective in age-related as well as AD-related retinal degeneration, and may be a result of alterations in innate immune function and oxidative stress in BMT recipient mice.	[Yang, Yue; Shiao, Christine; Hemingway, Jake Frederick; Jorstad, Nikolas L.; Shalloway, Bryan Richard; Chang, Rubens; Keene, C. Dirk] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Keene, CD (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	cdkeene@uw.edu	Keene, Christopher D/N-1806-2015	Jorstad, Nikolas/0000-0001-7906-9470; Keene, Christopher/0000-0002-5291-1469	National Institutes of Health [P50AG05136, T32AG000258, R01AG024011]; Nancy and Buster Alvord Endowed Chair in Neuropathology; NATIONAL INSTITUTE ON AGING [T32AG000258, P50AG005136, R01AG024011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy and Buster Alvord Endowed Chair in Neuropathology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants P50AG05136, T32AG000258, R01AG024011 and the Nancy and Buster Alvord Endowed Chair in Neuropathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; BLANKS JC, 1989, BRAIN RES, V501, P364, DOI 10.1016/0006-8993(89)90653-7; Blanks JC, 1996, NEUROBIOL AGING, V17, P385, DOI 10.1016/0197-4580(96)00009-7; Boettcher C, 2008, BRIT J OPHTHALMOL, V92, P272, DOI 10.1136/bjo.2007.126318; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borges HL, 2004, CELL DEATH DIFFER, V11, P494, DOI 10.1038/sj.cdd.4401366; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; CURCIO CA, 1993, ANN NEUROL, V33, P248, DOI 10.1002/ana.410330305; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Danesh-Meyer HV, 2006, NEUROLOGY, V67, P1852, DOI 10.1212/01.wnl.0000244490.07925.8b; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Frautschy SA, 1998, AM J PATHOL, V152, P307; Golde TE, 2003, J CLIN INVEST, V111, P11, DOI 10.1172/JCI200317527; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Gomez-Isla Teresa, 2008, Handb Clin Neurol, V89, P233, DOI 10.1016/S0072-9752(07)01222-5; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Guo L, 2010, CURR ALZHEIMER RES, V7, P3, DOI 10.2174/156720510790274491; Gupta N, 2008, CAN J OPHTHALMOL, V43, P53, DOI 10.3129/i07-185; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harwerth RS, 2008, INVEST OPHTH VIS SCI, V49, P4437, DOI 10.1167/iovs.08-1753; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Herzog KH, 2007, EUR J NEUROSCI, V25, P1349, DOI 10.1111/j.1460-9568.2007.05381.x; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Igarashi T, 2007, CURR EYE RES, V32, P543, DOI 10.1080/02713680701389333; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Jackson GR, 2003, NEUROL CLIN, V21, P709, DOI 10.1016/S0733-8619(02)00107-X; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Keene CD, 2010, AM J PATHOL, V177, P346, DOI 10.2353/ajpath.2010.090840; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Keri S, 1999, VISION RES, V39, P2261, DOI 10.1016/S0042-6989(98)00310-1; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lei Y, 2011, BRIT J OPHTHALMOL, V95, P727, DOI 10.1136/bjo.2010.180869; Leinonen V, 2010, ANN NEUROL, V68, P446, DOI 10.1002/ana.22100; Liu BQ, 2009, AM J PATHOL, V175, P2099, DOI 10.2353/ajpath.2009.090159; LOFFLER KU, 1995, INVEST OPHTH VIS SCI, V36, P24; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; MILLER NR, 1990, OPHTHALMOLOGY, V97, P7; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Otani A, 2012, AM J PATHOL, V180, P328, DOI 10.1016/j.ajpath.2011.09.025; Otth C, 2002, J ALZHEIMERS DIS, V4, P417, DOI 10.3233/JAD-2002-4508; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Quinn JF, 2007, NEUROBIOL AGING, V28, P213, DOI 10.1016/j.neurobiolaging.2005.12.014; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Schmidt SL, 2001, INT J DEV NEUROSCI, V19, P469, DOI 10.1016/S0736-5748(00)00068-X; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Tetewsky SJ, 1999, NEUROLOGY, V52, P958, DOI 10.1212/WNL.52.5.958; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Walsh DT, 2005, NEUROPATH APPL NEURO, V31, P491, DOI 10.1111/j.1365-2990.2005.00666.x; Wang AL, 2010, NEUROBIOL AGING, V31, P2002, DOI 10.1016/j.neurobiolaging.2008.10.019; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Yin YQ, 2003, J NEUROSCI, V23, P2284	80	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64246	10.1371/journal.pone.0064246	http://dx.doi.org/10.1371/journal.pone.0064246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750207	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900009
J	Zhou, LR; Hosohata, K; Gao, S; Gu, ZP; Wang, ZX				Zhou, Liran; Hosohata, Keiko; Gao, Shen; Gu, Zhongping; Wang, Zhengxin			cGMP-Dependent Protein Kinase I beta Interacts with p44/WDR77 to Regulate Androgen Receptor- Driven Gene Expression	PLOS ONE			English	Article							PROSTATIC INTRAEPITHELIAL NEOPLASIA; SMOOTH-MUSCLE; CANCER CELLS; MEDIATED TRANSCRIPTION; SIGNAL-TRANSDUCTION; MOLECULAR-BIOLOGY; INDUCE APOPTOSIS; MICE LACKING; COFACTOR P44; G ACTIVATION	The androgen receptor (AR) pathway plays critical roles in controlling differentiation and proliferation of prostate epithelial cells. We previously identified a novel AR cofactor, p44/WDR77, which specifically enhances AR transcriptional activity in the prostate gland and prostate cancer. To further elucidate p44/WDR77's role in the AR signaling pathway, we conducted a yeast two-hybrid screening and identified cGMP-dependent protein kinase (PKG) as a p44/WDR77-interacting protein. Further investigation by lusiferase assay and kinase assay demonstrated that PKG-I beta physically interacted with and phosphorylated both p44 and AR and enhanced AR transactivity in synergy with p44 in an androgen-and cGMP-dependent manner. Furthermore, PKG1 beta expression promoted p44/WDR77 nuclear translocation and inhibited prostate cancer cell growth via G1 cell cycle arrest. Our findings characterize PKG as a novel regulator of AR-mediated transcription by enhancing AR cofactor p44/WDR77's function, which provide a novel mechanism for the growth regulation of prostate cancer cells by the androgen signaling.	[Zhou, Liran; Hosohata, Keiko; Gao, Shen; Gu, Zhongping; Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Wang, ZX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	zhenwang@mdanderson.org			National Institute of Diabetes and Digestive and Kidney Diseases [1R01 DK065156 01]; National Institutes of Health; Cancer Center Support Core grant [CA16672]; National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065156] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Core grant; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant (1R01 DK065156 01) to Z. W. from the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Health and by a Cancer Center Support Core grant (CA16672) to The University of Texas M. D. Anderson Cancer Center from the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz A, 2001, PROSTATE, V47, P29; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Birschmann I, 2004, ACTA BIOCHIM POL, V51, P397; Brinkmann A, 1999, J STEROID BIOCH MOL, V69; Busch JL, 2002, J BIOL CHEM, V277, P34048, DOI 10.1074/jbc.M202761200; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chatterjee B, 2003, MOL CELL BIOCHEM, V253, P89, DOI 10.1023/A:1026057402945; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; Deguchi A, 2002, MOL CANCER THER, V1, P803; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Foster CS, 2000, SCAND J UROL NEPHROL, V34, P19, DOI 10.1080/003655900750169284; Francis SH, 2002, FRONT BIOSCI-LANDMRK, V7, pD580, DOI 10.2741/francis; Fukumoto S, 1999, CIRC RES, V85, P985; Gao S, 2004, PROSTATE, V59, P214, DOI 10.1002/pros.10375; Gao S, 2010, ENDOCRINOLOGY, V151, P3941, DOI 10.1210/en.2009-1080; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gertzberg N, 2000, AM J RESP CELL MOL, V22, P105, DOI 10.1165/ajrcmb.22.1.3801; GLYNN RJ, 1985, AM J EPIDEMIOL, V121, P78; Goluboff ET, 2001, EXPERT OPIN INV DRUG, V10, P1875, DOI 10.1517/13543784.10.10.1875; Goluboff ET, 1999, UROLOGY, V53, P440, DOI 10.1016/S0090-4295(98)00513-5; Gu Z., 2012, ONCOGENE; Gu ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022395; Gudi T, 1996, J BIOL CHEM, V271, P4597; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Haanen C, 2001, Curr Opin Investig Drugs, V2, P677; Hayward SW, 1996, ACTA ANAT, V155, P81; He B, 2003, EUR J BIOCHEM, V270, P2174, DOI 10.1046/j.1432-1033.2003.03574.x; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hou YL, 2006, CANCER LETT, V240, P60, DOI 10.1016/j.canlet.2005.08.035; Huang Y, 2001, CANCER RES, V61, P6918; Jenster G, 1999, SEMIN ONCOL, V26, P407; KELLOKUMPULEHTINEN P, 1985, BIOL NEONATE, V48, P157; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Kish J A, 2001, Cancer Control, V8, P487; Lim JTE, 1999, BIOCHEM PHARMACOL, V58, P1097, DOI 10.1016/S0006-2952(99)00200-2; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Liu GZ, 2003, J BIOL CHEM, V278, P14956, DOI 10.1074/jbc.M212229200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MCNEAL JE, 1988, AM J SURG PATHOL, V12, P619, DOI 10.1097/00000478-198808000-00003; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Ryan CW, 2005, BJU INT, V95, P963, DOI 10.1111/j.1464-410X.2005.05448.x; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Sakr WA, 2001, UROLOGY, V57, P115, DOI 10.1016/S0090-4295(00)00953-5; SAKR WA, 1995, PATHOL RES PRACT, V191, P838, DOI 10.1016/S0344-0338(11)80965-9; Smolenski A, 1998, N-S ARCH PHARMACOL, V358, P134, DOI 10.1007/PL00005234; Soh JW, 2001, J BIOL CHEM, V276, P16406, DOI 10.1074/jbc.C100079200; Swerdloff RS, 2004, BEST PRACT RES CL EN, V18, P349, DOI 10.1016/j.beem.2004.03.011; Taylor MK, 2002, J BIOL CHEM, V277, P37242, DOI 10.1074/jbc.M202060200; Thompson HJ, 1997, CANCER RES, V57, P267; Thompson WJ, 2000, CANCER RES, V60, P3338; TIMMS BG, 1994, J UROLOGY, V151, P1427, DOI 10.1016/S0022-5347(17)35273-4; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Wang G, 2006, ONCOGENE; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062; Zhu B, 2005, J CELL BIOCHEM, V94, P336, DOI 10.1002/jcb.20286	69	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63119	10.1371/journal.pone.0063119	http://dx.doi.org/10.1371/journal.pone.0063119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755100	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300006
J	Budnik, LT; Kloth, S; Baur, X; Preisser, AM; Schwarzenbach, H				Budnik, Lygia T.; Kloth, Stefan; Baur, Xaver; Preisser, Alexandra M.; Schwarzenbach, Heidi			Circulating Mitochondrial DNA as Biomarker Linking Environmental Chemical Exposure to Early Preclinical Lesions Elevation of mtDNA in Human Serum after Exposure to Carcinogenic Halo-Alkane-Based Pesticides	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; PROSTATE-CANCER; METHYL-BROMIDE; AGRICULTURAL PESTICIDES; GLUTATHIONE DEPLETION; NUCLEIC-ACIDS; COPY NUMBER; BONE-MARROW; MICRONUCLEI; HEALTH	There is a need for a panel of suitable biomarkers for detection of environmental chemical exposure leading to the initiation or progression of degenerative diseases or potentially, to cancer. As the peripheral blood may contain increased levels of circulating cell-free DNA in diseased individuals, we aimed to evaluate this DNA as effect biomarker recognizing vulnerability after exposure to environmental chemicals. We recruited 164 individuals presumably exposed to halo-alkane-based pesticides. Exposure evaluation was based on human biomonitoring analysis; as biomarker of exposure parent halo-methanes, -ethanes and their metabolites, as well as the hemoglobin-adducts methyl valine and hydroxyl ethyl valine in blood were used, complemented by expert evaluation of exposure and clinical intoxication symptoms as well as a questionnaire. Assessment showed exposures to halo alkanes in the concentration range being higher than non-cancer reference doses (RfD) but (mostly) lower than the occupational exposure limits. We quantified circulating DNA in serum from 86 individuals with confirmed exposure to off-gassing halo-alkane pesticides (in storage facilities or in home environment) and 30 non-exposed controls, and found that exposure was significantly associated with elevated serum levels of circulating mitochondrial DNA (in size of 79 bp, mtDNA-79, p = 0.0001). The decreased integrity of mtDNA (mtDNA-230/mtDNA-79) in exposed individuals implicates apoptotic processes (p = 0.015). The relative amounts of mtDNA-79 in serum were positively associated with the lag-time after intoxication to these chemicals (r = 0.99, p < 0.0001). Several months of post-exposure the specificity of this biomarker increased from 30% to 97% in patients with intoxication symptoms. Our findings indicate that mitochondrial DNA has a potential to serve as a biomarker recognizing vulnerable risk groups after exposure to toxic/carcinogenic chemicals.	[Budnik, Lygia T.; Kloth, Stefan; Baur, Xaver; Preisser, Alexandra M.] Univ Hamburg, Sch Med, Dept Occupat Hlth, Inst Occupat & Maritime Med, Hamburg, Germany; [Baur, Xaver] Charite Sch Med, Campus Benjamin Franklin, Inst Occupat Med, Berlin, Germany; [Baur, Xaver] Haukeland Hosp, Norwegian Ctr Maritime Med, N-5021 Bergen, Norway; [Schwarzenbach, Heidi] Univ Hamburg, Sch Med, Dept Tumor Biol, Hamburg, Germany	University of Hamburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bergen; Haukeland University Hospital; University of Hamburg	Budnik, LT (corresponding author), Univ Hamburg, Sch Med, Dept Occupat Hlth, Inst Occupat & Maritime Med, Hamburg, Germany.	L.Budnik@uke.uni-hamburg.de			Erich and Gertrud Roggenbuck Foundation, Hamburg, Germany; Hamburg Foundation for Fight against Cancer	Erich and Gertrud Roggenbuck Foundation, Hamburg, Germany; Hamburg Foundation for Fight against Cancer	This study was founded by the research grant from Erich and Gertrud Roggenbuck Foundation, Hamburg, Germany (to LTB, XB) and Hamburg Foundation for Fight against Cancer (to LTB). The study is also a part of the WHO-GPA collaborating project "New chemical health risk hazards in transportation and warehousing of cargo due to the process of globalization" (LTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavanja MCR, 2003, AM J EPIDEMIOL, V157, P800, DOI 10.1093/aje/kwg040; Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; *ATSDR CDCP, 2001, TOX SUBST PORT 1 2 D; Bolognesi C, 2012, NAT PROTOC, V7, P1125, DOI 10.1038/nprot.2012.043; BOLT HM, 1993, CRIT REV TOXICOL, V23, P237, DOI 10.3109/10408449309105011; Bonassi S, 2000, CANCER RES, V60, P1619; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; BOOKMAN EB, 2011, GENET EPIDEMIOL, DOI DOI 10.1002/GEPI.20571.[; Budnik LT, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-5; Budnik LT, 2010, J ENVIRON MONITOR, V12, P936, DOI 10.1039/b918428g; Carugno M, 2012, ENVIRON HEALTH PERSP, V120, P210, DOI 10.1289/ehp.1103979; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Cockburn M, 2011, AM J EPIDEMIOL, V173, P1280, DOI 10.1093/aje/kwr003; Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3; Cooper GS, 2011, INT J ENV RES PUB HE, V8, P3380, DOI 10.3390/ijerph8083380; DEKANT W, 1990, ENVIRON HEALTH PERSP, V88, P107, DOI 10.2307/3431059; *DFG, 2012, SEN COMM INV HLTH HA; Ellinger J, 2008, BJU INT, V102, P628, DOI 10.1111/j.1464-410X.2008.07613.x; Ellinger J, 2011, UROL ONCOL-SEMIN ORI, V29, P124, DOI 10.1016/j.urolonc.2009.05.010; Evans MD, 2010, FASEB J, V24, P1249, DOI 10.1096/fj.09-147124; Fahrenholtz S, 2010, J CHROMATOGR A, V1217, P8298, DOI 10.1016/j.chroma.2010.10.085; Fonnum F, 2004, J NEUROCHEM, V88, P513, DOI 10.1046/j.1471-4159.2003.02211.x; Goessl C, 2002, EUR UROL, V41, P668, DOI 10.1016/S0302-2838(02)00126-4; Gunier RB, 2001, ENVIRON HEALTH PERSP, V109, P1071, DOI 10.2307/3454963; HALLIER E, 1990, INT ARCH OCC ENV HEA, V62, P221, DOI 10.1007/BF00379437; Heinrich-Ramm R, 2002, INT J HYG ENVIR HEAL, V205, P493, DOI 10.1078/1438-4639-00173; KLAUNIG JE, 1986, ENVIRON HEALTH PERSP, V69, P89, DOI 10.2307/3430375; Lee S, 2002, ENVIRON HEALTH PERSP, V110, P1175, DOI 10.1289/ehp.021101175; Lucero L, 2000, MUTAT RES-GEN TOX EN, V464, P255, DOI 10.1016/S1383-5718(99)00200-4; Marczynski B, 2000, MUTAT RES-GEN TOX EN, V468, P203, DOI 10.1016/S1383-5718(00)00054-1; Mehra N, 2007, CLIN CANCER RES, V13, P421, DOI 10.1158/1078-0432.CCR-06-1087; Migliore L, 2002, MUTAT RES-REV MUTAT, V512, P135, DOI 10.1016/S1383-5742(02)00046-7; Motulski H.J., 1999, ANAL DATA GRAPHPAD P; Muller M, 1999, TOXICOL LETT, V107, P155, DOI 10.1016/S0378-4274(99)00042-9; Ohta S, 2006, ONCOGENE, V25, P4768, DOI 10.1038/sj.onc.1209602; Pastor S, 2003, MUTAGENESIS, V18, P249, DOI 10.1093/mutage/18.3.249; Preisser AM, 2011, SCI TOTAL ENVIRON, V409, P3106, DOI 10.1016/j.scitotenv.2011.04.053; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Schwarzenbach H, 2007, INT J CANCER, V120, P1465, DOI 10.1002/ijc.22470; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Schwarzenbach H, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2404; Shen M, 2008, ENVIRON MOL MUTAGEN, V49, P453, DOI 10.1002/em.20402; *UN FAO, 2007, GUID REG WOOD PACK M; Vlassov VV, 2007, BIOESSAYS, V29, P654, DOI 10.1002/bies.20604; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447	48	35	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64413	10.1371/journal.pone.0064413	http://dx.doi.org/10.1371/journal.pone.0064413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741329	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900041
J	Murugesan, S; Goldberg, EB; Dou, E; Brown, WJ				Murugesan, Sricharan; Goldberg, Elysa B.; Dou, Eda; Brown, William J.			Identification of Diverse Lipid Droplet Targeting Motifs in the PNPLA Family of Triglyceride Lipases	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; HORMONE-SENSITIVE LIPASE; HEPATITIS-C VIRUS; STORAGE DISEASE; PERILIPIN-A; TERMINAL REGION; ADIPOSE-TISSUE; CELL BIOLOGY; LIPOLYSIS; FAT	Members of the Patatin-like Phospholipase Domain containing Protein A (PNPLA) family play key roles in triglyceride hydrolysis, energy metabolism, and lipid droplet (LD) homoeostasis. Here we report the identification of two distinct LD targeting motifs (LTM) for PNPLA family members. Transient transfection of truncated versions of human adipose triglyceride lipase (ATGL, also known as PNPLA2), PNPLA3/adiponutrin, or PNPLA5 (GS2-like) fused to GFP revealed that the C-terminal third of these proteins contains sequences that are sufficient for targeting to LDs. Furthermore, fusing the C-termini of PNPLA3 or PNPLA5 confers LD localization to PNPLA4, which is otherwise cytoplasmic. Analyses of additional mutants in ATGL, PNPLA5, and Brummer Lipase, the Drosophila homolog of mammalian ATGL, identified two different types of LTMs. The first type, in PNPLA5 and Brummer lipase, is a set of loosely conserved basic residues, while the second type, in ATGL, is contained within a stretch of hydrophobic residues. These results show that even closely related members of the PNPLA family employ different molecular motifs to associate with LDs.	[Murugesan, Sricharan; Goldberg, Elysa B.; Dou, Eda; Brown, William J.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Cornell University	Brown, WJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	wjb5@cornell.edu	Brown, William/GXN-2777-2022	Murugesan, Sricharan/0000-0003-3045-3513	National Institutes of Health [DK51596]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK051596, R01DK051596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding came from National Institutes of Health grant DK51596 (WJB) http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Bartz R, 2007, MOL BIOL CELL, V18, P3015, DOI 10.1091/mbc.E06-09-0869; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Campagna F, 2008, BIOCHEM BIOPH RES CO, V377, P843, DOI 10.1016/j.bbrc.2008.10.081; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Ellong EN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021889; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7; Gao JG, 2006, J INVEST DERMATOL, V126, P2087, DOI 10.1038/sj.jid.5700327; Garcia A, 2003, J BIOL CHEM, V278, P625, DOI 10.1074/jbc.M206602200; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; Granneman JG, 2011, J ANIM SCI, V89, P701, DOI 10.2527/jas.2010-3370; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Hsieh K, 2012, J CELL SCI, V125, P4067, DOI 10.1242/jcs.104943; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Ingelmo-Torres M, 2009, TRAFFIC, V10, P1785, DOI 10.1111/j.1600-0854.2009.00994.x; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MURUGESAN S, DIFFERENTIAL L UNPUB; Nakamura N, 2003, BIOCHEM BIOPH RES CO, V306, P333, DOI 10.1016/S0006-291X(03)00979-3; Oberer M, 2011, CURR OPIN LIPIDOL, V22, P149, DOI 10.1097/MOL.0b013e328346230e; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Prieto ED, 2011, BIOCHEMISTRY-US, V50, P466, DOI 10.1021/bi1009634; Reue K, 2011, J LIPID RES, V52, P1865, DOI 10.1194/jlr.E020602; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Schweiger M, 2012, J LIPID RES; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Stapleton M., 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0080, DOI 10.1186/GB-2002-3-12-RESEARCH0080]; Stottrup BL, 2006, BIOPHYS J, V90, P3176, DOI 10.1529/biophysj.105.072959; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Takashima K, 2011, CELL STRUCT FUNCT, V36, P223, DOI 10.1247/csf.11035; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Yamaguchi T, 2010, BIOL PHARM BULL, V33, P342, DOI 10.1248/bpb.33.342; Yang XY, 2013, MOL ENDOCRINOL, V27, P116, DOI 10.1210/me.2012-1178; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zechner R, 2009, NATURE, V458, P1118, DOI 10.1038/4581118a; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	75	30	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64950	10.1371/journal.pone.0064950	http://dx.doi.org/10.1371/journal.pone.0064950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741432	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900145
J	Nock, CA; Greene, D; Delagrange, S; Follett, M; Fournier, R; Messier, C				Nock, Charles A.; Greene, David; Delagrange, Sylvain; Follett, Matt; Fournier, Richard; Messier, Christian			In Situ Quantification of Experimental Ice Accretion on Tree Crowns Using Terrestrial Laser Scanning	PLOS ONE			English	Article							STORM DAMAGE; SOUTHWESTERN VIRGINIA; HARDWOOD FOREST; BREAKAGE; CLIMATE	In the eastern hardwood forests of North America ice storms are an important disturbance event. Ice storms strongly influence community dynamics as well as urban infrastructure via catastrophic branch failure; further, the severity and frequency of ice storms are likely to increase with climate change. However, despite a long-standing interest into the effects of freezing rain on forests, the process of ice accretion and thus ice loading on branches remains poorly understood. This is because a number of challenges have prevented in situ measurements of ice on branches, including: 1) accessing and measuring branches in tall canopies, 2) limitations to travel during and immediately after events, and 3) the unpredictability of ice storms. Here, utilizing a novel combination of outdoor experimental icing, manual measurements and terrestrial laser scanning (TLS), we perform the first in situ measurements of ice accretion on branches at differing heights in a tree crown and with increasing duration of exposure. We found that TLS can reproduce both branch and iced branch diameters with high fidelity, but some TLS instruments do not detect ice. Contrary to the expectations of ice accretion models, radial accretion varied sharply within tree crowns. Initially, radial ice accretion was similar throughout the crown, but after 6.5 hours of irrigation (second scanning) radial ice accretion was much greater on upper branches than on lower (similar to factor of 3). The slope of the change in radial ice accretion along branches increased with duration of exposure and was significantly greater at the second scanning compared to the first. We conclude that outdoor icing experiments coupled with the use of TLS provide a robust basis for evaluation of models of ice accretion and breakage in tree crowns, facilitating estimation of the limiting breaking stress of branches by accurate measurements of ice loads.	[Nock, Charles A.; Follett, Matt] Univ Quebec, Dept Sci Biol, Ctr Forest Res, Montreal, PQ H3C 3P8, Canada; [Greene, David] Concordia Univ, Dept Geog Planning & Environm, Montreal, PQ, Canada; [Delagrange, Sylvain; Messier, Christian] Univ Quebec Outaouais, Dept Nat Sci, Inst Sci Foret Temperee, Ripon, PQ, Canada; [Fournier, Richard] Univ Sherbrooke, Ctr Applicat & Rech Teledetect, Dept Geomat Appl, Sherbrooke, PQ J1K 2R1, Canada	University of Quebec; University of Quebec Montreal; Concordia University - Canada; University of Quebec; University Quebec Outaouais; University of Sherbrooke	Nock, CA (corresponding author), Univ Quebec, Dept Sci Biol, Ctr Forest Res, CP 8888, Montreal, PQ H3C 3P8, Canada.	charles.nock@gmail.com			Hydro-Quebec-NSERC Research Chair	Hydro-Quebec-NSERC Research Chair	This study was funded by a Hydro-Quebec-NSERC Research Chair held by CM (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOERNER REJ, 1988, AM MIDL NAT, V119, P199, DOI 10.2307/2426069; BRUEDERLE LP, 1985, B TORREY BOT CLUB, V112, P167, DOI 10.2307/2996413; CANNELL MGR, 1989, TREE PHYSIOL, V5, P307, DOI 10.1093/treephys/5.3.307; Cheng CS, 2007, NAT HAZARD EARTH SYS, V7, P71, DOI 10.5194/nhess-7-71-2007; Cote JF, 2011, ENVIRON MODELL SOFTW, V26, P761, DOI 10.1016/j.envsoft.2010.12.008; Croxton WC, 1939, ECOLOGY, V20, P71, DOI 10.2307/1930805; DEUBER CG, 1940, AM FORESTS, V46, P210; Greene D, 2007, P 6 INT JOINT C AUT, P1; HARSHBERGER JW, 1904, CONTRIB BOT LAB U PE, V2, P345; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; ILLICK JS, 1916, FOR LEAVES, V15, P103; Jones K. F., 1998, EVALUATION SEVERITY; LEMON PC, 1961, B TORREY BOT CLUB, V88, P21, DOI 10.2307/2482410; Lynch DK, 2005, TR200685701 AER CORP; MAGARVEY RH, 1957, J METEOROL, V14, P182, DOI 10.1175/1520-0469(1957)014<0182:SMODSD>2.0.CO;2; MELANCON S, 1987, CAN J BOT, V65, P1157, DOI 10.1139/b87-161; NICHOLAS NS, 1989, CAN J FOREST RES, V19, P1487, DOI 10.1139/x89-226; Proulx OJ, 2001, CAN J FOREST RES, V31, P1758, DOI 10.1139/cjfr-31-10-1758; Rebertus AJ, 1997, AM MIDL NAT, V137, P48, DOI 10.2307/2426754; Rustad LE, 2012, CAN J FOREST RES, V42, P1810, DOI [10.1139/X2012-120, 10.1139/x2012-120]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEISCHAB FK, 1993, B TORREY BOT CLUB, V120, P64, DOI 10.2307/2996665; Shan-Shan Y, 1982, THESIS OHIO STATE U; SICCAMA TG, 1976, B TORREY BOT CLUB, V103, P180, DOI 10.2307/2484493; Warrillow M, 1999, J TORREY BOT SOC, V126, P147, DOI 10.2307/2997291; WHITNEY HE, 1984, B TORREY BOT CLUB, V111, P429, DOI 10.2307/2995892	26	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64865	10.1371/journal.pone.0064865	http://dx.doi.org/10.1371/journal.pone.0064865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741409	gold, Green Published			2022-12-27	WOS:000319799900122
J	Bordignon, V; El-Beirouthi, N; Gasperin, BG; Albornoz, MS; Martinez-Diaz, MA; Schneider, C; Laurin, D; Zadworny, D; Agellon, LB				Bordignon, Vilceu; El-Beirouthi, Nayla; Gasperin, Bernardo G.; Albornoz, Marcelo S.; Martinez-Diaz, Mario A.; Schneider, Carine; Laurin, Denyse; Zadworny, David; Agellon, Luis B.			Production of Cloned Pigs with Targeted Attenuation of Gene Expression	PLOS ONE			English	Article							LARGE ANIMAL-MODELS; NUCLEAR TRANSFER; RNA INTERFERENCE; SIGNIFICANT IMPROVEMENT; TRANSGENE EXPRESSION; CLONING; FIBROBLASTS; LIVESTOCK; EMBRYOS; CELLS	The objective of this study was to demonstrate that RNA interference (RNAi) and somatic cell nuclear transfer (SCNT) technologies can be used to attenuate the expression of specific genes in tissues of swine, a large animal species. Apolipoprotein E (apoE), a secreted glycoprotein known for its major role in lipid and lipoprotein metabolism and transport, was selected as the target gene for this study. Three synthetic small interfering RNAs (siRNA) targeting the porcine apoE mRNA were tested in porcine granulosa cells in primary culture and reduced apoE mRNA abundance ranging from 45-82% compared to control cells. The most effective sequence was selected for cloning into a short hairpin RNA (shRNA) expression vector under the control of RNA polymerase III (U6) promoter. Stably transfected fetal porcine fibroblast cells were generated and used to produce embryos with in vitro matured porcine oocytes, which were then transferred into the uterus of surrogate gilts. Seven live and one stillborn piglet were born from three gilts that became pregnant. Integration of the shRNA expression vector into the genome of clone piglets was confirmed by PCR and expression of the GFP transgene linked to the expression vector. Analysis showed that apoE protein levels in the liver and plasma of the clone pigs bearing the shRNA expression vector targeting the apoE mRNA was significantly reduced compared to control pigs cloned from non-transfected fibroblasts of the same cell line. These results demonstrate the feasibility of applying RNAi and SCNT technologies for introducing stable genetic modifications in somatic cells for eventual attenuation of gene expression in vivo in large animal species.	[Bordignon, Vilceu; El-Beirouthi, Nayla; Gasperin, Bernardo G.; Albornoz, Marcelo S.; Martinez-Diaz, Mario A.; Schneider, Carine; Laurin, Denyse; Zadworny, David] McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada; [Agellon, Luis B.] McGill Univ, Sch Dietet & Human Nutr, Quebec City, PQ, Canada	McGill University; McGill University	Bordignon, V (corresponding author), McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada.	vilceu.bordignon@mcgill.ca; luis.agellon@mcgill.ca	Gasperin, Bernardo Garziera/AAR-2674-2021; Gasperin, Bernardo/AHA-8288-2022	Gasperin, Bernardo/0000-0002-3715-2345; Bordignon, Vilceu/0000-0001-7076-7707	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Canada Research Chairs program; McGill University Collaborative Research Development Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs program(Canada Research Chairs); McGill University Collaborative Research Development Fund	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada (to V.B.), Canada Foundation for Innovation (to V.B. and L.B.A.), Canada Research Chairs program (to L.B.A.) and McGill University Collaborative Research Development Fund (to L.B.A. and V.B.). L.B.A. holds the Canada Research Chair in Biochemistry and Molecular Biology of Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Alonso-Gonzalez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035619; Bonk AJ, 2007, EPIGENETICS-US, V2, P179, DOI 10.4161/epi.2.3.4844; Bordignon V, 2003, BIOL REPROD, V68, P2013, DOI 10.1095/biolreprod.102.010066; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campeau E, 2011, BRIEF FUNCT GENOMICS, V10, P215, DOI 10.1093/bfgp/elr018; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Che L, 2007, THERIOGENOLOGY, V67, P1297, DOI 10.1016/j.theriogenology.2007.02.006; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; Dann Christina Tenenhaus, 2008, V450, P193, DOI 10.1007/978-1-60327-214-8_14; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Dehoux JP, 2007, FRONT BIOSCI-LANDMRK, V12, P4864, DOI 10.2741/2434; Dieckhoff B, 2008, XENOTRANSPLANTATION, V15, P36, DOI 10.1111/j.1399-3089.2008.00442.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galli C, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02045.x; Golding MC, 2006, P NATL ACAD SCI USA, V103, P5285, DOI 10.1073/pnas.0600813103; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Jeon BG, 2008, REPRODUCTION, V135, P815, DOI 10.1530/REP-07-0442; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kirk AD, 2003, IMMUNOL REV, V196, P176, DOI 10.1046/j.1600-065X.2003.00081.x; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kolber-Simonds D, 2004, P NATL ACAD SCI USA, V101, P7335, DOI 10.1073/pnas.0307819101; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Latham KE, 2005, BIOL CELL, V97, P119, DOI 10.1042/BC20040068; Lucifero D, 2006, BIOL REPROD, V75, P531, DOI 10.1095/biolreprod.106.051722; Luo YL, 2012, J INHERIT METAB DIS, V35, P695, DOI 10.1007/s10545-012-9475-0; Martinez-Diaz MA, 2010, CELL REPROGRAM, V12, P85, DOI 10.1089/cell.2009.0047; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; Niemann H, 2007, REPROD FERT DEVELOP, V19, P762, DOI 10.1071/RD07040; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Piedrahita JA, 2011, REPROD FERT DEVELOP, V23, P56, DOI 10.1071/RD10246; Ramsoondar J, 2009, XENOTRANSPLANTATION, V16, P164, DOI 10.1111/j.1399-3089.2009.00525.x; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Robl JM, 2007, THERIOGENOLOGY, V67, P127, DOI 10.1016/j.theriogenology.2006.09.034; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tessanne K, 2012, MOL REPROD DEV, V79, P176, DOI 10.1002/mrd.22007; Wall RJ, 1996, THERIOGENOLOGY, V45, P57, DOI 10.1016/0093-691X(95)00355-C; Wang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042356; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; WYNE KL, 1989, J BIOL CHEM, V264, P16530; Zhang Pumin, 2008, V442, P259, DOI 10.1007/978-1-59745-191-8_18; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	52	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64613	10.1371/journal.pone.0064613	http://dx.doi.org/10.1371/journal.pone.0064613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737990	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700054
J	Hwang, DG; Park, JH; Lim, JY; Kim, D; Choi, Y; Kim, S; Reeves, G; Yeom, SI; Lee, JS; Park, M; Kim, S; Choi, IY; Choi, D; Shin, C				Hwang, Dong-Gyu; Park, June Hyun; Lim, Jae Yun; Kim, Donghyun; Choi, Yourim; Kim, Soyoung; Reeves, Gregory; Yeom, Seon-In; Lee, Jeong-Soo; Park, Minkyu; Kim, Seungill; Choi, Ik-Young; Choi, Doil; Shin, Chanseok			The Hot Pepper (Capsicum annuum) MicroRNA Transcriptome Reveals Novel and Conserved Targets: A Foundation for Understanding MicroRNA Functional Roles in Hot Pepper	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; SMALL RNAS; PLANT MICRORNAS; DIFFERENTIAL EXPRESSION; DNA METHYLTRANSFERASES; LEAF DEVELOPMENT; TOMATO FRUIT; MIRNA GENES; F-BOX; IDENTIFICATION	MicroRNAs (miRNAs) are a class of non-coding RNAs approximately 21 nt in length which play important roles in regulating gene expression in plants. Although many miRNA studies have focused on a few model plants, miRNAs and their target genes remain largely unknown in hot pepper (Capsicum annuum), one of the most important crops cultivated worldwide. Here, we employed high-throughput sequencing technology to identify miRNAs in pepper extensively from 10 different libraries, including leaf, stem, root, flower, and six developmental stage fruits. Based on a bioinformatics pipeline, we successfully identified 29 and 35 families of conserved and novel miRNAs, respectively. Northern blot analysis was used to validate further the expression of representative miRNAs and to analyze their tissue-specific or developmental stage-specific expression patterns. Moreover, we computationally predicted miRNA targets, many of which were experimentally confirmed using 5' rapid amplification of cDNA ends analysis. One of the validated novel targets of miR-396 was a domain rearranged methyltransferase, the major de novo methylation enzyme, involved in RNA-directed DNA methylation in plants. This work provides the first reliable draft of the pepper miRNA transcriptome. It offers an expanded picture of pepper miRNAs in relation to other plants, providing a basis for understanding the functional roles of miRNAs in pepper.	[Hwang, Dong-Gyu; Park, June Hyun; Lim, Jae Yun; Kim, Donghyun; Choi, Yourim; Kim, Soyoung; Shin, Chanseok] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Reeves, Gregory] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA; [Yeom, Seon-In; Park, Minkyu; Kim, Seungill; Choi, Doil] Seoul Natl Univ, Dept Plant Sci, Coll Agr & Life Sci, Seoul, South Korea; [Lee, Jeong-Soo; Choi, Ik-Young] Seoul Natl Univ, Natl Instrumentat Ctr Environm Management, Coll Agr & Life Sci, Seoul, South Korea; [Choi, Doil; Shin, Chanseok] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea	Seoul National University (SNU); New Mexico State University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Shin, C (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	cshin@snu.ac.kr	Yeom, Seon-In/D-5420-2013; Choi, Doil/F-5002-2011; Kim, Seungill/AAR-1099-2021; CHOI, Ik-Young/ABI-6938-2020	Yeom, Seon-In/0000-0002-8385-0179; Kim, Seungill/0000-0001-6287-8693; Reeves, Gregory/0000-0002-3474-8960; Choi, Ik-Young/0000-0003-4168-0471	National Research Foundation of Korea (NRF); Korea government (MEST) [2012R1A2A2A01045528]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008206, PJ008011]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST; No. 2012R1A2A2A01045528) and the Next-Generation BioGreen 21 Program (No. PJ008206 and No. PJ008011), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Axtell MJ, 2008, BBA-GENE REGUL MECH, V1779, P725, DOI 10.1016/j.bbagrm.2008.02.007; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chuck G, 2010, CURR OPIN PLANT BIOL, V13, P40, DOI 10.1016/j.pbi.2009.08.006; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Emde AK, 2010, BIOINFORMATICS, V26, P123, DOI 10.1093/bioinformatics/btp601; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Fahlgren N, 2010, METHODS MOL BIOL, V592, P51, DOI 10.1007/978-1-60327-005-2_4; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Grant-Downton R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-643; Henderson IR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001182; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huang JJ, 2010, AFR J BIOTECHNOL, V9, P8506; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Itaya A, 2008, BBA-GENE REGUL MECH, V1779, P99, DOI 10.1016/j.bbagrm.2007.09.003; Jagadeeswaran G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-329; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kim HJ, 2011, GENOME, V54, P91, DOI 10.1139/G10-104; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Knapp S, 2002, J EXP BOT, V53, P2001, DOI 10.1093/jxb/erf068; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Mahfouz MM, 2010, PLANT SIGNAL BEHAV, V5, P806, DOI 10.4161/psb.5.7.11695; Mallory AC, 2008, TRENDS PLANT SCI, V13, P359, DOI 10.1016/j.tplants.2008.03.007; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Nozawa M, 2012, GENOME BIOL EVOL, V4, P230, DOI 10.1093/gbe/evs002; Oyama K, 2006, GENET RESOUR CROP EV, V53, P553, DOI 10.1007/s10722-004-2363-1; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Park M, 2012, PLANT J, V69, P1018, DOI 10.1111/j.1365-313X.2011.04851.x; Park M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-85; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044385; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Yang YW, 2010, J EXP BOT, V61, P697, DOI 10.1093/jxb/erp332; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang JG, 2008, GENE, V423, P1, DOI 10.1016/j.gene.2008.05.023; Zhang XH, 2011, FEBS LETT, V585, P435, DOI 10.1016/j.febslet.2010.12.036	99	49	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64238	10.1371/journal.pone.0064238	http://dx.doi.org/10.1371/journal.pone.0064238			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737975	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700039
J	Chen, HL; Wang, X; Tong, MM; Wu, D; Wu, SS; Chen, JX; Wang, XX; Wang, XL; Kang, Y; Tang, H; Tang, CS; Jiang, W				Chen, HuaLi; Wang, Xue; Tong, MingMing; Wu, Dan; Wu, Sisi; Chen, JiaXiang; Wang, XiaoXiao; Wang, XuLei; Kang, Yu; Tang, Hong; Tang, ChaoShu; Jiang, Wei			Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy	PLOS ONE			English	Article							RAT VENTRICULAR MYOCYTES; HEART-FAILURE; EXPRESSION; PEPTIDE; ADRENOMEDULLIN-2; HOMEOSTASIS; INHIBITION; GROWTH; CELLS	Left ventricular hypertrophy is a maladaptive response to pressure overload and an important risk factor for heart failure. Intermedin (IMD), a multi-functional peptide, plays important roles in cardiovascular protection. In this study, we revealed an autophagy-dependent mechanism involved in IMD's protection against cardiac remodeling and cardiomyocyte death in heart hypertrophy. We observed that transverse aortic contraction (TAC) induction, Ang II or ISO exposure induced remarkable increase in the expression of endogenous IMD and its receptor components, CRLR, RAMP1 and RAMP3, in mouse hearts and H9c2 cell cultures, respectively. Furthermore, the heart size, heart weight/body weight ratios, cardiomyocyte size and apoptosis, interstitial collagen, hypertrophic markers including ANP and BNP expression were also significantly increased, which were effectively suppressed by IMD supplementation. In addition, IMD induced capillary angiogenesis and improved functions in hypertrophic hearts. We further observed that IMD induced strong autophagy in hypertrophic hearts and cultured cells, which was paralleling with the decrease in cardiomyocyte size and apoptosis. Furthermore, an autophagy inhibitor, 3-MA, was used to block the IMD-augmented autophagy level, and then the protection of IMD on cardiomyocyte hypertrophy and apoptosis was almost abrogated. We also observed that IMD supplementation stirred intracellular cAMP production, and augmented the ERK1/2 phosphorylation induced by Ang II/ISO exposure in H9c2 cells. In addition, we inhibited PI3K, PKA and MAPK/ERK1/2 signaling pathways by using wortamannin, H89 and PD98059, respectively, in H9c2 cells co-incubating with both IMD and Ang II or ISO, and observed that these inhibitors effectively reduced IMD-augmented autophagy level, but only H89 and PD98059 pre-incubation abrogated the anti-apoptotic action of IMD. These results indicate that the endogenous IMD and its receptor complexes are induced in hypertrophic cardiomyocytes and proposed to play an important role in the pathogenesis of cardiac hypertrophy, and the autophagy stirred by IMD supplementation is involved in its protection against cardiomyocyte hypertrophy and apoptosis through the activation of both cAMP/PKA and MAPK/ERK1/2 pathways.	[Chen, HuaLi; Wang, Xue; Tong, MingMing; Wu, Dan; Wu, Sisi; Chen, JiaXiang; Wang, XiaoXiao; Wang, XuLei; Jiang, Wei] Sichuan Univ, West China Hosp, Mol Med Res Ctr, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Wang, XuLei] Southwest Jiaotong Univ, Sch Life Sci & Bioengn, Chengdu, Sichuan, Peoples R China; [Kang, Yu; Tang, Hong] Sichuan Univ, Dept Cardiol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Kang, Yu] Chengdu Univ Tradit Chinese Med, Teaching Hosp, Chengdu, Sichuan, Peoples R China; [Tang, ChaoShu] Peking Univ, Dept Physiol, Hlth Sci Ctr, Beijing 100871, Peoples R China	Sichuan University; Southwest Jiaotong University; Sichuan University; Chengdu University of Traditional Chinese Medicine; Peking University	Jiang, W (corresponding author), Sichuan Univ, West China Hosp, Mol Med Res Ctr, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	wcumsjw72@hotmail.com			National Natural Science Foundation of China [30871017, 31071001, 31271226, 81000056]; Key Projects in the Science and Technology Pillar Program of Sichuan Province [2009FZ0067]; National ST Major project [2012ZX09501001-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Science and Technology Pillar Program of Sichuan Province; National ST Major project	This work was supported by the National Natural Science Foundation of China (30871017, 31071001 and 31271226 to Dr. W. Jiang, 81000056 to Dr. S.S. Wu), the Key Projects in the Science and Technology Pillar Program of Sichuan Province (2009FZ0067 to Dr. W. Jiang), and the National S&T Major project (2012ZX09501001-003 to Dr. Canhua Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; Bell D, 2008, CELL PHYSIOL BIOCHEM, V21, P203, DOI 10.1159/000113870; Chang CL, 2005, MOL ENDOCRINOL, V19, P2824, DOI 10.1210/me.2004-0191; Cingolani HE, 2011, PFLUG ARCH EUR J PHY, V462, P29, DOI 10.1007/s00424-011-0930-9; Das S, 2006, J MOL CELL CARDIOL, V41, P248, DOI 10.1016/j.yjmcc.2006.03.009; Dong F, 2006, J APPL PHYSIOL, V101, P778, DOI 10.1152/japplphysiol.01631.2005; Doroudgar S, 2011, TRENDS MOL MED, V17, P207, DOI 10.1016/j.molmed.2010.12.003; Finckenberg P, 2010, J HYPERTENS, V28, pS33, DOI 10.1097/01.hjh.0000388492.73954.0b; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Goswami Shyamal K, 2006, Exp Clin Cardiol, V11, P183; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Hurtado O, 2010, NEUROSCIENCE, V171, P885, DOI 10.1016/j.neuroscience.2010.09.021; Jiang W, 2008, AM J PATHOL, V172, P592, DOI 10.2353/ajpath.2008.070834; Kamalov G, 2010, J CARDIOVASC PHARM, V56, P320, DOI 10.1097/FJC.0b013e3181ed064f; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Li JY, 2010, AUTOPHAGY, V6, P711, DOI 10.4161/auto.6.6.12397; Lopez-Andres N, 2008, ENDOCRINOLOGY, V149, P4970, DOI 10.1210/en.2008-0120; McQueen AP, 2005, J MOL CELL CARDIOL, V39, P882, DOI 10.1016/j.yjmcc.2005.07.017; OPARIL S, 1985, J AM COLL CARDIOL, V5, pB57, DOI 10.1016/S0735-1097(85)80528-3; PFEIFER U, 1987, J MOL CELL CARDIOL, V19, P1179, DOI 10.1016/S0022-2828(87)80528-X; Pires AL, 2013, J PHYSIOL-LONDON, V591, P677, DOI 10.1113/jphysiol.2012.240812; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Rothermel BA, 2008, CIRC RES, V103, P1363, DOI 10.1161/CIRCRESAHA.108.186551; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shizukuda Y, 2002, J MOL CELL CARDIOL, V34, P823, DOI 10.1006/jmcc.2002.2020; Smith RS, 2009, AM J PHYSIOL-HEART C, V297, pH1040, DOI 10.1152/ajpheart.00404.2009; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014; THEKKUMKARA TJ, 1995, MOL CELL BIOCHEM, V152, P77; TOMANEK RJ, 1990, J AM COLL CARDIOL, V15, P528, DOI 10.1016/0735-1097(90)90620-5; Uchida H, 2005, EUR J PHARMACOL, V518, P195, DOI 10.1016/j.ejphar.2005.06.029; Yang JH, 2010, J CARDIOVASC PHARM, V56, P45, DOI 10.1097/FJC.0b013e3181ddc785; Zou YZ, 2011, HYPERTENSION, V58, P1099, DOI 10.1161/HYPERTENSIONAHA.111.173500	38	62	65	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e64757	10.1371/journal.pone.0064757	http://dx.doi.org/10.1371/journal.pone.0064757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23737997	gold, Green Submitted, Green Published			2022-12-27	WOS:000319725500050
J	Anwar, N; Sem, XH; Rhen, M				Anwar, Naeem; Sem, Xiao Hui; Rhen, Mikael			Oxidoreductases that Act as Conditional Virulence Suppressors in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; NF-KAPPA-B; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; BACTERIAL; SECRETION; DSBA; THIOREDOXIN; EXPRESSION; GENE	In Salmonella enterica serovar Typhimurium, oxidoreductases of the thioredoxin superfamily contribute to bacterial invasiveness, intracellular replication and to the virulence in BALB/c mice as well as in the soil nematode Caenorhabditis elegans. The scsABCD gene cluster, present in many but not all enteric bacteria, codes for four putative oxidoreductases of the thioredoxin superfamily. Here we have analyzed the potential role of the scs genes in oxidative stress tolerance and virulence in S. Typhimurium. An scsABCD deletion mutant showed moderate sensitization to the redox-active transition metal ion copper and increased protein carbonylation upon exposure to hydrogen peroxide. Still, the scsABCD mutant was not significantly affected for invasiveness or intracellular replication in respectively cultured epithelial or macrophage-like cells. However, we noted a significant copper chloride sensitivity of SPI1 T3SS mediated invasiveness that strongly depended on the presence of the scs genes. The scsABCD deletion mutant was not attenuated in animal infection models. In contrast, the mutant showed a moderate increase in its competitive index upon intraperitoneal challenge and enhanced invasiveness in small intestinal ileal loops of BALB/c mice. Moreover, deletion of the scsABCD genes restored the invasiveness of a trxA mutant in epithelial cells and its virulence in C. elegans. Our findings thus demonstrate that the scs gene cluster conditionally affects virulence and underscore the complex interactions between oxidoreductases of the thioredoxin superfamily in maintaining host adaptation of S. Typhimurium.	[Anwar, Naeem; Rhen, Mikael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Sem, Xiao Hui] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore	Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Rhen, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	mikael.rhen@ki.se	Anwar, Naeem/A-6945-2011	Anwar, Naeem/0000-0001-8638-2158	Vetenskapsradet (Swedish Research Council) [VR-2011-3379]	Vetenskapsradet (Swedish Research Council)(Swedish Research Council)	This study was supported by grants from Vetenskapsradet (Swedish Research Council) to Mikael Rhen with grant number VR-2011-3379. Naeem Anwar is a Ph.D. fellow of Higher Education Commission of Pakistan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Agbor TA, 2011, CELL MICROBIOL, V13, P1858, DOI 10.1111/j.1462-5822.2011.01701.x; AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bjorkman J, 1996, FEMS MICROBIOL LETT, V139, P121, DOI 10.1016/0378-1097(96)00129-2; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; BRENNER S, 1974, GENETICS, V77, P71; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Chung J, 2000, MOL MICROBIOL, V35, P1099, DOI 10.1046/j.1365-2958.2000.01778.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Donnenberg MS, 1997, GENE, V192, P33, DOI 10.1016/S0378-1119(96)00826-8; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eriksson S, 2000, CELL MICROBIOL, V2, P239, DOI 10.1046/j.1462-5822.2000.00051.x; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Gao YL, 2012, TOXICOL IN VITRO, V26, P1, DOI 10.1016/j.tiv.2011.09.019; Gupta SD, 1997, J BACTERIOL, V179, P4977, DOI 10.1128/jb.179.16.4977-4984.1997; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Harrison JJ, 2009, ENVIRON MICROBIOL, V11, P2491, DOI 10.1111/j.1462-2920.2009.01973.x; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hobbie S, 1997, J IMMUNOL, V159, P5550; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; HURME R, 1994, J BIOL CHEM, V269, P10675; JACOBDUBUISSON F, 1994, P NATL ACAD SCI USA, V91, P11552, DOI 10.1073/pnas.91.24.11552; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Lee Y, 2009, FEMS MICROBIOL LETT, V297, P38, DOI 10.1111/j.1574-6968.2009.01650.x; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Lyons S, 2004, J CELL SCI, V117, P5771, DOI 10.1242/jcs.01500; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Mastroeni P, 2004, MICROBES INFECT, V6, P398, DOI 10.1016/j.micinf.2003.12.009; Mastroeni P, 2003, REV MED MICROBIOL, V14, P53; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Negrea A, 2009, J BACTERIOL, V191, P6918, DOI 10.1128/JB.00532-09; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; PALVA ET, 1978, J BACTERIOL, V136, P286, DOI 10.1128/JB.136.1.286-294.1978; Peters SE, 2010, INFECT IMMUN, V78, P326, DOI 10.1128/IAI.00768-09; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; RHEN M, 1988, MICROB PATHOGENESIS, V5, P275, DOI 10.1016/0882-4010(88)90100-3; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Sem X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045417; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Takemoto T, 1998, FREE RADICAL BIO MED, V24, P556, DOI 10.1016/S0891-5849(97)00287-6; WATARAI M, 1995, P NATL ACAD SCI USA, V92, P4927, DOI 10.1073/pnas.92.11.4927; XIE QW, 1994, J BIOL CHEM, V269, P4705; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7	70	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64948	10.1371/journal.pone.0064948	http://dx.doi.org/10.1371/journal.pone.0064948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750221	gold, Green Published, Green Submitted			2022-12-27	WOS:000319961900023
J	Chen, VL; Surana, NK; Duan, JY; Kasper, DL				Chen, Vincent L.; Surana, Neeraj K.; Duan, Jinyou; Kasper, Dennis L.			Role of Murine Intestinal Interleukin-1 Receptor 1-Expressing Lymphoid Tissue Inducer-Like Cells in Salmonella Infection	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; ROR-GAMMA-T; INDUCED IL-1-BETA; DENDRITIC CELLS; INNATE IMMUNITY; CRUCIAL ROLE; IL-22; IL-17; INFLAMMATION; DIFFERENTIATION	Interleukin (IL)-1 signaling plays a critical role in intestinal immunology. Here, we report that the major population of intestinal lamina propria lymphocytes expressing IL-1 receptor 1 (IL-1R1) is the lymphoid tissue inducer (LTi)-like cell, a type of innate lymphoid cell. These cells are significant producers of IL-22, and this IL-22 production depends on IL-1R1 signaling. LTi-like cells are required for defense against Salmonella enterica serovar Typhimurium. Moreover, colonic LTi-like cell numbers depend on the presence of the intestinal microbiota. LTi-like cells require IL-1R1 for production of protective cytokines and confer protection in infectious colitis, and their cell numbers in the colon depend upon having a microbiome.	[Chen, Vincent L.; Surana, Neeraj K.; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Surana, Neeraj K.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Duan, Jinyou] Northwest A&F Univ, Coll Sci, Yangling, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Northwest A&F University - China	Duan, JY (corresponding author), Northwest A&F Univ, Coll Sci, Yangling, Peoples R China.	jduan@nwsuaf.cn; dennis_kasper@hms.harvard.edu	duan, jinyou/I-9156-2012	Chen, Vincent/0000-0002-0157-6066	Crohn's and Colitis Foundation; NIH [F32 AI091104, K12 HD052896]; Faculty Career Development Award from Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052896, T32HD055148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI091104] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty Career Development Award from Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Crohn's and Colitis Foundation (http://www.ccfa.org/) Senior Research Award to DLK. NKS was supported by NIH (www.nih.gov) grants F32 AI091104 and K12 HD052896 and a Faculty Career Development Award from Boston Children's Hospital (www.childrenshospital.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baptista AP, 2012, MUCOSAL IMMUNOL; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Briercheck E, 2010, IMMUNITY, V32, P803; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Duan JY, 2011, CURR OPIN RHEUMATOL, V23, P372, DOI 10.1097/BOR.0b013e3283476d3e; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson C, 2005, SEMIN IMMUNOL, V17, P284, DOI 10.1016/j.smim.2005.05.010; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lane P, 2008, SEMIN IMMUNOL, V20, P159, DOI 10.1016/j.smim.2008.02.002; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Siegemund S, 2009, INT IMMUNOL, V21, P555, DOI 10.1093/intimm/dxp025; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wick MJ, 2002, CURR OPIN IMMUNOL, V14, P437, DOI 10.1016/S0952-7915(02)00364-3; Withers DR, 2012, J IMMUNOL, V189, P2094, DOI 10.4049/jimmunol.1201639; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	62	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65405	10.1371/journal.pone.0065405	http://dx.doi.org/10.1371/journal.pone.0065405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750260	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900062
J	Bosomworth, HJ; Adlard, PA; Ford, D; Valentine, RA				Bosomworth, Helen J.; Adlard, Paul A.; Ford, Dianne; Valentine, Ruth A.			Altered Expression of ZnT10 in Alzheimer's Disease Brain	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MESSENGER-RNA LEVELS; POSTMORTEM BRAIN; ZINC; TRANSPORTER; MANGANESE; MICE; HYPERMANGANESEMIA; POLYCYTHEMIA; TRAFFICKING	There is an increasing body of evidence suggesting that metal homeostasis is dysregulated in the pathology of Alzheimer's disease (AD). Although expression levels of several transporters belonging the SLC30 family, which comprises predominantly zinc transporters, have been studied in the AD brain, SLC30A10 (ZnT10) has not been studied in this context. To determine if dysregulated expression of ZnT10, which may transport both Zn and Mn, could be a factor that contributes to AD, we investigated if there were differences in ZnT10 mRNA levels in specimens of frontal cortex from AD patients and controls and also if brain tissue from the APP/PS1 transgenic (Tg) mouse model showed abnormal levels of ZnT10 mRNA expression. Our results show that ZnT10 is significantly (P<0.01) decreased in the frontal cortex in AD. Furthermore, we observed a significant decrease in ZnT10 mRNA levels in the APP/PS1-Tg mice compared with wild-type controls (P<0.01). Our results suggest that this dysregulation in ZnT10 could further contribute to disease progression.	[Bosomworth, Helen J.; Ford, Dianne; Valentine, Ruth A.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bosomworth, Helen J.; Valentine, Ruth A.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ford, Dianne] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adlard, Paul A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Valentine, RA (corresponding author), Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	ruth.valentine@ncl.ac.uk			UK Biotechnology and Biological Sciences Research Council [BBD01669X/2, BB/F019637/1]; Medical Research Council; National Health and Medical Research Council of Australia; Australian Research Council; UK Medical Research Council; Alzheimer's Research Trust; Alzheimer's Association through the Brains for Dementia Research Initiative; Alzheimer's Association through an NIHR Biomedical Research Centre Grant in Ageing and Health based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Alzheimer's Association through an NIHR Biomedical Research Centre Grant in Ageing and Health based at Newcastle upon Tyne Newcastle University; Alzheimer's Association (USA); Biotechnology and Biological Sciences Research Council [BB/F019637/1, BB/D01669X/1] Funding Source: researchfish; Medical Research Council [MR/L016451/1, G0400074, G0502157, G0900652, G1100540] Funding Source: researchfish; BBSRC [BB/D01669X/1, BB/F019637/1] Funding Source: UKRI; MRC [G0400074, G0900652, G0502157, G1100540, MR/L016451/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust; Alzheimer's Association through the Brains for Dementia Research Initiative; Alzheimer's Association through an NIHR Biomedical Research Centre Grant in Ageing and Health based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Alzheimer's Association through an NIHR Biomedical Research Centre Grant in Ageing and Health based at Newcastle upon Tyne Newcastle University; Alzheimer's Association (USA)(Alzheimer's Association); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Biotechnology and Biological Sciences Research Council Grants BBD01669X/2 (R. A. V.) and BB/F019637/1 (D. F.) and by a research studentship from the Medical Research Council (to H.J.B.). P.A.A is supported by grants from the National Health and Medical Research Council of Australia, The Australian Research Council and Alzheimer's Association (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TOPI-gGEM was generated and gifted by Dr Alison Howard, Newcastle University, U.K. Tissue made available for this study was provided by the Newcastle Brain Tissue Resource which is supported by the UK Medical Research Council, The Alzheimer's Research Trust and Alzheimer's Association through the Brains for Dementia Research Initiative, and through an NIHR Biomedical Research Centre Grant in Ageing and Health based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Beyer N, 2012, J ALZHEIMERS DIS, V29, P863, DOI 10.3233/JAD-2012-112105; Beyer N, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-53; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Cornett CR, 1998, NEUROTOXICOLOGY, V19, P339; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Dewitt MR, 2013, BIOCH BIOPHYS RES CO; Fairweather-Tait SJ, 2008, EXP GERONTOL, V43, P382, DOI 10.1016/j.exger.2007.10.015; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Lebda MA, 2012, NEUROTOXICOLOGY, V33, P98, DOI 10.1016/j.neuro.2011.12.008; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Liu Z, 2008, BIOCH BIOPHYS RES CO, V365, P814; Lovell MA, 2005, NEUROTOX RES, V7, P265, DOI 10.1007/BF03033884; Lyubartseva G, 2010, BRAIN PATHOL, V20, P343, DOI 10.1111/j.1750-3639.2009.00283.x; Meunier N, 2005, EUR J CLIN NUTR, V59, pS1, DOI 10.1038/sj.ejcn.1602286; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Smith JL, 2006, NEUROSCIENCE, V140, P879, DOI 10.1016/j.neuroscience.2006.02.049; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Zhang LH, 2008, NEUROBIOL AGING	26	35	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65475	10.1371/journal.pone.0065475	http://dx.doi.org/10.1371/journal.pone.0065475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741496	Green Published, Green Accepted, gold			2022-12-27	WOS:000319799900209
J	de Souza, DK; Koudou, BG; Bolay, FK; Boakye, DA; Bockarie, MJ				de Souza, Dziedzom K.; Koudou, Benjamin G.; Bolay, Fatorma K.; Boakye, Daniel A.; Bockarie, Moses J.			Filling the Gap 115 Years after Ronald Ross: The Distribution of the Anopheles coluzzii and Anopheles gambiae s.s from Freetown and Monrovia, West Africa	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; INSECTICIDE RESISTANCE; KDR MUTATION; BURKINA-FASO; MALARIA; COMPLEX; DIFFERENTIATION; IDENTIFICATION; INTROGRESSION; VECTOR	It was in Freetown, Sierra Leone, that the malaria mosquito Anopheles coastalis, now known as Anopheles gambiae, was first discovered as the vector of malaria, in 1899. That discovery led to a pioneering vector research in Sierra Leone and neighbouring Liberia, where mosquito species were extensively characterized. Unfortunately, the decade long civil conflicts of the 1990s, in both countries, resulted in a stagnation of the once vibrant research on disease vectors. This paper attempts to fill in some of the gaps on what is now known of the distribution of the sibling species of the An. gambiae complex, and especially the An. coluzzii and An. gambiae s.s, formerly known as the An. gambiae molecular M and S forms respectively, in the cities of Freetown and Monrovia.	[de Souza, Dziedzom K.; Boakye, Daniel A.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Koudou, Benjamin G.; Bockarie, Moses J.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England; [Bolay, Fatorma K.] Liberian Inst Biomed Res, Charlesville, Liberia; [Koudou, Benjamin G.] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire	University of Ghana; Liverpool School of Tropical Medicine; University of Liverpool	Bockarie, MJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.	Moses.Bockarie@liverpool.ac.uk	de Souza, Dziedzom/ABC-8432-2021; Bockarie, Moses/AAW-3130-2021; Bockarie, Moses/AAV-4578-2020	de Souza, Dziedzom/0000-0001-5000-6177; 	Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, through DFID; GSK	Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, through DFID; GSK(GlaxoSmithKline)	This study was supported by the Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, through funding from DFID and GSK. The funders however played no role in the publication of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bequaert J, 1930, AFRICAN REPUBLIC LIB, P825; Bockarie MJ, 1999, ANN TROP MED PARASIT, V93, P213, DOI 10.1080/00034989958465; Briscoe M, 1947, PSYCHE, V54, P245; BRISCOE M. S., 1950, MOSQUITO NEWS, V10, P19; BRISCOE MS, 1952, ECOLOGY, V33, P187, DOI 10.2307/1930639; BROWN A W, 1958, Bull World Health Organ, V18, P309; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Gentile G, 2004, INSECT MOL BIOL, V13, P371, DOI 10.1111/j.0962-1075.2004.00494.x; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Micks D W, 1960, Bull World Health Organ, V22, P519; MULLIS KB, 1990, SCI AM, V262, P56, DOI 10.1038/scientificamerican0490-56; POINDEXTER HA, 1950, AM J TROP MED, V30, P519; Reimer LJ, 2005, INSECT MOL BIOL, V14, P683, DOI 10.1111/j.1365-2583.2005.00599.x; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Storey J, 1967, AFRMAL77 WHO; Temu EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044986; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; Yawson AE, 2004, MED VET ENTOMOL, V18, P372, DOI 10.1111/j.0269-283X.2004.00519.x	24	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64939	10.1371/journal.pone.0064939	http://dx.doi.org/10.1371/journal.pone.0064939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741429	Green Published, gold, Green Accepted			2022-12-27	WOS:000319799900142
J	Jeon, J; Choi, J; Lee, GW; Dean, RA; Lee, YH				Jeon, Junhyun; Choi, Jaeyoung; Lee, Gir-Won; Dean, Ralph A.; Lee, Yong-Hwan			Experimental Evolution Reveals Genome-Wide Spectrum and Dynamics of Mutations in the Rice Blast Fungus, Magnaporthe oryzae	PLOS ONE			English	Article							CLONAL INTERFERENCE; MOLECULAR-SPECTRUM; PATHOGENICITY; ADAPTATION; VIRULENCE; SEQUENCE; GENES; RECOMBINATION; ORGANIZATION; FAMILY	Knowledge on mutation processes is central to interpreting genetic analysis data as well as understanding the underlying nature of almost all evolutionary phenomena. However, studies on genome-wide mutational spectrum and dynamics in fungal pathogens are scarce, hindering our understanding of their evolution and biology. Here, we explored changes in the phenotypes and genome sequences of the rice blast fungus Magnaporthe oryzae during the forced in vitro evolution by weekly transfer of cultures on artificial media. Through combination of experimental evolution with high throughput sequencing technology, we found that mutations accumulate rapidly prior to visible phenotypic changes and that both genetic drift and selection seem to contribute to shaping mutational landscape, suggesting the buffering capacity of fungal genome against mutations. Inference of mutational effects on phenotypes through the use of T-DNA insertion mutants suggested that at least some of the DNA sequence mutations are likely associated with the observed phenotypic changes. Furthermore, our data suggest oxidative damages and UV as major sources of mutation during subcultures. Taken together, our work revealed important properties of original source of variation in the genome of the rice blast fungus. We believe that these results provide not only insights into stability of pathogenicity and genome evolution in plant pathogenic fungi but also a model in which evolution of fungal pathogens in natura can be comparatively investigated.	[Jeon, Junhyun; Choi, Jaeyoung; Lee, Yong-Hwan] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Choi, Jaeyoung; Lee, Gir-Won; Lee, Yong-Hwan] Seoul Natl Univ, Fungal Bioinformat Lab, Seoul, South Korea; [Lee, Gir-Won] Soongsil Univ, Dept Bioinformat & Life Sci, Seoul, South Korea; [Jeon, Junhyun; Dean, Ralph A.] N Carolina State Univ, Funct Genom Program, Raleigh, NC 27695 USA; [Dean, Ralph A.] N Carolina State Univ, Dept Plant Pathol, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA; [Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Genet Resources, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Soongsil University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Seoul National University (SNU); Seoul National University (SNU)	Dean, RA (corresponding author), N Carolina State Univ, Funct Genom Program, Raleigh, NC 27695 USA.	radean2@ncsu.edu; yonglee@snu.ac.kr	Choi, Jaeyoung/H-8665-2013; Choi, Jaeyoung/T-5932-2019	Choi, Jaeyoung/0000-0003-2206-4593; Choi, Jaeyoung/0000-0003-2206-4593; Lee, Gil-Won/0000-0002-1621-1713	National Research Foundation of Korea grant; Korea government [2012-0001149, 2012-0000141]; TDPAF [309015-04-SB020]; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea [PJ00821201]; Brain Korea 21 Program; National Research Foundation of Korea [2012R1A6A3A04038022]	National Research Foundation of Korea grant(National Research Foundation of Korea); Korea government(Korean Government); TDPAF; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (2012-0001149 and 2012-0000141), the TDPAF (309015-04-SB020) and the Next-Generation BioGreen 21 Program of Rural Development Administration in Korea (PJ00821201). JJ is grateful for a graduate fellowship through the Brain Korea 21 Program and president post-doc fellowship from National Research Foundation of Korea (2012R1A6A3A04038022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, RES MICROBIOL, V155, P311, DOI 10.1016/j.resmic.2004.01.013; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; Gao WM, 2002, GENETICS, V162, P103; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; HAN SS, 1997, KOREAN J PLANT PATHO, V13, P408; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; KANG S, 2000, PLANT PATHOLOGY J, V16, P1; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Keller O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-278; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kohn LM, 2008, FUNGAL GENET BIOL, V45, P613, DOI 10.1016/j.fgb.2007.09.013; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindahl T, 1996, PHILOS T ROY SOC B, V351, P1529, DOI 10.1098/rstb.1996.0139; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Noguchi MT, 2006, PHYTOPATHOLOGY, V96, P746, DOI 10.1094/PHYTO-96-0746; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Park SY, 2010, PLANT PATHOLOGY J, V26, P313, DOI 10.5423/PPJ.2010.26.4.313; ROMAO J, 1992, P NATL ACAD SCI USA, V89, P5316, DOI 10.1073/pnas.89.12.5316; Sambrook J., 2001, MOL CLONING LAB MANU; Schoustra SE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030068; VALENT B, 1991, GENETICS, V127, P87; WAGNER JR, 1992, P NATL ACAD SCI USA, V89, P3380, DOI 10.1073/pnas.89.8.3380; Zheng W, 2009, FUNGAL GENET BIOL, V46, P450, DOI 10.1016/j.fgb.2009.03.005	32	15	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65416	10.1371/journal.pone.0065416	http://dx.doi.org/10.1371/journal.pone.0065416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741492	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900205
J	Kim, MH; Ahmed, S; Preidis, GA; Abrams, EJ; Hosseinipour, MC; Giordano, TP; Chiao, EY; Paul, ME; Bhalakia, A; Nanthuru, D; Kazembe, PN				Kim, Maria H.; Ahmed, Saeed; Preidis, Geoffrey A.; Abrams, Elaine J.; Hosseinipour, Mina C.; Giordano, Thomas P.; Chiao, Elizabeth Y.; Paul, Mary E.; Bhalakia, Avni; Nanthuru, Debora; Kazembe, Peter N.			Low Rates of Mother-to-Child HIV Transmission in a Routine Programmatic Setting in Lilongwe, Malawi	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FRENCH PERINATAL COHORT; INFECTED PREGNANT-WOMEN; SOUTH-AFRICA; VIRAL LOAD; PREVENTION; UGANDA; ZIDOVUDINE; INITIATION; TIME	Background: The Tingathe program utilizes community health workers to improve prevention of mother-to-child transmission (PMTCT) service delivery. We evaluated the impact of antiretroviral (ARV) regimen and maternal CD4+ count on HIV transmission within the Tingathe program in Lilongwe, Malawi. Methods: We reviewed clinical records of 1088 mother-infant pairs enrolled from March 2009 to March 2011 who completed follow-up to first DNA PCR. Eligibility for antiretroviral treatment (ART) was determined by CD4+ cell count (CD4+) for women not yet on ART. ART-eligible women initiated stavudine-lamivudine-nevirapine. Early ART was defined as ART for >= 14 weeks prior to delivery. For women ineligible for ART, optimal ARV prophylaxis was maternal AZT >= 6 weeks+sdNVP, and infant sdNVP+AZT for 1 week. HIV transmission rates were determined for ARV regimens, and factors associated with vertical transmission were identified using bivariate logistic regression. Results: Transmission rate at first PCR was 4.1%. Pairs receiving suboptimal ARV prophylaxis were more likely to transmit HIV (10.3%, 95% CI, 5.5-18.1%). ART was associated with reduced transmission (1.4%, 95% CI, 0.6-3.0%), with early ART associated with decreased transmission (no transmission), compared to all other treatment groups (p = 0.001). No association was detected between transmission and CD4+ categories (p = 0.337), trimester of pregnancy at enrollment (p = 0.100), or maternal age (p = 0.164). Conclusion: Low rates of MTCT of HIV are possible in resource-constrained settings under routine programmatic conditions. No transmissions were observed among women on ART for more than 14 weeks prior to delivery.	[Kim, Maria H.; Ahmed, Saeed; Preidis, Geoffrey A.; Paul, Mary E.; Bhalakia, Avni] Texas Childrens Hosp, Baylor Coll Med, Int Pediat AIDS Initiat, Houston, TX 77030 USA; [Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY USA; [Hosseinipour, Mina C.] Univ North Carolina Project, Lilongwe, Malawi; [Hosseinipour, Mina C.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Giordano, Thomas P.; Chiao, Elizabeth Y.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Nanthuru, Debora; Kazembe, Peter N.] Baylor Coll Med, Abbott Fund Childrens Clin Ctr Excellence, Lilongwe, Malawi	Baylor College of Medicine; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kim, MH (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Int Pediat AIDS Initiat, Houston, TX 77030 USA.	mhkim@bcm.edu	Preidis, Geoffrey A./W-5538-2019; Paul, Mary/AAA-2722-2021	Preidis, Geoffrey A./0000-0002-2206-6452; Giordano, Thomas/0000-0002-9346-5530; Chiao, Elizabeth/0000-0001-5752-2916	Clinton HIV-AIDS Initiative (CHAI); Bristol-Myers Squibb Foundation; Abbott Fund; Texas Children's Hospital; United States Agency For International Development (USAID)	Clinton HIV-AIDS Initiative (CHAI); Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); Abbott Fund(Abbott Laboratories); Texas Children's Hospital; United States Agency For International Development (USAID)(United States Agency for International Development (USAID))	The program was financially supported by the Clinton HIV-AIDS Initiative (CHAI), Bristol-Myers Squibb Foundation, Abbott Fund, Texas Children's Hospital, and United States Agency For International Development (USAID). The funders of the program that is described had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P148; [Anonymous], 2008, PREV MOTH CHILD TRAN; Barker PM, 2011, JAIDS-J ACQ IMM DEF, V56, pE45, DOI 10.1097/QAI.0b013e3181fdbf20; Braun M, 2011, JAIDS-J ACQ IMM DEF, V56, pE122, DOI 10.1097/QAI.0b013e31820a7f2f; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chen JY, 2010, JAIDS-J ACQ IMM DEF, V54, P102, DOI 10.1097/QAI.0b013e3181c080bf; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ford N, 2010, AIDS, V24, P1461, DOI 10.1097/QAD.0b013e32833a2a14; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Lilongwe District Health Office, 2008, SEM DAT; Mayaux MJ, 1997, J INFECT DIS, V175, P172, DOI 10.1093/infdis/175.1.172; Mirkuzie AH, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-50; Mnyani C, 2009, 5 IAS C HIV PATH TRE; Mofenson LM, 2004, ARCH PEDIAT ADOL MED, V158, P422, DOI 10.1001/archpedi.158.5.422; Moses A, 2008, AIDS, V22, P83, DOI 10.1097/QAD.0b013e3282f163b5; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; National Statistical Office Malawi and ORC Macro, 2005, MAL DEM HLTH SURV 20; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Saba J, 2002, LANCET, V359, P1178; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; Tubiana R, 2010, CLIN INFECT DIS, V50, P585, DOI 10.1086/650005; UNAIDS, 2012, TOG WE WILL END AIDS; Warszawski J, 2008, AIDS, V22, P289, DOI 10.1097/QAD.0b013e3282f3d63c; WHO, 2006, ANT DRUGS TREAT PREG; WHO/UNAIDS/UNICEF, 2009, UN ACC SCAL HIV PRIO; World Health Organization, 2021, ANT DRUGS TREAT PREG	38	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64979	10.1371/journal.pone.0064979	http://dx.doi.org/10.1371/journal.pone.0064979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741437	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900150
J	Lajugie, J; Mukhopadhyay, R; Schizas, M; Lailler, N; Fourel, N; Bouhassira, EE				Lajugie, Julien; Mukhopadhyay, Rituparna; Schizas, Michael; Lailler, Nathalie; Fourel, Nicolas; Bouhassira, Eric E.			Complete Genome Phasing of Family Quartet by Combination of Genetic, Physical and Population-Based Phasing Analysis	PLOS ONE			English	Article							HAPLOTYPES; INFERENCE	Phased genome maps are important to understand genetic and epigenetic regulation and disease mechanisms, particularly parental imprinting defects. Phasing is also critical to assess the functional consequences of genetic variants, and to allow precise definition of haplotype blocks which is useful to understand gene-flow and genotype-phenotype association at the population level. Transmission phasing by analysis of a family quartet allows the phasing of 95% of all variants as the uniformly heterozygous positions cannot be phased. Here, we report a phasing method based on a combination of transmission analysis, physical phasing by pair-end sequencing of libraries of staggered sizes and population-based analysis. Sequencing of a healthy Caucasians quartet at 120x coverage and combination of physical and transmission phasing yielded the phased genotypes of about 99.8% of the SNPs, indels and structural variants present in the quartet, a phasing rate significantly higher than what can be achieved using any single phasing method. A false positive SNP error rate below 10*E-7 per genome and per base was obtained using a combination of filters. We provide a complete list of SNPs, indels and structural variants, an analysis of haplotype block sizes, and an analysis of the false positive and negative variant calling error rates. Improved genome phasing and family sequencing will increase the power of genome-wide sequencing as a clinical diagnosis tool and has myriad basic science applications.	[Bouhassira, Eric E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Bouhassira, EE (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	eric.bouhassira@einstein.yu.edu	Bouhassira, Eric/AAZ-4184-2021		NYSTEM, the funding agency of New York State Empire Stem Cell Board [C024405, C024172]	NYSTEM, the funding agency of New York State Empire Stem Cell Board	All of the authors were supported in part by grants C024405 and C024172 from NYSTEM, the funding agency of New York State Empire Stem Cell Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Konfortov BA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl742; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lajugie J, 2011, BIOINFORMATICS, V27, P1889, DOI 10.1093/bioinformatics/btr309; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Xiao M, 2009, NAT METHODS, V6, P199, DOI [10.1038/nmeth.1301, 10.1038/NMETH.1301]; Yang H, 2011, P NATL ACAD SCI USA, V108, P12, DOI 10.1073/pnas.1016725108; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	20	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64571	10.1371/journal.pone.0064571	http://dx.doi.org/10.1371/journal.pone.0064571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741343	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900056
J	Lu, QY; Dong, NZ; Wang, Q; Yi, WX; Wang, YX; Zhang, SJ; Gu, HB; Zhao, X; Tang, XR; Jin, BQ; Wu, QY; Brass, LF; Zhu, L				Lu, Qiongyu; Dong, Ningzheng; Wang, Qi; Yi, Wenxiu; Wang, Yuxin; Zhang, Shengjie; Gu, Haibo; Zhao, Xin; Tang, Xiaorong; Jin, Boquan; Wu, Qingyu; Brass, Lawrence F.; Zhu, Li			Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; ALPHA-CONVERTING ENZYME; NECROSIS-FACTOR-ALPHA; SEMAPHORIN 4D; LYMPHOCYTE SEMAPHORIN; BIOLOGICAL-ACTIVITY; EXPRESSION; CD100; CELL; IMMUNE	Semaphorin 4D (Sema4D/CD100) is a 150-kDa transmembrane glycoprotein expressed by platelets and T-cells. When these cells are activated, Sema4D is cleaved proteolytically, generating a biologically active 120-kDa fragment (soluble Sema4D) capable of targeting receptors on platelets, B-cells, endothelial cells and tumor cells. However, its plasma levels and significance in heart failure (HF) have not been reported. In this study, we established an ELISA and detected soluble Sema4D in human plasma. In healthy controls, plasma Sema4D levels were higher in men than women (5.15 +/- 3.30 ng/mL, n = 63, vs. 4.19 +/- 2.39 ng/mL, n = 63, P<0.05). In HF patients, plasma Sema4D levels were significantly higher than those in healthy controls (8.94 +/- 5.89 ng/mL, n = 157 vs. 4.67 +/- 2.99 ng/mL, n = 126, P<0.0001) with the highest levels being in HF patients with diabetes mellitus (DM) (10.45 +/- 5.76 ng/mL, n = 40). We also found that there was a higher percentage of Sema4D(high) CD3(+) (P<0.01), CD4(+) (P<0.001), and CD8(+) (P<0.01) T-cells in samples from HF patients, but no changes in Sema4D expression levels in B cells and platelets. Therefore, our investigation shows that plasma Sema4D levels are increased in HF patients, especially in those who also have diabetes. There was an accompanying increase in the Sema4D(high) population of T-cells, suggesting a potential role of these T-cells in heart failure.	[Lu, Qiongyu; Dong, Ningzheng; Wang, Qi; Yi, Wenxiu; Zhang, Shengjie; Tang, Xiaorong; Wu, Qingyu; Zhu, Li] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China; [Dong, Ningzheng; Zhu, Li] Soochow Univ, Jiangsu Inst Hematol, Suzhou, Jiangsu, Peoples R China; [Zhao, Xin] Soochow Univ, Dept Cardiol, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China; [Gu, Haibo] Soochow Univ, Dept Cardiol, Affiliated Hosp 2, Suzhou, Jiangsu, Peoples R China; [Wang, Yuxin] Jilin Hosp Chinese Armed Police Force, Dept Pathol, Changchun, Jilin, Peoples R China; [Jin, Boquan] Fourth Mil Med Univ, Dept Immunol, Xian, Shanxi, Peoples R China; [Brass, Lawrence F.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Brass, Lawrence F.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Air Force Military Medical University; University of Pennsylvania; University of Pennsylvania	Zhu, L (corresponding author), Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China.	lizhusong@yahoo.com		Wu, Qingyu/0000-0003-0561-9315	National Science Foundation of China [81170132]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) from the Ministry of Education of China [K521102111]; Jiangsu Province's Key Discipline of Medicine [XK201118]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; NIH [HL40387, HL81012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P50HL081012] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) from the Ministry of Education of China; Jiangsu Province's Key Discipline of Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Science Foundation of China (81170132), Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) from the Ministry of Education of China (K521102111), Jiangsu Province's Key Discipline of Medicine (XK201118), and the Priority Academic Program Development of Jiangsu Higher Education Institutions of China to LZ and NIH HL40387 and HL81012 to LFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Besliu A, 2011, AUTOIMMUNITY, V44, P427, DOI 10.3109/08916934.2010.541171; Binmadi NO, 2011, ANGIOGENESIS, V14, P309, DOI 10.1007/s10456-011-9214-4; Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; Ch'ng ES, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-251; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; Dong NZ, 2012, CLIN CHIM ACTA, V413, P378, DOI 10.1016/j.cca.2011.10.032; Dong NZ, 2010, CLIN CHIM ACTA, V411, P1998, DOI 10.1016/j.cca.2010.08.021; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Ishida I, 2003, INT IMMUNOL, V15, P1027, DOI 10.1093/intimm/dxg098; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kato S, 2011, CANCER SCI, V102, P2029, DOI 10.1111/j.1349-7006.2011.02053.x; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Li M, 2006, J IMMUNOL, V177, P3406, DOI 10.4049/jimmunol.177.5.3406; Li M, 2009, IMMUNOLOGY, V128, P114, DOI 10.1111/j.1365-2567.2009.03098.x; Li NY, 2007, J IMMUNOL, V178, P4214, DOI 10.4049/jimmunol.178.7.4214; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Oikonomou E, 2011, HELL J CARDIOL, V52, P30; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2010, J BIOL CHEM, V285, P28200, DOI 10.1074/jbc.M110.147546; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Prevost N, 2002, P NATL ACAD SCI USA, V99, P9219, DOI 10.1073/pnas.142053899; Satoh H, 2004, CLIN SCI, V106, P301, DOI 10.1042/CS20030189; Satoh M, 2000, J AM COLL CARDIOL, V36, P1288, DOI 10.1016/S0735-1097(00)00827-5; Smith EP, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-30; Subramaniam V, 2009, FUND CLIN PHARMACOL, V23, P705, DOI 10.1111/j.1472-8206.2009.00776.x; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; von Bibra Helene, 2011, Curr Heart Fail Rep, V8, P242, DOI 10.1007/s11897-011-0070-8; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Wannemacher KM, 2010, BLOOD, V116, P5707, DOI 10.1182/blood-2010-04-279943; Xu Xiao-guang, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P80; Yndestad A, 2006, HEART FAIL REV, V11, P83, DOI 10.1007/s10741-006-9196-2; Yukawa K, 2010, INT J MOL MED, V26, P39, DOI 10.3892/ijmm_00000432; Zavadzkas JA, 2011, AM J PHYSIOL-HEART C, V301, pH1656, DOI 10.1152/ajpheart.00141.2011; Zhou H, 2012, ANGIOGENESIS, V15, P391, DOI 10.1007/s10456-012-9268-y; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104; Zhu L, 2009, ARTERIOSCL THROM VAS, V29, P1039, DOI 10.1161/ATVBAHA.109.185405; Zielonka M, 2010, EXP CELL RES, V316, P2477, DOI 10.1016/j.yexcr.2010.05.007	49	20	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64265	10.1371/journal.pone.0064265	http://dx.doi.org/10.1371/journal.pone.0064265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741311	gold, Green Published			2022-12-27	WOS:000319799900023
J	Shen, JL; Du, XY; Guo, DD; Cao, LZ; Gao, Y; Yang, Q; Li, PY; Liu, JB; Li, KC				Shen, Junlin; Du, Xiangying; Guo, Daode; Cao, Lizhen; Gao, Yan; Yang, Qi; Li, Pengyu; Liu, Jiabin; Li, Kuncheng			Prospective ECG-Triggered Coronary CT Angiography: Clinical Value of Noise-Based Tube Current Reduction Method with Iterative Reconstruction	PLOS ONE			English	Article							IMAGE QUALITY; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CARDIAC CT	Objectives: To evaluate the clinical value of noise-based tube current reduction method with iterative reconstruction for obtaining consistent image quality with dose optimization in prospective electrocardiogram (ECG)-triggered coronary CT angiography (CCTA). Materials and Methods: We performed a prospective randomized study evaluating 338 patients undergoing CCTA with prospective ECG-triggering. Patients were randomly assigned to fixed tube current with filtered back projection (Group 1, n = 113), noise-based tube current with filtered back projection (Group 2, n = 109) or with iterative reconstruction (Group 3, n = 116). Tube voltage was fixed at 120 kV. Qualitative image quality was rated on a 5-point scale (1 = impaired, to 5 = excellent, with 3-5 defined as diagnostic). Image noise and signal intensity were measured; signal-to-noise ratio was calculated; radiation dose parameters were recorded. Statistical analyses included one-way analysis of variance, chi-square test, Kruskal-Wallis test and multivariable linear regression. Results: Image noise was maintained at the target value of 35HU with small interquartile range for Group 2 (35.00-35.03HU) and Group 3 (34.99-35.02HU), while from 28.73 to 37.87HU for Group 1. All images in the three groups were acceptable for diagnosis. A relative 20% and 51% reduction in effective dose for Group 2 (2.9 mSv) and Group 3 (1.8 mSv) were achieved compared with Group 1 (3.7 mSv). After adjustment for scan characteristics, iterative reconstruction was associated with 26% reduction in effective dose. Conclusion: Noise-based tube current reduction method with iterative reconstruction maintains image noise precisely at the desired level and achieves consistent image quality. Meanwhile, effective dose can be reduced by more than 50%.	[Shen, Junlin; Du, Xiangying; Guo, Daode; Cao, Lizhen; Gao, Yan; Yang, Qi; Li, Pengyu; Liu, Jiabin; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University	Li, KC (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China.	kuncheng.li@gmail.com						Blankstein R, 2011, INT J CARDIOVAS IMAG, V27, P579, DOI 10.1007/s10554-010-9683-3; Bongartz G, 2004, EUROPEAN GUIDELINES; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Fleischmann D, 2011, EUR RADIOL, V21, P510, DOI 10.1007/s00330-011-2056-z; Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Hausleiter J, 2006, CIRCULATION, V113, P1305, DOI 10.1161/CIRCULATIONAHA.105.602490; Hausleiter J, 2009, JAMA-J AM MED ASSOC, V301, P500, DOI 10.1001/jama.2009.54; Hausleiter J, 2012, JACC-CARDIOVASC IMAG, V5, P484, DOI 10.1016/j.jcmg.2011.12.017; Hou Y, 2012, EUR J RADIOL, V81, P3905, DOI 10.1016/j.ejrad.2012.06.022; Hsieh J, 2006, MED PHYS, V33, P4236, DOI 10.1118/1.2361078; Hur G, 2007, AM J ROENTGENOL, V189, P188, DOI 10.2214/AJR.06.1201; Leipsic J, 2010, AM J ROENTGENOL, V195, P655, DOI 10.2214/AJR.10.4288; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; McCollough C, AAPM TASK GROUP 23 D; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Qi WW, 2009, KOREAN J RADIOL, V10, P568, DOI 10.3348/kjr.2009.10.6.568; Scheffel H, 2012, EUR J RADIOL, V81, pE363, DOI 10.1016/j.ejrad.2011.11.051; Shen JL, 2013, EUR J RADIOL, V82, P349, DOI 10.1016/j.ejrad.2012.10.008; Steigner ML, 2009, INT J CARDIOVAS IMAG, V25, P85, DOI 10.1007/s10554-008-9347-8; Sun ZH, 2012, EUR J RADIOL, V81, pE94, DOI 10.1016/j.ejrad.2011.01.070; Tatsugami F, 2009, AM J ROENTGENOL, V192, P635, DOI 10.2214/AJR.08.1390; Weigold WG, 2009, INT J CARDIOVAS IMAG, V25, P217, DOI 10.1007/s10554-009-9439-0	23	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65025	10.1371/journal.pone.0065025	http://dx.doi.org/10.1371/journal.pone.0065025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741444	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900157
J	Xie, P; Yu, T; Fu, XY; Tu, Y; Zou, Y; Lui, S; Zhao, XN; Huang, XQ; Kemp, GJ; Gong, QY				Xie, Peng; Yu, Tian; Fu, Xiaoyun; Tu, Ye; Zou, Yan; Lui, Su; Zhao, Xuna; Huang, Xiaoqi; Kemp, Graham J.; Gong, Qiyong			Altered Functional Connectivity in an Aged Rat Model of Postoperative Cognitive Dysfunction: A Study Using Resting-State Functional MRI	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOTOR CORTEX; HUMAN BRAIN; ANESTHESIA; NETWORKS; FLUCTUATION; SURGERY; FMRI; DETERIORATION; HIPPOCAMPUS	Background: Postoperative cognitive impairment is a common complication after cardiac and major non-cardiac surgery in the elderly, but its causes and mechanisms remain unclear. The purpose of the current study was to use resting-state functional magnetic resonance imaging (fMRI) to explore changes in the functional connectivity, i.e. the synchronization of low frequency fluctuation (LFF), in an animal model of cognitive impairment in aged rats. Methods: Aged (22 months) rats were anaesthetized with 40 mu g/kg fentanyl and 500 mu g/kg droperidol (intraperitoneal) for splenectomy. Cognitive function was assessed using Y maze prior to operation and on postoperative days 1, 3 and 9. To evaluate functional connectivity, resting-state fMRI data were acquired using a 3T MR imaging system with a 4 channel phase array rat head coil. Results: Cognitive function was impaired at postoperative days 1 and 3 compared with preoperative. Significant synchronized LFF was detected bilaterally in the primary somatosensory cortex and hippocampus preoperatively. By contrast, no significant LFF synchronization was detected in the right primary somatosensory cortex and right hippocampus on postoperative days 1 and 3, although the pattern of functional connectivity had become almost normal by day 9. Conclusion: Splenectomy performed under neuroleptic anaesthesia triggers a cognitive decline that is associated with altered spontaneous neuronal activity in the cortex and hippocampus.	[Xie, Peng; Yu, Tian; Fu, Xiaoyun; Tu, Ye] Zunyi Med Coll, Dept Anesthesiol, Zunyi, Guizhou, Peoples R China; [Zou, Yan] Zunyi Med Coll, Sch Publ Hlth, Zunyi, Guizhou, Peoples R China; [Lui, Su; Huang, Xiaoqi; Gong, Qiyong] Sichuan Univ, Huaxi MR Res Ctr HMRRC, Dept Radiol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Zhao, Xuna] Philips Med Syst Beijing, Beijing, Peoples R China; [Kemp, Graham J.] Univ Liverpool, Magnet Resonance & Image Anal Res Ctr MARIARC, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England	Zunyi Medical University; Zunyi Medical University; Sichuan University; Philips; Philips Healthcare; University of Liverpool	Yu, T (corresponding author), Zunyi Med Coll, Dept Anesthesiol, Zunyi, Guizhou, Peoples R China.	zyyutian@hotmail.com	Gong, Qiyong/W-3052-2019; Kemp, Graham J/A-7540-2008; Lui, Su/S-9132-2019; Huang, Xiaoqi/O-7904-2017	Gong, Qiyong/0000-0002-5912-4871; Kemp, Graham J/0000-0002-8324-9666; Huang, Xiaoqi/0000-0001-8686-5010	Storm a Strategic Pass Topic of Guizhou province [[2007] 1034]; National Natural Science Foundation [81030027, 81227002, 81220108013]; National Key Technologies RD Program [2012BAI01B03]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) of China; CMB Distinguished Professorship Award [F510000/G16916411]	Storm a Strategic Pass Topic of Guizhou province; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); CMB Distinguished Professorship Award	This work was supported by Storm a Strategic Pass Topic of Guizhou province (No. [2007] 1034), the National Natural Science Foundation (Grant Nos. 81030027, 81227002 and 81220108013), National Key Technologies R&D Program (Program No. 2012BAI01B03) and Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) of China. Qiyong Gong also acknowledges the support from his CMB Distinguished Professorship Award (Award No. F510000/G16916411) administered by the Institute of International Education, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; BEDFORD PD, 1955, LANCET, V2, P259; Bekker Alex Y, 2003, Best Pract Res Clin Anaesthesiol, V17, P259, DOI 10.1016/S1521-6896(03)00005-3; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cai YM, 2012, ANESTHESIOLOGY, V116, P84, DOI 10.1097/ALN.0b013e31823da7a2; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; Dodds C, 1998, BRIT J ANAESTH, V81, P449, DOI 10.1093/bja/81.3.449; EDWARDS H, 1981, JAMA-J AM MED ASSOC, V245, P1342, DOI 10.1001/jama.245.13.1342; Evered L, 2011, ANESTH ANALG, V112, P1179, DOI 10.1213/ANE.0b013e318215217e; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haase L, 2013, HUM BRAIN MAPP, V34, P530, DOI 10.1002/hbm.21451; Hanning CD, 2005, BRIT J ANAESTH, V95, P82, DOI 10.1093/bja/aei062; Hanning CD, 2003, EUR J ANAESTH, V20, P93, DOI 10.1097/00003643-200302000-00002; Hlinka J, 2010, MAGN RESON MATER PHY, V23, P367, DOI 10.1007/s10334-010-0199-6; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Kiviniemi V, 2004, MAGN RESON IMAGING, V22, P197, DOI 10.1016/j.mri.2003.09.007; Kiviniemi V, 2000, MAGN RESON MED, V44, P373, DOI 10.1002/1522-2594(200009)44:3<373::AID-MRM5>3.0.CO;2-P; Li SJ, 2000, MAGNET RESON MED, V43, P45, DOI 10.1002/(SICI)1522-2594(200001)43:1<45::AID-MRM6>3.0.CO;2-0; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Mawhinney LJ, 2012, BRAIN RES, V1431, P23, DOI 10.1016/j.brainres.2011.11.004; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; Paxinos G., 2004, J CHEM INF MODEL, V5th; Pelled G, 2004, MAGN RESON MED, V52, P913, DOI 10.1002/mrm.20229; Prvulovic D, 2011, PROG NEUROBIOL, V95, P557, DOI 10.1016/j.pneurobio.2011.05.008; Rasmussen LS, 1998, EUR J ANAESTH, V15, P761, DOI 10.1097/00003643-199811000-00026; Rasmussen LS, 2004, ACTA ANAESTH SCAND, V48, P1137, DOI 10.1111/j.1399-6576.2004.00502.x; Rentowl P, 2004, ANAESTHESIA, V59, P337, DOI 10.1111/j.1365-2044.2004.03678.x; RIIS J, 1983, ACTA ANAESTH SCAND, V27, P44, DOI 10.1111/j.1399-6576.1983.tb01903.x; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; Schultz SK, 2008, ANN CLIN PSYCHIATRY, V20, P204, DOI 10.1080/10401230802437530; Schwarz AJ, 2007, NEUROIMAGE, V34, P1627, DOI 10.1016/j.neuroimage.2006.11.010; Stein T, 2000, AM J NEURORADIOL, V21, P1397; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Terrando N, 2011, MAYO CLIN PROC, V86, P885, DOI 10.4065/mcp.2011.0332; Tu Y, 2011, PHARMACOLOGY, V88, P322, DOI 10.1159/000334168; Vizcaychipi MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026394; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Xie ZC, 2006, EXP GERONTOL, V41, P346, DOI 10.1016/j.exger.2006.01.014; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063; Zhu MM, 2004, J THERM BIOL, V29, P599, DOI 10.1016/j.jtherbio.2004.08.029	56	9	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64820	10.1371/journal.pone.0064820	http://dx.doi.org/10.1371/journal.pone.0064820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738003	gold, Green Submitted, Green Published			2022-12-27	WOS:000321394700064
J	Yin, SH; Yang, SL; Shang, YJ; Sun, SQ; Zhou, GQ; Jin, Y; Tian, H; Wu, JY; Liu, XT				Yin, Shuanghui; Yang, Shunli; Shang, Youjun; Sun, Shiqi; Zhou, Guangqing; Jin, Ye; Tian, Hong; Wu, Jinyan; Liu, Xiangtao			Characterization of Asia 1 sdAb from Camels Bactrianus (C. bactrianus) and Conjugation with Quantum Dots for Imaging FMDV in BHK-21 Cells	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; SINGLE-DOMAIN ANTIBODY; SEROTYPE-O; FRAGMENTS; REPLICATION; PROTEINS; IMMUNOGLOBULINS; TRANSLATION; DROMEDARY; PHAGE	Foot-and-mouth disease (FMD), caused by FMD virus (FMDV), is a highly contagious viral disease affecting cloven-hoofed animals. Camelids have a unique immunoglobulin profile, with the smallest functional heavy-chain antibodies (sdAb or VHH) naturally devoid of light chains with antigen-binding capacity. We screened and characterized five sdAbs against FMDV by immunized library from C. bactrianus with Asia 1 virus-like particles (VLPs). Three of five recombinant sdAbs were stably expressed in E. coli, remained highly soluble, and were serotype-specific for VP1 protein of FMDV Asia 1 by ELISA. These failed to completely neutralize the Asia 1 virus. According to the K-D value of binding affinity to three sdAbs, which ranged from 0.44 to 0.71 nm by SPR, sdAb-C6 was selected and conjugated with Zn/CdSe quantum dots (QDs) to form a QDs-C6 probe, which was used to trace and image the subcellular location of FMDV in BHK-21 cells. The results show that FMD virions were observed from 3 h. p.i., and most of virions were distributed on one side of the nucleus in the cytoplasm. We demonstrate the utility of sdAbs as functionalized QDs are powerful tools for FMDV research.	[Yin, Shuanghui; Yang, Shunli; Shang, Youjun; Sun, Shiqi; Zhou, Guangqing; Jin, Ye; Tian, Hong; Wu, Jinyan; Liu, Xiangtao] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Natl Foot & Mouth Dis Reference Lab, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Liu, XT (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Natl Foot & Mouth Dis Reference Lab, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China.	liuxiangtao@caas.cn	yang, shunli/HGA-4443-2022		China Agriculture Research System [CARS-39]; National Natural Science Foundation of China [31101803]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Agriculture Research System (CARS-39) and the National Natural Science Foundation of China (Grant No. 31101803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; ARLINGHAUS RB, 1969, P NATL ACAD SCI USA, V62, P821, DOI 10.1073/pnas.62.3.821; Ayelet G, 2009, EMERG INFECT DIS, V15, P1409, DOI 10.3201/eid1509.090091; BACHRACH HL, 1968, ANNU REV MICROBIOL, V22, P201, DOI 10.1146/annurev.mi.22.100168.001221; Belsham GJ, 2005, CURR TOP MICROBIOL, V288, P43; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; De Groeve K, 2010, J NUCL MED, V51, P782, DOI 10.2967/jnumed.109.070078; de los Santos T, 2007, J VIROL, V81, P12803, DOI 10.1128/JVI.01467-07; de los Santos T, 2009, J VIROL, V83, P1800, DOI 10.1128/JVI.02112-08; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Garcia-Briones M, 2006, VIROLOGY, V349, P409, DOI 10.1016/j.virol.2006.02.042; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Grubman MJ, 2000, REC RES DEV VIROL, V2, P123; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Iqbal U, 2010, BRIT J PHARMACOL, V160, P1016, DOI 10.1111/j.1476-5381.2010.00742.x; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; KANG AS, 1991, P NATL ACAD SCI USA, V88, P4363, DOI 10.1073/pnas.88.10.4363; King A.M.Q., 2000, VIRUS TAXONOMY, P657; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Klooster R, 2009, J IMMUNOL METHODS, V342, P1, DOI 10.1016/j.jim.2008.10.009; Knowles NJ, 2001, VET REC, V148, P258; Knox C, 2005, J GEN VIROL, V86, P687, DOI 10.1099/vir.0.80208-0; KUHN R, 1990, J VIROL, V64, P4625; Larska M, 2009, EPIDEMIOL INFECT, V137, P549, DOI 10.1017/S0950268808001088; Lawrence P, 2009, J VIROL, V83, P11356, DOI 10.1128/JVI.02677-08; [刘俊林 LIU Junlin], 2008, [甘肃农业大学学报, Journal of Gansu Agricultural University], V43, P18; Malirat V, 2011, VET MICROBIOL, V152, P74, DOI 10.1016/j.vetmic.2011.04.021; MCCULLOUGH KC, 1986, IMMUNOLOGY, V58, P421; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Olichon A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-7; Perruchini C, 2009, ACTA NEUROPATHOL, V118, P685, DOI 10.1007/s00401-009-0572-6; Pysz MA, 2010, CLIN RADIOL, V65, P500, DOI 10.1016/j.crad.2010.03.011; Rogach A.L., 2008, SEMICONDUCTOR NANOCR; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Rust RC, 2001, J VIROL, V75, P9808, DOI 10.1128/JVI.75.20.9808-9818.2001; RWEYEMAMU MM, 1978, J HYG-CAMBRIDGE, V81, P107, DOI 10.1017/S002217240005381X; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; SAMUEL AR, 1990, VACCINE, V8, P390, DOI 10.1016/0264-410X(90)90100-Z; Sukhanova A, 2012, NANOMED-NANOTECHNOL, V8, P516, DOI 10.1016/j.nano.2011.07.007; Valarcher JF, 2009, EMERG INFECT DIS, V15, P1046, DOI 10.3201/eid1507.081621; World Organization for Animal Health, 2004, MAN DIAGN TESTS VACC, P111; Xie HY, 2004, CHINESE J ANAL CHEM, V32, P1099; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731; Yin SH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-166; Zaman MB, 2009, J PHYS CHEM C, V113, P496, DOI 10.1021/jp809159k	52	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63500	10.1371/journal.pone.0063500	http://dx.doi.org/10.1371/journal.pone.0063500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737944	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700008
J	Gao, J; Li, LS; Wu, MQ; Liu, M; Xie, XH; Guo, JL; Tang, HL; Xie, XM				Gao, Jie; Li, Laisheng; Wu, Minqing; Liu, Min; Xie, Xinhua; Guo, Jiaoli; Tang, Hailin; Xie, Xiaoming			MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1	PLOS ONE			English	Article							PACLITAXEL-RESISTANCE; MICRORNA EXPRESSION; LUNG-CANCER; CELL-DEATH; IN-VIVO; METASTASIS; APOPTOSIS; TARGETS; CARCINOGENESIS; CHALLENGES	Breast cancer is the most commonly malignancies in women. MicroRNAs are a family of small non-coding RNAs 18-25 nucleotides in length that post-transcriptionally modulate gene expression. MiR-26a has been reported as a tumor suppressor microRNA in breast cancer, which is attributed mainly to targeting of MTDH and EZH2, however, the expression profile and therapeutic potential of miR-26a is still unclear. Here we demonstrate that miR-26a is down-regulated in breast cancer cells and clinical specimens and its modulation in breast cancer cells regulates cell proliferation, colony formation, migration and apoptosis. MCL-1, an anti-apoptotic member of the Bcl-2 family, as novel targets of miR-26a was found to be in reverse correlation with ectopic expression of miR-26a and knockdown of MCL-1 phenocopied the effect of miR-26a in breast cancer cell lines. It was further explored that miR-26a increased sensitivity of breast cancer cells to paclitaxel in which MCL-1 was involved. Thus, miR-26a impacts on cell proliferation and migration of breast cancer by regulating several carcinogenesis-related processes, including a novel mechanism involving the targeting of MCL-1.	[Gao, Jie; Wu, Minqing; Xie, Xinhua; Guo, Jiaoli; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Laisheng; Liu, Min] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Jie; Li, Laisheng; Wu, Minqing; Xie, Xinhua; Guo, Jiaoli; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xie, XM (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China.	xiexm@sysucc.org.cn	Li, Laisheng/G-6674-2015		National Natural Science Foundation of China [81272514, 31030061, 31100935]; China Postdoctoral Science Foundation [2012M520075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by funds from Key Program of National Natural Science Foundation of China number 31030061, National Natural Science Foundation of China number 81272514, National Natural Science Foundation of China (31100935), and the China Postdoctoral Science Foundation (2012M520075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2007, EXPERT REV MOL DIAGN, V7, P569, DOI 10.1586/14737159.7.5.569; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gong J., 2012, ONCOGENE; Holleman A, 2011, ONCOGENE, V30, P4386, DOI 10.1038/onc.2011.148; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kasinski AL, 2011, NAT REV CANCER, V11, P849; Kim SJ, 2011, J CONTROL RELEASE, V155, P427, DOI 10.1016/j.jconrel.2011.06.026; Kojima K, 2010, PROSTATE, V70, P1501, DOI 10.1002/pros.21185; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li L, 2012, CLIN EXP MED; Li L, 2012, MOL THER; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Rivera E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2573; Saito Y, 2012, INT J CANC; Sander S, 2009, CELL CYCLE, V8, P556, DOI 10.4161/cc.8.4.7599; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032115, 10.1371/journal.pone.0047003]; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046173; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang JX, 2012, CANC LETT; Zhang YK, 2011, BIOCHEM BIOPH RES CO, V414, P233, DOI 10.1016/j.bbrc.2011.09.063	48	49	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65138	10.1371/journal.pone.0065138	http://dx.doi.org/10.1371/journal.pone.0065138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750239	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900041
J	Ngai, KLK; Chan, MCW; Chan, PKS				Ngai, Karry L. K.; Chan, Martin C. W.; Chan, Paul K. S.			Replication and Transcription Activities of Ribonucleoprotein Complexes Reconstituted from Avian H5N1, H1N1pdm09 and H3N2 Influenza A Viruses	PLOS ONE			English	Article							N-TERMINAL REGION; RNA-POLYMERASE; PA SUBUNIT; CAP-BINDING; HOST RESTRICTION; VIRAL POLYMERASE; PROMOTER-BINDING; CONSERVED MOTIFS; PANDEMIC H1N1; PB2	Avian influenza viruses pose a serious pandemic threat to humans. Better knowledge on cross-species adaptation is important. This study examined the replication and transcription efficiency of ribonucleoprotein complexes reconstituted by plasmid co-transfection between H5N1, H1N1pdm09 and H3N2 influenza A viruses, and to identify mutations in the RNA polymerase subunit that affect human adaptation. Viral RNA polymerase subunits PB1, PB2, PA and NP derived from influenza viruses were co-expressed with pPoll-vNP-Luc in human cells, and with its function evaluated by luciferase reporter assay. A quantitative RT-PCR was used to measure vRNA, cRNA, and mRNA levels for assessing the replication and transcription efficiency. Mutations in polymerase subunit were created to identify signature of increased human adaptability. H5N1 ribonucleoprotein complexes incorporated with PB2 derived from H1N1pdm09 and H3N2 viruses increased the polymerase activity in human cells. Furthermore, single amino acid substitutions at PB2 of H5N1 could affect polymerase activity in a temperature-dependent manner. By using a highly sensitive quantitative reverse transcription-polymerase chain reaction, an obvious enhancement in replication and transcription activities of ribonucleoproteins was observed by the introduction of lysine at residue 627 in the H5N1 PB2 subunit. Although less strongly in polymerase activity, E158G mutation appeared to alter the accumulation of H5N1 RNA levels in a temperature-dependent manner, suggesting a temperature-dependent mechanism in regulating transcription and replication exists. H5N1 viruses can adapt to humans either by acquisition of PB2 from circulating human-adapted viruses through reassortment, or by mutations at critical sites in PB2. This information may help to predict the pandemic potential of newly emerged influenza strains, and provide a scientific basis for stepping up surveillance measures and vaccine production.	[Ngai, Karry L. K.; Chan, Martin C. W.; Chan, Paul K. S.] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Paul K. S.] Chinese Univ Hong Kong, Fac Med, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	Chan, Martin/B-3588-2009; Chan, Paul KS/J-9360-2013	Chan, Martin/0000-0002-1568-1596; Chan, Paul KS/0000-0002-6360-4608	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region	This research was supported by the Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; BRAAM J, 1983, CELL, V34, P609; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Honda A, 2007, GENES CELLS, V12, P133, DOI 10.1111/j.1365-2443.2007.01047.x; Kashiwagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015140; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lam WY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-528; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Liu D, 2009, SCI CHINA SER C, V52, P428, DOI 10.1007/s11427-009-0062-z; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Nakazono Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032634; Ng SSF, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-2; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040752; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10	38	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65038	10.1371/journal.pone.0065038	http://dx.doi.org/10.1371/journal.pone.0065038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750226	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900028
J	Antes, R; Ezra-Elia, R; Weinberger, D; Solomon, A; Ofri, R; Michaelson, DM				Antes, Ran; Ezra-Elia, Raaya; Weinberger, Dov; Solomon, Arie; Ofri, Ron; Michaelson, Daniel M.			ApoE4 Induces Synaptic and ERG Impairments in the Retina of Young Targeted Replacement ApoE4 Mice	PLOS ONE			English	Article							APOLIPOPROTEIN-E ALLELES; AMYLOID-BETA PEPTIDES; ALZHEIMERS-DISEASE; MACULAR DEGENERATION; TRANSGENIC MICE; VESICULAR GLUTAMATE; COGNITIVE DEFICITS; MOUSE MODEL; E GENE; EXPRESSION	The vertebrate retina, which is part of the central nervous system, is a window into the brain. The present study investigated the extent to which the retina can be used as a model for studying the pathological effects of apolipoprotein E4 (apoE4), the most prevalent genetic risk factor for Alzheimer's disease (AD). Immunohistochemical studies of retinas from young (4 months old) apoE4-targeted replacement mice and from corresponding mice which express the AD benign apoE3 allele, revealed that the density of the perikarya of the different classes of retinal neurons was not affected by apoE4. In contrast, the synaptic density of the retinal synaptic layers, which was assessed immunohistochemically and by immunoblot experiments, was significantly lower in the apoE4 than in the apoE3 mice. This was associated with reduced levels of the presynaptic vesicular glutamatergic transporter, VGluT1, but not of either the GABAergic vesicular transporter, VGaT, or the cholinergic vesicular transporter, VAChT, suggesting that the glutamatergic nerve terminals are preferentially affected by apoE4. In contrast, the post synaptic scaffold proteins PSD-95 and Gephyrin, which reside in excitatory and inhibitory synapses, respectively, were both elevated, and their ratio was not affected by apoE4. Electroretinogram (ERG) recordings revealed significant attenuation of mixed rod-cone responses in dark-adapted eyes of apoE4 mice. These findings suggest that the reduced ERG response in the apoE4 mice may be related to the observed decrease in the retinal nerve terminals and that the retina could be used as a novel model for non-invasive monitoring of the effects of apoE4 on the CNS.	[Antes, Ran; Michaelson, Daniel M.] Tel Aviv Univ, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Ezra-Elia, Raaya; Ofri, Ron] Hebrew Univ Jerusalem, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Weinberger, Dov] Rabin Med Ctr, Dept Ophthalmol, Petah Tiqwa, Israel; [Solomon, Arie] Tel Aviv Univ, Goldschleger Eye Res Inst, Tel Hashomer, Israel	Tel Aviv University; Hebrew University of Jerusalem; Rabin Medical Center; Tel Aviv University	Michaelson, DM (corresponding author), Tel Aviv Univ, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	dmichael@post.tau.ac.il	ofri, ron/R-8624-2019; Solomon, Arieh/AAF-4361-2021	OFRI, RON/0000-0002-3825-3113	German-Israeli Science Foundation (GIF) [1127-155.2/2010]; Joseph K. and Inez Eichenbaum Foundation; Diane Pregerson Glazer; Guilford Glazer Foundation; Harold and Eleanore Foonberg Foundation	German-Israeli Science Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Joseph K. and Inez Eichenbaum Foundation; Diane Pregerson Glazer; Guilford Glazer Foundation; Harold and Eleanore Foonberg Foundation	This work was supported in part by grants from the German-Israeli Science Foundation (GIF grant # 1127-155.2/2010), the Joseph K. and Inez Eichenbaum Foundation, the Diane Pregerson Glazer, the Guilford Glazer Foundation and the Harold and Eleanore Foonberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer A, 1995, Clin Anat, V8, P429; Arendt T, 1997, J NEUROSCI, V17, P516; Baird PN, 2004, INVEST OPHTH VIS SCI, V45, P1311, DOI 10.1167/iovs.03-1121; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Belinson H, 2008, J NEUROSCI, V28, P4690, DOI 10.1523/JNEUROSCI.5633-07.2008; Belinson H, 2009, J NEURAL TRANSM, V116, P1427, DOI 10.1007/s00702-009-0218-9; Bell KFS, 2006, EUR J PHARMACOL, V545, P11, DOI 10.1016/j.ejphar.2006.06.045; Birkenmeier G, 1996, NEUROREPORT, V8, P149, DOI 10.1097/00001756-199612200-00030; Blain JF, 2006, NEUROBIOL DIS, V21, P505, DOI 10.1016/j.nbd.2005.08.010; Bojanowski CM, 2006, ENVIRON MOL MUTAGEN, V47, P594, DOI 10.1002/em.20233; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Buttini M, 2002, J NEUROSCI, V22, P10539; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Chiu K, 2012, AGE, V34, P633, DOI 10.1007/s11357-011-9260-2; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cueva JG, 2002, J COMP NEUROL, V445, P227, DOI 10.1002/cne.10166; Dumanis SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017203; Francis PT, 2005, CNS SPECTRUMS, V10, P6, DOI 10.1017/S1092852900014164; Fritsche LG, 2009, HUM MUTAT, V30, P1048, DOI 10.1002/humu.20957; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Kihara AH, 2008, NEUROSCIENCE, V151, P995, DOI 10.1016/j.neuroscience.2007.09.088; Kirvell SL, 2006, J NEUROCHEM, V98, P939, DOI 10.1111/j.1471-4159.2006.03935.x; Klein RC, 2010, NEUROSCIENCE, V171, P1265, DOI 10.1016/j.neuroscience.2010.10.027; Koronyo Y, 2012, NEURODEGENER DIS, V10, P285, DOI 10.1159/000335154; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Kurumada S, 2007, INVEST OPHTH VIS SCI, V48, P1815, DOI 10.1167/iovs.06-0902; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Lorber B, 2009, J NEUROSCI RES, V87, P2645, DOI 10.1002/jnr.22095; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; MASLIAH E, 1991, AM J PATHOL, V138, P235; MASLIAH E, 1994, NEUROSCI LETT, V174, P67, DOI 10.1016/0304-3940(94)90121-X; Masliah E, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P91; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Michalski D, 2013, NEUROSCIENCE, V231, P328, DOI 10.1016/j.neuroscience.2012.11.046; Mueller SG, 2010, HUM BRAIN MAPP, V31, P1339, DOI 10.1002/hbm.20934; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; Revett TJ, 2013, J PSYCHIATR NEUROSCI, V38, P6, DOI 10.1503/jpn.110190; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Santos Arturo, 2002, Ophthalmic Genet, V23, P13, DOI 10.1076/opge.23.1.13.2203; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scheff SW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P101; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sen A, 2012, J BIOL CHEM, V287, P15947, DOI 10.1074/jbc.M111.312710; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Trotter JH, 2011, J NEUROSCI, V31, P14413, DOI 10.1523/JNEUROSCI.3135-11.2011; Wang CS, 2005, NEUROBIOL DIS, V18, P390, DOI 10.1016/j.nbd.2004.10.013; Zareparsi S, 2004, INVEST OPHTH VIS SCI, V45, P1306, DOI 10.1167/iovs.03-1253; Zepa L, 2011, INT J ALZHEIMERS DIS; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006	55	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64949	10.1371/journal.pone.0064949	http://dx.doi.org/10.1371/journal.pone.0064949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741431	Green Submitted, Green Published, gold			2022-12-27	WOS:000319799900144
J	Gooden, MJM; Wiersma, VR; Samplonius, DF; Gerssen, J; van Ginkel, RJ; Nijman, HW; Hirashima, M; Niki, T; Eggleton, P; Helfrich, W; Bremer, E				Gooden, Marloes J. M.; Wiersma, Valerie R.; Samplonius, Douwe F.; Gerssen, Jurjen; van Ginkel, Robert J.; Nijman, Hans W.; Hirashima, Mitsuomi; Niki, Toshiro; Eggleton, Paul; Helfrich, Wijnand; Bremer, Edwin			Galectin-9 Activates and Expands Human T-Helper 1 Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; TIM-3; BINDING; SUPPRESSES; DEATH; TH17	Galectin-9 (Gal-9) is known for induction of apoptosis in IFN-gamma and IL-17 producing T-cells and amelioration of autoimmunity in murine models. On the other hand, Gal-9 induced IFN-gamma positive T-cells in a sarcoma mouse model and in food allergy, suggesting that Gal-9 can have diametric effects on T-cell immunity. Here, we aimed to delineate the immunomodulatory effect of Gal-9 on human resting and ex vivo activated peripheral blood lymphocytes. Treatment of resting lymphocytes with low concentrations of Gal-9 (5-30 nM) induced apoptosis in similar to 60% of T-cells after 1 day, but activated the surviving T-cells. These viable T-cells started to expand after 4 days with up to 6 cell divisions by day 7 and an associated shift from naive towards central memory and IFN-gamma producing phenotype. In the presence of T-cell activation signals (anti-CD3/IL-2) Gal-9 did not induce T-cell expansion, but shifted the CD4/CD8 balance towards a CD4-dominated T-cell response. Thus, Gal-9 activates resting T-cells in the absence of typical T-cell activating signals and promotes their transition to a T-H1/C1 phenotype. In the presence of T-cell activating signals T-cell immunity is directed towards a CD4-driven response by Gal-9. Thus, Gal-9 may specifically enhance reactive immunological memory.	[Gooden, Marloes J. M.; Wiersma, Valerie R.; Samplonius, Douwe F.; Gerssen, Jurjen; van Ginkel, Robert J.; Helfrich, Wijnand; Bremer, Edwin] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [Gooden, Marloes J. M.; Nijman, Hans W.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Hirashima, Mitsuomi; Niki, Toshiro] GalPharma Co Ltd, Kagawa, Japan; [Hirashima, Mitsuomi; Niki, Toshiro] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Kagawa, Japan; [Eggleton, Paul] Univ Exeter, Sch Med, Exeter, Devon, England	University of Groningen; University of Groningen; Kagawa University; University of Exeter	Bremer, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands.	e.bremer@umcg.nl	Eggleton, Paul/A-9089-2015; Bremer, Edwin S/B-7508-2016	Bremer, Edwin S/0000-0002-0325-7376; Helfrich, Wijnand/0000-0001-7004-3995; Eggleton, Paul/0000-0001-8244-2125; Wiersma, Valerie R./0000-0001-8012-0376	Dutch Cancer Society [RUG 2009-4355, RUG2009-4542/RUG2011-5206, RUG2007-3784]; Netherlands Organization for Scientific Research; Melanoma Research Alliance; Alexander von Humboldt Foundation; European Community's Seventh Framework Programme (FP7) [215009]	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Melanoma Research Alliance; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Community's Seventh Framework Programme (FP7)	This work was supported by Dutch Cancer Society grants RUG 2009-4355 (E.B.), RUG2009-4542/RUG2011-5206 (E.B/W.H.) and RUG2007-3784 (W.H.), the Netherlands Organization for Scientific Research (E.B.), the Melanoma Research Alliance (E.B.), the Alexander von Humboldt Foundation (E.B.) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement (grant number 215009) (P.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Arikawa T, 2009, CLIN IMMUNOL, V133, P382, DOI 10.1016/j.clim.2009.09.004; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Bremer E, 2011, IMMUNOL LETT, V138, P161, DOI 10.1016/j.imlet.2011.04.004; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; de Kivit S, 2012, ALLERGY, V67, P343, DOI 10.1111/j.1398-9995.2011.02771.x; Elahi S, 2012, BLOOD, V119, P4192, DOI 10.1182/blood-2011-11-389585; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Kanzaki M, 2012, ENDOCRINOLOGY, V153, P612, DOI 10.1210/en.2011-1579; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Kishore U, 1997, MATRIX BIOL, V15, P583, DOI 10.1016/S0945-053X(97)90035-4; Kurose Y, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-23; Lu LH, 2007, J BIOCHEM, V141, P157, DOI 10.1093/jb/mvm019; Lv K, 2011, CLIN IMMUNOL, V140, P92, DOI 10.1016/j.clim.2011.03.017; Moon JY, 2012, AM J NEPHROL, V35, P164, DOI 10.1159/000334928; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Niki T, 2009, J BIOL CHEM, V284, P32344, DOI 10.1074/jbc.M109.035196; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; PALACIOS R, 1982, J IMMUNOL, V128, P337; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shim JA, 2012, IMMUNOBIOLOGY, V217, P657, DOI 10.1016/j.imbio.2011.11.002; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Vaitaitis GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038708; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Walzel H, 2000, GLYCOBIOLOGY, V10, P131, DOI 10.1093/glycob/10.2.131; Wang F, 2011, CELL IMMUNOL, V269, P22, DOI 10.1016/j.cellimm.2011.03.005; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	35	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65616	10.1371/journal.pone.0065616	http://dx.doi.org/10.1371/journal.pone.0065616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741502	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900215
J	Sambany, E; Pussard, E; Rajaonarivo, C; Raobijaona, H; Barennes, H				Sambany, Emercia; Pussard, Eric; Rajaonarivo, Christian; Raobijaona, Honore; Barennes, Hubert			Childhood Dysglycemia: Prevalence and Outcome in a Referral Hospital	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; SEVERE MALARIA; BLOOD-GLUCOSE; AFRICAN CHILDREN; SUBLINGUAL SUGAR; HYPOGLYCEMIA; HYPERGLYCEMIA; ADMISSION; TRANSMISSION; PREDICTORS	Introduction: Hypoglycemia is a defining feature of severe malaria and several other infectious diseases in children but the prevalence, significance, and prognosis of abnormal blood glucose, including hyperglycemia, have rarely been addressed in severely ill children in non-malaria endemic areas. Methods: In Madagascar, consecutive children (1 month-15 years) admitted to the pediatric ward of a referral hospital, were categorized using the integrated management of childhood illness (IMCI). Samples were taken once on admission for measuring blood glucose concentration. Glycemia levels (hypoglycemia <2.2 mmol/l; low glycemia: 2.2-4.4 mmol/l; normoglycemia >4.4-8.3 mmol/l; and hyperglycemia >8.3 mmol/l) were related to the IMCI algorithm and case fatality. Factors associated with blood glucose concentration and case fatality were analysed using univariate and multivariate analysis. Results: Of 420 children, 48.1% (n = 202) were severely ill; 3.1% (n = 13) had hypoglycemia; 20.0% (n = 84) low glycemia; 65.9% (n = 277) normoglycemia; and 10.9% (n = 46) hyperglycemia. In univariate analysis, hypoglycemia and hyperglycemia both showed significant increase in the risk of death, as compared to normal blood glucose (RR: 12.2, 95% CI: 6.2-23.7 and RR: 2.5, 95% CI: 1.0-6.2, respectively). Children with low glycemia had no increased risk of death (RR: 1.2, 95% CI: 0.4-3.2) despite a poorer IMCI status on admission. After logistic regression, hypoglycemia (RR: 19.4, 95% CI: 5.0-.74.7, hepatomegaly (RR: 12.2, 95% CI: 3.3-44.9) and coma (RR: 4.8, 95% CI: 1.3-17.6) were the features on admission associated with an increased risk of death. Conclusions: Dysglycemia in non-neonates is associated with increased mortality. These findings underline the need for the use of rapid screening tests to initiate early treatment. Alternative treatments such as oral or sublingual administration of glucose should be developed in structures with limited resources.	[Sambany, Emercia; Rajaonarivo, Christian; Barennes, Hubert] Inst Francophone Med Trop, Viangchan, Laos; [Pussard, Eric] Pharmacogenet & Hormonol CHU Bicetre Kremlin Bice, Paris, France; [Raobijaona, Honore] Hop Befelatanana, Serv Pediat, Antananarivo, Madagascar; [Barennes, Hubert] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Barennes, Hubert] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Barennes, Hubert] ANRS, Phnom Penh, Cambodia	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Barennes, H (corresponding author), Inst Francophone Med Trop, Viangchan, Laos.	barenneshub@yahoo.fr	PUSSARD, Eric/S-6059-2018; pussard, eric/J-9916-2013		Agence Universitaire de la Francophonie (AUF); Institut Francophone pour la Medecine Tropicale (IFMT)	Agence Universitaire de la Francophonie (AUF); Institut Francophone pour la Medecine Tropicale (IFMT)	Agence Universitaire de la Francophonie (AUF), Institut Francophone pour la Medecine Tropicale (IFMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the authors, and do not necessarily represent the official position of the funders.	ACHOKI R, 2009, J TROP PEDIAT; Andrianaivolambo L, 2010, ACTA TROP, V116, P240, DOI 10.1016/j.actatropica.2010.08.017; Barennes H, 2005, PEDIATRICS, V116, pE648, DOI 10.1542/peds.2004-2218; Barennes H, 2004, FOOD CHEM TOXICOL, V42, P809, DOI 10.1016/j.fct.2004.01.003; Elusiyan JBE, 2006, J TROP PEDIATRICS, V52, P96, DOI 10.1093/tropej/fmi068; Elusiyan JBE, 2006, PEDIATR EMERG CARE, V22, P488, DOI 10.1097/01.pec.0000227382.61390.0c; English M, 1998, QJM-MON J ASSOC PHYS, V91, P191, DOI 10.1093/qjmed/91.3.191; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Graz B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-242; Gupta Piyush, 1997, Indian Journal of Pediatrics, V64, P205, DOI 10.1007/BF02752447; Guyon AB, 2009, FOOD NUTR BULL, V30, P233, DOI 10.1177/156482650903000304; Haymond MW, 1999, ENDOCRIN METAB CLIN, V28, P663, DOI 10.1016/S0889-8529(05)70096-7; Jaffar S, 1997, AM J TROP MED HYG, V57, P20, DOI 10.4269/ajtmh.1997.57.20; Jan IS, 2009, INT J INFECT DIS, V13, P570, DOI 10.1016/j.ijid.2008.08.026; KAWO NG, 1990, LANCET, V336, P454, DOI 10.1016/0140-6736(90)92009-7; Klein GW, 2008, J PEDIATR-US, V153, P379, DOI 10.1016/j.jpeds.2008.04.012; Kochar D K, 1998, J Assoc Physicians India, V46, P923; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Meda HA, 1999, LANCET, V353, P536, DOI 10.1016/S0140-6736(99)01088-0; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; Ogetii GN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-334; Osier FHA, 2003, ARCH DIS CHILD, V88, P621, DOI 10.1136/adc.88.7.621; Palacio A, 2008, J HOSP MED, V3, P212, DOI 10.1002/jhm.309; Pidcoke HF, 2010, CRIT CARE MED, V38, P471, DOI 10.1097/CCM.0b013e3181bc826f; Rakotomanana F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-173; RAOBIJAONA H, 2000, MED AFR NOIRE, V47; Ravelomanana T, 2010, Bull Soc Pathol Exot, V103, P75, DOI 10.1007/s13149-010-0046-z; Reid SR, 2005, J EMERG MED, V29, P141, DOI 10.1016/j.jemermed.2005.02.004; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; TAYLOR TE, 1988, NEW ENGL J MED, V319, P1040, DOI 10.1056/NEJM198810203191602; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; Tuggle DW, 2008, AM SURGEON, V74, P195; Valerio G, 2001, ACTA PAEDIATR, V90, P618, DOI 10.1080/080352501750258658; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Verhoeven JJ, 2009, PEDIATR CRIT CARE ME, V10, P648, DOI 10.1097/PCC.0b013e3181ae787b; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; WHITE NJ, 1987, LANCET, V1, P708; *WHO, 2005, MOD IMCI HDB INT MAN; *WHO, 2011, SYST REV EFF SHORT I; *WHO, 2012, TREATM HYP SEV MALN; Willcox ML, 2010, TROP MED INT HEALTH, V15, P232, DOI 10.1111/j.1365-3156.2009.02444.x; Williams AF, 1997, B WORLD HEALTH ORGAN, V75, P261; Zijlmans WCWR, 2008, TROP MED INT HEALTH, V13, P626, DOI 10.1111/j.1365-3156.2008.02064.x	45	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65193	10.1371/journal.pone.0065193	http://dx.doi.org/10.1371/journal.pone.0065193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741481	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900194
J	Shah, RC; Janos, AL; Kline, JE; Yu, L; Leurgans, SE; Wilson, RS; Wei, P; Bennett, DA; Heilman, KM; Tsao, JW				Shah, Raj C.; Janos, Alicia L.; Kline, Julia E.; Yu, Lei; Leurgans, Sue E.; Wilson, Robert S.; Wei, Peter; Bennett, David A.; Heilman, Kenneth M.; Tsao, Jack W.			Cognitive Decline in Older Persons Initiating Anticholinergic Medications	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DRUGS; IMPAIRMENT; RISK; POPULATION; PEOPLE; ADULTS; IMPACT; AGE	Background: This study examines the effect of initiating medications with anticholinergic activity on the cognitive functions of older persons. Methods: Participants were 896 older community-dwelling, Catholic clergy without baseline dementia. Medication data was collected annually. The Anticholinergic Cognitive Burden Scale was utilized to identify use of a medication with probable or definite anticholinergic activity. Participants had at least two annual cognitive evaluations. Results: Over a mean follow-up of 10 years, the annual rate of global cognitive function decline for never users, prevalent users, and incident users was -0.062 (SE = 0.005), 20.081(SE = 0.011), and -0.096 (SE = 0.007) z-score units/year, respectively. Compared to never users, incident users had a more rapid decline (difference = -0.034 z-score units/year, SE = 0.008, p<0.001) while prevalent users did not have a significantly more rapid decline (p = 0.1). Conclusions: Older persons initiating a medication with anticholinergic activity have a steeper annual decline in cognitive functioning than those who are not taking these medications.	[Shah, Raj C.; Yu, Lei; Leurgans, Sue E.; Wilson, Robert S.; Bennett, David A.] Rush Univ, Med Ctr, RADC, Chicago, IL 60612 USA; [Shah, Raj C.] Rush Univ, Med Ctr, Dept Family Med, Chicago, IL 60612 USA; [Janos, Alicia L.; Kline, Julia E.; Wei, Peter; Tsao, Jack W.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Yu, Lei; Leurgans, Sue E.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Wilson, Robert S.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Heilman, Kenneth M.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Heilman, Kenneth M.] Malcom Randall Vet Affairs Med Ctr, Gainesville, FL USA; [Tsao, Jack W.] United States Navy Bur Med & Surg, Washington, DC USA	Rush University; Rush University; Uniformed Services University of the Health Sciences - USA; Rush University; Rush University; State University System of Florida; University of Florida	Tsao, JW (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.	jack.tsao@usuhs.edu	Shah, Raj/AAS-2210-2021; Yu, Lei/AAT-3685-2020	Shah, Raj/0000-0001-9706-9730; 	American Philosophical Society; National Institute on Aging [R01 AG15819, P30 AG10161]; Illinois Department of Public Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015819, P30AG010161] Funding Source: NIH RePORTER	American Philosophical Society; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a Daland Grant from the American Philosophical Society to JWT, by the National Institute on Aging grants R01 AG15819 and P30 AG10161 to DAB, and by the Illinois Department of Public Health to DAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal NT, 2005, J NEUROL NEUROSUR PS, V76, P1479, DOI 10.1136/jnnp.2004.053561; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Barnes DE, 2007, J AM GERIATR SOC, V55, P259, DOI 10.1111/j.1532-5415.2007.01040.x; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bottiggi KA, 2006, AM J GERIAT PSYCHIAT, V14, P980, DOI 10.1097/01.JGP.0000224619.87681.71; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Buchman AS, 2010, ARTHRIT CARE RES, V62, P1287, DOI 10.1002/acr.20200; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Carriere I, 2009, ARCH INTERN MED, V169, P1317, DOI 10.1001/archinternmed.2009.229; Epstein M, 1996, J AM SOC NEPHROL, V7, P1106; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; He W., 2005, US CENSUS BUREAU CUR, VP23-209, 65; Hilmer SN, 2007, ARCH INTERN MED, V167, P781, DOI 10.1001/archinte.167.8.781; HIXSON JE, 1990, J LIPID RES, V31, P545; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; Lechevallier-Michel N, 2005, BRIT J CLIN PHARMACO, V59, P143, DOI 10.1111/j.1365-2125.2004.02232.x; MCGEER PL, 1984, NEUROLOGY, V34, P741, DOI 10.1212/WNL.34.6.741; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MCPHILLIPS JB, 1989, AM J PREV MED, V5, P65, DOI 10.1016/S0749-3797(18)31107-3; Merchant RA, 2009, AGE AGEING, V38, P105, DOI 10.1093/ageing/afn240; Popescu BO, 2009, J NEUROL SCI, V283, P99, DOI 10.1016/j.jns.2009.02.321; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Wilson RS, 2003, NEUROLOGY, V61, P1479, DOI 10.1212/01.WNL.0000096167.56734.59; Wilson RS, 2005, J INT NEUROPSYCH SOC, V11, P400, DOI 10.1017/S1355617705050459; Yaffe K, 2010, J AM GERIATR SOC, V58, P889, DOI 10.1111/j.1532-5415.2010.02818.x	29	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64111	10.1371/journal.pone.0064111	http://dx.doi.org/10.1371/journal.pone.0064111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741303	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900015
J	Singh, H; Figliola, MJ; Dawson, MJ; Olivares, S; Zhang, L; Yang, G; Maiti, S; Manuri, P; Senyukov, V; Jena, B; Kebriaei, P; Champlin, RE; Huls, H; Cooper, LJN				Singh, Harjeet; Figliola, Matthew J.; Dawson, Margaret J.; Olivares, Simon; Zhang, Ling; Yang, Ge; Maiti, Sourindra; Manuri, Pallavi; Senyukov, Vladimir; Jena, Bipulendu; Kebriaei, Partow; Champlin, Richard E.; Huls, Helen; Cooper, Laurence J. N.			Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells	PLOS ONE			English	Article							ADOPTIVE IMMUNOTHERAPY; MALIGNANCIES; SPECIFICITY; THERAPY; TRANSPOSITION; PERSISTENCE	Adoptive transfer of T cells expressing a CD19-specific chimeric antigen receptor (CAR) is being evaluated in multiple clinical trials. Our current approach to adoptive immunotherapy is based on a second generation CAR (designated CD19RCD28) that signals through a CD28 and CD3-zeta endodomain. T cells are electroporated with DNA plasmids from the Sleeping Beauty (SB) transposon/transposase system to express this CAR. Stable integrants of genetically modified T cells can then be retrieved when co-cultured with designer artificial antigen presenting cells (aAPC) in the presence of interleukin (IL)-2 and 21. Here, we reveal how the platform technologies of SB-mediated transposition and CAR-dependent propagation on aAPC were adapted for human application. Indeed, we have initiated clinical trials in patients with high-risk B-lineage malignancies undergoing autologous and allogeneic hematopoietic stem-cell transplantation (HSCT). We describe the process to manufacture clinical grade CD19-specific T cells derived from healthy donors. Three validation runs were completed in compliance with current good manufacturing practice for Phase I/II trials demonstrating that by 28 days of co-culture on gamma-irradiated aAPC similar to 10(10) T cells were produced of which >95% expressed CAR. These genetically modified and propagated T cells met all quality control testing and release criteria in support of infusion.	[Singh, Harjeet; Figliola, Matthew J.; Dawson, Margaret J.; Olivares, Simon; Zhang, Ling; Yang, Ge; Maiti, Sourindra; Manuri, Pallavi; Senyukov, Vladimir; Jena, Bipulendu; Huls, Helen; Cooper, Laurence J. N.] Univ Texas MD Anderson Canc Ctr, Childrens Canc Hosp, Div Pediat, Houston, TX 77030 USA; [Kebriaei, Partow; Champlin, Richard E.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Cooper, Laurence J. N.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Cooper, LJN (corresponding author), Univ Texas MD Anderson Canc Ctr, Childrens Canc Hosp, Div Pediat, Houston, TX 77030 USA.	ljncooper@mdanderson.org	Jena, Bipulendu/G-8206-2014		Cancer Center Core Grant [CA16672]; Adee Heebe, Albert J. Ward Foundation; Ahuja family; Ann Parsons Memorial Foundation; Burroughs Wellcome Fund; Gillson Longenbaugh Foundation; Cancer Prevention and Research Institute of Texas; CLL Global Research Foundation; Department of Defense; Estate of Noelan L. Bibler; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Institute of Personalized Cancer Therapy; Leukemia and Lymphoma Society; Lymphoma Research Foundation; MDACC's Sister Institution Network Fund; Miller Foundation; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Production Assistance for Cellular Therapies (PACT); William Lawrence and Blanche Hughes Children's Foundation;  [RO1 CA124782];  [RO1 CA120956];  [RO1 CA141303];  [RO1 CA163587];  [RO1 CA174385];  [R33 CA116127];  [P01 CA148600]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA124782, R01CA141303, P01CA148600, R01CA120956, R33CA116127, R01CA163587, R01CA174385] Funding Source: NIH RePORTER	Cancer Center Core Grant; Adee Heebe, Albert J. Ward Foundation; Ahuja family; Ann Parsons Memorial Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Gillson Longenbaugh Foundation; Cancer Prevention and Research Institute of Texas; CLL Global Research Foundation; Department of Defense(United States Department of Defense); Estate of Noelan L. Bibler; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Institute of Personalized Cancer Therapy; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lymphoma Research Foundation; MDACC's Sister Institution Network Fund; Miller Foundation; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Production Assistance for Cellular Therapies (PACT); William Lawrence and Blanche Hughes Children's Foundation; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Cancer Center Core Grant (CA16672); RO1 (CA124782, CA120956, CA141303, CA163587, CA174385); R33 (CA116127); P01 (CA148600); Adee Heebe, Albert J. Ward Foundation; Ahuja family; Ann Parsons Memorial Foundation; Burroughs Wellcome Fund; Gillson Longenbaugh Foundation; Cancer Prevention and Research Institute of Texas; CLL Global Research Foundation; Department of Defense; Estate of Noelan L. Bibler; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Institute of Personalized Cancer Therapy; Leukemia and Lymphoma Society; Lymphoma Research Foundation; MDACC's Sister Institution Network Fund; Miller Foundation; Mr. Herb Simons; Mr. and Mrs. Joe H. Scales; Mr. Thomas Scott; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Production Assistance for Cellular Therapies (PACT); and William Lawrence and Blanche Hughes Children's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Cooper LJN, 2012, BLOOD, V119, P2700, DOI 10.1182/blood-2011-12-398719; Davies JK, 2010, CANCER RES, V70, P3915, DOI 10.1158/0008-5472.CAN-09-3845; Hollis RP, 2006, EXP HEMATOL, V34, P1333, DOI 10.1016/j.exphem.2006.05.023; Huls MH, 2013, JOVE-J VIS EXP, DOI 10.3791/50070; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2004, MOL THER, V9, P147, DOI 10.1016/j.ymthe.2003.11.009; Jena B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057838; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; Kalos M, 2011, SCI TRANSL MED, V3; Kebriaei P, 2012, HUM GENE THER, V23, P444, DOI 10.1089/hum.2011.167; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Mahmoud MS, 1999, BLOOD, V94, P3551, DOI 10.1182/blood.V94.10.3551.422k08_3551_3558; Maiti SN, 2013, J IMMUNOTHER, V36, P112, DOI 10.1097/CJI.0b013e3182811ce9; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rabinovich BA, 2008, IMMUNOL CELL BIOL, V86, P489, DOI 10.1038/icb.2008.41; Serrano LM, 2006, BLOOD, V107, P2643, DOI 10.1182/blood-2005-09-3904; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Singh H, 2011, CANCER RES, V71, P3516, DOI 10.1158/0008-5472.CAN-10-3843; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90	27	141	158	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64138	10.1371/journal.pone.0064138	http://dx.doi.org/10.1371/journal.pone.0064138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741305	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900017
J	Tingaud-Sequeira, A; Lozano, JJ; Zapater, C; Otero, D; Kube, M; Reinhardt, R; Cerda, J				Tingaud-Sequeira, Angele; Lozano, Juan-Jose; Zapater, Cinta; Otero, David; Kube, Michael; Reinhardt, Richard; Cerda, Joan			A Rapid Transcriptome Response Is Associated with Desiccation Resistance in Aerially-Exposed Killifish Embryos	PLOS ONE			English	Article							DUPLEX-SPECIFIC NUCLEASE; OXYGEN-CONSUMPTION RATE; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; FUNDULUS-HETEROCLITUS; PHYSIOLOGICAL PLASTICITY; MOLECULAR CHAPERONES; METABOLIC-REGULATION; FUNCTIONAL GENOMICS; NATURAL-POPULATIONS	Delayed hatching is a form of dormancy evolved in some amphibian and fish embryos to cope with environmental conditions transiently hostile to the survival of hatchlings or larvae. While diapause and cryptobiosis have been extensively studied in several animals, very little is known concerning the molecular mechanisms involved in the sensing and response of fish embryos to environmental cues. Embryos of the euryhaline killifish Fundulus heteroclitus advance dvelopment when exposed to air but hatching is suspended until flooding with seawater. Here, we investigated how transcriptome regulation underpins this adaptive response by examining changes in gene expression profiles of aerially incubated killifish embryos at similar to 100% relative humidity, compared to embryos continuously flooded in water. The results confirm that mid-gastrula embryos are able to stimulate development in response to aerial incubation, which is accompanied by the differential expression of at least 806 distinct genes during a 24 h period. Most of these genes (similar to 70%) appear to be differentially expressed within 3 h of aerial exposure, suggesting a broad and rapid transcriptomic response. This response seems to include an early sensing phase, which overlaps with a tissue remodeling and activation of embryonic development phase involving many regulatory and metabolic pathways. Interestingly, we found fast (0.5-1 h) transcriptional differences in representatives of classical "stress" proteins, such as some molecular chaperones, members of signalling pathways typically involved in the transduction of sensor signals to stress response genes, and oxidative stress-related proteins, similar to that described in other animals undergoing dormancy, diapause or desiccation. To our knowledge, these data represent the first transcriptional profiling of molecular processes associated with desiccation resistance during delayed hatching in non-mammalian vertebrates. The exceptional transcriptomic plasticity observed in killifish embryos provides an important insight as to how the embryos are able to rapidly adapt to non-lethal desiccation conditions.	[Tingaud-Sequeira, Angele; Zapater, Cinta; Otero, David; Cerda, Joan] CSIC, Inst Ciencies Mar, IRTA, Barcelona, Spain; [Lozano, Juan-Jose] CIBERHED, Barcelona, Spain; [Kube, Michael; Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); IRTA; Max Planck Society	Cerda, J (corresponding author), CSIC, Inst Ciencies Mar, IRTA, Barcelona, Spain.	joan.cerda@irta.cat	Zapater, Cinta/L-9406-2017; Cerdà, Joan/M-1099-2016; TINGAUD-SEQUEIRA, Angela/M-6023-2014	Zapater, Cinta/0000-0001-9326-7502; Cerdà, Joan/0000-0003-2568-6398; Lozano, Juan Jose/0000-0001-7613-3908; Reinhardt, Richard/0000-0001-9376-2132	European Commission (NEST) [012674]	European Commission (NEST)(European CommissionEuropean Commission Joint Research Centre)	This study was financially supported by the European Commission (NEST # 012674; Sleeping Beauty). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; ARMSTRON.PB, 1965, BIOL BULL, V128, P143, DOI 10.2307/1539545; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldwin Jamie L., 2006, Bulletin of the Mount Desert Island Biological Laboratory, V45, P45; Baldwin Jamie L., 2004, Bulletin of the Mount Desert Island Biological Laboratory, V43, P110; Banton MC, 2012, J EXP BIOL, V215, P4288, DOI 10.1242/jeb.074799; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bozinovic G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-132; Bozinovic G, 2010, AQUAT TOXICOL, V98, P221, DOI 10.1016/j.aquatox.2010.02.022; Chauvigne F, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00066; Cheng HL, 2010, MOL BIOL REP, V37, P2665, DOI 10.1007/s11033-009-9797-7; CHUAYPANANG S, 2012, THESIS ILLINOIS STAT; Chuaypanang S, 2013, J EXP ZOOL PART A, V319A, P179, DOI 10.1002/jez.1783; Clark MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029365; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Diehl F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e38; DIMICHELE L, 1980, J EXP ZOOL, V214, P181, DOI 10.1002/jez.1402140209; DIMICHELE L, 1984, PHYSIOL ZOOL, V57, P52, DOI 10.1086/physzool.57.1.30155967; DIMICHELE L, 1984, PHYSIOL ZOOL, V57, P46, DOI 10.1086/physzool.57.1.30155966; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Djavaheri-Mergny M, 2004, FEBS LETT, V578, P111, DOI 10.1016/j.febslet.2004.10.082; Dong CW, 2006, FISH SHELLFISH IMMUN, V21, P146, DOI 10.1016/j.fsi.2005.11.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fabra M, 2004, MOL REPROD DEV, V67, P282, DOI 10.1002/mrd.20018; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fisher MA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-108; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GLUTEK SM, 1990, J STEROID BIOCHEM, V37, P707, DOI 10.1016/0960-0760(90)90355-O; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; HARRINGTON RW, 1959, ECOLOGY, V40, P430, DOI 10.2307/1929760; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hecht J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-172; HEMING TA, 1988, FISH PHYSL, V11; Hiramatsu N, 2002, J EXP ZOOL, V292, P11, DOI 10.1002/jez.1138; Hoffmann EK, 2007, COMP BIOCHEM PHYS A, V148, P29, DOI 10.1016/j.cbpa.2006.11.023; Holmes RS, 2011, COMP BIOCHEM PHYS D, V6, P224, DOI 10.1016/j.cbd.2011.04.003; Huang TS, 2009, COMP BIOCHEM PHYS B, V154, P435, DOI 10.1016/j.cbpb.2009.08.009; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kawaguchi M, 2005, FEBS J, V272, P4315, DOI 10.1111/j.1742-4658.2005.04845.x; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; Kurtzman AL, 2000, J NEUROCHEM, V75, P48, DOI 10.1046/j.1471-4159.2000.0750048.x; Kwon JY, 2001, BIOL REPROD, V65, P1701, DOI 10.1095/biolreprod65.6.1701; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Lubzens E, 2010, TOP CURR GENET, V21, P1, DOI 10.1007/978-3-642-12422-8_1; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Martin K, 2011, INTEGR COMP BIOL, V51, P26, DOI 10.1093/icb/icr037; Martin KLM, 1999, AM ZOOL, V39, P279; Martin KLM, 2004, PHYSIOL BIOCHEM ZOOL, V77, P750, DOI 10.1086/421755; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Oleksiak MF, 2008, AQUAT TOXICOL, V90, P161, DOI 10.1016/j.aquatox.2008.08.010; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Parkinson J, 2004, BIOINFORMATICS, V20, P1398, DOI 10.1093/bioinformatics/bth101; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petersen CW, 2010, COPEIA, P203, DOI 10.1643/CP-08-229; Podrabsky JE, 2012, CELL CYCLE, V11, P1697, DOI 10.4161/cc.19881; Podrabsky JE, 2010, TOP CURR GENET, V21, P203, DOI 10.1007/978-3-642-12422-8_12; Podrabsky JE, 1998, HYDROBIOLOGIA, V362, P67; Poupard G, 2000, CELL TISSUE RES, V300, P251, DOI 10.1007/s004419900158; POWERS DA, 1991, ANNU REV GENET, V25, P629; Pri-Tal BM, 2011, GEN COMP ENDOCR, V174, P166, DOI 10.1016/j.ygcen.2011.08.016; Rabus R, 2002, PROTEOMICS, V2, P649, DOI 10.1002/1615-9861(200206)2:6<649::AID-PROT649>3.0.CO;2-R; Ricci C, 2001, HYDROBIOLOGIA, V446, P1, DOI 10.1023/A:1017548418201; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakaguchi A, 2004, J BIOCHEM, V136, P7, DOI 10.1093/jb/mvh097; SANCHEZ ER, 1990, J BIOL CHEM, V265, P22067; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SIRE MF, 1994, J EXP ZOOL, V269, P69, DOI 10.1002/jez.1402690109; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Taylor MH, 1999, AM ZOOL, V39, P313; TAYLOR MH, 1979, COPEIA, P291, DOI 10.2307/1443417; TAYLOR MH, 1977, COPEIA, P397; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Thisse B., 2001, R01RR15402 NIH; Tingaud-Sequeira A, 2007, GENE, V386, P98, DOI 10.1016/j.gene.2006.08.018; Tingaud-Sequeira A, 2011, COMP BIOCHEM PHYS A, V158, P221, DOI 10.1016/j.cbpa.2010.11.002; Tingaud-Sequeira A, 2009, AM J PHYSIOL-REG I, V296, pR1041, DOI 10.1152/ajpregu.91002.2008; Tse WKF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-637; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P14, DOI 10.1093/icb/icr017; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P111, DOI 10.1093/icb/icr046; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Whitehead A, 2011, J HERED, V102, P499, DOI 10.1093/jhered/esq077; Whitehead A, 2011, P NATL ACAD SCI USA, V108, P6193, DOI 10.1073/pnas.1017542108; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; WOURMS JP, 1972, J EXP ZOOL, V182, P389, DOI 10.1002/jez.1401820310; Zhang T, 2011, J BIOL CHEM, V286, P9514, DOI 10.1074/jbc.M110.134908; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	105	17	17	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64410	10.1371/journal.pone.0064410	http://dx.doi.org/10.1371/journal.pone.0064410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741328	Green Published, gold			2022-12-27	WOS:000319799900040
J	Wang, N; Kimball, RT; Braun, EL; Liang, B; Zhang, ZW				Wang, Ning; Kimball, Rebecca T.; Braun, Edward L.; Liang, Bin; Zhang, Zhengwang			Assessing Phylogenetic Relationships among Galliformes: A Multigene Phylogeny with Expanded Taxon Sampling in Phasianidae	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; GAMEBIRDS AVES; CYTOCHROME-B; BIRDS AVES; AVIAN TREE; EVOLUTION; MITOCHONDRIAL; NUCLEAR	Galliform birds (relatives of the chicken and turkey) have attracted substantial attention due to their importance to society and value as model systems. This makes understanding the evolutionary history of Galliformes, especially the species-rich family Phasianidae, particularly interesting and important for comparative studies in this group. Previous studies have differed in their conclusions regarding galliform phylogeny. Some of these studies have suggested that specific clades within this order underwent rapid radiations, potentially leading to the observed difficulty in resolving their phylogenetic relationships. Here we presented analyses of six nuclear intron sequences and two mitochondrial regions, an amount of sequence data larger than many previous studies, and expanded taxon sampling by collecting data from 88 galliform species and four anseriform outgroups. Our results corroborated recent studies describing relationships among the major families, and provided further evidence that the traditional division of the largest family, the Phasianidae into two major groups ("pheasants" and "partridges") is not valid. Within the Phasianidae, relationships among many genera have varied among studies and there has been little consensus for the placement of many taxa. Using this large dataset, with substantial sampling within the Phasianidae, we obtained strong bootstrap support to confirm some previously hypothesized relationships and we were able to exclude others. In addition, we added the first nuclear sequence data for the partridge and quail genera Ammoperdix, Caloperdix, Excalfactoria, and Margaroperdix, placing these taxa in the galliform tree of life with confidence. Despite the novel insights obtained by combining increased sampling of taxa and loci, our results suggest that additional data collection will be necessary to solve the remaining uncertainties.	[Wang, Ning; Zhang, Zhengwang] Beijing Normal Univ, Coll Life Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Beijing, Peoples R China; [Wang, Ning; Kimball, Rebecca T.; Braun, Edward L.] Univ Florida, Dept Biol, Gainesville, FL USA; [Wang, Ning; Liang, Bin] Hainan Normal Univ, Coll Life Sci, Key Lab Trop Plant & Anim Ecol, Minist Educ, Haikou, Peoples R China	Beijing Normal University; State University System of Florida; University of Florida; Hainan Normal University	Zhang, ZW (corresponding author), Beijing Normal Univ, Coll Life Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Beijing, Peoples R China.	zzw@bnu.edu.cn	Wang, Ning/ABD-7838-2020; Kimball, Rebecca/Q-6862-2019; Kimball, Rebecca T/C-2290-2009	Kimball, Rebecca/0000-0001-5449-5481; Zhang, Zhengwang/0000-0003-1063-7198; Braun, Edward/0000-0003-1643-5212	National Natural Science Foundation of China [30570234]; U.S. National Science Foundation [DEB-1118823]; National Key Project of Scientific and Technical Supporting Programs; Ministry of Science and Technology of China [2012BAC01B06]; China Scholarship Council; Direct For Biological Sciences [1118823] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Science Foundation(National Science Foundation (NSF)); National Key Project of Scientific and Technical Supporting Programs; Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Scholarship Council(China Scholarship Council); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by the National Natural Science Foundation of China (no. 30570234) and the U.S. National Science Foundation (grant DEB-1118823 to RTK and ELB). It was also supported by the National Key Project of Scientific and Technical Supporting Programs funded by Ministry of Science and Technology of China (2012BAC01B06). NW was supported on a fellowship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MH, 2001, AUK, V118, P799, DOI 10.1642/0004-8038(2001)118[0799:PUOAOI]2.0.CO;2; Bao XK, 2010, MOL PHYLOGENET EVOL, V56, P840, DOI 10.1016/j.ympev.2010.03.038; Beebe C. W., 1914, Zoologica New York, V1; Bloomer P, 1998, MOL PHYLOGENET EVOL, V9, P236, DOI 10.1006/mpev.1997.0469; Bonilla AJ, 2010, MOL PHYLOGENET EVOL, V56, P536, DOI 10.1016/j.ympev.2010.04.006; Braun EL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-141; Braun EL, 2002, SYST BIOL, V51, P614, DOI 10.1080/10635150290102294; Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Cohen C, 2012, IBIS, V154, P768, DOI 10.1111/j.1474-919X.2012.01269.x; Cox WA, 2007, AUK, V124, P71, DOI 10.1642/0004-8038(2007)124[71:PPOTNW]2.0.CO;2; CROWE T M, 1988, Transactions of the Royal Society of South Africa, V46, P317; Crowe TM, 2006, CLADISTICS, V22, P495, DOI 10.1111/j.1096-0031.2006.00120.x; Del Hoyo J., 1994, HDB BIRDS WORLD, V2; Delacour J., 1977, PHEASANTS WORLD; Dimcheff DE, 2002, MOL PHYLOGENET EVOL, V24, P203, DOI 10.1016/S1055-7903(02)00230-0; Dimcheff DE, 2001, J VIROL, V75, P2002, DOI 10.1128/JVI.75.4.2002-2009.2001; Dyke GJ, 2003, ZOOL J LINN SOC-LOND, V137, P227, DOI 10.1046/j.1096-3642.2003.00048.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eo SH, 2009, ZOOL SCR, V38, P465, DOI 10.1111/j.1463-6409.2008.00382.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FUMIHITO A, 1995, P NATL ACAD SCI USA, V92, P11053, DOI 10.1073/pnas.92.24.11053; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GUTIERREZ RJ, 1983, AUK, V100, P33, DOI 10.1093/auk/100.1.33; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Han KL, 2011, SYST BIOL, V60, P375, DOI 10.1093/sysbio/syq100; HELMBYCHOWSKI KM, 1986, P NATL ACAD SCI USA, V83, P688, DOI 10.1073/pnas.83.3.688; HENDERSON JY, 1981, EUR J BIOCHEM, V114, P439, DOI 10.1111/j.1432-1033.1981.tb05165.x; HUDSON GE, 1966, AM MIDL NAT, V76, P1, DOI 10.2307/2423235; HUDSON GEORGE E., 1964, AMER MIDLAND NAT, V71, P1, DOI 10.2307/2422689; Johnsgard P.A., 1986, PHEASANTS WORLD; Johnsgard PA, 1988, QUAILS PARTRIDGES FR; JOLLES J, 1976, J MOL EVOL, V8, P59, DOI 10.1007/BF01738883; Kaiser VB, 2007, MOL BIOL EVOL, V24, P338, DOI 10.1093/molbev/msl164; Kan XZ, 2010, GENET MOL RES, V9, P1625, DOI 10.4238/vol9-3gmr898; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kimball RT, 2008, J AVIAN BIOL, V39, P438, DOI 10.1111/j.2008.0908-8857.04270.x; Kimball Rebecca T., 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/423938; Kimball RT, 2009, MOL PHYLOGENET EVOL, V50, P654, DOI 10.1016/j.ympev.2008.11.018; Kimball RT, 1999, MOL PHYLOGENET EVOL, V11, P38, DOI 10.1006/mpev.1998.0562; Kimball RT, 2001, BIOL J LINN SOC, V73, P187, DOI 10.1006/bijl.2001.0536; Kolm N, 2007, J EVOLUTION BIOL, V20, P627, DOI 10.1111/j.1420-9101.2006.01248.x; KORNEGAY JR, 1993, J MOL EVOL, V37, P367, DOI 10.1007/BF00178867; Kriegs JO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-190; Kruger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032139; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Lislevand T, 2009, J EVOLUTION BIOL, V22, P1895, DOI 10.1111/j.1420-9101.2009.01802.x; Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu ZF, 2012, GENE, V502, P125, DOI 10.1016/j.gene.2012.04.068; Lucchini V, 1999, P 22 INT ORN C DURB, P732; Mayr G, 2008, CLADISTICS, V24, P74, DOI 10.1111/j.1096-0031.2007.00170.x; McGuire JA, 2007, EVOLUTION, V61, P2879, DOI 10.1111/j.1558-5646.2007.00239.x; Meng Y, 2008, BIOCHEM SYST ECOL, V36, P626, DOI 10.1016/j.bse.2008.01.007; Minh BQ, 2009, SYST BIOL, V58, P586, DOI 10.1093/sysbio/syp058; Mooers AO, 2005, CONSERV BIOL SER, V8, P120; Nadeau NJ, 2007, P ROY SOC B-BIOL SCI, V274, P1807, DOI 10.1098/rspb.2007.0174; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Pereira SL, 2006, MOL PHYLOGENET EVOL, V38, P499, DOI 10.1016/j.ympev.2005.07.007; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRAGER EM, 1976, J MOL EVOL, V8, P283, DOI 10.1007/BF01731001; Prychitko TM, 2000, MOL BIOL EVOL, V17, P1101, DOI 10.1093/oxfordjournals.molbev.a026391; Rambaut A., 2007, TRACER V1 4; RANDI E, 1991, BIOCHEM SYST ECOL, V19, P213, DOI 10.1016/0305-1978(91)90005-K; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208; Shaw TI, 2012, WEBSERVER SPECIES TR; Shen Yong-Yi, 2010, BMC Evol Biol, V10, P132, DOI 10.1186/1471-2148-10-132; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Smith EJ, 2005, GENETICA, V124, P23, DOI 10.1007/s10709-004-5184-4; Smith JV, 2013, SYST BIOL, V62, P35, DOI 10.1093/sysbio/sys067; Smythe AB, 2006, SYST BIOL, V55, P972, DOI 10.1080/10635150601089001; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOCK AD, 1982, CYTOGENET CELL GENET, V34, P136, DOI 10.1159/000131802; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Verheyen R., 1956, Bull Inst Sci nat Belg, V32, P1; Wang N, 2012, MOL BIOL EVOL, V29, P737, DOI 10.1093/molbev/msr230; WETMORE ALEXANDER, 1960, SMITHSONIAN MISC COLL, V139, P1; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	85	62	66	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64312	10.1371/journal.pone.0064312	http://dx.doi.org/10.1371/journal.pone.0064312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741315	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900027
J	Ebert-Zavos, E; Horvat-Gordon, M; Taylor, A; Bartell, PA				Ebert-Zavos, Elizabeth; Horvat-Gordon, Maria; Taylor, Alexander; Bartell, Paul A.			Biological Clocks in the Duodenum and the Diurnal Regulation of Duodenal and Plasma Serotonin	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; GASTROINTESTINAL-TRACT; PINEAL-GLAND; MELATONIN; RHYTHMS; RETINA; HYPOTHALAMUS; MOTILITY	Serotonin in blood plasma is primarily synthesized in the duodenum, as brain derived serotonin does not cross the blood-brain barrier. Because serotonin in the brain and retina is synthesized under the control of a circadian clock, we sought to determine if a circadian clock in the duodenum regulates serotonin synthesis and release in blood. We examined gene expression in the duodenum of chickens at different times of the day and found that the duodenum rhythmically expresses molecular circadian clock genes and genes controlling serotonin biosynthesis, specifically tryptophan hydroxylase, in a light dark cycle (LD). Analysis of the duodenum and blood plasma showed that the amount of serotonin in the duodenum varies across the day and that serotonin profiles in blood plasma are also rhythmic in LD, but were not rhythmic in constant darkness. Because serotonin in the gut affects duodenal nutrient absorption and gut motility, the control of serotonin production in the duodenum by LD cycles could provide an additional mechanism by which the external environment controls nutrient uptake and digestive function. The diurnal regulation of plasma serotonin may also serve as an additional biochemical signal in the blood encoding time and could be used by target tissues to indicate the status of nutrient absorption.	[Ebert-Zavos, Elizabeth; Horvat-Gordon, Maria; Bartell, Paul A.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Taylor, Alexander; Bartell, Paul A.] Penn State Univ, Intercollgiate Grad Program Physiol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bartell, PA (corresponding author), Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.	pab43@psu.edu			USDA National Institute of Food and Agriculture [2010-65206-20779]; Schreyer Honors College; College of Agricultural Sciences; Department of Poultry Science of the Pennsylvania State University	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Schreyer Honors College; College of Agricultural Sciences; Department of Poultry Science of the Pennsylvania State University	This project was supported in part by Competitive Grant no. 2010-65206-20779 from the USDA National Institute of Food and Agriculture. The authors also acknowledge funding from the Schreyer Honors College, the College of Agricultural Sciences, and the Department of Poultry Science of the Pennsylvania State University. The funders had no role in the design of the project or interpretation of the results.	Abraham U, 2003, CHRONOBIOL INT, V20, P657, DOI 10.1081/CBI-120022414; Abraham U, 2002, EUR J NEUROSCI, V16, P429, DOI 10.1046/j.1460-9568.2002.02102.x; Bailey MJ, 2004, J BIOL CHEM, V279, P52247, DOI 10.1074/jbc.M405679200; Bailey MJ, 2003, MOL ENDOCRINOL, V17, P2084, DOI 10.1210/me.2003-0121; Bailey MJ, 2002, FEBS LETT, V513, P169, DOI 10.1016/S0014-5793(02)02276-7; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brandstatter R, 2001, NEUROREPORT, V12, P1167, DOI 10.1097/00001756-200105080-00023; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; BUBENIK GA, 1989, J PINEAL RES, V7, P333, DOI 10.1111/j.1600-079X.1989.tb00909.x; CASSONE VM, 1984, J EXP ZOOL, V232, P539, DOI 10.1002/jez.1402320321; Chen JJ, 2004, GASTROENTEROLOGY, V126, pA411; Chin A, 2012, AM J PHYSIOL-GASTR L, V302, pG397, DOI 10.1152/ajpgi.00087.2011; Chong NW, 2003, J NEUROCHEM, V85, P851, DOI 10.1046/j.1471-4159.2003.01723.x; Chong NW, 2002, J BIOL CHEM, V275, P32991; Fu ZW, 2002, J BIOL RHYTHM, V17, P14, DOI 10.1177/074873002129002302; Fujimiya M, 1998, AM J PHYSIOL-GASTR L, V275, pG731, DOI 10.1152/ajpgi.1998.275.4.G731; Haque R, 2002, NEUROREPORT, V13, P2247, DOI 10.1097/00001756-200212030-00016; Herzog ED, 2001, SEMIN CELL DEV BIOL, V12, P295, DOI 10.1006/scdb.2001.0257; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V298, pG143, DOI 10.1152/ajpgi.00402.2009; Karaganis SP, 2009, GEN COMP ENDOCR, V161, P179, DOI 10.1016/j.ygcen.2008.12.015; Kojima S, 2011, BRIT J PHARMACOL, V162, P1179, DOI 10.1111/j.1476-5381.2010.01122.x; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Rosen CJ, 2009, NAT MED, V15, P145, DOI 10.1038/nm0209-145; Thomas K, 1989, NEUROSCI ABSTR, V15, P1396; Tischkau SA, 2011, CHRONOBIOL INT, V28, P10, DOI 10.3109/07420528.2010.530363; Van't Hof TJ, 1999, J BIOL RHYTHM, V14, P185, DOI 10.1177/074873099129000588; Velarde E, 2010, CHRONOBIOL INT, V27, P1178, DOI 10.3109/07420528.2010.496911; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yasuo S, 2003, ENDOCRINOLOGY, V144, P3742, DOI 10.1210/en.2003-0435; Yasuo S, 2002, EUR J NEUROSCI, V16, P1541, DOI 10.1046/j.1460-9568.2002.02222.x; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7; Yoshimura T, 2001, AM J PHYSIOL-REG I, V280, pR1185, DOI 10.1152/ajpregu.2001.280.4.R1185; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	37	14	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e58477	10.1371/journal.pone.0058477	http://dx.doi.org/10.1371/journal.pone.0058477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737937	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700001
J	Song, XJ; Xia, Y; Wang, NY; Zhang, LD; Shi, XL; Xu, YZ; Ye, TH; Shi, YJ; Zhu, YX; Yu, LT				Song Xuejiao; Xia Yong; Wang Ningyu; Zhang Lidan; Shi Xuanhong; Xu Youzhi; Ye Tinghong; Shi Yaojie; Zhu Yongxia; Yu Luoting			A Novel Benzothiazole Derivative YLT322 Induces Apoptosis via the Mitochondrial Apoptosis Pathway In Vitro with Anti-Tumor Activity in Solid Malignancies	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CYTOCHROME-C; BCL-2 FAMILY; CELL-DEATH; CANCER; ANTIOXIDANT; ACTIVATION; RELEASE; GROWTH; AKT	Benzothiazole derivatives are known for various biological activities, and their potency in cancer therapy has received considerable attention in recent years. YLT322, a novel synthesized benzothiazole derivative, exhibits potent anti-tumor activity via inducing apoptosis both in vitro and in vivo. In this study, we found that YLT322 showed growth inhibition against a broad spectrum of human cancer cells and induced apoptosis of HepG2 cells in a dose-and time-dependent manner. The occurrence of its apoptosis was associated with activation of caspases-3 and -9, but not caspase-8. YLT322 increased the expression of Bax, decreased the expression of Bcl-2, and induced the release of cytochrome c which activates the mitochondrial apoptotic pathway. The down-regulation of phosphorylated p42/44 MAPK and phosphorylated Akt was also observed. Moreover, YLT322 suppressed the growth of established tumors in xenograft models in mice without obvious side effects. Histological and immunohistochemical analyses revealed an increase in TUNEL and caspase-3-positive cells and a decrease in Ki67-positive cells upon YLT322. These results suggest that YLT322 may be a potential candidate for cancer therapy.	[Song Xuejiao; Xia Yong; Wang Ningyu; Shi Xuanhong; Xu Youzhi; Ye Tinghong; Shi Yaojie; Zhu Yongxia; Yu Luoting] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Song Xuejiao; Xia Yong; Wang Ningyu; Shi Xuanhong; Xu Youzhi; Ye Tinghong; Shi Yaojie; Zhu Yongxia; Yu Luoting] Sichuan Univ, West China Med Sch, West China Hosp, Ctr Canc, Chengdu 610064, Peoples R China; [Zhang Lidan] Sichuan Univ, Dept Pharmaceut & Bioengn, Sch Chem Engn, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Yu, LT (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	yuluot@scu.edu.cn	Shi, Yao/GXZ-6982-2022	Shi, Yao/0000-0003-0068-4804	Shijiazhuang Pharmaceutical Group Co., Ltd. [11H0684]	Shijiazhuang Pharmaceutical Group Co., Ltd.	This work was supported by Shijiazhuang Pharmaceutical Group Co., Ltd. (project name SKLB163; contract number 11H0684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2008, MOL CANCER THER, V7, P1708, DOI 10.1158/1535-7163.MCT-08-0354; Amundson SA, 2000, CANCER RES, V60, P6101; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Baffy G, 2012, AM J GASTROENTEROL, V107, P53, DOI 10.1038/ajg.2011.390; Belka C, 2004, INT J RADIAT ONCOL, V58, P542, DOI 10.1016/j.ijrobp.2003.09.067; Breous E, 2011, J HEPATOL, V54, P830, DOI 10.1016/j.jhep.2010.10.013; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Choi MJ, 2011, CANCER LETT, V306, P190, DOI 10.1016/j.canlet.2011.03.005; Chun KH, 2003, JNCI-J NATL CANCER I, V95, P291, DOI 10.1093/jnci/95.4.291; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; INOUE M, 1994, BIOCHEM BIOPH RES CO, V204, P898, DOI 10.1006/bbrc.1994.2544; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaur H, 2010, DIG J NANOMATER BIOS, V5, P67; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kline MP, 2008, EXP HEMATOL, V36, P568, DOI 10.1016/j.exphem.2008.01.003; Li ZG, 2009, CELL PHYSIOL BIOCHEM, V24, P95, DOI 10.1159/000227817; Liu M, 1998, CANCER RES, V58, P1723; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Mesner P W Jr, 1997, Adv Pharmacol, V41, P461, DOI 10.1016/S1054-3589(08)61069-8; Mielgo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007879; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Mott JL, 2007, HEPATOLOGY, V46, P906, DOI 10.1002/hep.21812; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Orlowski RZ, 2002, J BIOL CHEM, V277, P27864, DOI 10.1074/jbc.M201519200; Ratajczak J, 2001, BRIT J HAEMATOL, V115, P195, DOI 10.1046/j.1365-2141.2001.03058.x; Seitz SJ, 2010, INT J CANCER, V126, P2049, DOI 10.1002/ijc.24861; Shi XH, 2012, MOLECULES, V17, P3933, DOI 10.3390/molecules17043933; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Song EY, 2008, EUR J MED CHEM, V43, P1519, DOI 10.1016/j.ejmech.2007.10.008; Trisciuoglio D, 2012, CLIN CANCER RES, V18, P475, DOI 10.1158/1078-0432.CCR-11-0579; Wang Z, 2011, BIOORG MED CHEM LETT, V21, P1097, DOI 10.1016/j.bmcl.2010.12.124; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xu YZ, 2011, CANCER LETT, V313, P44, DOI 10.1016/j.canlet.2011.08.025	37	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63900	10.1371/journal.pone.0063900	http://dx.doi.org/10.1371/journal.pone.0063900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737957	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700020
J	Shi, JX; Li, JS; Hu, R; Li, CH; Wen, Y; Zheng, H; Zhang, F; Li, Q				Shi, Jia-Xin; Li, Jia-Shu; Hu, Rong; Li, Chun-Hua; Wen, Yan; Zheng, Hong; Zhang, Feng; Li, Qin			Diagnostic Value of sTREM-1 in Bronchoalveolar Lavage Fluid in ICU Patients With Bacterial Lung Infections: A Bivariate Meta-Analysis	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; MYELOID CELLS; PROGNOSTIC VALUE; RECEPTOR; PROCALCITONIN; HETEROGENEITY; PERFORMANCE; NEUTROPHILS; ACCURACY; REVIEWS	Background: The serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is a useful biomarker in differentiating bacterial infections from others. However, the diagnostic value of sTREM-1 in bronchoalveolar lavage fluid (BALF) in lung infections has not been well established. We performed a meta-analysis to assess the accuracy of sTREM-1 in BALF for diagnosis of bacterial lung infections in intensive care unit (ICU) patients. Methods: We searched PUBMED, EMBASE and Web of Knowledge (from January 1966 to October 2012) databases for relevant studies that reported diagnostic accuracy data of BALF sTREM-1 in the diagnosis of bacterial lung infections in ICU patients. Pooled sensitivity, specificity, and positive and negative likelihood ratios were calculated by a bivariate regression analysis. Measures of accuracy and Q point value (Q*) were calculated using summary receiver operating characteristic (SROC) curve. The potential between-studies heterogeneity was explored by subgroup analysis. Results: Nine studies were included in the present meta-analysis. Overall, the prevalence was 50.6%; the sensitivity was 0.87 (95% confidence interval (CI), 0.72-0.95); the specificity was 0.79 (95% CI, 0.56-0.92); the positive likelihood ratio (PLR) was 4.18 (95% CI, 1.78-9.86); the negative likelihood ratio (NLR) was 0.16 (95% CI, 0.07-0.36), and the diagnostic odds ratio (DOR) was 25.60 (95% CI, 7.28-89.93). The area under the SROC curve was 0.91 (95% CI, 0.88-0.93), with a Q* of 0.83. Subgroup analysis showed that the assay method and cutoff value influenced the diagnostic accuracy of sTREM-1. Conclusions: BALF sTREM-1 is a useful biomarker of bacterial lung infections in ICU patients. Further studies are needed to confirm the optimized cutoff value.	[Shi, Jia-Xin; Li, Jia-Shu; Hu, Rong; Li, Chun-Hua; Wen, Yan; Zheng, Hong; Zhang, Feng; Li, Qin] Xuzhou Med Coll, Affiliated Hosp, Lianyungang Peoples Hosp 1, Dept Resp Med, Lianyungang, Peoples R China	Xuzhou Medical University	Shi, JX (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Lianyungang Peoples Hosp 1, Dept Resp Med, Lianyungang, Peoples R China.	shijiaxin919@126.com; ljssm1118@sina.com			Medical Innovation Foundation of Lianyungang Health Bureau [09055, 1008]	Medical Innovation Foundation of Lianyungang Health Bureau	This study was supported by the Medical Innovation Foundation of Lianyungang Health Bureau (grant No. 09055 and No. 1008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand NJ, 2009, CHEST, V135, P641, DOI 10.1378/chest.08-1829; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Determann RM, 2005, INTENS CARE MED, V31, P1495, DOI 10.1007/s00134-005-2818-7; Duflo F, 2002, ANESTHESIOLOGY, V96, P74, DOI 10.1097/00000542-200201000-00018; El Solh AA, 2008, INTENS CARE MED, V34, P1012, DOI 10.1007/s00134-008-1087-7; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gibot S, 2007, SCAND J INFECT DIS, V39, P604, DOI 10.1080/00365540701199832; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horonenko G, 2007, CHEST, V132, P58, DOI 10.1378/chest.06-2731; Huh JW, 2008, CRIT CARE, V12, DOI 10.1186/cc6770; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Kamei K, 2010, J HEPATO-BIL-PAN SCI, V17, P305, DOI 10.1007/s00534-009-0191-6; Kofoed K, 2007, CRIT CARE, V11, DOI 10.1186/cc5723; Mahdy AM, 2006, CLIN VACCINE IMMUNOL, V13, P492, DOI 10.1128/CVI.13.4.492-495.2006; Man XY, 2009, INT J RESP, V29, P1473; Morris AC, 2010, THORAX, V65, P201, DOI 10.1136/thx.2009.122291; Oudhuis GJ, 2009, INTENS CARE MED, V35, P1265, DOI 10.1007/s00134-009-1463-y; Palazzo SJ, 2012, RESP CARE, V57, P2052, DOI 10.4187/respcare.01703; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Ramirez P, 2011, CRIT CARE, V15, DOI 10.1186/cc10015; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Srinivasan R, 2011, PEDIATR CRIT CARE ME, V12, P21, DOI 10.1097/PCC.0b013e3181e2a352; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Wang ZL, 2012, CHINESE J MED GUIDE, V14, P1014; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wu CL, 2011, RESPIROLOGY, V16, P487, DOI 10.1111/j.1440-1843.2011.01945.x	31	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65436	10.1371/journal.pone.0065436	http://dx.doi.org/10.1371/journal.pone.0065436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734253	Green Published, Green Submitted, gold			2022-12-27	WOS:000319725500013
J	Machado, RJA; Monteiro, NKV; Migliolo, L; Silva, ON; Pinto, MFS; Oliveira, AS; Franco, OL; Kiyota, S; Bemquerer, MP; Uchoa, AF; Morais, AHA; Santos, EA				Machado, Richele J. A.; Monteiro, Norberto K. V.; Migliolo, Ludovico; Silva, Osmar N.; Pinto, Michele F. S.; Oliveira, Adeliana S.; Franco, Octavio L.; Kiyota, Sumika; Bemquerer, Marcelo P.; Uchoa, Adriana F.; Morais, Ana H. A.; Santos, Elizeu A.			Characterization and Pharmacological Properties of a Novel Multifunctional Kunitz Inhibitor from Erythrina velutina Seeds	PLOS ONE			English	Article							SERINE PROTEINASE-INHIBITOR; URINARY TRYPSIN-INHIBITOR; MACULATUS COWPEA WEEVIL; AMINO-ACID-SEQUENCE; CHYMOTRYPSIN INHIBITOR; PROTEASE INHIBITORS; CECAL LIGATION; FOOD-INTAKE; PURIFICATION; SEPSIS	Inhibitors of peptidases isolated from leguminous seeds have been studied for their pharmacological properties. The present study focused on purification, biochemical characterization and anti-inflammatory and anticoagulant evaluation of a novel Kunitz trypsin inhibitor from Erythrina velutina seeds (EvTI). Trypsin inhibitors were purified by ammonium sulfate (30-60%), fractionation followed by Trypsin-Sepharose affinity chromatography and reversed-phase high performance liquid chromatography. The purified inhibitor showed molecular mass of 19,210.48 Da. Furthermore, a second isoform with 19,228.16 Da was also observed. The inhibitor that showed highest trypsin specificity and enhanced recovery yield was named EvTI (P2) and was selected for further analysis. The EvTI peptide fragments, generated by trypsin and pepsin digestion, were further analyzed by MALDI-ToF-ToF mass spectrometry, allowing a partial primary structure elucidation. EvTI exhibited inhibitory activity against trypsin with IC50 of 2.2x10(-8) mol.L-1 and constant inhibition (Ki) of 1.0x10(-8) mol.L-1, by a non-competitive mechanism. In addition to inhibit the activity of trypsin, EvTI also inhibited factor Xa and neutrophil elastase, but do not inhibit thrombin, chymotrypsin or peptidase 3. EvTI was investigated for its anti-inflammatory and anticoagulant properties. Firstly, EvTI showed no cytotoxic effect on human peripheral blood cells. Nevertheless, the inhibitor was able to prolong the clotting time in a dose-dependent manner by using in vitro and in vivo models. Due to anti-inflammatory and anticoagulant EvTI properties, two sepsis models were here challenged. EvTI inhibited leukocyte migration and specifically acted by inhibiting TNF-alpha release and stimulating IFN-alpha and IL-12 synthesis. The data presented clearly contribute to a better understanding of the use of Kunitz inhibitors in sepsis as a bioactive agent capable of interfering in blood coagulation and inflammation.	[Machado, Richele J. A.; Oliveira, Adeliana S.; Santos, Elizeu A.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Lab Quim & Funcao Prot Bioativa, BR-59072970 Natal, RN, Brazil; [Monteiro, Norberto K. V.; Morais, Ana H. A.] Univ Fed Rio Grande do Norte, Dept Nutr, Ctr Ciencias Saude, BR-59072970 Natal, RN, Brazil; [Migliolo, Ludovico; Silva, Osmar N.; Pinto, Michele F. S.; Franco, Octavio L.] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Ctr Anal Prote & Bioquim, Brasilia, DF, Brazil; [Bemquerer, Marcelo P.] Embrapa Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil; [Kiyota, Sumika] Ctr Pesquisa Desenvolvimento Sanidade Anim, Inst Biol, Lab Bioquim Prot & Peptideos, Sao Paulo, Brazil; [Uchoa, Adriana F.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Biol Celular & Genet, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Catolica de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte	Franco, OL (corresponding author), Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Ctr Anal Prote & Bioquim, Brasilia, DF, Brazil.	ocfranco@gmail.com	Silva, Osmar N./B-3183-2012; MIGLIOLO, LUDOVICO/AAV-6913-2021; Silva, Osmar/M-3270-2019; Uchôa, Adriana/F-9381-2013; Kiyota, Sumika/E-1450-2015; Franco, Octavio L/T-3020-2017; Bemquerer, Marcelo Porto/A-9688-2013; Monteiro, Norberto/AAH-5665-2020	Silva, Osmar N./0000-0003-2148-131X; MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Silva, Osmar/0000-0003-2148-131X; Bemquerer, Marcelo Porto/0000-0002-9740-5818; Machado, Richele/0000-0003-2321-4020; Santos, Elizeu/0000-0003-4372-2161; Franco, Octavio/0000-0001-9546-0525; , Norberto/0000-0002-5847-5733	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPDF (Fundacao de Amparo a Pesquisa do Distrito Federal); UCB (Universidade Catolica de Brasilia)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPDF (Fundacao de Amparo a Pesquisa do Distrito Federal)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); UCB (Universidade Catolica de Brasilia)	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPDF (Fundacao de Amparo a Pesquisa do Distrito Federal) and UCB (Universidade Catolica de Brasilia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2001, CRIT CARE MED, V29, pS28, DOI 10.1097/00003246-200107001-00013; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araujo CL, 2005, J AGR FOOD CHEM, V53, P4381, DOI 10.1021/jf0502505; Batista IFC, 1996, PHYTOCHEMISTRY, V41, P1017, DOI 10.1016/0031-9422(95)00710-5; Benjamim CF, 2001, MEDICINA RIBEIRAO PR, V34, P18, DOI 10.11606/issn.2176-7262.v34i1p18-26; Bhattacharyya A, 2006, PHYTOCHEMISTRY, V67, P232, DOI 10.1016/j.phytochem.2005.11.010; Bhattacharyya A, 2007, PLANT PHYSIOL BIOCH, V45, P169, DOI 10.1016/j.plaphy.2007.02.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao YZ, 2012, EXP TOXICOL PATHOL, V64, P543, DOI 10.1016/j.etp.2010.11.011; Cate HT, 2001, CRITICAL CARE MED, V29, P95; CHAN J, 1982, J AGR FOOD CHEM, V30, P42, DOI 10.1021/jf00109a008; de Oliveira MSG, 2012, REV BRAS FARMACOGN, V22, P157, DOI 10.1590/S0102-695X2011005000210; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Di Ciero L, 1998, J PROTEIN CHEM, V17, P827; Dixon M., 1979, ENZYMES, Vthird; dos Santos EA, 2012, AFFINITY CHROMATOGRAPHY, P211; Ebong S, 1999, INFECT IMMUN, V67, P6603; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Fan SG, 2005, BOT BULL ACAD SINICA, V46, P273; Garcia VA, 2004, PROTEIN J, V23, P343, DOI 10.1023/B:JOPC.0000032654.67733.d5; Golino Paolo, 2004, Current Vascular Pharmacology, V2, P319, DOI 10.2174/1570161043385402; Gomes CEM, 2005, PLANT PHYSIOL BIOCH, V43, P1095, DOI 10.1016/j.plaphy.2005.11.004; Gonzalez-gonzalez Y, 2003, BIOTECNOL APL, V20, P111; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Groutas WC, 1997, BIOCHEM BIOPH RES CO, V233, P697, DOI 10.1006/bbrc.1997.6526; Hahn BS, 1996, J BIOCHEM-TOKYO, V119, P835, DOI 10.1093/oxfordjournals.jbchem.a021319; Hayakawa M, 2010, SHOCK, V33, P14, DOI 10.1097/SHK.0b013e3181aa95c4; Holetz FB, 2002, MEM I OSWALDO CRUZ, V97, P1027, DOI 10.1590/S0074-02762002000700017; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Inoue K, 2008, J CLIN BIOCHEM NUTR, V43, P139, DOI 10.3164/jcbn.2008059; Johansson S, 2002, J NAT PROD, V65, P32, DOI 10.1021/np010323o; JOUBERT FJ, 1982, INT J BIOCHEM, V14, P187, DOI 10.1016/0020-711X(82)90137-9; JOUBERT FJ, 1981, H-S Z PHYSIOL CHEM, V362, P531, DOI 10.1515/bchm2.1981.362.1.531; KAKADE ML, 1974, CEREAL CHEM, V51, P376; KIMURA M, 1993, BIOSCI BIOTECH BIOCH, V57, P102, DOI 10.1271/bbb.57.102; Kishimura H, 2012, J FOOD BIOCHEM, V36, P93, DOI 10.1111/j.1745-4514.2010.00515.x; Komarnytsky S, 2011, INT J OBESITY, V35, P236, DOI 10.1038/ijo.2010.192; KOUZUMA Y, 1992, BIOSCI BIOTECH BIOCH, V56, P1819, DOI 10.1271/bbb.56.1819; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levi M, 2004, CRIT CARE, V8, P99, DOI 10.1186/cc2816; Levi M, 2010, HAMOSTASEOLOGIE, V30, P10; Lima TB, 2011, J NAT PROD, V74, P969, DOI 10.1021/np200312r; Macedo MLR, 2004, J AGR FOOD CHEM, V52, P2533, DOI 10.1021/jf035389z; Macedo R, PHYTOCHEMISTRY, V54, P1; Marshall JC, 2001, CRIT CARE MED, V29, pS99, DOI 10.1097/00003246-200107001-00032; MATCHETT MO, 1965, J CLIN PATHOL, V18, P465, DOI 10.1136/jcp.18.4.465; Matthay MA, 2001, NEW ENGL J MED, V344, P759, DOI 10.1056/NEJM200103083441009; Mello GC, 2001, J PROTEIN CHEM, V20, P625, DOI 10.1023/A:1013764118579; Monteiro NC V, 2011, THESIS U FEDERAL RIO; Moreno SE, 2006, J IMMUNOL, V177, P3218, DOI 10.4049/jimmunol.177.5.3218; Nakajima S, 2011, J AGR FOOD CHEM, V59, P9491, DOI 10.1021/jf200988f; Nishiyama Tomoki, 2006, J Anesth, V20, P179, DOI 10.1007/s00540-006-0396-7; OGAWA M, 1987, RES COMMUN CHEM PATH, V55, P271; Oliva MLV, 2000, BBA-PROTEIN STRUCT M, V1477, P64, DOI 10.1016/S0167-4838(99)00285-X; Oliva MLV, 1999, IMMUNOPHARMACOLOGY, V45, P163, DOI 10.1016/S0162-3109(99)00075-2; Oliveira AS, 2007, PLANT PHYSIOL BIOCH, V45, P858, DOI 10.1016/j.plaphy.2007.08.002; Oliveira AS, 2002, PESTIC BIOCHEM PHYS, V72, P122, DOI 10.1006/pest.2001.2591; Oliveira LM, 2007, AVALIACAO EFEITOS FR; Osuchowski MF, 2006, J IMMUNOLOGY, P0; OSuilleabhain C, 1996, SURGERY, V120, P290, DOI 10.1016/S0039-6060(96)80300-X; Pintao MCT, 2001, HEMOSTASIA TROMBOSE, V34, P282; Rabelo L, 2012, MAR DRUGS, V10, P727, DOI 10.3390/md10040727; Macedo MLR, 2007, PHYTOCHEMISTRY, V68, P1104, DOI 10.1016/j.phytochem.2007.01.024; Roy F, 2010, FOOD RES INT, V43, P432, DOI 10.1016/j.foodres.2009.09.002; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Satheesh LS, 2011, INDIAN J EXP BIOL, V49, P366; Scarafoni A, 2008, PHYTOCHEMISTRY, V69, P1820, DOI 10.1016/j.phytochem.2008.03.023; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shryock T. R., 2002, PERFORMANCE STANDARD; Siqueira-Batista Rodrigo, 2011, Rev. bras. ter. intensiva, V23, P207; STEIN RL, 1983, J AM CHEM SOC, V105, P5111, DOI 10.1021/ja00353a042; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Sun JA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/219793; TELIKEPALLI H, 1990, PHYTOCHEMISTRY, V29, P2005, DOI 10.1016/0031-9422(90)85056-L; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turecek Peter L, 2004, Curr Hematol Rep, V3, P331; Vasconcelos SMM, 2003, BIOL PHARM BULL, V26, P946, DOI 10.1248/bpb.26.946; XAVIERFILHO J, 1989, J AGR FOOD CHEM, V37, P1139, DOI 10.1021/jf00088a071; Ye XJ, 2009, PLANTA MED, V75, P550, DOI 10.1055/s-0029-1185312	80	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63571	10.1371/journal.pone.0063571	http://dx.doi.org/10.1371/journal.pone.0063571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23737945	gold, Green Published, Green Submitted			2022-12-27	WOS:000319733000014
J	Ang, M; Chong, W; Huang, HQ; Tay, WT; Wong, TY; He, MG; Aung, T; Mehta, JS				Ang, Marcus; Chong, Wesley; Huang, Huiqi; Tay, Wan Ting; Wong, Tien Yin; He, Ming-Guang; Aung, Tin; Mehta, Jodhbir S.			Comparison of Anterior Segment Optical Tomography Parameters Measured Using a Semi-Automatic Software to Standard Clinical Instruments	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; COHERENCE TOMOGRAPHY; CHAMBER DEPTH; ULTRASOUND BIOMICROSCOPY; ASSESSMENT PROGRAM; ANGLE-CLOSURE; NORMAL EYES; CHINESE; DIAMETER; IMAGES	Objective: To compare anterior segment parameters measured using a semi-automatic software (Zhongshan Angle Assessment Program, ZAP) applied to anterior segment optical coherence tomography (AS-OCT) images, with commonly used instruments. Methods: Cross-sectional study of a total of 1069 subjects (1069 eyes) from three population-based studies of adults aged 40-80 years. All subjects underwent AS-OCT imaging and ZAP software was applied to determine anterior chamber depth (ACD), central corneal thickness (CCT), anterior and keratometry (K) - readings. These were compared to auto-refraction, keratometry and ocular biometry measured using an IOLMaster, ultrasound pachymeter and auto-refractor respectively. Agreements between AS-OCT (ZAP) and clinical instrument modalities were described using Bland-Altman, 95% limits of agreement (LOA). Results: The mean age of our subjects was 56.9 +/- 9.5 years and 50.9% were male. The mean AS-OCT (ZAP) parameters of our study cohort were: ACD 3.29 +/- 0.35 mm, CCT 560.75 +/- 35.07 mu m; K-reading 46.7 +/- 62.72 D. There was good agreement between the measurements from ZAP analysis and each instrument and no violations in the assumptions of the LOA; albeit with a systematic bias for each comparison: AS-OCT consistently measured a deeper ACD compared to IOLMaster (95% LOA -0.24, 0.55); and a thicker CCT for the AS-OCT compared to ultrasound pachymetry (16.8 +/- 0.53 mu m 95% LOA -17.3, 50.8). AS-OCT had good agreement with auto-refractor with at least 95% of the measurements within the prediction interval (P value <0.001). Conclusion: This study demonstrates that there is good agreement between the measurements from the AS-OCT (ZAP) and conventional tools. However, small systematic biases remain that suggest that these measurement tools may not be interchanged.	[Ang, Marcus; Chong, Wesley; Wong, Tien Yin; Aung, Tin; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Ang, Marcus; Huang, Huiqi; Tay, Wan Ting; Wong, Tien Yin; He, Ming-Guang; Aung, Tin; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tien Yin; Aung, Tin; Mehta, Jodhbir S.] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore; [Wong, Tien Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [He, Ming-Guang] Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Zhongshan, Guangdong, Peoples R China; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; University of Melbourne; National University of Singapore	Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.	jodmehta@gmail.com	He, Mingguang/AAY-5239-2020; Mehta, Jodhbir/O-6192-2015; Wong, Tien Yin/AAC-9724-2020	He, Mingguang/0000-0002-6912-2810; Wong, Tien Yin/0000-0002-8448-1264				Ang M, 2012, INVEST OPHTH VIS SCI, V53, P120, DOI 10.1167/iovs.11-8386; Avila M, 2006, J CATARACT REFR SURG, V32, P1836, DOI 10.1016/j.jcrs.2006.07.015; Baikoff G, 2005, J CATARACT REFR SURG, V31, P1722, DOI 10.1016/j.jcrs.2005.02.030; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Chan JB, 2011, INVEST OPHTH VIS SCI, V52, P8884, DOI 10.1167/iovs.10-6411; Console JW, 2008, BRIT J OPHTHALMOL, V92, P1612, DOI 10.1136/bjo.2007.129932; Dada T, 2007, J CATARACT REFR SURG, V33, P837, DOI 10.1016/j.jcrs.2007.01.021; Dinc UA, 2010, OPHTHALMOLOGICA, V224, P341, DOI 10.1159/000313815; Doors M, 2009, GRAEF ARCH CLIN EXP, V247, P1139, DOI 10.1007/s00417-009-1086-6; Dorairaj S, 2007, T AM OPHTHAL SOC, V105, P108; Dorairaj Syril, 2007, Trans Am Ophthalmol Soc, V105, P99; Elbaz U, 2007, AM J OPHTHALMOL, V143, P48, DOI 10.1016/j.ajo.2006.08.031; Goldsmith JA, 2005, OPHTHALMOLOGY, V112, P238, DOI 10.1016/j.ophtha.2004.09.019; Hosny M, 2000, J REFRACT SURG, V16, P336; Lavanya R, 2007, BRIT J OPHTHALMOL, V91, P1023, DOI 10.1136/bjo.2006.113761; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Leung CK, 2010, BRIT J OPHTHALMOL, V94, P1184, DOI 10.1136/bjo.2009.167296; Nolan WP, 2006, AM J OPHTHALMOL, V141, P896, DOI 10.1016/j.ajo.2005.12.008; Radhakrishnan S, 2005, ARCH OPHTHALMOL-CHIC, V123, P1053, DOI 10.1001/archopht.123.8.1053; Sakata LM, 2008, ARCH OPHTHALMOL-CHIC, V126, P181, DOI 10.1001/archophthalmol.2007.46; Su DHW, 2008, BRIT J OPHTHALMOL, V92, P103, DOI 10.1136/bjo.2007.122572; Tan DKL, 2012, INVEST OPHTH VIS SCI, V53, P4860, DOI 10.1167/iovs.12-9787; Yazici AT, 2010, J REFRACT SURG, V26, P127, DOI 10.3928/1081597X-20100121-08; Yuen LH, 2010, INVEST OPHTH VIS SCI, V51, P3433, DOI 10.1167/iovs.09-4307; Zhao PS, 2007, AM J OPHTHALMOL, V143, P1047, DOI 10.1016/j.ajo.2007.01.050; Zheng YF, 2011, OPHTHALMOLOGY	27	24	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65559	10.1371/journal.pone.0065559	http://dx.doi.org/10.1371/journal.pone.0065559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750265	Green Published, gold			2022-12-27	WOS:000319961900067
J	Descamps, S				Descamps, Sebastien			Winter Temperature Affects the Prevalence of Ticks in an Arctic Seabird	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; IXODES-URIAE ACARI; MORTALITY; PENGUINS; IXODIDAE; ECOLOGY; COLONY; MODEL	The Arctic is rapidly warming and host-parasite relationships may be modified by such environmental changes. Here, I showed that the average winter temperature in Svalbard, Arctic Norway, explained almost 90% of the average prevalence of ticks in an Arctic seabird, the Brunnich's guillemot Uria lomvia. An increase of 1 degrees C in the average winter temperature at the nesting colony site was associated with a 5% increase in the number of birds infected by these ectoparasites in the subsequent breeding season. Guillemots were generally infested by only a few ticks (<5) and I found no direct effect of tick presence on their body condition and breeding success. However, the strong effect of average winter temperature described here clearly indicates that tick-seabird relationships in the Arctic may be strongly affected by ongoing climate warming.	Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway	Norwegian Polar Institute	Descamps, S (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	descamps@npolar.no		Chiaradia, Andre/0000-0002-6178-4211	MOSJ; SEAPOP	MOSJ; SEAPOP	This study was funded by programs MOSJ (http://mosj.npolar.no/) and SEAPOP (http://seapop.no/). There is no grant number for these funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov OA, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P653; [Anonymous], 2010, R LANG ENV STAT COMP; Barton TR, 1996, PARASITOLOGY, V112, P571, DOI 10.1017/S0031182000066154; Benoit JB, 2009, ANTARCT SCI, V21, P151, DOI 10.1017/S0954102008001685; Bergstrom S, 1999, INT J PARASITOL, V29, P1359, DOI 10.1016/S0020-7519(99)00088-0; Boulinier T, 1996, IBIS, V138, P326, DOI 10.1111/j.1474-919X.1996.tb04345.x; Coulson SJ, 2009, POLAR RES, V28, P399, DOI 10.1111/j.1751-8369.2009.00117.x; CROLL DA, 1991, CONDOR, V93, P496, DOI 10.2307/1368181; Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Davidson R, 2011, TRENDS PARASITOL, V27, P238, DOI 10.1016/j.pt.2011.02.001; Dietrich M, 2011, VECTOR-BORNE ZOONOT, V11, P453, DOI 10.1089/vbz.2010.0009; DUFFY DC, 1983, ECOLOGY, V64, P110, DOI 10.2307/1937334; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Eveleigh E. S., 1974, Acarologia, V16, P621; FEARE CJ, 1976, IBIS, V118, P112, DOI 10.1111/j.1474-919X.1976.tb02015.x; Gaston A.J., 1998, THE AUKS; Gaston AJ, 2002, IBIS, V144, P185, DOI 10.1046/j.1474-919X.2002.00038.x; Gauthier-Clerc M, 1998, COLON WATERBIRD, V21, P229, DOI 10.2307/1521910; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; Kutz SJ, 2009, VET PARASITOL, V163, P217, DOI 10.1016/j.vetpar.2009.06.008; LEE RE, 1987, PHYSIOL ZOOL, V60, P499, DOI 10.1086/physzool.60.4.30157912; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Mangin S, 2003, J AVIAN BIOL, V34, P30, DOI 10.1034/j.1600-048X.2003.02916.x; McCoy K, 1999, J PARASITOL, V85, P196, DOI 10.2307/3285619; McCoy KD, 2005, P ROY SOC B-BIOL SCI, V272, P2389, DOI 10.1098/rspb.2005.3230; McCoy KD, 2002, EVOL ECOL RES, V4, P441; Moller AP, 2009, BIOL REV, V84, P567, DOI 10.1111/j.1469-185X.2009.00087.x; Morbey YE, 1996, CAN J ZOOL, V74, P1585, DOI 10.1139/z96-172; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Potti J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001276; Wanless S, 1997, COLON WATERBIRD, V20, P540, DOI 10.2307/1521606	33	31	31	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65374	10.1371/journal.pone.0065374	http://dx.doi.org/10.1371/journal.pone.0065374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750259	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900061
J	Herget, M; Scheibinger, M; Guo, ZH; Jan, TA; Adams, CM; Cheng, AG; Heller, S				Herget, Meike; Scheibinger, Mirko; Guo, Zhaohua; Jan, Taha A.; Adams, Christopher M.; Cheng, Alan G.; Heller, Stefan			A Simple Method for Purification of Vestibular Hair Cells and Non-Sensory Cells, and Application for Proteomic Analysis	PLOS ONE			English	Article							EAR STEM-CELLS; INNER-EAR; MASS-SPECTROMETRY; RIBBON SYNAPSE; COCHLEA; OTOFERLIN; DEAFNESS; HEARING; PROTEIN; FORM	Mechanosensitive hair cells and supporting cells comprise the sensory epithelia of the inner ear. The paucity of both cell types has hampered molecular and cell biological studies, which often require large quantities of purified cells. Here, we report a strategy allowing the enrichment of relatively pure populations of vestibular hair cells and non-sensory cells including supporting cells. We utilized specific uptake of fluorescent styryl dyes for labeling of hair cells. Enzymatic isolation and flow cytometry was used to generate pure populations of sensory hair cells and non-sensory cells. We applied mass spectrometry to perform a qualitative high-resolution analysis of the proteomic makeup of both the hair cell and non-sensory cell populations. Our conservative analysis identified more than 600 proteins with a false discovery rate of <3% at the protein level and <1% at the peptide level. Analysis of proteins exclusively detected in either population revealed 64 proteins that were specific to hair cells and 103 proteins that were only detectable in non-sensory cells. Statistical analyses extended these groups by 53 proteins that are strongly upregulated in hair cells versus non-sensory cells and vice versa by 68 proteins. Our results demonstrate that enzymatic dissociation of styryl dye-labeled sensory hair cells and non-sensory cells is a valid method to generate pure enough cell populations for flow cytometry and subsequent molecular analyses.	[Herget, Meike; Scheibinger, Mirko; Guo, Zhaohua; Jan, Taha A.; Cheng, Alan G.; Heller, Stefan] Stanford Univ, Dept Otolaryngol HNS, Stanford, CA 94305 USA; [Herget, Meike; Scheibinger, Mirko; Guo, Zhaohua; Heller, Stefan] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Adams, Christopher M.] Stanford Univ, Mass Spectrometry Core, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Heller, S (corresponding author), Stanford Univ, Dept Otolaryngol HNS, Stanford, CA 94305 USA.	hellers@stanford.edu		Cheng, Alan/0000-0002-4702-8401; Jan, Taha/0000-0001-8971-7769	Deutsche Forschungsgemeinschaft; Stanford Dean's fellowship; National Institutes of Health [DC004563, DC010363]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC011043, R01DC012250, R01DC004563, P30DC010363] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stanford Dean's fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by postdoctoral grants from the Deutsche Forschungsgemeinschaft and a Stanford Dean's fellowship to MH, and National Institutes of Health grants DC004563 and DC010363 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashiri A, 2003, J Matern Fetal Neonatal Med, V14, P344, DOI 10.1080/713606702; BURRIDGE K, 1983, J CELL BIOL, V97, P359, DOI 10.1083/jcb.97.2.359; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; DECHESNE CJ, 1994, J COMP NEUROL, V346, P517, DOI 10.1002/cne.903460405; Doetzlhofer A, 2006, BRAIN RES, V1091, P282, DOI 10.1016/j.brainres.2006.02.071; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gale JE, 2000, JARO-J ASSOC RES OTO, V1, P172, DOI 10.1007/s101620010037; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Goodyear RJ, 2010, JARO-J ASSOC RES OTO, V11, P573, DOI 10.1007/s10162-010-0231-6; Goodyear RJ, 1999, J NEUROCYTOL, V28, P851, DOI 10.1023/A:1007070121751; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Jan TA, 2011, JOVE-J VIS EXP, DOI 10.3791/3432; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kachar B, 1997, HEARING RES, V107, P102, DOI 10.1016/S0378-5955(97)00027-0; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Meyers JR, 2003, J NEUROSCI, V23, P4054; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; Ronaghi M, 2012, STEM CELLS, V30, P69, DOI 10.1002/stem.785; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Safieddine S, 2012, ANNU REV NEUROSCI, V35, P509, DOI 10.1146/annurev-neuro-061010-113705; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Shin JB, 2013, NAT NEUROSCI, V16, P365, DOI 10.1038/nn.3312; Sinkkonen ST, 2011, SCI REP-UK, V1, DOI 10.1038/srep00026; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Spinelli KJ, 2012, P NATL ACAD SCI USA, V109, pE268, DOI 10.1073/pnas.1115866109; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Wang DX, 2012, PLANT BIOTECHNOL J, V10, P925, DOI 10.1111/j.1467-7652.2012.00721.x; Yang D, 2004, J NEUROBIOL, V58, P479, DOI 10.1002/neu.10289; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zheng JL, 1997, J NEUROSCI, V17, P8270	39	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66026	10.1371/journal.pone.0066026	http://dx.doi.org/10.1371/journal.pone.0066026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750277	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900079
J	Ozaki, A; Yoshida, K; Fuji, K; Kubota, S; Kai, W; Aoki, J; Kawabata, Y; Suzuki, J; Akita, K; Koyama, T; Nakagawa, M; Hotta, T; Tsuzaki, T; Okamoto, N; Araki, K; Sakamoto, T				Ozaki, Akiyuki; Yoshida, Kazunori; Fuji, Kanako; Kubota, Satoshi; Kai, Wataru; Aoki, Jun-ya; Kawabata, Yumi; Suzuki, Junpei; Akita, Kazuki; Koyama, Takashi; Nakagawa, Masahiro; Hotta, Takurou; Tsuzaki, Tatsuo; Okamoto, Nobuaki; Araki, Kazuo; Sakamoto, Takashi			Quantitative Trait Loci (QTL) Associated with Resistance to a Monogenean Parasite (Benedenia seriolae) in Yellowtail (Seriola quinqueradiata) through Genome Wide Analysis	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; FLOUNDER PARALICHTHYS-OLIVACEUS; JAPANESE FLOUNDER; LEPEOPHTHEIRUS-SALMONIS; WHIRLING DISEASE; LINKAGE MAPS; SUSCEPTIBILITY; IDENTIFICATION; SOFTWARE; VIRUS	Benedenia infections caused by the monogenean fluke ectoparasite Benedenia seriolae seriously impact marine finfish aquaculture. Genetic variation has been inferred to play a significant role in determining the susceptibility to this parasitic disease. To evaluate the genetic basis of Benedenia disease resistance in yellowtail (Seriola quinqueradiata), a genome-wide and chromosome-wide linkage analyses were initiated using F-1 yellowtail families (n = 90 per family) based on a high-density linkage map with 860 microsatellite and 142 single nucleotide polymorphism (SNP) markers. Two major quantitative trait loci (QTL) regions on linkage groups Squ2 (BDR-1) and Squ20 (BDR-2) were identified. These QTL regions explained 32.9-35.5% of the phenotypic variance. On the other hand, we investigated the relationship between QTL for susceptibility to B. seriolae and QTL for fish body size. The QTL related to growth was found on another linkage group (Squ7). As a result, this is the first genetic evidence that contributes to detailing phenotypic resistance to Benedenia disease, and the results will help resolve the mechanism of resistance to this important parasitic infection of yellowtail.	[Ozaki, Akiyuki; Kai, Wataru; Aoki, Jun-ya; Kawabata, Yumi; Araki, Kazuo] Fisheries Res Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Yoshida, Kazunori; Nakagawa, Masahiro; Hotta, Takurou; Tsuzaki, Tatsuo] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Nagasaki, Japan; [Fuji, Kanako; Kubota, Satoshi; Suzuki, Junpei; Akita, Kazuki; Koyama, Takashi; Okamoto, Nobuaki; Sakamoto, Takashi] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Minato Ku, Tokyo, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Tokyo University of Marine Science & Technology	Ozaki, A (corresponding author), Fisheries Res Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan.	aozaki@affrc.go.jp	Kubota, Satoshi/N-1279-2018; SAKAMOTO, Takashi/O-1949-2014	SAKAMOTO, Takashi/0000-0002-8399-851X; Kubota, Satoshi/0000-0002-6143-4430; KOYAMA, Takashi/0000-0001-7140-7244	ministry of Fisheries Research Agency (FRA); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	ministry of Fisheries Research Agency (FRA); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	The work was supported by ministry of Fisheries Research Agency (FRA) grants-in-aid for scientific research "New Technology of Fish Breeding''. And funded by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Baerwald MR, 2011, HEREDITY, V106, P920, DOI 10.1038/hdy.2010.137; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHURCHILL GA, 1994, GENETICS, V138, P963; Danzmann R.G., 2006, LINKAGE ANAL PACKAGE; FUJI K, 2012, BMC GENOMICS UNPUB; Fuji K, 2006, AQUACULTURE, V254, P203, DOI 10.1016/j.aquaculture.2005.11.024; Fuji K, 2010, AQUACULTURE, V308, pS51, DOI 10.1016/j.aquaculture.2010.06.035; Gharbi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-20; Glover KA, 2007, DIS AQUAT ORGAN, V76, P57, DOI 10.3354/dao076057; Glover KA, 2005, AQUACULTURE, V245, P19, DOI 10.1016/j.aquaculture.2004.11.047; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Hutson KS, 2007, AQUACULTURE, V271, P85, DOI 10.1016/j.aquaculture.2007.03.020; Hwang SD, 2011, MAR BIOTECHNOL, V13, P1086, DOI 10.1007/s10126-011-9371-x; ISHIKAWA A, 2010, JAPANESE ASS LAB ANI, V51, P51; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1995, THEOR APPL GENET, V91, P33, DOI 10.1007/BF00220855; KUBOTA S, 2009, 10 INT S GEN AQ BANG, P194; *MAFF, 2009, ANN STAT FISH AQ PRO; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Matsuyama T, 2007, DIS AQUAT ORGAN, V75, P79, DOI 10.3354/dao075079; Moen T, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-53; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; MUSHIAKE K, 1994, FISHERIES SCI, V60, P647, DOI 10.2331/fishsci.60.647; Mushiake K, 1998, FISHERIES SCI, V64, P727, DOI 10.2331/fishsci.64.727; Nagakura Y., 2010, J FISHERIES TECHNOLO, V3, P21; Nagakura Y., 2006, AQUAC SCI, V54, P335; Nakada M., 2008, FAO Fisheries Technical Paper, P199; Nichols KM, 2003, DIS AQUAT ORGAN, V56, P145, DOI 10.3354/dao056145; Ogawa K, 1996, VET PARASITOL, V64, P95, DOI 10.1016/0304-4017(96)00962-4; Ohara E, 2005, AQUACULTURE, V244, P41, DOI 10.1016/j.aquaculture.2004.10.022; Ohno Y, 2008, AQUACULTURE, V274, P30, DOI 10.1016/j.aquaculture.2007.11.013; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Ozakil A, 2007, FISH PATHOL, V42, P131, DOI 10.3147/jsfp.42.131; Ryce EKN, 2005, DIS AQUAT ORGAN, V63, P69, DOI 10.3354/dao063069; Ryce EKN, 2004, DIS AQUAT ORGAN, V59, P225, DOI 10.3354/dao059225; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yoshinaga T, 2002, INT J PARASITOL, V32, P381, DOI 10.1016/S0020-7519(01)00339-3	42	28	32	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64987	10.1371/journal.pone.0064987	http://dx.doi.org/10.1371/journal.pone.0064987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750223	Green Submitted, gold, Green Published			2022-12-27	WOS:000319961900025
J	Price, JC; Pollock, LM; Rudd, ML; Fogoros, SK; Mohamed, H; Hanigan, CL; Le Gallo, M; Zhang, SY; Cruz, P; Cherukuri, PF; Hansen, NF; McManus, KJ; Godwin, AK; Sgroi, DC; Mullikin, JC; Merino, MJ; Hieter, P; Bell, DW				Price, Jessica C.; Pollock, Lana M.; Rudd, Meghan L.; Fogoros, Sarah K.; Mohamed, Hassan; Hanigan, Christin L.; Le Gallo, Matthieu; Zhang, Suiyuan; Cruz, Pedro; Cherukuri, Praveen F.; Hansen, Nancy F.; McManus, Kirk J.; Godwin, Andrew K.; Sgroi, Dennis C.; Mullikin, James C.; Merino, Maria J.; Hieter, Philip; Bell, Daphne W.		NIH Intramural Sequencing Ctr NISC	Sequencing of Candidate Chromosome Instability Genes in Endometrial Cancers Cancers Reveals Somatic Mutations in ESCO1, CHTF18, and MRE11A	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; CTF18-REPLICATION FACTOR-C; ANTIGEN LOADER COMPLEX; DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; S-PHASE; SACCHAROMYCES-CEREVISIAE; COLORECTAL CANCERS; CONSERVED PROTEIN; HUMAN-CELLS	Most endometrial cancers can be classified histologically as endometrioid, serous, or clear cell. Non-endometrioid endometrial cancers (NEECs; serous and clear cell) are the most clinically aggressive of the three major histotypes and are characterized by aneuploidy, a feature of chromosome instability. The genetic alterations that underlie chromosome instability in endometrial cancer are poorly understood. In the present study, we used Sanger sequencing to search for nucleotide variants in the coding exons and splice junctions of 21 candidate chromosome instability genes, including 19 genes implicated in sister chromatid cohesion, from 24 primary, microsatellite-stable NEECs. Somatic mutations were verified by sequencing matched normal DNAs. We subsequently resequenced mutated genes from 41 additional NEECs as well as 42 endometrioid ECs (EECs). We uncovered nonsynonymous somatic mutations in ESCO1, CHTF18, and MRE11A in, respectively, 3.7% (4 of 107), 1.9% (2 of 107), and 1.9% (2 of 107) of endometrial tumors. Overall, 7.7% (5 of 65) of NEECs and 2.4% (1 of 42) of EECs had somatically mutated one or more of the three genes. A subset of mutations are predicted to impact protein function. The co-occurrence of somatic mutations in ESCO1 and CHTF18 was statistically significant (P = 0.0011, two-tailed Fisher's exact test). This is the first report of somatic mutations within ESCO1 and CHTF18 in endometrial tumors and of MRE11A mutations in microsatellite-stable endometrial tumors. Our findings warrant future studies to determine whether these mutations are driver events that contribute to the pathogenesis of endometrial cancer.	[Price, Jessica C.; Pollock, Lana M.; Rudd, Meghan L.; Fogoros, Sarah K.; Mohamed, Hassan; Hanigan, Christin L.; Le Gallo, Matthieu; Bell, Daphne W.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; NIH Intramural Sequencing Ctr NISC] NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Zhang, Suiyuan; Cruz, Pedro; Cherukuri, Praveen F.; Hansen, Nancy F.; Mullikin, James C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [McManus, Kirk J.] Univ Manitoba, Manitoba Inst Cell Biol, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Merino, Maria J.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hieter, Philip] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Manitoba; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of British Columbia	Bell, DW (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	belldaph@mail.nih.gov	Cherukuri, Praveen/AFU-2005-2022; Le Gallo, Matthieu/F-7188-2012; McManus, Kirk J./AAE-3521-2020; Sgroi, Dennis/AAV-2487-2021; Le Gallo, Matthieu/T-4181-2019	Cherukuri, Praveen/0000-0002-9509-1245; Le Gallo, Matthieu/0000-0001-9085-8155; McManus, Kirk J./0000-0003-0081-8737; 	National Human Genome Research Institute at NIH; NIH [CA016519, RO1-1CA112021-01]; Canadian Institutes of Health Research (CIHR) [MOP-38096]; Manitoba Health Research Council (MHRC); CIHR/MHRC RPP New Investigator award; NCI SPORE in breast cancer at Massachusetts General Hospital; Avon Foundation;  [U01 CA113916];  [R01 CA140323]; NATIONAL CANCER INSTITUTE [R01CA140323, P01CA016519, ZIESC000853, R01CA158162, R01CA112021, U01CA113916] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200338, ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER	National Human Genome Research Institute at NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council (MHRC); CIHR/MHRC RPP New Investigator award; NCI SPORE in breast cancer at Massachusetts General Hospital; Avon Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded, in part, by the Intramural Research Program of the National Human Genome Research Institute at NIH (DWB, JCM); NIH grant CA016519 (PH); Canadian Institutes of Health Research (CIHR) grant MOP-38096 (PH); Manitoba Health Research Council (MHRC) grant (KJM); CIHR/MHRC RPP New Investigator award (KJM); U01 CA113916 and R01 CA140323 (AKG); NIH RO1-1CA112021-01 (DCS); the NCI SPORE in breast cancer at Massachusetts General Hospital (DCS); and the Avon Foundation (DCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013, P1, DOI DOI 10.1017/CB09781107415324.004; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bell DW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002245; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Berkowitz KM, 2008, MOL HUM REPROD, V14, P143, DOI 10.1093/molehr/gan005; Bhangale TR, 2006, NAT GENET, V38, P1457, DOI 10.1038/ng1925; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; BURKS RT, 1994, ONCOGENE, V9, P1163; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chines P, 2005, AM J HUM GENET, V77, P1257; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; DUGGAN BD, 1994, J NATL CANCER I, V86, P1216, DOI 10.1093/jnci/86.16.1216; Esteller M, 1999, AM J PATHOL, V155, P1767, DOI 10.1016/S0002-9440(10)65492-2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; KOBAYASHI K, 1995, GENE CHROMOSOME CANC, V14, P128, DOI 10.1002/gcc.2870140207; Konski AA, 1996, AM J CLIN ONCOL-CANC, V19, P164, DOI 10.1097/00000421-199604000-00015; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Maradeo ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015381; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Micci F, 2004, GENE CHROMOSOME CANC, V40, P229, DOI 10.1002/gcc.20038; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moreau S, 1999, MOL CELL BIOL, V19, P556; Murakami T, 2010, J BIOL CHEM, V285, P34608, DOI 10.1074/jbc.M110.166710; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; NEWBURY R, 1990, OBSTET GYNECOL, V76, P251; O'Hara Andrea J, 2012, Adv Genomics Genet, V2012, P33; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Parnas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005497; Pere H, 1998, CANCER RES, V58, P892; Pradhan M, 2006, MODERN PATHOL, V19, P1227, DOI 10.1038/modpathol.3800641; PRAT J, 1994, CANCER, V74, P1778, DOI 10.1002/1097-0142(19940915)74:6<1778::AID-CNCR2820740621>3.0.CO;2-5; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Ries LAG, 2007, NIH PUB, V07-6215; Rocquain J, 2010, AM J HEMATOL, V85, P717, DOI 10.1002/ajh.21798; ROSENBERG P, 1989, GYNECOL ONCOL, V35, P50, DOI 10.1016/0090-8258(89)90010-3; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Sherman ME, 2000, MODERN PATHOL, V13, P295, DOI 10.1038/modpathol.3880051; Shiomi Y, 2007, J BIOL CHEM, V282, P20906, DOI 10.1074/jbc.M610102200; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302	67	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63313	10.1371/journal.pone.0063313	http://dx.doi.org/10.1371/journal.pone.0063313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755103	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300008
J	De Cesarei, A; Mastria, S; Codispoti, M				De Cesarei, Andrea; Mastria, Serena; Codispoti, Maurizio			Early Spatial Frequency Processing of Natural Images: An ERP Study	PLOS ONE			English	Article							LATERAL OCCIPITAL COMPLEX; HUMAN VISUAL-CORTEX; OBJECT-RECOGNITION; SCENE IDENTIFICATION; HUMAN BRAIN; ATTENTION; PERCEPTION; CONTRAST; STATISTICS; MODULATION	The present study examined the role of spatial stimulus frequencies in the early visual processing of natural scenes. The content of initially degraded (low-or high-pass filtered) pictures was progressively revealed in a sequence of steps by adding high or low spatial frequencies. Event Related Potentials (ERPs) were used to track the early stages of visual processing. Picture degradation modulated the topography of the P1, with an occipital midline distribution for the most degraded pictures, which became progressively more laterally distributed as pictures became more complete. Picture degradation also modulated the amplitude of the P2. For both low-passed and high-passed scenes, a linear relationship between the spectral power and the amplitude of the P1 and P2 was observed. These results are likely to reflect the progressive engagement of the lateral occipital complex as the amount of information in both the low and high portions of the frequency spectrum increased.	[De Cesarei, Andrea; Mastria, Serena; Codispoti, Maurizio] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna	De Cesarei, A (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	andrea.decesarei@unibo.it	Mastria, Serena/ABW-2289-2022; Codispoti, Maurizio/B-7672-2008	Mastria, Serena/0000-0003-4987-8255; Codispoti, Maurizio/0000-0002-7285-4342; De Cesarei, Andrea/0000-0002-6624-5006				Altmann CF, 2004, J COGNITIVE NEUROSCI, V16, P794, DOI 10.1162/089892904970825; Appelbaum LG, 2006, J NEUROSCI, V26, P11695, DOI 10.1523/JNEUROSCI.2741-06.2006; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; BRUNER JS, 1964, SCIENCE, V144, P424, DOI 10.1126/science.144.3617.424; Codispoti M, 2006, PROG BRAIN RES, V156, P53, DOI 10.1016/S0079-6123(06)56003-0; Codispoti M, 2012, PSYCHOPHYSIOLOGY, V49, P11, DOI 10.1111/j.1469-8986.2011.01284.x; De Cesarei A, 2013, REV NEUROSCIENCE, V24, P89, DOI 10.1515/revneuro-2012-0053; De Cesarei A, 2011, J NEUROSCI, V31, P17052, DOI 10.1523/JNEUROSCI.3745-11.2011; De Cesarei A, 2011, PSYCHON B REV, V18, P840, DOI 10.3758/s13423-011-0133-6; DeValois RL, 1990, SPATIAL VISION; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Doniger GM, 2000, J COGNITIVE NEUROSCI, V12, P615, DOI 10.1162/089892900562372; Ellemberg D, 2001, SPATIAL VISION, V15, P99, DOI 10.1163/15685680152692042; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; Ferber S, 2005, NEUROPSYCHOLOGIA, V43, P41, DOI 10.1016/j.neuropsychologia.2004.06.020; GOLLIN ES, 1960, PERCEPT MOTOR SKILL, V11, P289; Gomez Gonzalez C. M., 1994, BRAIN TOPOGRAPHY, V7, P41, DOI DOI 10.1007/BF01184836; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Han SH, 2005, HUM BRAIN MAPP, V26, P199, DOI 10.1002/hbm.20157; Hansen BC, 2011, VISUAL NEUROSCI, V28, P221, DOI 10.1017/S095252381100006X; Hughes HC, 1996, J COGNITIVE NEUROSCI, V8, P197, DOI 10.1162/jocn.1996.8.3.197; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Joubert OR, 2009, J VISION, V9, DOI 10.1167/9.1.2; Kayser C, 2004, CURR OPIN NEUROBIOL, V14, P468, DOI 10.1016/j.conb.2004.06.002; Kim JG, 2011, CEREB CORTEX, V21, P1738, DOI 10.1093/cercor/bhq240; Large ME, 2007, BRAIN RES, V1128, P130, DOI 10.1016/j.brainres.2006.10.023; Loftus GR, 2005, PSYCHON B REV, V12, P43, DOI 10.3758/BF03196348; Loschky LC, 2008, J VISION, V8, DOI 10.1167/8.1.4; Luck S.J., 2005, INTRO EVENT RELATED; Machilsen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025151; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marr D., 1982, VISION COMPUTATIONAL; Martinez A, 2001, CLIN NEUROPHYSIOL, V112, P1980, DOI 10.1016/S1388-2457(01)00660-5; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Murray MM, 2004, J NEUROSCI, V24, P6898, DOI 10.1523/JNEUROSCI.1996-04.2004; Murtha S, 1999, J COGNITIVE NEUROSCI, V11, P399, DOI 10.1162/089892999563508; Olman CA, 2004, VISION RES, V44, P669, DOI 10.1016/j.visres.2003.10.022; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PETERSON MA, 1994, PERCEPT PSYCHOPHYS, V56, P551, DOI 10.3758/BF03206951; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Rousselet GA, 2004, VISION RES, V44, P877, DOI 10.1016/j.visres.2003.11.014; Rousselet GA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00137; Schendan HE, 2007, PSYCHON B REV, V14, P612, DOI 10.3758/BF03196810; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Straube S, 2010, BRAIN RES, V1307, P89, DOI 10.1016/j.brainres.2009.10.043; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Viggiano MP, 2000, J EXP PSYCHOL GEN, V129, P107, DOI 10.1037/0096-3445.129.1.107	56	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65103	10.1371/journal.pone.0065103	http://dx.doi.org/10.1371/journal.pone.0065103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741468	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900181
J	Fazi, S; Vazquez, E; Casamayor, EO; Amalfitano, S; Butturini, A				Fazi, Stefano; Vazquez, Eusebi; Casamayor, Emilio O.; Amalfitano, Stefano; Butturini, Andrea			Stream Hydrological Fragmentation Drives Bacterioplankton Community Composition	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; MICROBIAL DIVERSITY; SEASONAL DYNAMICS; SP-NOV; BACTERIA; RIVER; WATER; LAKES; BIOGEOGRAPHY; IDENTIFICATION	In Mediterranean intermittent streams, the hydrological fragmentation in summer and the successive water flow re-convergence in autumn allow exploring how local processes shape the microbial community within the same habitat. The objectives of this study were to determine how bacterial community composition responded to hydrological fragmentation in summer, and to evaluate whether the seasonal shifts in community composition predominate over the effects of episodic habitat fragmentation. The bacterial community was assessed along the intermittent stream Fuirosos (Spain), at different levels of phylogenetic resolution by in situ hybridization, fingerprinting, and 16S rRNA gene sequencing. The hydrological fragmentation of the stream network strongly altered the biogeochemical conditions with the depletion of oxidized solutes and caused changes in dissolved organic carbon characteristics. In the isolated ponds, beta-Proteobacteria and Actinobacteria increased their abundance with a gradual reduction of the alpha-diversity as pond isolation time increased. Moreover, fingerprinting analysis clearly showed a shift in community composition between summer and autumn. In the context of a seasonal shift, the temporary stream fragmentation simultaneously reduced the microbial dispersion and affected local environmental conditions (shift in redox regime and quality of the dissolved organic matter) tightly shaping the bacterioplankton community composition.	[Fazi, Stefano; Amalfitano, Stefano] Natl Res Council Italy IRSA CNR, Water Res Inst, Rome, Italy; [Vazquez, Eusebi; Butturini, Andrea] Univ Barcelona, Fac Biol, Dept Ecol, Barcelona, Spain; [Casamayor, Emilio O.] Consejo Super Invest Cient CEAB CSIC, Ctr Estudios Avanzados Blanes, Dept Continental Ecol Biodivers & Biogeodynam Int, Blanes, Girona, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca sulle Acque (IRSA-CNR); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Fazi, S (corresponding author), Natl Res Council Italy IRSA CNR, Water Res Inst, Rome, Italy.	fazi@irsa.cnr.it	FAZI, STEFANO/AAX-5609-2020; Casamayor, Emilio/A-3676-2010; Butturini, Andrea/K-4991-2014; Amalfitano, Stefano/C-6737-2012; FAZI, STEFANO/L-3976-2017	FAZI, STEFANO/0000-0001-7688-7179; Casamayor, Emilio/0000-0001-7074-3318; Butturini, Andrea/0000-0002-7712-6328; Amalfitano, Stefano/0000-0002-6148-1472; FAZI, STEFANO/0000-0001-7688-7179	Ministerio de Economia a y Competitividad;  [CGL2011-30151-C02-02/BTE]	Ministerio de Economia a y Competitividad; 	Participation of AB and EV was supported by Project CGL2011-30151-C02-02/BTE, funded by Ministerio de Economia a y Competitividad. AB, EOC and EV are members of the Graccie Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2006, APPL ENVIRON MICROB, V72, P3489, DOI 10.1128/AEM.72.5.3489-3497.2006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amalfitano S, 2008, MICROB ECOL, V55, P270, DOI 10.1007/s00248-007-9274-6; ANDERS HJ, 1995, INT J SYST BACTERIOL, V45, P327, DOI 10.1099/00207713-45-2-327; Barberan A, 2011, MICROB ECOL, V61, P465, DOI 10.1007/s00248-010-9775-6; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Benstead JP, 2012, NAT GEOSCI, V5, P678, DOI 10.1038/ngeo1593; Besemer K, 2009, ISME J, V3, P1318, DOI 10.1038/ismej.2009.73; Bleich ME, 2009, BRAZ ARCH BIOL TECHN, V52, P755, DOI 10.1590/S1516-89132009000300028; Butturini A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2001WR001260; Butturini A, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000721; Casamayor EO, 2002, APPL ENVIRON MICROB, V68, P1706, DOI 10.1128/AEM.68.4.1706-1714.2002; Casamayor EO, 2000, APPL ENVIRON MICROB, V66, P499, DOI 10.1128/AEM.66.2.499-508.2000; Casamayor EO, 2001, AQUAT MICROB ECOL, V25, P237, DOI 10.3354/ame025237; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Comte J, 2009, ENVIRON MICROBIOL, V11, P1704, DOI 10.1111/j.1462-2920.2009.01897.x; Crump BC, 2003, APPL ENVIRON MICROB, V69, P2253, DOI 10.1128/AEM.69.4.2253-2268.2003; Curtis TP, 2005, SCIENCE, V309, P1331, DOI 10.1126/science.1118176; Demergasso C, 2008, EXTREMOPHILES, V12, P491, DOI 10.1007/s00792-008-0153-y; Fazi S, 2005, ENVIRON MICROBIOL, V7, P1633, DOI 10.1111/j.1462-2920.2005.00857.x; Fazi S, 2008, ENVIRON MICROBIOL, V10, P2760, DOI 10.1111/j.1462-2920.2008.01695.x; Fazi S, 2007, SYST APPL MICROBIOL, V30, P463, DOI 10.1016/j.syapm.2007.03.003; Ferrera I, 2004, APPL MICROBIOL BIOT, V64, P726, DOI [10.1007/s00253-004-1581-y, 10.1007/s00253-004-1582-x]; Fierer N, 2007, ECOLOGY, V88, P2162, DOI 10.1890/06-1746.1; Findlay SEG, 2003, LIMNOL OCEANOGR, V48, P1608, DOI 10.4319/lo.2003.48.4.1608; Gao XQ, 2005, AQUAT MICROB ECOL, V40, P51, DOI 10.3354/ame040051; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Hach, 1992, HACH WAT AN HDB; Hahn MW, 2006, CURR OPIN BIOTECH, V17, P256, DOI 10.1016/j.copbio.2006.05.006; Hervas A, 2009, ENVIRON MICROBIOL, V11, P1612, DOI 10.1111/j.1462-2920.2009.01926.x; Hood E, 2005, BIOGEOCHEMISTRY, V74, P231, DOI 10.1007/s10533-004-4322-5; Jackson RB, 2007, ECOLOGY, V88, P1343, DOI 10.1890/06-1882; Jezberova J, 2010, ENVIRON MICROBIOL, V12, P658, DOI 10.1111/j.1462-2920.2009.02106.x; Judd KE, 2006, ECOLOGY, V87, P2068, DOI 10.1890/0012-9658(2006)87[2068:VIDOMC]2.0.CO;2; Keeney DR, 1982, AGRON MONOGR ASA, V9; Kirchman DL, 2004, AQUAT MICROB ECOL, V35, P243, DOI 10.3354/ame035243; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Lindstrom ES, 2006, LIMNOL OCEANOGR, V51, P339, DOI 10.4319/lo.2006.51.1.0339; Logue JB, 2004, LIMNOL OCEANOGR, V49, P2001, DOI 10.4319/lo.2004.49.6.2001; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Logue Jurg Brendan, 2008, Freshwater Reviews, V1, P99, DOI 10.1608/FRJ-1.1.9; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Medici C, 2008, HYDROL PROCESS, V22, P3814, DOI 10.1002/hyp.6991; Muylaert K, 2002, APPL ENVIRON MICROB, V68, P4740, DOI 10.1128/AEM.68.10.4740-4750.2002; Ninyerola M, 2000, INT J CLIMATOL, V20, P1823, DOI 10.1002/1097-0088(20001130)20:14<1823::AID-JOC566>3.0.CO;2-B; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Portillo MC, 2012, ENVIRON MICROBIOL, V14, P2417, DOI 10.1111/j.1462-2920.2012.02785.x; Reche I, 2005, ECOLOGY, V86, P1715, DOI 10.1890/04-1587; Romani AM, 2006, MICROB ECOL, V52, P501, DOI 10.1007/s00248-006-9112-2; Romani AM, 2013, HYDROBIOLOGIA, V719, P43, DOI 10.1007/s10750-012-1302-y; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; SERVAIS P, 1989, APPL ENVIRON MICROB, V55, P2732, DOI 10.1128/AEM.55.10.2732-2734.1989; Song B, 1999, INT J SYST BACTERIOL, V49, P1129, DOI 10.1099/00207713-49-3-1129; Stanhope JW, 2009, J ENVIRON QUAL, V38, P2070, DOI 10.2134/jeq2008.0358; Stedmon CA, 2005, LIMNOL OCEANOGR, V50, P1415, DOI 10.4319/lo.2005.50.5.1415; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vazquez E, 2011, BIOGEOCHEMISTRY, V102, P59, DOI 10.1007/s10533-010-9421-x; von Schiller D, 2011, AQUAT SCI, V73, P485, DOI 10.1007/s00027-011-0195-6; Webster JR, 2007, J N AM BENTHOL SOC, V26, P375, DOI 10.1899/06-095.1; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Wu QLL, 2006, ENVIRON MICROBIOL, V8, P1660, DOI 10.1111/j.1462-2920.2006.01049.x; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Zoppini A, 2010, HYDROBIOLOGIA, V657, P37, DOI 10.1007/s10750-010-0199-6; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	70	51	51	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64109	10.1371/journal.pone.0064109	http://dx.doi.org/10.1371/journal.pone.0064109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741302	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900014
J	Jeselsohn, RM; Werner, L; Regan, MM; Fatima, A; Gilmore, L; Collins, LC; Beck, AH; Bailey, ST; He, HH; Buchwalter, G; Brown, M; Iglehart, JD; Richardson, A; Come, SE				Jeselsohn, Rinath M.; Werner, Lillian; Regan, Meredith M.; Fatima, Aquila; Gilmore, Lauren; Collins, Laura C.; Beck, Andrew H.; Bailey, Shannon T.; He, Housheng Hansen; Buchwalter, Gilles; Brown, Myles; Iglehart, J. Dirk; Richardson, Andrea; Come, Steven E.			Digital Quantification of Gene Expression in Sequential Breast Cancer Biopsies Reveals Activation of an Immune Response	PLOS ONE			English	Article							CORE NEEDLE-BIOPSY; ESTROGEN-RECEPTOR; GROWTH-FACTOR; TUMOR; ANASTROZOLE; TAMOXIFEN; PROLIFERATION; CHEMOTHERAPY; INFLAMMATION; DISCORDANCE	Advancements in molecular biology have unveiled multiple breast cancer promoting pathways and potential therapeutic targets. Large randomized clinical trials remain the ultimate means of validating therapeutic efficacy, but they require large cohorts of patients and are lengthy and costly. A useful approach is to conduct a window of opportunity study in which patients are exposed to a drug pre-surgically during the interval between the core needle biopsy and the definitive surgery. These are non-therapeutic studies and the end point is not clinical or pathological response but rather evaluation of molecular changes in the tumor specimens that can predict response. However, since the end points of the non-therapeutic studies are biologic, it is critical to first define the biologic changes that occur in the absence of treatment. In this study, we compared the molecular profiles of breast cancer tumors at the time of the diagnostic biopsy versus the definitive surgery in the absence of any intervention using the Nanostring nCounter platform. We found that while the majority of the transcripts did not vary between the two biopsies, there was evidence of activation of immune related genes in response to the first biopsy and further investigations of the immune changes after a biopsy in early breast cancer seem warranted.	[Jeselsohn, Rinath M.; Bailey, Shannon T.; He, Housheng Hansen; Buchwalter, Gilles; Brown, Myles] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Jeselsohn, Rinath M.; Bailey, Shannon T.; He, Housheng Hansen; Buchwalter, Gilles; Brown, Myles] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jeselsohn, Rinath M.; Bailey, Shannon T.; He, Housheng Hansen; Buchwalter, Gilles; Brown, Myles] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Werner, Lillian; Regan, Meredith M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Werner, Lillian; Regan, Meredith M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Fatima, Aquila; Iglehart, J. Dirk; Richardson, Andrea] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gilmore, Lauren; Collins, Laura C.; Beck, Andrew H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Iglehart, J. Dirk] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA 02215 USA; [Richardson, Andrea] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; [Come, Steven E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Breast Med Oncol Program, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Brown, M (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.	myles_brown@dfci.harvard.edu; scome@bidmc.harvard.edu	He, Hansen/ABD-8439-2020; Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021; Bailey, Shannon/B-8045-2014	He, Hansen/0000-0003-2898-3363; Brown, Myles/0000-0002-8213-1658; 	National Cancer Institute (NCI): DF/HCC SPORE in Breast Cancer [P50 CA089393, P01CA080111]; NATIONAL CANCER INSTITUTE [P01CA080111, P50CA089393] Funding Source: NIH RePORTER	National Cancer Institute (NCI): DF/HCC SPORE in Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute (NCI): DF/HCC SPORE in Breast Cancer (P50 CA089393) and P01CA080111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2006, BREAST CANCER RES TR, V100, P121, DOI 10.1007/s10549-006-9231-y; Arnedos M, 2009, ANN ONCOL, V20, P1948, DOI 10.1093/annonc/mdp234; Balko JM, 2012, NAT MED, V18, P1052, DOI 10.1038/nm.2795; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Baum M, 2002, LANCET, V359, P2131; Bolat F, 2006, J EXP CLIN CANC RES, V25, P365; Bonanni B, 2012, J CLIN ONCOL, V30, P2593, DOI 10.1200/JCO.2011.39.3769; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dowsett M, 2005, CLIN CANCER RES, V11, p951S; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guix M, 2008, J CLIN ONCOL, V26, P897, DOI 10.1200/JCO.2007.13.5939; Haneda Y, 2011, CYTOKINE, V55, P24, DOI 10.1016/j.cyto.2011.03.018; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lee AHS, 1997, J CLIN PATHOL, V50, P669, DOI 10.1136/jcp.50.8.669; Lee AV, 2001, CLIN CANCER RES, V7, p4429S; Li SC, 2012, BREAST CANCER RES TR, V135, P325, DOI 10.1007/s10549-012-2063-z; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lorgis V, 2011, BREAST, V20, P284, DOI 10.1016/j.breast.2010.12.007; MacManus CF, 2011, FASEB J, V25, P1856, DOI 10.1096/fj.10-170316; Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2009.09.009; Niraula S, 2012, BREAST CANC RES TREA; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Smith IE, 2007, J CLIN ONCOL, V25, P3816, DOI 10.1200/JCO.2006.09.6578; Sutherland RL, 1998, J MAMMARY GLAND BIOL, V3, P63, DOI 10.1023/A:1018774302092; Uy GB, 2010, CLIN BREAST CANCER, V10, P154, DOI 10.3816/CBC.2010.n.021; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Zhao W, 2011, J BIOL CHEM, V286, P5519, DOI 10.1074/jbc.M110.149823	36	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64225	10.1371/journal.pone.0064225	http://dx.doi.org/10.1371/journal.pone.0064225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741308	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900020
J	Pereira, MP; Werner, MU; Ringsted, TK; Rowbotham, MC; Taylor, BK; Dahl, JB				Pereira, Manuel P.; Werner, Mads U.; Ringsted, Thomas K.; Rowbotham, Michael C.; Taylor, Bradley K.; Dahl, Joergen B.			Does Naloxone Reinstate Secondary Hyperalgesia in Humans after Resolution of a Burn Injury? A Placebo-Controlled, Double-Blind, Randomized, Cross-Over Study	PLOS ONE			English	Article							HIGH-DOSE NALOXONE; PAIN MODULATION; MORPHINE; ANALGESIA; MODEL; HEAT; REMIFENTANIL; ANTAGONIST; NALTREXONE	Introduction: Development of secondary hyperalgesia following a cutaneous injury is a centrally mediated, robust phenomenon. The pathophysiological role of endogenous opioid signalling to the development of hyperalgesia is unclear. Recent animal studies, carried out after the resolution of inflammatory pain, have demonstrated reinstatement of tactile hypersensitivity following administration of m-opioid-receptor-antagonists. In the present study in humans, we analyzed the effect of naloxone when given after the resolution of secondary hyperalgesia following a first-degree burn injury. Methods: Twenty-two healthy volunteers were included in this placebo-controlled, randomized, double-blind, cross-over study. Following baseline assessment of thermal and mechanical thresholds, a first-degree burn injury (BI; 47 degrees C, 7 minutes, thermode area 12.5 cm(2)) was induced on the lower leg. Secondary hyperalgesia areas around the BI-area, and separately produced by brief thermal sensitization on the contralateral thigh (BTS; 45 degrees C, 3 minutes, area 12.5 cm(2)), were assessed using a polyamide monofilament at pre-BI and 1, 2, and 3 hours post-BI. At 72 hrs, BI and BTS secondary hyperalgesia areas were assessed prior to start of a 30 minutes intravenous infusion of naloxone (total dose 21 microg/kg) or placebo. Fifteen minutes after start of the infusion, BI and BTS secondary hyperalgesia areas were reassessed, along with mechanical and thermal thresholds. Results: Secondary hyperalgesia areas were demonstrable in all volunteers 1-3 hrs post-BI, but were not demonstrable at 72 hrs post-burn in 73-86% of the subjects. Neither magnitude of secondary hyperalgesia areas nor the mechanical and thermal thresholds were associated with naloxone-treated compared to placebo-treated subjects. Conclusion: Naloxone (21 microg/kg) did not reinstate secondary hyperalgesia when administered 72 hours after a first-degree burn injury and did not increase BTS-generated hyperalgesia. The negative results may be due to the low dose of naloxone or insufficient tissue injury to generate latent sensitization.	[Pereira, Manuel P.; Werner, Mads U.; Ringsted, Thomas K.] Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Ctr Multidisciplinary Pain, DK-2100 Copenhagen, Denmark; [Pereira, Manuel P.; Dahl, Joergen B.] Univ Copenhagen Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, DK-2100 Copenhagen, Denmark; [Rowbotham, Michael C.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Taylor, Bradley K.] Univ Kentucky, Med Ctr, Dept Physiol, Lexington, KY USA	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Kentucky	Pereira, MP (corresponding author), Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Ctr Multidisciplinary Pain, DK-2100 Copenhagen, Denmark.	mpflp47@gmail.com	Pereira, Manuel Pedro/AAP-8484-2020; Rowbotham, Michael/AAA-3606-2019	Werner, Mads/0000-0003-1540-8845	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA019656] Funding Source: NIH RePORTER; NIDA NIH HHS [K02 DA019656] Funding Source: Medline; NINDS NIH HHS [R01 NS045954] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS HP, 1986, STROKE, V17, P404, DOI 10.1161/01.STR.17.3.404; Andresen T, 2011, BRIT J PHARMACOL, V164, P934, DOI 10.1111/j.1476-5381.2010.01180.x; BARSAN WG, 1989, CRIT CARE MED, V17, P762, DOI 10.1097/00003246-198908000-00009; Brennum J, 2001, ACTA ANAESTH SCAND, V45, P954, DOI 10.1034/j.1399-6576.2001.450806.x; Cabanero D, 2009, ANESTHESIOLOGY, V111, P1334, DOI 10.1097/ALN.0b013e3181bfab61; Campillo A, 2011, EUR J PHARMACOL, V657, P89, DOI 10.1016/j.ejphar.2011.01.059; Campillo A, 2010, MOL PHARMACOL, V77, P185, DOI 10.1124/mol.109.059790; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; Chu LF, 2011, J PAIN, V12, P108, DOI 10.1016/j.jpain.2010.05.006; COHEN MR, 1982, LIFE SCI, V30, P2025, DOI 10.1016/0024-3205(82)90443-X; COHEN MR, 1985, PSYCHOSOM MED, V47, P132, DOI 10.1097/00006842-198503000-00004; COHEN MR, 1983, ARCH GEN PSYCHIAT, V40, P613; COHEN MR, 1984, BIOL PSYCHIAT, V19, P825; COHEN MR, 1981, LANCET, V2, P1110; COHEN MR, 1985, NEUROPEPTIDES, V6, P373, DOI 10.1016/0143-4179(85)90010-1; COHEN MR, 1985, BIOL PSYCHIAT, V20, P570, DOI 10.1016/0006-3223(85)90030-7; Corder G, 2012, IASP M 2012 14 WORLD; Corder G, 2012, SOC NEUR M 2012 NEW; Dirks J, 2003, J PAIN, V4, P122, DOI 10.1054/jpai.2003.10; Dirks J, 2002, ANESTHESIOLOGY, V97, P102, DOI 10.1097/00000542-200207000-00015; DIXON WJ, 1991, NEUROSCI BIOBEHAV R, V15, P47, DOI 10.1016/S0149-7634(05)80090-9; Drummond PD, 2000, ANESTH ANALG, V90, P923, DOI 10.1213/00000539-200004000-00027; FEDERICO F, 1991, ITAL J NEUROL SCI, V12, P557, DOI 10.1007/BF02336951; Frymoyer AR, 2007, J PAIN, V8, P19, DOI 10.1016/j.jpain.2006.05.010; Gauthier CA, 1999, PSYCHOPHARMACOLOGY, V144, P131, DOI 10.1007/s002130050985; Granot M, 2008, PAIN, V136, P142, DOI 10.1016/j.pain.2007.06.029; IASP, IASP TAX; Ilkjaer S, 1997, BRIT J ANAESTH, V79, P600, DOI 10.1093/bja/79.5.600; Koppert W, 2005, J PAIN, V6, P757, DOI 10.1016/j.jpain.2005.07.002; Koppert W, 2003, PAIN, V106, P91, DOI 10.1016/S0304-3959(03)00294-X; LAMOTTE RH, 1992, J PHYSIOL-LONDON, V448, P749, DOI 10.1113/jphysiol.1992.sp019068; Le Roy C, 2011, J PAIN, V12, P1069, DOI 10.1016/j.jpain.2011.04.011; Mikkelsen S, 1999, ANESTHESIOLOGY, V90, P1539, DOI 10.1097/00000542-199906000-00007; Naert ALG, 2008, PAIN, V138, P163, DOI 10.1016/j.pain.2007.11.018; Olesen SS, 2010, CLIN GASTROENTEROL H, V8, P724, DOI 10.1016/j.cgh.2010.03.005; OLINGER CP, 1990, STROKE, V21, P721, DOI 10.1161/01.STR.21.5.721; Pedersen JL, 1998, PAIN, V74, P139, DOI 10.1016/S0304-3959(97)00160-7; Peltz E, 2011, NEUROIMAGE, V54, P1324, DOI 10.1016/j.neuroimage.2010.09.012; Petersen KL, 2008, PAIN, V137, P395, DOI 10.1016/j.pain.2007.09.019; Petersen KL, 2003, J PAIN, V4, P400, DOI 10.1016/S1526-5900(03)00718-1; Pielsticker A, 2005, PAIN, V118, P215, DOI 10.1016/j.pain.2005.08.019; Price DD, 2002, PAIN, V99, P49, DOI 10.1016/S0304-3959(02)00053-2; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Ravn P, 2013, J PAIN RES, V6, P23, DOI 10.2147/JPR.S36827; Ravn Pernille, 2012, J Pain Res, V5, P313, DOI 10.2147/JPR.S33925; Rivat C, 2007, NEUROPSYCHOPHARMACOL, V32, P2217, DOI 10.1038/sj.npp.1301340; SADZOT B, 1990, Neurophysiologie Clinique, V20, P323, DOI 10.1016/S0987-7053(05)80202-3; Schoell ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012344; Schulte H, 2005, PAIN, V116, P366, DOI 10.1016/j.pain.2005.05.005; Seifert F, 2013, HUM BRAIN MAPP, V34, P1768, DOI 10.1002/hbm.22035; Seifert F, 2011, CURR OPIN ANESTHESIO, V24, P515, DOI 10.1097/ACO.0b013e32834a1079; SHANNON HE, 1976, PSYCHOPHARMACOLOGY, V50, P119, DOI 10.1007/BF00430479; Sirohi S, 2009, J PHARMACOL EXP THER, V330, P513, DOI 10.1124/jpet.109.152678; Sjolund KF, 1999, ANESTH ANALG, V88, P605, DOI 10.1097/00000539-199903000-00027; Staud R, 2012, J PAIN, V13, P725, DOI 10.1016/j.jpain.2012.04.006; Stubhaug A, 2007, ACTA ANAESTH SCAND, V51, P1138, DOI 10.1111/j.1399-6576.2007.01415.x; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Warncke T, 2000, PAIN, V86, P293, DOI 10.1016/S0304-3959(00)00260-8; Werner MU, 2012, PAIN, V153, P943, DOI 10.1016/j.pain.2012.02.017; Werner MU, 2002, PAIN, V98, P297, DOI 10.1016/S0304-3959(02)00030-1; Werner MU, 2002, REGION ANESTH PAIN M, V27, P254, DOI 10.1053/rapm.2002.30664; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021	63	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64608	10.1371/journal.pone.0064608	http://dx.doi.org/10.1371/journal.pone.0064608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741350	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900063
J	Ramirez, AM; Saillard, N; Yang, T; Franssen, MCR; Bouwmeester, HJ; Jongsma, MA				Ramirez, Aldana M.; Saillard, Nils; Yang, Ting; Franssen, Maurice C. R.; Bouwmeester, Harro J.; Jongsma, Maarten A.			Biosynthesis of Sesquiterpene Lactones in Pyrethrum (Tanacetum cinerariifolium)	PLOS ONE			English	Article							CICHORIUM-INTYBUS L.; GLANDULAR TRICHOMES; EXPRESSION; PARTHENOLIDE; MONOTERPENE; COSTUNOLIDE; FEVERFEW; SYNTHASE; CLONING; ACID	The daisy-like flowers of pyrethrum (Tanacetum cinerariifolium) are used to extract pyrethrins, a botanical insecticide with a long history of safe and effective use. Pyrethrum flowers also contain other potential defense compounds, particularly sesquiterpene lactones (STLs), which represent problematic allergenic residues in the extracts that are removed by the pyrethrum industry. The STLs are stored in glandular trichomes present on the pyrethrum achenes, and have been shown to be active against herbivores, micro-organisms and in the below-ground competition with other plants. Despite these reported bioactivities and industrial significance, the biosynthetic origin of pyrethrum sesquiterpene lactones remains unknown. In the present study, we show that germacratrien-12-oic acid is most likely the central precursor for all sesquiterpene lactones present in pyrethrum. The formation of the lactone ring depends on the regio- (C6 or C8) and stereo-selective (alpha or beta) hydroxylation of germacratrien-12-oic acid. Candidate genes implicated in three committed steps leading from farnesyl diphosphate to STL and other oxygenated derivatives of germacratrien-12-oic acid were retrieved from a pyrethrum trichome EST library, cloned, and characterized in yeast and in planta. The diversity and distribution of sesquiterpene lactones in different tissues and the correlation with the expression of these genes are shown and discussed.	[Ramirez, Aldana M.; Saillard, Nils; Yang, Ting; Jongsma, Maarten A.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Ramirez, Aldana M.; Yang, Ting; Bouwmeester, Harro J.] Univ Wageningen & Res Ctr, Lab Plant Physiol, Wageningen, Netherlands; [Ramirez, Aldana M.; Yang, Ting] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Franssen, Maurice C. R.] Univ Wageningen & Res Ctr, Organ Chem Lab, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Jongsma, MA (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	maarten.jongsma@wur.nl	Jongsma, Maarten A/A-2118-2010; Franssen, Maurice C.R./R-4026-2019; Bouwmeester, Harro J/C-1414-2008; Yang, Ting/J-1881-2015	Jongsma, Maarten A/0000-0001-5799-2301; Franssen, Maurice C.R./0000-0002-3615-9115; Bouwmeester, Harro/0000-0003-0907-2732; Yang, Ting/0000-0001-8872-8749	Technology Top Institute Green Genetics (Stichting TTI Groene Genetica) of the Netherlands [1C001RP]	Technology Top Institute Green Genetics (Stichting TTI Groene Genetica) of the Netherlands	This research was supported by Technology Top Institute Green Genetics (Stichting TTI Groene Genetica) of the Netherlands (grant no. 1C001RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEYSEKERA BF, 1985, BIOCHEM SYST ECOL, V13, P365, DOI 10.1016/0305-1978(85)90050-X; Adio AM, 2009, TETRAHEDRON, V65, P1533, DOI 10.1016/j.tet.2008.11.050; Arsenault PR, 2010, PLANT PHYSIOL, V154, P958, DOI 10.1104/pp.110.162552; BARTON DHR, 1960, J CHEM SOC, P2263, DOI 10.1039/jr9600002263; BARTON DHR, 1957, J CHEM SOC, P150, DOI 10.1039/jr9570000150; Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; Cankar K, 2011, FEBS LETT, V585, P178, DOI 10.1016/j.febslet.2010.11.040; CHOU JC, 1993, J CHEM ECOL, V19, P1439, DOI 10.1007/BF00984888; de Kraker JW, 1998, PLANT PHYSIOL, V117, P1381, DOI 10.1104/pp.117.4.1381; de Kraker JW, 2003, TETRAHEDRON, V59, P409, DOI 10.1016/S0040-4020(02)01479-5; de Kraker JW, 2002, PLANT PHYSIOL, V129, P257, DOI 10.1104/pp.010957; de Kraker JW, 2001, PLANT PHYSIOL, V125, P1930, DOI 10.1104/pp.125.4.1930; de Kraker JW, 1999, ACTA BOT GALLICA, V146, P111, DOI 10.1080/12538078.1999.10515807; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; DOSKOTCH RW, 1969, CAN J CHEMISTRY, V47, P1139, DOI 10.1139/v69-184; DOSKOTCH RW, 1971, CAN J CHEMISTRY, V49, P2103, DOI 10.1139/v71-341; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Fischer NH, 1990, SESQUITERPENE LACTON; Gopfert JC, 2005, PLANT BIOLOGY, V7, P148, DOI 10.1055/s-2005-837575; HEAD S. W., 1966, Pyrethrum Post, V8, P32; Hehner SP, 1999, J IMMUNOL, V163, P5617; IINO Y, 1972, AGR BIOL CHEM TOKYO, V36, P2505, DOI 10.1080/00021369.1972.10860561; Ikezawa N, 2011, J BIOL CHEM, V286, P21601, DOI 10.1074/jbc.M110.216804; Kumar A, 2005, CURR SCI INDIA, V89, P1489; Lesiak K, 2010, MELANOMA RES, V20, P21, DOI 10.1097/CMR.0b013e328333bbe4; Liu Q, 2011, PLOS ONE, V6; Majdi M, 2011, PHYTOCHEMISTRY, V72, P1739, DOI 10.1016/j.phytochem.2011.04.021; MCCASKILL D, 1995, PLANTA, V197, P49, DOI 10.1007/BF00239938; McConkey ME, 2000, PLANT PHYSIOL, V122, P215, DOI 10.1104/pp.122.1.215; Nelson David R., 2009, Human Genomics, V4, P59; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Osimitz TG, 2006, CUTAN OCUL TOXICOL, V25, P287, DOI 10.1080/15569520601013392; Outchkourov NS, 2003, PLANTA, V216, P1003, DOI 10.1007/s00425-002-0953-8; PICMAN AK, 1983, BIOCHEM SYST ECOL, V11, P183, DOI 10.1016/0305-1978(83)90050-9; PICMAN AK, 1983, BIOCHEM SYST ECOL, V11, P321; Ramirez AM, 2012, PLANT CELL, V24, P4252, DOI 10.1105/tpc.112.105031; RICKETT F. E., 1972, Pesticide Science, V3, P57, DOI 10.1002/ps.2780030109; Rickett F. E., 1973, Pesticide Science, V4, P801, DOI 10.1002/ps.2780040606; SASHIDA Y, 1983, PHYTOCHEMISTRY, V22, P1219, DOI 10.1016/0031-9422(83)80225-8; Schilmiller AL, 2010, PLANT PHYSIOL, V153, P1212, DOI 10.1104/pp.110.157214; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; van Herpen TWJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014222; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123	43	45	46	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65030	10.1371/journal.pone.0065030	http://dx.doi.org/10.1371/journal.pone.0065030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741445	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900158
J	Yuan, Y; Jiang, CY; Xu, H; Sun, Y; Hu, FF; Bian, JC; Liu, XZ; Gu, JH; Liu, ZP				Yuan, Yan; Jiang, Chen-yang; Xu, Hui; Sun, Ya; Hu, Fei-fei; Bian, Jian-chun; Liu, Xue-zhong; Gu, Jian-hong; Liu, Zong-ping			Cadmium-Induced Apoptosis in Primary Rat Cerebral Cortical Neurons Culture Is Mediated by a Calcium Signaling Pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; CELL-DEATH; MEMBRANE PERMEABILIZATION; BCL-2 FAMILY; EXPOSURE; CA2+; HOMEOSTASIS; ACTIVATION; KINASE	Cadmium (Cd) is an extremely toxic metal, capable of severely damaging several organs, including the brain. Studies have shown that Cd disrupts intracellular free calcium ([Ca2+](i)) homeostasis, leading to apoptosis in a variety of cells including primary murine neurons. Calcium is a ubiquitous intracellular ion which acts as a signaling mediator in numerous cellular processes including cell proliferation, differentiation, and survival/death. However, little is known about the role of calcium signaling in Cd-induced apoptosis in neuronal cells. Thus we investigated the role of calcium signaling in Cd-induced apoptosis in primary rat cerebral cortical neurons. Consistent with known toxic properties of Cd, exposure of cerebral cortical neurons to Cd caused morphological changes indicative of apoptosis and cell death. It also induced elevation of [Ca2+](i) and inhibition of Na+/K+-ATPase and Ca2+/Mg2+-ATPase activities. This Cd-induced elevation of [Ca2+](i) was suppressed by an IP3R inhibitor, 2-APB, suggesting that ER-regulated Ca2+ is involved. In addition, we observed elevation of reactive oxygen species (ROS) levels, dysfunction of cytochrome oxidase subunits (COX-I/II/III), depletion of mitochondrial membrane potential (DYm), and cleavage of caspase-9, caspase-3 and poly (ADP-ribose) polymerase (PARP) during Cd exposure. Z-VAD-fmk, a pan caspase inhibitor, partially prevented Cd-induced apoptosis and cell death. Interestingly, apoptosis, cell death and these cellular events induced by Cd were blocked by BAPTA-AM, a specific intracellular Ca2+ chelator. Furthermore, western blot analysis revealed an up-regulated expression of Bcl-2 and down-regulated expression of Bax. However, these were not blocked by BAPTA-AM. Thus Cd toxicity is in part due to its disruption of intracellular Ca2+ homeostasis, by compromising ATPases activities and ER-regulated Ca2+, and this elevation in Ca2+ triggers the activation of the Ca2+-mitochondria apoptotic signaling pathway. This study clarifies the signaling events underlying Cd neurotoxicity, and suggests that regulation of Cd-disrupted [Ca2+](i) homeostasis may be a new strategy for prevention of Cd-induced neurodegenerative diseases.	[Yuan, Yan; Jiang, Chen-yang; Xu, Hui; Sun, Ya; Hu, Fei-fei; Bian, Jian-chun; Liu, Xue-zhong; Gu, Jian-hong; Liu, Zong-ping] Yang Zhou Univ, Coll Vet Med, Yangzhou, Peoples R China	Yangzhou University	Liu, ZP (corresponding author), Yang Zhou Univ, Coll Vet Med, Yangzhou, Peoples R China.	liuzongping@yzu.edu.cn		YUAN, YAN/0000-0002-1658-5328	National Natural Science Foundation of China [31101866, 31172373]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 31101866, to Yan Yuan; No. 31172373, to Zong-ping Liu) (http://www.nsfc.gov.cn/Portal0/default152.htm) and a project Funded by Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JR, 2005, TOXICOL LETT, V159, P182, DOI 10.1016/j.toxlet.2005.05.016; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Biagioli M, 2008, CELL CALCIUM, V43, P184, DOI 10.1016/j.ceca.2007.05.003; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CHACON E, 1991, TOXICOL APPL PHARM, V107, P117, DOI 10.1016/0041-008X(91)90336-D; Chakraborti T, 1999, CELL SIGNAL, V11, P77, DOI 10.1016/S0898-6568(98)00025-4; Chatterjee S, 2009, MUTAT RES-FUND MOL M, V663, P22, DOI 10.1016/j.mrfmmm.2008.12.011; Chen L, 2008, FREE RADICAL BIO MED, V45, P1035, DOI 10.1016/j.freeradbiomed.2008.07.011; Chen L, 2011, FREE RADICAL BIO MED, V50, P624, DOI 10.1016/j.freeradbiomed.2010.12.032; Chen SJ, 2011, J NEUROCHEM, V119, P1108, DOI 10.1111/j.1471-4159.2011.07493.x; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Coccini T, 2013, HISTOL HISTOPATHOL, V28, P195, DOI 10.14670/HH-28.195; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cui ZG, 2011, TOXICOL IN VITRO, V25, P1687, DOI 10.1016/j.tiv.2011.07.008; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Fantin VR, 2006, ONCOGENE, V25, P4787, DOI 10.1038/sj.onc.1209599; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Foster KA, 2006, PROG NEUROBIOL, V79, P136, DOI 10.1016/j.pneurobio.2006.07.001; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327; Garceau N, 2010, AQUAT TOXICOL, V98, P107, DOI 10.1016/j.aquatox.2010.01.020; Grammatopoulos TN, 2004, NEUROSCI RES, V50, P299, DOI 10.1016/j.neures.2004.07.010; Hossain S, 2009, NEUROTOXICOLOGY, V30, P544, DOI 10.1016/j.neuro.2009.06.001; Jiang LF, 2007, BBA-PROTEINS PROTEOM, V1774, P1414, DOI 10.1016/j.bbapap.2007.08.014; Kawahara M, 2000, BRAIN RES BULL, V53, P389, DOI 10.1016/S0361-9230(00)00370-1; Kim J, 2004, TOXICOL SCI, V81, P518, DOI 10.1093/toxsci/kfh221; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Krumschnabel G, 2010, AQUAT TOXICOL, V99, P73, DOI 10.1016/j.aquatox.2010.04.005; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; LOHMANN RD, 1993, BIOCHEM BIOPH RES CO, V190, P1097, DOI 10.1006/bbrc.1993.1162; Long GJ, 1997, TOXICOL LETT, V91, P91, DOI 10.1016/S0378-4274(97)03880-0; Lopez E, 2006, FREE RADICAL BIO MED, V40, P940, DOI 10.1016/j.freeradbiomed.2005.10.062; Lopez E, 2003, BRIT J PHARMACOL, V138, P901, DOI 10.1038/sj.bjp.0705111; Lukawski K, 2005, NEUROTOXICOL TERATOL, V27, P575, DOI 10.1016/j.ntt.2005.05.009; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Matsumoto A, 2011, DIGEST DIS SCI, V56, P999, DOI 10.1007/s10620-010-1420-1; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mertens HJMM, 2002, GYNECOL OBSTET INVES, V53, P224, DOI 10.1159/000064569; Misra UK, 2003, CELL SIGNAL, V15, P1059, DOI 10.1016/S0898-6568(03)00117-7; Misra UK, 2002, CELL SIGNAL, V14, P327, DOI 10.1016/S0898-6568(01)00268-6; Napolitano JR, 2012, AM J PHYSIOL-LUNG C, V302, pL909, DOI 10.1152/ajplung.00351.2011; Navarro A, 2011, ENVIRON POLLUT, V159, P100, DOI 10.1016/j.envpol.2010.09.018; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nishimura Y, 2006, TOXICOL IN VITRO, V20, P211, DOI 10.1016/j.tiv.2005.06.006; Okuda B, 1997, CLIN NEUROL NEUROSUR, V99, P263, DOI 10.1016/S0303-8467(97)00090-5; Oliveira H, 2012, HUM EXP TOXICOL, V31, P1228, DOI 10.1177/0960327112445937; Onyango IG, 2005, NEUROBIOL DIS, V19, P312, DOI 10.1016/j.nbd.2005.01.026; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Prabu SM, 2011, J NUTR SCI VITAMINOL, V57, P177, DOI 10.3177/jnsv.57.177; Ruiz A, 2009, CELL CALCIUM, V46, P273, DOI 10.1016/j.ceca.2009.08.005; Sabolic I, 2006, NEPHRON PHYSIOL, V104, P107, DOI 10.1159/000095539; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sohal RS, 2008, MECH AGEING DEV, V129, P558, DOI 10.1016/j.mad.2008.04.006; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; THEVENOD F, 1992, BIOPHYS J, V63, P162, DOI 10.1016/S0006-3495(92)81575-8; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; VISSER GJ, 1993, BIOCHIM BIOPHYS ACTA, V1152, P26, DOI 10.1016/0005-2736(93)90227-Q; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang L, 2010, BIOL TRACE ELEM RES, V137, P69, DOI 10.1007/s12011-009-8560-1; Wang L, 2009, BIOL TRACE ELEM RES, V127, P53, DOI 10.1007/s12011-008-8223-7; Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9; Wang SH, 2009, CHEM-BIOL INTERACT, V181, P45, DOI 10.1016/j.cbi.2009.05.004; Wu XW, 2008, ENVIRON RES, V108, P233, DOI 10.1016/j.envres.2008.02.011; Xie ZY, 2010, TOXICOL LETT, V192, P115, DOI 10.1016/j.toxlet.2009.10.011; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Yeh JH, 2009, BASIC CLIN PHARMACOL, V104, P345, DOI 10.1111/j.1742-7843.2009.00391.x; Yuan Y, 2012, BIOMED ENVIRON SCI, V25, P172, DOI 10.3967/0895-3988.2012.02.008; Zhang HJ, 2012, AQUAT TOXICOL, V122, P67, DOI 10.1016/j.aquatox.2012.05.014	74	118	132	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64330	10.1371/journal.pone.0064330	http://dx.doi.org/10.1371/journal.pone.0064330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741317	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900029
J	Zhao, K; Chen, YH; Yan, WJ; Fu, XL				Zhao, Ke; Chen, Yu-Hsin; Yan, Wen-Jing; Fu, Xiaolan			To Bind or Not to Bind? Different Temporal Binding Effects from Voluntary Pressing and Releasing Actions	PLOS ONE			English	Article							CONSCIOUS INTENTION; TIME; AGENCY; CAUSALITY; INTERVAL; SYSTEMS; SENSE	Binding effect refers to the perceptual attraction between an action and an outcome leading to a subjective compression of time. Most studies investigating binding effects exclusively employ the "pressing" action without exploring other types of actions. The present study addresses this issue by introducing another action, releasing action or the voluntary lifting of the finger/wrist, to investigate the differences between voluntary pressing and releasing actions. Results reveal that releasing actions led to robust yet short-lived temporal binding effects, whereas pressing condition had steady temporal binding effects up to super-seconds. The two actions also differ in sensitivity to changes in temporal contiguity and contingency, which could be attributed to the difference in awareness of action. Extending upon current models of "willed action," our results provide insights from a temporal point of view and support the concept of a dual system consisting of predictive motor control and top-down mechanisms.	[Zhao, Ke; Chen, Yu-Hsin; Yan, Wen-Jing; Fu, Xiaolan] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Fu, XL (corresponding author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	fuxl@psych.ac.cn			973 Program [2011CB302201]; National Natural Science Foundation of China [61075042]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from 973 Program (2011CB302201) and the National Natural Science Foundation of China (61075042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buehner MJ, 2012, PSYCHOL SCI, V23, P1490, DOI 10.1177/0956797612444612; Cravo AM, 2011, ACTA PSYCHOL, V136, P157, DOI 10.1016/j.actpsy.2010.11.005; Cravo AM, 2009, EXP BRAIN RES, V199, P95, DOI 10.1007/s00221-009-1969-0; Eagleman DM, 2002, TRENDS COGN SCI, V6, P323, DOI 10.1016/S1364-6613(02)01945-9; Ebert JP, 2010, CONSCIOUS COGN, V19, P481, DOI 10.1016/j.concog.2009.10.002; Engbert K, 2007, J EXP PSYCHOL HUMAN, V33, P1261, DOI 10.1037/0096-1523.33.6.1261; Engbert K, 2008, COGNITION, V107, P693, DOI 10.1016/j.cognition.2007.07.021; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; HUME D, 1888, ENQUIRY HUMAN UNDERS; Humphreys GR, 2009, J EXP PSYCHOL HUMAN, V35, P1542, DOI 10.1037/a0014492; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MITRANI L, 1977, ACTIV NERV SUPER, V19, P103; Moore J, 2008, CONSCIOUS COGN, V17, P136, DOI 10.1016/j.concog.2006.12.004; Moore JW, 2012, CONSCIOUS COGN, V21, P546, DOI 10.1016/j.concog.2011.12.002; Moore JW, 2009, COGNITION, V110, P279, DOI 10.1016/j.cognition.2008.11.006; Orgs G, 2011, VIS COGN, V19, P833, DOI 10.1080/13506285.2011.598481; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Shanks D. R, 1985, HUM STUD, V11, P94, DOI [10.1353/hms.2011.0025, DOI 10.1353/HMS.2011.0025]; SHANKS DR, 1989, Q J EXP PSYCHOL-B, V41, P139; SHIFFRAR M, 1993, PSYCHOL SCI, V4, P379, DOI 10.1111/j.1467-9280.1993.tb00585.x; SHIFFRAR M, 1990, PSYCHOL SCI, V1, P257, DOI 10.1111/j.1467-9280.1990.tb00210.x; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Suter RS, 2011, COGNITION, V119, P454, DOI 10.1016/j.cognition.2011.01.018; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Wearden JH, 1999, BEHAV PROCESS, V46, P25, DOI 10.1016/S0376-6357(98)00059-X; Witney AG, 2001, NEUROREPORT, V12, P649, DOI 10.1097/00001756-200103260-00007; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551	34	7	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64819	10.1371/journal.pone.0064819	http://dx.doi.org/10.1371/journal.pone.0064819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741399	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900112
J	St Julien, KR; Jelliffe-Pawlowski, LL; Shaw, GM; Stevenson, DK; O'Brodovich, HM; Krasnow, MA				St Julien, Krystal R.; Jelliffe-Pawlowski, Laura L.; Shaw, Gary M.; Stevenson, David K.; O'Brodovich, Hugh M.; Krasnow, Mark A.		Stanford BPD Study Grp	High Quality Genome-Wide Genotyping from Archived Dried Blood Spots without DNA Amplification	PLOS ONE			English	Article							AMPLIFIED DNA; FILTER-PAPER; SAMPLES; PHENYLKETONURIA; EXTRACTION; FRESH; SNP	Spots of blood are routinely collected from newborn babies onto filter paper called Guthrie cards and used to screen for metabolic and genetic disorders. The archived dried blood spots are an important and precious resource for genomic research. Whole genome amplification of dried blood spot DNA has been used to provide DNA for genome-wide SNP genotyping. Here we describe a 96 well format procedure to extract DNA from a portion of a dried blood spot that provides sufficient unamplified genomic DNA for genome-wide single nucleotide polymorphism ( SNP) genotyping. We show that SNP genotyping of the unamplified DNA is more robust than genotyping amplified dried blood spot DNA, is comparable in cost, and can be done with thousands of samples. This procedure can be used for genome-wide association studies and other large-scale genomic analyses that require robust, high-accuracy genotyping of dried blood spot DNA.	[St Julien, Krystal R.; Krasnow, Mark A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [St Julien, Krystal R.; Krasnow, Mark A.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Shaw, Gary M.; Stevenson, David K.; O'Brodovich, Hugh M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Jelliffe-Pawlowski, Laura L.] Calif Dept Publ Hlth, Calif Genet Dis Screening Program, Richmond, VA USA; [Jelliffe-Pawlowski, Laura L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of California System; University of California San Francisco	Krasnow, MA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	krasnow@stanford.edu		Lazzeroni, Laura/0000-0002-1846-6920; Shaw, Gary/0000-0001-7438-4914	National Institutes of Health [RC2 HL101748]; BPD study group; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BPD study group; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by National Institutes of Health grant RC2 HL101748 to H.M.O. and the BPD study group, and a Howard Hughes Medical Institute Award to M.A.K. K.R.S. is a Howard Hughes Medical Institute Gilliam fellow and M.A.K is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caggana M, 1998, HUM MUTAT, V11, P404, DOI 10.1002/(SICI)1098-1004(1998)11:5<404::AID-HUMU8>3.0.CO;2-S; Catsburg A, 2007, J IMMUNOL METHODS, V321, P135, DOI 10.1016/j.jim.2007.01.015; Chaisomchit Sumonta, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P270; Chaisomchit Sumonta, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P641; Christensen RD, 2009, SEMIN PERINATOL, V33, P3, DOI 10.1053/j.semperi.2008.10.010; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gould JB, 2010, CLIN PERINATOL, V37, P71, DOI 10.1016/j.clp.2010.01.004; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Hamvas A, 2001, PEDIATR RES, V50, P666, DOI 10.1203/00006450-200111000-00021; Hannelius U, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032987; Hollegaard MV, 2007, CLIN CHEM, V53, P1161, DOI 10.1373/clinchem.2006.082313; Hollegaard MV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-58; Hollegaard MV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-297; Hollegaard MV, 2009, GENET TEST MOL BIOMA, V13, P173, DOI 10.1089/gtmb.2008.0073; Hollegaard MV, 2009, ELECTROPHORESIS, V30, P2532, DOI 10.1002/elps.200800655; Illumina, 2005, GENCALL DAT AN SOFTW; Illumina, 2010, OMN FAM MICR; Illumina, 2011, GENOMESTUDIO DAT AN; IOVANNISCI DM, 2000, EPICENTRE FORUM, V7, P6; McCabe E. R., 1991, GENOME RES, V1, P99, DOI [10.1101/gr.1.2.99, DOI 10.1101/GR.1.2.99]; Mei JV, 2001, AM SOC NUTR SCI, V131, p1631S; Oliphant A, 2002, BIOTECHNIQUES, P56; Paynter RA, 2006, CANCER EPIDEM BIOMAR, V15, P2533, DOI 10.1158/1055-9965.EPI-06-0219; Sjoholm MIL, 2007, CLIN CHEM, V53, P1401, DOI 10.1373/clinchem.2007.087510; Sorensen KM, 2007, GENET TEST, V11, P65, DOI 10.1089/gte.2006.0503; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842	26	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64710	10.1371/journal.pone.0064710	http://dx.doi.org/10.1371/journal.pone.0064710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737996	Green Submitted, Green Published, gold			2022-12-27	WOS:000321394700060
J	Usami, M; Iwadare, Y; Kodaira, M; Watanabe, K; Aoki, M; Katsumi, C; Matsuda, K; Makino, K; Iijima, S; Harada, M; Tanaka, H; Sasaki, Y; Tanaka, T; Ushijima, H; Saito, K				Usami, Masahide; Iwadare, Yoshitaka; Kodaira, Masaki; Watanabe, Kyota; Aoki, Momoko; Katsumi, Chiaki; Matsuda, Kumi; Makino, Kazunori; Iijima, Sonoko; Harada, Maiko; Tanaka, Hiromi; Sasaki, Yoshinori; Tanaka, Tetsuya; Ushijima, Hirokage; Saito, Kazuhiko			Sleep Duration among Children 8 Months after the 2011 Japan Earthquake and Tsunami	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NORWEGIAN CHILDREN; ADOLESCENTS	Background: To elucidate relationships between disaster damage conditions and sleep duration among children who survived the 2011 Japan earthquake and tsunami. Methods: The subjects comprised 12,524 children in kindergartens, elementary schools, and junior high schools in Ishinomaki City, Miyagi Prefecture, Japan. The Post Traumatic Stress Symptoms for Children 15 items (PTSSC-15), a self-completion questionnaire on traumatic symptoms, and a sleep questionnaire were distributed to them. A questionnaire regarding disaster damage conditions of the children's homes was distributed to their teachers. Of 12,524, an effective response was obtained from 11,692 (93.3%). Results: Relationships between sleep duration and traumatic symptoms were displayed low correlations. Children with house damage and/or evacuation experiences slept for a significantly shorter time than children without these experiences. Conclusion: It is critical not only to examine traumatic symptoms in children but also to collect sleep duration and disaster damage conditions following natural disasters.	[Usami, Masahide; Iwadare, Yoshitaka; Kodaira, Masaki; Watanabe, Kyota; Matsuda, Kumi; Makino, Kazunori; Iijima, Sonoko; Harada, Maiko; Tanaka, Hiromi; Sasaki, Yoshinori; Tanaka, Tetsuya; Saito, Kazuhiko] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Ichikawa, Japan; [Aoki, Momoko] Saitama Prefecture Psychiat Hosp, Dept Child & Adolescent Psychiat, Saitama, Japan; [Katsumi, Chiaki] Kitasato Univ, Dept Psychiat, Sagamihara, Kanagawa 228, Japan; [Ushijima, Hirokage] Kumamoto Univ, Grad Sch Med, Dept Psychiat, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Kitasato University; Kumamoto University	Usami, M (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Ichikawa, Japan.	usami.masahide@gmail.com	Usami, Masahide/G-1404-2015	Usami, Masahide/0000-0002-1145-9971				Becker SM, 2007, J CHILD ADOL PS NURS, V20, P148, DOI 10.1111/j.1744-6171.2007.00105.x; Carballo M, 2005, J ROY SOC MED, V98, P396, DOI 10.1258/jrsm.98.9.396; Chemtob CM, 2008, ARCH PEDIAT ADOL MED, V162, P126, DOI 10.1001/archpediatrics.2007.36; Du YB, 2012, DISASTERS, V36, P495, DOI 10.1111/j.1467-7717.2011.01271.x; Dyb Grete, 2011, Clin Child Psychol Psychiatry, V16, P621, DOI 10.1177/1359104510391048; Fujitani K, 2011, JPN J TRAUMA STRESS, V9, P162; Hafstad GS, 2011, PSYCHOL TRAUMA-US, V3, P130, DOI 10.1037/a0023236; HAMBLEN J., 2003, PTSD CHILDREN ADOLES; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Jensen TK, 2009, ARCH PEDIAT ADOL MED, V163, P856, DOI 10.1001/archpediatrics.2009.151; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; Kato H, 1996, ACTA PSYCHIAT; Lamarche L. J., 2007, J CLIN PSYCHIAT; Lavie P, 2001, NEW ENGLAND J MED; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Montgomery E, 2001, EUROPEAN J PUBLIC; Noll JG, 2006, J PEDIATR PSYCHOL, V31, P469, DOI 10.1093/jpepsy/jsj040; Piyasil V, 2008, ASEAN J PSYCHIATR, V9, P99; Piyasil Vinadda, 2007, Journal of the Medical Association of Thailand, V90, P2370; Tominaga Y, 2002, HATTATSU SHINRI RINS, V8, p29.36; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; Ularntinon Sirirat, 2008, J Med Assoc Thai, V91 Suppl 3, pS69; Usami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050721; Vijayakumar L, 2006, MENTAL HLTH STATUS C; WEISAETH L, 1989, ACTA PSYCHIAT SCAND, V80, P63, DOI 10.1111/j.1600-0447.1989.tb05255.x; WHO, 2005, TSUN WREAKS MENT HLT; WHO, MENT HLTH ASS POP AF	27	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e65398	10.1371/journal.pone.0065398	http://dx.doi.org/10.1371/journal.pone.0065398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177SC	23738015	gold, Green Submitted, Green Published			2022-12-27	WOS:000321394700076
J	Xi, M; Zhang, L; Zhao, L; Li, QQ; Guo, SP; Feng, ZZ; Deng, XW; Huang, XY; Liu, MZ				Xi, Mian; Zhang, Li; Zhao, Lei; Li, Qiao-Qiao; Guo, Su-Ping; Feng, Zi-Zhen; Deng, Xiao-Wu; Huang, Xiao-Yan; Liu, Meng-Zhong			Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis	PLOS ONE			English	Article							3-DIMENSIONAL CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; 4-DIMENSIONAL CT; PHASE-I; INVASION; OUTCOMES; DESIGN; TRIALS	Background: To report the feasibility, efficacy, and toxicity of stereotactic body radiotherapy (SBRT) for the treatment of portal vein tumor thrombosis (PVTT) and/or inferior vena cava tumor thrombosis (IVCTT) in patients with advanced hepatocellular carcinoma (HCC). Materials and methods: Forty-one patients treated with SBRT using volumetric modulated arc therapy (VMAT) for HCC with PVTT/IVCTT between July 2010 and May 2012 were analyzed. Of these, 33 had PVTT and 8 had IVCTT. SBRT was designed to target the tumor thrombosis and deliver a median total dose of 36 Gy (range, 30-48 Gy) in six fractions during two weeks. Results: The median follow-up was 10.0 months. At the time of analysis, 15 (36.6%) achieved complete response, 16 (39.0%) achieved partial response, 7 (17.1%) patients were stable, and three (7.3%) patients showed progressive disease. No treatment-related Grade 4/5 toxicity was seen within three months after SBRT. One patient had Grade 3 elevation of bilirubin. The one-year overall survival rate was 50.3%, with a median survival of 13.0 months. The only independent predictive factor associated with better survival was response to radiotherapy. Conclusions: VMAT-based SBRT is a safe and effective treatment option for PVTT/IVCTT in HCC. Prospective randomized controlled trials are warranted to validate the role of SBRT in these patients.	[Xi, Mian; Zhang, Li; Zhao, Lei; Li, Qiao-Qiao; Guo, Su-Ping; Feng, Zi-Zhen; Deng, Xiao-Wu; Huang, Xiao-Yan; Liu, Meng-Zhong] Sun Yat Sen Univ, Dept Radiat Oncol, State Key Lab Oncol Southern China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Liu, MZ (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, State Key Lab Oncol Southern China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	liumengzhong@126.com	Feng, Zizhen/G-2322-2014	Deng, Xiaowu/0000-0003-2923-1251; Feng, Zizhen/0000-0002-7763-1869				Bedford JL, 2009, PHYS MED BIOL, V54, pN167, DOI 10.1088/0031-9155/54/9/N04; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Choi BO, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-351; Feng M, 2011, SEMIN RADIAT ONCOL, V21, P271, DOI 10.1016/j.semradonc.2011.05.002; Han KH, 2008, CANCER-AM CANCER SOC, V113, P995, DOI 10.1002/cncr.23684; Huang YJ, 2009, INT J RADIAT ONCOL, V73, P1155, DOI 10.1016/j.ijrobp.2008.06.1486; Kim JH, 2009, ALIMENT PHARM THER, V29, P1291, DOI 10.1111/j.1365-2036.2009.04016.x; Kim JY, 2011, HEPATOL RES, V41, P813, DOI 10.1111/j.1872-034X.2011.00826.x; Koo JE, 2010, INT J RADIAT ONCOL, V78, P180, DOI 10.1016/j.ijrobp.2009.07.1730; Lee MT, 2009, J CLIN ONCOL, V27, P1585, DOI 10.1200/JCO.2008.20.0600; Lin CS, 2006, JPN J CLIN ONCOL, V36, P212, DOI 10.1093/jjco/hyl006; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Nakazawa T, 2007, ONCOLOGY-BASEL, V73, P90, DOI 10.1159/000120996; Palma DA, 2010, CANCER TREAT REV, V36, P393, DOI 10.1016/j.ctrv.2010.01.004; Pawlik TM, 2005, SURGERY, V137, P403, DOI 10.1016/j.surg.2004.12.012; Rim CH, 2012, JPN J CLIN ONCOL, V42, P721, DOI 10.1093/jjco/hys082; Scorsetti M, 2011, ACTA ONCOL, V50, P528, DOI 10.3109/0284186X.2011.558522; Toya R, 2007, RADIOTHER ONCOL, V84, P266, DOI 10.1016/j.radonc.2007.07.005; Tse RV, 2008, J CLIN ONCOL, V26, P657, DOI 10.1200/JCO.2007.14.3529; Xi M, 2007, RADIOTHER ONCOL, V84, P272, DOI 10.1016/j.radonc.2007.07.021; Yoon S, 2012, INT J RADIAT ONCOL, V82, P2004, DOI 10.1016/j.ijrobp.2011.03.019; Zeng ZC, 2005, INT J RADIAT ONCOL, V61, P432, DOI 10.1016/j.ijrobp.2004.05.025; Zhang L, 2012, J RADIAT RES, V53, P769, DOI 10.1093/jrr/rrs022	25	99	115	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63864	10.1371/journal.pone.0063864	http://dx.doi.org/10.1371/journal.pone.0063864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737955	Green Published, gold, Green Submitted			2022-12-27	WOS:000321394700018
J	Zhuang, PY; Shen, J; Zhu, XD; Lu, L; Wang, L; Tang, ZY; Sun, HC				Zhuang, Peng-Yuan; Shen, Jun; Zhu, Xiao-Dong; Lu, Lu; Wang, Lu; Tang, Zhao-You; Sun, Hui-Chuan			Prognostic Roles of Cross-Talk between Peritumoral Hepatocytes and Stromal Cells in Hepatocellular Carcinoma Involving Peritumoral VEGF-C, VEGFR-1 and VEGFR-3	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTRAHEPATIC RECURRENCE; MACROPHAGE RECRUITMENT; MICROVESSEL DENSITY; CURATIVE RESECTION; FACTOR RECEPTORS; RISK-FACTORS; EXPRESSION; LYMPHANGIOGENESIS; HEPATITIS	Background: Peritumoral liver tissue could play a potential role in hepatocellular carcinoma (HCC) progression and patient survival via angiogenesis- and lymphangiogensis-related factors. The prognostic role of these factors in hepatocytes and stromal cells in HCC patients after curative resection remains to be explored. Methods: Tumor tissue and surrounding peritumoral tissue were obtained from 145 resected HCC patients without lymph node metastasis (LNM) and 37 resected HCC patients with LNM. Tissue microarrays were constructed from duplicate cores of tumor tissue and surrounding peritumoral tissue from each resected specimen. Immunohistochemistry and real-time polymerase chain reaction were used to evaluate the expression of vascular endothelial growth factor-A (VEGF-A), VEGF-C, VEGF receptor-1(VEGFR-1), VEGFR-2, and VEGFR-3. Macrophage infiltration was determined by CD68 staining. Correlations between the expression of these factors and overall survival (OS) and time to recurrence (TTR) were studied. Results: The peritumoral expression of VEGF-A, VEGF-C, VEGFR-1, VEGFR-2, and VEGFR-3 were significantly higher than expression of these factors in tumors. VEGFR-1 was mostly located in peritumoral macrophages, while VEGF-C and VEGFR-3 were mostly located in peritumoral hepatocytes. HCC with high peritumoral co-expression of VEGF-C, VEGFR-1, and VEGFR-3 was associated with higher peritumoral distribution of macrophages (0.87% +/- 0.26% versus 0.45% +/- 0.20%), LNM (32.4% versus 12.0%), shorter TTR (10.2 months versus 34.5 months), and poor prognosis (19.4 months versus 49.3 months). Conclusion: Expression of VEGF-C, VEGFR-1, and VEGFR-3 in peritumoral liver tissue is associated with a unique type of HCC that has a poorer outcome after hepatectomy.	[Zhuang, Peng-Yuan; Shen, Jun] Shanghai Jiao Tong Univ, Dept Gen Surg, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhuang, Peng-Yuan; Zhu, Xiao-Dong; Lu, Lu; Wang, Lu; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China; [Zhuang, Peng-Yuan; Zhu, Xiao-Dong; Lu, Lu; Wang, Lu; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University	Sun, HC (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China.	toxoy@163.com	Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [81101851]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81101851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaoka N, 2006, ONCOL REP, V16, P3; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Dias S, 2001, P NATL ACAD SCI USA, V98, P10857, DOI 10.1073/pnas.191117498; Gocheva V, GENES DEV, V24, P241; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li J, INT J MOL SCI, V12, P2434; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Melgar-Lesmes P, GUT, V60, P1404; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Murakami M, 2008, ARTERIOSCL THROM VAS, V28, P658, DOI 10.1161/ATVBAHA.107.150433; Ng IOL, 2001, AM J CLIN PATHOL, V116, P838; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Schoppmann SF, 2006, BREAST CANCER RES TR, V99, P135, DOI 10.1007/s10549-006-9190-3; Shimamura T, 2000, J GASTROEN HEPATOL, V15, P640, DOI 10.1046/j.1440-1746.2000.02201.x; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Sun HC, 1999, J CANCER RES CLIN, V125, P419, DOI 10.1007/s004320050296; Sun HC, 2007, J HEPATOL, V47, P684, DOI 10.1016/j.jhep.2007.06.019; Sun HC, 2007, J SURG ONCOL, V96, P37, DOI 10.1002/jso.20772; Suzuki K, 1996, CANCER RES, V56, P3004; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; von Marschall Z, 2001, GUT, V48, P87, DOI 10.1136/gut.48.1.87; Yamaguchi R, 2000, ONCOL REP, V7, P725; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	31	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64598	10.1371/journal.pone.0064598	http://dx.doi.org/10.1371/journal.pone.0064598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737988	Green Submitted, gold, Green Published			2022-12-27	WOS:000321394700052
J	Cizza, G; Piaggi, P; Lucassen, EA; de Jonge, L; Walter, M; Mattingly, MS; Kalish, H; Csako, G; Rother, KI				Cizza, Giovanni; Piaggi, Paolo; Lucassen, Eliane A.; de Jonge, Lilian; Walter, Mary; Mattingly, Megan S.; Kalish, Heather; Csako, Gyorgy; Rother, Kristina I.		Sleep Extension Study Grp	Obstructive Sleep Apnea Is a Predictor of Abnormal Glucose Metabolism in Chronically Sleep Deprived Obese Adults	PLOS ONE			English	Article							INSULIN-RESISTANCE; DAYTIME SLEEPINESS; MEN; SENSITIVITY; DURATION	Context: Sleep abnormalities, including obstructive sleep apnea (OSA), have been associated with insulin resistance. Objective: To determine the relationship between sleep, including OSA, and glucose parameters in a prospectively assembled cohort of chronically sleep-deprived obese subjects. Design: Cross-sectional evaluation of a prospective cohort study. Setting: Tertiary Referral Research Clinical Center. Main Outcome Measure(s): Sleep duration and quality assessed by actigraphy, sleep diaries and questionnaires, OSA determined by a portable device; glucose metabolism assessed by oral glucose tolerance test (oGTT), and HbA(1)c concentrations in 96 obese individuals reporting sleeping less than 6.5 h on a regular basis. Results: Sixty % of subjects had an abnormal respiratory disturbance index (RDI >= 5) and 44% of these subjects had abnormal oGTT results. Severity of OSA as assessed by RDI score was associated with fasting glucose (R = 0.325, p = 0.001) and fasting insulin levels (rho = 0.217, p = 0.033). Subjects with moderate to severe OSA (RDI>15) had higher glucose concentrations at 120 min than those without OSA (RDI<5) (p = 0.017). Subjects with OSA also had significantly higher concentrations of plasma ACTH (p = 0.009). Several pro-inflammatory cytokines were higher in subjects with OSA (p<0.050). CRP levels were elevated in this sample, suggesting increased cardiovascular risk. Conclusions: OSA is associated with impaired glucose metabolism in obese, sleep deprived individuals. Since sleep apnea is common and frequently undiagnosed, health care providers should be aware of its occurrence and associated risks.	[Cizza, Giovanni; Lucassen, Eliane A.; de Jonge, Lilian; Walter, Mary; Mattingly, Megan S.] NIDDKD, Sect Neuroendocrinol Obes, Bethesda, MD 20892 USA; [Piaggi, Paolo] Univ Hosp Pisa, Endocrinol Unit, Obes Res Ctr, Pisa, Italy; [Lucassen, Eliane A.] Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands; [Kalish, Heather] Natl Inst Biomed & Bioengineering, Bethesda, MD USA; [Csako, Gyorgy] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Rother, Kristina I.] NIDDKD, Sect Pediat Diabet & Metab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pisa; Azienda Ospedaliero Universitaria Pisana; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Cizza, G (corresponding author), NIDDKD, Sect Neuroendocrinol Obes, Bethesda, MD 20892 USA.	cizzag@intra.niddk.nih.gov	Piaggi, Paolo/E-2539-2011	Piaggi, Paolo/0000-0003-2774-9161; de Jonge, Lilian/0000-0001-5900-0695	National Institutes of Health (NIH), Intramural Research Program: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK071006, ZIADK047049, ZIADK075015] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Intramural Research Program: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was fully supported by the National Institutes of Health (NIH), Intramural Research Program: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayappa I, 2008, J CLIN SLEEP MED, V4, P26; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cizza G, 2005, SLEEP, V28, P1217, DOI 10.1093/sleep/28.10.1217; Cizza G, 2009, HORM METAB RES, V41, P641, DOI 10.1055/s-0029-1220717; Cizza G, 2010, CLIN TRIALS, V7, P274, DOI 10.1177/1740774510368298; Fredheim JM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-84; Gruber A, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-22; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kelly KR, 2010, METABOLISM, V59, P200, DOI 10.1016/j.metabol.2009.07.014; Knutson KL, 2012, SLEEP MED, V13, P484, DOI 10.1016/j.sleep.2011.11.009; Lam JCM, 2012, SLEEP MED, V13, P15, DOI 10.1016/j.sleep.2011.07.015; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Louis M, 2009, J APPL PHYSIOL, V106, P1538, DOI 10.1152/japplphysiol.91523.2008; O'Rourke RW, 2011, DIABETOLOGIA, V54, P1480, DOI 10.1007/s00125-011-2103-y; Pamidi S, 2012, DIABETES CARE, V35, P2384, DOI 10.2337/dc12-0841; Papaioannou I, 2011, J CLIN SLEEP MED, V7, P486, DOI 10.5664/JCSM.1314; Peltier AC, 2012, CLIN AUTON RES, V22, P1, DOI 10.1007/s10286-011-0131-9; Pietzsch JB, 2011, SLEEP, V34, P695, DOI 10.5665/SLEEP.1030; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Tassone F, 2003, CLIN ENDOCRINOL, V59, P374, DOI 10.1046/j.1365-2265.2003.01859.x; Van Cauter E, 2004, GROWTH HORM IGF RES, V14, pS10, DOI 10.1016/j.ghir.2004.03.006; Van Cauter E, 2011, DIABETIC MED, V28, P1455, DOI 10.1111/j.1464-5491.2011.03459.x; Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Westbrook PR, 2005, CHEST, V128, P2166, DOI 10.1378/chest.128.4.2166; Yao J, 2011, P SOC PHOTO-OPT INS, V7965, p7965Z; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	31	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65400	10.1371/journal.pone.0065400	http://dx.doi.org/10.1371/journal.pone.0065400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734252	gold, Green Submitted, Green Published			2022-12-27	WOS:000319725500014
J	He, Y; Luo, MJ; Yi, MH; Sheng, Y; Cheng, YB; Zhou, RJ; Cheng, HH				He, Yan; Luo, Majing; Yi, Minhan; Sheng, Yue; Cheng, Yibin; Zhou, Rongjia; Cheng, Hanhua			Identification of a Testis-Enriched Heat Shock Protein and Fourteen Members of Hsp70 Family in the Swamp Eel	PLOS ONE			English	Article							SEX-DETERMINING GENE; RICE FIELD EEL; HEAT-SHOCK-PROTEIN-70 FAMILY; CELL GROWTH; HSPA2; R-SPONDIN1; APOPTOSIS; MEDAKA; MOUSE; DUPLICATION	Background: Gonad differentiation is one of the most important developmental events in vertebrates. Some heat shock proteins are associated with gonad development. Heat shock protein 70 (Hsp70) in the teleost fish and its roles in sex differentiation are poorly understood. Methods and Findings: We have identified a testis-enriched heat shock protein Hspa8b2 in the swamp eel using Western blot analysis and Mass Spectrometry (MS). Fourteen Hsp70 family genes were further identified in this species based on transcriptome information. The phylogenetic tree of Hsp70 family was constructed using the Maximum Likelihood method and their expression patterns in the swamp eel gonads were analyzed by reverse transcription-polymerase chain reaction (RT-PCR). Conclusion: There are fourteen gene members in the Hsp70 family in the swamp eel genome. Hsp70 family, particularly Hspa8, has expanded in the species. One of the family members Hspa8b2 is predominantly expressed in testis of the swamp eel.	[He, Yan] Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China; [Luo, Majing; Yi, Minhan; Sheng, Yue; Cheng, Yibin; Zhou, Rongjia; Cheng, Hanhua] Wuhan Univ, Coll Life Sci, Dept Genet, Wuhan 430072, Peoples R China	Huazhong Agricultural University; Wuhan University	Zhou, RJ (corresponding author), Wuhan Univ, Coll Life Sci, Dept Genet, Wuhan 430072, Peoples R China.	rjzhou@whu.edu.cn; hhcheng@whu.edu.cn	Zhou, Rongjia/N-9739-2019; Zhou, Rongjia/G-4660-2013	Zhou, Rongjia/0000-0002-9701-8009; Zhou, Rongjia/0000-0002-9701-8009	National Natural Science Foundation of China; National Key Basic Research project, National Key Technologies RD Program; Chinese 111 project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research project, National Key Technologies RD Program(National Basic Research Program of China); Chinese 111 project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China, the National Key Basic Research project, National Key Technologies R&D Program and the Chinese 111 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrionuevo F, 2010, INT J BIOCHEM CELL B, V42, P433, DOI 10.1016/j.biocel.2009.07.015; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Cheng H, 2003, CYTOGENET GENOME RES, V101, P274, DOI 10.1159/000074348; Daugaard M, 2005, CELL CYCLE, V4, P877, DOI 10.4161/cc.4.7.1838; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Eddy EM, 1999, REV REPROD, V4, P23, DOI 10.1530/revreprod/4.1.23; Filipczak PT, 2012, BIOCHEM CELL BIOL, V90, P224, DOI [10.1139/O11-083, 10.1139/o11-083]; Georg I, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101907; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; He Y, 2010, J EXP ZOOL PART B, V314B, P257, DOI 10.1002/jez.b.21333; Ito Y, 1998, J BIOCHEM, V124, P347, DOI 10.1093/oxfordjournals.jbchem.a022118; Jolesch A, 2012, EUR J CELL BIOL, V91, P48, DOI 10.1016/j.ejcb.2011.02.001; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kaufer S, 2012, J VIROL, V86, P1079, DOI 10.1128/JVI.02662-10; Kikuchi K, 2013, DEV DYNAM, V242, P339, DOI 10.1002/dvdy.23927; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KRAWCZYK Z, 1987, MOL BIOL REP, V12, P27, DOI 10.1007/BF00580647; Lavery R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003170; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Motiei M, 2013, ANDROLOGIA, V45, P66, DOI 10.1111/j.1439-0272.2012.01315.x; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; NEI M, 1969, NATURE, V221, P40, DOI 10.1038/221040a0; Nei M., 1992, 11 HIST WORKSH C OXF 11 HIST WORKSH C OXF; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Scieglinska D, 2008, J CELL BIOCHEM, V104, P2193, DOI 10.1002/jcb.21778; Son WY, 1999, MOL HUM REPROD, V5, P1122, DOI 10.1093/molehr/5.12.1122; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Wilhelm D, 2007, BIOESSAYS, V29, P314, DOI 10.1002/bies.20553; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; ZAKERI ZF, 1987, MOL CELL BIOL, V7, P1791, DOI 10.1128/MCB.7.5.1791; Zarkower D, 2013, CURR TOP DEV BIOL, V102, P327, DOI 10.1016/B978-0-12-416024-8.00012-X; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	48	18	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65269	10.1371/journal.pone.0065269	http://dx.doi.org/10.1371/journal.pone.0065269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750249	Green Published, Green Submitted, gold			2022-12-27	WOS:000319961900051
J	Wall, JS; Williams, A; Richey, T; Stuckey, A; Huang, Y; Wooliver, C; Macy, S; Heidel, E; Gupta, N; Lee, A; Rader, B; Martin, EB; Kennel, SJ				Wall, Jonathan S.; Williams, Angela; Richey, Tina; Stuckey, Alan; Huang, Ying; Wooliver, Craig; Macy, Sallie; Heidel, Eric; Gupta, Neil; Lee, Angela; Rader, Brianna; Martin, Emily B.; Kennel, Stephen J.			A Binding-Site Barrier Affects Imaging Efficiency of High Affinity Amyloid-Reactive Peptide Radiotracers In Vivo	PLOS ONE			English	Article							P COMPONENT; TC-99M-DPD SCINTIGRAPHY; MODELING ANALYSIS; DIAGNOSIS; ANTIBODIES; TASSER; TUMORS	Amyloid is a complex pathology associated with a growing number of diseases including Alzheimer's disease, type 2 diabetes, rheumatoid arthritis, and myeloma. The distribution and extent of amyloid deposition in body organs establishes the prognosis and can define treatment options; therefore, determining the amyloid load by using non-invasive molecular imaging is clinically important. We have identified a heparin-binding peptide designated p5 that, when radioiodinated, was capable of selectively imaging systemic visceral AA amyloidosis in a murine model of the disease. The p5 peptide was posited to bind effectively to amyloid deposits, relative to similarly charged polybasic heparin-reactive peptides, because it adopted a polar a helix secondary structure. We have now synthesized a variant, p5R, in which the 8 lysine amino acids of p5 have been replaced with arginine residues predisposing the peptide toward the a helical conformation in an effort to enhance the reactivity of the peptide with the amyloid substrate. The p5R peptide had higher affinity for amyloid and visualized AA amyloid in mice by using SPECT/CT imaging; however, the microdistribution, as evidenced in micro-autoradiographs, was dramatically altered relative to the p5 peptide due to its increased affinity and a resultant "binding site barrier'' effect. These data suggest that radioiodinated peptide p5R may be optimal for the in vivo detection of discreet, perivascular amyloid, as found in the brain and pancreatic vasculature, by using molecular imaging techniques; however, peptide p5, due to its increased penetration, may yield more quantitative imaging of expansive tissue amyloid deposits.	[Wall, Jonathan S.; Williams, Angela; Richey, Tina; Huang, Ying; Wooliver, Craig; Macy, Sallie; Gupta, Neil; Lee, Angela; Rader, Brianna; Martin, Emily B.; Kennel, Stephen J.] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA; [Wall, Jonathan S.; Stuckey, Alan; Kennel, Stephen J.] Univ Tennessee, Dept Radiol, Grad Sch Med, Knoxville, TN 37996 USA; [Heidel, Eric] Univ Tennessee, Grad Sch Med, Dept Surg, Knoxville, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Wall, JS (corresponding author), Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA.	jwall@utmck.edu		Wall, Jonathan/0000-0002-5516-8578; Heidel, Robert/0000-0002-1518-8072	National Institute Of Diabetes And Digestive And Kidney Diseases [R01DK079984]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079984] Funding Source: NIH RePORTER	National Institute Of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Award Number R01DK079984 from the National Institute Of Diabetes And Digestive And Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni G, 2013, J NUCL MED, V54, P213, DOI 10.2967/jnumed.111.102053; AXELRAD MA, 1982, LAB INVEST, V47, P139; Blancas-Mejia LM, 2013, ANN REV BIOCH; Crandall YM, 2008, BIOPOLYMERS, V89, P197, DOI 10.1002/bip.20891; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; FUJIMORI K, 1990, J NUCL MED, V31, P1191; FUJIMORI K, 1989, CANCER RES, V49, P5656; GEJYO F, 1995, CLIN NEPHROL, V44, pS14; Glaudemans AWJM, 2009, EUR J NUCL MED MOL I, V36, P702, DOI 10.1007/s00259-008-1037-1; Guan J, 2012, AM J PHYSIOL-HEART C, V302, pH544, DOI 10.1152/ajpheart.00815.2011; Hachulla E, 2002, JOINT BONE SPINE, V69, P538, DOI 10.1016/S1297-319X(02)00449-9; HAWKINS PN, 1995, EUR J NUCL MED, V22, P595, DOI 10.1007/BF01254559; Hawkins PN, 2002, CURR OPIN NEPHROL HY, V11, P649, DOI 10.1097/00041552-200211000-00013; Hazenberg BPC, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.043; Jayaraman G, 2000, FEBS LETT, V482, P154, DOI 10.1016/S0014-5793(00)01964-5; Johnson KA, 2013, ALZHEIMERS DEMENT; JUWEID M, 1992, CANCER RES, V52, P5144; Ketteler M, 2001, SEMIN DIALYSIS, V14, P90, DOI 10.1046/j.1525-139x.2001.00025.x; Loitfelder M, 2012, PANMINERVA MED, V54, P149; Magota K, 2011, EUR J NUCL MED MOL I, V38, P742, DOI 10.1007/s00259-010-1683-y; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Nitz M, 2008, CHEMBIOCHEM, V9, P1545, DOI 10.1002/cbic.200800056; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PEPYS MB, 1992, J INTERN MED, V232, P519, DOI 10.1111/j.1365-2796.1992.tb00630.x; Puille M, 2002, EUR J NUCL MED MOL I, V29, P376, DOI 10.1007/s00259-001-0730-0; Rapezzi C, 2008, J AM COLL CARDIOL, V51, P1509, DOI 10.1016/j.jacc.2007.12.038; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Rullo A, 2010, BIOPOLYMERS, V93, P290, DOI 10.1002/bip.21339; Schaadt BK, 2003, J NUCL MED, V44, P177; SJOHOLM I, 1972, FEBS LETT, V22, P109, DOI 10.1016/0014-5793(72)80232-1; Skaper SD, 2012, INT REV NEUROBIOL, V102, P277, DOI 10.1016/B978-0-12-386986-9.00011-9; Smyth DR, 2005, NUCL MED BIOL, V32, P885, DOI 10.1016/j.nucmedbio.2005.06.006; Solomon A, 1999, AM J PATHOL, V154, P1267, DOI 10.1016/S0002-9440(10)65378-3; VANOSDOL W, 1991, CANCER RES, V51, P4776; Wall JS, 2006, METHOD ENZYMOL, V412, P161, DOI 10.1016/S0076-6879(06)12011-X; Wall JS, 2013, AMYLOID, V20, P21, DOI 10.3109/13506129.2012.757216; Wall JS, 2012, MOL IMAGING BIOL, V14, P402, DOI 10.1007/s11307-011-0524-0; Wall JS, 2011, P NATL ACAD SCI USA, V108, pE586, DOI 10.1073/pnas.1103247108; Wall JS, 2008, COMPARATIVE MED, V58, P542; Westermark P, 2011, UPSALA J MED SCI, V116, P81, DOI 10.3109/03009734.2011.573884; Yang LC, 2012, NEW ENGL J MED, V367, P885, DOI 10.1056/NEJMp1208061; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	44	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66181	10.1371/journal.pone.0066181	http://dx.doi.org/10.1371/journal.pone.0066181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750281	Green Published, gold, Green Submitted			2022-12-27	WOS:000319961900083
J	Brodhun, F; Cristobal-Sarramian, A; Zabel, S; Newie, J; Hamberg, M; Feussner, I				Brodhun, Florian; Cristobal-Sarramian, Alvaro; Zabel, Sebastian; Newie, Julia; Hamberg, Mats; Feussner, Ivo			An Iron 13S-Lipoxygenase with an alpha-Linolenic Acid Specific Hydroperoxidase Activity from Fusarium oxysporum	PLOS ONE			English	Article							EPOXY ALCOHOL SYNTHASE; MANGANESE LIPOXYGENASE; MEMBRANE-BINDING; SOYBEAN LIPOXYGENASE-1; PRIMARY DETERMINANT; CATALYTIC-ACTIVITY; SITE; OXYLIPINS; PROTEIN; 12-LIPOXYGENASE	Jasmonates constitute a family of lipid-derived signaling molecules that are abundant in higher plants. The biosynthetic pathway leading to plant jasmonates is initiated by 13-lipoxygenase-catalyzed oxygenation of a-linolenic acid into its 13-hydroperoxide derivative. A number of plant pathogenic fungi (e.g. Fusarium oxysporum) are also capable of producing jasmonates, however, by a yet unknown biosynthetic pathway. In a search for lipoxygenase in F. oxysporum, a reverse genetic approach was used and one of two from the genome predicted lipoxygenases (FoxLOX) was cloned. The enzyme was heterologously expressed in E. coli, purified via affinity chromatography, and its reaction mechanism characterized. FoxLOX was found to be a non-heme iron lipoxygenase, which oxidizes C-18-polyunsaturated fatty acids to 13S-hydroperoxy derivatives by an antarafacial reaction mechanism where the bis-allylic hydrogen abstraction is the rate-limiting step. With a-linolenic acid as substrate FoxLOX was found to exhibit a multifunctional activity, because the hydroperoxy derivatives formed are further converted to dihydroxy-, keto-, and epoxy alcohol derivatives.	[Brodhun, Florian; Cristobal-Sarramian, Alvaro; Zabel, Sebastian; Newie, Julia; Feussner, Ivo] Georg August Univ, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Gottingen, Germany; [Hamberg, Mats] Karolinska Inst, Inst Med Biochem & Biophys MBB, Stockholm, Sweden	University of Gottingen; Karolinska Institutet	Feussner, I (corresponding author), Georg August Univ, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Gottingen, Germany.	ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Hamberg, Mats/0000-0002-8910-7810	DFG [IRTG-1422]; ERASMUS grant	DFG(German Research Foundation (DFG)); ERASMUS grant	This study was financially supported by the DFG in frame of IRTG-1422 and by an ERASMUS grant for ACS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Andreou A, 2010, J BIOL CHEM, V285, P14178, DOI 10.1074/jbc.M109.094771; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Andreou AZ, 2009, LIPIDS, V44, P207, DOI 10.1007/s11745-008-3264-4; Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; CHAMULITRAT W, 1992, J BIOL CHEM, V267, P9574; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026; Cristea N, 2007, J LIPID RES, V48, P890, DOI 10.1194/jlr.M600505-JLR200; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; Dainese E, 2005, J MOL BIOL, V349, P143, DOI 10.1016/j.jmb.2005.03.027; Dainese E, 2010, FASEB J, V24, P1725, DOI 10.1096/fj.09-141390; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gaffney BJ, 2001, APPL MAGN RESON, V21, P411, DOI 10.1007/BF03162417; GRECHKIN AN, 1991, BIOCHIM BIOPHYS ACTA, V1081, P79, DOI 10.1016/0005-2760(91)90253-E; Hamberg M, 1999, LIPIDS, V34, P1131, DOI 10.1007/s11745-999-0464-7; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; Hornung E, 2002, EUR J BIOCHEM, V269, P4852, DOI 10.1046/j.1432-1033.2002.03184.x; Hornung E, 1999, P NATL ACAD SCI USA, V96, P4192, DOI 10.1073/pnas.96.7.4192; HWANG CC, 1994, J AM CHEM SOC, V116, P795, DOI 10.1021/ja00081a061; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jerneren F, 2012, LIPIDS, V47, P65, DOI 10.1007/s11745-011-3622-5; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Lang I, 2008, BIOCHEM J, V410, P347, DOI 10.1042/BJ20071277; Lewis ER, 1999, J AM CHEM SOC, V121, P1395, DOI 10.1021/ja983083g; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; May C, 2000, EUR J BIOCHEM, V267, P1100, DOI 10.1046/j.1432-1327.2000.01105.x; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Miersch O, 1999, PHYTOCHEMISTRY, V50, P1147, DOI 10.1016/S0031-9422(98)00698-0; Miersch O, 1999, PHYTOCHEMISTRY, V50, P517, DOI 10.1016/S0031-9422(98)00596-2; MIERSCH O, 1987, PHYTOCHEMISTRY, V26, P1037, DOI 10.1016/S0031-9422(00)82345-6; Noverr MC, 2003, CLIN MICROBIOL REV, V16, P517, DOI 10.1128/CMR.16.3.517-533.2003; Oliw EH, 2002, PROSTAG OTH LIPID M, V68-9, P313, DOI 10.1016/S0090-6980(02)00037-0; Oliw EH, 2008, J LIPID RES, V49, P420, DOI 10.1194/jlr.M700514-JLR200; Oliw EH, 2011, BBA-MOL CELL BIOL L, V1811, P138, DOI 10.1016/j.bbalip.2010.12.002; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Plagemann I, 2013, J MOL CATAL B-ENZYM, V87, P99, DOI 10.1016/j.molcatb.2012.11.004; RIENDEAU D, 1991, BIOCHEM J, V274, P287, DOI 10.1042/bj2740287; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Segraves EN, 2003, BIOCHEMISTRY-US, V42, P5236, DOI 10.1021/bi0273462; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Su C, 2000, J BIOL CHEM, V275, P18830, DOI 10.1074/jbc.M001408200; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Tsukada K, 2010, PHYTOCHEMISTRY, V71, P2019, DOI 10.1016/j.phytochem.2010.09.013; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004; Wasternack C, 2013, BIOCHIMIE, V95, P79, DOI 10.1016/j.biochi.2012.06.005; Wennman A, 2013, J LIPID RES, V54, P762, DOI 10.1194/jlr.M033787; Wennman A, 2012, J BIOL CHEM, V287, P31757, DOI 10.1074/jbc.M112.364331; Wichard T, 2005, ANGEW CHEM INT EDIT, V44, P158, DOI 10.1002/anie.200460686; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003; Zheng YX, 2010, J BIOL CHEM, V285, P39866, DOI 10.1074/jbc.M110.155374	66	54	55	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64919	10.1371/journal.pone.0064919	http://dx.doi.org/10.1371/journal.pone.0064919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741422	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900135
J	Dickens, D; Yusof, SR; Abbott, NJ; Weksler, B; Romero, IA; Couraud, PO; Alfirevic, A; Pirmohamed, M; Owen, A				Dickens, David; Yusof, Siti R.; Abbott, N. Joan; Weksler, Babette; Romero, Ignacio A.; Couraud, Pierre-Olivier; Alfirevic, Ana; Pirmohamed, Munir; Owen, Andrew			A Multi-System Approach Assessing the Interaction of Anticonvulsants with P-gp	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GLYCOPROTEIN-MEDIATED EFFLUX; MULTIDRUG-RESISTANCE; ANTIEPILEPTIC DRUGS; PROTEASE INHIBITORS; GENE-EXPRESSION; EPILEPSY; TRANSPORT; CELLS; CARBAMAZEPINE	30% of epilepsy patients receiving antiepileptic drugs (AEDs) are not fully controlled by therapy. The drug transporter hypothesis for refractory epilepsy proposes that P-gp is over expressed at the epileptic focus with a role of P-gp in extruding AEDs from the brain. However, there is controversy regarding whether all AEDs are substrates for this transporter. Our aim was to investigate transport of phenytoin, lamotrigine and carbamazepine by using seven in-vitro transport models. Uptake assays in CEM/VBL cell lines, oocytes expressing human P-gp and an immortalised human brain endothelial cell line (hCMEC/D3) were carried out. Concentration equilibrium transport assays were performed in Caco-2, MDCKII +/- P-gp and LLC-PK1 +/- P-gp in the absence or presence of tariquidar, an inhibitor of P-gp. Finally, primary porcine brain endothelial cells were used to determine the apparent permeability (P-app) of the three AEDs in the absence or presence of P-gp inhibitors. We detected weak transport of phenytoin in two of the transport systems (MDCK and LLC-PK1 cells transfected with human P-gp) but not in the remaining five. No P-gp interaction was observed for lamotrigine or carbamazepine in any of the seven validated in-vitro transport models. Neither lamotrigine nor carbamazepine was a substrate for P-gp in any of the model systems tested. Our data suggest that P-gp is unlikely to contribute to the pathogenesis of refractory epilepsy through transport of carbamazepine or lamotrigine.	[Dickens, David; Alfirevic, Ana; Pirmohamed, Munir; Owen, Andrew] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Yusof, Siti R.; Abbott, N. Joan] Kings Coll London, Blood Brain Barrier Grp, Inst Pharmaceut Sci, London WC2R 2LS, England; [Weksler, Babette] Weill Cornell Med Coll, New York, NY USA; [Romero, Ignacio A.] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England; [Couraud, Pierre-Olivier] INSERM, Paris, France; [Couraud, Pierre-Olivier] CNRS, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Paris, France	University of Liverpool; University of London; King's College London; Cornell University; Open University - UK; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Dickens, D (corresponding author), Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England.	david.dickens@liverpool.ac.uk	Pirmohamed, Munir/H-6004-2011; Dickens, David/H-3105-2016; Yusof, Siti Rafidah/ABE-3533-2020; Dickens, David/N-4032-2019; Owen, Andrew/M-7509-2017; Yusof, Siti Rafidah/G-5930-2012	Pirmohamed, Munir/0000-0002-7534-7266; Dickens, David/0000-0001-8295-0752; Yusof, Siti Rafidah/0000-0003-2257-9933; Dickens, David/0000-0001-8295-0752; Owen, Andrew/0000-0002-9819-7651; Yusof, Siti Rafidah/0000-0003-2257-9933; Romero, Ignacio/0000-0002-0322-9180	EURIPIDES [201380]; Dept of Health (NHS Chair of Pharmacogenetics); MRC; EPSRC; RCUK; Ministry of Higher Education Malaysia; USM Penang; Wellcome Trust; Medical Research Council [G0700654B, G0800247] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10064] Funding Source: researchfish; MRC [G0800247] Funding Source: UKRI	EURIPIDES; Dept of Health (NHS Chair of Pharmacogenetics); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); RCUK(UK Research & Innovation (UKRI)); Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); USM Penang; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DD is funded by EURIPIDES, a Seventh Framework Programme (FP7/2007-2013), grant agreement no 201380. MP is a NIHR Senior Investigator and is also supported by the Dept of Health (NHS Chair of Pharmacogenetics), MRC and Wellcome Trust. AO would like to thank the MRC, EPSRC and RCUK for research support. SRY was supported by The Ministry of Higher Education Malaysia and USM Penang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakos E, 1997, BIOCHEM J, V323, P777, DOI 10.1042/bj3230777; Baltes S, 2007, NEUROPHARMACOLOGY, V52, P333, DOI 10.1016/j.neuropharm.2006.07.038; BECK WT, 1979, CANCER RES, V39, P2070; Bournissen FG, 2009, EPILEPSIA, V50, P898, DOI 10.1111/j.1528-1167.2008.01858.x; Cascorbi I, 2010, CLIN PHARMACOL THER, V87, P15, DOI 10.1038/clpt.2009.237; Cerveny L, 2006, EPILEPSIA, V47, P461, DOI 10.1111/j.1528-1167.2006.00453.x; Chandler B, 2003, JAIDS-J ACQ IMM DEF, V33, P551, DOI 10.1097/00126334-200308150-00001; Crowe A, 2006, J DRUG TARGET, V14, P291, DOI 10.1080/10611860600720814; Cucullo L, 2007, EPILEPSIA, V48, P505, DOI 10.1111/j.1528-1167.2006.00960.x; DAUCHY S, 2008, BIOCH PHARM; DICKENS D, 2011, BIOCH PHARM; Didziapetris R, 2003, J DRUG TARGET, V11, P391, DOI 10.1080/10611860310001648248; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; Fromm MF, 2003, EUR J CLIN INVEST, V33, P6, DOI 10.1046/j.1365-2362.33.s2.4.x; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hartkoorn RC, 2010, PHARMACOGENET GENOM, V20, P112, DOI 10.1097/FPC.0b013e328335b02d; Janneh O, 2008, BRIT J PHARMACOL, V155, P875, DOI 10.1038/bjp.2008.320; Kim WJ, 2010, PHARMACOGENET GENOM, V20, P249, DOI 10.1097/FPC.0b013e328338073a; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; LIU JY, 2012, BRAIN; Loscher Wolfgang, 2005, Epilepsy Curr, V5, P107, DOI 10.1111/j.1535-7511.2005.05311.x; LUNATORTOS C, 2008, NEUROPHARMACOLOGY; LUNATORTOS C, 2010, NEUROPHARMACOLOGY; Marchi N, 2010, CLIN PHARMACOL THER, V87, P13, DOI 10.1038/clpt.2009.225; Martin P, 2008, BRIT J PHARMACOL, V153, P805, DOI 10.1038/sj.bjp.0707601; Owen A, 2001, BRIT J CLIN PHARMACO, V51, P345, DOI 10.1046/j.1365-2125.2001.01359.x; Patabendige A., 2012, BRAIN RES; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Potschka H, 2002, NEUROSCI LETT, V327, P173, DOI 10.1016/S0304-3940(02)00423-8; Potschka H, 2001, NEUROREPORT, V12, P3557, DOI 10.1097/00001756-200111160-00037; Rivers F, 2008, EUR J PHARMACOL, V598, P1, DOI 10.1016/j.ejphar.2008.09.014; Rizzi M, 2002, J NEUROSCI, V22, P5833, DOI 10.1523/jneurosci.22-14-05833.2002; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; SCHRICKX J, 2006, THESIS UTRECHT U, pCH6; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Silis GJ, 2002, EPILEPSY BEHAV, V3, P427; Skinner RA, 2009, BRIT J PHARMACOL, V156, P1115, DOI 10.1111/j.1476-5381.2008.00129.x; Smith M, 2007, J DRUG TARGET, V15, P253, DOI 10.1080/10611860701288539; Sobczak K, 2010, METHODS, V51, P183, DOI 10.1016/j.ymeth.2009.12.001; Szoeke C, 2009, EPILEPSIA, V50, P1689, DOI 10.1111/j.1528-1167.2009.02059.x; Tai LM, 2009, BRAIN RES, V1292, P14, DOI 10.1016/j.brainres.2009.07.039; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; van Vliet EA, 2007, J PHARMACOL EXP THER, V322, P141, DOI 10.1124/jpet.107.121178; Vogler M, 2011, BIOCHEM BIOPH RES CO, V408, P344, DOI 10.1016/j.bbrc.2011.04.043; WANG HC, 1991, INT J BIOCHEM, V23, P271; Weiss J, 2003, J PHARMACOL EXP THER, V307, P262, DOI 10.1124/jpet.103.054197; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; ZHANG C, 2011, EPILEPSIA; Zhang CB, 2010, LIFE SCI, V86, P899, DOI 10.1016/j.lfs.2010.04.008	53	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64854	10.1371/journal.pone.0064854	http://dx.doi.org/10.1371/journal.pone.0064854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741405	gold, Green Submitted, Green Published			2022-12-27	WOS:000319799900118
J	Doix, ACM; Lefevre, F; Colson, SS				Doix, Aude-Clemence M.; Lefevre, Fabrice; Colson, Serge S.			Time Course of the Cross-Over Effect of Fatigue on the Contralateral Muscle after Unilateral Exercise	PLOS ONE			English	Article							VOLUNTARY ACTIVATION; NEUROMUSCULAR FUNCTION; SUPRASPINAL FACTORS; NEURAL DRIVE; STRENGTH; CONTRACTIONS; RELIABILITY; QUADRICEPS; MOVEMENT; HUMANS	We investigated the cross-over effect of muscle fatigue and its time course on the non-exercising contralateral limb (NEL) after unilateral fatiguing contractions of the ipsilateral exercising limb (EL). For this purpose, 15 males performed two bouts of 100-second maximal isometric knee extensions with the exercising limb, and neuromuscular function of both the EL and NEL was assessed before (PRE), after a first fatiguing exercise (MID) and after a second fatiguing exercise (POST). Maximal voluntary isometric torque production declined in the EL after the first bout of exercise (-9.6%; p < 0.001) while in the NEL, the decrease occurred after the second bout of exercise (-10.6%; p < 0.001). At MID, torque decline of the EL was strictly associated to an alteration of the mechanical twitch properties evoked by neurostimulation of the femoral nerve (i.e., peak twitch torque, maximal rate of twitch development). According to these markers, we suggest that peripheral fatigue occurred. At POST, after the second bout of exercise, the voluntary activation level of the knee extensor muscles was altered from PRE (-9.1%; p < 0.001), indicating an overall central failure in both the EL and NEL. These findings indicate that two bouts of unilateral fatiguing exercise were needed to induce a cross-over effect of muscle fatigue on the non-exercising contralateral limb. Differential adjustments of the motor pathway (peripheral fatigue vs. central fatigue) might contribute to the respective torque decline in the EL and the NEL. Given that our unilateral fatiguing exercise induced immediate maximal torque reduction in the EL and postponed the loss of torque production in the NEL, it is also concluded that the time course of muscle fatigue differed between limbs.	[Doix, Aude-Clemence M.; Lefevre, Fabrice; Colson, Serge S.] Univ Nice Sophia Antipolis, Nice, France; [Doix, Aude-Clemence M.; Lefevre, Fabrice; Colson, Serge S.] Univ Toulon & Var, Lab Human Motr, Nice, France; [Doix, Aude-Clemence M.] Norwegian Univ Sci & Technol, Dept Human Movement Sci, N-7034 Trondheim, Norway; [Lefevre, Fabrice] Int Hlth & Performance Inst, Barcelona, Spain	UDICE-French Research Universities; Universite Cote d'Azur; Universite de Toulon; Norwegian University of Science & Technology (NTNU)	Colson, SS (corresponding author), Univ Nice Sophia Antipolis, Nice, France.	colson@unice.fr			bilateral researcher exchange programme Aurora; Norwegian Research Council; French Ministry of Foreign affairs [27407SG]	bilateral researcher exchange programme Aurora; Norwegian Research Council(Research Council of NorwayEuropean Commission); French Ministry of Foreign affairs	This project was supported by the bilateral researcher exchange programme Aurora, financed by the Norwegian Research Council and the French Ministry of Foreign affairs (Grant number: 27407SG) (http://www.campusfrance.org/fr/aurora). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Amann M, 2008, J APPL PHYSIOL, V105, P1714, DOI 10.1152/japplphysiol.90456.2008; Behm DG, 1996, J APPL PHYSIOL, V81, P2267, DOI 10.1152/jappl.1996.81.5.2267; Berger LL, 2010, J ELECTROMYOGR KINES, V20, P947, DOI 10.1016/j.jelekin.2009.09.006; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; Bishop D, 2003, SPORTS MED, V33, P483, DOI 10.2165/00007256-200333070-00002; Carroll TJ, 2006, J APPL PHYSIOL, V101, P1514, DOI 10.1152/japplphysiol.00531.2006; Carson RG, 2004, J PHYSIOL-LONDON, V560, P929, DOI 10.1113/jphysiol.2004.069088; Dragert K, 2011, EXP BRAIN RES, V208, P217, DOI 10.1007/s00221-010-2472-3; Elmer SJ, 2013, EUR J APPL PHYSIOL, V113, P479, DOI 10.1007/s00421-012-2455-0; ENOKA RM, 1988, SPORTS MED, V6, P146, DOI 10.2165/00007256-198806030-00003; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; Fimland MS, 2009, EUR J APPL PHYSIOL, V107, P723, DOI 10.1007/s00421-009-1190-7; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Gondin J, 2005, MED SCI SPORT EXER, V37, P1291, DOI 10.1249/01.mss.0000175090.49048.41; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Kellis E, 1998, SPORTS MED, V25, P37, DOI 10.2165/00007256-199825010-00004; Kennedy A, 2013, EUR J APPL PHYSIOL, V113, P559, DOI 10.1007/s00421-012-2462-1; Kufel TJ, 2002, MUSCLE NERVE, V25, P438, DOI 10.1002/mus.10047; Martin PG, 2007, PFLUG ARCH EUR J PHY, V454, P957, DOI 10.1007/s00424-007-0243-1; MCILROY WE, 1992, BRAIN RES, V582, P85, DOI 10.1016/0006-8993(92)90320-9; Mclean SG, 2009, MED SCI SPORT EXER, V41, P1661, DOI 10.1249/MSS.0b013e31819ca07b; McNeil CJ, 2009, J PHYSIOL-LONDON, V587, P5601, DOI 10.1113/jphysiol.2009.180968; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Millet GY, 2004, SPORTS MED, V34, P105, DOI 10.2165/00007256-200434020-00004; MOSSO A, 1906, FATIGUE, pR14; Paillard T, 2010, NEUROSCI RES, V68, P301, DOI 10.1016/j.neures.2010.08.004; Place N, 2007, MUSCLE NERVE, V35, P486, DOI 10.1002/mus.20714; Post M, 2008, J APPL PHYSIOL, V105, P70, DOI 10.1152/japplphysiol.01298.2007; Jodie R, 2006, PFLUG ARCH EUR J PHY, V452, P199, DOI 10.1007/s00424-005-0027-4; ROONEY KJ, 1994, MED SCI SPORT EXER, V26, P1160; Strojnik V, 1998, J APPL PHYSIOL, V84, P344, DOI 10.1152/jappl.1998.84.1.344; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Todd G, 2005, J PHYSIOL-LONDON, V563, P621, DOI 10.1113/jphysiol.2004.077115; Todd G, 2004, MUSCLE NERVE, V29, P834, DOI 10.1002/mus.20027; Todd G, 2003, EXP BRAIN RES, V150, P308, DOI 10.1007/s00221-003-1379-7; Ulmer HV, 1996, EXPERIENTIA, V52, P416, DOI 10.1007/BF01919309; Vuillerme N, 2010, EUR J APPL PHYSIOL, V110, P207, DOI 10.1007/s00421-010-1449-z; Vuillerme N, 2009, GAIT POSTURE, V30, P122, DOI 10.1016/j.gaitpost.2009.03.004; Wittekind AL, 2011, BRIT J SPORT MED, V45, P114, DOI 10.1136/bjsm.2009.061580; Zijdewind I, 1998, NEUROSCI LETT, V253, P41, DOI 10.1016/S0304-3940(98)00609-0; Zijdewind I, 2001, J NEUROPHYSIOL, V85, P1907, DOI 10.1152/jn.2001.85.5.1907	47	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64910	10.1371/journal.pone.0064910	http://dx.doi.org/10.1371/journal.pone.0064910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741417	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900130
J	Gao, Y; Lui, WY				Gao, Ying; Lui, Wing-Yee			Transforming Growth Factor-beta 1 (TGF-beta 1) Regulates Cell Junction Restructuring via Smad-Mediated Repression and Clathrin-Mediated Endocytosis of Nectin-like Molecule 2 (Necl-2)	PLOS ONE			English	Article							BLOOD-TESTIS BARRIER; ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; MALE-INFERTILITY; SERTOLI-CELLS; ADHERENS JUNCTIONS; MESSENGER-RNA; TNF-ALPHA; DYNAMICS; MOUSE	Nectin-like molecule-2 (Necl-2), a junction molecule, is exclusively expressed by spermatogenic cells. It mediates homophilic interaction between germ cells and heterophilic interaction between Sertoli and germ cells. Knockout studies have shown that loss of Necl-2 causes male infertility, suggesting Necl-2-based cell adhesion is crucial for spermatogenesis. Transforming growth factor-beta s (TGF-beta s) are crucial for regulating cell junction restructuring that are required for spermatogenesis. In the present study, we aim to investigate the mechanism on how TGF-beta 1 regulates Necl-2 expression to achieve timely junction restructuring in the seminiferous epithelium during spermatogenesis. We have demonstrated that TGF-beta 1 reduces Necl-2 mRNA and protein levels at both transcriptional and post-translational levels. Using inhibitor and clathrin shRNA, we have revealed that TGF-beta 1 induces Necl-2 protein degradation via clathrin-dependent endocytosis. Endocytosis assays further confirmed that TGF-beta 1 accelerates the internalization of Necl-2 protein to cytosol. Immunofluorescence staining also revealed that TGF-beta 1 effectively removes Necl-2 from cell-cell interface. In addition, TGF-beta 1 reduces Necl-2 mRNA via down-regulating Necl-2 promoter activity. Mutational studies coupled with knockdown experiments have shown that TGF-beta 1-induced Necl-2 repression requires activation of Smad proteins. EMSA and ChIP assays further confirmed that TGF-beta 1 promotes the binding of Smad proteins onto MyoD and CCAATa motifs in vitro and in vivo. Taken together, TGF-beta 1 is a potent cytokine that provides an effective mechanism in controlling Necl-2 expression in the testis via Smad-dependent gene repression and clathrin-mediated endocytosis.	[Gao, Ying; Lui, Wing-Yee] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lui, WY (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	wylui@hku.hk	Lui, Wing Yee/A-2743-2010	Lui, Wing Yee/0000-0002-3096-1158	Hong Kong Research Grants Council [HKU773710M]; HKU/CRCG Seed Funding for Basic Research	Hong Kong Research Grants Council(Hong Kong Research Grants Council); HKU/CRCG Seed Funding for Basic Research	The work was funded by Hong Kong Research Grants Council (HKU773710M) and HKU/CRCG Seed Funding for Basic Research http://www.ugc.edu.hk/eng/rgc/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bouchard MJ, 2000, MOL CELL BIOL, V20, P2865, DOI 10.1128/MCB.20.8.2865-2873.2000; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Fujita E, 2006, MOL CELL BIOL, V26, P718, DOI 10.1128/MCB.26.2.718-726.2006; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Inagaki M, 2006, GENES CELLS, V11, P1125, DOI 10.1111/j.1365-2443.2006.01006.x; Ito Akihiko, 2008, Journal of Smooth Muscle Research, V44, P83, DOI 10.1540/jsmr.44.83; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lui WY, 2007, CYTOKINE GROWTH F R, V18, P299, DOI 10.1016/j.cytogfr.2007.04.009; Lui WY, 2007, J CELL PHYSIOL, V211, P638, DOI 10.1002/jcp.20970; Lui WY, 2003, INT J ANDROL, V26, P147, DOI 10.1046/j.1365-2605.2003.00410.x; Lui WY, 2001, ENDOCRINOLOGY, V142, P1865, DOI 10.1210/en.142.5.1865; Lui WY, 2003, BIOL REPROD, V68, P1597, DOI 10.1095/biolreprod.102.011387; Maekawa M, 2011, ANDROLOGIA, V43, P180, DOI 10.1111/j.1439-0272.2010.01049.x; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Surace EI, 2006, J ANDROL, V27, P816, DOI 10.2164/jandrol.106.000398; Sze KL, 2008, BIOCHEM J, V410, P575, DOI 10.1042/BJ20070901; Sze KL, 2008, J CELL PHYSIOL, V214, P334, DOI 10.1002/jcp.21201; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; TEERDS KJ, 1993, BIOL REPROD, V48, P40, DOI 10.1095/biolreprod48.1.40; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; van der Weyden L, 2006, MOL CELL BIOL, V26, P3595, DOI 10.1128/MCB.26.9.3595-3609.2006; Wakayama T, 2003, BIOL REPROD, V68, P1755, DOI 10.1095/biolreprod.102.012344; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Wakayama T, 2007, BIOL REPROD, V76, P1081, DOI 10.1095/biolreprod.106.058974; Wang Y, 2009, ENDOCRINOLOGY, V150, P2404, DOI 10.1210/en.2008-1239; Xia WL, 2006, J BIOL CHEM, V281, P16799, DOI 10.1074/jbc.M601618200; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Yamada D, 2006, MOL CELL BIOL, V26, P3610, DOI 10.1128/MCB.26.9.3610-3624.2006; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342	32	5	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64316	10.1371/journal.pone.0064316	http://dx.doi.org/10.1371/journal.pone.0064316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741316	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900028
J	Hamm, MP; Klassen, TP; Scott, SD; Moher, D; Hartling, L				Hamm, Michele P.; Klassen, Terry P.; Scott, Shannon D.; Moher, David; Hartling, Lisa			Education in Health Research Methodology: Use of a Wiki for Knowledge Translation	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; QUALITY ASSESSMENT; CLINICAL-TRIALS; BIAS; RISK; IMPACT	Introduction: A research-practice gap exists between what is known about conducting methodologically rigorous randomized controlled trials (RCTs) and what is done. Evidence consistently shows that pediatric RCTs are susceptible to high risk of bias; therefore novel methods of influencing the design and conduct of trials are required. The objective of this study was to develop and pilot test a wiki designed to educate pediatric trialists and trainees in the principles involved in minimizing risk of bias in RCTs. The focus was on preliminary usability testing of the wiki. Methods: The wiki was developed through adaptation of existing knowledge translation strategies and through tailoring the site to the identified needs of the end-users. The wiki was evaluated for usability and user preferences regarding the content and formatting. Semi-structured interviews were conducted with 15 trialists and systematic reviewers, representing varying levels of experience with risk of bias or the conduct of trials. Data were analyzed using content analysis. Results: Participants found the wiki to be well organized, easy to use, and straightforward to navigate. Suggestions for improvement tended to focus on clarification of the text or on esthetics, rather than on the content or format. Participants liked the additional features of the site that were supplementary to the text, such as the interactive examples, and the components that focused on practical applications, adding relevance to the theory presented. While the site could be used by both trialists and systematic reviewers, the lack of a clearly defined target audience caused some confusion among participants. Conclusions: Participants were supportive of using a wiki as a novel educational tool. The results of this pilot test will be used to refine the risk of bias wiki, which holds promise as a knowledge translation intervention for education in medical research methodology.	[Hamm, Michele P.; Hartling, Lisa] Univ Alberta, Fac Med & Dent, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Klassen, Terry P.] Univ Manitoba, Fac Med, Manitoba Inst Child Hlth, Winnipeg, MB, Canada; [Klassen, Terry P.] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Scott, Shannon D.] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada; [Scott, Shannon D.] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Moher, David] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Alberta; University of Manitoba; University of Manitoba; University of Alberta; University of Alberta; University of Ottawa; Ottawa Hospital Research Institute	Hamm, MP (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada.	michele.hamm@ualberta.ca	Moher, David/I-3408-2019	Moher, David/0000-0003-2434-4206; Klassen, Terry/0000-0002-5309-7091; Scott, Shannon D./0000-0002-2251-3742	KT Canada Fellowship Award from Knowledge Translation Canada	KT Canada Fellowship Award from Knowledge Translation Canada	MPH was supported by a KT Canada Fellowship Award from Knowledge Translation Canada ( http://ktclearinghouse.ca/ktcanada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHA I, 2008, Z EVID FORTBILD Q S6, V102, P9; Archambault PM, 2012, JMIR RES PROTOC, V1, DOI 10.2196/resprot.1993; Aripin KNBN, 2010, ARCH DIS CHILD, V95, P469, DOI 10.1136/adc.2009.173591; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Ballard Hubert O, 2004, J Perinatol, V24, P409, DOI 10.1038/sj.jp.7211142; Bassler D, 2007, J CLIN EPIDEMIOL, V60, P869, DOI 10.1016/j.jclinepi.2006.12.006; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Boulos Maged N Kamel, 2006, BMC Med Educ, V6, P41, DOI 10.1186/1472-6920-6-41; Caldwell PHY, 2002, J PEDIATR-US, V141, P798, DOI 10.1067/mpd.2002.129173; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; COHEN E, 2008, PEDIAT HLTH, V2, P151; Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Creswell J. W., 2007, QUALITATIVE INQUIRY; Crocetti MT, 2010, PEDIATRICS, V126, P298, DOI 10.1542/peds.2009-3121; DeMauro SB, 2011, PEDIATRICS, V128, pE639, DOI 10.1542/peds.2011-0377; Dulai SK, 2007, J PEDIATR ORTHOPED, V27, P573, DOI 10.1097/bpo.0b013e3180621f3e; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Farmer AP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub2; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Fordis M, 2005, JAMA-J AM MED ASSOC, V294, P1043, DOI 10.1001/jama.294.9.1043; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Goldstein NJ, 2007, FRONT SOC PSYCHOL, P167; Greene JA, 2011, J GEN INTERN MED, V26, P287, DOI 10.1007/s11606-010-1526-3; GRIMSHAW JM, 2001, MED CARE S, V39, P112; Hamm MP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-158; Hamm MP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-96; HAMM MP, ACAD MED IN PRESS; Hartling L, 2012, PEDIATRICS, V129, pS124, DOI 10.1542/peds.2012-0055E; Hartling L, 2012, PEDIATRICS, V129, pS112, DOI 10.1542/peds.2012-0055C; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Hawn C, 2009, HEALTH AFFAIR, V28, P361, DOI 10.1377/hlthaff.28.2.361; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Moss RL, 2001, J PEDIATR SURG, V36, P1182, DOI 10.1053/jpsu.2001.25749; NIELSEN BA, 2004, 12 COCHR C OCT 2 6 O; NONNECKE B, 2000, SIGCHI C HUM FACT CO; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Rheims S, 2008, PLOS MED, V5, P1223, DOI 10.1371/journal.pmed.0050166; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Thomson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013106; Tishler CL, 2011, PEDIATRICS, V127, P949, DOI 10.1542/peds.2010-2585; Uman LS, 2010, J PEDIATR PSYCHOL, V35, P693, DOI 10.1093/jpepsy/jsp104; VONELM E, 2006, 14 COCHR C OCT 23 26; Welk B, 2006, J UROLOGY, V176, P306, DOI 10.1016/S0022-5347(06)00560-X; Wensing M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-103	50	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64922	10.1371/journal.pone.0064922	http://dx.doi.org/10.1371/journal.pone.0064922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156DC	23741424	Green Published, gold			2022-12-27	WOS:000319799900137
J	Liu, L; Wang, ZW; Jiang, SQ; Shao, BF; Liu, JB; Zhang, SQ; Zhou, YL; Zhou, Y; Zhang, YX				Liu, Lei; Wang, Zhiwei; Jiang, Songqi; Shao, Bingfeng; Liu, Jibing; Zhang, Suqing; Zhou, Yilong; Zhou, Yuan; Zhang, Yixin			Perioperative Allogenenic Blood Transfusion Is Associated with Worse Clinical Outcomes for Hepatocellular Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							MALIGNANT HEPATOBILIARY DISEASES; 1222 CONSECUTIVE PATIENTS; HEPATIC RESECTION; CURATIVE RESECTION; SYSTEMATIC REVIEWS; FAS LIGAND; INTRAHEPATIC RECURRENCE; PROSPECTIVE DATABASE; PROGNOSTIC-FACTORS; CELL TRANSFUSION	Background and Objective: The impact of perioperative allogenenic blood transfusion (ABT) on clinical outcomes for hepatocellular carcinoma (HCC) is conflicting and unclear. The aim of this meta-analysis is to evaluate the association between ABT and HCC clinical outcomes. Outcomes evaluated were all-cause death, tumor recurrence and postoperative complications. Methods: Relevant articles were identified through MEDLINE search (up to November 2012). Meta-analyses were performed by using the fixed or random effect models. Study heterogeneity was assessed by Q-test and I-2 test. Publication bias was evaluated by funnel plots, Egger's and Begg's test. Results: A total of 5635 cases from 22 studies finally met our inclusion criteria. Meta-analysis indicated HCC patients with ABT had an increased risk of all-cause death at 3 and 5 years after surgery (respectively: OR = 1.92, 95% CI, 1.61-2.29, P<0.001; OR = 1.60, 95% CI, 1.47-1.73, P<0.001) compared with those without ABT. The risk of tumor recurrence was significantly higher for ABT cases at 1, 3 and 5 years (respectively: OR = 1.70, 95% CI, 1.38-2.10, P<0.001; OR = 1.22, 95% CI, 1.08-1.38, P<0.001; OR = 1.16, 95% CI, 1.08-1.24, P<0.001). The HCC cases with ABT significantly increased postoperative complications occurrence compared with non-ABT cases (OR = 1.78,95% CI, 1.34-2.37, P<0.001). Conclusions: The findings from the current meta-analysis demonstrated that ABT was associated with adverse clinical outcomes for HCC patients undergoing surgery, including increased death, recurrence and complications. Therefore, ABT should not be performed if possible.	[Liu, Lei; Jiang, Songqi; Shao, Bingfeng; Liu, Jibing; Zhang, Suqing; Zhou, Yilong; Zhou, Yuan; Zhang, Yixin] Affiliated Tumor Hosp Nantong Univ, Dept Surg, Nantong, Jiangsu, Peoples R China; [Wang, Zhiwei] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Surg, Shanghai 200030, Peoples R China	Nantong University; Shanghai Jiao Tong University	Zhang, YX (corresponding author), Affiliated Tumor Hosp Nantong Univ, Dept Surg, Nantong, Jiangsu, Peoples R China.	Doczhangyx@126.com			Natural Science Foundation Jiangsu Ministry of Health [H200957]	Natural Science Foundation Jiangsu Ministry of Health	This study was supported by a grant from The Natural Science Foundation Jiangsu Ministry of Health (grant no.: H200957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2010, LANGENBECK ARCH SURG, V395, P625, DOI 10.1007/s00423-010-0643-0; Acheson AG, 2012, ANN SURG, V256, P235, DOI 10.1097/SLA.0b013e31825b35d5; Akobeng AK, 2005, ARCH DIS CHILD, V90, P845, DOI 10.1136/adc.2004.058230; Asahara T, 1999, WORLD J SURG, V23, P676, DOI 10.1007/PL00012367; Blajchman MA, 1998, VOX SANG, V74, P315, DOI 10.1111/j.1423-0410.1998.tb05437.x; BRUNSON ME, 1990, TRANSFUSION, V30, P651, DOI 10.1046/j.1537-2995.1990.30790385527.x; Cescon M, 2009, ANN SURG, V249, P995, DOI 10.1097/SLA.0b013e3181a63c74; Choi GH, 2009, J GASTROEN HEPATOL, V24, P391, DOI 10.1111/j.1440-1746.2008.05637.x; Domen RE, 2003, ARCH PATHOL LAB MED, V127, P316; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Gang Chen, 2007, Journal of Zhejiang University-Science B, V8, P560, DOI 10.1631/jzus.2007.B0560; Ghio M, 1999, BLOOD, V93, P1770, DOI 10.1182/blood.V93.5.1770.405a14_1770_1777; Hanazaki K, 2005, HEPATO-GASTROENTEROL, V52, P524; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Huang J, 2009, J GASTROINTEST SURG, V13, P1627, DOI 10.1007/s11605-009-0933-4; Itasaka H, 1995, HEPATO-GASTROENTEROL, V42, P465; Kaibori M, 2008, ANTICANCER RES, V28, P1749; Kitagawa K, 2001, ANTICANCER RES, V21, P3663; Kuroda S, 2012, WORLD J SURG, V36, P651, DOI 10.1007/s00268-012-1425-3; Kwon AH, 2001, CANCER-AM CANCER SOC, V91, P771; Laurent C, 2005, J AM COLL SURGEONS, V201, P656, DOI 10.1016/j.jamcollsurg.2005.05.027; Leucht S, 2009, ACTA PSYCHIAT SCAND, V119, P443, DOI 10.1111/j.1600-0447.2009.01388.x; Mak A, 2010, INT J RHEUM DIS, V13, P101, DOI 10.1111/j.1756-185X.2010.01471.x; Makino Y, 2000, AM J GASTROENTEROL, V95, P1294; Marcucci C, 2004, BRIT MED BULL, V70, P15, DOI 10.1093/bmb/ldh023; Mathurin P, 2003, ALIMENT PHARM THER, V17, P1247, DOI 10.1046/j.1365-2036.2003.01580.x; MATSUMATA T, 1993, CANCER, V72, P1866, DOI 10.1002/1097-0142(19930915)72:6<1866::AID-CNCR2820720613>3.0.CO;2-F; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nanashima A, 2011, ANTICANCER RES, V31, P4545; NIELSEN HJ, 1995, BRIT J SURG, V82, P582, DOI 10.1002/bjs.1800820505; Okamura Y, 2011, J SURG ONCOL, V104, P814, DOI 10.1002/jso.21977; Peng BG, 2009, AM J SURG, V198, P313, DOI 10.1016/j.amjsurg.2008.09.026; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; Puppo F, 2000, INT IMMUNOL, V12, P195, DOI 10.1093/intimm/12.2.195; Puppo F, 2001, TRANSFUSION, V41, P416, DOI 10.1046/j.1537-2995.2001.41030416.x; Sasaki Y, 2002, CANCER-AM CANCER SOC, V94, P1777, DOI 10.1002/cncr.10402; Sasaki Y, 2006, ANN SURG, V244, P771, DOI 10.1097/01.sla.0000225126.56483.b3; Sauerland S, 2005, WORLD J SURG, V29, P582, DOI 10.1007/s00268-005-7917-7; Sugita S, 2008, EJSO-EUR J SURG ONC, V34, P339, DOI 10.1016/j.ejso.2007.02.010; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wall WJ, 2000, LIVER TRANSPLANT, V6, pS16, DOI 10.1053/jlts.2000.19010; Wang CC, 2009, ANN SURG ONCOL, V16, P1832, DOI 10.1245/s10434-009-0448-y; Wei AC, 2003, BRIT J SURG, V90, P33, DOI 10.1002/bjs.4018; Yamamoto J, 1996, BRIT J SURG, V83, P1219; Yang T, 2011, WORLD J SURG, V35, P2073, DOI 10.1007/s00268-011-1161-0; Yao HS, 2008, WORLD J SURG, V32, P2038, DOI 10.1007/s00268-008-9675-9; Ydy LRA, 2007, WORLD J SURG, V31, P2044, DOI 10.1007/s00268-007-9159-3	50	89	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64261	10.1371/journal.pone.0064261	http://dx.doi.org/10.1371/journal.pone.0064261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741309	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900021
J	Liu, Y; Yu, SF; Li, ZT; Ma, JJ; Zhang, YN; Wang, H; Yang, BY; Wu, CY				Liu, Yun; Yu, Sifei; Li, Zitao; Ma, Jiangjun; Zhang, Yannan; Wang, Hui; Yang, Binyan; Wu, Changyou			TGF-beta Enhanced IL-21-Induced Differentiation of Human IL-21-Producing CD4(+) T Cells via Smad3	PLOS ONE			English	Article							IL-21 RECEPTOR; INTERLEUKIN-21; GENERATION; PROMOTES; T(H)17; PROLIFERATION; ACTIVATION; EXPANSION; RESPONSES; PATHWAYS	IL-21 has pleiotropic effects on innate and adaptive immune response, and plays an important role in the development of autoimmune disease and antitumor activity. It has been reported that IL-21 is produced by CD4(+) T cells and NKT cells. However, the differentiation of IL-21-producing CD4(+) T cells in humans remains largely unclear. In the present study, we showed that cytokines of IL-1 beta, IL-6 or IL-21 induced differentiation of human IL-21-producing CD4(+) T cells, and TGF-beta enhanced the effect of inflammatory cytokines on the development of IL-21-producing CD4(+) T cells. Furthermore, we found that the majority of IL-21-producing cells were distinct from Th17 cells and Th1 cells since they did not co-express IL-17 and IFN-gamma. TGF-beta significantly inhibited the production of IFN-gamma and enhanced the effect of IL-21 on the development of IL-21-producing CD4(+) T cells. In addition, we found that IL-21 inhibited the differentiation of CD4(+) Foxp3(+) T cells induced by TGF-beta. Further study indicated that IL-21 induced phosphorylation of transcriptional factors of STAT1, STAT3 and STAT5, and TGF-beta induced phosphorylation of Smad3 in CD4(+) T cells. Taken together, our data indicated that TGF-beta enhanced IL-21-induced differentiation of IL-21-producing CD4(+) T cells, and the majority of IL-21-producing cells were different from Th17 and Th1 cells. Our results provide a new sight regarding the differentiation of human CD4(+) T cells.	[Wu, Changyou] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510275, Guangdong, Peoples R China; Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control Res, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wu, CY (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510275, Guangdong, Peoples R China.	changyou_wu@yahoo.com			introduction of innovative R&D team program of Guangdong Province [2009010058]; National Natural Science Foundation of China [81072403]	introduction of innovative R&D team program of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the introduction of innovative R&D team program of Guangdong Province (No. 2009010058) and National Natural Science Foundation of China (81072403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Caruso R, 2007, J IMMUNOL, V178, P5957, DOI 10.4049/jimmunol.178.9.5957; Collins M, 2003, IMMUNOL RES, V28, P131, DOI 10.1385/IR:28:2:131; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Di Carlo E, 2004, J IMMUNOL, V172, P1540, DOI 10.4049/jimmunol.172.3.1540; Distler JHW, 2005, ARTHRITIS RHEUM-US, V52, P856, DOI 10.1002/art.20883; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Konforte D, 2006, J IMMUNOL, V177, P8381, DOI 10.4049/jimmunol.177.12.8381; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li YQ, 2008, BLOOD, V111, P229, DOI 10.1182/blood-2007-05-089375; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mehta DS, 2004, IMMUNOL REV, V202, P84, DOI 10.1111/j.0105-2896.2004.00201.x; Moroz A, 2004, J IMMUNOL, V173, P900, DOI 10.4049/jimmunol.173.2.900; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wang G, 2003, CANCER RES, V63, P9016; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	35	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64612	10.1371/journal.pone.0064612	http://dx.doi.org/10.1371/journal.pone.0064612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741351	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900064
J	Martinez-Rodriguez, N; Posadas-Romero, C; Villarreal-Molina, T; Vallejo, M; Del-Valle-Mondragon, L; Ramirez-Bello, J; Valladares, A; Cruz-Lopez, M; Vargas-Alarcon, G				Martinez-Rodriguez, Nancy; Posadas-Romero, Carlos; Villarreal-Molina, Teresa; Vallejo, Maite; Del-Valle-Mondragon, Leonardo; Ramirez-Bello, Julian; Valladares, Adan; Cruz-Lopez, Miguel; Vargas-Alarcon, Gilberto			Single Nucleotide Polymorphisms of the Angiotensin-Converting Enzyme (ACE) Gene Are Associated with Essential Hypertension and Increased ACE Enzyme Levels in Mexican Individuals	PLOS ONE			English	Article							BLOOD-PRESSURE; LINKAGE; SEGREGATION; DISEASE; SYSTEM; I/D	Aim: To explore the role of the ACE gene polymorphisms in the risk of essential hypertension in Mexican Mestizo individuals and evaluate the correlation between these polymorphisms and the serum ACE levels. Methods: Nine ACE gene polymorphisms were genotyped by 5' exonuclease TaqMan genotyping assays and polymerase chain reaction (PCR) in 239 hypertensive and 371 non-hypertensive Mexican individuals. Haplotypes were constructed after linkage disequilibrium analysis. ACE serum levels were determined in selected individuals according to different haplotypes. Results: Under a dominant model, rs4291 rs4335, rs4344, rs4353, rs4362, and rs4363 polymorphisms were associated with an increased risk of hypertension after adjusting for age, gender, BMI, triglycerides, alcohol consumption, and smoking. Five polymorphisms (rs4335, rs4344, rs4353, rs4362 and rs4363) were in strong linkage disequilibrium and were included in four haplotypes: H1 (AAGCA), H2 (GGATG), H3 (AGATG), and H4 (AGACA). Haplotype H1 was associated with decreased risk of hypertension, while haplotype H2 was associated with an increased risk of hypertension (OR = 0.77, P = 0.023 and OR = 1.41, P = 0.004 respectively). According to the codominant model, the H2/H2 and H1/H2 haplotype combinations were significantly associated with risk of hypertension after adjusted by age, gender, BMI, triglycerides, alcohol consumption, and smoking (OR = 2.0; P = 0.002 and OR = 2.09; P = 0.011, respectively). Significant elevations in serum ACE concentrations were found in individuals with the H2 haplotype (H2/H2 and H2/H1) as compared to H1/H1 individuals (P = 0.0048). Conclusion: The results suggest that single nucleotide polymorphisms and the "GGATG" haplotype of the ACE gene are associated with the development of hypertension and with increased ACE enzyme levels.	[Martinez-Rodriguez, Nancy; Vargas-Alarcon, Gilberto] Inst Nacl Cardiol Ignacio Chavez INCICH, Dept Mol Biol, Mexico City, DF, Mexico; [Posadas-Romero, Carlos] INCICH, Dept Endocrinol, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa] Inst Nacl Med Genom INMEGEN, Genom Lab Cardiovasc Dis, Mexico City, DF, Mexico; [Vallejo, Maite] INCICH, Sociomed Dept, Mexico City, DF, Mexico; [Del-Valle-Mondragon, Leonardo] INCICH, Dept Pharmacol, Mexico City, DF, Mexico; [Ramirez-Bello, Julian] INMEGEN, Immunogenet Lab, Mexico City, DF, Mexico; [Valladares, Adan; Cruz-Lopez, Miguel] Ctr Med Siglo XXI, Biochem Unit, Mexico City, DF, Mexico; [Martinez-Rodriguez, Nancy] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico	National Institute of Cardiology - Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Vargas-Alarcon, G (corresponding author), Inst Nacl Cardiol Ignacio Chavez INCICH, Dept Mol Biol, Mexico City, DF, Mexico.	gvargas63@yahoo.com	Lopez, Miguel Cruz/O-5493-2018; Martinez, Nancy L/G-2077-2019; Ramírez-Bello, Julian/AAR-1308-2020	Lopez, Miguel Cruz/0000-0001-9985-6172; Martinez, Nancy L/0000-0002-7840-983X; Ramírez-Bello, Julian/0000-0002-4153-9315; del Valle-Mondragon, Leonardo/0000-0002-2999-1050; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690; Vargas-Alarcon, Gilberto/0000-0001-7916-5163	Consejo Nacional de Ciencia y Tecnologia (CONACyT); Consejo Nacional de Ciencia y Tecnologia [87356]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Nancy L. Martinez-Rodriguez was supported by a fellowship from the Consejo Nacional de Ciencia y Tecnologia (CONACyT). This work was supported in part by grants from the Consejo Nacional de Ciencia y Tecnologia (Project number 87356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghai TC, 2006, MOL PSYCHIATR, V11, P1003, DOI 10.1038/sj.mp.4001884; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Crisan D, 2000, J MOL DIAGN, V2, P105, DOI 10.1016/S1525-1578(10)60624-1; Davis GK, 1997, PHARMACOL THERAPEUT, V75, P43, DOI 10.1016/S0163-7258(97)00021-1; Dhar Soujatya, 2012, Indian Heart J, V64, P576, DOI 10.1016/j.ihj.2012.08.005; ERDOS EG, 1987, LAB INVEST, V56, P345; Esther CR, 1997, J CLIN INVEST, V99, P2375, DOI 10.1172/JCI119419; HUBERT C, 1991, J BIOL CHEM, V266, P15377; Jing QM, 2013, MOL BIOL REP, V40, P1249, DOI 10.1007/s11033-012-2167-x; Kabadou IA, 2013, CLIN LAB, V59, P85, DOI 10.7754/Clin.Lab.2013.111105; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; MATTEI MG, 1989, CYTOGENET CELL GENET, V51, P1041; Miller A, 1993, NUCLEIC ACIDS RES, V16, P1215; Rasyid Haerani, 2012, Acta Med Indones, V44, P280; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Sakai T, 2013, MOL VIS, V19, P213; Schork NJ, 1997, HYPERTENSION, V29, P145, DOI 10.1161/01.HYP.29.1.145; SHANMUGAM V, 1993, PCR METH APPL, V3, P120; TIRET L, 1992, AM J HUM GENET, V51, P197; Villard E, 1996, AM J HUM GENET, V58, P1268; Ward Ryk, 1995, P67; World Health Organization (WHO), 2003, J HYPERTENS, V17, P151; Yadav S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057305; Yang SJ, 2013, NUTRITION, V29, P525, DOI 10.1016/j.nut.2012.09.001; Yang W, 2012, ASIAN PAC J TROP MED, V5, P995, DOI 10.1016/S1995-7645(12)60189-8; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang XL, 2012, EXP THER MED, V4, P741, DOI 10.3892/etm.2012.650; Zhang ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046495; Zhu XF, 2000, AM J HUM GENET, V67, P1144; Zhu XF, 2003, HYPERTENSION, V41, P1027, DOI 10.1161/01.HYP.0000068681.69874.CB; Zhu XF, 2003, GENOME RES, V13, P173, DOI 10.1101/gr.302003; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	34	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65700	10.1371/journal.pone.0065700	http://dx.doi.org/10.1371/journal.pone.0065700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741507	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900220
J	Prouse, MB; Campbell, MM				Prouse, Michael B.; Campbell, Malcolm M.			Interactions between the R2R3-MYB Transcription Factor, AtMYB61, and Target DNA Binding Sites	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; TISSUE-SPECIFIC EXPRESSION; CIS-ACTING ELEMENTS; C-MYB; GENE FAMILY; ARABIDOPSIS-THALIANA; VASCULAR EXPRESSION; TRANSGENIC TOBACCO; C/EBP-BETA; IN-VITRO	Despite the prominent roles played by R2R3-MYB transcription factors in the regulation of plant gene expression, little is known about the details of how these proteins interact with their DNA targets. For example, while Arabidopsis thaliana R2R3-MYB protein AtMYB61 is known to alter transcript abundance of a specific set of target genes, little is known about the specific DNA sequences to which AtMYB61 binds. To address this gap in knowledge, DNA sequences bound by AtMYB61 were identified using cyclic amplification and selection of targets (CASTing). The DNA targets identified using this approach corresponded to AC elements, sequences enriched in adenosine and cytosine nucleotides. The preferred target sequence that bound with the greatest affinity to AtMYB61 recombinant protein was ACCTAC, the AC-I element. Mutational analyses based on the AC-I element showed that ACC nucleotides in the AC-I element served as the core recognition motif, critical for AtMYB61 binding. Molecular modelling predicted interactions between AtMYB61 amino acid residues and corresponding nucleotides in the DNA targets. The affinity between AtMYB61 and specific target DNA sequences did not correlate with AtMYB61-driven transcriptional activation with each of the target sequences. CASTing-selected motifs were found in the regulatory regions of genes previously shown to be regulated by AtMYB61. Taken together, these findings are consistent with the hypothesis that AtMYB61 regulates transcription from specific cis-acting AC elements in vivo. The results shed light on the specifics of DNA binding by an important family of plant-specific transcriptional regulators.	[Prouse, Michael B.; Campbell, Malcolm M.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Dept Cell & Syst Biol, Toronto, ON, Canada; [Campbell, Malcolm M.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Scarborough	Campbell, MM (corresponding author), Univ Toronto, Ctr Anal Genome Evolut & Funct, Dept Cell & Syst Biol, Toronto, ON, Canada.	malcolm.campbell@utoronto.ca		Campbell, Malcolm/0000-0002-1396-6651	Natural Science and Engineering Research Council of Canada (NSERC) Canadian Graduate Scholarship (CGSD); NSERC	Natural Science and Engineering Research Council of Canada (NSERC) Canadian Graduate Scholarship (CGSD)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was generously supported by a Natural Science and Engineering Research Council of Canada (NSERC) Canadian Graduate Scholarship (CGSD) awarded to MBP, and funding from NSERC to MMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BellLelong DA, 1997, PLANT PHYSIOL, V113, P729, DOI 10.1104/pp.113.3.729; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dubos C, 2005, PLANT J, V43, P348, DOI 10.1111/j.1365-313X.2005.02458.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; EBNETH A, 1994, BIOCHEMISTRY-US, V33, P14586, DOI 10.1021/bi00252a026; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Glover BJ, 1998, DEVELOPMENT, V125, P3497; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Gomez-Maldonado J, 2004, PLANT J, V39, P513, DOI 10.1111/j.1365-313X.2004.02153.x; Hall KB, 2008, NITROCELLULOSE FILTE, P105; Harlow E., 1988, ANTIBODIES LAB MANUA; HATTON D, 1995, PLANT J, V7, P859, DOI 10.1046/j.1365-313X.1995.07060859.x; HAUFFE KD, 1993, PLANT J, V4, P235, DOI 10.1046/j.1365-313X.1993.04020235.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; JOOS HJ, 1992, EUR J BIOCHEM, V204, P621, DOI 10.1111/j.1432-1033.1992.tb16675.x; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lacombe E, 2000, PLANT J, V23, P663, DOI 10.1046/j.1365-313x.2000.00838.x; Lauvergeat V, 2002, PLANT MOL BIOL, V50, P497, DOI 10.1023/A:1019817913604; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LEYVA A, 1992, PLANT CELL, V4, P263, DOI 10.1105/tpc.4.3.263; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Lipsick JS, 1996, ONCOGENE, V13, P223; LOGEMANN E, 1995, P NATL ACAD SCI USA, V92, P5905, DOI 10.1073/pnas.92.13.5905; LOIS R, 1989, EMBO J, V8, P1641, DOI 10.1002/j.1460-2075.1989.tb03554.x; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; Massie CE, 2008, EMBO REP, V9, P337, DOI 10.1038/embor.2008.44; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Newman LJ, 2004, PLANT J, V37, P239, DOI 10.1046/j.1365-313X.2003.01953.x; Ogata K, 1993, Nucleic Acids Symp Ser, P201; OGATA K, 1995, NAT STRUCT BIOL, V2, P309, DOI 10.1038/nsb0495-309; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Patzlaff A, 2003, PLANT MOL BIOL, V53, P597, DOI 10.1023/B:PLAN.0000019066.07933.d6; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Prouse MB, 2012, BBA-GENE REGUL MECH, V1819, P67, DOI 10.1016/j.bbagrm.2011.10.010; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Romano JM, 2012, NEW PHYTOL, V195, P774, DOI 10.1111/j.1469-8137.2012.04201.x; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Seguin A, 1997, PLANT MOL BIOL, V35, P281, DOI 10.1023/A:1005853404242; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Tahirov TH, 2001, ACTA CRYSTALLOGR D, V57, P1655, DOI 10.1107/S0907444901011982; TANIKAWA J, 1993, P NATL ACAD SCI USA, V90, P9320, DOI 10.1073/pnas.90.20.9320; Tombuloglu H, 2013, MOL GENET GENOMICS, V288, P141, DOI 10.1007/s00438-013-0740-1; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Wang JK, 2011, J ENDOCRINOL, V210, P15, DOI 10.1530/JOE-11-0010; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104	54	31	32	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65132	10.1371/journal.pone.0065132	http://dx.doi.org/10.1371/journal.pone.0065132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741471	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900184
J	Skappak, C; Regush, S; Cheung, PY; Adamko, DJ				Skappak, Christopher; Regush, Shana; Cheung, Po-Yin; Adamko, Darryl J.			Identifying Hypoxia in a Newborn Piglet Model Using Urinary NMR Metabolomic Profiling	PLOS ONE			English	Article							NEONATAL ENCEPHALOPATHY; ISCHEMIC ENCEPHALOPATHY; INTRAPARTUM ASPHYXIA; BRAIN; HYPOTHERMIA; RAT; 1-METHYLNICOTINAMIDE; REOXYGENATION; ABNORMALITIES; TRANSPORT	Establishing the severity of hypoxic insult during the delivery of a neonate is key step in the determining the type of therapy administered. While successful therapy is present, current methods for assessing hypoxic injuries in the neonate are limited. Urine Nuclear Magnetic Resonance (NMR) metabolomics allows for the rapid non-invasive assessment of a multitude breakdown products of physiological processes. In a newborn piglet model of hypoxia, we used NMR spectroscopy to determine the levels of metabolites in urine samples, which were correlated with physiological measurements. Using PLS-DA analysis, we identified 13 urinary metabolites that differentiated hypoxic versus nonhypoxic animals (1-methylnicotinamide, 2-oxoglutarate, alanine, asparagine, betaine, citrate, creatine, fumarate, hippurate, lactate, N-acetylglycine, N-carbamoyl-beta-alanine, and valine). Using this metabolomic profile, we then were able to blindly identify hypoxic animals correctly 84% of the time compared to nonhypoxic controls. This was better than using physiologic measures alone. Metabolomic profiling of urine has potential for identifying neonates that have undergone episodes of hypoxia.	[Skappak, Christopher; Regush, Shana; Cheung, Po-Yin; Adamko, Darryl J.] Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada; [Cheung, Po-Yin] Univ Alberta, Dept Pharmacol, Fac Med & Dent, Edmonton, AB, Canada; [Adamko, Darryl J.] Univ Alberta, Dept Med, Fac Med & Dent, Edmonton, AB, Canada; [Adamko, Darryl J.] Univ Saskatchewan, Dept Pediat, Fac Med, Saskatoon, SK, Canada	University of Alberta; University of Alberta; University of Alberta; University of Saskatchewan	Adamko, DJ (corresponding author), Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada.	darryl.adamko@usask.ca	Cheung, Po-Yin/C-2804-2013	Cheung, Po-Yin/0000-0002-7141-1523	Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada; University of Alberta	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta(University of Alberta)	The authors thank the Canadian National High Field NMR Centre (NANUC) for assistance and use of facilities. Operation of NANUC is funded by the Canadian Institutes of Health Research, the Natural Science and Engineering Research Council of Canada, and the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzori L, 2010, J MATERN-FETAL NEO M, V23, P134, DOI 10.3109/14767058.2010.517033; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Cheung PY, 2011, JOVE-J VIS EXP, DOI 10.3791/3166; Cheung PY, 2000, ACTA PAEDIATR, V89, P262, DOI 10.1080/080352500750028357; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; da Silva S, 2000, ACTA PAEDIATR, V89, P320, DOI 10.1080/080352500750028465; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; Dragun P, 2008, J PHYSIOL PHARMACOL, V59, P441; DREWES LR, 1977, AM J PHYSIOL, V233, pE326, DOI 10.1152/ajpendo.1977.233.4.E326; Fanos V, 2011, CLIN BIOCHEM, V44, P452, DOI 10.1016/j.clinbiochem.2011.03.006; FITCH CD, 1964, J CLIN INVEST, V43, P444, DOI 10.1172/JCI104929; Gebicki J, 2003, POL J PHARMACOL, V55, P109; GILSTRAP LC, 1987, OBSTET GYNECOL, V70, P191; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Griffin JL, 1998, J NEUROCHEM, V71, P2477; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Liu JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015322; MCARDLE CB, 1987, RADIOLOGY, V163, P395, DOI 10.1148/radiology.163.2.3550882; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Olli K, 2013, BRIT J NUTR, V109, P43, DOI 10.1017/S0007114512000888; RAFALOWSKA U, 1979, NEUROCHEM RES, V4, P355, DOI 10.1007/BF00963805; Rutherford M, 2010, EARLY HUM DEV, V86, P351, DOI 10.1016/j.earlhumdev.2010.05.014; Sartini S, 2012, J NEUROSCI RES, V90, P435, DOI 10.1002/jnr.22762; Saude EJ, 2007, METABOLOMICS, V3, P19, DOI 10.1007/s11306-006-0042-2; Shah Sachin, 2004, J Perinatol, V24, P16, DOI 10.1038/sj.jp.7211023; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Shankaran S, 2011, PEDIATRICS, V128, pE112, DOI 10.1542/peds.2010-2036; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Vairetti M, 2002, BBA-MOL BASIS DIS, V1587, P83, DOI 10.1016/S0925-4439(02)00067-4; Van Coster RN, 2005, BIOCHEM BIOPH RES CO, V338, P1322, DOI 10.1016/j.bbrc.2005.10.126; Van Walsum AMV, 2002, PEDIATR RES, V52, P56, DOI 10.1203/00006450-200207000-00012; White CRH, 2012, J MATERN-FETAL NEO M, V25, P1653, DOI 10.3109/14767058.2011.653421; Zhang H, 2008, J PERINAT MED, V36, P240, DOI 10.1515/JPM.2008.035	35	34	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65035	10.1371/journal.pone.0065035	http://dx.doi.org/10.1371/journal.pone.0065035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741447	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900160
J	Song, L; Yang, YJ; Dong, QT; Qian, HY; Gao, RL; Qiao, SB; Shen, R; He, ZX; Lu, MJ; Zhao, SH; Geng, YJ; Gersh, BJ				Song, Lei; Yang, Yue-Jin; Dong, Qiu-Ting; Qian, Hai-Yan; Gao, Run-Lin; Qiao, Shu-Bin; Shen, Rui; He, Zuo-Xiang; Lu, Min-Jie; Zhao, Shi-Hua; Geng, Yong-Jian; Gersh, Bernard J.			Atorvastatin Enhance Efficacy of Mesenchymal Stem Cells Treatment for Swine Myocardial Infarction via Activation of Nitric Oxide Synthase	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; IMPROVES SURVIVAL; PROTEIN-KINASE; TRANSPLANTATION; STATINS	Background: In a swine model of acute myocardial infarction (AMI), Statins can enhance the therapeutic efficacy of mesenchymal stem cell (MSCs) transplantation. However, the mechanisms remain unclear. This study aims at assessing whether atorvastatin (Ator) facilitates the effects of MSCs through activation of nitric oxide synthase (NOS), especially endothelial nitric oxide synthase (eNOS), which is known to protect against ischemic injury. Methods and Results: 42 miniswines were randomized into six groups (n = 7/group): Sham operation; AMI control; Ator only; MSC only, Ator+MSCs and Ator+MSCs+NG-nitrol-L-arginine (L-NNA), an inhibitor of NOS. In an open-heart surgery, swine coronary artery ligation and reperfusion model were established, and autologous bone-marrow MSCs were injected intramyocardium. Four weeks after transplantation, compared with the control group, Ator+MSCs animals exhibited decreased defect areas of both "perfusion" defined by Single-Photon Emission Computed Tomography (-6.2 +/- 1.8% vs. 2.0 +/- 5.1%, P = 0.0001) and "metabolism" defined by Positron Emission Tomography (-3.00 +/- 1.41% vs. 4.20 +/- 4.09%, P = 0.0004); Ejection fraction by Magnetic Resonance Imaging increased substantially (14.22 +/- 12.8% vs. 1.64 +/- 2.64%, P = 0.019). In addition, indices of inflammation, fibrosis, and apoptosis were reduced and survivals of MSCs or MSC-derived cells were increased in Ator+MSCs animals. In Ator or MSCs alone group, perfusion, metabolism, inflammation, fibrosis or apoptosis were reduced but there were no benefits in terms of heart function and cell survival. Furthermore, the above benefits of Ator+MSCs treatment could be partially blocked by L-NNA. Conclusions: Atorvastatin facilitates survival of implanted MSCs, improves function and morphology of infarcted hearts, mediated by activation of eNOS and alleviated by NOS inhibitor. The data reveal the cellular and molecular mechanism for anti-AMI therapy with a combination of statin and stem cells.	[Song, Lei; Yang, Yue-Jin; Dong, Qiu-Ting; Qian, Hai-Yan; Gao, Run-Lin; Qiao, Shu-Bin] Chinese Acad Med Sci, Fuwai Hosp, Coronary Heart Dis Ctr, Dept Cardiol, Beijing 100730, Peoples R China; [Song, Lei; Yang, Yue-Jin; Dong, Qiu-Ting; Qian, Hai-Yan; Gao, Run-Lin; Qiao, Shu-Bin; Shen, Rui; He, Zuo-Xiang; Lu, Min-Jie; Zhao, Shi-Hua] Chinese Acad Med Sci, Cardiovasc Inst, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Song, Lei; Yang, Yue-Jin; Dong, Qiu-Ting; Qian, Hai-Yan; Gao, Run-Lin; Qiao, Shu-Bin; Shen, Rui; He, Zuo-Xiang; Lu, Min-Jie; Zhao, Shi-Hua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shen, Rui; He, Zuo-Xiang] Chinese Acad Med Sci, Fuwai Hosp, Dept Nucl Med, Beijing 100730, Peoples R China; [Lu, Min-Jie; Zhao, Shi-Hua] Chinese Acad Med Sci, Fuwai Hosp, Dept Radiol, Beijing 100730, Peoples R China; [Geng, Yong-Jian] Univ Texas Houston, Hlth Sci Ctr, Dept Internal Med, Ctr Cardiovasc Biol & Atherosclerosis Res,Div Car, Houston, TX 77225 USA; [Gersh, Bernard J.] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Texas System; University of Texas Health Science Center Houston; Mayo Clinic	Yang, YJ (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Coronary Heart Dis Ctr, Dept Cardiol, Beijing 100730, Peoples R China.	yangyjfw@yahoo.com.cn	Dong, Qiuting/AAS-7540-2020; Lu, Minjie/AAF-5091-2020; Zhao, Shihua/A-7553-2019; Song, Lei/AAD-8993-2020	Dong, Qiuting/0000-0001-5204-4978; Lu, Minjie/0000-0001-8696-318X; Zhao, Shihua/0000-0003-1339-7476; Song, Lei/0000-0002-6657-9516	National High Technology Research and Development Program (863 Program) [2011AA020110]; China Health and Medical Development Foundation [2011-H25]; Research Fund of Capital Medical Development [2007-2018]; National Natural Science Foundation of China [81070169, 81170129, 81000091, 81000130]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); China Health and Medical Development Foundation; Research Fund of Capital Medical Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program (863 Program) [2011AA020110], the China Health and Medical Development Foundation [2011-H25], Research Fund of Capital Medical Development [2007-2018], and the National Natural Science Foundation of China [81070169, 81170129, 81000091, 81000130]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; BUXTON ILO, 1993, CIRC RES, V72, P387, DOI 10.1161/01.RES.72.2.387; Cannon RO, 2005, NAT CLIN PRACT CARD, V2, P88, DOI 10.1038/ncpcardio0096; Cao Qi-lin, 2008, V438, P361, DOI 10.1007/978-1-59745-133-8_28; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chen SF, 2004, CHINESE MED J-PEKING, V117, P1443; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Dong QT, 2011, INT J CARDIOL, V153, P311, DOI 10.1016/j.ijcard.2010.08.047; Forrester JS, 2009, JACC-CARDIOVASC INTE, V2, P1, DOI 10.1016/j.jcin.2008.10.010; Forte A, 2009, CURR VASC PHARMACOL, V7, P381, DOI 10.2174/157016109788340776; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Jiang CY, 2008, J ZHEJIANG UNIV-SC B, V9, P630, DOI 10.1631/jzus.B0820004; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Li LL, 2009, MOL BIOL REP, V36, P725, DOI 10.1007/s11033-008-9235-2; Nyolczas N, 2009, REGEN MED, V4, P407, DOI 10.2217/RME.09.14; Ohkawara H, 2010, CARDIOVASC RES, V88, P492, DOI 10.1093/cvr/cvq221; Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003; Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428; Qian HY, 2007, CHINESE MED J-PEKING, V120, P1416, DOI 10.1097/00029330-200708020-00008; Rho GJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3942, DOI [10.2735/3503, 10.2741/3503]; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Rosanio S, 2006, CARDIOVASC DRUG THER, V20, P27, DOI 10.1007/s10557-005-5203-4; Southan GJ, 1996, BIOCHEM PHARMACOL, V51, P383, DOI 10.1016/0006-2952(95)02099-3; van den Bos EJ, 2005, EUR J HEART FAIL, V7, P435, DOI 10.1016/j.ejheart.2003.12.022; Volz HC, 2011, EUR J HEART FAIL, V13, P1052, DOI 10.1093/eurjhf/hfr098; WEBER KT, 1990, CIRCULATION, V82, P1387, DOI 10.1161/01.CIR.82.4.1387; Weir C, 2008, HEART LUNG CIRC, V17, P395, DOI 10.1016/j.hlc.2008.01.006; Wolf D, 2009, STEM CELLS DEV, V18, P321, DOI 10.1089/scd.2008.0019; Xu RX, 2008, J CELL BIOCHEM, V103, P256, DOI 10.1002/jcb.21402; Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167; Yang YJ, 2007, EUR J HEART FAIL, V9, P30, DOI 10.1016/j.ejheart.2006.04.013; Yang YJ, 2009, ARTERIOSCL THROM VAS, V29, P2076, DOI 10.1161/ATVBAHA.109.189662	35	51	57	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65702	10.1371/journal.pone.0065702	http://dx.doi.org/10.1371/journal.pone.0065702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741509	gold, Green Published, Green Submitted			2022-12-27	WOS:000319799900222
J	Venkatesh, KK; Becker, JE; Kumarasamy, N; Nakamura, YM; Mayer, KH; Losina, E; Swaminathan, S; Flanigan, TP; Walensky, RP; Freedberg, KA				Venkatesh, Kartik K.; Becker, Jessica E.; Kumarasamy, Nagalingeswaran; Nakamura, Yoriko M.; Mayer, Kenneth H.; Losina, Elena; Swaminathan, Soumya; Flanigan, Timothy P.; Walensky, Rochelle P.; Freedberg, Kenneth A.			Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India	PLOS ONE			English	Article							1ST-LINE ANTIRETROVIRAL THERAPY; OBSERVATIONAL DATABASE; DEVELOPING-COUNTRIES; SOUTHERN INDIA; COTE-DIVOIRE; SCALING-UP; VIRAL LOAD; INFECTION; TRANSMISSION; METAANALYSIS	Background: Despite expanding access to antiretroviral therapy (ART), most of the estimated 2.3 to 2.5 million HIV-infected individuals in India remain undiagnosed. The questions of whom to test for HIV and at what frequency remain unclear. Methods: We used a simulation model of HIV testing and treatment to examine alternative HIV screening strategies: 1) current practice, 2) one-time, 3) every five years, and 4) annually; and we applied these strategies to three population scenarios: 1) the general Indian population ("national population''), i.e. base case (HIV prevalence 0.29%; incidence 0.032/100 person-years [PY]); 2) high-prevalence districts (HIV prevalence 0.8%; incidence 0.088/100 PY), and 3) high-risk groups (HIV prevalence 5.0%; incidence 0.552/100 PY). Cohort characteristics reflected Indians reporting for HIV testing, with a median age of 35 years, 66% men, and a mean CD4 count of 305 cells/mu l. The cost of a rapid HIV test was $3.33. Outcomes included life expectancy, HIV-related direct medical costs, incremental cost-effectiveness ratios (ICERs), and secondary transmission benefits. The threshold for "cost-effective" was defined as 3x the annual per capita GDP of India ($3,900/year of life saved [YLS]), or for "very cost-effective" was <1x the annual per capita GDP ($1,300/YLS). Results: Compared to current practice, one-time screening was very cost-effective in the national population (ICER: $1,100/YLS), high-prevalence districts (ICER: $800/YLS), and high-risk groups (ICER: $800/YLS). Screening every five years in the national population (ICER: $1,900/YLS) and annual screening in high-prevalence districts (ICER: $1,900/YLS) and high-risk groups (ICER: $1,800/YLS) were also cost-effective. Results were most sensitive to costs of care and linkage-to-care. Conclusions: In India, voluntary HIV screening of the national population every five years offers substantial clinical benefit and is cost-effective. Annual screening is cost-effective among high-risk groups and in high-prevalence districts nationally. Routine HIV screening in India should be implemented.	[Venkatesh, Kartik K.; Flanigan, Timothy P.] Brown Univ, Miriam Hosp, Alpert Med Sch, Dept Med,Div Infect Dis, Providence, RI USA; [Becker, Jessica E.] Yale Univ, Sch Med, New Haven, CT USA; [Kumarasamy, Nagalingeswaran] YR Gaitonde Ctr AIDS Res & Educ, Madras, Tamil Nadu, India; [Mayer, Kenneth H.] Fenway Hlth, Boston, MA USA; [Mayer, Kenneth H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Swaminathan, Soumya] Indian Council Med Res, TB Res Ctr, Dept Clin Res, Madras, Tamil Nadu, India; [Swaminathan, Soumya] WHO, CH-1211 Geneva, Switzerland; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Nakamura, Yoriko M.; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Nakamura, Yoriko M.; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Mayer, Kenneth H.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; Yale University; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Boston University	Freedberg, KA (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	kfreedberg@partners.org	Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892; Becker, Jessica/0000-0003-0522-2836	National Institute of Allergy and Infectious Diseases [R01 AI058736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Cost-effectiveness of Prevention AIDS Complications - International(CEPAC-I) Group is funded by National Institute of Allergy and Infectious Diseases (Grant no. National Institute of Allergy and Infectious Diseases, R01 AI058736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2002, INCR ACC HIV TEST CO; [Anonymous], 2009, INT DRUG PRIC IND GU; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bachani D, 2010, NATL MED J INDIA, V23, P7; Balakrishnan P, 2005, INDIAN J MED RES, V121, P345; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Bhore AV, 2003, INT J STD AIDS, V14, P37, DOI 10.1258/095646203321043246; Cecelia AJ, 2006, NATL MED J INDIA, V19, P14; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dandona L, 2008, AIDS, V22, pS43, DOI 10.1097/01.aids.0000327622.24232.aa; Dandona R, 2009, NATL MED J INDIA, V22, P289; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; Ganesh A, 2009, YRGCARE PHARM UNIT C; Gold R, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Homan R, 2000, EC ANALYSES YRG CARE; International Institute for Population Sciences Macro International, 2007, NAT FAM HLTH SURV NF, P2005; International Monetary Fund, 2010, WORLD EC OUTL DAT; Iqbal HS, 2008, J CLIN LAB ANAL, V22, P178, DOI 10.1002/jcla.20238; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, COUNTR PROGR REP UNG; Kumarasamy N, 2006, JAIDS-J ACQ IMM DEF, V41, P53, DOI 10.1097/01.qai.0000188123.15493.43; Kumarasamy N, 2003, CLIN INFECT DIS, V36, P79, DOI 10.1086/344756; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; NACO, 2007, GUIDELINES PREVENTIO; *NAT AIDS CONTR OR, 2007, OP GUID INT COUNS TE; National AIDS Control Organisation, 2010, NACO ART MON PUBL; National AIDS Control Organisation, 2009, FACTS FIG; National AIDS Control Organisation, 2010, CAR SUPP TREATM NAT; National AIDS Control Organisation, 2008, POL FRAM CHILDR AIDS; National AIDS Control Organisation, 2007, ANT THER GUID AD AD; National AIDS Control Organization, 2006, TECHN REP HIV EST 20; National AIDS Control Organization, 2010, ANN REP 2010 2011; National AIDS Control Organization and Central TB Division, 2009, NAT FRAM JOINT HIV T; Ng M, 2011, LANCET IN PRESS; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pandey A, 2009, INDIAN J MED RES, V129, P50; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sogarwal Ruchi, 2009, J Indian Med Assoc, V107, P288; Solomon S, 2006, POSTGRAD MED J, V82, P545, DOI 10.1136/pgmj.2006.044966; Solomon S, 2006, WHY ARE PEOPLE GETTI; Solomon S, 2008, SEX HEALTH, V5, P371, DOI 10.1071/SH07090; Srikrishnan A, 2007, PLOS ONE, pe3471; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; Uhler LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012747; Venkatesh KK, 2011, AIDS CARE, V23, P722, DOI 10.1080/09540121.2010.525616; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Walensky RP, 2002, JAIDS-J ACQ IMM DEF, V31, P27, DOI 10.1097/00126334-200209010-00004; Wang B, INCIDENCE OPPORTUNIS; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2010, COUNTR HLTH SYST PRO; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	61	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64604	10.1371/journal.pone.0064604	http://dx.doi.org/10.1371/journal.pone.0064604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741348	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900061
J	Buda, P; Reinbothe, T; Nagaraj, V; Mahdi, T; Luan, C; Tang, YZ; Axelsson, AS; Li, DQ; Rosengren, AH; Renstrom, E; Zhang, EM				Buda, Pawel; Reinbothe, Thomas; Nagaraj, Vini; Mahdi, Taman; Luan, Cheng; Tang, Yunzhao; Axelsson, Annika S.; Li, Daiqing; Rosengren, Anders H.; Renstrom, Erik; Zhang, Enming			Eukaryotic Translation Initiation Factor 3 Subunit E Controls Intracellular Calcium Homeostasis by Regulation of Cav1.2 Surface Expression	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN-SECRETION; DEPENDENT STIMULATION; CHANNELS; APOPTOSIS; DYNAMICS; DEATH; INT6	Inappropriate surface expression of voltage-gated Ca2+ channels (Ca-V) in pancreatic beta-cells may contribute to the development of type 2 diabetes. First, failure to increase intracellular Ca2+ concentrations at the sites of exocytosis impedes insulin release. Furthermore, excessive Ca2+ influx may trigger cytotoxic effects. The regulation of surface expression of Ca-V channels in the pancreatic beta-cells remains unknown. Here, we used real-time 3D confocal and TIRFM imaging, immunocytochemistry, cellular fractionation, immunoprecipitation and electrophysiology to study trafficking of L-type Ca(V)1.2 channels upon beta-cell stimulation. We found decreased surface expression of Ca(V)1.2 and a corresponding reduction in L-type whole-cell Ca2+ currents in insulin-secreting INS-1 832/13 cells upon protracted (15-30 min) stimulation. This internalization occurs by clathrin-dependent endocytosis and could be prevented by microtubule or dynamin inhibitors. eIF3e (Eukaryotic translation initiation factor 3 subunit E) is part of the protein translation initiation complex, but its effect on translation are modest and effects in ion channel trafficking have been suggested. The factor interacted with Ca(V)1.2 and regulated Ca(V)1.2 traffic bidirectionally. eIF3e silencing impaired Ca(V)1.2 internalization, which resulted in an increased intracellular Ca2+ load upon stimulation. These findings provide a mechanism for regulation of L-type Ca-V channel surface expression with consequences for beta-cell calcium homeostasis, which will affect pancreatic beta-cell function and insulin production.	[Buda, Pawel; Reinbothe, Thomas; Nagaraj, Vini; Mahdi, Taman; Luan, Cheng; Tang, Yunzhao; Axelsson, Annika S.; Rosengren, Anders H.; Renstrom, Erik; Zhang, Enming] Lund Univ, Ctr Diabet, Malmo, Sweden; [Tang, Yunzhao; Li, Daiqing] Tianjin Med Univ, Key Lab Hormones & Dev, Minist Hlth, Tianjin, Peoples R China; [Tang, Yunzhao; Li, Daiqing] Tianjin Med Univ, Metab Dis Hosp, Tianjin, Peoples R China	Lund University; Tianjin Medical University; Tianjin Medical University	Renstrom, E (corresponding author), Lund Univ, Ctr Diabet, Malmo, Sweden.	erik.renstrom@med.lu.se; enming.zhang@med.lu.se	Rosengren, Anders/GZL-3068-2022; Zhang, Enming/B-9438-2013; Nagaraj, Vini/P-3866-2019; Rosengren, Anders/E-8371-2012; Reinbothe, Thomas M./N-1532-2014	Nagaraj, Vini/0000-0001-6959-3623; Zhang, Enming/0000-0002-0401-4608; Rosengren, Anders/0000-0002-9333-5736; Reinbothe, Thomas M./0000-0002-8934-6109; Luan, Cheng/0000-0003-4466-0687	Swedish Research Council; NovoNordisk Foundation; Region Skane and Albert Pahlsson Foundation; Tianjin Major Scientific and Technological Project Grant [09ZCZDSF04500]; Early Stage Training network CaVNet; European Union; Juvenile Diabetes Research Foundation; Swedish Strategic Research area in diabetes EXODIAB; Knut and Alice Wallenberg foundation; Novo Nordisk Fonden [NNF13OC0005771] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk Foundation(Novo Nordisk Foundation); Region Skane and Albert Pahlsson Foundation; Tianjin Major Scientific and Technological Project Grant; Early Stage Training network CaVNet; European Union(European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Strategic Research area in diabetes EXODIAB; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Research Council, NovoNordisk Foundation, Region Skane and Albert Pahlsson Foundation to ER and AR, and a Tianjin Major Scientific and Technological Project Grant (09ZCZDSF04500) to DL. The fellowships of EZ, PB and TR were given by the Early Stage Training network CaVNet funded by the European Union. ER was a Senior Scientist and AR holds a Junior Researcher position at the SRC. This project is also supported by grants from the Juvenile Diabetes Research Foundation and the Swedish Strategic Research area in diabetes EXODIAB (ER PI and EZ co-PI). This work was done using imaging setups and real-time PCR equipment financed by the Knut and Alice Wallenberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mercer AJ, 2011, J NEUROSCI, V31, P4397, DOI 10.1523/JNEUROSCI.5921-10.2011; Navarro-Tableros V, 2007, AM J PHYSIOL-ENDOC M, V292, pE1018, DOI 10.1152/ajpendo.00457.2006; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Reinbothe TM, 2009, MOL ENDOCRINOL, V23, P893, DOI 10.1210/me.2008-0306; Renstrom E, 1998, DIABETOLOGIA, V41, pA14; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Vikman J, 2009, FASEB J, V23, P58, DOI 10.1096/fj.08-105734; Wappl E, 2002, J BIOL CHEM, V277, P6960, DOI 10.1074/jbc.M110948200; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	32	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64462	10.1371/journal.pone.0064462	http://dx.doi.org/10.1371/journal.pone.0064462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737983	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700048
J	Chen, IL; Lee, CH; Su, LH; Tang, YF; Chang, SJ; Liu, JW				Chen, I-Ling; Lee, Chen-Hsiang; Su, Li-Hsiang; Tang, Ya-Feng; Chang, Shun-Jen; Liu, Jien-Wei			Antibiotic Consumption and Healthcare-Associated Infections Caused by Multidrug-Resistant Gram-Negative Bacilli at a Large Medical Center in Taiwan from 2002 to 2009: Implicating the Importance of Antibiotic Stewardship	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; NOSOCOMIAL INFECTIONS; KLEBSIELLA-PNEUMONIAE; SUSCEPTIBILITY; IMPACT; USAGE	Background: Better depicting the relationship between antibiotic consumption and evolutionary healthcare-associated infections (HAIs) caused by multidrug-resistant Gram-negative bacilli (MDR-GNB) may help highlight the importance of antibiotic stewardship. Methodology/Principal Findings: The correlations between antibiotic consumption and MDR-GNB HAIs at a 2,700-bed primary care and tertiary referral center in Taiwan between 2002 and 2009 were assessed. MDR-GNB HAI referred to a HAI caused by MDR-Enterobacteriaceae, MDR-Pseudomonas aeruginosa or MDR-Acinetobacter spp.. Consumptions of individual antibiotics and MDR-GNB HAI series were first evaluated for trend over time. When a trend was significant, the presence or absence of associations between the selected clinically meaningful antibiotic resistance and antibiotic consumption was further explored using cross-correlation analyses. Significant major findings included (i) increased consumptions of extended-spectrum cephalosporins, carbapenems, aminopenicillins/beta-lactamase inhibitors, piperacillin/tazobactam, and fluoroquinolones, (ii) decreased consumptions of non-extended-spectrum cephalosporins, natural penicillins, aminopenicillins, ureidopenicillin and aminoglycosides, and (iii) decreasing trend in the incidence of the overall HAIs, stable trends in GNB HAIs and MDR-GNB HAIs throughout the study period, and increasing trend in HAIs caused by carbapenem-resistant (CR) Acinetobacter spp. since 2006. HAIs due to CR-Acinetobacter spp. was found to positively correlate with the consumptions of carbapenems, extended-spectrum cephalosporins, aminopenicillins/beta-lactamase inhibitors, piperacillin/tazobactam and fluoroquinolones, and negatively correlate with the consumptions of non-extended-spectrum cephalosporins, penicillins and aminoglycosides. No significant association was found between the increased use of piperacilllin/tazobactam and increasing HAIs due to CR-Acinetobacter spp.. Conclusions: The trend in overall HAIs decreased and trends in GNB HAIs and MDR-GNB HAIs remained stable over time suggesting that the infection control practice was effective during the study period, and the escalating HAIs due to CR-Acinetobacter spp. were driven by consumptions of broad-spectrum antibiotics other than piperacillin/tazobactam. Our data underscore the importance of antibiotic stewardship in the improvement of the trend of HAIs caused by Acinetobacter spp..	[Chen, I-Ling] Kaohsiung Chang Gung Mem Hosp, Dept Pharmacol, Kaohsiung, Taiwan; [Chen, I-Ling; Lee, Chen-Hsiang; Su, Li-Hsiang; Tang, Ya-Feng; Liu, Jien-Wei] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Lee, Chen-Hsiang; Liu, Jien-Wei] Kaohsiung Chang Gung Mem Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Chen-Hsiang; Liu, Jien-Wei] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chang, Shun-Jen] Natl Univ Kaohsiung, Dept Kinesiol Hlth & Leisure Studies, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National University Kaohsiung	Liu, JW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan.	drjwliu@yahoo.com.tw			National Science Council, Executive Yuan, Taipei, Taiwan [NSC 97-2314-B-182A-028]	National Science Council, Executive Yuan, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was partially supported by the grant NSC 97-2314-B-182A-028 from the National Science Council, Executive Yuan, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2005, GUID ATC CLASS DDD A; Bantar C, 2004, ANTIMICROB AGENTS CH, V48, P392, DOI 10.1128/AAC.48.2.392-395.2004; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Cook PP, 2004, J ANTIMICROB CHEMOTH, V53, P853, DOI 10.1093/jac/dkh163; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Harbarth Stephan, 1998, Clin Microbiol Infect, V4, P199, DOI 10.1111/j.1469-0691.1998.tb00669.x; HELFENSTEIN U, 1991, INT J EPIDEMIOL, V20, P808, DOI 10.1093/ije/20.3.808; Helfenstein U, 1996, Stat Methods Med Res, V5, P3, DOI 10.1177/096228029600500102; Hindler J, 1998, ESSENTIAL PROCEDURES, P205; Hsueh PR, 2005, INT J ANTIMICROB AG, V26, P463, DOI 10.1016/j.ijantimicag.2005.08.016; Huang CC, 2011, J MICROBIOL IMMUNOL, V44, P376, DOI 10.1016/j.jmii.2011.01.035; Lai CC, 2011, J ANTIMICROB CHEMOTH, V66, P1374, DOI 10.1093/jac/dkr103; Lan Chi-Kin, 2003, Journal of Microbiology Immunology and Infection, V36, P182; Lee CH, 2010, ANTIMICROB AGENTS CH, V54, P5395, DOI 10.1128/AAC.00083-10; Lee YT, 2012, J MICROBIOL IMMUNOL, V45, P43, DOI 10.1016/j.jmii.2011.09.020; Lepper PM, 2002, ANTIMICROB AGENTS CH, V46, P2920, DOI 10.1128/AAC.46.9.2920-2925.2002; Liu JW, 2012, ANTIMICROB AGENTS CH, V56, P1414, DOI 10.1128/AAC.05879-11; Liu JW, 2010, INT J ANTIMICROB AG, V35, P201, DOI 10.1016/j.ijantimicag.2009.09.019; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Metz-Gercek S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-61; Mutnick AH, 2004, J ANTIMICROB CHEMOTH, V53, P290, DOI 10.1093/jac/dkh039; NCCLS, 2002, M2A7 NCCLS; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Patterson JE, 2000, INFECT CONT HOSP EP, V21, P455, DOI 10.1086/501787; Pezzlo M, 1998, ESSENTIAL PROCEDURES, P95; Rice LB, 1996, CLIN INFECT DIS, V23, P118, DOI 10.1093/clinids/23.1.118; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004; Turnidge J, 2005, LANCET, V365, P548; Warren DK, 2001, CRIT CARE MED, V29, pN128, DOI 10.1097/00003246-200104001-00013; White RL, 2000, CLIN INFECT DIS, V31, P16, DOI 10.1086/313916	33	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e65621	10.1371/journal.pone.0065621	http://dx.doi.org/10.1371/journal.pone.0065621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23738018	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700079
J	Groen, MA; Whitehouse, AJO; Badcock, NA; Bishop, DVM				Groen, Margriet A.; Whitehouse, Andrew J. O.; Badcock, Nicholas A.; Bishop, Dorothy V. M.			Associations between Handedness and Cerebral Lateralisation for Language: A Comparison of Three Measures in Children	PLOS ONE			English	Article							TRANSCRANIAL DOPPLER SONOGRAPHY; CORPUS-CALLOSUM SIZE; HAND PREFERENCE; BRAIN LATERALIZATION; SPEECH; PERFORMANCE; SKILL; IMPAIRMENT; VALIDATION; ULTRASOUND	It has been known for many years that hand preference is associated with cerebral lateralisation for language, but the relationship is weak and indirect. It has been suggested that quantitative measures of differential hand skill or reaching preference may provide more valid measures than traditional inventories, but to date these have not been validated against direct measures of cerebral lateralisation. We investigated the associations of three different handedness assessments; 1) a hand preference inventory, 2) a measure of relative hand skill, and 3) performance on a reaching task; with cerebral lateralisation for language function as derived from functional transcranial Doppler ultrasound during a language production task, in a group of 57 typically developing children aged from 6 to 16 years. Significant correlations between cerebral lateralisation for language production and handedness were found for a short version of the inventory and for performance on the reaching task. However, confidence intervals for the correlations overlapped and no one measure emerged as clearly superior to the others. The best handedness measures accounted for only 8-16% of the variance in cerebral lateralisation. These findings indicate that researchers should not rely on handedness as an indicator of cerebral lateralisation for language. They also imply that lateralisation of language and motor functions in the human brain show considerable independence from one another.	[Groen, Margriet A.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Whitehouse, Andrew J. O.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Whitehouse, Andrew J. O.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Badcock, Nicholas A.] Macquarie Univ, Dept Cognit Sci, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia; [Whitehouse, Andrew J. O.; Badcock, Nicholas A.; Bishop, Dorothy V. M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Radboud University Nijmegen; Telethon Kids Institute; University of Western Australia; University of Western Australia; Macquarie University; University of Oxford	Groen, MA (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	m.groen@pwo.ru.nl	Groen, Margriet/A-5087-2012; Badcock, Nicholas/O-7227-2015; Whitehouse, Andrew J.O./AGJ-2519-2022	Groen, Margriet/0000-0002-6178-2937; Badcock, Nicholas/0000-0001-6862-4694; Whitehouse, Andrew J.O./0000-0001-8722-1575; Bishop, Dorothy/0000-0002-2448-4033	Wellcome Trust [082498/Z/07/Z]; National Health and Medical Research Council [1004065]	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a program grant from the Wellcome Trust (082498/Z/07/Z). Andrew J. O. Whitehouse is supported by a Career Development Fellowship from the National Health and Medical Research Council (no. 1004065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1974, NEUROPSYCHOLOGIA, V12, P527, DOI 10.1016/0028-3932(74)90083-9; ANNETT M, 1976, BRIT J PSYCHOL, V67, P587, DOI 10.1111/j.2044-8295.1976.tb01550.x; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Badcock NA, 2012, J NEUROSCI METH, V204, P383, DOI 10.1016/j.jneumeth.2011.11.018; Bishop D.V.M., 1990, HANDEDNESS DEVELOPME; Bishop Dorothy V M, 2010, J Vis Exp, DOI 10.3791/2161; Bishop DVM, 2009, NEUROPSYCHOLOGIA, V47, P587, DOI 10.1016/j.neuropsychologia.2008.09.013; Bishop DVM, 2005, DEV PSYCHOBIOL, V46, P362, DOI 10.1002/dev.20062; Bishop DVM, 2001, BEHAV GENET, V31, P339, DOI 10.1023/A:1012239617367; Bishop DVM, 1996, BRIT J PSYCHOL, V87, P269, DOI 10.1111/j.2044-8295.1996.tb02590.x; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; BRYDEN MP, 1994, NEUROPSYCHOLOGIA, V32, P991, DOI 10.1016/0028-3932(94)90048-5; Calvert G A, 1998, Laterality, V3, P255, DOI 10.1080/135765098397287; Corballis MC, 2009, PHILOS T R SOC B, V364, P867, DOI 10.1098/rstb.2008.0232; CROVITZ HF, 1962, AM J PSYCHOL, V75, P271, DOI 10.2307/1419611; Dassonville P, 1997, P NATL ACAD SCI USA, V94, P14015, DOI 10.1073/pnas.94.25.14015; Deppe M, 2004, NEUROIMAGE, V21, P1124, DOI 10.1016/j.neuroimage.2003.10.016; Deppe M, 1997, J NEUROSCI METH, V75, P147, DOI 10.1016/S0165-0270(97)00067-8; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Groen MA, 2012, BRAIN BEHAV, V2, P256, DOI 10.1002/brb3.56; Haag A, 2010, DEV MED CHILD NEUROL, V52, P331, DOI 10.1111/j.1469-8749.2009.03362.x; Josse G, 2008, J NEUROSCI, V28, P14132, DOI 10.1523/JNEUROSCI.4383-08.2008; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Lohmann H, 2005, NEUROIMAGE, V24, P780, DOI 10.1016/j.neuroimage.2004.08.053; Luders E, 2010, NEUROIMAGE, V52, P43, DOI 10.1016/j.neuroimage.2010.04.016; Lust JM, 2011, NEUROPSYCHOLOGIA, V49, P2375, DOI 10.1016/j.neuropsychologia.2011.04.011; McManus I C, 1984, Adv Neurol, V42, P125; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PETERS M, 1979, J MOTOR BEHAV, V11, P103; PROVINS KA, 1993, BRAIN COGNITION, V22, P171, DOI 10.1006/brcg.1993.1032; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; Reuters Thomson, WEB KNOWLEDGE V 5 6; Roid G.H., 1997, LEITER INT PERFORMAN; SATZ P, 1979, SCIENCE, V203, P1131, DOI 10.1126/science.424744; Steenhuis RE, 1989, J CLIN EXP NEUROPSYC, V11, P37; Szaflarski JP, 2012, BRAIN RES, V1433, P85, DOI 10.1016/j.brainres.2011.11.026; TAPLEY SM, 1985, NEUROPSYCHOLOGIA, V23, P215, DOI 10.1016/0028-3932(85)90105-8; Van der Haegen L, 2011, NEUROPSYCHOLOGIA, V49, P2879, DOI 10.1016/j.neuropsychologia.2011.06.014; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Whitehouse AJO, 2009, NEUROPSYCHOLOGIA, V47, P1938, DOI 10.1016/j.neuropsychologia.2009.03.005	40	41	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64876	10.1371/journal.pone.0064876	http://dx.doi.org/10.1371/journal.pone.0064876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177SC	23738006	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700067
J	Lee, JW; Kang, HJ; Choi, JY; Kim, NH; Jang, MK; Yeo, CW; Lee, SS; Kim, H; Park, JD; Park, KD; Shin, HY; Shin, JG; Ahn, HS				Lee, Ji Won; Kang, Hyoung Jin; Choi, Ji-Yeob; Kim, Nam Hee; Jang, Mi Kyung; Yeo, Chang-Woo; Lee, Sang Seop; Kim, Hyery; Park, June Dong; Park, Kyung Duk; Shin, Hee Young; Shin, Jae-Gook; Ahn, Hyo Seop			Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; LONG-TERM SAFETY; SERUM FERRITIN; OVERLOAD; EFFICACY; PHARMACOKINETICS; IRINOTECAN; THERAPY; DESFERRIOXAMINE; POLYMORPHISMS	Transfusion-associated iron overload induces systemic toxicity. Deferasirox, a convenient long acting oral agent, has recently been introduced in clinical practice with a promising efficacy. But there are some patients who experience drug-related toxicities and cannot tolerate it. To investigate effect of genetic variations on the toxicities and find optimal target population, we analyzed the genetic polymorphisms of UDP-glucuronosyltransferase 1A (UGT1A) subfamily, multi-drug resistance-associated protein 2 (MRP2) and breast cancer resistance protein (BCRP). A total of 20 functional genetic polymorphisms were analyzed in 98 patients who received deferasirox to reduce transfusion-induced iron overload. We retrospectively reviewed the medical records to find out the drug-related toxicities. Fifteen (15.3%) patients developed hepatotoxicity. Patients without wild-type allele carrying two MRP2 haplotypes containing -1774 del and/or -24T were at increased risk of developing hepatotoxicity compared to patients with the wild-type allele on multivariate analysis (OR = 7.17, 95% CI = 1.79-28.67, P = 0.005). Creatinine elevation was observed in 9 patients (9.2%). Body weight >= 40 kg and homozygosity for UGT1A1*6 were risk factors of creatinine elevation (OR = 8.48, 95% CI = 1.7-43.57, P = 0.010 and OR = 14.17, 95% CI = 1.34-150.35, P = 0.028). Our results indicate that functional genetic variants of enzymes to metabolize and transport deferasirox are associated with drug-related toxicities. Further studies are warranted to confirm the results as the pharmacogenetic biomarkers of deferasirox.	[Lee, Ji Won; Kang, Hyoung Jin; Kim, Nam Hee; Jang, Mi Kyung; Kim, Hyery; Park, June Dong; Park, Kyung Duk; Shin, Hee Young; Ahn, Hyo Seop] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Lee, Ji Won; Kang, Hyoung Jin; Kim, Nam Hee; Jang, Mi Kyung; Kim, Hyery; Park, Kyung Duk; Shin, Hee Young; Ahn, Hyo Seop] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Choi, Ji-Yeob] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea; [Yeo, Chang-Woo; Lee, Sang Seop; Shin, Jae-Gook] Inje Univ, Dept Pharmacol, Coll Med, Pusan, South Korea; [Yeo, Chang-Woo; Lee, Sang Seop; Shin, Jae-Gook] Inje Univ, Pharmacogen Res Ctr, Coll Med, Pusan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inje University; Inje University	Kang, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.	kanghj@snu.ac.kr		Park, June Dong/0000-0001-8113-1384	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A070001]; National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, R.O.K. [A111218-PG02]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, R.O.K.	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A070001), and by a grant of the National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, R.O.K. (A111218-PG02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2008, ANN ONCOL, V19, P2089, DOI 10.1093/annonc/mdn645; Altes A, 2002, BONE MARROW TRANSPL, V29, P987, DOI 10.1038/sj.bmt.1703570; Altes A, 2007, ANN HEMATOL, V86, P443, DOI 10.1007/s00277-007-0266-x; Armand P, 2007, BLOOD, V109, P4586, DOI 10.1182/blood-2006-10-054924; Aslam N, 2010, JCPSP-J COLL PHYSICI, V20, P551, DOI 04.2010/JCPSP.551553; Aydinok Y, 2012, EUR J HAEMATOL, V88, P431, DOI 10.1111/j.1600-0609.2012.01769.x; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Bruin GJM, 2008, DRUG METAB DISPOS, V36, P2523, DOI 10.1124/dmd.108.022962; Cappellini MD, 2011, BLOOD, V118, P884, DOI 10.1182/blood-2010-11-316646; Cappellini MD, 2007, CLIN THER, V29, P909, DOI 10.1016/j.clinthera.2007.05.007; Cappellini MD, 2010, HAEMATOL-HEMATOL J, V95, P557, DOI 10.3324/haematol.2009.014696; Cappellini MD, 2006, BLOOD, V107, P3455, DOI 10.1182/blood-2005-08-3430; Carlo H, 2007, KLIN PADIATR, V219, P158, DOI 10.1055/s-2007-973845; Choi JH, 2007, PHARMACOGENET GENOM, V17, P403, DOI 10.1097/01.fpc.0000236337.41799.b3; Evens AM, 2004, BONE MARROW TRANSPL, V34, P561, DOI 10.1038/sj.bmt.1704591; Galanello R, 2006, HAEMATOLOGICA, V91, P1343; Gardiner SJ, 2006, PHARMACOL REV, V58, P521, DOI 10.1124/pr.58.3.6; Han JY, 2006, J CLIN ONCOL, V24, P2237, DOI 10.1200/JCO.2005.03.0239; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Jensen PD, 2003, BLOOD, V101, P91, DOI 10.1182/blood-2002-06-1704; Kontoghiorghes GJ, 2008, EXPERT OPIN DRUG SAF, V7, P645, DOI 10.1517/14740330802137479 ; Kontoghiorghes GJ, 2007, EXPERT OPIN DRUG SAF, V6, P235, DOI 10.1517/14740338.6.3.235; Kushner J P, 2001, Hematology Am Soc Hematol Educ Program, P47; Lee JW, 2009, BONE MARROW TRANSPL, V44, P793, DOI 10.1038/bmt.2009.88; Lee SS, 2007, DRUG METAB DISPOS, V35, P623, DOI 10.1124/dmd.106.012302; LEWONTIN RC, 1988, GENETICS, V120, P849; Mao QC, 2005, AAPS J, V7, pE118, DOI 10.1208/aapsj070112; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; Miceli MH, 2006, BONE MARROW TRANSPL, V37, P857, DOI 10.1038/sj.bmt.1705340; Morado M., 2000, Hematology, V4, P505; Novartis Pharmaceuticals Corporation (per FDA), 2011, PROD INF EXJADE R OR; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; Piga A, 2006, HAEMATOL-HEMATOL J, V91, P873; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Porter J, 2008, EUR J HAEMATOL, V80, P168, DOI 10.1111/j.1600-0609.2007.00985.x; Satoh T, 2011, CANCER SCI, V102, P1868, DOI 10.1111/j.1349-7006.2011.02030.x; Shulman K, 2011, CANCER-AM CANCER SOC, V117, P3156, DOI 10.1002/cncr.25735; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sunakawa Y, 2011, CANCER CHEMOTH PHARM, V68, P279, DOI 10.1007/s00280-010-1485-8; Vichinsky E, 2007, BRIT J HAEMATOL, V136, P501, DOI 10.1111/j.1365-2141.2006.06455.x; Vichinsky E, 2011, BRIT J HAEMATOL, V154, P387, DOI 10.1111/j.1365-2141.2011.08720.x; Won Sung Chul, 2010, Korean J Hematol, V45, P58, DOI 10.5045/kjh.2010.45.1.58; Yea SS, 2008, THER DRUG MONIT, V30, P23, DOI 10.1097/FTD.0b013e3181633824	43	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64114	10.1371/journal.pone.0064114	http://dx.doi.org/10.1371/journal.pone.0064114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23737969	Green Published, Green Submitted, gold			2022-12-27	WOS:000321394700033
J	Wang, L; Mao, YX; Kong, FN; Li, GY; Ma, F; Zhang, BL; Sun, PP; Bi, GQ; Zhang, FF; Xue, HF; Cao, M				Wang, Li; Mao, Yunxiang; Kong, Fanna; Li, Guiyang; Ma, Fei; Zhang, Baolong; Sun, Peipei; Bi, Guiqi; Zhang, Fangfang; Xue, Hongfan; Cao, Min			Complete Sequence and Analysis of Plastid Genomes of Two Economically Important Red Algae: Pyropia haitanensis and Pyropia yezoensis	PLOS ONE			English	Article							PORPHYRA-YEZOENSIS; CHLOROPLAST DNA; GENE-TRANSFER; PHOTOSYNTHETIC EUKARYOTES; BANGIOPHYCIDAE RHODOPHYTA; MAXIMUM-LIKELIHOOD; CRYPTOPHYTE ALGA; PHYLOGENY; ORIGIN; GENERATION	Background: Pyropia haitanensis and P. yezoensis are two economically important marine crops that are also considered to be research models to study the physiological ecology of intertidal seaweed communities, evolutionary biology of plastids, and the origins of sexual reproduction. This plastid genome information will facilitate study of breeding, population genetics and phylogenetics. Principal Findings: We have fully sequenced using next-generation sequencing the circular plastid genomes of P. hatanensis (195,597 bp) and P. yezoensis (191,975 bp), the largest of all the plastid genomes of the red lineage sequenced to date. Organization and gene contents of the two plastids were similar, with 211-213 protein-coding genes (including 29-31 unknown-function ORFs), 37 tRNA genes, and 6 ribosomal RNA genes, suggesting a largest coding capacity in the red lineage. In each genome, 14 protein genes overlapped and no interrupted genes were found, indicating a high degree of genomic condensation. Pyropia maintain an ancient gene content and conserved gene clusters in their plastid genomes, containing nearly complete repertoires of the plastid genes known in photosynthetic eukaryotes. Similarity analysis based on the whole plastid genome sequences showed the distance between P. haitanensis and P. yezoensis (0.146) was much smaller than that of Porphyra purpurea and P. haitanensis (0.250), and P. yezoensis (0.251); this supports re-grouping the two species in a resurrected genus Pyropia while maintaining P. purpurea in genus Porphyra. Phylogenetic analysis supports a sister relationship between Bangiophyceae and Florideophyceae, though precise phylogenetic relationships between multicellular red alage and chromists were not fully resolved. Conclusions: These results indicate that Pyropia have compact plastid genomes. Large coding capacity and long intergenic regions contribute to the size of the largest plastid genomes reported for the red lineage. Possessing the largest coding capacity and ancient gene content yet found reveal that Pyropia are more primitive multicellular red algae.	[Wang, Li; Mao, Yunxiang; Kong, Fanna; Ma, Fei; Zhang, Baolong; Sun, Peipei; Bi, Guiqi; Zhang, Fangfang; Xue, Hongfan; Cao, Min] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Li, Guiyang] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Utilizat Marine Fisheries Res, Qingdao, Peoples R China	Ocean University of China; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Mao, YX (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	yxmao@ouc.edu.cn			National Natural Science Foundation of China [30972247, 30700621]; National High Technology Research and Development Program of China [2012AA10A411, 2012AA10A406, 2012AA100815]; Special Fund for Agro-scientific Research in the Public Interest [200903030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by National Natural Science Foundation of China (Grant Nos 30972247 and 30700621), National High Technology Research and Development Program of China (Grant Nos 2012AA10A411, 2012AA10A406, and 2012AA100815), and the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 200903030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Asamizu E, 2003, J PHYCOL, V39, P923, DOI 10.1046/j.1529-8817.2003.03003.x; Besnard G, 2002, THEOR APPL GENET, V105, P139, DOI 10.1007/s00122-002-0868-6; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; BHATTACHARYA D, 1995, J PHYCOL, V31, P489, DOI 10.1111/j.1529-8817.1995.tb02542.x; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Broom JE, 1999, J APPL PHYCOL, V11, P421, DOI 10.1023/A:1008162825908; Chan CX, 2012, PLANT PHYSIOL, V158, P2001, DOI 10.1104/pp.112.193896; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Chung SM, 2007, GENOME, V50, P215, DOI 10.1139/G07-003; Daniell H, 2005, TRENDS BIOTECHNOL, V23, P238, DOI 10.1016/j.tibtech.2005.03.008; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Fan XL, 2007, J PHYCOL, V43, P1287, DOI 10.1111/j.1529-8817.2007.00415.x; Fouad WM, 2009, TRANSGENIC RES, V18, P707, DOI 10.1007/s11248-009-9258-z; Gaikwad A, 2002, MOL GENET GENOMICS, V267, P45, DOI 10.1007/s00438-001-0631-8; Glockner G, 2000, J MOL EVOL, V51, P382; Gordon VS, 2011, J AM SOC HORTIC SCI, V136, P256, DOI 10.21273/JASHS.136.4.256; Grasser KD, 1997, EUR J BIOCHEM, V249, P70; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagopian JC, 2004, J MOL EVOL, V59, P464, DOI 10.1007/s00239-004-2638-3; Huang JL, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r109; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kathuria H, 2009, PLANT BIOTECHNOL J, V7, P512, DOI 10.1111/j.1467-7652.2009.00420.x; Khan H, 2007, MOL BIOL EVOL, V24, P1832, DOI 10.1093/molbev/msm101; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, PLANT PHYSIOL, V136, P2843, DOI 10.1104/pp.104.045187; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Mikami K, 2011, GENETIC TRANSFORMATION, P241; Moon DA, 1997, CURR GENET, V32, P132, DOI 10.1007/s002940050257; Muller KM, 2001, AM J BOT, V88, P1390, DOI 10.2307/3558445; Mumford TF., 1988, ALGAE HUMAN AFFAIRS, P87; Nikaido I, 2000, DNA RES, V7, P223, DOI 10.1093/dnares/7.3.223; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Niwa K, 2010, AQUACULTURE, V308, P6, DOI 10.1016/j.aquaculture.2010.08.007; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Oliveira MC, 2000, AM J BOT, V87, P482, DOI 10.2307/2656591; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Pinto G, 2003, CRYPTOGAMIE ALGOL, V24, P13; Puerta MVS, 2005, DNA RES, V12, P151, DOI 10.1093/dnares/12.2.151; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rice DW, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-31; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanchez-Puerta MV, 2007, MOL PHYLOGENET EVOL, V44, P885, DOI 10.1016/j.ympev.2007.03.003; Saunders GW, 2004, AM J BOT, V91, P1494, DOI 10.3732/ajb.91.10.1494; Simpson CL, 2002, PLANT PHYSIOL, V129, P957, DOI 10.1104/pp.010908; Sutherland JE, 2011, J PHYCOL, V47, P1131, DOI 10.1111/j.1529-8817.2011.01052.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; WANG SG, 1991, P NATL ACAD SCI USA, V88, P10783, DOI 10.1073/pnas.88.23.10783; Wattier RA, 2000, PLANT MOL BIOL REP, V18, P275, DOI 10.1007/BF02823999; West JA, 1999, HYDROBIOLOGIA, V399, P101; Xie CT, 2010, J PHYCOL, V46, P780, DOI 10.1111/j.1529-8817.2010.00855.x; Yan Xing-Hong, 2000, Phycological Research, V48, P177, DOI 10.1046/j.1440-1835.2000.00203.x; Yang H, 2011, CHINESE SCI BULL, V56, P2119, DOI 10.1007/s11434-011-4546-4; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoon HS, 2006, J PHYCOL, V42, P482, DOI 10.1111/j.1529-8817.2006.00210.x	63	51	54	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e65902	10.1371/journal.pone.0065902	http://dx.doi.org/10.1371/journal.pone.0065902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734264	Green Published, gold, Green Submitted			2022-12-27	WOS:000319725500002
J	Davis, AR; Coleman, D; Broad, A; Byrne, M; Dworjanyn, SA; Przeslawski, R				Davis, Andrew R.; Coleman, Daniel; Broad, Allison; Byrne, Maria; Dworjanyn, Symon A.; Przeslawski, Rachel			Complex Responses of Intertidal Molluscan Embryos to a Warming and Acidifying Ocean in the Presence of UV Radiation	PLOS ONE			English	Article							LIFE-HISTORY STAGES; CLIMATE-CHANGE; ULTRAVIOLET-RADIATION; ACIDIFICATION; TEMPERATURE; FERTILIZATION; LARVAE; STRESSORS; MORTALITY; EXPOSURE	Climate change and ocean acidification will expose marine organisms to synchronous multiple stressors, with early life stages being potentially most vulnerable to changing environmental conditions. We simultaneously exposed encapsulated molluscan embryos to three abiotic stressors-acidified conditions, elevated temperate, and solar UV radiation in large outdoor water tables in a multifactorial design. Solar UV radiation was modified with plastic filters, while levels of the other factors reflected IPCC predictions for near-future change. We quantified mortality and the rate of embryonic development for a mid-shore littorinid, Bembicium nanum, and low-shore opisthobranch, Dolabrifera brazieri. Outcomes were consistent for these model species with embryos faring significantly better at 26 degrees C than 22 degrees C. Mortality sharply increased at the lowest temperature (22 degrees C) and lowest pH (7.6) examined, producing a significant interaction. Under these conditions mortality approached 100% for each species, representing a 2- to 4-fold increase in mortality relative to warm (26 degrees C) non-acidified conditions. Predictably, development was more rapid at the highest temperature but this again interacted with acidified conditions. Development was slowed under acidified conditions at the lowest temperature. The presence of UV radiation had minimal impact on the outcomes, only slowing development for the littorinid and not interacting with the other factors. Our findings suggest that a warming ocean, at least to a threshold, may compensate for the effects of decreasing pH for some species. It also appears that stressors will interact in complex and unpredictable ways in a changing climate.	[Davis, Andrew R.; Coleman, Daniel; Broad, Allison; Przeslawski, Rachel] Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia; [Byrne, Maria] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia	University of Wollongong; University of Sydney; University of Sydney; Southern Cross University	Davis, AR (corresponding author), Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia.	adavis@uow.edu.au	Broad, Allison/AAY-5852-2021; Davis, Andy/H-3607-2011; Byrne, Maria/K-6355-2016; Dworjanyn, Symon A/O-5633-2017	Broad, Allison/0000-0002-1402-6098; Davis, Andy/0000-0002-8146-7424; Byrne, Maria/0000-0002-8902-9808; Dworjanyn, Symon A/0000-0002-6690-8033; Przeslawski, Rachel/0000-0003-0269-3755; Coleman, Daniel/0000-0002-2472-9993	Australian Research Council	Australian Research Council(Australian Research Council)	The authors gratefully acknowledge the financial support of the Australian Research Council (to MB and ARD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D. T., 1961, PROC LINN SOC N S WALES, V86, P203; Australian Radiation Protection and Nuclear Safety Agency, 2012, AUSTR UV IND MOD SYD; Benkendorff K, 2004, AQUAT CONSERV, V14, P263, DOI 10.1002/aqc.604; Breitburg DL, 1999, LIMNOL OCEANOGR, V44, P837, DOI 10.4319/lo.1999.44.3_part_2.0837; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DCWDS, 2010, DCWDS; Deschaseaux ESM, 2010, J EXP MAR BIOL ECOL, V383, P130, DOI 10.1016/j.jembe.2009.12.013; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Edgar GJ, 2000, AUSTR MARINE LIFE; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Grant KP, 1995, CAN J ZOOL, V73, P2292, DOI 10.1139/z95-271; Gutowska MA, 2010, J COMP PHYSIOL B, V180, P323, DOI 10.1007/s00360-009-0412-y; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HEARST JE, 1995, SCIENCE, V268, P1858, DOI 10.1126/science.7604259; Hoffman JR, 2003, J PHYCOL, V39, P268, DOI 10.1046/j.1529-8817.2003.01111.x; Hofmann DJ, 1999, SCI ASSESSMENT OZONE; *INT PAN CLIM CHAN, 2007, 4 IPCC; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Lough J. M., 2009, NCCARF PUBLICATION, V05/09; MORRIS S, 1983, ESTUAR COAST SHELF S, V17, P339, DOI 10.1016/0272-7714(83)90026-4; Moulin L, 2011, MAR POLLUT BULL, V62, P48, DOI 10.1016/j.marpolbul.2010.09.012; Nguyen HD, 2012, GLOBAL CHANGE BIOL, V18, P2466, DOI 10.1111/j.1365-2486.2012.02714.x; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pechenik J.A., 1987, P551; Pelletier E, 2006, PHOTOCHEM PHOTOBIOL, V82, P981, DOI 10.1562/2005-09-18-RA-688.1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Przeslawski R, 2007, MAR BIOL, V152, P991, DOI 10.1007/s00227-007-0748-3; Przeslawski R, 2005, MAR ECOL PROG SER, V298, P169, DOI 10.3354/meps298169; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Przeslawski R, 2004, MAR ECOL PROG SER, V268, P151, DOI 10.3354/meps268151; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; Przeslawski R, 2011, MOLLUSCAN RES, V31, P152; Rudman WB, 2010, SEASLUG FORUM; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; SPIGHT TM, 1975, OECOLOGIA, V21, P1, DOI 10.1007/BF00345889; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Tevini M., 1993, EFFECTS HUMANS ANIMA; TRUCHOT JP, 1980, RESP PHYSIOL, V39, P241, DOI 10.1016/0034-5687(80)90056-0; van Uitregt VO, 2007, GLOBAL CHANGE BIOL, V13, P1114, DOI 10.1111/j.1365-2486.2007.01353.x; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wraith J, 2006, J CHEM ECOL, V32, P993, DOI 10.1007/s10886-006-9054-7; Zippay ML, 2010, MAR BIOL, V157, P707, DOI 10.1007/s00227-009-1354-3	55	70	70	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55939	10.1371/journal.pone.0055939	http://dx.doi.org/10.1371/journal.pone.0055939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23741396	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400183
J	Ali, K; Warusevitane, A; Lally, F; Sim, J; Sills, S; Pountain, S; Nevatte, T; Allen, M; Roffe, C				Ali, Khalid; Warusevitane, Anushka; Lally, Frank; Sim, Julius; Sills, Sheila; Pountain, Sarah; Nevatte, Tracy; Allen, Martin; Roffe, Christine			The Stroke Oxygen Pilot Study: A Randomized Controlled Trial of the Effects of Routine Oxygen Supplementation Early after Acute Stroke-Effect on Key Outcomes at Six Months	PLOS ONE			English	Article							VALIDATION; SCALE	Introduction: Post-stroke hypoxia is common, and may adversely affect outcome. We have recently shown that oxygen supplementation may improve early neurological recovery. Here, we report the six-month outcomes of this pilot study. Methods: Patients with a clinical diagnosis of acute stroke were randomized within 24 h of admission to oxygen supplementation at 2 or 3 L/min for 72 h or to control treatment (room air). Outcomes (see below) were assessed by postal questionnaire at 6 months. Analysis was by intention-to-treat, and statistical significance was set at p <= 0.05. Results: Out of 301 patients randomized two refused/withdrew consent and 289 (148 in the oxygen and 141 in the control group) were included in the analysis: males 44%, 51%; mean (SD) age 73 (12), 71 (12); median (IQR) National Institutes of Health Stroke Scale score 6 (3, 10), 5 (3, 10) for the two groups respectively. At six months 22 (15%) patients in the oxygen group and 20 (14%) in the control group had died; mean survival in both groups was 162 days (p = 0.99). Median (IQR) scores for the primary outcome, the modified Rankin Scale, were 3 (1, 5) and 3 (1, 4) for the oxygen and control groups respectively. The covariate-adjusted odds ratio was 1.04 (95% CI 0.67, 1.60), indicating that the odds of a lower (i.e. better) score were non-significantly higher in the oxygen group (p = 0.86). The mean differences in the ability to perform basic (Barthel Index) and extended activities of daily living (NEADL), and quality of life (EuroQol) were also non-significant. Conclusions: None of the key outcomes differed at 6 months between the groups. Although not statistically significant and generally of small magnitude, the effects were predominantly in favour of the oxygen group; a larger trial, powered to show differences in longer-term functional outcomes, is now on-going.	[Ali, Khalid] Acad Dept Geriatr, Brighton, E Sussex, England; [Ali, Khalid] Sussex Med Sch, Brighton, E Sussex, England; [Warusevitane, Anushka; Lally, Frank; Sills, Sheila; Pountain, Sarah; Nevatte, Tracy; Roffe, Christine] North Staffordshire Combined Healthcare Trust, Stoke Stroke Res Grp, Stoke On Trent, Staffs, England; [Lally, Frank; Roffe, Christine] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England; [Sim, Julius] Keele Univ, Hlth Serv Res Unit, Keele, Staffs, England; [Allen, Martin] Univ Hosp North Staffordshire, Dept Resp Med, Stoke On Trent, Staffs, England	University of Brighton; Keele University; Keele University	Roffe, C (corresponding author), North Staffordshire Combined Healthcare Trust, Stoke Stroke Res Grp, Stoke On Trent, Staffs, England.	christine.roffe@northstaffs.nhs.uk	Roffe, Christine/AAT-5611-2020; Paul, Soumitra/E-5821-2015; Gayen, Dipak/N-8906-2017	Roffe, Christine/0000-0002-5259-6649; Ali, Nusrat/0000-0001-7356-6759; Paul, Soumitra/0000-0001-7560-5512; Datta, Swapan/0000-0003-2961-8915; Gayen, Dipak/0000-0002-4563-0992; SARKAR, SAILENDRA NATH/0000-0002-4059-8612	North Staffordshire Medical Institute; British Geriatrics Society	North Staffordshire Medical Institute; British Geriatrics Society	The authors would like to thank the North Staffordshire Medical Institute for funding the purchase of the pulse oximeters and the British Geriatrics Society for supporting Dr. KM Ali with a Specialist Registrar Research Start Up Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2006, STROKE, V37, P865, DOI 10.1161/01.STR.0000204053.36966.80; Ali Khalid, 2007, J Stroke Cerebrovasc Dis, V16, P239, DOI 10.1016/j.jstrokecerebrovasdis.2007.07.004; Appelros P, 2004, CEREBROVASC DIS, V17, P21, DOI 10.1159/000073894; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bravata DM, 2010, ARCH INTERN MED, V170, P804, DOI 10.1001/archinternmed.2010.92; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cabello JB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007160.pub2; Collin C, 1988, Int Disabil Stud, V10, P61; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Dennis M, 2012, STROKE, V43, P851, DOI 10.1161/STROKEAHA.111.639708; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Ellul J, 1998, AGE AGEING, V27, P115, DOI 10.1093/ageing/27.2.115; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; Lewis S, 2008, J NEUROL NEUROSUR PS, V79, P397, DOI 10.1136/jnnp.2007.126045; Nouri F., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Nuutinen J, 2006, ACTA NEUROL SCAND, V113, P100, DOI 10.1111/j.1600-0404.2005.00550.x; Robinson TG, 2005, J HYPERTENS, V23, P455; Roffe C, 2003, STROKE, V34, P2641, DOI 10.1161/01.STR.0000095188.65567.4F; Roffe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019113; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rowat AM, 2006, CEREBROVASC DIS, V21, P166, DOI 10.1159/000090528; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Silva Y, 2005, CEREBROVASC DIS, V19, P23, DOI 10.1159/000081908; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Sulter G, 2000, J NEUROL SCI, V179, P65, DOI 10.1016/S0022-510X(00)00378-6; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wright CC, 2003, J CLIN EPIDEMIOL, V56, P833, DOI 10.1016/S0895-4356(03)00155-0; Young FB, 2005, STROKE, V36, P2187, DOI 10.1161/01.STR.0000181089.41324.70	35	77	81	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e59274	10.1371/journal.pone.0059274	http://dx.doi.org/10.1371/journal.pone.0059274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23844166	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300001
J	Wu, XD; Satpathy, AT; Wumesh, KC; Liu, PT; Murphy, TL; Murphy, KM				Wu, Xiaodi; Satpathy, Ansuman T.; Wumesh, K. C.; Liu, Pentao; Murphy, Theresa L.; Murphy, Kenneth M.			Bcl11a Controls Flt3 Expression in Early Hematopoietic Progenitors and Is Required for pDC Development In Vivo	PLOS ONE			English	Article							DENDRITIC CELL-DEVELOPMENT; RECEPTOR-DEFICIENT MICE; INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; COMMON LYMPHOID PROGENITORS; TRANSCRIPTION FACTOR E2-2; RESCUES T-LYMPHOPOIESIS; MOUSE BONE-MARROW; FACTOR PU.1; STEM-CELLS; GM-CSF	Bcl11a is a transcription factor known to regulate lymphoid and erythroid development. Recent bioinformatic analysis of global gene expression patterns has suggested a role for Bcl11a in the development of dendritic cell (DC) lineages. We tested this hypothesis by analyzing the development of DC and other lineages in Bcl11a(-/-) mice. We found that Bcl11a was required for expression of IL-7 receptor (IL-7R) and Flt3 in early hematopoietic progenitor cells. In addition, we found severely decreased numbers of plasmacytoid dendritic cells (pDCs) in Bcl11a(-/-) fetal livers and in the bone marrow of Bcl11a(-/-) fetal liver chimeras. Moreover, Bcl11a(-/-) cells showed severely impaired in vitro development of Flt3L-derived pDCs and classical DCs (cDCs). In contrast, we found normal in vitro development of DCs from Bcl11a(-/-) fetal liver cells treated with GM-CSF. These results suggest that the persistent cDC development observed in Bcl11a(-/-) fetal liver chimeras reflects derivation from a Bcl11a- and Flt3-independent pathway in vivo.	[Wu, Xiaodi; Satpathy, Ansuman T.; Wumesh, K. C.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge, England; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Wellcome Trust Sanger Institute; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	kmurphy@wustl.edu		Satpathy, Ansuman/0000-0002-5167-537X	Howard Hughes Medical Institute, National Institutes of Health [AI076427-02]; Department of Defense [W81XWH-09-1-0185]; American Heart Association [12PRE8610005, 12PRE1205041912]; National Cancer Institute [P30 CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076427] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, National Institutes of Health(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute, National Institutes of Health (AI076427-02 to K. M. M.), and Department of Defense (W81XWH-09-1-0185 to K. M. M.); and by the American Heart Association (12PRE8610005 to A. T. S.; 12PRE1205041912 to W. K. C.). The Alvin J. Siteman Cancer Center is supported in part by the National Cancer Institute (P30 CA91842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Franco CB, 2010, CELL STEM CELL, V6, P361, DOI 10.1016/j.stem.2010.02.013; Freeden-Jeffry U, 1997, IMMUNITY, V7, P147; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kikuchi K, 2008, J IMMUNOL, V181, P383, DOI 10.4049/jimmunol.181.1.383; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moore TA, 1996, J IMMUNOL, V157, P2366; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakamura T, 2000, MOL CELL BIOL, V20, P3178, DOI 10.1128/MCB.20.9.3178-3186.2000; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Pulford K, 2006, LEUKEMIA, V20, P1439, DOI 10.1038/sj.leu.2404260; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Vogt TK, 2009, BLOOD, V113, P3961, DOI 10.1182/blood-2008-08-176321; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846	61	62	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64800	10.1371/journal.pone.0064800	http://dx.doi.org/10.1371/journal.pone.0064800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741395	Green Published, gold, Green Submitted			2022-12-27	WOS:000319799900108
J	Wang, Y; Wang, H; Zhang, W; Shao, C; Xu, P; Shi, CH; Shi, JG; Li, YM; Fu, Q; Xue, W; Lei, YH; Gao, JY; Wang, JY; Gao, XP; Li, JQ; Yuan, JL; Zhang, YT				Wang, Yong; Wang, He; Zhang, Wei; Shao, Chen; Xu, Peng; Shi, Chang Hong; Shi, Jian Guo; Li, Yu Mei; Fu, Qiang; Xue, Wei; Lei, Yong Hua; Gao, Jing Yu; Wang, Juan Ying; Gao, Xiao Ping; Li, Jin Qing; Yuan, Jian Lin; Zhang, Yun Tao			Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-kappa B/IKK Pathway-Induced Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; MAMMARY TUMORIGENESIS; B ACTIVATION; GROWTH; CYTOTOXICITY; REPLICATION; INHIBITION; EXPOSURE; BETA; NBS1	Bladder cancer is the most common malignant urological disease in China. Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years. Previous research has demonstrated that the isoflavone, genistein, can sensitize multiple cancer cell lines to HCPT treatment, such as prostate and cervical cancer. In this study, we investigated whether genistein could sensitize bladder cancer cell lines and bladder epithelial cell BDEC cells to HCPT treatment, and investigated the possible underlying molecular mechanisms. Genistein could significantly and dose-dependently sensitize multiple bladder cancer cell lines and BDEC cells to HCPT-induced apoptosis both in vitro and in vivo. Genistein and HCPT synergistically inhibited bladder cell growth and proliferation, and induced G2/M phase cell cycle arrest and apoptosis in TCCSUP bladder cancer cell and BDEC cell. Pretreatment with genistein sensitized BDEC and bladder cancer cell lines to HCPT-induced DNA damage by the synergistic activation of ataxia telangiectasia mutated (ATM) kinase. Genistein significantly attenuated the ability of HCPT to induce activation of the antiapoptotic NF-kappa B pathway both in vitro and in vivo in a bladder cancer xenograft model, and thus counteracted the antiapoptotic effect of the NF-kappa B pathway. This study indicates that genistein could act as a promising non-toxic agent to improve efficacy of HCPT bladder cancer chemotherapy.	[Wang, Yong; Wang, He; Zhang, Wei; Li, Yu Mei; Fu, Qiang; Xue, Wei; Lei, Yong Hua; Gao, Jing Yu; Wang, Juan Ying; Gao, Xiao Ping] Fourth Mil Med Univ, Tangdu Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China; [Shao, Chen; Yuan, Jian Lin; Zhang, Yun Tao] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China; [Xu, Peng] Fourth Mil Med Univ, Tangdu Hosp, Dept Med, Xian 710032, Shaanxi, Peoples R China; [Xu, Peng] Fourth Mil Med Univ, Tangdu Hosp, Training Dept, Xian 710032, Shaanxi, Peoples R China; [Shi, Chang Hong] Fourth Mil Med Univ, Dept Expt Anim, Xian 710032, Shaanxi, Peoples R China; [Shi, Jian Guo] Fourth Mil Med Univ, Dept Canc Res Inst, Xian 710032, Shaanxi, Peoples R China; [Li, Jin Qing] Fourth Mil Med Univ, Tangdu Hosp, Dept Plast Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zhang, YT (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China.	lijinqing@yahoo.cn; jianliny@fmmu.edu.cn; jiangru@fmmu.edu.cn	Wang, Chuan-Yue/C-9369-2015; Xu, Zhi-Qing David/H-9757-2013	Wang, Chuan-Yue/0000-0001-6549-3713; zhang, wei/0000-0001-8511-7360; Xu, Zhi-Qing David/0000-0002-0387-7559	National Natural Science Foundation of China [30901498, 30100185, 81250036, 30973000, 30872583, 81072116]; Natural Science Foundation of Shaan'xi Province, China [2009JQ4003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaan'xi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by grants from the National Natural Science Foundation of China (No. 30901498, No. 30100185, No. 81250036, No. 30973000, No. 30872583, No. 81072116) and the Natural Science Foundation of Shaan'xi Province, China (2009JQ4003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Cheon J, 2002, INT J UROL, V9, P445, DOI 10.1046/j.1442-2042.2002.00500.x; Choi EJ, 2004, LIFE SCI, V75, P499, DOI 10.1016/j.lfs.2004.01.010; Davis JN, 1999, NUTR CANCER, V35, P167, DOI 10.1207/S15327914NC352_11; Dheekollu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001257; Fu SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038465; Hilakivi-Clarke L, 1999, ONCOL REP, V6, P1089; Hilakivi-Clarke L, 1999, BRIT J CANCER, V80, P1682, DOI 10.1038/sj.bjc.6690584; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kakehi Y, 2010, JPN J CLIN ONCOL, V40, pi57, DOI 10.1093/jjco/hyq128; Kawakami K, 2011, BIOSCI BIOTECH BIOCH, V75, P650, DOI 10.1271/bbb.100738; Kim SH, 2009, ANN NY ACAD SCI, V1171, P495, DOI 10.1111/j.1749-6632.2009.04899.x; Kobayashi J, 2009, BIOCHEM BIOPH RES CO, V380, P752, DOI 10.1016/j.bbrc.2009.01.109; Kontos S, 2011, UROL INT, V87, P151, DOI 10.1159/000324262; Kumi-Diaka J, 2010, J MED FOOD, V13, P842, DOI 10.1089/jmf.2009.0199; Lavin MF, 2005, ADV EXP MED BIOL, V570, P457, DOI 10.1007/1-4020-3764-3_16; Li C, 2005, BRIT J CANCER, V92, P80, DOI 10.1038/sj.bjc.6602272; Manoharan N, 2010, ASIAN PAC J CANCER P, V11, P73; Morales R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026903; OKURA A, 1988, BIOCHEM BIOPH RES CO, V157, P183, DOI 10.1016/S0006-291X(88)80030-5; Papazisis KT, 2006, CANCER LETT, V233, P255, DOI 10.1016/j.canlet.2005.03.022; Perfettini JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002458; Qi WT, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-219; TANIZAWA A, 1994, J NATL CANCER I, V86, P836, DOI 10.1093/jnci/86.11.836; Ullah MF, 2011, MOL NUTR FOOD RES, V55, P553, DOI 10.1002/mnfr.201000329; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040955; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P1, DOI 10.3978/j.issn.2223-4292.2011.09.01; Wang Yong, 2003, Ai Zheng, V22, P1272; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Yee DS, 2011, UROLOGY, V78, P544, DOI 10.1016/j.urology.2011.02.042; [张思维 ZHANG Si-wei], 2009, [中华泌尿外科杂志, Chinese Journal of Urology], V30, P673; Zhou JR, 1998, CANCER RES, V58, P5231; Zuco V, 2010, CANCER LETT, V292, P186, DOI 10.1016/j.canlet.2009.12.001	33	172	181	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e50175	10.1371/journal.pone.0050175	http://dx.doi.org/10.1371/journal.pone.0050175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23741354	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600001
J	Li, HZ; Hou, S; Wu, X; Nandagopal, S; Lin, F; Kung, S; Marshall, AJ				Li, Hongzhao; Hou, Sen; Wu, Xun; Nandagopal, Saravanan; Lin, Francis; Kung, Sam; Marshall, Aaron James			The Tandem PH Domain-Containing Protein 2 (TAPP2) Regulates Chemokine-Induced Cytoskeletal Reorganization and Malignant B Cell Migration	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; DYSTROPHIN-GLYCOPROTEIN COMPLEX; PHOSPHOINOSITIDE 3-KINASES; ACTIN; CHEMOTAXIS; POLARITY; MOTILITY; CXCR4; RECEPTOR; RECRUITMENT	The intracellular signaling processes controlling malignant B cell migration and tissue localization remain largely undefined. Tandem PH domain-containing proteins TAPP1 and TAPP2 are adaptor proteins that specifically bind to phosphatidylinositol-3,4-bisphosphate, or PI(3,4) P2, a product of phosphoinositide 3-kinases (PI3K). While PI3K enzymes have a number of functions in cell biology, including cell migration, the functions of PI(3,4) P2 and its binding proteins are not well understood. Previously we found that TAPP2 is highly expressed in primary leukemic B cells that have strong migratory capacity. Here we find that SDF-1-dependent migration of human malignant B cells requires both PI3K signaling and TAPP2. Migration in a transwell assay is significantly impaired by pan-PI3K and isoform-selective PI3K inhibitors, or by TAPP2 shRNA knockdown (KD). Strikingly, TAPP2 KD in combination with PI3K inhibitor treatment nearly abolished the migration response, suggesting that TAPP2 may contribute some functions independent of the PI3K pathway. In microfluidic chamber cell tracking assays, TAPP2 KD cells show reduction in percentage of migrating cells, migration velocity and directionality. TAPP2 KD led to alterations in chemokine-induced rearrangement of the actin cytoskeleton and failure to form polarized morphology. TAPP2 co-localized with the stable F-actin-binding protein utrophin, with both molecules reciprocally localizing against F-actin accumulated at the leading edge upon SDF-1 stimulation. In TAPP2 KD cells, Rac was over-activated and localized to multiple membrane protrusions, suggesting that TAPP2 may act in concert with utrophin and stable F-actin to spatially restrict Rac activation and reduce formation of multiple membrane protrusions. TAPP2 function in cell migration is also apparent in the more complex context of B cell migration into stromal cell layers - a process that is only partially dependent on PI3K and SDF-1. In summary, this study identified TAPP2 as a novel regulator of malignant B cell migration and a potential therapeutic intervention target.	[Li, Hongzhao; Hou, Sen; Wu, Xun; Lin, Francis; Kung, Sam; Marshall, Aaron James] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Nandagopal, Saravanan; Lin, Francis] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada; [Marshall, Aaron James] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Marshall, AJ (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	marshall@ms.umanitoba.ca		Lin, Francis/0000-0003-1736-193X; Wu, Xun/0000-0001-7549-5464; Andalur Nandagopal, Saravanan/0000-0002-1787-3356; Marshall, Aaron/0000-0002-1175-5498; Pei, Zhen-Ming/0000-0003-1473-696X	Canadian Cancer Society [2011-700981]; Canadian Institutes of Health Research; Manitoba Health Research Council	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council	This research was funded by the Canadian Cancer Society (grant #2011-700981). HL was supported by studentship awards from the Canadian Institutes of Health Research and Manitoba Health Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002019; Allam A, 2004, J BIOL CHEM, V279, P39775, DOI 10.1074/jbc.M403367200; Allikian MJ, 2007, TRAFFIC, V8, P177, DOI 10.1111/j.1600-0854.2006.00519.x; Barber Mark A, 2006, Bull Cancer, V93, pE44; Bradstock KF, 2000, LEUKEMIA, V14, P882, DOI 10.1038/sj.leu.2401729; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Cheung SMS, 2007, CELL SIGNAL, V19, P902, DOI 10.1016/j.cellsig.2006.10.013; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; Costantini JL, 2009, BLOOD; Del Principe MI, 2006, BLOOD, V108, P853, DOI 10.1182/blood-2005-12-4986; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; HENDERSON AJ, 1990, J IMMUNOL, V145, P423; Hogan A, 2004, J BIOL CHEM, V279, P53717, DOI 10.1074/jbc.M410654200; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Landego I, 2012, EUR J IMMUNOL; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Marshall AJ, 2002, MOL CELL BIOL, V22, P5479, DOI 10.1128/MCB.22.15.5479-5491.2002; Mehes E, 2005, GLIA, V49, P492, DOI 10.1002/glia.20135; Narang A, 2006, J THEOR BIOL, V240, P538, DOI 10.1016/j.jtbi.2005.10.022; Niedermeier M, 2009, BLOOD, V113, P5549, DOI 10.1182/blood-2008-06-165068; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pauls SD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00224; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Ward SG, 2004, TRENDS IMMUNOL, V25, P67, DOI 10.1016/j.it.2003.12.003; Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Zhang TT, 2009, IMMUNOL REV, V232, P255, DOI 10.1111/j.1600-065X.2009.00838.x	43	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57809	10.1371/journal.pone.0057809	http://dx.doi.org/10.1371/journal.pone.0057809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460911	gold, Green Submitted, Green Published			2022-12-27	WOS:000315519000166
J	Li, XM; Yan, QY; Xie, SQ; Hu, W; Yu, YH; Hu, ZH				Li, Xuemei; Yan, Qingyun; Xie, Shouqi; Hu, Wei; Yu, Yuhe; Hu, Zihua			Gut Microbiota Contributes to the Growth of Fast-Growing Transgenic Common Carp (Cyprinus carpio L.)	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; DIET-INDUCED OBESITY; HOST METABOLISM; ENERGY; COMMUNITIES; ABSORPTION; ZEBRAFISH; DIVERSITY; SEQUENCES; ECOLOGY	Gut microbiota has shown tight and coordinated connection with various functions of its host such as metabolism, immunity, energy utilization, and health maintenance. To gain insight into whether gut microbes affect the metabolism of fish, we employed fast-growing transgenic common carp (Cyprinus carpio L.) to study the connections between its large body feature and gut microbes. Metagenome-based fingerprinting and high-throughput sequencing on bacterial 16S rRNA genes indicated that fish gut was dominated by Proteobacteria, Fusobacteria, Bacteroidetes and Firmicutes, which displayed significant differences between transgenic fish and wild-type controls. Analyses to study the association of gut microbes with the fish metabolism discovered three major phyla having significant relationships with the host metabolic factors. Biochemical and histological analyses indicated transgenic fish had increased carbohydrate but decreased lipid metabolisms. Additionally, transgenic fish has a significantly lower Bacteroidetes: Firmicutes ratio than that of wild-type controls, which is similar to mammals between obese and lean individuals. These findings suggest that gut microbiotas are associated with the growth of fast growing transgenic fish, and the relative abundance of Firmicutes over Bacteroidetes could be one of the factors contributing to its fast growth. Since the large body size of transgenic fish displays a proportional body growth, which is unlike obesity inhuman, the results together with the findings from others also suggest that the link between obesity and gut microbiota is likely more complex than a simple Bacteroidetes: Firmicutes ratio change.	[Li, Xuemei; Yan, Qingyun; Yu, Yuhe] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Yan, Qingyun; Xie, Shouqi; Hu, Wei] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Hu, Zihua] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Ctr Computat Res, Dept Ophthalmol,Dept Biostat,Dept Med, Buffalo, NY 14260 USA; [Li, Xuemei] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Minist Agr China, Key Lab Freshwater Biodivers Conservat, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Yu, YH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	yhyu@ihb.ac.cn; zihuahu@ccr.buffalo.edu		Ware, James/0000-0002-6110-5880; Cook, Stuart/0000-0001-6628-194X; Walsh, Roddy/0000-0001-5092-8825; Barton, Paul/0000-0002-1165-7767	Major State Basic Research Development Program of China [2009CB118705]; National Natural Science Foundation of China [31172084, 31071896]; State Key Laboratory of Freshwater Ecology and Biotechnology [2012FB03]; Knowledge Innovation Program of the Chinese Academy of Sciences [Y15E04]; Youth Innovation Promotion Association, CAS [Y22Z07]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Youth Innovation Promotion Association, CAS	This work was supported by the Major State Basic Research Development Program of China (2009CB118705), the National Natural Science Foundation of China (31172084, 31071896), the State Key Laboratory of Freshwater Ecology and Biotechnology (2012FB03), the Knowledge Innovation Program of the Chinese Academy of Sciences (Y15E04), and the Youth Innovation Promotion Association, CAS (Y22Z07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Berryman DE, 2010, J GERONTOL A-BIOL, V65, P31, DOI 10.1093/gerona/glp175; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Duan M, 2011, AQUACULTURE, V317, P175, DOI 10.1016/j.aquaculture.2011.04.013; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erman A, 2011, INT J OBESITY, V35, P1511, DOI 10.1038/ijo.2011.23; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Fu C, 2007, J FISH BIOL, V70, P347, DOI 10.1111/j.1095-8649.2007.01301.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guan B, 2008, AQUACULTURE, V284, P217, DOI 10.1016/j.aquaculture.2008.06.028; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li DL, 2007, CHINESE SCI BULL, V52, P1501, DOI 10.1007/s11434-007-0217-x; Li XM, 2012, J MICROBIOL, V50, P29, DOI 10.1007/s12275-012-1340-1; Li XM, 2011, J WORLD AQUACULT SOC, V42, P539, DOI 10.1111/j.1749-7345.2011.00496.x; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAUP DM, 1979, J PALEONTOL, V53, P1213; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rowan AK, 2003, FEMS MICROBIOL ECOL, V43, P195, DOI 10.1111/j.1574-6941.2003.tb01059.x; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wang YP, 2001, CHINESE SCI BULL, V46, P1174; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Yan QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030603; Yu YH, 2008, FEMS MICROBIOL ECOL, V63, P328, DOI 10.1111/j.1574-6941.2007.00430.x; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhu Z, 1992, TRANSGENIC FISH, P92, DOI [10.1142/9789814503600_0006, DOI 10.1142/9789814503600_0006]; Zhu Z, 1992, AGR BIOTECHNOLOGY, P106	52	89	97	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64577	10.1371/journal.pone.0064577	http://dx.doi.org/10.1371/journal.pone.0064577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23861798	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900057
J	Toh, HS; Cao, MJ; Daniels, E; Bateman, A				Toh, Huishi; Cao, Mingju; Daniels, Eugene; Bateman, Andrew			Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model	PLOS ONE			English	Article							GRANULIN-EPITHELIN PRECURSOR; PERLECAN PROTEIN CORE; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; TRANSGENIC MICE; BREAST-CANCER; HOST-DEFENSE; IN-VIVO; ANGIOGENESIS; VASCULOGENESIS	Progranulin is a secreted glycoprotein that regulates cell proliferation, migration and survival. It has roles in development, tumorigenesis, wound healing, neurodegeneration and inflammation. Endothelia in tumors, wounds and placenta express elevated levels of progranulin. In culture, progranulin activates endothelial proliferation and migration. This suggested that progranulin might regulate angiogenesis. It was, however, unclear how elevated endothelial progranulin levels influence vascular growth in vivo. To address this issue, we generated mice with progranulin expression targeted specifically to developing endothelial cells using a Tie2-promoter/enhancer construct. Three Tie2-Grn mouse lines were generated with varying Tie2-Grn copy number, and were called GrnLo, GrnMid, and GrnHi. All three lines showed increased mortality that correlates with Tie2-Grn copy number, with greatest mortality and lowest germline transmission in the GrnHi line. Death of the transgenic animals occurred around birth, and continued for three days after birth. Those that survived beyond day 3 survived into adulthood. Transgenic neonates that died showed vascular abnormalities of varying severity. Some exhibited bleeding into body cavities such as the pericardial space. Smaller localized hemorrhages were seen in many organs. Blood vessels were often dilated and thin-walled. To establish the development of these abnormalities, we examined mice at early (E10.5-14.5) and later (E15.5-17.5) developmental phases. Early events during vasculogenesis appear unaffected by Tie2-Grn as apparently normal primary vasculature had been established at E10.5. The earliest onset of vascular abnormality was at E15.5, with focal cerebral hemorrhage and enlarged vessels in various organs. Aberrant Tie2-Grn positive vessels showed thinning of the basement membrane and reduced investiture with mural cells. We conclude that progranulin promotes exaggerated vessel growth in vivo, with subsequent effects in the formation of the mural cell layer and weakening of vessel integrity. These results demonstrate that overexpression of progranulin in endothelial cells influences normal angiogenesis in vivo.	[Toh, Huishi; Cao, Mingju; Bateman, Andrew] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Med,Div Endocrinol & Metab, Montreal, PQ, Canada; [Daniels, Eugene] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University; Royal Victoria Hospital; McGill University	Bateman, A (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Med,Div Endocrinol & Metab, Montreal, PQ, Canada.	andrew.bateman@muhc.mcgill.ca		Bateman, Andrew/0000-0003-0597-769X; Toh, Huishi/0000-0002-8843-8263	Canadian Institute of Health Sciences (CIHR); Canadian Cancer Society Research Institute [CCSRI 700379]	Canadian Institute of Health Sciences (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This study was supported by grants from Canadian Institute of Health Sciences (CIHR) and Canadian Cancer Society Research Institute (CCSRI 700379.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2002, CIRCULATION, V105, P112, DOI 10.1161/hc0102.101437; Andres AC, 2010, J MAMMARY GLAND BIOL, V15, P319, DOI 10.1007/s10911-010-9186-9; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bishop A, 2008, J Wound Care, V17, P399; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen XY, 2008, CHINESE MED J-PEKING, V121, P881, DOI 10.1097/00029330-200805020-00004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Davidson B, 2004, CANCER-AM CANCER SOC, V100, P2139, DOI 10.1002/cncr.20219; Demir R, 2010, ACTA HISTOCHEM, V112, P203, DOI 10.1016/j.acthis.2009.04.004; Desmarais JA, 2008, REPRODUCTION, V136, P247, DOI 10.1530/REP-08-0044; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Evans V, 2000, PHYSIOL GENOMICS, V2, P67, DOI 10.1152/physiolgenomics.2000.2.2.67; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Khalid MEM, 1997, INT J GYNECOL OBSTET, V57, P259, DOI 10.1016/S0020-7292(97)00067-2; Li LQ, 2012, PATHOL RES PRACT, V208, P210, DOI 10.1016/j.prp.2012.02.001; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Miko I., 2008, NATURE ED, V1; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; PEREIRA R, 1994, J CLIN INVEST, V93, P1765, DOI 10.1172/JCI117161; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Ponce ML, 2001, ANGIOGENESIS PROTOCO; Praidou A, 2010, CURR DIABETES REV, V6, P304, DOI 10.2174/157339910793360815; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Segev A, 2004, CARDIOVASC RES, V63, P603, DOI 10.1016/j.cardiores.2004.03.028; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Silver L.M., 1995, MOUSE GENETICS CONCE; Sullivan DD, 2003, BRIT J CANCER, V89, P228, DOI 10.1038/sj.bjc.6601107; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Trampont P, 2004, HUM PATHOL, V35, P1353, DOI 10.1016/j.humpath.2004.07.003; Wang M, 2012, MED ONCOLOGY; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zeng X, 1998, DEV DYNAM, V211, P215, DOI 10.1002/(SICI)1097-0177(199803)211:3<215::AID-AJA3>3.0.CO;2-K; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	55	101	105	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64989	10.1371/journal.pone.0064989	http://dx.doi.org/10.1371/journal.pone.0064989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	24116025	Green Submitted, gold, Green Published			2022-12-27	WOS:000319799900154
J	Zhou, X; Mao, AQ; Wang, XB; Duan, XX; Yao, Y; Zhang, CX				Zhou, Xian; Mao, Anqiong; Wang, Xiaobin; Duan, Xiaoxia; Yao, Yi; Zhang, Chunxiang			Urine and Serum MicroRNA-1 as Novel Biomarkers for Myocardial Injury in Open-Heart Surgeries with Cardiopulmonary Bypass	PLOS ONE			English	Article							INFARCTION; TROPONIN; MARKER	MicroRNA-1 (miR-1) is a cardio-specific/enriched microRNA. Our recent studies have revealed that serum and urine miR-1 could be a novel sensitive biomarker for acute myocardial infarction. Open-heart surgeries with cardiopulmonary bypass (CPB) are often accompanied with surgery injury and CPB-associated injury on the hearts. However, the association of miR-1 and these intra-operative and post-operative cardiac injures is unknown. The objective of this study was to test the hypothesis that urine and serum miR-1 might be a novel biomarker for myocardial injuries in open-heart surgeries with CPB. Serum and urine miR-1 levels in 20 patients with elective mitral valve surgery were measured at pre-surgery, pre-CPB, 60 min post-CBP, and 24h post-CBP. Serum cardiac troponin-I (cTnI) was used as a positive control biomarker for cardiac injury. Compared with these in pre-operative and pre-CPB groups, the levels of miR-1 in serum and urine from patients after open-heart surgeries and CPB were significant increased at all observed time points. A similar pattern of serum cTnI levels and their strong positive correlation with miR-1 levels were identified in these patients. The results suggest that serum and urine miR-1 may be a novel sensitive biomarker for myocardial injury in open-heart surgeries with CPB.	[Zhou, Xian; Mao, Anqiong; Wang, Xiaobin; Duan, Xiaoxia; Yao, Yi] Luzhou Med Coll, Affiliated Hosp, Dept Internal Med & Anesthesiol & Crit Care Med, Luzhou, Sichuan Provinc, Peoples R China; [Zhang, Chunxiang] Rush Univ, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Dept Pharmacol, Chicago, IL 60612 USA	Southwest Medical University; Rush University; Rush University	Wang, XB (corresponding author), Luzhou Med Coll, Affiliated Hosp, Dept Internal Med & Anesthesiol & Crit Care Med, Luzhou, Sichuan Provinc, Peoples R China.	wangxiaobin67@yahoo.cn; chunxiang_zhang@rush.edu	zhang, xiang chun/HCH-7063-2022; Pan, Ting/AAX-1933-2021; Duan, xiaoxia/GMW-7041-2022	zhang, xiang chun/0000-0001-8303-6495; Duan, xiaoxia/0000-0002-6162-0428	NIH [HL080133, HL095707, HL109651]; American Heart Association [09GRNT2250567]; Projects of International Cooperation, Department of Science & Technology of Sichuan Province [2011HH0031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078812] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Projects of International Cooperation, Department of Science & Technology of Sichuan Province; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants HL080133, HL095707, HL109651 and a grant from the American Heart Association 09GRNT2250567 to C. Zhang. This project was also supported in part by the Projects of International Cooperation, Department of Science & Technology of Sichuan Province (2011HH0031) to X. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng YH, 2012, J MOL CELL CARDIOL, V53, P668, DOI 10.1016/j.yjmcc.2012.08.010; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Howie-Esquivel J, 2008, J CARDIOVASC NURS, V23, P124, DOI 10.1097/01.JCN.0000305072.49613.92; Knothe C, 1996, J CARDIOVASC SURG, V37, P367; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; MOAT NE, 1993, EUR J CARDIO-THORAC, V7, P563, DOI 10.1016/1010-7940(93)90241-3; Murphy GJ, 2004, J CARDIAC SURG, V19, P481, DOI 10.1111/j.0886-0440.2004.04101.x; Vermes E, 2000, ANN THORAC SURG, V70, P2087, DOI 10.1016/S0003-4975(00)02152-4; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641	12	66	71	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2013	8	4							e62245	10.1371/journal.pone.0062245	http://dx.doi.org/10.1371/journal.pone.0062245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130JR	23630629	Green Submitted, gold, Green Published			2022-12-27	WOS:000317911500086
J	Zhou, XX; Luo, J; Mills, L; Wu, SX; Pan, T; Geng, GN; Zhang, J; Luo, HH; Liu, C; Zhang, H				Zhou, Xiuxia; Luo, Juan; Mills, Lisa; Wu, Shuangxin; Pan, Ting; Geng, Guannan; Zhang, Jim; Luo, Haihua; Liu, Chao; Zhang, Hui			DDX5 Facilitates HIV-1 Replication as a Cellular Co-Factor of Rev	PLOS ONE			English	Article							BOX RNA HELICASE; IMMUNODEFICIENCY-VIRUS TYPE-1; CONSTITUTIVE TRANSPORT ELEMENT; TRANSCRIPTIONAL COACTIVATOR; MUTATIONAL ANALYSIS; TUMOR-SUPPRESSOR; D RETROVIRUS; PROTEIN P68; IDENTIFICATION; TRANSLATION	HIV-1 Rev plays an important role in the late phase of HIV-1 replication, which facilitates export of unspliced viral mRNAs from the nucleus to cytoplasm in infected cells. Recent studies have shown that DDX1 and DDX3 are co-factors of Rev for the export of HIV-1 transcripts. In this report, we have demonstrated that DDX5 (p68), which is a multifunctional DEAD-box RNA helicase, functions as a new cellular co-factor of HIV-1 Rev. We found that DDX5 affects Rev function through the Rev-RRE axis and subsequently enhances HIV-1 replication. Confocal microscopy and co-immunoprecipitation analysis indicated that DDX5 binds to Rev and this interaction is largely dependent on RNA. If the DEAD-box motif of DDX5 is mutated, DDX5 loses almost all of its ability to bind to Rev, indicating that the DEAD-box motif of DDX5 is required for the interaction between DDX5 and Rev. Our data indicate that interference of DDX5-Rev interaction could reduce HIV-1 replication and potentially provide a new molecular target for anti-HIV-1 therapeutics.	[Zhou, Xiuxia; Luo, Juan; Wu, Shuangxin; Pan, Ting; Geng, Guannan; Luo, Haihua; Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Xiuxia; Luo, Juan; Wu, Shuangxin; Pan, Ting; Geng, Guannan; Luo, Haihua; Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Xiuxia] Soochow Univ, Affiliated Hosp 1, Cyrus Tang Hematol Ctr, Jiangsu Inst Hematol, Suzhou, Peoples R China; [Mills, Lisa; Zhang, Jim; Zhang, Hui] Thomas Jefferson Univ, Ctr Human Virol, Dept Med, Div Infect Dis, Philadelphia, PA 19107 USA	Sun Yat Sen University; Sun Yat Sen University; Soochow University - China; Jefferson University	Liu, C (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China.	chaoliulc2013@126.com; hz08043@gmail.com	zhang, xiang chun/HCH-7063-2022; Pan, Ting/AAX-1933-2021; Duan, xiaoxia/GMW-7041-2022	zhang, xiang chun/0000-0001-8303-6495; Duan, xiaoxia/0000-0002-6162-0428	Guangdong Innovative Research Team Program [2009010058]; National Basic Research Program of China (973 Program) [2010CB912202]; National Natural Science Foundation of China [30972620, 81101255]; Natural Science Foundation of Guangdong [9251008901000022, 10451008901004204]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090171110083, 20100171120056]; US NIH [AI078812]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078812] Funding Source: NIH RePORTER	Guangdong Innovative Research Team Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Guangdong Innovative Research Team Program (NO. 2009010058), National Basic Research Program of China (973 Program) (No. 2010CB912202), National Natural Science Foundation of China (No.30972620, No.81101255), Natural Science Foundation of Guangdong (No.9251008901000022, No.10451008901004204), Specialized Research Fund for the Doctoral Program of Higher Education of China (No.20090171110083, No.20100171120056) and also funded by US NIH AI078812 (H.Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Bleoo S, 2001, MOL BIOL CELL, V12, P3046, DOI 10.1091/mbc.12.10.3046; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Daugherty MD, 2010, P NATL ACAD SCI USA, V107, P12481, DOI 10.1073/pnas.1007022107; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; FORD MJ, 1988, NATURE, V332, P736, DOI 10.1038/332736a0; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; HOPE T, 1995, CURR TOP MICROBIOL, V193, P91; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; Huang J., 2011, MOL CELL PROTEOMICS, V11; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Ishaq M, 2009, J CELL BIOCHEM, V106, P296, DOI 10.1002/jcb.22004; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jankowsky E, 2010, METHODS MOL BIOL, V587, P245, DOI 10.1007/978-1-60327-355-8_18; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Jost JP, 1999, NUCLEIC ACIDS RES, V27, P3245, DOI 10.1093/nar/27.16.3245; Kadare G, 1997, J VIROL, V71, P2583; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kjems J, 2000, Adv Pharmacol, V48, P251; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Liu C, 2012, J BIOL CHEM, V287, P29373, DOI 10.1074/jbc.M112.354001; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; Nicol S.M., 2012, ONCOGENE; Ogilvie VC, 2003, NUCLEIC ACIDS RES, V31, P1470, DOI 10.1093/nar/gkg236; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Tanaka K, 2009, ONCOGENE, V28, P2142, DOI 10.1038/onc.2009.89; Tang HL, 2000, J BIOL CHEM, V275, P32694, DOI 10.1074/jbc.M003933200; Tang HL, 1997, VIROLOGY, V228, P333, DOI 10.1006/viro.1996.8407; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Westberg C, 2000, J BIOL CHEM, V275, P21396, DOI 10.1074/jbc.M909887199; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	66	66	71	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e65040	10.1371/journal.pone.0065040	http://dx.doi.org/10.1371/journal.pone.0065040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23630629	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900162
J	Wang, W; Zhou, MW; Huang, WB; Zhang, XL				Wang, Wei; Zhou, Minwen; Huang, Wenbin; Zhang, Xiulan			Ex-PRESS Implantation Versus Trabeculectomy in Uncontrolled Glaucoma: A Meta-Analysis	PLOS ONE			English	Article							EX-PRESS(TM) MINI GLAUCOMA; FILTRATION DEVICE; SHUNT	Objective: To evaluate the efficacy and tolerability of Ex-PRESS implantation (Ex-Press) compared with trabeculectomy (Trab) in the treatment of patients with uncontrolled glaucoma. Methods: A comprehensive literature meta-analysis was performed according to the Cochrane Collaboration methodology to identify controlled clinical trials comparing Ex-Press with Trab. Efficacy estimates were measured by weight mean difference (WMD) for the percentage intraocular pressure (IOP) reduction from baseline to end-point, odds ratio (OR) for complete success, and qualified success rates. Tolerability estimates were measured by OR for adverse events. All outcomes were reported with a 95% confidence interval (CI). Data were synthesized by Stata 11.0 SE for Windows. Results: Eight controlled clinical trials meeting the predefined criteria were included in the meta-analysis. A total of 605 eyes from 559 patients with medically uncontrolled glaucoma were included. The weighted mean difference of the percentage IOP reduction from baseline was 2.33 (95% confidence interval: -22.59-7.24) when comparing Ex-Press with Trab. Ex-Press was associated with numerically greater, but nonsignificant, IOP lowering efficacy than Trab. The pooled odds ratio comparing Ex-Press with Trab were 0.93 (0.39, 2.23) for the complete success rate and 1.00 (0.39, 2.56) for the qualified success rate. Ex-Press was associated with a significantly lower frequency of hypotony and hyphema than Trab, with pooled ORs of 0.29 (0.13, 0.65) and 0.36 (0.13, 0.97), respectively. Conclusion: Ex-Press was associated with equivalent efficacy to Trab in lowering IOP. Comparable proportions of patients reached the IOP target with Ex-Press and Trab. Ex-Press was better tolerated than Trab.	[Wang, Wei; Zhou, Minwen; Huang, Wenbin; Zhang, Xiulan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn	Zhao, Zenghui/F-8061-2013	Zhao, Zenghui/0000-0002-6335-1655	National Natural Science Foundation of China [81170849]; Guangdong Provincial Natural Science Foundation [S2011020002401]; Fundamental Research Funds of State Key Laboratory of Ophthalmology [2011C02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds of State Key Laboratory of Ophthalmology	This work was supported in whole or in part by the National Natural Science Foundation of China (81170849), Guangdong Provincial Natural Science Foundation (S2011020002401), and the Fundamental Research Funds of State Key Laboratory of Ophthalmology (2011C02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz Hassan, 2011, Ophthalmic Surg Lasers Imaging, V42 Online, pe94, DOI 10.3928/15428877-20110922-01; Dahan E, 2005, J GLAUCOMA, V14, P98, DOI 10.1097/01.ijg.0000151688.34904.b7; Dahan E, 2012, EYE, V26, P703, DOI 10.1038/eye.2012.13; De Feo F, 2009, CAN J OPHTHALMOL, V44, P457, DOI 10.3129/i09-120; de Jong L, 2011, CLIN OPHTHALMOL, V5, P527, DOI 10.2147/OPTH.S18565; de Jong LAMS, 2009, ADV THER, V26, P336, DOI 10.1007/s12325-009-0017-6; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Francis BA, 2011, OPHTHALMOLOGY, V118, P1466, DOI 10.1016/j.ophtha.2011.03.028; Gallego-Pinazo R., 2009, Arch Soc Esp Oftalmol, V84, P293; Good TJ, 2011, AM J OPHTHALMOL, V151, P507, DOI 10.1016/j.ajo.2010.09.004; Hendrick AM, 2008, EXPERT REV MED DEVIC, V5, P673, DOI 10.1586/17434440.5.6.673; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Maris PJG, 2007, J GLAUCOMA, V16, P14, DOI 10.1097/01.ijg.0000243479.90403.cd; Marzette L, 2011, OPHTHAL SURG LAS IM, V42, P453, DOI 10.3928/15428877-20111017-03; Mosaed S, 2010, EXPERT REV MED DEVIC, V7, P661, DOI 10.1586/ERD.10.32; Nyska A, 2003, J GLAUCOMA, V12, P275, DOI 10.1097/00061198-200306000-00017; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rouse JM, 2012, DEV OPHTHALMOL, V50, P90, DOI 10.1159/000334780; Salim S, 2012, CURR OPIN OPHTHALMOL, V23, P89, DOI 10.1097/ICU.0b013e32834ff401; Seider MI, 2012, J GLAUCOMA, V21, P469, DOI 10.1097/IJG.0b013e3182182bfb; Sugiyama T, 2011, CLIN OPHTHALMOL, V5, P1063, DOI 10.2147/OPTH.S23129	21	93	100	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e63591	10.1371/journal.pone.0063591	http://dx.doi.org/10.1371/journal.pone.0063591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	24489511	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900008
J	Zhang, HD; Song, J; Ren, H; Xu, ZR; Wang, XN; Shan, LF; Fang, J				Zhang, Huidan; Song, Jin; Ren, Hui; Xu, Zhangrun; Wang, Xiaonan; Shan, Lianfeng; Fang, Jin			Detection of Low-Abundance KRAS Mutations in Colorectal Cancer Using Microfluidic Capillary Electrophoresis-Based Restriction Fragment Length Polymorphism Method with Optimized Assay Conditions	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; K-RAS MUTATIONS; CONTEMPORARY SAMPLE STACKING; REAL-TIME PCR; MICROCHIP ELECTROPHORESIS; FLUORESCENCE DETECTION; 1ST-LINE TREATMENT; ANTIBODY THERAPY; ENERGY-TRANSFER; DNA	Constitutively active KRAS mutations have been found to be involved in various processes of cancer development, and render tumor cells resistant to EGFR-targeted therapies. Mutation detection methods with higher sensitivity will increase the possibility of choosing the correct individual therapy. Here, we established a highly sensitive and efficient microfluidic capillary electrophoresis-based restriction fragment length polymorphism (mu CE-based RFLP) platform for low-abundance KRAS genotyping with the combination of mu CE and RFLP techniques. By using our self-built sensitive laser induced fluorescence (LIF) detector and a new DNA intercalating dye YOYO-1, the separation conditions of mu CE for Phi 174 HaeIII DNA marker were first optimized. Then, a Mav I digested 107-bp KRAS gene fragment was directly introduced into the microfluidic device and analyzed by mu CE, in which field amplified sample stacking (FASS) technique was employed to obtain the enrichment of the RFLP digestion products and extremely improved the sensitivity. The accurate analysis of KRAS statuses in HT29, LS174T, CCL187, SW480, Clone A, and CX-1 colorectal cancer (CRC) cell lines by mu CE-based RFLP were achieved in 5 min with picoliter-scale sample consumption, and as low as 0.01% of mutant KRAS could be identified from a large excess of wild-type genomic DNA (gDNA). In 98 paraffin-embedded CRC tissues, KRAS codon 12 mutations were discovered in 28 (28.6%), significantly higher than that obtained by direct sequencing (13, 13.3%). Clone sequencing confirmed these results and showed this system could detect at least 0.4% of the mutant KRAS in CRC tissue slides. Compared with direct sequencing, the new finding of the mu CE-based RFLP platform was that KRAS mutations in codon 12 were correlated with the patient's age. In conclusion, we established a sensitive, fast, and cost-effective screening method for KRAS mutations, and successfully detected low-abundance KRAS mutations in clinical samples, which will allow provision of more precise individualized cancer therapy.	[Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China; [Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Ren, Hui] Shenyang Anal Rectum Hosp, Dept Colon Surg, Shenyang, Peoples R China; [Xu, Zhangrun] Northeastern Univ, Res Ctr Analyt Sci, Shenyang, Peoples R China; [Shan, Lianfeng] China Med Univ, Coll Basic Med Sci, Dept Math, Shenyang, Peoples R China	China Medical University; China Medical University; Northeastern University - China; China Medical University	Fang, J (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China.	jfang61@gmail.com	Zhang, Huidan/K-8399-2015; Zhang, Hai-Lin/H-2715-2017	Chen, Guifen/0000-0002-5459-660X; Zhang, Hai-Lin/0000-0002-7426-2885	National Natural Science Foundation of China [30901727, 20975019, 20875103, 20375047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No. 30901727, 20975019, 20875103, 20375047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine R, 2009, J PHARMACEUT BIOMED, V50, P947, DOI 10.1016/j.jpba.2009.06.034; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Assenat E, 2011, ONCOLOGIST, V16, P1557, DOI 10.1634/theoncologist.2011-0141; Beard NR, 2003, ELECTROPHORESIS, V24, P732, DOI 10.1002/elps.200390088; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5720, DOI 10.1093/nar/21.24.5720; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5727, DOI 10.1093/nar/21.24.5727; Bornholdt J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-53; CAPELLA G, 1991, ENVIRON HEALTH PERSP, V93, P125, DOI 10.2307/3431180; Cavallini A, 2010, ANTICANCER RES, V30, P5251; Chowdhury J, 2007, J MOL DIAGN, V9, P521, DOI 10.2353/jmoldx.2007.070014; DELATTRE O, 1989, LANCET, V2, P353; Evenhuis CJ, 2009, ELECTROPHORESIS, V30, P897, DOI 10.1002/elps.200800643; Fang Q, 2002, ANAL CHEM, V74, P1223, DOI 10.1021/ac010925c; Gebauer P, 2009, ELECTROPHORESIS, V30, pS27, DOI 10.1002/elps.200900053; Gotz S, 2007, ANAL BIOANAL CHEM, V387, P183, DOI 10.1007/s00216-006-0820-8; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia ZJ, 2004, ANAL CHEM, V76, P5597, DOI 10.1021/ac0494477; Jiang GF, 2000, BIOSENS BIOELECTRON, V14, P861, DOI 10.1016/S0956-5663(99)00056-1; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kleparnik K, 2007, CHEM REV, V107, P5279, DOI 10.1021/cr0101860; Ko JMY, 1998, CANCER LETT, V134, P169, DOI 10.1016/S0304-3835(98)00257-2; Lanthaler AJ, 2011, DIAGN MOL PATHOL, V20, P90, DOI 10.1097/PDM.0b013e31820e5f9a; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; LODA M, 1994, HUM PATHOL, V25, P564, DOI 10.1016/0046-8177(94)90220-8; Loupakis F, 2012, CANCER-AM CANCER SOC, V118, P1523, DOI 10.1002/cncr.26460; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mala Z, 2009, J CHROMATOGR A, V1051, P147; Mala Z, 2007, ELECTROPHORESIS, V28, P243, DOI 10.1002/elps.200600397; Mala Z, 2009, ELECTROPHORESIS, V30, P215, DOI 10.1002/elps.200800433; Mao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036653; Marchetti A, 2009, NEW ENGL J MED, V360, P833, DOI 10.1056/NEJMc082346; Mayo Skye C, 2009, Expert Rev Gastroenterol Hepatol, V3, P131, DOI 10.1586/egh.09.8; Milano G, 2008, ANN ONCOL, V19, P2033, DOI 10.1093/annonc/mdn416; Minucci A, 2008, J SEP SCI, V31, P2694, DOI 10.1002/jssc.200800216; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Nachamkin I, 2001, J CLIN MICROBIOL, V39, P754, DOI 10.1128/JCM.39.2.754-757.2001; Nishikawa T, 2002, CLIN CHIM ACTA, V318, P107, DOI 10.1016/S0009-8981(01)00806-3; Ohno K, 2008, ELECTROPHORESIS, V29, P4443, DOI 10.1002/elps.200800121; OUDEJANS JJ, 1991, INT J CANCER, V49, P875, DOI 10.1002/ijc.2910490613; Petersen NJ, 2004, ELECTROPHORESIS, V25, P253, DOI 10.1002/elps.200305747; Qin JH, 2005, ELECTROPHORESIS, V26, P219, DOI 10.1002/elps.200406158; Sarasqueta AF, 2011, J MOL DIAGN, V13, P199, DOI 10.1016/j.jmoldx.2010.10.006; Schimanski CC, 2010, INT J COLORECTAL DIS, V25, P181, DOI 10.1007/s00384-009-0843-7; Schimanski CC, 1999, CANCER RES, V59, P5169; Scholtka B, 2009, CANCER EPIDEMIOL, V33, P123, DOI 10.1016/j.canep.2009.05.001; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sood A, 2012, CLIN COLORECTAL CANC, V11, P143, DOI 10.1016/j.clcc.2011.12.001; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; Weidlich S, 2011, BRIT J CANCER, V105, P246, DOI 10.1038/bjc.2011.197; Winder T, 2010, CANCER TREAT REV, V36, P550, DOI 10.1016/j.ctrv.2010.03.005; Wu CM, 2005, CANCER GENET CYTOGEN, V158, P55, DOI 10.1016/j.cancergencyto.2004.08.030; Xiao SX, 1997, PROG BIOCHEM BIOPHYS, V24, P375; Xu F, 2004, J CHROMATOGR A, V1051, P147, DOI 10.1016/j.chroma.2004.05.019; Yang YZ, 2006, ANAL CHEM, V78, P4752, DOI 10.1021/ac051735v; Zhang HD, 2011, LAB INVEST, V91, P788, DOI 10.1038/labinvest.2010.200; Zou HZ, 2009, GASTROENTEROLOGY, V136, P459, DOI 10.1053/j.gastro.2008.10.023	61	203	206	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54510	10.1371/journal.pone.0054510	http://dx.doi.org/10.1371/journal.pone.0054510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23750250	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500082
J	Zhang, GL; Huang, SQ; Duan, QH; Shu, W; Hou, YC; Zhu, SY; Miao, XP; Nie, SF; Wei, S; Guo, N; Shan, H; Xu, YH				Zhang, Guoliang; Huang, Shuqiong; Duan, Qionghong; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Guo, Nan; Shan, Hua; Xu, Yihua			Application of a Hybrid Model for Predicting the Incidence of Tuberculosis in Hubei, China	PLOS ONE			English	Article							TIME-SERIES; HEALTH SYSTEM; SEASONALITY; TRANSMISSION	Background: A prediction model for tuberculosis incidence is needed in China which may be used as a decision-supportive tool for planning health interventions and allocating health resources. Methods: The autoregressive integrated moving average (ARIMA) model was first constructed with the data of tuberculosis report rate in Hubei Province from Jan 2004 to Dec 2011. The data from Jan 2012 to Jun 2012 were used to validate the model. Then the generalized regression neural network (GRNN)-ARIMA combination model was established based on the constructed ARIMA model. Finally, the fitting and prediction accuracy of the two models was evaluated. Results: A total of 465,960 cases were reported between Jan 2004 and Dec 2011 in Hubei Province. The report rate of tuberculosis was highest in 2005 (119.932 per 100,000 population) and lowest in 2010 (84.724 per 100,000 population). The time series of tuberculosis report rate show a gradual secular decline and a striking seasonal variation. The ARIMA (2, 1, 0) x (0, 1, 1) 12 model was selected from several plausible ARIMA models. The residual mean square error of the GRNN-ARIMA model and ARIMA model were 0.4467 and 0.6521 in training part, and 0.0958 and 0.1133 in validation part, respectively. The mean absolute error and mean absolute percentage error of the hybrid model were also less than the ARIMA model. Discussion and Conclusions: The gradual decline in tuberculosis report rate may be attributed to the effect of intensive measures on tuberculosis. The striking seasonal variation may have resulted from several factors. We suppose that a delay in the surveillance system may also have contributed to the variation. According to the fitting and prediction accuracy, the hybrid model outperforms the traditional ARIMA model, which may facilitate the allocation of health resources in China.	[Zhang, Guoliang; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Xu, Yihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Huang, Shuqiong] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Duan, Qionghong] TB Inst TB Control & Prevent Wuhan City, Wuhan, Peoples R China; [Guo, Nan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shan, Hua] Johns Hopkins Med Inst, Dept Pathol, Div Blood Transfus, Baltimore, MD 21205 USA	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Xu, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	xuyihua_6@hotmail.com	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BuHamra S, 2003, APPL MATH MODEL, V27, P805, DOI 10.1016/S0307-904X(03)00079-9; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Chen XY, 2004, LANCET, V364, P417; Cheng G, 2005, T ROY SOC TROP MED H, V99, P355, DOI 10.1016/j.trstmh.2004.07.005; Debanne SM, 2000, EMERG INFECT DIS, V6, P148, DOI 10.3201/eid0602.000207; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hu WB, 2004, AM J TROP MED HYG, V71, P129, DOI 10.4269/ajtmh.2004.71.129; Jain A, 2007, APPL SOFT COMPUT, V7, P585, DOI 10.1016/j.asoc.2006.03.002; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Leung MT, 2000, COMPUT OPER RES, V27, P1093, DOI 10.1016/S0305-0548(99)00144-6; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li WM, 2008, NEURAL COMPUT APPL, V17, P441, DOI 10.1007/s00521-007-0131-9; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; Medeiros MC, 2000, IEEE T NEURAL NETWOR, V11, P1402, DOI 10.1109/72.883463; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076	31	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80969	10.1371/journal.pone.0080969	http://dx.doi.org/10.1371/journal.pone.0080969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223232	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200125
J	Zhang, A; Qi, QW; Jiang, LL; Zhou, F; Wang, JF				Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng			Population Exposure to PM2.5 in the Urban Area of Beijing	PLOS ONE			English	Article							COARSE PARTICLES; FINE PARTICLES; AIR-QUALITY	The air quality in Beijing, especially its PM2.5 level, has become of increasing public concern because of its importance and sensitivity related to health risks. A set of monitored PM2.5 data from 31 stations, released for the first time by the Beijing Environmental Protection Bureau, covering 37 days during autumn 2012, was processed using spatial interpolation and overlay analysis. Following analyses of these data, a distribution map of cumulative exceedance days of PM2.5 and a temporal variation map of PM2.5 for Beijing have been drawn. Computational and analytical results show periodic and directional trends of PM2.5 spreading and congregating in space, which reveals the regulation of PM2.5 overexposure on a discontinuous medium-term scale. With regard to the cumulative effect of PM2.5 on the human body, the harm from lower intensity overexposure in the medium term, and higher overexposure in the short term, are both obvious. Therefore, data of population distribution were integrated into the aforementioned PM2.5 spatial spectrum map. A spatial statistical analysis revealed the patterns of PM2.5 gross exposure and exposure probability of residents in the Beijing urban area. The methods and conclusions of this research reveal relationships between long-term overexposure to PM2.5 and people living in high-exposure areas of Beijing, during the autumn of 2012.	[Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Qi, QW (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	qiqw@igsnrr.ac.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	National Natural Science Foundation of China [41201412]; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Natural Science Foundation of China (41201412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar H, 2005, STOCH ENV RES RISK A, V19, P301, DOI 10.1007/s00477-005-0234-8; Bureau BCA Mapping BIoSa, 2005, BEIJ ADM DISTR ATL; Bureau BCA Mapping BIoSa, 2007, BEIJ ADM DISTR TUZH; China's Ministry of Environmental Protection, 2012, AMB AIR QUAL STAND; Du XA, 2010, J ENVIRON SCI-CHINA, V22, P1757, DOI 10.1016/S1001-0742(09)60316-8; Fann N, 2011, RISK ANAL, DOI DOI 10.1111/J.1539-6924.2011.01630.X; Gavett SH, 2001, INT ARCH ALLERGY IMM, V124, P109, DOI 10.1159/000053685; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Hao YP, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-3; Jorgensen NW, 2012, J AM COLL CARDIOL, V60; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kunii O, 2002, ARCH ENVIRON HEALTH, V57, P16, DOI 10.1080/00039890209602912; Li P, 2012, PLOS ONE; Lippmann M, 1998, ISSUES ENV SCI TECHN, V10, P75; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Municipality OftSPCoB Statistics BMBo Beijing SOotNBoSi, 2012, TAB 2010 POP CENS BE; Pang W, 2010, ENVIRONMETRICS, V21, P305, DOI 10.1002/env.1007; Qiu F, 2012, GISCI REMOTE SENS, V49, P644, DOI 10.2747/1548-1603.49.5.644; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Urbat M, 2004, ATMOS ENVIRON, V38, P3781, DOI 10.1016/j.atmosenv.2004.03.061; Vallejo M, 2006, J EXPO SCI ENV EPID, V16, P125, DOI 10.1038/sj.jea.7500447; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; [袁杨森 YUAN Yangsen], 2007, [生态环境, Ecology and Environment], V16, P18; Zhao W, 2012, GEOGRAPHICAL RES, V417-428	25	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63486	10.1371/journal.pone.0063486	http://dx.doi.org/10.1371/journal.pone.0063486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	24223232	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500073
J	Zhang, YB; Wei, C; Jiang, WD; Wang, L; Li, CR; Wang, YY; Dow, JM; Sun, WX				Zhang, Yuanbao; Wei, Chao; Jiang, Wendi; Wang, Lei; Li, Churui; Wang, Yunyue; Dow, John Maxwell; Sun, Wenxian			The HD-GYP Domain Protein RpfG of Xanthomonas oryzae pv. oryzicola Regulates Synthesis of Extracellular Polysaccharides that Contribute to Biofilm Formation and Virulence on Rice	PLOS ONE			English	Article							DIFFUSIBLE SIGNAL FACTOR; 2-COMPONENT SYSTEM; GENE-EXPRESSION; CAMPESTRIS; VESICATORIA; PHOSPHODIESTERASE; SEQUENCES; ACTIVATOR; BACTERIA; CLUSTER	Bacterial leaf streak caused by Xanthomonas oryzae pv. oryzicola (Xoc) is one of the most important diseases in rice. However, little is known about the pathogenicity mechanisms of Xoc. Here we have investigated the function of three HD-GYP domain regulatory proteins in biofilm formation, the synthesis of virulence factors and virulence of Xoc. Deletion of rpfG resulted in altered production of extracellular polysaccharides (EPS), abolished virulence on rice and enhanced biofilm formation, but had little effect on the secretion of proteases and motility. In contrast, mutational analysis showed that the other two HD-GYP domain proteins had no effect on virulence factor synthesis and tested phenotypes. Mutation of rpfG led to up-regulation of the type III secretion system and altered expression of three putative glycosyltransferase genes gumD, pgaC and xagB, which are part of operons directing the synthesis of different extracellular polysaccharides. The pgaABCD and xagABCD operons were greatly up-regulated in the Xoc Delta rpfG mutant, whereas the expression of the gum genes was unaltered or slightly enhanced. The elevated biofilm formation of the Xoc Delta rpfG mutant was dramatically reduced upon deletion of gumD, xagA and xagB, but not when pgaA and pgaC were deleted. Interestingly, only the Delta gumD mutant, among these single gene mutants, exhibits multiple phenotype alterations including reduced biofilm and EPS production and attenuated virulence on rice. These data indicate that RpfG is a global regulator that controls biofilm formation, EPS production and bacterial virulence in Xoc and that both gumD- and xagB-dependent EPS contribute to biofilm formation under different conditions.	[Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China; [Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Wei, Chao; Wang, Yunyue] Yunnan Agr Univ, Minist Educ, Key Lab Agr Biodivers & Plant Dis Management, Kunming, Peoples R China; [Dow, John Maxwell] Univ Coll Cork, Biosci Inst, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University; University College Cork	Zhang, YB (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	wxs@cau.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	973 program [2011CB100700]; National Natural Science Foundation of China (NSFC) [31272007]; PCSIRT Program [IRT1042, NCET-09-0736]; Ph.D. Programs Foundation of Ministry of Education of China; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	973 program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); PCSIRT Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the 973 program 2011CB100700, National Natural Science Foundation of China (NSFC) grant 31272007, PCSIRT Program IRT1042, NCET-09-0736 and Ph.D. Programs Foundation of Ministry of Education of China to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; AWODERU VA, 1991, TROP PEST MANAGE, V37, P356, DOI 10.1080/09670879109371614; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; BOYER MH, 1984, J BIOTECHNOL, V1, P241, DOI 10.1016/0168-1656(84)90009-9; CANNON FC, 1979, MOL GEN GENET, V174, P59, DOI 10.1007/BF00433306; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; Dow J M, 1994, Curr Top Microbiol Immunol, V192, P29; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe23; Feng JX, 2009, MICROBIOL-SGM, V155, P3033, DOI 10.1099/mic.0.028910-0; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Guo YP, 2012, MOL PLANT MICROBE IN, V25, P165, DOI 10.1094/MPMI-07-11-0184; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; HARDING NE, 1987, J BACTERIOL, V169, P2854, DOI 10.1128/jb.169.6.2854-2861.1987; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JIANG J, 2009, ACTA MICROBIOL SIN, V49, P1018; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Meng FH, 2011, J BACTERIOL, V193, P2477, DOI 10.1128/JB.01360-10; MOFFETT ML, 1983, PLANT BACTERIAL DIS, P393; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; OU SH, 1985, ROCE DIS; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Rai R, 2012, MOL PLANT MICROBE IN, V25, P789, DOI 10.1094/MPMI-11-11-0285-R; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Souza LCA, 2006, FEMS MICROBIOL LETT, V257, P236, DOI 10.1111/j.1574-6968.2006.00176.x; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x; Sun WX, 2011, MOL PLANT PATHOL, V12, P731, DOI [10.1111/j.1364-3703.2011.00707.x, 10.1111/J.1364-3703.2011.00707.X]; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Yang FH, 2012, MOL PLANT MICROBE IN, V25, P1361, DOI 10.1094/MPMI-01-12-0014-R; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1	73	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59428	10.1371/journal.pone.0059428	http://dx.doi.org/10.1371/journal.pone.0059428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	24223232	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700121
